Citrus Sinensis ID: 043932
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1017 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.954 | 0.961 | 0.445 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.950 | 0.943 | 0.465 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.941 | 0.929 | 0.432 | 0.0 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.868 | 0.901 | 0.356 | 1e-138 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.867 | 0.751 | 0.342 | 1e-136 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.939 | 0.867 | 0.321 | 1e-129 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.901 | 0.915 | 0.340 | 1e-129 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.872 | 0.789 | 0.323 | 1e-128 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.896 | 0.909 | 0.335 | 1e-126 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.919 | 0.848 | 0.312 | 1e-124 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 813 bits (2101), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/996 (44%), Positives = 639/996 (64%), Gaps = 25/996 (2%)
Query: 31 GQTNETDRLALLAIKSQL-HDTSGVTSSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRI 89
G T+ETDR ALL KSQ+ D V SSWN++ LC W GVTCG +++RVT L+L ++
Sbjct: 19 GFTDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQL 78
Query: 90 GGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCS 149
GG++SP +GNLSFL ++L +N F G IPQE+G L RLE L + N G IP L CS
Sbjct: 79 GGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCS 138
Query: 150 NLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSL 209
L+ LR+ +N+L G +P+E+GSL L L + N + G+LP +GNL+ LE +++ N+L
Sbjct: 139 RLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNL 198
Query: 210 GGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNL 269
G+IP+ + L + L + N FSG FP ++ N+SSL+ + + +N FSG L D+ + L
Sbjct: 199 EGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILL 258
Query: 270 PNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNN 329
PNL S +GGN F GSIP +LSN S +E L + N G + F ++ NL L L N+
Sbjct: 259 PNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNS 317
Query: 330 LGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGII 389
LG ++ DL+F+T LTNC+ L+ L + N+ G+LP SIANLS+ ++ +GG I G I
Sbjct: 318 LGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSI 377
Query: 390 PSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAK 449
P I NL+NL L + N L G +P +G+L NL+ L L+ N L G IP+ +GN+T L
Sbjct: 378 PYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLET 437
Query: 450 LVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGS 509
L +S N +G +P+SLGNC +L+ NKL G +P +++ I L + LD+S N+L GS
Sbjct: 438 LDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQL-LRLDMSGNSLIGS 496
Query: 510 LPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIK 569
LP IG L+NL L + N+ SG +P TL C+++E L + N F+G IP G L +K
Sbjct: 497 LPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVK 555
Query: 570 VLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGG 629
++ S+N+LSG IPE+ + S LE+LN S N+LEG+VP KG+F + T +S+ GN LCGG
Sbjct: 556 EVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGG 615
Query: 630 TDELHLPTCPSKGS---RKPKITLLKVLIPVAV----LCMVLSSCLTIVYARRRRSARKS 682
L C S+ +K L KV+I V+V L ++ + +T+++ R+R+ +++
Sbjct: 616 IMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKET 675
Query: 683 VDTSPR--EKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL 740
+ +P E +SY +L AT+ F+SSNM+G GSFG+VYK +L ++ +VAVKV+N+
Sbjct: 676 NNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNM 735
Query: 741 KQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQ 800
+++GA KSFMAEC++L++IRHRNL+K++T CSSID +G +F+AL++E M NGSL+ WLH
Sbjct: 736 QRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHP 795
Query: 801 SND---HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857
H LTL++R+NIAIDVAS ++YLH HC P+ H DLKPSNVLLD D+ +HV
Sbjct: 796 EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHV 855
Query: 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLEL 917
DFGLA+ L ++ SS+ G++GT+GY APEY +G + S+ GDVYSFGILLLE+
Sbjct: 856 SDFGLARLLLKFDEESFFNQLSSA-GVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEM 914
Query: 918 FTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECL 977
FTG+RPT+ F TL+ + K ALPE++++IVD +L I + ECL
Sbjct: 915 FTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESIL--------HIGLRVGFPVVECL 966
Query: 978 NAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013
+ +G+ C ESP R+ VV +L RE FF
Sbjct: 967 TMVFEVGLRCCEESPMNRLATSIVVKELISIRERFF 1002
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 777 bits (2007), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/999 (46%), Positives = 640/999 (64%), Gaps = 32/999 (3%)
Query: 33 TNETDRLALLAIKSQLHDTSGVT-SSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGG 91
T ETD+ ALL KSQ+ +TS V SWN+++ LC WTGV CG +H+RVT +DL ++ G
Sbjct: 36 TEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTG 95
Query: 92 ILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNL 151
++SP+VGNLSFLR +NL+DN FHG IP E+GNL RL+ L + NN F G IP LS CS+L
Sbjct: 96 VVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSL 155
Query: 152 IQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGG 211
L +S+N LE +P E GSL KL L++G+N LTG+ P +GNL++L++ N + G
Sbjct: 156 STLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEG 215
Query: 212 KIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPN 271
+IP + L+ ++ + N+F+G FP I N+SSL + + N FSGTL D LPN
Sbjct: 216 EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPN 275
Query: 272 LKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLG 331
L+ L +G N+F G+IP++LSN S++ LD+ N GK+ + F L+NL L L N+LG
Sbjct: 276 LQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLG 335
Query: 332 MGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPS 391
++ DLDF+ LTNCS L+ L++ N+ G+LP IANLS+ + E +GGN I G IP
Sbjct: 336 NYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPH 395
Query: 392 GIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLV 451
GI NLV+L L + N L G +P +GEL L+ + LY N L G IPS +GN++ L L
Sbjct: 396 GIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLY 455
Query: 452 MSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLP 511
+ NS +G+IPSSLG+C L+ N NKL G++P +L+ + +L V L++S N L G L
Sbjct: 456 LLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNVSFNLLVGPLR 514
Query: 512 LQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVL 571
IG LK L+ L +S N+ SG IP TL+ C+SLE+L + NSF G IP G L ++ L
Sbjct: 515 QDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFL 573
Query: 572 NFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTD 631
+ S NNLSG IPE++ N S L+ LN S N+ +G VPT+GVF + + +S+ GN+ LCGG
Sbjct: 574 DLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIP 633
Query: 632 ELHLPTC----PSKGSRKPK-ITLLKVLIPVAVLCMVLSSCLTIVYARRRRSARKSVDT- 685
L L C P + S K IT+ + A+L + L Y R +S R + +
Sbjct: 634 SLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEN 693
Query: 686 ----SPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK 741
SP + + +SY EL K T F+SSN+IG G+FG+V+KG LG VA+KV+NL
Sbjct: 694 DRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLC 753
Query: 742 QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS 801
++GA KSF+AEC+AL IRHRNL+K++TICSS D +G DF+ALV+E M NG+L+ WLH
Sbjct: 754 KRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP- 812
Query: 802 NDHLEVC-----KLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856
D +E L L R+NIAIDVASA+ YLH +C P+ H D+KPSN+LLD D+ +H
Sbjct: 813 -DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAH 871
Query: 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLE 916
V DFGLA+ L DT SS G++GT+GY APEY MG S+ GDVYSFGI+LLE
Sbjct: 872 VSDFGLAQLLLKFDRDTF-HIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLE 930
Query: 917 LFTGRRPTDAAFTEGLTLHEFAKIALPEK-VIEIVDPLLLIEVMANN-SMIQEDIRAKTQ 974
+FTG+RPT+ F +GLTLH F K AL ++ ++I D +L A + +M+
Sbjct: 931 IFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMV--------- 981
Query: 975 ECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013
ECL + R+GV CS ESP R+ M + ++KL RE+FF
Sbjct: 982 ECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFF 1020
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 770 bits (1987), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/1006 (43%), Positives = 619/1006 (61%), Gaps = 48/1006 (4%)
Query: 33 TNETDRLALLAIKSQLHDTSG--VTSSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIG 90
+NETD ALL KSQ+ + + V +SWN++ C W GVTCG R +RV L+L ++
Sbjct: 27 SNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLT 86
Query: 91 GILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSN 150
G++SP +GNLSFLR +NL+DNSF IPQ++G L RL+ L + N G IP++LS CS
Sbjct: 87 GVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSR 146
Query: 151 LIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLG 210
L + +S+N L +P+E+GSL KL L + KN LTG P +GNL++L+ N +
Sbjct: 147 LSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMR 206
Query: 211 GKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLP 270
G+IP + L +V + N FSG FP ++ NISSLE + L N FSG L D LP
Sbjct: 207 GEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLP 266
Query: 271 NLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330
NL+ L +G N F G+IP +L+N S++E D+ N G + + F L+NL WL + N+L
Sbjct: 267 NLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSL 326
Query: 331 GMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIP 390
G +++ L+F+ + NC+ L+ L + N+ GELP SIANLS+++ +G N I G IP
Sbjct: 327 GNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIP 386
Query: 391 SGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKL 450
I NLV+L L +++N L G +P G+L NLQ + LY N + G IPS GN+T+L KL
Sbjct: 387 HDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKL 446
Query: 451 VMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSL 510
++ NS G IP SLG C+ L+ N+L G +PQ++L I +L+ Y+DLSNN L G
Sbjct: 447 HLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHF 505
Query: 511 PLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKV 570
P ++G L+ LV L S N+ SG +P + C+S+E+L + NSF G IP + L S+K
Sbjct: 506 PEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKN 564
Query: 571 LNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGT 630
++FS+NNLSG+IP +L +L L LN S N EG VPT GVF + T +S+ GN +CGG
Sbjct: 565 VDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGV 624
Query: 631 DELHLPTCPSKGS---RKPKITLLKVLIPVAVLCMVLSSCLTIV------YARRRRSARK 681
E+ L C + S RKP KV V+ +C+ ++S L I+ + +R+
Sbjct: 625 REMQLKPCIVQASPRKRKPLSVRKKV---VSGICIGIASLLLIIIVASLCWFMKRKKKNN 681
Query: 682 SVDTSPREKQ-----FPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVK 736
+ D +P + VSY EL ATS F+S+N+IG G+FG+V+KG+LG + +VAVK
Sbjct: 682 ASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVK 741
Query: 737 VINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLED 796
V+NL + GA KSFMAEC+ + IRHRNL+K+IT+CSS+DS+G DF+ALV+E M GSL+
Sbjct: 742 VLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDM 801
Query: 797 WLH-----QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 851
WL + NDH LT +++NIAIDVASA+EYLH HC P+ H D+KPSN+LLD
Sbjct: 802 WLQLEDLERVNDHSR--SLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDD 859
Query: 852 DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFG 911
D+ +HV DFGLA+ L + ++ SS+ G++GT+GY APEY MG + S+ GDVYSFG
Sbjct: 860 DLTAHVSDFGLAQLLYKYDRESFLNQFSSA-GVRGTIGYAAPEYGMGGQPSIQGDVYSFG 918
Query: 912 ILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRA 971
ILLLE+F+G++PTD +F LH + K L ++ I E +R
Sbjct: 919 ILLLEMFSGKKPTDESFAGDYNLHSYTKSILSG-----------CTSSGGSNAIDEGLR- 966
Query: 972 KTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGRRA 1017
++++G+ CS E P +RM + V +L R FF +
Sbjct: 967 -------LVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSKT 1005
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1265), Expect = e-138, Method: Compositional matrix adjust.
Identities = 350/982 (35%), Positives = 515/982 (52%), Gaps = 99/982 (10%)
Query: 62 INLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI 121
+++C W+GV C +V LD+S + +GG +SP + NL+ L ++LS N F G+IP EI
Sbjct: 51 VDVCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEI 110
Query: 122 GNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVG 181
G+L L QL +S N L G IP E+G L +L L +G
Sbjct: 111 GSLHE-----------------------TLKQLSLSENLLHGNIPQELGLLNRLVYLDLG 147
Query: 182 KNYLTGRLPDFV---GNLSALEVFSITGNSLGGKIPTTLGL-LRNLVDLHVGGNQFSGTF 237
N L G +P + G+ S+L+ ++ NSL G+IP L+ L L + N+ +GT
Sbjct: 148 SNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTV 207
Query: 238 PQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPD--------S 289
P S+ N ++L+ + L N SG LP ++ +P L+ L + N+F + S
Sbjct: 208 PSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFAS 267
Query: 290 LSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSS 349
L+N+S+++ L+L N G+++ SS+++LS +NL Q
Sbjct: 268 LANSSDLQELELAGNSLGGEIT---SSVRHLS-VNLVQ---------------------- 301
Query: 350 LKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQL 409
+ L N+ G +P I+NL + + N + G IP + L L + + +N L
Sbjct: 302 ---IHLDQNRIHGSIPPEISNLLNLTLLNLS-SNLLSGPIPRELCKLSKLERVYLSNNHL 357
Query: 410 HGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQ 469
G IP +G++ L L + +N L GSIP GNL++L +L++ N L G +P SLG C
Sbjct: 358 TGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCI 417
Query: 470 NLIGFNASHNKLTGALPQQLLS-ITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSN 528
NL + SHN LTG +P +++S + L +YL+LS+N+L+G +PL++ + ++ + +SSN
Sbjct: 418 NLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSN 477
Query: 529 QFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLEN 588
+ SG IP L +C++LE+L++S N F +P SLG L +K L+ S N L+G IP +
Sbjct: 478 ELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQ 537
Query: 589 LSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTCPSKGS-RKPK 647
S L+ LNFS N L G V KG FS T S G+ LCG + C K
Sbjct: 538 SSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVL 595
Query: 648 ITLLKVLIPVAVLCMV---------LSSCLTIVYARRRRSARKSVDTSPREKQFPTVSYA 698
+ +L LI VLC+ LT+ K P+ +P +SY
Sbjct: 596 LPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPK---YPRISYQ 652
Query: 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK-SFMAECKALR 757
+L AT F +S++IG G FG VYKG+L + VAVKV++ K F SF EC+ L+
Sbjct: 653 QLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILK 711
Query: 758 NIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVN 817
RHRNLI+IIT CS F ALV M NGSLE L+ L LIQ VN
Sbjct: 712 RTRHRNLIRIITTCSK-----PGFNALVLPLMPNGSLERHLYPG--EYSSKNLDLIQLVN 764
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
I DVA I YLHH+ +VH DLKPSN+LLD +M + V DFG+++ + + +T S
Sbjct: 765 ICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVE-ETVSTD 823
Query: 878 SSSSIG-----IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932
S S G + G+VGY+APEY MG AS GDVYSFG+LLLE+ +GRRPTD EG
Sbjct: 824 DSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGS 883
Query: 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESP 992
+LHEF K P+ + I++ L E +E + +I +G++C+ +P
Sbjct: 884 SLHEFMKSHYPDSLEGIIEQAL---SRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNP 940
Query: 993 FERMEMRDVVAKLCHTRETFFG 1014
R +M DV ++ +E F
Sbjct: 941 STRPDMLDVAHEMGRLKEYLFA 962
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1253), Expect = e-136, Method: Compositional matrix adjust.
Identities = 335/977 (34%), Positives = 530/977 (54%), Gaps = 95/977 (9%)
Query: 97 VGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRV 156
+G L+ L ++LS N G+IP++ GNLL L+ L L N G IP + CS+L+QL +
Sbjct: 212 IGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLEL 271
Query: 157 SNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTT 216
+N+L G+IPAE+G+L++LQ L + KN LT +P + L+ L ++ N L G I
Sbjct: 272 YDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEE 331
Query: 217 LGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLA 276
+G L +L L + N F+G FPQSI N+ +L + + FN SG LP D+ + L NL++L+
Sbjct: 332 IGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL-LTNLRNLS 390
Query: 277 IGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTAN 336
N G IP S+SN + +++LDL NQ G++ F + NL+++++ +N+ +
Sbjct: 391 AHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHFTGEIPD 449
Query: 337 DLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNL 396
D+ NCS+L+ LS+A N G L I L I ++ N + G IP I NL
Sbjct: 450 DI------FNCSNLETLSVADNNLTGTLKPLIGKLQKLRI-LQVSYNSLTGPIPREIGNL 502
Query: 397 VNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMS--- 453
+L L + SN G IP + L LQGL +Y N L+G IP + ++ L+ L +S
Sbjct: 503 KDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNK 562
Query: 454 ----------------YNSLQGN-----IPSSLGNCQNLIGFNASHNKLTGALPQQLL-S 491
Y SLQGN IP+SL + L F+ S N LTG +P +LL S
Sbjct: 563 FSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLAS 622
Query: 492 ITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLD--- 548
+ + +YL+ SNN L G++P ++G L+ + ++ +S+N FSG IP +L C ++ LD
Sbjct: 623 LKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQ 682
Query: 549 ----------------------ISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFL 586
+S NSF G IP S G + + L+ SSNNL+G+IPE L
Sbjct: 683 NNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESL 742
Query: 587 ENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTCPSKGSRKP 646
NLS L+ L + N+L+G VP GVF + L GN LCG L T K S
Sbjct: 743 ANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFS 802
Query: 647 KITLLKVLI-------PVAVLCMVLSSCLTIVYARRRRSARKS---VDTSPREKQFPTVS 696
K T + ++I + +L +++ +C + S+ S +D++ + K+F
Sbjct: 803 KRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEP-- 860
Query: 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECK 754
EL +AT F S+N+IG S +VYKG L ED ++AVKV+NLK+ A K F E K
Sbjct: 861 -KELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWFYTEAK 918
Query: 755 ALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQ 814
L ++HRNL+KI+ + KALV M+NG+LED +H S + +L++
Sbjct: 919 TLSQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAPIG----SLLE 970
Query: 815 RVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTA 874
++++ + +AS I+YLH P+VH DLKP+N+LLD D V+HV DFG A+ L +
Sbjct: 971 KIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFRE---D 1027
Query: 875 SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPT--DAAFTEGL 932
T++S+ +GT+GY+APE+ + + DV+SFGI+++EL T +RPT + ++ +
Sbjct: 1028 GSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDM 1087
Query: 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESP 992
TL + + ++ +V ++++ +S++ K +E + +++ + C+ P
Sbjct: 1088 TLRQLVEKSIGNGRKGMVR---VLDMELGDSIVS----LKQEEAIEDFLKLCLFCTSSRP 1140
Query: 993 FERMEMRDVVAKLCHTR 1009
+R +M +++ L R
Sbjct: 1141 EDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 464 bits (1193), Expect = e-129, Method: Compositional matrix adjust.
Identities = 358/1113 (32%), Positives = 528/1113 (47%), Gaps = 158/1113 (14%)
Query: 11 LAILIWC-FSLLLINSPSFSAGQTNETDRLALLAIKSQLHDTSGVTSSWNN-TINLCQWT 68
LAI+I C FS +L+ S NE R+ LL K+ L+D++G +SWN N C WT
Sbjct: 8 LAIVILCSFSFILVRS-------LNEEGRV-LLEFKAFLNDSNGYLASWNQLDSNPCNWT 59
Query: 69 GVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLE 128
G+ C H + VT +DL+ + G LSP + L LR +N+S N G IPQ++ LE
Sbjct: 60 GIACTHL-RTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLE 118
Query: 129 KLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGR 188
L L N F G IP L+ L +L + N L G IP +IG+L LQ L + N LTG
Sbjct: 119 VLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGV 178
Query: 189 LPDFVGNL------------------------SALEVFSITGNSLGGKIPTTLGLLRNLV 224
+P + L +L+V + N L G +P L L+NL
Sbjct: 179 IPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLT 238
Query: 225 DLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFG 284
DL + N+ SG P S+ NIS LE + L N F+G++P +I L +K L + N G
Sbjct: 239 DLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIG-KLTKMKRLYLYTNQLTG 297
Query: 285 SIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSW---------------------- 322
IP + N + +D NQ G + +F + NL
Sbjct: 298 EIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLL 357
Query: 323 --LNLEQNNLGMGTANDLDFVTFLTNCS-------------------------------- 348
L+L N L +L F+ +L +
Sbjct: 358 EKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSG 417
Query: 349 ----------SLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVN 398
+L +LSL +N+ G +P + S+ + +G NQ+ G +P + NL N
Sbjct: 418 PIPAHFCRFQTLILLSLGSNKLSGNIPRDLKT-CKSLTKLMLGDNQLTGSLPIELFNLQN 476
Query: 399 LIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQ 458
L AL + N L G I +G+LKNL+ L L N G IP +GNLTK+ +S N L
Sbjct: 477 LTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLT 536
Query: 459 GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLK 518
G+IP LG+C + + S NK +G + Q+L + L + L LS+N L G +P G+L
Sbjct: 537 GHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEI-LRLSDNRLTGEIPHSFGDLT 595
Query: 519 NLVKLIISSNQFSGVIPVTLSTCVSLEY-LDISSNSFHGVIPHSLGFLKSIKVLNFSSNN 577
L++L + N S IPV L SL+ L+IS N+ G IP SLG L+ +++L + N
Sbjct: 596 RLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNK 655
Query: 578 LSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPT 637
LSG+IP + NL L N S+N+L G VP VF + GN LC P
Sbjct: 656 LSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPL 715
Query: 638 CPSK---------GSRKPKI-TLLKVLIPVAVLCMVLSSCLTIVYARRRRSARKSVDTSP 687
P GS++ KI T+ ++I L L C TI +RR A +++
Sbjct: 716 VPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTI---KRREPAFVALEDQT 772
Query: 688 REK-----QFPT--VSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL 740
+ FP +Y L AT F+ ++G+G+ G+VYK + E ++AVK +N
Sbjct: 773 KPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGE-VIAVKKLNS 831
Query: 741 KQKGAFK--SFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL 798
+ +GA SF AE L IRHRN++K+ C +S L++E M GSL + L
Sbjct: 832 RGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNS-----NLLLYEYMSKGSLGEQL 886
Query: 799 HQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858
+ + C L R IA+ A + YLHH C+P +VH D+K +N+LLD +HVG
Sbjct: 887 QRGEKN---CLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVG 943
Query: 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELF 918
DFGLAK +D + S S++ G+ GY+APEY + + D+YSFG++LLEL
Sbjct: 944 DFGLAKL-----IDLSYSKSMSAVA--GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELI 996
Query: 919 TGRRPTDAAFTEGLTLHEFAKIALPEKV--IEIVDPLLLIEVMANNSMIQEDIRAKTQEC 976
TG+ P +G L + + ++ + IE+ D L + +T
Sbjct: 997 TGKPPVQ-PLEQGGDLVNWVRRSIRNMIPTIEMFDARL------------DTNDKRTVHE 1043
Query: 977 LNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009
++ +++I + C+ SP R MR+VVA + R
Sbjct: 1044 MSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 462 bits (1189), Expect = e-129, Method: Compositional matrix adjust.
Identities = 337/989 (34%), Positives = 520/989 (52%), Gaps = 72/989 (7%)
Query: 36 TDRLALLAIKSQ--LHDTSGVTSSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGIL 93
T+ ALL++KS + + S + +SWN + C WTGVTC + VT LDLS + G L
Sbjct: 26 TELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTL 85
Query: 94 SPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQ 153
S V +L L+ ++L+ N G IP +I NL L L L NN F+G+ P LS S L+
Sbjct: 86 SSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELS--SGLVN 143
Query: 154 LRV---SNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLG 210
LRV NN L G +P + +L +L+ L +G NY +G++P G LE +++GN L
Sbjct: 144 LRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELT 203
Query: 211 GKIPTTLGLLRNLVDLHVG-GNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNL 269
GKIP +G L L +L++G N F P I N+S L R +G +P +I L
Sbjct: 204 GKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEI-GKL 262
Query: 270 PNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNN 329
L +L + N F G+I L S+++ +DL N F G++ FS LKNL+ LNL +N
Sbjct: 263 QKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNK 322
Query: 330 LGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGII 389
L G + F+ L++L L N F G +P + + ++ + N++ G +
Sbjct: 323 L-YGAIPE-----FIGEMPELEVLQLWENNFTGSIPQKLGE-NGRLVILDLSSNKLTGTL 375
Query: 390 P----SGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLT 445
P SG R L+ LI LG N L G+IPD +G+ ++L + + +N L GSIP + L
Sbjct: 376 PPNMCSGNR-LMTLITLG---NFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLP 431
Query: 446 KLAKLVMSYNSLQGNIPSSLGNCQNLIG-FNASHNKLTGALPQQLLSITTLSVYLDLSNN 504
KL+++ + N L G +P S G +G + S+N+L+G+LP + +++ + L L N
Sbjct: 432 KLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLL-LDGN 490
Query: 505 NLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGF 564
+GS+P +IG L+ L KL S N FSG I +S C L ++D+S N G IP+ L
Sbjct: 491 KFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTG 550
Query: 565 LKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNV 624
+K + LN S N+L G IP + ++ L ++FS+N+L G VP+ G FS S GN
Sbjct: 551 MKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNS 610
Query: 625 KLCGGTDELHLPTCPSKGSRKPKITLLKVLIP-----VAVLCMVLSSCLTIVYARRRRSA 679
LCG +L C KG+ + + L + C ++ + + I+ AR R+A
Sbjct: 611 HLCGP----YLGPC-GKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNA 665
Query: 680 RKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN 739
++ + R F + + N+IG+G G VYKG + + ++ VAVK +
Sbjct: 666 SEA--KAWRLTAFQRLDFT-CDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDL-VAVKRLA 721
Query: 740 LKQKGAFKS--FMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDW 797
G+ F AE + L IRHR++++++ CS+ ++ LV+E M NGSL +
Sbjct: 722 TMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET-----NLLVYEYMPNGSLGEV 776
Query: 798 LH-QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856
LH + HL R IA++ A + YLHH C P +VH D+K +N+LLD + +H
Sbjct: 777 LHGKKGGHLHWNT-----RYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAH 831
Query: 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLE 916
V DFGLAKFL S TS I G+ GY+APEY + DVYSFG++LLE
Sbjct: 832 VADFGLAKFLQD------SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 885
Query: 917 LFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQEC 976
L TG++P F +G+ + ++ + ++ + + V L +I++ ++ + E
Sbjct: 886 LITGKKPV-GEFGDGVDIVQWVR-SMTDSNKDCV--LKVIDLRLSSVPVHE--------- 932
Query: 977 LNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+ + + +LC E ER MR+VV L
Sbjct: 933 VTHVFYVALLCVEEQAVERPTMREVVQIL 961
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-128, Method: Compositional matrix adjust.
Identities = 325/1005 (32%), Positives = 512/1005 (50%), Gaps = 118/1005 (11%)
Query: 84 LSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLA---------LP- 133
L+N + GG + + LS LR N+ +N G +P+EIG+L LE+L LP
Sbjct: 140 LNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPR 199
Query: 134 --------------NNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLA 179
N FSG IPT + +C NL L ++ N + G++P EIG L+KLQ +
Sbjct: 200 SLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVI 259
Query: 180 VGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQ 239
+ +N +G +P +GNL++LE ++ GNSL G IP+ +G +++L L++ NQ +GT P+
Sbjct: 260 LWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPK 319
Query: 240 SICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEIL 299
+ +S + I N SG +P ++ + L+ L + N G IP+ LS N+ L
Sbjct: 320 ELGKLSKVMEIDFSENLLSGEIPVELS-KISELRLLYLFQNKLTGIIPNELSKLRNLAKL 378
Query: 300 DLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL------GMGTANDLDFVTFLTN------- 346
DL N G + F +L ++ L L N+L G+G + L V F N
Sbjct: 379 DLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIP 438
Query: 347 ---C--SSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIA 401
C S+L +L+L +N+ G +P + S+++ R+ GN++ G P+ + LVNL A
Sbjct: 439 PFICQQSNLILLNLGSNRIFGNIPPGVLR-CKSLLQLRVVGNRLTGQFPTELCKLVNLSA 497
Query: 402 LGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNI 461
+ + N+ G +P IG + LQ L L N ++P+ + L+ L +S NSL G I
Sbjct: 498 IELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPI 557
Query: 462 PSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLV 521
PS + NC+ L + S N G+LP +L S+ L + L LS N +G++P IGNL +L
Sbjct: 558 PSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEI-LRLSENRFSGNIPFTIGNLTHLT 616
Query: 522 KLIISSNQFSGVIPVTLSTCVSLEY-LDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSG 580
+L + N FSG IP L SL+ +++S N F G IP +G L + L+ ++N+LSG
Sbjct: 617 ELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSG 676
Query: 581 QIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTCPS 640
+IP ENLS L NFS+N+L G++P +F + T S GN LCGG HL +C
Sbjct: 677 EIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG----HLRSCDP 732
Query: 641 KGSRKPKITLLKV--------------------LIPVAVLCMVLSSCL--TIVYARRRRS 678
S P I+ LK L+ +A++ L + + T Y +
Sbjct: 733 SHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEP 792
Query: 679 ARKSVDTS--PREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVK 736
+ D P+E+ + ++ +AT F S ++G+G+ G+VYK ++ + I K
Sbjct: 793 FFQESDIYFVPKER----FTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKK 848
Query: 737 V------INLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMK 790
+ N SF AE L IRHRN++++ + C +G++ L++E M
Sbjct: 849 LESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCY---HQGSNSNLLLYEYMS 905
Query: 791 NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850
GSL + LH H + R IA+ A + YLHH C+P ++H D+K +N+L+D
Sbjct: 906 RGSLGELLHGGKSH----SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILID 961
Query: 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSF 910
+ +HVGDFGLAK + S S + G+ GY+APEY + + D+YSF
Sbjct: 962 ENFEAHVGDFGLAKVID-------MPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSF 1014
Query: 911 GILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVI--EIVDPLLLIEVMANNSMIQED 968
G++LLEL TG+ P +G L + + + + + EI+DP L + +++D
Sbjct: 1015 GVVLLELLTGKAPVQ-PLEQGGDLATWTRNHIRDHSLTSEILDPYL--------TKVEDD 1065
Query: 969 IRAKTQECLNAII---RIGVLCSMESPFERMEMRDVVAKLCHTRE 1010
+ LN +I +I VLC+ SP +R MR+VV L + E
Sbjct: 1066 V------ILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIESGE 1104
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-126, Method: Compositional matrix adjust.
Identities = 333/992 (33%), Positives = 512/992 (51%), Gaps = 80/992 (8%)
Query: 40 ALLAIKSQL----HDTSGVTSSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSP 95
ALL++K+ L D + SSW + + C W GVTC + VT LDLS + G LSP
Sbjct: 28 ALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSP 87
Query: 96 YVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLR 155
V +L L+ ++L++N G IP EI +L L L L NN F+G+ P +S S L+ LR
Sbjct: 88 DVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEIS--SGLVNLR 145
Query: 156 V---SNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGK 212
V NN L G +P + +L +L+ L +G NY G++P G+ +E +++GN L GK
Sbjct: 146 VLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGK 205
Query: 213 IPTTLGLLRNLVDLHVGG-NQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPN 271
IP +G L L +L++G N F P I N+S L R +G +P +I L
Sbjct: 206 IPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIG-KLQK 264
Query: 272 LKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLG 331
L +L + N F G + L S+++ +DL N F G++ F+ LKNL+ LNL +N L
Sbjct: 265 LDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKL- 323
Query: 332 MGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPS 391
+ F+ + L++L L N F G +P + + + + N++ G +P
Sbjct: 324 -----HGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGE-NGKLNLVDLSSNKLTGTLPP 377
Query: 392 GI---RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLA 448
+ L LI LG N L G+IPD +G+ ++L + + +N L GSIP G+ L KL
Sbjct: 378 NMCSGNKLETLITLG---NFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLT 434
Query: 449 KLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNG 508
++ + N L G +P + G NL + S+N+L+G LP + + T + L L N G
Sbjct: 435 QVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLL-LDGNKFQG 493
Query: 509 SLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSI 568
+P ++G L+ L K+ S N FSG I +S C L ++D+S N G IP+ + +K +
Sbjct: 494 PIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKIL 553
Query: 569 KVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCG 628
LN S N+L G IP + ++ L L+FS+N+L G VP G FS S GN LCG
Sbjct: 554 NYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCG 613
Query: 629 GTDELHLPTCP---SKG-----SRKPKITLLK-VLIPVAVLCMVLSSCLTIVYARRRRSA 679
+L C +KG S+ P +K +L+ ++C + + + I+ AR + A
Sbjct: 614 P----YLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKA 669
Query: 680 RKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN 739
+S + R F + + N+IG+G G VYKG++ ++ VAVK +
Sbjct: 670 SES--RAWRLTAFQRLDFT-CDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDL-VAVKRLA 725
Query: 740 LKQKGAFKS--FMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDW 797
+G+ F AE + L IRHR++++++ CS+ ++ LV+E M NGSL +
Sbjct: 726 AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET-----NLLVYEYMPNGSLGEV 780
Query: 798 LH-QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856
LH + HL R IA++ A + YLHH C P +VH D+K +N+LLD + +H
Sbjct: 781 LHGKKGGHLH-----WDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAH 835
Query: 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLE 916
V DFGLAKFL S TS I G+ GY+APEY + DVYSFG++LLE
Sbjct: 836 VADFGLAKFLQD------SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 889
Query: 917 LFTGRRPTDAAFTEGLTLHEFAKIAL---PEKVIEIVDPLLLIEVMANNSMIQEDIRAKT 973
L TGR+P F +G+ + ++ + + V++++DP L ++ I E
Sbjct: 890 LVTGRKPV-GEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRL------SSIPIHE------ 936
Query: 974 QECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+ + + +LC E ER MR+VV L
Sbjct: 937 ---VTHVFYVAMLCVEEQAVERPTMREVVQIL 965
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 340/1087 (31%), Positives = 513/1087 (47%), Gaps = 152/1087 (13%)
Query: 41 LLAIKSQLHDTSGVTSSWNNTINL-CQWTGVTCGHRHQ--RVTRLDLSNQRIGGILSPYV 97
LL IKS+ D +WN+ ++ C WTGV C + V L+LS+ + G LSP +
Sbjct: 34 LLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPSI 93
Query: 98 GNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVS 157
G L L+ ++LS N G+IP+EIGN LE L L NN F G IP + + +L L +
Sbjct: 94 GGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIY 153
Query: 158 NNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTL 217
NN++ G +P EIG+LL L L N ++G+LP +GNL L F N + G +P+ +
Sbjct: 154 NNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEI 213
Query: 218 GLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAI 277
G +LV L + NQ SG P+ I + L ++ L N FSG +P + + N +L++LA+
Sbjct: 214 GGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPRE-ISNCTSLETLAL 272
Query: 278 GGNNFFGSIPDSLS---------------------------------------------- 291
N G IP L
Sbjct: 273 YKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLE 332
Query: 292 --NASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL------GMGTANDLDFVTF 343
N +E+L L NQ G + ++ S+LKNLS L+L N L G L +
Sbjct: 333 LGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQL 392
Query: 344 LTNC------------SSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPS 391
N S L +L ++ N G +P + L S+MI +G N + G IP+
Sbjct: 393 FQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLC-LHSNMIILNLGTNNLSGNIPT 451
Query: 392 GIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLV 451
GI L+ L + N L G P + + N+ + L +N +GSIP VGN + L +L
Sbjct: 452 GITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQ 511
Query: 452 MSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLP 511
++ N G +P +G L N S NKLTG +P ++ + L LD+ NN +G+LP
Sbjct: 512 LADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQ-RLDMCCNNFSGTLP 570
Query: 512 LQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKV- 570
++G+L L L +S+N SG IPV L L L + N F+G IP LG L +++
Sbjct: 571 SEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIA 630
Query: 571 LNFSSNNLSGQIPEFLENLSFLEF------------------------LNFSHNDLEGEV 606
LN S N L+G+IP L NL LEF NFS+N L G +
Sbjct: 631 LNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPI 690
Query: 607 PTKGVFSSKTKLSLQGNVKLCGGTDELHL---PTCPSKGSRKP------KITLLKVLIPV 657
P + + + S GN LCG + P PS+ + KP KI + +
Sbjct: 691 P---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIG 747
Query: 658 AVLCMVLSSCLTIVYARRRRSARKSVDTSPREKQ----FPT---VSYAELSKATSEFASS 710
V M+++ + ++ R A + D P E FP ++ +L AT F S
Sbjct: 748 GVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDES 807
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG----AFKSFMAECKALRNIRHRNLIK 766
++G+G+ G+VYK +L + K+ + + G SF AE L NIRHRN++K
Sbjct: 808 FVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVK 867
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ C + +G++ L++E M GSL + LH + C L +R IA+ A +
Sbjct: 868 LHGFC---NHQGSNL--LLYEYMPKGSLGEILHDPS-----CNLDWSKRFKIALGAAQGL 917
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YLHH C+P + H D+K +N+LLD +HVGDFGLAK +D S S+I G
Sbjct: 918 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV-----IDMPHSKSMSAIA--G 970
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946
+ GY+APEY + + D+YS+G++LLEL TG+ P +G + + + +
Sbjct: 971 SYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQ-PIDQGGDVVNWVRSYIRRDA 1029
Query: 947 IE--IVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004
+ ++D L + ED R + + +++I +LC+ SP R MR VV
Sbjct: 1030 LSSGVLDARLTL----------EDERIVSH--MLTVLKIALLCTSVSPVARPSMRQVVLM 1077
Query: 1005 LCHTRET 1011
L + +
Sbjct: 1078 LIESERS 1084
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1017 | ||||||
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.973 | 0.951 | 0.503 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.974 | 0.520 | 0.500 | 0.0 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.974 | 0.980 | 0.496 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.984 | 0.979 | 0.481 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.974 | 0.964 | 0.486 | 0.0 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.971 | 0.967 | 0.490 | 0.0 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.983 | 0.975 | 0.493 | 0.0 | |
| 224116466 | 1008 | predicted protein [Populus trichocarpa] | 0.976 | 0.985 | 0.493 | 0.0 | |
| 224090977 | 1034 | predicted protein [Populus trichocarpa] | 0.988 | 0.971 | 0.473 | 0.0 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.981 | 0.975 | 0.486 | 0.0 |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/1015 (50%), Positives = 680/1015 (66%), Gaps = 25/1015 (2%)
Query: 19 SLLLINSPSFSAGQTNETDRLALLAIKSQL-HDTSGVTSSWNNTINLCQWTGVTCGHRHQ 77
SL+ + P NETDRLALLAIK+Q+ D G+T+SWN++++ C WTGVTCGHRHQ
Sbjct: 22 SLVRVQHPVVLPSHRNETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQ 81
Query: 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSF 137
RV L+L++ + G LSP +GNL+FL +NL N+FHG+IPQE+G L RL L L NNSF
Sbjct: 82 RVNTLNLNSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSF 141
Query: 138 SGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLS 197
SG IP NLSRCSNL+ R+ N L G+IP+ +GS K+ + + N LTG +PD +GNL+
Sbjct: 142 SGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLT 201
Query: 198 ALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRF 257
+++ S N L G IP LG L+ L + +G N FSG P S+ N+SSLE LP+N+
Sbjct: 202 SIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKL 261
Query: 258 SGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSL 317
G+LP+D+ LPNL+ L IG N+F GS+P SLSNASN+ D+ + F GKVSIDF +
Sbjct: 262 YGSLPWDLAFTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGM 321
Query: 318 KNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIE 377
NL L L N LG G A+DL F+ L C +LK+L L+ +QF G LP+SIANLS+ +++
Sbjct: 322 PNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMK 381
Query: 378 FRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSI 437
++ NQ+ G IP GI NLVNL L + +N G+IP +IG L+ L + L +N L G I
Sbjct: 382 LKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHI 441
Query: 438 PSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSV 497
PS +GN+T+L L + N L G IPSS GN L + S+N L G +P++++ + +L++
Sbjct: 442 PSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTI 501
Query: 498 YLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGV 557
L+L+ N L G LP ++ LKNL L +S N+ SG IP L +C++LE+L + N F G
Sbjct: 502 SLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGS 561
Query: 558 IPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTK 617
IP S L+ + L+ S NNLSGQIPEFL+ LS L LN S N+ EG++PTKGVF++ T
Sbjct: 562 IPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATS 620
Query: 618 LSLQGNVKLCGGTDELHLPTC----PSKGSRKPKITLLKVLIPVAVLCMVLSSCLTIVYA 673
S+ GN KLCGG ELHLP C P G K + L+ L+ L +VL L +V
Sbjct: 621 TSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLL-TGFLGLVLIMSL-LVIN 678
Query: 674 RRRRSARKSVDTSPREKQFP-TVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMI 732
R RR R+ TS K VSY L KAT F+S+N+IG G FGSVYKGILG+DE +
Sbjct: 679 RLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETV 738
Query: 733 VAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNG 792
VAVKVI L Q+GA KSF AEC+ALRNIRHRNL+K++T CSS+D +G DFKALV+E M NG
Sbjct: 739 VAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNG 798
Query: 793 SLEDWLH------QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 846
SLE+WLH + ND L + L+L QR+NIAIDVASA++YLHHHC P+VH DLKPSN
Sbjct: 799 SLENWLHPVPTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSN 856
Query: 847 VLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGD 906
+LLD+DM +HVGDFGLA+F+ + + SSSIG+KGT+GY APEY MG++ S GD
Sbjct: 857 ILLDNDMTAHVGDFGLARFI-PEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGD 915
Query: 907 VYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIE-------VM 959
YS+GILLLE+FTG+RPT++ F++ L LH F K+ALPE++ +I+DP L
Sbjct: 916 TYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTA 975
Query: 960 ANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014
A++S + R K ECL +I+RIGV CS+ESP ERM + + + +L R+ G
Sbjct: 976 ADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1030
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2448), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/1020 (50%), Positives = 684/1020 (67%), Gaps = 29/1020 (2%)
Query: 18 FSLLLINSPSFSAGQT----NETDRLALLAIKSQL-HDTSGVTSSWNNTINLCQWTGVTC 72
++++ ++SPS + T NETDRLALLAIK+Q+ D G+T+SWN++++ C WTGVTC
Sbjct: 48 YTIIFLHSPSPTTSSTILYGNETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTC 107
Query: 73 GHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLAL 132
GHRHQRV L+LS+ + G LSP +GNL+FL +NL N+FHG+IPQE+G L RL L L
Sbjct: 108 GHRHQRVNTLNLSSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNL 167
Query: 133 PNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDF 192
NNSFSG IP NLSRCSNL+ R+ N L G+IP+ +GS K+ + + N LTG +PD
Sbjct: 168 TNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDS 227
Query: 193 VGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYL 252
+GNL++++ S N L G IP LG L+ L + +G N FSG P S+ N+SSLE L
Sbjct: 228 LGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSL 287
Query: 253 PFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSI 312
P+N+ G+LP+D+ LPNL+ L IG N+F G +P SLSNASN+ D+ + F GKVSI
Sbjct: 288 PYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSI 347
Query: 313 DFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLS 372
DF + NL L L N LG G A+DL F+ L C +LK+L L+ +QF G LP+SIANLS
Sbjct: 348 DFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLS 407
Query: 373 SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNV 432
+ +++ ++ NQ+ G IP GI NLVNL L + +N G+IP +IG L+ L + L +N
Sbjct: 408 TQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQ 467
Query: 433 LQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSI 492
L G IPS +GN+T+L L + N L G IPSS GN L + S+N L G +P++++ +
Sbjct: 468 LSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDL 527
Query: 493 TTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSN 552
+L++ L+L+ N L G LP ++ LKNL L +S N+ SG IP L +C++LE+L + N
Sbjct: 528 VSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGN 587
Query: 553 SFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVF 612
F G IP S L+ + L+ S NNLSGQIPEFL+ LS L LN S N+ EG++PTKGVF
Sbjct: 588 FFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVF 646
Query: 613 SSKTKLSLQGNVKLCGGTDELHLPTC----PSKGSRKPKITLLKVLIPVAVLCMVLSSCL 668
++ T S+ GN KLCGG ELHLP C P G K + L+ L+ L +VL L
Sbjct: 647 NNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLL-TGFLGLVLIMSL 705
Query: 669 TIVYARRRRSARKSVDTSPREKQFP-TVSYAELSKATSEFASSNMIGQGSFGSVYKGILG 727
+V R RR R+ TS K VSY L KAT F+S+N+IG G FGSVYKG LG
Sbjct: 706 -LVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLG 764
Query: 728 EDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787
+DE +VAVKVI L Q+GA KSF AEC+ALRNIRHRNL+K++T CSS+D +G DFKALV+E
Sbjct: 765 QDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYE 824
Query: 788 CMKNGSLEDWLH------QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGD 841
M NGSLE+WLH + ND L + L+L QR+NIAIDVASA++YLHHHC P+VH D
Sbjct: 825 FMPNGSLENWLHPVPTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPIVHCD 882
Query: 842 LKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA 901
LKPSN+LLD+DM +HVGDFGLA+F+ + + SSSIG+KGT+GY APEY MG++
Sbjct: 883 LKPSNILLDNDMTAHVGDFGLARFI-PEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKV 941
Query: 902 SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIE---- 957
S GD YS+GILLLE+FTG+RPT++ F++ L LH F K+ALPE++ +I+DP L
Sbjct: 942 SALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKE 1001
Query: 958 ---VMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014
A++S + R K ECL +I+RIGV CS+ESP ERM + + + +L R+ G
Sbjct: 1002 EETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1061
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2402), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/1012 (49%), Positives = 676/1012 (66%), Gaps = 21/1012 (2%)
Query: 15 IWCFSLLLIN--SPSFSAGQTNETDRLALLAIKSQLHDTSGVTSSWNNTINLCQWTGVTC 72
I+C LLLI S SFS + NETDRL+LLA K+Q+ D SSWN + + C+W+GV C
Sbjct: 10 IFCPLLLLIIQLSFSFSLHEGNETDRLSLLAFKAQITDPLDALSSWNASTHFCKWSGVIC 69
Query: 73 GHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLAL 132
GHRHQR+ L+L + ++ G LSP++GNLSFLR +NL N F +IPQE+G L RL++L L
Sbjct: 70 GHRHQRIVELNLQSSQLTGNLSPHIGNLSFLRVLNLEGNYFSRDIPQELGRLFRLQRLVL 129
Query: 133 PNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDF 192
NN+FSG IP N+S CSNL+ L + +N L G+IPA++GSL KL + N L G +P
Sbjct: 130 GNNTFSGEIPVNISSCSNLLVLHLGSNNLTGKIPAQLGSLSKLGAFVLQGNNLVGDIPSS 189
Query: 193 VGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYL 252
GNLS+++ F T N L G IP +LG L+ L V N SGT P SICNISSL + L
Sbjct: 190 FGNLSSVQNFFWTKNYLRGGIPESLGNLKRLKYFAVAENDLSGTIPSSICNISSLAYVSL 249
Query: 253 PFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSI 312
N+ G+LP D+ +NLPNL L I N+ G IP +LSNAS + ++DL +N GK+
Sbjct: 250 GQNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPATLSNASKIFLVDLSYNNLTGKIP- 308
Query: 313 DFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLS 372
D +SL +L L + N+LG G +DL F+ L N ++L+ L + N F G LP ++N S
Sbjct: 309 DLASLPDLQKLLVHHNDLGNGEEDDLSFLYTLANSTNLESLGINDNNFGGVLPEIVSNFS 368
Query: 373 SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNV 432
+++ G NQI G IP+ I NL++L L +++NQLHG IP IG+L+NL L+L +N
Sbjct: 369 TNLKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKLQNLAALYLNENK 428
Query: 433 LQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSI 492
+ GSIPS +GN+T L ++ + N+LQG IP+SLGN L+ + S N L+G +P+++L I
Sbjct: 429 ISGSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNNLSGPIPKEVLGI 488
Query: 493 TTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSN 552
++LSV L L +N L GSLP ++G L NL L +S N+ SG IP +L +C SLE LD+ N
Sbjct: 489 SSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDSCKSLEGLDLGGN 548
Query: 553 SFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVF 612
F G +P L L+++++L S NNLSGQIP+FL++ LE L+ S+ND EGEVP +GVF
Sbjct: 549 FFEGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGVF 607
Query: 613 SSKTKLSLQGNVKLCGGTDELHLPTCPSKGSRKPK---ITLLKVLIPVAVLCMVLSSCLT 669
+ +++S+QGN KLCGG +L LP C S +PK +L + IP L +VL +
Sbjct: 608 ENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLILIIAIPCGFLGIVLMTSFL 667
Query: 670 IVYARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGED 729
+ Y+R+ + S + E F ++Y +L +AT F+SSN++G G+FGSVY+G L D
Sbjct: 668 LFYSRKTKDEPASGPS--WESSFQRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSD 725
Query: 730 EMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789
+VAVKV+NL +KGA KSFMAEC AL NIRHRNL+K+IT CSS D +G DFKALV+E M
Sbjct: 726 GAVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGNDFKALVYEFM 785
Query: 790 KNGSLEDWLHQ---SNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 846
NGSLE+WLH S+ E L L+QR+NIAIDVASA++YLH+HCQ P+VH DLKPSN
Sbjct: 786 VNGSLEEWLHPVHISDVTPETRNLDLVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSN 845
Query: 847 VLLDHDMVSHVGDFGLAKFL--SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMT 904
VLL DM + VGDFGLA+FL +S+QL SSS+G+KGT+GY APEY MGSE S
Sbjct: 846 VLLGDDMTACVGDFGLARFLPEASNQL---PADESSSVGLKGTIGYAAPEYGMGSEVSTY 902
Query: 905 GDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSM 964
GDVYS+GILLLE+FTGRRPTD F +G LH +AK+ LP+ V+E VDP L + M
Sbjct: 903 GDVYSYGILLLEMFTGRRPTDGMFKDGHNLHNYAKMVLPDNVLEFVDPTL----REHEEM 958
Query: 965 IQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGRR 1016
D K EC+ +II++G+ CS E P ERM + +VV +L RE GR+
Sbjct: 959 NHNDDSHKVMECMVSIIKVGLACSAELPGERMGIANVVVELHRIREMLDGRK 1010
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/1022 (48%), Positives = 669/1022 (65%), Gaps = 21/1022 (2%)
Query: 9 GCLAILIW--CFSLLLINSPSFSAGQTNETDRLALLAIKSQLH-DTSGVTSSWNNTINLC 65
G + ++W + L+ S SFS NETD+L+LL K+Q+ D G SSWN + C
Sbjct: 5 GTSSWILWPIFLQIYLLVSFSFSIYGGNETDKLSLLTFKAQITGDPLGKLSSWNESSQFC 64
Query: 66 QWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLL 125
QW+GVTCG RHQRV LDL + ++ G LSP++GNLSFLR +NL++NS IPQE+G L
Sbjct: 65 QWSGVTCGRRHQRVVELDLHSYQLVGSLSPHIGNLSFLRILNLANNSLSLYIPQELGRLF 124
Query: 126 RLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYL 185
RLE+L L NN+F G IP N+SRC+NL L S L G++PAE+G L KLQ L + N
Sbjct: 125 RLEELVLRNNTFDGGIPANISRCANLRILDFSRGNLTGKLPAELGLLSKLQVLTIELNNF 184
Query: 186 TGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNIS 245
G +P GNLSA+ + N+L G IP G L+ L L +G N SG P SI N+S
Sbjct: 185 VGEIPYSFGNLSAINAIYGSINNLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLS 244
Query: 246 SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQ 305
SL + P N+ G+LP + + LPNL+ I N F G IP + SNASN+ +G N
Sbjct: 245 SLTLLSFPVNQLYGSLPHTLGLTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNN 304
Query: 306 FKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTN-CSSLKILSLAANQFVGEL 364
F GKV SS +L L + NNLG G NDL+FV L N +SL+ L + N F G L
Sbjct: 305 FNGKVP-PLSSSHDLQVLGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVL 363
Query: 365 PHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQ 424
P ++N S+ +++ NQI G IP+ I NL+NL ALG+++NQL G IP +G+L+ L
Sbjct: 364 PEIVSNFSTKLMKMTFARNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLS 423
Query: 425 GLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGA 484
LFL N + G IPS +GN+T L ++ M N+L+G+IP SLGN Q L+ S N L+G
Sbjct: 424 DLFLNGNKISGMIPSSMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGP 483
Query: 485 LPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSL 544
+P++L+SI +LS+YL LS N L GSLP+++ L NL L +S N+FSG IP +L +CVSL
Sbjct: 484 IPKELVSIPSLSMYLVLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSL 543
Query: 545 EYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEG 604
E L + N G IP +L L++I+ LN S NNL+GQIPEFLE+ LE LN S ND EG
Sbjct: 544 ESLHLEENFLQGPIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEG 603
Query: 605 EVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTCPSK---GSRKPKITLLKVLIPVAVLC 661
EVP +G F + + +S+ GN KLCGG +L+L CPS S+ P + + L
Sbjct: 604 EVPVQGAFQNTSAISIFGNKKLCGGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLG 663
Query: 662 MVLSSCLTIVYARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSV 721
++L + Y R++ + + E FP V+Y +L AT F+S+N+IG+GSFGSV
Sbjct: 664 VILIISFLLFYCFRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSV 723
Query: 722 YKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781
+KGILG D+++VAVKV+NL +KGA KSFMAEC+AL++IRHRNL+K++T CSSID +G DF
Sbjct: 724 FKGILGPDKIVVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDF 783
Query: 782 KALVFECMKNGSLEDWLH--QSNDHLEVCK-LTLIQRVNIAIDVASAIEYLHHHCQPPMV 838
KALV+E M NG+LE+WLH Q++D K L L+ R+NIAI +ASA+ YLHH CQ P++
Sbjct: 784 KALVYEFMVNGNLEEWLHPVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPII 843
Query: 839 HGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG 898
H DLKPSN+LLD +M +HVGDFGLA+F S + +SS+G+KGT+GY APEY +G
Sbjct: 844 HCDLKPSNILLDTNMTAHVGDFGLARFHSE------ASNQTSSVGLKGTIGYAAPEYGIG 897
Query: 899 SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEV 958
+ S GDVYS+GILLLE+FTG+RP D F +GL LH +AK+ALP++++E+VDPLL+ E+
Sbjct: 898 GKVSTYGDVYSYGILLLEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREI 957
Query: 959 MANNSMIQEDIR----AKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014
+ NS + + + CL II++GV CS+E P ERM++ DVV +L ++T G
Sbjct: 958 RSVNSSDEMGMYHIGPHEISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLLG 1017
Query: 1015 RR 1016
R
Sbjct: 1018 TR 1019
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 911 bits (2354), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/1015 (48%), Positives = 672/1015 (66%), Gaps = 24/1015 (2%)
Query: 13 ILIWCFSLLLIN-SPSFSAGQTNETDRLALLAIKSQLHDTS-GVTSSWNNTINLCQWTGV 70
IL+W L +I S S +G+ NETDRL+LLA K+ + D + SSWN +++ C+W+G+
Sbjct: 10 ILLWVLFLKMIQLSCSSLSGRGNETDRLSLLAFKAHITDDPLHILSSWNESLHFCKWSGI 69
Query: 71 TCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKL 130
TCG RHQRV +DL + R+ G L+ ++GNLSFLR +NL +NS IPQEIG L RL L
Sbjct: 70 TCGSRHQRVIEIDLESSRLSGSLTAFIGNLSFLRVLNLQNNSLSHYIPQEIGRLFRLRTL 129
Query: 131 ALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP 190
L NSFSG IP N+S CSNL+ LR+ N L G++PAE+ SL KLQ NYLTG +
Sbjct: 130 ILRRNSFSGEIPVNISYCSNLLTLRLGRNNLTGKLPAELKSLSKLQMFEFEINYLTGEIS 189
Query: 191 DFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERI 250
NLS+LE+ T N+ G+IP ++G L++L +GG+ FSG P SI N+SSL +
Sbjct: 190 PSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGGSNFSGVIPPSIFNLSSLTIL 249
Query: 251 YLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKV 310
+P N+ G LP D+ +LP L+ L + N F GSIP ++SNASN+ LD+ N F GKV
Sbjct: 250 SVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTISNASNLVALDVSQNNFTGKV 309
Query: 311 SIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIAN 370
+ L NLS++ + +NNLG G +DL F+ L N ++L+IL++ N G LP ++N
Sbjct: 310 P-SLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNLEILAITENNLGGVLPEMLSN 368
Query: 371 LSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYK 430
S+ ++ G N+I G IPS I NL+ L ALG + N+L G+IP +G+LKNL L+L
Sbjct: 369 FSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELTGSIPSSLGKLKNLIKLYLND 428
Query: 431 NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLL 490
N + GSIPS +GN+T L+ + + N+L+G+IPSSLGNCQ ++ + S N L+G +P++L+
Sbjct: 429 NNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQMLLMDLSRNNLSGTIPKELI 488
Query: 491 SITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDIS 550
SI +LS+ LDLS N GSLP+++G L NL L +S N+ SG IP +L +C LE L +
Sbjct: 489 SIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEIPKSLGSCTRLETLYLQ 548
Query: 551 SNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKG 610
N+F G IP SL L+ I LN S NNL+GQIP F LE L+ S+ND EGEVP +G
Sbjct: 549 GNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEKLDLSYNDFEGEVPAEG 608
Query: 611 VFSSKTKLSLQGNVKLCGGTDELHLPTCPSKGSRKPKIT-LLKVLI----PVAVLCMVLS 665
VF + + S+ GN LCGG E++LP C S KPK + L+++I V ++L+
Sbjct: 609 VFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRLIIVVACCGVVGVLLLT 668
Query: 666 SCLTIVYARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGI 725
S L + R++ K S + F VSY L KAT F+S+N+IG GSFGSVYKGI
Sbjct: 669 SALLFCCLKMRKN--KEASGSSLDIFFQKVSYQNLLKATDGFSSANLIGAGSFGSVYKGI 726
Query: 726 LGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785
L DE I+AVKV+NL+ KGA +SFM EC+AL N+RHRNL+K++T CSS D + DFKALV
Sbjct: 727 LAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLTACSSSDFEENDFKALV 786
Query: 786 FECMKNGSLEDWLH--QSNDHLEVCK-LTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDL 842
+E M NGSLE+WLH Q+ D + + L+LI+R++I+IDVASA++YLH+ CQ P+VH DL
Sbjct: 787 YEYMVNGSLEEWLHPTQNPDQDQPPRILSLIERLSISIDVASALDYLHNQCQVPVVHCDL 846
Query: 843 KPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEAS 902
KPSN+LLD DM +HVGDFGLA+FL + + SSSIGI+GTVGY APEY MGS+ S
Sbjct: 847 KPSNILLDSDMTAHVGDFGLARFLIAA---PHHSSPSSSIGIRGTVGYAAPEYGMGSDVS 903
Query: 903 MTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLI------ 956
GDVY++GILLLELFTG++PTDA F +GL LH AK+A+P+++ DP LLI
Sbjct: 904 TYGDVYTYGILLLELFTGKKPTDAMFKDGLNLHILAKMAMPDRLALAADPFLLITEDEGT 963
Query: 957 --EVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009
+ + I R K CLN+I++IGV CS ESP +RM++ DV +L R
Sbjct: 964 SASATSASHRITCIARDKVLGCLNSILKIGVDCSAESPRDRMDISDVANELVRIR 1018
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2349), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/1010 (49%), Positives = 672/1010 (66%), Gaps = 22/1010 (2%)
Query: 10 CLAILIWCFSLLLINSPSFSAGQTNETDRLALLAIKSQL-HDTSGVTSSWNNTINLCQWT 68
C ++ SL+ + + TNETD LAL+ K+++ D G+ SSWN+TI+ CQW
Sbjct: 7 CFRSFVFLLSLISVTCSDY----TNETDLLALIQFKNKIVDDPLGIMSSWNSTIHFCQWH 62
Query: 69 GVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLE 128
GV+CG RHQRV L L + ++ G +SP++GNLSFLR ++L +NSF EIP ++G L L+
Sbjct: 63 GVSCGRRHQRVRVLALQSLKLSGTISPHIGNLSFLRELHLQNNSFFHEIPPQVGRLRSLQ 122
Query: 129 KLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGR 188
+L NNS SG IP ++S CSNLI +++ N L G+IP E+GSLLKL+ L + N LTG
Sbjct: 123 IFSLHNNSISGQIPPSISDCSNLISIKIEFNNLTGEIPMELGSLLKLKNLTLEVNGLTGT 182
Query: 189 LPDFVGNLSALEVFSITGNS-LGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSL 247
+P +GNLS+LE+ + N L G +P+TLG L+NL L++ N+ SG P SI N+SSL
Sbjct: 183 IPPSLGNLSSLEILRLEKNKILFGNVPSTLGKLKNLRILNLMDNRLSGVIPPSIFNLSSL 242
Query: 248 ERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFK 307
+ + FN F G LP DI ++LPNL+ +I N F GSIP S+SNASN+E+L + N
Sbjct: 243 TALDIGFNLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIELLQVSLNNLT 302
Query: 308 GKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHS 367
G+V L L++ L N+LG G ANDL F++ LTN ++L+ LS+ N F GELP
Sbjct: 303 GEVPT-LEKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRNNFGGELPKQ 361
Query: 368 IANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLF 427
I+NLS+ + + N I G IP+GI LVNL + +N++ G IP IGEL+NL+GL
Sbjct: 362 ISNLSTMLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIGELQNLEGLV 421
Query: 428 LYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQ 487
L N L G IPS VGNLTKL L + NSL+G+IPSSLGNC+ L+ N L+G +P
Sbjct: 422 LDYNNLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGDIPP 481
Query: 488 QLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYL 547
L I +L +Y+ S N+ +GSLP++IG L NL L +S N SG IP +L C+SLE L
Sbjct: 482 GLFGIFSL-LYICFSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLGGCISLEDL 540
Query: 548 DISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVP 607
++SN FHG IP +L L+ + NFS NNLSG+IPEF + + LE L+ S+N+ EG +P
Sbjct: 541 YMNSNFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEGMIP 600
Query: 608 TKGVFSSKTKLSLQGNVKLCGGTDELHLPTC----PSKGSRKPKITLLKVLIPVAVLCMV 663
+G+F + T +S+ GN +LCGG EL LP C P + K KI + + + +A+ +V
Sbjct: 601 DEGIFKNSTAVSVIGNSQLCGGNTELGLPRCKVHQPKRLKLKLKIAIFAITVLLALALVV 660
Query: 664 LSSCLTIVYARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYK 723
+CL + +RR+ R+ + S + VSY L KAT+ F+SSN++G GSFGSVYK
Sbjct: 661 --TCLFLCSSRRK---RREIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGSFGSVYK 715
Query: 724 GILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783
G+L ++ M++AVKV+NL ++GA +SF+AEC+ALRNIRHRNL+K++T CSSID G DFKA
Sbjct: 716 GMLDQNGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFKA 775
Query: 784 LVFECMKNGSLEDWLH-QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDL 842
+V+E M NGSLEDWLH L L+QR+NIAIDVA A+EYLHHHC+ P+ H DL
Sbjct: 776 IVYEFMANGSLEDWLHPTGTGGGTTLTLNLLQRLNIAIDVACALEYLHHHCEMPIAHCDL 835
Query: 843 KPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEAS 902
KPSNVLLD ++ HVGDFGLAKFLS LD + S+SIG++GT+GY PEY +G E S
Sbjct: 836 KPSNVLLDDELTGHVGDFGLAKFLSGASLDYPT-NESTSIGVRGTIGYAPPEYGVGGEVS 894
Query: 903 MTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANN 962
GD YS+GILLLE+FTG+RPTD F EG LH F K A+PE+V +I DP LL E +
Sbjct: 895 AYGDTYSYGILLLEMFTGKRPTDEMFREGSNLHNFVKRAVPEQVKQITDPTLLQEEPTGD 954
Query: 963 SMIQE--DIR-AKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009
E +R ++ ECLN+I+RIG+ CS+E P ERM++ D VA+L R
Sbjct: 955 DDKHEISSMRNSRPLECLNSILRIGISCSVEFPRERMKISDAVAQLHSVR 1004
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 906 bits (2342), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/1020 (49%), Positives = 669/1020 (65%), Gaps = 20/1020 (1%)
Query: 9 GCLAILIWCFSLLLINSP---SFSAGQTNETDRLALLAIKSQL-HDTSGVTSSWNNTINL 64
G + ++W L +I P S G NETDRL+LLA+KSQ+ +D G+ SSWN +++
Sbjct: 5 GMSSCILWLLFLQIIQLPIPFSLPTG-GNETDRLSLLALKSQITNDPFGMLSSWNESLHF 63
Query: 65 CQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNL 124
C W+GV CG RH+RV +DL + ++ G LSP++GNLSFLR + L +N F IPQE+G+L
Sbjct: 64 CDWSGVICGKRHRRVVEIDLHSAQLVGSLSPHIGNLSFLRILKLENNRFSHNIPQELGHL 123
Query: 125 LRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNY 184
RL L+L NN+F G IP N+S CSNL+ L +S N L G++P E+GSL KLQ NY
Sbjct: 124 FRLRMLSLENNTFDGKIPVNISHCSNLLILSLSGNNLTGKLPIELGSLSKLQVFFFQFNY 183
Query: 185 LTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNI 244
L G +P GNLSA+ GN L G IP ++G L++L G N +G P SI N+
Sbjct: 184 LVGGIPSSFGNLSAIIQIFGAGNYLQGGIPNSIGQLKSLKSFSFGRNNMTGMIPPSIYNL 243
Query: 245 SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFN 304
SSL R +P N+ G LP D+ + LPNL+ L + N F GSIP + SNAS + +++L N
Sbjct: 244 SSLMRFAVPVNQLHGNLPPDLGLTLPNLEILLMSFNRFSGSIPPTFSNASTIAVIELSNN 303
Query: 305 QFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGEL 364
G+V D SSL L WL ++ N LG G +DL F+ L N +SL+ LS+ N F G L
Sbjct: 304 NLTGRVP-DLSSLSKLRWLIVDVNYLGNGNDDDLSFLPPLANKTSLEELSINDNNFGGLL 362
Query: 365 PHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQ 424
P I+N S ++ G NQI G IPSGI NL+ L LG++ NQL G IP+ IG+L+NL
Sbjct: 363 PKIISNFSENLKRMTFGRNQIRGSIPSGIGNLIGLDTLGLEMNQLTGVIPNSIGKLQNLG 422
Query: 425 GLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGA 484
L L N + G+IPS +GN+T L ++ +S N+LQG IPSSLGNCQNL+ + N L+G+
Sbjct: 423 VLALGGNKISGNIPSSMGNITSLLEVYLSANNLQGRIPSSLGNCQNLLILHLDQNNLSGS 482
Query: 485 LPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSL 544
+P++++SI + S L LS N L GSLPL++G L NL +S N+ SG IP TL +CVSL
Sbjct: 483 IPKEVISIPSSSRILVLSENQLTGSLPLEVGKLANLGYFNLSHNRLSGEIPRTLGSCVSL 542
Query: 545 EYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEG 604
E+L + N F G IP SL L+++++LN S NNLSG+IP+FL L L L+ S N+LEG
Sbjct: 543 EFLYMEGNLFQGPIPESLSSLRALQILNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEG 602
Query: 605 EVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTCPSKGSRKPKITL---LKVLIPVAVLC 661
EVP +G+F+ + S+ GN KLCGG +L+L C SK SRK K + L + IP +
Sbjct: 603 EVPVQGIFARASGFSMLGNKKLCGGMPQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVG 662
Query: 662 MVLSSCLTIVYARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSV 721
++L + + + + +R + SP E F V+Y +L +AT+ F+ +N+IG GSFGSV
Sbjct: 663 IILVVSYMLFFFLKEKKSRPA-SGSPWESTFQRVAYEDLLQATNGFSPANLIGAGSFGSV 721
Query: 722 YKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781
YKGIL D VAVKV NL ++GA KSFMAEC AL NIRHRNL+K++T CS ID +G DF
Sbjct: 722 YKGILRSDGAAVAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDF 781
Query: 782 KALVFECMKNGSLEDWLHQSNDHLEVCK---LTLIQRVNIAIDVASAIEYLHHHCQPPMV 838
KALV+E M NGSLE+WLH + E + L+L+QR+NIAIDVASA++YLH+HCQ +V
Sbjct: 782 KALVYEFMVNGSLEEWLHPAQISDEAHRRRDLSLLQRLNIAIDVASALDYLHNHCQIAIV 841
Query: 839 HGDLKPSNVLLDHDMVSHVGDFGLAKFL--SSHQLDTASKTSSSSIGIKGTVGYVAPEYC 896
H DLKPSNVLLD D+ +HVGDFGLA+ L +SHQL +SSIG+KGT+GY APEY
Sbjct: 842 HCDLKPSNVLLDGDLTAHVGDFGLARLLPQASHQL---CLDQTSSIGLKGTIGYAAPEYG 898
Query: 897 MGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLI 956
+GSE S GDVYS+GILLLE+FTGRRPTD F +GL LH FAK ALP V E++DP+L+
Sbjct: 899 LGSEVSPYGDVYSYGILLLEVFTGRRPTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVT 958
Query: 957 EVMANNSMIQEDIR--AKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014
E + + ECL AI+++GV CS E P ERME+ V +L R G
Sbjct: 959 EAEETSGDASRRMSHIGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILLG 1018
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116466|ref|XP_002331904.1| predicted protein [Populus trichocarpa] gi|222874576|gb|EEF11707.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 903 bits (2334), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/1012 (49%), Positives = 679/1012 (67%), Gaps = 19/1012 (1%)
Query: 12 AILIWCFSLLLI-NSPSFSAGQTNETDRLALLAIKSQLHDTSGVTSSWNNTINLCQWTGV 70
+ ++W S +I +S SFS + +E D+L+LLA K+Q+ D + SSWN +++ CQW+GV
Sbjct: 3 SFILWFLSFQIIQHSFSFSLARGSEIDKLSLLAFKAQISDPTTKLSSWNESLHFCQWSGV 62
Query: 71 TCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKL 130
CG +HQRV LDL + ++ G LSP +GNLSFLR ++L +NSF IPQEIG L+RL+ L
Sbjct: 63 KCGRQHQRVIELDLHSSQLVGSLSPSIGNLSFLRLLSLENNSFTNAIPQEIGRLVRLQTL 122
Query: 131 ALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP 190
L NNSFSG IP+N+S CSNL++L + N L G +PA +GSL KLQ + KN L G++P
Sbjct: 123 ILGNNSFSGEIPSNISHCSNLLKLNLEGNNLTGNLPAGLGSLSKLQVFSFRKNNLDGKIP 182
Query: 191 DFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERI 250
NLS++ T N++ G IP+++G L+ L +G N SGT P S+ NISSL
Sbjct: 183 LSFENLSSIIEIDGTLNNIQGGIPSSIGKLKTLNFFSLGSNNLSGTIPASLYNISSLIHF 242
Query: 251 YLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKV 310
LP+N+F GTLP +I + LPNL+ L I N G +P +L NA+ + L +N+F GKV
Sbjct: 243 SLPYNQFHGTLPPNIGLTLPNLQYLGIHDNRLSGQLPATLINATKFTEIYLSYNKFTGKV 302
Query: 311 SIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIAN 370
+ + NL L++E+N LG G +DL F+ L+N S L+ L + N F G LP I+N
Sbjct: 303 PT-LAIMPNLRILSMEENGLGKGEDDDLSFLYTLSNSSKLEDLYIDNNNFGGVLPDIISN 361
Query: 371 LSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYK 430
S+ + + G NQI G IP GI NLV+L LG+++N L G+IP IG+L+NL FL +
Sbjct: 362 FSTKLKQMAFGSNQIRGTIPDGIGNLVSLDTLGLEANHLTGSIPSSIGKLQNLADFFLNE 421
Query: 431 NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLL 490
N L GSIPS +GN+T L ++ N+LQG+IP SLGNCQNL+ S N L+G +P+++L
Sbjct: 422 NKLSGSIPSSLGNITSLMQINFDQNNLQGSIPPSLGNCQNLLVLALSQNNLSGPIPKEVL 481
Query: 491 SITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDIS 550
SI++LS+YL LS N L GSLP ++G L L + IS N+ SG IP +L +C SLE+L +
Sbjct: 482 SISSLSMYLVLSENQLTGSLPFEVGKLVTLGYMDISKNRLSGEIPASLGSCESLEHLYLD 541
Query: 551 SNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKG 610
N G I SL L++++ LN S NNLSGQIP+FL +L L+ L+ S NDLEGEVP G
Sbjct: 542 GNFLQGPISESLRSLRALQDLNLSHNNLSGQIPKFLGDLK-LQSLDLSFNDLEGEVPMHG 600
Query: 611 VFSSKTKLSLQGNVKLCGGTDELHLPTCPSKGSRKPKIT---LLKVLIPVAVLCMVLSSC 667
VF + + +S+ GN LCGG +L+LPTC SK S KPK + L V IP + ++ +
Sbjct: 601 VFENTSAVSIAGNKNLCGGILQLNLPTCRSK-STKPKSSTKLTLTVAIPCGFIGLIFIAS 659
Query: 668 LTIVYARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILG 727
+ ++S RK+ + E F TV+Y +L +AT+ F+S N++G GSFGSVYKG+L
Sbjct: 660 FLFLCC-LKKSLRKTKNELSCEMPFRTVAYKDLLQATNGFSSGNLVGAGSFGSVYKGVLA 718
Query: 728 EDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787
D + VAVKV NL ++GA KSFM EC AL NIRHRNL+K++ C+ +D +G DFKALV+E
Sbjct: 719 FDGVTVAVKVFNLLREGASKSFMRECAALLNIRHRNLVKVLFACAGVDVQGNDFKALVYE 778
Query: 788 CMKNGSLEDWLHQSND-HLEVCK---LTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLK 843
M NGSLE+WLH + LEV + L LIQR+NIAIDVA+A++YLH+ C+ P+VH DLK
Sbjct: 779 FMINGSLEEWLHPIHTLDLEVHQPKNLNLIQRLNIAIDVANALDYLHNQCKMPIVHCDLK 838
Query: 844 PSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASM 903
PSNVLLD DM +HVGDFGL KFLS +S + +SS+G+KGTVGY APEY +GSE S
Sbjct: 839 PSNVLLDGDMTAHVGDFGLLKFLSEASC-QSSSSQTSSVGLKGTVGYAAPEYGIGSEVST 897
Query: 904 TGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNS 963
GDV+S+GILLLE+ TG+RPTD+ F +GL LH + KIALP++V++I DP LL EV
Sbjct: 898 FGDVHSYGILLLEMITGKRPTDSMFKDGLELHSYVKIALPDRVVDIADPKLLTEVDQGKG 957
Query: 964 MIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGR 1015
Q ECL +I +IGV CS + P ERM++ +VVA+L T+ F GR
Sbjct: 958 TDQ------IVECLISISKIGVFCSEKFPKERMDISNVVAELNRTKANFLGR 1003
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2317), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/1036 (47%), Positives = 684/1036 (66%), Gaps = 31/1036 (2%)
Query: 4 ISFSIGCLAILIWCFSLLLINSPSFSAGQT----NETDRLALLAIKSQLH-DTSGVTSSW 58
+S S+ IL CF ++ +++PSF+ T NETD LALLAIK+Q+ D G+ SSW
Sbjct: 1 MSCSLFLKVILQSCFVVIFLHAPSFTQAATTLSGNETDHLALLAIKAQIKLDPLGLMSSW 60
Query: 59 NNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIP 118
N++++ C W G+ CG+ HQRV L+LS+ + G LSP +GN+SFLR I+L N FHGEIP
Sbjct: 61 NDSLHFCNWGGIICGNLHQRVITLNLSHYGLVGSLSPQIGNMSFLRGISLEQNYFHGEIP 120
Query: 119 QEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTL 178
QEIG L RL+ + NNSFSG IP NLS CS+L+ LR+ NKL GQIP ++GSL KL+ +
Sbjct: 121 QEIGRLDRLKYINFSNNSFSGEIPANLSGCSSLLMLRLGFNKLTGQIPYQLGSLQKLERV 180
Query: 179 AVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFP 238
+ N L G +PD +GN+S++ S++ N+ G IP LG L+ L L +G N SG P
Sbjct: 181 QLHYNNLNGSVPDSLGNISSVRSLSLSVNNFEGSIPDALGRLKTLNFLGLGLNNLSGMIP 240
Query: 239 QSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEI 298
+I N+SSL LP+N+ GTLP D+ + LPNL+ L IG N F G +P S+SNASN+
Sbjct: 241 PTIFNLSSLIVFTLPYNQLHGTLPSDLGLTLPNLQVLNIGHNFFSGPLPVSISNASNLLE 300
Query: 299 LDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAAN 358
LD+ + F KV+IDF L NL L L N LG G A+DL F+ LT C +L++L L+ +
Sbjct: 301 LDIDTSNFT-KVTIDFGGLPNLWSLALSSNPLGKGEADDLSFIDSLTKCRNLRLLDLSNS 359
Query: 359 QFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIG 418
F G +P SI NLS+ + ++ GNQ+ G IP+ I NL+NL L ++ N L G+IP V+G
Sbjct: 360 HFGGVIPDSIGNLSTQLFLLKLRGNQLSGSIPTVIENLLNLAELTVEKNYLSGSIPSVLG 419
Query: 419 ELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASH 478
LK LQ L L +N L G IPS +GN+T+L + + N + G+IPSS GN + L + S
Sbjct: 420 NLKMLQRLDLSENKLSGLIPSSLGNITQLFEFHLQKNQIMGSIPSSFGNLKYLQNLDLSQ 479
Query: 479 NKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTL 538
N L+G +P++++ +++L++ L+L+ N L G LP + NL NL L +S N+ G IP +L
Sbjct: 480 NLLSGTIPKEVMGLSSLTISLNLAQNQLTGPLPPEAQNLMNLGYLDVSENKLYGQIPSSL 539
Query: 539 STCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFS 598
+CV+LE L + N F G IP S L+ ++ ++ S NNLSGQIP+FL+ L+ + LN S
Sbjct: 540 GSCVTLEKLHMQGNFFEGAIPPSFSSLRGLRDMDLSRNNLSGQIPQFLKRLALIS-LNLS 598
Query: 599 HNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTC------PSKGSRKPKITLLK 652
N EGEVP +G F + T +SL GN +LCGG +L LP C K SR+ K+ ++
Sbjct: 599 FNHFEGEVPREGAFLNATAISLSGNKRLCGGIPQLKLPRCVVNRSKNGKTSRRVKL-MIA 657
Query: 653 VLIPVAVLCMVLSSCLTIVYARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNM 712
+L P+ VL V+S + ++ R + + S +++ VSY L KAT+ F+S+N+
Sbjct: 658 ILTPLLVLVFVMSILVINRLRKKNRQSSLASSLSSKQELLLKVSYRNLHKATAGFSSANL 717
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG GSFGSVY+GIL +E +VAVKV+ ++Q+ KSFMAEC+ L+NIRHRNL+KI+T CS
Sbjct: 718 IGAGSFGSVYRGILDPNETVVAVKVLFMRQRKTLKSFMAECEILKNIRHRNLVKILTACS 777
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQS------NDHLEVCKLTLIQRVNIAIDVASAI 826
S+D +G DFKALV+E M NG+LE WLH N+ L++ L+ QR+NIAIDVA+A+
Sbjct: 778 SVDFQGNDFKALVYEFMPNGTLESWLHSFPRTNGINEDLKI--LSFHQRLNIAIDVAAAL 835
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YLH+ C P+VH DLKPSNVLLD+DM +HVGDFGLA+F+ ++ + + SSS+G+KG
Sbjct: 836 NYLHYQCHKPVVHCDLKPSNVLLDNDMTAHVGDFGLARFI-EEAINPSHRNESSSVGLKG 894
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946
TVGY APEY MGS+ SM GDVYS+GILLLE+FTG+RPTD F +GL LH F K ALP+++
Sbjct: 895 TVGYAAPEYGMGSKPSMNGDVYSYGILLLEMFTGKRPTDDMFHDGLDLHNFVKTALPDQI 954
Query: 947 IEIVDPLLLIEVMA--------NNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM 998
E+VDPL + N + + + QE L AI+RIG+ CS+ES ER +
Sbjct: 955 SEVVDPLFVTGGEGDEEETGHLENRTRGQIKKDQMQESLIAILRIGIACSVESINERKNV 1014
Query: 999 RDVVAKLCHTRETFFG 1014
+DV+ +L + R F G
Sbjct: 1015 KDVLTELQNVRRFFLG 1030
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 893 bits (2308), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/1022 (48%), Positives = 664/1022 (64%), Gaps = 24/1022 (2%)
Query: 3 NISFSIGCLAILIWCFSLLLINSPSFSAGQTNETDRLALLAIKSQLHDTSGVTSSWNNTI 62
NI +S+ L I S LL+ NETDRL+LLA K+Q+ D G SSWN ++
Sbjct: 9 NILYSLFLLIIQFSIASCLLVG---------NETDRLSLLAFKTQISDPLGKLSSWNESL 59
Query: 63 NLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIG 122
+ C+W+GV CG +H+RV LDL + ++ G LSP++GNLSFLR +NL NSF IPQE+G
Sbjct: 60 HFCEWSGVICGRKHRRVVELDLHSSQLAGSLSPHIGNLSFLRILNLEKNSFSYLIPQELG 119
Query: 123 NLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGK 182
L R+++L+L NN+FSG IP N+SRC+NL+ + +++N L G++PAE GSL KLQ L +
Sbjct: 120 RLFRIQELSLGNNTFSGEIPVNISRCTNLLSIGLASNNLTGKLPAEFGSLSKLQVLNFQR 179
Query: 183 NYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSIC 242
N+L G +P GNLS L++ N+L G IP ++G L+ L D G N SGT P SI
Sbjct: 180 NHLFGEIPPSYGNLSELQIIRGVRNNLQGGIPDSIGQLKRLADFTFGVNSLSGTIPSSIY 239
Query: 243 NISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLG 302
N+SSL R P N+ G LP ++ + LPNL + I N F G IP +LSNAS + L L
Sbjct: 240 NMSSLVRFSAPLNQLYGILPPELGLTLPNLDTFNILSNQFRGLIPSTLSNASKISDLQLR 299
Query: 303 FNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVG 362
N F GKV + L NL L L NNLG +DL F+ L N +SL+IL++ N F G
Sbjct: 300 NNSFTGKVP-SLAGLHNLQRLVLNFNNLGNNEDDDLGFLYPLANTTSLEILAINHNNFGG 358
Query: 363 ELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKN 422
LP + N S+ + IG N + G IP+ I L+ L LG++ NQL G IP IG+L+
Sbjct: 359 VLPEIVCNFSTKLRIMIIGENNLRGSIPTEIGKLIGLDTLGLELNQLTGIIPSSIGKLQR 418
Query: 423 LQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLT 482
L + N + G+IPS +GN+T L ++ N+LQG IPSSLGNCQNL+ N L+
Sbjct: 419 LGVFNINGNKISGNIPSSLGNITSLLEVYFFANNLQGRIPSSLGNCQNLLMLRLDQNNLS 478
Query: 483 GALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCV 542
G++P+++L I++LS+YLDL+ N L G LP ++G L +L L + N+ SG IP LS+CV
Sbjct: 479 GSIPKEVLGISSLSMYLDLAENQLIGPLPSEVGKLVHLGGLNVYKNRLSGEIPGILSSCV 538
Query: 543 SLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDL 602
SLE+L++ N F G IP SL L+++++LN S NNLSG+IP+FL L L+ S N+L
Sbjct: 539 SLEHLNLGPNFFQGSIPESLSSLRALQILNLSHNNLSGKIPKFLAEFKLLTSLDLSFNNL 598
Query: 603 EGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTCPSKGSRKPKITL---LKVLIPVAV 659
EGEVP +GVF+ + S+ GN KLCGG +L+L C SK SRK K + L + IP
Sbjct: 599 EGEVPVQGVFARASGFSMLGNKKLCGGRPQLNLSRCTSKKSRKLKSSTKMKLIIAIPCGF 658
Query: 660 LCMVLSSCLTIVYARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFG 719
+ ++L + + + + +R + SP E F V+Y +L +AT F+ +N+IG GSFG
Sbjct: 659 VGIILLVSYMLFFLLKEKKSRPA-SGSPWESTFQRVAYEDLLQATKGFSPANLIGAGSFG 717
Query: 720 SVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779
SVYKGIL D VAVKV NL ++GA KSFMAEC AL NIRHRNL+K++T CS ID +G
Sbjct: 718 SVYKGILRSDGAAVAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGN 777
Query: 780 DFKALVFECMKNGSLEDWLH--QSNDHLEVCK-LTLIQRVNIAIDVASAIEYLHHHCQPP 836
DFKALV+E M NGSLE+WLH Q +D V + L+L+QR+NIAIDVASA++YLH+HCQ
Sbjct: 778 DFKALVYEFMVNGSLEEWLHPVQISDEAHVRRDLSLLQRLNIAIDVASALDYLHNHCQIA 837
Query: 837 MVHGDLKPSNVLLDHDMVSHVGDFGLAKFL--SSHQLDTASKTSSSSIGIKGTVGYVAPE 894
+ H DLKPSNVLLD DM +HVGDFGLA+ L +SHQL +SSIG+KGT+GY APE
Sbjct: 838 VAHCDLKPSNVLLDGDMTAHVGDFGLARLLPQASHQL---CLDQTSSIGLKGTIGYAAPE 894
Query: 895 YCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLL 954
Y +GSE S GDVYS+GILLLE+FTGRRPT+ F +GL LH FAK ALP V E++DP+L
Sbjct: 895 YGLGSEVSPYGDVYSYGILLLEVFTGRRPTNGLFKDGLNLHNFAKTALPISVAEVLDPVL 954
Query: 955 LIEVMANNSMIQEDIR--AKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012
+ E + + ECL AI+++GV CS E P ERME+ V +L R
Sbjct: 955 VTEAEETSGDASRRMSHIGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHIL 1014
Query: 1013 FG 1014
G
Sbjct: 1015 LG 1016
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1017 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.950 | 0.943 | 0.449 | 1.1e-215 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.970 | 0.978 | 0.423 | 5.1e-209 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.970 | 0.976 | 0.416 | 2e-207 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.967 | 0.974 | 0.422 | 4.1e-207 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.952 | 0.939 | 0.412 | 2.2e-199 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.978 | 0.970 | 0.418 | 4.2e-198 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.698 | 0.873 | 0.418 | 2.1e-139 | |
| TAIR|locus:2120412 | 992 | BAM3 "BARELY ANY MERISTEM 3" [ | 0.869 | 0.891 | 0.317 | 1.6e-128 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.893 | 0.897 | 0.296 | 1e-124 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.829 | 0.766 | 0.322 | 4.7e-118 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2084 (738.7 bits), Expect = 1.1e-215, P = 1.1e-215
Identities = 449/999 (44%), Positives = 617/999 (61%)
Query: 33 TNETDRLALLAIKSQLHDTSGVT-SSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGG 91
T ETD+ ALL KSQ+ +TS V SWN+++ LC WTGV CG +H+RVT +DL ++ G
Sbjct: 36 TEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTG 95
Query: 92 ILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNL 151
++SP+VGNLSFLR +NL+DN FHG IP E+GNL RL+ L + NN F G IP LS CS+L
Sbjct: 96 VVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSL 155
Query: 152 IQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGG 211
L +S+N LE +P E GSL KL L++G+N LTG+ P +GNL++L++ N + G
Sbjct: 156 STLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEG 215
Query: 212 KIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPN 271
+IP + L+ ++ + N+F+G FP I N+SSL + + N FSGTL D LPN
Sbjct: 216 EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPN 275
Query: 272 LKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLG 331
L+ L +G N+F G+IP++LSN S++ LD+ N GK+ + F L+NL L L N+LG
Sbjct: 276 LQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLG 335
Query: 332 MGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPS 391
++ DLDF+ LTNCS L+ L++ N+ G+LP IANLS+ + E +GGN I G IP
Sbjct: 336 NYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPH 395
Query: 392 GIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLV 451
GI NLV+L L + N L G +P +GEL L+ + LY N L G IPS +GN++ L L
Sbjct: 396 GIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLY 455
Query: 452 MSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYXXXXXXXXXXXXX 511
+ NS +G+IPSSLG+C L+ N NKL G++P +L+ + +L V
Sbjct: 456 LLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNVSFNLLVGPLR 514
Query: 512 XQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVL 571
IG LK L+ L +S N+ SG IP TL+ C+SLE+L + NSF G IP G L ++ L
Sbjct: 515 QDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFL 573
Query: 572 NFSSNNLSGQIPXXXXXXXXXXXXXXXHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTD 631
+ S NNLSG IP N+ +G VPT+GVF + + +S+ GN+ LCGG
Sbjct: 574 DLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIP 633
Query: 632 ELHLPTCPSKGSRKPKITLLKVLIPV-AVLCMVLSSCLTIVYA----RRRRSARKSVDTS 686
L L C + R+ + I V AV+ +L CL +VY R +S R + + +
Sbjct: 634 SLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEN 693
Query: 687 PRE----KQF-PTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK 741
R K F +SY EL K T F+SSN+IG G+FG+V+KG LG VA+KV+NL
Sbjct: 694 DRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLC 753
Query: 742 QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS 801
++GA KSF+AEC+AL IRHRNL+K++TICSS D +G DF+ALV+E M NG+L+ WLH
Sbjct: 754 KRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP- 812
Query: 802 NDHLEVC-----KLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856
D +E L L R+NIAIDVASA+ YLH +C P+ H D+KPSN+LLD D+ +H
Sbjct: 813 -DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAH 871
Query: 857 VGDFGLAKFLSSHQLDTAXXXXXXXXXXXXXVGYVAPEYCMGSEASMTGDVYSFGILLLE 916
V DFGLA+ L DT +GY APEY MG S+ GDVYSFGI+LLE
Sbjct: 872 VSDFGLAQLLLKFDRDT-FHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLE 930
Query: 917 LFTGRRPTDAAFTEGLTLHEFAKIALPEK-VIEIVDPLLLIEVMANN-SMIQEDIRAKTQ 974
+FTG+RPT+ F +GLTLH F K AL ++ ++I D +L A + +M+
Sbjct: 931 IFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMV--------- 981
Query: 975 ECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013
ECL + R+GV CS ESP R+ M + ++KL RE+FF
Sbjct: 982 ECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFF 1020
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2021 (716.5 bits), Expect = 5.1e-209, P = 5.1e-209
Identities = 429/1013 (42%), Positives = 621/1013 (61%)
Query: 18 FSLLLINS-PSFSA-GQTNETDRLALLAIKSQLHDTS-GVTSSWNNTINLCQWTGVTCGH 74
F LL N+ A G T+E+DR ALL IKSQ+ ++ S+WNN+ LC W V CG
Sbjct: 4 FLLLAFNALMQLEAYGFTDESDRQALLEIKSQVSESKRDALSAWNNSFPLCSWKWVRCGR 63
Query: 75 RHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPN 134
+H+RVTRLDL ++GG++SP +GNLSFL Y++LS+NSF G IPQE+GNL RL+ LA+
Sbjct: 64 KHKRVTRLDLGGLQLGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGF 123
Query: 135 NSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVG 194
N G IP +LS CS L+ L + +N L +P+E+GSL KL L +G N L G+ P F+
Sbjct: 124 NYLEGEIPASLSNCSRLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIR 183
Query: 195 NLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPF 254
NL++L V ++ N L G+IP + +L +V L + N FSG FP + N+SSLE +YL
Sbjct: 184 NLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLG 243
Query: 255 NRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDF 314
N FSG L D LPN+ L++ GN G+IP +L+N S +E+ +G N+ G +S +F
Sbjct: 244 NGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNF 303
Query: 315 SSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSS 374
L+NL +L L N+LG + DL F+ LTNCS L LS++ N+ G LP SI N+S+
Sbjct: 304 GKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTE 363
Query: 375 MIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQ 434
+ + GN I+G IP I NL+ L +L + N L G +P +G L L L L+ N
Sbjct: 364 LTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFS 423
Query: 435 GSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITT 494
G IPS +GNLT+L KL +S NS +G +P SLG+C +++ +NKL G +P++++ I T
Sbjct: 424 GEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPT 483
Query: 495 LSVYXXXXXXXXXXXXXXQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSF 554
L V+ IG L+NLV+L++ +N SG +P TL C+S+E + + N F
Sbjct: 484 L-VHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHF 542
Query: 555 HGVIPHSLGFLKSIKVLNFSSNNLSGQIPXXXXXXXXXXXXXXXHNDLEGEVPTKGVFSS 614
G IP G L +K ++ S+NNLSG I N+ EG VPT+G+F +
Sbjct: 543 DGTIPDIKG-LMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQN 601
Query: 615 KTKLSLQGNVKLCGGTDELHLPTC----PSKGSRKPKITLLKVLIPVAV--LCMVLSSCL 668
T +S+ GN LCG EL L C P +R P + L KV I V+V ++L +
Sbjct: 602 ATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSL-LKKVAIGVSVGIALLLLLFIV 660
Query: 669 TIVYARRRRSARKSVDTSPREKQF--PTVSYAELSKATSEFASSNMIGQGSFGSVYKGIL 726
++ + ++R++ +K +++P + +SY +L AT F+SSN++G GSFG+V+K +L
Sbjct: 661 SLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALL 720
Query: 727 GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVF 786
+ IVAVKV+N++++GA KSFMAEC++L++IRHRNL+K++T C+SID +G +F+AL++
Sbjct: 721 QTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIY 780
Query: 787 ECMKNGSLEDWLHQSND---HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLK 843
E M NGSL+ WLH H LTL++R+NIAIDVAS ++YLH HC P+ H DLK
Sbjct: 781 EFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLK 840
Query: 844 PSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAXXXXXXXXXXXXXVGYVAPEYCMGSEASM 903
PSN+LLD D+ +HV DFGLA+ L ++ +GY APEY MG + S+
Sbjct: 841 PSNILLDDDLTAHVSDFGLARLLLKFDQES-FFNQLSSAGVRGTIGYAAPEYGMGGQPSI 899
Query: 904 TGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNS 963
GDVYSFG+L+LE+FTG+RPT+ F TL+ + K ALPE+V++I D +L +S
Sbjct: 900 HGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSIL------HS 953
Query: 964 MIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGRR 1016
++ + ECL I+ +G+ C ESP R+ + +L RE FF R
Sbjct: 954 GLR--VGFPVLECLKGILDVGLRCCEESPLNRLATSEAAKELISIRERFFKTR 1004
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2006 (711.2 bits), Expect = 2.0e-207, P = 2.0e-207
Identities = 424/1018 (41%), Positives = 623/1018 (61%)
Query: 14 LIWCFSL-LLINSPSFSAGQTNETDRLALLAIKSQLHDTS-GVTSSWNNTINLCQWTGVT 71
L+ FS LL+ + F T+ETDR ALL KSQ+ + V SSWNN+ LC W VT
Sbjct: 5 LLLSFSAHLLLGADGF----TDETDRQALLEFKSQVSEGKRDVLSSWNNSFPLCNWKWVT 60
Query: 72 CGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLA 131
CG +H+RVT L+L ++GGI+SP +GN+SFL ++LSDN+F G IP+E+GNL RLE L
Sbjct: 61 CGRKHKRVTHLNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLY 120
Query: 132 LPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPD 191
+ NS G IP LS CS L+ L + +N L +P+E+GSL KL L +G+N L G+LP
Sbjct: 121 MAFNSLEGGIPATLSNCSRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPR 180
Query: 192 FVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIY 251
+GNL++L+ T N++ G++P L L +V L + N+F G FP +I N+S+LE ++
Sbjct: 181 SLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLF 240
Query: 252 LPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVS 311
L + FSG+L D LPN++ L +G N+ G+IP +LSN S ++ + N G +
Sbjct: 241 LFGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIY 300
Query: 312 IDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANL 371
+F + +L +L+L +N LG T DL+F+ LTNC+ L++LS+ + G LP SIAN+
Sbjct: 301 PNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANM 360
Query: 372 SSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKN 431
S+ +I + GN FG IP I NL+ L L + N L G +P +G+L L L LY N
Sbjct: 361 STELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSN 420
Query: 432 VLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLS 491
+ G IPS +GNLT+L L +S NS +G +P SLG C +++ +NKL G +P++++
Sbjct: 421 RMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQ 480
Query: 492 ITTLSVYXXXXXXXXXXXXXXQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISS 551
I TL V IG+L+NLVKL + +N+FSG +P TL C+++E L +
Sbjct: 481 IPTL-VNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQG 539
Query: 552 NSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPXXXXXXXXXXXXXXXHNDLEGEVPTKGV 611
NSF G IP+ G L ++ ++ S+N+LSG IP N+ G+VP+KG
Sbjct: 540 NSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGN 598
Query: 612 FSSKTKLSLQGNVKLCGGTDELHLPTC-----P--SKGSRKPKITLLKVLIPVAVLCMVL 664
F + T + + GN LCGG +L L C P +K S K + V I +A+L +++
Sbjct: 599 FQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLV 658
Query: 665 SSCLTIVYARRRRSARKSVDTSPREKQF--PTVSYAELSKATSEFASSNMIGQGSFGSVY 722
+ + + + R+RR +++ + P + + +SY +L AT+ F+SSNM+G GSFG+V+
Sbjct: 659 IASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVF 718
Query: 723 KGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782
K +L + IVAVKV+N++++GA KSFMAEC++L++ RHRNL+K++T C+S D +G +F+
Sbjct: 719 KALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFR 778
Query: 783 ALVFECMKNGSLEDWLHQSNDHLEVCK----LTLIQRVNIAIDVASAIEYLHHHCQPPMV 838
AL++E + NGS++ WLH E+ + LTL++R+NI IDVAS ++YLH HC P+
Sbjct: 779 ALIYEYLPNGSVDMWLHPEEVE-EIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIA 837
Query: 839 HGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAXXXXXXXXXXXXXVGYVAPEYCMG 898
H DLKPSNVLL+ D+ +HV DFGLA+ L ++ +GY APEY MG
Sbjct: 838 HCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKES-FLNQLSSAGVRGTIGYAAPEYGMG 896
Query: 899 SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEV 958
+ S+ GDVYSFG+LLLE+FTG+RPTD F LTLH + K+ALPEKV EI D +L
Sbjct: 897 GQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAIL--- 953
Query: 959 MANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGRR 1016
I + +T ECL ++ +G+ C E P R+ +V +L RE FF R
Sbjct: 954 -----HIGLRVGFRTAECLTLVLEVGLRCCEEYPTNRLATSEVAKELISIRERFFKTR 1006
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2003 (710.2 bits), Expect = 4.1e-207, P = 4.1e-207
Identities = 427/1011 (42%), Positives = 616/1011 (60%)
Query: 18 FSLLLINSPSF--SAGQTNETDRLALLAIKSQL-HDTSGVTSSWNNTINLCQWTGVTCGH 74
F LL N+ + G T+ETDR ALL KSQ+ D V SSWN++ LC W GVTCG
Sbjct: 4 FLLLAFNALMLLETHGFTDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGR 63
Query: 75 RHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPN 134
+++RVT L+L ++GG++SP +GNLSFL ++L +N F G IPQE+G L RLE L +
Sbjct: 64 KNKRVTHLELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGI 123
Query: 135 NSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVG 194
N G IP L CS L+ LR+ +N+L G +P+E+GSL L L + N + G+LP +G
Sbjct: 124 NYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLG 183
Query: 195 NLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPF 254
NL+ LE +++ N+L G+IP+ + L + L + N FSG FP ++ N+SSL+ + + +
Sbjct: 184 NLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGY 243
Query: 255 NRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDF 314
N FSG L D+ + LPNL S +GGN F GSIP +LSN S +E L + N G + F
Sbjct: 244 NHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-F 302
Query: 315 SSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSS 374
++ NL L L N+LG ++ DL+F+T LTNC+ L+ L + N+ G+LP SIANLS+
Sbjct: 303 GNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAK 362
Query: 375 MIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQ 434
++ +GG I G IP I NL+NL L + N L G +P +G+L NL+ L L+ N L
Sbjct: 363 LVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLS 422
Query: 435 GSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITT 494
G IP+ +GN+T L L +S N +G +P+SLGNC +L+ NKL G +P +++ I
Sbjct: 423 GGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQ 482
Query: 495 LSVYXXXXXXXXXXXXXXQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSF 554
L + IG L+NL L + N+ SG +P TL C+++E L + N F
Sbjct: 483 L-LRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLF 541
Query: 555 HGVIPHSLGFLKSIKVLNFSSNNLSGQIPXXXXXXXXXXXXXXXHNDLEGEVPTKGVFSS 614
+G IP G L +K ++ S+N+LSG IP N+LEG+VP KG+F +
Sbjct: 542 YGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFEN 600
Query: 615 KTKLSLQGNVKLCGGTDELHLPTCPSKGS---RKPKITLLKVLIPVAV----LCMVLSSC 667
T +S+ GN LCGG L C S+ +K L KV+I V+V L ++ +
Sbjct: 601 ATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMAS 660
Query: 668 LTIVYARRRRSARKSVDTSPR--EKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGI 725
+T+++ R+R+ +++ + +P E +SY +L AT+ F+SSNM+G GSFG+VYK +
Sbjct: 661 VTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKAL 720
Query: 726 LGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785
L ++ +VAVKV+N++++GA KSFMAEC++L++IRHRNL+K++T CSSID +G +F+AL+
Sbjct: 721 LLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALI 780
Query: 786 FECMKNGSLEDWLHQSND---HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDL 842
+E M NGSL+ WLH H LTL++R+NIAIDVAS ++YLH HC P+ H DL
Sbjct: 781 YEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDL 840
Query: 843 KPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAXXXXXXXXXXXXXVGYVAPEYCMGSEAS 902
KPSNVLLD D+ +HV DFGLA+ L + + +GY APEY +G + S
Sbjct: 841 KPSNVLLDDDLTAHVSDFGLARLLLKFD-EESFFNQLSSAGVRGTIGYAAPEYGVGGQPS 899
Query: 903 MTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANN 962
+ GDVYSFGILLLE+FTG+RPT+ F TL+ + K ALPE++++IVD +L
Sbjct: 900 INGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESIL------- 952
Query: 963 SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013
I + ECL + +G+ C ESP R+ VV +L RE FF
Sbjct: 953 -HIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFF 1002
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1930 (684.5 bits), Expect = 2.2e-199, P = 2.2e-199
Identities = 420/1018 (41%), Positives = 601/1018 (59%)
Query: 21 LLINSPSFSAGQ-TNETDRLALLAIKSQLHDTSG--VTSSWNNTINLCQWTGVTCGHRHQ 77
LL+ F+ + +NETD ALL KSQ+ + + V +SWN++ C W GVTCG R +
Sbjct: 14 LLLQVCIFAQARFSNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRE 73
Query: 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSF 137
RV L+L ++ G++SP +GNLSFLR +NL+DNSF IPQ++G L RL+ L + N
Sbjct: 74 RVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLL 133
Query: 138 SGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLS 197
G IP++LS CS L + +S+N L +P+E+GSL KL L + KN LTG P +GNL+
Sbjct: 134 EGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLT 193
Query: 198 ALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRF 257
+L+ N + G+IP + L +V + N FSG FP ++ NISSLE + L N F
Sbjct: 194 SLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSF 253
Query: 258 SGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSL 317
SG L D LPNL+ L +G N F G+IP +L+N S++E D+ N G + + F L
Sbjct: 254 SGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKL 313
Query: 318 KNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIE 377
+NL WL + N+LG +++ L+F+ + NC+ L+ L + N+ GELP SIANLS+++
Sbjct: 314 RNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTS 373
Query: 378 FRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSI 437
+G N I G IP I NLV+L L +++N L G +P G+L NLQ + LY N + G I
Sbjct: 374 LFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEI 433
Query: 438 PSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSV 497
PS GN+T+L KL ++ NS G IP SLG C+ L+ N+L G +PQ++L I +L+
Sbjct: 434 PSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA- 492
Query: 498 YXXXXXXXXXXXXXXQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGV 557
Y ++G L+ LV L S N+ SG +P + C+S+E+L + NSF G
Sbjct: 493 YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGA 552
Query: 558 IPHSLGFLKSIKVLNFSSNNLSGQIPXXXXXXXXXXXXXXXHNDLEGEVPTKGVFSSKTK 617
IP + L S+K ++FS+NNLSG+IP N EG VPT GVF + T
Sbjct: 553 IP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATA 611
Query: 618 LSLQGNVKLCGGTDELHLPTCPSKGS---RKPKITLLKVLIPVAVLCMVLSSCLTIV--- 671
+S+ GN +CGG E+ L C + S RKP KV V+ +C+ ++S L I+
Sbjct: 612 VSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKV---VSGICIGIASLLLIIIVA 668
Query: 672 ---YARRRRSARKSVDTSPREK----QF-PTVSYAELSKATSEFASSNMIGQGSFGSVYK 723
+ +R+ + D +P + F VSY EL ATS F+S+N+IG G+FG+V+K
Sbjct: 669 SLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFK 728
Query: 724 GILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783
G+LG + +VAVKV+NL + GA KSFMAEC+ + IRHRNL+K+IT+CSS+DS+G DF+A
Sbjct: 729 GLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRA 788
Query: 784 LVFECMKNGSLEDWLH-----QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMV 838
LV+E M GSL+ WL + NDH LT +++NIAIDVASA+EYLH HC P+
Sbjct: 789 LVYEFMPKGSLDMWLQLEDLERVNDHSR--SLTPAEKLNIAIDVASALEYLHVHCHDPVA 846
Query: 839 HGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAXXXXXXXXXXXXXVGYVAPEYCMG 898
H D+KPSN+LLD D+ +HV DFGLA+ L + ++ +GY APEY MG
Sbjct: 847 HCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRES-FLNQFSSAGVRGTIGYAAPEYGMG 905
Query: 899 SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEV 958
+ S+ GDVYSFGILLLE+F+G++PTD +F LH + K L
Sbjct: 906 GQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSS---------- 955
Query: 959 MANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGRR 1016
++ I E +R ++++G+ CS E P +RM + V +L R FF +
Sbjct: 956 -GGSNAIDEGLRL--------VLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSK 1004
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1918 (680.2 bits), Expect = 4.2e-198, P = 4.2e-198
Identities = 426/1017 (41%), Positives = 603/1017 (59%)
Query: 11 LAILIWCFSLLLINSPSFSAGQTNET-DRLALLAIKSQLHDTSGVT-SSWNNTIN--LCQ 66
L + + FS LL+ PS S + D LALL+ KS L G + +SWN + + C
Sbjct: 6 LLLFVLLFSALLL-CPSSSDDDGDAAGDELALLSFKSSLLYQGGQSLASWNTSGHGQHCT 64
Query: 67 WTGVTCGHRHQR----VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIG 122
W GV CG R +R V +L L + + GI+SP +GNLSFLR ++L DN GEIP E+
Sbjct: 65 WVGVVCGRRRRRHPHRVVKLLLRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPELS 124
Query: 123 NLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLK-LQTLAVG 181
L RL+ L L +NS G+IP + C+ L L +S+N+L G IP EIG+ LK L L +
Sbjct: 125 RLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLY 184
Query: 182 KNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSI 241
KN L+G +P +GNL++L+ F ++ N L G IP++LG L +L+ +++G N SG P SI
Sbjct: 185 KNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSI 244
Query: 242 CNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDL 301
N+SSL + N+ G +P + L L+ + +G N F G IP S++NAS++ ++ +
Sbjct: 245 WNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQI 304
Query: 302 GFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFV 361
N F G ++ F L+NL+ L L +N +D F++ LTNCS L+ L+L N
Sbjct: 305 YGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLG 364
Query: 362 GELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELK 421
G LP+S +NLS+S+ + N+I G IP I NL+ L L + +N G++P +G LK
Sbjct: 365 GVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLK 424
Query: 422 NLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKL 481
NL L Y+N L GSIP +GNLT+L L++ N G IP +L N NL+ S N L
Sbjct: 425 NLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNL 484
Query: 482 TGALPQQLLSITTLSVYXXXXXXXXXXXXXXQIGNLKNLVKLIISSNQFSGVIPVTLSTC 541
+G +P +L +I TLS+ +IG+LKNLV+ SN+ SG IP TL C
Sbjct: 485 SGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDC 544
Query: 542 VSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPXXXXXXXXXXXXXXXHND 601
L YL + +N G IP +LG LK ++ L+ SSNNLSGQIP N
Sbjct: 545 QLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNS 604
Query: 602 LEGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTC-PSKGSRKPKITLLKVLIPVAVL 660
GEVPT G F++ + +S+QGN KLCGG +LHLP C P +RK +L + + +A
Sbjct: 605 FVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRK-HFPVLPISVSLAAA 663
Query: 661 CMVLSSCLTIVYARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGS 720
+LSS ++ +R +K + K P VSY++L KAT FA +N++G GSFGS
Sbjct: 664 LAILSSLYLLITWHKR--TKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGS 721
Query: 721 VYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780
VYKG L + VAVKV+ L+ A KSF AEC+ALRN+RHRNL+KI+TICSSID++G D
Sbjct: 722 VYKGKLNIQDH-VAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGND 780
Query: 781 FKALVFECMKNGSLEDWLH-QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVH 839
FKA+V++ M NGSLEDW+H ++ND + L L +RV I +DVA A++YLH H P+VH
Sbjct: 781 FKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVH 840
Query: 840 GDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAXXXXXXXXXXXXXVGYVAPEYCMGS 899
D+K SNVLLD DMV+HVGDFGLA+ L + +GY APEY +G
Sbjct: 841 CDIKSSNVLLDSDMVAHVGDFGLARILVDGT--SLIQQSTSSMGFIGTIGYAAPEYGVGL 898
Query: 900 EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVM 959
AS GD+YS+GIL+LE+ TG+RPTD+ F L L ++ ++ L +V ++VD L+++
Sbjct: 899 IASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILD-S 957
Query: 960 AN--NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014
N NS R T EC+ ++R+G+ CS E P R D++ +L ++ G
Sbjct: 958 ENWLNSTNNSPCRRIT-ECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNLSG 1013
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1364 (485.2 bits), Expect = 2.1e-139, P = 2.1e-139
Identities = 301/719 (41%), Positives = 416/719 (57%)
Query: 106 INLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQI 165
+ L ++ G I +GNL L L L +N SG IP LSR S L QL ++ N L G+I
Sbjct: 83 LRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEI 142
Query: 166 PAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVD 225
PA +G+L L L + N L+G +P +G L+ L ++ N+L G IP++ G LR L
Sbjct: 143 PAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSF 202
Query: 226 LHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGS 285
L + N SG P I NISSL + N+ SGTLP + NLP+L+ + + N F G
Sbjct: 203 LSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGR 262
Query: 286 IPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLT 345
IP S+ NASN+ I +G N F G V + ++NL L L + ND F+T LT
Sbjct: 263 IPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALT 322
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405
NCS+L+ + L +F G LP S++NLSSS++ I N+I G +P I NLVNL L +
Sbjct: 323 NCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLA 382
Query: 406 SNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSL 465
+N L G++P +LKNL+ L + N L GS+P +GNLT+L + + +N+ G IPS+L
Sbjct: 383 NNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTL 442
Query: 466 GNCQNLIGFNASHNKLTGALPQQLLSITTLSVYXXXXXXXXXXXXXXQIGNLKNLVKLII 525
GN L N HN G +P ++ SI LS +IG LKN+V+
Sbjct: 443 GNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHA 502
Query: 526 SSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPXX 585
SN+ SG P T+ C L++L + +N +G IP +L LK + L+ S NNLSGQIP
Sbjct: 503 DSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMS 562
Query: 586 XXXXXXXXXXXXXHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTCPSKGSRK 645
N GEVPT GVF++ +++ +QGN +CGG ELHLPTC K +K
Sbjct: 563 LGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKK 622
Query: 646 PK--ITLLKVLIPVAVLCMVLSSCLTIVYARRRRSARKSVDTSPREKQFPTVSYAELSKA 703
K I LL V+I + V S ++ +RR +K V + + P ++Y +L KA
Sbjct: 623 KKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRR--KKEVPATTSMQGHPMITYKQLVKA 680
Query: 704 TSEFASSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFKSFMAECKALRNI 759
T F+SS+++G GSFGSVYKG GE +VAV+V+ L+ A KSF AEC+ LRN
Sbjct: 681 TDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNT 740
Query: 760 RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLH-QSNDHLEVCKLTLIQRVN 817
RHRNL+KI+TICSSID++G DFKA+V++ M NGSLEDWLH ++ND E LTL QRV+
Sbjct: 741 RHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799
|
|
| TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 1.6e-128, Sum P(2) = 1.6e-128
Identities = 298/940 (31%), Positives = 470/940 (50%)
Query: 41 LLAIKSQLHDTSGVTSSWN--NTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVG 98
L+++K SWN N +LC WTGV+C + +Q +TRLDLSN I G +SP +
Sbjct: 38 LISLKQSFDSYDPSLDSWNIPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISGTISPEIS 97
Query: 99 NLS-FLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTN-LSRCSNLIQLRV 156
LS L ++++S NSF GE+P+EI L LE L + +N F G + T S+ + L+ L
Sbjct: 98 RLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMTQLVTLDA 157
Query: 157 SNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTT 216
+N G +P + +L +L+ L +G NY G +P G+ +L+ S++GN L G+IP
Sbjct: 158 YDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGNDLRGRIPNE 217
Query: 217 LGLLRNLVDLHVGG-NQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSL 275
L + LV L++G N + G P + +L + L G++P ++ NL NL+ L
Sbjct: 218 LANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELG-NLKNLEVL 276
Query: 276 AIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTA 335
+ N GS+P L N ++++ LDL N +G++ ++ S L+ L NL N L G
Sbjct: 277 FLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNRLH-G-- 333
Query: 336 NDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRN 395
+ F++ L+IL L N F G++P + + + ++IE + N++ G+IP +
Sbjct: 334 ---EIPEFVSELPDLQILKLWHNNFTGKIPSKLGS-NGNLIEIDLSTNKLTGLIPESLCF 389
Query: 396 LVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYN 455
L L + +N L G +P+ +G+ + L L +N L +P G+ L L+ L + N
Sbjct: 390 GRRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNN 449
Query: 456 SLQGNIPSS-LGNCQ--NLIGFNASHNKLTGALPQQLLSITTLSVYXXXXXXXXXXXXXX 512
L G IP GN Q +L N S+N+L+G +P + ++ +L +
Sbjct: 450 FLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPG- 508
Query: 513 QIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLN 572
+IG+LK+L+K+ +S N FSG P C+SL YLD+S N G IP + ++ + LN
Sbjct: 509 EIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLN 568
Query: 573 FSSNNLSGQIPXXXXXXXXXXXXXXXHNDLEGEVPTKGVFSSKTKLSLQGNVKLCG---- 628
S N+ + +P HN+ G VPT G FS S GN LCG
Sbjct: 569 VSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSN 628
Query: 629 ---GTDE------LHLPTCPSKGSRKPKITLLKVLIPVAVLCMVLSSCLTIVYARRRRSA 679
G+ L+ S+G K K+ + +L L + V RR
Sbjct: 629 PCNGSQNQSQSQLLNQNNARSRGEISAKF---KLFFGLGLLGFFLVFVVLAVVKNRRM-- 683
Query: 680 RKSVDTSPREKQFPTVSYAELSKATSEFASSN-MIGQGSFGSVYKGILGEDEMIVAVKVI 738
RK+ + F + + S+ E N +IG+G G VYKG++ E + K++
Sbjct: 684 RKNNPNLWKLIGFQKLGFR--SEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLL 741
Query: 739 NLKQKGAFKSFMA-ECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDW 797
+ + + + +A E + L IRHRN+++++ CS+ D LV+E M NGSL +
Sbjct: 742 TITKGSSHDNGLAAEIQTLGRIRHRNIVRLLAFCSN-----KDVNLLVYEYMPNGSLGEV 796
Query: 798 LHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857
LH L R+ IA++ A + YLHH C P ++H D+K +N+LL + +HV
Sbjct: 797 LHGKAGVF----LKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHV 852
Query: 858 GDFGLAKFLSSHQLDTAXXXXXXXXXXXXXVGYVAPEYCMGSEASMTGDVYSFGILLLEL 917
DFGLAKF+ D GY+APEY DVYSFG++LLEL
Sbjct: 853 ADFGLAKFMMQ---DNGASECMSSIAGSY--GYIAPEYAYTLRIDEKSDVYSFGVVLLEL 907
Query: 918 FTGRRPTDAAFTEGLTLHEFAKIALP---EKVIEIVDPLL 954
TGR+P D EG+ + +++KI + V++I+D L
Sbjct: 908 ITGRKPVDNFGEEGIDIVQWSKIQTNCNRQGVVKIIDQRL 947
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1091 (389.1 bits), Expect = 1.0e-124, Sum P(2) = 1.0e-124
Identities = 285/962 (29%), Positives = 481/962 (50%)
Query: 13 ILIWCFSLLLINSPSFSAGQTNETDRLALLAIKSQLHDTSGVTSSW--NNTINLCQWTGV 70
I+++ + + ++ S A N + LL++KS L D W ++T + C WTGV
Sbjct: 6 IVLFLYYCYIGSTSSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKLSDTSDHCNWTGV 65
Query: 71 TCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKL 130
C + + V +LDL+ + G +S + LS L N+S N F +P+ I L ++
Sbjct: 66 RC-NSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSIPPLKSID-- 122
Query: 131 ALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP 190
+ NSFSG++ + L+ L S N L G + ++G+L+ L+ L + N+ G LP
Sbjct: 123 -ISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLP 181
Query: 191 DFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERI 250
NL L ++GN+L G++P+ LG L +L +G N+F G P NI+SL+ +
Sbjct: 182 SSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYL 241
Query: 251 YLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKV 310
L + SG +P ++ L +L++L + NNF G+IP + + + +++LD N G++
Sbjct: 242 DLAIGKLSGEIPSELG-KLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEI 300
Query: 311 SIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIAN 370
++ + LKNL LNL +N L G+ +++ + L++L L N GELP +
Sbjct: 301 PMEITKLKNLQLLNLMRNKLS-GSIPPA-----ISSLAQLQVLELWNNTLSGELPSDLGK 354
Query: 371 LSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYK 430
+S + + N G IPS + N NL L + +N G IP + ++L + +
Sbjct: 355 -NSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQN 413
Query: 431 NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLL 490
N+L GSIP G G L KL +L ++ N L G IP + + +L + S N++ +LP +L
Sbjct: 414 NLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTIL 473
Query: 491 SITTLSVYXXXXXXXXXXXXXXQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDIS 550
SI L + Q + +L L +SSN +G IP ++++C L L++
Sbjct: 474 SIHNLQAFLVADNFISGEVPD-QFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLR 532
Query: 551 SNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPXXXXXXXXXXXXXXXHNDLEGEVPTKG 610
+N+ G IP + + ++ VL+ S+N+L+G +P +N L G VP G
Sbjct: 533 NNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPING 592
Query: 611 VFSSKTKLSLQGNVKLCGGTDELHLPTCP-------SKGSRKPKITLLKVLIPVA-VLCM 662
+ L+GN LCGG LP C S S K + LI +A VL +
Sbjct: 593 FLKTINPDDLRGNSGLCGGV----LPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLAL 648
Query: 663 VLSSCLTIVYARRRRSARKSVDTSPREKQFP--TVSYAELSKATSEFAS----SNMIGQG 716
+ + +T ++ S D + + ++P +++ L S+ + SNMIG G
Sbjct: 649 GILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMG 708
Query: 717 SFGSVYKGILGEDEMIVAVKVINLK----QKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+ G VYK + ++AVK + + G F+ E L +RHRN+++++
Sbjct: 709 ATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLY 768
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
+ D +V+E M NG+L D +H N + + + R NIA+ VA + YLHH
Sbjct: 769 N-DKN----MMIVYEFMLNGNLGDAIHGKNAAGRLL-VDWVSRYNIALGVAHGLAYLHHD 822
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAXXXXXXXXXXXXXVGYVA 892
C PP++H D+K +N+LLD ++ + + DFGLA+ ++ + +T GY+A
Sbjct: 823 CHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKK-ETVSMVAGSY-------GYIA 874
Query: 893 PEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVI--EIV 950
PEY + D+YS+G++LLEL TGRRP + F E + + E+ + + + + E +
Sbjct: 875 PEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEAL 934
Query: 951 DP 952
DP
Sbjct: 935 DP 936
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1049 (374.3 bits), Expect = 4.7e-118, Sum P(2) = 4.7e-118
Identities = 289/895 (32%), Positives = 436/895 (48%)
Query: 82 LDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTI 141
L + + + G++ P + L LR I N F G IP EI L+ L L N G++
Sbjct: 168 LVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSL 227
Query: 142 PTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEV 201
P L + NL L + N+L G+IP +G++ +L+ LA+ +NY TG +P +G L+ ++
Sbjct: 228 PKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKR 287
Query: 202 FSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTL 261
+ N L G+IP +G L + ++ NQ +G P+ +I +L+ ++L N G +
Sbjct: 288 LYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPI 347
Query: 262 PFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLS 321
P ++ L L+ L + N G+IP L + L L NQ +GK+ N S
Sbjct: 348 PRELG-ELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFS 406
Query: 322 WLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIG 381
L++ N+L G F F T L +LSL +N+ G +P + S + + +G
Sbjct: 407 VLDMSANSLS-GPI-PAHFCRFQT----LILLSLGSNKLSGNIPRDLKTCKS-LTKLMLG 459
Query: 382 GNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV 441
NQ+ G +P + NL NL AL + N L G I +G+LKNL+ L L N G IP +
Sbjct: 460 DNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEI 519
Query: 442 GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYXXX 501
GNLTK+ +S N L G+IP LG+C + + S NK +G + Q+L + L +
Sbjct: 520 GNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLS 579
Query: 502 XXXXXXXXXXXQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEY-LDISSNSFHGVIPH 560
G+L L++L + N S IPV L SL+ L+IS N+ G IP
Sbjct: 580 DNRLTGEIPHS-FGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPD 638
Query: 561 SLGFLKSIKVLNFSSNNLSGQIPXXXXXXXXXXXXXXXHNDLEGEVPTKGVFSSKTKLSL 620
SLG L+ +++L + N LSG+IP +N+L G VP VF +
Sbjct: 639 SLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNF 698
Query: 621 QGNVKLCGGTDELHLPTCP---SK------GSRKPKI-TLLKVLIPVAVLCMVLSSCLTI 670
GN LC P P SK GS++ KI T+ ++I L L C TI
Sbjct: 699 AGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTI 758
Query: 671 VYARRRRSARKSVD--TSPREKQ---FPT--VSYAELSKATSEFASSNMIGQGSFGSVYK 723
+RR A +++ T P FP +Y L AT F+ ++G+G+ G+VYK
Sbjct: 759 ---KRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYK 815
Query: 724 GILGEDEMIVAVKVINLKQKGAFK--SFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781
+ E ++AVK +N + +GA SF AE L IRHRN++K+ C +S
Sbjct: 816 AEMSGGE-VIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSN---- 870
Query: 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGD 841
L++E M GSL + L + + C L R IA+ A + YLHH C+P +VH D
Sbjct: 871 -LLLYEYMSKGSLGEQLQRGEKN---CLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRD 926
Query: 842 LKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAXXXXXXXXXXXXXVGYVAPEYCMGSEA 901
+K +N+LLD +HVGDFGLAK + GY+APEY +
Sbjct: 927 IKSNNILLDERFQAHVGDFGLAKLID-------LSYSKSMSAVAGSYGYIAPEYAYTMKV 979
Query: 902 SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV--IEIVDPLL 954
+ D+YSFG++LLEL TG+ P +G L + + ++ + IE+ D L
Sbjct: 980 TEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRSIRNMIPTIEMFDARL 1033
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4457 | 0.9547 | 0.9613 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1017 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-127 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 6e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 6e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| COG3173 | 321 | COG3173, COG3173, Predicted aminoglycoside phospho | 0.001 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.004 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 411 bits (1057), Expect = e-127
Identities = 310/964 (32%), Positives = 484/964 (50%), Gaps = 61/964 (6%)
Query: 13 ILIWCFSLLLINSPSFSAGQTNETDRLALLAIKSQLHDTSGVTSSWNNTINLCQWTGVTC 72
LI+ L +N FS E + LL+ KS ++D S+WN++ ++C W G+TC
Sbjct: 11 YLIFMLFFLFLN---FSMLHAEELE--LLLSFKSSINDPLKYLSNWNSSADVCLWQGITC 65
Query: 73 GHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNL-LRLEKLA 131
+ RV +DLS + I G +S + L +++ INLS+N G IP +I L L
Sbjct: 66 NN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN 124
Query: 132 LPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPD 191
L NN+F+G+IP NL L +SNN L G+IP +IGS L+ L +G N L G++P+
Sbjct: 125 LSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 192 FVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIY 251
+ NL++LE ++ N L G+IP LG +++L +++G N SG P I ++SL +
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242
Query: 252 LPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVS 311
L +N +G +P + NL NL+ L + N G IP S+ + + LDL N G++
Sbjct: 243 LVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
Query: 312 IDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANL 371
L+NL L+L NN G LT+ L++L L +N+F GE+P ++
Sbjct: 302 ELVIQLQNLEILHLFSNNF-TGK-----IPVALTSLPRLQVLQLWSNKFSGEIPKNLGK- 354
Query: 372 SSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKN 431
+++ + N + G IP G+ + NL L + SN L G IP +G ++L+ + L N
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
Query: 432 VLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLS 491
G +PS L + L +S N+LQG I S + +L + + NK G LP S
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS 474
Query: 492 ITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISS 551
+ LDLS N +G++P ++G+L L++L +S N+ SG IP LS+C L LD+S
Sbjct: 475 KRLEN--LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 552 NSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGV 611
N G IP S + + L+ S N LSG+IP+ L N+ L +N SHN L G +P+ G
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 612 FSSKTKLSLQGNVKLCGGTDELHLPTCPSKGSRKPKITLLKVLIPVAVLCMVLSSCLTIV 671
F + ++ GN+ LCGG LP C K RK + + ++ V
Sbjct: 593 FLAINASAVAGNIDLCGGDTTSGLPPC--KRVRKTPSWWFYITCTLGAFLVLALVAFGFV 650
Query: 672 YARRRR-SARKSVDTSPR--EKQFPTVSYAELSKATSEFASS----NMIGQGSFGSVYKG 724
+ R R K V+ E QF S S ++ SS N+I +G G+ YKG
Sbjct: 651 FIRGRNNLELKRVENEDGTWELQFFD-SKVSKSITINDILSSLKEENVISRGKKGASYKG 709
Query: 725 ILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784
++ M VK IN S +A+ + ++H N++K+I +C S KGA L
Sbjct: 710 KSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRS--EKGA---YL 760
Query: 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKP 844
+ E ++ +L + L L+ +R IAI +A A+ +LH C P +V G+L P
Sbjct: 761 IHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811
Query: 845 SNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMT 904
+++D H+ L L DT SS+ YVAPE + +
Sbjct: 812 EKIIIDGKDEPHL-RLSLPGLLC---TDTKCFISSA---------YVAPETRETKDITEK 858
Query: 905 GDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI-VDPLLLIEVMANNS 963
D+Y FG++L+EL TG+ P DA F ++ E+A+ + +++ +DP + +V N +
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918
Query: 964 MIQE 967
I E
Sbjct: 919 EIVE 922
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 73/234 (31%), Positives = 107/234 (45%), Gaps = 28/234 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFKSFMAECKALRNIRHRNLIKIITIC 771
+G+GSFG VY + +VA+KVI K K + + E K L+ ++H N I+ +
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPN---IVRLY 63
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+ + + LV E + G L D L + +L+ + + SA+EYLH
Sbjct: 64 DVFEDEDKLY--LVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQILSALEYLHS 115
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
+VH DLKP N+LLD D + DFGLA+ L + T GT Y+
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT---------TFVGTPEYM 163
Query: 892 APEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945
APE +G D++S G++L EL TG+ P F L E K K
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPK 213
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 5e-43
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK-SFMAECKALRNIRHRNLIKIITIC 771
+G+G FG+VY + VA+K+I + + + E + L+ + H N++K+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+ LV E + GSL+D L ++ KL+ + + I + + +EYLH
Sbjct: 61 EDE-----NHLYLVMEYCEGGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHS 110
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVS-HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ ++H DLKP N+LLD D + DFGL+K L+S S I GT Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD--------KSLLKTIVGTPAY 159
Query: 891 VAPEYCMG-SEASMTGDVYSFGILLLEL 917
+APE +G S D++S G++L EL
Sbjct: 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 3e-41
Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 31/220 (14%)
Query: 713 IGQGSFGSVYKGIL----GEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKI 767
+G+G+FG VYKG L E VAVK + + + F+ E ++ + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ +C+ +G +V E M G L D+L + + KLTL + +A+ +A +E
Sbjct: 67 LGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGE-----KLTLKDLLQMALQIAKGME 116
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
YL VH DL N L+ ++V + DFGL++ + D K + IK
Sbjct: 117 YLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED--DYYRKRGGGKLPIK-- 169
Query: 888 VGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
++APE + S DV+SFG+LL E+FT G +P
Sbjct: 170 --WMAPESLKDGKFTSKS---DVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 73/214 (34%), Positives = 107/214 (50%), Gaps = 25/214 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
+G GSFG+VYK IVAVK++ + ++ E + LR + H N++++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
D D LV E + G L D+L + L+ + IA+ + +EYLH
Sbjct: 67 F--EDK---DHLYLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEYLH 115
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ ++H DLKP N+LLD + V + DFGLAK L K+SSS GT Y
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKL--------LKSSSSLTTFVGTPWY 164
Query: 891 VAPEYCMGS-EASMTGDVYSFGILLLELFTGRRP 923
+APE +G DV+S G++L EL TG+ P
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 4e-40
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 31/221 (14%)
Query: 712 MIGQGSFGSVYKGIL----GEDEMIVAVKVINL-KQKGAFKSFMAECKALRNIRHRNLIK 766
+G+G+FG VYKG L E+ VAVK + + + F+ E + +R + H N++K
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
++ +C+ + +V E M G L D+L ++ +L+L ++ A+ +A +
Sbjct: 66 LLGVCTEEEPL-----MIVMEYMPGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGM 116
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
EYL +H DL N L+ ++V + DFGL++ L K
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-------KL 166
Query: 887 TVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ ++APE + S DV+SFG+LL E+FT G P
Sbjct: 167 PIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 7e-40
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 32/221 (14%)
Query: 712 MIGQGSFGSVYKGIL----GEDEMIVAVKVINL-KQKGAFKSFMAECKALRNIRHRNLIK 766
+G+G+FG VYKG L G+ ++ VAVK + + + F+ E + +R + H N++K
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
++ +C+ + +V E M+ G L +L ++ KL+L ++ A+ +A +
Sbjct: 66 LLGVCTEEEPL-----YIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGM 115
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
EYL +H DL N L+ ++V + DFGL++ L K
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-------KL 165
Query: 887 TVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ ++APE + S DV+SFG+LL E+FT G +P
Sbjct: 166 PIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 67/224 (29%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 711 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINL-KQKGAFKSFMAECKALRNIRHRNLIK 766
+G+G+FG VYKG L VAVK + + K F+ E + ++ + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCK---LTLIQRVNIAIDVA 823
++ +C+ + LV E M+ G L D+L +S + L+L ++ AI +A
Sbjct: 61 LLGVCTEEEPL-----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+EYL VH DL N L+ D+V + DFGL++ + D K + +
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD--DYYRKKTGGKLP 170
Query: 884 IKGTVGYVAPEYCMG---SEASMTGDVYSFGILLLELFT-GRRP 923
I+ ++APE + S DV+SFG+LL E+FT G P
Sbjct: 171 IR----WMAPESLKDGIFTSKS---DVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FKSFMAECKALRNIRHRNLIKII 768
++G+GSFGSVY + + ++AVK + L ++ E + L +++H N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ + + E + GSL L L +I++ + + Y
Sbjct: 66 GSERDEEKNTLN---IFLEYVSGGSLSSLLK-KFGKLP---EPVIRKY--TRQILEGLAY 116
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
LH + +VH D+K +N+L+D D V + DFG AK L +T + ++GT
Sbjct: 117 LHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD------IETGEGTGSVRGTP 167
Query: 889 GYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
++APE G E D++S G ++E+ TG+ P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 71/212 (33%), Positives = 106/212 (50%), Gaps = 27/212 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG+G FG V G + VAVK + A ++F+AE + +RH NL++++ +
Sbjct: 14 IGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVV- 69
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
+ +V E M GSL D+L + +TL Q++ A+DV +EYL
Sbjct: 70 -LQGNPL---YIVTEYMAKGSLVDYLRSRGRAV----ITLAQQLGFALDVCEGMEYLE-- 119
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
+ VH DL NVL+ D+V+ V DFGLAK + + S + +K T A
Sbjct: 120 -EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWT----A 167
Query: 893 PEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
PE + S DV+SFGILL E+++ GR P
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITIC 771
IG+G FG VYK VA+KVI L+ K + + E + L+ +H N++K
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-- 64
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
S K D +V E GSL+D L +N LT Q + ++ +EYLH
Sbjct: 65 -SYLKK--DELWIVMEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHS 116
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
+ ++H D+K +N+LL D + DFGL+ LS +K ++ + GT ++
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD------TKARNTMV---GTPYWM 164
Query: 892 APEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
APE G D++S GI +EL G+ P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 38/220 (17%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF-KSFMAECKALRNIRHRNLIKIITIC 771
+GQGS G VYK I A+K I++ F K + E K LR+ ++K
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----- 63
Query: 772 SSIDSKGADFK----ALVFECMKNGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVASA 825
GA +K ++V E M GSL D L + + V IA +
Sbjct: 64 ----CYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAY-------IARQILKG 111
Query: 826 IEYLH--HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
++YLH H ++H D+KPSN+L++ + DFG++K L + +
Sbjct: 112 LDYLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------ 161
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GTV Y++PE G S D++S G+ LLE G+ P
Sbjct: 162 --GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 72/233 (30%), Positives = 111/233 (47%), Gaps = 27/233 (11%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL 764
EF +G G FG V++G L ++ + VA+K++ + F E +AL+ +RH++L
Sbjct: 6 EEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
I + +CS + ++ E M+ GSL +L E L + +++A VA
Sbjct: 65 ISLFAVCS-----VGEPVYIITELMEKGSLLAFLRSP----EGQVLPVASLIDMACQVAE 115
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
+ YL +H DL N+L+ D+V V DFGLA+ + + +S I
Sbjct: 116 GMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK----EDVYLSSDKKIPY 168
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHE 936
K T APE S DV+SFGILL E+FT G+ P G+ HE
Sbjct: 169 KWT----APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP-----YPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRHRNLIKIITI 770
+G G FG V++G L + VAVK LK G K F+AE + ++ +RH LI++ +
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVK--TLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
C+ + +V E MK GSL ++L L L Q +++A VAS + YL
Sbjct: 70 CTLEEPI-----YIVTELMKYGSLLEYLQ----GGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+H DL NVL+ + + V DFGLA+ + + + G K + +
Sbjct: 121 AQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-------AREGAKFPIKW 170
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE + + S+ DV+SFGILL E+ T GR P
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 25/220 (11%)
Query: 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKI 767
N IG G+FG VY + + ++AVK I ++ K E K L ++H NL+K
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 768 ITICSSIDSKGADFKALVF-ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + K +F E G+LE+ L H + +I+ + + +
Sbjct: 65 YGV------EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRV--YTLQLLEGL 112
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YLH H +VH D+KP+N+ LDH+ V +GDFG A L ++ + + G
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN----TTTMGEEVQSLAG 165
Query: 887 TVGYVAPEYCMGSEASMTG---DVYSFGILLLELFTGRRP 923
T Y+APE G + G D++S G ++LE+ TG+RP
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (274), Expect = 1e-25
Identities = 76/222 (34%), Positives = 111/222 (50%), Gaps = 24/222 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRH-RNLIKII 768
+G+GSFG VY L D +VA+KV+ K + + F+ E + L ++ H N++K+
Sbjct: 8 LGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
S LV E + GSLED L + L+ + + I + SA+EY
Sbjct: 65 DFFQDEGS-----LYLVMEYVDGGSLEDLLKKIGRKG---PLSESEALFILAQILSALEY 116
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHD-MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
LH ++H D+KP N+LLD D V + DFGLAK L ++ S+ GT
Sbjct: 117 LHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST--SVGT 171
Query: 888 VGYVAPEYCMGSE---ASMTGDVYSFGILLLELFTGRRPTDA 926
GY+APE +G AS + D++S GI L EL TG P +
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 70/234 (29%), Positives = 113/234 (48%), Gaps = 45/234 (19%)
Query: 713 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNL 764
+G+G+FG V+ G D+ +VAVK LK+ A K F E + L N +H N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCK--------LTLIQRV 816
+K +C+ D +VFE M++G L +L K LTL Q +
Sbjct: 71 VKFYGVCTEGDPP-----IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 817 NIAIDVASAIEYL--HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTA 874
IA+ +AS + YL H VH DL N L+ +D+V +GDFG+++ +
Sbjct: 126 QIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDV-------- 172
Query: 875 SKTSSSSIGIKGT----VGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
++ + G + ++ PE M + + DV+SFG++L E+FT G++P
Sbjct: 173 --YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 71/221 (32%), Positives = 115/221 (52%), Gaps = 26/221 (11%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFKSFMAECKALRNIRHRN 763
+ ++IG+G+FG VYKG+ E VA+K I+L ++ A KS M E L+N++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLE-VCKLTLIQRVNIAIDV 822
++K I SI++ D ++ E +NGSL + + E + + + Q V
Sbjct: 61 IVKYIG---SIETS--DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------V 108
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+ YLH + ++H D+K +N+L D V + DFG+A +L+ SK +S +
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVAT-----KLNDVSKDDASVV 160
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT ++APE S AS D++S G ++EL TG P
Sbjct: 161 ---GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK--SFMAECKALRNIRHRNLIKIITI 770
+G G FG V+ G VAVK LK G +F+ E + ++ +RH L+++ +
Sbjct: 14 LGAGQFGEVWMG-TWNGTTKVAVKT--LKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
CS + +V E M GSL D+L KL L Q V++A +A + YL
Sbjct: 70 CS-----EEEPIYIVTEYMSKGSLLDFLKSGEGK----KLRLPQLVDMAAQIAEGMAYLE 120
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+H DL N+L+ ++V + DFGLA+ + D + + IK T
Sbjct: 121 ---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED---DEYTAREGAKFPIKWT--- 171
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE ++ DV+SFGILL E+ T GR P
Sbjct: 172 -APEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G+GSFG V + + A+KV+ + ++ + + E L I H ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAI 826
+ ++ + LV E G L + H S + E + A ++ A+
Sbjct: 60 --YAFQTEEKLY--LVLEYAPGGEL--FSHLSKEGRFSEERARF-------YAAEIVLAL 106
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
EYLH +++ DLKP N+LLD D + DFGLAK LS S+T++ G
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELS----SEGSRTNTFC----G 155
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T Y+APE +G D +S G+LL E+ TG+ P
Sbjct: 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 710 SNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFKS-FMAECKALRNIRHRN 763
+G+G FG V E VAVK +N + +S F E + LR + H N
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQ-VAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
++K +C + G L+ E + +GSL D+L + D ++ L + + + +
Sbjct: 68 IVKYKGVC---EKPGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQIC 119
Query: 824 SAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS-SHQLDTASKTSSSS 881
++YL +H DL N+L++ + + + DFGLAK L + S
Sbjct: 120 KGMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 882 IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPT 924
I + APE S+ S DV+SFG+ L ELFT P+
Sbjct: 176 I------FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 70/274 (25%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFKSFMAECKALRNIRHRNLI 765
IG+GSFG VY D + +K I+L K++ + + E K L+ + H N+I
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER---EDALNEVKILKKLNHPNII 62
Query: 766 KIITICSSIDSKGADFKA-----LVFECMKNGSLEDWLHQ---SNDHL---EVCKLTLIQ 814
K F+ +V E G L + + ++ +Q
Sbjct: 63 KYY----------ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-FVQ 111
Query: 815 RVNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
+ A++YLH ++H D+KP N+ L + + +GDFG++K LSS
Sbjct: 112 -------LCLALKYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--D 158
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMG---SEASMTGDVYSFGILLLELFTGRRPTDAAFTE 930
+KT + GT Y++PE C + S D++S G +L EL T + P +
Sbjct: 159 LAKT------VVGTPYYLSPELCQNKPYNYKS---DIWSLGCVLYELCTLKHPFEGENLL 209
Query: 931 GLTLHEFAKI------ALPEKV----IEIVDPLL 954
L KI +P + +V LL
Sbjct: 210 EL----ALKILKGQYPPIPSQYSSELRNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITI 770
IG+G++G VYK + +VA+K I ++ + G + + E K L+ +RH N++++ I
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 771 CSSIDSKGADFKALVFECMK---NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+S KG+ + +VFE M G L S + K T Q + ++
Sbjct: 67 VTS-KGKGSIY--MVFEYMDHDLTG-----LLDSPEV----KFTESQIKCYMKQLLEGLQ 114
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
YLH + ++H D+K SN+L+++D V + DFGLA+ + ++ ++ I T
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---SADYTNRVI----T 164
Query: 888 VGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
+ Y PE +G+ D++S G +L ELF G+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 37/267 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKAL-RNIRHRNLIKII 768
IG+GSF +V E A+K+++ L ++ K E + L R H +IK+
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ D + F V E NG L ++ + L A ++ A+EY
Sbjct: 69 --YTFQDEENLYF---VLEYAPNGELLQYIRK------YGSLDEKCTRFYAAEILLALEY 117
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK--- 885
LH ++H DLKP N+LLD DM + DFG AK L + ++K +++I +
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 886 ---------GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936
GT YV+PE A + D+++ G ++ ++ TG+ P + E LT +
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS-NEYLTFQK 233
Query: 937 FAKIAL------PEKVIEIVDPLLLIE 957
K+ P ++++ LL+++
Sbjct: 234 ILKLEYSFPPNFPPDAKDLIEKLLVLD 260
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 62/216 (28%), Positives = 114/216 (52%), Gaps = 22/216 (10%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRN 763
++ + +G G +G VY+G+ + + VAVK LK+ + F+ E ++ I+H N
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPN 63
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
L++++ +C+ + F ++ E M G+L D+L + + EV + L+ +A ++
Sbjct: 64 LVQLLGVCT----REPPF-YIITEFMTYGNLLDYL-RECNRQEVNAVVLLY---MATQIS 114
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
SA+EYL +H DL N L+ + + V DFGL++ ++ DT + + +
Sbjct: 115 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFP 168
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
IK T APE ++ S+ DV++FG+LL E+ T
Sbjct: 169 IKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 34/223 (15%)
Query: 711 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNL 764
+IG G FG V +G L G+ E+ VA+K LK F+ E + H N+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
I++ + + S+ ++ E M+NGSL+ +L +++ K T+ Q V + +AS
Sbjct: 68 IRLEGVVTK--SRPV---MIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIAS 117
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
++YL VH DL N+L++ ++V V DFGL++ L + T I I
Sbjct: 118 GMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED--SEATYTTKGGKIPI 172
Query: 885 KGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ T APE Y + AS DV+SFGI++ E+ + G RP
Sbjct: 173 RWT----APEAIAYRKFTSAS---DVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 70/225 (31%), Positives = 109/225 (48%), Gaps = 29/225 (12%)
Query: 705 SEFASSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRH 761
SE +G G FG V+ G G+ + VA+K+I +GA F+ E K + + H
Sbjct: 4 SELTFLKELGSGQFGVVHLGKWRGKID--VAIKMIR---EGAMSEDDFIEEAKVMMKLSH 58
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
NL+++ +C+ + F +V E M NG L ++L + + L ++ D
Sbjct: 59 PNLVQLYGVCTK---QRPIF--IVTEYMANGCLLNYL-RERKGKLGTEWLL----DMCSD 108
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
V A+EYL + +H DL N L+ D V V DFGLA+++ Q +SS
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-------TSS 158
Query: 882 IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTD 925
G K V + PE S S DV+SFG+L+ E+F+ G+ P +
Sbjct: 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 76/213 (35%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMI-VAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITIC 771
IG+G FG V +LG+ VAVK I K ++F+AE + +RH NL++++ +
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
++ KG + +V E M GSL D+L + L + ++DV A+EYL
Sbjct: 69 --VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEA 120
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
+ VH DL NVL+ D V+ V DFGL K SS Q DT K V +
Sbjct: 121 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTG----------KLPVKWT 166
Query: 892 APEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE + S DV+SFGILL E+++ GR P
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 69/213 (32%), Positives = 111/213 (52%), Gaps = 31/213 (14%)
Query: 713 IGQGSFGSVYKG-ILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITIC 771
IG+G FG+V +G G+ VAVK N+K ++F+ E + + H+NL++++ +
Sbjct: 14 IGEGEFGAVLQGEYTGQK---VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV- 67
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
I G +V E M G+L ++L L +++IQ + ++DVA +EYL
Sbjct: 68 --ILHNGL---YIVMELMSKGNLVNFLRTRGRAL----VSVIQLLQFSLDVAEGMEYLE- 117
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
+VH DL N+L+ D V+ V DFGLA+ + S +D + K V +
Sbjct: 118 --SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNS----------KLPVKWT 164
Query: 892 APEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE + S DV+S+G+LL E+F+ GR P
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 37/217 (17%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVK------VINLKQKGAFKSFMAECKALRNIRHRNLIK 766
IG+G+FG VYKG+L + VAVK +LK+K F+ E + L+ H N++K
Sbjct: 3 IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+I +C +V E + GSL +L + + L V KL + +++D A+ +
Sbjct: 57 LIGVCVQKQPI-----YIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGM 106
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS---SIG 883
EYL +H DL N L+ + V + DFG+ S + + T S I
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFGM-----SREEEGGIYTVSDGLKQIP 158
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG 920
IK T APE + DV+S+GILL E F+
Sbjct: 159 IKWT----APEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 69/224 (30%), Positives = 119/224 (53%), Gaps = 35/224 (15%)
Query: 712 MIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQKGAF-----KSFMAECKALRNIRHRN 763
+IG G FG V +G L G+ E+ VA+K + K + + F++E + H N
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL----KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 764 LIK---IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 820
+I ++T + ++ E M+NG+L+ +L Q ND + T+IQ V +
Sbjct: 67 IIHLEGVVTKSRPV--------MIITEFMENGALDSFLRQ-NDG----QFTVIQLVGMLR 113
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
+A+ ++YL + VH DL N+L++ ++V V DFGL++FL + DT+ T +S
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTS 167
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
S+G K + + APE + + DV+S+GI++ E+ + G RP
Sbjct: 168 SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 26/227 (11%)
Query: 705 SEFASSNMIGQGSFGSVYKGI---LGEDEMI-VAVKVINLKQ-KGAFKSFMAECKALRNI 759
+E ++G G+FG+VYKG+ GE I VA+KV+ + A K + E + ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 760 RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
H ++++++ IC S L+ + M G L D++ D++ L +N
Sbjct: 67 DHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYL-----LNWC 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+ +A + YL +VH DL NVL+ + DFGLAK L +
Sbjct: 116 VQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD--EKEYHAEG 170
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTD 925
+ IK ++A E + + DV+S+G+ + EL T G +P +
Sbjct: 171 GKVPIK----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRHR 762
SE IG G FG V+ G E VA+K I ++GA + F+ E + + + H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTI---REGAMSEEDFIEEAQVMMKLSHP 59
Query: 763 NLIKIITIC---SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
L+++ +C S I LVFE M++G L D+L + TL+ +
Sbjct: 60 KLVQLYGVCTERSPI--------CLVFEFMEHGCLSDYLRAQRGKFS--QETLLG---MC 106
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+DV + YL ++H DL N L+ + V V DFG+ +F+ Q +
Sbjct: 107 LDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-------T 156
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTD 925
SS G K V + +PE S+ S DV+SFG+L+ E+F+ G+ P +
Sbjct: 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 8e-21
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITI 770
+G+G++G VYK + IVA+K I L + G + + E L+ ++H N++K++ +
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
+ LVFE L+ +L + L LI+ I + + Y H
Sbjct: 67 IHTERKL-----YLVFEYCDM-DLKKYLDKRPGPLS---PNLIKS--IMYQLLRGLAYCH 115
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
H ++H DLKP N+L++ D V + DFGLA+ +T + + T+ Y
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI-----PLRTYTHEV---VTLWY 164
Query: 891 VAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
APE +GS+ T D++S G + E+ TG+
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-21
Identities = 63/228 (27%), Positives = 115/228 (50%), Gaps = 33/228 (14%)
Query: 713 IGQGSFGSVY----KGILGE-DEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKI 767
+G+G+FG V+ +L E D+M+VAVK + + A + F E + L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWL--HQSNDHL-------EVCKLTLIQRVNI 818
+C+ +VFE M++G L +L H + + +LTL Q + I
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
A +AS + YL VH DL N L+ +V +GDFG+++ + S T
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--------TD 176
Query: 879 SSSIGIKGT--VGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+G + + ++ PE + + + D++SFG++L E+FT G++P
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 34/233 (14%)
Query: 711 NMIGQGSFGSVYKGIL------GEDEMIVAVKVINLKQKGA----FKSFMAECKALRNIR 760
N +G G+FG VY+G G + VAVK + +KGA K F+ E + N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSN-DHLEVCKLTLIQRVNIA 819
H N++K++ +C + + ++ E M+ G L +L + + LTL + ++I
Sbjct: 58 HPNIVKLLGVCLLNEPQ-----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DHDMVSHVGDFGLAKFLSSHQLDTA 874
+DVA YL Q +H DL N L+ D D V +GDFGLA+ + D
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS--DYY 167
Query: 875 SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDA 926
K + ++ ++APE + + + DV+SFG+L+ E+ T G++P A
Sbjct: 168 RKEGEGLLPVR----WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 27/214 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRHRNLIKIITI 770
+GQG FG V+ G VA+K + + G ++F+ E + ++ +RH L+++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
S + +V E M GSL D+L L L Q V++A +AS + Y+
Sbjct: 70 VSE------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 119
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ VH DL+ +N+L+ ++V V DFGLA+ + ++ TA + G K + +
Sbjct: 120 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQ------GAKFPIKW 169
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE + ++ DV+SFGILL EL T GR P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 713 IGQGSFGSVY---KGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNL-I 765
I +G++G V+ K G+ I A+KVI + +K + E R+I +
Sbjct: 1 ISKGAYGRVFLAKKKSTGD---IYAIKVIKKADMIRKNQVDQVLTE----RDILSQAQSP 53
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
++ + S K + LV E + G L L E + R+ IA ++ A
Sbjct: 54 YVVKLYYSFQGKKNLY--LVMEYLPGGDLASLLENVGSLDED-----VARIYIA-EIVLA 105
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+EYLH + ++H DLKP N+L+D + + DFGL+K + + I
Sbjct: 106 LEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE +G S T D +S G +L E G P
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS--FMAECKALRNIRHRNLIKIITI 770
+G G FG V G + VA+K+I ++G+ F+ E K + + H L+++ +
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
C+ + + +V E M NG L ++L + + +L + + DV + YL
Sbjct: 68 CTK---QRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLE 117
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+H DL N L+D V DFGL++++ + +SS+G K V +
Sbjct: 118 SK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRW 167
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTD 925
PE + S+ S DV++FG+L+ E+++ G+ P +
Sbjct: 168 SPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 712 MIGQGSFGSVYKGI--LGEDEMI-VAVKVINLKQKGAFKS-FMAECKALRNIRHRNLIKI 767
IG+G FG VY+G+ E+E I VAVK + + F+ E +R H +++K+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
I + + + +V E G L +L + L++ L L + +++A+
Sbjct: 73 IGVITE------NPVWIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQLSTALA 121
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
YL VH D+ NVL+ +GDFGL+++L ASK + IK
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG---KLPIK-- 173
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
++APE + DV+ FG+ + E+ G +P
Sbjct: 174 --WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 24/226 (10%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIIT 769
++G+G+FG V+ D+ +V +K I ++Q K + EC+ L+ + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ ++ K +V E G+L +++ + + L L V I + L
Sbjct: 67 --NFLEDKAL---MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA-------L 114
Query: 830 HHHCQPPMVHGDLKPSNVLLD-HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
HH ++H DLK N+LLD H MV +GDFG++K LSS S + + GT
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---------KSKAYTVVGTP 165
Query: 889 GYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934
Y++PE C G + D+++ G +L EL + +R +AA L L
Sbjct: 166 CYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 33/229 (14%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL----KQKGAFKSFMAECKALR 757
S +IG G FG V++GIL G E+ VA+K + KQ+ + F++E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMG 61
Query: 758 NIRHRNLIKIITICSSIDSKGADFK--ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQR 815
H N+I++ + + FK ++ E M+NG+L+ +L + + + Q
Sbjct: 62 QFSHHNIIRLEGVVTK-------FKPAMIITEYMENGALDKYLRDHDG-----EFSSYQL 109
Query: 816 VNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875
V + +A+ ++YL VH DL N+L++ ++ V DFGL++ L T +
Sbjct: 110 VGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166
Query: 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
TS I I+ T APE + + DV+SFGI++ E+ + G RP
Sbjct: 167 -TSGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 69/230 (30%), Positives = 115/230 (50%), Gaps = 36/230 (15%)
Query: 713 IGQGSFGSVYKGILGE--------DEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL 764
+G+G+FG V+ L E D+M+VAVK + A K F E + L N++H ++
Sbjct: 13 LGEGAFGKVF---LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWL--HQSNDHLEV--------CKLTLIQ 814
+K +C D +VFE MK+G L +L H + + V +L L Q
Sbjct: 70 VKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 815 RVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTA 874
++IA +AS + YL VH DL N L+ +++ +GDFG+++ + S D
Sbjct: 125 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST--DYY 179
Query: 875 SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ + I+ ++ PE M + + DV+SFG++L E+FT G++P
Sbjct: 180 RVGGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 27/214 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRHRNLIKIITI 770
+G G FG V+ G + VAVK + + G +SF+ E + ++ +RH L+++ +
Sbjct: 14 LGNGQFGEVWMGTWNGNTK-VAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
S + +V E M GSL D+L L L V++A VA+ + Y+
Sbjct: 70 VSE------EPIYIVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIE 119
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ +H DL+ +N+L+ +V + DFGLA+ + ++ TA + G K + +
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQ------GAKFPIKW 169
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE + ++ DV+SFGILL EL T GR P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 27/214 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRHRNLIKIITI 770
+GQG FG V+ G VA+K + + G ++F+ E + ++ +RH L+ + +
Sbjct: 14 LGQGCFGEVWMGTW-NGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
S + +V E M GSL D+L + + L L Q V++A +A + Y+
Sbjct: 70 VSE------EPIYIVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYIE 119
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ +H DL+ +N+L+ ++V + DFGLA+ + ++ TA + G K + +
Sbjct: 120 ---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQ------GAKFPIKW 169
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE + ++ DV+SFGILL EL T GR P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 8e-19
Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 39/291 (13%)
Query: 704 TSEFASSNMIGQGSFGSVYKGI-LGEDEMI---VAVKVI-NLKQKGAFKSFMAECKALRN 758
+E ++G G FG+V+KGI + E + I VA+K I + + F+ A+ +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 759 IRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
+ H +++++ IC GA + LV + GSL D + Q D L+ +L +N
Sbjct: 66 LDHAYIVRLLGICP-----GASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRL-----LNW 114
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
+ +A + YL H MVH +L N+LL D + + DFG+A L D
Sbjct: 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP---DDKKYFY 168
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937
S K + ++A E + + DV+S+G+ + E+ + G P G+ HE
Sbjct: 169 SE---HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP-----YAGMRPHEV 220
Query: 938 AKI-----ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRI 983
+ L + I +D + VM MI E++R +E N R+
Sbjct: 221 PDLLEKGERLAQPQICTIDVYM---VMVKCWMIDENVRPTFKELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 9e-19
Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 35/223 (15%)
Query: 712 MIGQGSFGSVYKGIL---GEDEMIVAVKVINL----KQKGAFKSFMAECKALRNIRHRNL 764
+IG G FG V G L G+ E+ VA+K + KQ+ + F++E + H N+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFDHPNI 67
Query: 765 IK---IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
I ++T + +V E M+NGSL+ +L + + T+IQ V +
Sbjct: 68 IHLEGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQF-----TVIQLVGMLRG 114
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
+AS ++YL VH DL N+L++ ++V V DFGL++ L + A T
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTRGGK 170
Query: 882 IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
I I+ T APE + + DV+S+GI++ E+ + G RP
Sbjct: 171 IPIRWT----APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITIC 771
IG+G+ G VYK VA+K + L+++ + + E +++ +H N I
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPN------IV 78
Query: 772 SSIDS---KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLI--QRVNIAIDVASAI 826
DS + +V E M GSL D + Q + + Q + +V +
Sbjct: 79 DYYDSYLVGDELW--VVMEYMDGGSLTDIITQ-------NFVRMNEPQIAYVCREVLQGL 129
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
EYLH ++H D+K N+LL D + DFG A L+ + SK +S + G
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK----SKRNS----VVG 178
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T ++APE + D++S GI+ +E+ G P
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 62/217 (28%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FKSFMAECKALRNIRHRNLIKIITIC 771
IG G+ VY I + VA+K I+L++ E +A+ H N++K
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--YYT 66
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVASAIEY 828
S + D LV + GSL D + S + IA +V +EY
Sbjct: 67 SFVVG---DELWLVMPYLSGGSLLDIMKSSY------PRGGLDEAIIATVLKEVLKGLEY 117
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
LH + Q +H D+K N+LL D + DFG++ L D +T GT
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL----ADGGDRTRKVRKTFVGTP 170
Query: 889 GYVAPEYCMGSEASMT--GDVYSFGILLLELFTGRRP 923
++APE M D++SFGI +EL TG P
Sbjct: 171 CWMAPE-VMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 16/219 (7%)
Query: 712 MIGQGSFGSVYKGILGEDEMI---VAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIK 766
++G+G FGSV +G L +D+ VAVK + L + F++E +++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 767 IITICSSIDSKGADFKALV-FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+I +C S K +V MK+G L +L S KL L + +D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+EYL + +H DL N +L DM V DFGL+K + S D + + + +K
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG--DYYRQGRIAKMPVK 180
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
++A E + DV++FG+ + E+ T G+ P
Sbjct: 181 ----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 27/214 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRHRNLIKIITI 770
+G G FG V+ G VA+K +LKQ G+ ++F+AE ++ ++H L+++ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTK-VAIK--SLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
+ + ++ E M+NGSL D+L KLT+ + +++A +A + ++
Sbjct: 70 VTQ------EPIYIITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIE 119
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ +H DL+ +N+L+ + + DFGLA+ + ++ TA + G K + +
Sbjct: 120 ---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TARE------GAKFPIKW 169
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE ++ DV+SFGILL E+ T GR P
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FKSFMAECKALRNIRHRNLIKIITIC 771
+G G+ G V K + I+AVK I L+ A K + E L I+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY---IVGFY 65
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+ + G + E M GSL+ L + + L IA+ V + YLH
Sbjct: 66 GAFYNNGDIS--ICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
+ ++H D+KPSN+L++ + DFG++ L +++ +KT GT Y+
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL----VNSLAKTFV------GTSSYM 166
Query: 892 APEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
APE G++ S+ D++S G+ L+EL TGR P
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 28/212 (13%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI--NLKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
++G+G+FG V+KG L +D+ VAVK +L Q+ K F++E + L+ H N++K+I
Sbjct: 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+C+ +V E + G +L + D L+ +L V A+D A+ + YL
Sbjct: 60 VCTQRQPI-----YIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYL 109
Query: 830 H-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT- 887
+C +H DL N L+ + V + DFG+ S Q D +SS G+K
Sbjct: 110 ESKNC----IHRDLAARNCLVGENNVLKISDFGM-----SRQEDDGIYSSS---GLKQIP 157
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+ + APE S DV+S+GILL E F+
Sbjct: 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 60/235 (25%), Positives = 90/235 (38%), Gaps = 49/235 (20%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFKSFMAECKALRNIRHRNLIKI 767
IG+GSFG+V K D I+ K I+ K+K + ++E LR ++H N I
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK---QQLVSEVNILRELKHPN---I 61
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQR------------ 815
+ I + +V E + G L LIQ+
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLA---------------QLIQKCKKERKYIEEEF 106
Query: 816 -VNIAIDVASAIEYLHH--HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLD 872
I + A+ H+ ++H DLKP+N+ LD + +GDFGLAK L
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 873 TASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAA 927
+ GT Y++PE D++S G L+ EL P A
Sbjct: 167 AKTYV--------GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVI------NLKQKGAFKSFMAECKALRNIRHRNLIK 766
IG+G+FG V+ G L D VAVK +LK K F+ E + L+ H N+++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+I +C+ K + +V E ++ G +L L+V LIQ V + A+ +
Sbjct: 58 LIGVCTQ---KQPIY--IVMELVQGGDFLTFLRTEGPRLKV--KELIQMVE---NAAAGM 107
Query: 827 EYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
EYL HC +H DL N L+ V + DFG+++ + +S+ G+K
Sbjct: 108 EYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSR-------EEEDGVYASTGGMK 156
Query: 886 GT-VGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
V + APE S DV+SFGILL E F+
Sbjct: 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGE--DEMIVAVKVINLKQKGAF--KSFMAECKALRNIR 760
SE +G G FG V+ LG+ ++ VA+K IN +GA + F+ E K + +
Sbjct: 4 SELTFMKELGSGQFGVVH---LGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLS 57
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 820
H L+++ +C K +V E M+NG L ++L Q L L +++
Sbjct: 58 HPKLVQLYGVC--TQQKPL---YIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQ 107
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
DV +EYL + +H DL N L+ V V DFG+ +++ + +S
Sbjct: 108 DVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TS 157
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
S G K V + PE S+ S DV+SFG+L+ E+FT G+ P
Sbjct: 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 63/243 (25%), Positives = 118/243 (48%), Gaps = 35/243 (14%)
Query: 699 ELSKATSEFASSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQKGAFK---SFMAE 752
E+ + F +G+G+FG VYKG L E +V + LK+ K F E
Sbjct: 1 EIPLSAVRF--LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 753 CKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVC---- 808
+ + +++H N++ ++ +C+ ++FE + +G L ++L +++ H +V
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPT-----CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 809 ------KLTLIQRVNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861
L ++IAI +A+ +EYL HH VH DL N L+ + + DFG
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFG 169
Query: 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-G 920
L++ + S D S S + ++ ++ PE + + + D++SFG++L E+F+ G
Sbjct: 170 LSRDIYSA--DYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFSYG 223
Query: 921 RRP 923
+P
Sbjct: 224 LQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G+GS+GSVYK I E +VA+KV+ + + + + E L+ ++K
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKY----- 63
Query: 773 SIDSKGADFKA----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVASA 825
G+ FK +V E GS+ +D +++ TL + IA
Sbjct: 64 ----YGSYFKNTDLWIVMEYCGAGSV-------SDIMKITNKTLTEE-EIAAILYQTLKG 111
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+EYLH + +H D+K N+LL+ + + + DFG +S DT +K ++ +
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG----VSGQLTDTMAKRNT----VI 160
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT ++APE + D++S GI +E+ G+ P
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 35/227 (15%)
Query: 712 MIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA---FKSFMAECKALRNI-RHR 762
+G+G+FG V K + VAVK+ LK ++E + ++ I +H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQ----------SNDHLEVCKLTL 812
N+I ++ +C+ +G + +V E +G+L D+L + LT
Sbjct: 77 NIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 813 IQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLD 872
V+ A VA +E+L +H DL NVL+ D V + DFGLA+ + H +D
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI--HHID 186
Query: 873 TASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
KT++ + +K ++APE + DV+SFG+LL E+FT
Sbjct: 187 YYRKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G G FG V + A+K + + + G + +E + L H ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ D K + ++ E G L L + R IA V A EYL
Sbjct: 60 -RTFKDKK---YIYMLMEYCLGGELWTILR-DRGLFD----EYTARFYIAC-VVLAFEYL 109
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H+ +++ DLKP N+LLD + + DFG AK L S Q KT + GT
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTWT----FCGTPE 157
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
YVAPE + + D +S GILL EL TGR P
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVIN----LKQKGAFKSFMAECKALRNIRHRN 763
+GQGSFG VY+G+ GE E VA+K +N ++++ F+ E ++ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER---IEFLNEASVMKEFNCHH 70
Query: 764 LIKIITICSSIDSKGADFKALV-FECMKNGSLEDWLHQSN-DHLEVCKL---TLIQRVNI 818
+++++ + S G LV E M G L+ +L + L TL + + +
Sbjct: 71 VVRLLGVV----STGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
A ++A + YL VH DL N ++ D+ +GDFG+ + + D K
Sbjct: 125 AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET--DYYRKGG 179
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+ ++ ++APE + DV+SFG++L E+ T
Sbjct: 180 KGLLPVR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 68/233 (29%), Positives = 102/233 (43%), Gaps = 61/233 (26%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK---SFMA--ECKALRNIRHRNLIKI 767
+G+G++ VYK E IVA+K I L ++ K +F A E K L+ ++H N+I +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVAS 824
+ + LVFE M D LE +I+ +I + D+ S
Sbjct: 68 LDVFGH-----KSNINLVFEFM-----------ETD-LEK----VIKDKSIVLTPADIKS 106
Query: 825 -------AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS------HQL 871
+EYLH + ++H DLKP+N+L+ D V + DFGLA+ S HQ+
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163
Query: 872 DTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGRRP 923
T Y APE G+ G D++S G + EL R P
Sbjct: 164 --------------VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 64/224 (28%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 713 IGQGSFGSV-----YKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKI 767
+G+G+FG V Y +D+++VAVK + A K F E + L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWL--HQSNDHLEV-----CKLTLIQRVNIAI 820
+C D +VFE MK+G L +L H + L +LT Q ++IA
Sbjct: 73 YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
+A+ + YL VH DL N L+ +++ +GDFG+++ + D +
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHT 182
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ I+ ++ PE M + + DV+S G++L E+FT G++P
Sbjct: 183 MLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 66/246 (26%), Positives = 107/246 (43%), Gaps = 36/246 (14%)
Query: 710 SNMIGQGSFGSVYKGILGEDEMIVAVK--VINLKQKGAFKSFMAECKALRNIR---HRNL 764
IG+G++G+VYK VA+K + L ++G S + E L+ + H N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDW-LHQSNDH-----LEVCKLTLIQRVNI 818
++++ +C + LVFE + D L L + ++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV------DQDLATYLSKCPKPGLPPETIK-----DL 112
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
+ +++LH H +VH DLKP N+L+ D + DFGLA+ S + TS
Sbjct: 113 MRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE----MALTS 165
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE-F 937
+ T+ Y APE + S + D++S G + ELF RRP +E L + F
Sbjct: 166 -----VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIF 219
Query: 938 AKIALP 943
I LP
Sbjct: 220 DVIGLP 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 713 IGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIK 766
+G G+FGSV KG+ E+ VAVK LKQ K F+ E + + H +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKT--LKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+I +C KG LV E G L +L + + V L + A VA +
Sbjct: 61 LIGVC-----KGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKEL-----AHQVAMGM 108
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YL VH DL NVLL + + + DFG+ S L S ++ +
Sbjct: 109 AYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGM-----SRALGAGSDYYRATTAGRW 160
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ + APE + S DV+S+G+ L E F+ G +P
Sbjct: 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 78/282 (27%), Positives = 133/282 (47%), Gaps = 39/282 (13%)
Query: 705 SEFASSNMIGQGSFGSVYKGI-LGEDEMI---VAVKVIN-LKQKGAFKSFMAECKALRNI 759
+E ++G G+FG+VYKGI + E E + VA+K++N A FM E + ++
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66
Query: 760 RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
H +L++++ +C S + LV + M +G L D++H+ D++ L +N
Sbjct: 67 DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWC 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+ +A + YL + +VH DL NVL+ + DFGLA+ L + + +
Sbjct: 116 VQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD--- 169
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938
G K + ++A E + + DV+S+G+ + EL T G +P D G+ E
Sbjct: 170 ---GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-----GIPTREIP 221
Query: 939 KI-----ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQE 975
+ LP+ I +D + VM MI D R K +E
Sbjct: 222 DLLEKGERLPQPPICTIDVYM---VMVKCWMIDADSRPKFKE 260
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-17
Identities = 70/241 (29%), Positives = 116/241 (48%), Gaps = 44/241 (18%)
Query: 706 EFASSNMI-----GQGSFGSVYK----GILGE--DEMI-VAVKVINLKQKGAFKSF---M 750
EF ++ G+G FG V + GI D+ + VAVK+ LK K +
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLI 65
Query: 751 AECKALRNI-RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS-----NDH 804
+E + ++ I +H+N+I ++ +C+ +G + ++ E G+L ++L +
Sbjct: 66 SEMELMKLIGKHKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYT 120
Query: 805 LEVCK-----LTLIQRVNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVG 858
++ K L+ V+ A VA +EYL C +H DL NVL+ D V +
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIA 176
Query: 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELF 918
DFGLA+ H +D KTS+ + +K ++APE + DV+SFGIL+ E+F
Sbjct: 177 DFGLAR--GVHDIDYYKKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIF 230
Query: 919 T 919
T
Sbjct: 231 T 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK----GAFKSFMAECKALRNIRHRNLIK 766
+IG+G+FG V + + + A+K +N KQK G+ ++ + E + L+ + H L+
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 767 IITICSSI-DSKGADFKALVFECMKNGSLEDWLHQSNDHLE-VCKLTLIQRVNIAIDVAS 824
+ S D + LV + + G L L Q E K ++
Sbjct: 65 L---WYSFQDE---ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVL 111
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
A+EYLH ++H D+KP N+LLD H+ DF +A ++ L T
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT---------ST 159
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT GY+APE S+ D +S G+ E G+RP
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK----QKGAFKSFMAECKALRNIRHRNLIKII 768
+G+G FGSV +G L +D+ I+ V V +K + + F++E ++ H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 769 TIC-SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQR--VNIAIDVASA 825
+C +++S+G ++ MK+G L +L S L C L + V D+AS
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS--RLGDCPQYLPTQMLVKFMTDIASG 124
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+EYL +H DL N +L+ +M V DFGL+K + + + + K
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA------K 175
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
V ++A E + DV+SFG+ + E+ T G+ P
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITI 770
IG+G+ G V+K E VA+K + L++ G + E KAL+ +H ++K++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
+ G+ F LV E M L + L L Q + + + Y+H
Sbjct: 66 --DVFPHGSGF-VLVMEYMP-SDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMH 116
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS-------SHQLDTASKTSSSSIG 883
++H DLKP+N+L+ D V + DFGLA+ S SHQ+
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV------------ 161
Query: 884 IKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
T Y APE G+ G D+++ G + EL G
Sbjct: 162 --ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 63/226 (27%), Positives = 93/226 (41%), Gaps = 48/226 (21%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG G++G VYK +VA+KVI L+ F+ E L+ RH N++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF---- 66
Query: 773 SIDSKGADFKA----LVFECMKNGSLEDWLHQSNDHLE------VCKLTLIQRVNIAIDV 822
G+ + +V E GSL+D + L VC+ TL
Sbjct: 67 -----GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---------- 111
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+ YLH + +H D+K +N+LL D GD LA F S QL S I
Sbjct: 112 -KGLAYLHETGK---IHRDIKGANILLTED-----GDVKLADFGVSAQLTATIAKRKSFI 162
Query: 883 GIKGTVGYVAPEYCMGSEASMTG-----DVYSFGILLLELFTGRRP 923
GT ++APE + + G D+++ GI +EL + P
Sbjct: 163 ---GTPYWMAPE--VAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 61/221 (27%), Positives = 114/221 (51%), Gaps = 25/221 (11%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINL---------KQKGAFKSFMAECKALRNIRHR 762
+IG GSFGSVY G+ ++AVK + L +++ + E L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 822
N+++ + SS+D AD + E + GS+ L+ E TL++ N +
Sbjct: 67 NIVQYLG--SSLD---ADHLNIFLEYVPGGSVAALLNNYGAFEE----TLVR--NFVRQI 115
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+ YLH+ ++H D+K +N+L+D+ + DFG++K L ++ L T + + S+
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+G+V ++APE + + D++S G L++E+ TG+ P
Sbjct: 173 --QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 712 MIGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKI 767
+G+G+FGSV Y + +VAVK + + F E + L++++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+C S + LV E + GSL D+L + + L+ KL L A + +E
Sbjct: 71 KGVCYSAGRRNL---RLVMEYLPYGSLRDYLQKHRERLDHRKLLLY-----ASQICKGME 122
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
YL VH DL N+L++ + +GDFGL K L + + S
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES-----P 174
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+ + APE S+ S+ DV+SFG++L ELFT
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 39/211 (18%)
Query: 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVI 558
L L N L G +P I L++L + +S N G IP +L + SLE LD+S NSF+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 559 PHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKL 618
P SLG L S+++LN + N+LSG++P L G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHR-----ASF 520
Query: 619 SLQGNVKLCGGTDELHLPTCPSKGSRKPKITL-LKVLIPVAVLCMVLSSCLTIVYARRRR 677
+ N LCG L C S KI + V VA L +V+ + + + +RR+
Sbjct: 521 NFTDNAGLCGIPG---LRACGPHLSVGAKIGIAFGVS--VAFLFLVICA---MCWWKRRQ 572
Query: 678 SARKSVDTSPREKQFPTVSYAELSKATSEFA 708
+ ++ + RE YA KA + F+
Sbjct: 573 NILRAQRIAARE-----APYA---KARTHFS 595
|
Length = 623 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
IG+G F VYK I D +VA+K + + A + + E L+ + H N+IK +
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV--NIAIDVASAIE 827
S I++ + +V E G L + H + K + +R + + SA+E
Sbjct: 70 --SFIENNELN---IVLELADAGDLSRMI----KHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
++H ++H D+KP+NV + V +GD GL +F SS S GT
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GT 169
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y++PE + + D++S G LL E+ + P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 75/252 (29%), Positives = 109/252 (43%), Gaps = 52/252 (20%)
Query: 713 IGQGSFGSVYKGIL--------GEDEMIVAVKVINLKQKGAFKS-FMAECKALRNIRHRN 763
+G+G FG V L G EM VAVK + + S + E L+ + H N
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEM-VAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
++K CS KG L+ E + GSL D+L + L L Q + A +
Sbjct: 68 IVKYKGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQIC 117
Query: 824 SAIEYLH--HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL-SSHQLDTASKTSSS 880
+ YLH H+ +H DL NVLLD+D + +GDFGLAK + H+ + S
Sbjct: 118 EGMAYLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940
V + A E ++ S DV+SFG+ L EL T H +K
Sbjct: 173 P------VFWYAVECLKENKFSYASDVWSFGVTLYELLT---------------HCDSKQ 211
Query: 941 ALPEKVIEIVDP 952
+ P+K E++ P
Sbjct: 212 SPPKKFEEMIGP 223
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 32/248 (12%)
Query: 682 SVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK 741
S +S + S +K+ SE N IG G+ G+VYK I + A+KVI
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN 110
Query: 742 QKGAFKSFMA-ECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQ 800
+ + + E + LR++ H N++K C + + + L+ E M GSLE
Sbjct: 111 HEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG--TH 163
Query: 801 SNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860
D + ++A + S I YLH +VH D+KPSN+L++ + DF
Sbjct: 164 IADEQFLA--------DVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADF 212
Query: 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYC-----MGSEASMTGDVYSFGILLL 915
G+++ L+ T +SS GT+ Y++PE G+ GD++S G+ +L
Sbjct: 213 GVSRILAQ----TMDPCNSSV----GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264
Query: 916 ELFTGRRP 923
E + GR P
Sbjct: 265 EFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA--ECKALRNIRHRN 763
+F N IG+GSFG V+K + D+ + A+K I+L + + A E + L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
+I+ S KG +V E +NG L L L Q I +
Sbjct: 61 IIRYY---ESFLDKGK--LNIVMEYAENGDLHKLLKMQRGR----PLPEDQVWRFFIQIL 111
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+ +LH ++H D+K N+ LD +GD G+AK LS + + T
Sbjct: 112 LGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANT------ 160
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
I GT Y++PE C + DV++ G++L E TG+ P DA
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 40/221 (18%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF------KSFMAECKALRNIRHRNLI 765
++G+G++G V K IVA+K K K + K+ + E K LR +RH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVA 823
+ KG + LVFE ++ LE L S L + + + Q +
Sbjct: 64 NLKEAFRR---KGRLY--LVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQ------ 111
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
AI Y H H ++H D+KP N+L+ V + DFG A+ L ++ +S
Sbjct: 112 -AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR-------ARPASPLTD 160
Query: 884 IKGTVGYVAPEYCMGSEASMTG---DVYSFGILLLELFTGR 921
T Y APE +G + G DV++ G ++ EL G
Sbjct: 161 YVATRWYRAPELLVGD--TNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 60/233 (25%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF------KSFMAECKALRNIRHRNLIK 766
IG G++G V + VA+K I+ F K + E K LR++RH N+I
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN----VFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 767 IITICSSIDSKGADFKAL--VFECMKNGSLEDWLHQ--------SNDHLEVCKLTLIQRV 816
++ I DF + V E M E LH+ ++DH + L Q
Sbjct: 64 LLDI--LRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDH---IQYFLYQ-- 111
Query: 817 NIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875
+ ++YLH + +H DLKPSN+L++ + + DFGLA+ + + +
Sbjct: 112 -----ILRGLKYLHSANV----IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 876 KTSSSSIGIKGTVGYV------APEYCMGSEASMTG-DVYSFGILLLELFTGR 921
T YV APE + S D++S G + EL T +
Sbjct: 163 LT-----------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-16
Identities = 76/284 (26%), Positives = 129/284 (45%), Gaps = 43/284 (15%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL---GEDEMI-VAVKVI-NLKQKGAFKSFMAECKALRNI 759
+EF ++G G+FG+VYKG+ GE I VA+K + A K + E + ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 760 RHRNLIKIITIC--SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVN 817
+ ++ +++ IC S++ L+ + M G L D++ + D+ + L+ N
Sbjct: 67 DNPHVCRLLGICLTSTVQ--------LITQLMPFGCLLDYVREHKDN--IGSQYLL---N 113
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
+ +A + YL +VH DL NVL+ + DFGLAK L A +
Sbjct: 114 WCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL------GADEK 164
Query: 878 SSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHE 936
+ G K + ++A E + + DV+S+G+ + EL T G +P D G+ E
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----GIPASE 219
Query: 937 FAKI-----ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQE 975
+ I LP+ I +D + +M MI D R K +E
Sbjct: 220 ISSILEKGERLPQPPICTIDVYM---IMVKCWMIDADSRPKFRE 260
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHR 762
+EF N IG+G++G VY+ IVA+K + + + G S + E L N+RH
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 763 NLIKIITICSSIDSKGADFKALVFE-CMKN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAI 820
N++++ + + K D LV E C ++ SL D + + Q + +
Sbjct: 67 NIVELKEV---VVGKHLDSIFLVMEYCEQDLASLLDNMP--------TPFSESQVKCLML 115
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
+ ++YLH + ++H DLK SN+LL + DFGLA+ K
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-- 170
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
T+ Y APE +G T D+++ G +L EL +
Sbjct: 171 ------TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 41/236 (17%)
Query: 713 IGQGSFGSVYK----GIL-GEDEMIVAVKVINLKQKGAF---KSFMAECKALRNIRHRNL 764
IGQG+FG V++ G+L E +VAVK+ LK++ + F E + H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLED--------WLHQ-SNDHLEV-------C 808
+K++ +C+ L+FE M G L + S+
Sbjct: 71 VKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 809 KLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS 868
L+ +++ IA VA+ + YL + VH DL N L+ +MV + DFGL++ + S
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 869 HQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
AS+ + +I I+ ++ PE + + DV+++G++L E+F+ G +P
Sbjct: 183 ADYYKASE--NDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFKSFMAECKALRNIRHRNLIK 766
++G GSFGSVY+G+ +D AVK ++L + A K E L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ D+ + E + GSL L + E +I+ + +
Sbjct: 67 YLGTEREEDNL-----YIFLELVPGGSLAKLLKKYGSFPE----PVIR--LYTRQILLGL 115
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
EYLH VH D+K +N+L+D + V + DFG+AK Q+ S S KG
Sbjct: 116 EYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKS----FKG 163
Query: 887 TVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRP 923
+ ++APE + D++S G +LE+ TG+ P
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 711 NMIGQGSFGSVYKGILGEDEMI---VAVKVIN-LKQKGAFKSFMAECKALRNIRHRNLIK 766
+IG+G FG VY G L + + AVK +N + + F+ E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
++ IC + S+G+ L + MK+G L +++ + V L + + VA +
Sbjct: 61 LLGIC--LPSEGSPLVVLPY--MKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
EYL VH DL N +LD V DFGLA+ + D + + G K
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI----YDKEYYSVHNHTGAKL 164
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
V ++A E + + DV+SFG+LL EL T
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 8e-16
Identities = 63/222 (28%), Positives = 92/222 (41%), Gaps = 44/222 (19%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVK------VINLKQKGAFKSFMAECKALRNIRHRNLIK 766
+G GSFG V A+K ++ LKQ + + E + L++IRH L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ---VEHVLNEKRILQSIRHPFLVN 65
Query: 767 IITICSSIDSKGA--DFKAL--VFECMKNGSLEDWLHQSND-HLEVCKLTLIQRVNIAID 821
+ G+ D L V E + G L L +S V + A
Sbjct: 66 LY---------GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF-------YAAQ 109
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
V A+EYLH +V+ DLKP N+LLD D + DFG AK + T +
Sbjct: 110 VVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-------TYT-- 157
Query: 882 IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ GT Y+APE + D ++ GIL+ E+ G P
Sbjct: 158 --LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 1e-15
Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 62/284 (21%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR----------HR 762
+G+G++G V+K I + +VA+K I F +F A R R H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVN---IA 819
N++K++ + + + K D LVFE M E LH V + +++ V+ I
Sbjct: 68 NIVKLLNVIKAENDK--DI-YLVFEYM-----ETDLHA------VIRANILEDVHKRYIM 113
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+ A++Y+H ++H DLKPSN+LL+ D + DFGLA+ LS + + + +
Sbjct: 114 YQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938
+ T Y APE +GS G D++S G +L E+ G+ F TL++
Sbjct: 171 DYV---ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK----PLFPGTSTLNQLE 223
Query: 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIR 982
KI IEV+ S EDI + ++
Sbjct: 224 KI---------------IEVIGPPS--AEDIESIKSPFAATMLD 250
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 713 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGA-FKSFMAECKALRNIRHRNLIKI 767
+G+G FG V Y VAVK + + G E + LRN+ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
IC+ + G K L+ E + +GSL+++L ++ + + L Q++ A+ + ++
Sbjct: 72 KGICT--EDGGNGIK-LIMEFLPSGSLKEYLPRNKNKI-----NLKQQLKYAVQICKGMD 123
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
YL VH DL NVL++ + +GDFGL K + + + K S
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS-----P 175
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
V + APE + S+ + DV+SFG+ L EL T
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 73/245 (29%), Positives = 102/245 (41%), Gaps = 52/245 (21%)
Query: 696 SYAEL-SKATSE--FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FKSF 749
AEL SK E F IG GSFG+VY +VA+K ++ K + ++
Sbjct: 3 EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62
Query: 750 MAECKALRNIRHRNLIKIITICSSIDSKGADFKA----LVFE-CMKNGSLEDWLHQSNDH 804
+ E + L+ +RH N +I+ KG + LV E C+ + S D
Sbjct: 63 IKEVRFLQQLRHPN---------TIEYKGCYLREHTAWLVMEYCLGSAS---------DI 104
Query: 805 LEVCKLTLIQRVNIAI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861
LEV K L Q V IA + YLH H +H D+K N+LL + DFG
Sbjct: 105 LEVHKKPL-QEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFG 160
Query: 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTG--DVYSFGILLLELF 918
A +S GT ++APE + E G DV+S GI +EL
Sbjct: 161 SASLVSPAN------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL- 207
Query: 919 TGRRP 923
R+P
Sbjct: 208 AERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 29/218 (13%)
Query: 713 IGQGSFGSVYKGILG--EDEMIVAVKVI-NLKQKGAFK-SFMAECKALRNIRHRNLIKII 768
+G G+FG+V KG+ + E VAVK++ N A K + E ++ + + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLT-LIQRVNIAIDVASAIE 827
IC A+ LV E + G L +L Q N H+ +T L+ +V++ + +
Sbjct: 63 GICE------AESWMLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGM------K 109
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
YL VH DL NVLL + + DFGL+K L + + +KT K
Sbjct: 110 YLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-----KWP 161
Query: 888 VGYVAPEYCMG-SEASMTGDVYSFGILLLELFT-GRRP 923
V + APE CM + S DV+SFG+L+ E F+ G++P
Sbjct: 162 VKWYAPE-CMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITI 770
IG+G++G VYK IVA+K I L+ +G K+ + E K L+ + H N+IK++ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVASAIEY 828
KG D LVFE M L + L + K L Q + + +
Sbjct: 67 ---FRHKG-DL-YLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ-------LLQGLAF 113
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
H H ++H DLKP N+L++ + V + DFGLA+ S T
Sbjct: 114 CHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--------TR 162
Query: 889 GYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
Y APE +G + T D++S G + EL + R
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G FG V+ G + VAVK + + ++F+ E ++ ++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYY-NNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
+ ++ E M GSL D+L E K+ L + ++ + +A + Y+
Sbjct: 72 KEEPI-----YIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE-- 120
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
+ +H DL+ +NVL+ ++ + DFGLA+ + ++ TA + G K + + A
Sbjct: 121 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TARE------GAKFPIKWTA 172
Query: 893 PEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
PE ++ DV+SFGILL E+ T G+ P
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-15
Identities = 40/111 (36%), Positives = 60/111 (54%), Gaps = 4/111 (3%)
Query: 67 WTGVTCG----HRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIG 122
W+G C + L L NQ + G + + L L+ INLS NS G IP +G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 123 NLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLL 173
++ LE L L NSF+G+IP +L + ++L L ++ N L G++PA +G L
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 37/228 (16%)
Query: 713 IGQGSFGSVYKG-ILGEDE------MIVAVKVINLKQKGAFKSF---MAECKALRNI-RH 761
+G+G FG V +G D+ + VAVK+ LK K ++E + ++ I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSN----DH-LEVCK-----LT 811
+N+I ++ C+ + LV E G+L ++L D+ + CK LT
Sbjct: 78 KNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 812 LIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQL 871
V+ A VA +EYL +H DL NVL+ D V + DFGLA+ H +
Sbjct: 133 FKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNI 187
Query: 872 DTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
D KT++ + +K ++APE + DV+SFG+LL E+FT
Sbjct: 188 DYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 16/224 (7%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDE---MIVAVKVI--NLKQKGAFKSFMAECKALRNIRH 761
F M+G+G FGSV + L ++ VAVK++ ++ + F+ E ++ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 762 RNLIKIITICSSIDSKGA-DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 820
N+IK+I + +KG ++ MK+G L +L S E L L V I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
D+AS +EYL +H DL N +L+ +M V DFGL+K + S D + +S
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG--DYYRQGCAS 175
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ +K ++A E + + DV++FG+ + E+ T G+ P
Sbjct: 176 KLPVK----WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 64/234 (27%), Positives = 113/234 (48%), Gaps = 24/234 (10%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVK-VINLKQKGAFKSFMA--ECKALRNIRH 761
S++ IGQG+FG V+K + + IVA+K V+ +K F A E K L+ ++H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF-PITALREIKILQLLKH 70
Query: 762 RNLIKIITICSSIDSKGADFKA---LVFE-CMKNGSLEDWLHQSNDHLEVCKLTLIQRVN 817
N++ +I IC + + +K LVFE C + L L N K TL +
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD--LAGLLSNKN-----VKFTLSEIKK 123
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
+ + + + Y+H + ++H D+K +N+L+ D + + DFGLA+ S + ++
Sbjct: 124 VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 878 SSSSIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGRRPTDAAFTE 930
++ + T+ Y PE +G D++ G ++ E++T R P TE
Sbjct: 181 TNRVV----TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTE 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G+G FG V + + A K +N LK++ ++ M E + L + R I++
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF---IVS 57
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ + +K D LV M G L H N E + + S +E+L
Sbjct: 58 LAYAFQTK-TDL-CLVMTIMNGGDLR--YHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H +++ DLKP NVLLD+D + D GLA L D SKT G GT G
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL----KDGQSKTK----GYAGTPG 162
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
++APE G E + D ++ G+ L E+ R P
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 74/253 (29%), Positives = 119/253 (47%), Gaps = 35/253 (13%)
Query: 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFK-SFMAECKALRN 758
+ +F IG+G++G VYK + +VA+K + L +K F + + E K LR
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 759 IRHRNLIKIITICSSIDSKGADFKA------LVFECMKN---GSLEDWL-HQSNDHLEVC 808
+ HRN++ + I + DFK LVFE M + G LE L H S DH++
Sbjct: 63 LNHRNIVNLKEIVTD-KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121
Query: 809 KLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS 868
L++ + Y H + +H D+K SN+LL++ + DFGLA+ +S
Sbjct: 122 MKQLLE----------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 869 HQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAA 927
+ + ++ I T+ Y PE +G E DV+S G +L ELFT ++P A
Sbjct: 169 ---EESRPYTNKVI----TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQA 220
Query: 928 FTEGLTLHEFAKI 940
E L +++
Sbjct: 221 NQELAQLELISRL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 713 IGQGSFGSVYKGI---LGEDEMIVAVKVI-NLKQKGAFKSFMAECKALRNIRHRNLIKII 768
+G GSFG V +G G + VAVK + + K F+ E + ++ H NLI++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ + +V E GSL D L + D L ++ + + A+ +A+ + Y
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLRK--DALGHFLISTL--CDYAVQIANGMRY 112
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
L +H DL N+LL D +GDFGL L +K
Sbjct: 113 LE---SKRFIHRDLAARNILLASDDKVKIGDFGL-----MRALPQNEDHYVMEEHLKVPF 164
Query: 889 GYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ APE S AS DV+ FG+ L E+FT G P
Sbjct: 165 AWCAPESLRTRTFSHAS---DVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G+G FG V + + A K ++ LK++ + + E K L + R I++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF---IVS 57
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ + ++K D LV M G L+ ++ + + + A + +E+L
Sbjct: 58 LAYAFETK--DDLCLVMTLMNGGDLKYHIYNVGEP----GFPEARAIFYAAQIICGLEHL 111
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H Q +V+ DLKP NVLLD + D GLA L + GT G
Sbjct: 112 H---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---------GTPG 159
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+APE G + D ++ G L E+ GR P
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 68/231 (29%), Positives = 96/231 (41%), Gaps = 46/231 (19%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL 764
F IG+GSFG VYK I +VA+KVI+L+ +A I ++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE------------EAEDEIE--DI 46
Query: 765 IKIITICSSIDS-----------KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLI 813
+ I S S KG+ ++ E GS D L + KL
Sbjct: 47 QQEIQFLSQCRSPYITKYYGSFLKGSKL-WIIMEYCGGGSCLDLL-------KPGKLDET 98
Query: 814 QRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQL-D 872
I +V +EYLH + +H D+K +N+LL + GD LA F S QL
Sbjct: 99 YIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEE-----GDVKLADFGVSGQLTS 150
Query: 873 TASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T SK ++ GT ++APE S D++S GI +EL G P
Sbjct: 151 TMSKRNT----FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 23/158 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSF-----MAECKALRNI-RHRNLIK 766
+G G+FGSVY E +VA+K K K F S+ + E K+LR + H N++K
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + ++ F VFE M+ L+Q + + +I + +
Sbjct: 63 LKEVF--RENDELYF---VFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864
++H H H DLKP N+L+ V + DFGLA+
Sbjct: 113 AHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 33/226 (14%)
Query: 713 IGQGSFGSVYKG-ILGEDE----MIVAVKVINLKQKGAFKSF---MAECKALRNI-RHRN 763
+G+G FG V +G D+ + V V LK K ++E + ++ I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSN----------DHLEVCKLTLI 813
+I ++ C+ G + ++ E G+L ++L + +L+
Sbjct: 86 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 814 QRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
V+ A VA +EYL +H DL NVL+ D V + DFGLA+ + H +D
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 195
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
KT++ + +K ++APE + DV+SFG+LL E+FT
Sbjct: 196 YKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 54/224 (24%), Positives = 104/224 (46%), Gaps = 32/224 (14%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINL----------KQKGAFKSFMAECKALRNIRH 761
+IG+G++G VY + ++AVK + L +QK K+ +E + L+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
N+++ + ++ ++ E + GS+ L E ++V
Sbjct: 68 LNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV----- 117
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
+ YLH ++H DLK N+L+D D + + DFG++K D + +
Sbjct: 118 -LEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK----KSDDIYD--NDQN 167
Query: 882 IGIKGTVGYVAPEYCMGSEASMTG--DVYSFGILLLELFTGRRP 923
+ ++G+V ++APE + D++S G ++LE+F GRRP
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI--NLKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
++G+GS+G V K E IVA+K + K K M E + L+ +RH NL+ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSND-HLEVCKLTLIQRVNIAIDVASAIEY 828
+ + LVFE + + L+D N + L Q + IE+
Sbjct: 68 VF-----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ-------ILRGIEF 115
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
H H ++H D+KP N+L+ V + DFG A+ L++ + T
Sbjct: 116 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--------TR 164
Query: 889 GYVAPEYCMG-SEASMTGDVYSFGILLLELFTG 920
Y APE +G ++ D+++ G L+ E+ TG
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 71/228 (31%), Positives = 104/228 (45%), Gaps = 44/228 (19%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIK 766
F IG+GSFG VYKGI + +VA+K+I+L++ AE + +I+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE---- 52
Query: 767 IITICSSIDSK------GADFKA----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV 816
IT+ S DS G+ K ++ E + GS D L LE + I R
Sbjct: 53 -ITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILR- 108
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQL-DTAS 875
++ ++YLH + +H D+K +NVLL S GD LA F + QL DT
Sbjct: 109 ----EILKGLDYLHSERK---IHRDIKAANVLL-----SEQGDVKLADFGVAGQLTDTQI 156
Query: 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
K ++ GT ++APE S D++S GI +EL G P
Sbjct: 157 KRNT----FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFKSFMAECKALRNIRHRNLIKIITIC 771
+G+G++ +VYKG IVA+K I+L ++G + + E ++ ++H N++++ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+ ++K LVFE M D + H L + + I + H
Sbjct: 68 HT-ENK----LMLVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
+ ++H DLKP N+L++ + DFGLA+ T S+ + T+ Y
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLAR-----AFGIPVNTFSNEV---VTLWYR 167
Query: 892 APEYCMGSEASMTG-DVYSFGILLLELFTGR 921
AP+ +GS T D++S G ++ E+ TGR
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRH 761
A + + + +G+GS+ +VYKGI + +VA+KVI++K ++G + + E L+ ++H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
N++ + I + ++ VFE M L ++ Q L + L
Sbjct: 63 ANIVLLHDIIHTKET-----LTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFM-----FQ 111
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
+ + Y+H ++H DLKP N+L +S++G+ LA F + S+T SS
Sbjct: 112 LLRGLAYIHGQ---HILHRDLKPQNLL-----ISYLGELKLADFGLARAKSIPSQTYSSE 163
Query: 882 IGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGR 921
+ T+ Y P+ +G+ + S D++ G + +E+ G+
Sbjct: 164 V---VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G FG V+ + VAVK + + ++F+AE ++ ++H L+K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTK-VAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
+ ++ E M GSL D+L E K L + ++ + +A + ++
Sbjct: 72 K------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 119
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
Q +H DL+ +N+L+ +V + DFGLA+ + ++ TA + G K + + A
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TARE------GAKFPIKWTA 171
Query: 893 PEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
PE ++ DV+SFGILL+E+ T GR P
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 60/228 (26%), Positives = 110/228 (48%), Gaps = 41/228 (17%)
Query: 711 NMIGQGSFGSVYKGILGED--EMIVAVKVIN-LKQKGAFKSFMAECKALRNI-RHRNLIK 766
++IG+G+FG V + ++ +D +M A+K++ + + F E + L + H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQS----------NDHLEVCKLTLIQRV 816
++ C +++G + A+ E G+L D+L +S +H LT Q +
Sbjct: 68 LLGAC---ENRGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK 876
A DVA+ ++YL + +H DL NVL+ ++ S + DFGL++
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR------------ 167
Query: 877 TSSSSIGIKGTVG-----YVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+ +K T+G ++A E S + DV+SFG+LL E+ +
Sbjct: 168 --GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 70/250 (28%), Positives = 105/250 (42%), Gaps = 16/250 (6%)
Query: 267 VNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLE 326
+ L NL SL + NN P SN++ LDL N+ + + +L NL L+L
Sbjct: 113 LELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLS 171
Query: 327 QNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIF 386
N+L D L+N S+L L L+ N+ L S++ E + N I
Sbjct: 172 FNDL-------SDLPKLLSNLSNLNNLDLSGNKI--SDLPPEIELLSALEELDLSNNSII 222
Query: 387 GIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTK 446
+ S + NL NL L + +N+L +P+ IG L NL+ L L N Q S S +G+LT
Sbjct: 223 -ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNN--QISSISSLGSLTN 278
Query: 447 LAKLVMSYNSLQGNIPS--SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNN 504
L +L +S NSL +P L L+ K +L + + S+
Sbjct: 279 LRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSP 338
Query: 505 NLNGSLPLQI 514
L
Sbjct: 339 EALSILESLN 348
|
Length = 394 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVK---VINLKQKGAFKSFMAECKALRNIRH 761
+ F IG+G F VY+ D + VA+K + +L A + E L+ + H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV--NIA 819
N+IK S I+ + +V E G L + H + K + ++
Sbjct: 62 PNVIKYYA--SFIEDNELN---IVLELADAGDLSRMIK----HFKKQKRLIPEKTVWKYF 112
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+ + SA+E++H ++H D+KP+NV + V +GD GL +F S SKT++
Sbjct: 113 VQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-------SKTTA 162
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ + GT Y++PE + + D++S G LL E+ + P
Sbjct: 163 AH-SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 66/256 (25%), Positives = 101/256 (39%), Gaps = 37/256 (14%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF-KSFMAECKALRNIRHRNL 764
+ + +G+G+ GSV K L MI A+K I K + E + ++ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 765 IKIITIC-----SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLI--QRV- 816
+K SSI + E + GSL+ +V K ++V
Sbjct: 62 VKYYGAFLDESSSSI--------GIAMEYCEGGSLDSIYK------KVKKRGGRIGEKVL 107
Query: 817 -NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875
IA V + YLH ++H D+KPSN+LL + DFG++ L + T
Sbjct: 108 GKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-- 162
Query: 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935
GT Y+APE G S+T DV+S G+ LLE+ R P L
Sbjct: 163 --------FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI 214
Query: 936 EFAKIALPEKVIEIVD 951
E + E+ D
Sbjct: 215 ELLSYIVNMPNPELKD 230
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 713 IGQGSFGSVYKGI--LGEDEMIVAVKVI-NLKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G G+FG V KG+ + + ++ VA+KV+ N +K M E + + + + ++++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+C A+ LV E G L +L D + V + V + V+ ++YL
Sbjct: 63 VCE------AEALMLVMEMASGGPLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYL 111
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
VH DL NVLL + + + DFGL+K L + D+ K S+ K +
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD--DSYYKARSAG---KWPLK 163
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ APE + S DV+S+GI + E F+ G++P
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFKSFMAECKALRNIRHRNLIKI 767
+G+GS+GSVYK D A+K ++L K++ + + E + L ++ H N+I
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER---EDAVNEIRILASVNHPNIISY 64
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ +D +V E G L + + ++ I R I I + ++
Sbjct: 65 KE--AFLDGNKL---CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQLLRGLQ 117
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
LH ++H DLK +N+LL + + +GD G++K L +KT GT
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQI------GT 164
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
Y+APE G S D++S G LL E+ T P +A
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMI----VAVK-VINLKQKGAFKSFMAECKALRNIRH 761
S+++ +G+FG ++ GIL +++ V VK V + + + E L + H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQR--VNIA 819
+N++ I+ +C + +++ M G+L+ +L Q L + V++A
Sbjct: 68 QNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL---SSHQL-DTAS 875
I +A + YLH ++H D+ N ++D ++ + D L++ L H L D +
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+ V ++A E + E S DV+SFG+LL EL T
Sbjct: 181 RP----------VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 711 NMIGQGSFGSVYKG-ILGED----EMIVAVKVINLKQKGAFKS-FMAECKALRNIRHRNL 764
+G G+FG VY+G G D E+ VAVK + +S F+ E + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLE-VCKLTLIQRVNIAIDVA 823
+++I + + ++ E M G L+ +L ++ E LT+ + A DVA
Sbjct: 72 VRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
+YL + +H D+ N LL V+ + DFG+A+ + ++ K +
Sbjct: 127 KGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI--YRASYYRKGGRA 181
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ IK ++ PE + + DV+SFG+LL E+F+ G P
Sbjct: 182 MLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 68/217 (31%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN----LKQKGAFKSFMAECKAL-RNIRHRNLIKI 767
IG+GSFG V D AVKV+ LK+K K MAE L +N++H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-KHIMAERNVLLKNVKHPFLVGL 61
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAI 826
+ AD V + + G L L + E R A ++ASA+
Sbjct: 62 -----HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-------RARFYAAEIASAL 109
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YLH +++ DLKP N+LLD + DFGL K + SKT+S+ G
Sbjct: 110 GYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGIEHSKTTST---FCG 158
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T Y+APE T D + G +L E+ G P
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 73/231 (31%), Positives = 104/231 (45%), Gaps = 49/231 (21%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FKSFMAECKALRNIRHRN 763
F + IG GSFG+VY +VAVK ++ K ++ + E K L+ ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 764 LIKIITICSSIDSKGADFKA----LVFE-CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
+I+ KG K LV E C+ + S D LEV K L Q V I
Sbjct: 83 ---------TIEYKGCYLKEHTAWLVMEYCLGSAS---------DLLEVHKKPL-QEVEI 123
Query: 819 AIDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875
A A++ YLH H M+H D+K N+LL + DFG +AS
Sbjct: 124 AAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG-----------SAS 169
Query: 876 KTSSSSIGIKGTVGYVAPEYCMG-SEASMTG--DVYSFGILLLELFTGRRP 923
K+S ++ GT ++APE + E G DV+S GI +EL R+P
Sbjct: 170 KSSPAN-SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 44/228 (19%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIK 766
F IG+GSFG V+KGI + +VA+K+I+L++ AE + +I+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE---- 52
Query: 767 IITICSSIDSK------GADFKA----LVFECMKNGSLEDWLHQSN-DHLEVCKLTLIQR 815
IT+ S DS G+ K ++ E + GS D L D ++ T+++
Sbjct: 53 -ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLK- 108
Query: 816 VNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875
++ ++YLH + +H D+K +NVLL + DFG+A L+ Q+ +
Sbjct: 109 -----EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160
Query: 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT ++APE S D++S GI +EL G P
Sbjct: 161 --------FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA--ECKALRNIRHRNLIKIITI 770
+G+G+FG ED+ +V K +NL + + A E L ++H N II
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN---IIAY 64
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAIE 827
+ + E G+L D + + L E+ L Q + SA+
Sbjct: 65 YNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-------IVSAVS 115
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
Y+H + ++H D+K N+ L + +GDFG++K L S + + GT
Sbjct: 116 YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--------VVGT 164
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
Y++PE C G + + D+++ G +L EL T +R DA
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-13
Identities = 31/89 (34%), Positives = 52/89 (58%)
Query: 130 LALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRL 189
L L N G IP ++S+ +L + +S N + G IP +GS+ L+ L + N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 190 PDFVGNLSALEVFSITGNSLGGKIPTTLG 218
P+ +G L++L + ++ GNSL G++P LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIK 766
F IG+GSFG V+KGI + +VA+K+I+L++ AE + +I+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE---- 52
Query: 767 IITICSSIDSK------GADFKA----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV 816
IT+ S DS G+ K ++ E + GS + D LE L Q
Sbjct: 53 -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 104
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK 876
I ++ ++YLH + +H D+K +NVLL + DFG+A L+ Q+
Sbjct: 105 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN-- 159
Query: 877 TSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT ++APE S D++S GI +EL G P
Sbjct: 160 ------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 76/292 (26%), Positives = 132/292 (45%), Gaps = 41/292 (14%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL---GEDEMI-VAVKVI--NLKQKGAFKSFMAECKALRN 758
+E ++G G+FG+VYKGI GE+ I VA+KV+ N K A K + E +
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAG 65
Query: 759 IRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
+ + +++ IC + + LV + M G L D++ ++ D + L +N
Sbjct: 66 VGSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNW 114
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
+ +A + YL + +VH DL NVL+ + DFGLA+ L +T
Sbjct: 115 CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD------IDETE 165
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937
+ G K + ++A E + + DV+S+G+ + EL T G +P D G+ E
Sbjct: 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-----GIPAREI 220
Query: 938 AKI-----ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIG 984
+ LP+ I +D + +M MI + R + +E ++ R+
Sbjct: 221 PDLLEKGERLPQPPICTIDVYM---IMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 44/234 (18%)
Query: 713 IGQGSFGSVYKGILGEDE-----MIVAVKVINLKQKGA----FKSFMAECKALRNIRHRN 763
+G+G FG V K + VAVK++ ++ A + ++E L+ + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSN------------------DHL 805
+IK+ CS G L+ E K GSL +L +S D+
Sbjct: 65 VIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 806 EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865
+ LT+ ++ A ++ ++YL + +VH DL NVL+ + DFGL++
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR- 175
Query: 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
++ D+ K S I +K ++A E + DV+SFG+LL E+ T
Sbjct: 176 -DVYEEDSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 44/232 (18%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFKSFMAECKALRNIRHRN 763
S + +IG+G++G+VY+G +VA+K+INL E L +R
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 764 LIKII----------TICSSID-SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTL 812
I + ++ ++G + L MK G + E +++
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL----MKAGPIA----------EKY-ISV 105
Query: 813 IQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLD 872
I R +V A++Y+H ++H D+K +N+L+ + + DFG+A L+
Sbjct: 106 IIR-----EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ---- 153
Query: 873 TASKTSSSSIGIKGTVGYVAPEYCM-GSEASMTGDVYSFGILLLELFTGRRP 923
SS GT ++APE G D++S GI + E+ TG P
Sbjct: 154 ----NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 61/231 (26%), Positives = 110/231 (47%), Gaps = 40/231 (17%)
Query: 706 EFASSNM-----IGQGSFGSVYK----GILGEDEMI-VAVKVINLKQKGAFK-SFMAECK 754
EF +N+ +G G+FG V + G+ D ++ VAVK++ + + + M+E K
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 755 ALRNI-RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLI 813
+ ++ H N++ ++ C+ G ++ E G L ++L + + LTL
Sbjct: 91 IMSHLGNHENIVNLLGACT----IGGPI-LVITEYCCYGDLLNFLRRKRESF----LTLE 141
Query: 814 QRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLD 872
++ + VA + +L +C +H DL NVLL H + + DFGLA+ +
Sbjct: 142 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI------ 191
Query: 873 TASKTSSSSIGIKGT----VGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+ S+ +KG V ++APE + DV+S+GILL E+F+
Sbjct: 192 ----MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IGQG+ G+VY I VA+K +NL+Q+ + + E +R +H N I +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPN------IVN 80
Query: 773 SIDSK-GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVASAIEY 828
+DS D +V E + GSL D V T + IA + A+E+
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTD----------VVTETCMDEGQIAAVCRECLQALEF 130
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
LH + ++H D+K N+LL D + DFG ++ Q SK S+ + GT
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRST----MVGTP 179
Query: 889 GYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
++APE D++S GI+ +E+ G P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 61/222 (27%), Positives = 110/222 (49%), Gaps = 34/222 (15%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVIN----LKQKGAFKSFMAECKALRNIRHRN 763
+GQGSFG VY+G GE E VAVK +N L+++ F+ E ++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 70
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLH----QSNDHLEVCKLTLIQRVNIA 819
+++++ + S KG +V E M +G L+ +L ++ ++ TL + + +A
Sbjct: 71 VVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
++A + YL+ VH DL N ++ HD +GDFG+ + + ++ D K
Sbjct: 126 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRK--- 177
Query: 880 SSIGIKG--TVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
G KG V ++APE + + D++SFG++L E+ +
Sbjct: 178 ---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 24/237 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIR---HRNLIKI 767
IG G++G+VYK VA+K + ++ + G S + E L+ + H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ +C++ + LVFE + + L +L D + L ++ ++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+LH +C +VH DLKP N+L+ + DFGLA+ S T + T
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP---------VVVT 170
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE-FAKIALP 943
+ Y APE + S + D++S G + E+F R+P +E L + F I LP
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLP 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 36/89 (40%), Positives = 55/89 (61%)
Query: 401 ALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGN 460
LG+ + L G IP+ I +L++LQ + L N ++G+IP +G++T L L +SYNS G+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 461 IPSSLGNCQNLIGFNASHNKLTGALPQQL 489
IP SLG +L N + N L+G +P L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 37/228 (16%)
Query: 713 IGQGSFGSVYKG-ILGEDE------MIVAVKVI--NLKQKGAFKSFMAECKALRNI-RHR 762
+G+G FG V LG D+ + VAVK++ + +K ++E + ++ I +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHK 81
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQ--------SNDHLEVC--KLTL 812
N+I ++ C+ + +V E G+L ++L S D V ++T
Sbjct: 82 NIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 813 IQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQL 871
V+ VA +EYL C +H DL NVL+ + V + DFGLA+ + +
Sbjct: 137 KDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR--DVNNI 190
Query: 872 DTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
D KT++ + +K ++APE + DV+SFG+L+ E+FT
Sbjct: 191 DYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 63/264 (23%), Positives = 100/264 (37%), Gaps = 57/264 (21%)
Query: 713 IGQGSFGSVY---KGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHR-NLIKII 768
I +G+FGSVY K G+ I +K ++ K + AE + + K+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV---------NIA 819
S SK D+ LV E + G +LI+ +
Sbjct: 64 ---YSFQSK--DYLYLVMEYLNGGDCA---------------SLIKTLGGLPEDWAKQYI 103
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+V +E LH Q ++H D+KP N+L+D + DFGL S+
Sbjct: 104 AEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGL------------SRNGL 148
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP-----TDAAFTEGLT- 933
+ GT Y+APE +G D +S G ++ E G P DA F L+
Sbjct: 149 ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208
Query: 934 ---LHEFAKIALPEKVIEIVDPLL 954
E K + +++++ LL
Sbjct: 209 RINWPEEVKEFCSPEAVDLINRLL 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 66/285 (23%), Positives = 129/285 (45%), Gaps = 40/285 (14%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFKS---FMAECKALRNIRHRNL 764
+GQGSFG VY+GI E E VA+K +N + + + F+ E ++ ++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHV 71
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLE----VCKLTLIQRVNIAI 820
++++ + S ++ E M G L+ +L +E +L + + +A
Sbjct: 72 VRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
++A + YL+ + VH DL N ++ D +GDFG+ + + ++ D K
Sbjct: 127 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRK---- 177
Query: 881 SIGIKG--TVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937
G KG V +++PE + DV+SFG++L E+ T +P +G++ +
Sbjct: 178 --GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQGMSNEQV 230
Query: 938 AKIALPEKVIEIVD--PLLLIEVMANNSMIQEDIRAKTQECLNAI 980
+ + +++ D P +L E+M +R E +++I
Sbjct: 231 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVK------VINLKQKGAFKSFMAECKALRN 758
+ +G G+FG V+ E A+K VI LKQ+ + E + L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKE 57
Query: 759 IRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
+ H +I++ + D + F ++ E + G L +L S + + +
Sbjct: 58 VSHPFIIRLF--WTEHDQR---FLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFY 106
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
A ++ A+EYLH +V+ DLKP N+LLD + + DFG AK K
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK-----------KLR 152
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGRRP 923
+ + GT Y+APE + S+ D ++ GIL+ E+ G P
Sbjct: 153 DRTWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 62/242 (25%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 699 ELSKATSEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFKS-FMAE 752
E++ +T F +G+ FG VYKG L GE VA+K + K +G + F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 753 CKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEV----- 807
++H N++ ++ + + +++F + L ++L + H +V
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPL-----SMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 808 ---CKLTL--IQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862
K TL V+I +A+ +E+L H +VH DL NVL+ + + D GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GR 921
F + D +S + I+ +++PE M + S+ D++S+G++L E+F+ G
Sbjct: 171 --FREVYAADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 922 RP 923
+P
Sbjct: 225 QP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-12
Identities = 68/241 (28%), Positives = 107/241 (44%), Gaps = 48/241 (19%)
Query: 712 MIGQGSFGSVYKGILGEDEMI---VAVKVIN--------LKQKGAFKSFMAECKALRNIR 760
+IG+G G VY L D + VA+K I LK K F+ E K ++
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLK-----KRFLREAKIAADLI 60
Query: 761 HRNLIKIITICSSIDS--------KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTL 812
H ++ + +ICS D +G K+L+ + SL S + E K ++
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL------SKELAE--KTSV 112
Query: 813 IQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLD 872
++I + + IEY+H ++H DLKP N+LL + D+G A F + D
Sbjct: 113 GAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 873 --------TASKTSSSSI--GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRR 922
SS +I I GT Y+APE +G AS + D+Y+ G++L ++ T
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229
Query: 923 P 923
P
Sbjct: 230 P 230
|
Length = 932 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 70/243 (28%), Positives = 119/243 (48%), Gaps = 36/243 (14%)
Query: 712 MIGQGSFGSVY--KGILGEDE-MIVAVKVI---NLKQKGAFKSFMAECKALRNIRHRNLI 765
++GQGSFG V+ + I G D + A+KV+ LK + ++ M E L + H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDV 822
K+ + ++G + L+ + ++ G L L S + + E K L + +
Sbjct: 62 KL---HYAFQTEGKLY--LILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAE-------L 107
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
A A+++LH +++ DLKP N+LLD + + DFGL+K +D K S
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYS--- 157
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAA-FTEGLTLHEFAKIA 941
GTV Y+APE + + D +SFG+L+ E+ TG P E +T+ AK+
Sbjct: 158 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG 216
Query: 942 LPE 944
+P+
Sbjct: 217 MPQ 219
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 47/228 (20%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF------KSFMAECKALRNIRHRNLIK 766
IG G++G V I VA+K K AF K + E K LR+ +H N+I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTLRELKILRHFKHDNIIA 68
Query: 767 IITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ--------SNDHLEVCKLTLIQRV 816
I I + GADFK +V + M++ LH + +H+ L++
Sbjct: 69 IRDI---LRPPGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYFLYQLLR-- 118
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK 876
++Y+H ++H DLKPSN+L++ D +GDFG+A+ LSS +
Sbjct: 119 --------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167
Query: 877 TSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRP 923
+ T Y APE + E + D++S G + E+ GRR
Sbjct: 168 MTEYV----ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 31/228 (13%)
Query: 713 IGQGSFGSVYKGIL----GEDEMIVAVKVI-NLKQKGAFKSFMAECKALRNIRHRNLIKI 767
+G+ +FG +YKG L + +VA+K + ++ + F E + + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEV-----------CKLTLIQRV 816
+ + + ++FE + G L ++L + H +V L +
Sbjct: 73 LGVVTQEQPV-----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK 876
+IAI +A+ +EYL H VH DL N+L+ + + D GL++ + S D
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA--DYYRV 182
Query: 877 TSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
S + I+ ++ PE M + S D++SFG++L E+F+ G +P
Sbjct: 183 QPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFKSFMAECKALRNIRHRNLIK 766
++GQG+FG VY + +AVK + K + E + L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
C D + F E M GS++D L E T+ ++ I +
Sbjct: 69 YYG-CLRDDETLSIF----MEYMPGGSVKDQLKAYGALTE----TVTRKYTRQI--LEGV 117
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
EYLH + +VH D+K +N+L D +GDFG +K L Q +S T S+ G
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICSSGTGMKSV--TG 169
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T +++PE G DV+S G ++E+ T + P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 713 IGQGSFGSVYKG-----ILGEDEMIVAVKVIN-LKQKGAFKSFMAECKALRNIRHRNLIK 766
+G+G FG V+ E +V VK + K + F E R + H+N+++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCK---LTLIQRVNIAIDVA 823
++ +C + A+ ++ E G L+ +L + E K L+ Q+V + +A
Sbjct: 73 LLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+++L + VH DL N L+ V L+K D +
Sbjct: 128 LGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK-------DVYNSEYYKLRN 177
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+ ++APE + S DV+SFG+L+ E+FT
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITIC 771
IG+G++G VYK + +VA+K++++ + + E LR H N+
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 772 SSIDSKGADFKA-LVFECMKNGSLEDW---LHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ G D + LV E GS+ D L + L+ + I R + +
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGLA 127
Query: 828 YLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YLH + +H D+K N+LL + + DFG+ S QLD+ ++ I G
Sbjct: 128 YLHENKV----IHRDIKGQNILLTKNAEVKLVDFGV-----SAQLDSTLGRRNTFI---G 175
Query: 887 TVGYVAPEY--CMGS-EAS--MTGDVYSFGILLLELFTGRRP 923
T ++APE C +AS DV+S GI +EL G+ P
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 27/225 (12%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVK---VINLKQKGAFKSFMAECKALRNIRH 761
+ F IG+G F VY+ D VA+K + + A + + E L+ + H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 762 RNLIKIITICSSIDSKGADFKA-LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV--NI 818
N+IK + DS D + +V E G L Q + + K + +R
Sbjct: 62 PNVIKYL------DSFIEDNELNIVLELADAGDLS----QMIKYFKKQKRLIPERTVWKY 111
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
+ + SA+E++H ++H D+KP+NV + V +GD GL +F S SKT+
Sbjct: 112 FVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-------SKTT 161
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
++ + GT Y++PE + + D++S G LL E+ + P
Sbjct: 162 AAH-SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 56/228 (24%), Positives = 107/228 (46%), Gaps = 41/228 (17%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FKSFMAECKALRNI-RHRNLIK 766
++IG+G+FG V K + +D + + + +K+ + + F E + L + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSN----------DHLEVCKLTLIQRV 816
++ C + +G + A+ E +G+L D+L +S + L+ Q +
Sbjct: 61 LLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK 876
+ A DVA ++YL Q +H DL N+L+ + V+ + DFGL++
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR------------ 160
Query: 877 TSSSSIGIKGTVG-----YVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+ +K T+G ++A E S + DV+S+G+LL E+ +
Sbjct: 161 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 8e-12
Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVK-VINLKQKGAFK-SFMAECKALRNIRHRNLIKIITI 770
+G+G+FG VYK + +VA+K ++ +K F + + E K L+ ++H N++ +I +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 771 CSSIDSKGADFKALVFECM--KNGSLEDWLHQSNDHLEVC--KLTLIQRVNIAIDVASAI 826
K + V+ + L L + L K ++Q + I
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQ-------LLEGI 128
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YLH + ++H D+K +N+L+D+ + + DFGLA+ + G G
Sbjct: 129 NYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR------PYDGPPPNPKGGGGGG 179
Query: 887 TVGYV---------APEYCMGSEASMTG-DVYSFGILLLELFTGR 921
T Y PE +G T D++ G + E+FT R
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G+FG VYK E + A K+I ++ + + FM E L +H N++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA-Y 71
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
++K ++ E G+L+ + LE LT Q + + A+ +LH H
Sbjct: 72 FYENK----LWILIEFCDGGALDSIM----LELER-GLTEPQIRYVCRQMLEALNFLHSH 122
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
++H DLK N+LL D + DFG+ S+ T K + GT ++A
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDT----FIGTPYWMA 171
Query: 893 PEYCMGSEASMT-----GDVYSFGILLLELFTGRRP 923
PE D++S GI L+EL P
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 28/213 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITIC 771
+G+G++ +V+KG E +VA+K I L+ ++GA + + E L+N++H N++ + I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVC-KLTLIQRVNIAI-DVASAIEYL 829
+ LVFE L+ L Q D+ C L + V I + + + Y
Sbjct: 73 HTERCL-----TLVFE-----YLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H ++H DLKP N+L++ + DFGLA+ S +KT S+ + T+
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS-----VPTKTYSNEV---VTLW 168
Query: 890 YVAPEYCMGS-EASMTGDVYSFGILLLELFTGR 921
Y P+ +GS E S D++ G +L E+ TGR
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITIC 771
+G+GS+ +VYKG +VA+K I L+ +GA + + E L++++H N I+T+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN---IVTLH 69
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWL--HQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
I +K LVFE + L+ ++ + +L L Q + + Y
Sbjct: 70 DIIHTKKT--LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ-------LLRGLAYC 119
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H ++H DLKP N+L+ + DFGLA+ S SKT S+ + T+
Sbjct: 120 HQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS-----VPSKTYSNEV---VTLW 168
Query: 890 YVAPEYCMGS-EASMTGDVYSFGILLLELFTGR 921
Y P+ +GS E S + D++ G + E+ TGR
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 57/234 (24%), Positives = 108/234 (46%), Gaps = 41/234 (17%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-R 760
++ ++IG+G+FG V K + +D + + + +K+ K + F E + L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSN----------DHLEVCKL 810
H N+I ++ C + +G + L E +G+L D+L +S + L
Sbjct: 67 HPNIINLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 811 TLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQ 870
+ Q ++ A DVA ++YL Q +H DL N+L+ + V+ + DFGL++
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------ 172
Query: 871 LDTASKTSSSSIGIKGTVG-----YVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+ +K T+G ++A E S + DV+S+G+LL E+ +
Sbjct: 173 --------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 48/231 (20%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FKSFMAECKALRNIRHRN 763
F+ IG GSFG+VY + +VA+K ++ K + ++ + E + L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 764 LIKIITICSSIDSKGADFKA----LVFE-CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
+I +G + LV E C+ + S D LEV K L Q V I
Sbjct: 77 ---------TIQYRGCYLREHTAWLVMEYCLGSAS---------DLLEVHKKPL-QEVEI 117
Query: 819 AIDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875
A A++ YLH H M+H D+K N+LL + +GDFG A ++
Sbjct: 118 AAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------- 167
Query: 876 KTSSSSIGIKGTVGYVAPEYCMG-SEASMTG--DVYSFGILLLELFTGRRP 923
++ + GT ++APE + E G DV+S GI +EL + P
Sbjct: 168 --ANXFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 54/224 (24%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIK------ 766
+G G+FG VYK E ++ A KVI+ K + + +M E L + H N++K
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 767 -------IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
+I C+ G A++ E LE L + + VCK TL
Sbjct: 73 YENNLWILIEFCA-----GGAVDAVMLE------LERPLTEPQIRV-VCKQTL------- 113
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF-LSSHQLDTASKTS 878
A+ YLH + ++H DLK N+L D GD LA F +S+ T +
Sbjct: 114 ----EALNYLH---ENKIIHRDLKAGNILFTLD-----GDIKLADFGVSAKNTRTIQRRD 161
Query: 879 SSSIGIKGTVGYVAPEYCMGSEAS-----MTGDVYSFGILLLEL 917
S GT ++APE M + DV+S GI L+E+
Sbjct: 162 S----FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 33/228 (14%)
Query: 706 EFASSN---MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHR 762
E+ + ++G+G++G VY ++ +A+K I + + E ++HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 822
N+++ + DS+ FK + E + GSL L L+ + T+I +
Sbjct: 66 NIVQYL----GSDSENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK---QI 117
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
++YLH + +VH D+K NVL++ + V + DFG +K L+ ++ ++T
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTET---- 168
Query: 882 IGIKGTVGYVAPEYC------MGSEASMTGDVYSFGILLLELFTGRRP 923
GT+ Y+APE G+ A D++S G ++E+ TG+ P
Sbjct: 169 --FTGTLQYMAPEVIDKGPRGYGAPA----DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 28/213 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITIC 771
+G+G++ +VYKG + +VA+K I L+ ++GA + + E L++++H N++ + I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSND--HLEVCKLTLIQRVNIAIDVASAIEYL 829
+ S LVFE + + L+ +L + ++ KL L Q + + Y
Sbjct: 74 HTEKSL-----TLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ-------LLRGLNYC 120
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H ++H DLKP N+L++ + DFGLA+ S +KT S+ + T+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS-----IPTKTYSNEV---VTLW 169
Query: 890 YVAPEYCMGS-EASMTGDVYSFGILLLELFTGR 921
Y P+ +GS + S D++ G + E+ TGR
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 49/231 (21%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR--HRNLIKIITI 770
+G+G++G V K I+AVK I +A N + R L+ +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI---------------RATVNSQEQKRLLMDLDIS 53
Query: 771 CSSIDSK------GADFK-ALVFECMK--NGSLEDWLHQSNDHLEVCKLTLIQRV--NIA 819
S+D GA F+ V+ CM+ + SL+ + + D LT+ + + IA
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDK----GLTIPEDILGKIA 109
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+ + A+EYLH + ++H D+KPSNVL++ + + DFG +S + +D+ +KT
Sbjct: 110 VSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFG----ISGYLVDSVAKTID 163
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTG-----DVYSFGILLLELFTGRRPTD 925
+ G Y+APE + E + G DV+S GI ++EL TGR P D
Sbjct: 164 A-----GCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 67/230 (29%), Positives = 97/230 (42%), Gaps = 54/230 (23%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF------KSFMAECKALRNIRHRNLIK 766
IG+G++G V E VA+K I AF K + E K LR++ H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIA----NAFDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQ--------SNDHLEVCKLTLIQRVNI 818
I I + + +V+E M LHQ S+DH C+ L Q
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDH---CQYFLYQ---- 116
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
+ ++Y+H ++H DLKPSN+LL+ + + DFGLA +T+
Sbjct: 117 ---LLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA------------RTT 158
Query: 879 SSSIGIKG----TVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGRRP 923
S T Y APE + T DV+S G + EL GR+P
Sbjct: 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-11
Identities = 32/88 (36%), Positives = 52/88 (59%)
Query: 154 LRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKI 213
L + N L G IP +I L LQ++ + N + G +P +G++++LEV ++ NS G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 214 PTTLGLLRNLVDLHVGGNQFSGTFPQSI 241
P +LG L +L L++ GN SG P ++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 30/220 (13%)
Query: 713 IGQGSFGSVYKGI-LGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIR---HRNLIK 766
IG+G++G V+K L VA+K + ++ ++G S + E LR++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH---LEVCKLTLIQRVNIAIDVA 823
+ +C+ + LVFE + + L +L + + E K + Q +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-------LL 120
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+++LH H +VH DLKP N+L+ + DFGLA+ S T+
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--------- 168
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ T+ Y APE + S + D++S G + E+F R+P
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 37/223 (16%)
Query: 712 MIGQGSFGSVYKGIL---GEDEMIVAVKVI----NLKQKGAFKSFMAECKALRNIRHRNL 764
++G G FG + +G L + E+ VA+ + + KQ+ + F+AE L H N+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR---RGFLAEALTLGQFDHSNI 68
Query: 765 IK---IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
++ +IT +++ +V E M NG+L+ +L + +L Q + +
Sbjct: 69 VRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPG 115
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
+AS ++YL + VH L VL++ D+V + F + + S+ ++
Sbjct: 116 LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSEAIYTT 165
Query: 882 IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ K V + APE S DV+SFGI++ E+ + G RP
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 56/227 (24%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA------FKSFMAECKALRNI 759
E+ ++G+G++G+VY G+ + ++I AVK + L ++ E L+++
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTNQGQLI-AVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59
Query: 760 RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEV--CKLTLIQRVN 817
+H N+++ + C ++ ++ E + GS+ L++ E CK T
Sbjct: 60 KHVNIVQYLGTCLDDNT-----ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK----- 109
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
+ + YLH++C +VH D+K +NV+L + + + DFG A+ L+ T
Sbjct: 110 ---QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA---WVGLHGT 160
Query: 878 SSSSI-GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
S+ + + GT ++APE S D++S G + E+ TG+ P
Sbjct: 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 72/253 (28%), Positives = 107/253 (42%), Gaps = 12/253 (4%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
+T LDL N I I S L+ ++LSDN +P + NL L+ L L N S
Sbjct: 118 LTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS 176
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
+P LS SNL L +S NK+ +P EI L L+ L + N + L + NL
Sbjct: 177 -DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKN 233
Query: 199 LEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFS 258
L ++ N L +P ++G L NL L + NQ + S+ ++++L + L N S
Sbjct: 234 LSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLS 290
Query: 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLK 318
LP ++ L L + + S N IL G S L+
Sbjct: 291 NALPLIALLLLLLELLLNLLLTLKALEL-KLNSILLNNNILSNGETSS----PEALSILE 345
Query: 319 NLSWLNLEQNNLG 331
+L+ L N L
Sbjct: 346 SLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 31/80 (38%), Positives = 47/80 (58%)
Query: 387 GIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTK 446
G IP+ I L +L ++ + N + G IP +G + +L+ L L N GSIP +G LT
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 447 LAKLVMSYNSLQGNIPSSLG 466
L L ++ NSL G +P++LG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS---FMAECKALRNIRHRNLIKIIT 769
IG G FG V G + V V L+ + + F+ E + R+++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLH-QSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
C+ + LV E G L+ +L L T +QR +A ++A + +
Sbjct: 63 QCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLH 115
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
LH + +H DL N LL D+ +GD+GL+ + ++ D + ++
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSH--NKYKEDYYVTPDQLWVPLR--- 167
Query: 889 GYVAPEYC-------MGSEASMTGDVYSFGILLLELFT-GRRP 923
++APE + + + +V+S G+ + ELF G +P
Sbjct: 168 -WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 72/306 (23%), Positives = 124/306 (40%), Gaps = 61/306 (19%)
Query: 706 EFASSNMIGQGSFGSVYK-GILGEDEMIVAVKVINLKQ----KGA------FKSFMAECK 754
E+A +G G+FG VYK + ++A+K IN+ K ++E
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 755 ALR-NIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDW---LHQSNDHLEVCKL 810
++ +RH N+++ D +V + ++ L + L + ++
Sbjct: 61 IIKEQLRHPNIVRYYKTFLE-----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115
Query: 811 TLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQ 870
NI + + A+ YLH + +VH DL P+N++L D + DFGLAK Q
Sbjct: 116 W-----NIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----Q 163
Query: 871 LDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTE 930
SK +S + GT+ Y PE DV++FG +L ++ T + P
Sbjct: 164 KQPESKLTS----VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP------- 212
Query: 931 GLTLHEFAKIALPEKVIEIV-DPLLLIEVMANNSMIQEDIRAKTQECLNA-------IIR 982
+ ++L K++E V +PL M ED+ CL II+
Sbjct: 213 ---FYSTNMLSLATKIVEAVYEPL-------PEGMYSEDVTDVITSCLTPDAEARPDIIQ 262
Query: 983 IGVLCS 988
+ + S
Sbjct: 263 VSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 33/223 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G GS G V+ + + + VAVK I L + K + E K +R + H N++K+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 773 SIDSK-GADFKAL--------VFECMKNGSLEDWLHQ---SNDHLEVCKLTLIQRVNIAI 820
S D +L V E M+ L + L Q S +H + L++
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLR------ 125
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
++Y+H ++H DLKP+NV ++ D+V +GDFGLA+ + H S
Sbjct: 126 ----GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY----SHKGY 174
Query: 880 SSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGR 921
S G+ T Y +P + + + D+++ G + E+ TG+
Sbjct: 175 LSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFKSFMAECKALRNIRHRNLIKIITI 770
IG+G++G VYK +VA+K I L + +G + + E L+ + H N++K++ +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
I ++ + LVFE + + L+ ++ S L L LI+ + + + + H
Sbjct: 68 ---IHTENKLY--LVFEFL-HQDLKKFMDASP--LSGIPLPLIK--SYLFQLLQGLAFCH 117
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
H ++H DLKP N+L++ + + DFGLA+ +T + + T+ Y
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV---VTLWY 166
Query: 891 VAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
APE +G + T D++S G + E+ T R
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 36/232 (15%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVK-VINLKQKGAFKSF-------------MAECKAL 756
+G+G++G V K IVA+K V ++ + E K +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 757 RNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV 816
I+H N++ ++ + DF LV + M L+ + + +LT Q
Sbjct: 75 NEIKHENIMGLVDVYVE-----GDFINLVMDIM-ASDLKKVVDRK------IRLTESQVK 122
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA-KFLSSHQLDTAS 875
I + + + + LH +H DL P+N+ ++ + + DFGLA ++ DT S
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 876 KTSSSSIGIKG-----TVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGR 921
K + + T+ Y APE MG+E D++S G + EL TG+
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 36/215 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G+FG VYK E + A KVI K + + +M E + L H ++K++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---- 75
Query: 773 SIDSKGADFK----ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
GA + ++ E G+++ + + + L ++ +I R + A++Y
Sbjct: 76 -----GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR-----QMLEALQY 125
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF-LSSHQLDTASKTSSSSIGIKGT 887
LH ++H DLK NVLL D GD LA F +S+ + T + S GT
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLD-----GDIKLADFGVSAKNVKTLQRRDS----FIGT 173
Query: 888 VGYVAPEYCM-----GSEASMTGDVYSFGILLLEL 917
++APE M + D++S GI L+E+
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-11
Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
+HH M+H D+K +N+LL + + +GDFG +K ++ D +T GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT------FCGTP 209
Query: 889 GYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAA 927
YVAPE S D++S G+LL EL T +RP D
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248
|
Length = 496 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK---SFMAECKALRNIRHRNLIKIIT 769
IG G FG V + D + V V LK + K F+ + R ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
C A LVFE + G L+ +L Q H +L L+QR +A ++A+ + ++
Sbjct: 63 QCVE-----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHM 115
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H H +H DL N L D+ VGD+G+ S ++ D + ++
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLR---- 166
Query: 890 YVAPEYC-------MGSEASMTGDVYSFGILLLELF 918
++APE + +E + +V++ G+ L ELF
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-11
Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+IG+GS+G V I VA+K IN + + E K LR +RH ++++I
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 770 ICSSIDSKGADFKAL--VFECMKNGSLEDWLHQ---SNDHL--EVCKLTLIQRVNIAIDV 822
I + +FK + VFE M E LHQ +ND L E + L Q +
Sbjct: 67 IMLPPSRR--EFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQ-------L 112
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
A++Y+H + H DLKP N+L + D + DFGLA+ DT + +
Sbjct: 113 LRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPTAIFWTD- 165
Query: 883 GIKGTVGYVAPEYC--MGSEASMTGDVYSFGILLLELFTGR 921
T Y APE C S+ + D++S G + E+ TG+
Sbjct: 166 -YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 61/233 (26%), Positives = 108/233 (46%), Gaps = 48/233 (20%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRN 763
++ IG+G++G VYKG + IVA+K I L+ ++G + + E L+ ++H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQ--SNDHL--EVCKLTLIQRVNIA 819
++ + + +S+ L+FE + + L+ +L ++ E+ K L Q
Sbjct: 61 IVCLQDVLMQ-ESR----LYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQ----- 109
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+ I + H ++H DLKP N+L+D+ V + DFGLA+
Sbjct: 110 --ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR--------------- 149
Query: 880 SSIGIK--------GTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRP 923
+ GI T+ Y APE +GS S D++S G + E+ T ++P
Sbjct: 150 -AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLI 765
+F + +G G+ G V K +I+A K+I+L+ K A ++ + + L+ + N
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 63
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
I+ + S G ++ E M GSL+ L ++ E ++ +V+IA V
Sbjct: 64 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKRIPE----EILGKVSIA--VLRG 115
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+ YL Q ++H D+KPSN+L V+ G+ L F S QL S +
Sbjct: 116 LAYLREKHQ--IMHRDVKPSNIL-----VNSRGEIKLCDFGVSGQL-----IDSMANSFV 163
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y++PE G+ S+ D++S G+ L+EL GR P
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKAL-RNIRHRNLIKI 767
+IG+GSFG V +E AVKV+ K +K K M+E L +N++H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ AD V + + G L L + E C L R A ++ASA+
Sbjct: 62 -----HFSFQTADKLYFVLDYINGGELFYHLQR-----ERCFLEPRARF-YAAEIASALG 110
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
YLH +V+ DLKP N+LLD + DFGL K ++ TS+ GT
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTST----FCGT 159
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+APE T D + G +L E+ G P
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 47/234 (20%)
Query: 713 IGQGSFGSVY----KGI---LGEDE-------MIVAVKVINLK-QKGAFKSFMAECKALR 757
+G+G FG V+ +G+ LGE ++VAVK++ K A F+ E K +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 758 NIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVN 817
+++ N+I+++ +C S D ++ E M+NG L +L Q I V+
Sbjct: 73 RLKNPNIIRLLGVCVSDDPL-----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 818 I------AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQL 871
I A+ +AS ++YL VH DL N L+ + + DFG+++ L
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL----- 179
Query: 872 DTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG------DVYSFGILLLELFT 919
S I+G V P M E+ + G DV++FG+ L E+FT
Sbjct: 180 -----YSGDYYRIQGRA--VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 72/231 (31%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FKSFMAECKALRNIRHRN 763
F IG GSFG+VY +VA+K ++ K + ++ + E K L+ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 764 LIKIITICSSIDSKGADFKA----LVFE-CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
SI+ KG + LV E C+ + S D LEV K L Q V I
Sbjct: 87 ---------SIEYKGCYLREHTAWLVMEYCLGSAS---------DLLEVHKKPL-QEVEI 127
Query: 819 AIDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875
A A++ YLH H M+H D+K N+LL + DFG A S
Sbjct: 128 AAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP------- 177
Query: 876 KTSSSSIGIKGTVGYVAPEYCMG-SEASMTG--DVYSFGILLLELFTGRRP 923
++S + GT ++APE + E G DV+S GI +EL R+P
Sbjct: 178 --ANSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITIC 771
+G+GS+ +VYKG + +VA+KVI L+ ++G + + E L+ ++H N++ + I
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWL--HQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ ++ LVFE + L ++ H H E KL L Q + + Y+
Sbjct: 73 HTKET-----LTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQ-------LLRGLSYI 119
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H Q ++H DLKP N+L+ + DFGLA+ S S T S+ + T+
Sbjct: 120 H---QRYILHRDLKPQNLLISDTGELKLADFGLARAKS-----VPSHTYSNEV---VTLW 168
Query: 890 YVAPEYCMGS-EASMTGDVYSFGILLLELFTG 920
Y P+ +GS E S D++ G + +E+ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNI-RHRNLIKI 767
++G+GSFG V L + + AVKV+ + Q + M E + L +H L ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
S +K F V E + G L + +S + + A ++ ++
Sbjct: 62 H---SCFQTKDRLF--FVMEYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQ 110
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+LH +++ DLK NVLLD + + DFG+ K + TS+ GT
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK----EGILGGVTTST----FCGT 159
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
Y+APE D ++ G+LL E+ G+ P +
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 45/224 (20%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
IG+G++G VYK IVA+K I L+ +G + + E L+ + H N+++++ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWL----HQSNDHLEVCKLTLIQRVNIAIDVASAI 826
S ++K LVFE + + L+ ++ D + K L Q + I
Sbjct: 67 VHS-ENK----LYLVFEFL-DLDLKKYMDSSPLTGLD-PPLIKSYLYQLL-------QGI 112
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS------SHQLDTASKTSSS 880
Y H H ++H DLKP N+L+D + + DFGLA+ +H++
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-------- 161
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGRRP 923
T+ Y APE +GS T D++S G + E+ RRP
Sbjct: 162 ------TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 74/243 (30%), Positives = 114/243 (46%), Gaps = 30/243 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIK----II 768
IG+G+FG VY+ + I A+KV++ K+ A K +A RNI R L+ I+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKE-VAHTIGERNILVRTLLDESPFIV 59
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI-DVASAIE 827
+ S + + LV + M G L W Q R I ++ A+E
Sbjct: 60 GLKFSFQTDSDLY--LVTDYMSGGELF-WHLQKEGRFSE------DRAKFYIAELVLALE 110
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+LH + +V+ DLKP N+LLD + DFGL+K L T +KT+++ GT
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK----ANL-TDNKTTNT---FCGT 159
Query: 888 VGYVAPEYCMGSEASMTG--DVYSFGILLLELFTGRRPTDAAFTEGL-TLHEFAKIALPE 944
Y+APE + E T D +S G+L+ E+ G P A T+ + F K+ P+
Sbjct: 160 TEYLAPEVLL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK 218
Query: 945 KVI 947
V+
Sbjct: 219 NVL 221
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 34/91 (37%), Positives = 57/91 (62%), Gaps = 1/91 (1%)
Query: 425 GLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGA 484
GL L L+G IP+ + L L + +S NS++GNIP SLG+ +L + S+N G+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 485 LPQQLLSITTLSVYLDLSNNNLNGSLPLQIG 515
+P+ L +T+L + L+L+ N+L+G +P +G
Sbjct: 482 IPESLGQLTSLRI-LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 57/213 (26%), Positives = 107/213 (50%), Gaps = 28/213 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITIC 771
+G+G++ +V+KG E +VA+K I L+ ++GA + + E L++++H N++ + I
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEV--CKLTLIQRVNIAIDVASAIEYL 829
+ S LVFE + + L+ ++ + + + K+ L Q + + Y
Sbjct: 74 HTDKSL-----TLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ-------ILRGLAYC 120
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H ++H DLKP N+L++ + DFGLA+ S +KT S+ + T+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS-----VPTKTYSNEV---VTLW 169
Query: 890 YVAPEYCMG-SEASMTGDVYSFGILLLELFTGR 921
Y P+ +G SE S D++ G + E+ +GR
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 32/225 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS------FMAECKALRNIRHRNLIK 766
IG G FG V +LGE ++ + +K+ A + F+ E + R + H N+++
Sbjct: 3 IGNGWFGKV---LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ C LV E G L+++L + + + + +A +VAS +
Sbjct: 60 CLGQCIESIPY-----LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ-RMACEVASGL 113
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
+LH Q +H DL N L D+ +GD+GLA L + D ++ ++
Sbjct: 114 LWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR- 167
Query: 887 TVGYVAPEYC-------MGSEASMTGDVYSFGILLLELFT-GRRP 923
++APE + + + +++S G+ + ELFT +P
Sbjct: 168 ---WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 40/233 (17%)
Query: 707 FASSNM-----IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFKSFMAECKALRNIR 760
F + ++ IG+G+FG+V K + I+AVK I K + + + +R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58
Query: 761 HRNLIKIITICSSIDSKGADFK---ALVFECMK--NGSLEDWLHQSNDHLEVCKLTLIQR 815
+ I+ GA F+ + CM+ + SL+ + + L+ + +
Sbjct: 59 SSDCPYIVKF------YGALFREGDCWI--CMELMDISLDKFYKYVYEVLKSV---IPEE 107
Query: 816 V--NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
+ IA+ A+ YL + ++H D+KPSN+LLD + + DFG+ S +D+
Sbjct: 108 ILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI----SGQLVDS 161
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMGSEAS---MTGDVYSFGILLLELFTGRRP 923
+KT + G Y+APE S + DV+S GI L E+ TG+ P
Sbjct: 162 IAKTRDA-----GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 63/253 (24%), Positives = 108/253 (42%), Gaps = 62/253 (24%)
Query: 693 PTVSYAELSKATSE----FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS 748
PT EL+K E + + + +G G++GSV + + VAVK K F+S
Sbjct: 1 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQS 56
Query: 749 FM------AECKALRNIRHRNLIKIITICSSIDS-------------KGADFKALVFECM 789
+ E + L++++H N+I ++ + + S GAD +V +C
Sbjct: 57 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQ 115
Query: 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
K ++DH++ + + ++Y+H ++H DLKPSN+ +
Sbjct: 116 K---------LTDDHVQF----------LIYQILRGLKYIH---SADIIHRDLKPSNLAV 153
Query: 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVY 908
+ D + DFGLA+ T G T Y APE + + T D++
Sbjct: 154 NEDCELKILDFGLAR-----------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 202
Query: 909 SFGILLLELFTGR 921
S G ++ EL TGR
Sbjct: 203 SVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRN------IRHRNLI 765
M+G+GSFG V+ L A+K LK+ EC + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVC-KLTLIQRVNIAIDVAS 824
+ + +K F V E + G L H++ C K L + A ++
Sbjct: 60 HLYC---TFQTKENLF--FVMEYLNGGDLMF-------HIQSCHKFDLPRATFYAAEIIC 107
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
+++LH +V+ DLK N+LLD D + DFG+ K + +KT +
Sbjct: 108 GLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK----ENMLGDAKTCT----F 156
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE +G + + + D +SFG+LL E+ G+ P
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLI 765
+F + +G G+ G V+K +I+A K+I+L+ K A ++ + + L+ + N
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 63
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
I+ + S G ++ E M GSL+ L ++ E ++ +V+IA V
Sbjct: 64 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 115
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+ YL + ++H D+KPSN+L V+ G+ L F S QL S +
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNIL-----VNSRGEIKLCDFGVSGQL-----IDSMANSFV 163
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y++PE G+ S+ D++S G+ L+E+ GR P
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 48/235 (20%)
Query: 713 IGQGSFGSVY----KGIL------------GEDEMIVAVKVINLK-QKGAFKSFMAECKA 755
+G+G FG V+ +G+ G ++VAVK++ K A F+ E K
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 756 LRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL--HQSNDHLEVCKLTLI 813
+ ++ N+I+++ +C I S D ++ E M+NG L +L H+ + E + I
Sbjct: 73 MSRLKDPNIIRLLAVC--ITS---DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 814 QR---VNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQ 870
+ +A +AS ++YL VH DL N L+ + + DFG+++ L
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---- 180
Query: 871 LDTASKTSSSSIGIKGTVGYVAPEYCMGSEA------SMTGDVYSFGILLLELFT 919
S I+G V P M E+ + DV++FG+ L E+ T
Sbjct: 181 ------YSGDYYRIQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 24/220 (10%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKAL--RNIRHR-N 763
F ++G+G FG V + + A K + +K K E AL + I + N
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGESMALNEKQILEKVN 58
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
++++ + ++K D LV M G L+ ++ H+ + V A ++
Sbjct: 59 SRFVVSLAYAYETK--DALCLVLTLMNGGDLKFHIY----HMGEAGFEEGRAVFYAAEIC 112
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+E LH Q +V+ DLKP N+LLD + D GLA + Q + G
Sbjct: 113 CGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---------TIKG 160
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GTVGY+APE + + D ++ G LL E+ G+ P
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 5e-10
Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 28/236 (11%)
Query: 689 EKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS 748
EK VS + K + F IGQG+ G+VY + VA++ +NL+Q+ +
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 749 FMAECKALRNIRHRNLIKIITICSSIDSK-GADFKALVFECMKNGSLEDWLHQSNDHLEV 807
+ E +R ++ N++ + +DS D +V E + GSL D + E
Sbjct: 64 IINEILVMRENKNPNIV------NYLDSYLVGDELWVVMEYLAGGSLTDVV------TET 111
Query: 808 CKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867
C + Q + + A+E+LH + ++H D+K N+LL D + DFG ++
Sbjct: 112 C-MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Q SK S+ + GT ++APE D++S GI+ +E+ G P
Sbjct: 168 PEQ----SKRST----MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 43/221 (19%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF-KSFMAECKALRNIRHRNLIKIIT 769
++G G+ G+VYK I+AVKVI L K M+E ++I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE------------LEILY 54
Query: 770 ICSS---IDSKGADFK----ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 822
C S I GA F ++ E M GSL D + +H+ + R IA+ V
Sbjct: 55 KCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIPEHV-------LGR--IAVAV 104
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+ YL ++H D+KPSN+L++ + DFG+ S+ +++ +KT
Sbjct: 105 VKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGV----STQLVNSIAKTYV--- 154
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE G + + DV+S GI +EL GR P
Sbjct: 155 ---GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL 764
S + IG+GS G V VAVK ++L+++ + E +R+ +H N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 765 IKIITICSSIDSK-GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
+++ S D +V E ++ G+L D + + + E Q + + V
Sbjct: 79 VEMY------SSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLAVL 125
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
A+ +LH ++H D+K ++LL D + DFG +S + + S
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK---EVPRRKS----- 174
Query: 884 IKGTVGYVAPEYC----MGSEASMTGDVYSFGILLLELFTGRRP 923
+ GT ++APE G+E D++S GI+++E+ G P
Sbjct: 175 LVGTPYWMAPEVISRLPYGTEV----DIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 6e-10
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 28/236 (11%)
Query: 689 EKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS 748
EK VS + K + F IGQG+ G+VY I VA+K +NL+Q+ +
Sbjct: 6 EKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL 62
Query: 749 FMAECKALRNIRHRNLIKIITICSSIDSK-GADFKALVFECMKNGSLEDWLHQSNDHLEV 807
+ E +R ++ N++ + +DS D +V E + GSL D + E
Sbjct: 63 IINEILVMRENKNPNIV------NYLDSYLVGDELWVVMEYLAGGSLTDVV------TET 110
Query: 808 CKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867
C + Q + + A+++LH + ++H D+K N+LL D + DFG ++
Sbjct: 111 C-MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
Query: 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Q SK S+ + GT ++APE D++S GI+ +E+ G P
Sbjct: 167 PEQ----SKRST----MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 40/131 (30%), Positives = 62/131 (47%), Gaps = 15/131 (11%)
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
+ + + A+ YL ++H D+KPSN+LLD + DFG++ L +D+ +KT
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL----VDSKAKT 172
Query: 878 SSSSIGIKGTVGYVAPEYC----MGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933
S G Y+APE + + DV+S GI L+EL TG+ P TE
Sbjct: 173 RS-----AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227
Query: 934 LHEFAKIALPE 944
L + + P
Sbjct: 228 LTKILQEEPPS 238
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 37/229 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITI 770
IG+G++G VYK +A+K I L+Q+ G + + E L+ ++H N++++ +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSND---HLEVCKLTLIQRVNIAIDVASAIE 827
S + + LVFE + + L+ + S D + + K L Q + I
Sbjct: 70 VHS-EKR----LYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQ-------ILRGIA 116
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVS-HVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
Y H H ++H DLKP N+L+D + + DFGLA+ +T + +
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-----AFGIPVRTFTHEV---V 165
Query: 887 TVGYVAPEYCMGSEASMTG-DVYSFGILLLE------LFTGRRPTDAAF 928
T+ Y APE +GS T D++S G + E LF G D F
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 34/231 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFKSFMAECKALRNIRHRNLIKI 767
IG+GSFG +Y D +K I+L K+K A K E L ++H N I
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPN---I 61
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+T +S G F +V E G L +++ L L V I++ ++
Sbjct: 62 VTFFASFQENGRLF--IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL----GLK 115
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHD-MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
++H ++H D+K N+ L + MV+ +GDFG+A+ QL+ + + + + +G
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-----QLNDSMELAYTCVG--- 164
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937
T Y++PE C + D++S G +L EL T + P EG LH+
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP-----FEGNNLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFKSFMAECKALRNIRHRNLIK 766
++GQG+FG VY + +A K + + + E + L+N++H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE---R 65
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
I+ + + + E M GS++D L E +++ +
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGM 119
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YLH + +VH D+K +N+L D +GDFG +S +L T + + + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG-----ASKRLQTICMSGTGIRSVTG 171
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T +++PE G DV+S G ++E+ T + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 65/244 (26%), Positives = 111/244 (45%), Gaps = 34/244 (13%)
Query: 684 DTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGI---LGEDEMIVAVKVINL 740
D EK VS + K + + IGQG+ G+V+ I G++ VA+K INL
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEK---IGQGASGTVFTAIDVATGQE---VAIKQINL 54
Query: 741 KQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK-GADFKALVFECMKNGSLEDWLH 799
+++ + + E ++ +++ N++ + DS D +V E + GSL D +
Sbjct: 55 QKQPKKELIINEILVMKELKNPNIVNFL------DSFLVGDELFVVMEYLAGGSLTDVV- 107
Query: 800 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859
E C + Q + + A+E+LH + ++H D+K NVLL D + D
Sbjct: 108 -----TETC-MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTD 158
Query: 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
FG ++ Q SK S+ + GT ++APE D++S GI+ +E+
Sbjct: 159 FGFCAQITPEQ----SKRST----MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE 210
Query: 920 GRRP 923
G P
Sbjct: 211 GEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
IG+G++G+V+K E IVA+K + L +G S + E L+ ++H+N++++ +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 771 CSSIDSKGADFKALVFE-CMKNGSLEDWLHQSNDHLE--VCKLTLIQRVNIAIDVASAIE 827
S D K LVFE C ++ L+ + N ++ + K + Q + +
Sbjct: 68 LHS-DKK----LTLVFEYCDQD--LKKYFDSCNGDIDPEIVKSFMFQ-------LLKGLA 113
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+ H H ++H DLKP N+L++ + + DFGLA+ + S+ + T
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVRCYSAEV---VT 162
Query: 888 VGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGRRP 923
+ Y P+ G++ T D++S G + EL RP
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 67/216 (31%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKAL-RNIRHRNLIKI 767
+IG+GSFG V D AVKV+ K +K MAE L +N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ A+ V + + G L + H E C L R A +VASAI
Sbjct: 62 -----HYSFQTAEKLYFVLDYVNGGEL--FFHLQR---ERCFLEPRARF-YAAEVASAIG 110
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
YLH +++ DLKP N+LLD + DFGL K ++ TS+ GT
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTST----FCGT 159
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+APE T D + G +L E+ G P
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 62/240 (25%), Positives = 96/240 (40%), Gaps = 58/240 (24%)
Query: 705 SEFASSNMIGQGSFGSVY---KGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRN 758
+F +GQG +G V+ K GE IVA+K + L + + + E L
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGE---IVALKRMKKSLLFKLNEVRHVLTERDILTT 57
Query: 759 IRHRNLIKIITICSSIDSK----------GADFKALVFECMKNGSLEDWLHQSNDHLEVC 808
+ L+K++ + D + G DF+ L+ G L S DH
Sbjct: 58 TKSEWLVKLLY--AFQDDEYLYLAMEYVPGGDFRTLL---NNLGVL------SEDH---- 102
Query: 809 KLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFL 866
R +A ++ A++ LH + +H DLKP N L+D H+ DFGL+K
Sbjct: 103 -----ARFYMA-EMFEAVDALH---ELGYIHRDLKPENFLIDAS--GHIKLTDFGLSK-- 149
Query: 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
+ +S + G+ Y+APE G T D +S G +L E G P
Sbjct: 150 -----GIVTYANS----VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG+GS G V + +VAVK ++L+++ + E +R+ +H N++++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 84
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
D +V E ++ G+L D + + + E Q + + V A+ LH
Sbjct: 85 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLKALSVLHAQ 135
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
++H D+K ++LL HD + DFG SK + GT ++A
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA--------QVSKEVPRRKSLVGTPYWMA 184
Query: 893 PEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
PE D++S GI+++E+ G P
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 26/219 (11%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKII 768
++G+GSFG V L E + AVKV+ + Q + M E + L R+ + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAIE 827
C + D V E + G L H++ + R A ++ SA+
Sbjct: 62 YCCF----QTPDRLFFVMEFVNGGDLMF-------HIQKSRRFDEARARFYAAEITSALM 110
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+LH +++ DLK NVLLDH+ + DFG+ K + TS+ GT
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTST----FCGT 159
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
Y+APE + D ++ G+LL E+ G P +A
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 5e-09
Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 42/245 (17%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRH 761
+F +IG+G+FG V+ + + A+KV+ + ++ AE L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
++K+ S D + LV E M G L + L + + E + R IA +
Sbjct: 61 PWIVKLY--YSFQDE---EHLYLVMEYMPGGDLMNLLIRKDVFPE--ETA---RFYIA-E 109
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLA-KFLSSHQ---LDTAS 875
+ A++ +H + +H D+KP N+L+D D H+ DFGL K + S
Sbjct: 110 LVLALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 876 KTSSSSIGIK-----------------GTVGYVAPEYCMGSEASMTGDVYSFGILLLELF 918
+ GT Y+APE G+ + D +S G++L E+
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 919 TGRRP 923
G P
Sbjct: 225 YGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIIT-- 769
+IG+G FG VY + + A+K ++ K+ K E AL R ++ +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALN---ERIMLSLVSTG 54
Query: 770 -----ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
+C + D + + M G L L Q E + A ++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK------EMRFYATEIIL 108
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
+E++H+ +V+ DLKP+N+LLD + D GLA D + K +S+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV-- 156
Query: 885 KGTVGYVAPEYCM-GSEASMTGDVYSFGILLLELFTGRRP 923
GT GY+APE G+ + D +S G +L +L G P
Sbjct: 157 -GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 75/306 (24%), Positives = 131/306 (42%), Gaps = 55/306 (17%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHR 762
++F ++G+G++G V K E + IVA+K ++ ++ + E K LR ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL-EVCKLTLIQRVNIAID 821
N I+ + + +G + LVFE ++ LE N E + + Q +
Sbjct: 61 N---IVELKEAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK---- 111
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
AI + H + +VH D+KP N+L+ H+ V + DFG A+ LS ++++
Sbjct: 112 ---AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLS-------EGSNANY 158
Query: 882 IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLE------LFTGRRPTDAAFT------ 929
T Y +PE +G+ D++S G +L E LF G D FT
Sbjct: 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG 218
Query: 930 ----EGLTLH----EFAKIALP---------EKVIEIVDPLLLIEVMANNSMIQEDIRAK 972
E + L F + P + + I+ +LL ++M N + R
Sbjct: 219 PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLL-DLMKNLLKLNPTDRYL 277
Query: 973 TQECLN 978
T++CLN
Sbjct: 278 TEQCLN 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 5e-09
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 46/233 (19%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF-KSFMAECKALRNIRHRN 763
+ + + IG+G++G V + VA+K I+ + F + + E K LR +H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 764 LIKI--ITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ-------SNDHLEVCKLTL 812
+I I I S +S F +V E M E L++ SNDH + L
Sbjct: 65 IIGILDIIRPPSFES----FNDVYIVQELM-----ETDLYKLIKTQHLSNDH---IQYFL 112
Query: 813 IQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLD 872
Q + ++Y+H ++H DLKPSN+LL+ + + DFGLA+
Sbjct: 113 YQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR-------- 154
Query: 873 TASKTSSSSIGIKGTVG---YVAPEYCMGS-EASMTGDVYSFGILLLELFTGR 921
A + + V Y APE + S + D++S G +L E+ + R
Sbjct: 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 60/229 (26%), Positives = 89/229 (38%), Gaps = 42/229 (18%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVK------VINLKQKGAFKSFMAECKALRN 758
S+F +G GSFG V A+K ++ +KQ + E L
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ---VQHVAQEKSILME 74
Query: 759 IRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS----NDHLEVCKLTLIQ 814
+ H ++ ++ CS D F + E + G L L ++ ND V K
Sbjct: 75 LSHPFIVNMM--CSFQDENRVYF---LLEFVVGGELFTHLRKAGRFPND---VAKF---- 122
Query: 815 RVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTA 874
++ A EYLH +++ DLKP N+LLD+ V DFG AK
Sbjct: 123 ---YHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---------- 166
Query: 875 SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
K + + GT Y+APE D ++ G+LL E G P
Sbjct: 167 -KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 35/229 (15%)
Query: 707 FASSNMIGQGSFGSVY--KGILGEDE-MIVAVKVIN-----LKQKGAFKSFMAECKALRN 758
F ++G G++G V+ + + G D + A+KV+ K K A + E + L
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTA-EHTRTERQVLEA 60
Query: 759 IRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
+R + + D+K L+ + + G L L+Q +H ++ RV I
Sbjct: 61 VRRCPFLVTLHYAFQTDTK----LHLILDYVNGGELFTHLYQR-EHFTESEV----RVYI 111
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASK 876
A ++ A+++LH Q +++ D+K N+LLD + HV DFGL+K + + + A
Sbjct: 112 A-EIVLALDHLH---QLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYS 165
Query: 877 TSSSSIGIKGTVGYVAPEYCMGSEA--SMTGDVYSFGILLLELFTGRRP 923
GT+ Y+APE G D +S G+L EL TG P
Sbjct: 166 FC-------GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 6e-09
Identities = 23/41 (56%), Positives = 26/41 (63%), Gaps = 2/41 (4%)
Query: 34 NETDRLALLAIKSQL-HDTSGVTSSWN-NTINLCQWTGVTC 72
DR ALLA KS L D SG SSWN ++ + C WTGVTC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 51/224 (22%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVK---------VINLKQKGAFKSFMAECKALRNIRHRN 763
IG+GS+G V+K E IVA+K VI K + E + L+ ++H N
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-------KIALREIRMLKQLKHPN 61
Query: 764 LIKIITICSSIDSKGADFKA-----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
L+ +I + F+ LVFE + ++ L++ + LI++ I
Sbjct: 62 LVNLIEV----------FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKK--I 105
Query: 819 AIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
A+ + H H+C +H D+KP N+L+ + DFG A+ L+ D
Sbjct: 106 IWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 878 SSSSIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTG 920
+ T Y APE +G DV++ G + EL TG
Sbjct: 162 A--------TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-09
Identities = 73/323 (22%), Positives = 131/323 (40%), Gaps = 12/323 (3%)
Query: 109 SDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAE 168
++ +P + LL L+ L+ S S NL L L ++ N+L I E
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNIS-E 111
Query: 169 IGSLLKLQTLAVGKNYLTGRLPDFVGNLSA-LEVFSITGNSLGGKIPTTLGLLRNLVDLH 227
+ L L +L + N +T +P +G L + L+ ++ N + +P+ L L NL +L
Sbjct: 112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLD 169
Query: 228 VGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIP 287
+ N S P+ + N+S+L + L N+ S LP + L L+ L + N+ +
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLP-PEIELLSALEELDLSNNSII-ELL 225
Query: 288 DSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTA-NDLDFVTFLTN 346
SLSN N+ L+L N+ + +L NL L+L N + ++ L + L
Sbjct: 226 SSLSNLKNLSGLELSNNKLEDLPES-IGNLSNLETLDLSNNQISSISSLGSLTNLRELDL 284
Query: 347 CSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRN-LVNLIALGMQ 405
+ +L + L + NL ++ + N I + AL +
Sbjct: 285 SGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSIL 344
Query: 406 SNQLHGTIPDVIGELKNLQGLFL 428
+ + D + NL +
Sbjct: 345 ESLNNLWTLDNALDESNLNRYIV 367
|
Length = 394 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 44/222 (19%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN------LKQKGAFKSFMAECKALRNIRHRNLIK 766
+G G++G V + VA+K ++ + K ++ E + L+++ H N+I
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHENVIG 78
Query: 767 IITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ---SNDHLEVCKLTLIQRVNIAID 821
++ + + S DF+ LV M L + + S+DH++ +
Sbjct: 79 LLDVFTP-ASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQF----------LVYQ 126
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
+ ++Y+H ++H DLKPSN+ ++ D + DFGLA+ T
Sbjct: 127 ILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----------HTDDEM 172
Query: 882 IGIKGTVGYVAPE--YCMGSEASMTGDVYSFGILLLELFTGR 921
G T Y APE + T D++S G ++ EL TG+
Sbjct: 173 TGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKA--LRNIRHRNLIKIITI 770
+G+GS+G V D +K +NL+ + AE +A L ++H N I+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVAY 64
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
S + + ++ C + G L L + L L Q V + +A A++YLH
Sbjct: 65 RESWEGEDGLLYIVMGFC-EGGDLYHKLKEQKGKL----LPENQVVEWFVQIAMALQYLH 119
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ ++H DLK NV L + VGD G+A+ L + Q D AS + GT Y
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMAST-------LIGTPYY 168
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
++PE + DV++ G + E+ T + +A
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-08
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 32/202 (15%)
Query: 733 VAVKVI------NLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS--KGADFKAL 784
VA+K++ Q+ F+ A C L H N++ ++ DS
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVALL------DSGEAPPGLLFA 56
Query: 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKP 844
VFE + +L + L + D L + + + V A+ H+ +VH DLKP
Sbjct: 57 VFEYVPGRTLREVL--AADGA----LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKP 107
Query: 845 SNVLLD-HDMVSH--VGDFGLAKFLS-SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE 900
N+++ + H V DFG+ L D A+ T ++ + GT Y APE G
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEV--LGTPTYCAPEQLRGEP 165
Query: 901 ASMTGDVYSFGILLLELFTGRR 922
+ D+Y++G++ LE TG+R
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIIT-- 769
+IG+G FG VY + + A+K ++ K+ K E AL R ++ +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALN---ERIMLSLVSTG 54
Query: 770 -----ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
+C S D + + + M G L L Q E + A ++
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA------EMRFYAAEIIL 108
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
+E++H+ +V+ DLKP+N+LLD + D GLA D + K +S+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV-- 156
Query: 885 KGTVGYVAPEYCM-GSEASMTGDVYSFGILLLELFTGRRP 923
GT GY+APE G + D +S G +L +L G P
Sbjct: 157 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 48/224 (21%), Positives = 99/224 (44%), Gaps = 29/224 (12%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINL------KQKGAFKSFMAECKALRNIRHRNLI 765
+G G+F S Y+ + ++AVK + +Q+ ++ E + + + H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+ + + F V E M GS+ L + E + +++
Sbjct: 67 R----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRG 115
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLD---HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+ YLH + ++H D+K +N+L+D + + DFG A L++ +
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAA----KGTGAGEFQG 166
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
+ GT+ ++APE G + + DV+S G +++E+ T + P +A
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-08
Identities = 64/231 (27%), Positives = 112/231 (48%), Gaps = 33/231 (14%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFK-SFMAECKALRNIRHRN 763
E+ N I +G++G VY+ + IVA+K + + K+K F + + E L ++H N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNG--SLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
I+T+ + D +V E +++ SL + + Q EV K ++Q
Sbjct: 66 ---IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV-KCLMLQ------- 114
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
+ S + +LH + ++H DLK SN+LL++ + + DFGLA+ S L ++
Sbjct: 115 LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS-PLKPYTQ----- 165
Query: 882 IGIKGTVGYVAPEYCMGSEASMTG-DVYS----FGILLLE--LFTGRRPTD 925
+ T+ Y APE +G++ T D++S F LL + LF G+ D
Sbjct: 166 --LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS-----FMAECKALRNIRHRNLIK 766
++GQG+FG VY + +AVK + + S E + L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVN--IAIDVAS 824
+ ++ E M GS++D L L + V +
Sbjct: 69 YYGCLRDPMERTL---SIFMEHMPGGSIKDQLKSYG--------ALTENVTRKYTRQILE 117
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
+ YLH + +VH D+K +N+L D +GDFG +S +L T + + +
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG-----ASKRLQTICLSGTGMKSV 169
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT +++PE G D++S G ++E+ T + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 16/112 (14%)
Query: 818 IAIDVASAIEYLH--HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875
IA+ V + YL+ H ++H D+KPSN+L++ + DFG++ L + DT
Sbjct: 108 IAVAVVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163
Query: 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAA 927
TS+ Y++PE G + ++ DV+S GI ++EL G+ P +
Sbjct: 164 GTST----------YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 11/105 (10%)
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
A ++ +++LH +++ DLK NVLLD D + DFG+ K ++ K S
Sbjct: 102 AAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK----ENMNGEGKAS 154
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ GT Y+APE G + + + D +SFG+LL E+ G+ P
Sbjct: 155 T----FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 58/229 (25%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFM------AECKALRNIRHRN--- 763
+G G++GSV VAVK K F+S + E + L++++H N
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 764 LIKIITICSSIDS----------KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLI 813
L+ + T +SI++ GAD +V +C K S++H++ L+
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGADLNNIV-KCQK---------LSDEHVQFLIYQLL 128
Query: 814 QRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
+ ++Y+H ++H DLKPSNV ++ D + DFGLA+
Sbjct: 129 R----------GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--------- 166
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGR 921
+ G T Y APE + + T D++S G ++ EL G+
Sbjct: 167 --QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G+G FG V + + A K ++ LK+K K + E + L + N I+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ + +SK LV M G L+ ++ ++ L + + ++ + + I +L
Sbjct: 58 LAYAFESK--THLCLVMSLMNGGDLKYHIY----NVGERGLEMERVIHYSAQITCGILHL 111
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H +V+ D+KP NVLLD + D GLA +L + + GT G
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAV-----ELKDGKTITQRA----GTNG 159
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+APE S D ++ G + E+ GR P
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 36/218 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G+ G V K + +I+A K+I+L+ K A+RN R L K++ C+
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIK----------PAIRNQIIREL-KVLHECN 57
Query: 773 S---IDSKGADFK----ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
S + GA + ++ E M GSL+ L ++ E ++ +++IA V
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----NILGKISIA--VLRG 111
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+ YL + ++H D+KPSN+L V+ G+ L F S QL S +
Sbjct: 112 LTYLREKHK--IMHRDVKPSNIL-----VNSRGEIKLCDFGVSGQL-----IDSMANSFV 159
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y++PE G+ ++ D++S G+ L+E+ GR P
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG+GS G V VAVK+++L+++ + E +R+ +H+N++++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK--S 86
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
+ G + L+ E ++ G+L D + Q+ +L Q + V A+ YLH
Sbjct: 87 YL--VGEELWVLM-EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ 136
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
++H D+K ++LL D + DFG +S D + S + GT ++A
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK---DVPKRKS-----LVGTPYWMA 185
Query: 893 PEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
PE + D++S GI+++E+ G P
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
A ++ A+ +LH + +++ DLK NVLLD D + D+G+ K L TS
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTS 154
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
+ GT Y+APE G E + D ++ G+L+ E+ GR P D
Sbjct: 155 T----FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-08
Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 21/132 (15%)
Query: 810 LTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869
L L Q +A + SAI+Y+H + ++H D+K NVL++ +GDFG A F
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDICLGDFGAACFAR-- 311
Query: 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLE-------LFTG-- 920
S ++ GI GTV APE G + + D++S G+++ E LF+
Sbjct: 312 ----GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASR 367
Query: 921 ---RRPTDAAFT 929
RRP DA
Sbjct: 368 GDERRPYDAQIL 379
|
Length = 461 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 26/221 (11%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRN---IRHRN 763
F ++G+G FG V + + A K + +K K E AL + N
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRL---EKKRIKKRKGESMALNEKQILEKVN 58
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQ-SNDHLEVCKLTLIQRVNIAIDV 822
++ + + ++K D LV M G L+ ++ N E + + A ++
Sbjct: 59 SQFVVNLAYAYETK--DALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-----LFYAAEI 111
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+E LH + V+ DLKP N+LLD + D GLA + +
Sbjct: 112 LCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR--------- 159
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
G GTVGY+APE +++ D + G L+ E+ G+ P
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 53/227 (23%), Positives = 100/227 (44%), Gaps = 47/227 (20%)
Query: 713 IGQGSFGSVYKGI---LGED----EMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLI 765
+GQG+F ++KGI +G+ + V +KV++ + +SF + + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+C D +V E +K GSL+ +L ++ + + + ++ +A +A A
Sbjct: 63 LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWA 112
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+ +L + HG++ NVLL + G+ K S GI
Sbjct: 113 LHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL--------------SDPGIS 155
Query: 886 GTV----------GYVAPEYCMGSEASMT--GDVYSFGILLLELFTG 920
TV +V PE C+ + +++ D +SFG L E+F+G
Sbjct: 156 ITVLPKEILLERIPWVPPE-CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 31/222 (13%)
Query: 712 MIGQGSFGSVY--KGILGEDE-----MIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL 764
++G G++G V+ + + G D M V K +++ + E + L +IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI-DVA 823
+ + D+K L+ + + G L L Q E Q V I ++
Sbjct: 67 LVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRERFKE-------QEVQIYSGEIV 115
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
A+E+LH + +++ D+K N+LLD + + DFGL+K +++ A
Sbjct: 116 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA-------YS 165
Query: 884 IKGTVGYVAPEYCMGSEASMTG--DVYSFGILLLELFTGRRP 923
GT+ Y+AP+ G + D +S G+L+ EL TG P
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 712 MIGQGSFGSVY--KGILGED-EMIVAVKVINLKQKGAFKSF--MAECKALRNIRHRNLIK 766
++G+G +G V+ + + G D I A+KV LK+ ++ A KA RNI +K
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEA--VK 58
Query: 767 IITICSSIDSKGADFKA-LVFECMKNGSLEDWLHQSNDHLE-VCKLTLIQRVNIAIDVAS 824
I I + K L+ E + G L L + +E L + ++
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISL 111
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
A+E+LH +++ DLKP N+LLD + DFGL K S T + T
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHT------F 160
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT+ Y+APE M S D +S G L+ ++ TG P
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG+GS G V VAVK ++L+++ + E +R+ H N++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN--- 86
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
D +V E ++ G+L D + + + E Q + + V A+ YLH+
Sbjct: 87 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 137
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
++H D+K ++LL D + DFG SK + GT ++A
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCA--------QVSKEVPKRKSLVGTPYWMA 186
Query: 893 PEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
PE D++S GI+++E+ G P
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHR-NLIKIITIC 771
IG+GSFG V + + + I A+K I K +S + A R + + N I+ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
S S + L F + G L L + E R A ++ A+E LH
Sbjct: 60 FSFQSPEKLYLVLAF--INGGELFHHLQR-----EGRFDLSRARFYTA-ELLCALENLH- 110
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
+ +++ DLKP N+LLD+ + DFGL K + KT++ GT Y+
Sbjct: 111 --KFNVIYRDLKPENILLDYQGHIALCDFGLCKL----NMKDDDKTNT----FCGTPEYL 160
Query: 892 APEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
APE +G + D ++ G+LL E+ TG P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 68/243 (27%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK--SFMAECKALRNIRHRN 763
+F +++G+G FG V I A+KV+ A + SF E + + +I N
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS--N 59
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
I + + K D LV E G L L++ D + + Q +A
Sbjct: 60 SPWIPQLQYAFQDK--DNLYLVMEYQPGGDLLSLLNRYEDQFDE---DMAQ-----FYLA 109
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+ +H Q VH D+KP NVL+D G LA F S+ +L TA+K +S +
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLID-----RTGHIKLADFGSAARL-TANKMVNSKLP 163
Query: 884 IKGTVGYVAPEYCM---GSEASMTG---DVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937
+ GT Y+APE G G D +S G++ E+ GR P F EG + +
Sbjct: 164 V-GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP----FHEGTSAKTY 218
Query: 938 AKI 940
I
Sbjct: 219 NNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-08
Identities = 35/100 (35%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK-FLSSHQLDTASKTSSSSIG 883
A++ +H M+H DLK +N+ L + +GDFG +K + S LD AS
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC----- 232
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE S D++S G++L EL T RP
Sbjct: 233 --GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 712 MIGQGSFGSVYKGIL-GEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKI 767
++G+GSFG V L G DE + A+KV+ + Q M E + L +
Sbjct: 2 VLGKGSFGKVMLAELKGTDE-VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT- 59
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ +K F V E + G L + +S K + A +V A+
Sbjct: 60 -ALHCCFQTKDRLF--FVMEYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALM 110
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+LH H +++ DLK N+LLD + + DFG+ K + T+++ GT
Sbjct: 111 FLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-----EGILNGVTTTT---FCGT 159
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
Y+APE E + D ++ G+L+ E+ G+ P +A
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 713 IGQGSFGSVYKGIL--GEDEMIVAVKVI---NLKQKGAFKSFMAECKALRNIRHRNLIKI 767
IG+G++G VYK G+D A+K + G +S E LR ++H N++ +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV---NIAIDVAS 824
+ + K L+F+ ++ D H + K I ++ + +
Sbjct: 68 VEVFLEHADKSV---YLLFDYAEH----DLWQIIKFHRQA-KRVSIPPSMVKSLLWQILN 119
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH----VGDFGLAKFLSSHQLDTASKTSSS 880
+ YLH + ++H DLKP+N+L+ + +GD GLA+ ++ K +
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA-----PLKPLAD 171
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFT 919
+ T+ Y APE +G+ D+++ G + EL T
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 33/243 (13%)
Query: 686 SPREKQFPTVSYAELS-KATSEFASSNMIGQGSFG---SVYKGILGEDEMIVAVKVIN-- 739
S + QF +V A+ + + IG G+ G + + +LG + VAVK ++
Sbjct: 1 SEEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLG---INVAVKKLSRP 57
Query: 740 LKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA--LVFECMKNGSLEDW 797
+ + K E L+ + H+N+I ++ + + S +F+ LV E M + +L
Sbjct: 58 FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL-EEFQDVYLVMELM-DANLCQV 115
Query: 798 LHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857
+H DH + L L Q + I++LH ++H DLKPSN+++ D +
Sbjct: 116 IHMELDHERMSYL-LYQ-------MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 164
Query: 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLEL 917
DFGLA+ ++ + T T Y APE +G D++S G ++ EL
Sbjct: 165 LDFGLARTACTNFMMTPYVV---------TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
Query: 918 FTG 920
G
Sbjct: 216 VKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 61/242 (25%), Positives = 95/242 (39%), Gaps = 50/242 (20%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G+G G V+ L + A+KV++ K ++ K + E + L + H + T
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP---FLPT 65
Query: 770 ICSSIDSKGADFKALVFE-CMKNGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASA 825
+ +S + + LV + C G L L + EV + A +V A
Sbjct: 66 LYASFQT--ETYLCLVMDYCP-GGELFRLLQRQPGKCLSEEVARF-------YAAEVLLA 115
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHD---MVSHVGDFGLAKFLSS--HQLDTASKTSSS 880
+EYLH +V+ DLKP N+LL M+S DF L+K + A + S
Sbjct: 116 LEYLH--LLG-IVYRDLKPENILLHESGHIMLS---DFDLSKQSDVEPPPVSKALRKGSR 169
Query: 881 SIGIK-------------------GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR 921
+ GT Y+APE G D ++ GILL E+ G
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
Query: 922 RP 923
P
Sbjct: 230 TP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
+ +++ A+ +LH + +++ DLK NVLLD + + D+G+ K + TS
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTS 154
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
+ GT Y+APE G + + D ++ G+L+ E+ GR P D
Sbjct: 155 T----FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 32/105 (30%), Positives = 55/105 (52%), Gaps = 11/105 (10%)
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
A ++ +++LH +++ DLK NV+LD D + DFG+ K + ++ S
Sbjct: 102 AAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRAS 154
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ GT Y+APE G + + + D +SFG+LL E+ G+ P
Sbjct: 155 T----FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-07
Identities = 59/188 (31%), Positives = 88/188 (46%), Gaps = 6/188 (3%)
Query: 436 SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTL 495
+ NL L L ++ N L+ NI L NL + +N +T P L + L
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNITDIPPLIGLLKSNL 142
Query: 496 SVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFH 555
LDLS+N + SLP + NL NL L +S N S +P LS +L LD+S N
Sbjct: 143 K-ELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 556 GVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSK 615
+P + L +++ L+ S+N++ ++ L NL L L S+N LE + G S+
Sbjct: 200 -DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNL 257
Query: 616 TKLSLQGN 623
L L N
Sbjct: 258 ETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 57/240 (23%), Positives = 95/240 (39%), Gaps = 49/240 (20%)
Query: 713 IGQGSFGSVY----KGILGEDEMI------------VAVKVINL-KQKGAFKSFMAECKA 755
+G+G FG V+ G+ E VAVKV+ A + F+ E K
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 756 LRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL--HQSNDHLEVCKLTLI 813
L + N+ +++ +C+ ++ E M+NG L +L H + C +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPP-----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 814 QR---VNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQ 870
+ +A +AS + YL VH DL N L+ + + DFG+++ L
Sbjct: 128 SFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL---- 180
Query: 871 LDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG------DVYSFGILLLELFT-GRRP 923
SS ++G P M E+ + G DV++FG+ L E+ T R
Sbjct: 181 ------YSSDYYRVQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKAL--RNIRHRN 763
+F ++G+GSFG V + + A+K+ LK+ + EC + R + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
+T S + D V E + G L + Q V K Q V A +++
Sbjct: 59 KPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEIS 111
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+ +LH + +++ DLK NV+LD + + DFG+ K H +D + +
Sbjct: 112 VGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT----- 160
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
GT Y+APE + D +++G+LL E+ G+ P D
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 62/217 (28%), Positives = 89/217 (41%), Gaps = 28/217 (12%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKAL-RNIRHRNLIKI 767
+IG+GSFG V D AVKV+ K + K MAE L +N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAI 826
+ + V + + G L L + E R A ++ASA+
Sbjct: 62 -----HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE-------PRARFYAAEIASAL 109
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YLH +V+ DLKP N+LLD + DFGL K S ++ G
Sbjct: 110 GYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--------EGIAQSDTTTTFCG 158
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T Y+APE T D + G +L E+ G P
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
+++ A+ YLH + +++ DLK NVLLD + + D+G+ K + +
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--------EGLRPGDT 152
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
+ GT Y+APE G + + D ++ G+L+ E+ GR P D
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 41/223 (18%)
Query: 712 MIGQGSFGSV-----------YKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR 760
++G+G+FG V Y + + E+I+A K + E + L+N R
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIA--------KDEVAHTLTESRVLKNTR 53
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 820
H L ++ S +K D V E + G L + H S + + T
Sbjct: 54 HPFLT---SLKYSFQTK--DRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRF----YGA 102
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
++ SA++YLH +V+ DLK N++LD D + DFGL K D A+ +
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKT-- 154
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE ++ D + G+++ E+ GR P
Sbjct: 155 ---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 13/105 (12%)
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK-FLSSHQLDTASKTSS 879
++ A+E+LH + +V+ D+K N+LLD + + DFGL+K FLS + T S
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS---- 165
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGRRP 923
GT+ Y+APE G D +S GIL+ EL TG P
Sbjct: 166 ----FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN----LKQKGAFKSFMAECKALRNIRH 761
+F +IG+G+FG V + E I A+K++N LK+ AE R
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKR--------AETACFR--EE 51
Query: 762 RNLIKIITICSSIDS-----KGADFKALVFECMKNGSLEDWLHQSNDHL--EVCKLTLIQ 814
RN++ + C I + + ++ LV + G L L + D L ++ + + +
Sbjct: 52 RNVL-VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAE 110
Query: 815 RVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTA 874
V +AI +I LH+ VH D+KP NVLLD + G LA F S +++
Sbjct: 111 MV-LAIH---SIHQLHY------VHRDIKPDNVLLDMN-----GHIRLADFGSCLKMNQ- 154
Query: 875 SKTSSSSIGIKGTVGYVAPEYCMGSEASMTG-----DVYSFGILLLELFTGRRP 923
T SS+ + GT Y++PE E M D +S G+ + E+ G P
Sbjct: 155 DGTVQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 29/82 (35%), Positives = 50/82 (60%), Gaps = 1/82 (1%)
Query: 209 LGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVN 268
L G IP + LR+L +++ GN G P S+ +I+SLE + L +N F+G++P + +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP-ESLGQ 488
Query: 269 LPNLKSLAIGGNNFFGSIPDSL 290
L +L+ L + GN+ G +P +L
Sbjct: 489 LTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 27/226 (11%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLI 765
F ++G G++G VYKG + + A+KV+++ + E L+ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 766 KIITICSSIDSKGADFKA-LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQR--VNIAIDV 822
+ G D + LV E GS+ D + + + TL + I ++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN------TLKEEWIAYICREI 120
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+ +LH H ++H D+K NVLL + + DFG+ S QLD ++ I
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV-----SAQLDRTVGRRNTFI 172
Query: 883 GIKGTVGYVAPEYCMGSEA-----SMTGDVYSFGILLLELFTGRRP 923
GT ++APE E D++S GI +E+ G P
Sbjct: 173 ---GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAEC--KALRNIRHRNLIK 766
++G+G+FG VY + +AVK + Q+ + + EC + L+N+RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 767 IITICSSIDSKGADFKALVF-ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+ K K +F E M GS++D L E + +R I
Sbjct: 69 YYGCLRDPEEK----KLSIFVEYMPGGSIKDQLKAYGALTE----NVTRRYTRQI--LQG 118
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+ YLH + +VH D+K +N+L D +GDFG +S ++ T + + +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG-----ASKRIQTICMSGTGIKSVT 170
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT +++PE G DV+S ++E+ T + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 4e-07
Identities = 21/60 (35%), Positives = 33/60 (55%)
Query: 543 SLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDL 602
+L+ LD+S+N + + L ++KVL+ S NNL+ PE L L L+ S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 37/111 (33%), Positives = 57/111 (51%), Gaps = 11/111 (9%)
Query: 810 LTLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS 868
LT + ++ VA +E+L +C VH DL NVLL + + DFGLA+ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDI-M 288
Query: 869 HQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
H + SK S+ V ++APE + + DV+S+GILL E+F+
Sbjct: 289 HDSNYVSKGSTFL-----PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 27/238 (11%)
Query: 695 VSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECK 754
+ + L F ++G G++G VYKG + + A+KV+++ + + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEIN 64
Query: 755 ALRNI-RHRNLIKIITICSSIDSKGADFKA-LVFECMKNGSLEDWLHQS--NDHLEVCKL 810
L+ HRN+ G D + LV E GS+ D + + N E +
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-I 123
Query: 811 TLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQ 870
I R ++ + +LH H ++H D+K NVLL + + DFG+ S Q
Sbjct: 124 AYICR-----EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV-----SAQ 170
Query: 871 LDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-----SMTGDVYSFGILLLELFTGRRP 923
LD ++ I GT ++APE E D++S GI +E+ G P
Sbjct: 171 LDRTVGRRNTFI---GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 712 MIGQGSFGSV-----------YKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR 760
++G+G+FG V Y + + E+IVA K + E + L+N R
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--------KDEVAHTLTENRVLQNSR 53
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-A 819
H L + + D V E G L + H S + ++ R
Sbjct: 54 HPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRE-----RVFSEDRARFYG 101
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
++ SA++YLH + +V+ DLK N++LD D + DFGL K K +
Sbjct: 102 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGA 151
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ GT Y+APE ++ D + G+++ E+ GR P
Sbjct: 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-07
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 42/221 (19%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVI------NLKQKGAFKSFMAECKALRNIRHRNLIK 766
+G G++G+V + VA+K + L K A++ E + L++++H N+I
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78
Query: 767 IITICS---SIDSKGADFKALVFECMKN--GSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
++ + + S+D + DF LV M G L S D ++ +++
Sbjct: 79 LLDVFTPDLSLD-RFHDF-YLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK------- 129
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
++Y+H ++H DLKP N+ ++ D + DFGLA+ +T S
Sbjct: 130 ---GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------QTDSEM 172
Query: 882 IGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGR 921
G T Y APE + + T D++S G ++ E+ TG+
Sbjct: 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 35/222 (15%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITIC 771
+G+G++GSVYK + + +A+K I L+ + F + E L H+ + I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61
Query: 772 SSIDSKGADF-KALVFECMK---NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+D GA F + V+ CM+ GSL D L+ E +++R I V ++
Sbjct: 62 --VDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLK 116
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+L ++H D+KP+NVL++ + + DFG +S + + + +KT +IG +
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKT---NIGCQ-- 165
Query: 888 VGYVAPEYCMGSEASMTG------DVYSFGILLLELFTGRRP 923
Y+APE + DV+S G+ +LE+ GR P
Sbjct: 166 -SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 66/257 (25%), Positives = 112/257 (43%), Gaps = 35/257 (13%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHR 762
+F +IG+G+FG V L + + A+K++N + ++ F E L N ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL--EVCKLTLIQRVNIAI 820
I T+ + + + LV + G L L + D L ++ + L + V IAI
Sbjct: 62 ---WITTLHYAFQDENNLY--LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAI 115
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
D ++ LH+ VH D+KP N+L+D + G LA F S +L T S
Sbjct: 116 D---SVHQLHY------VHRDIKPDNILMDMN-----GHIRLADFGSCLKL-MEDGTVQS 160
Query: 881 SIGIKGTVGYVAPEYCMGSEASM-----TGDVYSFGILLLELFTGRRPTDAAF---TEGL 932
S+ + GT Y++PE E D +S G+ + E+ G P A T G
Sbjct: 161 SVAV-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 219
Query: 933 TLHEFAKIALPEKVIEI 949
++ + P +V ++
Sbjct: 220 IMNHKERFQFPAQVTDV 236
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-06
Identities = 18/60 (30%), Positives = 32/60 (53%)
Query: 519 NLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578
NL L +S+N+ + + +L+ LD+S N+ + P + L S++ L+ S NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 712 MIGQGSFGSVYKGILGEDE---MIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLI 765
++G+G+FG V IL ++ A+K++ + K + E + L+N RH L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+ + D V E G L + H S + + T + ++ SA
Sbjct: 59 AL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEIVSA 107
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+EYLH +V+ D+K N++LD D + DFGL K D A+ +
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKT-----FC 156
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE ++ D + G+++ E+ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 15/117 (12%)
Query: 805 LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864
+ +C + I+R V AI+YLH + ++H D+K N+ ++H +GDFG A
Sbjct: 179 IAICDILAIER-----SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230
Query: 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR 921
F ++ G GT+ APE D++S GI+L E+ T
Sbjct: 231 F-------PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 720 SVYKGILGEDEMIV-AVKVINLKQKGAFKSFMAECKALRNIRHRNLIKI----ITICSSI 774
S+YKGI E+I+ K + K E K LR I N++KI I I +
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQ 834
+L+ E G L + L + D L+ ++++AID + L+ +
Sbjct: 95 PRL-----SLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 835 PPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPE 894
P + +L + L+ + + GL K LSS ++ + Y + +
Sbjct: 144 KP--YKNLTSVSFLVTENYKLKIICHGLEKILSS--------PPFKNVN---FMVYFSYK 190
Query: 895 YCMG--SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932
SE ++ D+YS G++L E+FTG+ P + T+ +
Sbjct: 191 MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230
|
Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 25/124 (20%)
Query: 816 VNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTA 874
++ + VA + +L +C +H DL N+LL H ++ + DFGLA+ +
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI-------- 264
Query: 875 SKTSSSSIGIKGT----VGYVAPEYCMGSEASMTGDVYSFGILLLELFT------GRRPT 924
+ S+ +KG V ++APE + DV+S+GILL E+F+ P
Sbjct: 265 --RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322
Query: 925 DAAF 928
D+ F
Sbjct: 323 DSKF 326
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-06
Identities = 26/81 (32%), Positives = 46/81 (56%), Gaps = 1/81 (1%)
Query: 362 GELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELK 421
G +P+ I+ L + + GN I G IP + ++ +L L + N +G+IP+ +G+L
Sbjct: 432 GFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 422 NLQGLFLYKNVLQGSIPSGVG 442
+L+ L L N L G +P+ +G
Sbjct: 491 SLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 32/105 (30%), Positives = 48/105 (45%), Gaps = 12/105 (11%)
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
A ++ +E LH +V+ DLKP N+LLD + D GLA + +
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR----- 159
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
G GTVGY+APE + + D + G L+ E+ G+ P
Sbjct: 160 ----GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI------RHRNLIK 766
IG G+FG V+ D VA+K K F++ ++ + R + +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK----KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQ--------SNDHLEVCKLTLIQRVNI 818
+ I + +V E M++ LH+ S+DH+ K+ L Q
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSD-----LHKIIVSPQPLSSDHV---KVFLYQ---- 111
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
+ ++YLH ++H D+KP N+L++ + V + DFGLA+ + D + +
Sbjct: 112 ---ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPDESKHMT 162
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
+ T Y APE MGS + D++S G + EL R
Sbjct: 163 QEVV----TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 65/257 (25%), Positives = 105/257 (40%), Gaps = 35/257 (13%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHR 762
+F +IG+G+FG V + + A+K++N + ++ F E L N R
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL--EVCKLTLIQRVNIAI 820
I + + + + LV + G L L + D L ++ + L + V +AI
Sbjct: 62 ---WITNLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-LAI 115
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
D + Y VH D+KP NVLL D H+ LA F S +L A T S
Sbjct: 116 DSVHQLGY---------VHRDIKPDNVLL--DKNGHI---RLADFGSCLRLL-ADGTVQS 160
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTG-----DVYSFGILLLELFTGRRPTDA---AFTEGL 932
++ + GT Y++PE E D +S G+ + E+ G P A T G
Sbjct: 161 NVAV-GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 219
Query: 933 TLHEFAKIALPEKVIEI 949
++ P V ++
Sbjct: 220 IMNHKEHFQFPPDVTDV 236
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLI 765
+F IG G++G VYK + A+KVI L+ F E +++ +H N++
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 766 KIITICSSIDSKGADFKALVFECMK---NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 822
D ++ CM+ GSL+D H + L+ Q ++ +
Sbjct: 70 AYFGSYLRRDK--------LWICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRET 115
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+ YLH + +H D+K +N+LL + + DFG++ +++ T +K S
Sbjct: 116 LQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA----TIAKRKS--- 165
Query: 883 GIKGTVGYVAPEYCMGSEA---SMTGDVYSFGILLLEL 917
GT ++APE + D+++ GI +EL
Sbjct: 166 -FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 28/227 (12%)
Query: 713 IGQGSFGSVYKGIL---GEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKI 767
IG+GSFG K IL ED +K IN+ + E L N++H N I
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN---I 61
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ S + G + +V + + G L ++ L Q ++ + + A++
Sbjct: 62 VQYQESFEENGNLY--IVMDYCEGGDLYKKINAQRGVL----FPEDQILDWFVQICLALK 115
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
++H ++H D+K N+ L D +GDFG+A+ L+S T + GT
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--------TVELARTCIGT 164
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934
Y++PE C + D+++ G +L E+ T + +A + L L
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G++G VYK + AVK+I L+ F E ++ +H N++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 773 SIDSKGADFKALVFECMK---NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
S + ++ CM+ GSL+D H + L ++ + R + + YL
Sbjct: 77 S--------REKLWICMEYCGGGSLQDIYHVTGP-LSELQIAYVCR-----ETLQGLAYL 122
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H + +H D+K +N+LL + + DFG+A +++ T +K S GT
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITA----TIAKRKS----FIGTPY 171
Query: 890 YVAPEYCMGSEA---SMTGDVYSFGILLLEL 917
++APE + + D+++ GI +EL
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 33/219 (15%)
Query: 712 MIGQGSFGSVYKGILGEDEM---IVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLI 765
++G+G+FG V IL ++ A+K++ + K + E + L+N RH L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVAS 824
+ + D V E G L HL ++ R ++ S
Sbjct: 59 AL-----KYSFQTHDRLCFVMEYANGGEL-------FFHLSRERVFSEDRARFYGAEIVS 106
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
A+ YLH +V+ DLK N++LD D + DFGL K + + +
Sbjct: 107 ALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKT----F 155
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE ++ D + G+++ E+ GR P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 57/227 (25%), Positives = 89/227 (39%), Gaps = 38/227 (16%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKAL---RNIRHRN 763
F ++G+G FG V + + A K + +K K E AL R + N
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKRILEKVN 58
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
++++ + ++K D LV M G L K + N D
Sbjct: 59 SRFVVSLAYAYETK--DALCLVLTIMNGGDL--------------KFHIYNMGNPGFDEQ 102
Query: 824 SAIEYLHHHC-------QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK 876
AI Y C + +V+ DLKP N+LLD + D GLA + +
Sbjct: 103 RAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE------ 156
Query: 877 TSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ G GTVGY+APE + + + D + G L+ E+ G+ P
Sbjct: 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 56/246 (22%), Positives = 104/246 (42%), Gaps = 38/246 (15%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLI-KIIT 769
IG+G++G VYK +VA+K L+ ++G + + E L+ + I +++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWL--HQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ + G LVFE + + L+ ++ + + I+ + + +
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPA-KTIK--SFMYQLLKGVA 124
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHD-MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
+ H H ++H DLKP N+L+D + + D GL + + SI +K
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR--------------AFSIPVKS 167
Query: 887 ------TVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRR--PTDAAFTEGLTLHEF 937
T+ Y APE +GS S D++S G + E+ + P D+ + LH F
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIF 225
Query: 938 AKIALP 943
+ P
Sbjct: 226 KLLGTP 231
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 21/224 (9%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFKSFMAECKALRNIRHRNLIKIITI 770
++G+GSFG + A+K I L K A + E L ++H N I+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN---IVAF 63
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
S ++ G + +V E G L + L L V + + ++++H
Sbjct: 64 KESFEADGHLY--IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL----GVQHIH 117
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ ++H D+K N+ L + +GDFG A+ L+S + + GT Y
Sbjct: 118 ---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--------PGAYACTYVGTPYY 166
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934
V PE + D++S G +L EL T + P A + L L
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 27/100 (27%), Positives = 50/100 (50%), Gaps = 4/100 (4%)
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK 876
NI D+ + +EY+H H + HGD+KP N+++D + ++ D+G+A H
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186
Query: 877 TSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLE 916
+ +GT+ Y + G+ + GD+ S G +L+
Sbjct: 187 KEQKDLH-RGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-----RHRNLIKI 767
IG+G++G V+K + ++ AVK+++ E +A NI H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVN---IAIDVAS 824
+ D K D LV E GS+ D L L +R+ IA +
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTD--------LVKGFLKRGERMEEPIIAYILHE 132
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
A+ L H +H D+K +N+LL + + DFG+ S QL + ++S+
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV-----SAQLTSTRLRRNTSV-- 185
Query: 885 KGTVGYVAPEY--C---MGSEASMTGDVYSFGILLLELFTGRRP 923
GT ++APE C + S DV+S GI +EL G P
Sbjct: 186 -GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 15/91 (16%)
Query: 838 VHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT----VGYVAP 893
+H D+ NVLL V+ + DFGLA+ + + S+ +KG V ++AP
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDI----------MNDSNYVVKGNARLPVKWMAP 283
Query: 894 EYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
E ++ DV+S+GILL E+F+ G+ P
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 53/235 (22%), Positives = 84/235 (35%), Gaps = 57/235 (24%)
Query: 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVI--NLKQKGAFKSFMAECKALRNIRH 761
T+ + +G G+FG V VA+K I K E K L+++RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 762 RNLIKIITICSS--------IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLI 813
N+I + I S + G D L + + LE Q
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLEKQFIQY------------ 112
Query: 814 QRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
+ ++Y+H +VH DLKPSN+L++ + + DFGLA+
Sbjct: 113 ----FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--- 162
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG-------DVYSFGILLLELFTGR 921
GYV+ Y E +T D++S G + E+ G+
Sbjct: 163 --------------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-06
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 713 IGQGSFGSV---YKGILGEDEMIVAVKVIN------LKQKGAFKSFMAECKALRNIRHRN 763
IG G+ G V Y + G++ VA+K ++ K A++ ++ + H+N
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN---VAIKKLSRPFQNVTHAKRAYREL----VLMKLVNHKN 76
Query: 764 LIKIITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
+I ++ + +F+ LV E M + +L + DH + L L Q
Sbjct: 77 IIGLLN-VFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYL-LYQ------- 126
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
+ I++LH ++H DLKPSN+++ D + DFGLA+ TA TS
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAG-TSFMM 174
Query: 882 IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR 921
T Y APE +G D++S G ++ E+ G
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 24/219 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITIC 771
IG+G++G VYK +D + AVK+++ + AE L+++ H N++K +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
D LV E GS+ + + L +C L I+ + A+ L H
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKG----LLICGQRL-DEAMISYILYGALLGLQH 143
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
++H D+K +N+LL + + DFG+ S QL + ++S+ GT ++
Sbjct: 144 LHNNRIIHRDVKGNNILLTTEGGVKLVDFGV-----SAQLTSTRLRRNTSV---GTPFWM 195
Query: 892 APE-------YCMGSEASMTGDVYSFGILLLELFTGRRP 923
APE Y +A DV+S GI +EL G P
Sbjct: 196 APEVIACEQQYDYSYDARC--DVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-06
Identities = 28/72 (38%), Positives = 44/72 (61%), Gaps = 1/72 (1%)
Query: 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLK 318
G +P DI L +L+S+ + GN+ G+IP SL + +++E+LDL +N F G + L
Sbjct: 432 GFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 319 NLSWLNLEQNNL 330
+L LNL N+L
Sbjct: 491 SLRILNLNGNSL 502
|
Length = 623 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 11/111 (9%)
Query: 810 LTLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS 868
L+ + V + VA+ +E+L +C VH DL NVL+ + + DFGLA+ +
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIM- 290
Query: 869 HQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+ SK S+ + +K ++APE + + DV+SFGILL E+FT
Sbjct: 291 RDSNYISK-GSTFLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 1e-05
Identities = 47/181 (25%), Positives = 73/181 (40%), Gaps = 39/181 (21%)
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEV--CKLTLIQRVNI 818
+ N IK+ +++ L+ + +K+G L D L + L K + Q V
Sbjct: 68 NPNFIKLYYSVTTLKGH-----VLIMDYIKDGDLFDLL-KKEGKLSEAEVKKIIRQLVE- 120
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS-HVGDFGLAKFLSSHQLDTASKT 877
A+ LH H ++H D+K NVL D ++ D+GL K
Sbjct: 121 ------ALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK------------- 158
Query: 878 SSSSIGIK----GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933
IG GT+ Y +PE G ++ D ++ G+L EL TG+ P E L
Sbjct: 159 ---IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215
Query: 934 L 934
L
Sbjct: 216 L 216
|
Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 54/248 (21%), Positives = 102/248 (41%), Gaps = 40/248 (16%)
Query: 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAV----KVINL-----KQKGAFKSFMAE 752
K++ + M+ +G+ S +K ++ E ++++ + V+NL K G +
Sbjct: 34 KSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEF 93
Query: 753 CK------------------ALRNIRHRNLIKIITICSSID--SKGADFKALVFECMKNG 792
CK ++ + R + + S +D + L +
Sbjct: 94 CKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153
Query: 793 SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDH 851
S Q D L LT+ + + VA +E+L C +H DL N+LL
Sbjct: 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKC----IHRDLAARNILLSE 209
Query: 852 DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFG 911
+ V + DFGLA+ + ++ + S+ + +K ++APE + DV+SFG
Sbjct: 210 NNVVKICDFGLARDI--YKDPDYVRKGSARLPLK----WMAPESIFDKVYTTQSDVWSFG 263
Query: 912 ILLLELFT 919
+LL E+F+
Sbjct: 264 VLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 11/87 (12%)
Query: 837 MVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYC 896
+V+ DLKP N+LLD D + DFG AK +DT + T + GT Y+APE
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYT------LCGTPEYIAPEIL 200
Query: 897 MGSEASMTGDVYSFGILLLELFTGRRP 923
+ D ++ GI + E+ G P
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 11/105 (10%)
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
A V ++YLH + +V+ DLK N+LLD + + DFGL K + +TS
Sbjct: 107 AACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTS 159
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ GT ++APE + + D + G+L+ E+ G P
Sbjct: 160 T----FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 41/185 (22%), Positives = 80/185 (43%), Gaps = 34/185 (18%)
Query: 737 VINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM----KNG 792
V+ + QKG + + E L+N+ H ++I++ ++ S CM +
Sbjct: 95 VLKIGQKG---TTLIEAMLLQNVNHPSVIRMK---DTLVSGAI-------TCMVLPHYSS 141
Query: 793 SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 852
L +L + + L + + +I++ + + YLH ++H D+K N+ ++
Sbjct: 142 DLYTYLTKRSRPLPIDQALIIEK-----QILEGLRYLHAQ---RIIHRDVKTENIFINDV 193
Query: 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGI 912
+GD G A+F +G+ GTV APE + + D++S GI
Sbjct: 194 DQVCIGDLGAAQFPVVAPAF---------LGLAGTVETNAPEVLARDKYNSKADIWSAGI 244
Query: 913 LLLEL 917
+L E+
Sbjct: 245 VLFEM 249
|
Length = 357 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 712 MIGQGSFGSVYKGILGED---EMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKII 768
++G+GSFG V +L E + + A+K+ LK+ + EC + R L
Sbjct: 7 VLGKGSFGKV---MLAERKGTDELYAIKI--LKKDVIIQDDDVEC-TMVEKRVLALPGKP 60
Query: 769 TICSSIDS--KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + S + D V E + G L + Q V K V A ++A +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPHAVFYAAEIAIGL 114
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
+LH +++ DLK NV+LD + + DFG+ K + ++T G
Sbjct: 115 FFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRT------FCG 163
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
T Y+APE + D ++FG+LL E+ G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 27/166 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFM-----AECKALRNIR-HRNLIK 766
IG+G+F V K + A+K K FKS E +ALR + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVAS 824
+I + D K ALVFE M + +L + + L + K + Q +
Sbjct: 63 LIEVL--FDRKTGRL-ALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLL-------K 111
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQ 870
+++++H + + H D+KP N+L+ D++ + DFG + + S
Sbjct: 112 SLDHMHRN---GIFHRDIKPENILIKDDILK-LADFGSCRGIYSKP 153
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/226 (23%), Positives = 103/226 (45%), Gaps = 34/226 (15%)
Query: 713 IGQGSFGSVYKGILG------------EDEMIVAVKVINLKQKGAFKSFMAECKALRNIR 760
+G+G+ +Y GIL E E+ V +KV++ + +F +R +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 820
H++++ + +C D + +V E ++ G L+ ++H+ +D LT + +A
Sbjct: 63 HKHIVLLYGVCVR-DVE----NIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAK 112
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
+ASA+ YL +VHG++ N+LL + + G+ G LS + +
Sbjct: 113 QLASALSYLE---DKDLVHGNVCTKNILLAREGID--GECGPFIKLSDPGIPITVLSRQE 167
Query: 881 SIGIKGTVGYVAPEYCMGSEASMT--GDVYSFGILLLEL-FTGRRP 923
+ + ++APE C+ +++ D +SFG L E+ + G P
Sbjct: 168 CV---ERIPWIAPE-CVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 57/249 (22%), Positives = 104/249 (41%), Gaps = 45/249 (18%)
Query: 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAV----KVINL-----KQKGAFKSFMAEC 753
A+ + M+ +G+ S YK ++ E ++++ + V+NL K G + C
Sbjct: 35 ASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYC 94
Query: 754 K------ALRNIRH-----------RNLIKIITIC----SSIDSKGA-DFKALVFECMKN 791
K LR+ R + +K S+ S + + + +
Sbjct: 95 KFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLS 154
Query: 792 GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLD 850
ED + D L LTL ++ + VA +E+L C +H DL N+LL
Sbjct: 155 DVEED---EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILLS 207
Query: 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSF 910
+ V + DFGLA+ + ++ + + + +K ++APE + DV+SF
Sbjct: 208 ENNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WMAPESIFDKVYTTQSDVWSF 261
Query: 911 GILLLELFT 919
G+LL E+F+
Sbjct: 262 GVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 20/154 (12%)
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCK--LTLIQRVNIAIDVASAI 826
+I SS S + F ++ SL D + + ++ K LTL + + VA +
Sbjct: 140 SITSSQSSASSGF-------VEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGM 192
Query: 827 EYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
E+L C +H DL N+LL + V + DFGLA+ + ++ + + + +K
Sbjct: 193 EFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDI--YKDPDYVRKGDARLPLK 246
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
++APE ++ DV+SFG+LL E+F+
Sbjct: 247 ----WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 65/227 (28%), Positives = 98/227 (43%), Gaps = 42/227 (18%)
Query: 713 IGQGSFGSV--YKGILGEDEMIVAVK-VINLKQKGAF-KSFMAECKALRNIR-HRNLIKI 767
+GQG++G V + +E VA+K + N+ K K + E K LR+ R H+N+ +
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 768 ITICSSIDSKGADFKALVFECM--------KNGS-LEDWLHQSNDHLEVCKLTLIQRVNI 818
+ + + L E M ++G L D QS + +C L I N+
Sbjct: 68 YDM-DIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANV 126
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
+H DLKP N+L++ D + DFGLA+ S + + A +
Sbjct: 127 -------------------LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTG--DVYSFGILLLELFTGRRP 923
T Y APE M S S T DV+S G +L EL GR+P
Sbjct: 168 ----EYVATRWYRAPE-IMLSFQSYTKAIDVWSVGCILAELL-GRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-05
Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKALRNIRHR 762
EF I +G+FG VY G + + AVKV+ ++ K AE AL
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA----- 59
Query: 763 NLIK---IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
L K I+ + S+ S A+ LV E + G ++ LH E + I
Sbjct: 60 -LSKSPFIVHLYYSLQS--ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----- 111
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864
+VA A++YLH H ++H DLKP N+L+ ++ + DFGL+K
Sbjct: 112 -EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-05
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKI--- 767
N+IG GSFG VY+ I + VA+K + Q +K+ E ++N+ H N+I +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN--RELLIMKNLNHINIIFLKDY 127
Query: 768 -ITICSSIDSKGADFKALVFECMKNGSLEDWLHQS-NDHLEVCKLTLIQRVNIAIDVASA 825
T C + K F +V E + + H + N+H L L + + A
Sbjct: 128 YYTECFKKNEKNI-FLNVVMEFIPQTVHKYMKHYARNNH----ALPLFLVKLYSYQLCRA 182
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVS-HVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
+ Y+H + H DLKP N+L+D + + + DFG AK L + Q S+
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---------RSVSY 230
Query: 885 KGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTG 920
+ Y APE +G+ T D++S G ++ E+ G
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 24/218 (11%)
Query: 712 MIGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITI 770
++G+GSFG V G DE+ A+K+ LK+ + EC + R L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELY-AIKI--LKKDVVIQDDDVECTMVEK-RVLALSGKPPF 62
Query: 771 CSSIDS--KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ + S + D V E + G L + Q V + V A ++A + +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ------VGRFKEPHAVFYAAEIAIGLFF 116
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
LH +++ DLK NV+LD + + DFG+ K + D + + GT
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT-----FCGTP 165
Query: 889 GYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
Y+APE + D ++FG+LL E+ G+ P +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 48/202 (23%), Positives = 93/202 (46%), Gaps = 28/202 (13%)
Query: 731 MIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789
++VAVK++ K A F+ E K L ++ N+I+++ +C D ++ E M
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDP-----LCMITEYM 101
Query: 790 KNGSLEDWL--HQSNDHLEVCKLTLIQR-----------VNIAIDVASAIEYLHHHCQPP 836
+NG L +L H +D E + +++A+ +AS ++YL
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLN 158
Query: 837 MVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYC 896
VH DL N L+ ++ + DFG+++ L + D + + I+ ++A E
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAG--DYYRIQGRAVLPIR----WMAWECI 212
Query: 897 MGSEASMTGDVYSFGILLLELF 918
+ + + DV++FG+ L E+
Sbjct: 213 LMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-05
Identities = 35/129 (27%), Positives = 53/129 (41%), Gaps = 33/129 (25%)
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL----------------AKFLSS 868
AI+ +H +H D+KP N+LLD + DFGL + L S
Sbjct: 113 AIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 869 HQLDTASKTSSSSIGIK--------------GTVGYVAPEYCMGSEASMTGDVYSFGILL 914
+ LD SK SS + GT Y+APE + + + D +S G+++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 915 LELFTGRRP 923
E+ G P
Sbjct: 230 YEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 57/252 (22%), Positives = 99/252 (39%), Gaps = 52/252 (20%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNL 764
+F S +IG+G+FG V + I A+K++ K+ M E + + +IR R++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERDI 54
Query: 765 IK------IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
+ ++ + S K + L+ E + G + L + + E I +
Sbjct: 55 LVEADGAWVVKMFYSFQDKRNLY--LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL 112
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL------------ 866
AID + ++H D+KP N+LLD + DFGL L
Sbjct: 113 AIDAIHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNL 163
Query: 867 --------------SSHQLDTASKTSSS-SIGIKGTVGYVAPEYCMGSEASMTGDVYSFG 911
S + +T K + GT Y+APE M + + D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223
Query: 912 ILLLELFTGRRP 923
+++ E+ G P
Sbjct: 224 VIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAF-KSFMAECKALRNIRHRNL 764
+ S +G G++GSV I VA+K ++ Q F K E L++++H N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 765 IKIITICSSIDSKGADFKA--LVFECMKNGSLED--WLHQSNDHLEVCKLTLIQRVNIAI 820
I ++ + +S S G +F+ LV M+ L+ S D ++ +
Sbjct: 77 IGLLDVFTSAVS-GDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY----------LVY 124
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
+ ++Y+H ++H DLKP N+ ++ D + DFGLA+ +
Sbjct: 125 QMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------HADAE 170
Query: 881 SIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGR 921
G T Y APE + + T D++S G ++ E+ TG+
Sbjct: 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 9e-05
Identities = 20/60 (33%), Positives = 27/60 (45%)
Query: 271 NLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330
NLKSL + N + N+++LDL N FS L +L L+L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-05
Identities = 72/330 (21%), Positives = 115/330 (34%), Gaps = 62/330 (18%)
Query: 627 CGGTDELHLPTCPSKGSRKPKITLLKVLIPVAVLCMVLSSCLTIVYARRRRSARKSVDTS 686
C E P + L+ P L + S+ A S + D S
Sbjct: 59 CAEAAEKVSIMAPERADPTGAHRALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSDAS 118
Query: 687 PREKQFPTVSYA---ELSKA----TSEF-ASSNMIG---QGSFGSVY----KGILGEDEM 731
+ A L++A EF A +I G+FG ++ + E E
Sbjct: 119 HLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAE- 177
Query: 732 IVAVKVINLKQKGAFKS-----------------FMAECKALRNIRHRNLIKIITICSSI 774
A + +N +G K E AL + H N++KI I S
Sbjct: 178 --ARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSE 235
Query: 775 D-----SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
++ DF F M + + DW + L Q I + A+EY+
Sbjct: 236 ANTYMITQKYDFDLYSF--MYDEAF-DWKDRP---------LLKQTRAIMKQLLCAVEYI 283
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H ++H D+K N+ L+ D +GDFG A + + G GTV
Sbjct: 284 H---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-------AFDYGWVGTVA 333
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFT 919
+PE G D++S G++LL++ +
Sbjct: 334 TNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 16/109 (14%)
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG--DFGLAKF--------LSSHQLDTA 874
A+EYLH++ +VH DLKP N+L+ + H+ DFGL+K L ++
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITS--MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 875 SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
++ + GT Y+APE + D ++ GI+L E G P
Sbjct: 168 TREFLDK-QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 713 IGQGSFGSV---YKGILGEDEMIVAVKVIN--LKQKGAFKSFMAECKALRNIRHRNLIKI 767
IG G+ G V Y +L + VA+K ++ + + K E ++ + H+N+I +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 768 ITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+ + + S +F+ LV E M + +L + DH + L L Q +
Sbjct: 82 LNVFTPQKSL-EEFQDVYLVMELM-DANLCQVIQMELDHERMSYL-LYQML-------CG 131
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
I++LH ++H DLKPSN+++ D + DFGLA+ + TS
Sbjct: 132 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFMMTPYV 179
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLE------LFTGRRPTD 925
T Y APE +G D++S G ++ E LF GR D
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 52/203 (25%), Positives = 78/203 (38%), Gaps = 33/203 (16%)
Query: 733 VAVKVINL--KQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMK 790
VAVK INL K K E R ++H N++ +T +DS+ +V M
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT-SFIVDSE----LYVVSPLMA 82
Query: 791 NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLL 849
GS ED L E I I DV +A++Y+H +H +K S++LL
Sbjct: 83 YGSCEDLL--KTHFPEGLPELAI--AFILKDVLNALDYIHSKGF----IHRSVKASHILL 134
Query: 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTS----SSSIGIKGTVGYVAPEYCMGSEASMTG 905
D L+ S + K + +++PE + ++ G
Sbjct: 135 SGDGKVV-----LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL---QQNLQG 186
Query: 906 -----DVYSFGILLLELFTGRRP 923
D+YS GI EL G P
Sbjct: 187 YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 61/247 (24%), Positives = 108/247 (43%), Gaps = 39/247 (15%)
Query: 686 SPREKQFPTVSYAELS-KATSEFASSNMIGQGSFGSV---YKGILGEDEMIVAVKVIN-- 739
S R+ F +V + + + + IG G+ G V Y IL E VA+K ++
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL---ERNVAIKKLSRP 60
Query: 740 LKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL--VFECMKNGSLEDW 797
+ + K E ++ + H+N+I ++ + + S +F+ + V E M + +L
Sbjct: 61 FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL-EEFQDVYIVMELM-DANLCQV 118
Query: 798 LHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857
+ DH + L L Q + I++LH ++H DLKPSN+++ D +
Sbjct: 119 IQMELDHERMSYL-LYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTV---GYVAPEYCMGSEASMTGDVYSFGILL 914
DFGLA +T+ +S + V Y APE +G D++S G ++
Sbjct: 168 LDFGLA------------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215
Query: 915 LELFTGR 921
E+ G
Sbjct: 216 GEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 56/246 (22%), Positives = 98/246 (39%), Gaps = 40/246 (16%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNL 764
+F S +IG+G+FG V + + A+K++ K K + +A R+I +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADS 60
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
+ ++ + S K + L+ E + G + L + + E I +AID
Sbjct: 61 LWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH 118
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS-----------SHQL-- 871
+ ++H D+KP N+LLD + DFGL L +H L
Sbjct: 119 QLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 872 -----DTASKTSSSS---------IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLEL 917
+ SK + + GT Y+APE M + + D +S G+++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 918 FTGRRP 923
G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 713 IGQGSFGSVYKGIL--GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITI 770
+G+G++G VYK G+DE A+K I + G S E LR ++H N+I + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 771 CSSIDSKGADFKA-LVFECMKNG--SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
S +D K L+F+ ++ + + S + + +L ++ + I
Sbjct: 67 FLS----HSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSH----VGDFGLAKFLSSHQLDTASKTSSSSIG 883
YLH + ++H DLKP+N+L+ + + D G A+ +S K +
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS-----PLKPLADLDP 174
Query: 884 IKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFT 919
+ T Y APE +G+ D+++ G + EL T
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 21/57 (36%), Positives = 26/57 (45%)
Query: 498 YLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSF 554
LDLSNN L L NL L +S N + + P S SL LD+S N+
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 713 IGQGSFGSVYKGIL--GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITI 770
+G+G++G VYK G+D+ A+K I + G S E LR ++H N+I + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 771 CSSIDSKGADFKA-LVFECMKNG--SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
S AD K L+F+ ++ + + S + + +L ++ + I
Sbjct: 67 FLS----HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSH----VGDFGLAKFLSSHQLDTASKTSSSSIG 883
YLH + ++H DLKP+N+L+ + + D G A+ +S K +
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS-----PLKPLADLDP 174
Query: 884 IKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFT 919
+ T Y APE +G+ D+++ G + EL T
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 52/224 (23%)
Query: 713 IGQGSFGSVY-----KGILGED-EMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIK 766
+G+GSFG+VY K + E +++ + V L ++ E + L + H ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAIVK 66
Query: 767 ------------IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQ 814
IIT + + D K + E G L+ Q
Sbjct: 67 FHASFLERDAFCIIT--EYCEGRDLDCK--LEELKHTGK---------------TLSENQ 107
Query: 815 RVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL-SSHQLDT 873
I + + Y+H Q ++H DLK N+ L ++++ +GDFG+++ L S L T
Sbjct: 108 VCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLAT 163
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLEL 917
GT Y++PE D++S G +L E+
Sbjct: 164 T---------FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-04
Identities = 81/320 (25%), Positives = 119/320 (37%), Gaps = 55/320 (17%)
Query: 103 LRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPT----------NLSRCSNL- 151
L + LSD S E+P I L +LE L + +PT NLS CS L
Sbjct: 659 LETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLK 718
Query: 152 ----IQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGN 207
I +S L+ E S L+L+ NL L + +
Sbjct: 719 SFPDISTNISWLDLDETAIEEFPSNLRLE------------------NLDELILCEMKSE 760
Query: 208 SLGGKI----PTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPF 263
L ++ P L +L L + P SI N+ LE + + TLP
Sbjct: 761 KLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT 820
Query: 264 DIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWL 323
I NL +L+SL + G + + PD +N S++ + G + + FS+L L
Sbjct: 821 GI--NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIEEVPWWIE-KFSNLSFLD-- 875
Query: 324 NLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGN 383
M N+L V+ N S LK L G L + N S S E + +
Sbjct: 876 --------MNGCNNLQRVSL--NISKLKHLETVDFSDCGALTEASWNGSPS--EVAMATD 923
Query: 384 QIFGIIPSGIR-NLVNLIAL 402
I +PS + N +N L
Sbjct: 924 NIHSKLPSTVCINFINCFNL 943
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 35/179 (19%)
Query: 752 ECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLE-VCKL 810
E L+ I HR +I +I +K+ V CM + + +++ L
Sbjct: 136 EIDILKTISHRAIINLIHAYR--------WKSTV--CM---VMPKYKCDLFTYVDRSGPL 182
Query: 811 TLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQ 870
L Q + I + A+ YLH ++H D+K N+ LD + +GDFG A L
Sbjct: 183 PLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL---- 235
Query: 871 LDTASKTSSSSIGIKGTVGYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRP 923
A + G GT+ +PE YC + D++S G++L E+
Sbjct: 236 --DAHPDTPQCYGWSGTLETNSPELLALDPYCAKT------DIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 34/144 (23%), Positives = 58/144 (40%), Gaps = 39/144 (27%)
Query: 815 RVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL---------AKF 865
R IA ++ AIE +H + +H D+KP N+L+D D + DFGL +K+
Sbjct: 104 RFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 866 LSSHQ---------LDTASKTSSSSI-----------------GIKGTVGYVAPEYCMGS 899
+ S+ + + GT Y+APE + +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 900 EASMTGDVYSFGILLLELFTGRRP 923
+ D +S G++L E+ G+ P
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|225714 COG3173, COG3173, Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 17/109 (15%)
Query: 764 LIKIITICSSIDS-KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 822
L + SID+ D + L W + K L R I +
Sbjct: 130 LADFLAELHSIDAAGLPDPGKPNAY--RGRQLARWDDE----YRRAKKELGGR----IPL 179
Query: 823 ASA-IEYLHHHC-----QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865
A I++L + P +VHGD +P N+++D + V D+ LA
Sbjct: 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228
|
Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.004
Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 7/106 (6%)
Query: 288 DSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNC 347
DS ++ L L +G + D S L++L +NL N++ L +
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG------SI 465
Query: 348 SSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI 393
+SL++L L+ N F G +P S+ L+S I + GN + G +P+ +
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRI-LNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.004
Identities = 53/245 (21%), Positives = 97/245 (39%), Gaps = 41/245 (16%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRH 761
+E+ IG G FG V+ + K I+ LK++ + E +R ++H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNVMRELKH 71
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
+N+++ I +K ++ E G L + + + I V+I
Sbjct: 72 KNIVRYI---DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI--VDITRQ 126
Query: 822 VASAIEYLHHHCQPP----MVHGDLKPSNVLLDHDM-----------------VSHVGDF 860
+ A+ Y H+ P ++H DLKP N+ L + ++ +GDF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASM--TGDVYSFGILLLELF 918
GL+K + S + GT Y +PE + S D+++ G ++ EL
Sbjct: 187 GLSKNIG---------IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 919 TGRRP 923
+G+ P
Sbjct: 238 SGKTP 242
|
Length = 1021 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1017 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.31 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.95 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.92 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.86 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.76 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.49 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.42 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-117 Score=1127.60 Aligned_cols=918 Identities=31% Similarity=0.516 Sum_probs=782.3
Q ss_pred CHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCC
Q 043932 34 NETDRLALLAIKSQLHDTSGVTSSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSF 113 (1017)
Q Consensus 34 ~~~~~~aLl~~k~~~~~~~~~~~sw~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l 113 (1017)
+++|+.||++||+++.||.+.+.+|+...+||.|.||+|++ .++|+.|||++|+++|.+++.+..+++|++|+|++|.+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 66899999999999999988899998878999999999975 56999999999999999999999999999999999999
Q ss_pred CCCCCcccc-cccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCcc
Q 043932 114 HGEIPQEIG-NLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDF 192 (1017)
Q Consensus 114 ~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 192 (1017)
+|.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+++.+|..
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 999998876 999999999999999998886 57899999999999999999999999999999999999999999999
Q ss_pred ccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCcc
Q 043932 193 VGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNL 272 (1017)
Q Consensus 193 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 272 (1017)
++++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|.+++.+|.. +.++++|
T Consensus 184 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L 262 (968)
T PLN00113 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS-LGNLKNL 262 (968)
T ss_pred hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh-HhCCCCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999888764 6789999
Q ss_pred ceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccE
Q 043932 273 KSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKI 352 (1017)
Q Consensus 273 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~ 352 (1017)
++|+|++|++++.+|..+.++++|+.|++++|.+.+..|..+..+++|+.|++++|.+.... +..+..+++|+.
T Consensus 263 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~------~~~~~~l~~L~~ 336 (968)
T PLN00113 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI------PVALTSLPRLQV 336 (968)
T ss_pred CEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcC------ChhHhcCCCCCE
Confidence 99999999999999999999999999999999999999999999999999999999986533 345778999999
Q ss_pred EeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccc
Q 043932 353 LSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNV 432 (1017)
Q Consensus 353 L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 432 (1017)
|++++|.+.+.+|..+..+ .+|+.|++++|++++..|..+..+.+|+.|++++|++.+..|..+..+++|+.|+|++|+
T Consensus 337 L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~ 415 (968)
T PLN00113 337 LQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415 (968)
T ss_pred EECcCCCCcCcCChHHhCC-CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCE
Confidence 9999999999999988876 579999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccc
Q 043932 433 LQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPL 512 (1017)
Q Consensus 433 l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~ 512 (1017)
+++.+|..|.++++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+. .. .++.|+|++|++++.+|.
T Consensus 416 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~-~L~~L~ls~n~l~~~~~~ 493 (968)
T PLN00113 416 FSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SK-RLENLDLSRNQFSGAVPR 493 (968)
T ss_pred eeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cc-cceEEECcCCccCCccCh
Confidence 9999999999999999999999999999999999999999999999999988887653 23 345799999999999999
Q ss_pred cccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCC
Q 043932 513 QIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFL 592 (1017)
Q Consensus 513 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 592 (1017)
.+.++++|+.|+|++|++++.+|..+.++++|+.|+|++|++++.+|..|..+++|+.|+|++|+++|.+|..+.++++|
T Consensus 494 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 573 (968)
T PLN00113 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESL 573 (968)
T ss_pred hhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCcCCCCCCCCCCCCCCCCccceeEeehhHHHHHHHHHHHHHhhh
Q 043932 593 EFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTCPSKGSRKPKITLLKVLIPVAVLCMVLSSCLTIVY 672 (1017)
Q Consensus 593 ~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~c~~~~~~~~~~~~~~i~i~~~~~~~~l~~~l~~~~ 672 (1017)
+.|++++|+++|.+|..+.+.++....+.||+.+||.+.....++|..... + ....+.+++.++++++++++++.+++
T Consensus 574 ~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (968)
T PLN00113 574 VQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK-T-PSWWFYITCTLGAFLVLALVAFGFVF 651 (968)
T ss_pred CEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc-c-ceeeeehhHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999776555677854322 1 11112222222222222222222333
Q ss_pred hhhhccc-CcCCCCCcc--CCC------CCCcCHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc
Q 043932 673 ARRRRSA-RKSVDTSPR--EKQ------FPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK 743 (1017)
Q Consensus 673 ~~~~~~~-~~~~~~~~~--~~~------~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~ 743 (1017)
+++|+.. .+....... +.. ...++++ .....|...++||+|+||.||+|++..+++.||||.+.....
T Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~ 728 (968)
T PLN00113 652 IRGRNNLELKRVENEDGTWELQFFDSKVSKSITIN---DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728 (968)
T ss_pred HHhhhcccccccccccccccccccccccchhhhHH---HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc
Confidence 3332211 111111100 000 0112222 334567788899999999999999988999999999864332
Q ss_pred chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHH
Q 043932 744 GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823 (1017)
Q Consensus 744 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~ 823 (1017)
. ..+|++.+++++||||++++++|... +..++||||+++|+|.++++ .++|.++.+|+.||+
T Consensus 729 ~----~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia 790 (968)
T PLN00113 729 I----PSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIA 790 (968)
T ss_pred c----cHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHH
Confidence 1 23568889999999999999999765 56799999999999999995 368899999999999
Q ss_pred HHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCc
Q 043932 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASM 903 (1017)
Q Consensus 824 ~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 903 (1017)
+|++|||..++++|+||||||+||+++.++.+++. ||.+..... .....||+.|+|||++.+..++.
T Consensus 791 ~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~ 857 (968)
T PLN00113 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------------DTKCFISSAYVAPETRETKDITE 857 (968)
T ss_pred HHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------------CCCccccccccCcccccCCCCCc
Confidence 99999996656699999999999999999988875 665432211 01135789999999999989999
Q ss_pred cccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc-hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHH
Q 043932 904 TGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE-KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIR 982 (1017)
Q Consensus 904 ~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 982 (1017)
++|||||||++|||+||+.||+..........+|.+..... ....++|+.+... .....++..++.+
T Consensus 858 ~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~ 925 (968)
T PLN00113 858 KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD------------VSVNQNEIVEVMN 925 (968)
T ss_pred ccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC------------CCccHHHHHHHHH
Confidence 99999999999999999999976555455555565543322 2333344333111 0112234567889
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 983 IGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 983 li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
++.+||+.||++||+|+||+++|+++.+..
T Consensus 926 l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 926 LALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 999999999999999999999999987643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-61 Score=618.39 Aligned_cols=518 Identities=33% Similarity=0.529 Sum_probs=486.4
Q ss_pred CCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCccc-CCCcceEeecccccccccCcccccccCCccEEE
Q 043932 101 SFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLS-RCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLA 179 (1017)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 179 (1017)
.+++.|||++|.++|.+|..|..+++|++|+|++|+++|.+|..+. ++++|++|+|++|++++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4799999999999999999999999999999999999999998766 999999999999999998886 5689999999
Q ss_pred eccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCcc
Q 043932 180 VGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259 (1017)
Q Consensus 180 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 259 (1017)
|++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|.+++
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChh
Q 043932 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339 (1017)
Q Consensus 260 ~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 339 (1017)
.+|.. +.++++|++|++++|++++.+|..++++++|+.|++++|++.+..|..+..+++|++|++++|.+...
T Consensus 227 ~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~------ 299 (968)
T PLN00113 227 EIPYE-IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE------ 299 (968)
T ss_pred cCChh-HhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccC------
Confidence 88865 56899999999999999999999999999999999999999999999999999999999999998643
Q ss_pred hHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcc
Q 043932 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGE 419 (1017)
Q Consensus 340 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 419 (1017)
.+..+.++++|+.|++++|.+.+.+|..+..+ ++|+.|++++|.+.+..|..++.+++|+.|++++|++.+..|..++.
T Consensus 300 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~ 378 (968)
T PLN00113 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSL-PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378 (968)
T ss_pred CChhHcCCCCCcEEECCCCccCCcCChhHhcC-CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence 23457789999999999999999999888876 46999999999999999999999999999999999999999999999
Q ss_pred cccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhccccccee
Q 043932 420 LKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYL 499 (1017)
Q Consensus 420 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L 499 (1017)
+++|+.|++++|.+.+.+|..+.++++|+.|++++|++++.+|..|.++++|+.|++++|++++.+|..+..+..+ ++|
T Consensus 379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L 457 (968)
T PLN00113 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL-QML 457 (968)
T ss_pred cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCC-cEE
Confidence 9999999999999999999999999999999999999999999999999999999999999999999887777665 469
Q ss_pred ccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCccc
Q 043932 500 DLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLS 579 (1017)
Q Consensus 500 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 579 (1017)
+|++|++.+.+|..+ ..++|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|+++
T Consensus 458 ~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 536 (968)
T PLN00113 458 SLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536 (968)
T ss_pred ECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence 999999999888866 4689999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCChhhhcccCCCcEEEcccCCCcCcCCC-CCCCCCCCcccccCcccccCCc
Q 043932 580 GQIPEFLENLSFLEFLNFSHNDLEGEVPT-KGVFSSKTKLSLQGNVKLCGGT 630 (1017)
Q Consensus 580 ~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~ 630 (1017)
|.+|..+.++++|+.|||++|+++|.+|. ...+.++..+++.+|+..+..|
T Consensus 537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 99999999999999999999999999886 3567889999999998776444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=390.43 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=211.6
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc-eeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD-FKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~ 783 (1017)
+.+..+.||+|..|+||+|+++.+++.+|+|++.... ....+++.+|++++++.+||+||+++|.|... . .++
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~is 154 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEEIS 154 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----CceEE
Confidence 4556789999999999999999999999999996443 34568899999999999999999999999765 3 589
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||++|+|++++...+ ++++....+|+.+|++||.|||+ + +||||||||+|||++..|++||||||.
T Consensus 155 I~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred eehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence 9999999999999998764 78999999999999999999996 6 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
++.+... ....++||..|||||.+.+..|+.++||||||++++|+.+|+.||...........+.....+
T Consensus 226 S~~lvnS----------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv 295 (364)
T KOG0581|consen 226 SGILVNS----------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV 295 (364)
T ss_pred cHHhhhh----------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh
Confidence 9876432 334578999999999999999999999999999999999999999775222222222211111
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQ-ECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.+.. +..+. .+++++.+++..|+++||.+||++.|+++|=.
T Consensus 296 ~~pp-----------------------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 296 DEPP-----------------------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred cCCC-----------------------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 1100 01111 36788999999999999999999999998744
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=403.95 Aligned_cols=290 Identities=41% Similarity=0.659 Sum_probs=240.7
Q ss_pred CCCCcCHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeee
Q 043932 691 QFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITI 770 (1017)
Q Consensus 691 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 770 (1017)
....+++.++..+|++|...++||+|+||.||+|... +++.||||.+........++|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4567899999999999999999999999999999997 458899998875443314669999999999999999999999
Q ss_pred eecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 771 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
|.+.+. ..++||||+++|+|.+++...... .++|.++++||.++|+||+|||+.+++.||||||||+|||+|
T Consensus 140 C~e~~~----~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 140 CLEGGE----HRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred EecCCc----eEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 987621 589999999999999999876531 789999999999999999999999888999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCccccc-ccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCccc-
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI-KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAF- 928 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~- 928 (1017)
+++++||+|||+|+...... .. .... .||.+|+|||++.....+.|+|||||||++.|++||+.|.+...
T Consensus 212 ~~~~aKlsDFGLa~~~~~~~--~~------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~ 283 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEGD--TS------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP 283 (361)
T ss_pred CCCCEEccCccCcccCCccc--cc------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC
Confidence 99999999999996543200 00 0011 69999999999998899999999999999999999999987654
Q ss_pred ccCccHHHHHHhhcCc-hhhhhccchhhH-HHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 929 TEGLTLHEFAKIALPE-KVIEIVDPLLLI-EVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~-~~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.....+..|+...... .+.+++|+.+.. .+. ..++..++..++.+|++.+|.+||+|.||++.|+
T Consensus 284 ~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~-------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 284 RGELSLVEWAKPLLEEGKLREIVDPRLKEGEYP-------------DEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred cccccHHHHHHHHHHCcchhheeCCCccCCCCC-------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 3334477777655544 688888988642 110 0145667899999999999999999999999997
Q ss_pred hccc
Q 043932 1007 HTRE 1010 (1017)
Q Consensus 1007 ~~~~ 1010 (1017)
.+..
T Consensus 351 ~~~~ 354 (361)
T KOG1187|consen 351 GILS 354 (361)
T ss_pred hhcc
Confidence 6553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=384.29 Aligned_cols=256 Identities=23% Similarity=0.317 Sum_probs=210.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-------chHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-------GAFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
.+.|.+.+.+|+|+||.|-+|..+.+|+.||||+++...- .......+|+++|++++|||||++++++...
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-- 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-- 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--
Confidence 4578889999999999999999999999999999974321 1223457999999999999999999999776
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC---C
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---M 853 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~ 853 (1017)
+..|+||||++||+|.+++-.++ .+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ .
T Consensus 249 ---ds~YmVlE~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 249 ---DSSYMVLEYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred ---CceEEEEEEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcce
Confidence 66799999999999999998765 566777788999999999999999 99999999999999766 7
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCC---cCccccchhHHHHHHHHHhCCCCCCccccc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE---ASMTGDVYSFGILLLELFTGRRPTDAAFTE 930 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~ 930 (1017)
.+||+|||+|+.... .......+||+.|.|||++.+.. +..++||||+||++|-+++|.+||.....+
T Consensus 317 llKItDFGlAK~~g~---------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGE---------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred EEEecccchhhcccc---------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 899999999997652 33455689999999999997654 344889999999999999999999876544
Q ss_pred CccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 931 GLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.....+..+..+.. .+..+.++.++..++|.+||..||++|||+.|+++|=.
T Consensus 388 ~sl~eQI~~G~y~f------------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 388 PSLKEQILKGRYAF------------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred ccHHHHHhcCcccc------------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 32233332222211 12345566788899999999999999999999998743
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=397.21 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=212.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.+|...+.||+|+|+.||++++..+|..||+|++... .....+.+.+|+++.+.++|||||+++++|++. ++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-----~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-----NN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-----Cc
Confidence 5799999999999999999999889999999999753 344567889999999999999999999999776 88
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
+|+|.|+|+.++|.+++++.+ ++++.+++.+.+||+.||.|||++ +|+|||||..|+|++++.++||+|||
T Consensus 93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 999999999999999998554 899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|..+..+. ......+|||.|.|||++.....+..+||||+|||+|-|++|++||+...-. ..+.+..
T Consensus 164 LAt~le~~~--------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----ety~~Ik 231 (592)
T KOG0575|consen 164 LATQLEYDG--------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----ETYNKIK 231 (592)
T ss_pred eeeeecCcc--------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----HHHHHHH
Confidence 999876332 2233478999999999999999999999999999999999999999764211 1111111
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.. ++. .+.....+..++|.++|+.||.+|||+++|+.+=
T Consensus 232 ~~----~Y~---------------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 232 LN----EYS---------------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred hc----Ccc---------------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 10 000 1112355678999999999999999999999764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=377.50 Aligned_cols=203 Identities=32% Similarity=0.556 Sum_probs=183.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
..+|...+.||+|+||+||+|+++.++..||||.+... .+...+.+..|+.+++.++|||||++++++... ++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----Ce
Confidence 46888999999999999999999999999999999766 455567788999999999999999999998776 78
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC------CCe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD------MVS 855 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~ 855 (1017)
.|+|||||.||||.+|++..+ .+++..++.++.|+|.||++||++ +||||||||+|||++.. -.+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceE
Confidence 999999999999999999875 789999999999999999999999 99999999999999765 468
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccc
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFT 929 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~ 929 (1017)
||+|||+|+.+.+.. .....+|++.|||||+++..+|+.|+|+||+|+|+|++++|+.||+....
T Consensus 155 KIADFGfAR~L~~~~---------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 155 KIADFGFARFLQPGS---------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred EecccchhhhCCchh---------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 999999999886433 23347899999999999999999999999999999999999999986533
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=364.77 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=211.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
..+|++.++||+|+||+||+|.+..+|..||.|.++... ..+.+....|+.++++++|||||++++.-.. ++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence 347899999999999999999999999999999998443 3445678899999999999999999984222 12244
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCC-CceeecCCCCceEeCCCCCeEEeec
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQP-PMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
.+||||||++|+|.++++..+. +.+.+++..+|+++.|++.||.++|++.+. -|+||||||.||+++.+|.+||+||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 7899999999999999987654 446899999999999999999999995332 2889999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++++.... ......+|||.||+||.+.+.+|++++||||+||++|||+.-++||.+. .+....+.
T Consensus 173 GL~r~l~s~~--------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~K 239 (375)
T KOG0591|consen 173 GLGRFLSSKT--------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKK 239 (375)
T ss_pred hhHhHhcchh--------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHH
Confidence 9999886432 3344589999999999999999999999999999999999999999875 12121111
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhH-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKT-QECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
....+. ++.+ .-++..+..++..|+..||+.||+...+++.+..
T Consensus 240 I~qgd~-----------------------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 240 IEQGDY-----------------------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHcCCC-----------------------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111111 1111 2346778999999999999999996555555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=360.03 Aligned_cols=278 Identities=21% Similarity=0.284 Sum_probs=212.1
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
+.|+...++|+|+||.||+++++++|+.||||.+....+ ...+...+|++++++++|||+|.++++|... ...
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-----rkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-----RKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-----cee
Confidence 467888999999999999999999999999999964433 3346678999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++|+|||+. ++.+-+..... .++...+.++++|++.|+.|+|++ ++|||||||+||||+.+|.+||||||+
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred EEEeeecch-HHHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 999999988 66666666543 688899999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH-Hh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA-KI 940 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~ 940 (1017)
|+..... ....+.++.|.+|+|||.+.| .+|+.++||||+||++.||++|.+.|++..+-+..+.... -.
T Consensus 148 AR~L~~p--------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG 219 (396)
T KOG0593|consen 148 ARTLSAP--------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG 219 (396)
T ss_pred hHhhcCC--------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence 9987631 122334678999999999887 6899999999999999999999999988654332221111 11
Q ss_pred hcCchhhhhccc-hhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDP-LLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+....+... .....+.-....-.+............+.+++..|++.||++|++.+|++.|
T Consensus 220 ~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 220 NLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 122222222111 0100000000011122233444556678999999999999999999999865
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=390.41 Aligned_cols=262 Identities=32% Similarity=0.463 Sum_probs=211.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEE-EEEEEeeecCcch--HHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMI-VAVKVINLKQKGA--FKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.+..+.+.+|+|+||+||+|.++ |+. ||||++...+... .+.|.+|+.++.+++|||||+++|+|.... ..
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~ 114 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GS 114 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----Cc
Confidence 34455667999999999999997 444 9999997544322 568999999999999999999999997651 15
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC-ceeecCCCCceEeCCCC-CeEEee
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP-MVHGDLKPSNVLLDHDM-VSHVGD 859 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~D 859 (1017)
.++||||+++|+|.+++... ....+++..++.+|.|||+||.|||++ + ||||||||+|||++.++ ++||+|
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECC
Confidence 79999999999999999874 124899999999999999999999999 7 99999999999999997 999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCccccc--CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM--GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
||+++...... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||...... ......
T Consensus 188 FGlsr~~~~~~--------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~~v 258 (362)
T KOG0192|consen 188 FGLSREKVISK--------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVASAV 258 (362)
T ss_pred Cccceeecccc--------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHH
Confidence 99998654321 1122257999999999999 568999999999999999999999999875331 111111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1014 (1017)
+....+ +....++++.+..++.+||+.||++||++.|++..|+.+...+..
T Consensus 259 ~~~~~R--------------------------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 259 VVGGLR--------------------------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HhcCCC--------------------------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 110000 111223688899999999999999999999999999998876543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=386.31 Aligned_cols=482 Identities=29% Similarity=0.417 Sum_probs=413.6
Q ss_pred ccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcc
Q 043932 120 EIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199 (1017)
Q Consensus 120 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 199 (1017)
.+..-..|+.|.+++|.+. .+-+.+.++..|.+|++++|+++ ..|.+++.+.+++.|++++|.++ .+|+.++.+.+|
T Consensus 40 ~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l 116 (565)
T KOG0472|consen 40 NWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISL 116 (565)
T ss_pred hhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhh
Confidence 3445567899999999998 56667889999999999999998 78889999999999999999998 789999999999
Q ss_pred cEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecc
Q 043932 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGG 279 (1017)
Q Consensus 200 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~ 279 (1017)
..|+++.|.+. ..|++++.+-.|..|+..+|+++ ..|+.+.++.+|..+++.+|.+. .+|++... ++.|++||..+
T Consensus 117 ~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~ 192 (565)
T KOG0472|consen 117 VKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNS 192 (565)
T ss_pred hhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHH-HHHHHhcccch
Confidence 99999999997 78888999999999999999998 78999999999999999999998 77777765 99999999999
Q ss_pred cccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcc
Q 043932 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQ 359 (1017)
Q Consensus 280 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 359 (1017)
|-+. .+|..++.+.+|+.|+|..|+|...+ .|.++..|++|+++.|+|+..++. ...++++|.+|||.+|+
T Consensus 193 N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae------~~~~L~~l~vLDLRdNk 263 (565)
T KOG0472|consen 193 NLLE-TLPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAE------HLKHLNSLLVLDLRDNK 263 (565)
T ss_pred hhhh-cCChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHH------Hhcccccceeeeccccc
Confidence 9997 88999999999999999999998544 899999999999999999876654 35689999999999999
Q ss_pred cccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccc--cccceec--cccccc-
Q 043932 360 FVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELK--NLQGLFL--YKNVLQ- 434 (1017)
Q Consensus 360 l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L--~~N~l~- 434 (1017)
++ ++|+.++.+ .+|.+|++++|.|++ .|..++++ .|+.|.+.+|.+..+..+.+.+-+ -|++|.= ..-.++
T Consensus 264 lk-e~Pde~clL-rsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~ 339 (565)
T KOG0472|consen 264 LK-EVPDEICLL-RSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQ 339 (565)
T ss_pred cc-cCchHHHHh-hhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCC
Confidence 98 899998877 469999999999985 67889999 999999999999865555444321 1333321 111111
Q ss_pred --------cc-cCc---ccccccccceeeccCcccCCCCccccccccC---CceeecCCCcccCCccchhhhccccccee
Q 043932 435 --------GS-IPS---GVGNLTKLAKLVMSYNSLQGNIPSSLGNCQN---LIGFNASHNKLTGALPQQLLSITTLSVYL 499 (1017)
Q Consensus 435 --------~~-~p~---~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~---L~~L~ls~N~l~~~~p~~~~~~~~~~~~L 499 (1017)
+. .+. ....+.+.+.|+++.-+++ .+|+..+.... ....+++.|++. .+|..+..+..+.+.+
T Consensus 340 se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l 417 (565)
T KOG0472|consen 340 SEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDL 417 (565)
T ss_pred CcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHH
Confidence 11 111 1234567899999999999 66766554444 788999999998 8999999999998889
Q ss_pred ccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCccc
Q 043932 500 DLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLS 579 (1017)
Q Consensus 500 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 579 (1017)
++++|.+. .+|..++.+++|..|+|++|.+. .+|..++.+..|+.||+|.|+|. .+|..+..+..|+++-.++|++.
T Consensus 418 ~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~ 494 (565)
T KOG0472|consen 418 VLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG 494 (565)
T ss_pred HhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc
Confidence 99999996 78999999999999999999998 78999999999999999999999 78999999999999999999999
Q ss_pred CCChhhhcccCCCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccc
Q 043932 580 GQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKL 626 (1017)
Q Consensus 580 ~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~ 626 (1017)
...|..+.++.+|.+|||.+|.+...+|..|.+.+++.+.+.|||+.
T Consensus 495 ~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 495 SVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 87777799999999999999999999999999999999999999854
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=342.09 Aligned_cols=277 Identities=22% Similarity=0.269 Sum_probs=219.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.+|...+++|+|.||.||+|++..+|+.||||.++..... ......+|++.++.++|+||+.++++|... +..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----Cce
Confidence 4788899999999999999999999999999999865432 235678999999999999999999998665 668
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
.+|+||++. +|+..++.... .++..++..++.++++|++|+|++ .|+||||||.|+|++.+|.+||+|||+
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred EEEEEeccc-cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 899999977 99999987653 889999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
|+.+......... .+-|.+|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.+..+- .++....+..
T Consensus 148 Ar~f~~p~~~~~~--------~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~L 218 (318)
T KOG0659|consen 148 ARFFGSPNRIQTH--------QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRAL 218 (318)
T ss_pred hhccCCCCccccc--------ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHc
Confidence 9988754422211 2578999999998875 6999999999999999999999877765332 3333333333
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..+...++.+-....++..-.....+........+.+...+++..|+.+||.+|+++.|++++
T Consensus 219 GTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 333333333333333333222222222333455567778999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=374.48 Aligned_cols=280 Identities=22% Similarity=0.256 Sum_probs=217.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHH-HHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK-SFMAECKALRNIR-HRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|.+.++||.|.||.||+|+...++..||||.++..-....+ .=.+|++.++++. ||||+++.+++.+.+ ..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence 46899999999999999999999999999999999755433222 2358999999998 999999999986552 27
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+|||||+. +|++.++.++ +.+++.+++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccc
Confidence 9999999966 9999999875 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
+|+...... ..+.++.|.+|+|||++.. ..|+.+.||||+|||++|+.+-++.|.+..+.+.. ..+...
T Consensus 156 LARev~Skp---------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi-~KIc~V 225 (538)
T KOG0661|consen 156 LAREVRSKP---------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI-YKICEV 225 (538)
T ss_pred cccccccCC---------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH-HHHHHH
Confidence 999765332 3344788999999998755 56899999999999999999999999886544332 223332
Q ss_pred hcCchhhhhccchhhHHHHhh--cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 941 ALPEKVIEIVDPLLLIEVMAN--NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
...+...++.........+.- .......+......++.+..+++.+|+.+||.+||||.|.+++--
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 222222222211111111110 111222333444557888999999999999999999999998743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=371.32 Aligned_cols=281 Identities=26% Similarity=0.329 Sum_probs=221.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.+.|+.+++||+|.||.||+|++..+|+.||+|.+.... +.......+|+.+|++++||||+++.+...+.. ...
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---Cce
Confidence 456888899999999999999999999999999998665 344566789999999999999999999987652 367
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
+|+|+|||++ ||..++.... ..+++.++..+++|++.||+|+|++ ||+|||||.+|||||.+|.+||+|||
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred EEEEEecccc-hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence 8999999988 9999887654 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
+|+++...... ..+..+-|.+|+|||.+.|. .|+.++|+||.|||+.||++|++.|.+. .+..+++.+.+.
T Consensus 264 LAr~y~~~~~~-------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~-tEveQl~kIfkl 335 (560)
T KOG0600|consen 264 LARFYTPSGSA-------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR-TEVEQLHKIFKL 335 (560)
T ss_pred ceeeccCCCCc-------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc-cHHHHHHHHHHH
Confidence 99987654422 23346789999999999885 6999999999999999999999999874 333445555544
Q ss_pred hcCchhhhhccchhh-HHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLL-IEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+....+....+. ...+.........+++.....+....+|+..+|..||++|.||.++++.
T Consensus 336 cGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 336 CGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred hCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 433221111100111 0111111122333444555667788999999999999999999998764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=380.57 Aligned_cols=264 Identities=28% Similarity=0.450 Sum_probs=215.0
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
....+.++..+.||+|.||+||.|.+. ....||+|.++.... ..+.|.+|+++|++++|++||+++++|... +
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~ 274 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----E 274 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecC-----C
Confidence 334455677889999999999999997 344799999985533 347889999999999999999999999765 3
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
.+||||||++.|+|.+|++... ...+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+||
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~----~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTRE----GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcC----CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccc
Confidence 5899999999999999999732 24789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+|+...++....... -.-+..|.|||.+....++.|||||||||+||||+| |+.||...... +...
T Consensus 348 GLAr~~~d~~Y~~~~~-------~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----ev~~ 415 (468)
T KOG0197|consen 348 GLARLIGDDEYTASEG-------GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----EVLE 415 (468)
T ss_pred ccccccCCCceeecCC-------CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----HHHH
Confidence 9999655444322211 223678999999999999999999999999999999 88898764222 1111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1013 (1017)
.++. ..+ -+.+..||+++.++|..||+.+|++|||++.+...++++.....
T Consensus 416 ---------~le~--------GyR------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 416 ---------LLER--------GYR------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred ---------HHhc--------cCc------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 1110 111 12345689999999999999999999999999999998876544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=374.21 Aligned_cols=262 Identities=25% Similarity=0.374 Sum_probs=214.9
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCC
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDS 776 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 776 (1017)
.+...+|.+++.||+|+|++|++|+...+++.||||++.+. .....+.+..|-++|.+| .||.|++++..|.+.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-- 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-- 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--
Confidence 44567899999999999999999999999999999998633 122335667888899999 899999999888665
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
...|+|+||+++|+|.+++++.+ .+++...+.+|.||+.|++|||++ |||||||||+|||+|+||++|
T Consensus 147 ---~sLYFvLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 147 ---ESLYFVLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred ---cceEEEEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence 67999999999999999999886 789999999999999999999999 999999999999999999999
Q ss_pred Eeecccccccccccccccc-----cCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC
Q 043932 857 VGDFGLAKFLSSHQLDTAS-----KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG 931 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 931 (1017)
|+|||.|+.+.+....... ........++||..|.+||++.+...++.+||||||||+|+|+.|++||.+..+ .
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-y 293 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-Y 293 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-H
Confidence 9999999998765543111 111222558999999999999999999999999999999999999999987422 1
Q ss_pred ccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 932 LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..+..+....+ ......++...+|+.+.|..||.+|+|+.||.+|-
T Consensus 294 liFqkI~~l~y----------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 LIFQKIQALDY----------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHHhcc----------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11111111110 11122356678999999999999999999998774
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=387.20 Aligned_cols=475 Identities=28% Similarity=0.412 Sum_probs=372.5
Q ss_pred eEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecc
Q 043932 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVS 157 (1017)
Q Consensus 78 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (1017)
....+++++|.+.. +.+.+.+|..|.+|++++|+++ +.|.+++.+..++.|+.++|+++ .+|..++.+.+|+.|+.+
T Consensus 46 ~l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 36678899998864 4577889999999999999998 88999999999999999999999 899999999999999999
Q ss_pred cccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCcccccc
Q 043932 158 NNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTF 237 (1017)
Q Consensus 158 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 237 (1017)
+|.+. .+|+.++.+..|..|+..+|+++ ..|+.++++.+|..|++.+|++....|..+. ++.|++||+.+|.++ .+
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tl 198 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TL 198 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cC
Confidence 99998 78889999999999999999998 6788889999999999999999866665555 999999999999887 88
Q ss_pred chhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccc-cCCccceeecccCcccceeeccccc
Q 043932 238 PQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLS-NASNVEILDLGFNQFKGKVSIDFSS 316 (1017)
Q Consensus 238 p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~ 316 (1017)
|..++.+.+|+.|||..|++. .+| -|.++..|++|+++.|+|. .+|.... +++++.+|||.+|+++ ..|..+.-
T Consensus 199 P~~lg~l~~L~~LyL~~Nki~-~lP--ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl 273 (565)
T KOG0472|consen 199 PPELGGLESLELLYLRRNKIR-FLP--EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL 273 (565)
T ss_pred ChhhcchhhhHHHHhhhcccc-cCC--CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence 999999999999999999998 777 3678889999999999998 5665554 8999999999999998 56778888
Q ss_pred cCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcc-cceEE-------EecCCcc---
Q 043932 317 LKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSS-SMIEF-------RIGGNQI--- 385 (1017)
Q Consensus 317 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~-~L~~L-------~l~~N~i--- 385 (1017)
+++|++||+++|.|+..... ++++ .|+.|-+.+|.+...--+-+...+. -|++| .++.-+=
T Consensus 274 LrsL~rLDlSNN~is~Lp~s-------Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e 345 (565)
T KOG0472|consen 274 LRSLERLDLSNNDISSLPYS-------LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE 345 (565)
T ss_pred hhhhhhhcccCCccccCCcc-------cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc
Confidence 99999999999999876554 7888 8999999999886321111111100 01111 1111100
Q ss_pred -----ccccCccccccccccEEeccccCCCCCcchhhccccc---ccceeccccccccccCcccccccccce-eeccCcc
Q 043932 386 -----FGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKN---LQGLFLYKNVLQGSIPSGVGNLTKLAK-LVMSYNS 456 (1017)
Q Consensus 386 -----~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~-L~Ls~N~ 456 (1017)
..........+.+.+.|+++.-+++. +|+....... .+..++++|++. ++|..+..++.+.+ +++++|.
T Consensus 346 ~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~ 423 (565)
T KOG0472|consen 346 TAMTLPSESFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNK 423 (565)
T ss_pred ccCCCCCCcccchhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCc
Confidence 00111223445667778888777773 4444333333 677778888887 67777776666444 4455555
Q ss_pred cCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccc
Q 043932 457 LQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPV 536 (1017)
Q Consensus 457 i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 536 (1017)
++ .+|..++.+++|..|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|.
T Consensus 424 is-fv~~~l~~l~kLt~L~L~NN~Ln--------------------------~LP~e~~~lv~Lq~LnlS~NrFr-~lP~ 475 (565)
T KOG0472|consen 424 IS-FVPLELSQLQKLTFLDLSNNLLN--------------------------DLPEEMGSLVRLQTLNLSFNRFR-MLPE 475 (565)
T ss_pred cc-cchHHHHhhhcceeeecccchhh--------------------------hcchhhhhhhhhheecccccccc-cchH
Confidence 54 67777777777777777777665 57778888888899999999888 7888
Q ss_pred cccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCc
Q 043932 537 TLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE 603 (1017)
Q Consensus 537 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 603 (1017)
.+..+..|+.+-.++|++..+.|+.+.+|.+|.+|||.+|.+. .+|..++++++|+.|++++|+|.
T Consensus 476 ~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 476 CLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 8888888888888889998777777889999999999999998 78888999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=359.25 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=205.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|++.++||+|+||+||.++.+++++.||+|++++.. ....+....|..++.+++||.||+++..|++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~----- 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE----- 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC-----
Confidence 3568999999999999999999999999999999997543 34557788999999999999999999888765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..|+|+||+.||.|...+++.+ .+++..++-++.+|+.||.|||++ +|||||+||+|||+|.+|+++|+|
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEec
Confidence 78999999999999999998765 789999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+++..... ......++||+.|||||++.+..|+.++|.||+|+++|||++|.+||...... ++.+
T Consensus 169 FgL~k~~~~~--------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~ 235 (357)
T KOG0598|consen 169 FGLCKEDLKD--------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYD 235 (357)
T ss_pred cccchhcccC--------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHH
Confidence 9999854321 12233479999999999999999999999999999999999999999875322 1111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC----CHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM----EMRDVV 1002 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl 1002 (1017)
.....+. .....-...+..+++.+.+..||++|. .+.+|-
T Consensus 236 ~I~~~k~-----------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 236 KILKGKL-----------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred HHhcCcC-----------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 1111110 000001245578899999999999995 455543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=374.84 Aligned_cols=269 Identities=28% Similarity=0.448 Sum_probs=217.5
Q ss_pred CHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeec
Q 043932 696 SYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 696 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
+..+++...+++.+.+.||+|+||+||+|+|.++ ||||+++.... +..+.|.+|+.++++-+|.||+-+.|||..
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3466777778888999999999999999999754 99999986653 456889999999999999999999999965
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
+ . ..||+.+|+|.+|+.+++... .+++..+.+.||+|||+||.|||.+ +|||||||..|||+.+++
T Consensus 460 p-----~-~AIiTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~ 525 (678)
T KOG0193|consen 460 P-----P-LAIITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDL 525 (678)
T ss_pred C-----c-eeeeehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCC
Confidence 4 3 389999999999999998765 3899999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCC---CcCccccchhHHHHHHHHHhCCCCCCccccc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS---EASMTGDVYSFGILLLELFTGRRPTDAAFTE 930 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~ 930 (1017)
.|||+|||++..-..-. .........|..-|||||+++.. +|++.+||||||+|+|||++|..||.....+
T Consensus 526 kVkIgDFGLatvk~~w~------g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d 599 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWS------GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD 599 (678)
T ss_pred cEEEecccceeeeeeec------cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence 99999999997543211 11111224578899999999653 6899999999999999999999999843222
Q ss_pred CccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 931 GLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
.. .|.... ....++.......|+.++++|+..||.++|++||.+.+|+..|+.+..
T Consensus 600 qI---ifmVGr---------------------G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 600 QI---IFMVGR---------------------GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred he---EEEecc---------------------cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11 010000 001112233445778899999999999999999999999998888776
Q ss_pred c
Q 043932 1011 T 1011 (1017)
Q Consensus 1011 ~ 1011 (1017)
+
T Consensus 656 ~ 656 (678)
T KOG0193|consen 656 S 656 (678)
T ss_pred c
Confidence 4
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=360.24 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=209.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
..+|...+.||+|+||+||++.+..+|...|||.+...+....+.+.+|+.++++++|||||+++|....... ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence 4467888999999999999999998899999999986644446778999999999999999999997443311 3689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-CCCeEEeeccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVSHVGDFGL 862 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~ 862 (1017)
+.|||+++|+|.+++...++ .+++..+..+++||++||+|||++ |||||||||+|||++. ++.+||+|||.
T Consensus 93 i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence 99999999999999998753 689999999999999999999999 9999999999999999 79999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++...... ........+.||+.|||||++.. ....+++||||+||++.||+||++||..... .........
T Consensus 165 a~~~~~~~-----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~---~~~~~~~ig 236 (313)
T KOG0198|consen 165 AKKLESKG-----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE---EAEALLLIG 236 (313)
T ss_pred cccccccc-----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc---hHHHHHHHh
Confidence 98665311 11122334789999999999985 3445699999999999999999999976311 111111111
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
...... ..+...+++..+++.+|+..||++||||.|+++|.....
T Consensus 237 ~~~~~P-----------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 237 REDSLP-----------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ccCCCC-----------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 111000 111223567889999999999999999999999876544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=368.01 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=212.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
..|+..++||+|+.|.||.|+...+++.||||.+........+-+.+|+.+|+..+|+|||.+++.|... +..|+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEE
Confidence 4677788999999999999999999999999999988777777889999999999999999999987655 67999
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||++||+|.+.+... .+++.++..|++++++||+|||.+ ||+|||||.+||+++.+|.+||+|||++.
T Consensus 348 VMEym~ggsLTDvVt~~-------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred EEeecCCCchhhhhhcc-------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence 99999999999999765 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
.+..... ....++||++|||||+.....|++++||||||++++||+.|.+||-... .+..........
T Consensus 418 qi~~~~~--------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~----PlrAlyLIa~ng 485 (550)
T KOG0578|consen 418 QISEEQS--------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRALYLIATNG 485 (550)
T ss_pred ccccccC--------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC----hHHHHHHHhhcC
Confidence 7654332 3345789999999999999999999999999999999999999986421 111111111000
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..++ ......+..+.+++.+||+.||++||+|.|+|+|=
T Consensus 486 -~P~l---------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 486 -TPKL---------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred -CCCc---------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 0000 11223467899999999999999999999999873
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=339.75 Aligned_cols=280 Identities=21% Similarity=0.265 Sum_probs=213.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|+..+.|++|+||.||+|+++.+++.||+|.++..... -.-.-.+|+.++.+++|||||.+.++.... ..+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccce
Confidence 45788999999999999999999999999999999855422 223457999999999999999999987544 3367
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
+|+|||||+. +|...+...+. ++...++..+..|+++|++|||.. .|+||||||+|+|+++.|.+||+|||
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence 9999999988 99999988763 889999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
+|+.++... ...+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.|++++++.|.+...-+.....+...
T Consensus 223 LAR~ygsp~--------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll 294 (419)
T KOG0663|consen 223 LAREYGSPL--------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL 294 (419)
T ss_pred hhhhhcCCc--------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence 999876432 223346789999999998875 59999999999999999999999998864433222222222
Q ss_pred hcCch--hhhhccchhhHHHHhhcchhHHHhHHhHHH--HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEK--VIEIVDPLLLIEVMANNSMIQEDIRAKTQE--CLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..|.+ +..+....... ...........++..... ..+.-.+++..++.+||.+|.||+|.++|
T Consensus 295 GtPte~iwpg~~~lp~~k-~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 295 GTPSEAIWPGYSELPAVK-KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCCccccCCCccccchhh-ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 22221 11111111111 011111112222222222 23667899999999999999999998875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.64 Aligned_cols=287 Identities=23% Similarity=0.281 Sum_probs=224.6
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEee--ecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
......|...+.||+|+||.|+.|.++.+|+.||||.+. .......++..+|++.++.++|+||+.+.+++.......
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 334556777899999999999999999999999999987 555666788999999999999999999999987744455
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
-..+|+|+|+|+. +|...++... .++...+..+.+|+++||+|+|+. +|+|||+||.|++++.+..+||+
T Consensus 98 f~DvYiV~elMet-DL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~ 167 (359)
T KOG0660|consen 98 FNDVYLVFELMET-DLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKIC 167 (359)
T ss_pred cceeEEehhHHhh-HHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEec
Confidence 5789999999954 9999998764 589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|||+|+..... ......+.++.|.+|+|||++.. ..|+.+.||||.|||+.||++|++.|.+...-. ++...
T Consensus 168 DFGLAR~~~~~------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~-Ql~lI 240 (359)
T KOG0660|consen 168 DFGLARYLDKF------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH-QLQLI 240 (359)
T ss_pred cccceeecccc------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH-HHHHH
Confidence 99999987543 22344456789999999998744 679999999999999999999999998753321 22222
Q ss_pred HHhhc--Cch-hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 938 AKIAL--PEK-VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~--~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..... ++. +..+-...........................+...+++.+||..||.+|+|++|+++|
T Consensus 241 ~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 241 LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 22111 111 22222222222222122223333344555677888999999999999999999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=348.70 Aligned_cols=268 Identities=23% Similarity=0.313 Sum_probs=214.1
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
...++|+..++||.|..++||+|+....++.||||++..+.- ...+.+.+|+..|+.++||||++++..|... .
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~ 97 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-----S 97 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-----c
Confidence 345789999999999999999999999999999999986653 3358899999999999999999999988776 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||.||.+|++.+.++.... ..+++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.|||+||
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYP----DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCc
Confidence 79999999999999999987653 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC--CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|.+..+..... ... ... ..++||+.|||||+++. ..|+.|+||||||++..|+.+|..||.....-...+...
T Consensus 171 gvsa~l~~~G~--R~~-~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL- 245 (516)
T KOG0582|consen 171 GVSASLFDSGD--RQV-TRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL- 245 (516)
T ss_pred eeeeeecccCc--eee-Eee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-
Confidence 99876655431 111 111 55789999999999644 469999999999999999999999997643221111111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+...|.......+ ..........+.+++..|+++||.+||||++++++
T Consensus 246 qn~pp~~~t~~~~------------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 246 QNDPPTLLTSGLD------------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCCCCCcccccCC------------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111111111111 11122335578999999999999999999999876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=327.11 Aligned_cols=279 Identities=19% Similarity=0.239 Sum_probs=221.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.+|+|||+.||.++...+++.||+|.+.....+..+..++|++..++++|||++++++++......+..+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35699999999999999999999999999999999987777778899999999999999999999998876655567889
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
|++++|+..|+|.+.++.... +...+++.++++|+.+|++||++||+. .++++||||||.||++++.+.+++.|||.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~--kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKI--KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEeehhccccHHHHHHHHhh--cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 999999999999999987543 334799999999999999999999998 34699999999999999999999999999
Q ss_pred ccccccccccccc-cCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 863 AKFLSSHQLDTAS-KTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 863 a~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
++...-.-..... ..-.....-..|..|+|||.+. +...++++|||||||++|+|+.|..||+.....+.++.-.+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 8755321100000 0011112235789999999884 34578999999999999999999999987655443321111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
.. +.. . .+....+++.+.+++.+|++.||.+||++.|++.++.++.
T Consensus 256 ~n-----------~q~-------------s-~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QN-----------AQI-------------S-IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ec-----------ccc-------------c-cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 10 000 0 0001114778999999999999999999999999998753
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=369.11 Aligned_cols=393 Identities=22% Similarity=0.240 Sum_probs=287.9
Q ss_pred ccccCCCCcccccCCCcccCC--CcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEe
Q 043932 128 EKLALPNNSFSGTIPTNLSRC--SNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSIT 205 (1017)
Q Consensus 128 ~~L~L~~n~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 205 (1017)
..|+++.+.+...--..+..+ +.-+.||+++|+++..-+..|.++++|+++++.+|.++ .+|...+...+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 346777776653211112221 23456888888888777888888888888888888888 667666666668888888
Q ss_pred cCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCC
Q 043932 206 GNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGS 285 (1017)
Q Consensus 206 ~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~ 285 (1017)
+|.|+..-.+++..++.|+.|||+.|.|+.+.-..|..-.++++|+|++|+|+ .+....|..+.+|..|.|+.|+++..
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLsrNrittL 212 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLSRNRITTL 212 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccc-ccccccccccchheeeecccCccccc
Confidence 88887777777777777888888887777554456666667777777777776 66666666677777777777777755
Q ss_pred CCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccc
Q 043932 286 IPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELP 365 (1017)
Q Consensus 286 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 365 (1017)
.+..|+++++|+.|+|..|+|.-..-..|.++++|+.|.|..|.|.....+. |..+.+
T Consensus 213 p~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~------Fy~l~k---------------- 270 (873)
T KOG4194|consen 213 PQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGA------FYGLEK---------------- 270 (873)
T ss_pred CHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcc------eeeecc----------------
Confidence 5566666777777777777776554556666666666666666665444332 233444
Q ss_pred hhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCccccccc
Q 043932 366 HSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLT 445 (1017)
Q Consensus 366 ~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 445 (1017)
+++|+|..|+++..-..++.+|+.|+.|+|++|.|..+.++...-.++|++|+|+.|+|+...+..|..|.
T Consensus 271 ---------me~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~ 341 (873)
T KOG4194|consen 271 ---------MEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS 341 (873)
T ss_pred ---------cceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH
Confidence 44444444445555667788888888888888888888888888888888888888888877778888888
Q ss_pred ccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEc
Q 043932 446 KLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLII 525 (1017)
Q Consensus 446 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 525 (1017)
.|+.|+|++|+|+..-...|..+++|+.|||++|.|+..+.+ -...|..+++|+.|+|
T Consensus 342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED----------------------aa~~f~gl~~LrkL~l 399 (873)
T KOG4194|consen 342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED----------------------AAVAFNGLPSLRKLRL 399 (873)
T ss_pred HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec----------------------chhhhccchhhhheee
Confidence 888888888888877777888888888888888888754433 1234677889999999
Q ss_pred cCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCC
Q 043932 526 SSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSN 576 (1017)
Q Consensus 526 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 576 (1017)
.+|+|+.+...+|.++++|+.|||.+|.|..+.|++|..+ .|+.|-++.-
T Consensus 400 ~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs 449 (873)
T KOG4194|consen 400 TGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS 449 (873)
T ss_pred cCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence 9999997777889999999999999999998999999998 8888876543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=358.67 Aligned_cols=248 Identities=30% Similarity=0.466 Sum_probs=210.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+..+ .+.+.+.+|++++++++||||+.++++|+.. .+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-----~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-----AHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-----ceE
Confidence 478888999999999999999999999999999975543 4467789999999999999999999998766 789
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
|+|+||+.| +|..++.... .++++++..|+.|++.||.|||+. +|+|||+||.||+++.+|.+|+||||+
T Consensus 77 ~vVte~a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred EEEehhhhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 999999977 9999998765 799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
|+.+.... .....+.|||.|||||+..+..|+..+|+||+|||+||+++|++||... .+.+.++...
T Consensus 147 Ar~m~~~t--------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~ 213 (808)
T KOG0597|consen 147 ARAMSTNT--------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSIL 213 (808)
T ss_pred hhhcccCc--------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHh
Confidence 99765422 2334578999999999999999999999999999999999999999753 1222222211
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+++ .-+......+..++...+.+||.+|.+..+++.|
T Consensus 214 ~d~v------------------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 214 KDPV------------------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cCCC------------------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1110 0111346678899999999999999999998876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=377.00 Aligned_cols=264 Identities=26% Similarity=0.471 Sum_probs=217.2
Q ss_pred ccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.+....+.||+|.||+||+|+.. ++...||||.++..... ...+|++|++.+..++|||||+++|+|...
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~---- 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG---- 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC----
Confidence 45566789999999999999974 34577999999866655 778999999999999999999999999876
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCcc--------ccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLE--------VCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
+-.++|+|||..|||.+|++....... ..+++..+.+.||.|||.||.||-++ .+|||||..+|+||.
T Consensus 562 -~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 562 -DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred -CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 568999999999999999986543211 33489999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccc
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFT 929 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 929 (1017)
++..|||+|||+++.....+....... ..-..+|||||.+..++|+.+||||||||++||+++ |+.||.+...
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~------t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGN------TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCC------ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence 999999999999997765554332211 123679999999999999999999999999999999 9999877533
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
++ ..+ .+.. ..+-..++.||.++++||..||+..|++||+++||-..|+...
T Consensus 712 ~E--VIe------------~i~~--------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 712 QE--VIE------------CIRA--------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HH--HHH------------HHHc--------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 21 111 1100 0112345678999999999999999999999999998888765
Q ss_pred c
Q 043932 1010 E 1010 (1017)
Q Consensus 1010 ~ 1010 (1017)
+
T Consensus 764 ~ 764 (774)
T KOG1026|consen 764 Q 764 (774)
T ss_pred h
Confidence 4
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.78 Aligned_cols=278 Identities=24% Similarity=0.327 Sum_probs=210.1
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
.|...+++|+|+||.||+|...++++.||||..-.+.+ --.+|+++|+.++|||||++..+|....+.+.-+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 57778999999999999999999999999998864432 12479999999999999999999877655444567799
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-CCeEEeeccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVSHVGDFGLAK 864 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~ 864 (1017)
|||++. +|.++++.... ...+++...+.-+..||++||+|||+. +|+||||||+|+|||.+ |.+||||||.|+
T Consensus 101 leymP~-tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHhchH-HHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 999987 99999985321 123778888899999999999999998 99999999999999977 999999999999
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
....++. ...+..|..|+|||.+.|. .|+.+.||||.|||+.||+-|++.|.+... ..++.++.+....
T Consensus 175 ~L~~~ep---------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 175 VLVKGEP---------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGT 244 (364)
T ss_pred eeccCCC---------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCC
Confidence 8765432 2346789999999998774 699999999999999999999999988533 3344444444332
Q ss_pred chhhhh--ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEI--VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~--~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+...++ +.+... +............+-.....+++..+++.++++++|.+|.++.|+++|
T Consensus 245 Pt~e~I~~mn~~y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 245 PTREDIKSMNPNYT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CCHHHHhhcCcccc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 221111 111100 000000000000011234457788999999999999999999999865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=352.00 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=207.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|+.+.+||+|+||.||+|+.+.+|..+|+|++++.. ....+.+..|-.+|...++|.||+++..|.+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~----- 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK----- 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-----
Confidence 3468999999999999999999999999999999998654 45567888999999999999999999988765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
++.|+||||++||++..++...+ .+++..++.++.+++.|+..+|.. |+|||||||+|+|||..|++||+|
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence 88999999999999999998775 799999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccc-----------------c-cc---------------------CCCcccccccCccccCcccccCCC
Q 043932 860 FGLAKFLSSHQLDT-----------------A-SK---------------------TSSSSIGIKGTVGYVAPEYCMGSE 900 (1017)
Q Consensus 860 fG~a~~~~~~~~~~-----------------~-~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~ 900 (1017)
||+++-+....... . .. ........+|||-|+|||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 99996443210000 0 00 000113467999999999999999
Q ss_pred cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHH
Q 043932 901 ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAI 980 (1017)
Q Consensus 901 ~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 980 (1017)
|+..+|.||+|||+|||+.|.+||.+..... .|.+...-. ..+. .+....+.++.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~----T~rkI~nwr--~~l~-------------------fP~~~~~s~eA 419 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQE----TYRKIVNWR--ETLK-------------------FPEEVDLSDEA 419 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHh--hhcc-------------------CCCcCcccHHH
Confidence 9999999999999999999999998754321 121111000 0000 01111234677
Q ss_pred HHHHhhccCCCCCCCCC---HHHHHHH
Q 043932 981 IRIGVLCSMESPFERME---MRDVVAK 1004 (1017)
Q Consensus 981 ~~li~~cl~~dP~~RPs---~~evl~~ 1004 (1017)
.++|.+|+. ||++|.- +.||.+|
T Consensus 420 ~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 420 KDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 899999999 9999975 6666544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.60 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=206.0
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec----Cc-chHHHHHHHHHHHHhcC-CCCceeeeeeeecCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK----QK-GAFKSFMAECKALRNIR-HRNLIKIITICSSID 775 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 775 (1017)
...+.|.+.+.||+|+||+|+.|.+..+++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 4467899999999999999999999999999999977643 11 23456678999999998 99999999999766
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-CC
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MV 854 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 854 (1017)
...++||||+.||+|.+++...+ ++.+.++..+++|++.|++|+|++ ||+||||||+||+++.+ +.
T Consensus 93 ----~~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 93 ----TKIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred ----CeEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence 56999999999999999999843 788899999999999999999999 99999999999999999 99
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccCCC-cC-ccccchhHHHHHHHHHhCCCCCCcccccCc
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE-AS-MTGDVYSFGILLLELFTGRRPTDAAFTEGL 932 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~pf~~~~~~~~ 932 (1017)
+||+|||++..... ........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+......
T Consensus 160 ~Kl~DFG~s~~~~~--------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~- 230 (370)
T KOG0583|consen 160 LKLSDFGLSAISPG--------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN- 230 (370)
T ss_pred EEEeccccccccCC--------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-
Confidence 99999999987631 122334478999999999999977 75 78999999999999999999998732110
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHH-HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQEC-LNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.......... .+ +... ..++..++.+|+..||.+|+++.|++++
T Consensus 231 l~~ki~~~~~--~~--------------------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 231 LYRKIRKGEF--KI--------------------------PSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred HHHHHhcCCc--cC--------------------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 0111000000 00 1111 4567899999999999999999999954
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=358.10 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=209.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.+-|+.++.||.|+.|.|..|++..+|+.+|||++.... ......+.+|+-+|+.+.||||++++++++.. .
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-----~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-----Q 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-----c
Confidence 356888999999999999999999999999999997552 22345678999999999999999999998765 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
++|+|.||+++|.|.+++-..+ ++++.++.++++||+.|+.|+|.. +|+|||+||+|+++|..+.+||+||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence 8999999999999999998776 789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+|....++. .....+|++.|+|||++.|.+| +.++||||+|||+|.|+||+.||+++. +.....
T Consensus 157 GMAsLe~~gk---------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~LLl 222 (786)
T KOG0588|consen 157 GMASLEVPGK---------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRVLLL 222 (786)
T ss_pred ceeecccCCc---------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHHHHH
Confidence 9998644322 2334689999999999999887 689999999999999999999998531 111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
... ...-..+..++.+..+|+.+|+..||++|.|++||++|-.
T Consensus 223 KV~------------------------~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 223 KVQ------------------------RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHH------------------------cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 000 0001122344677899999999999999999999998854
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=350.04 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=208.6
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
..|+..+.||+|+||.||+|.+..+++.||+|++.... ++..+.+++|+.++.+++++||.++|+.+... ..++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccHH
Confidence 46777899999999999999999999999999998654 45568899999999999999999999988766 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
++|||+.||++.+.++... .+++..+.-|.+++..|+.|||.+ +.+|||||+.||++..+|.+|++|||.+
T Consensus 88 iiMey~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred HHHHHhcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence 9999999999999998764 447778888999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
....... .....++||+.|||||++++..|+.|+||||||++.|||.+|.+|+....+.... ..++
T Consensus 159 ~ql~~~~--------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------flIp 224 (467)
T KOG0201|consen 159 GQLTNTV--------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------FLIP 224 (467)
T ss_pred eeeechh--------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------Eecc
Confidence 7664322 2224589999999999999989999999999999999999999998764331100 0001
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .|.+ ...+.+.+++++..|+++||+.||+|.++++|
T Consensus 225 k~~----PP~L------------------~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 225 KSA----PPRL------------------DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCC----CCcc------------------ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 100 0111 11346779999999999999999999999876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=323.12 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=181.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|+..+.||.|+||.|.+++.+.+|..+|+|++....- ...+...+|-.+++.+.||.++++++.|.+. +
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-----~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-----S 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-----C
Confidence 3478889999999999999999999999999999975542 3446677899999999999999999988665 8
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
+.|+||||++||.|..++++.+ ++++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 8999999999999999999875 789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
|.|+..... ....+|||.|+|||++..+.+..++|.|||||++|||+.|.+||....
T Consensus 189 GFAK~v~~r-----------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 189 GFAKRVSGR-----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred cceEEecCc-----------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 999976432 344789999999999999999999999999999999999999997643
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=372.22 Aligned_cols=273 Identities=21% Similarity=0.275 Sum_probs=217.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeee-eecCCCCC-Cc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITI-CSSIDSKG-AD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~~~~~~-~~ 780 (1017)
..++++.++|.+|||+.||.|++...|..||+|++-..++...+...+|+++|++|+ |+|||.+++. .......+ .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 457788899999999999999999887999999998778888899999999999996 9999999993 33222333 46
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
++++.||||+||.|-+++..+-. ..+++.++++|+.|+++|+++||.. +++|||||||-||||++.+|..|||||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 78899999999999999987642 3599999999999999999999998 678999999999999999999999999
Q ss_pred cccccccccccc-ccccCCCcccccccCccccCcccc---cCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 861 GLAKFLSSHQLD-TASKTSSSSIGIKGTVGYVAPEYC---MGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 861 G~a~~~~~~~~~-~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|.|+........ .....-........|+.|+|||++ .+...++|+|||||||+||-|+....||+....-...-..
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~ 270 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN 270 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc
Confidence 999754322100 000001111223579999999987 5678999999999999999999999999864221111000
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
+ .+| ....+...+.+||..||+.||.+||++-||++++.+++.+-
T Consensus 271 Y---~~P----------------------------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 271 Y---SFP----------------------------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred c---cCC----------------------------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 0 001 11245778999999999999999999999999999887654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=356.65 Aligned_cols=367 Identities=20% Similarity=0.214 Sum_probs=300.2
Q ss_pred CCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEec
Q 043932 102 FLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVG 181 (1017)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 181 (1017)
.-+.||||+|.+...-+..|.++++|++++|.+|.++ .||...+...+|+.|+|.+|.|+..-.+++.-++.|+.|||+
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3567999999999888888899999999999999998 888877777889999999999987777888889999999999
Q ss_pred cccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCcccc
Q 043932 182 KNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTL 261 (1017)
Q Consensus 182 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l 261 (1017)
.|.|+.+.-..|..-.++++|+|++|+|+..-...|..+.+|.+|.|++|+|+...+..|.++++|+.|+|..|+|. .+
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir-iv 236 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR-IV 236 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee-ee
Confidence 99998666677887788999999999998888888888889999999999998666677888999999999999886 55
Q ss_pred CchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhH
Q 043932 262 PFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFV 341 (1017)
Q Consensus 262 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 341 (1017)
..-.|.++++|+.|.|..|++...-...|..+.++++|+|+.|++.......+-+++.|+.|+|++|.|..+..+.
T Consensus 237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~---- 312 (873)
T KOG4194|consen 237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS---- 312 (873)
T ss_pred hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch----
Confidence 5566888899999999999888777778888889999999999988888888888888888888888887766654
Q ss_pred hhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcch---hhc
Q 043932 342 TFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPD---VIG 418 (1017)
Q Consensus 342 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~ 418 (1017)
...+++|+.|+|++|+++..-+.++. ..+.|++|+|++|.|..+....|..+.+|+.|||++|.|+..+-+ .|.
T Consensus 313 --WsftqkL~~LdLs~N~i~~l~~~sf~-~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~ 389 (873)
T KOG4194|consen 313 --WSFTQKLKELDLSSNRITRLDEGSFR-VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFN 389 (873)
T ss_pred --hhhcccceeEeccccccccCChhHHH-HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhc
Confidence 34567888888888888844344444 345688888888888887778888888888888888888765543 477
Q ss_pred ccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCC
Q 043932 419 ELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASH 478 (1017)
Q Consensus 419 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~ 478 (1017)
+|++|+.|+|.+|++..+.-.+|.++..|++|+|.+|.|..+-|.+|..| +|+.|-+..
T Consensus 390 gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 390 GLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred cchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 78888888888888885555678888888888888888887888888877 777776543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=351.71 Aligned_cols=246 Identities=26% Similarity=0.434 Sum_probs=204.3
Q ss_pred ccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEe
Q 043932 709 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFEC 788 (1017)
Q Consensus 709 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 788 (1017)
..+-||.|+.|.||+|+.. ++.||||.++. .-..+++-|++++||||+.+.|+|... ..+||||||
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiMEf 193 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIMEF 193 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeeec
Confidence 3567999999999999996 67899998752 223578889999999999999999776 789999999
Q ss_pred ccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccccc
Q 043932 789 MKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS 868 (1017)
Q Consensus 789 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 868 (1017)
|..|-|.+.++..+ +++....+.+..+||.||.|||.+ .|||||||.-||||+.+..+||+|||-++...+
T Consensus 194 Ca~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred cccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999999999765 788889999999999999999999 999999999999999999999999999986543
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhh
Q 043932 869 HQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIE 948 (1017)
Q Consensus 869 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1017)
. .....+.||..|||||+++..+.++|+||||||||+|||+||..||......... | .... ....
T Consensus 265 ~---------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---w--GVGs-NsL~ 329 (904)
T KOG4721|consen 265 K---------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---W--GVGS-NSLH 329 (904)
T ss_pred h---------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---E--eccC-Cccc
Confidence 2 1123478999999999999999999999999999999999999999753221110 0 0000 0000
Q ss_pred hccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccc
Q 043932 949 IVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013 (1017)
Q Consensus 949 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1013 (1017)
-..+..|++.|+-|+++||+..|..||++.+++.||+.+....+
T Consensus 330 ---------------------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 330 ---------------------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred ---------------------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 12345788899999999999999999999999999998876554
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.68 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=207.2
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--------------chHHHHHHHHHHHHhcCCCCcee
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------------GAFKSFMAECKALRNIRHRNLIK 766 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~ 766 (1017)
.+..++|++.+.||+|.||.|-+|++..+++.||||++.+... ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3456789999999999999999999999999999999964321 12357889999999999999999
Q ss_pred eeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCc
Q 043932 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 846 (1017)
Q Consensus 767 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 846 (1017)
++++..+. ..+.+|+|+|||..|.+...=.. ...+++.++++++++++.||+|||.+ |||||||||+|
T Consensus 173 LiEvLDDP---~s~~~YlVley~s~G~v~w~p~d------~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsN 240 (576)
T KOG0585|consen 173 LIEVLDDP---ESDKLYLVLEYCSKGEVKWCPPD------KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSN 240 (576)
T ss_pred EEEeecCc---ccCceEEEEEeccCCccccCCCC------cccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhh
Confidence 99998554 34789999999998877543211 12389999999999999999999999 99999999999
Q ss_pred eEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCC----cCccccchhHHHHHHHHHhCCC
Q 043932 847 VLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE----ASMTGDVYSFGILLLELFTGRR 922 (1017)
Q Consensus 847 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~ 922 (1017)
+|++++|++||+|||.+..+....... ........+|||.|+|||.+.+.. .+.+.||||+||++|.|+.|+.
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~---~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEG---SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccc---cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 999999999999999998764331111 111222368999999999987632 3678899999999999999999
Q ss_pred CCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 923 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
||-+.+.. .-+.+ ++...+. .+...+..+.+.++|.+||++||++|.+..+|.
T Consensus 318 PF~~~~~~----~l~~K---------Ivn~pL~--------------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 318 PFFDDFEL----ELFDK---------IVNDPLE--------------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred CcccchHH----HHHHH---------HhcCccc--------------CCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 99764321 11111 1111000 011124467789999999999999999999998
Q ss_pred HHHhhcc
Q 043932 1003 AKLCHTR 1009 (1017)
Q Consensus 1003 ~~L~~~~ 1009 (1017)
.|..-.+
T Consensus 371 ~Hpwvt~ 377 (576)
T KOG0585|consen 371 LHPWVTR 377 (576)
T ss_pred ecceecc
Confidence 8876544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.90 Aligned_cols=272 Identities=26% Similarity=0.360 Sum_probs=203.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHh--cCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRN--IRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
....+..++||+|+||.||+|+.. ++.||||++...++ +.|++|-++.+. ++|+||++++++-...+.. ...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccc
Confidence 345566789999999999999995 58999999975443 556777776664 4899999999875444333 457
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC------CCCceeecCCCCceEeCCCCCe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC------QPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
+++|+||.+.|+|.+|++.+ .++|.+..+|+..+++||+|||+.. +|+|+|||||++||||..|+++
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 89999999999999999986 7899999999999999999999864 5789999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCCC------cCccccchhHHHHHHHHHhCCCCCCc---
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE------ASMTGDVYSFGILLLELFTGRRPTDA--- 926 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~pf~~--- 926 (1017)
.|+|||+|..+..... .......+||.+|||||++.+.. .-.+.||||+|.|+|||++...-++.
T Consensus 356 cIaDFGLAl~~~p~~~------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v 429 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKP------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV 429 (534)
T ss_pred EeeccceeEEecCCCC------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence 9999999998874432 22333468999999999997742 23468999999999999996554321
Q ss_pred ---------ccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC
Q 043932 927 ---------AFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME 997 (1017)
Q Consensus 927 ---------~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 997 (1017)
.......+.++....+.++....+...+ ........+.+.+..||+.||+.|.|
T Consensus 430 p~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W-----------------~~h~~~~~l~et~EeCWDhDaeARLT 492 (534)
T KOG3653|consen 430 PEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAW-----------------RKHAGMAVLCETIEECWDHDAEARLT 492 (534)
T ss_pred CcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhh-----------------hcCccHHHHHHHHHHHcCCchhhhhh
Confidence 1111222222222222211111111000 00133567889999999999999999
Q ss_pred HHHHHHHHhhcccc
Q 043932 998 MRDVVAKLCHTRET 1011 (1017)
Q Consensus 998 ~~evl~~L~~~~~~ 1011 (1017)
|.=|.+++.++...
T Consensus 493 A~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 493 AGCVEERMAELMML 506 (534)
T ss_pred hHHHHHHHHHHhcc
Confidence 99888888776543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=360.08 Aligned_cols=267 Identities=24% Similarity=0.363 Sum_probs=205.3
Q ss_pred hccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 776 (1017)
.++|++.++||+|+||.||+|.+. .+++.||+|++.... ....+.+.+|+.+++++ +||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 468999999999999999999852 345679999987433 23346788999999999 899999999988543
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCc---------------------------------------------------
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHL--------------------------------------------------- 805 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 805 (1017)
....++||||+++|+|.+++.......
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 245789999999999999997542110
Q ss_pred -----cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCc
Q 043932 806 -----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880 (1017)
Q Consensus 806 -----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 880 (1017)
....+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~------~~ 232 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------VR 232 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch------hc
Confidence 013578889999999999999999999 9999999999999999999999999999765322110 01
Q ss_pred ccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHH
Q 043932 881 SIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVM 959 (1017)
Q Consensus 881 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 959 (1017)
.....++..|+|||++.+..++.++|||||||++|||++ |..||........ ...... ... .
T Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~---~~~-----~-------- 295 (338)
T cd05102 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLK---DGT-----R-------- 295 (338)
T ss_pred ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHh---cCC-----C--------
Confidence 112346788999999998889999999999999999997 9999976322111 100000 000 0
Q ss_pred hhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 960 ANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
......+++.+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 296 ----------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 296 ----------MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00011235678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=328.59 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=209.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..+|++.+.||+|.||+|-+|.....|+.||||.++.. ++.+.-.+.+|+++|..++||||+.++++|... +
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-----d 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-----D 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-----c
Confidence 35789999999999999999999889999999999744 334456788999999999999999999998654 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
...|||||..+|.|++|+...+ .+++.+.+++++||..|+.|+|.+ +|||||||.+|||+|.++.+||+||
T Consensus 127 KIvivMEYaS~GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERG------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence 7999999999999999998775 799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|++-.+... .....++|++-|.+||++.|.+| ++.+|-||+||++|-++.|..||++.... ..+.++..
T Consensus 198 GLSNly~~~---------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-~lvrQIs~ 267 (668)
T KOG0611|consen 198 GLSNLYADK---------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-RLVRQISR 267 (668)
T ss_pred chhhhhccc---------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-HHHHHhhc
Confidence 999877543 33455899999999999999887 57899999999999999999999874221 11112111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
..+.+ | +-+....-+|++|+..+|++|.|+.+|..|..
T Consensus 268 GaYrE-------P----------------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 268 GAYRE-------P----------------------ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ccccC-------C----------------------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11111 0 11334567899999999999999999998864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=330.23 Aligned_cols=288 Identities=22% Similarity=0.316 Sum_probs=214.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCC-ceeeeeeeecCCC-CCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRN-LIKIITICSSIDS-KGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~-~~~ 779 (1017)
...|...++||+|+||+||+|+.+.+|+.||+|.+....+ .......+|+.++++++|+| |+++++++..... .+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4467778899999999999999999999999999986544 34567789999999999999 9999999877532 233
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||++. +|.+++....... ..++...+..+++||+.||+|||++ +|+||||||+||+|+++|.+||+|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 478899999966 9999998765311 2466688999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||+|+.+.-+.. ..+.-++|..|+|||++.+. .|+...||||+|||++||+++++-|++..+.+.....+.
T Consensus 164 FGlAra~~ip~~--------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 164 FGLARAFSIPMR--------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred cchHHHhcCCcc--------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 999986542221 12234689999999999886 689999999999999999999999988755333322222
Q ss_pred HhhcCc--hhhhhccchhhHHHHhhcchhH--HHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhc
Q 043932 939 KIALPE--KVIEIVDPLLLIEVMANNSMIQ--EDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK--LCHT 1008 (1017)
Q Consensus 939 ~~~~~~--~~~~~~d~~l~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 1008 (1017)
....|. .+..+.. ..++......+. ...............+++.+|++++|.+|.||+.+++| +..+
T Consensus 236 ~lGtP~e~~Wp~v~~---~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSS---LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HcCCCCccCCCCccc---cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 222221 1111110 011110001110 11111111122467899999999999999999999987 4443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=310.98 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=213.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++++.||+|.||.||.|+.+.++..||+|++.+.+ ....+++.+|+++-..++||||++++++|.+. .
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-----~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-----K 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-----c
Confidence 568999999999999999999999999999999997553 23457889999999999999999999999765 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+++||..+|++...++..+. .++++.....++.|+|.|+.|+|.+ +|+||||||+|+|++.++..||+||
T Consensus 96 riyLilEya~~gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eeEEEEEecCCchHHHHHHhccc----ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCC
Confidence 79999999999999999985543 3688888999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|.+...+ .......+||..|.|||...+...+..+|+|++|+..||++.|.+||.... .+..+.+..+.
T Consensus 169 GwsV~~p----------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~ 237 (281)
T KOG0580|consen 169 GWSVHAP----------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV 237 (281)
T ss_pred CceeecC----------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc
Confidence 9987543 222334789999999999999999999999999999999999999998764 33333333222
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
.. .+| ...+....++|.+|+..+|.+|.+..|+++|-..
T Consensus 238 ~~-------~~p---------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 238 DL-------KFP---------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred cc-------cCC---------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 11 111 2235567899999999999999999999988543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.26 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=206.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..+.|++.++||+|.|+.||++.+..+|+.+|+|++... .....+.+.+|+.+-+.++||||+++.+.+.+. .
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-----~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----S 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-----c
Confidence 356788899999999999999999999999999998633 233568889999999999999999999987655 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC---CCCCeEE
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVSHV 857 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl 857 (1017)
+.|+|+|+++|++|..-+-.+ ..+++..+-..++||++||.|+|.+ +|||||+||+|+++. ...-+||
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred eeEEEEecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceee
Confidence 889999999999988655433 2678888999999999999999999 999999999999994 3457999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||+|...... ....+++|||+|||||+++..+|+..+|||+.|||+|-++.|.+||.+.... ..++++
T Consensus 155 ~~FGvAi~l~~g---------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I 224 (355)
T KOG0033|consen 155 ADFGLAIEVNDG---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQI 224 (355)
T ss_pred cccceEEEeCCc---------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHH
Confidence 999999876522 2334578999999999999999999999999999999999999999874322 111111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.+..+. + + ...+....++.++++++|+..||.+|.|+.|.+.|-.
T Consensus 225 ~~g~yd-----~-~------------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 225 KAGAYD-----Y-P------------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred hccccC-----C-C------------------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 111110 0 0 0122344667789999999999999999999987643
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=379.34 Aligned_cols=484 Identities=27% Similarity=0.334 Sum_probs=401.0
Q ss_pred EEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccc
Q 043932 106 INLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYL 185 (1017)
Q Consensus 106 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 185 (1017)
+|+++.+++ .||.-+..-..++.|+++.|.+-...-+.+.+..+|+.|||++|+++ ..|..+..+.+|+.|.++.|.+
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 566777776 67777666656888888888776322334455666999999999887 7888888889999999999998
Q ss_pred cCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchh
Q 043932 186 TGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDI 265 (1017)
Q Consensus 186 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~ 265 (1017)
. ..|.+.+++.+|++|.|.+|.+. ..|.++..+++|+.|+++.|++. .+|..+..++.++.+..++|.....++.
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~-- 155 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ-- 155 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc--
Confidence 8 67788889999999999999886 78899999999999999999987 8899999999999999999933223332
Q ss_pred hccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhc
Q 043932 266 VVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLT 345 (1017)
Q Consensus 266 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~ 345 (1017)
..++.+++..|.+.+.++..+..+.. .|||++|.+. ...+..+.+|+.|..+.|+++....
T Consensus 156 ----~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~---------- 216 (1081)
T KOG0618|consen 156 ----TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI---------- 216 (1081)
T ss_pred ----ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe----------
Confidence 23889999999999988888888777 7999999987 4567888999999999999976543
Q ss_pred ccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccc
Q 043932 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQG 425 (1017)
Q Consensus 346 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 425 (1017)
.-++|+.|+.++|.++...+ ...+.+++.+++++|++++.+ ++++.+.+|+.|+..+|+|+ ..|..+..+++|+.
T Consensus 217 ~g~~l~~L~a~~n~l~~~~~---~p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~ 291 (1081)
T KOG0618|consen 217 SGPSLTALYADHNPLTTLDV---HPVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVS 291 (1081)
T ss_pred cCcchheeeeccCcceeecc---ccccccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHH
Confidence 35789999999999984333 234567999999999999765 99999999999999999996 88999999999999
Q ss_pred eeccccccccccCcccccccccceeeccCcccCCCCcccc-ccccC-CceeecCCCcccCCccchhhhcccccceeccCC
Q 043932 426 LFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSL-GNCQN-LIGFNASHNKLTGALPQQLLSITTLSVYLDLSN 503 (1017)
Q Consensus 426 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~-L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~ 503 (1017)
|....|.++ -+|.....++.|++|+|..|+|. ..|+.+ .-+.. |..|+.+.|++. ..|..-......++.|.|.+
T Consensus 292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~Lylan 368 (1081)
T KOG0618|consen 292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLAN 368 (1081)
T ss_pred HHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhc
Confidence 999999999 78888888999999999999999 555543 33333 788999999998 55533222334445799999
Q ss_pred CcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCCh
Q 043932 504 NNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIP 583 (1017)
Q Consensus 504 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 583 (1017)
|.++...-..+.+.+.|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|+++..++.|++|...+|+|. ..|
T Consensus 369 N~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 369 NHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred CcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 9999887777899999999999999999655566899999999999999999 67899999999999999999999 677
Q ss_pred hhhcccCCCcEEEcccCCCcC-cCCCCCCCCCCCcccccCcccc
Q 043932 584 EFLENLSFLEFLNFSHNDLEG-EVPTKGVFSSKTKLSLQGNVKL 626 (1017)
Q Consensus 584 ~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~~~~~~~~n~~~ 626 (1017)
.+..++.|+++|+|.|+|+- .+|.......++.+++.||+|+
T Consensus 447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 78999999999999999986 4444445578999999999974
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=344.63 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=213.3
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|..++++|+|+||.++.++++.+++.||+|.+..... .......+|+.++++++|||||.+.+.|... ....
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~----~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED----GQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC----CceE
Confidence 578899999999999999999999999999999986543 3344678999999999999999999988654 2348
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
+|||+||+||++.+.+.+.++ ..++++.+..++.|++.|+.|||++ +|+|||||+.|||++.++.+||+|||+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence 999999999999999988753 4789999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
|+...... .....++||+.||+||.+.+.+|..|+||||+||++|||++-+++|.+..............
T Consensus 153 aK~l~~~~--------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-- 222 (426)
T KOG0589|consen 153 AKILNPED--------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-- 222 (426)
T ss_pred hhhcCCch--------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--
Confidence 99876543 12334789999999999999999999999999999999999999998753322111111000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..+....+..++..++..|++.+|..||++.+++.+
T Consensus 223 --------------------------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 --------------------------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --------------------------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 012233457789999999999999999999999887
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=358.62 Aligned_cols=271 Identities=25% Similarity=0.415 Sum_probs=220.1
Q ss_pred CcCHHHHHHhhc---------cccccCcccccCCceEEEEEeCCCc---EEEEEEEeeecCc-chHHHHHHHHHHHHhcC
Q 043932 694 TVSYAELSKATS---------EFASSNMIGQGSFGSVYKGILGEDE---MIVAVKVINLKQK-GAFKSFMAECKALRNIR 760 (1017)
Q Consensus 694 ~~~~~~~~~~~~---------~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~ 760 (1017)
..+|+|..++.. ...+.++||.|.||+||+|+.+..+ ..||||.++.... ....+|..|+.+|.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 455665444443 3456789999999999999997655 5699999986543 45678999999999999
Q ss_pred CCCceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceee
Q 043932 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHG 840 (1017)
Q Consensus 761 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 840 (1017)
||||+++.|+.... .-++||+|||++|+|+.|++.+.+ .+++.+...+.++||.||+||-+. ++|||
T Consensus 689 HPNIIrLEGVVTks-----~PvMIiTEyMENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsdm---~YVHR 755 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKS-----KPVMIITEYMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSDM---NYVHR 755 (996)
T ss_pred CCcEEEEEEEEecC-----ceeEEEhhhhhCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhhc---Cchhh
Confidence 99999999998665 568999999999999999998865 789999999999999999999999 99999
Q ss_pred cCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-
Q 043932 841 DLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT- 919 (1017)
Q Consensus 841 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt- 919 (1017)
||.++||||+.+-.+|++|||+++...++. ....... +-.-+.+|.|||.+...+++.++||||||++|||.++
T Consensus 756 DLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~----GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSy 830 (996)
T KOG0196|consen 756 DLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTL----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 830 (996)
T ss_pred hhhhhheeeccceEEEeccccceeecccCC-Ccccccc----CCccceeecChhHhhhcccCchhhccccceEEEEeccc
Confidence 999999999999999999999999775443 1111111 1123578999999999999999999999999999988
Q ss_pred CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 920 GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 920 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
|..||.....++.......... -+.+.+|+..|.+||..||++|-.+||.+.
T Consensus 831 GERPYWdmSNQdVIkaIe~gyR----------------------------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~ 882 (996)
T KOG0196|consen 831 GERPYWDMSNQDVIKAIEQGYR----------------------------LPPPMDCPAALYQLMLDCWQKDRNRRPKFA 882 (996)
T ss_pred CCCcccccchHHHHHHHHhccC----------------------------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHH
Confidence 9999987544321111111111 123457899999999999999999999999
Q ss_pred HHHHHHhhccc
Q 043932 1000 DVVAKLCHTRE 1010 (1017)
Q Consensus 1000 evl~~L~~~~~ 1010 (1017)
||+..|.++-.
T Consensus 883 qiV~~lDklIr 893 (996)
T KOG0196|consen 883 QIVSTLDKLIR 893 (996)
T ss_pred HHHHHHHHHhc
Confidence 99999988654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=353.20 Aligned_cols=283 Identities=23% Similarity=0.268 Sum_probs=204.6
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.++||+|+||.||+|++..++..||||++... ......++.+|++++++++||||+++++++...........|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999999999999999998642 223345688999999999999999999988655444445689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||++ ++|.+++.... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 9999995 69999987653 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccC--CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+........ ........||+.|+|||++.+ ..++.++||||+||++|||++|++||....... .........
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~ 224 (338)
T cd07859 151 RVAFNDTPT-----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLL 224 (338)
T ss_pred cccccccCc-----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHh
Confidence 754321110 111123568999999999866 578999999999999999999999997642210 111111100
Q ss_pred c--CchhhhhccchhhHHHHhhcc-hhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 L--PEKVIEIVDPLLLIEVMANNS-MIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~--~~~~~~~~d~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. +......+.......+..... .............++.+.+++.+||+.||++|||++|++++
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 000000000000000000000 00000011112345678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.39 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=202.1
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 778 (1017)
..++|...++||+|+||+|++|..+.+++.+|||++++.. .++.+..+.|-+++... +||.++.++..|.+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~---- 441 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK---- 441 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC----
Confidence 3568999999999999999999999999999999998653 45677888899998877 599999999998776
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+++|+||||+.||++..+.+. ..+++..++-+|..|+.||+|||++ +|||||||.+|||+|.+|++||+
T Consensus 442 -~~l~fvmey~~Ggdm~~~~~~-------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 442 -EHLFFVMEYVAGGDLMHHIHT-------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred -CeEEEEEEecCCCcEEEEEec-------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence 889999999999995444332 3799999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||+++.--- ......+++||+.|||||++.+..|+.++|.|||||+||||+.|..||.++.+++. ...+.
T Consensus 511 DFGlcKe~m~--------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-FdsI~ 581 (694)
T KOG0694|consen 511 DFGLCKEGMG--------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-FDSIV 581 (694)
T ss_pred ccccccccCC--------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHh
Confidence 9999984321 22234568999999999999999999999999999999999999999987644311 11111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM 998 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 998 (1017)
. + + ...+.-++.+...++++++..+|++|.-+
T Consensus 582 ~----d------------~------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 N----D------------E------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred c----C------------C------------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 0 0 0 01122336678899999999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=341.58 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=200.6
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
|+..+.||+|+||+||+|.+..+++.||+|++.... ......+.+|++++++++|++|+++++++... +..+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeEE
Confidence 677889999999999999999999999999986432 22234577899999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 77 lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred EEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999988865321 2688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
....... ......||..|+|||++.+..++.++||||+||++|||++|+.||........ ....... ..
T Consensus 150 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~-~~ 218 (285)
T cd05631 150 VQIPEGE---------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRR-VK 218 (285)
T ss_pred EEcCCCC---------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHH-hh
Confidence 7653221 11224689999999999998999999999999999999999999976432111 0111000 00
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1004 (1017)
.. ........++.+.+++.+||+.||.+||+ ++|++++
T Consensus 219 ~~-----------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 ED-----------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cc-----------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 00 00111223567889999999999999997 8888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.60 Aligned_cols=259 Identities=25% Similarity=0.331 Sum_probs=210.8
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--------chHHHHHHHHHHHHhc-CCCCceeeeee
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFKSFMAECKALRNI-RHRNLIKIITI 770 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~ 770 (1017)
.......|...+.+|+|..++|.++.++.++..+|+|++..... ...+.-.+|+.+++++ .||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 34455678888999999999999999999999999999974321 1234566899999999 69999999999
Q ss_pred eecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 771 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
|... .+.++|+|.++.|.|.||+... ..+++.+.++|++|+.+|++|||.+ .|||||+||+||+++
T Consensus 92 yes~-----sF~FlVFdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILld 157 (411)
T KOG0599|consen 92 YESD-----AFVFLVFDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLD 157 (411)
T ss_pred ccCc-----chhhhhhhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeec
Confidence 8766 7899999999999999999865 4899999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCccccc------CCCcCccccchhHHHHHHHHHhCCCCC
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM------GSEASMTGDVYSFGILLLELFTGRRPT 924 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf 924 (1017)
++.++||+|||+|+.+.+++ .....+|||+|.|||.+. ...|+..+|+||+|||+|.++.|.+||
T Consensus 158 dn~~i~isDFGFa~~l~~Ge---------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPGE---------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred cccceEEeccceeeccCCch---------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 99999999999999776433 333478999999999883 235889999999999999999999999
Q ss_pred CcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 925 DAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....+ -..+.-..... .+...+.+.+.....++++.+|++.||.+|.|++|+++|
T Consensus 229 wHRkQ-mlMLR~ImeGk------------------------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 229 WHRKQ-MLMLRMIMEGK------------------------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hHHHH-HHHHHHHHhcc------------------------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 65211 00111110000 011123456667889999999999999999999999987
Q ss_pred Hh
Q 043932 1005 LC 1006 (1017)
Q Consensus 1005 L~ 1006 (1017)
-.
T Consensus 284 pf 285 (411)
T KOG0599|consen 284 PF 285 (411)
T ss_pred hH
Confidence 43
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=342.85 Aligned_cols=277 Identities=22% Similarity=0.302 Sum_probs=202.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.++||+|+||+||+|++..+++.||+|+++.... .....+.+|++++++++||||+++++++... +..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-----RCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeE
Confidence 3579999999999999999999999999999999874432 2345678999999999999999999988654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++ +|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence 999999975 99999876542 578899999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++...... .......|++.|+|||++.+ ..++.++||||+||++|||++|++||......+. ........
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~ 220 (288)
T cd07871 150 ARAKSVPT--------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLL 220 (288)
T ss_pred eeeccCCC--------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence 87543211 11122467999999998865 5689999999999999999999999976432211 11111111
Q ss_pred c---CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 L---PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. ++....+.+...............+. .........+..+++.+|+++||.+|||++|+++|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 221 GTPTEETWPGITSNEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CCCChHHhhccccchhhhccccCccCCCch-HHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1 11111111110000000000000000 00111234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=371.99 Aligned_cols=268 Identities=25% Similarity=0.430 Sum_probs=215.9
Q ss_pred ccccccCcccccCCceEEEEEeCCC-----cEEEEEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGED-----EMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
...+..+.||+|.||.||.|...+. ...||||.++.. +.....+|.+|..+|+.++|||||+++|+|.+.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~---- 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS---- 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC----
Confidence 3456678999999999999998643 234899988754 345668899999999999999999999999764
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCC-CccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSND-HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
...+|++|||++|+|..|+++.+. ......++..+.+.++.|||+|+.||+++ ++|||||..+|+|++....|||
T Consensus 768 -~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 768 -GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred -CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence 557899999999999999998632 22345799999999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~ 936 (1017)
+|||+|+.+...++...... -.-...|||||.++...++.|+|||||||++||++| |..||......+... .
T Consensus 844 aDFGlArDiy~~~yyr~~~~------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~-~ 916 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGE------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL-D 916 (1025)
T ss_pred cccchhHhhhhchheeccCc------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-H
Confidence 99999996554443322211 123468999999999999999999999999999999 999997643321110 0
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccccc
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1014 (1017)
+.. .. .-..+..|++.++++|.+||+.+|++||++..+++.+..+.+.+.+
T Consensus 917 ~~~---------------------gg------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 917 VLE---------------------GG------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred HHh---------------------CC------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 100 00 1123456899999999999999999999999999999988876554
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=342.12 Aligned_cols=278 Identities=22% Similarity=0.279 Sum_probs=203.9
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++... +..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-----GKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-----CEE
Confidence 36899999999999999999999999999999987542 23346778999999999999999999988654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||++++.+..+.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred EEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 9999999987776554332 2688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh--
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI-- 940 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-- 940 (1017)
+........ .......||+.|+|||++.+..++.++||||+||++|||++|++||......+. .......
T Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~ 218 (287)
T cd07848 147 ARNLSEGSN-------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLG 218 (287)
T ss_pred ccccccccc-------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhC
Confidence 986532211 111234689999999999888899999999999999999999999976432111 1111111
Q ss_pred hcCchhhhhc--cchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIV--DPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~--d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..+....... ++........................+..+.+++.+||+.||++|||++|+++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 219 PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred CCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111100000 000000000000000000011122356779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.46 Aligned_cols=274 Identities=24% Similarity=0.372 Sum_probs=218.8
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHh--cCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRN--IRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
...+.+..+.||+|.||+||+|.++ |+.||||++...++ +.+.+|.++++. ++|+||+.+++.-... .....
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~T 282 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWT 282 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccC-CCceE
Confidence 4457788899999999999999997 77899999986654 345567776664 4999999999874332 23346
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhC-----CCCCceeecCCCCceEeCCCCCe
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH-----CQPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
..|+|++|.+.|||+||+.+. .++....++++..+|.||+|||.. .+|.|+|||||+.||||..++.+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 789999999999999999875 789999999999999999999975 36899999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCC------CcCccccchhHHHHHHHHHhC---------
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS------EASMTGDVYSFGILLLELFTG--------- 920 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg--------- 920 (1017)
.|+|+|+|......... ........+||.+|||||++... +....+||||||.|+||+...
T Consensus 356 ~IADLGLAv~h~~~t~~----idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDT----IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred EEeeceeeEEecccCCc----ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 99999999876543211 12223346899999999999653 123468999999999999763
Q ss_pred -CCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 921 -RRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 921 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
+.||....+.+.+++++.+...-+++...++..+ ...++...+.++|+.||..+|.-|-||=
T Consensus 432 y~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW-----------------~s~~~l~~m~klMkeCW~~Np~aRltAL 494 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW-----------------KSDPALRVMAKLMKECWYANPAARLTAL 494 (513)
T ss_pred hcCCcccCCCCCCCHHHHhcceeecccCCCCCccc-----------------ccCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence 4688877777788888877766655544444333 2335677899999999999999999999
Q ss_pred HHHHHHhhccc
Q 043932 1000 DVVAKLCHTRE 1010 (1017)
Q Consensus 1000 evl~~L~~~~~ 1010 (1017)
.+-+.|.++.+
T Consensus 495 riKKtl~~l~~ 505 (513)
T KOG2052|consen 495 RIKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHHhc
Confidence 99888887764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=345.15 Aligned_cols=276 Identities=22% Similarity=0.341 Sum_probs=207.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||.||+|++..++..||+|++..... ...+++.+|++++++++||||+++++++... +..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence 4689999999999999999999999999999999975433 3346789999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 99999999999999997653 5789999999999999999999852 699999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... +........
T Consensus 151 ~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~ 218 (331)
T cd06649 151 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPV 218 (331)
T ss_pred cccccccc----------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccc
Confidence 87553211 122468999999999999889999999999999999999999996532211 111111000
Q ss_pred Cch---hhhhc----------------c--chh-hHHHHhhcchhHHHhHH-hHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 943 PEK---VIEIV----------------D--PLL-LIEVMANNSMIQEDIRA-KTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 943 ~~~---~~~~~----------------d--~~l-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
... ..... + +.. ..+... ......... ....+++++.+++.+||++||++|||+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ 296 (331)
T cd06649 219 VDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLD--YIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLK 296 (331)
T ss_pred cccccCCccccCcccccccccccccccccccchhHHHHHH--HHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHH
Confidence 000 00000 0 000 000000 000000000 0112467799999999999999999999
Q ss_pred HHHHHHh
Q 043932 1000 DVVAKLC 1006 (1017)
Q Consensus 1000 evl~~L~ 1006 (1017)
|++++-.
T Consensus 297 ell~h~~ 303 (331)
T cd06649 297 MLMNHTF 303 (331)
T ss_pred HHhcChH
Confidence 9998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=343.95 Aligned_cols=247 Identities=23% Similarity=0.298 Sum_probs=201.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+. +.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----Ce
Confidence 36889999999999999999999899999999987432 22345688999999999999999999887543 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 899999999999999997654 688899999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......
T Consensus 147 ~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i 210 (291)
T cd05612 147 FAKKLRDR-----------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKI 210 (291)
T ss_pred cchhccCC-----------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence 98765321 11246899999999999988999999999999999999999999753211 100000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAKL 1005 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 1005 (1017)
.... . .........+.+++.+||+.||.+||+ ++|+++|-
T Consensus 211 ~~~~-----------------~-------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 211 LAGK-----------------L-------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred HhCC-----------------c-------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 0000 0 001112456789999999999999995 89988774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=347.72 Aligned_cols=243 Identities=23% Similarity=0.306 Sum_probs=196.9
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
++||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++... +..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999997432 23445678899999999999999999988654 67899999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
|+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999999999987653 688999999999999999999999 99999999999999999999999999987432
Q ss_pred cccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhh
Q 043932 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVI 947 (1017)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 947 (1017)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus 147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~~~~~~~~- 212 (323)
T cd05571 147 SDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEI- 212 (323)
T ss_pred cCC--------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcCCC-
Confidence 111 1122356999999999999989999999999999999999999999653211 11110000000
Q ss_pred hhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 948 EIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 948 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
......++++.+++.+||+.||++|| ++.|+++|
T Consensus 213 -----------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 -----------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 00112356688999999999999999 79998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.05 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=199.8
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecCcch---HHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
..||+|++|.||+|.+ +|+.||||++....... .+.+.+|+.++++++||||+++++++.+.. .+....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5799999999999998 58899999997543332 467889999999999999999999986521 22356899999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
|+++|+|.+++.... .+++.....++.|++.|++|||+.. +++||||||+||+++.++.+||+|||+++...
T Consensus 103 y~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 103 YCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred eCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 999999999997653 6789999999999999999999732 78899999999999999999999999987653
Q ss_pred cccccccccCCCcccccccCccccCcccccC--CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCch
Q 043932 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ..........+.
T Consensus 175 ~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~- 241 (283)
T PHA02988 175 SPP-----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-IYDLIINKNNSL- 241 (283)
T ss_pred ccc-----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcCCCC-
Confidence 211 12357899999999976 678999999999999999999999997542110 000000000000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
.....+++.+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 242 -------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 -------------------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -------------------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0011346779999999999999999999999999988754
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=347.10 Aligned_cols=278 Identities=23% Similarity=0.293 Sum_probs=209.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-C-----CCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-H-----RNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~ 777 (1017)
..+|.+.++||+|+||.|.+|.+..+++.||||+++.. +....+...|+.+|..++ | -|+|+++++|...
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--- 260 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--- 260 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc---
Confidence 34899999999999999999999999999999999743 344466778999999996 4 3999999998765
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC--CCe
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD--MVS 855 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~ 855 (1017)
++.|||+|.++. +|+++++.+. ...++...++.|+.||+.||.+||+. +|||+||||||||+.+. ..+
T Consensus 261 --~HlciVfELL~~-NLYellK~n~----f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 261 --NHLCIVFELLST-NLYELLKNNK----FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred --cceeeeehhhhh-hHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCce
Confidence 889999999955 9999999874 34799999999999999999999999 99999999999999654 479
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHH
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 935 (1017)
||+|||.|++....- ..+..+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.... .++.
T Consensus 331 KVIDFGSSc~~~q~v-----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~-DQl~ 398 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRV-----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY-DQLA 398 (586)
T ss_pred eEEecccccccCCcc-----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH-HHHH
Confidence 999999998765322 1356788999999999999999999999999999999999888875432 2222
Q ss_pred HHHHhh--cCchhhhh-------ccc-hhhHH----HH-----------h-----hcchhHH----HhHHhHH-HHHHHH
Q 043932 936 EFAKIA--LPEKVIEI-------VDP-LLLIE----VM-----------A-----NNSMIQE----DIRAKTQ-ECLNAI 980 (1017)
Q Consensus 936 ~~~~~~--~~~~~~~~-------~d~-~l~~~----~~-----------~-----~~~~~~~----~~~~~~~-~~~~~l 980 (1017)
.+.... .+..+.+. ++. ..... .. . ......+ ....... .....+
T Consensus 399 ~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F 478 (586)
T KOG0667|consen 399 RIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLF 478 (586)
T ss_pred HHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHH
Confidence 222221 11111111 111 00000 00 0 0000000 1111111 345678
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 981 IRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 981 ~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
.+++.+|+.+||.+|+|+.|+++|-.-
T Consensus 479 ~dflk~~L~~dP~~R~tp~qal~Hpfl 505 (586)
T KOG0667|consen 479 IDFLKRCLEWDPAERITPAQALNHPFL 505 (586)
T ss_pred HHHHHHHhccCchhcCCHHHHhcCccc
Confidence 999999999999999999999987543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.59 Aligned_cols=278 Identities=22% Similarity=0.333 Sum_probs=202.3
Q ss_pred ccccccCcccccCCceEEEEEeCC-CcEEEEEEEeeecC--cchHHHHHHHHHHHHhc---CCCCceeeeeeeecCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGE-DEMIVAVKVINLKQ--KGAFKSFMAECKALRNI---RHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 778 (1017)
.+|++.+.||+|+||+||+|++.. +++.||+|++.... ......+.+|+.+++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999999854 57889999987433 22234566777777665 6999999999986544444
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
....++||||++ ++|.+++..... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 467899999996 599999876432 3588999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|++||......+ .+....
T Consensus 153 Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~ 222 (290)
T cd07862 153 DFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKIL 222 (290)
T ss_pred cccceEeccCCc---------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH
Confidence 999997653221 1123468999999999988889999999999999999999999997643221 111111
Q ss_pred Hhhc---CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIAL---PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... ++....... ....... .............+++.+.+++.+|++.||++|||+.|+++|
T Consensus 223 ~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 223 DVIGLPGEEDWPRDVA--LPRQAFH--SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HHhCCCChhhchhhhc--ccchhcc--CCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 1111 111000000 0000000 000001111122346678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.15 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=204.3
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++... +.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-----EY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-----CE
Confidence 36899999999999999999999899999999997442 23446788999999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence 899999999999999997653 678999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++..... ......||+.|+|||++.+..++.++||||+||++|||++|..||......+ ........
T Consensus 147 ~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~- 213 (333)
T cd05600 147 LSKGIVT-----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKYW- 213 (333)
T ss_pred CCccccc-----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHhc-
Confidence 9975432 1123568999999999999899999999999999999999999997542211 01110000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... ..+.. ......+++++.+++.+|+..+|.+||++.|++++
T Consensus 214 -~~~~---~~~~~---------------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 214 -KETL---QRPVY---------------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -cccc---cCCCC---------------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000 00000 00001335678899999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.19 Aligned_cols=277 Identities=21% Similarity=0.306 Sum_probs=201.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++... +..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-----CeE
Confidence 4689999999999999999999998999999999874432 2234677899999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||++ ++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 99999995 588888876532 678899999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.................
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 221 (303)
T cd07869 150 ARAKSVPS--------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221 (303)
T ss_pred ceeccCCC--------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 87543211 11122468999999999866 4578899999999999999999999976432211111111111
Q ss_pred cCchhhhhcc----chhhHHHHhhcchhHHHhHHh--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVD----PLLLIEVMANNSMIQEDIRAK--TQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d----~~l~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.......+.. +....+...... ....... ....++.+.+++.+|++.||++|||+.|+++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 222 GTPNEDTWPGVHSLPHFKPERFTLYS--PKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred CCCChhhccchhhccccccccccccC--CccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 1000000000 000000000000 0000000 01123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.28 Aligned_cols=247 Identities=23% Similarity=0.293 Sum_probs=201.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++... +
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----N 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----C
Confidence 357899999999999999999999999999999997432 23346788999999999999999999988654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence 7899999999999999998654 678889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+...
T Consensus 163 g~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i 227 (329)
T PTZ00263 163 GFAKKVPDRT-----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYEKI 227 (329)
T ss_pred cCceEcCCCc-----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHHHHH
Confidence 9997653211 1246899999999999988999999999999999999999999653211 111100
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1004 (1017)
.... . .....++..+.+++.+||+.||.+||+ +.++++|
T Consensus 228 -~~~~--------~----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 228 -LAGR--------L----------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -hcCC--------c----------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0000 0 000012456789999999999999997 6888866
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.01 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=209.0
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCc----EEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeec
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDE----MIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
+-.-++....++||+|.||.||+|+....+ ..||||..+.. .....+++.+|+++|+.++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 333445566799999999999999986532 23899998752 35667899999999999999999999999876
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
. .-+++|||+|.||+|.+|++.... .++..++..++.++|.||+|||++ +++||||..+|+|++.++
T Consensus 233 ~-----~Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 233 E-----EPLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKG 299 (474)
T ss_pred C-----CccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCC
Confidence 5 558999999999999999998763 689999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGL 932 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 932 (1017)
.+||+|||+++.......... ...-+.+|+|||.+....|++++|||||||++||+++ |..||.+....
T Consensus 300 ~vKISDFGLs~~~~~~~~~~~--------~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-- 369 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYVMKKF--------LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-- 369 (474)
T ss_pred eEEeCccccccCCcceeeccc--------cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--
Confidence 999999999875431111110 0124678999999999999999999999999999999 88898764322
Q ss_pred cHHHHH-HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 933 TLHEFA-KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 933 ~~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
.....+ ....+ + ......+..+..++.+||..||++||+|.++.+.++.+...
T Consensus 370 ~v~~kI~~~~~r--------------------~------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 370 EVKAKIVKNGYR--------------------M------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HHHHHHHhcCcc--------------------C------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 111111 10010 0 01113467788899999999999999999999999987654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=349.16 Aligned_cols=264 Identities=22% Similarity=0.374 Sum_probs=203.8
Q ss_pred hccccccCcccccCCceEEEEEe-----CCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 776 (1017)
.++|++.++||+|+||.||+|++ .+++..||||+++... ....+.+.+|+++++.+ +||||++++++|...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 45799999999999999999974 3456789999986433 23446788999999999 899999999998655
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCC----------------------------------------------------
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDH---------------------------------------------------- 804 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 804 (1017)
+..++||||+++|+|.++++.....
T Consensus 112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 5689999999999999999754310
Q ss_pred -----------------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 805 -----------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 805 -----------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
.+...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0112578899999999999999999999 99999999999999999999999999997654
Q ss_pred cccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchh
Q 043932 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ............
T Consensus 266 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~-- 336 (375)
T cd05104 266 NDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRM-- 336 (375)
T ss_pred Cccccc------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccC--
Confidence 322100 0111235678999999999899999999999999999998 888986532211 111111100000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
......+.++.+++.+||+.||++||++.||++.|++.
T Consensus 337 ------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 ------------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00011245789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=338.36 Aligned_cols=269 Identities=22% Similarity=0.358 Sum_probs=201.6
Q ss_pred hccccccCcccccCCceEEEEEeCC----------------CcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE----------------DEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIK 766 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 766 (1017)
.++|++.++||+|+||.||+|.+.. ++..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578999999999999999998632 34579999987543 233467889999999999999999
Q ss_pred eeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCC-------------ccccccCHHHHHHHHHHHHHHHHHHhhCC
Q 043932 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH-------------LEVCKLTLIQRVNIAIDVASAIEYLHHHC 833 (1017)
Q Consensus 767 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 833 (1017)
+++++... +..++||||+++|+|.+++...... .....+++.++..++.||+.||+|||+.
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~- 157 (304)
T cd05096 84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL- 157 (304)
T ss_pred EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 99998654 5689999999999999998654211 1113578889999999999999999999
Q ss_pred CCCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHH
Q 043932 834 QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGIL 913 (1017)
Q Consensus 834 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 913 (1017)
+|+||||||+||+++.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||++
T Consensus 158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 229 (304)
T cd05096 158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR------IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT 229 (304)
T ss_pred --CccccCcchhheEEcCCccEEECCCccceecccCceeE------ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHH
Confidence 99999999999999999999999999997654322111 1112345788999999988889999999999999
Q ss_pred HHHHHh--CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCC
Q 043932 914 LLELFT--GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMES 991 (1017)
Q Consensus 914 l~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 991 (1017)
+|||++ +..||...... ................. .......++..+.+++.+||+.|
T Consensus 230 l~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~li~~cl~~~ 288 (304)
T cd05096 230 LWEILMLCKEQPYGELTDE--QVIENAGEFFRDQGRQV-------------------YLFRPPPCPQGLYELMLQCWSRD 288 (304)
T ss_pred HHHHHHccCCCCCCcCCHH--HHHHHHHHHhhhccccc-------------------cccCCCCCCHHHHHHHHHHccCC
Confidence 999987 55677543211 11110000000000000 00011234677899999999999
Q ss_pred CCCCCCHHHHHHHHhh
Q 043932 992 PFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 992 P~~RPs~~evl~~L~~ 1007 (1017)
|++|||+.||.+.|++
T Consensus 289 p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 289 CRERPSFSDIHAFLTE 304 (304)
T ss_pred chhCcCHHHHHHHHhC
Confidence 9999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=347.19 Aligned_cols=266 Identities=22% Similarity=0.362 Sum_probs=204.5
Q ss_pred hhccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSSID 775 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 775 (1017)
..++|++.+.||+|+||.||+|++.. ++..||+|++.... ....+.+.+|+++++.+ +|+||++++++|...
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~- 114 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG- 114 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence 45589999999999999999998643 33579999997443 23346788999999999 899999999998654
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCC---------------------------------------------------
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDH--------------------------------------------------- 804 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 804 (1017)
+..++||||+++|+|.+++......
T Consensus 115 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 115 ----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 5689999999999999998653210
Q ss_pred -------------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccc
Q 043932 805 -------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQL 871 (1017)
Q Consensus 805 -------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 871 (1017)
....++++.++++++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 0123578899999999999999999999 999999999999999999999999999976532211
Q ss_pred cccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchhhhhc
Q 043932 872 DTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIEIV 950 (1017)
Q Consensus 872 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1017)
. .......++..|+|||++.+..++.++|||||||++|||++ |+.||........ ............
T Consensus 268 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~~~~~----- 335 (374)
T cd05106 268 Y------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRGYQMS----- 335 (374)
T ss_pred e------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcccCcc-----
Confidence 0 01111235678999999988899999999999999999997 9999976422211 111111000000
Q ss_pred cchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 951 DPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 951 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
.....++++.+++.+||+.||++||++.+|++.|+++.
T Consensus 336 ---------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 ---------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00112467899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=342.18 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=196.2
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
+.||+|+||.||+|++..+++.||+|++... .......+.+|+++++.++||||+++++++... +..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence 4699999999999999999999999999743 223445677899999999999999999988654 67899999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
|+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999999999887653 688999999999999999999999 99999999999999999999999999987432
Q ss_pred cccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhh
Q 043932 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVI 947 (1017)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 947 (1017)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus 147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~~- 212 (323)
T cd05595 147 SDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEEI- 212 (323)
T ss_pred CCC--------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCC-
Confidence 111 1112356899999999999889999999999999999999999999653221 11000000000
Q ss_pred hhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 948 EIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 948 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
.....+++++.+++.+||+.||++|| ++.+++++
T Consensus 213 -----------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 -----------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 00112356788999999999999998 89888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=340.18 Aligned_cols=201 Identities=25% Similarity=0.405 Sum_probs=175.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.++||+|+||.||+|++..++..+|+|++..... ...+.+.+|++++++++||||++++++|... ++.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence 4689999999999999999999999999999999875432 3346788999999999999999999998765 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++|+|.+++.... .+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 99999999999999997653 5788899999999999999999742 699999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
+....... .....||..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 151 ~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 151 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred chhhhhhc----------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 87553211 11246899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=345.65 Aligned_cols=272 Identities=19% Similarity=0.203 Sum_probs=200.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
.+|++.+.||+|+||.||+|.+..+++.||+|... .+.+.+|++++++++||||+++++++... ...++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYN-----KFTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----CeeEE
Confidence 57999999999999999999999999999999753 24567899999999999999999998654 66899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
|+|++. ++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 161 v~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred EEecCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 999995 68998887643 578999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCccccc------CccHHHHH
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTE------GLTLHEFA 938 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~------~~~~~~~~ 938 (1017)
...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+....
T Consensus 231 ~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~ 303 (391)
T PHA03212 231 FPVDIN-------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303 (391)
T ss_pred cccccc-------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH
Confidence 532211 11122357999999999999889999999999999999999999887543211 11111111
Q ss_pred Hhhc--CchhhhhccchhhHHH---HhhcchhH--HHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIAL--PEKVIEIVDPLLLIEV---MANNSMIQ--EDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~--~~~~~~~~d~~l~~~~---~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... +..............+ ........ ........+.+.++.+++.+||+.||++|||++|++++
T Consensus 304 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 1111 1000000000000000 00000000 00001122456788999999999999999999999865
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=348.86 Aligned_cols=260 Identities=21% Similarity=0.302 Sum_probs=199.0
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+. ++.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CEE
Confidence 5888999999999999999999999999999997542 23446788999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 99999999999999997653 678889999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccc---------------------------------------ccCCCcccccccCccccCcccccCCCcCc
Q 043932 863 AKFLSSHQLDTA---------------------------------------SKTSSSSIGIKGTVGYVAPEYCMGSEASM 903 (1017)
Q Consensus 863 a~~~~~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 903 (1017)
++.+........ ...........||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 864321100000 00000112357999999999999888999
Q ss_pred cccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHH
Q 043932 904 TGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRI 983 (1017)
Q Consensus 904 ~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 983 (1017)
++||||+||++|||++|+.||.......... ... ...... .. .....+++++.++
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~-~i~--~~~~~~-~~---------------------~~~~~~s~~~~dl 282 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQL-KVI--NWENTL-HI---------------------PPQVKLSPEAVDL 282 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHH-HHH--cccccc-CC---------------------CCCCCCCHHHHHH
Confidence 9999999999999999999997643211100 000 000000 00 0001124566778
Q ss_pred Hhh--ccCCCCCCCCCHHHHHHH
Q 043932 984 GVL--CSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 984 i~~--cl~~dP~~RPs~~evl~~ 1004 (1017)
+.+ |+..+|.+||++.|+++|
T Consensus 283 i~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 283 ITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHccCcccccCCCCHHHHhcC
Confidence 877 555666679999999886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=316.71 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=209.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
+-|.+.++||+|+||.||+|.++++|..+|||.+... ...+++.+|+.+|++++.|++|++||.|... ...|+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDLWI 105 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDLWI 105 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccC-----CceEe
Confidence 3477889999999999999999999999999998654 3457899999999999999999999987654 56899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
|||||..|+..+.++.++. ++++.++..+.+..++||+|||.. .-+|||||..||+++.+|++||+|||.|.
T Consensus 106 VMEYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred ehhhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccc
Confidence 9999999999999998764 899999999999999999999999 89999999999999999999999999997
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
.+.+.. .....+.||+.|||||++..-.|..++||||+|++..||..|++||.....-... ..+|.
T Consensus 178 QLTDTM--------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------FMIPT 243 (502)
T KOG0574|consen 178 QLTDTM--------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------FMIPT 243 (502)
T ss_pred hhhhhH--------HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------EeccC
Confidence 654321 2233478999999999999989999999999999999999999999763221000 00111
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..... -.++++.+.++.+++++|+-..|++|-||.++++|-
T Consensus 244 ~PPPT--------------------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 244 KPPPT--------------------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCCCC--------------------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 10000 012334467899999999999999999999998874
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=341.45 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=196.7
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
++||+|+||.||+|++..+++.||+|++.... ......+.+|+++++.++||||+++++++... +..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999997432 33456788899999999999999999988654 67899999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
|+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999999999887653 688999999999999999999999 99999999999999999999999999987532
Q ss_pred cccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhh
Q 043932 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVI 947 (1017)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 947 (1017)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus 147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~~~- 212 (328)
T cd05593 147 TDA--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEDI- 212 (328)
T ss_pred Ccc--------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccCCc-
Confidence 111 1112356899999999999889999999999999999999999999653211 11111000000
Q ss_pred hhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 948 EIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 948 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
......+..+.+++.+||+.||++|| ++.|+++|
T Consensus 213 -----------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 -----------------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -----------------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00112345678999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=343.76 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=200.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCc-EEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDE-MIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~----- 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE----- 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-----
Confidence 457999999999999999999876554 789999986432 23446788999999999999999999998655
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence 67899999999999999998654 688999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+..
T Consensus 175 FG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~ 239 (340)
T PTZ00426 175 FGFAKVVDTR-----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----LIYQK 239 (340)
T ss_pred CCCCeecCCC-----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----HHHHH
Confidence 9999765321 11256899999999999888999999999999999999999999753221 00110
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
. .... . ..+...++.+.+++.+|++.||++|+ +++|+++|
T Consensus 240 i-~~~~-----------------~-------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 240 I-LEGI-----------------I-------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred H-hcCC-----------------C-------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 0000 0 00011244578999999999999995 89998876
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=353.60 Aligned_cols=279 Identities=21% Similarity=0.293 Sum_probs=199.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC---CCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS---KGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~ 780 (1017)
..+|++.++||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..... ....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999999899999999885332 234579999999999999999988644321 2224
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-CeEEee
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VSHVGD 859 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 859 (1017)
+.++||||+++ ++.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 57799999975 78777754321 223689999999999999999999999 999999999999998665 799999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||+|+...... ......||+.|+|||++.+. .++.++||||+||++|||++|.+||.+....+ .+....
T Consensus 215 FGla~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~ 284 (440)
T PTZ00036 215 FGSAKNLLAGQ---------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRII 284 (440)
T ss_pred cccchhccCCC---------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence 99998654221 11235689999999988764 68999999999999999999999997643221 111111
Q ss_pred HhhcCch--hhhhccchhhHHHHhhcchhHHHhH-HhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEK--VIEIVDPLLLIEVMANNSMIQEDIR-AKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....... ......+....... ......... ......++++.+++.+||++||.+|||+.|+++|
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKF--PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccC--CccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 1111100 00000000000000 000000000 1112345678999999999999999999999876
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=317.12 Aligned_cols=262 Identities=24% Similarity=0.321 Sum_probs=210.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.+.|+..+.||+|.-|+||+|+..+++..+|+|++.... .....+...|-++|+.++||.++.+|+.++.. .
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-----~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-----K 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-----c
Confidence 346778899999999999999999999999999997543 34456778899999999999999999999776 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
+.|+|||||+||+|....+++.. ..+++..++-++.+++-||+|||-. |||+|||||+||||.++|++.|+||
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~----~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPG----KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCC----CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence 89999999999999999887754 5899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccc-------------------------------ccc-----------------cccCCCcccccccCccccC
Q 043932 861 GLAKFLSSHQ-------------------------------LDT-----------------ASKTSSSSIGIKGTVGYVA 892 (1017)
Q Consensus 861 G~a~~~~~~~-------------------------------~~~-----------------~~~~~~~~~~~~gt~~y~a 892 (1017)
.++....... ... ..........++||-.|.|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 9986542100 000 0111223345789999999
Q ss_pred cccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHh
Q 043932 893 PEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAK 972 (1017)
Q Consensus 893 PE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~ 972 (1017)
||++.|...+.++|.|+|||++|||+.|..||.+..... ++........ .+ ..
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~~~l--~F------------------------p~ 356 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVGQPL--KF------------------------PE 356 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhcCCC--cC------------------------CC
Confidence 999999999999999999999999999999998764432 2222111100 00 00
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCC----HHHHHHH
Q 043932 973 TQECLNAIIRIGVLCSMESPFERME----MRDVVAK 1004 (1017)
Q Consensus 973 ~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~ 1004 (1017)
..+.+....+||++.|.+||.+|.. |.||-+|
T Consensus 357 ~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 357 EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred CCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 1133567899999999999999998 8887665
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.77 Aligned_cols=258 Identities=25% Similarity=0.429 Sum_probs=214.7
Q ss_pred hccccccCcccccCCceEEEEEeCCC----cEEEEEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED----EMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.+..+..++||+|-||.||+|....- .-.||||.-+.. ..+..+.|..|..+|+.++||||++++|+|.+.
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---- 463 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---- 463 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc----
Confidence 34455677999999999999997432 345899988753 344568899999999999999999999999763
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
..|||||.++.|.|..|++.+.. .++......++.||+.||+|||+. ..|||||..+||+|.....||++
T Consensus 464 --P~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 464 --PMWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred --ceeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 47999999999999999998765 788999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++.+.+........ ..-+..|||||.+.-..++.++|||.|||.+||++. |..||.+....+.....-
T Consensus 534 DFGLSR~~ed~~yYkaS~-------~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE 606 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASR-------GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE 606 (974)
T ss_pred ccchhhhccccchhhccc-------cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec
Confidence 999999988766544432 223678999999999999999999999999999988 999998743322110000
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
..+..+.+..|++.++.++.+||.+||.+||.+.|+.+.|+++.+
T Consensus 607 ----------------------------nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 607 ----------------------------NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----------------------------CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 011124456789999999999999999999999999999998875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=339.26 Aligned_cols=241 Identities=24% Similarity=0.323 Sum_probs=194.1
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 713 lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
||+|+||.||+|++..+++.||+|++... .......+.+|+.++++++||||+++++++... +..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCC
Confidence 69999999999999999999999998743 233456778899999999999999999988654 6789999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999997653 688999999999999999999999 9999999999999999999999999998753221
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1017)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.........
T Consensus 147 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~---- 209 (312)
T cd05585 147 D--------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEP---- 209 (312)
T ss_pred C--------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCC----
Confidence 1 112235689999999999998999999999999999999999999975321 11111100000
Q ss_pred ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 043932 950 VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME---MRDVVAK 1004 (1017)
Q Consensus 950 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 1004 (1017)
.......++.+.+++.+||+.||++||+ +.|++.|
T Consensus 210 --------------------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 210 --------------------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred --------------------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 0001123566889999999999999985 6676655
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=349.28 Aligned_cols=259 Identities=20% Similarity=0.295 Sum_probs=201.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.++||+|+||+||+|++..+++.||||++.... ....+.+.+|+++++.++||||+++++++... ++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-----NY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----Ce
Confidence 37899999999999999999999999999999997432 23345678899999999999999999998765 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 899999999999999997653 689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccc------------------------------CCCcccccccCccccCcccccCCCcCccccchhHH
Q 043932 862 LAKFLSSHQLDTASK------------------------------TSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFG 911 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 911 (1017)
+++.+.......... .........||+.|+|||++.+..++.++||||+|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 987653221100000 00011124699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCcccccCccHHHHHHhh-cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCC
Q 043932 912 ILLLELFTGRRPTDAAFTEGLTLHEFAKIA-LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSME 990 (1017)
Q Consensus 912 ~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 990 (1017)
|++|||++|..||...... ....... ..... ... .....++.+.+++.+|+.
T Consensus 227 ~il~el~~G~~Pf~~~~~~----~~~~~i~~~~~~~-~~~---------------------~~~~~s~~~~~li~~ll~- 279 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQ----ETYRKIINWKETL-QFP---------------------DEVPLSPEAKDLIKRLCC- 279 (364)
T ss_pred hHHHHhhcCCCCCCCCCHH----HHHHHHHcCCCcc-CCC---------------------CCCCCCHHHHHHHHHHcc-
Confidence 9999999999999754221 1110000 00000 000 000124567888999996
Q ss_pred CCCCCCC---HHHHHHH
Q 043932 991 SPFERME---MRDVVAK 1004 (1017)
Q Consensus 991 dP~~RPs---~~evl~~ 1004 (1017)
+|.+|++ +.|+++|
T Consensus 280 ~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 280 EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CHhhcCCCCCHHHHhcC
Confidence 9999998 9998876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=330.73 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=202.9
Q ss_pred hccccccCcccccCCceEEEEEeC---CCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..+|++.+.||+|+||.||+|.+. ..+..||+|.++.... .....+.+|+..+++++||||+++++++...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG----- 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-----
Confidence 357899999999999999999874 3567899999875432 3345788999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +++||||||+||+++.++.++++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence 66899999999999999997643 2689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||.+......... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ..+..
T Consensus 151 fg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~ 221 (266)
T cd05064 151 FRRLQEDKSEAIY-------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAV 221 (266)
T ss_pred Ccccccccccchh-------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH
Confidence 9987643211100 0111235678999999998899999999999999999875 999997542211 00000
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
..... ......++..+.+++.+||+.+|++||++.|+.+.|+++
T Consensus 222 ~~~~~--------------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 EDGFR--------------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HCCCC--------------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00000 001123466789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.05 Aligned_cols=279 Identities=20% Similarity=0.293 Sum_probs=202.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhc---CCCCceeeeeeeecCCCCCCc
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNI---RHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+|++.+.||+|+||+||+|++..+++.||+|.+.... ......+.+|+++++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999999999999999987432 22224456677777665 699999999998765444456
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++ +|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 78999999975 89998876432 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|++....... ......||..|+|||++.+..++.++||||+||++|||++|++||......+ ........
T Consensus 153 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~ 222 (288)
T cd07863 153 GLARIYSCQM---------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDL 222 (288)
T ss_pred CccccccCcc---------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHH
Confidence 9997654221 1122468999999999988889999999999999999999999996543221 11111111
Q ss_pred hcCchhhhhcc-chhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVD-PLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........+.. ........ .............++++++.+++.+|++.||++|||+.|+++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAF--SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCCCChhhCccccccccccc--CCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 10000000000 00000000 0000001112223456678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.78 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=208.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.++||+|+||.||+|++..+++.||||.+.... ......+.+|+++++.++||||+++++++... +.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence 57899999999999999999999899999999886432 23345688999999999999999999988654 57
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++|+|.+++..... ....+++.++..++.|++.||+|||++ +++||||||+||+++.++.++|+|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence 8999999999999998864321 123578899999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
.+........ ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||....... ..+....
T Consensus 152 ~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~~ 220 (267)
T cd08228 152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQKI 220 (267)
T ss_pred cceeccchhH--------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHHHHH
Confidence 9886543221 1112458889999999988889999999999999999999999986532211 1111110
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
... ..+. .....++..+.+++.+||+.+|++||++.||++.++.++
T Consensus 221 ~~~-----~~~~-----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 221 EQC-----DYPP-----------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hcC-----CCCC-----------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 0000 011233567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.21 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=201.8
Q ss_pred cccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEeccC
Q 043932 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKN 791 (1017)
Q Consensus 712 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 791 (1017)
++|+|.||+||.|++.++...+|||.+...+....+-+.+|+...++++|.|||+++|.|... ++.-|.||.++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-----Gf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-----GFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC-----CeEEEEeecCCC
Confidence 799999999999999999999999999877766677788999999999999999999997654 688899999999
Q ss_pred CCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC-CCCCeEEeeccccccccccc
Q 043932 792 GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVSHVGDFGLAKFLSSHQ 870 (1017)
Q Consensus 792 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~ 870 (1017)
|+|.+.++...+. -+=.+.++-.+.+||++||+|||+. .|||||||-+||+|+ -.|.+||+|||-++....
T Consensus 657 GSLSsLLrskWGP---lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-- 728 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGP---LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-- 728 (1226)
T ss_pred CcHHHHHHhccCC---CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc--
Confidence 9999999986541 1226777888999999999999999 999999999999996 468999999999987643
Q ss_pred ccccccCCCcccccccCccccCcccccCC--CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhh
Q 043932 871 LDTASKTSSSSIGIKGTVGYVAPEYCMGS--EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIE 948 (1017)
Q Consensus 871 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1017)
.......+.||..|||||++..+ .|+.++|||||||++.||.||++||...... ...+.+...-.
T Consensus 729 ------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---qAAMFkVGmyK---- 795 (1226)
T KOG4279|consen 729 ------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---QAAMFKVGMYK---- 795 (1226)
T ss_pred ------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---hHhhhhhccee----
Confidence 22334457899999999999664 5899999999999999999999999653221 11111111000
Q ss_pred hccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 949 IVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 949 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
+. ++.+.+...+...+|.+|+.+||.+||+|+++++
T Consensus 796 -vH------------------P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 -VH------------------PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -cC------------------CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 00 2233455677889999999999999999999875
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.63 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=195.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|+..++||+|+||+||+|++..+++.||||++..... ...+.+.+|+++++.++|+||+++++++... +..
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 147 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-----GEI 147 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-----CeE
Confidence 3467778999999999999999998999999999864433 3346788999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++|+|.+.. ...+..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 148 ~lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 148 QVLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred EEEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccccc
Confidence 9999999999986532 345677889999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC-----CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
++...... .......||..|+|||++.. ...+.++|||||||++|||++|+.||...... .....
T Consensus 215 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~ 284 (353)
T PLN00034 215 SRILAQTM--------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASL 284 (353)
T ss_pred ceeccccc--------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHH
Confidence 97653211 11123468999999998743 23456899999999999999999999742211 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
........ .......++.++.+++.+||+.||++||++.|+++|-
T Consensus 285 ~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 285 MCAICMSQ-----------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred HHHHhccC-----------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 10000000 0001123356789999999999999999999999874
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=354.60 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=208.5
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC-
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK- 777 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 777 (1017)
....++|.+.++||+|+||+||+|++..+++.||||++.... ......+.+|+..+..++|+|++++.+.+...+..
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344579999999999999999999999999999999987543 33446778899999999999999998876544321
Q ss_pred --CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCe
Q 043932 778 --GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 778 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
.....++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 12247899999999999999975432 224688999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHH
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 935 (1017)
||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 183 kL~DFGls~~~~~~~~------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~ 251 (496)
T PTZ00283 183 KLGDFGFSKMYAATVS------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----E 251 (496)
T ss_pred EEEecccCeecccccc------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----H
Confidence 9999999986543211 1112235799999999999998999999999999999999999999975321 1
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........... ......+++++.+++.+||+.||.+||++.+++++
T Consensus 252 ~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 EVMHKTLAGRY-----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHhcCCC-----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111000000 00112235678999999999999999999999875
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=356.06 Aligned_cols=256 Identities=21% Similarity=0.252 Sum_probs=204.2
Q ss_pred ccccccCcccccCCceEEEEEeCCC-cEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGED-EMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
..|.+.+.||+|+||.||+|....+ +..||+|.+..........+.+|+++++.++||||+++++++... +..|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEE
Confidence 4589999999999999999998877 788999987655555556778899999999999999999998765 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++|+|.+++..... ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 142 lv~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 99999999999998865321 123688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
+.+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... +.......
T Consensus 217 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~~~~ 285 (478)
T PTZ00267 217 KQYSDSVS------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQVLY 285 (478)
T ss_pred eecCCccc------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh
Confidence 86543211 11122356999999999999989999999999999999999999999653211 11110000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... ......++..+.+++.+||+.||++||++.+++++
T Consensus 286 ~~~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 286 GKY-----------------------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCC-----------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 000 00011235678999999999999999999998754
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.50 Aligned_cols=262 Identities=24% Similarity=0.457 Sum_probs=206.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCc-----EEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDE-----MIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
++|++.+.||+|+||.||+|.....+ ..||+|.+..... .....+.+|++.+++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE---- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC----
Confidence 47889999999999999999986544 6799999864432 3346788999999999999999999988654
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCcc----------ccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceE
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLE----------VCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 848 (1017)
...+++|||+++++|.+++.......+ ...+++.+++.++.|++.||+|||+. +++||||||+||+
T Consensus 81 -~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 81 -QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 567999999999999999976532111 14688999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcc
Q 043932 849 LDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAA 927 (1017)
Q Consensus 849 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 927 (1017)
+++++.+||+|||++......... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYY------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred EcCCCcEEECCCcceeeccccccc------cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999998755322211 11112346788999999988889999999999999999998 99998753
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
...+ ...... ... .......++.++.+++.+||+.||.+||++.||+++|+.
T Consensus 231 ~~~~--~~~~i~---~~~-----------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 231 SNQE--VIEMIR---SRQ-----------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CHHH--HHHHHH---cCC-----------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2211 100000 000 001123457789999999999999999999999999975
Q ss_pred c
Q 043932 1008 T 1008 (1017)
Q Consensus 1008 ~ 1008 (1017)
+
T Consensus 283 ~ 283 (283)
T cd05048 283 W 283 (283)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.34 Aligned_cols=209 Identities=24% Similarity=0.336 Sum_probs=176.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.++||+|+||+||+|++..+++.||+|++.... ......+.+|+.++++++|++|+++++.+.+. ..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-----~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-----LN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----Ce
Confidence 47889999999999999999999999999999997432 23345678899999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 899999999999999997653 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccc---------------------------cCCCcccccccCccccCcccccCCCcCccccchhHHHHH
Q 043932 862 LAKFLSSHQLDTAS---------------------------KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILL 914 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 914 (1017)
+++........... ..........||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 99765321100000 000011235799999999999998999999999999999
Q ss_pred HHHHhCCCCCCcc
Q 043932 915 LELFTGRRPTDAA 927 (1017)
Q Consensus 915 ~elltg~~pf~~~ 927 (1017)
|||++|+.||...
T Consensus 227 ~ell~G~~Pf~~~ 239 (363)
T cd05628 227 YEMLIGYPPFCSE 239 (363)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=335.01 Aligned_cols=276 Identities=21% Similarity=0.307 Sum_probs=202.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++|.+.+.||+|+||+||+|++..+++.||+|.++.... .....+.+|++++++++||||+++++++... +..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEE
Confidence 578999999999999999999998999999999874432 2335677899999999999999999998654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++ +|.+++..... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 99999975 89888876542 578899999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh-
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA- 941 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~- 941 (1017)
........ ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ........
T Consensus 152 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~ 222 (309)
T cd07872 152 RAKSVPTK--------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLG 222 (309)
T ss_pred eecCCCcc--------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhC
Confidence 75432110 1112357899999998865 4688999999999999999999999976433211 11111111
Q ss_pred cCc--hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPE--KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~--~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+. .+..+................. .........++++.+++.+|++.||.+|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFPKYKPQ-PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcCccCCC-chhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 111 0111111000000000000000 0001122346678899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=340.72 Aligned_cols=280 Identities=20% Similarity=0.222 Sum_probs=203.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 779 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..... ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999999999999999998643 23345677899999999999999999998864422 122
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...|+||||+++ ++.+.+.. .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 457999999965 67766642 467888999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ........
T Consensus 167 fg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~ 236 (359)
T cd07876 167 FGLARTACTNF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIE 236 (359)
T ss_pred CCCccccccCc---------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 99987543211 112346899999999999989999999999999999999999999764221 11111111
Q ss_pred hhcCchhhhhccch--hhHHHHhhcch-----hH--------HHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPL--LLIEVMANNSM-----IQ--------EDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~--l~~~~~~~~~~-----~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... ....++.+.. ....+...... .. +..........+.+.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 237 QLG-TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred hcC-CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 110 0000000000 00000000000 00 00000111234668999999999999999999999987
Q ss_pred H
Q 043932 1005 L 1005 (1017)
Q Consensus 1005 L 1005 (1017)
-
T Consensus 316 p 316 (359)
T cd07876 316 P 316 (359)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=343.21 Aligned_cols=268 Identities=25% Similarity=0.365 Sum_probs=206.9
Q ss_pred HhhccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecCc-chHHHHHHHHHHHHhcC-CCCceeeeeeeecC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQK-GAFKSFMAECKALRNIR-HRNLIKIITICSSI 774 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 774 (1017)
...++|++.++||+|+||.||+|++.. .+..||||++..... ...+.+.+|+++++++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 345689999999999999999998743 235799999975433 33467889999999995 99999999998654
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCCc-------------------------------------------------
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHL------------------------------------------------- 805 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------- 805 (1017)
+..|+||||+++|+|.+++.......
T Consensus 114 -----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 114 -----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred -----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 66899999999999999987542100
Q ss_pred -----------------------------------------cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCC
Q 043932 806 -----------------------------------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKP 844 (1017)
Q Consensus 806 -----------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 844 (1017)
....+++.++..++.||++||+|||+. +|+||||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp 265 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA 265 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence 012478888999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCC
Q 043932 845 SNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923 (1017)
Q Consensus 845 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 923 (1017)
+||+++.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P 339 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNY------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccc------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999765322111 11112356788999999988889999999999999999997 9999
Q ss_pred CCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 924 TDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 924 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
|............ ...... ......++.++.+++.+||+.||++||++.+|.+
T Consensus 340 ~~~~~~~~~~~~~-~~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 340 YPGMIVDSTFYNK-IKSGYR--------------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CcccchhHHHHHH-HhcCCC--------------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 8754221111000 000000 0011234667899999999999999999999999
Q ss_pred HHhhccc
Q 043932 1004 KLCHTRE 1010 (1017)
Q Consensus 1004 ~L~~~~~ 1010 (1017)
.|+.+.+
T Consensus 393 ~l~~l~~ 399 (400)
T cd05105 393 IVESLLP 399 (400)
T ss_pred HHHHHcC
Confidence 9998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.24 Aligned_cols=267 Identities=24% Similarity=0.361 Sum_probs=205.6
Q ss_pred hccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 776 (1017)
.++|++.++||+|+||.||+|.+.. +++.||+|++.... ....+.+.+|+.+++++ +|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence 4589999999999999999997543 35789999987432 23346678899999999 899999999988643
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCC----------------------------------------------------
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDH---------------------------------------------------- 804 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 804 (1017)
....++||||+++++|.+++......
T Consensus 84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 25678999999999999998653210
Q ss_pred ---ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcc
Q 043932 805 ---LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881 (1017)
Q Consensus 805 ---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 881 (1017)
.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+....... ..
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~------~~ 232 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RK 232 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh------hc
Confidence 0013689999999999999999999999 99999999999999999999999999998654322111 11
Q ss_pred cccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHh
Q 043932 882 IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMA 960 (1017)
Q Consensus 882 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 960 (1017)
....++..|+|||++.+..++.++||||+||++|||++ |..||......+ ............
T Consensus 233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~---------------- 295 (337)
T cd05054 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRM---------------- 295 (337)
T ss_pred cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCC----------------
Confidence 12346778999999999999999999999999999998 999986532211 111100000000
Q ss_pred hcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 961 NNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 961 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
.....+.+++.+++.+||+.+|++||++.|++++|+++.+
T Consensus 296 ----------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 ----------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011234678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=340.41 Aligned_cols=243 Identities=23% Similarity=0.304 Sum_probs=195.4
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|+++++.++||||+++++++... +..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999997432 23346677899999999999999999988654 67899999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
|+++|+|.+++.... .+++.++..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999999887653 68999999999999999999997 7 9999999999999999999999999998743
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~~~~ 213 (325)
T cd05594 147 IKDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEI 213 (325)
T ss_pred CCCC--------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhcCCC
Confidence 2111 1112346999999999999889999999999999999999999999653211 11110000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
......++++.+++.+|++.||++|+ ++.++++|
T Consensus 214 ------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 ------------------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00112345688999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=343.37 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=205.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|.+.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+++++.++||||+++++++... ++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-----EH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-----Ce
Confidence 37899999999999999999999999999999997432 24456788999999999999999999987654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence 899999999999999998653 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccc---------------------cccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhC
Q 043932 862 LAKFLSSHQLDT---------------------ASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG 920 (1017)
Q Consensus 862 ~a~~~~~~~~~~---------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 920 (1017)
++.......... ............||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 998654322000 00001112235699999999999999999999999999999999999
Q ss_pred CCCCCcccccCccHHHHHHhhc-CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-H
Q 043932 921 RRPTDAAFTEGLTLHEFAKIAL-PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-M 998 (1017)
Q Consensus 921 ~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~ 998 (1017)
+.||...... ..+..... .... .. .....+++.+.+++.+|++ ||.+||+ +
T Consensus 227 ~~Pf~~~~~~----~~~~~i~~~~~~~---~~-------------------p~~~~~~~~~~~li~~ll~-dp~~R~~s~ 279 (350)
T cd05573 227 FPPFYSDTLQ----ETYNKIINWKESL---RF-------------------PPDPPVSPEAIDLICRLLC-DPEDRLGSF 279 (350)
T ss_pred CCCCCCCCHH----HHHHHHhccCCcc---cC-------------------CCCCCCCHHHHHHHHHHcc-ChhhcCCCH
Confidence 9999764311 11111000 0000 00 0000135678899999997 9999999 9
Q ss_pred HHHHHHH
Q 043932 999 RDVVAKL 1005 (1017)
Q Consensus 999 ~evl~~L 1005 (1017)
+|++++-
T Consensus 280 ~~ll~hp 286 (350)
T cd05573 280 EEIKSHP 286 (350)
T ss_pred HHHhcCC
Confidence 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.91 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=194.6
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||.||+|++..+++.||+|++.... ....+.+..|.++++.+ +||||+++++++... +..|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence 46999999999999999899999999997432 23345677888888876 799999999998654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999987654 688899999999999999999999 9999999999999999999999999998753
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~~~- 212 (321)
T cd05591 147 ILNG--------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDD- 212 (321)
T ss_pred ccCC--------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC-
Confidence 2211 1112356899999999999889999999999999999999999999764221 1111000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-------EMRDVVAK 1004 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 1004 (1017)
.. ....++.++.+++.+|++.||++|| ++.+++++
T Consensus 213 --~~---------------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 --VL---------------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CC---------------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00 0011245678999999999999999 88888766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=328.24 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=195.8
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 713 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
||+|+||+||+|.+..+++.||+|.+..... ...+.+..|+++++.++|+||+++.+++... ...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCC
Confidence 6999999999999999999999999864322 2335677899999999999999999887654 6689999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++|+|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 76 ~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 76 NGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 99999988754321 223689999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1017)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ............
T Consensus 151 ~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~---- 217 (280)
T cd05608 151 QS--------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILNDS---- 217 (280)
T ss_pred Cc--------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhcccC----
Confidence 21 11234689999999999998999999999999999999999999975322111 111111000000
Q ss_pred ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 950 VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 950 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
......++..+.+++.+|++.||++|| +++|+++|
T Consensus 218 --------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 218 --------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 001122456788999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=346.09 Aligned_cols=261 Identities=19% Similarity=0.242 Sum_probs=199.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.++||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++... ++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-----QY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----Ce
Confidence 36889999999999999999999999999999986432 23346788899999999999999999998654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 899999999999999997653 678889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccc--------ccC-------------------------------CCcccccccCccccCcccccCCCcC
Q 043932 862 LAKFLSSHQLDTA--------SKT-------------------------------SSSSIGIKGTVGYVAPEYCMGSEAS 902 (1017)
Q Consensus 862 ~a~~~~~~~~~~~--------~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 902 (1017)
+++.+........ ... ........||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 9964322110000 000 0000124699999999999988999
Q ss_pred ccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHH
Q 043932 903 MTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIR 982 (1017)
Q Consensus 903 ~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 982 (1017)
.++||||+||++|||++|..||....... ....... ..... .+. .....+.++.+
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~--~~~~~-~~p---------------------~~~~~s~~~~d 281 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHE-TYRKIIN--WRETL-YFP---------------------DDIHLSVEAED 281 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHH-HHHHHHc--cCCcc-CCC---------------------CCCCCCHHHHH
Confidence 99999999999999999999997532211 0110000 00000 000 00112456788
Q ss_pred HHhhccCCCCCCC---CCHHHHHHHH
Q 043932 983 IGVLCSMESPFER---MEMRDVVAKL 1005 (1017)
Q Consensus 983 li~~cl~~dP~~R---Ps~~evl~~L 1005 (1017)
++.+|++ +|.+| +++.|+++|-
T Consensus 282 li~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 282 LIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred HHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 9999997 67765 5999998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=345.03 Aligned_cols=370 Identities=26% Similarity=0.447 Sum_probs=234.7
Q ss_pred CCCCCCEEEccCCCCCC-CCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccE
Q 043932 99 NLSFLRYINLSDNSFHG-EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQT 177 (1017)
Q Consensus 99 ~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 177 (1017)
-|+..+-.|+++|.|+| ..|.....+++++.|.|...++. .+|..++.|.+|++|.+++|++. .+-+.++.|+.|+.
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS 82 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence 35566667777777773 56666666666666666666666 56666666666666666666665 44455555556666
Q ss_pred EEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccC
Q 043932 178 LAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRF 257 (1017)
Q Consensus 178 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 257 (1017)
+.+..|++.. .-+|..+-.+..|..||||+|+++ ..|..+..-+++-.|+||+|+|
T Consensus 83 v~~R~N~LKn-----------------------sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~I 138 (1255)
T KOG0444|consen 83 VIVRDNNLKN-----------------------SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNI 138 (1255)
T ss_pred Hhhhcccccc-----------------------CCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcc
Confidence 6655555541 235666667777777777777777 6677777778888888888888
Q ss_pred ccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCC
Q 043932 258 SGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTAND 337 (1017)
Q Consensus 258 ~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 337 (1017)
. +||..+|.++..|-.||||+|++. .+|..+..+..|+.|+|++|.+....-..+..+++|+
T Consensus 139 e-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~---------------- 200 (1255)
T KOG0444|consen 139 E-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLS---------------- 200 (1255)
T ss_pred c-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhh----------------
Confidence 7 888888888888888888888887 6777888888888888888887643333333333333
Q ss_pred hhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhh
Q 043932 338 LDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVI 417 (1017)
Q Consensus 338 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 417 (1017)
+|.+++.+=+ ...+|.++..+.||..+|||.|.+. +.|+.+
T Consensus 201 --------------vLhms~TqRT------------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl 241 (1255)
T KOG0444|consen 201 --------------VLHMSNTQRT------------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECL 241 (1255)
T ss_pred --------------hhhcccccch------------------------hhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence 3333333211 0124455555666666666666665 556666
Q ss_pred cccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccc
Q 043932 418 GELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSV 497 (1017)
Q Consensus 418 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~ 497 (1017)
-++++|+.|+||+|+|+ .+....+.-.+|+.|+||+|+++ .+|++++.++.|+.|.+.+|+++
T Consensus 242 y~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~--------------- 304 (1255)
T KOG0444|consen 242 YKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT--------------- 304 (1255)
T ss_pred hhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc---------------
Confidence 66666666666666665 33334444455555666666655 55555555555555555555554
Q ss_pred eeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCc
Q 043932 498 YLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNN 577 (1017)
Q Consensus 498 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 577 (1017)
+ .-+|..++.+.+|+.+..++|.+. ..|+.++.|..|+.|.|+.|+|- ..|+++.-|+.|+.|||..|.
T Consensus 305 --------F-eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 305 --------F-EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred --------c-cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 1 135666666666666666666665 56666666666666666666665 456666666666666666664
Q ss_pred cc
Q 043932 578 LS 579 (1017)
Q Consensus 578 l~ 579 (1017)
-.
T Consensus 374 nL 375 (1255)
T KOG0444|consen 374 NL 375 (1255)
T ss_pred Cc
Confidence 44
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=336.58 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=193.7
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||+||+|++..+++.||+|++... .....+.+..|..++... +||||+++++++... +..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEE
Confidence 4699999999999999999999999998743 233456677888888877 699999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999999999987654 688999999999999999999999 9999999999999999999999999998753
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~ 213 (320)
T cd05590 147 IFNG--------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDEV 213 (320)
T ss_pred CcCC--------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCCC
Confidence 2111 1112356899999999999888999999999999999999999999753221 11111000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM------RDVVAK 1004 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 1004 (1017)
. .....+..+.+++.+|++.||++||++ +++++|
T Consensus 214 ---~---------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 ---V---------------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred ---C---------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0 001124567899999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.48 Aligned_cols=254 Identities=25% Similarity=0.306 Sum_probs=211.3
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 778 (1017)
....|++.+.||+|.||.||+++.+.+|+.+|+|++..... ...+.+.+|+.+|+++. ||||+.+++++.+.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~---- 108 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP---- 108 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC----
Confidence 35678999999999999999999999999999999975543 23468899999999998 99999999999776
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC----CC
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD----MV 854 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~ 854 (1017)
..+++|||++.||.|.+.+... .+++..+..++.|++.|++|||+. ||+|||+||+|+|+... +.
T Consensus 109 -~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 109 -DSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred -CeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence 6799999999999999999865 289999999999999999999999 99999999999999543 57
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
+|++|||+|...... ......+||+.|+|||++.+..|+..+||||+|+++|.|++|.+||.+........
T Consensus 178 ik~~DFGla~~~~~~---------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~ 248 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKPG---------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL 248 (382)
T ss_pred EEEeeCCCceEccCC---------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence 999999999876541 22334789999999999999999999999999999999999999998764332211
Q ss_pred HHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
......+ ++. ...+........+++..|+..||.+|+|+.++++|-
T Consensus 249 -~i~~~~~-----~f~-------------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 249 -AILRGDF-----DFT-------------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred -HHHcCCC-----CCC-------------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 1111111 011 122334467789999999999999999999999984
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=343.17 Aligned_cols=256 Identities=18% Similarity=0.267 Sum_probs=201.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|++.++||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~----- 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD----- 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence 4568999999999999999999999999999999996432 22335577899999999999999999988654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
++.++||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence 6789999999999999998653 467888899999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCC----CcCccccchhHHHHHHHHHhCCCCCCcccccCccHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS----EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 935 (1017)
||++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .
T Consensus 186 fG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~ 254 (370)
T cd05596 186 FGTCMKMDANGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----G 254 (370)
T ss_pred ccceeeccCCCc-------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----H
Confidence 999976532211 011235699999999998653 4789999999999999999999999764221 1
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE--RMEMRDVVAKL 1005 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 1005 (1017)
.+...........+ .....++.++.+++.+|++.+|.+ ||++.|+++|-
T Consensus 255 ~~~~i~~~~~~~~~---------------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 255 TYSKIMDHKNSLTF---------------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHHHHHcCCCcCCC---------------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 11111000000000 000123567889999999999998 99999998874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.29 Aligned_cols=208 Identities=22% Similarity=0.327 Sum_probs=174.5
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
+|++.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++... +..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEE
Confidence 6889999999999999999999999999999987442 23346788999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 99999999999999997653 578889999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccc---------------------------------------cccCCCcccccccCccccCcccccCCCcCc
Q 043932 863 AKFLSSHQLDT---------------------------------------ASKTSSSSIGIKGTVGYVAPEYCMGSEASM 903 (1017)
Q Consensus 863 a~~~~~~~~~~---------------------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 903 (1017)
+..+....... ............||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 75432100000 000000112357999999999999989999
Q ss_pred cccchhHHHHHHHHHhCCCCCCcc
Q 043932 904 TGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 904 ~~DvwslG~il~elltg~~pf~~~ 927 (1017)
++||||+||++|||++|++||...
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=336.97 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=194.1
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHH---HhcCCCCceeeeeeeecCCCCCCc
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKAL---RNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++ +.++||||+++++++... +
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----D 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----C
Confidence 677889999999999999999999999999997432 23345566666554 566899999999998654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+++|+|..++... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 789999999999999887642 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........
T Consensus 146 g~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~~i~~~ 216 (324)
T cd05589 146 GLCKEGMGFG--------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFDSIVND 216 (324)
T ss_pred cCCccCCCCC--------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC
Confidence 9986432111 11223579999999999999899999999999999999999999997542210 00000000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
. ......++..+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ~----------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 E----------------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred C----------------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0 000112356678999999999999999 57777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=329.30 Aligned_cols=265 Identities=23% Similarity=0.438 Sum_probs=217.9
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
++++-...+....++||-|.||.||.|.|+.-.-.||||.++ .+....++|.+|+.+|+.++|||+|+++|+|...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E--- 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--- 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC---
Confidence 445555567778899999999999999999888999999997 4455679999999999999999999999999765
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
.-.|||+|||..|+|.+|+++... ..++....+.+|.||+.||+||..+ ++|||||..+|+||.++..||+
T Consensus 336 --pPFYIiTEfM~yGNLLdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 336 --PPFYIITEFMCYGNLLDYLRECNR----SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred --CCeEEEEecccCccHHHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEe
Confidence 457999999999999999998653 3567777889999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~ 936 (1017)
+|||+++.+..+...... +..-...|.|||-+....++.|+|||+|||++||+.| |..||.+.... +
T Consensus 407 ADFGLsRlMtgDTYTAHA-------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----q 474 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTAHA-------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----Q 474 (1157)
T ss_pred eccchhhhhcCCceeccc-------CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----H
Confidence 999999988654322211 1234678999999999999999999999999999999 99998764211 1
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
+.+++.... + -..++.|++.++++|++||+++|.+||++.|+-+.++.+-.
T Consensus 475 ---------VY~LLEkgy--------R------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 475 ---------VYGLLEKGY--------R------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ---------HHHHHhccc--------c------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 111111110 0 12345789999999999999999999999999998887643
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=325.55 Aligned_cols=265 Identities=26% Similarity=0.425 Sum_probs=205.1
Q ss_pred ccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCc
Q 043932 707 FASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGAD 780 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 780 (1017)
|++.+.||+|+||.||+|....+ +..||+|+++... ......+.+|++.++.++||||+++++++..... .+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999998653 4789999987543 2334678899999999999999999998765433 2334
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.+++...........+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 5799999999999999986543222334689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...+...
T Consensus 158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYR------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLR 229 (273)
T ss_pred cceeecccccccc------ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 9998664332111 0111235678999999988889999999999999999999 88888653211 1111110
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
.... ......++..+.+++.+|++.||++||++.|++++|+++
T Consensus 230 ~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNR--------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCC--------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 001123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=336.38 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=197.3
Q ss_pred cccccCcccccCCceEEEEEeC---CCcEEEEEEEeeecC----cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCC
Q 043932 706 EFASSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 777 (1017)
+|++.+.||+|+||.||+|+.. .+++.||+|++.... ....+.+.+|+.+++++ +|++|+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--- 77 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC---
Confidence 4788999999999999999874 468899999987432 22345678899999999 599999999887554
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
+..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 78 --~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 78 --AKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred --CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence 67899999999999999997653 688999999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 147 ~DfG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~ 218 (332)
T cd05614 147 TDFGLSKEFLSEEK-------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSE 218 (332)
T ss_pred eeCcCCccccccCC-------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHH
Confidence 99999876432211 111235699999999999775 47889999999999999999999997532221 1111
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
+...... .++ ......+..+.+++.+|++.||++|| ++++++++
T Consensus 219 ~~~~~~~------~~~------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 219 VSRRILK------CDP------------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHhc------CCC------------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1110000 000 00112355678999999999999999 77788776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=334.66 Aligned_cols=259 Identities=24% Similarity=0.415 Sum_probs=203.6
Q ss_pred ccccccCcccccCCceEEEEEeCCCcE----EEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.+|+..+.||+|+||.||+|++..++. .||+|++.... ....+++.+|+.+++.++||||++++++|...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 478999999999999999999865554 48999986443 23456788999999999999999999998642
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
..++|+||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence 35799999999999999986542 578889999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ......
T Consensus 153 fG~a~~~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~ 224 (316)
T cd05108 153 FGLAKLLGADEKEY------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL 224 (316)
T ss_pred ccccccccCCCcce------eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 99998764322111 0111234678999999998899999999999999999998 99998653211 011111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
..... . .....++..+.+++.+||+.||++||++.++++++..+.+.
T Consensus 225 ~~~~~--~------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 225 EKGER--L------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred hCCCC--C------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00000 0 00112345678999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=342.39 Aligned_cols=281 Identities=20% Similarity=0.233 Sum_probs=203.9
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.++||+|+||.||+|++..+++.||+|++... .....+++.+|+++++.++||||+++++++...+.......|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999889999999998643 223446788999999999999999999998765433334789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence 9999996 58888876543 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...... ...........
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g 222 (372)
T cd07853 151 RVEEPDES-------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLG 222 (372)
T ss_pred eecccCcc-------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcC
Confidence 76532211 111224578999999998774 4789999999999999999999999764322 11111111111
Q ss_pred Cchhhhhccc--hhhHHHHhhcchh--HHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDP--LLLIEVMANNSMI--QEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~--~l~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.....++... ............. .........+.++++.+++.+|++.||++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 1111000000 0000000000000 000001112335678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=325.04 Aligned_cols=257 Identities=23% Similarity=0.445 Sum_probs=205.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
..+|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|++++++++||||+++++++... +..+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY 78 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcE
Confidence 34688889999999999999999988999999998743 33356788999999999999999999988654 5679
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccc
Confidence 99999999999999976432 3688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +......
T Consensus 152 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~ 219 (263)
T cd05052 152 RLMTGDTYT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLE 219 (263)
T ss_pred cccccceee-------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH
Confidence 765432211 0111234678999999988899999999999999999998 99998653211 1111000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
.. .. ......++.++.+++.+|++.||++||++.|+++.|+.+
T Consensus 220 ~~-----~~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 220 KG-----YR------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CC-----CC------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00 00 001112356789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.15 Aligned_cols=249 Identities=21% Similarity=0.410 Sum_probs=206.2
Q ss_pred cccCcccccCCceEEEEEeCCCcEEEEEEEeee----cCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 708 ASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL----KQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 708 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+...+||+|+|-+||+|.+..+|..||--.++. ..+...++|..|+.+|+.|+||||+++++++.+.+. ....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence 446689999999999999999998887554432 223445889999999999999999999999877643 5678
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-CCCeEEeeccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVSHVGDFGL 862 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~ 862 (1017)
+|+|.+..|+|..|.++.+ +.+...+..|++||++||.|||++ .|+|||||||-+||||+. .|.|||+|+|+
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred eeeecccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence 9999999999999999876 788999999999999999999998 679999999999999976 48999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
|+..... ....++|||.|||||... ..|...+||||||+.+.||.|+.+||.........+.+......
T Consensus 193 Atl~r~s----------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 193 ATLLRKS----------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred HHHhhcc----------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence 9876422 222368999999999887 58999999999999999999999999765444344444444444
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
|..+..+.| ++++++|.+|+.. .++|||+.|++++
T Consensus 262 P~sl~kV~d--------------------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 262 PAALSKVKD--------------------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHhhccCC--------------------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 444444444 4578999999999 9999999999875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=329.11 Aligned_cols=262 Identities=28% Similarity=0.483 Sum_probs=206.0
Q ss_pred hccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++|.+.+.||+|+||.||+|++.. +++.||+|++...... ..+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 3568889999999999999998743 3578999998755443 457889999999999999999999998655
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCC--------CccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSND--------HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
...++||||+++++|.+++..... ......+++.++..++.|++.|++|||++ +++||||||+||++
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 668999999999999999986532 11234688999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCccc
Q 043932 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAF 928 (1017)
Q Consensus 850 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~ 928 (1017)
+.++.+||+|||.+......... .......+++.|+|||++.+..++.++||||+||++|||++ |..||....
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred cCCCeEEECCcccceecccCcce------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999998754322111 01112345788999999999899999999999999999998 999986532
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
... ...... .... ......++..+.+++.+||+.||++||++.||++.|++
T Consensus 230 ~~~--~~~~~~---~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 230 NEE--VIECIT---QGRL-----------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHH--HHHHHH---cCCc-----------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 211 111100 0000 00011235678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=334.06 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=190.7
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||+||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++... +..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999997432 23334556677777654 899999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999999987653 688999999999999999999999 9999999999999999999999999998754
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~~~-- 211 (316)
T cd05592 147 MNGE--------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDSILND-- 211 (316)
T ss_pred CCCC--------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcC--
Confidence 3211 1122356899999999999988999999999999999999999999754221 111000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR-DVVAK 1004 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 1004 (1017)
.+ .....++.++.+++.+||+.||++||++. +++++
T Consensus 212 ----~~------------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 212 ----RP------------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred ----CC------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 00 00111245678999999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=336.10 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=196.1
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCC-CceeeeeeeecCCCCCCce
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHR-NLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 781 (1017)
+|++.+.||+|+||.||+|++..+++.||+|++... .....+.+..|.++++.+.|+ +|+++++++... +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CE
Confidence 578899999999999999999999999999999743 233456778899999999765 577888877554 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 899999999999999997653 578899999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......
T Consensus 147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i 213 (324)
T cd05587 147 MCKENIFGG--------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQSI 213 (324)
T ss_pred cceecCCCC--------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence 986432111 1122356899999999999989999999999999999999999999754221 110000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM-----RDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 1004 (1017)
.... .......+.++.+++.+|+..||.+|+++ .++++|
T Consensus 214 ~~~~------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 214 MEHN------------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HcCC------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0000 00011224567899999999999999986 566654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=328.09 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=200.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.|++.++||+|+||+||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++... +..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeE
Confidence 47888999999999999999998999999999864321 2234567899999999999999999988654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999988865421 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ........ .
T Consensus 149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~-~ 217 (285)
T cd05605 149 AVEIPEGE---------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERR-V 217 (285)
T ss_pred ceecCCCC---------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHH-h
Confidence 87653221 1112468999999999988889999999999999999999999997532210 00111000 0
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
.. .........+..+.+++.+|++.||++|| ++++++++
T Consensus 218 ~~-----------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 218 KE-----------------------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred hh-----------------------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00 00011123456788999999999999999 88898776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=329.57 Aligned_cols=265 Identities=25% Similarity=0.436 Sum_probs=208.1
Q ss_pred ccccccCcccccCCceEEEEEe-----CCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.+|.+.+.||+|+||+||+|.. ..++..||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----- 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence 5788999999999999999985 335667999998765555567889999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCC-------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDH-------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 852 (1017)
+..++||||+++++|.+++...... .....+++.+++.++.|++.||+|||++ +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 6789999999999999999754310 1223589999999999999999999999 99999999999999999
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccC
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEG 931 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 931 (1017)
+.+||+|||.++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~ 230 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230 (288)
T ss_pred CcEEeccCCccccccCCcee------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999998755322110 01112345788999999988889999999999999999998 899986542211
Q ss_pred ccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 932 LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
........... .....++.++.+++.+||+.||.+|||+.|+.+.|+++...
T Consensus 231 -~~~~i~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 -VIECITQGRVL---------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHHHHHcCCcC---------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00000000000 00012345689999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.66 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=202.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++... +..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEE
Confidence 45799999999999999999999989999999999765555556788999999999999999999998654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++.... .+++.++..++.|++.|++|||+. +|+|||+||+||+++.++.++|+|||++
T Consensus 83 iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999987543 678999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
....... .......|+..|+|||.+. ...++.++||||+||++|||++|+.||......... ......
T Consensus 154 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~ 224 (267)
T cd06646 154 AKITATI--------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKS 224 (267)
T ss_pred eeecccc--------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecC
Confidence 7653211 1112246889999999874 345788999999999999999999998543211100 000000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
... .+.. ......+..+.+++.+||+.||++||+++++++++
T Consensus 225 ~~~-------~~~~----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 NFQ-------PPKL----------------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCC-------CCCC----------------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000 0000 00112346788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=336.79 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=195.1
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||.||+|++..+++.||+|+++... ....+.+.+|..+++.+ +||||+++++++... +..|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence 46999999999999999999999999997432 23345678899999988 799999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999999999887653 689999999999999999999999 9999999999999999999999999998642
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC---ccHHHHHHhhcC
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG---LTLHEFAKIALP 943 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~---~~~~~~~~~~~~ 943 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||+...... .....+......
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 218 (329)
T cd05588 147 IRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL 218 (329)
T ss_pred ccCC--------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH
Confidence 2111 11223578999999999999899999999999999999999999996432111 000011000000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME------MRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 1004 (1017)
.. . ...+..++.++.+++.+|++.||.+||+ +.++++|
T Consensus 219 ~~----------------~-------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 219 EK----------------Q-------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred cC----------------C-------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 00 0 0001123556889999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=324.94 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=208.7
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
+...+|++.++||+|+||.||+|.+.. +..+|+|++..........+.+|+.+++.++|+||+++++++... +.
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 76 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EP 76 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CC
Confidence 345689999999999999999999986 888999999866655567889999999999999999999988654 56
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcccc
Confidence 8999999999999999976432 3689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 940 (1017)
.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ....... .
T Consensus 150 ~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~~~~-~ 219 (261)
T cd05148 150 LARLIKEDVYL--------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYDQIT-A 219 (261)
T ss_pred chhhcCCcccc--------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHHHHH-h
Confidence 99765432111 112345778999999988889999999999999999998 89998653211 0111100 0
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
... ......+++.+.+++.+|++.||++|||++++++.|+.+
T Consensus 220 ~~~--------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 220 GYR--------------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCc--------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 000 001123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=346.67 Aligned_cols=260 Identities=20% Similarity=0.262 Sum_probs=198.9
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++... +.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-----DN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CE
Confidence 36899999999999999999999999999999986432 22346678999999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 899999999999999997653 578888999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccc-----------------------------------cccCCCcccccccCccccCcccccCCCcCcccc
Q 043932 862 LAKFLSSHQLDT-----------------------------------ASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGD 906 (1017)
Q Consensus 862 ~a~~~~~~~~~~-----------------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 906 (1017)
+|..+....... ............||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 985332100000 000001112357999999999999989999999
Q ss_pred chhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhh
Q 043932 907 VYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVL 986 (1017)
Q Consensus 907 vwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 986 (1017)
|||+||++|||++|+.||.......... ... ...... .. .....+++++.+++.+
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~-~i~--~~~~~~-~~---------------------~~~~~~s~~~~~li~~ 281 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQL-KVI--NWETTL-HI---------------------PSQAKLSREASDLILR 281 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHH-HHh--ccCccc-cC---------------------CCCCCCCHHHHHHHHH
Confidence 9999999999999999997643211100 000 000000 00 0001224556777777
Q ss_pred ccCCCCCCCC---CHHHHHHH
Q 043932 987 CSMESPFERM---EMRDVVAK 1004 (1017)
Q Consensus 987 cl~~dP~~RP---s~~evl~~ 1004 (1017)
|+ .+|.+|+ ++.|+++|
T Consensus 282 l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 282 LC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred Hh-cCHhhcCCCCCHHHHhCC
Confidence 66 5999999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=334.74 Aligned_cols=248 Identities=22% Similarity=0.322 Sum_probs=194.0
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
+.||+|+||+||+|++..+++.||+|++... .....+.+.+|+.++.++ +||||+++++++... +..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence 4699999999999999999999999999753 223445677888888877 899999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999999999887653 689999999999999999999999 9999999999999999999999999998743
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC---ccHHHHH-Hhhc
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG---LTLHEFA-KIAL 942 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~---~~~~~~~-~~~~ 942 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+. ....
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~ 218 (329)
T cd05618 147 LRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 218 (329)
T ss_pred cCCC--------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh
Confidence 2111 11123568999999999999899999999999999999999999996421111 0000110 0000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM------RDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 1004 (1017)
... ...+...+..+.+++.+||+.||++||++ .++++|
T Consensus 219 ~~~------------------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 219 EKQ------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred cCC------------------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 000 00111235567899999999999999984 677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=326.98 Aligned_cols=277 Identities=27% Similarity=0.400 Sum_probs=206.3
Q ss_pred ccccccCcccccCCceEEEEEe----CCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.+|++.+.||+|+||+||+|.. ..+++.||+|.+........+.+.+|++++++++||||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 4788899999999999999984 456889999998766555567889999999999999999999987543 225
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence 68999999999999999976432 588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|++........... ......++..|+|||.+.+..++.++||||+||++|||++|..|+...... +...
T Consensus 153 g~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~ 221 (284)
T cd05081 153 GLTKVLPQDKEYYK-----VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRM 221 (284)
T ss_pred cccccccCCCccee-----ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhh
Confidence 99986643221100 001122455699999998888999999999999999999998776432111 1100
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
.............+. +....... ......++..+.+++.+||+.+|++|||+.||++.|+.++
T Consensus 222 ~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 222 MGNDKQGQMIVYHLI-ELLKNNGR-----LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cccccccccchHHHH-HHHhcCCc-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000000000000000 00000000 0111234567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=350.77 Aligned_cols=281 Identities=20% Similarity=0.267 Sum_probs=198.6
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCC------CCceeeeeee
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRH------RNLIKIITIC 771 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~ 771 (1017)
+++....++|++.++||+|+||+||+|.+..+++.||||+++.... ..+.+..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3444557899999999999999999999998999999999864322 22445667777777654 4588888887
Q ss_pred ecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeC
Q 043932 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 772 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~ 850 (1017)
... ..+.|+|||++ +++|.+++.... .+++.++..|+.||+.||+|||+ . +||||||||+|||++
T Consensus 201 ~~~----~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~ 266 (467)
T PTZ00284 201 QNE----TGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILME 266 (467)
T ss_pred EcC----CceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEe
Confidence 543 25689999998 679999887653 68999999999999999999997 6 899999999999998
Q ss_pred CCC----------------CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHH
Q 043932 851 HDM----------------VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILL 914 (1017)
Q Consensus 851 ~~~----------------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 914 (1017)
.++ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 335 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCcc-----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence 765 499999998753211 11235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCcccccCccHHHHHHh--hcCchhhhhccchhhHHHHhhcch---------hHHHhH---HhHHHHHHHH
Q 043932 915 LELFTGRRPTDAAFTEGLTLHEFAKI--ALPEKVIEIVDPLLLIEVMANNSM---------IQEDIR---AKTQECLNAI 980 (1017)
Q Consensus 915 ~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~---------~~~~~~---~~~~~~~~~l 980 (1017)
|||++|+.||+..... ..+..+... ..+..+..........++...... +..... .......+.+
T Consensus 336 ~elltG~~pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (467)
T PTZ00284 336 YELYTGKLLYDTHDNL-EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLL 414 (467)
T ss_pred HHHHhCCCCCCCCChH-HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHH
Confidence 9999999999764321 111111111 111111110000000000000000 000000 0000123568
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 981 IRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 981 ~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.+++.+||++||++|||++|+++|=
T Consensus 415 ~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 415 CDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HHHHHHhCCcChhhCCCHHHHhcCc
Confidence 8999999999999999999999863
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=356.93 Aligned_cols=272 Identities=24% Similarity=0.303 Sum_probs=206.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.++||+|+||.||+|++..+++.||+|++.... ....+++.+|++++++++||||+++++++... +.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CE
Confidence 57999999999999999999999999999999986432 22346788999999999999999999998654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCC-----ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 782 KALVFECMKNGSLEDWLHQSNDH-----LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
.++||||++||+|.+++...... ......++..++.++.||++||+|||++ +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 89999999999999998753210 0123467788899999999999999999 999999999999999999999
Q ss_pred Eeeccccccccccccccc----------ccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 043932 857 VGDFGLAKFLSSHQLDTA----------SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 926 (1017)
|+|||+++.......... ...........||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999986622110000 0000111235799999999999998999999999999999999999999975
Q ss_pred ccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHH
Q 043932 927 AFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-MRDVVAKL 1005 (1017)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L 1005 (1017)
......... ... .++.. .....+.++.+.+++.+|++.||++||+ ++++++.|
T Consensus 234 ~~~~ki~~~----~~i-------~~P~~---------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 234 KKGRKISYR----DVI-------LSPIE---------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred cchhhhhhh----hhc-------cChhh---------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 322111000 000 00000 0011234667889999999999999964 67777777
Q ss_pred hhccc
Q 043932 1006 CHTRE 1010 (1017)
Q Consensus 1006 ~~~~~ 1010 (1017)
+...+
T Consensus 288 e~~lq 292 (932)
T PRK13184 288 EPHLQ 292 (932)
T ss_pred HHHHh
Confidence 76543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=340.19 Aligned_cols=257 Identities=18% Similarity=0.262 Sum_probs=199.5
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
...++|++.++||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~---- 115 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD---- 115 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----
Confidence 34578999999999999999999999999999999986422 22345678899999999999999999988654
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..|+||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 116 -~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 116 -KYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred -CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEE
Confidence 6789999999999999999653 478889999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCC----CcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS----EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
|||+|........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......
T Consensus 185 DFG~a~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---- 253 (370)
T cd05621 185 DFGTCMKMDETGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---- 253 (370)
T ss_pred ecccceecccCCc-------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----
Confidence 9999986542211 011235699999999998654 3788999999999999999999999754221
Q ss_pred HHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE--RMEMRDVVAKL 1005 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 1005 (1017)
..+...........+ ......+..+.+++..|++.+|.+ ||++.|+++|-
T Consensus 254 ~~~~~i~~~~~~~~~---------------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 254 GTYSKIMDHKNSLNF---------------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred HHHHHHHhCCcccCC---------------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 111111000000000 001123456778888999865544 89999999883
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=336.87 Aligned_cols=280 Identities=21% Similarity=0.278 Sum_probs=204.1
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KG 778 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 778 (1017)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345789999999999999999999998999999999864322 234567789999999999999999998754322 22
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
....|+++|++ +++|.+++... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 24578999988 77999887642 589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ....+
T Consensus 161 Dfg~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~ 228 (343)
T cd07878 161 DFGLARQADDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRI 228 (343)
T ss_pred CCccceecCCC-----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHH
Confidence 99999754321 123468999999999877 468899999999999999999999997532211 11111
Q ss_pred HHhhc--CchhhhhccchhhHHHHhh-cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 938 AKIAL--PEKVIEIVDPLLLIEVMAN-NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~--~~~~~~~~d~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..... +......+.......+... ................+.+.+++.+|++.||.+|||+.|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11110 1111111111111111000 0000111111122234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=325.74 Aligned_cols=265 Identities=25% Similarity=0.428 Sum_probs=202.7
Q ss_pred ccccCcccccCCceEEEEEeCCCcE--EEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCce
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEM--IVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGADF 781 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 781 (1017)
|.+.++||+|+||.||+|++..++. .||+|.++.. .....+.+.+|+++++.++|+||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999876664 6899988643 23445678899999999999999999998754322 22345
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++|+|.+++...........+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999999885433222234689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 940 (1017)
+++......... ......+++.|+|||...+..++.++||||||+++|||++ |+.||...... ........
T Consensus 158 ~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDYYR------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQ 229 (272)
T ss_pred cccccCccccee------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence 998764322110 0111245778999999998889999999999999999999 88898653211 11110000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
... ......++..+.+++.+||+.||++|||+.|++++|+.+
T Consensus 230 --~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 --GNR------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --CCC------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 000112355689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=321.04 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=198.9
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
++|++.+.||+|+||.||+|++. ++..+|+|.+.... ...+.+.+|++++++++||||+++++++... +..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEEE
Confidence 56888999999999999999986 45679999876333 3346788999999999999999999998654 56899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence 9999999999999876432 578999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ........ ..
T Consensus 149 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-~~~~i~~~-~~ 219 (256)
T cd05114 149 YVLDDEYT-------SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-VVEMISRG-FR 219 (256)
T ss_pred ccCCCcee-------ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCC-CC
Confidence 65322211 1112345678999999988889999999999999999999 899986532110 00110000 00
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
... ....+..+.+++.+||+.||++||++.|+++.|.
T Consensus 220 -----~~~---------------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 -----LYR---------------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -----CCC---------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 0112456899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=333.38 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=191.8
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||.||+|++..+++.||+|+++... ....+....|..++... +||+|+++++++... ++.|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-----EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-----CEEEEEE
Confidence 46999999999999999999999999997532 23345567788888765 899999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999999999987643 678999999999999999999999 9999999999999999999999999998643
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+......
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~~---- 212 (316)
T cd05620 147 VFGD--------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVDT---- 212 (316)
T ss_pred ccCC--------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC----
Confidence 2111 1122356899999999999989999999999999999999999999754221 0000000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR-DVVAK 1004 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 1004 (1017)
+ .....+..++.+++.+|++.||++||++. ++++|
T Consensus 213 -----~------------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 213 -----P------------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred -----C------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0 00011245678999999999999999984 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.21 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=200.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++... +.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-----~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-----DN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----Ce
Confidence 36889999999999999999999999999999997442 23446688899999999999999999987654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 8999999999999999987532 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCccccc------CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHH
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM------GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 935 (1017)
++......... ......||+.|+|||++. +..++.++||||+||++|||++|+.||...... .
T Consensus 148 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~ 216 (330)
T cd05601 148 SAARLTANKMV-------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----K 216 (330)
T ss_pred CCeECCCCCce-------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----H
Confidence 99865432211 112246899999999986 456789999999999999999999999753221 1
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+............. .....+..+.+++..|++ +|++||++.++++|
T Consensus 217 ~~~~i~~~~~~~~~~---------------------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 217 TYNNIMNFQRFLKFP---------------------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHcCCCccCCC---------------------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111100000000000 001235567889999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.66 Aligned_cols=263 Identities=22% Similarity=0.405 Sum_probs=202.6
Q ss_pred hhccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ....++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 46789999999999999999998642 457799999864322 3345688999999999999999999988544
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCcc----ccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLE----VCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 852 (1017)
...++||||+++|+|.+++........ ...+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 82 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 82 ---QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred ---CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 568999999999999999976432111 23467889999999999999999999 99999999999999999
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccC
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEG 931 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 931 (1017)
+.++|+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~- 228 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE- 228 (277)
T ss_pred CCEEECCCCCccccCCcceee------cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 999999999987553222111 0111245788999999988889999999999999999999 78888653211
Q ss_pred ccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 932 LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
+.......... ......++..+.+++.+|++.||++|||+.|++++|++
T Consensus 229 ----~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 229 ----QVLRFVMEGGL-----------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----HHHHHHHcCCc-----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11110000000 00111235678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.41 Aligned_cols=251 Identities=21% Similarity=0.322 Sum_probs=208.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+.+-|...+.||+|.|+.|-+|++.-+|..||||++.+..-+ ....+.+|++.|+.++|||||++|++.... .
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----T 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----T 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-----c
Confidence 355688889999999999999999999999999999866433 345788999999999999999999998665 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe-CCCCCeEEee
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-DHDMVSHVGD 859 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~D 859 (1017)
..|+|+|.-++|+|.+|+-++.. .+.+.-..+++.||+.|+.|+|.. .||||||||+||.+ ..-|-|||.|
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~-----Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEE-----GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhc-----cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeee
Confidence 79999999999999999988753 788899999999999999999999 99999999999865 5679999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcC-ccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEAS-MTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||++-.+.+.+ .....+|+..|.|||++.|..|+ +++||||+|||+|.+++|++||+...+.+.
T Consensus 163 FGFSNkf~PG~---------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------ 227 (864)
T KOG4717|consen 163 FGFSNKFQPGK---------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------ 227 (864)
T ss_pred ccccccCCCcc---------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------
Confidence 99997665332 33457899999999999998886 678999999999999999999987544321
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+..++|-. -..+.....+..++|..|+..||.+|.+.+||+.+
T Consensus 228 -------LTmImDCK----------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 228 -------LTMIMDCK----------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -------hhhhhccc----------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 11111110 01223446678999999999999999999998754
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=338.55 Aligned_cols=280 Identities=18% Similarity=0.212 Sum_probs=203.4
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KG 778 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 778 (1017)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..... ..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34579999999999999999999999899999999986432 2334677889999999999999999998764422 12
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
....++||||+++ ++.+++.. .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 3467999999965 77776642 478888999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .....
T Consensus 162 Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~ 231 (355)
T cd07874 162 DFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVI 231 (355)
T ss_pred eCcccccCCCcc---------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 999997543221 11234689999999999998999999999999999999999999976422111 11111
Q ss_pred Hhh-cCc-hhhhhccchhhHHHHhhcch-----hH--------HHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 939 KIA-LPE-KVIEIVDPLLLIEVMANNSM-----IQ--------EDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 939 ~~~-~~~-~~~~~~d~~l~~~~~~~~~~-----~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
... .+. .......+... .+...... .. +............+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 232 EQLGTPCPEFMKKLQPTVR-NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHhCCCCHHHHHhhcHHHH-HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 110 000 00000000000 00000000 00 0000011123456889999999999999999999998
Q ss_pred H
Q 043932 1004 K 1004 (1017)
Q Consensus 1004 ~ 1004 (1017)
+
T Consensus 311 h 311 (355)
T cd07874 311 H 311 (355)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=331.94 Aligned_cols=242 Identities=25% Similarity=0.383 Sum_probs=191.4
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
+.||+|+||+||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++.+. +..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence 46999999999999999999999999997532 23345566788888765 899999999998654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999997643 678899999999999999999999 9999999999999999999999999998743
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.....
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~----- 211 (316)
T cd05619 147 MLGD--------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMD----- 211 (316)
T ss_pred CCCC--------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----
Confidence 2111 1112356899999999999888999999999999999999999999753211 000000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR-DVVA 1003 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1003 (1017)
.+. .......++.+++.+|++.||++||++. ++.+
T Consensus 212 ----~~~------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 ----NPC------------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ----CCC------------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 000 0011245678999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=333.24 Aligned_cols=244 Identities=23% Similarity=0.291 Sum_probs=193.7
Q ss_pred CcccccCCceEEEEEeC---CCcEEEEEEEeeecC----cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 711 NMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++||+|+||.||+|+.. .+++.||+|++.... ......+.+|+++++.++||||+++++++... +..|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeEE
Confidence 67999999999999874 467899999987432 22335677899999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 77 LILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred EEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999997654 578888899999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........
T Consensus 148 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~ 214 (323)
T cd05584 148 KESIHEG--------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILK 214 (323)
T ss_pred eecccCC--------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc
Confidence 7432211 1112356899999999999888999999999999999999999999753221 11100000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAKL 1005 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 1005 (1017)
.. . ......++.+.+++.+|++.||++|| ++.+++++-
T Consensus 215 ~~-----------------~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 215 GK-----------------L-------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CC-----------------C-------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 00 0 00112245678999999999999999 888887753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=329.05 Aligned_cols=252 Identities=26% Similarity=0.347 Sum_probs=205.1
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.|.-.+.||.|+||.||-|++..+...||||.+....+ ..+..+.+|+.++++++|||++.+.|+|... ...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----chH
Confidence 45667889999999999999999999999999985543 4567899999999999999999999998654 567
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
|+|||||-| +-.|++.-.+. ++.+.++..|..+.+.||+|||+. +.||||||..|||+++.|.|||+|||.
T Consensus 102 WLVMEYClG-SAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 102 WLVMEYCLG-SASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred HHHHHHHhc-cHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence 999999955 88888876654 788999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC---CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG---SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|....+. ..++|||+|||||++.. +.|+-++||||+|++..|+...++|+..... ...+..++.
T Consensus 173 Asi~~PA------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQ 239 (948)
T KOG0577|consen 173 ASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQ 239 (948)
T ss_pred hhhcCch------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHh
Confidence 9866432 34789999999999843 5799999999999999999999999754311 111111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
..-| .+ ...+.++.|.+++..|+++-|.+|||..+++.|---.++
T Consensus 240 NesP---------tL-----------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 240 NESP---------TL-----------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred cCCC---------CC-----------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 1111 11 012336678999999999999999999999988655443
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=334.00 Aligned_cols=248 Identities=22% Similarity=0.316 Sum_probs=196.1
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCce
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
+|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+..|..++..+ +|++|+++++++... +.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CE
Confidence 5788999999999999999999999999999987432 22334567788888777 589999999887654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 899999999999999987653 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........
T Consensus 147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~i~~~~ 217 (323)
T cd05616 147 MCKENMWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHN 217 (323)
T ss_pred CceecCCCC--------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence 987432111 11123568999999999999899999999999999999999999997542211 010000000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM-----RDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 1004 (1017)
. ......+.++.+++.+|++.||++|+++ .++.++
T Consensus 218 ~----------------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 V----------------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred C----------------------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0 0011234567899999999999999984 566544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=338.20 Aligned_cols=280 Identities=18% Similarity=0.204 Sum_probs=204.1
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 779 (1017)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++...+. ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999999989999999998643 23344677899999999999999999998754322 223
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...|+||||+++ +|.+++.. .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 467999999965 78777743 467888999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+++...... ......||..|+|||++.+..++.++||||+||++|||++|+.||......+ .......
T Consensus 170 fG~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~ 239 (364)
T cd07875 170 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIE 239 (364)
T ss_pred CCCccccCCCC---------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 99997543211 1123468999999999999899999999999999999999999997643221 1111111
Q ss_pred hhc-C-chhhhhccchhhHHHHhhcch----h--------HHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IAL-P-EKVIEIVDPLLLIEVMANNSM----I--------QEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~-~-~~~~~~~d~~l~~~~~~~~~~----~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... + ......+.+............ . .+............+.+++.+|++.||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 100 0 011111111110000000000 0 000000111124568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.76 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=208.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++|++++++++++... +.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 57899999999999999999999899999999886432 23356788999999999999999999998654 66
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++|+|.+++..... ....+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence 8999999999999999875321 223688999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
.+........ ......|+..|+|||.+.+..++.++||||+||++|+|++|+.||..... .........
T Consensus 152 ~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~ 220 (267)
T cd08224 152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKI 220 (267)
T ss_pred eeeeccCCCc--------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhh
Confidence 9876542211 11124578899999999888899999999999999999999999865321 111111100
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
.... .+. .....++..+.+++.+|+..+|++||++.+|++.++.+.
T Consensus 221 ~~~~-----~~~-----------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 221 EKCD-----YPP-----------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hcCC-----CCC-----------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0000 000 001134567889999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.66 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=207.9
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||.||+|++..+++.||||.+.... ....+++.+|+.+++.++||||+++++++... +.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence 47888999999999999999998899999999886432 23346788999999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++++|.+++..... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence 8999999999999999875321 123689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
.+....... .......|+..|+|||.+.+..++.++||||+|+++|+|++|..||...... .....+..
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~ 220 (267)
T cd08229 152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI 220 (267)
T ss_pred hhhccccCC--------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh
Confidence 987654221 1112246889999999998888999999999999999999999998653221 11111000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
.....+. .....+++++.+++.+|++.||++|||+.+|++.++++.
T Consensus 221 -----~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 221 -----EQCDYPP-----------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -----hcCCCCC-----------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000000 001124667899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=327.04 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=204.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|+|++++++++... .+.+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEE
Confidence 35889999999999999999999889999999999866655567888999999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 94 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EeecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999998643 478889999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||........ .........+
T Consensus 164 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 234 (296)
T cd06654 164 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP 234 (296)
T ss_pred hhcccccc--------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCCC
Confidence 75432211 11124588999999999888899999999999999999999999965422111 0000000000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. ......+..+.+++.+||..||++||++.|++++
T Consensus 235 ----~~---------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 235 ----EL---------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ----CC---------------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 0011234568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=326.43 Aligned_cols=273 Identities=26% Similarity=0.347 Sum_probs=203.8
Q ss_pred cc-cccCcccccCCceEEEEEe----CCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 706 EF-ASSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 706 ~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
+| ++.+.||+|+||+||++.. ..++..||+|++..... ...+.+.+|++++++++||||+++++++... +.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 44 8889999999999987653 35678899999875432 3456788999999999999999999987543 22
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++++|.+++... .+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~d 150 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGD 150 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEee
Confidence 5689999999999999999753 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+++......... .......++..|+|||.+.+..++.++||||||+++|||++|..||...... ......
T Consensus 151 fg~~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~ 222 (283)
T cd05080 151 FGLAKAVPEGHEYY-----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIG 222 (283)
T ss_pred cccccccCCcchhh-----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhc
Confidence 99998654322100 0011123567799999998888999999999999999999999998653221 111110
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
...... ..... .+....... ......++.++.+++.+||+.||++|||++++++.|+++.
T Consensus 223 ~~~~~~----~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 223 PKQGQM----TVVRL-IELLERGMR-----LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccccc----chhhh-hhhhhcCCC-----CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000000 00000 000000000 0112234678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=332.80 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=195.2
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
+.||+|+||+||+|++..+++.||+|++.... ......+.+|.++++.+ +||||+++++++... +..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999997432 33446677888998888 799999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999999999987653 689999999999999999999999 9999999999999999999999999998643
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ..........
T Consensus 147 ~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~~i~~~~- 212 (318)
T cd05570 147 ILGG--------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQSILEDE- 212 (318)
T ss_pred CcCC--------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHHHHHcCC-
Confidence 2111 1112246899999999999989999999999999999999999999753211 1110000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM-----RDVVAK 1004 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 1004 (1017)
. .....++..+.+++.+||+.||.+||++ .+++++
T Consensus 213 ----------------~-------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 213 ----------------V-------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----------------C-------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0 0011235668899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=323.43 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=202.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++... +..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEE
Confidence 35788899999999999999999989999999999866555556788999999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++.... .+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred EEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceee
Confidence 9999999999999987653 688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
....... .......|+..|+|||++. ...++.++||||+||++|+|++|+.||........ .......
T Consensus 154 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~ 224 (267)
T cd06645 154 AQITATI--------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKS 224 (267)
T ss_pred eEccCcc--------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhcc
Confidence 7553211 1112346899999999874 44588899999999999999999999864322110 0000000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .+.. .....++..+.+++.+|++.||++||++++++++
T Consensus 225 ~~~-------~~~~----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 NFQ-------PPKL----------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCC-------CCcc----------------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 0000 0001124567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.19 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=195.9
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
+.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++++... ...++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeec
Confidence 46999999999999999899999999876433 23346788999999999999999999998654 5689999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++++|.+++.... ..+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+......
T Consensus 76 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 76 QGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred cCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence 9999999997543 2578999999999999999999999 9999999999999999999999999998754321
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIE 948 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1017)
.... ......++..|+|||.+.+..++.++||||+||++|||++ |..||....... .........+.
T Consensus 148 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~~---- 215 (252)
T cd05084 148 VYAS------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVRL---- 215 (252)
T ss_pred cccc------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCC----
Confidence 1000 0011123567999999988889999999999999999998 888886432110 00000000000
Q ss_pred hccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 949 IVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 949 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.....++..+.+++.+|++.||++|||+.|+++.|+
T Consensus 216 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 ----------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ----------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 011123567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.05 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=200.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcE----EEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
++|++.+.||+|+||+||+|.+..+++ .|++|.+.... .....++..|+..+++++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 478889999999999999999976665 47777765332 2334667788889999999999999998742
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++|+||+++|+|.+++..... .+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D 152 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD 152 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence 346799999999999999976542 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||.++........ .......++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ..+..
T Consensus 153 fg~~~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~ 224 (279)
T cd05111 153 FGVADLLYPDDKK------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLL 224 (279)
T ss_pred CccceeccCCCcc------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence 9999865432211 11112457788999999988889999999999999999998 999986542210 11111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
..... ... ...++..+.+++.+||..||++|||+.|+++.|..+.+
T Consensus 225 ~~~~~-----~~~---------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 225 EKGER-----LAQ---------------------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HCCCc-----CCC---------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 00000 000 01124457889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.11 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=204.0
Q ss_pred hccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.+.||+|+||+||+|++..+ ...||+|++..... .....+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS----- 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-----
Confidence 35789999999999999999998643 46799999874432 3346788999999999999999999988654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.++|+|
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~d 149 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD 149 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECc
Confidence 568999999999999999976542 688999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ......
T Consensus 150 fg~~~~~~~~~~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~ 221 (266)
T cd05033 150 FGLSRRLEDSEATYT------TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAV 221 (266)
T ss_pred cchhhccccccccee------ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHH
Confidence 999987642111100 011235678999999988889999999999999999998 99998543211 000000
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
..... ......+++.+.+++.+|++.+|++||++.||+++|+++
T Consensus 222 ~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 EDGYR--------------------------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HcCCC--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00000 000112356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.93 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=193.3
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 713 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
||+|+||.||+++...+|+.||+|.+.... ....+.+..|++++++++||||+++++++... .+.++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecC
Confidence 699999999999999999999999986322 12234556799999999999999999988654 6789999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 76 ~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 76 NGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 99999988865432 3578899999999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1017)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... .............
T Consensus 149 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~---- 214 (277)
T cd05607 149 K---------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDE---- 214 (277)
T ss_pred c---------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccc----
Confidence 1 1112458999999999988889999999999999999999999996532211 1111111100000
Q ss_pred ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 950 VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 950 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.......+++++.+++.+||+.||++||++.|+++.+
T Consensus 215 -------------------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 215 -------------------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -------------------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 0000112356789999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=327.55 Aligned_cols=264 Identities=27% Similarity=0.449 Sum_probs=207.4
Q ss_pred ccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.+|.+.+.||+|+||.||+|++. .++..+++|.+........+.+.+|++.+++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG----- 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-----
Confidence 46888899999999999999863 34567999998755555557789999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
+..++||||+++++|.+++...... .....+++..++.++.||+.|++|||++ +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 5689999999999999999764310 0113588999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCccc
Q 043932 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAF 928 (1017)
Q Consensus 850 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~ 928 (1017)
+.++.++|+|||++......... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred ccCCcEEECCCCcccccCCCcee------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999755432211 11112356789999999998889999999999999999999 999986532
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
... ........... .....++..+.+++.+||+.||++||++.+|++.|+++
T Consensus 231 ~~~-----~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 231 NTE-----VIECITQGRVL-----------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHH-----HHHHHhCCCCC-----------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 211 11000000000 00112356789999999999999999999999999988
Q ss_pred cc
Q 043932 1009 RE 1010 (1017)
Q Consensus 1009 ~~ 1010 (1017)
..
T Consensus 283 ~~ 284 (291)
T cd05094 283 GK 284 (291)
T ss_pred Hh
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=329.10 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=208.6
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
+-|.++..||.|+||.||+|..+.++...|.|++........+.+.-|++++..++||+||++++.|+.. +..|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----CceEE
Confidence 3567788899999999999999988888899999888888889999999999999999999999987655 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
..|||.||-.+..+-.-+. .+++.++..+++|++.||.|||++ .|||||||..|||++-+|.++|+|||.+.
T Consensus 107 liEFC~GGAVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred EEeecCCchHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccc
Confidence 9999999999988876553 899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccccccccCCCcccccccCccccCcccc-----cCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYC-----MGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
.... .......+.|||+|||||+. ...+|++++||||||+++.||..+.+|-..- .......+
T Consensus 179 Kn~~--------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel----npMRVllK 246 (1187)
T KOG0579|consen 179 KNKS--------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL----NPMRVLLK 246 (1187)
T ss_pred cchh--------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc----chHHHHHH
Confidence 4321 22333458999999999986 4568999999999999999999999996432 11222222
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
....+. ..+.. +......+.+++.+||..||..||++.++++|-
T Consensus 247 iaKSeP-PTLlq---------------------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 247 IAKSEP-PTLLQ---------------------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred HhhcCC-CcccC---------------------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 222111 01111 122355688999999999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=321.66 Aligned_cols=256 Identities=23% Similarity=0.427 Sum_probs=202.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCcE
Confidence 467899999999999999999976 56679999876433 2357889999999999999999999987544 5679
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence 99999999999999976421 3678889999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
......... ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||....... .........
T Consensus 151 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~ 221 (261)
T cd05072 151 RVIEDNEYT-------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGY 221 (261)
T ss_pred eecCCCcee-------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCC
Confidence 865432111 1112345778999999988889999999999999999998 999986532111 111000000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
+. .....++.++.+++.+|+..+|++||+++++.+.|+++
T Consensus 222 ~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 RM--------------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CC--------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00 00112356788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=297.95 Aligned_cols=262 Identities=22% Similarity=0.281 Sum_probs=209.0
Q ss_pred Hhhcccccc-CcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCC
Q 043932 702 KATSEFASS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 702 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 779 (1017)
..+++|++. ++||-|-.|.|..+.++.+++.+|+|++... ...++|++..-.. .|||||.++++|... ..+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~r 131 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGR 131 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCc
Confidence 456677764 5899999999999999999999999998633 3456788876655 699999999998553 4456
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC---CCCeE
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVSH 856 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k 856 (1017)
.+..+|||+++||.|...++.++. ..+++.++..|++||+.|+.|||+. +|.||||||+|+|.+. +..+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~----~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGD----QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccc----ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceE
Confidence 788999999999999999998764 4799999999999999999999999 9999999999999964 45799
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|+|||+|+..... ......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||........+ .
T Consensus 205 LtDfGFAK~t~~~---------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais--p 273 (400)
T KOG0604|consen 205 LTDFGFAKETQEP---------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--P 273 (400)
T ss_pred ecccccccccCCC---------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC--h
Confidence 9999999865421 1222346799999999999999999999999999999999999999875432111 1
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
-.+..+.....++. .+.+.+.+++.+++|+.+|+.+|.+|.|+.|++++=.
T Consensus 274 gMk~rI~~gqy~FP-------------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 274 GMKRRIRTGQYEFP-------------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred hHHhHhhccCccCC-------------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 11111111111111 2345677888999999999999999999999987644
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.07 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=203.7
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCC-C
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKG-A 779 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~ 779 (1017)
.+.+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +|+|++++++++......+ .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 456789999999999999999999999999999999875433 346778899999998 7999999999986643322 3
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++++|.+++..... ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 568999999999999999986432 3688999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
||++....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||......
T Consensus 155 fg~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---- 222 (272)
T cd06637 155 FGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---- 222 (272)
T ss_pred CCCceeccccc--------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----
Confidence 99987543211 1112356899999999986 335788999999999999999999998643211
Q ss_pred HHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....... ...... .....++..+.+++.+||..||.+|||+.|++++
T Consensus 223 ~~~~~~~-~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 223 RALFLIP-RNPAPR----------------------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHHHHHh-cCCCCC----------------------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1110000 000000 0011234568899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.21 Aligned_cols=278 Identities=21% Similarity=0.264 Sum_probs=201.9
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||+|++|.||+|++..++..||+|++.... ....+.+.+|+.++++++|||++++++++... +..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEE
Confidence 4788899999999999999999899999999986443 22346788999999999999999999998654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||++ ++|.+++..... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred EEEecCC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence 9999997 589998875431 23689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
....... .......+++.|+|||++.+. .++.++||||+||++|+|++|++||............... ..
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~-~~ 219 (285)
T cd07861 149 RAFGIPV--------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRI-LG 219 (285)
T ss_pred eecCCCc--------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-hC
Confidence 7543211 011123568899999988654 4788999999999999999999999764322111111100 00
Q ss_pred CchhhhhccchhhHHHHhhc-chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANN-SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......+.......++.... .............+++++.+++.+||+.||++|||+.||+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred CCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000000000 000011111122356778899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=322.70 Aligned_cols=251 Identities=32% Similarity=0.515 Sum_probs=191.4
Q ss_pred ccCcccccCCceEEEEEeC----CCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 709 SSNMIGQGSFGSVYKGILG----EDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 709 ~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+.+.||.|.||.||+|.+. ..+..|+||+++.... ...+.+.+|++.+++++||||++++|++... +..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-----cccc
Confidence 4568999999999999997 4568899999965433 3468899999999999999999999999743 4489
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++|+|.+++.... ...+++.++..|+.||++||+|||++ +++|+||+++||+++.++.+||+|||++
T Consensus 78 lv~e~~~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~ 150 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS 150 (259)
T ss_dssp EEEE--TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred ccccccccccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 9999999999999999862 13789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
......... .......+...|+|||.+.+..++.++||||||+++||+++ |+.||...... ++.....
T Consensus 151 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----~~~~~~~ 219 (259)
T PF07714_consen 151 RPISEKSKY------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----EIIEKLK 219 (259)
T ss_dssp EETTTSSSE------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----HHHHHHH
T ss_pred ccccccccc------ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccc
Confidence 866221111 11112346778999999988889999999999999999999 78887653111 1111000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.... ......++..+.+++.+||+.||++||++.|+++.|
T Consensus 220 ~~~~-----------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQR-----------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEE-----------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccc-----------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0000 001112466789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.03 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=203.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-----chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-----GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD----- 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence 468899999999999999999988999999999874422 2235688899999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 57899999999999999987653 578889999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||.++........ ........|+..|+|||++.+..++.++||||+|+++|||++|+.||...... .....
T Consensus 148 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~ 218 (263)
T cd06625 148 FGASKRLQTICSS-----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFK 218 (263)
T ss_pred cccceeccccccc-----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHH
Confidence 9998765322110 11112245788999999999988999999999999999999999998653111 11111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
....... ......++..+.+++.+||..+|.+|||+.|++++.
T Consensus 219 ~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 219 IATQPTN-----------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HhccCCC-----------------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 1000000 001122356788999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.70 Aligned_cols=251 Identities=26% Similarity=0.348 Sum_probs=198.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++|++.++||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++... +..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEE
Confidence 36788899999999999999999899999999987542 23346788999999999999999999998765 6678
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++
T Consensus 76 lv~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 76 ICTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred EEEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 999999999997652 467888899999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccH--HHHHHhh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL--HEFAKIA 941 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~ 941 (1017)
....... .....||..|+|||++.+..++.++||||+||++|+|++|+.||.......... .......
T Consensus 143 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 212 (279)
T cd06619 143 TQLVNSI----------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212 (279)
T ss_pred eeccccc----------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH
Confidence 7543211 122468999999999998889999999999999999999999997533221110 0000000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..+ ..+.. .....++++.+++.+|++.||++||+++|++++-
T Consensus 213 ~~~-----~~~~~-----------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 213 VDE-----DPPVL-----------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred hcc-----CCCCC-----------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 000 00000 0011245688999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.27 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=199.1
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
++|++.+.||+|+||+||+|++.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++... +..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEE
Confidence 478889999999999999998863 45699998864332 346789999999999999999999998654 45799
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++|+|.+++..... .+++.+++.++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence 9999999999999976532 689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..........
T Consensus 149 ~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~ 219 (256)
T cd05113 149 YVLDDEYT-------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLR 219 (256)
T ss_pred ecCCCcee-------ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCC
Confidence 65432211 1112345678999999988889999999999999999999 999986432110 0000000000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
. ......+..+.+++.+||+.||.+||++.++++.++
T Consensus 220 ~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 L--------------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C--------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 000112467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.91 Aligned_cols=254 Identities=28% Similarity=0.437 Sum_probs=200.4
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchH--HHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
|++.+.||+|+||+||+|++..+++.||+|++........ ....+|+.++++++||||+++++++... ...++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-----NYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-----SEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-----ccccc
Confidence 6788999999999999999999999999999986654332 2345699999999999999999998764 77899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++++|.+++.... .+++.+++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 76 v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 999999999999998332 689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCccccc-CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
.... .........++..|+|||++. +..++.++||||+|+++|+|++|..||...... ............
T Consensus 147 ~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~~ 217 (260)
T PF00069_consen 147 KLSE--------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKILKR 217 (260)
T ss_dssp ESTS--------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHHHT
T ss_pred cccc--------cccccccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhcccc
Confidence 5411 111222356899999999998 788999999999999999999999999764110 000000000000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... . .........++.+++.+||+.||++||++.+++++
T Consensus 218 ~~~~---------~------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 218 PLPS---------S------------SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHH---------H------------TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccc---------c------------ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0 00000113689999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=354.80 Aligned_cols=263 Identities=20% Similarity=0.285 Sum_probs=202.6
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.....++|.+.+.||+|+||+||+|++..++..||+|++.... ......+..|+.++++++||||++++++|....
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~-- 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA-- 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC--
Confidence 3445678999999999999999999999999999999987442 234567889999999999999999999875432
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCC----CCceeecCCCCceEeCC--
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQ----PPMVHGDLKPSNVLLDH-- 851 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~ivH~Dlkp~NIll~~-- 851 (1017)
....|+||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 86 -~~~lyIVMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 86 -NQKLYILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 2568999999999999999976421 12368999999999999999999998521 25999999999999964
Q ss_pred ---------------CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccC--CCcCccccchhHHHHH
Q 043932 852 ---------------DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--SEASMTGDVYSFGILL 914 (1017)
Q Consensus 852 ---------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 914 (1017)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||+
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL 233 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccc---------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence 2458999999997653221 1123468999999999854 4588999999999999
Q ss_pred HHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC
Q 043932 915 LELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE 994 (1017)
Q Consensus 915 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 994 (1017)
|||++|+.||..... ........... +. ......+..+.+++..||+.+|.+
T Consensus 234 YELLTGk~PF~~~~~----~~qli~~lk~~-------p~-----------------lpi~~~S~eL~dLI~~~L~~dPee 285 (1021)
T PTZ00266 234 YELCSGKTPFHKANN----FSQLISELKRG-------PD-----------------LPIKGKSKELNILIKNLLNLSAKE 285 (1021)
T ss_pred HHHHHCCCCCCcCCc----HHHHHHHHhcC-------CC-----------------CCcCCCCHHHHHHHHHHhcCChhH
Confidence 999999999965321 11111110000 00 000112466889999999999999
Q ss_pred CCCHHHHHHH
Q 043932 995 RMEMRDVVAK 1004 (1017)
Q Consensus 995 RPs~~evl~~ 1004 (1017)
||++.|++++
T Consensus 286 RPSa~QlL~h 295 (1021)
T PTZ00266 286 RPSALQCLGY 295 (1021)
T ss_pred CcCHHHHhcc
Confidence 9999999853
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.30 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=194.1
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.++.++ +||+|+++++++... +..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEE
Confidence 46999999999999999999999999997532 23446678899999888 699999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999999999887653 689999999999999999999999 9999999999999999999999999998743
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC-ccHHHHHHhhcCch
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG-LTLHEFAKIALPEK 945 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~ 945 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..............
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 218 (327)
T cd05617 147 LGPG--------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218 (327)
T ss_pred cCCC--------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC
Confidence 2111 11123568999999999999899999999999999999999999996532211 11111100000000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM------RDVVAK 1004 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 1004 (1017)
. .......+..+.+++.+|++.||++||++ .++++|
T Consensus 219 ----------------~-------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 219 ----------------P-------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ----------------C-------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 0 00011224567899999999999999985 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=327.32 Aligned_cols=204 Identities=24% Similarity=0.318 Sum_probs=163.5
Q ss_pred cCcccccCCceEEEEEeC--CCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 710 SNMIGQGSFGSVYKGILG--EDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
.++||+|+||+||+|++. .+++.||+|.+.... ....+.+|++++++++||||+++++++.... ....++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEe
Confidence 468999999999999975 366889999986432 2345778999999999999999999875432 256899999
Q ss_pred eccCCCHHHHHhhCCCC---ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe----CCCCCeEEeec
Q 043932 788 CMKNGSLEDWLHQSNDH---LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVSHVGDF 860 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Df 860 (1017)
|+++ +|.+++...... .....+++..+..++.||+.||+|||++ +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9854 898887643211 1123588999999999999999999999 99999999999999 45679999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
|+++....... .........||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCc-----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99986543211 1111223578999999999877 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.72 Aligned_cols=271 Identities=22% Similarity=0.279 Sum_probs=209.3
Q ss_pred cCHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeec
Q 043932 695 VSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSS 773 (1017)
Q Consensus 695 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 773 (1017)
+.++++..+.++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4456667788999999999999999999999999999999998864322 235678899999999 69999999998865
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
......+..++||||+++++|.+++..... ....+++..+..++.|+++|+.|||+. +++||||||+||+++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 544445678999999999999998864321 123678899999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccC-----CCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----SEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
.+||+|||++........ ......|++.|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 162 ~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred CEEEccCCceeecccCCC--------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999876532211 1122468999999998753 347889999999999999999999986532
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.. .......... .....+ ...+...+.+++.+||+.||++|||+.|++++.
T Consensus 234 ~~----~~~~~~~~~~-~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 234 PM----RALFKIPRNP-PPTLHQ---------------------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hh----HHHhhccccC-CCcccC---------------------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 1111000000 000000 011245688999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.33 Aligned_cols=276 Identities=22% Similarity=0.326 Sum_probs=204.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++|++.++||+|+||.||+|++..++..||+|.+..... ....++.+|++++++++||||+++++++... ++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEE
Confidence 368899999999999999999999999999999875433 2345688999999999999999999998655 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
+||||+++++|.+++.... .+++..+..++.|+++||+|||+ . +++||||||+||+++.++.+||+|||+
T Consensus 76 lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred EEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCC
Confidence 9999999999999997653 67899999999999999999997 5 899999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 147 ~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~ 214 (308)
T cd06615 147 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPV 214 (308)
T ss_pred cccccccc----------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCcc
Confidence 86543211 12246889999999998888999999999999999999999998653221 1111111000
Q ss_pred Cchhh---------hhccchhhHHHHhhcch-hHHHhHH-hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 943 PEKVI---------EIVDPLLLIEVMANNSM-IQEDIRA-KTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 943 ~~~~~---------~~~d~~l~~~~~~~~~~-~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
..... ...+............. .....+. ....++.++.+++.+|+..||++||++.|++++-.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 215 SEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred ccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000 00000000000000000 0000000 00124567899999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.22 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=205.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcE----EEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
..+|++.++||+|+||+||+|++..+++ .||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 3578899999999999999999866665 489999864433 335678899999999999999999998854
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
...++++||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence 236799999999999999976432 689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++......... ......++..|+|||...+..++.++|||||||++|||++ |..||...... .....
T Consensus 152 dfG~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~ 223 (279)
T cd05109 152 DFGLARLLDIDETEY------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDL 223 (279)
T ss_pred CCCceeeccccccee------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 999998664322110 0111235678999999988889999999999999999998 89998653211 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
...... ......++..+.+++.+||+.||++||++.|+++.++.+....
T Consensus 224 ~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 224 LEKGER--------------------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHCCCc--------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 110000 0001123567889999999999999999999999999887765
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.21 Aligned_cols=266 Identities=27% Similarity=0.397 Sum_probs=206.2
Q ss_pred HhhccccccCcccccCCceEEEEEeCCC-----cEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeecC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGED-----EMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSSI 774 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 774 (1017)
...++|++.+.||+|+||.||+|.+... ...||+|.+.... .....++.+|+++++++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3456789999999999999999998643 3789999987432 23346688999999999 899999999988654
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKP 844 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 844 (1017)
+..++||||+++|+|.+++...... .....+++..++.++.|++.|++|||+. +|+||||||
T Consensus 89 -----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp 160 (293)
T cd05053 89 -----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA 160 (293)
T ss_pred -----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence 5689999999999999999754210 1234689999999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCC
Q 043932 845 SNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923 (1017)
Q Consensus 845 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 923 (1017)
+||+++.++.+||+|||.++.......... .....++..|+|||++.+..++.++|||||||++||+++ |..|
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 234 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceec------cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCC
Confidence 999999999999999999986643221111 111235678999999988889999999999999999998 9999
Q ss_pred CCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 924 TDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 924 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
|...... +.......... ......++..+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~-----~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 235 YPGIPVE-----ELFKLLKEGYR-----------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred CCCCCHH-----HHHHHHHcCCc-----------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 8653211 11110000000 0011123567889999999999999999999999
Q ss_pred HHhhcc
Q 043932 1004 KLCHTR 1009 (1017)
Q Consensus 1004 ~L~~~~ 1009 (1017)
.|+++.
T Consensus 287 ~l~~~~ 292 (293)
T cd05053 287 DLDRML 292 (293)
T ss_pred HHHHhh
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.45 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=203.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||+|++|.||+|.+..+++.||+|.+... .....+.+.+|++++++++|||++++++++... +..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence 477889999999999999999999999999998743 234457788999999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++.+++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 99999999999999986421 3688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
+....... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~ 215 (256)
T cd08529 149 KLLSDNTN--------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----ALILKIIR 215 (256)
T ss_pred eeccCccc--------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHc
Confidence 86543221 112245789999999999888999999999999999999999999754311 11000000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. .......++..+.+++.+|++.+|++||++.|++++
T Consensus 216 ~~-----------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 GV-----------------------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CC-----------------------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 000111345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.93 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=202.6
Q ss_pred hccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.++++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 4678999999999999999999976 678899998864432 3345688999999999999999999987654
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCC-ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC---
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM--- 853 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 853 (1017)
+..++||||+++++|.+++...+.. .....+++.++..++.||+.|++|||+. +++||||||+||+++.++
T Consensus 82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence 5578999999999999999765421 1223689999999999999999999999 999999999999998754
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGL 932 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 932 (1017)
.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~- 229 (277)
T cd05036 157 VAKIADFGMARDIYRASYYR------KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE- 229 (277)
T ss_pred ceEeccCccccccCCcccee------cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 69999999998653221110 0111234568999999988889999999999999999997 999987532211
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.........+ ......++..+.+++.+|++.+|++||++.+|+++|.
T Consensus 230 -~~~~~~~~~~--------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 -VMEFVTGGGR--------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -HHHHHHcCCc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111000000 0001123567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.67 Aligned_cols=261 Identities=23% Similarity=0.410 Sum_probs=202.2
Q ss_pred ccccccCcccccCCceEEEEEe----CCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
++|++.+.||+|+||+||+|.. ..++..||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE----- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----
Confidence 4688889999999999999985 34567899999874332 3346788999999999999999999987654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCC-----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceE
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDH-----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 848 (1017)
+..|+||||+++++|.+++...... .....+++.++..++.|++.||+|||++ +++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 5689999999999999998643210 0123578899999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcc
Q 043932 849 LDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAA 927 (1017)
Q Consensus 849 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 927 (1017)
++.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYR------VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred EcCCCcEEeccccccccccCCccee------cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999998654322111 1112345778999999988889999999999999999998 99898653
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
... ...+....... ......+++++.+++.+|++.||++||++.+|.++|..
T Consensus 231 ~~~--~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 231 SNQ--EVIEMVRKRQL--------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CHH--HHHHHHHcCCc--------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 211 11111110000 00111235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.57 Aligned_cols=267 Identities=23% Similarity=0.337 Sum_probs=203.5
Q ss_pred hccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 776 (1017)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence 458999999999999999999853 457889999997543 23346788999999999 689999999987543
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCc---------------------------------------------------
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHL--------------------------------------------------- 805 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 805 (1017)
....++||||+++|+|.+++.......
T Consensus 84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 245789999999999999987532100
Q ss_pred ----------cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccccccc
Q 043932 806 ----------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875 (1017)
Q Consensus 806 ----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 875 (1017)
....+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--- 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch---
Confidence 012478889999999999999999999 9999999999999999999999999998765322110
Q ss_pred cCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchhhhhccchh
Q 043932 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLL 954 (1017)
Q Consensus 876 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 954 (1017)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||........ ...........
T Consensus 236 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~---------- 301 (343)
T cd05103 236 ---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRM---------- 301 (343)
T ss_pred ---hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccCCC----------
Confidence 00111345678999999988889999999999999999997 9999865322110 00000000000
Q ss_pred hHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 955 LIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
......++++.+++.+||+.||++||++.||+++|+.+.+
T Consensus 302 ----------------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 302 ----------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ----------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000123568899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=337.60 Aligned_cols=263 Identities=18% Similarity=0.261 Sum_probs=202.7
Q ss_pred HHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeec
Q 043932 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 697 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
..+.....++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556689999999999999999999999999999999986432 2234567789999999999999999998865
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
. ++.++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 115 ~-----~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 115 D-----RYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred C-----CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCC
Confidence 4 6789999999999999998653 478888999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCC----CcCccccchhHHHHHHHHHhCCCCCCcccc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS----EASMTGDVYSFGILLLELFTGRRPTDAAFT 929 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~ 929 (1017)
.+||+|||++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 180 ~ikL~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 180 HLKLADFGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred CEEEEeCCceeEcCcCCc-------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 999999999986542211 111235699999999998654 378899999999999999999999975322
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHh
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE--RMEMRDVVAKLC 1006 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~ 1006 (1017)
. ..+............. .....+..+.+++.+|+..+|.+ ||++.|+++|..
T Consensus 253 ~----~~~~~i~~~~~~~~~~---------------------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 253 V----GTYSKIMNHKNSLTFP---------------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred H----HHHHHHHcCCCcccCC---------------------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 1 1111110000000000 01123556788999999844443 789999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.99 Aligned_cols=256 Identities=30% Similarity=0.464 Sum_probs=203.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||.||+|.+. +++.||+|.++... ...+.+.+|++++++++||||+++++++... +..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCee
Confidence 457889999999999999999986 45789999987543 2346788999999999999999999987654 5689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++
T Consensus 78 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred eeeecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence 9999999999999997643 23689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+........ .......+..|+|||++.+..++.++||||||+++|||++ |+.||....... ..... ....
T Consensus 151 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~-~~~~ 221 (261)
T cd05068 151 RVIKEDIYE-------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQV-DQGY 221 (261)
T ss_pred EEccCCccc-------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH-HcCC
Confidence 876422110 0111223468999999988889999999999999999999 999986532110 00000 0000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
. ......++..+.+++.+|++.||.+||++.++++.|+++
T Consensus 222 ~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 R--------------------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred C--------------------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 000112356789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=331.24 Aligned_cols=238 Identities=27% Similarity=0.312 Sum_probs=187.4
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHH-HHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECK-ALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
+.||+|+||+||+|++..+++.||+|++.... ....+++.+|.. +++.++||||+++++++... +..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEE
Confidence 46999999999999999999999999997432 222344455544 46778999999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999999999987653 688899999999999999999999 9999999999999999999999999998743
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~- 212 (323)
T cd05575 147 IEHS--------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNKP- 212 (323)
T ss_pred ccCC--------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcCC-
Confidence 2111 1122356899999999999989999999999999999999999999753211 1111100000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
. ......+..+.+++.+|++.||.+||++.
T Consensus 213 ----------------~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 ----------------L-------RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----------------C-------CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0 00011255688999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=337.96 Aligned_cols=209 Identities=24% Similarity=0.337 Sum_probs=176.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.++..++||+|+++++.+... ++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-----RN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CE
Confidence 36888999999999999999999999999999997432 33456778899999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 899999999999999997653 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccc---------------------------cCCCcccccccCccccCcccccCCCcCccccchhHHHHH
Q 043932 862 LAKFLSSHQLDTAS---------------------------KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILL 914 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 914 (1017)
++............ ..........||+.|+|||++.+..++.++||||+||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 98755321100000 000011235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCcc
Q 043932 915 LELFTGRRPTDAA 927 (1017)
Q Consensus 915 ~elltg~~pf~~~ 927 (1017)
|||++|+.||...
T Consensus 227 yel~tG~~Pf~~~ 239 (360)
T cd05627 227 YEMLIGYPPFCSE 239 (360)
T ss_pred eecccCCCCCCCC
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=321.31 Aligned_cols=265 Identities=23% Similarity=0.354 Sum_probs=210.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.+...+.++||+|-||+|.+++.. .+..||||+++.... ...+.|.+|+++|.+++||||++++|+|..+ +.+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePi 610 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPL 610 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----Cch
Confidence 346778899999999999999986 478999999986654 4458899999999999999999999999876 557
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++|+||++.|+|.+|+..+.. .........+|+.||+.||+||.+. ++||||+.+.|+|++.++++||+|||+
T Consensus 611 cmI~EYmEnGDLnqFl~ahea----pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHEL----PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccC----cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccc
Confidence 999999999999999988742 1245556677999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh--CCCCCCcccccCccHHHHHHh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT--GRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~~~~~~~~~~ 940 (1017)
++-+...+...... ..+-+.+|||||.+.-.+++.++|||+||+++||+++ ...||....++ +..+-..
T Consensus 684 sR~lysg~yy~vqg------r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~- 754 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQG------RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAG- 754 (807)
T ss_pred ccccccCCceeeec------ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhh-
Confidence 98665444322211 1345689999999988899999999999999999876 77788654332 1111111
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
++.+..-... ....+.-|+..+.+++.+||..|-++||+++++..+|.+.
T Consensus 755 -------~~~~~~~~~~-----------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 755 -------EFFRDQGRQV-----------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -------hhcCCCCcce-----------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111111000 1123445788999999999999999999999999888764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=353.76 Aligned_cols=487 Identities=26% Similarity=0.335 Sum_probs=370.0
Q ss_pred eEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecc
Q 043932 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVS 157 (1017)
Q Consensus 78 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (1017)
+++.|+++.|-+-..+-+.+.+.-+|++|||++|.+. ..|..+..+.+|+.|+++.|.+. .+|.+..++.+|++|.|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 4777777777665544444445555888888888887 77888888888888888888888 788888888888888888
Q ss_pred cccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCcccccc
Q 043932 158 NNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTF 237 (1017)
Q Consensus 158 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 237 (1017)
+|.+. ..|.++..+++|+.|+++.|.+. .+|..+..++.++.+..++|.... .++... ++.+++..|.+.+.+
T Consensus 100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~ 172 (1081)
T KOG0618|consen 100 NNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSF 172 (1081)
T ss_pred cchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccch
Confidence 88887 77888888888888888888887 678888888888888888882221 222222 778888888888888
Q ss_pred chhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeecccccc
Q 043932 238 PQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSL 317 (1017)
Q Consensus 238 p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 317 (1017)
+..+..++. .|+|++|.+. .+. ...+++|+.|....|++... --..++|+.|+.++|.++...+. ..-
T Consensus 173 ~~~i~~l~~--~ldLr~N~~~-~~d---ls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~--p~p 240 (1081)
T KOG0618|consen 173 LIDIYNLTH--QLDLRYNEME-VLD---LSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVH--PVP 240 (1081)
T ss_pred hcchhhhhe--eeecccchhh-hhh---hhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeeccc--ccc
Confidence 887777776 7888888876 332 34667888888888887632 12346788888888888733222 123
Q ss_pred CccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccc
Q 043932 318 KNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLV 397 (1017)
Q Consensus 318 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~ 397 (1017)
.+|++++++.|+++. .+.+++.+.+|+.++..+|+++ .+|..+.... +|+.|....|.+.. +|.....++
T Consensus 241 ~nl~~~dis~n~l~~-------lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~-~L~~l~~~~nel~y-ip~~le~~~ 310 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSN-------LPEWIGACANLEALNANHNRLV-ALPLRISRIT-SLVSLSAAYNELEY-IPPFLEGLK 310 (1081)
T ss_pred ccceeeecchhhhhc-------chHHHHhcccceEecccchhHH-hhHHHHhhhh-hHHHHHhhhhhhhh-CCCcccccc
Confidence 478888888888864 3356778888888888888885 6777666653 58888888888875 566778889
Q ss_pred cccEEeccccCCCCCcchhhccccc-ccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeec
Q 043932 398 NLIALGMQSNQLHGTIPDVIGELKN-LQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNA 476 (1017)
Q Consensus 398 ~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l 476 (1017)
.|+.|+|..|+|...++..|.-+.. |..|+.+.|++.......=..++.|+.|++.+|.++...-..+.++.+|+.|+|
T Consensus 311 sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL 390 (1081)
T KOG0618|consen 311 SLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL 390 (1081)
T ss_pred eeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence 9999999999998555555555544 788888888888443333345678999999999999877778889999999999
Q ss_pred CCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCC
Q 043932 477 SHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHG 556 (1017)
Q Consensus 477 s~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 556 (1017)
++|+|. .+|+....-...++.|+||+|+++ .+|..+.++..|++|...+|++. ..| .+..++.|+.+|+|.|+|+.
T Consensus 391 syNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 391 SYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred cccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 999998 788776666555667999999998 68889999999999999999998 667 78899999999999999985
Q ss_pred CC-CccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccC
Q 043932 557 VI-PHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600 (1017)
Q Consensus 557 ~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 600 (1017)
.. |...-. ++|++|||++|.-.-..-..|..+.++...+++-|
T Consensus 467 ~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 467 VTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 43 332222 89999999999744355566777777887887777
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.05 Aligned_cols=277 Identities=21% Similarity=0.302 Sum_probs=202.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|.+.... ......+.+|+.++++++||||+++++++... +..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC-----CeE
Confidence 357999999999999999999999899999999987443 23345677899999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||++ ++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcc
Confidence 99999997 599998876542 578899999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+....... .......+++.|+|||++.+. .++.++||||+||++|||++|++||......+ .........
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~ 221 (301)
T cd07873 151 ARAKSIPT--------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRIL 221 (301)
T ss_pred hhccCCCC--------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHc
Confidence 87543211 011123578899999988654 57889999999999999999999997643211 111111110
Q ss_pred c---CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 L---PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. ...+....+....... .................++.+.+++.+|++.||.+|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 222 GTPTEETWPGILSNEEFKSY-NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CCCChhhchhhhcccccccc-ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0001111100000000 000000000111122345678899999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.11 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=201.6
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
.|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++|||++++++++... +..++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEEE
Confidence 367889999999999999999999999999998765555567888999999999999999999988654 678999
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
|||+++++|..++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 81 ~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 81 IEFCAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccc
Confidence 99999999999886533 2689999999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
..... .......|+..|+|||++. +..++.++||||+||++|||++|++||....... ........
T Consensus 153 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~ 223 (282)
T cd06643 153 NTRTI--------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKS 223 (282)
T ss_pred ccccc--------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhc
Confidence 43211 1112246899999999884 3457889999999999999999999986532111 11111000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
..+ .. .....++..+.+++.+||+.||.+||++.+++++-.
T Consensus 224 ~~~----~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 224 EPP----TL---------------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred CCC----CC---------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 000 00 001123567889999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.35 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=201.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.++||+|+||.||+|++..+ ..||+|++..... ..+.+.+|++++++++||||+++++++.. +..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcE
Confidence 45799999999999999999998755 4599999874332 34678899999999999999999987632 3468
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred EEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence 99999999999999976421 3578999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
......... ......++..|+|||+..+..++.++||||+||++|||++ |..||....... .......
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----~~~~~~~ 218 (262)
T cd05071 150 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVER 218 (262)
T ss_pred eeccccccc-------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----HHHHHhc
Confidence 765432211 1112346778999999988889999999999999999999 888886532210 0000000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
. .. .....+++..+.+++.+|++.||++||++.++++.|++.
T Consensus 219 ~------~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 G------YR------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred C------CC------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 00 001123466789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.25 Aligned_cols=242 Identities=22% Similarity=0.316 Sum_probs=191.9
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCce
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 781 (1017)
+|+..+.||+|+||+||+|++..+++.||+|++.... ....+.+..|..+++.+. |++|+++.+++... +.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CE
Confidence 4677889999999999999999999999999987432 233456778888888885 57788888877554 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 899999999999999987653 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........
T Consensus 147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-~~~~i~~~~ 217 (323)
T cd05615 147 MCKEHMVDG--------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-LFQSIMEHN 217 (323)
T ss_pred cccccCCCC--------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence 987532211 11123468999999999998889999999999999999999999997642210 000000000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM 998 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 998 (1017)
. ..+...+.++.+++.+|++.||.+|++.
T Consensus 218 ~----------------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 V----------------------------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C----------------------------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 0011224567899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.02 Aligned_cols=261 Identities=26% Similarity=0.432 Sum_probs=203.8
Q ss_pred ccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.+|...++||+|+||.||+|+.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG----- 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----
Confidence 57788999999999999999743 35678999998765555567899999999999999999999988654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCC---------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDH---------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
+..++||||+++++|.+++...... .....+++.+++.++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 5679999999999999999765321 1113588999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccc
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFT 929 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 929 (1017)
+++.+||+|||++......... .......+++.|+|||.+.+..++.++|||||||++|||++ |.+||.....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 9999999999998755322110 11112345788999999998889999999999999999998 8999864322
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
.. .........+ ......+++.+.+++.+||+.||.+||++.||++.|++
T Consensus 231 ~~--~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 231 TE--AIECITQGRE--------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HH--HHHHHHcCcc--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11 0000000000 00111345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.17 Aligned_cols=252 Identities=29% Similarity=0.451 Sum_probs=198.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
.+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|++++++++||||+++++++... +..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceEE
Confidence 46888999999999999999986 466799999864332 235688899999999999999999987544 56899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++++|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence 9999999999999976542 688999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ .... .....
T Consensus 149 ~~~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~-~~~~~- 218 (256)
T cd05059 149 YVLDDQYT-------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVES-VSAGY- 218 (256)
T ss_pred eccccccc-------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HHHH-HHcCC-
Confidence 65322110 0111234567999999988889999999999999999999 899986532211 0000 00000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
. ......++.++.+++.+|+..+|++|||+.|+++.|.
T Consensus 219 -------~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 219 -------R------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -------c------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0 0001124667899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.38 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=195.2
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEee--ecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 779 (1017)
....|++.+.||+||.+.||++...+ .+.||+|.+. ..+.....-|.+|+..|.++ .|.+|+++++|-...
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d----- 432 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD----- 432 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-----
Confidence 34679999999999999999999874 4556666654 23445567899999999999 599999999986543
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
++.|+||||-+ .+|..++++... ..+...++.+..||+.|+.++|.+ ||||.||||.|+++- .|.+||+|
T Consensus 433 ~~lYmvmE~Gd-~DL~kiL~k~~~-----~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLID 502 (677)
T KOG0596|consen 433 GYLYMVMECGD-IDLNKILKKKKS-----IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLID 502 (677)
T ss_pred ceEEEEeeccc-ccHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeee
Confidence 88999999864 499999998764 333337888999999999999999 999999999999984 67999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCC-----------CcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-----------EASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
||+|..+..+.... .....+||+.|||||.+... +.++++||||+|||+|+|+.|++||....
T Consensus 503 FGIA~aI~~DTTsI------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 503 FGIANAIQPDTTSI------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred echhcccCccccce------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 99998776544222 22336899999999998442 25788999999999999999999996531
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. .+. ++..+.+|.-..++.. +. ...++.++++.||.+||.+||+..|+++|
T Consensus 577 n------~~a------Kl~aI~~P~~~Iefp~--------~~-----~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 N------QIA------KLHAITDPNHEIEFPD--------IP-----ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred H------HHH------HHHhhcCCCccccccC--------CC-----CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1 111 2223333322111110 00 12338999999999999999999999976
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.94 Aligned_cols=240 Identities=28% Similarity=0.320 Sum_probs=187.4
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHH-HHHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAEC-KALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
+.||+|+||+||+|++..+++.||+|++.... ......+..|. .+++.++||||+++++++... +..|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence 46999999999999999999999999997432 12223344444 356778999999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999999999997653 577888899999999999999999 9999999999999999999999999998743
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +.........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~- 212 (325)
T cd05602 147 IEHN--------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNILNKP- 212 (325)
T ss_pred ccCC--------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHHHHHhCC-
Confidence 2211 1122356999999999999989999999999999999999999999753221 1110000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDV 1001 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1001 (1017)
. ......+..+.+++.+|++.||.+||++.+.
T Consensus 213 ----------------~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 213 ----------------L-------QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred ----------------c-------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 0 0011235568899999999999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.24 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=199.9
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
|+..++||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++|++++++++.+... +..+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEEE
Confidence 6777899999999999999999999999999864322 2234567899999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 77 lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred EEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 99999999999999865432 3588999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
....... ......|+..|+|||++.+..++.++||||+||++|+|++|+.||....... .......
T Consensus 150 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~~~---- 215 (285)
T cd05630 150 VHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVER---- 215 (285)
T ss_pred eecCCCc---------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHHHh----
Confidence 7543211 1112468999999999998889999999999999999999999997532210 0000000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAKL 1005 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 1005 (1017)
..+. . . ......+++.+.+++.+||+.||++||| +.|+++|-
T Consensus 216 -----~~~~-~-----------~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 216 -----LVKE-V-----------Q---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred -----hhhh-h-----------h---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 0000 0 0 0011223566889999999999999999 88988753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=324.07 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=204.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|+||+++++++... ++.+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEE
Confidence 46899999999999999999999889999999999866555567788999999999999999999998654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 93 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred EeecccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence 999999999999998653 578889999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......+++.|+|||.+.+..++.++||||+||++|++++|+.||........... ......+
T Consensus 163 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~~~~ 233 (297)
T cd06656 163 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTP 233 (297)
T ss_pred eEccCCcc--------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccCCCC
Confidence 75432211 11124588899999999888899999999999999999999999965322111000 0000000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. . ......+..+.+++.+||+.||++||++.+++++
T Consensus 234 ~----~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 234 E----L---------------------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred C----C---------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 0011234567899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=319.16 Aligned_cols=275 Identities=24% Similarity=0.398 Sum_probs=204.4
Q ss_pred ccccccCcccccCCceEEEEEe----CCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.-|++.+.||+|+||.||+|+. ..++..||+|.++... ....+.+.+|++++++++|||++++++++... +.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 3478899999999999999984 3567889999987443 33446788999999999999999999988553 22
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ +++||||||+||+++.++.++|+|
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECC
Confidence 56799999999999999997543 2579999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+++......... .......++..|+|||++.+..++.++|||||||++|||++++.|+...... . .+
T Consensus 153 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~---~~ 221 (284)
T cd05079 153 FGLTKAIETDKEYY-----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---F---LK 221 (284)
T ss_pred CccccccccCccce-----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---h---hh
Confidence 99998654322110 1111245777899999998888999999999999999999988775432111 0 00
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
...+... +....... ........ ......++..+.+++.+|++.||++||++.++++.++++
T Consensus 222 ~~~~~~~-~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 222 MIGPTHG-QMTVTRLV-RVLEEGKR-----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hcccccc-cccHHHHH-HHHHcCcc-----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000 00000000 00000000 001123467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=333.98 Aligned_cols=269 Identities=25% Similarity=0.343 Sum_probs=206.1
Q ss_pred HHHhhccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQK-GAFKSFMAECKALRNIR-HRNLIKIITICS 772 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 772 (1017)
+....++|.+.++||+|+||.||+|++. ..++.||+|++..... ...+.+.+|++++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3444567889999999999999999964 3456899999975432 23457889999999997 999999999986
Q ss_pred cCCCCCCceeEEEEEeccCCCHHHHHhhCCCC------------------------------------------------
Q 043932 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDH------------------------------------------------ 804 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------ 804 (1017)
.. +..++||||+++|+|.++++..+..
T Consensus 112 ~~-----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 112 KG-----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred cC-----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 54 5689999999999999999764310
Q ss_pred --------------------------------------------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceee
Q 043932 805 --------------------------------------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHG 840 (1017)
Q Consensus 805 --------------------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 840 (1017)
.....+++.++..++.|++.||+|||+. +++||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHr 263 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHR 263 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcc
Confidence 0113467888999999999999999999 99999
Q ss_pred cCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-
Q 043932 841 DLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT- 919 (1017)
Q Consensus 841 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt- 919 (1017)
||||+||++++++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~ 337 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNY------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceeccccccc------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHc
Confidence 99999999999999999999999765322110 01112346789999999988889999999999999999998
Q ss_pred CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 920 GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 920 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
|..||......+. .........+. .....++.++.+++.+||..+|.+||+++
T Consensus 338 g~~P~~~~~~~~~-~~~~~~~~~~~--------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ 390 (401)
T cd05107 338 GGTPYPELPMNEQ-FYNAIKRGYRM--------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFS 390 (401)
T ss_pred CCCCCCCCCchHH-HHHHHHcCCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 8899865321110 00000000000 00112356789999999999999999999
Q ss_pred HHHHHHhhcc
Q 043932 1000 DVVAKLCHTR 1009 (1017)
Q Consensus 1000 evl~~L~~~~ 1009 (1017)
||++.|+.+.
T Consensus 391 ell~~L~~~~ 400 (401)
T cd05107 391 QLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHHh
Confidence 9999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=322.42 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=204.6
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
..+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+..++.++|||++++++++... +..+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-----DELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-----ceEE
Confidence 35799999999999999999999989999999999766555567888999999999999999999998654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+|+||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++
T Consensus 93 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 93 VVMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred EEEEecCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999998643 578999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......|+..|+|||.+.+..++.++|||||||++|++++|+.||........ ....... ..
T Consensus 163 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~-~~ 232 (296)
T cd06655 163 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATN-GT 232 (296)
T ss_pred hhcccccc--------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc-CC
Confidence 75543221 11124588999999999888899999999999999999999999976422110 0000000 00
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. ......+++.+.+++.+||..||++||++.+++++
T Consensus 233 ~~------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 233 PE------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cc------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 00111235678899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.50 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=203.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCc---EEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDE---MIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..+|+..+.||+|+||.||+|+...++ ..+|+|.+.... ....+.+.+|++++++++|||++++.+++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF----- 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----
Confidence 357888999999999999999986554 379999986543 33456788999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence 568999999999999999976432 688999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||++........... .......+..|+|||++.+..++.++|||||||++||+++ |+.||...... +..
T Consensus 151 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~ 220 (268)
T cd05063 151 FGLSRVLEDDPEGTY-----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVM 220 (268)
T ss_pred Cccceecccccccce-----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHH
Confidence 999876543211110 0111223567999999988889999999999999999998 99998653221 111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
....... ......+++.++.+++.+|++.+|++||++.+|++.|+++
T Consensus 221 ~~i~~~~-----------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 221 KAINDGF-----------------------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHhcCC-----------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1000000 0001113456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=324.99 Aligned_cols=263 Identities=25% Similarity=0.401 Sum_probs=203.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcE--EEEEEEeeec-CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEM--IVAVKVINLK-QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 780 (1017)
++|++.++||+|+||.||+|....++. .+++|.++.. .....+.+.+|+++++++ +||||+++++++... +
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----G 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----C
Confidence 578999999999999999999876664 4688887632 233456788999999999 799999999988654 5
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCc----------cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHL----------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
..++||||+++++|.+++....... ....+++..++.++.|++.|++|||++ +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 6899999999999999997643111 113588999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccc
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFT 929 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 929 (1017)
.++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYV---------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred CCCeEEECCcCCCcccccee---------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999986322110 0001123567999999988889999999999999999997 9999965322
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
. ........ .. . ......++..+.+++.+|++.+|.+||++.++++.|+.+.
T Consensus 225 ~-----~~~~~~~~-~~----~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 225 A-----ELYEKLPQ-GY----R------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred H-----HHHHHHhc-CC----C------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 11100000 00 0 0011123567899999999999999999999999999887
Q ss_pred ccc
Q 043932 1010 ETF 1012 (1017)
Q Consensus 1010 ~~~ 1012 (1017)
+.+
T Consensus 277 ~~~ 279 (297)
T cd05089 277 EAR 279 (297)
T ss_pred Hhh
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=315.80 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=205.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||.||+|.+..+++.+|+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEE
Confidence 35789999999999999999999888999999999866655678899999999999999999999987654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
++|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.+
T Consensus 77 l~~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccc
Confidence 9999999999999987653 2688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCC---CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS---EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
....... .......++..|+|||.+.+. .++.++||||+|+++|||++|+.||........ .......
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~ 219 (262)
T cd06613 149 AQLTATI--------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKS 219 (262)
T ss_pred hhhhhhh--------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc
Confidence 7654211 011224678899999998776 788999999999999999999999865321110 0000000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... +. .......+.++.+++.+||+.||.+|||+.+|+.+
T Consensus 220 ~~~~-------~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 220 NFPP-------PK----------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cCCC-------cc----------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00 00112335678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=333.29 Aligned_cols=239 Identities=25% Similarity=0.317 Sum_probs=190.4
Q ss_pred CcccccCCceEEEEEe---CCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 711 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
+.||+|+||.||++++ ..+++.||+|++..... .....+.+|++++++++||||+++++++... +..|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEEE
Confidence 5799999999999986 35788999999974332 2335567899999999999999999998654 678999
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999999987543 689999999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCch
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 148 ~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i~~~~ 214 (318)
T cd05582 148 SIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMILKAK 214 (318)
T ss_pred cCCCC--------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHHHcCC
Confidence 43221 1122356899999999999888999999999999999999999999753211 1100000000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRD 1000 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1000 (1017)
. ......++.+.+++.+||+.||++||++.+
T Consensus 215 ~------------------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 L------------------------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 001123456789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=322.36 Aligned_cols=269 Identities=22% Similarity=0.287 Sum_probs=208.4
Q ss_pred CHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecC
Q 043932 696 SYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSI 774 (1017)
Q Consensus 696 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 774 (1017)
...++..+.++|.+.+.||+|+||.||+|....+++.||+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34556667889999999999999999999999899999999986432 2235677899999999 899999999998765
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 854 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 854 (1017)
+....+..++||||+++++|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 44444678999999999999998864321 123688999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccCC-----CcCccccchhHHHHHHHHHhCCCCCCcccc
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-----EASMTGDVYSFGILLLELFTGRRPTDAAFT 929 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~ 929 (1017)
+||+|||.+......... .....|+..|+|||.+... .++.++||||+||++|||++|+.||.....
T Consensus 167 ~kl~dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EEEeecccchhccccccc--------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 999999998765422211 1124578999999987543 368899999999999999999999865322
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. ......... +. ...+ .......+.+++.+|++.||++||++.|++++
T Consensus 239 ~~-~~~~~~~~~-~~---~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 239 VK-TLFKIPRNP-PP---TLLH---------------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH-HHHHHhcCC-CC---CCCc---------------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 111110000 00 0000 11224568999999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.41 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=201.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEE--EEEEEeeec-CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMI--VAVKVINLK-QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.+.||+|+||.||+|++..++.. +|+|.+... .....+.+.+|++++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~----- 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----
Confidence 35788899999999999999998777654 577766532 223446788999999999 899999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCc----------cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHL----------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
+..++||||+++++|.+++....... ....+++.+++.++.|++.|++|||++ +++||||||+||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 56899999999999999997653211 123678999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCccc
Q 043932 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAF 928 (1017)
Q Consensus 850 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~ 928 (1017)
+.++.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||+| |..||....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred cCCCcEEeCccccCcccchhh---------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 999999999999986321100 0011234668999999988889999999999999999998 999986432
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
.. +..... +... . ......+++.+.+++.+|++.+|++||++.+++++++.+
T Consensus 229 ~~-----~~~~~~-~~~~----~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 229 CA-----ELYEKL-PQGY----R------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred hH-----HHHHHH-hcCC----c------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 21 111100 0000 0 000112345688999999999999999999999999876
Q ss_pred cc
Q 043932 1009 RE 1010 (1017)
Q Consensus 1009 ~~ 1010 (1017)
.+
T Consensus 281 ~~ 282 (303)
T cd05088 281 LE 282 (303)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=320.45 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=198.5
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
|+..++||+|+||+||+|.+..+++.||+|.+.... ......+.+|++++++++|++++++.+++... +..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEEE
Confidence 667788999999999999999999999999986432 22234577899999999999999999887654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 99999999999988865421 2689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ...... ...
T Consensus 150 ~~~~~~~---------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~-~~~ 218 (285)
T cd05632 150 VKIPEGE---------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDR-RVL 218 (285)
T ss_pred eecCCCC---------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hhh
Confidence 7543211 11224689999999999888899999999999999999999999975322110 011100 000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1004 (1017)
... .......+..+.+++..|++.||++||+ +.+++++
T Consensus 219 ~~~-----------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 219 ETE-----------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccc-----------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 000 0011123556789999999999999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=337.10 Aligned_cols=275 Identities=20% Similarity=0.223 Sum_probs=199.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
...|.+.+.||+|+||.||+|++..+++.||||... ...+.+|++++++++|+||+++++++... +..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEE
Confidence 447999999999999999999999999999999643 23456899999999999999999988654 6689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+|||++. ++|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 237 lv~e~~~-~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred EEEEccC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 9999995 699998876432 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCccccc---Cc---cHHHH
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTE---GL---TLHEF 937 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~---~~---~~~~~ 937 (1017)
+....... ........||..|+|||++.+..++.++|||||||++|||++|..|+...... .. .+...
T Consensus 308 ~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~ 381 (461)
T PHA03211 308 CFARGSWS------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381 (461)
T ss_pred eecccccc------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHH
Confidence 86542211 11112356999999999999989999999999999999999988765332111 01 11111
Q ss_pred HHh-hcC-chhhhhccchhhHHHHhhcchh-----HHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 938 AKI-ALP-EKVIEIVDPLLLIEVMANNSMI-----QEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 938 ~~~-~~~-~~~~~~~d~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... ... ..........+...+....... ....-.........+.+++.+||+.||.+|||+.|++++
T Consensus 382 i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 382 IRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 100 0010101111111111000000 000000011223468899999999999999999999986
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=321.25 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=201.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.+.|++.++||+|+||.||+|++..+++.||+|++........+.+.+|+++++.++|||++++++++... ...+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEE
Confidence 35789999999999999999999989999999999866666677889999999999999999999988654 5789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|..++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 86 lv~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred EEEecCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccc
Confidence 9999999999998886543 2688999999999999999999999 9999999999999999999999999988
Q ss_pred cccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
....... .......++..|+|||++. ...++.++|||||||++|||++|+.||...... .......
T Consensus 158 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~ 228 (292)
T cd06644 158 AKNVKTL--------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIA 228 (292)
T ss_pred eeccccc--------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHh
Confidence 6532211 1112245788999999884 345688999999999999999999998653211 0011110
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....+ .. .....++.++.+++.+||+.||++||++.|++++
T Consensus 229 ~~~~~----~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 229 KSEPP----TL---------------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cCCCc----cC---------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 00 0011234567899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=323.52 Aligned_cols=269 Identities=25% Similarity=0.378 Sum_probs=207.5
Q ss_pred hccccccCcccccCCceEEEEEeCC-------CcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeecC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSSI 774 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 774 (1017)
.++|.+.+.||+|+||.||+|++.. +...||+|.+.... .....++.+|+++++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4689999999999999999998643 23569999987542 23346788899999999 799999999998654
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKP 844 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 844 (1017)
+..++||||+++|+|.+++...... .....+++.++..++.|++.||+|||+. +++||||||
T Consensus 97 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 97 -----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 5689999999999999999865321 1123588999999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCC
Q 043932 845 SNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923 (1017)
Q Consensus 845 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 923 (1017)
+||+++.++.+||+|||.+.......... ......++..|+|||++.+..++.++||||+||++|||++ |..|
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p 242 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYK------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhh------ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999987553221110 0111234578999999988889999999999999999998 8888
Q ss_pred CCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 924 TDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 924 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
|..... .+.......... ......++.++.+++.+|++.+|++||++.||++
T Consensus 243 ~~~~~~-----~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 243 YPGVPV-----EELFKLLKEGHR-----------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred CCcCCH-----HHHHHHHHcCCC-----------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 864321 111111000000 0011233567889999999999999999999999
Q ss_pred HHhhccccccc
Q 043932 1004 KLCHTRETFFG 1014 (1017)
Q Consensus 1004 ~L~~~~~~~~~ 1014 (1017)
.|+.+.+....
T Consensus 295 ~l~~~~~~~~~ 305 (307)
T cd05098 295 DLDRILALTSN 305 (307)
T ss_pred HHHHHHHHhhc
Confidence 99998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=319.69 Aligned_cols=261 Identities=22% Similarity=0.360 Sum_probs=201.8
Q ss_pred ccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.+|++.+.||+|+||.||+|.+.. .+..||+|++...... ..+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~---- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE---- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----
Confidence 457888999999999999998753 3578999999754332 245688999999999999999999998655
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCC----------CccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceE
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSND----------HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 848 (1017)
+..++++||+++++|.+++..... ......+++..+..++.|++.||+|+|++ +|+||||||+||+
T Consensus 81 -~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 81 -QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 567899999999999999863211 01123578889999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcc
Q 043932 849 LDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAA 927 (1017)
Q Consensus 849 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 927 (1017)
+++++.+||+|||+++........ .......+++.|+|||.+.+..++.++||||+||++|||++ |..||...
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYY------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred ecCCCceEecccccccccccchhe------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999998765432211 11112346789999999988889999999999999999998 88888653
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
... +.......... ......++..+.+++.+|++.+|++||++.||++.|+.
T Consensus 231 ~~~-----~~~~~i~~~~~-----------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 231 SNQ-----DVIEMIRNRQV-----------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CHH-----HHHHHHHcCCc-----------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 211 11111000000 01112346778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=316.29 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=200.0
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.+++.+.....||+|+||.||+|++..++..||+|.+........+.+.+|+.++++++|+||+++++++... +.
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 79 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GF 79 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CE
Confidence 3445555567899999999999999989999999998766555667889999999999999999999998654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCcccccc--CHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-CCCeEEe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKL--TLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVSHVG 858 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~ 858 (1017)
.++|+||+++++|.+++..... .+ ++..+..++.||+.|++|||+. +|+||||||+||+++. ++.++|+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~ 151 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKIS 151 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcc-----cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEe
Confidence 8999999999999999986432 34 7788889999999999999999 9999999999999976 6799999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCC--CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS--EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|||.+........ ......|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||........ ..
T Consensus 152 dfg~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~ 221 (268)
T cd06624 152 DFGTSKRLAGINP--------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AM 221 (268)
T ss_pred cchhheecccCCC--------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hH
Confidence 9999875532111 11123578999999998654 378899999999999999999999864321110 00
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+...... ........+.+++.+++.+||+.+|++|||+.|++++
T Consensus 222 ~~~~~~~------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 222 FKVGMFK------------------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhhhhhc------------------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000000 0000112335678899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=319.54 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=202.9
Q ss_pred cccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 706 EFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
+|++.+.||+|+||.||+|+... ....+|+|.+..... ...+++.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD----- 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----
Confidence 47788999999999999998743 235689998864432 3346788999999999999999999988654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCC------------------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeec
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDH------------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGD 841 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 841 (1017)
+..++||||+.+|+|.+++...... .....+++.+++.++.|++.|++|||+. +++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 5579999999999999998754211 1123588999999999999999999999 999999
Q ss_pred CCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-C
Q 043932 842 LKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-G 920 (1017)
Q Consensus 842 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g 920 (1017)
|||+||++++++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g 226 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYV------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchh------cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence 99999999999999999999987553222110 1112345678999999988889999999999999999999 9
Q ss_pred CCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 043932 921 RRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRD 1000 (1017)
Q Consensus 921 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1000 (1017)
..||.....+ ........... ......++.++.+++.+|++.+|++||++.|
T Consensus 227 ~~p~~~~~~~--~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 227 GNPYPGIAPE--RLFNLLKTGYR--------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred CCCCCCCCHH--HHHHHHhCCCC--------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 9998653211 01111100000 0001123567889999999999999999999
Q ss_pred HHHHHhhccc
Q 043932 1001 VVAKLCHTRE 1010 (1017)
Q Consensus 1001 vl~~L~~~~~ 1010 (1017)
+++.|+++..
T Consensus 279 i~~~l~~~~~ 288 (290)
T cd05045 279 ISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHh
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.62 Aligned_cols=251 Identities=19% Similarity=0.263 Sum_probs=201.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
+|++.++||+|+||.||++++..++..||+|.++... ....+.+.+|+.+++.++|+|++++++++... +..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence 4788899999999999999999999999999986432 33456788899999999999999999988654 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++++|||.+.
T Consensus 76 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 9999999999999875432 3578899999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
...... .......|++.|+|||++.+..++.++||||+|+++|+|++|..||...... .........
T Consensus 149 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~ 215 (255)
T cd08219 149 LLTSPG--------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKVCQG 215 (255)
T ss_pred eecccc--------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHHhcC
Confidence 653221 1112346889999999998888999999999999999999999999753211 111000000
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. ......++..+.+++.+||+.||++||++.|++..
T Consensus 216 ~~-----------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SY-----------------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC-----------------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 00011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.26 Aligned_cols=260 Identities=24% Similarity=0.395 Sum_probs=203.4
Q ss_pred hccccccCcccccCCceEEEEEe-----CCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 776 (1017)
.++|.+.+.||+|+||.||+|.+ ..++..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 45799999999999999999985 3356689999987543 23346788999999999 799999999988654
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
+..++||||+++|+|.++++.... ..+++.++..++.|++.|++|||++ +++|+||||+||+++.++.++
T Consensus 112 ---~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 112 ---GPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred ---CceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence 568999999999999999976432 2489999999999999999999999 999999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~ 935 (1017)
++|||+++........ .......++..|+|||.+.+..++.++||||+||++|||++ |..||........ ..
T Consensus 182 l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~ 254 (302)
T cd05055 182 ICDFGLARDIMNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FY 254 (302)
T ss_pred ECCCcccccccCCCce------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HH
Confidence 9999998765432110 01112346788999999988889999999999999999998 9999865422110 10
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
.......+. ......++++.+++.+|+..+|++||++.|+++.|+++
T Consensus 255 ~~~~~~~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 KLIKEGYRM--------------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHcCCcC--------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 110000000 00011245789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=332.14 Aligned_cols=193 Identities=23% Similarity=0.354 Sum_probs=165.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
...+|++.+.||+|+||.||+|++..+++.||+|+.... ....|+.++++++||||+++++++... ...
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeC-----Cee
Confidence 345799999999999999999999989999999975322 235689999999999999999998765 668
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+. ++|.+++.... ..+++.+++.|+.||+.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 133 ~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred EEEEEccC-CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence 99999995 58999887643 2689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCC
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPT 924 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 924 (1017)
++..... .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 204 a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 204 AQFPVVA---------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccC---------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 8743211 1112356899999999999989999999999999999999965554
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.32 Aligned_cols=256 Identities=22% Similarity=0.263 Sum_probs=196.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++... ++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-----NN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-----Ce
Confidence 47899999999999999999999999999999997422 23345688899999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 8999999999999999976432 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC-----CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..
T Consensus 148 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~----~~ 216 (331)
T cd05597 148 SCLRLLADGT-------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----ET 216 (331)
T ss_pred ceeecCCCCC-------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH----HH
Confidence 9876543221 01112468999999999863 35788999999999999999999999753211 11
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPF--ERMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 1004 (1017)
+........... .......+++.+.+++.+|+..++. .||++.++++|
T Consensus 217 ~~~i~~~~~~~~--------------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 217 YGKIMNHKEHFQ--------------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHcCCCccc--------------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111000000000 0001112355678888887765444 38899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=321.13 Aligned_cols=262 Identities=23% Similarity=0.387 Sum_probs=204.0
Q ss_pred hccccccCcccccCCceEEEEEeCCC-----cEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED-----EMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++|++.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC---
Confidence 45789999999999999999998643 47899999864432 3345788999999999999999999998654
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCc----cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHL----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
...++||||+++|+|.+++....... ....+++..++.++.|++.|++|||+. +++||||||+||+++.++
T Consensus 82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 66899999999999999997643211 123578899999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGL 932 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 932 (1017)
.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||.......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 229 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE- 229 (277)
T ss_pred CEEECCcccchhhccCccc------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-
Confidence 9999999998765432211 11112346789999999988889999999999999999998 999986432111
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
...... .... ......++.++.+++.+||+.+|++|||+.|+++.|+.
T Consensus 230 -~~~~~~---~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 230 -VLKFVI---DGGH-----------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -HHHHHh---cCCC-----------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111110 0000 00111235678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.63 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=203.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----CeEE
Confidence 46799999999999999999999888999999999876666667889999999999999999999998654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... .+++.+++.++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 79 ILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred EEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence 99999999999999876532 689999999999999999999999 9999999999999999999999999988
Q ss_pred cccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
....... .......|++.|+|||.+. +..++.++||||+|+++|||++|+.||...... ....
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~ 218 (280)
T cd06611 151 AKNKSTL--------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLL 218 (280)
T ss_pred hhhcccc--------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHH
Confidence 6543211 1112346899999999874 335678999999999999999999999653211 1111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...... .+.. .....++.++.+++.+||+.||++||++.+++++
T Consensus 219 ~~~~~~------~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 219 KILKSE------PPTL----------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHhcCC------CCCc----------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 100000 0000 0011234568899999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=322.18 Aligned_cols=266 Identities=23% Similarity=0.370 Sum_probs=203.7
Q ss_pred HhhccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSID 775 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 775 (1017)
...++|++.++||+|+||.||+|..++ .+..||+|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG- 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 346789999999999999999997642 356899998764432 2334678899999999999999999987654
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCc----cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHL----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 851 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 851 (1017)
+..++||||+++|+|.+++....... .....++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 82 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~ 154 (288)
T cd05061 82 ----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAH 154 (288)
T ss_pred ----CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcC
Confidence 56799999999999999997643211 123457788899999999999999999 9999999999999999
Q ss_pred CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCccccc
Q 043932 852 DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTE 930 (1017)
Q Consensus 852 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~ 930 (1017)
++.++|+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....+
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~ 228 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228 (288)
T ss_pred CCcEEECcCCcccccccccccc------ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999987553322110 0111235678999999988889999999999999999998 78888653211
Q ss_pred CccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 931 GLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
+.......... ......+++.+.+++.+|++.||++|||+.|+++.+++..
T Consensus 229 -----~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 229 -----QVLKFVMDGGY-----------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -----HHHHHHHcCCC-----------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111000000 0001123567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=320.60 Aligned_cols=269 Identities=22% Similarity=0.339 Sum_probs=200.2
Q ss_pred hccccccCcccccCCceEEEEEeCCC--------------cEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED--------------EMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKII 768 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~ 768 (1017)
..+|++.++||+|+||.||+|++... ...||+|.+.... ......+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35899999999999999999987543 2358999987442 23345788999999999999999999
Q ss_pred eeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCC------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecC
Q 043932 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDL 842 (1017)
Q Consensus 769 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 842 (1017)
+++... +..++||||+++++|.+++...... .....+++.+++.++.|++.|++|||+. +++||||
T Consensus 84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl 155 (295)
T cd05097 84 GVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL 155 (295)
T ss_pred EEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 998654 5689999999999999998653210 0112478899999999999999999999 9999999
Q ss_pred CCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh--C
Q 043932 843 KPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT--G 920 (1017)
Q Consensus 843 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g 920 (1017)
||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~ 229 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcce------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCC
Confidence 999999999999999999998765322211 01112345778999999988889999999999999999998 5
Q ss_pred CCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 043932 921 RRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRD 1000 (1017)
Q Consensus 921 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1000 (1017)
..||....... ........ .+......+ ......+++.+.+++.+|++.||++||++.+
T Consensus 230 ~~p~~~~~~~~-~~~~~~~~---------~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 230 EQPYSLLSDEQ-VIENTGEF---------FRNQGRQIY-----------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred CCCCcccChHH-HHHHHHHh---------hhhcccccc-----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 66776432110 00000000 000000000 0001123567999999999999999999999
Q ss_pred HHHHHhh
Q 043932 1001 VVAKLCH 1007 (1017)
Q Consensus 1001 vl~~L~~ 1007 (1017)
|++.|+.
T Consensus 289 i~~~l~~ 295 (295)
T cd05097 289 IHHFLRE 295 (295)
T ss_pred HHHHHhC
Confidence 9998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.75 Aligned_cols=239 Identities=27% Similarity=0.301 Sum_probs=187.6
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHH-HHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECK-ALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||+||+|++..+|+.||+|++.... ....+.+..|.. +++.++||||+++++++... +..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEE
Confidence 46999999999999999999999999997432 223344555554 46778999999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999887653 688999999999999999999999 9999999999999999999999999998743
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +.........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~~~- 212 (325)
T cd05604 147 IAQS--------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILHKP- 212 (325)
T ss_pred CCCC--------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHcCC-
Confidence 2111 1122356899999999999989999999999999999999999999753211 1111000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRD 1000 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1000 (1017)
. ......+..+.+++.+|++.||.+||++.+
T Consensus 213 -------~----------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 213 -------L----------------VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred -------c----------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 0 000112456788999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=335.30 Aligned_cols=276 Identities=20% Similarity=0.217 Sum_probs=199.7
Q ss_pred hccccccCcccccCCceEEEEEeCC--CcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE--DEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
..+|.+.+.||+|+||.||+|...+ +++.||+|.+... +...+|++++++++||||+++++++... ..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWK-----ST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeC-----CE
Confidence 3579999999999999999998643 4678999987533 2346899999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++|||++. ++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.++|+|||
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence 899999995 58999885432 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC--ccHHHHHH
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG--LTLHEFAK 939 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--~~~~~~~~ 939 (1017)
+++....... ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+....+
T Consensus 231 ~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 231 AACKLDAHPD------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred cccccCcccc------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 9976543221 111223579999999999999899999999999999999999999997643321 11111111
Q ss_pred hhc--CchhhhhccchhhHHHHhhcchhH--HHhHH--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 940 IAL--PEKVIEIVDPLLLIEVMANNSMIQ--EDIRA--KTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 940 ~~~--~~~~~~~~d~~l~~~~~~~~~~~~--~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
... +..........+...+........ ...+. .....+.++.+++.+|++.||++|||+.|++.+=
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 305 CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 110 000000000000000000000000 00000 0012345678899999999999999999999873
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.85 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=195.0
Q ss_pred cccccCCceEEEEEeC--CCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEe
Q 043932 712 MIGQGSFGSVYKGILG--EDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFEC 788 (1017)
Q Consensus 712 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 788 (1017)
.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 3899999999999875 4566799999875433 234668899999999999999999998742 457899999
Q ss_pred ccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccccc
Q 043932 789 MKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS 868 (1017)
Q Consensus 789 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 868 (1017)
+++++|.+++..... .+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 76 ASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred CCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 999999999975432 689999999999999999999999 999999999999999999999999999975532
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchhh
Q 043932 869 HQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVI 947 (1017)
Q Consensus 869 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 947 (1017)
...... ......++..|+|||.+.+..++.++|||||||++||+++ |..||....... .........+
T Consensus 148 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~---- 216 (257)
T cd05115 148 DDSYYK-----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKR---- 216 (257)
T ss_pred Ccccee-----ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC----
Confidence 221100 0111224678999999988889999999999999999996 999987542210 1010000000
Q ss_pred hhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 948 EIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 948 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
......+++++.+++.+||..||++||++.+|.+.|+.+
T Consensus 217 ----------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 ----------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 001123467789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=327.96 Aligned_cols=238 Identities=27% Similarity=0.297 Sum_probs=186.3
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHH-HHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECK-ALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||.||+|++..+++.||+|++.... ......+.+|.. +++.++||||+++++++... +..|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999987432 222344555554 57888999999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999998887543 678889999999999999999999 9999999999999999999999999998743
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~ 213 (321)
T cd05603 147 VEPE--------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHKPL 213 (321)
T ss_pred CCCC--------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcCCC
Confidence 2111 111235689999999999988899999999999999999999999975321 111111000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
.........+.+++.+|++.||.+||++.
T Consensus 214 ------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 ------------------------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 00112245678999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.08 Aligned_cols=268 Identities=22% Similarity=0.360 Sum_probs=201.4
Q ss_pred ccccccCcccccCCceEEEEEeCC----------------CcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGE----------------DEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKI 767 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~ 767 (1017)
++|++.++||+|+||.||+|++.. ++..||+|++.... ....+.+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 579999999999999999986532 34579999987543 2344678899999999999999999
Q ss_pred eeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCC-----ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecC
Q 043932 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH-----LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDL 842 (1017)
Q Consensus 768 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 842 (1017)
++++... +..++||||+++|+|.+++...... .....+++.++..++.|++.|++|||+. +++||||
T Consensus 85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 85 LAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 9998654 5679999999999999999765321 1123578889999999999999999999 9999999
Q ss_pred CCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh--C
Q 043932 843 KPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT--G 920 (1017)
Q Consensus 843 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g 920 (1017)
||+||+++.++.++|+|||+++.+....... ......++..|+|||...+..++.++|||||||++|||++ |
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~ 230 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYR------IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCccee------ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence 9999999999999999999987653322110 0111234678999998888889999999999999999998 7
Q ss_pred CCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 043932 921 RRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRD 1000 (1017)
Q Consensus 921 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1000 (1017)
..||...... +.... ..+........ ........+++.+.+++.+||+.||.+||++.|
T Consensus 231 ~~p~~~~~~~-----~~~~~-----~~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 289 (296)
T cd05095 231 EQPYSQLSDE-----QVIEN-----TGEFFRDQGRQ-----------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE 289 (296)
T ss_pred CCCccccChH-----HHHHH-----HHHHHhhcccc-----------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 7887643221 11100 00000000000 000011234577899999999999999999999
Q ss_pred HHHHHhh
Q 043932 1001 VVAKLCH 1007 (1017)
Q Consensus 1001 vl~~L~~ 1007 (1017)
|.+.|++
T Consensus 290 i~~~l~~ 296 (296)
T cd05095 290 IHATLLE 296 (296)
T ss_pred HHHHHhC
Confidence 9998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=314.26 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=204.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.++||+|+||.||+|++..+++.||+|.+..... .+.+.+|++++++++||||+++++++... ...|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEE
Confidence 3578999999999999999999998889999999875433 57899999999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+++||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 75 l~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccc
Confidence 9999999999999997644 3789999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... .. .
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~----~~--~ 212 (256)
T cd06612 147 GQLTDTMA--------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF----MI--P 212 (256)
T ss_pred hhcccCcc--------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh----hh--c
Confidence 86543211 1112457889999999988889999999999999999999999987532211000 00 0
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. ..+. ......+...+.+++.+|++.||++|||+.|++++
T Consensus 213 ~~----~~~~----------------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 213 NK----PPPT----------------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cC----CCCC----------------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00 0000 00111234678899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.26 Aligned_cols=269 Identities=21% Similarity=0.342 Sum_probs=203.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCc----------------EEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDE----------------MIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIK 766 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 766 (1017)
..+|++.+.||+|+||.||+|++...+ ..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457899999999999999999876533 568999987543 234567889999999999999999
Q ss_pred eeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCC-----ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeec
Q 043932 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH-----LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGD 841 (1017)
Q Consensus 767 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 841 (1017)
+++++... +..++||||+++++|.+++...... .....+++..++.++.|++.||+|||+. +++|||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 99998654 5689999999999999999765421 1123689999999999999999999999 999999
Q ss_pred CCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh--
Q 043932 842 LKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-- 919 (1017)
Q Consensus 842 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-- 919 (1017)
|||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+..++.++|||||||++|||++
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYR------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCccee------ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 99999999999999999999987553322111 1112346788999999988889999999999999999998
Q ss_pred CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 920 GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 920 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
|..||....... .+..... ..... .. . ........++.++.+++.+|++.||++|||+.
T Consensus 230 ~~~p~~~~~~~~-~~~~~~~-~~~~~-----~~-----------~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 288 (296)
T cd05051 230 REQPYEHLTDQQ-VIENAGH-FFRDD-----GR-----------Q---IYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288 (296)
T ss_pred CCCCCCCcChHH-HHHHHHh-ccccc-----cc-----------c---ccCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence 677775432110 0000000 00000 00 0 00001112356789999999999999999999
Q ss_pred HHHHHHhh
Q 043932 1000 DVVAKLCH 1007 (1017)
Q Consensus 1000 evl~~L~~ 1007 (1017)
||++.|+.
T Consensus 289 el~~~L~~ 296 (296)
T cd05051 289 EIHLFLQR 296 (296)
T ss_pred HHHHHhcC
Confidence 99998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=344.24 Aligned_cols=268 Identities=24% Similarity=0.363 Sum_probs=200.9
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC---
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS--- 776 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 776 (1017)
.+...+|+..++||+||||.||+|+.+-+|+.||||.+... +......+.+|+..+++++|||||+++..+.+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 56677899999999999999999999999999999999755 34455778899999999999999999843211110
Q ss_pred --------------------------------------------------------------------------------
Q 043932 777 -------------------------------------------------------------------------------- 776 (1017)
Q Consensus 777 -------------------------------------------------------------------------------- 776 (1017)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred --C-----------------------------CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHH
Q 043932 777 --K-----------------------------GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825 (1017)
Q Consensus 777 --~-----------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~ 825 (1017)
. .....||-||||+.-++.++++++.- .-.....+++++||++|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-----~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-----NSQRDEAWRLFREILEG 709 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-----chhhHHHHHHHHHHHHH
Confidence 0 00246899999999888888876531 11466789999999999
Q ss_pred HHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc------cc----cccccccCCCcccccccCccccCccc
Q 043932 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS------SH----QLDTASKTSSSSIGIKGTVGYVAPEY 895 (1017)
Q Consensus 826 L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~------~~----~~~~~~~~~~~~~~~~gt~~y~aPE~ 895 (1017)
|+|+|++ |||||||||.|||+++++.|||+|||+|+... .. ............+..+||.-|+|||+
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999999 99999999999999999999999999998732 00 00111112223456789999999999
Q ss_pred ccCC---CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHh
Q 043932 896 CMGS---EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAK 972 (1017)
Q Consensus 896 ~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~ 972 (1017)
+.+. .|+.|+||||+|+|++||+. ||....+....+........|.. ..+.++
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~-------------------- 842 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDP-------------------- 842 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccc--------------------
Confidence 9765 49999999999999999986 67654333222323233333332 112221
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 973 TQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 973 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
..+.-.++|.+|++.||.+||||.|++.
T Consensus 843 ---~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 843 ---EHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ---cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 1233478999999999999999999985
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.32 Aligned_cols=277 Identities=20% Similarity=0.276 Sum_probs=199.2
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+|++++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceE
Confidence 47888999999999999999999999999999874322 2235677899999999999999999987544 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+|+||++ ++|.+++..... .+++..++.++.||++||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 76 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 9999997 488888765432 689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+...... .......++..|+|||++.+. .++.++||||+||++|||++|+.|+..................
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
T cd07839 147 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218 (284)
T ss_pred hccCCCC--------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence 7553221 011123578899999988764 4789999999999999999999986543222111111111111
Q ss_pred CchhhhhccchhhHHHHh-hcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMA-NNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......+........... ................++++.+++.+||+.||.+|||++|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 100000000000000000 00000000011122346778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.83 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=197.6
Q ss_pred CcccccCCceEEEEEeCCCc---EEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDE---MIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||.||+|.+...+ ..||+|.+..... ...+++.+|+++++.++|||++++++++.. +..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence 47999999999999875544 7899999874443 245678899999999999999999998642 3568999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999999998653 678999999999999999999999 9999999999999999999999999999866
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCch
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..........+
T Consensus 146 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~~-- 216 (257)
T cd05060 146 GAGSDYY-----RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGER-- 216 (257)
T ss_pred ecCCccc-----ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCc--
Confidence 4322110 01111224568999999988889999999999999999998 99998653211 11111110000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
......++..+.+++.+|+..+|++||++.++++.|+++.
T Consensus 217 ------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 ------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0011123567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=317.09 Aligned_cols=260 Identities=26% Similarity=0.441 Sum_probs=202.6
Q ss_pred ccccccCcccccCCceEEEEEeCCCcE---EEEEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEM---IVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.+|++.+.||+|+||.||+|++..+++ .||+|++... .....+++..|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----R 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-----C
Confidence 468889999999999999999876554 6999998754 233457889999999999999999999987544 5
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++++|.+++..... .+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+|++||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence 67999999999999999976542 688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|.+............ ........+..|+|||.+.+..++.++||||+||++||+++ |..||...... .......
T Consensus 151 g~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~ 225 (269)
T cd05065 151 GLSRFLEDDTSDPTY---TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIE 225 (269)
T ss_pred ccccccccCcccccc---ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHH
Confidence 998765432211110 00011112457999999998889999999999999999887 99998653211 0111100
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
...+ .....+++..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 226 ~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QDYR--------------------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCc--------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 001123456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.95 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=195.3
Q ss_pred cccccCCceEEEEEe--CCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 712 MIGQGSFGSVYKGIL--GEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 712 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
.||+|+||.||+|.+ ..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.. +..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 689999999999965 45678899999864432 235678899999999999999999998742 34689999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
|+++|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 76 LAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 999999999997543 688999999999999999999999 99999999999999999999999999997654
Q ss_pred cccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchh
Q 043932 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
...... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ...........
T Consensus 147 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~~--- 216 (257)
T cd05116 147 ADENYY-----KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGER--- 216 (257)
T ss_pred CCCCee-----eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCC---
Confidence 322110 00111234678999999988889999999999999999998 99999753221 11111110000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
......+++++.+++.+||+.||++||++.+|.+.|+..
T Consensus 217 -----------------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 -----------------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 001112456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.41 Aligned_cols=267 Identities=24% Similarity=0.389 Sum_probs=206.8
Q ss_pred hhccccccCcccccCCceEEEEEeC-------CCcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeec
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILG-------EDEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSS 773 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 773 (1017)
...+|.+.+.||+|+||.||+|++. .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3568899999999999999999752 234679999986432 23456788999999999 89999999999865
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLK 843 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 843 (1017)
. ...++||||+++|+|.+++...... .....+++.++..++.||+.||+|||++ +++|||||
T Consensus 93 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk 164 (304)
T cd05101 93 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA 164 (304)
T ss_pred C-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 4 5689999999999999999864321 1123678899999999999999999999 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCC
Q 043932 844 PSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRR 922 (1017)
Q Consensus 844 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~ 922 (1017)
|+||+++.++.+||+|||.++......... ......+++.|+|||++.+..++.++||||||+++||+++ |..
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 238 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccc------cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999998664322111 1112345678999999988889999999999999999998 788
Q ss_pred CCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 923 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
||..... .+.......... ......++..+.+++.+||+.+|++||++.|++
T Consensus 239 p~~~~~~-----~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l 290 (304)
T cd05101 239 PYPGIPV-----EELFKLLKEGHR-----------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290 (304)
T ss_pred CcccCCH-----HHHHHHHHcCCc-----------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 8754311 111111000000 001123466789999999999999999999999
Q ss_pred HHHhhcccc
Q 043932 1003 AKLCHTRET 1011 (1017)
Q Consensus 1003 ~~L~~~~~~ 1011 (1017)
+.|+++...
T Consensus 291 ~~l~~~~~~ 299 (304)
T cd05101 291 EDLDRILTL 299 (304)
T ss_pred HHHHHHHHh
Confidence 999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.49 Aligned_cols=282 Identities=18% Similarity=0.159 Sum_probs=198.1
Q ss_pred ccCccccc--CCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 709 SSNMIGQG--SFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 709 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
+.++||+| +|++||+++++.+++.||+|++.... ....+.+.+|+++++.++||||+++++++... +..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 46789999 67899999999999999999987543 23345677899999999999999999998765 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+.
T Consensus 77 v~e~~~~~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEeccCCCcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 9999999999999975432 2588999999999999999999999 99999999999999999999999998754
Q ss_pred ccccccccccccCCCcccccccCccccCcccccC--CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
........... .........++..|+|||++.+ ..++.++||||+||++|||++|+.||.......... .......
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRV-VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTV 227 (327)
T ss_pred ccccccccccc-cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhcCCc
Confidence 33211100000 0011112356788999999876 458899999999999999999999997532211111 1111000
Q ss_pred Cchhh-------hh--------ccchhhHHHH---hhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVI-------EI--------VDPLLLIEVM---ANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~-------~~--------~d~~l~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+.... +. .+........ ................+.+.+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000 00 0000000000 000000000011223446788999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=316.13 Aligned_cols=240 Identities=23% Similarity=0.363 Sum_probs=185.9
Q ss_pred cccccCCceEEEEEeCC------------------------CcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceee
Q 043932 712 MIGQGSFGSVYKGILGE------------------------DEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKI 767 (1017)
Q Consensus 712 ~lg~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 767 (1017)
.||+|+||.||+|.... ....||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998532 124589998875544445678889999999999999999
Q ss_pred eeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCce
Q 043932 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNV 847 (1017)
Q Consensus 768 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 847 (1017)
++++... ...++||||+++|+|..++..... .+++..+..++.||++||+|||++ +|+||||||+||
T Consensus 82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni 148 (274)
T cd05076 82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI 148 (274)
T ss_pred EEEEEeC-----CceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence 9998755 567999999999999999876432 678999999999999999999999 999999999999
Q ss_pred EeCCCC-------CeEEeecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHH-
Q 043932 848 LLDHDM-------VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELF- 918 (1017)
Q Consensus 848 ll~~~~-------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell- 918 (1017)
+++..+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~ 216 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216 (274)
T ss_pred EEeccCcccCccceeeecCCccccccccc------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 997654 4799999987643211 11246788999998865 56899999999999999995
Q ss_pred hCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 043932 919 TGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM 998 (1017)
Q Consensus 919 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 998 (1017)
+|+.||....... ...+..... . ........+.+++.+||+.+|++||++
T Consensus 217 ~g~~p~~~~~~~~--~~~~~~~~~---------------------~-------~~~~~~~~~~~li~~cl~~~p~~Rps~ 266 (274)
T cd05076 217 DGEVPLKERTPSE--KERFYEKKH---------------------R-------LPEPSCKELATLISQCLTYEPTQRPSF 266 (274)
T ss_pred CCCCCccccChHH--HHHHHHhcc---------------------C-------CCCCCChHHHHHHHHHcccChhhCcCH
Confidence 6999986532211 001100000 0 000113457899999999999999999
Q ss_pred HHHHHHHh
Q 043932 999 RDVVAKLC 1006 (1017)
Q Consensus 999 ~evl~~L~ 1006 (1017)
.++++.|+
T Consensus 267 ~~il~~L~ 274 (274)
T cd05076 267 RTILRDLT 274 (274)
T ss_pred HHHHHhhC
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=318.73 Aligned_cols=267 Identities=22% Similarity=0.325 Sum_probs=207.6
Q ss_pred cCHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeec
Q 043932 695 VSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSS 773 (1017)
Q Consensus 695 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 773 (1017)
.+..++..+.+.|++.+.||+|+||.||+|++..+++.||+|++..... ...++..|+.+++++ +|+|++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 3455666677899999999999999999999998999999999865432 335678899999998 79999999998854
Q ss_pred CCC-CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC
Q 043932 774 IDS-KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 774 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 852 (1017)
... ...++.++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 322 224678999999999999999976432 3578888999999999999999999 99999999999999999
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
+.++|+|||++....... .......|+..|+|||.+. +..++.++||||+||++|||++|+.||...
T Consensus 158 ~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred CCEEEeeCcchhhhhccc--------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 999999999987543211 0112246899999999875 345788999999999999999999999653
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... ......... ..+ ......++..+.+++.+||+.||.+||++.|++++
T Consensus 230 ~~~----~~~~~~~~~------~~~-----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 230 HPM----RALFLIPRN------PPP-----------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CHH----hhhhhHhhC------CCC-----------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 211 000000000 000 00111345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.12 Aligned_cols=254 Identities=28% Similarity=0.475 Sum_probs=200.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++|++++++++++.. ...+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcE
Confidence 457899999999999999999886 556799999875433 34678999999999999999999988632 3468
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +++||||||+||++++++.++|+|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence 99999999999999976431 3588999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........ ..
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~-~~ 220 (260)
T cd05070 150 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-EVLEQVER-GY 220 (260)
T ss_pred eeccCcccc-------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHc-CC
Confidence 765432210 1111235678999999988889999999999999999999 88898653211 00111000 00
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
+ .......+..+.+++.+|++.||++|||+.++.+.|++
T Consensus 221 ~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 R--------------------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred C--------------------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 00112235678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=335.09 Aligned_cols=370 Identities=25% Similarity=0.379 Sum_probs=274.5
Q ss_pred CcceEeeccccccc-ccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeE
Q 043932 149 SNLIQLRVSNNKLE-GQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLH 227 (1017)
Q Consensus 149 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 227 (1017)
+-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-------------------------~vPeEL~~lqkLEHLs 61 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-------------------------QVPEELSRLQKLEHLS 61 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-------------------------hChHHHHHHhhhhhhh
Confidence 33445566666666 345555555556666655555554 4455555555555555
Q ss_pred eecCccccccchhhcccCcCcEEeCCCccCc-cccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcc
Q 043932 228 VGGNQFSGTFPQSICNISSLERIYLPFNRFS-GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQF 306 (1017)
Q Consensus 228 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 306 (1017)
+++|++. .+-..+..++.|+.+.+..|++. ..+|.++| .+..|+.||||+|+++ ..|..+....++-+|+||+|+|
T Consensus 62 ~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~I 138 (1255)
T KOG0444|consen 62 MAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNI 138 (1255)
T ss_pred hhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcc
Confidence 5555554 33444555555666666666553 24666665 5777888888888887 7788888888899999999999
Q ss_pred cceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccc
Q 043932 307 KGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIF 386 (1017)
Q Consensus 307 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~ 386 (1017)
..++...|.++..|-.|||++|++...++ ....+..|++|+|++|.+.- +.
T Consensus 139 etIPn~lfinLtDLLfLDLS~NrLe~LPP-------Q~RRL~~LqtL~Ls~NPL~h------fQ---------------- 189 (1255)
T KOG0444|consen 139 ETIPNSLFINLTDLLFLDLSNNRLEMLPP-------QIRRLSMLQTLKLSNNPLNH------FQ---------------- 189 (1255)
T ss_pred ccCCchHHHhhHhHhhhccccchhhhcCH-------HHHHHhhhhhhhcCCChhhH------HH----------------
Confidence 88887788888888888888888875443 35677778888888876540 11
Q ss_pred cccCccccccccccEEeccccCCC-CCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCcccc
Q 043932 387 GIIPSGIRNLVNLIALGMQSNQLH-GTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSL 465 (1017)
Q Consensus 387 ~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~ 465 (1017)
-..+..+++|+.|.+++.+-+ ..+|.++.++.+|..+|||.|.+. ..|+.+.++++|+.|+||+|+|+ .+....
T Consensus 190 ---LrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~ 264 (1255)
T KOG0444|consen 190 ---LRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTE 264 (1255)
T ss_pred ---HhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccH
Confidence 122345667788888776533 356777888888888888888887 67777888888888888888887 444455
Q ss_pred ccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCccc-ccccccccccccc
Q 043932 466 GNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFS-GVIPVTLSTCVSL 544 (1017)
Q Consensus 466 ~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L 544 (1017)
....+|+.|++|+|+++ .+|++++.+++|+.|++.+|+++ .-+|..++++.+|
T Consensus 265 ~~W~~lEtLNlSrNQLt--------------------------~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~L 318 (1255)
T KOG0444|consen 265 GEWENLETLNLSRNQLT--------------------------VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQL 318 (1255)
T ss_pred HHHhhhhhhccccchhc--------------------------cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhh
Confidence 55667777777777776 68899999999999999999997 3579999999999
Q ss_pred eEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCC
Q 043932 545 EYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT 608 (1017)
Q Consensus 545 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 608 (1017)
+.+..++|+|. ..|+.++.+.+|+.|.|+.|++- ..|+.+.-|+-|++|||..|+=---+|.
T Consensus 319 evf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 319 EVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred HHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 99999999999 88999999999999999999998 7999999999999999999975545553
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=315.58 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=201.7
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc---------hHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---------AFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|++++++++||||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 477889999999999999999888999999988643321 225678899999999999999999988654
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
+..++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++
T Consensus 79 ---~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 79 ---DHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred ---CccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 67899999999999999997653 578889999999999999999999 999999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|+|||.++.......... .........|+..|+|||.+.+..++.++||||+||++|+|++|+.||...... ..
T Consensus 147 l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~ 220 (267)
T cd06628 147 ISDFGISKKLEANSLSTK--TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QA 220 (267)
T ss_pred ecccCCCcccccccccCC--ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HH
Confidence 999999986653221111 111112345889999999998888999999999999999999999999753211 11
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..... ....+ ......+..+.+++.+||+.||.+||++.|++++
T Consensus 221 ~~~~~------~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 221 IFKIG------ENASP------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHh------ccCCC------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 10000 00000 0111235678899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=319.10 Aligned_cols=277 Identities=22% Similarity=0.304 Sum_probs=203.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++|||++++++++... ...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEE
Confidence 468899999999999999999998999999999864432 2335678999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++++|..+..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred EEEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 99999999988888765432 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh-
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI- 940 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~- 940 (1017)
+........ ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+. .......
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~ 217 (286)
T cd07847 147 ARILTGPGD--------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTL 217 (286)
T ss_pred ceecCCCcc--------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh
Confidence 986543221 1112457889999999876 4578999999999999999999999976432211 1111100
Q ss_pred -hcCchhhhhccchhh-HHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 -ALPEKVIEIVDPLLL-IEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 -~~~~~~~~~~d~~l~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.......+..+.... .....................+..+.+++.+|++.||++||++.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 218 GDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000011100000 0000000000000111122346778999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.60 Aligned_cols=241 Identities=22% Similarity=0.381 Sum_probs=187.5
Q ss_pred CcccccCCceEEEEEeCC------------CcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 711 NMIGQGSFGSVYKGILGE------------DEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
+.||+|+||.||+|+... ....||+|++..........+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~---- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD---- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 468999999999998642 2345899988765555556788999999999999999999998654
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC----
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV---- 854 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 854 (1017)
...++||||+++|+|..++..... .+++..++.++.||++||+|||++ +|+||||||+||+++.++.
T Consensus 77 -~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 77 -VENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred -CCCEEEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence 557899999999999999875432 689999999999999999999999 9999999999999987664
Q ss_pred ---eEEeecccccccccccccccccCCCcccccccCccccCccccc-CCCcCccccchhHHHHHHHHH-hCCCCCCcccc
Q 043932 855 ---SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-GSEASMTGDVYSFGILLLELF-TGRRPTDAAFT 929 (1017)
Q Consensus 855 ---~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~pf~~~~~ 929 (1017)
++++|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.....
T Consensus 148 ~~~~~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 148 GPFIKLSDPGIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CceeEeCCCCCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 899999998654211 1235788999999886 466899999999999999998 58888754321
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.. ......... . ......+.+.+++.+||+.||.+||++.+|+++++
T Consensus 216 ~~--~~~~~~~~~-----~-----------------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 216 AE--KERFYEGQC-----M-----------------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hH--HHHHHhcCc-----c-----------------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 10 000000000 0 00011356889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.88 Aligned_cols=267 Identities=25% Similarity=0.407 Sum_probs=205.3
Q ss_pred hhccccccCcccccCCceEEEEEeC-------CCcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeec
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILG-------EDEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSS 773 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 773 (1017)
..++|.+.++||+|+||.||+|++. .....||+|.+.... ......+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3468899999999999999999863 235679999987433 23456788999999999 69999999998865
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLK 843 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 843 (1017)
. +..++||||+++|+|.+++...... .....+++.++..++.|++.||+|||++ +++|||||
T Consensus 90 ~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlk 161 (314)
T cd05099 90 E-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLA 161 (314)
T ss_pred C-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 4 5689999999999999999764321 1124689999999999999999999999 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCC
Q 043932 844 PSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRR 922 (1017)
Q Consensus 844 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~ 922 (1017)
|+||+++.++.+||+|||.++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~ 235 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKK------TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccccc------cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCC
Confidence 9999999999999999999986543221110 111234567999999988889999999999999999999 888
Q ss_pred CCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 923 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
||...... ........... ......++.++.+++.+|+..||++||++.|++
T Consensus 236 p~~~~~~~-----~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 287 (314)
T cd05099 236 PYPGIPVE-----ELFKLLREGHR-----------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV 287 (314)
T ss_pred CCCCCCHH-----HHHHHHHcCCC-----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 98653211 11110000000 001112356788999999999999999999999
Q ss_pred HHHhhcccc
Q 043932 1003 AKLCHTRET 1011 (1017)
Q Consensus 1003 ~~L~~~~~~ 1011 (1017)
+.|+++...
T Consensus 288 ~~l~~~~~~ 296 (314)
T cd05099 288 EALDKVLAA 296 (314)
T ss_pred HHHHHHHHH
Confidence 999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.79 Aligned_cols=276 Identities=26% Similarity=0.409 Sum_probs=207.8
Q ss_pred ccccccCcccccCCceEEEEEeCC----CcEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGE----DEMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
++|++.+.||+|+||.||+|++.. ++..||+|++...... ..+.+.+|++.++.++||||+++++++... +.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence 467788999999999999999643 4789999999755443 457899999999999999999999987553 23
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
.+.++||||+++++|.+++..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 678999999999999999976542 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||.+.......... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... +..
T Consensus 153 fg~~~~~~~~~~~~-----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~ 224 (284)
T cd05038 153 FGLAKVLPEDKDYY-----YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIG 224 (284)
T ss_pred cccccccccCCcce-----eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccc
Confidence 99998765222110 0111123566799999998888999999999999999999999998653222110 000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
........ .... +....... ......++.++.+++.+|++.+|++||++.||+++|+.++
T Consensus 225 ~~~~~~~~----~~~~-~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 225 IAQGQMIV----TRLL-ELLKEGER-----LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cccccccH----HHHH-HHHHcCCc-----CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 00000000 0000 00000000 0112234578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=297.24 Aligned_cols=287 Identities=21% Similarity=0.252 Sum_probs=206.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCc----EEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDE----MIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
..|+....||+|.||.||+|....+. +.+|+|.++...+ .......+|+..++.++|||++.+..++...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 47889999999999999999665443 2689999975432 2335678999999999999999999988764
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC----CC
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD----MV 854 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~ 854 (1017)
...+++++||.+. +|.+.++-.+.... ..++...+..|+.||+.|+.|||++ =|+|||+||.||||..+ |.
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence 2678999999988 99999987654333 5889999999999999999999999 79999999999999887 89
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccC--
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEG-- 931 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~-- 931 (1017)
|||+|||+|+.+...-. .-.....++.|.+|+|||.+.|. .|+++.||||.|||+.||+|-++.|.+.....
T Consensus 175 VKIaDlGlaR~~~~plk-----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~ 249 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLK-----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT 249 (438)
T ss_pred eEeecccHHHHhhcccc-----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhccc
Confidence 99999999998754221 11223346789999999998875 69999999999999999999999887643221
Q ss_pred ---c---cHHHHHHhhcCchhhhhcc------c-hhhHHHHhhcch---hHHHhHHhHHHHHHHHHHHHhhccCCCCCCC
Q 043932 932 ---L---TLHEFAKIALPEKVIEIVD------P-LLLIEVMANNSM---IQEDIRAKTQECLNAIIRIGVLCSMESPFER 995 (1017)
Q Consensus 932 ---~---~~~~~~~~~~~~~~~~~~d------~-~l~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 995 (1017)
. ++..+......+...++.+ - ....++...... +... -.....-++.-.+++.+++.+||.+|
T Consensus 250 ~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~-~~~~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 250 KNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKY-YHKHKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred CCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHH-HHHhcCCCchHHHHHHHHhccCchhh
Confidence 1 1112221111111111111 0 011111100000 0000 00111112336789999999999999
Q ss_pred CCHHHHHHHHh
Q 043932 996 MEMRDVVAKLC 1006 (1017)
Q Consensus 996 Ps~~evl~~L~ 1006 (1017)
.|+++.+++.-
T Consensus 329 Ita~qAleh~y 339 (438)
T KOG0666|consen 329 ITAEQALEHPY 339 (438)
T ss_pred ccHHHHhcccc
Confidence 99999998753
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=316.37 Aligned_cols=257 Identities=23% Similarity=0.404 Sum_probs=203.4
Q ss_pred ccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.+|.+.++||+|+||.||+|.+... ...||+|...... ....+.+.+|+.++++++||||+++++++.. +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 4688899999999999999997543 3568999887554 3445678999999999999999999998753 3
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~ 151 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF 151 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence 46899999999999999976532 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+++......... .....++..|+|||.+.+..++.++||||||+++||+++ |..||........ ......
T Consensus 152 g~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~~~ 223 (270)
T cd05056 152 GLSRYLEDESYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGRIEN 223 (270)
T ss_pred ceeeeccccccee-------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHc
Confidence 9987654322111 011234578999999988889999999999999999986 9999965422110 000000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
... ......++..+.+++.+|+..+|++|||+.++++.|+++++
T Consensus 224 ---~~~------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 224 ---GER------------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---CCc------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000 00112345678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.65 Aligned_cols=254 Identities=25% Similarity=0.462 Sum_probs=201.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.++||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|+|++++++++.. +..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcE
Confidence 457899999999999999999976 567899999874433 34678899999999999999999987632 4579
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence 99999999999999876432 3688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
......... ......++..|+|||++.+..++.++||||||+++||+++ |+.||....... .........
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~ 220 (260)
T cd05067 150 RLIEDNEYT-------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGY 220 (260)
T ss_pred eecCCCCcc-------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCC
Confidence 765422111 1112345778999999988889999999999999999999 999997532210 000000000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
+. .....++.++.+++.+|++.+|++||+++++++.|+.
T Consensus 221 ~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RM--------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00 0011235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.68 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=197.0
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-----chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-----GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+|+..+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CCC
Confidence 68889999999999999999998999999999864321 2345688899999999999999999987543 125
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..+++|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~df 150 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 150 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 6789999999999999997653 578899999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|++......... ........++..|+|||.+.+..++.++||||+||++|||++|+.||...... ......
T Consensus 151 g~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~~~~~ 221 (266)
T cd06651 151 GASKRLQTICMS-----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AAIFKI 221 (266)
T ss_pred CCcccccccccc-----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HHHHHH
Confidence 998755321100 11112245889999999999888999999999999999999999999753111 111110
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... ..+ .......+.+.+++ +|+..+|++||+++||++|
T Consensus 222 ~~~~-----~~~------------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 222 ATQP-----TNP------------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hcCC-----CCC------------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0000 000 00112244556666 6888999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=316.22 Aligned_cols=241 Identities=23% Similarity=0.369 Sum_probs=188.1
Q ss_pred CcccccCCceEEEEEeCCCcE-------EEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 711 NMIGQGSFGSVYKGILGEDEM-------IVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+.||+|+||.||+|.+...+. .||+|.+........+.+.+|+.+++.++|||++++++++... +..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence 469999999999999865443 4888888655555557788999999999999999999998754 5678
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC--------e
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV--------S 855 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~ 855 (1017)
+||||+++|+|.+++..... .+++..++.++.||+.|++|||++ +|+||||||+||+++.++. +
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence 99999999999999986542 678999999999999999999999 9999999999999987765 5
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCC-CCCCcccccCcc
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGR-RPTDAAFTEGLT 933 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~ 933 (1017)
+++|||.+...... ....++..|+|||++.+. .++.++||||||+++|||++|. .||...... .
T Consensus 148 ~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~- 213 (258)
T cd05078 148 KLSDPGISITVLPK------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-K- 213 (258)
T ss_pred EecccccccccCCc------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-H-
Confidence 89999987644211 124578899999999764 5789999999999999999985 554432111 0
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
....... . . ........++.+++.+||+.||++|||++++++.|+
T Consensus 214 ~~~~~~~--~-------------------~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 214 KLQFYED--R-------------------H-------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHc--c-------------------c-------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 0 0 000112356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.67 Aligned_cols=250 Identities=30% Similarity=0.396 Sum_probs=199.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
.+|++.+.||+|+||.||+|... +..||+|.+... ...+.+.+|+.++++++|+|++++++++... .+..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEE
Confidence 47889999999999999999875 677999988533 2346788999999999999999999976432 245799
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.
T Consensus 78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred EEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence 9999999999999976532 2578999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .........
T Consensus 151 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~~~ 214 (256)
T cd05082 151 EASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEK 214 (256)
T ss_pred eccccC-----------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhc
Confidence 543211 11234668999999988889999999999999999998 9999864311 111110000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
.. . ......+++.+.+++.+|++.+|++|||+.+++++|+.+
T Consensus 215 ~~-----~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 215 GY-----K------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CC-----C------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00 0 001123466789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.12 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=202.4
Q ss_pred hccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..+|++.+.||+|+||.||+|++..+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS----- 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence 35788999999999999999998533 3479999886433 23346788999999999999999999998644
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~d 149 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSD 149 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCC
Confidence 568999999999999999976542 678999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||++........... ......++..|+|||.+.+..++.++||||||+++||+++ |..||......+ .....
T Consensus 150 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~ 222 (267)
T cd05066 150 FGLSRVLEDDPEAAY-----TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAI 222 (267)
T ss_pred CCcccccccccceee-----ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHH
Confidence 999986643221100 0111234568999999998889999999999999999887 999986532110 00000
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
..... ......+++.+.+++.+|++.+|.+||++.++++.|+++
T Consensus 223 ~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 EEGYR--------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred hCCCc--------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00000 000112356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.73 Aligned_cols=250 Identities=27% Similarity=0.356 Sum_probs=203.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++|++.+.||.|+||.||+|++..+++.||+|++.... ......+.+|+++++.++|+|++++++++... ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence 36888999999999999999999999999999987553 34456788999999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+|+||+++++|.+++... .+++.+++.++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 999999999999998753 678999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
+...... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .. .......+
T Consensus 146 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-~~-~~~~~~~~ 215 (274)
T cd06609 146 GQLTSTM--------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-VL-FLIPKNNP 215 (274)
T ss_pred eeecccc--------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-HH-HHhhhcCC
Confidence 8764321 11122467889999999988889999999999999999999999996532110 00 00000000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. .. .. ..++..+.+++.+|+..||++|||+++++++
T Consensus 216 ~--------~~---------------~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 P--------SL---------------EG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred C--------CC---------------cc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 00 00 0135568899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.75 Aligned_cols=267 Identities=21% Similarity=0.311 Sum_probs=206.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++... +..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence 3578899999999999999999998999999999875433 3457788999999999999999999998665 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++++|.+++.... .+++..+..++.|++.|+.|||+.. +++||||||+||+++.++.++|+|||+
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred EEEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCc
Confidence 99999999999999987643 6789999999999999999999732 899999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... .....|+..|+|||++.+..++.++|||||||++|++++|+.||.......... ..
T Consensus 151 ~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~ 214 (284)
T cd06620 151 SGELINSI----------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DD 214 (284)
T ss_pred ccchhhhc----------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hh
Confidence 86442111 112468999999999988889999999999999999999999997643321100 00
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
+..+.+...... .. ........+++..+.+++.+|++.||++|||+.|++++..-+.
T Consensus 215 ~~~~~~~~~~~~-----~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 215 PMGILDLLQQIV-----QE-----PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hhHHHHHHHHHh-----hc-----cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 000000000000 00 0000011124667899999999999999999999998754433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=327.19 Aligned_cols=284 Identities=20% Similarity=0.230 Sum_probs=206.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.++||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++...........
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999999999999986432 2344667889999999999999999998766544445678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++|+||+++ ++.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEehhccc-CHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 999999965 888887543 688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+......... ........||..|+|||.+.+ ..++.++||||+||++|+|++|+.||....... ....+....
T Consensus 153 ~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~ 226 (336)
T cd07849 153 ARIADPEHDH-----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVL 226 (336)
T ss_pred eeeccccccc-----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHc
Confidence 8765432211 111223568999999998754 468899999999999999999999996532111 111111100
Q ss_pred ---cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 ---LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ---~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.++....+.+.........................++++.+++.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111111111100000000000000011112346778999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.85 Aligned_cols=276 Identities=21% Similarity=0.242 Sum_probs=204.4
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++|||++++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-----SGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeeE
Confidence 5888999999999999999999899999999987554 23356788999999999999999999998654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+ +++|.+++.... ..+++.+++.++.||++||+|||+. +++|+||||+||+++.++.++|+|||.+
T Consensus 76 ~v~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred EEeccc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 999999 999999987654 2689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
........ .......|+..|+|||.+.+. .++.++||||+|+++|||++|.+||...... ...........
T Consensus 147 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~ 218 (286)
T cd07832 147 RLFSEEEP-------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLG 218 (286)
T ss_pred ccccCCCC-------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcC
Confidence 86543221 011124688999999988654 4689999999999999999998888653221 11111111100
Q ss_pred Cc---hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PE---KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~---~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. ...+..+........ ..............+...++.+++.+|++.||.+||+++++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKIT-FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCChHHHhhccCcchhhccc-CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000000000 00000001111223445789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=317.04 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=208.4
Q ss_pred hccccccCcccccCCceEEEEEeCC----CcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE----DEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.++|++.++||+|+||.||+|.+.. ++..||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 4689999999999999999999875 36789999886432 23456788999999999999999999987543
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCC--ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDH--LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
....++++||+++++|.+++...... .....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence 25678999999999999999764321 1124689999999999999999999999 999999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~ 935 (1017)
|+|||+++.+........ .....++..|+|||++.+..++.++|||||||++||+++ |+.||...... ...
T Consensus 158 l~d~g~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~ 229 (280)
T cd05043 158 ITDNALSRDLFPMDYHCL------GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMA 229 (280)
T ss_pred ECCCCCcccccCCceEEe------CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHH
Confidence 999999986543221111 111346778999999988889999999999999999999 99998653211 111
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
........ ......+++++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 230 ~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 230 AYLKDGYR--------------------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHHcCCC--------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11110000 000112356789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.26 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=202.5
Q ss_pred hccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG--- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC---
Confidence 4679999999999999999999743 578899999875432 3346788999999999999999999988654
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCC----------------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeec
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDH----------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGD 841 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 841 (1017)
+..++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||+. +++|||
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 81 --KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred --CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 5679999999999999999754211 1123578899999999999999999999 999999
Q ss_pred CCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-C
Q 043932 842 LKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-G 920 (1017)
Q Consensus 842 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g 920 (1017)
|||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+..++.++|||||||++|||++ |
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~ 229 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYK------ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 229 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCcccc------ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999987543221100 0111234677999999988889999999999999999998 8
Q ss_pred CCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 043932 921 RRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRD 1000 (1017)
Q Consensus 921 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1000 (1017)
..||...... +.......... ......++.++.+++.+|++.||++|||+.|
T Consensus 230 ~~p~~~~~~~-----~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 230 MQPYYGMAHE-----EVIYYVRDGNV-----------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred CCCCCCCCHH-----HHHHHHhcCCC-----------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 8888543211 11110000000 0001123567899999999999999999999
Q ss_pred HHHHHhh
Q 043932 1001 VVAKLCH 1007 (1017)
Q Consensus 1001 vl~~L~~ 1007 (1017)
+++.|++
T Consensus 282 l~~~l~~ 288 (288)
T cd05050 282 INRILQR 288 (288)
T ss_pred HHHHhhC
Confidence 9998874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.22 Aligned_cols=204 Identities=24% Similarity=0.328 Sum_probs=163.0
Q ss_pred cCcccccCCceEEEEEeCC--CcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 710 SNMIGQGSFGSVYKGILGE--DEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
+.+||+|+||+||+|+... ++..||+|.+.... ....+.+|++++++++||||+++++++.... ....++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEe
Confidence 3579999999999999754 56789999886432 2346778999999999999999999885432 256899999
Q ss_pred eccCCCHHHHHhhCCC---CccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe----CCCCCeEEeec
Q 043932 788 CMKNGSLEDWLHQSND---HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVSHVGDF 860 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Df 860 (1017)
|+++ +|.+++..... ......+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9865 88888754321 11223588999999999999999999999 99999999999999 56679999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
|+++........ ........||+.|+|||++.+ ..++.++||||+||++|||+||++||...
T Consensus 157 G~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCccc-----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999866432211 111223568999999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.47 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=202.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
..|+..+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEE
Confidence 46778899999999999999999889999999987543 34457788999999999999999999998664 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++... .+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++
T Consensus 79 lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 999999999999998643 578889999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......++..|+|||++.+..++.++|||||||++|||++|+.||......... .......
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~- 217 (277)
T cd06640 149 GQLTDTQI--------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--FLIPKNN- 217 (277)
T ss_pred eeccCCcc--------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--hhhhcCC-
Confidence 76543221 111245788999999998888999999999999999999999998653221100 0000000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. ......++..+.+++.+||+.+|++||++.+++++
T Consensus 218 -------~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 -------P------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -------C------------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0 01122346678899999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.84 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=202.1
Q ss_pred CcccccCCceEEEEEeCCC---cEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGED---EMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||.||+|.+... +..||+|++...... ..+.+.+|++.++.++|+|++++++++... ...++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEEE
Confidence 4799999999999999866 889999999755443 367889999999999999999999988653 6789999
Q ss_pred EeccCCCHHHHHhhCCCC---ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 787 ECMKNGSLEDWLHQSNDH---LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
||+++++|.+++...... .....+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence 999999999999875210 0123789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
........ ........++..|+|||.+.+..++.++||||+|+++|||++ |..||...... +......
T Consensus 153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~ 221 (262)
T cd00192 153 RDVYDDDY------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----EVLEYLR 221 (262)
T ss_pred cccccccc------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH
Confidence 87654321 011123457889999999988889999999999999999999 69998764211 1111000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
... .......++.++.+++.+|++.+|++||++.|++++|+
T Consensus 222 ~~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 KGY-----------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred cCC-----------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 00111233677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=291.89 Aligned_cols=279 Identities=19% Similarity=0.287 Sum_probs=211.0
Q ss_pred CHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecC
Q 043932 696 SYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSI 774 (1017)
Q Consensus 696 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 774 (1017)
.+.|+.+.++ +.||+|+|+.|--+....+|..||||++.+.......++.+|++++.+. .|+||++++++|.+.
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4677777764 4799999999999999999999999999877667778999999999999 599999999999765
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM- 853 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 853 (1017)
+..|+|||-+.||+|...+.++. .+++.++.++.++|+.||.|||.+ ||.|||+||+|||-....
T Consensus 149 -----~~FYLVfEKm~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~ 214 (463)
T KOG0607|consen 149 -----TRFYLVFEKMRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNK 214 (463)
T ss_pred -----ceEEEEEecccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCC
Confidence 67899999999999999998765 789999999999999999999999 999999999999986654
Q ss_pred --CeEEeecccccccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCCc
Q 043932 854 --VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTDA 926 (1017)
Q Consensus 854 --~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~ 926 (1017)
-+|||||.++.-......-. ..........+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||.+
T Consensus 215 vsPvKiCDfDLgSg~k~~~~~s-pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 215 VSPVKICDFDLGSGIKLNNDCS-PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred cCceeeeccccccccccCCCCC-CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 57999999886544322111 11233444578999999999862 24689999999999999999999999976
Q ss_pred ccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 927 AFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.=.++--+ -+ .+.-..-...+...+.+....+ ....+..++.+-.+++...+..||.+|-++.+++.+
T Consensus 294 ~Cg~dCGW---dr----Ge~Cr~CQ~~LFesIQEGkYeF---PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 294 HCGADCGW---DR----GEVCRVCQNKLFESIQEGKYEF---PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred ccCCcCCc---cC----CCccHHHHHHHHHHHhccCCcC---ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 32221100 00 0000000001111111111100 112345567778899999999999999999998874
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=327.07 Aligned_cols=256 Identities=22% Similarity=0.269 Sum_probs=197.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|..++..++|++|+++++++... ++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-----~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-----NY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CE
Confidence 47899999999999999999999999999999986422 22345578899999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 8999999999999999986432 678889999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC-----CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..
T Consensus 148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~ 216 (331)
T cd05624 148 SCLKMNQDGT-------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ET 216 (331)
T ss_pred ceeeccCCCc-------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----HH
Confidence 9976543221 01112468999999999875 45788999999999999999999999753211 11
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE--RMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1004 (1017)
+.......... ..+....+.++++.+++.+|++.+|.+ |++++++++|
T Consensus 217 ~~~i~~~~~~~--------------------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 217 YGKIMNHEERF--------------------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHcCCCcc--------------------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11110000000 000111123566788899998876654 5688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.71 Aligned_cols=265 Identities=26% Similarity=0.401 Sum_probs=205.2
Q ss_pred hccccccCcccccCCceEEEEEeCC-------CcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeecC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSSI 774 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 774 (1017)
..+|++.+.||+|+||.||+|++.. .+..||+|++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 4579999999999999999998642 23468999887433 23456788999999999 799999999998654
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCC----------CccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSND----------HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKP 844 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 844 (1017)
+..++||||+++|+|.+++..... ......+++.++..++.|++.||+|||++ +++||||||
T Consensus 91 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 162 (334)
T cd05100 91 -----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA 162 (334)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence 568999999999999999976431 11234688999999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCC
Q 043932 845 SNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923 (1017)
Q Consensus 845 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 923 (1017)
+||+++.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccc------cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999999999999997654322111 1111234578999999998889999999999999999998 8888
Q ss_pred CCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 924 TDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 924 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
|..... .+.......... ......++.++.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~~~~-----~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~ 288 (334)
T cd05100 237 YPGIPV-----EELFKLLKEGHR-----------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288 (334)
T ss_pred CCCCCH-----HHHHHHHHcCCC-----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 865321 111111000000 0011123567889999999999999999999999
Q ss_pred HHhhccc
Q 043932 1004 KLCHTRE 1010 (1017)
Q Consensus 1004 ~L~~~~~ 1010 (1017)
+|+.+..
T Consensus 289 ~l~~~~~ 295 (334)
T cd05100 289 DLDRVLT 295 (334)
T ss_pred HHHHHhh
Confidence 9998873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=314.05 Aligned_cols=266 Identities=24% Similarity=0.283 Sum_probs=204.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++|...++||.|++|.||+|.+..+++.||+|.+..... ....++.+|++++++++||||++++++|...+ ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence 367888999999999999999998999999999875433 34567889999999999999999999885432 25689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ....++...+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 78 lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EEEEecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence 99999999999998764321 123678899999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
....... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||...........+.......
T Consensus 153 ~~~~~~~----------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd06621 153 GELVNSL----------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222 (287)
T ss_pred ccccccc----------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc
Confidence 6543211 012357889999999988889999999999999999999999997653211111111110000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.......+ ........++.+.+++.+|++.+|++|||+.|++++-
T Consensus 223 ~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 223 MPNPELKD-----------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCchhhcc-----------------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 00000000 0000012356789999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.65 Aligned_cols=256 Identities=25% Similarity=0.443 Sum_probs=193.8
Q ss_pred CcccccCCceEEEEEeCC---CcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
+.||+|+||.||+|.+.. .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++... .+..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 468999999999998643 35679999885332 33456788999999999999999999977543 14578999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+.+|+|.+++..... ..++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999976432 467788899999999999999999 9999999999999999999999999998755
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhC-CCCCCcccccCccHHHHHHhhcCch
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG-RRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
......... ......++..|+|||.+.+..++.++|||||||++|||++| .+||..... ...........
T Consensus 149 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~~~~~ 219 (262)
T cd05058 149 YDKEYYSVH----NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----FDITVYLLQGR 219 (262)
T ss_pred cCCcceeec----ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHhcCC
Confidence 332111110 11123467789999999888899999999999999999995 555543211 11111000000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
. ......+++.+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 220 -----~------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 -----R------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -----C------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 00011234578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=326.22 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=196.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.++||+|+||+||++++..+++.||+|++.... ......+.+|+.++..++|++|+++++++... +.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-----NN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CE
Confidence 37889999999999999999999999999999986422 22334578899999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 8999999999999999986432 688889999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
++........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..
T Consensus 148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~----~~ 216 (332)
T cd05623 148 SCLKLMEDGT-------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ET 216 (332)
T ss_pred hheecccCCc-------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH----HH
Confidence 9875432110 1112246999999999986 345789999999999999999999999753211 11
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE--RMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1004 (1017)
+.......... ..+.....++.++.+++.+|+..+|.+ |+++.|+++|
T Consensus 217 ~~~i~~~~~~~--------------------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 217 YGKIMNHKERF--------------------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHhCCCccc--------------------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11110000000 000111233566788888888665544 7899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.95 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=199.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
++|.+.+.||+|+||.||+|.+..+ ..||+|.+.... ...+.+.+|++++++++|+|++++++++.. +..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcEE
Confidence 5688999999999999999998754 459999876433 234678899999999999999999988632 34689
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+.
T Consensus 78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred EEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence 9999999999999976432 3578999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......++..|+|||...+..++.++||||+|+++|||++ |+.||....... ....... ...
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~-~~~ 221 (260)
T cd05069 151 LIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-VLEQVER-GYR 221 (260)
T ss_pred EccCCccc-------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc-CCC
Confidence 65432211 1112346778999999988889999999999999999999 899987532211 0111000 000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
. ......+..+.+++.+|+..||++||++++|++.|++
T Consensus 222 ~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 M--------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred C--------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 0011235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.16 Aligned_cols=276 Identities=22% Similarity=0.324 Sum_probs=200.2
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|+..+.||+|++|.||+|++..+++.||||.+.... ....+.+.+|++++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEE
Confidence 4788899999999999999999899999999986443 22335788999999999999999999987544 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+. ++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred EEeeccc-cCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 9999996 589998875432 3688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCC-cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE-ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
........ ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||..................
T Consensus 148 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 219 (284)
T cd07860 148 RAFGVPVR--------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 219 (284)
T ss_pred hhcccCcc--------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 75532210 011124688999999887644 688999999999999999999999764322111111111111
Q ss_pred Cch-hhhhccchhhHHHHhhcchh-HHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEK-VIEIVDPLLLIEVMANNSMI-QEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~-~~~~~d~~l~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+.. ....... ...+......+ .............++.+++.+|++.||++|||++|++++
T Consensus 220 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 220 PDEVVWPGVTS--LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred CChhhhhhhhH--HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 110 0000000 00000000000 000111112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.45 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=204.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|+..++||+|+||.||.++...+++.|++|.+.... ....+++.+|++++++++|+||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence 5888999999999999999999999999999987543 34456788999999999999999999998654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EEEEecCCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 99999999999999986531 3688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......|++.|+|||.+.+..++.++||||+|+++|||++|..||...... +.......
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~ 215 (256)
T cd08221 149 KILGSEYS--------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQ 215 (256)
T ss_pred EEcccccc--------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc
Confidence 76543221 112346899999999998888899999999999999999999998653211 11100000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
... ......++.++.+++.+|++.+|++||+++|+++++
T Consensus 216 ~~~-----------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 216 GNY-----------------------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCC-----------------------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 000 000123356788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.93 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=199.9
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc------chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
+|++.+.||+|+||+||+|... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD----- 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----
Confidence 5788999999999999999875 788899999864321 2235688899999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++.+.. .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 67899999999999999997643 578899999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||.+........... .........|+..|+|||++.+..++.++||||+||++|+|++|+.||....... ....
T Consensus 146 fg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~ 219 (265)
T cd06631 146 FGCARRLAWVGLHGT--HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----AMFY 219 (265)
T ss_pred chhhHhhhhcccccc--ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----HHHH
Confidence 999876532111110 1111223568999999999998889999999999999999999999996532111 1000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....... . ......++.++.+++.+|++.+|++||++.|++++
T Consensus 220 ~~~~~~~----~------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 220 IGAHRGL----M------------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred hhhccCC----C------------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 0 00111235668899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=351.16 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=207.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.+-+|.....||.|.||.||-|...++|...|+|.+...+ ....+.+.+|..++..++|||+|+++|+-... +
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----e 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----E 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----H
Confidence 3447888899999999999999999999999999886443 34557788999999999999999999985443 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..+|.||||++|+|.+.+...+ ..++.....+..|++.|++|||++ |||||||||+||+++.+|.+|++||
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecc
Confidence 6899999999999999998764 456667777899999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCC---CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS---EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|.|..+..+. ...........||+.|||||++.+. ....++||||+|||+.||+||+.||.....+-....+.
T Consensus 1379 Gsa~ki~~~~----~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V 1454 (1509)
T KOG4645|consen 1379 GSAVKIKNNA----QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV 1454 (1509)
T ss_pred cceeEecCch----hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH
Confidence 9998876542 1112334467899999999999764 35678999999999999999999997643331111111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.....| ..+.....+-.+++..|+..||++|.++.|++++=
T Consensus 1455 ~~gh~P---------------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1455 AAGHKP---------------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred hccCCC---------------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 111111 11122456678899999999999999999988764
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.62 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=198.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-----cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.+|++.++||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 47889999999999999999999999999999886332 123457888999999999999999999875432 2
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 56789999999999999987653 578888999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||.+......... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 150 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~ 220 (265)
T cd06652 150 FGASKRLQTICLS-----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFK 220 (265)
T ss_pred Ccccccccccccc-----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHH
Confidence 9998765321111 01112245889999999998888999999999999999999999998643111 11111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...... . ..........+.+++.+|+. +|++||+++|++++
T Consensus 221 ~~~~~~-----~------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 221 IATQPT-----N------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HhcCCC-----C------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 100000 0 00112234567788888884 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.81 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=200.3
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|++++++++|+||+++++++... +..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeEE
Confidence 3688999999999999999999989999999988754 233456788999999999999999999987654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++.... ....+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred EEEeecCCCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 9999999999999987642 1236899999999999999999999632 8999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCC------CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS------EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
....... .....|+..|+|||.+.+. .++.++||||+||++|+|++|+.||....... .....
T Consensus 151 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~ 219 (286)
T cd06622 151 GNLVASL----------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQL 219 (286)
T ss_pred ccccCCc----------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHH
Confidence 7543211 1123578899999998554 35889999999999999999999996532111 00000
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
... .+. ........++.++.+++.+|++.+|++||++.+++++-
T Consensus 220 ~~~---------~~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 220 SAI---------VDG---------------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred HHH---------hhc---------------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 000 000 00011123466788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.76 Aligned_cols=251 Identities=31% Similarity=0.456 Sum_probs=202.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeE
Confidence 457888999999999999999975 77899999975544 457889999999999999999999997653 6689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence 99999999999999976532 2589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... ...++..|+|||.+.+..++.++||||+|+++||+++ |..||....... .........
T Consensus 150 ~~~~~~~~-----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~ 216 (256)
T cd05039 150 KEASQGQD-----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKGY 216 (256)
T ss_pred cccccccc-----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcCC
Confidence 76532110 1234668999999988889999999999999999997 999986532110 000000000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
+ ......+++.+.+++.+|+..+|++||+++|++++|+.+
T Consensus 217 ~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 R--------------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred C--------------------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 000112356789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.46 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=201.4
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+.+.+|++++++++|+|++++++.+... ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE----DGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC----CCEEE
Confidence 4888999999999999999999889999999987443 23446788999999999999999999876432 24679
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++
T Consensus 77 lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 99999999999999976432 3589999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
....... .......|++.|+|||++.+..++.++||||+|+++|++++|+.||...... ........
T Consensus 150 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~ 216 (257)
T cd08223 150 RVLENQC--------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRIIE 216 (257)
T ss_pred EEecccC--------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHh
Confidence 7653221 1112346889999999999888999999999999999999999998653211 11100000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .......++.+.+++.+|++.||++||++.|++++
T Consensus 217 ~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 217 GKL-----------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cCC-----------------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00112235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=327.00 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=186.8
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc---CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI---RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 713 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
||+|+||+||+|++..+++.||+|++.... ......+..|..++... +||||+++++++... +..|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence 799999999999999999999999986432 12233455666666655 699999999988655 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999987653 688999999999999999999999 9999999999999999999999999998753
Q ss_pred ccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCch
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
.... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... +.........
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~i~~~~ 213 (330)
T cd05586 147 LTDN--------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRNIAFGK 213 (330)
T ss_pred CCCC--------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHHHHcCC
Confidence 2211 111235699999999998764 4799999999999999999999999753211 1111000000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC----CHHHHHHH
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM----EMRDVVAK 1004 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~ 1004 (1017)
. .+. ....++.+.+++.+||+.||.+|| ++.|+++|
T Consensus 214 ~-~~~----------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 214 V-RFP----------------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred C-CCC----------------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0 000 001245678999999999999998 56776664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=310.48 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=195.4
Q ss_pred CcccccCCceEEEEEeCCCcE--EEEEEEeeec-CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEM--IVAVKVINLK-QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||.||+|++.+++. .+|+|.+... .....+.+.+|+++++++ +||||+++++++... +..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEE
Confidence 469999999999999987765 4688887633 233456788999999999 799999999998654 5679999
Q ss_pred EeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 787 ECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
||+++|+|.+++...... .....+++.+++.++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999999764311 1123578999999999999999999999 999999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~ 935 (1017)
++|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 153 l~dfgl~~~~~~~~---------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----- 218 (270)
T cd05047 153 IADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----- 218 (270)
T ss_pred ECCCCCccccchhh---------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----
Confidence 99999985321100 0011224567999999988889999999999999999997 99998653211
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
........... ......++.++.+++.+|++.||.+|||+.|+++.|+.+.
T Consensus 219 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 ELYEKLPQGYR-----------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHhCCCC-----------------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11110000000 0001123456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.08 Aligned_cols=257 Identities=21% Similarity=0.349 Sum_probs=201.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc------chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
+|+..+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++|+|++++++++...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED----- 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----
Confidence 47888999999999999999988999999999874331 2346788999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-CeEEe
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VSHVG 858 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~ 858 (1017)
+..++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +++|+||+|+||+++.++ .+||+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 67899999999999999997643 678899999999999999999999 999999999999998776 59999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||.+.......... ........|+..|+|||.+.+..++.++||||+|+++|++++|..||........ .....
T Consensus 147 dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~ 221 (268)
T cd06630 147 DFGAAARLAAKGTGA----GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIF 221 (268)
T ss_pred ccccccccccccccC----CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHH
Confidence 999987664321111 1111234688999999999888899999999999999999999999964322111 11100
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...... .. .......++.+.+++.+|++.+|++||++.|++++
T Consensus 222 ~~~~~~-----~~------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 222 KIASAT-----TA------------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHhccC-----CC------------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 000000 00 01112335678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.13 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=204.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++|+..+.||+|+||.||+|.+..+++.||+|.+..... ...+++.+|++++++++||||+++++++... +..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence 367888999999999999999998999999999875532 3456788999999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
+|+||+++++|.+++.... ..+++..+..++.|++.|++|||+ . +++||||||+||+++.++.++|+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999998653 278899999999999999999999 8 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+........ ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..............+...
T Consensus 148 ~~~~~~~~~----------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 217 (265)
T cd06605 148 SGQLVNSLA----------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV 217 (265)
T ss_pred chhhHHHHh----------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh
Confidence 875532110 0145788999999998889999999999999999999999999764322111111111100
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .+.. ....++.++.+++.+|+..||++|||+.|++++
T Consensus 218 ~~~-----~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 218 NEP-----PPRL-----------------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cCC-----CCCC-----------------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000 0000 001146678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.54 Aligned_cols=256 Identities=27% Similarity=0.478 Sum_probs=202.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.++||+|+||.||+|.+. +++.||+|.+..... ..+++.+|+.++++++|+|++++++++... ...
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 76 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-----EPI 76 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecC-----Cce
Confidence 3468999999999999999999986 557799999874433 346789999999999999999999987543 567
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred EEEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccc
Confidence 999999999999999976432 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+......... ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||...... ........ .
T Consensus 150 ~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~-~ 220 (261)
T cd05034 150 ARLIEDDEYT-------AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVER-G 220 (261)
T ss_pred ceeccchhhh-------hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc-C
Confidence 8765432110 1111234678999999998889999999999999999999 99998653211 01111000 0
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
.. ......++.++.+++.+|++.+|++||+++|+.+.|+.
T Consensus 221 ~~--------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 YR--------------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC--------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 00011225678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.75 Aligned_cols=276 Identities=22% Similarity=0.281 Sum_probs=201.9
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc-----hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+..|++++++++|+||+++++++... +
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-----S 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-----C
Confidence 478889999999999999999988999999999754322 235567899999999999999999998653 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+ +|+|.+++.... ..+++.+++.++.||++||+|||++ +++||||||+||+++.++.++|+||
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 789999999 889999997643 2689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|++........ ......++..|+|||.+.+ ..++.++||||+||++|||++|.+||......+ .......
T Consensus 147 g~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~ 217 (298)
T cd07841 147 GLARSFGSPNR--------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFE 217 (298)
T ss_pred eeeeeccCCCc--------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHH
Confidence 99986543211 1112346788999998855 457899999999999999999988876533211 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...........+......+..................+..+.+++.+|++.||++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 218 ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 10000000000000000000000000111112223446788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.30 Aligned_cols=259 Identities=24% Similarity=0.423 Sum_probs=203.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcE----EEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.+|++.+.||+|+||.||+|.+..++. .||+|....... .....+.+|+..+++++|||++++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 578899999999999999999876554 589998865433 344678899999999999999999998864
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++|+|.+++..... .+++..+..++.||+.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence 457899999999999999986543 589999999999999999999998 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||.++......... ......++..|+|||.+....++.++||||||+++||+++ |+.||......+ .....
T Consensus 153 fg~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~ 224 (279)
T cd05057 153 FGLAKLLDVDEKEY------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLL 224 (279)
T ss_pred CcccccccCcccce------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHH
Confidence 99998664222110 0011224678999999988889999999999999999998 999987642211 11111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
..... . .....++..+.+++.+||..||.+||++.++++.++.+.++
T Consensus 225 ~~~~~-----~---------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 225 EKGER-----L---------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred hCCCC-----C---------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00000 0 00011234678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=316.46 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=200.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+.|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++++... +..+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----CceE
Confidence 35677788999999999999998889999999987443 33456788999999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++... .+++..+..++.|+++|+.|||++ +++|+||+|+||+++.++.++++|||++
T Consensus 79 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 79 IIMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccc
Confidence 999999999999998642 578899999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... ........
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~-- 216 (277)
T cd06642 149 GQLTDTQI--------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKN-- 216 (277)
T ss_pred ccccCcch--------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcC--
Confidence 76543211 1112457889999999998889999999999999999999999986432111 00000000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..+ .....++..+.+++.+|++.+|++||++.|++++-
T Consensus 217 ------~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 217 ------SPP------------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ------CCC------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 000 00112356688999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.56 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=205.2
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCC-CCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDS-KGA 779 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 779 (1017)
..+++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+++++++ +|+||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356899999999999999999999998899999999875543 346788999999999 79999999999876533 234
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 678999999999999999875431 123688999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccC-----CCcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
||.+....... .......|+..|+|||++.. ..++.++||||+||++|+|++|+.||...... ...
T Consensus 157 ~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~ 227 (275)
T cd06608 157 FGVSAQLDSTL--------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RAL 227 (275)
T ss_pred Cccceecccch--------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHH
Confidence 99987653221 11122458899999998753 34678999999999999999999999643211 111
Q ss_pred HHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...... ..+.. ......++.+.+++.+|+..||++|||+.|++++
T Consensus 228 ~~~~~~---------~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 228 FKIPRN---------PPPTL----------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHhhcc---------CCCCC----------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 110000 00000 0112245678899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.22 Aligned_cols=247 Identities=27% Similarity=0.421 Sum_probs=194.0
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
++||+|+||.||+|... ++..||+|++..... .....+.+|++++++++||||+++++++... +..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECC
Confidence 46999999999999975 678899999865433 2234688999999999999999999998654 5679999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++++|.+++..... .+++.+++.++.|++.||.|+|+. +++||||||+||+++.++.+||+|||++......
T Consensus 75 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 75 PGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 99999999876432 578999999999999999999999 9999999999999999999999999998754321
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIE 948 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1017)
... ......++..|+|||++.+..++.++||||||+++|++++ |..||...... ..........
T Consensus 147 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~~~~~~~~~--- 211 (250)
T cd05085 147 IYS-------SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QAREQVEKGY--- 211 (250)
T ss_pred ccc-------cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHcCC---
Confidence 110 0011234678999999988889999999999999999998 99998653221 1100000000
Q ss_pred hccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 949 IVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 949 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
. ......++..+.+++.+|+..+|++||++.|+++.|.
T Consensus 212 --~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 --R------------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --C------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0 0001123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=309.55 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=189.5
Q ss_pred CcccccCCceEEEEEeCC--CcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGE--DEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
+.||+|+||.||+|.... ++..+|+|.+..... .....+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEE
Confidence 468999999999998643 456799998865432 2335788899999999999999999988654 56799999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
|+++|+|.+++...... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++...
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999764321 123456778889999999999999999 99999999999999999999999999986543
Q ss_pred cccccccccCCCcccccccCccccCcccccCC-------CcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-------EASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
..... .......|+..|+|||++.+. .++.++||||||+++|||++ |+.||........ ...
T Consensus 152 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~-- 221 (269)
T cd05087 152 KEDYY------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTY-- 221 (269)
T ss_pred Cccee------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHH--
Confidence 22110 111224578899999988642 35789999999999999996 9999965322111 000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
..........++.. ....++.+.+++..|+ .+|++|||++||++.|+
T Consensus 222 -~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 222 -TVREQQLKLPKPRL------------------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -HhhcccCCCCCCcc------------------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000001111110 0112456788999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=311.03 Aligned_cols=265 Identities=26% Similarity=0.422 Sum_probs=201.6
Q ss_pred ccccCcccccCCceEEEEEeC---CCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC-c
Q 043932 707 FASSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA-D 780 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~-~ 780 (1017)
|.+.++||+|+||.||+|.+. .+++.||||++.... ....+++.+|++++++++||||+++++++......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999864 357899999986442 2345678899999999999999999998765433221 2
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++++||+++|+|.+++...........+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3578999999999999876433222223578899999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|.++......... ......+++.|++||.+.+..++.++|||||||++|||++ |++||...... .......
T Consensus 158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYR------QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI 229 (273)
T ss_pred cccccccCCccee------cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH
Confidence 9988654322111 1112345678999999988889999999999999999999 88888643221 0000000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
..... .....++..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 230 --~~~~~------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 --KGNRL------------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --cCCcC------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 00012356789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=287.15 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=201.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++.+....||.|+-|.||+++.+.+|...|||.+.... +.+.+++...++++..- +.|.||+.+|||... ..+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV 166 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDV 166 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chH
Confidence 44556778999999999999999999999999997554 45668888888887766 489999999999765 457
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++.||.+.- .++..+++... ++++.-+-++...+++||.||.+++ +|+|||+||+|||+|+.|.+|+||||+
T Consensus 167 ~IcMelMs~-C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccc
Confidence 899998844 67777776553 6888888899999999999999886 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC---CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG---SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
+.++-+.... ....|.+.|||||.+.- ..|+.++||||||+.++|+.||+.||.....+-..+.....
T Consensus 239 sGrlvdSkAh---------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 239 SGRLVDSKAH---------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred cceeeccccc---------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence 9877544422 22468999999999854 46889999999999999999999999875444333322222
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
. .| |.+.. ....++.+.+++..||+.|+.+||...++++|=
T Consensus 310 ~-eP--------P~L~~----------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 310 E-EP--------PLLPG----------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred c-CC--------CCCCc----------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 1 11 11100 011366789999999999999999999998863
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.83 Aligned_cols=278 Identities=21% Similarity=0.293 Sum_probs=199.6
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|++++++++|+||+++++++... ++.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK-----KTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC-----CeE
Confidence 3678999999999999999999998999999999874432 2234567899999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++ +|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccc
Confidence 999999975 99999876542 678999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++....... ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.................
T Consensus 150 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~ 221 (291)
T cd07844 150 ARAKSVPSK--------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221 (291)
T ss_pred ccccCCCCc--------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhc
Confidence 864321110 0111246889999998876 4578999999999999999999999965432111111111110
Q ss_pred c---CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 L---PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECL--NAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. +.......+........ ................. ..+.+++.+|++.||++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 222 GTPTEETWPGVSSNPEFKPYS-FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred CCCChhhhhhhhhcccccccc-ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 00000000000000000 00000000011111112 567899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.60 Aligned_cols=260 Identities=26% Similarity=0.437 Sum_probs=202.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcE----EEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.++|+..+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 3578889999999999999999876664 578888764432 2234688999999999999999999988542
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
..++|+||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~ 151 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 151 (303)
T ss_pred --CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEc
Confidence 35799999999999999876542 578899999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++........ .......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ....+
T Consensus 152 Dfg~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~ 223 (303)
T cd05110 152 DFGLARLLEGDEKE------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDL 223 (303)
T ss_pred cccccccccCcccc------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence 99999865432211 01112345778999999988889999999999999999997 89998653211 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
....... .....++..+.+++.+||..+|++||++.++++.++.+.+.
T Consensus 224 ~~~~~~~--------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 224 LEKGERL--------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHCCCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1100000 00011245678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.11 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=199.2
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
.|.....||+|+||.||++.+..++..||||.+........+.+.+|+..++.++|+|++++++.+... ++.++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEEE
Confidence 344456799999999999999888999999998765555567788999999999999999999987654 678999
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
|||+++++|.+++... .+++.++..++.||+.|++|||++ +|+||||||+||+++.++.++|+|||++..
T Consensus 98 ~e~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 98 MEFLEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred EeCCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 9999999999988542 578899999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCch
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
..... .......|+..|+|||.+.+..++.++||||+|+++|||++|+.||...... ......
T Consensus 168 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~----- 230 (292)
T cd06658 168 VSKEV--------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRI----- 230 (292)
T ss_pred ccccc--------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-----
Confidence 43211 1112246889999999998888999999999999999999999998653211 000000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.....+.. ......+..+.+++.+|+..||.+|||++|++++
T Consensus 231 -~~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 -RDNLPPRV----------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -HhcCCCcc----------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00000000 0011234567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=318.82 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=204.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc---hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|+..+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-----TY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-----CE
Confidence 3688899999999999999999988999999999754322 446788999999999999999999987554 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence 8999999999999999875432 3689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccc---------------------cCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhC
Q 043932 862 LAKFLSSHQLDTAS---------------------KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG 920 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 920 (1017)
++............ ..........||..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98765322111000 001111235689999999999988899999999999999999999
Q ss_pred CCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC---
Q 043932 921 RRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME--- 997 (1017)
Q Consensus 921 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs--- 997 (1017)
+.||...... ....... +... .. ......++.+.+++.+|++.||++||+
T Consensus 229 ~~pf~~~~~~-~~~~~~~------------~~~~---------~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 281 (316)
T cd05574 229 TTPFKGSNRD-ETFSNIL------------KKEV---------TF-----PGSPPVSSSARDLIRKLLVKDPSKRLGSKR 281 (316)
T ss_pred CCCCCCCchH-HHHHHHh------------cCCc---------cC-----CCccccCHHHHHHHHHHccCCHhHCCCchh
Confidence 9999754221 1111000 0000 00 000113677899999999999999999
Q ss_pred -HHHHHHH
Q 043932 998 -MRDVVAK 1004 (1017)
Q Consensus 998 -~~evl~~ 1004 (1017)
++|++++
T Consensus 282 ~~~~ll~~ 289 (316)
T cd05574 282 GAAEIKQH 289 (316)
T ss_pred hHHHHHcC
Confidence 7777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.78 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=196.6
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
++||+|+||.||+|.+.. ++.||+|.+...... ..+.+.+|++++++++|+||+++++++... ...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcC
Confidence 479999999999999986 899999998755443 456789999999999999999999988654 6689999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++++|.+++..... .+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+......
T Consensus 75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999976432 578899999999999999999999 9999999999999999999999999998755321
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIE 948 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1017)
.... ......++..|+|||.+.+..++.++||||+||++|||++ |..||....... ..........
T Consensus 147 ~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~~~~~~----- 213 (251)
T cd05041 147 IYTV------SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERIESGYR----- 213 (251)
T ss_pred ccee------ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHHhcCCC-----
Confidence 1100 0011234567999999988889999999999999999999 888886532210 0010000000
Q ss_pred hccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 949 IVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 949 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
......++.++.+++.+|++.+|++||++.|+++.|+.
T Consensus 214 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 214 ---------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ---------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 00011235678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=309.11 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=203.7
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||.|+||.||+|.+..++..||+|++.... ....+++.+|++++++++||||+++++++... +....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 4788899999999999999999999999999987443 23446788899999999999999999977543 225679
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHh-----hCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH-----HHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
++|||+++++|.+++..... ....+++.+++.++.|++.||+||| +. +++|+||||+||+++.++.+||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred EEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence 99999999999999976422 2247899999999999999999999 76 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....
T Consensus 153 d~g~~~~~~~~~~--------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~ 219 (265)
T cd08217 153 DFGLAKILGHDSS--------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLA 219 (265)
T ss_pred cccccccccCCcc--------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HHHH
Confidence 9999986643221 01224689999999999888899999999999999999999999976421 1111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........ .......+..+.+++.+|++.+|++||++.||+++
T Consensus 220 ~~~~~~~~-----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 220 SKIKEGKF-----------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHhcCCC-----------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 10000000 01112335678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.81 Aligned_cols=277 Identities=24% Similarity=0.337 Sum_probs=202.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.++||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++... +..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeE
Confidence 368899999999999999999988899999998764332 2346688999999999999999999998544 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||++++++.++..... .+++.++..++.||+.|++|||+. +++||||+|+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred EEEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 99999999999988765432 578999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh-
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI- 940 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~- 940 (1017)
+....... .......++..|+|||++.+ ..++.++||||||+++|||++|++||......+ ........
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~ 217 (286)
T cd07846 147 ARTLAAPG--------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCL 217 (286)
T ss_pred eeeccCCc--------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHh
Confidence 87653321 11122457899999998876 347889999999999999999999986532211 11111100
Q ss_pred -hcCchhhhhccchhhHHHH-hhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 -ALPEKVIEIVDPLLLIEVM-ANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 -~~~~~~~~~~d~~l~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+......+........ .................+..+.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred CCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0011111111100000000 000000011111223456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=314.94 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=198.9
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
|.....||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++|||++++++++... +..++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEEEEE
Confidence 33455799999999999999888999999999765555557788999999999999999999988654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++++|.+++... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 98 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 98 EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred ecCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999999987542 578999999999999999999999 9999999999999999999999999998754
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
..... ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ....... ...
T Consensus 168 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~-~~~- 233 (297)
T cd06659 168 SKDVP--------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKRLR-DSP- 233 (297)
T ss_pred ccccc--------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh-ccC-
Confidence 32211 112246899999999998888999999999999999999999998653211 1111100 000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+.. ......+..+.+++.+|++.+|++||+++|++++
T Consensus 234 ----~~~~----------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 ----PPKL----------------KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ----CCCc----------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 0011224567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.03 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=196.8
Q ss_pred CcccccCCceEEEEEeCCCc------EEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 711 NMIGQGSFGSVYKGILGEDE------MIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+.||+|+||.||+|++.... +.||+|.+.... ......+.+|+.+++.++||||+++++++... +..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCeE
Confidence 46999999999999986433 679999886443 23456788999999999999999999988654 5689
Q ss_pred EEEEeccCCCHHHHHhhCCCCc-cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-----CeEE
Q 043932 784 LVFECMKNGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-----VSHV 857 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl 857 (1017)
+||||+++++|.+++....... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .+++
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999997643211 223578999999999999999999999 999999999999999887 8999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~ 936 (1017)
+|||++.......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 153 ~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~ 224 (269)
T cd05044 153 GDFGLARDIYKSDYYR------KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQ 224 (269)
T ss_pred CCcccccccccccccc------cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHH
Confidence 9999987654322111 1112345788999999998889999999999999999998 99998643211 0100
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
... ... . ......++..+.+++.+||..+|.+||++.++++.|++
T Consensus 225 ~~~---~~~------------------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 225 HVT---AGG------------------R-----LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHh---cCC------------------c-----cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 000 0 00112335678999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.50 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=198.4
Q ss_pred CcccccCCceEEEEEeCC-Cc--EEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGE-DE--MIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|++|.||+|.+.. .+ ..||+|.+..... ...+.+.+|+..+++++||||+++++++.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999999864 23 3699999976655 556788999999999999999999998753 4579999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence 99999999999987541 3689999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCch
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
...... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ ....... ...
T Consensus 148 ~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~--~~~ 218 (257)
T cd05040 148 PQNEDH-----YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDK--EGE 218 (257)
T ss_pred cccccc-----eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh--cCC
Confidence 432211 011112457789999999988889999999999999999999 999986432211 0000000 000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
. .......+..+.+++.+|++.+|++||++.|+++.|.+
T Consensus 219 --~---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 219 --R---------------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred --c---------------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 0 00011235678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=322.60 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=207.9
Q ss_pred cccccCcccccCCceEEEEEeCCCcE----EEEEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+.+..++||+|+||+||+|.+...|+ +||+|++... .....+++.+|+.+|.+++|||+++++++|...
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------ 770 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------ 770 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------
Confidence 44557899999999999999965553 5899988643 344568899999999999999999999999664
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
...||++|++.|+|.+|++.+++ .+-....+.|..|||+||.|||++ ++|||||..+||||..-..+||.||
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdf 842 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDF 842 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEec
Confidence 36799999999999999998775 788889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+|+.......+.... ...-.+.|||-|.+....|+.++|||||||++||++| |..|+++...++ +.
T Consensus 843 gla~ll~~d~~ey~~~------~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~- 910 (1177)
T KOG1025|consen 843 GLAKLLAPDEKEYSAP------GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----IP- 910 (1177)
T ss_pred chhhccCccccccccc------ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----hh-
Confidence 9999876544322221 1234678999999999999999999999999999999 999987753221 10
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
+.+.. . +.-..+.-|+..++.++.+||..|+..||+++++.+.+.+..
T Consensus 911 --------dlle~---------g-----eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 911 --------DLLEK---------G-----ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred --------HHHhc---------c-----ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 00000 0 001223456778899999999999999999999998887754
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.93 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=203.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|.+.+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++|||++++++++... +..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEE
Confidence 46899999999999999999999888999999998765555567788999999999999999999988654 6689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+|+||+++++|.+++... .+++.++..++.|++.|++|||++ +++||||||+||+++.++.++|+|||++
T Consensus 93 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred EEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 999999999999998753 468889999999999999999999 9999999999999999999999999988
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......|++.|+|||.+.+..++.++||||||+++|++++|+.||.......... ..... +
T Consensus 163 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~~--~ 231 (293)
T cd06647 163 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN--G 231 (293)
T ss_pred eccccccc--------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhcC--C
Confidence 75543221 1122458899999999988889999999999999999999999997542211100 00000 0
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. +. .......+..+.+++.+||+.+|++||++.+++.+
T Consensus 232 ~-------~~----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 T-------PE----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C-------CC----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 00111234568899999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.02 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=202.1
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||+|+||.||+++...+++.||+|.+.... ....+++.+|++++++++||||+++++++... ++.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEE
Confidence 5888999999999999999999899999999987432 33446788999999999999999999987554 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 99999999999999876432 2578899999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~ 215 (256)
T cd08218 149 RVLNSTVE--------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVLKIIR 215 (256)
T ss_pred eecCcchh--------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHHHHhc
Confidence 76543211 111245788999999998888999999999999999999999998643211 11100000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .......+..+.+++.+|++.+|++||++.||+++
T Consensus 216 ~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 216 GSY-----------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCC-----------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000 00112335678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.44 Aligned_cols=256 Identities=22% Similarity=0.393 Sum_probs=198.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc----------chHHHHHHHHHHHHhcCCCCceeeeeeeecCC
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK----------GAFKSFMAECKALRNIRHRNLIKIITICSSID 775 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 775 (1017)
+|.+.+.||+|+||.||+|....+++.||+|.++.... ...+.+.+|+.++++++|||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 57788999999999999999988899999998863211 1134677899999999999999999988654
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCe
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
+..++||||+++++|.++++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+
T Consensus 81 ----~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 81 ----EYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred ----CceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 67899999999999999997653 688899999999999999999999 99999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCCC--cCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE--ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
+++|||.++....... ........|+..|+|||.+.... ++.++||||+|+++||+++|..||.....
T Consensus 148 ~l~d~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---- 217 (272)
T cd06629 148 KISDFGISKKSDDIYD------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---- 217 (272)
T ss_pred EEeecccccccccccc------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----
Confidence 9999999875432110 01112345889999999987654 78999999999999999999999864211
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........... ....+. .....+++..+.+++.+|+..||++||++.||+++
T Consensus 218 ~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 218 IAAMFKLGNKR-SAPPIP------------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHHHhhccc-cCCcCC------------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111100000 000000 00112346778999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=313.53 Aligned_cols=286 Identities=19% Similarity=0.252 Sum_probs=204.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.+++.+. ||||+++++++...+..+...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 368899999999999999999999999999999864432 23467788999999994 699999999887654434456
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-CCCeEEeec
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVSHVGDF 860 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df 860 (1017)
.|+||||+++ +|.+++...... ....+++..++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999986 899988754321 123689999999999999999999999 9999999999999998 899999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|.+........ ......+++.|+|||++.+ ..++.++||||+|+++|+|++|..||...............
T Consensus 156 g~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 227 (295)
T cd07837 156 GLGRAFSIPVK--------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227 (295)
T ss_pred ccceecCCCcc--------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 99875532110 0111246888999998865 45789999999999999999999999764222111111110
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+.. ..+................+..........++++.+++.+|++.||.+||++.|++.+
T Consensus 228 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 228 LGTPTE-QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCCCCh-hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000100 0000000000000000001111122223456788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=306.47 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=200.2
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-----cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+|+..+.||+|+||+||+|....+++.||+|.+.... +...+.+.+|+++++.++|+||+++++++... .
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----D 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----C
Confidence 4778899999999999999998889999999987543 22456788999999999999999999987654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 7899999999999999997653 578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCC-cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE-ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|.+....... ......|+..|+|||.+.... ++.++|+||+|+++|+|++|+.||...... .....
T Consensus 147 ~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----~~~~~ 213 (258)
T cd06632 147 GMAKQVVEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----AAVFK 213 (258)
T ss_pred ccceeccccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----HHHHH
Confidence 9987653221 112346889999999987766 899999999999999999999998653211 11000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....... ......+.+.+.+++.+|++.+|++||++.+++++
T Consensus 214 ~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 214 IGRSKEL-----------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHhcccC-----------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0000000 00111235667889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=314.04 Aligned_cols=280 Identities=22% Similarity=0.315 Sum_probs=199.1
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+++++.++|+||+++++++... +.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK-----ET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-----Ce
Confidence 45789999999999999999999998999999999865432 2234677899999999999999999998654 57
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+. +++.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence 899999995 688877765432 567888899999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
+++....... ......++..|+|||.+.+. .++.++||||+||++|||++|+.||.........+.+....
T Consensus 149 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 220 (291)
T cd07870 149 LARAKSIPSQ--------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220 (291)
T ss_pred cccccCCCCC--------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH
Confidence 9875432110 11123578899999998764 57889999999999999999999997643321111111110
Q ss_pred -hcCchh--hhhcc-chhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 -ALPEKV--IEIVD-PLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 -~~~~~~--~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..+... ..... +.....+.....................+.+++.+|+..||++|||+.|++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 221 LGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 001000 00000 00000000000000000000000124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=322.68 Aligned_cols=286 Identities=22% Similarity=0.242 Sum_probs=209.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
..+|.+.+.||+|+||+||+|++..+++.||||.+... .....+.+.+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999999999999999998643 2333466778999999999999999999886553333356
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence 899999995 68999887543 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH-
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK- 939 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~- 939 (1017)
++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||....... .......
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~ 224 (337)
T cd07858 154 LARTTSEKG--------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITEL 224 (337)
T ss_pred cccccCCCc--------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHH
Confidence 997653221 11122457889999998765 468899999999999999999999997542110 0111110
Q ss_pred --hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhc
Q 043932 940 --IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK--LCHT 1008 (1017)
Q Consensus 940 --~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 1008 (1017)
...++....+.+........................+++++.+++.+|++.||++|||++|++++ ++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00111111111111111000000000111112223467788999999999999999999999988 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=292.38 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=200.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|...++||+|.||+|.+++.+.+++.||+|++++.. +++...-..|-++++..+||.+..+...|... +.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-----dr 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-----DR 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-----ce
Confidence 57888999999999999999999999999999997543 44456667899999999999999887776655 78
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+.||.|.-.+.+.+ .+++...+-+..+|+.||.|||++ +||.||+|.+|.++|.||++||+|||
T Consensus 243 lCFVMeyanGGeLf~HLsrer------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRER------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred EEEEEEEccCceEeeehhhhh------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecc
Confidence 999999999999998887654 788888888999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+++.-.. .......++|||.|.|||++....|+.++|.|.+||++|||++|+.||.....+.
T Consensus 314 LCKE~I~--------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---------- 375 (516)
T KOG0690|consen 314 LCKEEIK--------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---------- 375 (516)
T ss_pred cchhccc--------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------
Confidence 9974321 2233445899999999999999999999999999999999999999997643221
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
+.+++- ..+ ...+....++...++...+..||.+|. .++||.++
T Consensus 376 ----LFeLIl---~ed------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 376 ----LFELIL---MED------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ----HHHHHH---hhh------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 111100 000 001122245567888889999999996 35666544
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=307.73 Aligned_cols=256 Identities=26% Similarity=0.415 Sum_probs=202.3
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|++++++++|+||+++++++... +..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEE
Confidence 588899999999999999999889999999999755443 567889999999999999999999987544 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999997643 578889999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCC---cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE---ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
........... .......++..|+|||++.+.. ++.++||||||+++||+++|+.||........ .....
T Consensus 147 ~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~~~ 219 (264)
T cd06626 147 VKLKNNTTTMG----EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHV 219 (264)
T ss_pred cccCCCCCccc----ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHHHH
Confidence 87643321111 0011246789999999998765 88999999999999999999999965321110 00000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... .+.. .....++..+.+++.+|++.+|.+||++.|++.+
T Consensus 220 ~~~~------~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 220 GAGH------KPPI----------------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred hcCC------CCCC----------------CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 0000 0011235567899999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=307.10 Aligned_cols=250 Identities=24% Similarity=0.409 Sum_probs=200.7
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|++++++++|||++++++.+... +..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEE
Confidence 5888999999999999999999899999999987543 23456788999999999999999999987543 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-CCeEEeeccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVSHVGDFGL 862 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~ 862 (1017)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||++ +++||||||+||+++.+ +.+|++|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 99999999999999976432 3578999999999999999999999 99999999999999865 4689999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ......
T Consensus 149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~--- 215 (256)
T cd08220 149 SKILSSKS---------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL-VLKIMS--- 215 (256)
T ss_pred ceecCCCc---------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH-HHHHHh---
Confidence 98654321 11124688999999999888889999999999999999999999865322110 000000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... ......++..+.+++.+||+.||++|||+.|++++
T Consensus 216 -~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 216 -GTF-----------------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -cCC-----------------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000 00011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=306.69 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=198.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
..+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|++++++++||+++++++++... ...+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPIC 75 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceE
Confidence 357888999999999999999986 466899998864332 236788999999999999999999987554 5679
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred EEEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcce
Confidence 99999999999999976532 578899999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
......... ......++..|+|||.+.+..++.++||||+|+++|||++ |+.||...... ......
T Consensus 148 ~~~~~~~~~-------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~- 214 (256)
T cd05112 148 RFVLDDQYT-------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETI- 214 (256)
T ss_pred eecccCccc-------ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHH-
Confidence 755322110 1112235678999999988889999999999999999998 99998653211 111100
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.... ....+ ...++++.+++.+||+.+|++||++.|++++|.
T Consensus 215 ~~~~-~~~~~---------------------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 215 NAGF-RLYKP---------------------RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred hCCC-CCCCC---------------------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0000 00000 012467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=320.33 Aligned_cols=286 Identities=22% Similarity=0.268 Sum_probs=207.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 468999999999999999999999999999999987542 233467788999999999999999999875543 23467
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 899999995 59999887543 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
++......... .........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ........
T Consensus 153 ~~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~ 227 (334)
T cd07855 153 MARGLSSSPTE----HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSV 227 (334)
T ss_pred cceeecccCcC----CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHH
Confidence 99765432211 1111223468999999998865 468899999999999999999999997642211 11111110
Q ss_pred --hcCchhhhhccchhhHHHHhh-cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 941 --ALPEKVIEIVDPLLLIEVMAN-NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 941 --~~~~~~~~~~d~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..+....+............. ...............++++.+++.+|++.||++||++++++++-
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 001111110000000000000 00000000111233467899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=320.49 Aligned_cols=280 Identities=19% Similarity=0.212 Sum_probs=204.1
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 779 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.++++++||||+++++++..... .+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999999999999999998632 22334567789999999999999999998764422 223
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...|+||||+.+ +|.+++.. .++..++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 467999999964 88888753 368888999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++....... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...... ........
T Consensus 162 fg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~ 231 (353)
T cd07850 162 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIE 231 (353)
T ss_pred CccceeCCCCC---------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence 99997653221 112245789999999999989999999999999999999999999754221 11111111
Q ss_pred hh-c-CchhhhhccchhhHHHHhhcc----hhHHHh---------HHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IA-L-PEKVIEIVDPLLLIEVMANNS----MIQEDI---------RAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~-~-~~~~~~~~d~~l~~~~~~~~~----~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. . +..+.+..+............ .+.... .......++.+.+++.+|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 0 111111111111100000000 000000 00012345678899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=287.10 Aligned_cols=288 Identities=22% Similarity=0.348 Sum_probs=208.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC---CC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS---KG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 778 (1017)
.+.|....+||+|.||+||+|+.+.+|+.||+|++-.+. ..-.....+|++++..++|+|++.+++.|..... .+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 346777889999999999999999999999998765332 2233567899999999999999999998865433 23
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
....|+||++|+. +|...+.... .+++..++.+++.++..||.|+|.. .|+|||+||+|++|+.+|.+||+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence 4468999999988 9999987654 3889999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|||+|+.+...+.... ...+..+.|.+|++||.+.| ..|+++.|||+.|||+.||+||.+.+.+.... .++..+
T Consensus 167 DFGlar~fs~~~n~~k----prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-qql~~I 241 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVK----PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-QQLHLI 241 (376)
T ss_pred ccccccceecccccCC----CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-HHHHHH
Confidence 9999987654332211 12334567999999998877 46999999999999999999999998775332 111111
Q ss_pred HHh--hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 938 AKI--ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQEC------LNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 938 ~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
... ....++..-+|..-...-.... ...........+. .++-.+++.+++..||.+|+++++++.|--
T Consensus 242 s~LcGs~tkevWP~~d~lpL~~sie~e-Pl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 242 SQLCGSITKEVWPNVDNLPLYQSIELE-PLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HHHhccCCcccCCCcccchHHHhccCC-CCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 111 1111111111211111100000 0000000111111 235678999999999999999999987753
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=312.52 Aligned_cols=279 Identities=21% Similarity=0.272 Sum_probs=202.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.++++++||||+++++++...+ ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 3578899999999999999999998999999999975432 22345678999999999999999999876542 267
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++ +|.+++..... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~~-~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 81 IYMVMEYVEH-DLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred EEEEehhcCc-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence 8999999975 99999876542 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
++........ ......+++.|+|||.+.+. .++.++||||+|+++|||++|++||........ .......
T Consensus 152 ~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~ 222 (293)
T cd07843 152 LAREYGSPLK--------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKL 222 (293)
T ss_pred ceeeccCCcc--------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH
Confidence 9886643210 11123578899999988764 468999999999999999999999975432111 1111110
Q ss_pred hc-Cch--hhhhccchhhHHHHhhcchhHHHhHHhHHH--HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 AL-PEK--VIEIVDPLLLIEVMANNSMIQEDIRAKTQE--CLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~-~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. +.. +..+.+-....... ............... ..+.+.+++.+|++.||++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 223 LGTPTEKIWPGFSELPGAKKKT-FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hCCCchHHHHHhhccchhcccc-cccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000 00000000000000 000000001111111 36678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.88 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=187.3
Q ss_pred CcccccCCceEEEEEeCC--CcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGE--DEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
+.||+|+||+||+|+... ....+|+|.+..... .....+.+|++.++.++||||+++++++... ...++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEE
Confidence 369999999999997532 345788888764332 2345678999999999999999999988654 56899999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
|+++|+|.+++....... ....++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred eCCCCcHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 999999999998754311 12456778899999999999999999 99999999999999999999999999986543
Q ss_pred cccccccccCCCcccccccCccccCcccccC-------CCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-------SEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
...... ......++..|+|||++.. ..++.++||||+||++|||++ |..||......+ .......
T Consensus 152 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~ 224 (269)
T cd05042 152 PEDYYI------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVR 224 (269)
T ss_pred cchhee------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhh
Confidence 221100 0112346778999998743 356889999999999999999 788886532211 1111110
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.......++. ....+++.+.+++..|+ .||++|||++||++.|.
T Consensus 225 ----~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 ----EQDIKLPKPQ------------------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ----ccCccCCCCc------------------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000111110 11123556677888888 59999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=316.57 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=205.2
Q ss_pred cccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 706 EFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
+....++||+|+||.|++|.|... ...||||.+...... ....|.+|+.+|.+++|||++++||+..+ ..
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QP 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------ch
Confidence 445568899999999999999643 356999999866544 66899999999999999999999999764 23
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
..+|||.++.|+|.+.++... ...+.......++.|||.||.||.++ ++||||+..+|+++-....+||+|||
T Consensus 185 ~mMV~ELaplGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred hhHHhhhcccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence 579999999999999998832 24788889999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 940 (1017)
+.+-+...+...... ....-...|+|||.+....++.++|||+|||++|||+| |..||.+....
T Consensus 258 LmRaLg~ned~Yvm~-----p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---------- 322 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMA-----PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---------- 322 (1039)
T ss_pred ceeccCCCCcceEec-----CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------
Confidence 999876544222111 11234678999999999999999999999999999999 88898764221
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.+.+.+|... .-...+.|++.+++++..||..+|++|||+..|.+.+
T Consensus 323 ----qIL~~iD~~e--------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 323 ----QILKNIDAGE--------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ----HHHHhccccc--------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1222222110 1134457899999999999999999999999997544
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.35 Aligned_cols=275 Identities=23% Similarity=0.323 Sum_probs=203.1
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
+|++.++||+|++|.||+|++..+++.||+|++..... ...+.+.+|++++++++|+||+++++++... +..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence 58889999999999999999999999999999875533 2346677899999999999999999998665 56899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++ +|.+++..... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||++.
T Consensus 76 v~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EEecCCc-cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 9999975 89998876432 23689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh-c
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA-L 942 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~ 942 (1017)
....... ......++..|+|||.+.+. .++.++||||+||++|+|++|+.||......+ ......... .
T Consensus 149 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~ 219 (284)
T cd07836 149 AFGIPVN--------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGT 219 (284)
T ss_pred hhcCCcc--------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Confidence 5532110 11123578899999988664 57889999999999999999999997643221 111111110 0
Q ss_pred C--chhhhhccchhhHHHHhh-cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 P--EKVIEIVDPLLLIEVMAN-NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~--~~~~~~~d~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+ ..+..+.+. ..+... ..............++..+.+++.+|++.||.+||++.|++++
T Consensus 220 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 220 PTESTWPGISQL---PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CChhhHHHHhcC---chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 001001000 000000 0000111112223456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.60 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=205.5
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
+|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|++.+++++|+|++++++++... ...++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEEE
Confidence 68889999999999999999998999999999876544 3457889999999999999999999998654 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
||||+++++|.+++.... .+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+
T Consensus 77 v~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 77 VLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred EEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999998653 68999999999999999999999 8 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+.......
T Consensus 148 ~~~~~~~~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~ 217 (264)
T cd06623 148 KVLENTLDQ--------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICD 217 (264)
T ss_pred eecccCCCc--------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhc
Confidence 765432211 11245789999999998888999999999999999999999999764321 11111111000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQE-CLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... ...... ++..+.+++.+|+..+|++||++.|++++
T Consensus 218 ~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 218 GPP-----------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCC-----------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 001111 46678999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.07 Aligned_cols=254 Identities=24% Similarity=0.445 Sum_probs=200.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+... ....+.+.+|++++++++|+||+++.+++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence 468899999999999999999875 4567999988643 2334678899999999999999999988753 3468
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ...++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence 99999999999999976432 3678889999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
......... ......++..|+|||++.+..++.++|||||||++|++++ |+.||...... ..........
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~ 220 (260)
T cd05073 150 RVIEDNEYT-------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY 220 (260)
T ss_pred eeccCCCcc-------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCC
Confidence 765432110 1112345678999999988889999999999999999999 99998753211 1111100000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
.. ......+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 ~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 RM--------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CC--------------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 0112235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=310.09 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=194.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHH-HHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKA-LRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.+.||+|+||.||+|++..+|+.||+|+++.... .....+..|+.. ++..+||||+++++++... +..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcE
Confidence 368899999999999999999999999999999875432 223455556665 5666899999999998654 568
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||++ |+|.+++..... ....+++..++.++.||+.||+|||++. +++||||||+||+++.++.+||+|||.
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~ 150 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI 150 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999996 589888875432 1246899999999999999999999853 799999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC----CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG----SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
+....... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... .....
T Consensus 151 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~ 218 (283)
T cd06617 151 SGYLVDSV---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQLK 218 (283)
T ss_pred cccccccc---------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHHHH
Confidence 87653211 1112357889999998865 35688999999999999999999998642211 11111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .. ..+.. ....++.++.+++.+||..+|++||++.+++++
T Consensus 219 ~~~-~~-----~~~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 219 QVV-EE-----PSPQL-----------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHH-hc-----CCCCC-----------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100 00 00000 001235678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.26 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=198.0
Q ss_pred CHHHHHHhhccccccCcc--cccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeee
Q 043932 696 SYAELSKATSEFASSNMI--GQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICS 772 (1017)
Q Consensus 696 ~~~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 772 (1017)
+..+.....++|++.+.+ |+|+||.||+++...++..+|+|++........ |+.....+ +|||++++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence 345556667788888877 999999999999999999999999864432211 22222222 7999999999986
Q ss_pred cCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC
Q 043932 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 852 (1017)
.. +..++||||+++++|.+++.... .+++.++..++.|+++|++|||+. +++||||||+||+++.+
T Consensus 80 ~~-----~~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 80 TL-----KGHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRA 145 (267)
T ss_pred cC-----CeeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCC
Confidence 65 57899999999999999997653 689999999999999999999999 99999999999999999
Q ss_pred C-CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC
Q 043932 853 M-VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG 931 (1017)
Q Consensus 853 ~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 931 (1017)
+ .++|+|||.+....... ...|+..|+|||++.+..++.++||||+|+++|||++|+.||.......
T Consensus 146 ~~~~~l~dfg~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTPS------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred CCeEEEecCccceecCCCc------------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 8 99999999987543211 2357899999999998889999999999999999999999998543332
Q ss_pred ccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 043932 932 LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-MRDVVAK 1004 (1017)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 1004 (1017)
.....+.... ... .......++.+.+++.+|++.||.+||+ ++|++++
T Consensus 214 ~~~~~~~~~~-~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 214 LDLESLLKRQ-QKK------------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred hhHHHHHHhh-ccc------------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 2222221111 000 0011134667899999999999999996 5988854
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=315.72 Aligned_cols=280 Identities=23% Similarity=0.307 Sum_probs=201.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++|+|++++++++.... .+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 4689999999999999999999999999999999875432 22345668999999999999999999875432 256
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++ +|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 7999999965 8998887643 3689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
.+....... .......++..|+|||.+.+ ..++.++||||+||++|||++|++||....... ........
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~ 224 (309)
T cd07845 154 LARTYGLPA--------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQL 224 (309)
T ss_pred eeeecCCcc--------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence 998654321 01112245788999999865 457899999999999999999999997542211 11111111
Q ss_pred hc-Cc-hhh-hhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 941 AL-PE-KVI-EIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 941 ~~-~~-~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.. +. ... ...+......+...... ...........++.+.+++.+|++.||++|||+.|++++-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 225 LGTPNESIWPGFSDLPLVGKFTLPKQP-YNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred cCCCChhhchhhhcccccccccccCCC-CCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00 00 000 00000000000000000 0001111122366788999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.24 Aligned_cols=262 Identities=25% Similarity=0.330 Sum_probs=205.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++|++.+.||+|+||+||+|....++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+... +..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEEE
Confidence 47899999999999999999998889999999986433 23457789999999999999999999987654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++
T Consensus 76 iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 99999999999999976421 12688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
.......... ........|+..|+|||.+... .++.++|||||||++|+|++|+.||....... .........
T Consensus 150 ~~~~~~~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~- 223 (267)
T cd06610 150 ASLADGGDRT----RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND- 223 (267)
T ss_pred HHhccCcccc----ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC-
Confidence 7665432111 0112234689999999998776 78999999999999999999999997542211 111111100
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+..... .......++.+.+++.+|++.||++||++.|++++
T Consensus 224 ~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 PPSLET---------------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCcCC---------------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 00012345678999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=310.97 Aligned_cols=275 Identities=23% Similarity=0.315 Sum_probs=200.0
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
|++.+.||+|++|.||+|.+..+|+.||+|++.... ....+.+.+|++++++++|||++++++++... +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence 677889999999999999999899999999987543 22345688899999999999999999998654 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||++ ++|.+++..... ..+++..++.++.|+++||+|||++ +++||||+|+||+++.++.++|+|||.+.
T Consensus 76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEeccC-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 999995 699999876542 3689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh-c
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA-L 942 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~ 942 (1017)
....... ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||........ ........ .
T Consensus 148 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 218 (283)
T cd07835 148 AFGVPVR--------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGT 218 (283)
T ss_pred ccCCCcc--------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCC
Confidence 5432110 01112468899999988664 578899999999999999999999975432111 11111110 1
Q ss_pred CchhhhhccchhhHHHHhhcc-hhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNS-MIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+.... +-......++..... .............+..+.+++.+|++.||++|||++|++++
T Consensus 219 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 219 PDEDV-WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred CChHH-hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11000 000000000000000 00001111122345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.29 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=199.9
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+++++.++||||+++++.+... ++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-----RH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-----CE
Confidence 36888999999999999999999999999999987543 23345778999999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 899999999999999997653 678999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccc-------ccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 862 LAKFLSSHQLDTA-------SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 862 ~a~~~~~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
.++.......... ...........|+..|+|||.+.+..++.++|||||||++||+++|..||......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---- 222 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---- 222 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 9864211100000 00001111245788999999998888999999999999999999999999653211
Q ss_pred HHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
+......... ...+ .....++..+.+++.+|++.||++||++.++.+.++.
T Consensus 223 -~~~~~~~~~~---~~~~------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 -ELFGQVISDD---IEWP------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -HHHHHHHhcc---cCCC------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111000000 0000 0001235678999999999999999995544444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.64 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=207.8
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.....|.+.+.||+|.|++|.+|++..++..||||++....-. ....+.+|+++|+.++|||||+++.+....
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~----- 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE----- 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----
Confidence 3456899999999999999999999999999999999865432 334588999999999999999999998765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
..+|+||||+.+|.+++|+.... +..+..+..++.|+.+|++|+|++ .|||||||++||+++.+..+||+|
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHG------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcc------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeec
Confidence 67999999999999999999876 456688889999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||++.++.... ....++|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||++..-.+....
T Consensus 199 fgfS~~~~~~~---------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r--- 266 (596)
T KOG0586|consen 199 FGFSTFFDYGL---------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR--- 266 (596)
T ss_pred cccceeecccc---------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch---
Confidence 99999886433 2334789999999999999775 6899999999999999999999987533211110
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
-+.+.+. + ..-...+..+++++++-.+|.+|++.+++.++-
T Consensus 267 --------------vl~gk~r-----I-------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 267 --------------VLRGKYR-----I-------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred --------------heeeeec-----c-------cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 0000000 0 001134567899999999999999999998764
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.74 Aligned_cols=252 Identities=29% Similarity=0.514 Sum_probs=200.3
Q ss_pred ccccCcccccCCceEEEEEeCCCc----EEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDE----MIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
+++.+.||+|+||.||+|++...+ ..||+|++...... ..+.+..|++.++.++|+||+++++++... +.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence 356789999999999999998766 88999999755433 567889999999999999999999988654 56
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.+++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence 8999999999999999986542 1289999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 940 (1017)
.+........... ....+++.|+|||.+.+..++.++||||+|+++|+|++ |.+||..... ......
T Consensus 149 ~~~~~~~~~~~~~-------~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~ 216 (258)
T smart00219 149 LSRDLYDDDYYKK-------KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EEVLEY 216 (258)
T ss_pred Cceeccccccccc-------ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH
Confidence 9986654321111 01236789999999988889999999999999999998 7888765211 111110
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
...... ......++.++.+++.+|++.||++|||+.|+++.|
T Consensus 217 ~~~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 LKKGYR-----------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HhcCCC-----------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000000 000112466789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.60 Aligned_cols=239 Identities=24% Similarity=0.432 Sum_probs=188.8
Q ss_pred CcccccCCceEEEEEeCCCc----------EEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 711 NMIGQGSFGSVYKGILGEDE----------MIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 46999999999999998666 45888887644433 5788899999999999999999998754 2
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-------
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM------- 853 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~------- 853 (1017)
..++||||+++|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence 35899999999999999987542 678999999999999999999999 999999999999999888
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCC--CcCccccchhHHHHHHHHHh-CCCCCCccccc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS--EASMTGDVYSFGILLLELFT-GRRPTDAAFTE 930 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~pf~~~~~~ 930 (1017)
.+||+|||++...... ....++..|+|||++.+. .++.++||||+|+++|||++ |..||......
T Consensus 146 ~~kl~Dfg~a~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 146 FIKLSDPGIPITVLSR------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred eEEeCCCCcccccccc------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 7999999998764321 113467789999998776 78999999999999999999 57777553211
Q ss_pred CccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 931 GLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
. ...... .... .. ......+.+++.+||..+|.+||++.|+++.|+
T Consensus 214 -~-~~~~~~--~~~~---~~-----------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 214 -E-KERFYQ--DQHR---LP-----------------------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -h-HHHHHh--cCCC---CC-----------------------CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 000000 0000 00 000156889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.37 Aligned_cols=261 Identities=22% Similarity=0.380 Sum_probs=201.8
Q ss_pred ccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
++|++.+.||+|+||+||+|+.+. +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA---- 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC----
Confidence 578889999999999999999753 3467999988654433 456789999999999999999999988654
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCc---cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
+..++||||+++|+|.+++....... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence 56799999999999999997654211 112589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccH
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTL 934 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 934 (1017)
+++|||++........ .......++..|+|||.+.+..++.++||||+|+++|++++ |..||....... .
T Consensus 157 ~l~~~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~ 227 (275)
T cd05046 157 KVSLLSLSKDVYNSEY-------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--V 227 (275)
T ss_pred EEcccccccccCcccc-------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--H
Confidence 9999999864432111 11112346778999999988888999999999999999999 788885432110 0
Q ss_pred HHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
...... ... .. .....++..+.+++.+|++.||++||++.|+++.|++
T Consensus 228 ~~~~~~---~~~-~~---------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 228 LNRLQA---GKL-EL---------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HHHHHc---CCc-CC---------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 000000 000 00 0011235678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.26 Aligned_cols=274 Identities=18% Similarity=0.219 Sum_probs=197.0
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCceeEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
|++.++||+|+||.||+|++..+++.||+|+++.... .......+|+..++++. |+|++++++++.+.. .+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence 6678899999999999999998999999999874322 22234457888898885 999999999986531 256799
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||++ +++.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||.++
T Consensus 78 v~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 78 VFELMD-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred EEecCC-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 999997 58888887643 2689999999999999999999999 9999999999999999 999999999997
Q ss_pred ccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc-
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL- 942 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 942 (1017)
...... ......++..|+|||.+.+ ..++.++||||+||++|||++|..||......+ ..........
T Consensus 148 ~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~~~ 217 (282)
T cd07831 148 GIYSKP---------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVLGT 217 (282)
T ss_pred ccccCC---------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHcCC
Confidence 653221 1112457889999997644 457889999999999999999999997643211 1111111000
Q ss_pred -CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 -PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 -~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
++.+...........+ .........+......++..+.+++.+|++.+|++||+++|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 218 PDAEVLKKFRKSRHMNY-NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCHHHHHhhcccccccc-cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0101000000000000 000000111122233457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=304.38 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=199.4
Q ss_pred cccccCcccccCCceEEEEEeCC-CcEEEEEEEeeecC----------cchHHHHHHHHHHHHh-cCCCCceeeeeeeec
Q 043932 706 EFASSNMIGQGSFGSVYKGILGE-DEMIVAVKVINLKQ----------KGAFKSFMAECKALRN-IRHRNLIKIITICSS 773 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 773 (1017)
+|++.+.||+|+||.||+|.+.. .++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 67889999886322 2234567788888875 699999999999865
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~ 852 (1017)
. +..++||||+++++|.+++..... ....+++..++.++.|++.|+.|||+ . +++|+||+|+||+++.+
T Consensus 81 ~-----~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 81 N-----DRLYIVMDLIEGAPLGEHFNSLKE--KKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED 150 (269)
T ss_pred C-----CeEEEEEecCCCCcHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC
Confidence 4 678999999999999998864321 12368899999999999999999996 5 89999999999999999
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCc
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 932 (1017)
+.+||+|||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 151 ~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-- 219 (269)
T cd08528 151 DKVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-- 219 (269)
T ss_pred CcEEEecccceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--
Confidence 999999999997654322 112346889999999998888999999999999999999999998643111
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
........... .+ .....++..+.+++.+|++.||++||++.|+.+++++
T Consensus 220 ---~~~~~~~~~~~----~~------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 220 ---SLATKIVEAVY----EP------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ---HHHHHHhhccC----Cc------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11000000000 00 0001234678899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=312.19 Aligned_cols=246 Identities=25% Similarity=0.303 Sum_probs=200.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++... +.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----Ce
Confidence 36889999999999999999999899999999987432 23346788999999999999999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 899999999999999997653 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++...... .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...... .......
T Consensus 147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~ 211 (290)
T cd05580 147 FAKRVKGR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEKIL 211 (290)
T ss_pred CccccCCC-----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh
Confidence 98765322 11245889999999998888899999999999999999999998653211 0000000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
... .......+..+.+++.+||..||.+|| +++|++++
T Consensus 212 -~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 212 -EGK------------------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -cCC------------------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 000 000111245678999999999999999 77887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=312.13 Aligned_cols=278 Identities=24% Similarity=0.314 Sum_probs=203.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++|+||+++++++... +..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEE
Confidence 36889999999999999999999899999999986432 33347788999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||++++.+..+..... .+++.++..++.||+.|++|||+. +++|||++|+||++++++.+||+|||.
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 76 YLVFEYVERTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 99999999877766554432 578999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh-
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI- 940 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~- 940 (1017)
+........ .......++..|+|||++.+. .++.++||||+|+++|+|++|++||......+. .......
T Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~ 218 (288)
T cd07833 147 ARALRARPA-------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCL 218 (288)
T ss_pred ccccCCCcc-------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence 876543221 111224678899999999887 789999999999999999999999975422111 1110000
Q ss_pred -hcCchhhhhcc--chhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 -ALPEKVIEIVD--PLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 -~~~~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..+........ +.......................++.++.+++.+||..+|++||++++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 219 GPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 01111000000 00000000000000000001112246789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.25 Aligned_cols=285 Identities=23% Similarity=0.270 Sum_probs=208.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCC-CCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSID-SKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~ 783 (1017)
.|...+.||+|+||.||+|+++.+|+.||||.++... ....++..+|++++++++|+|||+++++-.+.. ..-.+...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455678999999999999999999999999997543 344577889999999999999999998743332 01135678
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC--CCC--CeEEee
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--HDM--VSHVGD 859 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~D 859 (1017)
+|||||.+|||+..+++.. ....+++.+.+.+..+++.||.|||++ +||||||||.||++- .+| ..||+|
T Consensus 94 lvmEyC~gGsL~~~L~~PE---N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPE---NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred EEEeecCCCcHHHHhcCcc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence 9999999999999998654 446899999999999999999999999 999999999999983 333 579999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||.|+..+++. ....++||..|.+||.+.. +.|+..+|.|||||++|+++||..||..........+...
T Consensus 168 fG~Arel~d~s---------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 168 FGAARELDDNS---------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred ccccccCCCCC---------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 99999776433 3345789999999999984 7889999999999999999999999976544321111111
Q ss_pred H--hhcCchhhhhccchhhHHHHhhcchhHHHhH---HhHHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHhhccc
Q 043932 939 K--IALPEKVIEIVDPLLLIEVMANNSMIQEDIR---AKTQECLNAIIRIGVLCSMESPFERM--EMRDVVAKLCHTRE 1010 (1017)
Q Consensus 939 ~--~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~ 1010 (1017)
. ...+..+.-..++...+. ..++..++ .........+-+++..++..+|.+|- ...+..+.+.+|..
T Consensus 239 ~~~tkkp~~v~i~~~~~eNgp-----v~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 239 HIITKKPSGVAIGAQEEENGP-----VEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hhhccCCCceeEeeecccCCc-----eeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1 111211111111111111 01111111 11223344566777888899999998 77777776666654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=302.97 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=185.5
Q ss_pred CcccccCCceEEEEEeCCC--cEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGED--EMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
+.||+|+||+||+|+...+ ...+++|.+.... ....+.+.+|+..++.++||||++++++|... ...++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence 3699999999999976433 2346677665433 23456889999999999999999999998654 56799999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
|+++|+|.+++.+.... ....++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence 99999999999864321 23467778889999999999999999 99999999999999999999999999986432
Q ss_pred cccccccccCCCcccccccCccccCcccccC-------CCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-------SEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
.... ........|+..|+|||++.. ..++.++|||||||++|||++ |..||...... .......
T Consensus 151 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~- 222 (268)
T cd05086 151 KEDY------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVI- 222 (268)
T ss_pred cchh------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-
Confidence 1110 011122457889999998743 245789999999999999997 56677543211 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
........++... ....+.+.+++..|| .+|++||+++||++.|.
T Consensus 223 ---~~~~~~~~~~~~~------------------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 223 ---KDQQVKLFKPQLE------------------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---hhcccccCCCccC------------------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111111111110 112456778888999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=263.20 Aligned_cols=271 Identities=21% Similarity=0.309 Sum_probs=201.0
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|...++||+|.||+||+|+..++++.||+|.++.++. .......+|+-+++.++|+|||+++++.... ...-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeE
Confidence 56778899999999999999999999999999986543 3456778999999999999999999987554 6688
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+|+|||.. +|..|...-.+ .++.+.++.++.|+++|+.|+|++ ++.|||+||+|.+|+.+|+.|++|||+|
T Consensus 78 lvfe~cdq-dlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred EeHHHhhH-HHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 99999965 99999887654 788899999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCC-cCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE-ASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+.++-.- .....-+.|.+|++|.++.|.+ |+...|+||.|||+.|+.. |++.|.+....+ ++..+.+..
T Consensus 149 rafgipv--------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~l 219 (292)
T KOG0662|consen 149 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLL 219 (292)
T ss_pred hhcCCce--------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHh
Confidence 8765322 1112235689999999998865 8889999999999999988 666677654332 222222221
Q ss_pred -cCch-----hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 -LPEK-----VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 -~~~~-----~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+.+ +....|-....-+. ....+ ..........=.+++++.+.-+|.+|.++++.+++
T Consensus 220 g~p~ed~wps~t~lpdyk~yp~yp-attsw----sqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 220 GTPTEDQWPSMTKLPDYKPYPIYP-ATTSW----SQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCccccCCccccCCCCcccCCcc-ccchH----HHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111 11111100000000 00000 01111222334577788888999999999998875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.29 Aligned_cols=270 Identities=20% Similarity=0.261 Sum_probs=192.4
Q ss_pred hccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecCcchH-----------HHHHHHHHHHHhcCCCCceeeee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQKGAF-----------KSFMAECKALRNIRHRNLIKIIT 769 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 769 (1017)
.++|++.++||+|+||+||+|.+..+ +..+|+|+......... .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999999877 66778887543332110 11223344556678999999998
Q ss_pred eeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
++..... ...+.++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 91 ~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 91 CGSFKRC-RMYYRFILLEKLVE-NTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred eeeEecC-CceEEEEEEehhcc-CHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 7654322 12355788888744 7777765432 356778899999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccc
Q 043932 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFT 929 (1017)
Q Consensus 850 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~ 929 (1017)
+.++.++|+|||+|+.+........ ..........||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIE-YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccc-cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999987643221111 011112234699999999999999999999999999999999999999976522
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
..... ....... ...+... ......+++.+.+++..|++.+|++||++.++.+.++
T Consensus 239 ~~~~~-~~~~~~~---~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGNLI-HAAKCDF---IKRLHEG-----------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chHHH-HHhHHHH---HHHhhhh-----------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 21111 1100000 0000000 0012234677999999999999999999999998763
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=306.03 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=199.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
+|...++||+|++|.||+|.+..+++.||+|++........+.+.+|+.+++.++|||++++++++... ++.++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEEE
Confidence 455567899999999999999888999999998755555556788999999999999999999987654 678999
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
+||+++++|.+++... ++++.++..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||.+..
T Consensus 95 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 95 MEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EeccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999999998762 578899999999999999999999 999999999999999999999999998865
Q ss_pred cccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCch
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
..... .......|+..|+|||.+.+..++.++||||+|+++|||++|+.||..... ........ ...
T Consensus 165 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~~~~~-~~~ 231 (285)
T cd06648 165 VSKEV--------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAMKRIR-DNL 231 (285)
T ss_pred hccCC--------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHH-hcC
Confidence 43211 111124588999999999888899999999999999999999999865321 11111000 000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+.. .....++..+.+++.+||+.+|++||++.+++++
T Consensus 232 -----~~~~----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 232 -----PPKL----------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -----CCCC----------------cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0000 0011235678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=318.70 Aligned_cols=284 Identities=21% Similarity=0.290 Sum_probs=202.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC-----
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG----- 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~----- 778 (1017)
..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|++++++++||||+++++++.......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999999999999999997666666678889999999999999999998765432211
Q ss_pred ----CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-CC
Q 043932 779 ----ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DM 853 (1017)
Q Consensus 779 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~ 853 (1017)
....++||||++ ++|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||+++. ++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 145789999997 5998888643 578999999999999999999999 9999999999999974 56
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 932 (1017)
.+|++|||.+......... ........|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 227 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSH-----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227 (342)
T ss_pred eEEECCcccceecCCcccc-----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 7899999998765322110 111112357889999997654 5678899999999999999999999975432211
Q ss_pred cHHHHHHhhcCc--hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 933 TLHEFAKIALPE--KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 933 ~~~~~~~~~~~~--~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
............ ....... ..........................++.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 228 MQLILESVPVVREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHHhcCCCChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 111100000000 0000000 0000000000000000111122345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=310.78 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=197.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
...|+..+.||+|+||+||+|++..+++.||+|++..... ...+.+.+|+++++.++|||++++.+++... +
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----H 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----C
Confidence 3568889999999999999999988899999999864432 2345688999999999999999999998764 5
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||++ |++.+++..... .+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+||
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeec
Confidence 6899999996 588887765432 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|++...... ....|+..|+|||++. ...++.++||||||+++|||++|+.||........ .
T Consensus 160 g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~----~ 223 (307)
T cd06607 160 GSASLVSPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----L 223 (307)
T ss_pred CcceecCCC------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----H
Confidence 998754321 1245788999999874 35688999999999999999999999865321110 0
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
....... .+. .....++..+.+++.+||+.||++||++.+++.+..
T Consensus 224 ~~~~~~~------~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 224 YHIAQND------SPT-----------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHhcCC------CCC-----------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0000000 000 001124567899999999999999999999988643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=304.40 Aligned_cols=247 Identities=28% Similarity=0.452 Sum_probs=196.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence 5689999999999999999975 57789999986432 34678899999999999999999998753 23689
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence 9999999999999976532 3578999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
...... .....+..|+|||.+.+..++.++||||+||++|||++ |+.||...... ........
T Consensus 149 ~~~~~~-----------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~ 212 (254)
T cd05083 149 VGSMGV-----------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVKECVEK 212 (254)
T ss_pred eccccC-----------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHHHhC
Confidence 542211 11234568999999988889999999999999999998 99998653221 11100000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
. . . ......++..+.+++.+|++.+|++||+++++++.|++
T Consensus 213 ~---------~---------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 213 G---------Y---------R-----MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred C---------C---------C-----CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 0 0 00011335678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.14 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=187.5
Q ss_pred cccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHh---cCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRN---IRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 712 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
+||+|+||.||+|.+..+++.||+|.+..... .....+.+|..+++. .+||+++.+++++... +..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence 48999999999999998999999999864321 112233445444433 4799999999988654 568999
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999999987653 689999999999999999999999 999999999999999999999999999865
Q ss_pred cccccccccccCCCcccccccCccccCccccc-CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
..... .....|+..|+|||.+. +..++.++||||+||++|||++|..||....... ..........
T Consensus 147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~- 213 (279)
T cd05633 147 FSKKK----------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLT- 213 (279)
T ss_pred ccccC----------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHHhhc-
Confidence 43211 11235899999999886 4568899999999999999999999997543221 1111110000
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAKL 1005 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 1005 (1017)
.. .......+.++.+++.+|++.||++|| +++|+++|-
T Consensus 214 -----~~------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 214 -----VN------------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred -----CC------------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 00 001122356788999999999999999 699998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.83 Aligned_cols=288 Identities=23% Similarity=0.327 Sum_probs=202.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC---
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSK--- 777 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 777 (1017)
..++|++.++||+|+||.||+|++..+++.||+|.+..... .....+.+|++++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34679999999999999999999999999999999864432 2234567899999999999999999998654321
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
.....++||||+++ ++.+++.... ..+++.+++.++.||+.||+|||++ +++|+||||+||+++.++.+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL 160 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence 23467999999965 8888886543 2689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
+|||.+.......... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~ 235 (310)
T cd07865 161 ADFGLARAFSLSKNSK----PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTL 235 (310)
T ss_pred CcCCCcccccCCcccC----CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 9999998664322111 1111234578899999988664 4788999999999999999999998754321 11111
Q ss_pred HHH--hhcCchhhhhccchhhHHHHhhcchhHHHhHH--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 937 FAK--IALPEKVIEIVDPLLLIEVMANNSMIQEDIRA--KTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~--~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... ...+..+....+.....+.............. ........+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 111 11111111000000000000000000000000 000123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=315.51 Aligned_cols=284 Identities=22% Similarity=0.321 Sum_probs=204.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++++ +||||+++++++...+ .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~---~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN---D 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---C
Confidence 456899999999999999999999888999999988532 223345677899999999 9999999999875432 2
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence 46799999997 5999988653 567888999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||.+.......... .........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .....
T Consensus 151 ~g~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~ 226 (337)
T cd07852 151 FGLARSLSELEENP---ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKII 226 (337)
T ss_pred ccchhccccccccc---cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Confidence 99998664322110 0112223568999999998755 4578999999999999999999999975432211 11111
Q ss_pred Hhh-c-CchhhhhccchhhHHHHhhc-chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIA-L-PEKVIEIVDPLLLIEVMANN-SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~-~-~~~~~~~~d~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... . +......+............ .............++.++.+++.+|++.||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 110 0 00000000000000000000 000000111122356789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=305.12 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=201.4
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-----ENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeE
Confidence 4788999999999999999999889999999997443 23457889999999999999999999887544 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++|+||+++++|.+++.... .+++.++..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 99999999999999997652 688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ....+.....
T Consensus 147 ~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~ 215 (258)
T cd05578 147 ATKVTPDT---------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQE 215 (258)
T ss_pred ccccCCCc---------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhc
Confidence 87654321 112245888999999998888999999999999999999999999764322 1111111100
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH--HHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM--RDVVA 1003 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~ 1003 (1017)
. . ........+..+.+++.+||+.||.+||++ +|+++
T Consensus 216 ~-~-----------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 216 T-A-----------------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred c-c-----------------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0 0 000111235678899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=315.86 Aligned_cols=283 Identities=21% Similarity=0.250 Sum_probs=209.1
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+..+....|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999999889999999987543 33457788999999999999999999998765433445789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++ +|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+
T Consensus 81 lv~e~~~~-~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEecchhh-hHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 99999974 8999887543 789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh-
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA- 941 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~- 941 (1017)
......... ........++..|+|||.+.+. .++.++||||+|+++|+|++|++||........ ........
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~ 224 (330)
T cd07834 151 RGVDPDEDE-----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLG 224 (330)
T ss_pred Eeecccccc-----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcC
Confidence 876433210 0111224578899999999887 789999999999999999999999976532211 11111110
Q ss_pred c-CchhhhhccchhhHHHHhh-cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 L-PEKVIEIVDPLLLIEVMAN-NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~-~~~~~~~~d~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. +..............+... .............+.+..+.+++.+||+.||++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 0001110111111111100 0000011111222356778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.45 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=199.7
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
-|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+..+++++||||+++++++... +..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEE
Confidence 4777889999999999999998889999999986433 23446788999999999999999999998654 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 80 v~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 80 IMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred EEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence 99999999999998643 578999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
....... ......|+..|+|||.+.+..++.++||||+||++|+|++|..||...... ..........+
T Consensus 150 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~- 218 (277)
T cd06641 150 QLTDTQI--------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKNNP- 218 (277)
T ss_pred ecccchh--------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcCCC-
Confidence 6543211 111245788999999998888899999999999999999999998643211 00000000000
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......++..+.+++.+|++.+|.+||++.+++++
T Consensus 219 -------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 -------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -------------------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00011235668899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.93 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=206.0
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
...+.|+..+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|++.+++++|+|++++++++... +.
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CE
Confidence 345678888999999999999999998899999999976544 457788999999999999999999998765 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++|+||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence 899999999999999998754 2689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .........
T Consensus 162 ~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~~ 232 (286)
T cd06614 162 FAAQLTKEKS--------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTKG 232 (286)
T ss_pred hhhhhccchh--------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcC
Confidence 9875542211 1122357889999999988889999999999999999999999986532110 000000000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.+ . ......++..+.+++.+|++.+|.+||++.+++++-
T Consensus 233 ~~----~---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 233 IP----P---------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CC----C---------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 00 0 001112356788999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=304.38 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=198.3
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcC---CCCceeeeeeeecCCCCCCce
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIR---HRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+++.+|+.++++++ |||++++++++... ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----PR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----CE
Confidence 4778899999999999999998899999999987542 344567889999999996 99999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++++|.++++.. .+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 89999999999999998643 678999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
.+....... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~ 213 (277)
T cd06917 147 VAALLNQNS--------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMML 213 (277)
T ss_pred ceeecCCCc--------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhc
Confidence 998664322 11122468899999998865 457899999999999999999999996532110 0000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... ..+.+. ....+.++.+++.+|++.||++||++.|++++
T Consensus 214 ~~~~-----~~~~~~-----------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 214 IPKS-----KPPRLE-----------------DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cccC-----CCCCCC-----------------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0000 000000 00135678899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=304.48 Aligned_cols=278 Identities=22% Similarity=0.316 Sum_probs=202.4
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhc---CCCCceeeeeeeecCCCCCCce
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNI---RHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++++ +|+|++++++++...+..+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778899999999999999988899999999974322 2234566788777666 5999999999987764434445
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.+++|||+.+ +|.+++..... ..+++.+++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence 8999999975 89998876432 2589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
.+....... ......++..|+|||++.+..++.++||||+||++|||++|++||...... .....+....
T Consensus 153 ~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~ 222 (287)
T cd07838 153 LARIYSFEM---------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVI 222 (287)
T ss_pred cceeccCCc---------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHc
Confidence 987653221 111234788999999999888999999999999999999999998764322 1122221111
Q ss_pred cCchhhhhccch-hhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPL-LLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.......+.... ...... .............+....+.+++.+||+.||++||++.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSF--PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCChHhcCCCcccchhhc--ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 100000000000 000000 0000111122233456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=305.48 Aligned_cols=277 Identities=23% Similarity=0.321 Sum_probs=203.2
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++|+|++++++++...+ .+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 667889999999999999999889999999998653 333467889999999999999999999986542 357899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++ +|.+++.... ..+++.+++.++.||++|++|||+. +++|+||||+||++++++.+||+|||.+.
T Consensus 78 v~e~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 78 VFEYMDH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred Eeccccc-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 9999975 8998887543 2689999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~ 220 (287)
T cd07840 149 PYTKRNS-------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGS 220 (287)
T ss_pred eccCCCc-------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 6643321 01112356788999998765 45789999999999999999999999764321 111111111110
Q ss_pred c---hhhhhccchhhHHHHhhcchhHHHhHHhHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 E---KVIEIVDPLLLIEVMANNSMIQEDIRAKTQE-CLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~---~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. ......+. ...................... ++.++.+++.+|++.+|++||++++++++
T Consensus 221 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 221 PTDENWPGVSKL-PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred Cchhhccccccc-hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00000000 0000000011111112222223 37789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=302.11 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=200.3
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-----cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.+|++.+.||+|+||.||+|++..++..||+|++.... ....+.+.+|++++++++|+||+++++++.... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 47889999999999999999999899999999875321 233467889999999999999999999875432 2
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 56789999999999999987643 578889999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||.++....... .........|+..|+|||.+.+..++.++|||||||++|++++|+.||..... ......
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~ 220 (264)
T cd06653 150 FGASKRIQTICM-----SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFK 220 (264)
T ss_pred cccccccccccc-----cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHH
Confidence 999976532110 01111234689999999999888899999999999999999999999965311 111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...... . ........+++.+++.+|++ +|.+||++.+++.|
T Consensus 221 ~~~~~~-----~------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 221 IATQPT-----K------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHcCCC-----C------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 110000 0 00112235678999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=330.61 Aligned_cols=282 Identities=20% Similarity=0.191 Sum_probs=190.3
Q ss_pred hhccccccCcccccCCceEEEEEeCCCc-EEEEEEEe--------------e---ecCcchHHHHHHHHHHHHhcCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDE-MIVAVKVI--------------N---LKQKGAFKSFMAECKALRNIRHRNL 764 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~ni 764 (1017)
..++|++.++||+|+||+||+|..+... ..++.|.+ . .........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998764322 22222211 0 0111234567899999999999999
Q ss_pred eeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCC
Q 043932 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKP 844 (1017)
Q Consensus 765 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 844 (1017)
+++++++... +..|+|+|++. +++.+++........ ......++..++.||+.||+|||++ +||||||||
T Consensus 226 v~l~~~~~~~-----~~~~lv~e~~~-~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP 295 (501)
T PHA03210 226 LKIEEILRSE-----ANTYMITQKYD-FDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295 (501)
T ss_pred CcEeEEEEEC-----CeeEEEEeccc-cCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 9999998765 56799999985 488887764422111 2334667888999999999999999 999999999
Q ss_pred CceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCC
Q 043932 845 SNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPT 924 (1017)
Q Consensus 845 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 924 (1017)
+|||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKERE-------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCcccc-------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999986643221 1112357999999999999989999999999999999999988654
Q ss_pred CcccccC--ccHHHHHHhhcCchhhhhccchh-hHHHHh------hcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCC
Q 043932 925 DAAFTEG--LTLHEFAKIALPEKVIEIVDPLL-LIEVMA------NNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFER 995 (1017)
Q Consensus 925 ~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 995 (1017)
....... ..+.+...... ....++.+... ..++.. ....+...+. ....+..+.+++.+|+++||.+|
T Consensus 369 ~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~R 445 (501)
T PHA03210 369 IGDGGGKPGKQLLKIIDSLS-VCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR--NLGLPADFEYPLVKMLTFDWHLR 445 (501)
T ss_pred ccCCCCCHHHHHHHHHHhcc-cChhhcCCcHHHHHHHhhhhhcccCccchhhHHH--hcCCChHHHHHHHHHhccCcccC
Confidence 3221111 11111111100 00001111000 000000 0000111110 11234567888999999999999
Q ss_pred CCHHHHHHH
Q 043932 996 MEMRDVVAK 1004 (1017)
Q Consensus 996 Ps~~evl~~ 1004 (1017)
||+.|++++
T Consensus 446 psa~elL~h 454 (501)
T PHA03210 446 PGAAELLAL 454 (501)
T ss_pred cCHHHHhhC
Confidence 999999876
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=312.24 Aligned_cols=281 Identities=19% Similarity=0.233 Sum_probs=196.3
Q ss_pred Cccccc--CCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQG--SFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
..||+| +||+||+|++..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++... +..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEE
Confidence 356666 899999999999999999999875432 3346788999999999999999999998764 6689999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+.++++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+...
T Consensus 79 e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 79 PFMAYGSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred ecccCCCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 99999999999887532 2588999999999999999999999 9999999999999999999999999865433
Q ss_pred ccccccccccCCCcccccccCccccCcccccCC--CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS--EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
......... .........++..|+|||++.+. .++.++||||+||++|||++|+.||...................+
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd08226 152 VRNGQKAKV-VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230 (328)
T ss_pred hccCccccc-cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC
Confidence 211100000 00001112356779999998763 478999999999999999999999976432211111110000000
Q ss_pred hhhhhccchhhHHH---------------Hhhc---chh-HHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 945 KVIEIVDPLLLIEV---------------MANN---SMI-QEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~---------------~~~~---~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
......+...... .... ... ..........+.+.+.+++.+||+.||++|||++|++++-
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 231 -LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred -ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0000000000000 0000 000 0000112345678899999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.76 Aligned_cols=277 Identities=22% Similarity=0.279 Sum_probs=198.1
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.+.||+|++|+||+|++..+++.||+|.+..... ...+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeE
Confidence 478899999999999999999998999999999864332 2345688999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-CCCeEEeecc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVSHVGDFG 861 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 861 (1017)
++||||++ +++.+++..... ...++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 99999996 588888765432 2457888889999999999999999 9999999999999985 5679999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
++....... .......+++.|+|||++.+. .++.++||||+||++|+|++|++||......+... +....
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~-~~~~~ 219 (294)
T PLN00009 149 LARAFGIPV--------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRI 219 (294)
T ss_pred cccccCCCc--------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHH
Confidence 997543211 011123578899999988664 57899999999999999999999997643221111 11100
Q ss_pred hcCchhhhhccc-hhhHHHHhhc-chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDP-LLLIEVMANN-SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~-~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. ......++. ....++.... ..............++++.+++.+|++.||++||++.+++++
T Consensus 220 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 220 LG-TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hC-CCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000000000 0000000000 000001111122345678999999999999999999999874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=309.62 Aligned_cols=285 Identities=18% Similarity=0.256 Sum_probs=202.0
Q ss_pred cccccCcccccCCceEEEEEeCC--CcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 706 EFASSNMIGQGSFGSVYKGILGE--DEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+|++.++||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 47888999999999999999988 78999999997632 33446778899999999999999999998654 235
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC----CCCeE
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH----DMVSH 856 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~k 856 (1017)
..++||||+++ ++.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence 78999999975 787777543321 113688999999999999999999999 9999999999999999 89999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCc---
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGL--- 932 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~--- 932 (1017)
|+|||++......... ........++..|+|||++.+. .++.++|||||||++|+|++|++||........
T Consensus 153 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 227 (316)
T cd07842 153 IGDLGLARLFNAPLKP-----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227 (316)
T ss_pred ECCCccccccCCCccc-----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccc
Confidence 9999999865432211 1112235678999999988664 578999999999999999999999976533320
Q ss_pred -----cHHHHHHhhcCch---hhhhcc-chhhH--HHHhhcchhH-HHhHH-hH--HHHHHHHHHHHhhccCCCCCCCCC
Q 043932 933 -----TLHEFAKIALPEK---VIEIVD-PLLLI--EVMANNSMIQ-EDIRA-KT--QECLNAIIRIGVLCSMESPFERME 997 (1017)
Q Consensus 933 -----~~~~~~~~~~~~~---~~~~~d-~~l~~--~~~~~~~~~~-~~~~~-~~--~~~~~~l~~li~~cl~~dP~~RPs 997 (1017)
............. ...... +.... +... ..... ..... .. .....++.+++.+|++.||++|||
T Consensus 228 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 306 (316)
T cd07842 228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFK-TKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306 (316)
T ss_pred hhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhcc-CCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC
Confidence 0011100000000 000000 00000 0000 00000 00000 00 134567899999999999999999
Q ss_pred HHHHHHH
Q 043932 998 MRDVVAK 1004 (1017)
Q Consensus 998 ~~evl~~ 1004 (1017)
+.|++++
T Consensus 307 ~~eil~~ 313 (316)
T cd07842 307 AEEALEH 313 (316)
T ss_pred HHHHhcC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=313.48 Aligned_cols=283 Identities=20% Similarity=0.274 Sum_probs=202.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 780 (1017)
..+|.+.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999998899999999986432 2233567899999999999999999998865422 1224
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred eEEEEeccccc-CHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 56899999964 7777652 1578899999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .......
T Consensus 162 g~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~ 229 (342)
T cd07879 162 GLARHADAE-----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 229 (342)
T ss_pred CCCcCCCCC-----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 998754211 112457889999999866 468899999999999999999999997642211 1111111
Q ss_pred h-hcC-chhhhhccchhhHHHHhh-cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhccc
Q 043932 940 I-ALP-EKVIEIVDPLLLIEVMAN-NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK--LCHTRE 1010 (1017)
Q Consensus 940 ~-~~~-~~~~~~~d~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~ 1010 (1017)
. ..+ ....+..+......+... ..................+.+++.+|++.||++||++.|++++ ++..++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 011 111111111100000000 0000111111122345678899999999999999999999976 555543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=311.79 Aligned_cols=291 Identities=20% Similarity=0.273 Sum_probs=203.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--hHHHHHHHHHHHHhcCCCCceeeeeeeecCCC---CC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHRNLIKIITICSSIDS---KG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 778 (1017)
.++|++.++||+|+||.||+|++..+++.||+|++...... ....+.+|++++++++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999989999999998644322 23466789999999999999999998754422 12
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
....++||||+++ ++.+.+.... ..+++.++..++.|+++||+|||++ +++||||||+||++++++.++|+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 3567999999965 7877776533 3689999999999999999999999 99999999999999999999999
Q ss_pred eccccccccccccccccc---CCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 859 DFGLAKFLSSHQLDTASK---TSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
|||++............. .........|++.|+|||.+.+. .++.++||||+||++|||++|++||....... ..
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~ 236 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QL 236 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999997654322111100 11112334678899999987654 57899999999999999999999997543221 11
Q ss_pred HHHHHhhcCchhhhhccchhhHHHH--hhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVM--ANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
................+........ ..................+.+.+++.+|++.||++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1111110000000000000000000 000000011111222334678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=307.59 Aligned_cols=251 Identities=26% Similarity=0.330 Sum_probs=198.0
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.|...+.||+|+||.||+|++..++..||+|++..... ...+.+.+|++++++++|||++++++++... +..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeE
Confidence 47778899999999999999988999999999874322 2345788899999999999999999998664 568
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+.+ ++.+++.... ..+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||+
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 999999965 8888776543 2689999999999999999999999 999999999999999999999999998
Q ss_pred ccccccccccccccCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
+...... ....|+..|+|||.+. +..++.++|||||||++|||++|+.||...... ........
T Consensus 172 ~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~ 238 (317)
T cd06635 172 ASIASPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ 238 (317)
T ss_pred ccccCCc------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh
Confidence 8644321 1245788999999874 456889999999999999999999998653111 00111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
...+ ......+++.+.+++.+|++.+|.+||++.+++++.....
T Consensus 239 ~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 239 NESP--------------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ccCC--------------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000 0001123556889999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=297.78 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=203.9
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
+|+..+.||+|++|.||+|.+..+++.|++|++........+.+.+|++.+++++|++++++++++... ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence 477889999999999999999988999999999766554567889999999999999999999988654 668999
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
+||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 99999999999987653 2689999999999999999999998 999999999999999999999999999876
Q ss_pred cccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCch
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
...... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... .... ... ..
T Consensus 148 ~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~-~~~---~~ 213 (253)
T cd05122 148 LSDTKA---------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-ALFK-IAT---NG 213 (253)
T ss_pred cccccc---------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-HHHH-HHh---cC
Confidence 543221 123468899999999988889999999999999999999999987532110 0000 000 00
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...... ...++..+.+++.+|++.||++|||+.|++++
T Consensus 214 ~~~~~~---------------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 214 PPGLRN---------------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCCcCc---------------------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 01124668999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=293.24 Aligned_cols=273 Identities=22% Similarity=0.296 Sum_probs=202.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CC-----CceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HR-----NLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~ 777 (1017)
..+|.+...+|+|.||.|.++.+..++..||||+++.-. ...+...-|+++++++. +. -++++.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr--- 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR--- 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc---
Confidence 779999999999999999999999999999999997332 23355677999999993 22 356666666444
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC------
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH------ 851 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~------ 851 (1017)
++.|+|+|.+ |-|+.+++..+.- .+++...++.+++|++++++|||+. +++|-||||+||++..
T Consensus 164 --ghiCivfell-G~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 164 --GHICIVFELL-GLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred --CceEEEEecc-ChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 7789999988 6699999987642 4789999999999999999999999 9999999999999832
Q ss_pred --------------CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHH
Q 043932 852 --------------DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLEL 917 (1017)
Q Consensus 852 --------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 917 (1017)
...++++|||.|++..+.. ..++.|..|+|||++.+-.++.++||||+|||++|+
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc-----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 2358999999998654322 235789999999999999999999999999999999
Q ss_pred HhCCCCCCcccccC-ccHHHHHHhhcCchhhhhccchhhHHHHh--------------------hcchhHHHhHHhHHHH
Q 043932 918 FTGRRPTDAAFTEG-LTLHEFAKIALPEKVIEIVDPLLLIEVMA--------------------NNSMIQEDIRAKTQEC 976 (1017)
Q Consensus 918 ltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~--------------------~~~~~~~~~~~~~~~~ 976 (1017)
+||...|+.-...+ ..+-+.+-.+.|..+..-. ....+.. ..... ..........
T Consensus 303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~---~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl-~~~~~~~d~e 378 (415)
T KOG0671|consen 303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKT---RKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPL-KKYMLQDDLE 378 (415)
T ss_pred eccceecccCCcHHHHHHHHHhhCCCcHHHhhhh---hhHhhhhcccccCccccccccchhhhcCCccH-HHHhccCcHH
Confidence 99999997643211 1111111112222221111 0001000 01111 1111223345
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 977 LNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 977 ~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..++.+|+++|+.+||.+|+|+.|+++|=
T Consensus 379 ~~~LfDLl~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 379 HVQLFDLLRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred HhHHHHHHHHHHccCccccccHHHHhcCH
Confidence 67799999999999999999999998763
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=300.12 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=199.9
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++|+||+++++.+... ...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEE
Confidence 4788899999999999999999999999999987542 23346778999999999999999999987654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-CeEEeeccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VSHVGDFGL 862 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~ 862 (1017)
+|+||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++ .+|++|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 99999999999999976432 2578999999999999999999999 999999999999999886 469999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... .......|++.|+|||++.+..++.++||||+|+++|||++|+.||...... +......
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~ 215 (257)
T cd08225 149 ARQLNDSM--------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKIC 215 (257)
T ss_pred chhccCCc--------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHh
Confidence 87654221 0111235889999999998888999999999999999999999998653211 1111111
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..... ......+..+.+++.+|++.+|++|||+.|++++
T Consensus 216 ~~~~~-----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 216 QGYFA-----------------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred cccCC-----------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 10000 0011224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=303.89 Aligned_cols=274 Identities=23% Similarity=0.290 Sum_probs=203.3
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
|++.+.||+|++|.||+|.+..+++.+|+|.+..... .....+.+|++++++++|+||+++++++... +..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 5677899999999999999998999999999875432 2456788899999999999999999987654 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++ ++.+++.... ..+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||.+.
T Consensus 76 v~e~~~~-~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EEeccCC-CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 9999975 8988887643 2789999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc-
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL- 942 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 942 (1017)
...... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+. .........
T Consensus 147 ~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~ 217 (283)
T cd05118 147 SFGSPV--------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGT 217 (283)
T ss_pred ecCCCc--------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCC
Confidence 664322 011123578899999998776 789999999999999999999999976432111 111111100
Q ss_pred --CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 --PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 --~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+.......+........ ..............+++.++.+++.+||+.||.+||++.|++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFS-FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred CchHhcccchhhhhhhhhh-hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00011111100000000 00000011122234567889999999999999999999999865
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=304.68 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=196.9
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
..+||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++|+|++++++++... +..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEEEecC
Confidence 46799999999999999989999999998655444556788999999999999999999988665 6789999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 100 ~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 100 EGGALTDIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred CCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 999999987543 578899999999999999999999 9999999999999999999999999988654321
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1017)
. .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ..........+...
T Consensus 170 ~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~--- 236 (292)
T cd06657 170 V--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPKL--- 236 (292)
T ss_pred c--------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCccc---
Confidence 1 0112245889999999998888899999999999999999999998653211 00111111111100
Q ss_pred ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 950 VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 950 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.....++..+.+++.+|++.||.+||++.+++++
T Consensus 237 ---------------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 237 ---------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ---------------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 0011234567889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=311.04 Aligned_cols=283 Identities=21% Similarity=0.254 Sum_probs=200.8
Q ss_pred cccccCcccccCCceEEEEEeCCC--cEEEEEEEeeec--CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCc
Q 043932 706 EFASSNMIGQGSFGSVYKGILGED--EMIVAVKVINLK--QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+|++.+.||+|+||.||+|++..+ +..||+|++... .....+.+.+|+++++++ +||||+++++++.... .+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 478889999999999999999877 889999998643 222346778899999999 5999999998764331 2235
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++++||++ ++|.+++.... .+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 6789999986 59999986543 688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|.++........ .........||..|+|||++.+ ..++.++||||+||++|++++|++||....... .......
T Consensus 150 g~a~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~ 224 (332)
T cd07857 150 GLARGFSENPGE----NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQ 224 (332)
T ss_pred CCceeccccccc----ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHH
Confidence 999866432211 1111223578999999998765 468999999999999999999999987543211 1111111
Q ss_pred hhc-C--chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IAL-P--EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~-~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... + +....+.++.......................+...+.+++.+|++.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 110 0 0011111110000000000000000111112235678999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=307.41 Aligned_cols=285 Identities=23% Similarity=0.316 Sum_probs=204.6
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC---
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS--- 776 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 776 (1017)
...++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|++++++++|||++++++++.+...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999999899999999997543 2233567789999999999999999998865431
Q ss_pred --CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC
Q 043932 777 --KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 854 (1017)
Q Consensus 777 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 854 (1017)
.+....++|+||+++ ++.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 123478999999976 7777776542 2689999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
+||+|||.+........ .......++..|+|||.+.+. .++.++||||+||++|||++|++||...... ..
T Consensus 155 ~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~ 226 (302)
T cd07864 155 IKLADFGLARLYNSEES-------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQ 226 (302)
T ss_pred EEeCcccccccccCCcc-------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HH
Confidence 99999999976543221 011113467889999988653 5788999999999999999999999753221 11
Q ss_pred HHHHHHhhc---CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 934 LHEFAKIAL---PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 934 ~~~~~~~~~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......... +....++........ ..................+..+.+++.+||+.||++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 227 LELISRLCGSPCPAVWPDVIKLPYFNT-MKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHHHhCCCChhhcccccccccccc-cccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111 111111100000000 0000000011111222346778999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=301.93 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=193.6
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 713 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
||+|+||+||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++... +..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-----DDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-----CeEEEEEecC
Confidence 699999999999999899999999986432 22345567899999999999999999988654 6789999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++++|.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999976542 3689999999999999999999999 9999999999999999999999999998765321
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1017)
. ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... ............
T Consensus 149 ~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~----- 213 (277)
T cd05577 149 K---------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTLEM----- 213 (277)
T ss_pred C---------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhccccc-----
Confidence 1 1112357889999999988889999999999999999999999996543211 111111100000
Q ss_pred ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 950 VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 950 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
........++.+.+++.+||+.||++|| ++.+++++
T Consensus 214 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 214 -------------------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred -------------------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 0001112356788999999999999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=311.28 Aligned_cols=285 Identities=20% Similarity=0.253 Sum_probs=205.5
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCC
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSID 775 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 775 (1017)
.++....++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 345567789999999999999999999998899999999986432 223456788999999999999999999875432
Q ss_pred C-CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC
Q 043932 776 S-KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 854 (1017)
Q Consensus 776 ~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 854 (1017)
. ......+++++++ +++|.+++... .+++..++.++.|+++|++|||+. +|+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 2 1224568888887 77999887643 578999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
+||+|||++...... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..
T Consensus 159 ~kl~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~ 226 (345)
T cd07877 159 LKILDFGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQ 226 (345)
T ss_pred EEEeccccccccccc-----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999998753211 122467899999998866 46788999999999999999999999653221 11
Q ss_pred HHHHHHhh--cCchhhhhccchhhHHHHhhc-chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 934 LHEFAKIA--LPEKVIEIVDPLLLIEVMANN-SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 934 ~~~~~~~~--~~~~~~~~~d~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
........ .+......+.......+.... ..............+..+.+++.+|++.||.+||++.|++++=
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 11111111 111111111111111110000 0000000011112356788999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=308.13 Aligned_cols=271 Identities=20% Similarity=0.202 Sum_probs=192.5
Q ss_pred CCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEeccCCCH
Q 043932 717 SFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSL 794 (1017)
Q Consensus 717 ~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL 794 (1017)
++|.||.++...+++.||+|++... .....+.+.+|++++++++|+||+++++++... +..+++|||+++|+|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCH
Confidence 4456666666668999999999754 234557889999999999999999999988654 668999999999999
Q ss_pred HHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccccccccccc
Q 043932 795 EDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTA 874 (1017)
Q Consensus 795 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 874 (1017)
.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+..........
T Consensus 87 ~~~l~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~- 158 (314)
T cd08216 87 EDLLKTHFP----EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ- 158 (314)
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc-
Confidence 999986432 2578899999999999999999999 99999999999999999999999999887553222111
Q ss_pred ccCCCcccccccCccccCcccccCC--CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccc
Q 043932 875 SKTSSSSIGIKGTVGYVAPEYCMGS--EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDP 952 (1017)
Q Consensus 875 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 952 (1017)
...........++..|+|||++.+. .++.++||||+||++|||++|+.||............ .....+. .++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~----~~~~ 233 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPC----LLDK 233 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCcc----cccc
Confidence 0111112334578899999998663 5789999999999999999999999754222111111 1101110 0000
Q ss_pred hhhHHHHh----------hcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 953 LLLIEVMA----------NNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 953 ~l~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
........ ..................++.+++.+||+.||++|||++|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00000000 000000011112233456789999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=311.14 Aligned_cols=285 Identities=20% Similarity=0.290 Sum_probs=200.0
Q ss_pred cccc-ccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcch--------------HHHHHHHHHHHHhcCCCCceeeee
Q 043932 705 SEFA-SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--------------FKSFMAECKALRNIRHRNLIKIIT 769 (1017)
Q Consensus 705 ~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~ 769 (1017)
++|. +.+.||+|+||+||+|.+..+++.||+|++....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4577999999999999999899999999986432211 125678999999999999999999
Q ss_pred eeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
++... ++.++||||++ |+|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++
T Consensus 88 ~~~~~-----~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill 152 (335)
T PTZ00024 88 VYVEG-----DFINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI 152 (335)
T ss_pred EEecC-----CcEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence 98654 67899999996 59999987543 688999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccccccccccc------cCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCC
Q 043932 850 DHDMVSHVGDFGLAKFLSSHQLDTAS------KTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRR 922 (1017)
Q Consensus 850 ~~~~~~kl~DfG~a~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~ 922 (1017)
+.++.++|+|||.+............ ..........++..|+|||.+.+. .++.++||||+||++|||++|++
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999765421110000 001111223568899999998764 46899999999999999999999
Q ss_pred CCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 923 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
||......+. ...............+.+......+.................++.++.+++.+|++.||++||++.|++
T Consensus 233 p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 233 LFPGENEIDQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCCCCCHHHH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 9976432211 111111100000000000000000000000000111112223456788999999999999999999998
Q ss_pred HHH
Q 043932 1003 AKL 1005 (1017)
Q Consensus 1003 ~~L 1005 (1017)
.+-
T Consensus 312 ~~~ 314 (335)
T PTZ00024 312 KHE 314 (335)
T ss_pred cCc
Confidence 753
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=309.16 Aligned_cols=278 Identities=22% Similarity=0.273 Sum_probs=203.1
Q ss_pred HHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
++...+++|++.++||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++.+++...
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 81 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-- 81 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC--
Confidence 34456789999999999999999999999999999999875322 23346778899999999999999999987543
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
....++||||+ +++|.++++.. .+++..+..++.|+++||+|||+. +|+||||+|+||+++.++.++
T Consensus 82 --~~~~~lv~e~~-~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~ 148 (328)
T cd07856 82 --LEDIYFVTELL-GTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLK 148 (328)
T ss_pred --CCcEEEEeehh-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEE
Confidence 24578999998 56999888643 567888889999999999999999 999999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 935 (1017)
|+|||.+...... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... ...
T Consensus 149 l~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~ 216 (328)
T cd07856 149 ICDFGLARIQDPQ-----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFS 216 (328)
T ss_pred eCccccccccCCC-----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 9999998743211 112457889999998765 568999999999999999999999997543211 011
Q ss_pred HHHHh--hcCchhh-hhccchhhHHHHhh-cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 936 EFAKI--ALPEKVI-EIVDPLLLIEVMAN-NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 936 ~~~~~--~~~~~~~-~~~d~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..... ..++++. ...+... .++... ..............+++.+.+++.+|++.+|++||++.|++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 217 IITDLLGTPPDDVINTICSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHhCCCCHHHHHhccchhh-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11110 0111111 1111110 000000 0000000111112345788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=307.16 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=194.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|...++||+|+||.||++.+..+++.||+|.+..... .....+.+|+.++.++. |+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcE
Confidence 356667899999999999999999999999999874432 34467889999999996 99999999987653 567
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
+++|||++. ++.++...... .....+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~e~~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~ 154 (288)
T cd06616 79 WICMELMDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGI 154 (288)
T ss_pred EEEEecccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecch
Confidence 899999864 66554432100 01136899999999999999999999632 899999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCC---CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS---EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
+....... ......|+..|+|||++.+. .++.++||||+||++|||++|+.||..... .......
T Consensus 155 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~ 222 (288)
T cd06616 155 SGQLVDSI---------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQ 222 (288)
T ss_pred hHHhccCC---------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhh
Confidence 87553211 11123578899999998775 688999999999999999999999865321 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. .... .+.+. ......++.++.+++.+|++.||++|||+.||+++
T Consensus 223 ~-~~~~-----~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 223 V-VKGD-----PPILS--------------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred h-cCCC-----CCcCC--------------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 00000 00112346678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.72 Aligned_cols=244 Identities=26% Similarity=0.334 Sum_probs=195.2
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 713 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
||.|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence 699999999999999889999999987432 23446788999999999999999999987654 6789999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 76 LGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9999999997653 578999999999999999999999 9999999999999999999999999999865432
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1017)
. ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.....+. ...+........
T Consensus 147 ~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~---- 211 (262)
T cd05572 147 Q---------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNG---- 211 (262)
T ss_pred c---------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCC----
Confidence 1 1112457889999999988889999999999999999999999997643211 111110000000
Q ss_pred ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 043932 950 VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAK 1004 (1017)
Q Consensus 950 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1004 (1017)
........++.+.+++.+||+.+|++||+ ++|++++
T Consensus 212 -------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 212 -------------------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred -------------------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 00011122567899999999999999999 7887764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.70 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=205.3
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|+..+.||+|++|.||+|.+..+++.|++|++..... ...+.+.+|++.+++++||||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 47788999999999999999998999999999875543 44678899999999999999999999876432 25689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+|+||+++++|.+++.... .+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999999998653 789999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
......... .......++..|+|||.+.+..++.++||||+|+++|+|++|..||...... ..........
T Consensus 149 ~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~ 219 (260)
T cd06606 149 KRLGDIETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALYKIGSS 219 (260)
T ss_pred Eeccccccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHhcccc
Confidence 876543211 0112246889999999998888999999999999999999999999764311 1111110000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .......+..+.+++.+|++.||++||++.|++++
T Consensus 220 ~~~-----------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 GEP-----------------------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCC-----------------------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 000 01111225678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=310.00 Aligned_cols=279 Identities=20% Similarity=0.261 Sum_probs=204.1
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC-CC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK-GA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~ 779 (1017)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++...... ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999999999999999985432 22345678999999999999999999988654221 12
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+ +++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 3568999998 77999888642 578999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||++...... .....+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||....... ......
T Consensus 162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~ 229 (343)
T cd07880 162 FGLARQTDSE-----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIM 229 (343)
T ss_pred cccccccccC-----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 9998754321 112457889999998876 458899999999999999999999997542211 111111
Q ss_pred Hhh--cCchhhhhccchhhHHHHhhcchh-HHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIA--LPEKVIEIVDPLLLIEVMANNSMI-QEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~--~~~~~~~~~d~~l~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .+..+.+.+.......+....... ..........+...+.+++.+|++.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111 111111111111111111100000 011112223456678999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=297.74 Aligned_cols=243 Identities=22% Similarity=0.295 Sum_probs=186.3
Q ss_pred cccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHH---HHHhcCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECK---ALRNIRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 712 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
+||+|+||.||+|.+..+++.||+|.+..... .....+..|.. .++...||+|+++++++... +..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEE
Confidence 48999999999999988899999999874321 11122334433 34445799999999988654 678999
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
|||+++|+|.+++.... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999999887543 689999999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
..... .....|+..|+|||.+.+. .++.++||||+||++|||++|+.||........ .........
T Consensus 147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~- 213 (278)
T cd05606 147 FSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT- 213 (278)
T ss_pred cCccC----------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhc-
Confidence 43211 1124689999999998754 688999999999999999999999976422111 000000000
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
.++ ......+.++.+++.+|+..+|.+|| ++.|++++
T Consensus 214 -----~~~------------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 214 -----MAV------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -----cCC------------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 000 00112256788999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.47 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=204.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+++++.++|||++++.+.+... +..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 57888999999999999999998899999999975543 4557788999999999999999999987654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+|+||+++++|.+++..... ....+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence 99999999999999987531 124789999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
....... .......|++.|+|||...+..++.++||||+|+++|+|++|+.||...... ........
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~ 217 (258)
T cd08215 151 KVLSSTV--------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKILK 217 (258)
T ss_pred eecccCc--------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHHhc
Confidence 7654322 1112246889999999998888999999999999999999999998654211 11111000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... ......++..+.+++.+|+..+|++||++.|++++
T Consensus 218 ~~~-----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 218 GQY-----------------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCC-----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00011235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=298.21 Aligned_cols=243 Identities=21% Similarity=0.290 Sum_probs=187.2
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHH-HhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKAL-RNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|..++ ...+|+|++++++++... +..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEE
Confidence 569999999999999998999999999864432 1223344555444 445899999999998654 6789999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++...
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 9999999999997653 678999999999999999999999 9999999999999999999999999998753
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchh
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
.. .....|+..|+|||.+.+..++.++||||+|+++|||++|..||....... ...........
T Consensus 148 ~~------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--- 211 (260)
T cd05611 148 LE------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRIN--- 211 (260)
T ss_pred cc------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcccC---
Confidence 22 112457889999999988888999999999999999999999996532210 00000000000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. ......++..+.+++.+|++.||++||++.++.+.
T Consensus 212 ------------------~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 212 ------------------WP---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred ------------------CC---CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 00 00111346778999999999999999977654443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=297.07 Aligned_cols=249 Identities=28% Similarity=0.426 Sum_probs=202.8
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.+.||+|++|.||+|++..+++.||+|.+..... ...+.+.+|++++++++|+|++++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence 47888999999999999999998899999999976544 4557889999999999999999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 9999999999999997653 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
......... .....++..|+|||...+..++.++||||+|+++|+|++|+.||..... .........
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~- 213 (254)
T cd06627 147 TKLNDVSKD--------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ- 213 (254)
T ss_pred eecCCCccc--------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc-
Confidence 866532211 1224578999999999887889999999999999999999999864321 111111000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .......++.+.+++.+|+..+|++||++.|++.+
T Consensus 214 ~~~-----------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 214 DDH-----------------------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred cCC-----------------------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 000 00111235678899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=295.13 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=202.6
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
+.|+.-++||+|+||.||-++.+.+|+.||.|.+.+.. +.......+|-+++.++..+.||.+-..|.+. +.
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-----d~ 259 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK-----DA 259 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC-----Cc
Confidence 45777889999999999999999999999999886332 22334567899999999999999988777665 77
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+|+..|.||+|.-.+.+.+. +.+++..++-+|.+|+.||++||.. +||+||+||+|||+|+.|+++|+|.|
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred eEEEEEeecCCceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence 9999999999999988877653 5799999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|..+...+. ....+||.+|||||++.+..|+...|.||+||++|||+.|+.||...-...
T Consensus 333 LAvei~~g~~---------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------- 393 (591)
T KOG0986|consen 333 LAVEIPEGKP---------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------- 393 (591)
T ss_pred eEEecCCCCc---------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----------
Confidence 9998765442 223479999999999999999999999999999999999999996532110
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
-.+-+|.....+ ........+++..++....|+.||++|. .+.||-+|
T Consensus 394 ----k~eEvdrr~~~~-----------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 394 ----KREEVDRRTLED-----------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ----hHHHHHHHHhcc-----------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 001112111111 0112234466788899999999999997 34455443
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=298.48 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=202.7
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+|++.++||+|+||.||+|++..+++.+|+|.+.... ......+.+|++++++++|+||+++.+++... ...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 4788999999999999999999899999999987543 23346778899999999999999999887654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEehhcCCCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence 99999999999999876321 123688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
....... .....|+..|+|||.+.+..++.++|+||+|+++|||++|+.||...... ........
T Consensus 151 ~~~~~~~----------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~ 215 (256)
T cd08530 151 KVLKKNM----------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRYKVQR 215 (256)
T ss_pred hhhccCC----------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhc
Confidence 7664321 11235788999999999888999999999999999999999999754221 11100000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. .......++.++.+++.+|++.+|++||++.|++++
T Consensus 216 ~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 GK-----------------------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CC-----------------------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 001112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=311.95 Aligned_cols=279 Identities=20% Similarity=0.292 Sum_probs=203.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 779 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.++++++|||++++.+++...+. ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467899999999999999999999989999999998643 22334667789999999999999999987754422 222
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++|+||+ +++|.+++... .+++.++..++.|+++|++|||+. +|+||||||+||+++.++.++|+|
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 4589999998 66999998752 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||++...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||....... ......
T Consensus 162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~ 229 (343)
T cd07851 162 FGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIM 229 (343)
T ss_pred cccccccccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence 9998755321 112457889999998865 367899999999999999999999997542211 111111
Q ss_pred Hhh--cCchhhhhccchhhHHHHhhc-chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIA--LPEKVIEIVDPLLLIEVMANN-SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~--~~~~~~~~~d~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .++.+..-+.......+.... ...+.........+++++.+++.+|++.||++|||+.||+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 100 011111111111011111000 000011111122346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=299.08 Aligned_cols=253 Identities=25% Similarity=0.322 Sum_probs=195.0
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 713 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++.+... ...|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecC
Confidence 6899999999999998899999999875433 3456788999999999999999999887543 6789999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 9999999997653 689999999999999999999999 9999999999999999999999999998754322
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1017)
................++..|+|||...+..++.++||||||+++|++++|..||...... ..........
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~---- 217 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNGK---- 217 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCC----
Confidence 1110000011222346788999999998888999999999999999999999999754211 1100000000
Q ss_pred ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 950 VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 950 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
... ......+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 218 -------------~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 -------------IEW-----PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -------------cCC-----CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000 000012567899999999999999999955554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=301.70 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=195.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++.+. .||||+++++++... ..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----SD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----Ce
Confidence 4678899999999999999999998899999999975432 3345567788777777 499999999998654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
.++||||++ +++.++...... .+++..+..++.|++.|++|||+ . +|+||||+|+||+++.++.+||+||
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECcc
Confidence 899999985 488887765432 68899999999999999999997 5 8999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCC----cCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE----ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|.+........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||............
T Consensus 160 g~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 230 (296)
T cd06618 160 GISGRLVDSKA---------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK 230 (296)
T ss_pred ccchhccCCCc---------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH
Confidence 99876532211 11234788999999987653 788999999999999999999999653211111111
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
......+ ... ....++.++.+++.+|++.||++||++.+++++-
T Consensus 231 ~~~~~~~----~~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 231 ILQEEPP----SLP---------------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HhcCCCC----CCC---------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1000000 000 0002356789999999999999999999998774
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=300.11 Aligned_cols=245 Identities=27% Similarity=0.369 Sum_probs=193.3
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
|...++||+|+||+||+|++..+++.||+|++..... ...+.+.+|+++++.++|||++++++++... +..|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence 6667789999999999999998999999999874332 3345678899999999999999999998765 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+. |++.+++..... .+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+
T Consensus 98 lv~e~~~-~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 9999996 588888765432 688999999999999999999999 9999999999999999999999999988
Q ss_pred cccccccccccccCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
..... .....|+..|+|||++. +..++.++|||||||++|||++|..||........ .......
T Consensus 169 ~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~ 235 (313)
T cd06633 169 SKSSP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN 235 (313)
T ss_pred cccCC------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhc
Confidence 63221 11246889999999974 35688899999999999999999999865321100 0000000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..+. . .....+..+.+++.+|++.+|.+||++.+++.+
T Consensus 236 ~~~~---------~-----------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 DSPT---------L-----------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCC---------C-----------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0 011224568899999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=302.63 Aligned_cols=254 Identities=25% Similarity=0.336 Sum_probs=199.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
...|+..+.||+|+||.||+|++..++..||+|.+... .....+++.+|+++++.++|+|++++.+++... .
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----C
Confidence 34577788999999999999999989999999998643 223345778899999999999999999998654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+. |++.+++..... .+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+||
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCc
Confidence 7899999996 588887765432 578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|++...... ....|+..|+|||.+. ...++.++|||||||++|+|++|+.||...... ......
T Consensus 160 g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~ 226 (308)
T cd06634 160 GSASIMAPA------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHI 226 (308)
T ss_pred ccceeecCc------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHH
Confidence 998754321 1245788999999874 346788999999999999999999998653111 001111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
.....+ . .....++..+.+++.+||+.+|++||++.+++++-.....
T Consensus 227 ~~~~~~---------~-----------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 227 AQNESP---------A-----------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred hhcCCC---------C-----------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 100000 0 0011235668899999999999999999999988665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.26 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=216.4
Q ss_pred HHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCC
Q 043932 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSID 775 (1017)
Q Consensus 697 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 775 (1017)
++.+...++.|.+.++||.|.+|.||+++...+++.+|+|+.......+ +++..|+.+++.. .|||++.++|++.-.+
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3444456678999999999999999999999999999999987554443 6677899999888 6999999999998887
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCe
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
....+..|+|||||.+||..|+++... ..++.|..+..|++.++.|+.+||.. .++|||||-.||+++.++.|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 777899999999999999999998765 35899999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccC-----CCcCccccchhHHHHHHHHHhCCCCCCccccc
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----SEASMTGDVYSFGILLLELFTGRRPTDAAFTE 930 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 930 (1017)
|++|||.+..... +.......+||+.|||||++.- ..|+.++|+||+|++..||.-|.+|+.....-
T Consensus 163 KLvDFGvSaQlds--------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 163 KLVDFGVSAQLDS--------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred EEeeeeeeeeeec--------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence 9999999876543 2233345789999999999843 34778999999999999999999998664322
Q ss_pred CccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 931 GLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.....+.. ....... .+..-.+++.++|..|+..|-++||++.++++|
T Consensus 235 ----raLF~IpR-NPPPkLk---------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 ----RALFLIPR-NPPPKLK---------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----hhhccCCC-CCCcccc---------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111110 0001111 122336779999999999999999999999876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=291.14 Aligned_cols=267 Identities=22% Similarity=0.349 Sum_probs=203.5
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-------cchHHHHHHHHHHHHhcCCCCceeeeeeeecC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-------KGAFKSFMAECKALRNIRHRNLIKIITICSSI 774 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 774 (1017)
...++|-....||+|+|+.||+|.+....+.||||+-.... ....+...+|.++.+.++||.||++|+|+.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 34568889999999999999999999889999999875321 12245678999999999999999999998654
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC---
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH--- 851 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--- 851 (1017)
.+..|-|+|||+|.+|+-|+++.+ .+++.+++.|+.||+.||.||.+. .++|||-||||.|||+..
T Consensus 540 ----tdsFCTVLEYceGNDLDFYLKQhk------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 540 ----TDSFCTVLEYCEGNDLDFYLKQHK------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred ----cccceeeeeecCCCchhHHHHhhh------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence 356799999999999999999875 789999999999999999999998 679999999999999843
Q ss_pred CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccC----CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 852 DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG----SEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 852 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
-|.+||.|||+++++.+....... .-.......||.+|.+||.+.- .+.+.++||||+|||+|..+.|+.||...
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vd-GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVD-GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred cceeEeeecchhhhccCCccCccc-ceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 478999999999998765433221 1122334679999999998743 24688999999999999999999999865
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
......+.+ ..+..-.++.- +.-.....+...+|++|+++.-++|....++..
T Consensus 688 qsQQdILqe-NTIlkAtEVqF----------------------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 688 QSQQDILQE-NTILKATEVQF----------------------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhHHHHHhh-hchhcceeccC----------------------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 332111111 00000000000 000122455678899999999999988777643
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=299.12 Aligned_cols=273 Identities=23% Similarity=0.323 Sum_probs=200.9
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
|+..+.||+|+||.||+|+...+++.||+|++.... ....+.+..|++++++++|+|++++++++... +..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 566788999999999999999899999999998653 33346778899999999999999999988654 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||++ ++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.+.
T Consensus 76 v~e~~~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred EecCcC-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 999997 59999998753 2689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc-
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL- 942 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 942 (1017)
....... ......++..|+|||.+.+. .++.++||||+||++||+++|++||......+ ..........
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~ 217 (282)
T cd07829 147 AFGIPLR--------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQILGT 217 (282)
T ss_pred ccCCCcc--------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHhCC
Confidence 6542211 11123457789999998776 78999999999999999999999996643211 1111111100
Q ss_pred --CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 --PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 --~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+.......+-....... ...............+..+.+++.+|++.||++||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 218 PTEESWPGVTKLPDYKPTF--PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred CcHHHHHhhcccccccccc--cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000000000 0000000011122236679999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=298.61 Aligned_cols=275 Identities=22% Similarity=0.266 Sum_probs=197.5
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCceeEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
|++.+.||+|+||+||+|+...+++.||+|.+..... .......+|+..+++++ |+|++++++++... +..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEEE
Confidence 6778899999999999999998899999999864422 22234557899999998 99999999988653 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+ +|+|.+++.... ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+.
T Consensus 76 v~e~~-~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EEecC-CCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 99999 779999887653 13689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
...... ......++..|+|||++.+ ..++.++||||||+++|||++|++||......+. .........+
T Consensus 148 ~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~ 217 (283)
T cd07830 148 EIRSRP---------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGT 217 (283)
T ss_pred eccCCC---------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCC
Confidence 553221 1112457889999998754 4578999999999999999999999965422111 1111110000
Q ss_pred chhhhhccchhhHHHHhh--cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMAN--NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.....+.+.......... ...............+..+.+++.+|++.||++|||++|++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 218 PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred CChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000000000 0000000111111225678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.81 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=203.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 780 (1017)
++|.+.+.||+|+||.||+|+...++..||+|++.... ....+.+.+|++++++++ ||||+++++++... +
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----E 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----c
Confidence 36889999999999999999999899999999986432 233467788999999998 99999999987544 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++++||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 7899999999999999998654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccc------------cCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 861 GLAKFLSSHQLDTAS------------KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
|++............ ..........|+..|+|||+..+..++.++||||+|+++|++++|+.||....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999876543321100 00112233568899999999988889999999999999999999999997542
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH----HHHHHH
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM----RDVVAK 1004 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~ 1004 (1017)
.. ....... + ... ......++.+.+++.+||+.||++||++ +|++++
T Consensus 227 ~~----~~~~~~~---------~---------~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 227 EY----LTFQKIL---------K---------LEY-------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HH----HHHHHHH---------h---------cCC-------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11 0000000 0 000 0011225668899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=295.32 Aligned_cols=246 Identities=23% Similarity=0.321 Sum_probs=194.9
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
.++||+|.||+||-|+++.+|+.||||++.+.. ......+++|+.+++.++||.||.+.-.|++. +.+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEeh
Confidence 478999999999999999999999999997432 33347889999999999999999999888766 77999999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC---CCeEEeeccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVSHVGDFGLAK 864 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~ 864 (1017)
-+.| ++.+++-.. +..++++....-+..||+.||.|||.+ +|||+|+||+|||+... -.+||||||+|+
T Consensus 644 Kl~G-DMLEMILSs----EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 644 KLHG-DMLEMILSS----EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred hhcc-hHHHHHHHh----hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 9955 766665443 224888888888999999999999999 99999999999999654 479999999999
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
++++.. ....++||+.|.|||+++.+.|...-|+||.|||+|.-++|..||..+.+-..++.. +...+|.
T Consensus 716 iIgEks---------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN-AaFMyPp 785 (888)
T KOG4236|consen 716 IIGEKS---------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN-AAFMYPP 785 (888)
T ss_pred ecchhh---------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc-cccccCC
Confidence 887533 233478999999999999999999999999999999999999999764322111111 1111111
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..+.++....+++|...++..-.+|-+..+-+.|
T Consensus 786 --------------------------~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 786 --------------------------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred --------------------------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1234455666777778888888888887765544
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-33 Score=320.33 Aligned_cols=265 Identities=21% Similarity=0.270 Sum_probs=206.2
Q ss_pred HHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeec
Q 043932 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 697 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
..++.-..++|.+.++||+|+||.|..++++.+++.||+|++.+. .......|..|-++|..-+.+-|+.+...|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 345555668999999999999999999999999999999999752 23445678999999998899999999887765
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
. .+.|+||||++||+|-..+.... ++++..++.++..|+-||..+|+. |+|||||||+|||+|..|
T Consensus 147 ~-----~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 147 E-----RYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred c-----cceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence 5 88999999999999999998764 689999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccC-----CCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----SEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
++||+|||.+-.+..++.- .....+|||-|.+||++.. +.|++.+|.||+||++|||+.|..||..+.
T Consensus 213 HikLADFGsClkm~~dG~V-------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADGTV-------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred cEeeccchhHHhcCCCCcE-------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 9999999999877643311 1123579999999999842 468999999999999999999999997642
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHH
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME---MRDVVAKL 1005 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L 1005 (1017)
- ...|.++.--..... ++ ...+++++..++|.+.+. +|+.|.. +.++-.|-
T Consensus 286 l----veTY~KIm~hk~~l~----------------FP-----~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 286 L----VETYGKIMNHKESLS----------------FP-----DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred H----HHHHHHHhchhhhcC----------------CC-----cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 2 111211111100000 00 001235566777776655 6778777 88887765
Q ss_pred hhc
Q 043932 1006 CHT 1008 (1017)
Q Consensus 1006 ~~~ 1008 (1017)
.--
T Consensus 340 FF~ 342 (1317)
T KOG0612|consen 340 FFE 342 (1317)
T ss_pred ccc
Confidence 443
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=296.14 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=195.2
Q ss_pred cccccCcccccCCceEEEEEeC---CCcEEEEEEEeeecC----cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCC
Q 043932 706 EFASSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 777 (1017)
+|++.+.||+|+||.||+|+.. .+|..||+|++.... ....+.+.+|+++++++ +|++|+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--- 77 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC---
Confidence 4788899999999999999984 478899999987432 22346678899999999 599999999887654
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||
T Consensus 78 --~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 78 --TKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred --CeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence 57899999999999999997653 578889999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCC--CcCccccchhHHHHHHHHHhCCCCCCcccccCccHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS--EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 935 (1017)
+|||++......... ......|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ....
T Consensus 147 ~dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~ 218 (290)
T cd05613 147 TDFGLSKEFHEDEVE-------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQA 218 (290)
T ss_pred eeCccceeccccccc-------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHH
Confidence 999998765432211 11124688999999998653 4678999999999999999999998643211 1111
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
.+........ ......+...+.+++.+|++.||++|| ++.+++++
T Consensus 219 ~~~~~~~~~~------------------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 219 EISRRILKSE------------------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHhhccC------------------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1111110000 000112356688999999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=295.82 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=196.9
Q ss_pred cccccCcccccCCceEEEEEeC---CCcEEEEEEEeeecC----cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCC
Q 043932 706 EFASSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 777 (1017)
+|++.+.||+|+||.||+|++. .+++.||||++.... ....+.+.+|++++.++ +||+|+++++.+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--- 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--- 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence 4778899999999999999864 357889999987432 22345678899999999 599999999887544
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
...++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|
T Consensus 78 --~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 78 --TKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred --CEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 56899999999999999987543 578899999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCC--cCccccchhHHHHHHHHHhCCCCCCcccccCccHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE--ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 935 (1017)
+|||++........ .......|+..|+|||.+.+.. .+.++||||+|+++|||++|..||...... ....
T Consensus 147 ~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~ 218 (288)
T cd05583 147 TDFGLSKEFLAEEE-------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQS 218 (288)
T ss_pred EECccccccccccc-------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHH
Confidence 99999876532211 1111245889999999987654 788999999999999999999998642211 1111
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
...+..... .......++..+.+++.+|++.||++|||++++.+.|+..
T Consensus 219 ~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 219 EISRRILKS------------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHHcc------------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111110000 0001112345678999999999999999988877666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=293.20 Aligned_cols=252 Identities=19% Similarity=0.247 Sum_probs=195.0
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-----cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+|.+.++||+|+||.||+|++...+..+++|+.+... .....++..|+.++++++||||+++++++... .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence 5888999999999999999998777667777765321 22334567899999999999999999987544 5
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++++|.+++..... ....+++.+++.++.|++.|+.|||+. +++|+||||+||+++. +.++|+||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKH--TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence 68999999999999998875321 123789999999999999999999999 9999999999999975 57999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|.+........ ......|++.|+|||.+.+..++.++||||+|+++|+|++|..||..... .......
T Consensus 150 g~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----~~~~~~~ 217 (260)
T cd08222 150 GVSRLLMGSCD--------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----LSVVLRI 217 (260)
T ss_pred CceeecCCCcc--------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHH
Confidence 99876532211 11124578899999999888889999999999999999999999864211 1111110
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .. ......++.++.+++.+|++.||++||++.|++++
T Consensus 218 -~~~-----~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 218 -VEG-----PT------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -HcC-----CC------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 000 00 01112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-33 Score=283.51 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=196.8
Q ss_pred cCHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhc-CCCCceeeeee
Q 043932 695 VSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNI-RHRNLIKIITI 770 (1017)
Q Consensus 695 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 770 (1017)
.+-.+ .....+|....+||+|+||+|.+|..+.+.+.||||+++.+ +.+..+--+.|-+++... +-|.++++..+
T Consensus 340 ~~~~d-~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 340 SSKRD-RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred CCccc-ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence 33344 23345899999999999999999999999999999999744 233445556677777766 57788888888
Q ss_pred eecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 771 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
|.+. +..|+||||+.||+|--.+++.+ ++.+..+.-+|.+||-||-|||++ ||+.||||.+|||++
T Consensus 419 FQTm-----DRLyFVMEyvnGGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd 484 (683)
T KOG0696|consen 419 FQTM-----DRLYFVMEYVNGGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLD 484 (683)
T ss_pred hhhh-----hheeeEEEEecCchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEec
Confidence 7766 77999999999999999898776 567777888999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCccccc
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTE 930 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 930 (1017)
.+|++||+|||+++.--- .......++|||.|+|||++...+|+.++|.||+||++|||+.|++||++..++
T Consensus 485 ~eGHiKi~DFGmcKEni~--------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 485 SEGHIKIADFGMCKENIF--------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred cCCceEeeeccccccccc--------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 999999999999874221 112233579999999999999999999999999999999999999999986443
Q ss_pred CccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC
Q 043932 931 GLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME 997 (1017)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 997 (1017)
+. ...+..... ..+...+.+...++...+...|.+|..
T Consensus 557 el-F~aI~ehnv----------------------------syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 557 EL-FQAIMEHNV----------------------------SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HH-HHHHHHccC----------------------------cCcccccHHHHHHHHHHhhcCCccccC
Confidence 21 111111000 111223455677788888899999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-34 Score=277.72 Aligned_cols=256 Identities=23% Similarity=0.258 Sum_probs=192.7
Q ss_pred ccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 709 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 709 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
-...||.|+||+|++-.++.+|+..|||.++.... .+.+++..|.+...+- +.||||+++|.+... +..|+.|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcWiCM 142 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCWICM 142 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----CceeeeH
Confidence 34679999999999999999999999999986554 4557888888876555 799999999987654 5579999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
|.|+- +++.+.+.... .....+++.-+-+|+...+.||.||.+.. .|||||+||+|||++..|.+||||||++..+
T Consensus 143 ELMd~-SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHhh-hHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 99954 77766543211 12247888888889999999999999765 8999999999999999999999999998765
Q ss_pred ccccccccccCCCcccccccCccccCcccccC--CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
...-. .+.-.|...|||||.+.. ..|+.++||||+|+++||+.||..||..-...-.++.+.+....|.
T Consensus 219 v~SiA---------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~ 289 (361)
T KOG1006|consen 219 VDSIA---------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI 289 (361)
T ss_pred HHHHH---------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe
Confidence 43221 112358889999999854 3589999999999999999999999876432211222211111111
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
-. . .....+....+.+++..|+.+|-..||...++.++
T Consensus 290 l~---~-------------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LL---F-------------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ec---C-------------------cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 00 0 01112346678999999999999999999987653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=324.97 Aligned_cols=148 Identities=30% Similarity=0.444 Sum_probs=131.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|.+.++||+|+||+||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++... +
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-----N 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-----C
Confidence 357999999999999999999999999999999997433 22346788899999999999999999887654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
+.|+||||+++++|.+++.... .+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence 7899999999999999997643 578889999999999999999999 9999999999999999999999999
Q ss_pred ccccc
Q 043932 861 GLAKF 865 (1017)
Q Consensus 861 G~a~~ 865 (1017)
|+++.
T Consensus 149 Gls~~ 153 (669)
T cd05610 149 GLSKV 153 (669)
T ss_pred CCCcc
Confidence 99863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=297.73 Aligned_cols=244 Identities=25% Similarity=0.273 Sum_probs=196.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
+..|.....+|.|+|+.|-.+.+..+++..++|++.... ..-.+|+.++... +||||+++.+.+.+. .+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~-----~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDG-----KEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCC-----cee
Confidence 557778888999999999999999999999999997552 2234677666666 799999999998655 778
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe-CCCCCeEEeecc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-DHDMVSHVGDFG 861 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfG 861 (1017)
|+|||.+.|+-+.+.+...+ ....++..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|+|||
T Consensus 392 ~~v~e~l~g~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred eeeehhccccHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEec
Confidence 99999999998887776553 22267788999999999999999 99999999999999 689999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
.++..... ....+-|..|.|||+.....|++++|+||||+++|+|++|+.||.....+ .....+..
T Consensus 462 ~a~~~~~~-----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~ 527 (612)
T KOG0603|consen 462 FWSELERS-----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQ 527 (612)
T ss_pred hhhhCchh-----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhc
Confidence 99866533 11124588999999999999999999999999999999999999875333 11111111
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
.+ + .....+++.++|+.+||+.||.+||+|.|+..+=..
T Consensus 528 ~~-~--------------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 MP-K--------------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CC-c--------------------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11 1 112346678999999999999999999999876544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=282.76 Aligned_cols=241 Identities=28% Similarity=0.348 Sum_probs=193.1
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 713 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
||+|+||.||+|.+..+++.||+|++..... .....+..|++++++++|||++++++.+... +..++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecC
Confidence 6999999999999988899999999875432 2456788999999999999999999887544 6789999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccc
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 869 (1017)
++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9999999998653 578999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh
Q 043932 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949 (1017)
Q Consensus 870 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1017)
. .......++..|+|||...+...+.++|+||||+++|++++|+.||..... .+.........
T Consensus 147 ~--------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~---- 209 (250)
T cd05123 147 G--------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDP---- 209 (250)
T ss_pred C--------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCC----
Confidence 1 111234678899999999888889999999999999999999999965422 11111000000
Q ss_pred ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH---HHHHHH
Q 043932 950 VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM---RDVVAK 1004 (1017)
Q Consensus 950 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~---~evl~~ 1004 (1017)
.......+..+.+++.+|+..||++||++ ++++++
T Consensus 210 --------------------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 210 --------------------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 00011125668899999999999999999 555543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=314.85 Aligned_cols=268 Identities=26% Similarity=0.410 Sum_probs=208.0
Q ss_pred HhhccccccCcccccCCceEEEEEeCC-------CcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeee
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICS 772 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 772 (1017)
...++..+.+.+|+|.||.|++|.... ....||||..+... ..+.+.+..|+++|+.+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 334455667799999999999998531 14679999987443 34567899999999999 6999999999997
Q ss_pred cCCCCCCceeEEEEEeccCCCHHHHHhhCC---------CCccc-cccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecC
Q 043932 773 SIDSKGADFKALVFECMKNGSLEDWLHQSN---------DHLEV-CKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDL 842 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 842 (1017)
.. ...++|+||++.|+|.+|++..+ ..... ..++..+.+.++.|||.|++||++. ++||||+
T Consensus 373 ~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDL 444 (609)
T KOG0200|consen 373 QD-----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDL 444 (609)
T ss_pred cC-----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhh
Confidence 63 66899999999999999999876 11111 2489999999999999999999999 9999999
Q ss_pred CCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CC
Q 043932 843 KPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GR 921 (1017)
Q Consensus 843 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~ 921 (1017)
..+||+++++..+||+|||+|+.............. +. -...|||||.+....|+.++||||||+++||++| |.
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~----~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSA----GT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCC----Cc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence 999999999999999999999865443322211110 00 1346999999999999999999999999999999 89
Q ss_pred CCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 043932 922 RPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDV 1001 (1017)
Q Consensus 922 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1001 (1017)
.||.+.... ..+.++.+.. .....+..|.++++++|+.||+.+|++||++.|+
T Consensus 520 ~PYp~~~~~-~~l~~~l~~G--------------------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~ 572 (609)
T KOG0200|consen 520 TPYPGIPPT-EELLEFLKEG--------------------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSEC 572 (609)
T ss_pred CCCCCCCcH-HHHHHHHhcC--------------------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 998762111 0011111100 0112344568889999999999999999999999
Q ss_pred HHHHhhcc
Q 043932 1002 VAKLCHTR 1009 (1017)
Q Consensus 1002 l~~L~~~~ 1009 (1017)
.+.++...
T Consensus 573 ~~~~~~~l 580 (609)
T KOG0200|consen 573 VEFFEKHL 580 (609)
T ss_pred HHHHHHHH
Confidence 99998843
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=258.10 Aligned_cols=275 Identities=20% Similarity=0.287 Sum_probs=213.4
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCce
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 781 (1017)
..++|++.+++|+|.|++||.|....+.+.++||+++.-. .+.+.+|+.+++.+. ||||++++++..+... ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S---kt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPES---KT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccc---cC
Confidence 3578999999999999999999998899999999997443 367889999999996 9999999999876544 55
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-CCeEEeec
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVSHVGDF 860 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 860 (1017)
..+|+||+.+.+...... .++..+++..+.|++.||.|+|+. ||.|||+||.|++||.. ..++|+|+
T Consensus 110 paLiFE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred chhHhhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence 689999999988777653 677888999999999999999999 99999999999999865 57999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+|.++.+..... -.+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||....+...++...++
T Consensus 178 GLAEFYHp~~eYn---------VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 178 GLAEFYHPGKEYN---------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred chHhhcCCCceee---------eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 9999886544211 2346778899998865 45889999999999999999999999877666666777776
Q ss_pred hhcCchhhhhccchh---hHHHHh---h--cchhHHHhHHhHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLL---LIEVMA---N--NSMIQEDIRAKTQE-CLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l---~~~~~~---~--~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....+++..+++..- ...+.. . ...+...+...... ..++..+++.+.+.+|-.+||||+|.++|
T Consensus 249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 665555444332211 111110 1 11122222222222 24778899999999999999999998875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=268.98 Aligned_cols=272 Identities=24% Similarity=0.351 Sum_probs=211.3
Q ss_pred HHHHhhccccccCcccccCCceEEEEEeCCCc-----EEEEEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeee
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDE-----MIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICS 772 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 772 (1017)
++.....+++...++-+|.||.||.|.+++.. +.|-+|.++.. ++-....+..|.-.+..+.|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34444456777778999999999999887543 23556655422 2334567888998899999999999999986
Q ss_pred cCCCCCCceeEEEEEeccCCCHHHHHhhCC--CCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 773 SIDSKGADFKALVFECMKNGSLEDWLHQSN--DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
+. ....+.++.+..-|+|..|+...+ +....+.++..+...++.|++.|++|||.+ +|||.||..+|.+|+
T Consensus 358 e~----~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 358 ED----YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred ec----cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 53 366789999999999999998432 222345788889999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccc
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFT 929 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 929 (1017)
+.-++||+|=.+++..-+.+...-... --.+..||+||.+....|+.++|||||||++|||+| |+.||...++
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDn------EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDN------ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred hheeEEeccchhccccCcccccccCCC------CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 999999999999987655443332222 234678999999999999999999999999999999 9999865322
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
.....+.....++ ..+-+|++++..+|.-||..+|++||+++|++.-|.++.
T Consensus 505 -----------------------fEm~~ylkdGyRl-----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 505 -----------------------FEMEHYLKDGYRL-----AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -----------------------HHHHHHHhcccee-----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 2111211111111 234478999999999999999999999999999998865
Q ss_pred cc
Q 043932 1010 ET 1011 (1017)
Q Consensus 1010 ~~ 1011 (1017)
..
T Consensus 557 ~q 558 (563)
T KOG1024|consen 557 TQ 558 (563)
T ss_pred HH
Confidence 43
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=307.39 Aligned_cols=277 Identities=19% Similarity=0.143 Sum_probs=174.3
Q ss_pred hhccccccCcccccCCceEEEEEeCCC----cEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecC-CCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGED----EMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSI-DSK 777 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~ 777 (1017)
..++|.+.++||+|+||.||+|++..+ +..||+|.+...... +....| .++...+.++..++..+... ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 467899999999999999999999888 899999987533221 111111 12222233333332222111 112
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCc--------------cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCC
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHL--------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLK 843 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 843 (1017)
.....++||||+++++|.+++....... .........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 3467899999999999999987542100 001122345668999999999999999 99999999
Q ss_pred CCceEeCC-CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCC----------------------C
Q 043932 844 PSNVLLDH-DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS----------------------E 900 (1017)
Q Consensus 844 p~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~ 900 (1017)
|+|||++. ++.+||+|||+|+...... ......+.||+.|+|||.+... .
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999986 5799999999997653221 1112235789999999966332 1
Q ss_pred cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC--chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHH
Q 043932 901 ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP--EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLN 978 (1017)
Q Consensus 901 ~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~ 978 (1017)
++.++||||+||++|||+++..|++.... .+......... ..+.....+....+.. . ..........
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-------~-~~~~~d~~~~ 424 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSNLI---QFNRQLKRNDYDLVAWRKLVEPRASPDLR-------R-GFEVLDLDGG 424 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchHHH---HHHHHHHhcCCcHHHHHHhhccccchhhh-------h-hhhhccccch
Confidence 34467999999999999997776543210 00000000000 0000111110000000 0 0000111233
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 979 AIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 979 ~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+++.+|++.||++|||+.|+++|
T Consensus 425 ~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 425 AGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhCC
Confidence 45689999999999999999999987
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=280.79 Aligned_cols=221 Identities=19% Similarity=0.134 Sum_probs=175.5
Q ss_pred cCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEeccCCCHH
Q 043932 716 GSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLE 795 (1017)
Q Consensus 716 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 795 (1017)
|.||.||+|++..+++.||+|.+.... .+.+|...+....|||++++++++... +..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCCHH
Confidence 899999999999999999999987543 223455555556799999999987654 6789999999999999
Q ss_pred HHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccccccc
Q 043932 796 DWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875 (1017)
Q Consensus 796 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 875 (1017)
+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+.......
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----- 139 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----- 139 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----
Confidence 9987653 588999999999999999999999 99999999999999999999999999876543211
Q ss_pred cCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhh
Q 043932 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLL 955 (1017)
Q Consensus 876 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 955 (1017)
....++..|+|||.+.+..++.++||||+|+++|||++|+.|+........ .....
T Consensus 140 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~~~~~--- 195 (237)
T cd05576 140 ------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------THTTL--- 195 (237)
T ss_pred ------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------ccccc---
Confidence 113457789999999888899999999999999999999988753211100 00000
Q ss_pred HHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 956 IEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 956 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
.....+++.+.+++.+|++.||++||++.
T Consensus 196 ---------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 196 ---------------NIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred ---------------CCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 00011245688999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.22 Aligned_cols=136 Identities=26% Similarity=0.441 Sum_probs=117.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-----C---CCceeeeeeeecCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-----H---RNLIKIITICSSIDS 776 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~~ 776 (1017)
.+|.+.++||-|.|++||+|.+.++.+.||+|+.+.. ....+....|++++++++ | .+||++++.|... +
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs-G 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS-G 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-C
Confidence 6899999999999999999999999999999998743 233466788999999983 2 4899999998765 4
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
....++|+|+|++ |.+|..++....- +.++...+.+|++||+.||.|||..| ||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4558999999999 5589998886532 47899999999999999999999998 99999999999999
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=249.41 Aligned_cols=220 Identities=23% Similarity=0.284 Sum_probs=176.1
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCC
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 778 (1017)
+...++...+..||+|+||.|-+.++..+|+..|+|.+...-. ...++..+|+.+..+. .+|.+|.++|.+...
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re---- 117 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE---- 117 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc----
Confidence 3344556667789999999999999999999999999975533 3456778888887666 799999999976443
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
..+++.||.+.- +|+.+.++.-. ....+++..+-+||..+..||.|||++- .|+|||+||+|||++.+|++|+|
T Consensus 118 -gdvwIcME~M~t-Sldkfy~~v~~--~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 118 -GDVWICMELMDT-SLDKFYRKVLK--KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred -ccEEEeHHHhhh-hHHHHHHHHHh--cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEc
Confidence 568999999965 88877665322 2347899999999999999999999985 89999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC----CCcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG----SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
|||.+-.+.+.-.. +.-.|...|||||.+.. ..|+-++||||+|+.+.||.++++||+.....-.++
T Consensus 192 DFGIsG~L~dSiAk---------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 192 DFGISGYLVDSIAK---------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred ccccceeehhhhHH---------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 99999776432211 11357889999999844 368999999999999999999999998765554444
Q ss_pred HHHHH
Q 043932 935 HEFAK 939 (1017)
Q Consensus 935 ~~~~~ 939 (1017)
.+.+.
T Consensus 263 kqvVe 267 (282)
T KOG0984|consen 263 KQVVE 267 (282)
T ss_pred HHHhc
Confidence 44443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=262.38 Aligned_cols=202 Identities=24% Similarity=0.374 Sum_probs=174.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 779 (1017)
..+|...++||+|+|++|..++++.+.+.||+|++++. +.+...-.+.|-.+..+. +||.+|.+..+|.+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte----- 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE----- 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-----
Confidence 45789999999999999999999999999999999743 333445556677777766 799999999888665
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++|.||++||+|--.+++.+ +++++.++-+..+|+-||.|||++ ||+.||+|.+||++|..|++|+.|
T Consensus 324 srlffvieyv~ggdlmfhmqrqr------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhh------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence 67899999999999987777654 789999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
||+++.--. .......++|||.|.|||++.+..|.+.+|.|++||+++||+.|+.||+..
T Consensus 395 ygmcke~l~--------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 395 YGMCKEGLG--------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred cchhhcCCC--------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 999874321 122234589999999999999999999999999999999999999999863
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=282.74 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=202.6
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++++++..||-|+||.|-++........+|+|++++. +....+.+..|-.+|...+.|.||++|-.|.+. .+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~-----ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS-----KY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc-----hh
Confidence 4556677899999999999999866666899988643 334456788899999999999999999877544 88
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
+|+.||-|-||.+...++..+ .++.....-++..+++|++|||++ +||+|||||+|.+++.+|-+||.|||
T Consensus 495 vYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence 999999999999999999876 677788888999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+.+.. ......++|||.|.|||++..+..+.++|.||+|+++||+++|.+||.+..+- ..+....
T Consensus 566 FAKki~~---------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----ktYn~IL 632 (732)
T KOG0614|consen 566 FAKKIGS---------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----KTYNLIL 632 (732)
T ss_pred hHHHhcc---------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHH
Confidence 9998753 33455689999999999999999999999999999999999999999874221 1111110
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhh
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAKLCH 1007 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~ 1007 (1017)
.. +|. -..+..+...-.+++++..+.+|.+|.. +.+|-+|-.-
T Consensus 633 kG------id~-----------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 633 KG------IDK-----------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred hh------hhh-----------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 00 110 0112233455678888999999999975 6666666443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-31 Score=261.55 Aligned_cols=281 Identities=20% Similarity=0.231 Sum_probs=195.7
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
.+..+.||-|+||.||.+++..+|+.||+|.+... .-...+++.+|++++..++|.|++..+++.......--.+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999999999999999988632 2234578899999999999999999988764432222245678
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
|+|.+.. +|...+-.. ..++...+.-+.+||++||+|||+. +|.||||||.|.+++.+...||||||+|+
T Consensus 135 ~TELmQS-DLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSP------QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHh-hhhheeccC------CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence 8888844 888777543 3788888999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
..+..+.. ..+.-+-|.+|+|||+++|. .|+.+.||||.|||+.|++..+..|.....- .++.-+......
T Consensus 205 vee~d~~~-------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-qQL~lItdLLGT 276 (449)
T KOG0664|consen 205 TWDQRDRL-------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-EQLQMIIDLLGT 276 (449)
T ss_pred ccchhhhh-------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-HHHHHHHHHhCC
Confidence 76543311 11123568899999999885 6999999999999999999999888764321 111111111111
Q ss_pred chhhhhccchhh--HHHHhhcchhHHHhH-----HhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 944 EKVIEIVDPLLL--IEVMANNSMIQEDIR-----AKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 944 ~~~~~~~d~~l~--~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
+.. +.+.-... ...+.+....+++.. ........+-..+...++..||++|.+..+.+.+.-
T Consensus 277 Ps~-EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 277 PSQ-EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred CcH-HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 100 00000000 000000000011100 001122234567788899999999999999887653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=287.87 Aligned_cols=277 Identities=17% Similarity=0.190 Sum_probs=184.2
Q ss_pred hhccccccCcccccCCceEEEEEeC----------------CCcEEEEEEEeeecCcchHHH--------------HHHH
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILG----------------EDEMIVAVKVINLKQKGAFKS--------------FMAE 752 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 752 (1017)
..++|++.++||+|+||+||+|.+. ..++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 245679999987543322222 3346
Q ss_pred HHHHHhcCCCC-----ceeeeeeeecCCCC---CCceeEEEEEeccCCCHHHHHhhCCCC------------------cc
Q 043932 753 CKALRNIRHRN-----LIKIITICSSIDSK---GADFKALVFECMKNGSLEDWLHQSNDH------------------LE 806 (1017)
Q Consensus 753 ~~~l~~l~h~n-----iv~~~~~~~~~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~ 806 (1017)
+.++.+++|.+ +++++++|...... ..+..++||||+++++|.++++..... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 67777776554 46777777543211 135679999999999999998753211 01
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCccccccc
Q 043932 807 VCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886 (1017)
Q Consensus 807 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~g 886 (1017)
...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ .......+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-------~~~~~g~~ 372 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-------FNPLYGML 372 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-------cCccccCC
Confidence 12456788899999999999999999 999999999999999999999999999975432110 00111235
Q ss_pred CccccCcccccCCC--------------------c--CccccchhHHHHHHHHHhCCC-CCCcccccCccHHHHHHhhcC
Q 043932 887 TVGYVAPEYCMGSE--------------------A--SMTGDVYSFGILLLELFTGRR-PTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 887 t~~y~aPE~~~~~~--------------------~--~~~~DvwslG~il~elltg~~-pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
|+.|+|||.+.... + ..+.||||+||++|+|++|.. ||............ ..
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-----~~ 447 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-----YD 447 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh-----cc
Confidence 78999999875432 1 124799999999999999875 66432111000000 00
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCC---CCCCCHHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESP---FERMEMRDVVAKL 1005 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~L 1005 (1017)
.....+. .+..... + -.......+..++++.+|+..+| .+|+|++|+++|-
T Consensus 448 ~~~~~~r------~~~~~~~----~-~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 448 NDLNRWR------MYKGQKY----D-FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred chHHHHH------hhcccCC----C-cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 0000000 0000000 0 01122345678899999999876 6899999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=267.55 Aligned_cols=240 Identities=28% Similarity=0.381 Sum_probs=192.5
Q ss_pred CCceEEEEEeCCCcEEEEEEEeeecCcch-HHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEeccCCCHH
Q 043932 717 SFGSVYKGILGEDEMIVAVKVINLKQKGA-FKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLE 795 (1017)
Q Consensus 717 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 795 (1017)
+||.||+|++..+++.||+|++....... .+.+.+|++.+++++|+|++++++++... ...++||||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence 58999999999889999999997655444 68899999999999999999999988654 6789999999999999
Q ss_pred HHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccccccc
Q 043932 796 DWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875 (1017)
Q Consensus 796 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 875 (1017)
+++.... .+++..++.++.+++.+++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 76 ~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----- 141 (244)
T smart00220 76 DLLKKRG------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----- 141 (244)
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence 9987653 378899999999999999999999 99999999999999999999999999998664322
Q ss_pred cCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhh
Q 043932 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLL 955 (1017)
Q Consensus 876 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 955 (1017)
......++..|+|||.+.+..++.++||||+|+++|++++|..||........ ..+.........
T Consensus 142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~---------- 206 (244)
T smart00220 142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKKIGKPKPPF---------- 206 (244)
T ss_pred ----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhccCCCC----------
Confidence 11224578899999999888889999999999999999999999865311111 111100000000
Q ss_pred HHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 956 IEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 956 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......++.++.+++.+|+..+|++||++.+++++
T Consensus 207 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 207 --------------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred --------------ccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 00000035678999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=287.95 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=184.7
Q ss_pred cCcccccCCce-EEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 710 SNMIGQGSFGS-VYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 710 ~~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
.+++|.|+.|+ ||+|... |+.||||.+-. +......+|++.++.- +|||||++++.- .+..+.||+.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE 583 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE 583 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence 45789999985 8999995 78999998752 2335667999999988 699999998753 34489999999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC---C--CCeEEeeccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---D--MVSHVGDFGL 862 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfG~ 862 (1017)
.|.. +|.+++..... +.........+.+..|+++||++||+. +||||||||.||||+. + .+++|+|||+
T Consensus 584 LC~~-sL~dlie~~~~--d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGL--DVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred Hhhh-hHHHHHhcccc--chhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccc
Confidence 9966 99999987521 111222245677899999999999998 9999999999999976 3 4789999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhC-CCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG-RRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++....++..... ..+..||-+|+|||++.....+.++||||+||++|+.++| .+||......+.. +.
T Consensus 658 sKkl~~~~sS~~r-----~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N------Il 726 (903)
T KOG1027|consen 658 SKKLAGGKSSFSR-----LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN------IL 726 (903)
T ss_pred ccccCCCcchhhc-----ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh------hh
Confidence 9988654422221 3446799999999999998888899999999999999995 9999764322111 00
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... .... ++ ...++ +..++|.+|+.+||..||+|.+|+.|
T Consensus 727 ~~~~--~L~~-------------L~-----~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 727 TGNY--TLVH-------------LE-----PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cCcc--ceee-------------ec-----cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0000 0000 00 00111 56899999999999999999999865
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=270.82 Aligned_cols=213 Identities=22% Similarity=0.307 Sum_probs=176.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
+-|..++.||-|+||+|.++...++...||+|.+.+.+ +........|-++|...+.+-||++|..|.+. +.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-----dn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-----Cc
Confidence 35777889999999999999999999999999987554 33446677899999999999999999887665 78
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||++||++-.++-+.+ .+.+.-++.++.++..|+++.|.. |+|||||||+|||||.+|++||.|||
T Consensus 704 LYFVMdYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence 999999999999999887764 577777888889999999999999 99999999999999999999999999
Q ss_pred cccccc---cccccc-------------------------------cccCCCcccccccCccccCcccccCCCcCccccc
Q 043932 862 LAKFLS---SHQLDT-------------------------------ASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDV 907 (1017)
Q Consensus 862 ~a~~~~---~~~~~~-------------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 907 (1017)
+++-+. +.+... ....+......+||+.|+|||++....|+..+|.
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 986431 000000 0000111123579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCcccccC
Q 043932 908 YSFGILLLELFTGRRPTDAAFTEG 931 (1017)
Q Consensus 908 wslG~il~elltg~~pf~~~~~~~ 931 (1017)
||.|||+|||+.|++||......+
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCc
Confidence 999999999999999998765543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=269.14 Aligned_cols=280 Identities=20% Similarity=0.285 Sum_probs=208.2
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC------CCCceeeeeeeecCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR------HRNLIKIITICSSIDS 776 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 776 (1017)
..++|.+....|+|-|++|..|.+..-|..||||++... ....+.=.+|+++|+++. --|+++++-.|...
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk-- 506 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK-- 506 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc--
Confidence 456899999999999999999999988999999999743 333456678999999995 24888888776554
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-CCe
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVS 855 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~ 855 (1017)
++.|+|||.+. -+|.+.++..+. ...+....+..++.|+.-||..|-.. +|+|.||||+||||++. ..+
T Consensus 507 ---nHLClVFE~Ls-lNLRevLKKyG~---nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 507 ---NHLCLVFEPLS-LNLREVLKKYGR---NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred ---ceeEEEehhhh-chHHHHHHHhCc---ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 88999999984 499999998763 35688899999999999999999998 99999999999999875 578
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc-H
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT-L 934 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~ 934 (1017)
||||||.|.+....+..+ +..+..|+|||++.|..|+...|+||.||++||+.||+..|++.....+. +
T Consensus 577 KLCDfGSA~~~~eneitP----------YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 577 KLCDFGSASFASENEITP----------YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred eeccCccccccccccccH----------HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 999999999887655433 34567899999999999999999999999999999999999875332111 1
Q ss_pred HHHHHhhcCchhh---hhccchhhHH------------------HHhh---cchhHHHh------HHhHHHHHHHHHHHH
Q 043932 935 HEFAKIALPEKVI---EIVDPLLLIE------------------VMAN---NSMIQEDI------RAKTQECLNAIIRIG 984 (1017)
Q Consensus 935 ~~~~~~~~~~~~~---~~~d~~l~~~------------------~~~~---~~~~~~~~------~~~~~~~~~~l~~li 984 (1017)
.--.+..+|.++. .+.|..+-.+ ++.. ...+...+ +........+|.+|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 1111222222211 0111110000 0000 00011111 112234567899999
Q ss_pred hhccCCCCCCCCCHHHHHHHH
Q 043932 985 VLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 985 ~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.+|+..||++|.|..|+++|-
T Consensus 727 dkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred HHHhccChhhcCCHHHHhcCC
Confidence 999999999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=272.77 Aligned_cols=200 Identities=26% Similarity=0.384 Sum_probs=172.5
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--------chHHHHHHHHHHHHhcC---CCCceeeeee
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFKSFMAECKALRNIR---HRNLIKIITI 770 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~~~~~ 770 (1017)
+...+|+..+.+|+|+||.|+.|.++.+...|+||.+.+..- .....+--|+++|..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 344579999999999999999999999999999999864321 11123446999999997 9999999999
Q ss_pred eecCCCCCCceeEEEEEec-cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 771 CSSIDSKGADFKALVFECM-KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 771 ~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
|++. +++|++||-. ++-+|.+++.... .+++.+...|++||+.|+++||++ +|||||||-+||.+
T Consensus 638 FEdd-----d~yyl~te~hg~gIDLFd~IE~kp------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenviv 703 (772)
T KOG1152|consen 638 FEDD-----DYYYLETEVHGEGIDLFDFIEFKP------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIV 703 (772)
T ss_pred eecC-----CeeEEEecCCCCCcchhhhhhccC------ccchHHHHHHHHHHHhcccccccc---CceecccccccEEE
Confidence 9765 7899999986 4458999998765 789999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCC
Q 043932 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTD 925 (1017)
Q Consensus 850 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~ 925 (1017)
+.+|.+||+|||.|.....+. ...++||..|.|||++.|.+| +..-||||+|+++|.++....||.
T Consensus 704 d~~g~~klidfgsaa~~ksgp----------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKSGP----------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ecCCeEEEeeccchhhhcCCC----------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999998765433 234789999999999999887 677899999999999999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-30 Score=277.70 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=204.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|...+++|.|.||.||+|++..+++..|+|+++....+.++-.++|+-+++..+||||+.+++-+... +..|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~-----dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----DKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh-----cCcE
Confidence 45788999999999999999999999999999999988888888899999999999999999999987654 5689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
++||||.+|+|.+..+..+ ++++.++..+.+..++|++|||++ +-+|||||-.||++++.|.+|++|||.+
T Consensus 89 icMEycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred EEEEecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence 9999999999999877654 789999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccCCCcccccccCccccCcccc---cCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYC---MGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
..+.. +-.....+.||++|||||+. +...|...+|||+.|+...|+-.-++|-..-... ..+.-+.+.
T Consensus 160 aqita--------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r~l~LmTkS 230 (829)
T KOG0576|consen 160 AQITA--------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-RALFLMTKS 230 (829)
T ss_pred hhhhh--------hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-HHHHHhhcc
Confidence 65432 22233457899999999986 3456889999999999999998888774221110 000001111
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. +.....|+. .-.+.+-++++.|+..+|++||+++.+++|
T Consensus 231 ~~--qpp~lkDk~---------------------kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 231 GF--QPPTLKDKT---------------------KWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CC--CCCcccCCc---------------------cchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 10 001111111 124557889999999999999999988763
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=257.36 Aligned_cols=287 Identities=25% Similarity=0.309 Sum_probs=208.5
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCC---CcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCC
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSID 775 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 775 (1017)
+......|...++||+|+|++||+|.+.. .++.||+|.+...+.. .++.+|++++..+ .+.||+++.+++...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnn- 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNN- 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccC-
Confidence 33445678999999999999999999987 6789999998766554 5688999999999 589999999987544
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-CCC
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMV 854 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~ 854 (1017)
+.+++|+||++..+..++.. .++..++..+++.+..||+++|.+ |||||||||.|++.+. .+.
T Consensus 108 ----d~v~ivlp~~~H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 108 ----DQVAIVLPYFEHDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred ----CeeEEEecccCccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCC
Confidence 77999999999999999886 467889999999999999999999 9999999999999975 467
Q ss_pred eEEeeccccccccccc------c------cc----------------c--------ccCCCcccccccCccccCcccccC
Q 043932 855 SHVGDFGLAKFLSSHQ------L------DT----------------A--------SKTSSSSIGIKGTVGYVAPEYCMG 898 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~------~------~~----------------~--------~~~~~~~~~~~gt~~y~aPE~~~~ 898 (1017)
-.|+|||+|....... . .. + ...........||++|+|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 8999999998321110 0 00 0 000111123569999999999876
Q ss_pred C-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh---------cc-------chhhHHHHhh
Q 043932 899 S-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI---------VD-------PLLLIEVMAN 961 (1017)
Q Consensus 899 ~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~d-------~~l~~~~~~~ 961 (1017)
- ..+.++||||.|||+.-++++++||....++-..+.+.+.......+... ++ +.....+..-
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 4 57899999999999999999999997766655555555444333222211 11 0000001000
Q ss_pred -cchhHH-----HhHHhHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 962 -NSMIQE-----DIRAKTQE-CLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 962 -~~~~~~-----~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
...+.. -......+ .+..+.+++.+|+..||.+|.||+|.++|-
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 000000 00111122 334789999999999999999999998763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=249.40 Aligned_cols=275 Identities=21% Similarity=0.233 Sum_probs=201.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC-CCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK-GAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 780 (1017)
..+|.-.+.+|.|.- .|..|.+.-.++.||+|..... .....++..+|...+..+.|+||++++.++...... ...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888889999998 8888888888999999987532 334567888999999999999999999988543221 224
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+|||++.. +|.+.+.. .++-+.+..|..|++.|++|||+. ||+||||||+||++..++.+||.||
T Consensus 95 e~y~v~e~m~~-nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM--------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence 67999999955 99998873 467778899999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+|+..... -..+.++.|..|+|||++.+..+.+.+||||.||++.||++|+..|.+. ..+.+|.+.
T Consensus 163 g~ar~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki 229 (369)
T KOG0665|consen 163 GLARTEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKI 229 (369)
T ss_pred hhhcccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHH
Confidence 999854322 2334578899999999999988999999999999999999999998753 223333322
Q ss_pred hc----Cc-hhhhhccchhhHHHHhhc----chhHHHhH--------HhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 941 AL----PE-KVIEIVDPLLLIEVMANN----SMIQEDIR--------AKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 941 ~~----~~-~~~~~~d~~l~~~~~~~~----~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
.- +. .+.+-..+.....+.... ..+....+ +...-......+++.+||-.||++|.++.+++.
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 10 10 011111111100000000 00000000 001112345678999999999999999999987
Q ss_pred H
Q 043932 1004 K 1004 (1017)
Q Consensus 1004 ~ 1004 (1017)
|
T Consensus 310 H 310 (369)
T KOG0665|consen 310 H 310 (369)
T ss_pred C
Confidence 6
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=239.09 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=191.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.+.|.+.+.+|+|.||.+-+++++++.+.+|+|.++... ...++|.+|...--.+ .|.||+.-|++-.. ..+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq----t~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ----TSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh----cCceE
Confidence 457899999999999999999999999999999987443 3457899998876666 59999998875432 23678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC--CCCCeEEeec
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--HDMVSHVGDF 860 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Df 860 (1017)
++++||++.|+|.+-+... .+.+....+++.|+++|+.|||++ .+||||||.+||||- +..++|+|||
T Consensus 98 vF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred EEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence 9999999999999988764 467778889999999999999999 999999999999983 3458999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCC-----CcCccccchhHHHHHHHHHhCCCCCCcccccCccHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-----EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 935 (1017)
|..+..+.-- ....-+..|.|||..... ...+.+|||.||+++|.++||++||+.....+..+.
T Consensus 168 G~t~k~g~tV-----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~ 236 (378)
T KOG1345|consen 168 GLTRKVGTTV-----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW 236 (378)
T ss_pred ccccccCcee-----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence 9987543211 112245679999987432 357789999999999999999999987665555554
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+|.+-..... +..+.......+...++.++-+..+|++|--..++.+.
T Consensus 237 ~~~~w~~rk~---------------------~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 237 EWEQWLKRKN---------------------PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred HHHHHhcccC---------------------ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 4433221110 01122233345667888888999999999554444433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=239.17 Aligned_cols=212 Identities=30% Similarity=0.518 Sum_probs=182.6
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEeccC
Q 043932 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKN 791 (1017)
Q Consensus 713 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 791 (1017)
||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.++|++++++++++... ...+++|||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence 68999999999999888999999999755432 346789999999999999999999998654 678999999999
Q ss_pred CCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-CCCeEEeeccccccccccc
Q 043932 792 GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVSHVGDFGLAKFLSSHQ 870 (1017)
Q Consensus 792 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~ 870 (1017)
++|.+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 76 ~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 76 GSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 99999997652 2678999999999999999999999 9999999999999999 8999999999997654322
Q ss_pred ccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh
Q 043932 871 LDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949 (1017)
Q Consensus 871 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1017)
. ......+...|++||..... .++.++|+|++|++++++
T Consensus 148 ~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------- 187 (215)
T cd00180 148 S--------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------- 187 (215)
T ss_pred c--------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence 1 11224578899999998877 788999999999999999
Q ss_pred ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 950 VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 950 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..+.+++.+|++.||++||++.++++++
T Consensus 188 ----------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2467889999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-28 Score=249.38 Aligned_cols=426 Identities=20% Similarity=0.240 Sum_probs=248.9
Q ss_pred cCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEec-CCC
Q 043932 131 ALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITG-NSL 209 (1017)
Q Consensus 131 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l 209 (1017)
+-++-.++ ++|..+.. .-+.++|..|+|+.+.|.+|+.+++|+.|||++|+|+.+-|++|.++.+|..|-+.+ |+|
T Consensus 52 dCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 52 DCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred EccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 33444455 56665433 456777778888866677788888888888888888877777787777776666555 777
Q ss_pred CCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCc
Q 043932 210 GGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDS 289 (1017)
Q Consensus 210 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 289 (1017)
+......|++|.+|+.|.+.-|++.-+..++|..+++|..|.+-.|.+. .++...|..+..++.+.+..|.+..
T Consensus 129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic----- 202 (498)
T KOG4237|consen 129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC----- 202 (498)
T ss_pred hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc-----
Confidence 7655667777777777777777777666666777777777777777665 5565556666666666666665321
Q ss_pred cccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHH
Q 043932 290 LSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIA 369 (1017)
Q Consensus 290 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 369 (1017)
.++++.+.. +....+..+++..-.....+.++++....+.. +...+..+..--.+.....+..|..-+
T Consensus 203 dCnL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~k-----f~c~~esl~s~~~~~d~~d~~cP~~cf 270 (498)
T KOG4237|consen 203 DCNLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARK-----FLCSLESLPSRLSSEDFPDSICPAKCF 270 (498)
T ss_pred ccccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhh-----hhhhHHhHHHhhccccCcCCcChHHHH
Confidence 122222111 11223334555555555666666665544432 222233332223333444456666656
Q ss_pred hhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccce
Q 043932 370 NLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAK 449 (1017)
Q Consensus 370 ~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 449 (1017)
...++|+.|+|++|+|+.+-+.+|.++..+++|.|..|+|..+....|.++..|+.|+|++|+|+...|.+|..+.+|..
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~ 350 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLST 350 (498)
T ss_pred hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeee
Confidence 66667777777777777777777888888888888888877777777777888888888888887777777777777888
Q ss_pred eeccCcccCCCC-----cccc-----------ccccCCceeecCCCcccC---CccchhhhcccccceeccCCCcCCCCc
Q 043932 450 LVMSYNSLQGNI-----PSSL-----------GNCQNLIGFNASHNKLTG---ALPQQLLSITTLSVYLDLSNNNLNGSL 510 (1017)
Q Consensus 450 L~Ls~N~i~~~~-----p~~~-----------~~l~~L~~L~ls~N~l~~---~~p~~~~~~~~~~~~L~Ls~N~l~~~~ 510 (1017)
|+|-.|.+--.. .+|+ ..-..++.++++.+.+.. .-|.+.....+ +.-
T Consensus 351 l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s-------------~~c 417 (498)
T KOG4237|consen 351 LNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTS-------------SPC 417 (498)
T ss_pred eehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCC-------------CCC
Confidence 877777664110 0000 111233444444443321 01111100000 000
Q ss_pred cccccccccceE-EEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhccc
Q 043932 511 PLQIGNLKNLVK-LIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENL 589 (1017)
Q Consensus 511 p~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 589 (1017)
| ..++-+.+ ..-|++.++ .+|..+- ..-.+|++.+|.++ .+|+. .+.+| .+|||+|+++..--..|.++
T Consensus 418 P---~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~ 487 (498)
T KOG4237|consen 418 P---PPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNM 487 (498)
T ss_pred C---CCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccch
Confidence 1 11222222 223333333 4443321 23456667777776 34544 45556 66777777765555556667
Q ss_pred CCCcEEEcccC
Q 043932 590 SFLEFLNFSHN 600 (1017)
Q Consensus 590 ~~L~~L~l~~N 600 (1017)
++|.+|-||+|
T Consensus 488 tql~tlilsyn 498 (498)
T KOG4237|consen 488 TQLSTLILSYN 498 (498)
T ss_pred hhhheeEEecC
Confidence 77777766665
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=236.79 Aligned_cols=200 Identities=32% Similarity=0.508 Sum_probs=172.2
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
|.+.+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence 56678899999999999999988899999999865544 567889999999999999999999987654 568999
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
+||+++++|.+++..... .+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred EeccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 999999999999986542 178899999999999999999999 999999999999999999999999999886
Q ss_pred cccccccccccCCCcccccccCccccCcccc-cCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYC-MGSEASMTGDVYSFGILLLELFTGRRPTDA 926 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~~ 926 (1017)
...... .......++..|++||.+ ....++.++|||++|+++|||++|+.||..
T Consensus 148 ~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDLA-------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCccc-------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 643220 011224578889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-28 Score=247.01 Aligned_cols=386 Identities=18% Similarity=0.186 Sum_probs=219.7
Q ss_pred EEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCC-CccCccccCchhhccCCccceeeecc
Q 043932 201 VFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLP-FNRFSGTLPFDIVVNLPNLKSLAIGG 279 (1017)
Q Consensus 201 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls-~N~l~~~l~~~~~~~l~~L~~L~L~~ 279 (1017)
+++|..|+|+...+.+|+.+++|+.|||++|+|+.+-|++|..+.+|..|-+- +|+|+ .+|...|.++..|+.|.+.-
T Consensus 71 eirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNa 149 (498)
T KOG4237|consen 71 EIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNA 149 (498)
T ss_pred EEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcCh
Confidence 34444444444444444444444444444444444444444444444333322 24444 44555555555555555555
Q ss_pred cccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCC------CCCCChhhHhhhcccCcccEE
Q 043932 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGM------GTANDLDFVTFLTNCSSLKIL 353 (1017)
Q Consensus 280 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~~~~l~~l~~L~~L 353 (1017)
|++.....++|..++++..|.+.+|.+..+....|..+..++++.+..|..-. .....-..+..++......-.
T Consensus 150 n~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~ 229 (498)
T KOG4237|consen 150 NHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPY 229 (498)
T ss_pred hhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchH
Confidence 55554444455555555555555555554444455555555555555444210 000000011112222333333
Q ss_pred eccCcccccccchhHHhhcccce-EEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccc
Q 043932 354 SLAANQFVGELPHSIANLSSSMI-EFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNV 432 (1017)
Q Consensus 354 ~Ls~N~l~~~~p~~~~~~~~~L~-~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 432 (1017)
.+.++++..+-+.-+......+. .+....+....-+...|+.|++|+.|+|++|+|+++.+.+|.++..+++|.|.+|+
T Consensus 230 rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~ 309 (498)
T KOG4237|consen 230 RLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNK 309 (498)
T ss_pred HHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcch
Confidence 44444444222222222211121 12222233333344679999999999999999999999999999999999999999
Q ss_pred cccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCcc-chhhhcccccceeccCCCcCCCCcc
Q 043932 433 LQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALP-QQLLSITTLSVYLDLSNNNLNGSLP 511 (1017)
Q Consensus 433 l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~~~~~~~~L~Ls~N~l~~~~p 511 (1017)
|..+-...|.++..|+.|+|.+|+|+...|.+|..+..|..|+|-.|.+--.-- .++.. .|..+.-.|..|
T Consensus 310 l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~--------Wlr~~~~~~~~~ 381 (498)
T KOG4237|consen 310 LEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE--------WLRKKSVVGNPR 381 (498)
T ss_pred HHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH--------HHhhCCCCCCCC
Confidence 997777789999999999999999999999999999999999999887752211 11111 122223222222
Q ss_pred ccccccccceEEEccCCcccc---ccccccc---------ccccceEE-eccCCccCCCCCccccccccCcEEeccCCcc
Q 043932 512 LQIGNLKNLVKLIISSNQFSG---VIPVTLS---------TCVSLEYL-DISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578 (1017)
Q Consensus 512 ~~~~~l~~L~~L~Ls~N~l~~---~~p~~~~---------~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 578 (1017)
- ++-..++.+.++.+.+.. ..|++.+ .++-+... .-|++.++ .+|.-+ ...-..|+|.+|.+
T Consensus 382 C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~i--P~d~telyl~gn~~ 456 (498)
T KOG4237|consen 382 C--QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGI--PVDVTELYLDGNAI 456 (498)
T ss_pred C--CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCC--CchhHHHhcccchh
Confidence 1 223345666666665532 1233322 23334333 44555555 455433 24566789999999
Q ss_pred cCCChhhhcccCCCcEEEcccCCCcC
Q 043932 579 SGQIPEFLENLSFLEFLNFSHNDLEG 604 (1017)
Q Consensus 579 ~~~~p~~~~~l~~L~~L~l~~N~l~~ 604 (1017)
+ .+|.. .+.+| .+|+|+|+++.
T Consensus 457 ~-~vp~~--~~~~l-~~dls~n~i~~ 478 (498)
T KOG4237|consen 457 T-SVPDE--LLRSL-LLDLSNNRISS 478 (498)
T ss_pred c-ccCHH--HHhhh-hcccccCceeh
Confidence 9 67776 66778 89999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=218.90 Aligned_cols=169 Identities=20% Similarity=0.216 Sum_probs=128.4
Q ss_pred CCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccc
Q 043932 792 GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQL 871 (1017)
Q Consensus 792 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 871 (1017)
|+|.++++... ..+++.+++.|+.||+.||+|||++ + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-
Confidence 68999998644 2689999999999999999999998 6 999999999999999 99987654211
Q ss_pred cccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhcc
Q 043932 872 DTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVD 951 (1017)
Q Consensus 872 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 951 (1017)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..................+...
T Consensus 64 ------------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 126 (176)
T smart00750 64 ------------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP----- 126 (176)
T ss_pred ------------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc-----
Confidence 258899999999999999999999999999999999999996543222222221111110000
Q ss_pred chhhHHHHhhcchhHHHhHHhHHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 952 PLLLIEVMANNSMIQEDIRAKTQECL--NAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 952 ~~l~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
.......... .++.+++.+|+..||.+||++.|+++++..+..
T Consensus 127 ----------------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 127 ----------------RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ----------------cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0000111122 368999999999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-24 Score=269.46 Aligned_cols=176 Identities=22% Similarity=0.323 Sum_probs=107.3
Q ss_pred CeEEEEEcCCCCCcc--ccCcccCCCCCCCEEEccCCC------CCCCCCccccccc-ccccccCCCCcccccCCCcccC
Q 043932 77 QRVTRLDLSNQRIGG--ILSPYVGNLSFLRYINLSDNS------FHGEIPQEIGNLL-RLEKLALPNNSFSGTIPTNLSR 147 (1017)
Q Consensus 77 ~~v~~l~l~~~~l~~--~~~~~l~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~ 147 (1017)
.+|..+.+.-..+.. .-+.+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..+ .
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~ 609 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-R 609 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-C
Confidence 455555554444332 223457788888888886653 2334666666654 4777777777776 667666 4
Q ss_pred CCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeE
Q 043932 148 CSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLH 227 (1017)
Q Consensus 148 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 227 (1017)
..+|++|+|++|++. .+|..+..+++|+.|+|++|.....+|. ++.+++|+.|+|++|.....+|..++.+++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 577777777777776 5666667777777777776654445553 56666666666666655555666666666666666
Q ss_pred eecCccccccchhhcccCcCcEEeCCCccC
Q 043932 228 VGGNQFSGTFPQSICNISSLERIYLPFNRF 257 (1017)
Q Consensus 228 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 257 (1017)
+++|..-+.+|..+ ++++|+.|++++|..
T Consensus 688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 688 MSRCENLEILPTGI-NLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCCCcCccCCcC-CCCCCCEEeCCCCCC
Confidence 66554333444433 455555555555543
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=272.85 Aligned_cols=209 Identities=17% Similarity=0.237 Sum_probs=140.9
Q ss_pred hcCC-CCceeeeeeeecCCCC--CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCC
Q 043932 758 NIRH-RNLIKIITICSSIDSK--GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQ 834 (1017)
Q Consensus 758 ~l~h-~niv~~~~~~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 834 (1017)
.++| +||++++++|...... ..+..+.++||+ +++|.+++.... ..+++.+++.++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 4455 5888888877333221 124567888987 559999997543 3689999999999999999999999
Q ss_pred CCceeecCCCCceEeCCCCC-------------------eEEeecccccccccccc---ccc-----ccCCCcccccccC
Q 043932 835 PPMVHGDLKPSNVLLDHDMV-------------------SHVGDFGLAKFLSSHQL---DTA-----SKTSSSSIGIKGT 887 (1017)
Q Consensus 835 ~~ivH~Dlkp~NIll~~~~~-------------------~kl~DfG~a~~~~~~~~---~~~-----~~~~~~~~~~~gt 887 (1017)
+|+||||||+|||++..+. +|++|||+++....... ... ...........||
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 9999999999999965444 45555555543211000 000 0000011124689
Q ss_pred ccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHH
Q 043932 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQE 967 (1017)
Q Consensus 888 ~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 967 (1017)
+.|||||++.+..++.++|||||||++|||++|.+|+..... ..........+ +
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~--------~--------------- 232 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLP--------P--------------- 232 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcC--------h---------------
Confidence 999999999998999999999999999999999888643210 01111000000 0
Q ss_pred HhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 968 DIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
...........++.+||+.||.+||++.|++++-
T Consensus 233 ----~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 233 ----QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred ----hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 0001123346778899999999999999998764
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=266.83 Aligned_cols=180 Identities=24% Similarity=0.287 Sum_probs=105.4
Q ss_pred cccccccccccccCCCCc------ccccCCCcccCCC-cceEeecccccccccCcccccccCCccEEEeccccccCCCCc
Q 043932 119 QEIGNLLRLEKLALPNNS------FSGTIPTNLSRCS-NLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPD 191 (1017)
Q Consensus 119 ~~~~~l~~L~~L~L~~n~------l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 191 (1017)
.+|.++.+|+.|.+..+. +...+|..+..++ +|+.|++.+|.+. .+|..| ...+|++|++.+|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 456667777777665442 2334555555553 4777777776665 556555 3566777777777666 4556
Q ss_pred cccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCc
Q 043932 192 FVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPN 271 (1017)
Q Consensus 192 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 271 (1017)
.+..+++|+.|+|++|...+.+|. ++.+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|... ++++
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~s 705 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLKS 705 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCCC
Confidence 666667777777766554444543 5666667777776665555666666666666666666654434555433 4566
Q ss_pred cceeeecccccCCCCCCccccCCccceeecccCccc
Q 043932 272 LKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFK 307 (1017)
Q Consensus 272 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 307 (1017)
|+.|++++|...+.+|.. ..+|+.|++++|.+.
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE 738 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence 666666665444344332 234455555555443
|
syringae 6; Provisional |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=208.66 Aligned_cols=267 Identities=19% Similarity=0.273 Sum_probs=201.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
-.|+++++||+|+||.++.|+..-++++||||.-...++ ..++..|++..+.+ ..+.|..++.|-.++ .+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG-----~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEG-----KYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeecccc-----chhh
Confidence 379999999999999999999999999999998654433 36778899999888 578888887664333 5567
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-----CCeEEe
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-----MVSHVG 858 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~ 858 (1017)
+|+|.+ |.+|+|.+.-.++ +++..++..||.|++.-++|+|++ .+|.|||||+|+||... ..+.++
T Consensus 101 LVidLL-GPSLEDLFD~CgR-----~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGR-----RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcC-----cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence 999988 7799999876653 899999999999999999999999 99999999999999654 468999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||+|+.+.+.+.....+ ........||.+||+-....|.+.+.+.|+-|+|-++++.+-|..||.+-.. +.....+.
T Consensus 172 DFGmAK~YrDp~TkqHIP-YrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA-~tnK~kYe 249 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIP-YREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-DTNKEKYE 249 (449)
T ss_pred eccchhhhcCccccccCc-cccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC-cchHHHHH
Confidence 999999887665444332 3344557899999999999999999999999999999999999999987422 22222222
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
++.-.... ..+.......+.++..-+.-.-..+-.+-|..+-+...+.++.
T Consensus 250 KIGe~Kr~--------------------T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 250 KIGETKRS--------------------TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred Hhcccccc--------------------CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 22111100 0011122234555666666666677778887766555554444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=199.91 Aligned_cols=268 Identities=23% Similarity=0.273 Sum_probs=196.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCC-CCceeeeeeeecCCCCCCce
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRH-RNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~ 781 (1017)
..+.|.++++||+|+||.+|.|....+|..||||+-..... ..++..|..+.+.+++ ..|..+..|..+. .+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~-----~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEK-----DY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcccc-----cc
Confidence 35689999999999999999999999999999999754332 3567789999998864 4555555554333 66
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC---CCeEEe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVSHVG 858 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~ 858 (1017)
-.+|||.. |.+|++.+.-.. +.++..+++-+|-|++.-++|+|.+ ++|||||||+|+++.-+ ..+.++
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred ceeeeecc-CccHHHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEE
Confidence 78999998 779999987654 3789999999999999999999999 99999999999999643 578999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||+|+.+.+.......+ ........||.+|.+-....+.+.+.+.|+-|+|.++.+.-.|..||++...... ...+
T Consensus 157 DFGLaKky~d~~t~~HIp-yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-~QKy- 233 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIP-YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-KQKY- 233 (341)
T ss_pred eccchhhhccccccccCc-cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-HHHH-
Confidence 999999886544333322 2333456899999999998888899999999999999999999999987532211 1111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
+++.+..-. ..+...-...|.++.-.+.-|-..--++-|...-+-+.++.+
T Consensus 234 -----EkI~EkK~s--------------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 234 -----EKISEKKMS--------------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred -----HHHHHhhcC--------------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 111110000 001111223356666777777777777777766555444433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=227.13 Aligned_cols=173 Identities=18% Similarity=0.146 Sum_probs=132.3
Q ss_pred HhhccccccCcccccCCceEEEEEeCC-CcEEEEEEEeeec-----CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGE-DEMIVAVKVINLK-----QKGAFKSFMAECKALRNIRHRNLIKIITICSSID 775 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 775 (1017)
...++|.+.++||+|+||+||+|++.. +++.||||++... .....+.+.+|++++++++|+|+++.+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 345689999999999999999999875 6788899987532 122346689999999999999998533221
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecC-CCCceEeCCCCC
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDL-KPSNVLLDHDMV 854 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~ 854 (1017)
+..|+||||++|++|... ... . ...++.|+++||+|||++ ||+|||| ||+||+++.++.
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~~---------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RPH---------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Ccc---------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCC
Confidence 236899999999999632 110 1 135788999999999999 9999999 999999999999
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccC
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG 898 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 898 (1017)
+||+|||+|+.+...................+++.|+|||.+..
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999999997754332211111122235678999999999854
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=243.18 Aligned_cols=263 Identities=29% Similarity=0.367 Sum_probs=142.0
Q ss_pred CcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEe
Q 043932 245 SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLN 324 (1017)
Q Consensus 245 ~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 324 (1017)
..-..|+|+.|.++ .+|..+. ++|+.|++++|+++ .+|.. +++|++|+|++|+|+.+.+ ..++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~LtsLP~----lp~s----- 263 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTSLPV----LPPG----- 263 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCcccC----cccc-----
Confidence 34556777777776 6676543 35677777777776 34432 3556666666666653321 1233
Q ss_pred cccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEec
Q 043932 325 LEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGM 404 (1017)
Q Consensus 325 L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L 404 (1017)
|+.|++++|.++ .+|. .+..|+.|++++|+++.+ |. ..++|+.|+|
T Consensus 264 -------------------------L~~L~Ls~N~L~-~Lp~----lp~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdL 309 (788)
T PRK15387 264 -------------------------LLELSIFSNPLT-HLPA----LPSGLCKLWIFGNQLTSL-PV---LPPGLQELSV 309 (788)
T ss_pred -------------------------cceeeccCCchh-hhhh----chhhcCEEECcCCccccc-cc---cccccceeEC
Confidence 444444444443 2222 112344445555554432 21 1245666666
Q ss_pred cccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCC
Q 043932 405 QSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGA 484 (1017)
Q Consensus 405 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~ 484 (1017)
++|+|++. |.. ..+|+.|++++|+++ .+|.. ..+|++|+|++|+|+ .+|.. ..+|+.|++++|+|+
T Consensus 310 S~N~L~~L-p~l---p~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~-- 375 (788)
T PRK15387 310 SDNQLASL-PAL---PSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-- 375 (788)
T ss_pred CCCccccC-CCC---cccccccccccCccc-ccccc---ccccceEecCCCccC-CCCCC---Ccccceehhhccccc--
Confidence 66666532 321 134555566666665 23421 134556666666665 23332 123444455555544
Q ss_pred ccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccc
Q 043932 485 LPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGF 564 (1017)
Q Consensus 485 ~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 564 (1017)
.+|.. ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|..
T Consensus 376 ------------------------~LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l--- 420 (788)
T PRK15387 376 ------------------------SLPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML--- 420 (788)
T ss_pred ------------------------cCccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---
Confidence 23332 2356677777777763 4432 2456777777777774 4543
Q ss_pred cccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCC
Q 043932 565 LKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT 608 (1017)
Q Consensus 565 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 608 (1017)
..+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|.
T Consensus 421 ~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 421 PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 245666777777776 5677777777777777777777766554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=222.74 Aligned_cols=269 Identities=21% Similarity=0.244 Sum_probs=197.6
Q ss_pred cccccCcccccCCceEEEEEeCCCc-EEEEEEEeeecCcchHHHHHHHHHHHHhcCC----CCceeeeeeeecCCCCCCc
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDE-MIVAVKVINLKQKGAFKSFMAECKALRNIRH----RNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 780 (1017)
+|.+.++||+|+||.||.|.+..++ ..+|+|+...........+..|..++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 8999999999999999999998664 6789998875543332367788898888863 58888887753 1236
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-----CCe
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-----MVS 855 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~ 855 (1017)
+.++||+.+ |.+|.++..... ...++..++..|+.|++.+|+++|+. |++||||||+|+.+... ..+
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence 789999988 779999886654 24899999999999999999999999 99999999999999765 468
Q ss_pred EEeecccccccc--cccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 856 HVGDFGLAKFLS--SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 856 kl~DfG~a~~~~--~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
.+.|||+|+.+. ................+.||..|+++++..+.+.+++.|+||++.++.|+..|..||........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~- 245 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL- 245 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-
Confidence 999999998332 22211111111213456799999999999999999999999999999999999999965432211
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
...+......... .. .....+.++.++...+-..+..++|....+.+.+++...
T Consensus 246 ~~~~~~~~~~~~~----~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 246 KSKFEKDPRKLLT----DR-------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHHHHHHhhhhcc----cc-------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 1111111000000 00 011124556666666667899999999999888776554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=243.19 Aligned_cols=268 Identities=28% Similarity=0.343 Sum_probs=188.1
Q ss_pred cCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceee
Q 043932 221 RNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILD 300 (1017)
Q Consensus 221 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 300 (1017)
.+-..|+|++|.++ .+|..+. ++|+.|++++|+++ .+|. ..++|++|+|++|+|+ .+|.. .++|+.|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccC-cccCc---ccccceee
Confidence 34678999999999 6888775 48999999999998 6774 3589999999999999 45643 46899999
Q ss_pred cccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEe
Q 043932 301 LGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRI 380 (1017)
Q Consensus 301 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l 380 (1017)
+++|+++.+.. . ..+|+.|++++|+++..+. ..++|+.|+|++|++++ +|.
T Consensus 269 Ls~N~L~~Lp~-l---p~~L~~L~Ls~N~Lt~LP~----------~p~~L~~LdLS~N~L~~-Lp~-------------- 319 (788)
T PRK15387 269 IFSNPLTHLPA-L---PSGLCKLWIFGNQLTSLPV----------LPPGLQELSVSDNQLAS-LPA-------------- 319 (788)
T ss_pred ccCCchhhhhh-c---hhhcCEEECcCCccccccc----------cccccceeECCCCcccc-CCC--------------
Confidence 99999985433 2 2467777777777764321 12456666666666652 221
Q ss_pred cCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCC
Q 043932 381 GGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGN 460 (1017)
Q Consensus 381 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~ 460 (1017)
. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .
T Consensus 320 -----------l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~ 376 (788)
T PRK15387 320 -----------L---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-S 376 (788)
T ss_pred -----------C---cccccccccccCcccc-cccc---ccccceEecCCCccC-CCCCCC---cccceehhhccccc-c
Confidence 1 1235566666666663 3321 246777777777777 355432 46777888888888 3
Q ss_pred CccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccc
Q 043932 461 IPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLST 540 (1017)
Q Consensus 461 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 540 (1017)
+|.. ..+|+.|++++|+|+ .+|.. .++|+.|++++|+|++ +|..
T Consensus 377 LP~l---~~~L~~LdLs~N~Lt--------------------------~LP~l---~s~L~~LdLS~N~Lss-IP~l--- 420 (788)
T PRK15387 377 LPAL---PSGLKELIVSGNRLT--------------------------SLPVL---PSELKELMVSGNRLTS-LPML--- 420 (788)
T ss_pred Cccc---ccccceEEecCCccc--------------------------CCCCc---ccCCCEEEccCCcCCC-CCcc---
Confidence 5643 245677777777766 12321 2467888888888884 5643
Q ss_pred cccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhccc
Q 043932 541 CVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENL 589 (1017)
Q Consensus 541 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 589 (1017)
..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+
T Consensus 421 ~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 421 PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 346788899999998 578888899999999999999998888877544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=238.71 Aligned_cols=335 Identities=18% Similarity=0.274 Sum_probs=186.8
Q ss_pred CCCCHHHHHHHHHHHHhcCCCCCCCCC----CCCCCCCCceee----------------EEECCCCCeEEEEEcCCCCCc
Q 043932 31 GQTNETDRLALLAIKSQLHDTSGVTSS----WNNTINLCQWTG----------------VTCGHRHQRVTRLDLSNQRIG 90 (1017)
Q Consensus 31 ~~~~~~~~~aLl~~k~~~~~~~~~~~s----w~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~l~ 90 (1017)
+.+.++|.+.++.+.+.+.-|. ...+ |++.++.|.=.. |.|. .+.||.+..-+....
T Consensus 58 ~~~~~~~~~~~~~~~~~l~~p~-~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~~~ 134 (754)
T PRK15370 58 ETASPEEIKSKFECLRMLAFPA-YADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESEQA 134 (754)
T ss_pred CCCCHHHHHHHHHHHHHhcCCc-hhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCccccccccccccc
Confidence 3467899999999999997653 4455 999989995433 7774 345676666653222
Q ss_pred cccCcccCCCCCCCEEE----ccCCCCCCCCC---ccc-----ccccccccccCCCCcccccCCCcccCCCcceEeeccc
Q 043932 91 GILSPYVGNLSFLRYIN----LSDNSFHGEIP---QEI-----GNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158 (1017)
Q Consensus 91 ~~~~~~l~~l~~L~~L~----L~~n~l~~~~p---~~~-----~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 158 (1017)
......-.. -.+.. -..+.-.++-+ ..+ +-..+...|+|+++.++ .+|..+. ++|+.|+|++
T Consensus 135 ~~~~~~~~~---~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~ 208 (754)
T PRK15370 135 SSASGSKDA---VNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDN 208 (754)
T ss_pred ccCCCCCCh---hhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecC
Confidence 111100000 00000 00010000000 001 01134566666666666 4565543 3567777777
Q ss_pred ccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccc
Q 043932 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFP 238 (1017)
Q Consensus 159 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p 238 (1017)
|+++ .+|..+. .+|++|++++|+++ .+|..+. .+|+.|+|++|.+. .+|..+. .+|+.|++++|+|+ .+|
T Consensus 209 N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP 278 (754)
T PRK15370 209 NELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLP 278 (754)
T ss_pred CCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccc
Confidence 7776 4555443 36777777777766 3454443 35777777777776 4555443 46777777777777 456
Q ss_pred hhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccC
Q 043932 239 QSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLK 318 (1017)
Q Consensus 239 ~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 318 (1017)
..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.++++ |..+. +
T Consensus 279 ~~l~--~sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~l~--~ 346 (754)
T PRK15370 279 ENLP--EELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSL-PASLP--P 346 (754)
T ss_pred cccC--CCCcEEECCCCccc-cCcccch---hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccccC-Chhhc--C
Confidence 5543 46777777777776 4554332 467777888887773 454432 5788888888887753 33332 4
Q ss_pred ccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCcccccccc
Q 043932 319 NLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVN 398 (1017)
Q Consensus 319 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~ 398 (1017)
+|+.|++++|++...+.. + .++|+.|+|++|+++ .+|..+. .+
T Consensus 347 sL~~L~Ls~N~L~~LP~~-------l--p~~L~~LdLs~N~Lt-~LP~~l~---------------------------~s 389 (754)
T PRK15370 347 ELQVLDVSKNQITVLPET-------L--PPTITTLDVSRNALT-NLPENLP---------------------------AA 389 (754)
T ss_pred cccEEECCCCCCCcCChh-------h--cCCcCEEECCCCcCC-CCCHhHH---------------------------HH
Confidence 666666666665432210 1 134555555555555 3333221 14
Q ss_pred ccEEeccccCCCCCcch----hhcccccccceeccccccc
Q 043932 399 LIALGMQSNQLHGTIPD----VIGELKNLQGLFLYKNVLQ 434 (1017)
Q Consensus 399 L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~ 434 (1017)
|+.|++++|+|. .+|. .++.++++..|+|.+|.++
T Consensus 390 L~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 390 LQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 555666666665 2332 2333466667777777665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-23 Score=239.16 Aligned_cols=257 Identities=22% Similarity=0.258 Sum_probs=191.2
Q ss_pred cccCcccccCCceEEEEEeCCCcEEEEEEEeee----cC-c-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 708 ASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL----KQ-K-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 708 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~-~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
...+++|.|.+|.|+.+........++.|.+.. .. . .....+..|+.+-..+.|+|++..+..+...+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----- 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----- 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence 346789999999888888876666566665431 11 1 111225677878888899999888877655522
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
..-+||||++ +|..++.... .+...++..+++|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred chhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence 2334999999 9999998653 678889999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCc-cccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASM-TGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
.+..+.-.... ......+++|+..|+|||++.+.+|.+ ..||||.|++++.|.+|+.||......+..... .
T Consensus 466 ~~~vf~~~~e~----~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~ 538 (601)
T KOG0590|consen 466 AASVFRYPWEK----NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---N 538 (601)
T ss_pred cceeeccCcch----hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---h
Confidence 99766422211 123345678999999999999998875 589999999999999999999876554433200 0
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
....+ ..............+.+-..++.+|++.||.+|.|+++|++
T Consensus 539 ~~~~~-----------------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 539 NYSDQ-----------------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccc-----------------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000 00111112233455677889999999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-23 Score=199.96 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=186.3
Q ss_pred cccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 708 ASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 708 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
....+|.+...|+.|+|++.++ .+++|++...+-. ..+.|.+|.-.++-+.||||+.+++.|..+ ....++
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~i 265 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVII 265 (448)
T ss_pred hhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEe
Confidence 3455789999999999999744 4777887654432 236788999999999999999999999766 668899
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe--ecccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG--DFGLA 863 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DfG~a 863 (1017)
..|++.|+|+..++.... ...+-.++.+++.+||+|++|||+.. +-|-.--+.+..|+||++.+++|. |--++
T Consensus 266 sq~mp~gslynvlhe~t~----vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTS----VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred eeeccchHHHHHHhcCcc----EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceee
Confidence 999999999999987653 46788899999999999999999983 334445689999999999988873 33222
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCc---CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA---SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
.. ..+..-.+.||+||.++.++. -.++|+|||++++||+.|...||..-..-+........
T Consensus 341 fq---------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale- 404 (448)
T KOG0195|consen 341 FQ---------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE- 404 (448)
T ss_pred ee---------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc-
Confidence 11 011234788999999987653 46799999999999999999999764322111110000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
.+ ....+......+.+++.-|+..||.+||.+..|+-.|++..
T Consensus 405 ----gl----------------------rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 ----GL----------------------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----cc----------------------cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 00 01122234667889999999999999999999998887753
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-22 Score=226.50 Aligned_cols=256 Identities=22% Similarity=0.224 Sum_probs=182.4
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc----chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK----GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
+|...+.+|++.|=+|.+|++. .|. |+||++-..++ ..+++..+|++ ...++|||++++..+.... ..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~-----kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD-----KA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh-----HH
Confidence 6777889999999999999997 454 89999865543 22344455555 5566999999988764433 55
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+|-+|..+ +|+|.+..++ .+...+.+.|+.|++.|+..+|.. ||+|||||.+||||+.-+-+.|+||.
T Consensus 96 AylvRqyvkh-nLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred HHHHHHHHhh-hhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence 6888899866 9999998664 678888999999999999999999 99999999999999999999999998
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCC----------C-cCccccchhHHHHHHHHHh-CCCCCCcccc
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS----------E-ASMTGDVYSFGILLLELFT-GRRPTDAAFT 929 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~il~ellt-g~~pf~~~~~ 929 (1017)
.-+...-.+.++.. ..........-..|.|||.+... . .+++.||||+||++.|+++ |++||.-.
T Consensus 166 sFKPtYLPeDNPad-f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-- 242 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPAD-FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-- 242 (1431)
T ss_pred ccCCccCCCCCccc-ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--
Confidence 65533222211111 11111122334579999987431 1 5778999999999999999 78888642
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
++-.+.... -.++....+. . ....+..++..|++.||++|.+|++.++.-+++
T Consensus 243 ---QL~aYr~~~-------~~~~e~~Le~--------------I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 243 ---QLLAYRSGN-------ADDPEQLLEK--------------I--EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ---HHHhHhccC-------ccCHHHHHHh--------------C--cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111111110 0011000000 0 022578899999999999999999999885543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.1e-21 Score=225.94 Aligned_cols=213 Identities=21% Similarity=0.394 Sum_probs=133.8
Q ss_pred CceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCc
Q 043932 65 CQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTN 144 (1017)
Q Consensus 65 c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 144 (1017)
+.|+-..|.. ..++.|++++++++.. |..+. ++|+.|+|++|+|+ .+|..+. .+|++|+|++|+|+ .+|..
T Consensus 168 a~~r~~~Cl~--~~~~~L~L~~~~LtsL-P~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~ 238 (754)
T PRK15370 168 AVQRMRDCLK--NNKTELRLKILGLTTI-PACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPAT 238 (754)
T ss_pred HHHHHHhhcc--cCceEEEeCCCCcCcC-Ccccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChh
Confidence 3455556743 3568899999988864 44443 47889999999988 6777664 58889999988888 67765
Q ss_pred ccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcc
Q 043932 145 LSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLV 224 (1017)
Q Consensus 145 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 224 (1017)
+. .+|+.|+|++|++. .+|..+. .+|+.|++++|+++ .+|..+. ++|+.|++++|++++ +|..+. ++|+
T Consensus 239 l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~ 307 (754)
T PRK15370 239 LP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGIT 307 (754)
T ss_pred hh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHH
Confidence 54 47888888888887 6676664 47888888888887 4565553 467777777777763 343332 3566
Q ss_pred eeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccC
Q 043932 225 DLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFN 304 (1017)
Q Consensus 225 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N 304 (1017)
.|++++|+++. +|..+. ++|+.|++++|.++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+|++|
T Consensus 308 ~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N 377 (754)
T PRK15370 308 HLNVQSNSLTA-LPETLP--PGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRN 377 (754)
T ss_pred HHHhcCCcccc-CCcccc--ccceeccccCCccc-cCChhhc---CcccEEECCCCCCC-cCChhhc--CCcCEEECCCC
Confidence 66666666662 343332 45666666666655 3443321 35555555555554 3343321 34444444444
Q ss_pred ccc
Q 043932 305 QFK 307 (1017)
Q Consensus 305 ~l~ 307 (1017)
+++
T Consensus 378 ~Lt 380 (754)
T PRK15370 378 ALT 380 (754)
T ss_pred cCC
Confidence 444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-19 Score=203.12 Aligned_cols=264 Identities=29% Similarity=0.408 Sum_probs=194.5
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc---hHHHHHHHHHHHHhcCCC-CceeeeeeeecCCCCCCcee
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFKSFMAECKALRNIRHR-NLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 782 (1017)
|.+.+.||.|+||.||++.+. ..+|+|.+...... ....+.+|+..++.+.|+ +++++.+++... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence 677889999999999999997 67899998754332 367889999999999888 799999988433 347
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-CeEEeecc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VSHVGDFG 861 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG 861 (1017)
+++++++.++++.+++...... ..++......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence 9999999999999777655321 3688899999999999999999999 999999999999999988 79999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC---CCcCccccchhHHHHHHHHHhCCCCCCccccc--CccHHH
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG---SEASMTGDVYSFGILLLELFTGRRPTDAAFTE--GLTLHE 936 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~--~~~~~~ 936 (1017)
.+............. .......||..|+|||.+.+ ..+....|+||+|++++++++|..||...... ......
T Consensus 148 ~~~~~~~~~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~ 225 (384)
T COG0515 148 LAKLLPDPGSTSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225 (384)
T ss_pred cceecCCCCcccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence 998554322111000 12334679999999999987 57889999999999999999999997654321 011111
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
................ ... ......+.+++..|+..+|..|.++.+....
T Consensus 226 ~~~~~~~~~~~~~~~~---------------~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 226 IILELPTPSLASPLSP---------------SNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHhcCCcccccccCc---------------ccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111110000000000 000 1223567888889999999999999887664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-21 Score=198.99 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=156.1
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcC----------CCCceeeeeee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIR----------HRNLIKIITIC 771 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~----------h~niv~~~~~~ 771 (1017)
..+...+.||.|+++.||.+++.++++.+|+|++..... ..++++.+|.-....+. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 356677899999999999999999999999999875543 34567777765555432 21222222222
Q ss_pred ecCCC-------CCCc-----eeEEEEEeccCCCHHHHHhh---CCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 043932 772 SSIDS-------KGAD-----FKALVFECMKNGSLEDWLHQ---SNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP 836 (1017)
Q Consensus 772 ~~~~~-------~~~~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 836 (1017)
..... .+.. ..+++|+-+. +||.+++.. ... ....+....+..+..|+++.+++||+. |
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~--~~~~l~~~arl~lT~Q~I~lvA~Lh~~---G 165 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQ--THSPLAFAARLSLTVQMIRLVANLHSY---G 165 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTT--TSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhccc--ccchhHHHHHHHHHHHHHHHHHHHhhc---c
Confidence 11100 0011 2367888774 489888653 211 122455667778889999999999999 9
Q ss_pred ceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccC--------CCcCccccch
Q 043932 837 MVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--------SEASMTGDVY 908 (1017)
Q Consensus 837 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvw 908 (1017)
+||+||+|+|++++.+|.++|+||+.....+..... ...+..|.|||.... ..++.+.|.|
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW 234 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAW 234 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----------cCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence 999999999999999999999999987655432110 124577999997633 2478899999
Q ss_pred hHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhcc
Q 043932 909 SFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCS 988 (1017)
Q Consensus 909 slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 988 (1017)
++|+++|.|++|..||+.......... +...+. +.++.+..+|..+|
T Consensus 235 ~LG~~ly~lWC~~lPf~~~~~~~~~~~--------------------------------~f~~C~-~~Pe~v~~LI~~lL 281 (288)
T PF14531_consen 235 QLGITLYSLWCGRLPFGLSSPEADPEW--------------------------------DFSRCR-DMPEPVQFLIRGLL 281 (288)
T ss_dssp HHHHHHHHHHHSS-STCCCGGGSTSGG--------------------------------GGTTSS----HHHHHHHHHHT
T ss_pred HHHHHHHHHHHccCCCCCCCccccccc--------------------------------cchhcC-CcCHHHHHHHHHHc
Confidence 999999999999999986533211100 112222 56888999999999
Q ss_pred CCCCCCC
Q 043932 989 MESPFER 995 (1017)
Q Consensus 989 ~~dP~~R 995 (1017)
+.||.+|
T Consensus 282 ~~~~~~R 288 (288)
T PF14531_consen 282 QRNPEDR 288 (288)
T ss_dssp -SSGGGS
T ss_pred cCCcccC
Confidence 9999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=194.14 Aligned_cols=204 Identities=21% Similarity=0.257 Sum_probs=145.5
Q ss_pred CCCCceeeeeeeecCCC----------------------CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHH
Q 043932 760 RHRNLIKIITICSSIDS----------------------KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVN 817 (1017)
Q Consensus 760 ~h~niv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 817 (1017)
+|||||++.++|.+.-. ......|+||..++. +|.+|+..+ ..+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-------~~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-------HRSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-------CCchHHHHH
Confidence 59999999987643211 112457899999966 999999865 346667778
Q ss_pred HHHHHHHHHHHHhhCCCCCceeecCCCCceEe--CCCC--CeEEeecccccccccccccccccCCCcccccccCccccCc
Q 043932 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL--DHDM--VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAP 893 (1017)
Q Consensus 818 i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 893 (1017)
++.|+++|+.|||.+ ||.|||+|++||++ ++|+ ...++|||++--.+.....-. .........|...-|||
T Consensus 346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlp--y~S~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLP--YESDEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccc--cccccccCCCcceecch
Confidence 999999999999999 99999999999998 4554 467899998754333222211 12222334578889999
Q ss_pred ccccCCC------cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHH
Q 043932 894 EYCMGSE------ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQE 967 (1017)
Q Consensus 894 E~~~~~~------~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 967 (1017)
|+....+ ...++|.|+.|.+.||+++...||.....-......+.+ .
T Consensus 421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe---------------------------~ 473 (598)
T KOG4158|consen 421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE---------------------------S 473 (598)
T ss_pred hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh---------------------------h
Confidence 9885532 346899999999999999999999763221111111221 1
Q ss_pred HhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 968 DIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 968 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
.++.....+++.+.+++...++.||++|+++.-...
T Consensus 474 qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 474 QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred hCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 223344556778899999999999999998754433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=189.48 Aligned_cols=176 Identities=16% Similarity=0.156 Sum_probs=133.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHH---H------HHHHHHHHHhcCCCCceeeeeeeec
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK---S------FMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
..++|+..+++|+|+||.||++.. ++..+|+|++........+ . +.+|++.+.++.|++|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357899999999999999999766 3557999999754333222 2 6789999999999999999988654
Q ss_pred CCCC---CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 774 IDSK---GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 774 ~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
.... .....++||||++|.+|.++.. ++. ....+++.+++.+|+. |++|||+||+||+++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 3221 1245789999999999988732 222 2456999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHH
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELF 918 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 918 (1017)
.+| ++++|||.......... ...+.....+..++|||+||+++....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a--------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKA--------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhh--------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 988 99999998765422110 011334445678999999999877553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.1e-20 Score=185.09 Aligned_cols=139 Identities=17% Similarity=0.121 Sum_probs=108.1
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--h-------H-----------------HHHHHHHHHHHhcCCCC
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--A-------F-----------------KSFMAECKALRNIRHRN 763 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n 763 (1017)
.+.||+|+||.||+|.+. +|+.||||+++..... . . ....+|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999754211 0 0 12235999999998877
Q ss_pred ceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHH-hhCCCCCceeecC
Q 043932 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDL 842 (1017)
Q Consensus 764 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dl 842 (1017)
+.....+.. ...++||||++++++....... ..++..++..++.|++.+|+|+ |+. ||+||||
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 644332211 1237999999988776543322 2678899999999999999999 688 9999999
Q ss_pred CCCceEeCCCCCeEEeeccccccc
Q 043932 843 KPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 843 kp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+||+++ ++.++|+|||+|...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=176.13 Aligned_cols=193 Identities=16% Similarity=0.050 Sum_probs=139.7
Q ss_pred cccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc----chHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCcee
Q 043932 708 ASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK----GAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 708 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.+...|++|+||+||.+.. .+.+++.+.+..... .....+.+|+++++++. |+++.+++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 3567899999999998776 567787776653322 11235789999999995 5889999886 235
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecC-CCCceEeCCCCCeEEeecc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDL-KPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfG 861 (1017)
+++|||++|.+|.+.... ....++.|++.+++++|++ ||+|||| ||+||+++.++.++|+|||
T Consensus 74 ~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred EEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence 899999999998754321 1134778999999999999 9999999 7999999999999999999
Q ss_pred ccccccccccc----c-cccCCCcccccccCccccCcccccCC-CcC-ccccchhHHHHHHHHHhCCCCCCcc
Q 043932 862 LAKFLSSHQLD----T-ASKTSSSSIGIKGTVGYVAPEYCMGS-EAS-MTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 862 ~a~~~~~~~~~----~-~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
+|......... . ..-..-.......++.|++|+..... ..+ .+.+.++-|+-+|.++|+..|+..+
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 99855432210 0 00000000112367888888854332 233 5678999999999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.7e-19 Score=178.63 Aligned_cols=139 Identities=22% Similarity=0.212 Sum_probs=110.1
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcch--------------------------HHHHHHHHHHHHhcCCCC
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--------------------------FKSFMAECKALRNIRHRN 763 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 763 (1017)
.+.||+|+||.||+|++. +|+.||||+++...... ...+..|++.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 89999999997542110 112357899999999988
Q ss_pred ceeeeeeeecCCCCCCceeEEEEEeccCCCHHHH-HhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeec
Q 043932 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDW-LHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGD 841 (1017)
Q Consensus 764 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~D 841 (1017)
+.....+... ..++||||++++++... +.. ..++..+...++.|++.++.++|+ . ||+|||
T Consensus 81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD 143 (190)
T cd05145 81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD 143 (190)
T ss_pred CCCceEEEec-------CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 7544443221 23799999998865433 332 256788899999999999999999 8 999999
Q ss_pred CCCCceEeCCCCCeEEeecccccccc
Q 043932 842 LKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 842 lkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
|||+||+++ ++.++|+|||+|....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999998 8999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-20 Score=207.40 Aligned_cols=261 Identities=23% Similarity=0.281 Sum_probs=129.7
Q ss_pred EEEcCCCCCc-cccCcccCCCCCCCEEEccCCCCCCC----CCcccccccccccccCCCCcccc------cCCCcccCCC
Q 043932 81 RLDLSNQRIG-GILSPYVGNLSFLRYINLSDNSFHGE----IPQEIGNLLRLEKLALPNNSFSG------TIPTNLSRCS 149 (1017)
Q Consensus 81 ~l~l~~~~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~------~~p~~l~~l~ 149 (1017)
.|+|.++.++ ......+..+..|++|+++++.+++. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566666665 23334455556666666666666432 34444455556666666655541 1223344455
Q ss_pred cceEeecccccccccCcccccccCC---ccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccc-cCcce
Q 043932 150 NLIQLRVSNNKLEGQIPAEIGSLLK---LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLL-RNLVD 225 (1017)
Q Consensus 150 ~L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l-~~L~~ 225 (1017)
+|++|+|++|.+.+..+..+..+.+ |++|++++|++++... ..+...+..+ ++|+.
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceE
Confidence 5555555555554444444433333 4555554444442100 1112223333 45555
Q ss_pred eEeecCcccc----ccchhhcccCcCcEEeCCCccCccccCchh---hccCCccceeeecccccCCC----CCCccccCC
Q 043932 226 LHVGGNQFSG----TFPQSICNISSLERIYLPFNRFSGTLPFDI---VVNLPNLKSLAIGGNNFFGS----IPDSLSNAS 294 (1017)
Q Consensus 226 L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~---~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~ 294 (1017)
|++++|.+++ .++..+..+++|++|+|++|.+++.....+ +..+++|++|++++|.+++. ++..+..++
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 5555555542 122334444555555555555543111111 12234566666666655432 223344556
Q ss_pred ccceeecccCcccceeecccc-----ccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccc
Q 043932 295 NVEILDLGFNQFKGKVSIDFS-----SLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGE 363 (1017)
Q Consensus 295 ~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 363 (1017)
+|++|++++|++++.....+. ..+.|++|++++|.++..+. ..+...+..+++|+++++++|.+...
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~--~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGA--KDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHH--HHHHHHHhcCCCccEEECCCCCCcHH
Confidence 677777777766643333222 13567777777776653322 23334455566777777777777644
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.1e-21 Score=173.55 Aligned_cols=166 Identities=28% Similarity=0.484 Sum_probs=103.0
Q ss_pred cccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCC
Q 043932 392 GIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNL 471 (1017)
Q Consensus 392 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 471 (1017)
.+-++.+.+.|.|++|+++ ..|+.+..+.+|+.|++++|+++ ..|..++.+++|+.|+++-|++. +.|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 3445566666777777776 55556666777777777777776 56666666666777766666666 666666666666
Q ss_pred ceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccC
Q 043932 472 IGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISS 551 (1017)
Q Consensus 472 ~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 551 (1017)
+.|||.+|++.. ..+|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+..
T Consensus 105 evldltynnl~e------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrd 159 (264)
T KOG0617|consen 105 EVLDLTYNNLNE------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRD 159 (264)
T ss_pred hhhhcccccccc------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeecc
Confidence 666666666651 134555555666666666666666 5566666666666666666
Q ss_pred CccCCCCCccccccccCcEEeccCCcccCCChhhhc
Q 043932 552 NSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLE 587 (1017)
Q Consensus 552 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 587 (1017)
|.+- ..|..++.+++|+.|.+.+|+++ .+|..++
T Consensus 160 ndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~ 193 (264)
T KOG0617|consen 160 NDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELA 193 (264)
T ss_pred Cchh-hCcHHHHHHHHHHHHhcccceee-ecChhhh
Confidence 6555 34555666666666666666655 4444444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-20 Score=208.39 Aligned_cols=182 Identities=22% Similarity=0.283 Sum_probs=132.1
Q ss_pred eEEEEEcCCCCCccc----cCcccCCCCCCCEEEccCCCCCC------CCCcccccccccccccCCCCcccccCCCcccC
Q 043932 78 RVTRLDLSNQRIGGI----LSPYVGNLSFLRYINLSDNSFHG------EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSR 147 (1017)
Q Consensus 78 ~v~~l~l~~~~l~~~----~~~~l~~l~~L~~L~L~~n~l~~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 147 (1017)
.++.|+++++.++.. ++..+...+.|+.|+++++.+.+ .++..+..+++|++|++++|.+.+..+..+..
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~ 103 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES 103 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence 389999999998643 55678888999999999998873 24566778899999999999998777766666
Q ss_pred CCc---ceEeecccccccc----cCccccccc-CCccEEEeccccccCC----CCccccCCCcccEEEEecCCCCCC---
Q 043932 148 CSN---LIQLRVSNNKLEG----QIPAEIGSL-LKLQTLAVGKNYLTGR----LPDFVGNLSALEVFSITGNSLGGK--- 212 (1017)
Q Consensus 148 l~~---L~~L~L~~n~l~~----~~p~~~~~l-~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~--- 212 (1017)
+.+ |++|++++|++++ .+...+..+ ++|++|++++|.+++. ++..+..+.+|+.|++++|.+++.
T Consensus 104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 183 (319)
T cd00116 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183 (319)
T ss_pred HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence 665 9999999999984 333455666 8889999999988843 234456667788888888877642
Q ss_pred -CCcccccccCcceeEeecCccccc----cchhhcccCcCcEEeCCCccCcc
Q 043932 213 -IPTTLGLLRNLVDLHVGGNQFSGT----FPQSICNISSLERIYLPFNRFSG 259 (1017)
Q Consensus 213 -~~~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 259 (1017)
++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++
T Consensus 184 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 233344455777777777776533 23344555666666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-20 Score=170.33 Aligned_cols=180 Identities=24% Similarity=0.392 Sum_probs=159.9
Q ss_pred hcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhccccc
Q 043932 417 IGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLS 496 (1017)
Q Consensus 417 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~ 496 (1017)
+-.+.+.+.|.||+|+++ .+|..+..+.+|+.|++++|+|+ ..|.+++.++.|+.|+++-|++.
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-------------- 92 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-------------- 92 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh--------------
Confidence 345778899999999999 78888999999999999999999 78999999999999999999987
Q ss_pred ceeccCCCcCCCCccccccccccceEEEccCCcccc-cccccccccccceEEeccCCccCCCCCccccccccCcEEeccC
Q 043932 497 VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSG-VIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSS 575 (1017)
Q Consensus 497 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 575 (1017)
.+|..|+.++.|+.|||++|.+.. ..|..|-.++.|+-|+|++|.+. .+|..++++++|+.|.+.+
T Consensus 93 ------------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrd 159 (264)
T KOG0617|consen 93 ------------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRD 159 (264)
T ss_pred ------------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeecc
Confidence 678899999999999999999974 68999999999999999999999 7888899999999999999
Q ss_pred CcccCCChhhhcccCCCcEEEcccCCCcCcCCCCCCCCC---CCcccccCcccc
Q 043932 576 NNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSS---KTKLSLQGNVKL 626 (1017)
Q Consensus 576 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~---~~~~~~~~n~~~ 626 (1017)
|.+- ..|..++.+++|+.|.+.+|+|+-.+|..+.+.- -....+..|||.
T Consensus 160 ndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 160 NDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred Cchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 9998 7999999999999999999999999998665432 234456667665
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.7e-18 Score=171.36 Aligned_cols=139 Identities=17% Similarity=0.227 Sum_probs=108.3
Q ss_pred cccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-----CCCCceeeeeeeecCCCCCCcee
Q 043932 708 ASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-----RHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 708 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.-.+.||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ +||||++++|++.+.. +...+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 4457899999999995 6666655 69998765454567889999999999 5799999999987652 22343
Q ss_pred E-EEEEe--ccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHH-HHHhhCCCCCceeecCCCCceEeCCC----CC
Q 043932 783 A-LVFEC--MKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI-EYLHHHCQPPMVHGDLKPSNVLLDHD----MV 854 (1017)
Q Consensus 783 ~-lv~e~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~~----~~ 854 (1017)
+ +|+|| +.+|+|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+||+++.. +.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 4 78999 5579999999653 24444 35677888777 999999 99999999999999743 48
Q ss_pred eEEeecccc
Q 043932 855 SHVGDFGLA 863 (1017)
Q Consensus 855 ~kl~DfG~a 863 (1017)
++|+||+.+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.9e-19 Score=192.50 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=162.2
Q ss_pred ccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeee-------eeecCCC
Q 043932 707 FASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIIT-------ICSSIDS 776 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-------~~~~~~~ 776 (1017)
+.+.+..++.+++.+...+...+ ...++-|..............+++..+....|-+..-..+ .......
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 34445556666665555444322 2223333333222122233444555444443333332222 1111111
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
....+.||.|++|+..+|.+|+...+. ....++.....++.|++.|++| + +.+|||+||.||+...+..+|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhh
Confidence 122468899999999999999976542 2466788889999999999999 6 899999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|+|||+........ .........+...||..||+||.+.+..|+.++||||+|++++|++. +|...+........
T Consensus 397 IgDFgl~ts~~~~~--~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d 471 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDE--TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTD 471 (516)
T ss_pred hhhhhheeecccCC--cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhh
Confidence 99999988665433 22222334455689999999999999999999999999999999997 33332222122222
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
.....+|+. . ..+ .+.=..++.+++...|.+||++.++.
T Consensus 472 ~r~g~ip~~--------~------------------~~d-~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 472 IRDGIIPPE--------F------------------LQD-YPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhcCCCChH--------H------------------hhc-CcHHHHHHHHhcCCCcccCchHHHHh
Confidence 222222211 0 111 12235788899999999999665543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.6e-18 Score=187.60 Aligned_cols=218 Identities=27% Similarity=0.379 Sum_probs=161.9
Q ss_pred HHhcCCCCceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCC
Q 043932 756 LRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQP 835 (1017)
Q Consensus 756 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~ 835 (1017)
|+.+.|.|+.+++|.+... ...+.|.+||..|+|.|.+.... ..+++.....+.++|+.||+|+|..
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~s--- 67 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHNS--- 67 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhcC---
Confidence 4568899999999999766 66899999999999999998743 4789999999999999999999988
Q ss_pred Cc-eeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCC-------cCccccc
Q 043932 836 PM-VHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE-------ASMTGDV 907 (1017)
Q Consensus 836 ~i-vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv 907 (1017)
.| .|+.+++.|.+++....+|++|||+........... ......-..-|.|||.+.+.. .+.++||
T Consensus 68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~------~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi 141 (484)
T KOG1023|consen 68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPE------AHHPIRKALLWTAPELLRGALSQSLESALTQKGDI 141 (484)
T ss_pred cceeeeeeccccceeeeeEEEEechhhhccccccccccc------ccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence 55 899999999999999999999999987664311000 011112345799999987641 4677999
Q ss_pred hhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhc
Q 043932 908 YSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLC 987 (1017)
Q Consensus 908 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 987 (1017)
||||++++|+++.+.||+........ .+.+..... .......| .+.... +.++++..++.+|
T Consensus 142 Ys~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP---------------~i~~~~-e~~~~l~~l~~~c 203 (484)
T KOG1023|consen 142 YSFGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-GGSNPFRP---------------SIELLN-ELPPELLLLVARC 203 (484)
T ss_pred ehHHHHHHHHHhccCccccccccCCh-HHHHHHHHh-cCCCCcCc---------------chhhhh-hcchHHHHHHHHh
Confidence 99999999999999999875433222 111111000 00011111 111111 4456799999999
Q ss_pred cCCCCCCCCCHHHHHHHHhhccc
Q 043932 988 SMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 988 l~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
|..+|++||++++|-..++.+..
T Consensus 204 w~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 204 WEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccChhhCccHHHHHhhhhhhcc
Confidence 99999999999999888877654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.3e-18 Score=200.49 Aligned_cols=201 Identities=21% Similarity=0.259 Sum_probs=154.4
Q ss_pred HHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC---CCCceeeeeeeecCC
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR---HRNLIKIITICSSID 775 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 775 (1017)
+.......|.+.+.||+|+||+||+|...+ |+.||+|+-+....-+ |.--.+++.+++ -+.|..+..++...
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~- 766 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQ- 766 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccC-
Confidence 334455688999999999999999999985 9999999976444321 111223344444 23333333333222
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC----
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---- 851 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---- 851 (1017)
+.-++|+||.+.|+|.+++...+ .+++.-++.++.|+++.+++||.. +|||+||||+|+++..
T Consensus 767 ----~~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 767 ----NASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred ----CcceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCC
Confidence 44579999999999999998543 789999999999999999999999 9999999999999943
Q ss_pred ---CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCC
Q 043932 852 ---DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923 (1017)
Q Consensus 852 ---~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 923 (1017)
...++|+|||.+-.+..-. ........++|-.+-.+|...|..+++.+|-|.++.+++.|+.|++-
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFP------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred CCcccceEEEecccceeeeEcC------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 3468999999987553211 12233456789999999999999999999999999999999999854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.5e-19 Score=193.61 Aligned_cols=187 Identities=26% Similarity=0.311 Sum_probs=154.0
Q ss_pred cccccCCceEEEEEe---CCCcEEEEEEEeeecCcc--hHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCceeEEE
Q 043932 712 MIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 712 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
++|+|+||.|++++. .+.|..+|+|+.+..... .......|..++...+ ||.++++...+... ...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHh
Confidence 479999999998754 345677999988643211 1124556778888886 99999998877655 567899
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
++|..+|++...+.... .+++.....+...++-|++++|+. +++|||+|++||+++.+|++++.|||.++.
T Consensus 76 ld~~rgg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEV------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hhhcccchhhhccccCC------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence 99999999998887654 567777788888999999999999 999999999999999999999999999986
Q ss_pred cccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 926 (1017)
.-..+. .+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 147 ~v~~~~------------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 147 AVKEKI------------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hHhhhh------------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 543321 16899999999998 467889999999999999999999976
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=171.61 Aligned_cols=143 Identities=20% Similarity=0.147 Sum_probs=111.7
Q ss_pred ccccccCcccccCCceEEEEE-eCCCcEEEEEEEeeecCcc------------------------hHHHHHHHHHHHHhc
Q 043932 705 SEFASSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKG------------------------AFKSFMAECKALRNI 759 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 759 (1017)
.-|++.+.||+|+||.||+|. +..+|+.||+|+++..... ....+.+|++.++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999999 6668999999998743210 012356899999999
Q ss_pred CCC--CceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC-
Q 043932 760 RHR--NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP- 836 (1017)
Q Consensus 760 ~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~- 836 (1017)
.+. .+.+++++ ...++||||++++++..+..... .....+...++.|++.++++||+. +
T Consensus 108 ~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---g~ 169 (237)
T smart00090 108 YEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE---GE 169 (237)
T ss_pred HhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc---CC
Confidence 753 34444442 12479999999988876543222 345566788999999999999999 9
Q ss_pred ceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 837 MVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 837 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
|+||||||+||+++ ++.++|+|||.|...
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999998754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.6e-17 Score=194.96 Aligned_cols=152 Identities=32% Similarity=0.519 Sum_probs=123.4
Q ss_pred CCCCHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCC----ceeeEEECC--CC--CeEEEEEcCCCCCccccCcccCCCCC
Q 043932 31 GQTNETDRLALLAIKSQLHDTSGVTSSWNNTINLC----QWTGVTCGH--RH--QRVTRLDLSNQRIGGILSPYVGNLSF 102 (1017)
Q Consensus 31 ~~~~~~~~~aLl~~k~~~~~~~~~~~sw~~~~~~c----~w~gv~c~~--~~--~~v~~l~l~~~~l~~~~~~~l~~l~~ 102 (1017)
..+.++|..||++||+++.++.. .+|+++ .|| .|.||+|.. .. .+|+.|+|++|+++|.+|+.++.+++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 34677899999999999977643 489864 342 799999953 22 35889999999999988888999999
Q ss_pred CCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCccccccc-CCccEEEec
Q 043932 103 LRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSL-LKLQTLAVG 181 (1017)
Q Consensus 103 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~L~ 181 (1017)
|+.|+|++|.++|.+|..++.+++|++|+|++|+++|.+|..++++++|++|+|++|+++|.+|..++.+ .++..+++.
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~ 523 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEec
Confidence 9999999999988888888888888888888888888888888888888888888888888888877653 356666766
Q ss_pred cccc
Q 043932 182 KNYL 185 (1017)
Q Consensus 182 ~n~l 185 (1017)
+|..
T Consensus 524 ~N~~ 527 (623)
T PLN03150 524 DNAG 527 (623)
T ss_pred CCcc
Confidence 6653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-17 Score=193.43 Aligned_cols=215 Identities=25% Similarity=0.355 Sum_probs=147.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
...+|..++.|..|+||.||.++++.+.+.+|+|+=+ .. .+++ ||..+.+ ..
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----------lilR-----nilt~a~-----------np 132 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----------LILR-----NILTFAG-----------NP 132 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----------hhhh-----ccccccC-----------Cc
Confidence 3467889999999999999999999999999996432 11 1111 1222221 12
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
+.| |+=.+.++..+ .++. +++.+++|+|+. +|+|||+||+|.+|+.-|++|+.|||+
T Consensus 133 fvv------gDc~tllk~~g------~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 133 FVV------GDCATLLKNIG------PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGL 189 (1205)
T ss_pred cee------chhhhhcccCC------CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhh
Confidence 233 34444444432 2222 237899999999 999999999999999999999999999
Q ss_pred cccccc--------ccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 863 AKFLSS--------HQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 863 a~~~~~--------~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
++.... ..+.... .......++||+.|+|||++....|+..+|.|++|+|+||.+.|+.||.++..++ .+
T Consensus 190 sk~GLms~atnl~eg~I~k~t-~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lf 267 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDT-HEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LF 267 (1205)
T ss_pred hhhhhhhccchhhhcchHHHH-HHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HH
Confidence 875321 1111111 1112234689999999999999999999999999999999999999998864331 11
Q ss_pred HHHHHhh--cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC
Q 043932 935 HEFAKIA--LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME 997 (1017)
Q Consensus 935 ~~~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 997 (1017)
..++... +++ .....+.+..+++.+.++.+|.+|--
T Consensus 268 g~visd~i~wpE---------------------------~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 268 GQVISDDIEWPE---------------------------EDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhhhhhccccc---------------------------cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 1111111 111 11123566788889999999999963
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=158.68 Aligned_cols=134 Identities=20% Similarity=0.311 Sum_probs=109.7
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--------hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--------AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
+.||+|++|.||+|.+ .+..|++|+....... ...++.+|++++..+.|+++.....++... +..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 5799999999999998 5667999986533211 124577899999999999887766665433 446
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||++|++|.+++.... . ++..++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 89999999999999986431 1 7788999999999999999 999999999999999 78999999998
Q ss_pred ccc
Q 043932 863 AKF 865 (1017)
Q Consensus 863 a~~ 865 (1017)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=156.75 Aligned_cols=141 Identities=23% Similarity=0.188 Sum_probs=109.3
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc----------------------hHHHHHHHHHHHHhc
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG----------------------AFKSFMAECKALRNI 759 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l 759 (1017)
....-|.+.+.||+|+||.||+|... +|+.||||++...... .......|+..+..+
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 33334788899999999999999985 7899999997643210 012356788889888
Q ss_pred CCC--CceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 043932 760 RHR--NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPM 837 (1017)
Q Consensus 760 ~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 837 (1017)
.|+ .+.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+. +|
T Consensus 91 ~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~---gi 146 (198)
T cd05144 91 YEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH---GI 146 (198)
T ss_pred HHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC---CC
Confidence 777 34444432 234899999999998765321 23456889999999999999 99
Q ss_pred eeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 838 VHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 838 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
+||||||+||++++++.++|+|||.+....
T Consensus 147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.3e-15 Score=178.09 Aligned_cols=144 Identities=23% Similarity=0.301 Sum_probs=111.8
Q ss_pred HHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--Cc------chHHHHHHHHHHHHhcCCCCceeee
Q 043932 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QK------GAFKSFMAECKALRNIRHRNLIKII 768 (1017)
Q Consensus 697 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~~~ 768 (1017)
+.........|...+.||+|+||+||+|.+.... +++|+.... .. ...+++.+|+++++.++|++++...
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3333344455677899999999999999986443 444433211 11 1235678999999999999998877
Q ss_pred eeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceE
Q 043932 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848 (1017)
Q Consensus 769 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 848 (1017)
.++... ...++||||+++++|.+++. ....++.|++++++|||+. +++|||+||+||+
T Consensus 403 ~~~~~~-----~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NIL 460 (535)
T PRK09605 403 IYDVDP-----EEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFI 460 (535)
T ss_pred EEEEeC-----CCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEE
Confidence 665443 34689999999999999875 2456899999999999999 9999999999999
Q ss_pred eCCCCCeEEeecccccc
Q 043932 849 LDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 849 l~~~~~~kl~DfG~a~~ 865 (1017)
+ .++.++|+|||+++.
T Consensus 461 l-~~~~~~liDFGla~~ 476 (535)
T PRK09605 461 V-RDDRLYLIDFGLGKY 476 (535)
T ss_pred E-ECCcEEEEeCccccc
Confidence 9 678999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=156.19 Aligned_cols=130 Identities=24% Similarity=0.334 Sum_probs=103.0
Q ss_pred cccccCCceEEEEEeCCCcEEEEEEEeeecCc--------chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 712 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.||+|+||.||+|.+ ++..|++|+...... ...+++.+|+++++.++|+++.....++... +..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 489999999999996 467899998653211 1125677899999999887655444443322 3458
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||++|++|.+++.... . .++.|++.+|+++|+. +++|||++|+||+++ ++.++++|||.+
T Consensus 74 lv~e~~~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEECCccHHHHHhhcH------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 9999999999999875431 1 6899999999999999 999999999999999 889999999988
Q ss_pred cc
Q 043932 864 KF 865 (1017)
Q Consensus 864 ~~ 865 (1017)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.6e-15 Score=175.61 Aligned_cols=119 Identities=34% Similarity=0.584 Sum_probs=99.8
Q ss_pred cceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcc
Q 043932 519 NLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFS 598 (1017)
Q Consensus 519 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 598 (1017)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|+.+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36788999999998889889999999999999999998899889999999999999999999999999999999999999
Q ss_pred cCCCcCcCCCC--CCCCCCCcccccCcccccCCcCCCCCCCCCC
Q 043932 599 HNDLEGEVPTK--GVFSSKTKLSLQGNVKLCGGTDELHLPTCPS 640 (1017)
Q Consensus 599 ~N~l~~~~~~~--~~~~~~~~~~~~~n~~~c~~~~~~~~~~c~~ 640 (1017)
+|+++|.+|.. ..+..+..+++.+|+.+|+.+. .+.|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~~ 539 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACGP 539 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCcc
Confidence 99999988863 2233456788999999999764 356753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.2e-14 Score=145.91 Aligned_cols=136 Identities=24% Similarity=0.282 Sum_probs=97.2
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--hHHH----------------------HHHHHHHHHhcCCC--C
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKS----------------------FMAECKALRNIRHR--N 763 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--n 763 (1017)
.+.||+|+||+||+|.+. +++.||||++...... .... ...|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999987 7889999998743221 1111 13455556555433 2
Q ss_pred ceeeeeeeecCCCCCCceeEEEEEeccCCCHHH-HHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeec
Q 043932 764 LIKIITICSSIDSKGADFKALVFECMKNGSLED-WLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGD 841 (1017)
Q Consensus 764 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~D 841 (1017)
+.+.+++ ...++||||++++++.. .+... ... .+...++.+++.++.++|. . +|+|||
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 4444432 23589999999954321 11111 011 5677899999999999999 7 999999
Q ss_pred CCCCceEeCCCCCeEEeecccccccc
Q 043932 842 LKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 842 lkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
|||+||+++ ++.++++|||.+....
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CChhhEEEE-CCcEEEEECccccccc
Confidence 999999999 8999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.53 E-value=7e-16 Score=166.95 Aligned_cols=182 Identities=30% Similarity=0.494 Sum_probs=124.7
Q ss_pred cccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCce
Q 043932 394 RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIG 473 (1017)
Q Consensus 394 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 473 (1017)
..+..-...||+.|++. .+|..++.+..|+.+.|+.|.+. .+|..+.++..|++|||+.|+++ ..|..++.|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34555667888899988 78888888999999999999998 78888999999999999999998 6777777764 788
Q ss_pred eecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCc
Q 043932 474 FNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNS 553 (1017)
Q Consensus 474 L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 553 (1017)
|-+++|+++ .+|..+....++ ..||.+.|.+. .+|..++++.+|+.|.+..|++. ..|..++.| .|..||+|.|+
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl-~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNk 222 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTL-AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNK 222 (722)
T ss_pred EEEecCccc-cCCcccccchhH-HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCc
Confidence 888888887 556555532222 23555555555 45555666666666666666665 344445433 35566666666
Q ss_pred cCCCCCccccccccCcEEeccCCcccCCChhhh
Q 043932 554 FHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFL 586 (1017)
Q Consensus 554 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 586 (1017)
++ .+|-.|.+|+.|++|-|.+|.|. ..|..+
T Consensus 223 is-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 223 IS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred ee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 66 45666666666666666666665 444444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.2e-14 Score=138.57 Aligned_cols=135 Identities=21% Similarity=0.255 Sum_probs=110.1
Q ss_pred ccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCC--CCceeeeeeeecCCCCCCceeEEEE
Q 043932 709 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRH--RNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 709 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++.+++++.... +..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEE
Confidence 35679999999999999853 6799999864433 4678899999999976 5888888776433 5679999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
||++++.+..+ +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 73 e~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99988766543 3455677899999999999986444799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-13 Score=144.44 Aligned_cols=139 Identities=17% Similarity=0.134 Sum_probs=105.5
Q ss_pred cCccc-ccCCceEEEEEeCCCcEEEEEEEeeecC-------------cchHHHHHHHHHHHHhcCCCCc--eeeeeeeec
Q 043932 710 SNMIG-QGSFGSVYKGILGEDEMIVAVKVINLKQ-------------KGAFKSFMAECKALRNIRHRNL--IKIITICSS 773 (1017)
Q Consensus 710 ~~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~ 773 (1017)
..+|| .|+.|+||.+... +..+|||.+.... .....++.+|++++.+++|+++ ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35687 8999999999885 6678999885321 1123567889999999988774 667766433
Q ss_pred CCCCCCceeEEEEEeccC-CCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC
Q 043932 774 IDSKGADFKALVFECMKN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 852 (1017)
... .....++||||++| .+|.+++... .++.. .+.|++.++.+||+. ||+||||||+|||++.+
T Consensus 114 ~~~-~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 114 RHG-LFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD 178 (239)
T ss_pred ecC-cceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence 211 11234699999997 6999988643 23433 357899999999999 99999999999999999
Q ss_pred CCeEEeecccccc
Q 043932 853 MVSHVGDFGLAKF 865 (1017)
Q Consensus 853 ~~~kl~DfG~a~~ 865 (1017)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 9999999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.5e-15 Score=178.10 Aligned_cols=257 Identities=24% Similarity=0.268 Sum_probs=188.8
Q ss_pred hccccccCcccccCCceEEEEEeCC-CcEEEEEEEeeecC--cchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE-DEMIVAVKVINLKQ--KGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 779 (1017)
...|...+.||+|+|+.|-.+.... ....+|+|.+.... ....++...|..+-+.+. |+|++++++.....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~----- 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP----- 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----
Confidence 3467778889999999999888743 34557777765443 233455556787777776 99999999875443
Q ss_pred ceeEEEEEeccCCCHHHHH-hhCCCCccccccCHHHHHHHHHHHHHHHHHHh-hCCCCCceeecCCCCceEeCCCC-CeE
Q 043932 780 DFKALVFECMKNGSLEDWL-HQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDM-VSH 856 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~k 856 (1017)
++.+++++|..++++.+-+ .... ...+....-.++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~ 165 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK 165 (601)
T ss_pred cccccccCcccccccccccccCCc-----cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence 7789999999999998887 3322 13455566678999999999999 77 999999999999999999 999
Q ss_pred Eeeccccccccc-ccccccccCCCccccccc-CccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 857 VGDFGLAKFLSS-HQLDTASKTSSSSIGIKG-TVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 857 l~DfG~a~~~~~-~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
++|||+|..+.. ... ........| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+........
T Consensus 166 ~~df~~At~~~~~~g~------~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~ 239 (601)
T KOG0590|consen 166 IADFGLATAYRNKNGA------ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR 239 (601)
T ss_pred CCCchhhccccccCCc------ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc
Confidence 999999987654 221 122223467 9999999999884 4577899999999999999999999876555433
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
...|........ ...+........++..+++..+|.+|.+.+++..
T Consensus 240 ~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 240 YSSWKSNKGRFT------------------------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ceeecccccccc------------------------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 333322211000 0011122445678888999999999999888643
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.6e-15 Score=161.54 Aligned_cols=215 Identities=28% Similarity=0.412 Sum_probs=127.4
Q ss_pred eEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccE
Q 043932 322 WLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIA 401 (1017)
Q Consensus 322 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~ 401 (1017)
.|.|++-++...+..... ..+.--...||+.|++. ++|..++ .+..|+.
T Consensus 54 ~l~Ls~rrlk~fpr~a~~-----~~ltdt~~aDlsrNR~~-elp~~~~-------------------------~f~~Le~ 102 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAAS-----YDLTDTVFADLSRNRFS-ELPEEAC-------------------------AFVSLES 102 (722)
T ss_pred ccccccchhhcCCCcccc-----ccccchhhhhccccccc-cCchHHH-------------------------HHHHHHH
Confidence 455555555444333211 23444456677777766 5555444 4444445
Q ss_pred EeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcc
Q 043932 402 LGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKL 481 (1017)
Q Consensus 402 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l 481 (1017)
|.|..|.+. .+|..++.+..|+.|+|+.|+++ ..|..++.|+ |+.|.+++|+++ .+|+.++.+..|..||.+.|.+
T Consensus 103 liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei 178 (722)
T KOG0532|consen 103 LILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI 178 (722)
T ss_pred HHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhh
Confidence 555555554 44555555555555555555554 4444444444 555555555555 4455555555555555555555
Q ss_pred cCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCcc
Q 043932 482 TGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHS 561 (1017)
Q Consensus 482 ~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 561 (1017)
. .+|.++..+.++.. |.++.|++. .+|.+++.| .|..||+|.|+++ .+|..|..|..|++|-|.+|.|+ ..|..
T Consensus 179 ~-slpsql~~l~slr~-l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAq 252 (722)
T KOG0532|consen 179 Q-SLPSQLGYLTSLRD-LNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQ 252 (722)
T ss_pred h-hchHHhhhHHHHHH-HHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHH
Confidence 4 45555544444432 444555554 567777744 5899999999999 89999999999999999999999 56666
Q ss_pred cc---ccccCcEEeccCCc
Q 043932 562 LG---FLKSIKVLNFSSNN 577 (1017)
Q Consensus 562 ~~---~l~~L~~L~Ls~N~ 577 (1017)
+. ...--|+|+..-++
T Consensus 253 IC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 253 ICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred HHhccceeeeeeecchhcc
Confidence 54 33445677766664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.9e-13 Score=148.19 Aligned_cols=260 Identities=24% Similarity=0.270 Sum_probs=185.1
Q ss_pred cccccCcccc--cCCceEEEEEe--CCCcEEEEEEEee--ecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCC
Q 043932 706 EFASSNMIGQ--GSFGSVYKGIL--GEDEMIVAVKVIN--LKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 706 ~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 778 (1017)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+ ........+-.+|+...+.+ .|++.++....+...
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~---- 190 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS---- 190 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC----
Confidence 4666788999 99999999999 8889999999843 22223334445777777777 499999966655433
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHH----HHHHHhhCCCCCceeecCCCCceEeCCC-C
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS----AIEYLHHHCQPPMVHGDLKPSNVLLDHD-M 853 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~ 853 (1017)
+..++-+|++. .++.++...... .++....+.+..+... |+.++|+. +++|-|+||+||+...+ .
T Consensus 191 -~~lfiqtE~~~-~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 191 -GILFIQTELCG-ESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred -Ccceeeecccc-chhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence 67889999985 688888776542 4677788888888888 99999999 99999999999999999 8
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
..+++|||+...+.+..+...... .....|...|++||...+ .++.++|||++|.++.+..+|..+....... .
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~---~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~ 334 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKV---SKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS--S 334 (524)
T ss_pred eeecCCcceeEEccCCccccceee---eecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC--C
Confidence 899999999988876553333221 122357788999998876 7889999999999999999987765432111 0
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
+.+..+..++. ++. ..-..++...+..|++.+|..|++++.+. .+.-|....
T Consensus 335 W~~~r~~~ip~---e~~-----------------------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~-~l~~i~s~~ 386 (524)
T KOG0601|consen 335 WSQLRQGYIPL---EFC-----------------------EGGSSSLRSVTSQMLDEDPRLRLTAQILT-ALNVIHSKL 386 (524)
T ss_pred ccccccccCch---hhh-----------------------cCcchhhhhHHHHhcCcchhhhhHHHHHh-ccccccchh
Confidence 00000000111 011 11123445588899999999999987654 444444433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.9e-13 Score=133.95 Aligned_cols=216 Identities=19% Similarity=0.250 Sum_probs=147.4
Q ss_pred HHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhC
Q 043932 753 CKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832 (1017)
Q Consensus 753 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 832 (1017)
..-+-++.|.|+|++..|+.+....+.....+++||++.|++..++++.+. ....+......+++.||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 334555679999999999987766667788999999999999999987653 334677888889999999999999997
Q ss_pred CCCCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHH
Q 043932 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGI 912 (1017)
Q Consensus 833 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 912 (1017)
.|.|+|+++..+-|++..+|-+|++--.-..... ..... .......-.+-++|.|||.=.....+.++|||+||+
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~-s~~~~---~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHP-SVNST---REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM 270 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCccccch-hhhhh---hHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence 7799999999999999999988874221111110 00000 001111124678999999766667788999999999
Q ss_pred HHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCC
Q 043932 913 LLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESP 992 (1017)
Q Consensus 913 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 992 (1017)
...||..+..--.......... +.....+-. . ....=...+.+|++..|
T Consensus 271 cAlemailEiq~tnseS~~~~e---------e~ia~~i~~------------l----------en~lqr~~i~kcl~~eP 319 (458)
T KOG1266|consen 271 CALEMAILEIQSTNSESKVEVE---------ENIANVIIG------------L----------ENGLQRGSITKCLEGEP 319 (458)
T ss_pred HHHHHHHheeccCCCcceeehh---------hhhhhheee------------c----------cCccccCcCcccccCCC
Confidence 9999988765321110100000 000000000 0 00111356779999999
Q ss_pred CCCCCHHHHHHHHh
Q 043932 993 FERMEMRDVVAKLC 1006 (1017)
Q Consensus 993 ~~RPs~~evl~~L~ 1006 (1017)
..||+|.+++.|.-
T Consensus 320 ~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 320 NGRPDARLLLFHPL 333 (458)
T ss_pred CCCcchhhhhcCce
Confidence 99999999887643
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.1e-13 Score=151.84 Aligned_cols=182 Identities=36% Similarity=0.542 Sum_probs=101.6
Q ss_pred cccccccEEeccccCCCCCcchhhcccc-cccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCc
Q 043932 394 RNLVNLIALGMQSNQLHGTIPDVIGELK-NLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLI 472 (1017)
Q Consensus 394 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~ 472 (1017)
..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+
T Consensus 113 ~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~ 189 (394)
T COG4886 113 LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN 189 (394)
T ss_pred hcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhh
Confidence 33456677777777776 4444455553 7777777777776 55556677777777777777777 4555554666777
Q ss_pred eeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCC
Q 043932 473 GFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSN 552 (1017)
Q Consensus 473 ~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 552 (1017)
.|++++|+++ .+|. .......|++|++++|++. ..+..+.++.++..|.+++|
T Consensus 190 ~L~ls~N~i~-~l~~-------------------------~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n 242 (394)
T COG4886 190 NLDLSGNKIS-DLPP-------------------------EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242 (394)
T ss_pred heeccCCccc-cCch-------------------------hhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCc
Confidence 7777777776 3333 2223333455555555322 23344455555555555555
Q ss_pred ccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCC
Q 043932 553 SFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT 608 (1017)
Q Consensus 553 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 608 (1017)
++.. .+..++.++.|++|++++|+++. ++. +..+.+|+.|++++|.+...+|.
T Consensus 243 ~~~~-~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 243 KLED-LPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred eeee-ccchhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchh
Confidence 5542 24445555555555555555552 222 55555555555555555544443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.1e-12 Score=143.43 Aligned_cols=142 Identities=20% Similarity=0.224 Sum_probs=99.7
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecCcchH----------------------------------------HHHH
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF----------------------------------------KSFM 750 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 750 (1017)
+.||.|++|.||+|+.. +|+.||||+.+....... -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999986 789999999864321100 0244
Q ss_pred HHHHHHHhcC----CCCceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHH-H
Q 043932 751 AECKALRNIR----HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS-A 825 (1017)
Q Consensus 751 ~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~-~ 825 (1017)
+|++.+.++. |.+-+.+-.++.+. ....++||||++|++|.++...... .. ....++.+++. .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~~ 269 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARSF 269 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHHH
Confidence 5565555552 33333333333222 1346899999999999887653211 11 23456666666 4
Q ss_pred HHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccccc
Q 043932 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS 868 (1017)
Q Consensus 826 L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 868 (1017)
+..+|.. |++|+|+||.||+++.++.++++|||++..+.+
T Consensus 270 l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 270 LNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7888988 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.5e-12 Score=149.27 Aligned_cols=200 Identities=29% Similarity=0.452 Sum_probs=112.8
Q ss_pred EEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCC-cceEeecccccccccCcccccccCCccEEEeccc
Q 043932 105 YINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCS-NLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKN 183 (1017)
Q Consensus 105 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 183 (1017)
.|+++.|.+.. .+..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 45555555431 2223344455555555555555 4555555553 5666666666555 44445555566666666666
Q ss_pred cccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCc
Q 043932 184 YLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPF 263 (1017)
Q Consensus 184 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~ 263 (1017)
+++ .+|...+.+++|+.|++++|+++ .+|...+.+..|++|.+++|.+. ..+..+.+++++..+.+..|++. .+ .
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~-~ 248 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DL-P 248 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ec-c
Confidence 655 34444445556666666666665 44444444555666666666433 34555666666666666666664 21 2
Q ss_pred hhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccc
Q 043932 264 DIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDF 314 (1017)
Q Consensus 264 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 314 (1017)
.....+++++.|++++|.++. ++. ++.+.+++.|++++|.+....+...
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred chhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhhh
Confidence 334456667777777777763 333 6777777777777777766555443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=9.3e-14 Score=142.79 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=126.9
Q ss_pred CeEEEEEcCCCCCcc----ccCcccCCCCCCCEEEccCCCCCC----CCCcccccccccccccCCCCcccccCCCcccCC
Q 043932 77 QRVTRLDLSNQRIGG----ILSPYVGNLSFLRYINLSDNSFHG----EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRC 148 (1017)
Q Consensus 77 ~~v~~l~l~~~~l~~----~~~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 148 (1017)
..++.|+|++|.++. .+.+.+.+.++|+..++|+- ++| ++|+.+.- +.+.+..+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~-----------------l~~aL~~~ 91 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKM-----------------LSKALLGC 91 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHH-----------------HHHHHhcC
Confidence 357888888888864 34556777888888888873 333 45544321 11233445
Q ss_pred CcceEeecccccccccCcccc----cccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcc
Q 043932 149 SNLIQLRVSNNKLEGQIPAEI----GSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLV 224 (1017)
Q Consensus 149 ~~L~~L~L~~n~l~~~~p~~~----~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 224 (1017)
++|++||||+|.+....+..| .++..|++|.|.+|.+.-.-...++ ..|..|. .|+. .+.-++|+
T Consensus 92 ~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~kk-------~~~~~~Lr 160 (382)
T KOG1909|consen 92 PKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNKK-------AASKPKLR 160 (382)
T ss_pred CceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHhc-------cCCCcceE
Confidence 566666666666654333332 3445566666666555411111111 0122111 1111 11224566
Q ss_pred eeEeecCccccc----cchhhcccCcCcEEeCCCccCcc---ccCchhhccCCccceeeecccccCCC----CCCccccC
Q 043932 225 DLHVGGNQFSGT----FPQSICNISSLERIYLPFNRFSG---TLPFDIVVNLPNLKSLAIGGNNFFGS----IPDSLSNA 293 (1017)
Q Consensus 225 ~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~---~l~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l 293 (1017)
++..++|++... +...|...+.|+.+.+++|.|.. .+-...+..+++|+.|||.+|.++.. +...++.+
T Consensus 161 v~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~ 240 (382)
T KOG1909|consen 161 VFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSW 240 (382)
T ss_pred EEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhccc
Confidence 666666665422 22344555666666666666531 11122344555666666666655422 33445555
Q ss_pred CccceeecccCcccceeeccc-----cccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCccc
Q 043932 294 SNVEILDLGFNQFKGKVSIDF-----SSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360 (1017)
Q Consensus 294 ~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 360 (1017)
++|+.|++++|.+......+| ...++|+.|.|.+|.|+......+ .......+.|..|+|++|.+
T Consensus 241 ~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~l--a~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 241 PHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALAL--AACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred chheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHH--HHHHhcchhhHHhcCCcccc
Confidence 566666666666654444332 224556666666665544333221 12233355555666666655
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-11 Score=142.42 Aligned_cols=150 Identities=18% Similarity=0.190 Sum_probs=96.6
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc------------------------------h----HH---
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG------------------------------A----FK--- 747 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------------------~----~~--- 747 (1017)
.+|+. +.||+|++|.||+|+.+++|+.||||+.+..-.. . .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 7899999999999999877999999999743110 0 01
Q ss_pred ---HHHHHHHHHHhcC----CCCceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHH
Q 043932 748 ---SFMAECKALRNIR----HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 820 (1017)
Q Consensus 748 ---~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~ 820 (1017)
.+.+|+..+.+++ +...+.+-.++.+. ....++||||++|+++.++-.-.........+....+..++.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 1334444444442 33333333333221 134689999999999987532111100111233333444444
Q ss_pred HHHHHHHHHhhCCCCCceeecCCCCceEeCCCC----CeEEeecccccccccc
Q 043932 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM----VSHVGDFGLAKFLSSH 869 (1017)
Q Consensus 821 qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~a~~~~~~ 869 (1017)
|+. .. |++|+|+||.||+++.++ .++++|||++..+++.
T Consensus 275 Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 275 QVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 443 45 999999999999999988 9999999999877543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.8e-11 Score=116.86 Aligned_cols=137 Identities=20% Similarity=0.164 Sum_probs=99.8
Q ss_pred cCcccccCCceEEEEEeCC------CcEEEEEEEeeecC----------------------cchHHHHH----HHHHHHH
Q 043932 710 SNMIGQGSFGSVYKGILGE------DEMIVAVKVINLKQ----------------------KGAFKSFM----AECKALR 757 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~ 757 (1017)
...||.|.-+.||.|...+ .+..+|||+++... ....+.+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998753 35789999986210 01122333 7999999
Q ss_pred hcC--CCCceeeeeeeecCCCCCCceeEEEEEeccCCCHHH-HHhhCCCCccccccCHHHHHHHHHHHHHHHHHH-hhCC
Q 043932 758 NIR--HRNLIKIITICSSIDSKGADFKALVFECMKNGSLED-WLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHC 833 (1017)
Q Consensus 758 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ 833 (1017)
++. .-++.+++++ ...++||||+.+..+.. .++. ..++..+...+..|++.+|..+ |..
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~~- 144 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKEC- 144 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 984 3567777765 22479999997654321 2221 1344456677889999999999 788
Q ss_pred CCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 834 QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 834 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
++||||+++.||+++ ++.+.++|||.|...
T Consensus 145 --glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 145 --NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred --CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999999999997 568999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8.7e-11 Score=131.88 Aligned_cols=171 Identities=22% Similarity=0.268 Sum_probs=130.5
Q ss_pred EEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCC
Q 043932 723 KGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSN 802 (1017)
Q Consensus 723 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 802 (1017)
.|..+.++.+|.|..++...........+.++.++.++||||+++++.+... +..|+|+|.+. .|..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~ylvTErV~--Pl~~~lk~l- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTLYLVTERVR--PLETVLKEL- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhccc-----CceEEEeeccc--cHHHHHHHh-
Confidence 4667778889999998766654456677889999999999999999987654 57899999884 688888743
Q ss_pred CCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCccc
Q 043932 803 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882 (1017)
Q Consensus 803 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 882 (1017)
....+...+.||+.||.|||+.+ +++|++|.-+-|+|+..|+.||++|.++........ ...
T Consensus 102 --------~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------~~~ 163 (690)
T KOG1243|consen 102 --------GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------PAK 163 (690)
T ss_pred --------HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--------ccc
Confidence 35567778999999999999765 999999999999999999999999998865432111 000
Q ss_pred ccccCccccCcccccCCCcCccccchhHHHHHHHHHhCC
Q 043932 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR 921 (1017)
Q Consensus 883 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 921 (1017)
...--..|..|+.+.... -..|.|.|||+++|++.|.
T Consensus 164 ~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 111223466677543322 3469999999999999993
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.3e-12 Score=127.90 Aligned_cols=132 Identities=24% Similarity=0.265 Sum_probs=92.9
Q ss_pred cccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEE
Q 043932 445 TKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLI 524 (1017)
Q Consensus 445 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 524 (1017)
..|+.+|||+|.|+ .+.++..-.+.++.|++|+|.++ .+ ..+..+++|+.||
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~--------------------------~v-~nLa~L~~L~~LD 335 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR--------------------------TV-QNLAELPQLQLLD 335 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee--------------------------ee-hhhhhcccceEee
Confidence 34555666666665 44455555555555555555554 22 2366788889999
Q ss_pred ccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCCh-hhhcccCCCcEEEcccCCCc
Q 043932 525 ISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIP-EFLENLSFLEFLNFSHNDLE 603 (1017)
Q Consensus 525 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 603 (1017)
||+|.++ .+-..-.++.+.+.|.|+.|.+... .-++.+-+|..||+++|+|..... ..+++||.|+.+.|.+|++.
T Consensus 336 LS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 336 LSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred cccchhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 9999887 4445556778888999999988743 347788889999999998874322 46889999999999999998
Q ss_pred CcCC
Q 043932 604 GEVP 607 (1017)
Q Consensus 604 ~~~~ 607 (1017)
+.+.
T Consensus 413 ~~vd 416 (490)
T KOG1259|consen 413 GSVD 416 (490)
T ss_pred ccch
Confidence 7554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.8e-11 Score=117.29 Aligned_cols=130 Identities=17% Similarity=0.123 Sum_probs=94.9
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCce-eeeeeeecCCCCCCceeEEEEEe
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLI-KIITICSSIDSKGADFKALVFEC 788 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~ 788 (1017)
.+.++.|.++.||+++.. +..|++|+...... ....+.+|+++++.+.+..++ +++.+.. ...++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEEEe
Confidence 356899999999999975 67899999764432 123457899999988654443 4444321 124799999
Q ss_pred ccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC--CCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 789 MKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC--QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 789 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
++|.++.+. . . ....++.+++++++.||+.. +.+++|+|++|.||+++ ++.++++|||.+.
T Consensus 73 i~G~~l~~~-~---------~----~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE-D---------F----SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc-c---------c----cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999887543 0 0 11235679999999999982 12359999999999999 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.2e-12 Score=125.48 Aligned_cols=142 Identities=25% Similarity=0.283 Sum_probs=111.8
Q ss_pred CCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhh
Q 043932 411 GTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLL 490 (1017)
Q Consensus 411 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 490 (1017)
|..-..+..+..|++||||+|.|+ .+.++..-+++++.|++|+|.|.. + +.+..+++|..||||+|.++
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-------- 342 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-------- 342 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH--------
Confidence 344445556778899999999998 677778888999999999999983 3 33788899999999999887
Q ss_pred hcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCC-CccccccccCc
Q 043932 491 SITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVI-PHSLGFLKSIK 569 (1017)
Q Consensus 491 ~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~ 569 (1017)
.+-.+-..+.|.++|.|++|.|... ..++++-+|..||+++|++.... -..++++|-|+
T Consensus 343 ------------------~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE 402 (490)
T KOG1259|consen 343 ------------------ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLE 402 (490)
T ss_pred ------------------hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHH
Confidence 1222334577889999999999743 34778889999999999998543 24689999999
Q ss_pred EEeccCCcccCCChh
Q 043932 570 VLNFSSNNLSGQIPE 584 (1017)
Q Consensus 570 ~L~Ls~N~l~~~~p~ 584 (1017)
.|.|.+|.+.+ +|+
T Consensus 403 ~l~L~~NPl~~-~vd 416 (490)
T KOG1259|consen 403 TLRLTGNPLAG-SVD 416 (490)
T ss_pred HHhhcCCCccc-cch
Confidence 99999999995 444
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.6e-12 Score=128.18 Aligned_cols=231 Identities=19% Similarity=0.207 Sum_probs=118.4
Q ss_pred ccccCCccEEEeccccccCC----CCccccCCCcccEEEEecCC---CCCCCCccc-------ccccCcceeEeecCccc
Q 043932 169 IGSLLKLQTLAVGKNYLTGR----LPDFVGNLSALEVFSITGNS---LGGKIPTTL-------GLLRNLVDLHVGGNQFS 234 (1017)
Q Consensus 169 ~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~---l~~~~~~~l-------~~l~~L~~L~L~~n~l~ 234 (1017)
+.....++.++|++|.+... +...+.+.++|+.-++++-- +...+|+++ ...++|+.|+||.|.|.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 34455667777777766522 22334555566666655431 112233322 22345555555555554
Q ss_pred cccchh----hcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCccccee
Q 043932 235 GTFPQS----ICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKV 310 (1017)
Q Consensus 235 ~~~p~~----l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 310 (1017)
...+.. +.++++|++|+|.+|.+. ......+. ..|..|. .| ...+.-++|+++..++|++....
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~--~al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen~g 173 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLG--RALFELA--VN-------KKAASKPKLRVFICGRNRLENGG 173 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHH--HHHHHHH--HH-------hccCCCcceEEEEeecccccccc
Confidence 332222 234455555555555543 11111100 1112111 11 12334567888888888877544
Q ss_pred ec----cccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccc
Q 043932 311 SI----DFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIF 386 (1017)
Q Consensus 311 ~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~ 386 (1017)
.. .|...+.|+.+.+++|.|...+. ......+..+++|++|||.+|-|+......+.
T Consensus 174 a~~~A~~~~~~~~leevr~~qN~I~~eG~--~al~eal~~~~~LevLdl~DNtft~egs~~La----------------- 234 (382)
T KOG1909|consen 174 ATALAEAFQSHPTLEEVRLSQNGIRPEGV--TALAEALEHCPHLEVLDLRDNTFTLEGSVALA----------------- 234 (382)
T ss_pred HHHHHHHHHhccccceEEEecccccCchh--HHHHHHHHhCCcceeeecccchhhhHHHHHHH-----------------
Confidence 33 35666788888888888766554 24445677778888888888877643332222
Q ss_pred cccCccccccccccEEeccccCCCCCcchhhc-----ccccccceeccccccc
Q 043932 387 GIIPSGIRNLVNLIALGMQSNQLHGTIPDVIG-----ELKNLQGLFLYKNVLQ 434 (1017)
Q Consensus 387 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~ 434 (1017)
..+..+++|+.|++++|.+.......|. ..++|+.|.|.+|.++
T Consensus 235 ----kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 235 ----KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred ----HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 3344455666666666666543332221 2345555555555554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.6e-11 Score=117.22 Aligned_cols=126 Identities=25% Similarity=0.325 Sum_probs=43.6
Q ss_pred cccccccceeeccCcccCCCCccccc-cccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCcccccccccc
Q 043932 441 VGNLTKLAKLVMSYNSLQGNIPSSLG-NCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKN 519 (1017)
Q Consensus 441 ~~~l~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~ 519 (1017)
+.+..++++|+|++|+|+. + +.++ .+.+|+.||+++|.|+ .+ ..+..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~--------------------------~l-~~l~~L~~ 65 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT--------------------------KL-EGLPGLPR 65 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S-----------------------------TT----TT
T ss_pred ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc--------------------------cc-cCccChhh
Confidence 3344566777777777763 2 2343 4566666666666665 11 13455777
Q ss_pred ceEEEccCCcccccccccc-cccccceEEeccCCccCCCCC-ccccccccCcEEeccCCcccCCChh----hhcccCCCc
Q 043932 520 LVKLIISSNQFSGVIPVTL-STCVSLEYLDISSNSFHGVIP-HSLGFLKSIKVLNFSSNNLSGQIPE----FLENLSFLE 593 (1017)
Q Consensus 520 L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~ 593 (1017)
|+.|++++|+|+.+ ++.+ ..+++|++|+|++|+|...-- ..+..+++|+.|+|.+|+++.. +. .+..+|+|+
T Consensus 66 L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk 143 (175)
T PF14580_consen 66 LKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLK 143 (175)
T ss_dssp --EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-S
T ss_pred hhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhh
Confidence 88888888888743 3333 457788888888888775322 3466778888888888888743 32 346778888
Q ss_pred EEEc
Q 043932 594 FLNF 597 (1017)
Q Consensus 594 ~L~l 597 (1017)
.||-
T Consensus 144 ~LD~ 147 (175)
T PF14580_consen 144 VLDG 147 (175)
T ss_dssp EETT
T ss_pred eeCC
Confidence 7764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.2e-12 Score=132.43 Aligned_cols=210 Identities=21% Similarity=0.199 Sum_probs=130.8
Q ss_pred ccccccccccCCCCcccccCC--CcccCCCcceEeecccccccccCc--ccccccCCccEEEeccccccCCCCc-cccCC
Q 043932 122 GNLLRLEKLALPNNSFSGTIP--TNLSRCSNLIQLRVSNNKLEGQIP--AEIGSLLKLQTLAVGKNYLTGRLPD-FVGNL 196 (1017)
Q Consensus 122 ~~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l 196 (1017)
.++.+|+...|.+..+. ..+ .....|++++.||||.|-+..-.| .-...|++|+.|+|+.|++...... .-..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 35778888888888876 333 356678889999999988764322 3346788888888888887632221 12356
Q ss_pred CcccEEEEecCCCCCC-CCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCcccee
Q 043932 197 SALEVFSITGNSLGGK-IPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSL 275 (1017)
Q Consensus 197 ~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L 275 (1017)
++|+.|.|+.|.++-. +-..+..+++|+.|+|..|............++.|++|||++|++...-.......++.|..|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 7778888888877632 222344567788888887753333344445567777788887777532222334566777777
Q ss_pred eecccccCCC-CCCc-----cccCCccceeecccCcccceee-ccccccCccceEecccCcCCC
Q 043932 276 AIGGNNFFGS-IPDS-----LSNASNVEILDLGFNQFKGKVS-IDFSSLKNLSWLNLEQNNLGM 332 (1017)
Q Consensus 276 ~L~~n~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 332 (1017)
+++.+.+... .|+. ....++|++|++..|+|..... ..+..+++|+.|.+..|.+..
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 7777777643 2333 3445667777777777653221 123344555666655555544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.5e-11 Score=133.38 Aligned_cols=252 Identities=19% Similarity=0.151 Sum_probs=173.0
Q ss_pred HHhhccccccCcccccCCceEEEEEeC-CCcEEEEEEEeeecCcchHH--HHHHHHHHHHhc-CCCCceeeeeeeecCCC
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILG-EDEMIVAVKVINLKQKGAFK--SFMAECKALRNI-RHRNLIKIITICSSIDS 776 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 776 (1017)
.....+|..+..||.|.|+.|+.+..+ .++..|++|........... .-..|+.+...+ .|.++++++..+...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-- 338 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-- 338 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--
Confidence 445567888899999999999998876 67888999977533222111 123466666656 588888877665544
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-CCe
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVS 855 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~ 855 (1017)
+..|+--||+++++........ ..+++..++.+..|++.++.++|+. .++|+|+||+||++..+ +..
T Consensus 339 ---r~~~ip~e~~~~~s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 339 ---RQGYIPLEFCEGGSSSLRSVTS------QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred ---ccccCchhhhcCcchhhhhHHH------HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhh
Confidence 4456889999999887766322 2567778889999999999999999 99999999999999886 788
Q ss_pred EEeecccccccccccccccccCCCcccccccCcccc--CcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV--APEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
+++|||.++.+.-... ...+.-++. +|+......+..++|+||||..++|.++|..--... ..
T Consensus 407 ~~~~~~~~t~~~~~~~-----------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~--- 471 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFSSG-----------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQ--- 471 (524)
T ss_pred hccccccccccceecc-----------cccccccccccchhhccccccccccccccccccccccccCcccCccc-cc---
Confidence 9999999864321110 012233344 555556667889999999999999999987643221 10
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
.........+ ........+..+...+...||..||.+.++..+.+..+
T Consensus 472 ~~~i~~~~~p----------------------------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 472 SLTIRSGDTP----------------------------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ceeeeccccc----------------------------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000000000 00011244566777888999999999998876655443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.9e-10 Score=115.95 Aligned_cols=275 Identities=15% Similarity=0.120 Sum_probs=168.0
Q ss_pred ccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeec--CCCCCCceeEEE
Q 043932 709 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSS--IDSKGADFKALV 785 (1017)
Q Consensus 709 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~~~~~~lv 785 (1017)
.++.||+|+.+.+|-.-.-.+ .+.|++.........+ .+..|... .||-+-.-+.+-.. ..........+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 467899999999996544322 4568887544332222 23334433 56644332221100 011122336788
Q ss_pred EEeccCC-CHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 786 FECMKNG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 786 ~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
|..+++. ....+++............|...+++++.++.+.+.||+. |.+-+|+.++|+||++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 8888764 2444443322222335678999999999999999999999 99999999999999999999998865443
Q ss_pred ccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhC-CCCCCccccc---CccHH
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTG-RRPTDAAFTE---GLTLH 935 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~---~~~~~ 935 (1017)
... ........+|...|.+||.-. +...+...|.|.+|+++++++.| ++||.+.... ....+
T Consensus 166 i~~---------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 166 INA---------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred ecc---------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 321 111222357899999999754 33457789999999999999986 9999764221 11111
Q ss_pred -HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHHhhccccc
Q 043932 936 -EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMES--PFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 936 -~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~~~ 1012 (1017)
.+....+- +.. ................-.++.+..+..+|+... |.-|||++..+..|..+++++
T Consensus 237 ~~Ia~g~f~-------ya~-----~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 237 TDIAHGRFA-------YAS-----DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhhhcceee-------ech-----hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11111000 000 000000111111122233556677777787653 568999999999998887765
Q ss_pred c
Q 043932 1013 F 1013 (1017)
Q Consensus 1013 ~ 1013 (1017)
.
T Consensus 305 ~ 305 (637)
T COG4248 305 K 305 (637)
T ss_pred h
Confidence 3
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.3e-11 Score=139.38 Aligned_cols=85 Identities=26% Similarity=0.272 Sum_probs=39.4
Q ss_pred ceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCC---Chhh-hcccCCCcEE
Q 043932 520 LVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQ---IPEF-LENLSFLEFL 595 (1017)
Q Consensus 520 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L 595 (1017)
|+.+++++|++. ..+..+..+..+..|++++|++...- .+.....+..+.++.|.+... .... ....+.++.+
T Consensus 234 L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (414)
T KOG0531|consen 234 LRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTL 310 (414)
T ss_pred HHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhhhcccccccccccccc
Confidence 444444444444 22233444445555555555554321 133344445555555554411 1111 3445566666
Q ss_pred EcccCCCcCcCC
Q 043932 596 NFSHNDLEGEVP 607 (1017)
Q Consensus 596 ~l~~N~l~~~~~ 607 (1017)
.+.+|+.....+
T Consensus 311 ~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 311 TLELNPIRKISS 322 (414)
T ss_pred ccccCccccccc
Confidence 666666665443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=9e-11 Score=114.42 Aligned_cols=105 Identities=28% Similarity=0.383 Sum_probs=25.5
Q ss_pred cccccccCCCCcccccCCCccc-CCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccc-cCCCcccEE
Q 043932 125 LRLEKLALPNNSFSGTIPTNLS-RCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFV-GNLSALEVF 202 (1017)
Q Consensus 125 ~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L 202 (1017)
.++++|+|++|.|+ .+ +.++ .+.+|+.|||++|.++.. +.+..+++|++|++++|+|+. +++.+ ..+++|++|
T Consensus 19 ~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred cccccccccccccc-cc-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEE
Confidence 34455555555554 22 2233 345555555555555522 234445555555555555552 22222 235555555
Q ss_pred EEecCCCCCCC-CcccccccCcceeEeecCccc
Q 043932 203 SITGNSLGGKI-PTTLGLLRNLVDLHVGGNQFS 234 (1017)
Q Consensus 203 ~L~~N~l~~~~-~~~l~~l~~L~~L~L~~n~l~ 234 (1017)
+|++|+|...- -..++.+++|++|+|.+|.++
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 55555554311 134445566666666666655
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.7e-11 Score=138.72 Aligned_cols=251 Identities=24% Similarity=0.228 Sum_probs=142.8
Q ss_pred ccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccE
Q 043932 122 GNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEV 201 (1017)
Q Consensus 122 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 201 (1017)
..+..++.+.+..|.+. .+-..+..+++|+.|+|.+|+|.. +...+..+++|++|++++|.|+.+. .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhh
Confidence 34556666666666666 333446667777777777777763 3333666677777777777776442 2455566777
Q ss_pred EEEecCCCCCCCCcccccccCcceeEeecCccccccc-hhhcccCcCcEEeCCCccCccccCchhhccCCccceeeeccc
Q 043932 202 FSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFP-QSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGN 280 (1017)
Q Consensus 202 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n 280 (1017)
|++++|.++. ...+..+++|+.+++++|+++...+ . ...+.+++.+++..|.+. .+. ....+..+..+++..|
T Consensus 145 L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~-~i~--~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 145 LNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR-EIE--GLDLLKKLVLLSLLDN 218 (414)
T ss_pred heeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh-ccc--chHHHHHHHHhhcccc
Confidence 7777777742 2344446777777777777764433 2 466677777777777765 222 1223344555566777
Q ss_pred ccCCCCCCccccCC--ccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCc
Q 043932 281 NFFGSIPDSLSNAS--NVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAAN 358 (1017)
Q Consensus 281 ~l~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 358 (1017)
.++..-+ +..+. .|+.+++++|++.... ..+..+.++..|++.+|++..... +.....+..+.+..|
T Consensus 219 ~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~~~--------~~~~~~~~~~~~~~~ 287 (414)
T KOG0531|consen 219 KISKLEG--LNELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISNLEG--------LERLPKLSELWLNDN 287 (414)
T ss_pred cceeccC--cccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccccccc--------ccccchHHHhccCcc
Confidence 6653221 22222 2677777777766332 445556666677777666644322 233344444444444
Q ss_pred ccccccchhHHhhcccceEEEecCCccccccC-ccccccccccEEeccccCCCCCcch
Q 043932 359 QFVGELPHSIANLSSSMIEFRIGGNQIFGIIP-SGIRNLVNLIALGMQSNQLHGTIPD 415 (1017)
Q Consensus 359 ~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~ 415 (1017)
.+... . .... ........++...+..|.+....+.
T Consensus 288 ~~~~~-~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 288 KLALS-E---------------------AISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred hhcch-h---------------------hhhccccccccccccccccccCcccccccc
Confidence 44311 0 0111 1145566777888888877755543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.5e-11 Score=125.90 Aligned_cols=210 Identities=22% Similarity=0.206 Sum_probs=113.1
Q ss_pred hcccCcCcEEeCCCccCccccCc-hhhccCCccceeeecccccCCC--CCCccccCCccceeecccCcccceeecc-ccc
Q 043932 241 ICNISSLERIYLPFNRFSGTLPF-DIVVNLPNLKSLAIGGNNFFGS--IPDSLSNASNVEILDLGFNQFKGKVSID-FSS 316 (1017)
Q Consensus 241 l~~l~~L~~L~Ls~N~l~~~l~~-~~~~~l~~L~~L~L~~n~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~ 316 (1017)
-+++.+|+.+.|.+.... .++. .....+++++.|+|++|-++.- +..-...+++|+.|+|+.|++....... -..
T Consensus 117 Qsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence 345677788888777775 2222 3445566777777777766521 1222344556666666666654222111 112
Q ss_pred cCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCcccccc
Q 043932 317 LKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNL 396 (1017)
Q Consensus 317 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l 396 (1017)
+++|+.|.|+.|.+ +-.--..+....++++.|+|..|....+.......+
T Consensus 196 l~~lK~L~l~~CGl------------------------------s~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~ 245 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGL------------------------------SWKDVQWILLTFPSLEVLYLEANEIILIKATSTKIL 245 (505)
T ss_pred hhhhheEEeccCCC------------------------------CHHHHHHHHHhCCcHHHhhhhcccccceecchhhhh
Confidence 34444444444444 322222222223344444454443323333444555
Q ss_pred ccccEEeccccCCCCCc-chhhcccccccceeccccccccc-cCcc-----cccccccceeeccCcccCCCCc--ccccc
Q 043932 397 VNLIALGMQSNQLHGTI-PDVIGELKNLQGLFLYKNVLQGS-IPSG-----VGNLTKLAKLVMSYNSLQGNIP--SSLGN 467 (1017)
Q Consensus 397 ~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~i~~~~p--~~~~~ 467 (1017)
..|+.|||++|++.... -...+.++.|+.|+++.+.+... .|+. ...+++|++|+++.|+|.. .+ ..+..
T Consensus 246 ~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-w~sl~~l~~ 324 (505)
T KOG3207|consen 246 QTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-WRSLNHLRT 324 (505)
T ss_pred hHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcccc-ccccchhhc
Confidence 66777777777765322 13456677777777777777633 2222 3456788888888888862 22 12334
Q ss_pred ccCCceeecCCCccc
Q 043932 468 CQNLIGFNASHNKLT 482 (1017)
Q Consensus 468 l~~L~~L~ls~N~l~ 482 (1017)
+++|+.|.+..|.++
T Consensus 325 l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 325 LENLKHLRITLNYLN 339 (505)
T ss_pred cchhhhhhccccccc
Confidence 566666666677665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-09 Score=102.29 Aligned_cols=129 Identities=26% Similarity=0.317 Sum_probs=95.4
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC--------cchHHHHHHHHHHHHhcCC--CCceeeeeeeecCCCCCCc
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--------KGAFKSFMAECKALRNIRH--RNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~ 780 (1017)
..+++|+-+.+|.+.+. |..+++|.-..+. +-..++..+|+.++.+++- -++..++++. . +
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~-----~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P-----D 72 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C-----C
Confidence 46899999999999874 4446777543221 1123456789999998853 3444444442 2 4
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
...|+|||++|..|.+++... ...++..+-.-+.-||.. ||||+|+.++||++..++ +.++||
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf 135 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF 135 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence 457999999999999888754 134667777788889999 999999999999997665 999999
Q ss_pred ccccc
Q 043932 861 GLAKF 865 (1017)
Q Consensus 861 G~a~~ 865 (1017)
|++.+
T Consensus 136 GLg~~ 140 (204)
T COG3642 136 GLGEF 140 (204)
T ss_pred Ccccc
Confidence 99874
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.3e-10 Score=82.72 Aligned_cols=39 Identities=56% Similarity=1.020 Sum_probs=31.4
Q ss_pred HHHHHHHHHHHHhcC-CCCCCCCCCCCC--CCCCceeeEEEC
Q 043932 35 ETDRLALLAIKSQLH-DTSGVTSSWNNT--INLCQWTGVTCG 73 (1017)
Q Consensus 35 ~~~~~aLl~~k~~~~-~~~~~~~sw~~~--~~~c~w~gv~c~ 73 (1017)
++|++||++||+++. ||.+.+++|+.+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 679999999999998 677899999876 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.7e-09 Score=99.91 Aligned_cols=142 Identities=23% Similarity=0.251 Sum_probs=100.6
Q ss_pred ccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--------cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 709 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--------KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 709 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
....+.||+-+.|+++.+. |+.+.||.-.... +-..++..+|++.+.+++--.|.-..-++.+. .
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----Y 83 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----C
Confidence 4678999999999999984 7777787643221 11245677899999988533322222222222 2
Q ss_pred eeEEEEEeccC-CCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC---CeE
Q 043932 781 FKALVFECMKN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---VSH 856 (1017)
Q Consensus 781 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k 856 (1017)
.-.++|||++| .++.+++...-. ..........++.+|-+.+.-||.. +|+|+||..+||++..++ .+.
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence 23699999977 478888876532 1223333478899999999999999 999999999999996654 458
Q ss_pred Eeeccccc
Q 043932 857 VGDFGLAK 864 (1017)
Q Consensus 857 l~DfG~a~ 864 (1017)
++|||++.
T Consensus 157 lIdfgls~ 164 (229)
T KOG3087|consen 157 LIDFGLSS 164 (229)
T ss_pred EEeecchh
Confidence 99999975
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6e-10 Score=135.76 Aligned_cols=130 Identities=28% Similarity=0.363 Sum_probs=100.4
Q ss_pred CeEEEEEcCCCC--CccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEe
Q 043932 77 QRVTRLDLSNQR--IGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQL 154 (1017)
Q Consensus 77 ~~v~~l~l~~~~--l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 154 (1017)
..++.|-+.+|. +.......|..++.|++||||+|.=-+.+|.++++|-+|++|+|++..++ .+|..+++|.+|.+|
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 357777787776 55555566888999999999998666689999999999999999999999 899999999999999
Q ss_pred ecccccccccCcccccccCCccEEEecccc--ccCCCCccccCCCcccEEEEecC
Q 043932 155 RVSNNKLEGQIPAEIGSLLKLQTLAVGKNY--LTGRLPDFVGNLSALEVFSITGN 207 (1017)
Q Consensus 155 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~N 207 (1017)
++..+.-...+|..+..+.+|++|.+..-. .+...-..+.++.+|+.+.....
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~ 678 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS 678 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc
Confidence 999887666667777889999999987654 22233344556666666655433
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.6e-09 Score=110.04 Aligned_cols=145 Identities=22% Similarity=0.264 Sum_probs=108.5
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCC--CCceeeeeeeecCCCCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRH--RNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
+.++.|.++.||+++.. +|+.+++|+...... .....+.+|+++++.+.+ ..+.+++.+..... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 56899999999999985 357899999764332 134678899999999965 34566777654321 1134689999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC---------------------------------- 833 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------- 833 (1017)
|++|.++.+.+.. ..++..+...++.++++++++||+..
T Consensus 81 ~i~G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 81 RVDGRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EeCCEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 9999888775431 14667777888888888888888531
Q ss_pred -------------------CCCceeecCCCCceEeCC--CCCeEEeecccccc
Q 043932 834 -------------------QPPMVHGDLKPSNVLLDH--DMVSHVGDFGLAKF 865 (1017)
Q Consensus 834 -------------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~ 865 (1017)
+..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 67789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.1e-10 Score=134.08 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=167.2
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..+.+.+.+-+.+|.++.++.+.-..+|...++|+...... ...+....+-.+.-..++|-++....- ....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence 45567778899999999999998887886667776543221 111222222222212234444443322 1223
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++|++|+.+++|..-++..+ ..+.+..+.....+..+.+|||.. .+.|||++|.|++...+++.++.|
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~ 947 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSG------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD 947 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCC------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence 55789999999999999988765 233334445566778899999998 799999999999999999999999
Q ss_pred ccccccccccc----c----------------cccc-c--CCCcccccccCccccCcccccCCCcCccccchhHHHHHHH
Q 043932 860 FGLAKFLSSHQ----L----------------DTAS-K--TSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLE 916 (1017)
Q Consensus 860 fG~a~~~~~~~----~----------------~~~~-~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e 916 (1017)
||......... . .... . .........||+.|.+||...+.....++|.|+.|++++|
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence 98443221100 0 0000 0 0011234679999999999999999999999999999999
Q ss_pred HHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC
Q 043932 917 LFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM 996 (1017)
Q Consensus 917 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 996 (1017)
.++|.+||.....+... ........+ + .....+......+++...+..+|.+|-
T Consensus 1028 ~l~g~pp~na~tpq~~f-~ni~~~~~~-----~--------------------p~g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQIF-ENILNRDIP-----W--------------------PEGPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred hhcCCCCCCCcchhhhh-hccccCCCC-----C--------------------CCCccccChhhhhhhhhhhccCchhcc
Confidence 99999999875433111 000000000 0 011112244566777788888999998
Q ss_pred CHH
Q 043932 997 EMR 999 (1017)
Q Consensus 997 s~~ 999 (1017)
.|.
T Consensus 1082 ~a~ 1084 (1205)
T KOG0606|consen 1082 GAK 1084 (1205)
T ss_pred Ccc
Confidence 765
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=7.3e-10 Score=88.78 Aligned_cols=60 Identities=33% Similarity=0.538 Sum_probs=37.1
Q ss_pred cceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcc
Q 043932 519 NLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578 (1017)
Q Consensus 519 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 578 (1017)
+|++|++++|+++...+..|.++++|+.|++++|+++.+.|++|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 456666666666655555666666666666666666655556666666666666666653
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-09 Score=87.65 Aligned_cols=61 Identities=36% Similarity=0.597 Sum_probs=57.8
Q ss_pred ccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCC
Q 043932 542 VSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDL 602 (1017)
Q Consensus 542 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 602 (1017)
++|+.|++++|+|+.+.+++|..+++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999988889999999999999999999988888999999999999999986
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=8.2e-08 Score=104.66 Aligned_cols=178 Identities=16% Similarity=0.170 Sum_probs=134.4
Q ss_pred CCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEEeccC-CCHH
Q 043932 717 SFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKN-GSLE 795 (1017)
Q Consensus 717 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 795 (1017)
--.+.|++....+|..|++|+++.........-..-+++++++.|+|+|++.+++... .-+....++|++|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~-tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTY-TFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhh-ccCcceEEEEEecCCCCchHH
Confidence 3458999999999999999999543332222334567889999999999999988743 2334678999999986 4787
Q ss_pred HHHhhCCC---------CccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 796 DWLHQSND---------HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 796 ~~l~~~~~---------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
++.-.... ..+....++..+|.++.|+..||.++|+. |+.-+-+.|.+|+++.+.+++|...|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 76544322 12445688899999999999999999999 9999999999999999999999887776544
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCC
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 923 (1017)
..+. + |-+. --.+-|.=.+|.++..|.||..-
T Consensus 444 ~~d~---------------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDP---------------T-------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCC---------------C-------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 3211 0 1111 12356899999999999999654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2e-09 Score=131.27 Aligned_cols=84 Identities=24% Similarity=0.361 Sum_probs=36.7
Q ss_pred cccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCccc
Q 043932 121 IGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALE 200 (1017)
Q Consensus 121 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 200 (1017)
|..++.|++|||++|.=-+.+|..+++|-+|++|+|+++.++ .+|..+++|.+|.+|++..+.-...+|.....|++|+
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr 645 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLR 645 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhccccc
Confidence 334444444444444333344444444444444444444444 4444444444444444444433323333333344444
Q ss_pred EEEEe
Q 043932 201 VFSIT 205 (1017)
Q Consensus 201 ~L~L~ 205 (1017)
+|.+.
T Consensus 646 ~L~l~ 650 (889)
T KOG4658|consen 646 VLRLP 650 (889)
T ss_pred EEEee
Confidence 44443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.2e-08 Score=101.36 Aligned_cols=135 Identities=25% Similarity=0.209 Sum_probs=100.2
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-----------------c-----chHHHHHHHHHHHHhcCCC-
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----------------K-----GAFKSFMAECKALRNIRHR- 762 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~-----~~~~~~~~E~~~l~~l~h~- 762 (1017)
-+.++..||-|.-+.||.|.+. .|.++|||.-+... . .......+|.++|.++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3556789999999999999997 78889999653110 0 1123457899999999644
Q ss_pred -CceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeec
Q 043932 763 -NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGD 841 (1017)
Q Consensus 763 -niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 841 (1017)
.+.+.+++ +..++||||++|-.|... +++....-.++..|++-+...-.. ||||+|
T Consensus 171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----------r~~~en~~~il~~il~~~~~~~~~---GiVHGD 227 (304)
T COG0478 171 VKVPKPIAW---------NRHAVVMEYIEGVELYRL-----------RLDVENPDEILDKILEEVRKAYRR---GIVHGD 227 (304)
T ss_pred CCCCCcccc---------ccceeeeehcccceeecc-----------cCcccCHHHHHHHHHHHHHHHHHc---CccccC
Confidence 77777765 556899999998666543 122334445566666666655566 999999
Q ss_pred CCCCceEeCCCCCeEEeeccccc
Q 043932 842 LKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 842 lkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
+.+-||+++++|.+.++||-.+.
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred CchheEEEecCCCEEEEeCcccc
Confidence 99999999999999999997665
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.5e-08 Score=101.49 Aligned_cols=145 Identities=15% Similarity=0.063 Sum_probs=100.7
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecCcc-hH----------HHHHHHHHHHHhcC--CCCceeeeeeeecCCCC
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AF----------KSFMAECKALRNIR--HRNLIKIITICSSIDSK 777 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~ 777 (1017)
+.+-+.....|++++. .|+.|.||........ .. ..+.+|...+.++. .-.+.+.+++.......
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 3444444445777766 4678999977432211 11 13778999988884 33344555554332221
Q ss_pred CCceeEEEEEeccCC-CHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-----
Q 043932 778 GADFKALVFECMKNG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH----- 851 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----- 851 (1017)
....-++|||++++. +|.+++..... ...+...+..++.+++..++-||.. ||+|+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 124568999999886 89999864211 2445667788999999999999999 9999999999999975
Q ss_pred --CCCeEEeeccccc
Q 043932 852 --DMVSHVGDFGLAK 864 (1017)
Q Consensus 852 --~~~~kl~DfG~a~ 864 (1017)
++.+.++||+.+.
T Consensus 179 ~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 179 EEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCceEEEEECCccc
Confidence 4688999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.3e-08 Score=99.37 Aligned_cols=125 Identities=24% Similarity=0.248 Sum_probs=81.4
Q ss_pred eEEEEEeCCCcEEEEEEEeeecC--------------c-------c-----hHHHHHHHHHHHHhcCCC--Cceeeeeee
Q 043932 720 SVYKGILGEDEMIVAVKVINLKQ--------------K-------G-----AFKSFMAECKALRNIRHR--NLIKIITIC 771 (1017)
Q Consensus 720 ~V~~~~~~~~~~~vavK~~~~~~--------------~-------~-----~~~~~~~E~~~l~~l~h~--niv~~~~~~ 771 (1017)
.||.|... +|..+|+|+.+... . . ......+|++.|.++... ++.+++++-
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999985 67899999986210 0 0 123456899999999644 567777652
Q ss_pred ecCCCCCCceeEEEEEecc--CCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHH-HhhCCCCCceeecCCCCceE
Q 043932 772 SSIDSKGADFKALVFECMK--NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY-LHHHCQPPMVHGDLKPSNVL 848 (1017)
Q Consensus 772 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~ivH~Dlkp~NIl 848 (1017)
.-++||||++ |..+..+.... ++..+...++.+++..+.. +|.. ||+|+|+.+.||+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl 139 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL 139 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred ---------CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence 2379999998 54554433221 1123455677888886666 4677 9999999999999
Q ss_pred eCCCCCeEEeeccccccc
Q 043932 849 LDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 849 l~~~~~~kl~DfG~a~~~ 866 (1017)
++++ .+.++|||.+...
T Consensus 140 v~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EETT-CEEE--GTTEEET
T ss_pred eecc-eEEEEecCcceec
Confidence 9887 9999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-10 Score=129.61 Aligned_cols=91 Identities=29% Similarity=0.291 Sum_probs=62.2
Q ss_pred cccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCCh-hhhcccCC
Q 043932 513 QIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIP-EFLENLSF 591 (1017)
Q Consensus 513 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~ 591 (1017)
.+..++.|++|||+.|++.-+.--...++. |+.|.|++|-++.. ..+.+|++|+.||||+|-|++.-. ..++.|..
T Consensus 204 ~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~ 280 (1096)
T KOG1859|consen 204 NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSS 280 (1096)
T ss_pred HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHH
Confidence 566677888888888888744434445555 88888888877743 236777888888888887775322 23456677
Q ss_pred CcEEEcccCCCcCcC
Q 043932 592 LEFLNFSHNDLEGEV 606 (1017)
Q Consensus 592 L~~L~l~~N~l~~~~ 606 (1017)
|+.|+|.+|++.+.+
T Consensus 281 L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 281 LIVLWLEGNPLCCAP 295 (1096)
T ss_pred HHHHhhcCCccccCH
Confidence 777888888877643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=8.4e-10 Score=123.43 Aligned_cols=58 Identities=28% Similarity=0.221 Sum_probs=42.8
Q ss_pred ceEEEccCCcccccccccccccccceEEeccCCccCCCCC-ccccccccCcEEeccCCccc
Q 043932 520 LVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIP-HSLGFLKSIKVLNFSSNNLS 579 (1017)
Q Consensus 520 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 579 (1017)
|+.|.|++|.++.. ..+.++.+|+.||||+|-|.+.-. ..++.|..|+.|+|.+|.+-
T Consensus 234 L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 234 LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 88888888888743 246778888888888888775422 23566778888888888887
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.3e-08 Score=115.24 Aligned_cols=155 Identities=15% Similarity=0.236 Sum_probs=103.1
Q ss_pred HHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccccccccccccc-CCCcccccccCccccCcccccCC
Q 043932 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK-TSSSSIGIKGTVGYVAPEYCMGS 899 (1017)
Q Consensus 821 qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~ 899 (1017)
+++.|+.|+|... ++||++|.|++|.++..+..||+.|+.+............. ......-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4558999999874 99999999999999999999999999886554321111111 11111112345689999999998
Q ss_pred CcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHH
Q 043932 900 EASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLN 978 (1017)
Q Consensus 900 ~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~ 978 (1017)
..+.++|+||+|+.+|.+.. |+.-+....... . +......... .......+.++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~--~--~~~~~~~~~~---------------------~~~~~s~~~p~ 239 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL--S--YSFSRNLLNA---------------------GAFGYSNNLPS 239 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcc--h--hhhhhccccc---------------------ccccccccCcH
Confidence 89999999999999999994 555554421110 0 0000000000 00011134577
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHH
Q 043932 979 AIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 979 ~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
++.+-+.+++..++..||++.++.
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhh
Confidence 788888899999999999776654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=1e-06 Score=87.81 Aligned_cols=142 Identities=16% Similarity=0.115 Sum_probs=104.8
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEEeeec---C---cchHHHHHHHHHHHHhcC--CCCceeeeeeeecCCCCCCceeEE
Q 043932 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK---Q---KGAFKSFMAECKALRNIR--HRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 713 lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
-|+||.+.|+..... |..+-+|.-... . +.....|.+|+..+.++. .-.+.+++ ++...........+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 467899999998875 335778865411 0 234578999999999984 33355555 443332333455689
Q ss_pred EEEeccC-CCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC--eEEeecc
Q 043932 785 VFECMKN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV--SHVGDFG 861 (1017)
Q Consensus 785 v~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG 861 (1017)
|+|-+++ .+|.+++..... .+.+..++..+..+++..++-||+. |+.|+|+.+.||+++.++. ++++||.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 9998753 489999865421 2557777889999999999999999 9999999999999987677 9999998
Q ss_pred ccc
Q 043932 862 LAK 864 (1017)
Q Consensus 862 ~a~ 864 (1017)
-++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.2e-07 Score=91.11 Aligned_cols=109 Identities=27% Similarity=0.313 Sum_probs=85.6
Q ss_pred HHHHHHHHHHHhcC--CCCceeeeeeeecCCCCCCceeEEEEEeccCC-CHHHHHhhCCCCccccccCHHHHHHHHHHHH
Q 043932 747 KSFMAECKALRNIR--HRNLIKIITICSSIDSKGADFKALVFECMKNG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823 (1017)
Q Consensus 747 ~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~ 823 (1017)
.+..+|...+.++. .-.+.+.+++........ ...++|+|++++. +|.+++.... ..+......++.+++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALA 128 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHH
Confidence 46778888888774 445566677665432222 4568999999874 7999988643 245667788999999
Q ss_pred HHHHHHhhCCCCCceeecCCCCceEeCCCC---CeEEeecccccc
Q 043932 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---VSHVGDFGLAKF 865 (1017)
Q Consensus 824 ~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~ 865 (1017)
..++-||+. ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 129 ~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 129 RLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999 999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=9.2e-09 Score=91.87 Aligned_cols=83 Identities=22% Similarity=0.313 Sum_probs=42.4
Q ss_pred cceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcc
Q 043932 519 NLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFS 598 (1017)
Q Consensus 519 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 598 (1017)
.|+..+|++|.+....+..-...+.++.|+|++|+|+ .+|..+..++.|+.||++.|.+. ..|..+..|.+|..||..
T Consensus 54 el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 54 ELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred eEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence 3444555555555322222233345555555555555 24444555555555555555555 445555555555555555
Q ss_pred cCCCc
Q 043932 599 HNDLE 603 (1017)
Q Consensus 599 ~N~l~ 603 (1017)
+|.+.
T Consensus 132 ~na~~ 136 (177)
T KOG4579|consen 132 ENARA 136 (177)
T ss_pred CCccc
Confidence 55544
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.2e-08 Score=96.58 Aligned_cols=234 Identities=25% Similarity=0.311 Sum_probs=122.8
Q ss_pred eEEEEEcCCCCCccc----cCcccCCCCCCCEEEccCCCCCC----CCCcc-------cccccccccccCCCCcccccCC
Q 043932 78 RVTRLDLSNQRIGGI----LSPYVGNLSFLRYINLSDNSFHG----EIPQE-------IGNLLRLEKLALPNNSFSGTIP 142 (1017)
Q Consensus 78 ~v~~l~l~~~~l~~~----~~~~l~~l~~L~~L~L~~n~l~~----~~p~~-------~~~l~~L~~L~L~~n~l~~~~p 142 (1017)
.++.+||++|.|+.. +...+.+-.+|+..++|+- ++| ++|+. +-++++|+..+||.|.|....|
T Consensus 31 ~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~-ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~~ 109 (388)
T COG5238 31 ELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDA-FTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFP 109 (388)
T ss_pred ceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhh-hhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcccc
Confidence 478899999998754 3445667788899888873 333 33433 3456777777777777776666
Q ss_pred Ccc----cCCCcceEeecccccccccCccccc-------------ccCCccEEEeccccccCCCCccccCCCcccEEEEe
Q 043932 143 TNL----SRCSNLIQLRVSNNKLEGQIPAEIG-------------SLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSIT 205 (1017)
Q Consensus 143 ~~l----~~l~~L~~L~L~~n~l~~~~p~~~~-------------~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 205 (1017)
..+ +.-+.|++|.|++|.+....-.-++ +-|.|++.....|++.. .|....
T Consensus 110 e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlen-gs~~~~----------- 177 (388)
T COG5238 110 EELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLEN-GSKELS----------- 177 (388)
T ss_pred hHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhcc-CcHHHH-----------
Confidence 543 3456777777777766422222222 23445555555555541 111100
Q ss_pred cCCCCCCCCcccccccCcceeEeecCccccc-----cchhhcccCcCcEEeCCCccCccc---cCchhhccCCccceeee
Q 043932 206 GNSLGGKIPTTLGLLRNLVDLHVGGNQFSGT-----FPQSICNISSLERIYLPFNRFSGT---LPFDIVVNLPNLKSLAI 277 (1017)
Q Consensus 206 ~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~---l~~~~~~~l~~L~~L~L 277 (1017)
...|..-..|+++.+..|.|... +-..+..+.+|+.|||..|.++-. .-.......+.|+.|.+
T Consensus 178 --------a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~l 249 (388)
T COG5238 178 --------AALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRL 249 (388)
T ss_pred --------HHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccc
Confidence 00111112444555555544311 001123345555555555555410 01112233445666666
Q ss_pred cccccCCCCCCcc------ccCCccceeecccCcccceeecc-------ccccCccceEecccCcCCC
Q 043932 278 GGNNFFGSIPDSL------SNASNVEILDLGFNQFKGKVSID-------FSSLKNLSWLNLEQNNLGM 332 (1017)
Q Consensus 278 ~~n~l~~~~p~~l------~~l~~L~~L~Ls~N~l~~~~~~~-------~~~l~~L~~L~L~~N~l~~ 332 (1017)
.+|-++..-.+++ ...++|..|-..+|.+.+..-.. =..++-|..|.+.+|++..
T Consensus 250 nDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E 317 (388)
T COG5238 250 NDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKE 317 (388)
T ss_pred cchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchh
Confidence 6665553322221 12356666777777655433222 1356677778888888754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1017 | ||||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-48 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-42 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-48 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-42 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-08 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 9e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 9e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 4e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 5e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 6e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-05 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-04 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 3e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-04 |
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 507 bits (1309), Expect = e-167
Identities = 163/574 (28%), Positives = 270/574 (47%), Gaps = 25/574 (4%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
LD+S+ + P++G+ S L+++++S N G+ + I L+ L + +N F G
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
IP +L L ++ NK G+IP + G+ L L + N+ G +P F G+ S
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 199 LEVFSITGNSLGGKIPT-TLGLLRNLVDLHVGGNQFSGTFPQSICNIS-SLERIYLPFNR 256
LE +++ N+ G++P TL +R L L + N+FSG P+S+ N+S SL + L N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 257 FSGTLPFDIVVN-LPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFS 315
FSG + ++ N L+ L + N F G IP +LSN S + L L FN G +
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 316 SLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSM 375
SL L L L N L G L +L+ L L N GE+P ++N ++ +
Sbjct: 440 SLSKLRDLKLWLNMLE-GE-----IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN-L 492
Query: 376 IEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQG 435
+ N++ G IP I L NL L + +N G IP +G+ ++L L L N+ G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 436 SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHN--KLTGALPQQLLSIT 493
+IP+ + + ++ N + G + N + + N + G +QL ++
Sbjct: 553 TIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 494 TLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNS 553
T ++++ G N +++ L +S N SG IP + + L L++ N
Sbjct: 609 TR-NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 554 FHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFS 613
G IP +G L+ + +L+ SSN L G+IP+ + L+ L ++ S+N+L G +P G F
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 614 SKTKLSLQGNVKLCGGTDELHLPTCPSKGSRKPK 647
+ N LCG LP C +
Sbjct: 728 TFPPAKFLNNPGLCG----YPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 479 bits (1234), Expect = e-156
Identities = 177/614 (28%), Positives = 279/614 (45%), Gaps = 35/614 (5%)
Query: 25 SPSFSAGQTNETDRLALLAIKSQLHDTSGVTSSWNNTINLCQWTGVTCGHRHQRVTRLDL 84
S S Q+ + L++ K L D + W++ N C + GVTC R +VT +DL
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPD-KNLLPDWSSNKNPCTFDGVTC--RDDKVTSIDL 57
Query: 85 SN---QRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTI 141
S+ +S + +L+ L + LS++ +G + L L L NS SG +
Sbjct: 58 SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPV 116
Query: 142 PT--NLSRCSNLIQLRVSNNKLEGQIPAEIGSLL-KLQTLAVGKNYLTGRLPD---FVGN 195
T +L CS L L VS+N L+ G L L+ L + N ++G
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 196 LSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFN 255
L+ +I+GN + G + + NL L V N FS P + + S+L+ + + N
Sbjct: 177 CGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGN 233
Query: 256 RFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID-F 314
+ SG I LK L I N F G IP +++ L L N+F G++
Sbjct: 234 KLSGDFSRAI-STCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLS 290
Query: 315 SSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELP-HSIANLSS 373
+ L+ L+L N+ G F +CS L+ L+L++N F GELP ++ +
Sbjct: 291 GACDTLTGLDLSGNHF-YGA-----VPPFFGSCSLLESLALSSNNFSGELPMDTLLKM-R 343
Query: 374 SMIEFRIGGNQIFGIIPSGIRNL-VNLIALGMQSNQLHGTIPDVIGE--LKNLQGLFLYK 430
+ + N+ G +P + NL +L+ L + SN G I + + LQ L+L
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403
Query: 431 NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLL 490
N G IP + N ++L L +S+N L G IPSSLG+ L N L G +PQ+L+
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463
Query: 491 SITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDIS 550
+ TL L L N+L G +P + N NL + +S+N+ +G IP + +L L +S
Sbjct: 464 YVKTLET-LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 551 SNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKG 610
+NSF G IP LG +S+ L+ ++N +G IP + S NF +
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYI---K 579
Query: 611 VFSSKTKLSLQGNV 624
K + GN+
Sbjct: 580 NDGMKKECHGAGNL 593
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 413 bits (1065), Expect = e-131
Identities = 156/552 (28%), Positives = 246/552 (44%), Gaps = 50/552 (9%)
Query: 82 LDLS-NQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI---GNLLRLEKLALPNNSF 137
L++S N L+ L ++LS NS G L+ LA+ N
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190
Query: 138 SGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLS 197
SG + +SRC NL L VS+N IP F+G+ S
Sbjct: 191 SGDVD--VSRCVNLEFLDVSSNNFSTGIP-------------------------FLGDCS 223
Query: 198 ALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRF 257
AL+ I+GN L G + L L++ NQF G P SL+ + L N+F
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPL--KSLQYLSLAENKF 281
Query: 258 SGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID-FSS 316
+G +P + L L + GN+F+G++P + S +E L L N F G++ +D
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
Query: 317 LKNLSWLNLEQNNLGMGTANDLDFVTFLTNCS-SLKILSLAANQFVGELPHSIANLS-SS 374
++ L L+L N G LTN S SL L L++N F G + ++ ++
Sbjct: 342 MRGLKVLDLSFNEF-SGE-----LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 375 MIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQ 434
+ E + N G IP + N L++L + N L GTIP +G L L+ L L+ N+L+
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 435 GSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITT 494
G IP + + L L++ +N L G IPS L NC NL + S+N+LTG +P+ + +
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
Query: 495 LSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSF 554
L++ L LSNN+ +G++P ++G+ ++L+ L +++N F+G IP + I++N
Sbjct: 516 LAI-LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFI 570
Query: 555 HGVIPHSLGFLKSIKVLNFSSN--NLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTK-GV 611
G + K + + N G E L LS N + G
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 612 FSSKTKLSLQGN 623
S L + N
Sbjct: 631 NGSMMFLDMSYN 642
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-25
Identities = 38/130 (29%), Positives = 65/130 (50%), Gaps = 1/130 (0%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
+++++ GG SP N + ++++S N G IP+EIG++ L L L +N S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
G+IP + L L +S+NKL+G+IP + +L L + + N L+G +P+ G
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFET 728
Query: 199 LEVFSITGNS 208
N
Sbjct: 729 FPPAKFLNNP 738
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-17
Identities = 31/90 (34%), Positives = 48/90 (53%)
Query: 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136
+ LD+S + G + +G++ +L +NL N G IP E+G+L L L L +N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 137 FSGTIPTNLSRCSNLIQLRVSNNKLEGQIP 166
G IP +S + L ++ +SNN L G IP
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = 9e-97
Identities = 94/620 (15%), Positives = 176/620 (28%), Gaps = 93/620 (15%)
Query: 37 DRLALLAIKSQLH--------DTSGVTSSWNNTINLCQWT---GVTCGHRHQRVTRLDLS 85
D LAL I L+ + ++WN L W GV+
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN------------ 78
Query: 86 NQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG----TI 141
+ + ++L G +P IG L LE LAL ++
Sbjct: 79 -------------SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125
Query: 142 PTNLSRCSNLIQLRVSNNKLEGQIPAEIG--SLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
P +S + Q + + L + + +
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
N++ + + L L ++G + F + E + +
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYK 239
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSI------- 312
T NL +L + + +P L ++++++ N+ +
Sbjct: 240 TEDLKW-DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 313 -DFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANL 371
D + + + + NNL T L L +L NQ G+LP + +
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVE-----TSLQKMKKLGMLECLYNQLEGKLP-AFGSE 352
Query: 372 SSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDV--IGELKNLQGLFLY 429
+ + NQI I + + L N+L IP++ + + +
Sbjct: 353 -IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFS 410
Query: 430 KNVLQG-------SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLT 482
N + + ++ + +S N + L N N LT
Sbjct: 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470
Query: 483 G-------ALPQQLLSITTLSVYLDLSNNNLNGSLP-LQIGNLKNLVKLIISSNQFSGVI 534
+ + L +DL N L + L LV + +S N FS
Sbjct: 471 EIPKNSLKDENENFKNTYLL-TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-F 528
Query: 535 PVTLSTCVSLEYLDI------SSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLEN 588
P +L+ I N P + S+ L SN++ + N
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN 588
Query: 589 LSFLEFLNFSHNDLEGEVPT 608
+ L+ N +
Sbjct: 589 ---ISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 4e-71
Identities = 68/455 (14%), Positives = 143/455 (31%), Gaps = 47/455 (10%)
Query: 194 GNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSG----TFPQSICNISSLER 249
+ + S+ G G++P +G L L L +G + P+ I S E+
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 250 IYLPFNRFSGTLPFDI-VVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKG 308
+ T + +L I + SI S + N
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 309 KVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSI 368
VS L L + + C + + + Q
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPF-----------VAENICEAWENENSEYAQQYKTEDLKW 245
Query: 369 ANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLH--------GTIPDVIGEL 420
NL + + + +P+ ++ L + + + N+
Sbjct: 246 DNLKD-LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVG 304
Query: 421 KNLQGLFLYKNVLQ-GSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHN 479
+ +Q +++ N L+ + + + + KL L YN L+G +P+ G+ L N ++N
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYN 363
Query: 480 KLTGALPQQLLSITTLSVYLDLSNNNLNGSLP--LQIGNLKNLVKLIISSNQFSGV---- 533
++T +P T L ++N L +P ++ + + S N+ V
Sbjct: 364 QITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421
Query: 534 ---IPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSG-------QIP 583
+ T +++ +++S+N + +N N L+
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
Query: 584 EFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKL 618
E +N L ++ N L + ++ L
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYL 515
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 5e-68
Identities = 80/528 (15%), Positives = 144/528 (27%), Gaps = 117/528 (22%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGE-------------------IPQE 120
T++ + I + S V L+ LR + ++ F E +
Sbjct: 186 TQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244
Query: 121 IGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAV 180
NL L + + N +PT L + + V+ N+ L
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADA-- 301
Query: 181 GKNYLTGRLPDFVGNLSALEVFSITGNSL-GGKIPTTLGLLRNLVDLHVGGNQFSGTFPQ 239
+++ I N+L + T+L ++ L L NQ G P
Sbjct: 302 -------------PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP- 347
Query: 240 SICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEIL 299
+ + L + L +N+ + +P + +++L+ N IP+
Sbjct: 348 AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNK-LKYIPNIFD-------- 397
Query: 300 DLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQ 359
S+ +S ++ N +G S+
Sbjct: 398 --------------AKSVSVMSAIDFSYNEIG----------------------SVDGKN 421
Query: 360 FVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHG-------T 412
F L + ++ + NQI L ++ + N L
Sbjct: 422 F-DPLDPTPFKG-INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 413 IPDVIGELKNLQGLFLYKNVLQGSIPS-GVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNL 471
+ L + L N L L L + +SYNS P+ N L
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 472 IGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFS 531
GF + D N P I +L +L I SN
Sbjct: 539 KGFGIRNQ-------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR 579
Query: 532 GVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLS 579
V ++ LDI N + + + +
Sbjct: 580 KVNEKITP---NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-46
Identities = 46/295 (15%), Positives = 95/295 (32%), Gaps = 23/295 (7%)
Query: 344 LTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFG----IIPSGIRNLVNL 399
L + + LSL G +P +I L+ + +G + P GI ++
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTE-LEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 400 IALGMQSNQLHGTIPDVIGELK--NLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSL 457
T D +L + + Q SI K ++ N++
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 458 QGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNL 517
+ ++ L F ++ + + + L+ NL
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN------ENSEYAQQYKTEDLKWDNL 248
Query: 518 KNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGV--------IPHSLGFLKSIK 569
K+L + + + +P L ++ ++++ N + I+
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQ 308
Query: 570 VLNFSSNNL-SGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGN 623
++ NNL + + L+ + L L +N LEG++P G L+L N
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYN 363
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 1e-93
Identities = 85/308 (27%), Positives = 136/308 (44%), Gaps = 14/308 (4%)
Query: 338 LDFVTFLTNCSSL----KILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFG--IIPS 391
L L N ++L ++G L + + + + G + IPS
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPS 70
Query: 392 GIRNLVNLIALGMQS-NQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKL 450
+ NL L L + N L G IP I +L L L++ + G+IP + + L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 451 VMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSL 510
SYN+L G +P S+ + NL+G N+++GA+P S + L + +S N L G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 511 PLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKV 570
P NL NL + +S N G V + + + + ++ NS + +G K++
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248
Query: 571 LNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGT 630
L+ +N + G +P+ L L FL LN S N+L GE+P G + N LCG
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS- 307
Query: 631 DELHLPTC 638
LP C
Sbjct: 308 ---PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 5e-86
Identities = 90/305 (29%), Positives = 137/305 (44%), Gaps = 13/305 (4%)
Query: 33 TNETDRLALLAIKSQLHDTSGVTSSWNNTINLCQ--WTGVTCGHRHQ--RVTRLDLSNQR 88
N D+ ALL IK L + + + SSW T + C W GV C Q RV LDLS
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 89 IGG--ILSPYVGNLSFLRYINLSD-NSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNL 145
+ + + NL +L ++ + N+ G IP I L +L L + + + SG IP L
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 146 SRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVF-SI 204
S+ L+ L S N L G +P I SL L + N ++G +PD G+ S L +I
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 205 TGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFD 264
+ N L GKIP T L NL + + N G + + ++I+L N + L
Sbjct: 182 SRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK- 239
Query: 265 IVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLN 324
V NL L + N +G++P L+ + L++ FN G++ +L+
Sbjct: 240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSA 297
Query: 325 LEQNN 329
N
Sbjct: 298 YANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-62
Identities = 76/315 (24%), Positives = 115/315 (36%), Gaps = 42/315 (13%)
Query: 203 SITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTF--PQSICNISSLERIYLP-FNRFSG 259
+ G + T + +L + G + P S+ N+ L +Y+ N G
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKN 319
+P I L L L I N G+IPD LS + LD +N G ++ S
Sbjct: 92 PIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG--TLPPS---- 144
Query: 320 LSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFR 379
+++ +L ++ N+ G +P S + S
Sbjct: 145 ------------------------ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 380 IGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPS 439
I N++ G IP NL NL + + N L G + G KN Q + L KN L +
Sbjct: 181 ISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 440 GVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQ--QLLSITTLSV 497
VG L L + N + G +P L + L N S N L G +PQ L +
Sbjct: 240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA- 297
Query: 498 YLDLSNNNLNGSLPL 512
+NN PL
Sbjct: 298 ---YANNKCLCGSPL 309
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 310 bits (795), Expect = 5e-93
Identities = 112/578 (19%), Positives = 203/578 (35%), Gaps = 32/578 (5%)
Query: 74 HRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALP 133
R+ ++T LD+ I + L L+ +NL N + L +L L
Sbjct: 46 TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105
Query: 134 NNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPD-- 191
+NS + NLI L +S+N L L LQ L + N + +
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 192 FVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSIC---NISSLE 248
+ S+L+ ++ N + P + L L + Q + + +C +S+
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 249 RIYLPFNRFSGTLPFDIVVNL--PNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQF 306
+ L ++ S + L NL L + NN DS + +E L +N
Sbjct: 226 NLSLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
Query: 307 KGKVSIDFSSLKNLSWLNLEQNNLGMGTAN----DLDFVTFLTNCSSLKILSLAANQFVG 362
+ S L N+ +LNL+++ + +D +F L+ L++ N G
Sbjct: 285 QHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF-QWLKCLEHLNMEDNDIPG 343
Query: 363 ELPHSIANLSSSMIEFRIGGN--QIFGIIPSGIRNLVN--LIALGMQSNQLHGTIPDVIG 418
+ L ++ + + + + +L + L L + N++ D
Sbjct: 344 IKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402
Query: 419 ELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNAS 477
L +L+ L L N + + L + ++ +SYN +S +L
Sbjct: 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLR 462
Query: 478 HNKLTGALPQQLLSITTLS--VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFS---- 531
L + L LDLSNNN+ + L+ L L + N +
Sbjct: 463 RVALKN-VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWK 521
Query: 532 ----GVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLE 587
G L L L++ SN F + L +K+++ NNL+
Sbjct: 522 HANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581
Query: 588 NLSFLEFLNFSHNDLEGEVPT--KGVFSSKTKLSLQGN 623
N L+ LN N + F + T+L ++ N
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = 2e-91
Identities = 102/560 (18%), Positives = 200/560 (35%), Gaps = 44/560 (7%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
+T L+L++ ++ + + S L +++ N+ P+ L L+ L L +N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
+ C+NL +L + +N ++ L TL + N L+ L
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 199 LEVFSITGNSLGGKIPTTLGLLRN--LVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR 256
L+ ++ N + L + N L L + NQ P I L ++L +
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 257 FSGTLPFDI--VVNLPNLKSLAIGGNNFFGSIPDSLSN--ASNVEILDLGFNQFKGKVSI 312
+L + + ++++L++ + + + +N+ +LDL +N +
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 313 DFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLS 372
F+ L L + LE NN+ L + +++ L+L + +
Sbjct: 267 SFAWLPQLEYFFLEYNNI-----QHLFSHSL-HGLFNVRYLNLKRSFTKQSISL------ 314
Query: 373 SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNV 432
+ I + L L L M+ N + G ++ L NL+ L L +
Sbjct: 315 ----------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 433 LQGSIPSGVG----NLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQ 488
+ + L L ++ N + + +L + N++ L Q
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 489 LLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGV--IPVTLSTCVSLEY 546
+ LS N + +L +L++ V P +L
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484
Query: 547 LDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLS--------GQIPEFLENLSFLEFLNFS 598
LD+S+N+ + L L+ +++L+ NNL+ G FL+ LS L LN
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 599 HNDLEGEVPTKGVFSSKTKL 618
N + VF +L
Sbjct: 545 SNGFDEIPV--EVFKDLFEL 562
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 3e-90
Identities = 114/569 (20%), Positives = 203/569 (35%), Gaps = 41/569 (7%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
T L L + I I + L ++LS N L L++L L NN
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 140 TIPTNLS--RCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVG--- 194
L S+L +L +S+N+++ P ++ +L L + L L + +
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219
Query: 195 NLSALEVFSITGNSLGGKIPTTLGLLR--NLVDLHVGGNQFSGTFPQSICNISSLERIYL 252
+++ S++ + L TT L+ NL L + N + S + LE +L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 253 PFNRFSGTLPFDIVVNLPNLKSL---------AIGGNNFFGSIPDSLSNASNVEILDLGF 303
+N L + L N++ L +I + S +E L++
Sbjct: 280 EYNNIQH-LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 304 NQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGE 363
N G S F+ L NL +L+L + + T + FV+ S L IL+L N+
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL--AHSPLHILNLTKNKISKI 396
Query: 364 LPHSIANLSSSMIEFRIGGNQIFGIIPSG-IRNLVNLIALGMQSNQLHGTIPDVIGELKN 422
+ + L + +G N+I + R L N+ + + N+ + + +
Sbjct: 397 ESDAFSWLGH-LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455
Query: 423 LQGLFLYKNVLQG--SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNK 480
LQ L L + L+ S PS L L L +S N++ L + L + HN
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515
Query: 481 LTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLST 540
L L + G + L +L L + SN F +
Sbjct: 516 LA-----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558
Query: 541 CVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPE-FLENLSFLEFLNFSH 599
L+ +D+ N+ + + S+K LN N ++ + F L L+
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 600 NDLEGEVPTKGVFSSKTKLSLQGNVKLCG 628
N + + F + + +L
Sbjct: 619 NPFDCTCESIAWFVNWINETHTNIPELSS 647
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 1e-76
Identities = 101/549 (18%), Positives = 186/549 (33%), Gaps = 41/549 (7%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIG--NLLRLEKLALPNNSF 137
LDLS+ + L L+ + LS+N +E+ L+KL L +N
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 138 SGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIG---SLLKLQTLAVGKNYLTGRLPDFVG 194
P L L ++N +L + ++ + ++ L++ + L+
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
Query: 195 NL--SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYL 252
L + L + ++ N+L + L L + N F S+ + ++ + L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 253 PFNRFSG--------TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFN 304
+ + L L+ L + N+ G + + N++ L L +
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 305 QFKGKV--SIDFSSLKN--LSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360
+ + F SL + L LNL +N + + ++ F + L++L L N+
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKI-----SKIESDAF-SWLGHLEVLDLGLNEI 417
Query: 361 VGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHG--TIPDVIG 418
EL ++ E + N+ + + + +L L ++ L + P
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 419 ELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQ--------GNIPSSLGNCQN 470
L+NL L L N + + L KL L + +N+L G L +
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 471 LIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQF 530
L N N + + L +DL NNLN N +L L + N
Sbjct: 538 LHILNLESNGFDEIPVEVFKDLFEL-KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 531 SGVIPVTLSTCV-SLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQI----PEF 585
+ V +L LD+ N F F+ I + + LS P
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPH 656
Query: 586 LENLSFLEF 594
F
Sbjct: 657 YHGFPVRLF 665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 22/85 (25%), Positives = 29/85 (34%), Gaps = 8/85 (9%)
Query: 542 VSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHND 601
VS E D S +P L +I VLN + N L S L L+ N
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 602 LEGEVPTKGVFSSKTKL---SLQGN 623
+ P + L +LQ N
Sbjct: 61 ISKLEP--ELCQKLPMLKVLNLQHN 83
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = 2e-92
Identities = 109/555 (19%), Positives = 191/555 (34%), Gaps = 41/555 (7%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
LDLS + + S + L+ ++LS +L L L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTG-RLPDFVGNLS 197
S S+L +L L IG L L+ L V N + +LP++ NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 198 ALEVFSITGNSLGGKIPTTLGLLRNL----VDLHVGGNQFSGTFPQSICNISSLERIYLP 253
LE ++ N + T L +L + + L + N + P + I L ++ L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLR 208
Query: 254 FNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID 313
N S + + L L+ + F D
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE---------------------KFD 247
Query: 314 FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSS 373
S+L+ L L +E+ L D + +++ SL + S +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS---YNF 304
Query: 374 SMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVL 433
+ + +++L L G +L +L+ L L +N L
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGL 359
Query: 434 Q--GSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLS 491
G T L L +S+N + + S+ + L + H+ L +
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 492 ITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVI-PVTLSTCVSLEYLDIS 550
+YLD+S+ + + L +L L ++ N F P + +L +LD+S
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 551 SNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT-- 608
+ P + L S++VLN S NN + L+ L+ L++S N +
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538
Query: 609 KGVFSSKTKLSLQGN 623
+ SS L+L N
Sbjct: 539 QHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 4e-70
Identities = 95/483 (19%), Positives = 156/483 (32%), Gaps = 33/483 (6%)
Query: 141 IPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALE 200
IP NL + L +S N L S +LQ L + + + +LS L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 201 VFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGT 260
+TGN + L +L L + I ++ +L+ + + N
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 261 LPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEI----LDLGFNQFKGKVSIDFSS 316
+ NL NL+ L + N L + + LDL N F
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 317 LKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGE--LPHSIANLSSS 374
+ L L L N + + + L++ L +F E L +
Sbjct: 200 I-RLHKLTLRNNFDSLNVMKT-----CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
Query: 375 MIEFRIGGNQI------FGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL 428
+ I ++ I L N+ + + S + Q L L
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLEL 311
Query: 429 YKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLT--GALP 486
+ +L +L ++ S +G S + +L + S N L+ G
Sbjct: 312 VNCKFGQFPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCS 366
Query: 487 QQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPV-TLSTCVSLE 545
Q T+L YLDLS N + + L+ L L + + + +L
Sbjct: 367 QSDFGTTSLK-YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 546 YLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQI-PEFLENLSFLEFLNFSHNDLEG 604
YLDIS L S++VL + N+ P+ L L FL+ S LE
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 605 EVP 607
P
Sbjct: 485 LSP 487
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 5e-65
Identities = 90/510 (17%), Positives = 175/510 (34%), Gaps = 51/510 (10%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHG-EIPQEIGNLLRLEKLALPNNSFS 138
+L + + + +G+L L+ +N++ N ++P+ NL LE L L +N
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 139 GTIPTNLSRCSNL----IQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP-DFV 193
T+L + + L +S N + I ++L L + N+ + + +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
Query: 194 GNLSALEVFSITGNSLGGKI---PTTLGLLRNLVDLHVGGNQFS------GTFPQSICNI 244
L+ LEV + + L L +L + + + +
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 245 SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF-------------------FGS 285
+++ L F + L + F G
Sbjct: 282 TNVSSFSLVSVTIERVKDFS---YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 286 IPDSLSNASNVEILDLGFNQ--FKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTF 343
S + ++E LDL N FKG S +L +L+L N + ++N
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN------- 391
Query: 344 LTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALG 403
L+ L + S+ ++I I L +L L
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 404 MQSNQLHGTI-PDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIP 462
M N PD+ EL+NL L L + L+ P+ +L+ L L MS+N+
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 463 SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQ--IGNLKNL 520
+L + S N + + Q+L + +L+L+ N+ + Q + +K+
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQ 571
Query: 521 VKLIISSNQFSGVIPVTLSTCVSLEYLDIS 550
+L++ + P + + L+I+
Sbjct: 572 RQLLVEVERMECATPSDKQG-MPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 30/159 (18%), Positives = 53/159 (33%), Gaps = 7/159 (4%)
Query: 467 NCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIIS 526
N+ + +P L T LDLS N L + L L +S
Sbjct: 6 VVPNIT-YQCMELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 527 SNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFL 586
+ + + L L ++ N + + L S++ L NL+ +
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 587 ENLSFLEFLNFSHNDLEGEVPTKGVFSSK--TKLSLQGN 623
+L L+ LN +HN ++ + + L L N
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-12
Identities = 25/128 (19%), Positives = 47/128 (36%), Gaps = 3/128 (2%)
Query: 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136
+ +T LDLS ++ + +LS L+ +N+S N+F L L+ L N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 137 FSGTIPTNLSRC-SNLIQLRVSNNKLEGQIPAE--IGSLLKLQTLAVGKNYLTGRLPDFV 193
+ L S+L L ++ N + + + + L V + P
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 194 GNLSALEV 201
+ L +
Sbjct: 590 QGMPVLSL 597
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 4e-85
Identities = 103/643 (16%), Positives = 193/643 (30%), Gaps = 87/643 (13%)
Query: 27 SFSAGQTNETDRLALLAIKSQLH-----------DTSGVTSSWNNTINLCQW---TGVTC 72
D AL AI L + + + +WN L W GV
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL 319
Query: 73 GHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLAL 132
+ + RVT L L+ G + +G L+ L+ ++ +S L +
Sbjct: 320 DN-NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 133 PNNSFSGTIPTNLS------RCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLT 186
+ S+L+Q ++ N I + LK + N +T
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 187 GRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISS 246
+ + L+ L++ + N + S N+
Sbjct: 439 F-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-----DYAKQYENEELSWSNLKD 492
Query: 247 LERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF---------FGSIPDSLSNASNVE 297
L + L LP + +LP L+SL I N + + D ++
Sbjct: 493 LTDVELYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 298 ILDLGFNQFKG-KVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLA 356
I +G+N + S + L L+ N + + L L L
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--------HLEAFGTNVKLTDLKLD 603
Query: 357 ANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPS-GIRNLVNLIALGMQSNQLHGTIPD 415
NQ E+P + + N++ I +++ + ++ N++ +
Sbjct: 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
Query: 416 V-----IGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQ-------GNIPS 463
+ + N + L N +Q + ++ +++S N +
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722
Query: 464 SLGNCQNLIGFNASHNKLTGALPQQLL--SITTLSVYLDLSNNNLNGSLPLQIGNLKNLV 521
+ N L + NKLT L ++ LS +D+S N + S P Q N L
Sbjct: 723 NYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSN-MDVSYNCFS-SFPTQPLNSSQLK 779
Query: 522 KLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQ 581
I D N P + S+ L SN++
Sbjct: 780 AFGIRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK- 820
Query: 582 IPEFLENLSFLEFLNFSHNDL-EGEVPTKGVFSSKTKLSLQGN 623
+ E + L L+ + N +V + + L +
Sbjct: 821 VDE--KLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 215 bits (548), Expect = 4e-58
Identities = 78/534 (14%), Positives = 143/534 (26%), Gaps = 127/534 (23%)
Query: 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHG-------------------EIP 118
+ T++ RI I S + L+ L+ I +++ F
Sbjct: 426 KDTQIGNLTNRITFI-SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE 484
Query: 119 QEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTL 178
NL L + L N +P L L L ++ N+
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADW------ 537
Query: 179 AVGKNYLTGRLPDFVGNLSALEVFSITGNSLGG-KIPTTLGLLRNLVDLHVGGNQFSGTF 237
RL D +++F + N+L +L + L L N+
Sbjct: 538 --------TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RH 587
Query: 238 PQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPD--SLSNASN 295
++ L + L +N+ +P D ++ L N IP+ + +
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK-LKYIPNIFNAKSVYV 645
Query: 296 VEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSL 355
+ +D +N+ + S+ + +N L
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL------------------------- 680
Query: 356 AANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQL------ 409
N+I + + + +N +
Sbjct: 681 -------------------------SYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 410 -HGTIPDVIGELKNLQGLFLYKNVLQGSIPS--GVGNLTKLAKLVMSYNSLQGNIPSSLG 466
L + L N L S+ L L+ + +SYN P+
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773
Query: 467 NCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIIS 526
N L F H D N + P I +L++L I
Sbjct: 774 NSSQLKAFGIRHQ-------------------RDAEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 527 SNQFSGVIPVTLSTCVSLEYLDISSNSF-HGVIPHSLGFLKS-IKVLNFSSNNL 578
SN V L LDI+ N + ++++ + VL +
Sbjct: 815 SNDIRKVDEKLTP---QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 6e-83
Identities = 101/315 (32%), Positives = 161/315 (51%), Gaps = 34/315 (10%)
Query: 696 SYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECK 754
S EL A+ F++ N++G+G FG VYKG L D +VAVK + + +G F E +
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 755 ALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQ 814
+ HRNL+++ C + + LV+ M NGS+ L + + L +
Sbjct: 80 MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPES--QPPLDWPK 132
Query: 815 RVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTA 874
R IA+ A + YLH HC P ++H D+K +N+LLD + + VGDFGLAK +
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---- 188
Query: 875 SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFT---EG 931
+ + ++GT+G++APEY ++S DV+ +G++LLEL TG+R D A +
Sbjct: 189 ---THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 932 LTLHEFAKIALPE-KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSME 990
+ L ++ K L E K+ +VD L E + +I++ +LC+
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNY--------------KDEEVEQLIQVALLCTQS 291
Query: 991 SPFERMEMRDVVAKL 1005
SP ER +M +VV L
Sbjct: 292 SPMERPKMSEVVRML 306
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 3e-78
Identities = 105/538 (19%), Positives = 192/538 (35%), Gaps = 23/538 (4%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
L+ S + I + L L +++L+ + + RL+ L L N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
T LS L L + + + L++L +G N+++
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 199 LEVFSITGNSLGGKIPTTLGLLRNL--VDLHVGGNQFSGTFPQSICNISSLERIYLPFNR 256
L+V N++ + L+ + L++ GN + + + + + +
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQ 213
Query: 257 FSGTLPFDIV-VNLPNLKSLAIGGNNFFGSIPDSLSN--ASNVEILDLGFNQFKGKVSID 313
+ + + +L + P +VE ++L + F S
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 314 FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSS 373
F L L+L +L + + L S+LK L L+AN+F S +N
Sbjct: 274 FHCFSGLQELDLTATHLS-------ELPSGLVGLSTLKKLVLSANKFENLCQISASNF-P 325
Query: 374 SMIEFRIGGNQIFGIIPSG-IRNLVNLIALGMQSNQLH--GTIPDVIGELKNLQGLFLYK 430
S+ I GN + +G + NL NL L + + + + L +LQ L L
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385
Query: 431 NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIP-SSLGNCQNLIGFNASHNKLTGALPQQL 489
N +L L +++ L+ S N L N SH+ L + Q
Sbjct: 386 NEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445
Query: 490 LSITTLSVYLDLSNNNLNGSLPLQIG---NLKNLVKLIISSNQFSGVIPVTLSTCVSLEY 546
+ L +L+L N+ + L L L++S S + ++ + +
Sbjct: 446 DGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504
Query: 547 LDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEG 604
+D+S N +L LK I LN +SN++S +P L LS +N N L+
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-73
Identities = 103/566 (18%), Positives = 187/566 (33%), Gaps = 28/566 (4%)
Query: 71 TCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKL 130
C + T + N + I + + S N L+ L L
Sbjct: 7 KCIEKEVNKT-YNCENLGLNEIPG---TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 131 ALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP 190
L L L ++ N L + L+ L + ++
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122
Query: 191 DFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERI 250
+ N LE + N + L L N + + ++ +
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL 182
Query: 251 YLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNAS--NVEILDLGFNQFKG 308
L N + +SL GG I L N++ ++ + +
Sbjct: 183 SLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242
Query: 309 KVSIDFSSLKNLS--WLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPH 366
F L +S +NL+++ ++ TF S L+ L L A ELP
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYF-----FNISSNTF-HCFSGLQELDLTATHL-SELPS 295
Query: 367 SIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTI-PDVIGELKNLQG 425
+ L S++ + + N+ + N +L L ++ N + + L+NL+
Sbjct: 296 GLVGL-STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 426 LFLYKNVLQGSIPSGV--GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTG 483
L L + ++ S + NL+ L L +SYN + C L + + +L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 484 ALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPV---TLST 540
Q L L+LS++ L+ S L L L + N F +L T
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474
Query: 541 CVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
LE L +S + H+ LK + ++ S N L+ E L +L + +LN + N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASN 533
Query: 601 DLEGEVPTKGVFSSKTKLS---LQGN 623
+ +P + ++ L+ N
Sbjct: 534 HISIILP--SLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-54
Identities = 84/490 (17%), Positives = 161/490 (32%), Gaps = 27/490 (5%)
Query: 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNL--LRLEKLALPN 134
+ + L L + I I P L+ ++ +N+ H +++ +L L L
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 135 NSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIG--SLLKLQTLAVGKNYLTGRLPDF 192
N + I + L + I + ++ L P
Sbjct: 189 NDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 193 VGNLSA--LEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERI 250
L +E ++ + T L +L + S P + +S+L+++
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306
Query: 251 YLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSI-PDSLSNASNVEILDLGFNQFKGK 309
L N+F L N P+L L+I GN + L N N+ LDL + +
Sbjct: 307 VLSANKFEN-LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365
Query: 310 VSID--FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHS 367
+ +L +L LNL N L F C L++L LA + + S
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEP-----LSLKTEAF-KECPQLELLDLAFTRLKVKDAQS 419
Query: 368 IANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTI---PDVIGELKNLQ 424
+ + + + L L L +Q N + + L L+
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479
Query: 425 GLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGA 484
L L L +L + + +S+N L + +L + + + N + N ++
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISII 538
Query: 485 LPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSL 544
LP L ++ ++L N L+ + N+ L + + L
Sbjct: 539 LPSLLPILSQQR-TINLRQNPLDCT----CSNIYFLEWYKENMQKLEDTEDTLCENPPLL 593
Query: 545 EYLDISSNSF 554
+ +S +
Sbjct: 594 RGVRLSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-45
Identities = 68/395 (17%), Positives = 136/395 (34%), Gaps = 18/395 (4%)
Query: 75 RHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGN--LLRLEKLAL 132
+ L+L+ I GI P + + + +N I + + N + L
Sbjct: 177 QQATNLSLNLNGNDIAGI-EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 133 PNNSFSGTIPTNLSRCS--NLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP 190
+ P ++ + + + LQ L + +L+ LP
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP 294
Query: 191 DFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGT-FPQSICNISSLER 249
+ LS L+ ++ N + +L L + GN + N+ +L
Sbjct: 295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 250 IYLPFNRFSG-TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKG 308
+ L + + NL +L+SL + N ++ +E+LDL F + K
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 309 KVSID-FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHS 367
K + F +L L LNL + L + + +L+ L+L N F
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQ------LFDGLPALQHLNLQGNHFPKGNIQK 468
Query: 368 IANLS--SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQG 425
+L + + + I +L + + + N+L + + + LK +
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY- 527
Query: 426 LFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGN 460
L L N + +PS + L++ + + N L
Sbjct: 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 5e-75
Identities = 101/541 (18%), Positives = 186/541 (34%), Gaps = 34/541 (6%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
+DLS + + S N S L++++LS + L L L L N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTG-RLPDFVGNLS 197
P + S ++L L KL IG L+ L+ L V N++ +LP + NL+
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 198 ALEVFSITGNSLGGKIPTTLGLLRNL----VDLHVGGNQFSGTFPQSICNISSLERIYLP 253
L ++ N + L LR + L + N L + L
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLR 212
Query: 254 FNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNAS--------NVEILDLGFNQ 305
N S + + NL L + F + S ++ L +
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 306 FKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELP 365
+ F L N+S ++L + + ++ + + LS+ Q
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVS--------IKYLEDVPKHFKWQSLSIIRCQLKQFPT 324
Query: 366 HSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELK--NL 423
+ L + N+ I L +L L + N L + +L +L
Sbjct: 325 LDLPFLK----SLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378
Query: 424 QGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIP-SSLGNCQNLIGFNASHNKLT 482
+ L L N + + L +L L +++L+ S+ + + L+ + S+
Sbjct: 379 RHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 483 GALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLKNLVKLIISSNQFSGVIPVTLSTC 541
L +T+L+ L ++ N+ + + N NL L +S Q + T
Sbjct: 438 IDFDGIFLGLTSLN-TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 542 VSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHND 601
L+ L++S N+ + L S+ L+ S N + L F N ++N
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 602 L 602
+
Sbjct: 557 V 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 4e-61
Identities = 100/528 (18%), Positives = 178/528 (33%), Gaps = 41/528 (7%)
Query: 115 GEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLK 174
G + I + + + S +P ++ S+ + +S N L+ + +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 175 LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFS 234
LQ L + + + L L +TGN + P + L +L +L + +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 235 GTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNAS 294
I + +L+++ + N NL NL + + N + L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 295 N----VEILDLGFNQFKGKVSIDFSSLKNLS--WLNLEQNNLGMGTANDLDFVTFLTNCS 348
LD+ N I + + + L L N + T L N +
Sbjct: 178 ENPQVNLSLDMSLNPID---FIQDQAFQGIKLHELTLRGNFN-----SSNIMKTCLQNLA 229
Query: 349 SLKILSLAANQFVGEL------PHSIANLSS-SMIEFRIGGNQIFGIIPSGIRNLVNLIA 401
L + L +F E P + L ++ EFR+ F L N+ A
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289
Query: 402 LGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNI 461
+ + + + DV Q L + + L+ P+ +L L L ++ N +I
Sbjct: 290 MSLAGVSIK-YLEDVPKHF-KWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKG--SI 342
Query: 462 PSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSV-YLDLSNNNLNGSLPLQIGNLKNL 520
+L + S N L+ + + T S+ +LDLS N + L+ L
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEEL 401
Query: 521 VKLIISSNQFSGVIPV-TLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLS 579
L + V + L YLDIS + L S+ L + N+
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461
Query: 580 GQIP-EFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKL---SLQGN 623
N + L FL+ S LE GVF + +L ++ N
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISW--GVFDTLHRLQLLNMSHN 507
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-32
Identities = 54/312 (17%), Positives = 110/312 (35%), Gaps = 20/312 (6%)
Query: 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSF 137
+ L+ L+ + ++L+ S + +++ + + L++
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319
Query: 138 SGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNL- 196
+L L L ++ NK I + +L L L + +N L+ +L
Sbjct: 320 KQFPTLDL---PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 197 -SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQS-ICNISSLERIYLPF 254
++L ++ N + L L L + S ++ L + + +
Sbjct: 375 TNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433
Query: 255 NRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIP-DSLSNASNVEILDLGFNQFKGKVSID 313
I + L +L +L + GN+F + + +N +N+ LDL Q +
Sbjct: 434 TNTK-IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
Query: 314 FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSS 373
F +L L LN+ NNL LD + SL L + N+ + +
Sbjct: 493 FDTLHRLQLLNMSHNNL-----LFLDSSHY-NQLYSLSTLDCSFNRIET-SKGILQHFPK 545
Query: 374 SMIEFRIGGNQI 385
S+ F + N +
Sbjct: 546 SLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 18/85 (21%), Positives = 30/85 (35%)
Query: 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136
+T LDLS ++ I L L+ +N+S N+ L L L N
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 137 FSGTIPTNLSRCSNLIQLRVSNNKL 161
+ +L ++NN +
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSV 557
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 2e-72
Identities = 98/341 (28%), Positives = 156/341 (45%), Gaps = 43/341 (12%)
Query: 674 RRRRSARKSVDTSPREKQFP----TVSYAELSKATSEFASSNMIGQGSFGSVYKGILGED 729
+ ++ D P V +L +AT+ F +IG G FG VYKG+L D
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RD 62
Query: 730 EMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789
VA+K + + F E + L RH +L+ +I C + L+++ M
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYM 117
Query: 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
+NG+L+ L+ S+ ++ QR+ I I A + YLH ++H D+K N+LL
Sbjct: 118 ENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILL 172
Query: 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG---SEASMTGD 906
D + V + DFG++K + +T S++ +KGT+GY+ PEY + +E S D
Sbjct: 173 DENFVPKITDFGISKKGTE-----LDQTHLSTV-VKGTLGYIDPEYFIKGRLTEKS---D 223
Query: 907 VYSFGILLLELFTGRRPTDAAFTEG-LTLHEFAKIALPE-KVIEIVDPLLLIEVMANNSM 964
VYSFG++L E+ R + + L E+A + ++ +IVDP L
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL---------- 273
Query: 965 IQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+ IR E L V C S +R M DV+ KL
Sbjct: 274 -ADKIRP---ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 9e-68
Identities = 87/342 (25%), Positives = 140/342 (40%), Gaps = 64/342 (18%)
Query: 684 DTSPREKQFPTVSYAELSKATSEF------ASSNMIGQGSFGSVYKGILGEDEMIVAVKV 737
+ +F + S+ EL T+ F N +G+G FG VYKG + + VAVK
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKK 61
Query: 738 INLKQKGAFKS------FMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKN 791
L + F E K + +H NL++++ S D LV+ M N
Sbjct: 62 --LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPN 114
Query: 792 GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 851
GSL D L + L+ R IA A+ I +LH + +H D+K +N+LLD
Sbjct: 115 GSLLDRLSCLDGTP---PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDE 168
Query: 852 DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG------ 905
+ + DFGLA+ + ++T +S I GT Y+APE + G
Sbjct: 169 AFTAKISDFGLARA-----SEKFAQTVMTS-RIVGTTAYMAPEA-------LRGEITPKS 215
Query: 906 DVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK--VIEIVDPLLLIEVMANNS 963
D+YSFG++LLE+ TG D L + + E+ + + +D + N++
Sbjct: 216 DIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKM------NDA 268
Query: 964 MIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+ C E +R +++ V L
Sbjct: 269 DSTSVEAM---------YSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-58
Identities = 70/329 (21%), Positives = 129/329 (39%), Gaps = 49/329 (14%)
Query: 696 SYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKA 755
L + + +G FG V+K L + VAVK+ ++ K +++ E +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 756 LRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQR 815
L ++H N+++ I + L+ + GSL D+L + ++ +
Sbjct: 72 LPGMKHENILQFIGAEKR-GTSVDVDLWLITAFHEKGSLSDFLKAN-------VVSWNEL 123
Query: 816 VNIAIDVASAIEYLHHH-------CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS 868
+IA +A + YLH +P + H D+K NVLL +++ + + DFGLA +
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 869 HQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-----EASMTGDVYSFGILLLELFTGRRP 923
K++ + G GT Y+APE G+ +A + D+Y+ G++L EL +
Sbjct: 184 ------GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 924 TDAAFTEGLTLHEFAKIALP--EKVIEIV-----DPLLLIEVMANNSMIQEDIRAKTQEC 976
D E + E P E + E+V P+L +
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH-------------AG 284
Query: 977 LNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+ + C R+ V ++
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-56
Identities = 74/328 (22%), Positives = 135/328 (41%), Gaps = 36/328 (10%)
Query: 696 SYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECK- 754
+ +E S +IG+G +G+VYKG L E VAVKV + + ++F+ E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKNI 58
Query: 755 -ALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLI 813
+ + H N+ + I + + G LV E NGSL +L +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-------TSDWV 111
Query: 814 QRVNIAIDVASAIEYLH------HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867
+A V + YLH H +P + H DL NVL+ +D + DFGL+ L+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-------EASMTGDVYSFGILLLELFTG 920
++L + +++I GT+ Y+APE G+ A D+Y+ G++ E+F
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM- 230
Query: 921 RRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSM---IQEDIRAKTQECL 977
R TD E + + ++A +V + +++ E + + +
Sbjct: 231 -RCTDLFPGESVPEY---QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK-ENSLAV 285
Query: 978 NAIIRIGVLCSMESPFERMEMRDVVAKL 1005
++ C + R+ + ++
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAEERM 313
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-56
Identities = 102/532 (19%), Positives = 183/532 (34%), Gaps = 39/532 (7%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
LDLS + + S + L+ ++LS +L L L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLT-GRLPDFVGNLS 197
S S+L +L L IG L L+ L V N + +LP++ NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 198 ALEVFSITGNSLGGKIPTTLGLLRNL----VDLHVGGNQFSGTFPQSICNISSLERIYLP 253
LE ++ N + T L +L + + L + N + L ++ L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 254 FNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID 313
N S + + L L+ + F + D
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEF------------------RNEGNLE---KFD 247
Query: 314 FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSS 373
S+L+ L L +E+ L D + +++ SL + S +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS---YNF 304
Query: 374 SMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVL 433
+ + +++L L SN+ +V +L +L+ L L +N L
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGNAFSEV--DLPSLEFLDLSRNGL 359
Query: 434 Q--GSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLS 491
G T L L +S+N + + S+ + L + H+ L +
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 492 ITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVI-PVTLSTCVSLEYLDIS 550
+YLD+S+ + + L +L L ++ N F P + +L +LD+S
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 551 SNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDL 602
+ P + L S++VLN +SN L + L+ L+ + N
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-48
Identities = 108/521 (20%), Positives = 174/521 (33%), Gaps = 52/521 (9%)
Query: 141 IPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALE 200
IP NL + L +S N L S +LQ L + + + +LS L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 201 VFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGT 260
+TGN + L +L L + I ++ +L+ + + N
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 261 LPFDIVVNLPNLKSLAIGGN---------------------------NFFGSIPDSLSNA 293
+ NL NL+ L + N N I
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 294 SNVEILDLGFNQFKGKVSID-FSSLKNLSWLNLEQNNL-GMGTANDLDFVTFLTNCS-SL 350
+ L L N V L L L G D C+ ++
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 351 KILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIP-SGIRNLVNLIALGMQSNQL 409
+ LA + + + N +++ F + I + S +L + + Q
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319
Query: 410 HGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQ--GNIPSSLGN 467
+LK+L+ L N + S V +L L L +S N L G S
Sbjct: 320 PT------LKLKSLKRLTFTSNKGG-NAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 468 CQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLKNLVKLIIS 526
+L + S N + + L + L +LD ++NL + +L+NL+ L IS
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 527 SNQFSGVIPVTLSTCVSLEYLDISSNSFHGVI-PHSLGFLKSIKVLNFSSNNLSGQIPEF 585
+ SLE L ++ NSF P L+++ L+ S L P
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 586 LENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLS---LQGN 623
+LS L+ LN + N L+ VP G+F T L L N
Sbjct: 490 FNSLSSLQVLNMASNQLK-SVP-DGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-30
Identities = 88/406 (21%), Positives = 148/406 (36%), Gaps = 39/406 (9%)
Query: 78 RVTRLDLSNQRIGGILSPYVGNLSFLRY----INLSDNSFHGEIPQEIGNLLRLEKLALP 133
+ LDLS+ +I I + L + ++LS N + I +RL KL L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 134 NNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPA------EIGSLLKLQTLAVGKNYLTG 187
NN S + L L V L + +L L L + + L
Sbjct: 209 NNFDSLNVMKTC--IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 188 ------RLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSI 241
+ D L+ + FS+ ++ + L + +F
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQ---FPT 321
Query: 242 CNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGN--NFFGSIPDSLSNASNVEIL 299
+ SL+R+ N+ V+LP+L+ L + N +F G S ++++ L
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSE---VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 300 DLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQ 359
DL FN +S +F L+ L L+ + +NL + + + +L L ++
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-----KQMSEFSVFLSLRNLIYLDISHTH 432
Query: 360 FVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGTIPDVIG 418
L SS+ ++ GN I L NL L + QL P
Sbjct: 433 TRVAFNGIFNGL-SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 419 ELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPS 463
L +LQ L + N L+ S+P G+ LT L K+ + N + P
Sbjct: 492 SLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-17
Identities = 33/160 (20%), Positives = 55/160 (34%), Gaps = 9/160 (5%)
Query: 467 NCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIIS 526
N+ + +P L T LDLS N L + L L +S
Sbjct: 6 VVPNIT-YQCMELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 527 SNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFL 586
+ + + L L ++ N + + L S++ L NL+ +
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 587 ENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKL---SLQGN 623
+L L+ LN +HN ++ FS+ T L L N
Sbjct: 121 GHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSN 159
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-54
Identities = 117/485 (24%), Positives = 193/485 (39%), Gaps = 45/485 (9%)
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158
L+ L + + Q +L ++ L + +NL Q+ SN
Sbjct: 22 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 77
Query: 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLG 218
N+L P + +L KL + + N + + NL+ L ++ N + L
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI--TDIDPLK 131
Query: 219 LLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIG 278
L NL L + N S ++ ++SL+++ N+ + P NL L+ L I
Sbjct: 132 NLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLA---NLTTLERLDIS 185
Query: 279 GNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDL 338
N S L+ +N+E L NQ L NL L+L N L
Sbjct: 186 SNKV--SDISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQ--------L 233
Query: 339 DFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVN 398
+ L + ++L L LA NQ P ++ L + + E ++G NQI I P + L
Sbjct: 234 KDIGTLASLTNLTDLDLANNQISNLAP--LSGL-TKLTELKLGANQISNISP--LAGLTA 288
Query: 399 LIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQ 458
L L + NQL P I LKNL L LY N + P V +LTKL +L N +
Sbjct: 289 LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS 344
Query: 459 GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLK 518
SSL N N+ +A HN+++ P L ++T ++ L L++ + P+
Sbjct: 345 D--VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT-QLGLNDQAWT-NAPVNYKANV 398
Query: 519 NLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578
++ + + + P T+S S DI+ N S F + + + +
Sbjct: 399 SIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVT-IGKGTTTF 456
Query: 579 SGQIP 583
SG +
Sbjct: 457 SGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-53
Identities = 106/484 (21%), Positives = 186/484 (38%), Gaps = 45/484 (9%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
+ L + +L + + + + L L ++ NN +
Sbjct: 26 KMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT 81
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
P L + L+ + ++NN++ P + +L L L + N +T D + NL+
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTN 135
Query: 199 LEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFS 258
L ++ N++ + L L +L L G T + + N+++LER+ + N+ S
Sbjct: 136 LNRLELSSNTI--SDISALSGLTSLQQLSFGNQV---TDLKPLANLTTLERLDISSNKVS 190
Query: 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLK 318
L NL+SL N P L +N++ L L NQ K + +SL
Sbjct: 191 DISVLA---KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLT 243
Query: 319 NLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEF 378
NL+ L+L N + + L+ + L L L ANQ P +A L++ +
Sbjct: 244 NLTDLDLANNQI--------SNLAPLSGLTKLTELKLGANQISNISP--LAGLTA-LTNL 292
Query: 379 RIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIP 438
+ NQ+ I P I NL NL L + N + P + L LQ LF Y N + S
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDV 346
Query: 439 SGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVY 498
S + NLT + L +N + P L N + + T A +++ +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT- 403
Query: 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVI 558
+ N P I + + + I+ N S V+ + + + +F G +
Sbjct: 404 --VKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTF-SQPVTIGKGTTTFSGTV 460
Query: 559 PHSL 562
L
Sbjct: 461 TQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-51
Identities = 96/477 (20%), Positives = 171/477 (35%), Gaps = 70/477 (14%)
Query: 143 TNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVF 202
+ + ++ + + + L ++ TL + + D V L+ L
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 73
Query: 203 SITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLP 262
+ + N L P L L LVD+ + NQ + + N+++L + L N+ + P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP 129
Query: 263 FDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSW 322
NL NL L + N S +LS ++++ L G ++L L
Sbjct: 130 LK---NLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQVTD---LKPLANLTTLER 181
Query: 323 LNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGG 382
L++ N + ++ L ++L+ L
Sbjct: 182 LDISSNKV--------SDISVLAKLTNLESLIA-------------------------TN 208
Query: 383 NQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVG 442
NQI I P + L NL L + NQL + L NL L L N + P +
Sbjct: 209 NQISDITP--LGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LS 262
Query: 443 NLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLS 502
LTKL +L + N + S L L + N+L P + ++ L+ YL L
Sbjct: 263 GLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLT-YLTLY 317
Query: 503 NNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSL 562
NN++ P+ +L L +L +N+ S V L+ ++ +L N + P L
Sbjct: 318 FNNISDISPV--SSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--L 371
Query: 563 GFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLS 619
L I L + + + N+S + ++ G + S +
Sbjct: 372 ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV----KNVTGALIAPATISDGGSYT 424
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-50
Identities = 98/487 (20%), Positives = 184/487 (37%), Gaps = 45/487 (9%)
Query: 121 IGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAV 180
L K L + + T+ + + L+ + + + L L +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 181 GKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQS 240
N LT + NL+ L + N + P L L NL L + NQ + P
Sbjct: 76 SNNQLTD-ITPL-KNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-- 129
Query: 241 ICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILD 300
+ N+++L R+ L N S L +L+ L+ GN P L+N + +E LD
Sbjct: 130 LKNLTNLNRLELSSNTISDISALS---GLTSLQQLSF-GNQVTDLKP--LANLTTLERLD 183
Query: 301 LGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360
+ N+ + + L NL L N + +T L ++L LSL NQ
Sbjct: 184 ISSNKVSDISVL--AKLTNLESLIATNNQISD--------ITPLGILTNLDELSLNGNQL 233
Query: 361 VGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGEL 420
++A+L +++ + + NQI + P + L L L + +NQ+ P + L
Sbjct: 234 KD--IGTLASL-TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGL 286
Query: 421 KNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNK 480
L L L +N L+ P + NL L L + +N++ P + + L +NK
Sbjct: 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342
Query: 481 LTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLST 540
++ L ++T ++ +L +N ++ P + NL + +L ++ ++ +
Sbjct: 343 VSD--VSSLANLTNIN-WLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 397
Query: 541 CVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
+ + + + P ++ S + + N S E S +
Sbjct: 398 VSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTT 454
Query: 601 DLEGEVP 607
G V
Sbjct: 455 TFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-49
Identities = 97/431 (22%), Positives = 160/431 (37%), Gaps = 46/431 (10%)
Query: 195 NLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPF 254
L+ + ++ + L + L + +++L +I
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 77
Query: 255 NRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDF 314
N+ + P NL L + + N P L+N +N+ L L NQ
Sbjct: 78 NQLTDITPLK---NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPL 130
Query: 315 SSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSS 374
+L NL+ L L N + ++ L+ +SL+ LS NQ P +ANL++
Sbjct: 131 KNLTNLNRLELSSNTISD--------ISALSGLTSLQQLSFG-NQVTDLKP--LANLTT- 178
Query: 375 MIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQ 434
+ I N++ I S + L NL +L +NQ+ P +G L NL L L N L+
Sbjct: 179 LERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234
Query: 435 GSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITT 494
+ +LT L L ++ N + P L L N+++ + +
Sbjct: 235 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-----ISPLAG 285
Query: 495 LS--VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSN 552
L+ L+L+ N L P I NLKNL L + N S + P +S+ L+ L +N
Sbjct: 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341
Query: 553 SFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVF 612
SL L +I L+ N +S P L NL+ + L +
Sbjct: 342 KVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 397
Query: 613 SSKTKLSLQGN 623
S
Sbjct: 398 VSIPNTVKNVT 408
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-53
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 28/221 (12%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRN 763
E ++G+G+FG V K +D VA+K ++ + K+F+ E + L + H N
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKD---VAIKQ--IESESERKAFIVELRQLSRVNHPN 62
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
++K+ C + LV E + GSL + LH + + T ++ + +
Sbjct: 63 IVKLYGACLNPVC-------LVMEYAEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQCS 112
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+ YLH ++H DLKP N+LL V + DFG A + +H T++
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------MTNN--- 163
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
KG+ ++APE GS S DV+S+GI+L E+ T R+P
Sbjct: 164 --KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-53
Identities = 70/253 (27%), Positives = 117/253 (46%), Gaps = 23/253 (9%)
Query: 674 RRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGIL-GEDEMI 732
+ + T+ + ++ + IG GSFG+V++ G D
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD--- 62
Query: 733 VAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMK 790
VAVK++ + F+ E ++ +RH N++ + + ++V E +
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLS 117
Query: 791 NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850
GSL LH+S +L +R+++A DVA + YLH+ PP+VH +LK N+L+D
Sbjct: 118 RGSLYRLLHKSGARE---QLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVD 173
Query: 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSF 910
V DFGL++ +S T SS GT ++APE ++ DVYSF
Sbjct: 174 KKYTVKVCDFGLSRLKAS--------TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 911 GILLLELFTGRRP 923
G++L EL T ++P
Sbjct: 226 GVILWELATLQQP 238
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-50
Identities = 115/559 (20%), Positives = 195/559 (34%), Gaps = 61/559 (10%)
Query: 98 GNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVS 157
G ++F R+ NL+ ++PQ L E+L L N ++ L L +
Sbjct: 6 GRIAFYRFCNLT------QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELG 56
Query: 158 NNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKI--P 214
+ I E +L L+ L +G + + PD L L + L +
Sbjct: 57 SQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKD 116
Query: 215 TTLGLLRNLVDLHVGGNQFSG-TFPQSICNISSLERIYLPFNRFSGTLPFDIVVNL--PN 271
L+ L L + NQ S ++SL+ I N+ + + L
Sbjct: 117 GYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKT 175
Query: 272 LKSLAIGGNNFFGSIPDSLSNASNV------EILDLGFNQFKGKVSIDFSS--------- 316
L ++ N+ + + N EILD+ N + ++ +FS+
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
Query: 317 ---LKNLSWLNLEQNNLGMGTANDLDFVTFLTNC-SSLKILSLAANQFVGELPHSIANLS 372
++ +N+ D D TF SS++ L L+ L
Sbjct: 236 LILAHHIMGAGFGFHNI-----KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK 290
Query: 373 SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNV 432
+ + N+I I L NL L + N L L + + L KN
Sbjct: 291 D-LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 433 LQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLS 491
+ I L KL L + N+L +++ ++ S NKL LP+ L+
Sbjct: 350 IA-IIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVT-LPKINLT 402
Query: 492 ITTLSVYLDLSNNNLNGSLPLQI-GNLKNLVKLIISSNQFSGVIP-VTLSTCVSLEYLDI 549
+ LS N L L + +L LI++ N+FS T S SLE L +
Sbjct: 403 AN----LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 550 SSNSFHGVIPHSL-----GFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEG 604
N L L ++VL + N L+ P +L+ L L+ + N L
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT- 517
Query: 605 EVPTKGVFSSKTKLSLQGN 623
+ + ++ L + N
Sbjct: 518 VLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-44
Identities = 110/539 (20%), Positives = 196/539 (36%), Gaps = 55/539 (10%)
Query: 80 TRLDLSNQRIGGILSPYV-GNLSFLRYINLSDNSFHGEIPQEI-GNLLRLEKLALPNNSF 137
L+L +Q + NL LR ++L + + + + L L +L L
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGL 109
Query: 138 SGTI--PTNLSRCSNLIQLRVSNNKLEG-QIPAEIGSLLKLQTLAVGKNYLTGRLPDFVG 194
S + L +L +S N++ + G L L+++ N + +
Sbjct: 110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE 169
Query: 195 NLSA--LEVFSITGNSLGGKIPTTLGLLRN------LVDLHVGGNQFSGTFPQSICN-IS 245
L L FS+ NSL ++ G N L L V GN ++ + N IS
Sbjct: 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS 229
Query: 246 SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSN--ASNVEILDLGF 303
+ L + ++ G +N ++ + S+V LDL
Sbjct: 230 KSQAFSL--------------ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSH 275
Query: 304 NQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGE 363
S F +LK+L LNL N + N + F +L++L+L+ N GE
Sbjct: 276 GFVFSLNSRVFETLKDLKVLNLAYNKI-----NKIADEAF-YGLDNLQVLNLSYNLL-GE 328
Query: 364 LPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNL 423
L S + + N I I + L L L ++ N L I + ++
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSI 383
Query: 424 QGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQG-NIPSSLGNCQNLIGFNASHNKLT 482
+FL N L ++P + +S N L+ +I L +L + N+ +
Sbjct: 384 PDIFLSGNKLV-TLPKINLTAN---LIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439
Query: 483 GALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-----GNLKNLVKLIISSNQFSGVIPVT 537
Q S L L N L + ++ L +L L ++ N + + P
Sbjct: 440 SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGV 499
Query: 538 LSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLN 596
S +L L ++SN + + ++++L+ S N L P+ +LS L+ +
Sbjct: 500 FSHLTALRGLSLNSNRLTVLSHND--LPANLEILDISRNQLLAPNPDVFVSLSVLDITH 556
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-25
Identities = 68/428 (15%), Positives = 137/428 (32%), Gaps = 61/428 (14%)
Query: 75 RHQRVTRLDLSNQRIGGILSPYVGNLS------FLRYINLSDNSFHGEIPQEIGNLL--- 125
+ + ++ L+ + +S G L +++S N + +I N +
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 126 ---------RLEKLALPNNSFSGTIPTNLS--RCSNLIQLRVSNNKLEGQIPAEIGSLLK 174
+ ++ + S++ L +S+ + +L
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
Query: 175 LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFS 234
L+ L + N + + L L+V +++ N LG + L + + + N +
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 235 GTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNAS 294
Q+ + L+ + L N + T+ +P++ + + GN +L+
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNALT-TIH-----FIPSIPDIFLSGNKLVTLPKINLTA-- 403
Query: 295 NVEILDLGFNQFKG-KVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKIL 353
++ L N+ + + + +L L L QN + + SL+ L
Sbjct: 404 --NLIHLSENRLENLDILYFLLRVPHLQILILNQNRF-----SSCSGDQTPSENPSLEQL 456
Query: 354 SLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTI 413
L N + L +L L + N L+
Sbjct: 457 FLGENMLQLAWETELC--------------------WDVFEGLSHLQVLYLNHNYLNSLP 496
Query: 414 PDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIG 473
P V L L+GL L N L + L L +S N L P +L
Sbjct: 497 PGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDVF---VSLSV 551
Query: 474 FNASHNKL 481
+ +HNK
Sbjct: 552 LDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-24
Identities = 71/310 (22%), Positives = 112/310 (36%), Gaps = 23/310 (7%)
Query: 73 GHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLAL 132
G V LDLS+ + + S L L+ +NL+ N + + L L+ L L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 133 PNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDF 192
N +N + + + N + L KLQTL + N LT
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----T 376
Query: 193 VGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSI-CNISSLERIY 251
+ + ++ ++GN L + L NL+ L N+ + L+ +
Sbjct: 377 IHFIPSIPDIFLSGNKL--VTLPKINLTANLIHLS--ENRLENLDILYFLLRVPHLQILI 432
Query: 252 LPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSI-----PDSLSNASNVEILDLGFNQF 306
L NRFS P+L+ L +G N + D S++++L L N
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
Query: 307 KGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPH 366
FS L L L+L N L L N L+IL ++ NQ + P
Sbjct: 493 NSLPPGVFSHLTALRGLSLNSNRL-----TVLSHNDLPAN---LEILDISRNQLLAPNPD 544
Query: 367 SIANLSSSMI 376
+LS I
Sbjct: 545 VFVSLSVLDI 554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 36/228 (15%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGA--FKSFMAECKALRNIRH 761
+ + + G ++KG G D + VKV+ ++ + F EC LR H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGND---IVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
N++ ++ C S A L+ M GSL + LH+ + + Q V A+D
Sbjct: 67 PNVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALD 119
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
+A + +LH +P + L +V++D DM + + + S
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP------------ 166
Query: 882 IGIKGTVGYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRP 923
G +VAPE ++ D++SF +LL EL T P
Sbjct: 167 -GRMYAPAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 38/226 (16%)
Query: 711 NMIGQGSFGSVYKGIL-GEDEMIVAVKVINLK----QKGAFKSFMAECKALRNIRHRNLI 765
+IG G FG VY+ G++ VAVK ++ E K ++H N+I
Sbjct: 13 EIIGIGGFGKVYRAFWIGDE---VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+ +C K + LV E + G L L ++ VN A+ +A
Sbjct: 70 ALRGVCL----KEPNL-CLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARG 117
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH--------VGDFGLAKFLSSHQLDTASKT 877
+ YLH P++H DLK SN+L+ + + + DFGLA+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----------WH 167
Query: 878 SSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
++ + G ++APE S S DV+S+G+LL EL TG P
Sbjct: 168 RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 38/233 (16%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVI-------NLKQKGAFKSFMAECKALR 757
+E IG+G FG V+KG L +D+ +VA+K + + F+ F E +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 758 NIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVN 817
N+ H N++K+ + + +V E + G L L + ++
Sbjct: 79 NLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLR 126
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-----HDMVSHVGDFGLAKFLSSHQLD 872
+ +D+A IEY+ + PP+VH DL+ N+ L + + V DFGL++
Sbjct: 127 LMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------- 178
Query: 873 TASKTSSSSIGIKGTVGYVAPEYCMGSEASMT--GDVYSFGILLLELFTGRRP 923
+ S G+ G ++APE E S T D YSF ++L + TG P
Sbjct: 179 ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 5e-49
Identities = 99/511 (19%), Positives = 183/511 (35%), Gaps = 40/511 (7%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI-GNLLRLEKLALPNNSF 137
+ LDLS +I I + + L+ + L + + I + +L LE L L +N
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHL 86
Query: 138 SGTIPTNLSRCSNLIQLRVSNNKL-EGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFV-GN 195
S + S+L L + N + + +L LQTL +G +
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 196 LSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFN 255
L++L I SL +L +R++ L + ++ + +SS+ + L
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 256 RFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFS 315
+ F + + + D FN+ K+
Sbjct: 207 NLA-RFQFSPLPVDEVSSPM-------------KKLAFRGSVLTDESFNELL-KLLRYIL 251
Query: 316 SLKNLSWLNLEQNNLGMGTANDLDFVTFLTN--CSSLKILSLAANQFVGELPHSIANLSS 373
L + + + N LG ++ D V+ L +++ L + +L + L
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL-E 310
Query: 374 SMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTI---PDVIGELKNLQGLFLYK 430
+ + +++F + S ++L +L L + N + G +LQ L L +
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 431 NVLQGSIPSGVG---NLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQ 487
N L+ S+ L L L +S N+ +P S + + N S + +
Sbjct: 371 NHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT 427
Query: 488 QLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYL 547
+ LD+SNNNL+ S L L L +L IS N+ + +L L +
Sbjct: 428 CIPQTLE---VLDVSNNNLD-SFSL---FLPRLQELYISRNKLKTLPDASLFP--VLLVM 478
Query: 548 DISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578
IS N V L S++ + +N
Sbjct: 479 KISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-41
Identities = 92/521 (17%), Positives = 171/521 (32%), Gaps = 62/521 (11%)
Query: 148 CSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGN 207
C + IP+ + +++L + N +T + + L+V + +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 208 SLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVV 267
+ L +L L + N S +SSL+ + L N + +
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
Query: 268 NLPNLKSLAIGGNNFFGSIP-DSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLE 326
NL NL++L IG F I + +++ L++ + S S++++ L L
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 327 QNNLGMGTANDLDFVTFLT--------------------------NCSSLKILSLAANQF 360
+ D ++ + + + L F
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 361 VGELPHSIANLSSSMIEF-RIGGNQIFGIIPSGIR--------NLVNLIALGMQSNQLHG 411
L L S +EF N + PS V + L + L
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 412 TIPDVIGELKNLQGLFLYKNVLQGSIPSGVG-NLTKLAKLVMSYNSLQGNI---PSSLGN 467
+ V L+ ++ + + + + +P +L L L +S N + + G
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
Query: 468 CQNLIGFNASHNKLTGALPQQLLSITTLS--VYLDLSNNNLNGSLPLQIGNLKNLVKLII 525
+L S N L ++ + + TL LD+S N + +P + + L +
Sbjct: 360 WPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNL 417
Query: 526 SSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEF 585
SS V +LE LD+S+N+ L ++ L S N L +P+
Sbjct: 418 SSTGIRVVKTCIPQ---TLEVLDVSNNNLDSFSLF----LPRLQELYISRNKLK-TLPDA 469
Query: 586 LENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLS---LQGN 623
L + S N L + G+F T L L N
Sbjct: 470 S-LFPVLLVMKISRNQL--KSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 56/361 (15%), Positives = 119/361 (32%), Gaps = 31/361 (8%)
Query: 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136
+ + L L +L + LS +RY+ L D + + +
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
Query: 137 FSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNL 196
S + + L++ + +++E + +L L ++ + L
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVE----FDDCTLNGLGDFNPSESDVVSELGKV--ET 285
Query: 197 SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR 256
+ I L + T LL + + V ++ ++ SLE + L N
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENL 345
Query: 257 FS--GTLPFDIVVNLPNLKSLAIGGNNF--FGSIPDSLSNASNVEILDLGFNQFKGKVSI 312
P+L++L + N+ + L N+ LD+ N F +
Sbjct: 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404
Query: 313 DFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNC--SSLKILSLAANQFVGELPHSIAN 370
+ + +LNL + + C +L++L ++ N +
Sbjct: 405 SCQWPEKMRFLNLSSTGI-----------RVVKTCIPQTLEVLDVSNNNL-DSFSLFLPR 452
Query: 371 LSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYK 430
L E I N++ + + L+ + + NQL + L +LQ ++L+
Sbjct: 453 LQ----ELYISRNKLKTLPDAS--LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 431 N 431
N
Sbjct: 507 N 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-15
Identities = 37/211 (17%), Positives = 76/211 (36%), Gaps = 18/211 (8%)
Query: 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQE---IGNLLRLEKLALPN 134
+V R+ + N ++ + + +L L +++LS+N E + G L+ L L
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 135 NSFSGTIPTNLSRCSNLIQLRV---SNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPD 191
N ++ L L S N +P K++ L + + +
Sbjct: 371 NHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT 427
Query: 192 FVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIY 251
LEV ++ N+L L L +L++ N+ L +
Sbjct: 428 --CIPQTLEVLDVSNNNL-DSFSL---FLPRLQELYISRNKL--KTLPDASLFPVLLVMK 479
Query: 252 LPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF 282
+ N+ ++P I L +L+ + + N +
Sbjct: 480 ISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-48
Identities = 57/257 (22%), Positives = 98/257 (38%), Gaps = 31/257 (12%)
Query: 678 SARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKV 737
+ S + PR+ ++ E + +IG+G FG VY G + VA+++
Sbjct: 6 LSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRL 62
Query: 738 INLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLE 795
I++++ + K+F E A R RH N++ + C S A++ K +L
Sbjct: 63 IDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PPHLAIITSLCKGRTLY 117
Query: 796 DWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS 855
+ + L + + IA ++ + YLH ++H DLK NV D+ V
Sbjct: 118 SVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKV- 168
Query: 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG---------D 906
+ DFGL Q G + ++APE D
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNG---WLCHLAPEIIRQLSPDTEEDKLPFSKHSD 225
Query: 907 VYSFGILLLELFTGRRP 923
V++ G + EL P
Sbjct: 226 VFALGTIWYELHAREWP 242
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 8e-48
Identities = 99/521 (19%), Positives = 176/521 (33%), Gaps = 86/521 (16%)
Query: 93 LSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLS------ 146
++P + +FL+ ++ E+P E N+ + + + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 147 -------RCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
+L ++N L +P L++L N LT LP+ +L +L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSL 116
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
V + +L L L L V NQ P + N S L+ I + N
Sbjct: 117 LVDNNNLKALS-------DLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK- 166
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKN 319
LP P+L+ +A GNN +P+ L N + + N K + +
Sbjct: 167 KLP----DLPPSLEFIAA-GNNQLEELPE-LQNLPFLTAIYADNNSLK---KL-PDLPLS 216
Query: 320 LSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFR 379
L + N L+ + L N L + N LP +L +
Sbjct: 217 LESIVAGNNI--------LEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA----LN 263
Query: 380 IGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPS 439
+ N + +P ++L L + L P NL L N ++ S+
Sbjct: 264 VRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCD 314
Query: 440 GVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYL 499
+L +L +S N L +P+ + L AS N L +P+ ++ L
Sbjct: 315 LPPSLE---ELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQNLK----QL 362
Query: 500 DLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIP 559
+ N L P ++++L ++ + V +L+ L + +N P
Sbjct: 363 HVEYNPLR-EFPDIPESVEDL----RMNSHLAEV----PELPQNLKQLHVETNPLR-EFP 412
Query: 560 HSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
S++ L +S + E LE F H+
Sbjct: 413 DIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 6e-46
Identities = 91/487 (18%), Positives = 169/487 (34%), Gaps = 80/487 (16%)
Query: 117 IPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQ 176
I + L++ +++ + +P + + + ++ E P G ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 177 TLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGT 236
+ + L +P +L L N +
Sbjct: 62 VSRLRDCLDRQ-----------AHELELNNLGL-SSLPELPP---HLESLVASCNSLT-E 105
Query: 237 FPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNV 296
P+ ++ SL S P L+ L + NN +P+ L N+S +
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSD--------LPPLLEYLGV-SNNQLEKLPE-LQNSSFL 155
Query: 297 EILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLA 356
+I+D+ N K + +L ++ N L+ + L N L +
Sbjct: 156 KIIDVDNNSLK---KL-PDLPPSLEFIAAGNNQ--------LEELPELQNLPFLTAIYAD 203
Query: 357 ANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDV 416
N +LP +L G N + ++NL L + +N L T+PD
Sbjct: 204 NNSLK-KLPDLPLSLE----SIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPD- 254
Query: 417 IGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNA 476
+L+ L + N L +P +LT L +S N + N L NA
Sbjct: 255 --LPPSLEALNVRDNYLT-DLPELPQSLT---FLDVSENIFS-GLSELPPNLYYL---NA 304
Query: 477 SHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPV 536
S N++ +L S+ L++SNN L LP L+ +LI S N + +P
Sbjct: 305 SSNEIR-SLCDLPPSLEE----LNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPE 354
Query: 537 TLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLN 596
+L+ L + N P ++ +++ N+ ++PE +N L+ L+
Sbjct: 355 LPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQN---LKQLH 402
Query: 597 FSHNDLE 603
N L
Sbjct: 403 VETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-40
Identities = 90/457 (19%), Positives = 162/457 (35%), Gaps = 72/457 (15%)
Query: 75 RHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPN 134
++ L+L+N + + L + S NS E+P+ +L L
Sbjct: 69 LDRQAHELELNNLGLSSLPE----LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 135 NSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVG 194
+ S P L L VSNN+LE ++P E+ + L+ + V N L +LPD
Sbjct: 124 KALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 195 NLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPF 254
+L + + N L ++P L L L ++ N P + LE I
Sbjct: 174 SLEFI---AAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGN 224
Query: 255 NRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDF 314
N LP + NLP L ++ N ++PD + + + D
Sbjct: 225 NILE-ELPE--LQNLPFLTTIYADNNLL-KTLPDLPPSLEALNVRDNYLTDLP------- 273
Query: 315 SSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSS 374
++L++L++ +N + L +L L+ ++N+ L +L
Sbjct: 274 ELPQSLTFLDVSENIF-----SGLS-----ELPPNLYYLNASSNEIR-SLCDLPPSLE-- 320
Query: 375 MIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQ 434
E + N++ +P+ L LIA N L +P+ +NL+ L + N L+
Sbjct: 321 --ELNVSNNKL-IELPALPPRLERLIASF---NHLA-EVPE---LPQNLKQLHVEYNPLR 370
Query: 435 GSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITT 494
P ++ L NS +P N + L + N L P S+
Sbjct: 371 -EFPDIPESVEDL-----RMNSHLAEVPELPQNLKQL---HVETNPLR-EFPDIPESVE- 419
Query: 495 LSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFS 531
L +++ + L + +
Sbjct: 420 ---DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-23
Identities = 45/224 (20%), Positives = 85/224 (37%), Gaps = 34/224 (15%)
Query: 413 IPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGN----- 467
I LQ + + L +P N+ + +++ + N P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 468 --------CQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKN 519
+ ++ L+ +LP+ + + L S N+L LP +LK+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES----LVASCNSLT-ELPELPQSLKS 115
Query: 520 LVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLS 579
L+ + S + P LEYL +S+N +P L +K+++ +N+L
Sbjct: 116 LLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK 166
Query: 580 GQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGN 623
++P+ + LEF+ +N LE E+P T + N
Sbjct: 167 -KLPDLPPS---LEFIAAGNNQLE-ELPELQNLPFLTAIYADNN 205
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 82/301 (27%), Positives = 132/301 (43%), Gaps = 57/301 (18%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
IG GSFG+VYKG D VAVK++N+ ++F E LR RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
++ A+V + + SL LH S K + + ++IA A ++YLH
Sbjct: 89 STA------PQLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLH 137
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
++H DLK +N+ L D +GDFGLA S S + G++ +
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG------SHQFEQLSGSILW 188
Query: 891 VAPEYCMG------SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944
+APE S S DVY+FGI+L EL TG+ P ++ I +
Sbjct: 189 MAPEVIRMQDSNPYSFQS---DVYAFGIVLYELMTGQLP-------------YSNINNRD 232
Query: 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004
++IE+V L + S ++ + C + R+ C + ER ++A+
Sbjct: 233 QIIEMVGRGSL---SPDLSKVRSN-------CPKRMKRLMAECLKKKRDERPSFPRILAE 282
Query: 1005 L 1005
+
Sbjct: 283 I 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 8e-47
Identities = 51/228 (22%), Positives = 96/228 (42%), Gaps = 30/228 (13%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECK--ALRNIRHRNLIKII 768
+G+G +G V++G + VAVK+ + + + KS+ E + +RH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ L+ + GSL D+L + L + + I + +AS + +
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAH 120
Query: 829 LH-----HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
LH +P + H DLK N+L+ + + D GLA S + ++ +
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ----STNQLDVGNNP 176
Query: 884 IKGTVGYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
GT Y+APE ++ D+++FG++L E+
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 25/228 (10%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL 764
S+ ++G+G FG K E ++ +K + + ++F+ E K +R + H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
+K I + K + E +K G+L + + + QRV+ A D+AS
Sbjct: 70 LKFIGVL----YKDKRL-NFITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIAS 119
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS------KTS 878
+ YLH ++H DL N L+ + V DFGLA+ + +
Sbjct: 120 GMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 879 SSSIGIKGTVGYVAPEYCMG---SEASMTGDVYSFGILLLELFTGRRP 923
+ G ++APE G E DV+SFGI+L E+
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKV---DVFSFGIVLCEIIGRVNA 221
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 9e-46
Identities = 80/381 (20%), Positives = 155/381 (40%), Gaps = 36/381 (9%)
Query: 223 LVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF 282
L + FP +++ R L + + + L ++ L + G
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKV 56
Query: 283 FGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVT 342
SI + +N+E L+L NQ S+L L+ L + N + ++
Sbjct: 57 -ASIQG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--------TDIS 104
Query: 343 FLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIAL 402
L N ++L+ L L + +ANL+ M +G N + S + N+ L L
Sbjct: 105 ALQNLTNLRELYLNEDNISD--ISPLANLTK-MYSLNLGANHNLSDL-SPLSNMTGLNYL 160
Query: 403 GMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIP 462
+ +++ P I L +L L L N ++ P + +LT L N + P
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216
Query: 463 SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVK 522
+ N L +NK+T P L +++ L+ +L++ N ++ + + +L L
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSP--LANLSQLT-WLEIGTNQIS-DIN-AVKDLTKLKM 269
Query: 523 LIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQI 582
L + SNQ S + L+ L L +++N +G L ++ L S N+++
Sbjct: 270 LNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR 327
Query: 583 PEFLENLSFLEFLNFSHNDLE 603
P L +LS ++ +F++ ++
Sbjct: 328 P--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-45
Identities = 82/379 (21%), Positives = 151/379 (39%), Gaps = 35/379 (9%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
L I I +L+ L S + L + KL +
Sbjct: 3 ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV-- 56
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
+ +NL L ++ N++ P + +L+KL L +G N +T + NL+ L
Sbjct: 57 ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNL 112
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
+ +++ P L L + L++G N + + N++ L + + ++
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKN 319
P NL +L SL++ N P L++ +++ NQ +++
Sbjct: 170 VTPIA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTR 222
Query: 320 LSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFR 379
L+ L + N + DL L N S L L + NQ +++ +L + +
Sbjct: 223 LNSLKIGNNKI-----TDLS---PLANLSQLTWLEIGTNQISD--INAVKDL-TKLKMLN 271
Query: 380 IGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPS 439
+G NQI I S + NL L +L + +NQL +VIG L NL LFL +N + P
Sbjct: 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP- 328
Query: 440 GVGNLTKLAKLVMSYNSLQ 458
+ +L+K+ + ++
Sbjct: 329 -LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-45
Identities = 73/366 (19%), Positives = 144/366 (39%), Gaps = 36/366 (9%)
Query: 215 TTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKS 274
L + + + + + S+ ++ + + + + L NL+
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASIQGIE---YLTNLEY 70
Query: 275 LAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID-FSSLKNLSWLNLEQNNLGMG 333
L + GN P LSN + L +G N+ I +L NL L L ++N+
Sbjct: 71 LNLNGNQITDISP--LSNLVKLTNLYIGTNKIT---DISALQNLTNLRELYLNEDNI--- 122
Query: 334 TANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI 393
+D+ + LT + L+L AN + ++N++ + + +++ + P I
Sbjct: 123 --SDISPLANLTK---MYSLNLGANHNLS-DLSPLSNMTG-LNYLTVTESKVKDVTP--I 173
Query: 394 RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMS 453
NL +L +L + NQ+ P + L +L Y N + P V N+T+L L +
Sbjct: 174 ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIG 229
Query: 454 YNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQ 513
N + S L N L N+++ + +T L L++ +N ++
Sbjct: 230 NNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLK-MLNVGSNQISDISV-- 282
Query: 514 IGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNF 573
+ NL L L +++NQ + +L L +S N + P L L + +F
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
Query: 574 SSNNLS 579
++ +
Sbjct: 341 ANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-38
Identities = 76/332 (22%), Positives = 140/332 (42%), Gaps = 33/332 (9%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
+T+L ++ +++ I + L+ L Y+NL+ N P + NL++L L + N
Sbjct: 46 ITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI- 100
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
T + L +NL +L ++ + + P + +L K+ +L +G N+ + N++
Sbjct: 101 -TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTG 156
Query: 199 LEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFS 258
L ++T + + P + L +L L + NQ + +++SL N+ +
Sbjct: 157 LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQIT 212
Query: 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID-FSSL 317
P N+ L SL IG N P L+N S + L++G NQ I+ L
Sbjct: 213 DITPVA---NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS---DINAVKDL 264
Query: 318 KNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIE 377
L LN+ N + ++ L N S L L L NQ E I L +++
Sbjct: 265 TKLKMLNVGSNQISD--------ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGL-TNLTT 315
Query: 378 FRIGGNQIFGIIPSGIRNLVNLIALGMQSNQL 409
+ N I I P + +L + + + +
Sbjct: 316 LFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 53/259 (20%), Positives = 100/259 (38%), Gaps = 24/259 (9%)
Query: 367 SIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGL 426
A+L+ I + + ++ L ++ L + ++ +I I L NL+ L
Sbjct: 17 PDADLAE-GIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71
Query: 427 FLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALP 486
L N + P + NL KL L + N + S+L N NL + + ++
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD--- 124
Query: 487 QQLLSITTLS--VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSL 544
+ + L+ L+L N+ S + N+ L L ++ ++ V P ++ L
Sbjct: 125 --ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDL 179
Query: 545 EYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEG 604
L ++ N + P L L S+ N ++ P + N++ L L +N +
Sbjct: 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
Query: 605 EVPTKGVFSSKTKLSLQGN 623
P S T L + N
Sbjct: 236 LSPLAN-LSQLTWLEIGTN 253
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-45
Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 30/228 (13%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECK--ALRNIRHRNLIKII 768
IG+G FG V++G +E VAVK+ + +++ +S+ E + +RH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ + LV + ++GSL D+L++ +T+ + +A+ AS + +
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAH 154
Query: 829 LH-----HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
LH +P + H DLK N+L+ + + D GLA S +
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS----ATDTIDIAPNH 210
Query: 884 IKGTVGYVAPEYCMGS------EASMTGDVYSFGILLLELFTGRRPTD 925
GT Y+APE S E+ D+Y+ G++ E+
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-45
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 26/226 (11%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITI 770
IG+G +G V+ G ++ VAVKV ++ ++ E +RH N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAA 99
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
L+ + +NGSL D+L + L + +A S + +LH
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLH 151
Query: 831 -----HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+P + H DLK N+L+ + + D GLA S ++
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS----DTNEVDIPPNTRV 207
Query: 886 GTVGYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
GT Y+ PE ++ + D+YSFG++L E+
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 57/329 (17%), Positives = 108/329 (32%), Gaps = 28/329 (8%)
Query: 268 NLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQ 327
+ ++L G+ D LS D + ++ N
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWR----QANSNNPQIETRTG 65
Query: 328 NNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFG 387
L D + T L L + + P LS + I +
Sbjct: 66 RAL----KATADLLEDATQ-PGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGL-M 117
Query: 388 IIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGN---- 443
+P ++ L L + N L +P I L L+ L + +P + +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 444 -----LTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVY 498
L L L + + ++ ++P+S+ N QNL ++ L+ AL + + L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL-EE 233
Query: 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISS-NQFSGVIPVTLSTCVSLEYLDISSNSFHGV 557
LDL + P G L +LI+ + +P+ + LE LD+
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 558 IPHSLGFLKSIKVLNFSSNNLSGQIPEFL 586
+P + L + ++ +L Q+ +
Sbjct: 293 LPSLIAQLPANCIILV-PPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 57/382 (14%), Positives = 114/382 (29%), Gaps = 62/382 (16%)
Query: 187 GRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISS 246
G + S E G++ L + + N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 247 LERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQF 306
+ T P +L + PD S+++ + +
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGL 116
Query: 307 KGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTF---LTNCSSLKILSLAANQFVGE 363
++ L L L +N L + + + L+ LS+ A + E
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPL----------RALPASIASLNRLRELSIRACPELTE 165
Query: 364 LPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNL 423
LP +A+ + + LVNL +L ++ + ++P I L+NL
Sbjct: 166 LPEPLASTDA----------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL 208
Query: 424 QGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTG 483
+ L + + L ++ + +L KL +L + + N P G L
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL------------ 255
Query: 484 ALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVS 543
L L + + +LPL I L L KL + +P ++ +
Sbjct: 256 -------------KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 544 LEYLDISSNSFHGVIPHSLGFL 565
+ + + + H
Sbjct: 303 NCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 62/382 (16%), Positives = 109/382 (28%), Gaps = 70/382 (18%)
Query: 91 GILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSN 150
G + + S + ++ + R + +N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 151 LIQLRVSNNKLEGQIPAEIGSL--LKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNS 208
+ L+ + L + L + PD LS L+ +I
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 209 LGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVN 268
L ++P T+ L L + N P SI +
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLR-ALPASIA-------------------------S 148
Query: 269 LPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQN 328
L L+ L+I +P+ L++ S + L NL L LE
Sbjct: 149 LNRLRELSIRACPELTELPEPLASTDA---------------SGEHQGLVNLQSLRLEWT 193
Query: 329 NLGMGTANDLDFVTFL----TNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQ 384
+ L N +LK L + + L +I +L + E + G
Sbjct: 194 GI-----------RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL-PKLEELDLRGCT 240
Query: 385 IFGIIPSGIRNLVNLIALGMQS-NQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGN 443
P L L ++ + L T+P I L L+ L L V +PS +
Sbjct: 241 ALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
Query: 444 LTKLAKLVMSYNSLQGNIPSSL 465
L +++ + LQ +
Sbjct: 300 LPANCIILVPPH-LQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-35
Identities = 48/242 (19%), Positives = 92/242 (38%), Gaps = 19/242 (7%)
Query: 75 RHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPN 134
L+L + + LS L+++ + E+P + LE L L
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136
Query: 135 NSFSGTIPTNLSRCSNLIQLRVS-NNKLEGQIPAEIGS---------LLKLQTLAVGKNY 184
N +P +++ + L +L + +L ++P + S L+ LQ+L +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELT-ELPEPLASTDASGEHQGLVNLQSLRLEWTG 194
Query: 185 LTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNI 244
+ LP + NL L+ I + L + + L L +L + G +P
Sbjct: 195 IR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 245 SSLERIYLP-FNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGF 303
+ L+R+ L + TLP DI L L+ L + G +P ++ I+ +
Sbjct: 253 APLKRLILKDCSNLL-TLPLDI-HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310
Query: 304 NQ 305
+
Sbjct: 311 HL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 44/287 (15%), Positives = 84/287 (29%), Gaps = 30/287 (10%)
Query: 343 FLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIAL 402
+ S + L + + ++ ++ N N
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNA-----DRNRWHSAWRQANSNNPQIE 61
Query: 403 GMQSNQLHGTIPDVIGELK--NLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGN 460
L D++ + L L L P L+ L + + L
Sbjct: 62 TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 461 IPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNL 520
+P ++ L + N L ALP + S+ L L + LP + +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL-RELSIRACPELTELPEPLASTD-- 174
Query: 521 VKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSG 580
V+L+ L + +P S+ L+++K L ++ LS
Sbjct: 175 -------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS- 219
Query: 581 QIPEFLENLSFLEFLNFSHNDLEGEVPTK-GVFSSKTKLSLQGNVKL 626
+ + +L LE L+ P G + +L L+ L
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 37/192 (19%), Positives = 72/192 (37%), Gaps = 13/192 (6%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGN---------LLRLEKL 130
L L+ + L + +L+ LR +++ E+P+ + + L+ L+ L
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 131 ALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP 190
L ++P +++ NL L++ N+ L + I L KL+ L + P
Sbjct: 189 RLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
Query: 191 DFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERI 250
G + L+ + S +P + L L L + G P I + + I
Sbjct: 247 PIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306
Query: 251 YLPFNRFSGTLP 262
+P + L
Sbjct: 307 LVPPH-LQAQLD 317
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 34/224 (15%), Positives = 67/224 (29%), Gaps = 20/224 (8%)
Query: 411 GTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQN 470
G+ + L+ + + + + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 471 LIGFNASHNKLTGALPQQLLSITTLS-VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQ 529
+ L A L T V L+L + L P Q L +L + I +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 530 FSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENL 589
+P T+ LE L ++ N +P S+ L ++ L+ + ++PE L +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 590 SF---------LEFLNFSHNDLEGEVPTK-GVFSSKTKLSLQGN 623
L+ L + +P + L ++ +
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 22/111 (19%), Positives = 43/111 (38%), Gaps = 1/111 (0%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
L + N + L P + +L L ++L + P G L++L L + S
Sbjct: 209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP 190
T+P ++ R + L +L + ++P+ I L + V +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 19/93 (20%), Positives = 33/93 (35%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
LDL P G + L+ + L D S +P +I L +LEKL L
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSL 172
+P+ +++ + V + +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 711 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQKGA----FKSFMAECKALRNIRHRN 763
++G+G FGSV +G L + VAVK +K + + F++E +++ H N
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
+I+++ +C + S+G ++ MK G L +L S + L + +D+A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 824 SAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+EYL + + +H DL N +L DM V DFGL+K + + D + + +
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGDYYRQGRIAKM 211
Query: 883 GIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+K A E + + S DV++FG+ + E+ T G P
Sbjct: 212 PVKWI----AIESLADRVYTSKS---DVWAFGVTMWEIATRGMTP 249
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-37
Identities = 92/482 (19%), Positives = 176/482 (36%), Gaps = 28/482 (5%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
T L++S I + + + +LS LR + +S N LE L L +N
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEG-QIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLS 197
NL L +S N + I E G++ +L+ L + +L + +L+
Sbjct: 83 KISCHPTV---NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 198 ALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRF 257
+V + G + G K L++ + + I ++S L +
Sbjct: 140 ISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 258 SGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSL 317
L + ++ + + S +N+E F + +
Sbjct: 198 KCVLEDNKCSYFLSILA------KLQTNPKLSNLTLNNIETTWNSFIRI-----LQLVWH 246
Query: 318 KNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIE 377
+ + ++ L G + DF T+ +L I + ++ F G I + S+M
Sbjct: 247 TTVWYFSISNVKL-QGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNI 304
Query: 378 FRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSI 437
+ + + + L +N L T+ + G L L+ L L N L+ +
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 438 PSGVG---NLTKLAKLVMSYNSLQGNIPSSL-GNCQNLIGFNASHNKLTGALPQQLLSIT 493
+ L +L +S NS+ + ++L+ N S N LT + + L
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRI 423
Query: 494 TLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNS 553
LDL +N + S+P Q+ L+ L +L ++SNQ V SL+ + + +N
Sbjct: 424 K---VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNP 479
Query: 554 FH 555
+
Sbjct: 480 WD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 92/476 (19%), Positives = 172/476 (36%), Gaps = 28/476 (5%)
Query: 141 IPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFV-GNLSAL 199
+P +LS L +S N + ++I SL KL+ L + N + L V L
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQEL 71
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQF-SGTFPQSICNISSLERIYLPFNRFS 258
E ++ N L KI NL L + N F + + N+S L+ + L
Sbjct: 72 EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSI-PDSLSN--ASNVEILDLGFNQFKGKVSIDFS 315
+ +L K L + G + P+ L + ++ I+ +F + +
Sbjct: 129 -KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187
Query: 316 SLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANL--SS 373
++ NL N++ + L + L L L+L + I L +
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247
Query: 374 SMIEFRIGGNQIFGIIPSGI-----RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL 428
++ F I ++ G + +L L + S+ + N+
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307
Query: 429 YKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQ 487
+ + + ++ L S N L + + G+ L N+L L +
Sbjct: 308 TVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSK 365
Query: 488 QLLSITTLS--VYLDLSNNNLNGSLPLQI-GNLKNLVKLIISSNQFSGVIPVTLSTCVSL 544
T + LD+S N+++ K+L+ L +SSN + I L +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RI 423
Query: 545 EYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
+ LD+ SN IP + L++++ LN +SN L + L+ L+ + N
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 73/421 (17%), Positives = 131/421 (31%), Gaps = 52/421 (12%)
Query: 245 SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFN 304
+ + N S L +++L L+ L I N +E LDL N
Sbjct: 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 305 QFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGEL 364
+ I NL L+L N + L N S LK L L+
Sbjct: 80 KLV---KISCHPTVNLKHLDLSFNAF-----DALPICKEFGNMSQLKFLGLSTTHLEKSS 131
Query: 365 PHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLV--NLIALGMQSNQLHGTIPDVIGELKN 422
IA+L+ S + +G P G+++ +L + + + H + + + N
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 423 LQGLFLYKNVLQG------SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQ---NLIG 473
L+ + + SI + + KL+ L ++ N + +
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 474 FNASHNKLTGALPQQLLSITTLSV----------------------------YLDLSNNN 505
F+ S+ KL G L + + S+ + + +
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
Query: 506 LNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGF- 564
L + + L S+N + + LE L + N + +
Sbjct: 312 TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT 371
Query: 565 -LKSIKVLNFSSNNLSGQIP-EFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQG 622
+KS++ L+ S N++S L LN S N L + L L
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-PPRIKVLDLHS 430
Query: 623 N 623
N
Sbjct: 431 N 431
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 52/262 (19%), Positives = 94/262 (35%), Gaps = 15/262 (5%)
Query: 369 ANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL 428
+LS I N I + S I +L L L + N++ V + L+ L L
Sbjct: 17 KDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDL 76
Query: 429 YKNVLQGSIPSGVGNLTKLAKLVMSYNSLQG-NIPSSLGNCQNLIGFNASHNKLTGALPQ 487
N L I L L +S+N+ I GN L S L +
Sbjct: 77 SHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 488 QLLSITTLSVYLDLSNNNLNGSLP--LQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLE 545
+ + V L L P LQ N ++L + ++ +F ++ V++ T +LE
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193
Query: 546 YLDISSNSFHGVIPHSLGFLKSI------KVLNFSSNNLSGQ-IPEFLENL--SFLEFLN 596
+I + L L + L ++ + L+ + + + + +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 597 FSHNDLEGEVPTKGVFSSKTKL 618
S+ L+G++ + S T L
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSL 275
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 41/154 (26%), Positives = 63/154 (40%), Gaps = 8/154 (5%)
Query: 475 NASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVI 534
+ S N L +P+ L TT L++S N ++ I +L L LIIS N+ +
Sbjct: 6 DRSKNGLI-HVPKDLSQKTT---ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 535 PVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL-SGQIPEFLENLSFLE 593
LEYLD+S N + S ++K L+ S N + I + N+S L+
Sbjct: 62 ISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLK 118
Query: 594 FLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLC 627
FL S LE + +K+ L
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 9e-07
Identities = 37/179 (20%), Positives = 71/179 (39%), Gaps = 8/179 (4%)
Query: 59 NNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIP 118
N T++ + + C + LD SN + + G+L+ L + L N E+
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364
Query: 119 QEIG---NLLRLEKLALPNNSFSGTIPTNL-SRCSNLIQLRVSNNKLEGQIPAEIGSLLK 174
+ + L++L + NS S S +L+ L +S+N L I + +
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPR 422
Query: 175 LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQF 233
++ L + N + +P V L AL+ ++ N L L +L + + N +
Sbjct: 423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-37
Identities = 70/490 (14%), Positives = 142/490 (28%), Gaps = 74/490 (15%)
Query: 117 IPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQ 176
I + N R + + ++S + + N+ +L +S N L A++ KL+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 177 TLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGT 236
L + N L D +LS L + N + L + ++ LH N S
Sbjct: 62 LLNLSSNVLYE-TLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-- 112
Query: 237 FPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNV 296
+ K++ + N S V
Sbjct: 113 -----------------------RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 297 EILDLGFNQFKG-KVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSL 355
+ LDL N+ + +S L LNL+ N + D+ LK L L
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-----YDVKGQVVFAK---LKTLDL 198
Query: 356 AANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPD 415
++N+ L+ + ++ + + +++N+L I
Sbjct: 199 SSNK-----------LAF---------------MGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 416 VIGELKNLQGLFLYKNVLQ-GSIPSGVGNLTKLAKLVM-SYNSLQGNIPSSLGNCQNLIG 473
+ +NL+ L N G++ ++ + + L G
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
Query: 474 FNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGV 533
L +L+++ L + L + N ++ Q+ V
Sbjct: 292 GAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTV 351
Query: 534 IPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLE 593
I + L+ + + + + + ++ E S L+
Sbjct: 352 IDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQ 410
Query: 594 FLNFSHNDLE 603
L E
Sbjct: 411 LLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-35
Identities = 65/518 (12%), Positives = 149/518 (28%), Gaps = 47/518 (9%)
Query: 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136
R +++ + L+ + ++ ++LS N ++ +LE L L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 137 FSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNL 196
T+ L S L L ++NN ++ E+ ++TL N ++ R+
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRG 119
Query: 197 SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSG-TFPQSICNISSLERIYLPFN 255
+ + N + G + L + N+ F + + +LE + L +N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 256 RFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFS 315
+ + LK+L + N + +A+ V + L N+ +
Sbjct: 180 FIY-DVKGQV--VFAKLKTLDLSSNK-LAFMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 316 SLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSM 375
+NL +L N GT D + ++ ++A +L +
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDF-------FSKNQRVQTVAKQTV-KKLTGQNEEECTVP 286
Query: 376 IEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQG 435
G + L+ L G+ +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-------------------- 326
Query: 436 SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTL 495
+ N + ++ + I Q I L + + L
Sbjct: 327 RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386
Query: 496 SVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFS-GVIPVTLSTCVSLEYLDISSNSF 554
L + + + L L ++ + ++ D+ +
Sbjct: 387 DGTLQQAVGQIELQHATE--EQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444
Query: 555 HGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFL 592
+ + K + + + + + E + L
Sbjct: 445 TQLAEENARLKKLNGEADLALASANATLQELVVREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 50/320 (15%), Positives = 116/320 (36%), Gaps = 24/320 (7%)
Query: 285 SIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFL 344
+I + N + +I + + K ++ S N+ L+L N L + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL-----SQISAADL- 54
Query: 345 TNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGM 404
+ L++L+L++N E + +L S++ + N + + ++ L
Sbjct: 55 APFTKLELLNLSSNVLY-ETL-DLESL-STLRTLDLNNNYV-----QELLVGPSIETLHA 106
Query: 405 QSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQG-NIPS 463
+N + + + + ++L N + G +++ L + N + N
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 464 SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKL 523
+ L N +N + + + L LDLS+N L + + + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKT-LDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 524 IISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIP 583
+ +N+ +I L +LE+ D+ N FH F K+ +V + +
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTG 277
Query: 584 EFLENLSFLEFLNFSHNDLE 603
+ E + ++ E
Sbjct: 278 QNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-34
Identities = 56/359 (15%), Positives = 117/359 (32%), Gaps = 24/359 (6%)
Query: 264 DIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWL 323
+I N K + ++ ++ +A NV+ LDL N + D + L L
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 324 NLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGN 383
NL N L L + S+L+ L L N + S+ N
Sbjct: 64 NLSSNVLYE--------TLDLESLSTLRTLDLNNNYV-----QELLVG-PSIETLHAANN 109
Query: 384 QIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQG-SIPSGVG 442
I + S + N+ + +N++ G +Q L L N + +
Sbjct: 110 NISRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 443 NLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLS 502
+ L L + YN + ++ + L + S NKL + + S ++ ++ L
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-WISLR 222
Query: 503 NNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSL 562
NN L + + +NL + N F + + ++ + + +
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNE 280
Query: 563 GFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQ 621
+ ++ + F + L L+ + +G + + + +
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-24
Identities = 41/214 (19%), Positives = 81/214 (37%), Gaps = 17/214 (7%)
Query: 413 IPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLI 472
I ++ + + + L+ ++ S + + +L +S N L + L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 473 GFNASHNKLTGALPQQLLSITTLS--VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQF 530
N S N L + L + +LS LDL+NN + ++ ++ L ++N
Sbjct: 62 LLNLSSNVLY-----ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 531 SGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSG-QIPEFLENL 589
S V + + +++N + G ++ L+ N + E +
Sbjct: 112 SRVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 590 SFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGN 623
LE LN +N + +V + VF+ L L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSN 201
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 24/224 (10%)
Query: 711 NMIGQGSFGSVYKGIL---GEDEMIVAVKVI--NLKQKGAFKSFMAECKALRNIRHRNLI 765
M+G+G FGSV + L + VAVK++ ++ + F+ E ++ H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 766 KIITICSSIDSKGADFKAL-VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
K++ + +KG + + MK+G L +L S L L V +D+A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 825 AIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+EYL + +H DL N +L DM V DFGL++ + + D + +S +
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDYYRQGCASKLP 202
Query: 884 IKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+K A E + + S DV++FG+ + E+ T G+ P
Sbjct: 203 VKWL----ALESLADNLYTVHS---DVWAFGVTMWEIMTRGQTP 239
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 64/231 (27%), Positives = 93/231 (40%), Gaps = 36/231 (15%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL---GEDEMIVAVKVIN---LKQKGAFKSFMAECKALRN 758
+ +G GSFG V +G + VAVK + L Q A F+ E A+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 759 IRHRNLIKIITICSS--IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV 816
+ HRNLI++ + + + +V E GSL D L + H L
Sbjct: 78 LDHRNLIRLYGVVLTPPM--------KMVTELAPLGSLLDRLRKHQGHF-----LLGTLS 124
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK 876
A+ VA + YL +H DL N+LL + +GDFGL + L + D
Sbjct: 125 RYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-DHYVM 180
Query: 877 TSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ APE S AS D + FG+ L E+FT G+ P
Sbjct: 181 QEHRKVPFAWC----APESLKTRTFSHAS---DTWMFGVTLWEMFTYGQEP 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-37
Identities = 58/230 (25%), Positives = 105/230 (45%), Gaps = 36/230 (15%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLK---QKGAFKSFMAECKALR 757
+EF ++G G+FG+VYKG+ + ++ VA+K L+ A K + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72
Query: 758 NIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVN 817
++ + ++ +++ IC + L+ + M G L D++ + D++ L +N
Sbjct: 73 SVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LN 121
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
+ +A + YL +VH DL NVL+ + DFGLAK L + +
Sbjct: 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYHA 176
Query: 878 SSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ IK A E + + + S DV+S+G+ + EL T G +P
Sbjct: 177 EGGKVPIKWM----ALESILHRIYTHQS---DVWSYGVTVWELMTFGSKP 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-37
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITIC 771
IG+G+FG V+ G L D +VAVK F+ E + L+ H N++++I +C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+ +V E ++ G +L ++ +L + + + D A+ +EYL
Sbjct: 182 TQKQP-----IYIVMELVQGGDFLTFL-RTEGA----RLRVKTLLQMVGDAAAGMEYLES 231
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
+H DL N L+ V + DFG+++ + A+ + +K T
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG--VYAASGGLRQVPVKWT---- 282
Query: 892 APE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE Y S S DV+SFGILL E F+ G P
Sbjct: 283 APEALNYGRYSSES---DVWSFGILLWETFSLGASP 315
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 711 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNL 764
+IG+G FG VY G ++ + A+K L + ++F+ E +R + H N+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKS--LSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
+ +I I +G ++ M +G L ++ + T+ ++ + VA
Sbjct: 85 LALIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQRNP-----TVKDLISFGLQVAR 135
Query: 825 AIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+EYL VH DL N +LD V DFGLA+ + + + + + +
Sbjct: 136 GMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 884 IKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+K T A E + S DV+SFG+LL EL T G P
Sbjct: 192 VKWT----ALESLQTYRFTTKS---DVWSFGVLLWELLTRGAPP 228
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-36
Identities = 64/402 (15%), Positives = 141/402 (35%), Gaps = 31/402 (7%)
Query: 131 ALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP 190
P I +NL + + + E +L + + + +
Sbjct: 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 62
Query: 191 DFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERI 250
+ + +E+ ++ + + L++G N P N+ L +
Sbjct: 63 ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122
Query: 251 YLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDS-LSNASNVEILDLGFNQFKGK 309
L N S +LP I N P L +L++ NN I D ++++ L L N+
Sbjct: 123 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNN-LERIEDDTFQATTSLQNLQLSSNRLT-- 178
Query: 310 VSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIA 369
+D S + +L N+ N L + L +++ L + N +
Sbjct: 179 -HVDLSLIPSLFHANVSYNLL-----------STLAIPIAVEELDASHNSIN-VVR---G 222
Query: 370 NLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLY 429
++ + ++ N + + + N L+ + + N+L + +++ L+ L++
Sbjct: 223 PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280
Query: 430 KNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQL 489
N L ++ + L L +S+N L ++ + L HN + L
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST 337
Query: 490 LSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFS 531
TL L LS+N+ + + + +N+ + +
Sbjct: 338 HH--TLK-NLTLSHNDWDCNSLRAL--FRNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-36
Identities = 81/389 (20%), Positives = 132/389 (33%), Gaps = 52/389 (13%)
Query: 236 TFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASN 295
++ +++ F+ + L N K + + L +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 296 VEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSL 355
VE+L+L Q + + F+ + L + N + L F N L +L L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-----RYLPPHVF-QNVPLLTVLVL 124
Query: 356 AANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGTIP 414
N LSS +P GI N L L M +N L
Sbjct: 125 ERND-----------LSS---------------LPRGIFHNTPKLTTLSMSNNNLERIED 158
Query: 415 DVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGF 474
D +LQ L L N L + + L +SYN L S+L +
Sbjct: 159 DTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEEL 210
Query: 475 NASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVI 534
+ASHN + + +T L L +NNL + N LV++ +S N+ ++
Sbjct: 211 DASHNSINVVRGPVNVELTI----LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIM 264
Query: 535 PVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEF 594
LE L IS+N + + ++KVL+ S N+L + LE
Sbjct: 265 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322
Query: 595 LNFSHNDLEGEVPTKGVFSSKTKLSLQGN 623
L HN + + + L+L N
Sbjct: 323 LYLDHNSIV-TLKL-STHHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 62/364 (17%), Positives = 120/364 (32%), Gaps = 30/364 (8%)
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTN-LSRCSNLIQLRVS 157
+++ + E L + + N++ +P L + L ++
Sbjct: 19 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLN 77
Query: 158 NNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTT 216
+ ++E +I +Q L +G N + P N+ L V + N L
Sbjct: 78 DLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGI 136
Query: 217 LGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLA 276
L L + N + +SL+ + L NR + + +P+L
Sbjct: 137 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFHAN 192
Query: 277 IGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTAN 336
+ N +L+ VE LD N + L+ L L+ NN
Sbjct: 193 VSYNLL-----STLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNN------- 237
Query: 337 DLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNL 396
L +L N L + L+ N+ + H + + I N++ + + +
Sbjct: 238 -LTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKM-QRLERLYISNNRL-VALNLYGQPI 294
Query: 397 VNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNS 456
L L + N L + + L+ L+L N + ++ L L +S+N
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHND 350
Query: 457 LQGN 460
N
Sbjct: 351 WDCN 354
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 67/391 (17%), Positives = 131/391 (33%), Gaps = 58/391 (14%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI-GNLLRLEKLALPNNSFS 138
+ N + + + + + + +NL+D EI ++KL + N+
Sbjct: 48 KIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106
Query: 139 GTIPTN-LSRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFVGNL 196
+P + L L + N L +P I + KL TL++ N L D
Sbjct: 107 -YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 164
Query: 197 SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR 256
++L+ ++ N L + L L+ +L +V N S ++ ++E + N
Sbjct: 165 TSLQNLQLSSNRL-THVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 216
Query: 257 FSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSS 316
+ + + L L + NN + L N + +DL +N+ + + F
Sbjct: 217 IN-VVRGPV---NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVK 270
Query: 317 LKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMI 376
++ L L + N L A +L +LK+L L+ N L
Sbjct: 271 MQRLERLYISNNRL---VALNLYG----QPIPTLKVLDLSHNH-----------LLH--- 309
Query: 377 EFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGS 436
+ L L + N + T+ + L+ L L N +
Sbjct: 310 ------------VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN 354
Query: 437 IPSGVGNLTKLAKLVMSYNSLQGNIPSSLGN 467
+ +A+ + I L +
Sbjct: 355 SLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 56/287 (19%), Positives = 106/287 (36%), Gaps = 29/287 (10%)
Query: 76 HQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI-GNLLRLEKLALPN 134
+ +L + I + N+ L + L N +P+ I N +L L++ N
Sbjct: 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSN 150
Query: 135 NSFSGTIPTN-LSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFV 193
N+ I + ++L L++S+N+L + + + L V N L+ +
Sbjct: 151 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TL 201
Query: 194 GNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLP 253
A+E + NS+ + + L L + N T + N L + L
Sbjct: 202 AIPIAVEELDASHNSI-NVVRG--PVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLS 256
Query: 254 FNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID 313
+N + + V + L+ L I N ++ +++LDL N V +
Sbjct: 257 YNELE-KIMYHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL-HVERN 313
Query: 314 FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360
L L L+ N++ L T +LK L+L+ N +
Sbjct: 314 QPQFDRLENLYLDHNSI-----VTLKLSTH----HTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 18/110 (16%), Positives = 40/110 (36%), Gaps = 5/110 (4%)
Query: 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136
+ +DLS + I+ + L + +S+N + + L+ L L +N
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 137 FSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLT 186
+ N + L L + +N + + + + L+ L + N
Sbjct: 307 LL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 70/307 (22%), Positives = 121/307 (39%), Gaps = 45/307 (14%)
Query: 640 SKGSRKPKITLLKVLIPVAVL---CMVLSSCLTIVYARRRRSARKSVDTSPREKQFPTVS 696
R+ +L+P + L+ ++ S + +
Sbjct: 12 HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71
Query: 697 YAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ-- 742
EL +A + +IG+G FG VY G L ++ AVK L +
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRIT 129
Query: 743 -KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS 801
G F+ E +++ H N++ ++ IC S+G+ +V MK+G L +++ ++
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI-RN 184
Query: 802 NDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860
H T+ + + VA +++L VH DL N +LD V DF
Sbjct: 185 ETH----NPTVKDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADF 236
Query: 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLEL 917
GLA+ + + D+ + + + +K A E + S DV+SFG+LL EL
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKS---DVWSFGVLLWEL 289
Query: 918 FT-GRRP 923
T G P
Sbjct: 290 MTRGAPP 296
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 711 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNL 764
+IG+G FG VY G L ++ AVK L + G F+ E +++ H N+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
+ ++ IC S+G+ +V MK+G L +++ ++ H T+ + + VA
Sbjct: 89 LSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI-RNETH----NPTVKDLIGFGLQVAK 139
Query: 825 AIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
++YL VH DL N +LD V DFGLA+ + + + + + +
Sbjct: 140 GMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 884 IKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+K A E + S DV+SFG+LL EL T G P
Sbjct: 196 VKWM----ALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPP 232
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 64/251 (25%), Positives = 106/251 (42%), Gaps = 35/251 (13%)
Query: 713 IGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHRNLIK 766
+G+G+FGSV +VAVK L+ G + F E + L+ + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + LV E + +G L D+L + L+ +L + + + +
Sbjct: 89 YRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGM 140
Query: 827 EYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
EYL C VH DL N+L++ + + DFGLAK L + D I
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIF 195
Query: 886 GTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP-TDAAFTEGLTLHEFAKI 940
APE + S S DV+SFG++L ELFT + + +A + E
Sbjct: 196 WY----APESLSDNIFSRQS---DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
Query: 941 ALPEKVIEIVD 951
AL ++E+++
Sbjct: 249 ALSR-LLELLE 258
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 33/218 (15%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRHRNLIKIITI 770
+G G +G VY+G+ + + VAVK + + + F+ E ++ I+H NL++++ +
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL- 829
C+ ++ E M G+L D+L + N +++ + + +A ++SA+EYL
Sbjct: 78 CTREPP-----FYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLE 128
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
+ +H DL N L+ + + V DFGL++ ++ DT + + + IK T
Sbjct: 129 KKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWT-- 179
Query: 890 YVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE Y S S DV++FG+LL E+ T G P
Sbjct: 180 --APESLAYNKFSIKS---DVWAFGVLLWEIATYGMSP 212
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-36
Identities = 68/222 (30%), Positives = 110/222 (49%), Gaps = 35/222 (15%)
Query: 713 IGQGSFGSVYKGIL---GEDEMIVAVKVIN----LKQKGAFKSFMAECKALRNIRHRNLI 765
IG G G V G L G+ ++ VA+K + +Q+ + F++E + H N+I
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFLSEASIMGQFDHPNII 113
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
++ + + +V E M+NGSL+ +L +++D + T++Q V + V +
Sbjct: 114 RLEGVVTRGRLA-----MIVTEYMENGSLDTFL-RTHDG----QFTIMQLVGMLRGVGAG 163
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+ YL VH DL NVL+D ++V V DFGL++ L D A T+ I I+
Sbjct: 164 MRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-DAAYTTTGGKIPIR 219
Query: 886 GTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
T APE + S AS DV+SFG+++ E+ G RP
Sbjct: 220 WT----APEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERP 254
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 713 IGQGSFGSVYKGIL----GEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLI 765
+G+G FG V VAVK LK E + LRN+ H N++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
K IC+ G + L+ E + +GSL+++L N + K+ L Q++ A+ +
Sbjct: 87 KYKGICTE---DGGNGIKLIMEFLPSGSLKEYL-PKNKN----KINLKQQLKYAVQICKG 138
Query: 826 IEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
++YL VH DL NVL++ + +GDFGL K + + + + + +
Sbjct: 139 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EYYTVKDDRDSPV 193
Query: 885 KGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE AS DV+SFG+ L EL T
Sbjct: 194 FWY----APECLMQSKFYIAS---DVWSFGVTLHELLTYCDSD 229
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 69/216 (31%), Positives = 103/216 (47%), Gaps = 35/216 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG+G FG V G ++ VAVK +K ++F+AE + +RH NL++++ +
Sbjct: 29 IGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HH 831
+ +V E M GSL D+L L + ++DV A+EYL +
Sbjct: 85 ----EEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
+ VH DL NVL+ D V+ V DFGL K + +S + + +K T
Sbjct: 137 NF----VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT---- 181
Query: 892 APE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE S S DV+SFGILL E+++ GR P
Sbjct: 182 APEALREKKFSTKS---DVWSFGILLWEIYSFGRVP 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 68/223 (30%), Positives = 109/223 (48%), Gaps = 37/223 (16%)
Query: 713 IGQGSFGSVYKGIL---GEDEMIVAVKVIN----LKQKGAFKSFMAECKALRNIRHRNLI 765
+G G FG V G L + E+ VA+K + KQ+ + F+ E + H N+I
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNII 109
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
++ + + +V E M+NGSL+ +L + +D + T+IQ V + +AS
Sbjct: 110 RLEGVVTKSKPV-----MIVTEYMENGSLDSFL-RKHDA----QFTVIQLVGMLRGIASG 159
Query: 826 IEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
++YL VH DL N+L++ ++V V DFGL + L + A T I I
Sbjct: 160 MKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-EAAYTTRGGKIPI 214
Query: 885 KGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ T +PE Y + AS DV+S+GI+L E+ + G RP
Sbjct: 215 RWT----SPEAIAYRKFTSAS---DVWSYGIVLWEVMSYGERP 250
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 59/222 (26%), Positives = 115/222 (51%), Gaps = 25/222 (11%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRHR 762
++ + +G G +G VY+G+ + + VAVK + + + F+ E ++ I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 822
NL++++ +C ++ F ++ E M G+L D+L + N +++ + + +A +
Sbjct: 277 NLVQLLGVC----TREPPFY-IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQI 327
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+SA+EYL +H +L N L+ + + V DFGL++ ++ DT + + +
Sbjct: 328 SSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKF 381
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
IK T APE ++ S+ DV++FG+LL E+ T G P
Sbjct: 382 PIKWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 49/317 (15%), Positives = 115/317 (36%), Gaps = 24/317 (7%)
Query: 285 SIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFL 344
+I + N + +I + + K ++ S N+ L+L N L + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL-----SQISAADL- 54
Query: 345 TNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGM 404
+ L++L+L++N E + +L S++ + N + + ++ L
Sbjct: 55 APFTKLELLNLSSNVLY-ETL-DLESL-STLRTLDLNNNYV-----QELLVGPSIETLHA 106
Query: 405 QSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQG-NIPS 463
+N + + + + ++L N + G +++ L + N + N
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 464 SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKL 523
+ L N +N + + + L LDLS+N L + + + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKT-LDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 524 IISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIP 583
+ +N+ +I L +LE+ D+ N FH F K+ +V + +
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTG 277
Query: 584 EFLENLSFLEFLNFSHN 600
+ E + ++
Sbjct: 278 QNEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 50/279 (17%), Positives = 94/279 (33%), Gaps = 17/279 (6%)
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405
N + KI + + L + + + E + GN + I + + L L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 406 SNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSL 465
SN L+ D + L L+ L L N +Q + + L + N++ + S
Sbjct: 67 SNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-RVSCSR 118
Query: 466 GNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNG-SLPLQIGNLKNLVKLI 524
G Q ++NK+T + + YLDL N ++ + + L L
Sbjct: 119 G--QGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 525 ISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPE 584
+ N V L+ LD+SSN + + ++ +N L I +
Sbjct: 176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 585 FLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGN 623
L LE + N ++ ++
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 45/290 (15%), Positives = 100/290 (34%), Gaps = 21/290 (7%)
Query: 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136
R +++ + L+ + ++ ++LS N ++ +LE L L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 137 FSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNL 196
+L S L L ++NN ++ E+ ++TL N ++ R+
Sbjct: 70 LY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRG 119
Query: 197 SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSG-TFPQSICNISSLERIYLPFN 255
+ + N + G + L + N+ F + + +LE + L +N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 256 RFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFS 315
+ + LK+L + N + +A+ V + L N+ +
Sbjct: 180 FIY-DVKGQV--VFAKLKTLDLSSNK-LAFMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 316 SLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELP 365
+NL +L N GT D + ++ ++ + +
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDF-----FSKNQRVQTVAKQTVKKLTGQN 279
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 56/320 (17%), Positives = 105/320 (32%), Gaps = 50/320 (15%)
Query: 117 IPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQ 176
I + N R + + ++S + + N+ +L +S N L A++ KL+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 177 TLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGT 236
L + N L D +LS L + N + L + ++ LH N S
Sbjct: 62 LLNLSSNVLYE-TLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-- 112
Query: 237 FPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNV 296
+ K++ + N S V
Sbjct: 113 -----------------------RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 297 EILDLGFNQFKGKVSID--FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILS 354
+ LDL N+ V+ +S L LNL+ N + D+ LK L
Sbjct: 147 QYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFI-----YDVKGQVVFAK---LKTLD 197
Query: 355 LAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIP 414
L++N+ + + + + + N++ +I +R NL ++ N H
Sbjct: 198 LSSNKLA-FMGPEFQSA-AGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFH-CGT 253
Query: 415 DVIGELKNLQGLFLYKNVLQ 434
KN + + K ++
Sbjct: 254 LRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 47/311 (15%), Positives = 114/311 (36%), Gaps = 30/311 (9%)
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158
N + + ++D+S + + +++L L N S +L+ + L L +S+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLG 218
N L + ++ SL L+TL + NY+ + ++E N++ ++
Sbjct: 68 NVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVS--CS 117
Query: 219 LLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIG 278
+ ++++ N+ + S ++ + L N ++ + L+ L +
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 279 GNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDL 338
N + + + + ++ LDL N+ + +F S ++W++L N L +
Sbjct: 178 YNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA-- 232
Query: 339 DFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVN 398
L +L+ L N F ++ +F ++ + ++ L
Sbjct: 233 -----LRFSQNLEHFDLRGNGFH----------CGTLRDFFSKNQRVQTVAKQTVKKLTG 277
Query: 399 LIALGMQSNQL 409
L
Sbjct: 278 QNEEECTVPTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 41/214 (19%), Positives = 81/214 (37%), Gaps = 17/214 (7%)
Query: 413 IPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLI 472
I ++ + + + L+ ++ S + + +L +S N L + L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 473 GFNASHNKLTGALPQQLLSITTLS--VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQF 530
N S N L + L + +LS LDL+NN + ++ ++ L ++N
Sbjct: 62 LLNLSSNVLY-----ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 531 SGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSG-QIPEFLENL 589
S V + + +++N + G ++ L+ N + E +
Sbjct: 112 SRVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 590 SFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGN 623
LE LN +N + +V + VF+ L L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSN 201
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 18/95 (18%), Positives = 41/95 (43%), Gaps = 2/95 (2%)
Query: 509 SLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSI 568
++ N ++ + + + +++ LD+S N + L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 569 KVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE 603
++LN SSN L + + E+LS L L+ ++N ++
Sbjct: 61 ELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYVQ 93
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 70/223 (31%), Positives = 113/223 (50%), Gaps = 36/223 (16%)
Query: 713 IGQGSFGSVYKGIL----GEDEMIVAVKVIN----LKQKGAFKSFMAECKALRNIRHRNL 764
IG G FG VYKG+L G+ E+ VA+K + KQ+ F+ E + H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDFLGEAGIMGQFSHHNI 108
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
I++ + S ++ E M+NG+L+ +L + D + +++Q V + +A+
Sbjct: 109 IRLEGVISKYKPM-----MIITEYMENGALDKFL-REKDG----EFSVLQLVGMLRGIAA 158
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
++YL + VH DL N+L++ ++V V DFGL++ L + TS I I
Sbjct: 159 GMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EATYTTSGGKIPI 214
Query: 885 KGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ T APE Y + AS DV+SFGI++ E+ T G RP
Sbjct: 215 RWT----APEAISYRKFTSAS---DVWSFGIVMWEVMTYGERP 250
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLK-QKGAFKSFMAECKALRNI 759
+E ++G G FG+V+KG+ ++ V +KVI K + +F++ A+ ++
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 760 RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
H ++++++ +C LV + + GSL D + Q L +N
Sbjct: 73 DHAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGAL-----GPQLLLNWG 121
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+ +A + YL H MVH +L NVLL V DFG+A L D S
Sbjct: 122 VQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSE 176
Query: 880 SSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ IK A E + + S DV+S+G+ + EL T G P
Sbjct: 177 AKTPIKWM----ALESIHFGKYTHQS---DVWSYGVTVWELMTFGAEP 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 71/249 (28%), Positives = 110/249 (44%), Gaps = 40/249 (16%)
Query: 685 TSPREKQFPTVSYAELSKATSEFASS-----NMIGQGSFGSVYKGILGEDEMIVAVKVIN 739
P+ + + E ++ IG+G FG V G ++ VAVK
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC-- 223
Query: 740 LKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLH 799
+K ++F+AE + +RH NL++++ + + +V E M GSL D+L
Sbjct: 224 IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLR 279
Query: 800 QSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858
L + ++DV A+EYL ++ VH DL NVL+ D V+ V
Sbjct: 280 SRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVS 331
Query: 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLL 915
DFGL K + +S + + +K T APE S S DV+SFGILL
Sbjct: 332 DFGLTK-------EASSTQDTGKLPVKWT----APEALREKKFSTKS---DVWSFGILLW 377
Query: 916 ELFT-GRRP 923
E+++ GR P
Sbjct: 378 EIYSFGRVP 386
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 713 IGQGSFGSVYKGIL--GEDEMIVAVKVI--NLKQKGAFKSFMAECKALRNIRHRNLIKII 768
+G G+FG+V KG + VAVK++ +AE ++ + + ++++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
IC + + LV E + G L +L Q N H+ + + V+ ++Y
Sbjct: 85 GICEA------ESWMLVMEMAELGPLNKYL-QQNRHV-----KDKNIIELVHQVSMGMKY 132
Query: 829 L-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
L + VH DL NVLL + + DFGL+K L + + + + +K
Sbjct: 133 LEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWY 187
Query: 888 VGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE Y S S DV+SFG+L+ E F+ G++P
Sbjct: 188 ----APECINYYKFSSKS---DVWSFGVLMWEAFSYGQKP 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 36/230 (15%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLK---QKGAFKSFMAECKALR 757
+EF ++G G+FG+VYKG+ + ++ VA+K L+ A K + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72
Query: 758 NIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVN 817
++ + ++ +++ IC + L+ + M G L D++ + D++ +N
Sbjct: 73 SVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNI-----GSQYLLN 121
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
+ +A + YL +VH DL NVL+ + DFGLAK L + +
Sbjct: 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYHA 176
Query: 878 SSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ IK A E + + + S DV+S+G+ + EL T G +P
Sbjct: 177 EGGKVPIKWM----ALESILHRIYTHQS---DVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 713 IGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKII 768
+G+G+FGSV +VAVK + + + F E + L++++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+C S + L+ E + GSL D+L Q + ++ I+ + + +EY
Sbjct: 78 GVCYSAGRRNL---KLIMEYLPYGSLRDYL-QKHKE----RIDHIKLLQYTSQICKGMEY 129
Query: 829 LH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
L +H DL N+L++++ +GDFGL K L + + I
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EFFKVKEPGESPIFWY 184
Query: 888 VGYVAPE---YCMGSEASMTGDVYSFGILLLELFT 919
APE S AS DV+SFG++L ELFT
Sbjct: 185 ----APESLTESKFSVAS---DVWSFGVVLYELFT 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FKSFMAECKALRNIRHRNLIKIITI 770
+G G FG V G + VA+K+I +G+ F+ E K + N+ H L+++ +
Sbjct: 32 LGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL- 829
C+ ++ E M NG L ++L + H + Q + + DV A+EYL
Sbjct: 88 CTKQRPI-----FIITEYMANGCLLNYL-REMRH----RFQTQQLLEMCKDVCEAMEYLE 137
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
+H DL N L++ V V DFGL++++ D + + S ++ +
Sbjct: 138 SKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWS-- 188
Query: 890 YVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
PE Y S S D+++FG+L+ E+++ G+ P
Sbjct: 189 --PPEVLMYSKFSSKS---DIWAFGVLMWEIYSLGKMP 221
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 713 IGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKII 768
+G+G+FGSV +VAVK + + + F E + L++++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+C S + L+ E + GSL D+L Q + ++ I+ + + +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYL-QKHKE----RIDHIKLLQYTSQICKGMEY 160
Query: 829 LH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
L +H DL N+L++++ +GDFGL K L + + I
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EYYKVKEPGESPIFWY 215
Query: 888 VGYVAPE---YCMGSEASMTGDVYSFGILLLELFT 919
APE S AS DV+SFG++L ELFT
Sbjct: 216 ----APESLTESKFSVAS---DVWSFGVVLYELFT 243
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
IG+GSF +VYKG+ E + VA + ++ K + F E + L+ ++H N+++
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY-- 91
Query: 771 CSSIDSKGADFKALVF--ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
S +S K +V E M +G+L+ +L + + + + +++
Sbjct: 92 -DSWESTVKGKKCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQF 144
Query: 829 LHHHCQPPMVHGDLKPSNVLLDH-DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
LH PP++H DLK N+ + +GD GLA + + GT
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----------VIGT 193
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
++APE + + DVY+FG+ +LE+ T P
Sbjct: 194 PEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 63/223 (28%), Positives = 87/223 (39%), Gaps = 36/223 (16%)
Query: 713 IGQGSFGSVYKGIL----GEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLI 765
+G+G FG V +VAVK LK + E LR + H ++I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
K C + LV E + GSL D+L + + L Q + A +
Sbjct: 97 KYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEG 146
Query: 826 IEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
+ YLH H +H DL NVLLD+D + +GDFGLAK + + +
Sbjct: 147 MAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPV 201
Query: 885 KGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE AS DV+SFG+ L EL T
Sbjct: 202 FWY----APECLKEYKFYYAS---DVWSFGVTLYELLTHCDSS 237
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 35/218 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FKSFMAECKALRNIRHRNLIKIITI 770
+G G FG V G + + VAVK+I +G+ F E + + + H L+K +
Sbjct: 16 LGSGQFGVVKLGKW-KGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL- 829
CS +V E + NG L ++L +S+ L Q + + DV + +L
Sbjct: 72 CSKEYPI-----YIVTEYISNGCLLNYL-RSHGK----GLEPSQLLEMCYDVCEGMAFLE 121
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H +H DL N L+D D+ V DFG+ +++ D + + +K +
Sbjct: 122 SHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWS-- 172
Query: 890 YVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE Y S S DV++FGIL+ E+F+ G+ P
Sbjct: 173 --APEVFHYFKYSSKS---DVWAFGILMWEVFSLGKMP 205
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 30/238 (12%)
Query: 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR 760
+ S+F ++GQG+FG V K D A+K I + + ++E L ++
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 761 HRNLIKIITICSSIDSKGADFKA--------LVFECMKNGSLEDWLHQSNDHLEVCKLTL 812
H+ +++ + A + E +NG+L D +H N + +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR----- 115
Query: 813 IQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLD 872
+ + + A+ Y+H ++H DLKP N+ +D +GDFGLAK +
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 873 TASKTSSSSIGIK------GTVGYVAPEYCMGS----EASMTGDVYSFGILLLELFTG 920
+ + GT YVA E G+ E D+YS GI+ E+
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI---DMYSLGIIFFEMIYP 227
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-34
Identities = 80/463 (17%), Positives = 141/463 (30%), Gaps = 57/463 (12%)
Query: 127 LEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLT 186
T + + + L L N+ + + I L L L N +T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 187 GRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISS 246
L + + L + N L + + L L L+ N+ + +
Sbjct: 78 T-LD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPL 128
Query: 247 LERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQF 306
L + N + + + L L N + ++ + + LD FN+
Sbjct: 129 LTYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182
Query: 307 KGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPH 366
+D S K L+ LN + NN+ LD L L ++N+ E+
Sbjct: 183 T---ELDVSQNKLLNRLNCDTNNI-----TKLDL----NQNIQLTFLDCSSNKLT-EID- 228
Query: 367 SIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGL 426
+ L + + F N + + S L L L L I + L
Sbjct: 229 -VTPL-TQLTYFDCSVNPLTELDVS---TLSKLTTLHCIQTDLL-EID--LTHNTQLIYF 280
Query: 427 FLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALP 486
+ V + T+L L + + L L+ ++ +LT L
Sbjct: 281 QAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD 334
Query: 487 QQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVT-----LSTC 541
+S T L N ++ +G + L + Q + T L+
Sbjct: 335 ---VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389
Query: 542 VSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPE 584
VS + LD N + I G + + NLS P
Sbjct: 390 VSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-32
Identities = 87/460 (18%), Positives = 157/460 (34%), Gaps = 59/460 (12%)
Query: 82 LDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTI 141
+ + + L+ L ++ ++S ++ I L L KL +N+ + T+
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TL 79
Query: 142 PTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEV 201
LS+ +NL L +NKL + + L KL L N LT V L
Sbjct: 80 D--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTY 131
Query: 202 FSITGNSLGGKIPTTLGL--LRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
+ N+L T + + L +L N+ + + L + FN+ +
Sbjct: 132 LNCARNTL-----TEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT- 183
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKN 319
L L L NN + L+ + LD N+ ID + L
Sbjct: 184 ELDVS---QNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT---EIDVTPLTQ 234
Query: 320 LSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFR 379
L++ + N L +LD + S L L + E+ + ++ +I F+
Sbjct: 235 LTYFDCSVNPL-----TELDV----STLSKLTTLHCIQTDLL-EIDLTH---NTQLIYFQ 281
Query: 380 IGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPS 439
G + + + + L L Q+ + + + + L L+L L +
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD- 334
Query: 440 GVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLT----GALPQQLLSITTL 495
V + TKL L +Q + S+G L + + L L+I
Sbjct: 335 -VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVS 391
Query: 496 SVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIP 535
LD N +N + G + + I+ S P
Sbjct: 392 PDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 60/406 (14%), Positives = 125/406 (30%), Gaps = 50/406 (12%)
Query: 197 SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR 256
+ + L L L + + I ++ L ++ N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75
Query: 257 FSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSS 316
+ TL NL LA N ++ ++ + + L+ N+ +D S
Sbjct: 76 IT-TLDL---SQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT---KLDVSQ 125
Query: 317 LKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMI 376
L++LN +N L ++D +++ + L L N+ + +L + + +
Sbjct: 126 NPLLTYLNCARNTL-----TEID----VSHNTQLTELDCHLNKKITKLD--VTPQTQ-LT 173
Query: 377 EFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGS 436
N+I + S L L +N + + + + L L N L
Sbjct: 174 TLDCSFNKITELDVS---QNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-E 226
Query: 437 IPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLS 496
I V LT+L S N L + S L + L + +T +
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLE------IDLTHNT 275
Query: 497 VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHG 556
+ L + + L L + + + LS L YL +++
Sbjct: 276 QLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE 332
Query: 557 VIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDL 602
+ + +K L+ + ++ + + L +
Sbjct: 333 L---DVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 42/251 (16%), Positives = 82/251 (32%), Gaps = 29/251 (11%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
T LD S +I + V L +N N+ ++ + ++L L +N +
Sbjct: 173 TTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT- 225
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
I ++ + L S N L ++ + +L KL TL + L + + + + L
Sbjct: 226 EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQL 277
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
F G ++ + L L + + L +YL +
Sbjct: 278 IYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT- 331
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKN 319
L + LKSL+ + S+ + Q +++ +L N
Sbjct: 332 ELDVS---HNTKLKSLSCVNAH-IQDFS-SVGKIPALNNNFEAEGQT---ITMPKETLTN 383
Query: 320 LSWLNLEQNNL 330
S +L
Sbjct: 384 NSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 40/245 (16%), Positives = 75/245 (30%), Gaps = 24/245 (9%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
T LD S+ ++ I V L+ L Y + S N E+ + L +L L
Sbjct: 215 TFLDCSSNKLTEID---VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL- 267
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
I L+ + LI + + ++ ++ +L L +T L + L
Sbjct: 268 EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKL 320
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
+ L ++ + L L F S+ I +L + +
Sbjct: 321 VYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTIT 375
Query: 260 TLPFDIVVNL----PNLKSLAIGGNNFFGSIPD-SLSNASNVEILDLGFNQFKGKVSIDF 314
+ N + L GN D + + + I + V+ F
Sbjct: 376 MPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTF 435
Query: 315 SSLKN 319
+S
Sbjct: 436 TSENG 440
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 35/218 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FKSFMAECKALRNIRHRNLIKIITI 770
IG G FG V+ G ++ VA+K I +GA + F+ E + + + H L+++ +
Sbjct: 16 IGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL- 829
C LV E M++G L D+L ++ + + +DV + YL
Sbjct: 72 CLEQAPI-----CLVTEFMEHGCLSDYL-RTQRG----LFAAETLLGMCLDVCEGMAYLE 121
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
+H DL N L+ + V V DFG+ +F+ D + ++ + +K
Sbjct: 122 EACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWA-- 172
Query: 890 YVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+PE + S S DV+SFG+L+ E+F+ G+ P
Sbjct: 173 --SPEVFSFSRYSSKS---DVWSFGVLMWEVFSEGKIP 205
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 55/222 (24%), Positives = 106/222 (47%), Gaps = 38/222 (17%)
Query: 713 IGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIK 766
+G+G FG VY+G+ +++ VAVK K+ + FM+E ++N+ H +++K
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+I I + ++ E G L +L + N + L ++ V ++ + A+
Sbjct: 78 LIGIIEE------EPTWIIMELYPYGELGHYL-ERNKN----SLKVLTLVLYSLQICKAM 126
Query: 827 EYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
YL +C VH D+ N+L+ +GDFGL++++ + K S + + IK
Sbjct: 127 AYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED---EDYYKASVTRLPIK 179
Query: 886 GTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+PE + + AS DV+ F + + E+ + G++P
Sbjct: 180 WM----SPESINFRRFTTAS---DVWMFAVCMWEILSFGKQP 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 46/226 (20%)
Query: 713 IGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIK 766
IG+G FG V++GI + VA+K K + F+ E +R H +++K
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 767 IITICSS----IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 822
+I + + I + E G L +L Q + L L + A +
Sbjct: 81 LIGVITENPVWI----------IMELCTLGELRSFL-QVRKY----SLDLASLILYAYQL 125
Query: 823 ASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS 881
++A+ YL VH D+ NVL+ + +GDFGL++++ T K S
Sbjct: 126 STALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGK 178
Query: 882 IGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ IK APE + + AS DV+ FG+ + E+ G +P
Sbjct: 179 LPIKWM----APESINFRRFTSAS---DVWMFGVCMWEILMHGVKP 217
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 713 IGQGSFGSVYKGIL--GEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKI 767
+G G+FGSV +G+ + ++ VA+KV LK +K + M E + + + + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
I +C + + LV E G L +L ++ + + V+ ++
Sbjct: 76 IGVCQA------EALMLVMEMAGGGPLHKFL-VGKRE----EIPVSNVAELLHQVSMGMK 124
Query: 828 YL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YL + VH DL NVLL + + + DFGL+K L + + S+ +K
Sbjct: 125 YLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKW 179
Query: 887 TVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE + S S DV+S+G+ + E + G++P
Sbjct: 180 Y----APECINFRKFSSRS---DVWSYGVTMWEALSYGQKP 213
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-33
Identities = 81/387 (20%), Positives = 132/387 (34%), Gaps = 52/387 (13%)
Query: 238 PQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVE 297
++ +++ F+ + L N K + + L + VE
Sbjct: 20 DSNLQYDCVFYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 298 ILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAA 357
+L+L Q + + F+ + L + N + L F N L +L L
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-----RYLPPHVF-QNVPLLTVLVLER 132
Query: 358 NQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGTIPDV 416
N LSS +P GI N L L M +N L D
Sbjct: 133 ND-----------LSS---------------LPRGIFHNTPKLTTLSMSNNNLERIEDDT 166
Query: 417 IGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNA 476
+LQ L L N L + + L +SYN L S+L + +A
Sbjct: 167 FQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDA 218
Query: 477 SHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPV 536
SHN + + +T L L +NNL + N LV++ +S N+ ++
Sbjct: 219 SHNSINVVRGPVNVELTI----LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYH 272
Query: 537 TLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLN 596
LE L IS+N + + ++KVL+ S N+L + LE L
Sbjct: 273 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330
Query: 597 FSHNDLEGEVPTKGVFSSKTKLSLQGN 623
HN + + + L+L N
Sbjct: 331 LDHNSIV-TLKL-STHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-33
Identities = 81/517 (15%), Positives = 169/517 (32%), Gaps = 67/517 (12%)
Query: 103 LRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLE 162
RY + I + + + + +N + N+ +
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 163 GQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLR 221
++PA + S +++ L + + I +
Sbjct: 65 -KLPAALLDSFRQVELLNLNDLQIE----------------EIDTYAFAY--------AH 99
Query: 222 NLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNN 281
+ L++G N P N+ L + L N S +LP I N P L +L++ NN
Sbjct: 100 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 158
Query: 282 FFGSIPDS-LSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDF 340
I D ++++ L L N+ +D S + +L N+ N L
Sbjct: 159 -LERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLL---------- 204
Query: 341 VTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLI 400
+ L +++ L + N + ++ + ++ N + + + N L+
Sbjct: 205 -STLAIPIAVEELDASHNSIN-VVR---GPVNVELTILKLQHNNLTDT--AWLLNYPGLV 257
Query: 401 ALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGN 460
+ + N+L + +++ L+ L++ N L ++ + L L +S+N L +
Sbjct: 258 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-H 315
Query: 461 IPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNL 520
+ + L HN + L TL L LS+N+ + + + +N+
Sbjct: 316 VERNQPQFDRLENLYLDHNSIV-TLKLSTHH--TLK-NLTLSHNDWDCNSLRAL--FRNV 369
Query: 521 VKLIISSNQFSGVIPVTLS---TCVSLEY-------LDISSNSFHGVIPHSLGFLKSIKV 570
+ + I L C + I+ S + + G +
Sbjct: 370 ARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDT 429
Query: 571 LNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVP 607
+N + + L E L N+L EV
Sbjct: 430 INSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-32
Identities = 78/515 (15%), Positives = 156/515 (30%), Gaps = 65/515 (12%)
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTN-LSRCSNLIQLRVS 157
+++ + E L + + N++ +P L + L ++
Sbjct: 25 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLN 83
Query: 158 NNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTT 216
+ ++E +I +Q L +G N + P N+ L V + N L
Sbjct: 84 DLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGI 142
Query: 217 LGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLA 276
L L + N + +SL+ + L NR + + +P+L
Sbjct: 143 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFHAN 198
Query: 277 IGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTAN 336
+ N +L+ VE LD N + L+ L L+ NNL
Sbjct: 199 VSYNLL-----STLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD---- 246
Query: 337 DLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNL 396
+L N L + L N++ I+ +
Sbjct: 247 ----TAWLLNYPGLVEVDL-------------------------SYNELEKIMYHPFVKM 277
Query: 397 VNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNS 456
L L + +N+L + + L+ L L N L + +L L + +NS
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 335
Query: 457 LQGNIPSSLGNCQNLIGFNASHNKLTG----ALPQQLLSITTLSVYLDLSNNNLNGSLPL 512
+ + L L SHN AL + + +
Sbjct: 336 IV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 392
Query: 513 QIGNLKNLVKLIISSNQFSGVI---PVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIK 569
+ K + ++ + V+ C + + ++ + H + L+ +
Sbjct: 393 CKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNE 452
Query: 570 VLNFSSNNLSGQI----PEFLENLSFLEFLNFSHN 600
L N L ++ E ++ L+ L+ +
Sbjct: 453 QLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEID 487
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 1e-19
Identities = 62/456 (13%), Positives = 126/456 (27%), Gaps = 53/456 (11%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
T L +SN + I + L+ + LS N + + + L + N
Sbjct: 150 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-- 204
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
+ L+ + +L S+N + + ++L L + N LT +
Sbjct: 205 ---STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAWLLN----- 252
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
LV++ + N+ + LER+Y+ NR
Sbjct: 253 --------------------YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 291
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKN 319
L +P LK L + N+ + + +E L L N ++ S+
Sbjct: 292 ALNLYG-QPIPTLKVLDLSHNH-LLHVERNQPQFDRLENLYLDHNSIV---TLKLSTHHT 346
Query: 320 LSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFR 379
L L L N+ + N + + +Q L +
Sbjct: 347 LKNLTLSHNDW-----DCNSLRALFRNVARPAVDDA--DQHCKIDYQLEHGLCCKESDKP 399
Query: 380 IGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNV-LQGSIP 438
+ I + + V + ++ + + G+ L N L+ +
Sbjct: 400 YLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVN 459
Query: 439 SGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVY 498
+ +L + L + + + NL + + L + T L
Sbjct: 460 ELRAEVQQLTNEQIQQEQLLQGLHAEI--DTNLRRYRLPKDGLARSSDNLNKVFTHLKER 517
Query: 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVI 534
K L + +
Sbjct: 518 QAFKLRETQARRTEADAKQKETEDLEQENIALEKQL 553
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 2e-11
Identities = 26/160 (16%), Positives = 58/160 (36%), Gaps = 11/160 (6%)
Query: 472 IGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLP-----LQIGNLKNLVKLIIS 526
+G +N P+ + L + +++ + L N +
Sbjct: 1 VGGQQRYNVKP-RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFK 59
Query: 527 SNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFL 586
++ + L + +E L+++ + ++ + +I+ L N + P
Sbjct: 60 NSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF 119
Query: 587 ENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKL---SLQGN 623
+N+ L L NDL +P +G+F + KL S+ N
Sbjct: 120 QNVPLLTVLVLERNDLS-SLP-RGIFHNTPKLTTLSMSNN 157
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 45/283 (15%), Positives = 91/283 (32%), Gaps = 15/283 (5%)
Query: 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136
+ +DLS + I+ + L + +S+N + + L+ L L +N
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 137 FSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTG-RLPDFVGN 195
+ N + L L + +N + + + + L+ L + N L N
Sbjct: 313 LL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRN 368
Query: 196 LSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFN 255
++ ++ KI L + + + Q I S +E++
Sbjct: 369 VARP---AVDDADQHCKIDY---QLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQG 422
Query: 256 RFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQF---KGKVSI 312
R S T + V +L + + G ++ N E+ L Q + +
Sbjct: 423 RCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGL 482
Query: 313 DFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSL 355
NL L ++ L + N T L + K+
Sbjct: 483 HAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRET 525
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 53/234 (22%), Positives = 91/234 (38%), Gaps = 31/234 (13%)
Query: 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR 760
+ +F +IG G FG V+K D +K + + A + E KAL +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 761 HRNLIK-----------IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCK 809
H N++ T + + E G+LE W+ + K
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----K 118
Query: 810 LTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869
L + + + + ++Y+H +++ DLKPSN+ L +GDFGL L +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN- 174
Query: 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+T KGT+ Y++PE + D+Y+ G++L EL
Sbjct: 175 ---DGKRTR-----SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 18/220 (8%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK-SFMAECKALRNIRHRNLIKIIT- 769
+G+G FG V++ D+ A+K I L + + M E KAL + H +++
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 770 ------ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
S + + + + +L+DW++ E + + +I + +A
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL---HIFLQIA 128
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS----HQLDTASKTSS 879
A+E+LH ++H DLKPSN+ D V VGDFGL + + T +
Sbjct: 129 EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
G GT Y++PE G+ S D++S G++L EL
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 43/230 (18%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRNIRHR 762
+G G FG V+ G VAVK + +G+ +F+AE ++ ++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 763 NLIKIITICSS----IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
L+++ + + I + E M+NGSL D+L + KLT+ + +++
Sbjct: 69 RLVRLYAVVTQEPIYI----------ITEYMENGSLVDFLKTPSGI----KLTINKLLDM 114
Query: 819 AIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
A +A + ++ + +H DL+ +N+L+ + + DFGLA+ + + +
Sbjct: 115 AAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAR 167
Query: 878 SSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ IK T APE Y + S DV+SFGILL E+ T GR P
Sbjct: 168 EGAKFPIKWT----APEAINYGTFTIKS---DVWSFGILLTEIVTHGRIP 210
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 20/231 (8%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G+G F V D A+K I ++ + E R H N+++++
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA--Y 94
Query: 773 SIDSKGADFKA-LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+ +GA +A L+ K G+L + + + D LT Q + + + + +E +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLLLGICRGLEAIH- 151
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS--IGIKGTVG 889
H DLKP+N+LL + + D G ++ + + + + T+
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA-CIHVEGSRQALTLQDWAAQRCTIS 208
Query: 890 YVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934
Y APE +C+ E + DV+S G +L + G P D F +G ++
Sbjct: 209 YRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-33
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 29/223 (13%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL 764
+G G FG V+ VAVK + + ++F+AE ++ ++H L
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKL 245
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
+K+ + + + ++ E M GSL D+L K L + ++ + +A
Sbjct: 246 VKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAE 295
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
+ ++ +H DL+ +N+L+ +V + DFGLA+ + + + + I
Sbjct: 296 GMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPI 349
Query: 885 KGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
K T APE + + S DV+SFGILL+E+ T GR P
Sbjct: 350 KWT----APEAINFGSFTIKS---DVWSFGILLMEIVTYGRIP 385
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-33
Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 25/221 (11%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK-SFMAECKALRNIRHRN 763
+GQG FG V+ G VA+K LK +F+ E + ++ +RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
L+++ + S + +V E M GSL D+L L L Q V++A +A
Sbjct: 241 LVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIA 290
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
S + Y+ VH DL+ +N+L+ ++V V DFGLA+ + + + +
Sbjct: 291 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFP 344
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
IK T APE + ++ DV+SFGILL EL T GR P
Sbjct: 345 IKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-33
Identities = 80/409 (19%), Positives = 138/409 (33%), Gaps = 59/409 (14%)
Query: 115 GEIPQEIGNLLR--LEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSL 172
+ Q++ L L + + + T+P L +++ L + +N L +PA
Sbjct: 28 AAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP-- 81
Query: 173 LKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQ 232
+L+TL V N LT LP L L +FS L L L L + GNQ
Sbjct: 82 -ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQ 132
Query: 233 FSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSN 292
+ + P L+ + + N+ + +LP L L N S+P S
Sbjct: 133 LT-SLPVLPPG---LQELSVSDNQLA-SLP----ALPSELCKLWAYNNQL-TSLPMLPSG 182
Query: 293 ASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKI 352
++ L + NQ S+ + L L N L + S LK
Sbjct: 183 ---LQELSVSDNQLA---SLP-TLPSELYKLWAYNNRL----------TSLPALPSGLKE 225
Query: 353 LSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGT 412
L ++ N+ LP + L E + GN++ +P L++L + NQL
Sbjct: 226 LIVSGNRL-TSLPVLPSELK----ELMVSGNRL-TSLPMLPSGLLSLS---VYRNQLT-R 275
Query: 413 IPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLI 472
+P+ + L + + L N L + +T S+ + L
Sbjct: 276 LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH 335
Query: 473 GFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLV 521
A+ + L A + + + L + L
Sbjct: 336 --LAAADWLVPAREGEPAPADRWH---MFGQEDNADAFSLFLDRLSETE 379
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 76/383 (19%), Positives = 129/383 (33%), Gaps = 57/383 (14%)
Query: 219 LLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIG 278
L L+VG + + T P + + + +P N + +LP P L++L +
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLP----ALPPELRTLEVS 89
Query: 279 GNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDL 338
GN S+P + I + L L + N L
Sbjct: 90 GNQL-TSLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT------- 134
Query: 339 DFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVN 398
+ L+ LS++ NQ LP + L NQ+ +P L
Sbjct: 135 ---SLPVLPPGLQELSVSDNQL-ASLPALPSELCK----LWAYNNQL-TSLPMLPSGLQE 185
Query: 399 LIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQ 458
L + NQL ++P + EL L Y N L S+P+ L +L ++S N L
Sbjct: 186 LS---VSDNQLA-SLPTLPSELYKLW---AYNNRLT-SLPALPSGLKEL---IVSGNRLT 234
Query: 459 GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLK 518
++P + L S N+LT +LP + +L + N L LP + +L
Sbjct: 235 -SLPVLPSELKEL---MVSGNRLT-SLPMLPSGLLSL----SVYRNQLT-RLPESLIHLS 284
Query: 519 NLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578
+ + + N S TL + S + + L+ ++ +
Sbjct: 285 SETTVNLEGNPLS---ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341
Query: 579 SGQIPEFLENLSFLEFLNFSHND 601
E E + F D
Sbjct: 342 LVPARE-GEPAPADRWHMFGQED 363
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-31
Identities = 76/330 (23%), Positives = 120/330 (36%), Gaps = 54/330 (16%)
Query: 294 SNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKIL 353
+ +L++G + ++ +++ L + NNL + L+ L
Sbjct: 40 NGNAVLNVGESGLT---TLPDCLPAHITTLVIPDNNL----------TSLPALPPELRTL 86
Query: 354 SLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTI 413
++ NQ LP L + F + + L L + NQL ++
Sbjct: 87 EVSGNQLT-SLPVLPPGLLE-LSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SL 136
Query: 414 PDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIG 473
P LQ L + N L S+P+ L KL N L ++P Q L
Sbjct: 137 PV---LPPGLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSGLQEL-- 186
Query: 474 FNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGV 533
+ S N+L +LP + L NN L SLP LK +LI+S N+ +
Sbjct: 187 -SVSDNQLA-SLPTLPSELYKL----WAYNNRLT-SLPALPSGLK---ELIVSGNRLTS- 235
Query: 534 IPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLE 593
+PV S L+ L +S N +P L S L+ N L+ ++PE L +LS
Sbjct: 236 LPVLPS---ELKELMVSGNRLTS-LPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSET 287
Query: 594 FLNFSHNDLEGEVPTKGVFSSKTKLSLQGN 623
+N N L T T
Sbjct: 288 TVNLEGNPL--SERTLQALREITSAPGYSG 315
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-22
Identities = 69/357 (19%), Positives = 119/357 (33%), Gaps = 62/357 (17%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
L++S ++ L L L + +P L +L + N +
Sbjct: 84 RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH----LPALPSGLCKLW---IFGNQLT- 134
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
++P L +L VS+N+L +PA L L N LT LP L L
Sbjct: 135 SLPVLP---PGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQEL 186
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
S++ N L +PT L L + N+ + + P L+ + + NR +
Sbjct: 187 ---SVSDNQL-ASLPTLPSELYKLWAYN---NRLT-SLPALPSG---LKELIVSGNRLT- 234
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKN 319
+LP V LK L + N S+P S + L + NQ ++ L +
Sbjct: 235 SLP----VLPSELKELMV-SGNRLTSLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSS 285
Query: 320 LSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFR 379
+ +NLE N L + T + +I S S +I F
Sbjct: 286 ETTVNLEGNPL-----------SERTLQALREITSA-------------PGYSGPIIRFD 321
Query: 380 IGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGS 436
+ G + + + + + G+ N L+ + L +
Sbjct: 322 MAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 22/125 (17%), Positives = 40/125 (32%), Gaps = 14/125 (11%)
Query: 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVI 558
+ S ++ L + + + +P L + L I N+ +
Sbjct: 21 AEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SL 76
Query: 559 PHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKL 618
P L++ L S N L+ +P L L + L +P+ KL
Sbjct: 77 PALPPELRT---LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPS-----GLCKL 126
Query: 619 SLQGN 623
+ GN
Sbjct: 127 WIFGN 131
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-33
Identities = 51/246 (20%), Positives = 95/246 (38%), Gaps = 38/246 (15%)
Query: 712 MIGQGSFGSVYKGILGEDEMI----VAVKVINLKQKGAFKS-FMAECKALRNIRHRNLIK 766
I G G +Y L D + V +K + ++ MAE + L + H ++++
Sbjct: 87 CIAHGGLGWIY---LALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
I D G +V E + SL+ Q KL + + + +++ A+
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPAL 195
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YLH +V+ DLKP N++L + + + D G + S + G
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI----------NSFGYLY--G 239
Query: 887 TVGYVAPEYCMG--SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944
T G+ APE + A+ D+Y+ G L L + + +GL + + +
Sbjct: 240 TPGFQAPEIVRTGPTVAT---DIYTVGRTLAALTLDLPTRNGRYVDGLP-EDDPVLKTYD 295
Query: 945 KVIEIV 950
++
Sbjct: 296 SYGRLL 301
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 74/348 (21%), Positives = 133/348 (38%), Gaps = 41/348 (11%)
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
F ++P+ + + +LDLG N+ K +F+S +L L L +N + ++
Sbjct: 20 RKRFVAVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-----AVE 72
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNL 399
F N +L+ L L +N+ +P + S++ + I N+I ++ ++L NL
Sbjct: 73 PGAF-NNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130
Query: 400 IALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQ 458
+L + N L L +L+ L L K L SIP+ +L L L + + ++
Sbjct: 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
Query: 459 GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLK 518
S L L++S+ ++
Sbjct: 190 AIRDYSFKRLYRL-------------------------KVLEISHWPYLDTMTPNCLYGL 224
Query: 519 NLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578
NL L I+ + V + + V L +L++S N + L L ++ + L
Sbjct: 225 NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL 284
Query: 579 SGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKL---SLQGN 623
+ P L++L LN S N L + + VF S L L N
Sbjct: 285 AVVEPYAFRGLNYLRVLNVSGNQLT-TLE-ESVFHSVGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-30
Identities = 67/325 (20%), Positives = 126/325 (38%), Gaps = 21/325 (6%)
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID---FSS 316
+P I + L +G N D ++ ++E L+L N +++ F++
Sbjct: 25 AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS---AVEPGAFNN 78
Query: 317 LKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMI 376
L NL L L N L + F T S+L L ++ N+ V L + +L + +
Sbjct: 79 LFNLRTLGLRSNRL-----KLIPLGVF-TGLSNLTKLDISENKIVILLDYMFQDLYN-LK 131
Query: 377 EFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGS 436
+G N + I L +L L ++ L + + L L L L + +
Sbjct: 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-A 190
Query: 437 IPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTL 495
I L +L L +S+ + + NL + +H LT A+P +
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVY 249
Query: 496 SVYLDLSNNNLNGSLPLQI-GNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSF 554
+L+LS N ++ ++ + L L ++ + Q + V P L L++S N
Sbjct: 250 LRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL 308
Query: 555 HGVIPHSLGFLKSIKVLNFSSNNLS 579
+ + +++ L SN L+
Sbjct: 309 TTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-27
Identities = 69/407 (16%), Positives = 130/407 (31%), Gaps = 95/407 (23%)
Query: 65 CQWTG--VTCGHRH---------QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSF 113
C V C + LDL RI + + L + L++N
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 114 HGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSL 172
A+ +F+ NL L + +N+L+ IP + L
Sbjct: 69 S----------------AVEPGAFNN--------LFNLRTLGLRSNRLK-LIPLGVFTGL 103
Query: 173 LKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQ 232
L L + +N + + L NL L VG N
Sbjct: 104 SNLTKLDISENKIV----------------ILLDYMFQD--------LYNLKSLEVGDND 139
Query: 233 FSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSN 292
++ ++SLE++ L + ++P + + +L L L + N S
Sbjct: 140 LVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKR 198
Query: 293 ASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKI 352
+++L++ + ++ + NL+ L++ NL + ++ + L+
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-----TAVPYLAV-RHLVYLRF 252
Query: 353 LSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGT 412
L+L N I I S + L+ L + + QL
Sbjct: 253 LNL-------------------------SYNPISTIEGSMLHELLRLQEIQLVGGQLAVV 287
Query: 413 IPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQ 458
P L L+ L + N L ++ V ++ L L++ N L
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 17/219 (7%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIIT 769
IG GS+G K D I+ K ++ + + ++E LR ++H N I+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVR 69
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
I + +V E + G L + + + + + + + A++
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLALKEC 127
Query: 830 H--HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
H ++H DLKP+NV LD +GDFGLA+ L+ S + GT
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH----DTSFAKT----FVGT 179
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926
Y++PE + D++S G LL EL P A
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 38/231 (16%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKI 767
+G+G+FG V+ +D+M+VAVK + A K F E + L N++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWL----------HQSNDHLEVCKLTLIQRVN 817
+C D +VFE MK+G L +L +L L Q ++
Sbjct: 83 YGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 818 IAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK 876
IA +AS + YL H VH DL N L+ +++ +GDFG+++ + + D
Sbjct: 138 IASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYRV 191
Query: 877 TSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ + I+ PE Y + S DV+SFG++L E+FT G++P
Sbjct: 192 GGHTMLPIRWM----PPESIMYRKFTTES---DVWSFGVILWEIFTYGKQP 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 37/228 (16%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNL 764
+GQGSFG VY+G+ E E VA+K + + F+ E ++ ++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKT--VNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWL----HQSNDHLEVCKLTLIQRVNIAI 820
++++ + S ++ E M G L+ +L ++ + +L + + +A
Sbjct: 91 VRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 821 DVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
++A + YL+ + VH DL N ++ D +GDFG+ + + D K
Sbjct: 146 EIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYET--DYYRKGGK 199
Query: 880 SSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ ++ +PE + + S DV+SFG++L E+ T +P
Sbjct: 200 GLLPVRWM----SPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQP 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 43/234 (18%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNL 764
+G+ FG VYKG L GE VA+K LK + F E ++H N+
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWL----------HQSNDHLEVCKLTLIQ 814
+ ++ + + +++F +G L ++L +D L
Sbjct: 75 VCLLGVVTKDQPL-----SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 815 RVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
V++ +A+ +EYL HH VH DL NVL+ + + D GL + + + D
Sbjct: 130 FVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREV--YAADY 183
Query: 874 ASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+S + I+ APE Y S S D++S+G++L E+F+ G +P
Sbjct: 184 YKLLGNSLLPIRWM----APEAIMYGKFSIDS---DIWSYGVVLWEVFSYGLQP 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 61/230 (26%), Positives = 109/230 (47%), Gaps = 37/230 (16%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKI 767
+G+G+FG V+ +D+M+VAVK + + A + F E + L ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWL---------HQSNDHLEVCKLTLIQRVNI 818
+C+ +VFE M++G L +L + + L L Q + +
Sbjct: 109 FGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 819 AIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
A VA+ + YL H VH DL N L+ +V +GDFG+++ + + D
Sbjct: 164 ASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYRVG 217
Query: 878 SSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ + I+ PE Y + S DV+SFG++L E+FT G++P
Sbjct: 218 GRTMLPIRWM----PPESILYRKFTTES---DVWSFGVVLWEIFTYGKQP 260
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-32
Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 25/221 (11%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK-SFMAECKALRNIRHRN 763
+GQG FG V+ G VA+K LK +F+ E + ++ +RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
L+++ + S + +V E M GSL D+L L L Q V++A +A
Sbjct: 324 LVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIA 373
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
S + Y+ VH DL+ +N+L+ ++V V DFGLA+ + + + +
Sbjct: 374 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFP 427
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
IK T APE + ++ DV+SFGILL EL T GR P
Sbjct: 428 IKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 53/229 (23%), Positives = 102/229 (44%), Gaps = 39/229 (17%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA----FKSFMAECKALRNIRHRN 763
+G G+FG VY+G + + VAVK + + F+ E + H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS-NDHLEVCKLTLIQRVNIAIDV 822
+++ I + + ++ E M G L+ +L ++ + L ++ +++A D+
Sbjct: 95 IVRCIGVSLQSLP-----RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 823 ASAIEYL-HHHCQPPMVHGDLKPSNVLLD---HDMVSHVGDFGLAKFLSSHQLDTASKTS 878
A +YL +H +H D+ N LL V+ +GDFG+A+ + ++ K
Sbjct: 150 ACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYRKGG 203
Query: 879 SSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ + +K PE + + + D +SFG+LL E+F+ G P
Sbjct: 204 CAMLPVKWM----PPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMP 245
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 61/252 (24%), Positives = 99/252 (39%), Gaps = 37/252 (14%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKII 768
IG G V++ L E + I A+K +NL++ S+ E L ++ + KII
Sbjct: 34 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 91
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ + + +V EC N L WL + + +R + ++ A+
Sbjct: 92 RLYDYEITDQYIY--MVMECG-NIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHT 142
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
+H H +VH DLKP+N L+ M+ + DFG+A + + GTV
Sbjct: 143 IHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVGTV 192
Query: 889 GYVAPEYCMGSEASMTG-----------DVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937
Y+ PE +S DV+S G +L + G+ P + LH
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-- 250
Query: 938 AKIALPEKVIEI 949
I P IE
Sbjct: 251 -AIIDPNHEIEF 261
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 52/242 (21%), Positives = 92/242 (38%), Gaps = 31/242 (12%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITI 770
++GQG+ +V++G + + A+KV N M E + L+ + H+N++K+ I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
+ K L+ E GSL L + L + + + DV + +L
Sbjct: 76 ---EEETTTRHKVLIMEFCPCGSLYTVLEE---PSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 831 HHCQPPMVHGDLKPSNVLL----DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
+ +VH ++KP N++ D V + DFG A+ L D + + G
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVS------LYG 177
Query: 887 TVGYVAPEYCMGSEASMTG--------DVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938
T Y+ P+ + D++S G+ TG P
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 939 KI 940
KI
Sbjct: 238 KI 239
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-32
Identities = 63/300 (21%), Positives = 112/300 (37%), Gaps = 60/300 (20%)
Query: 660 LCMVLSSCLTIVYARRRRSARKSVDTSPREKQFPTVS-------------YAELSKATS- 705
C +++ R ++ +++ + P+ YAE+
Sbjct: 317 YCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDT 376
Query: 706 ---------EFASSNM-----IGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGA 745
E + IG+G FG V++GI M VA+K K
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNCTSDSV 434
Query: 746 FKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL 805
+ F+ E +R H +++K+I + + + ++ E G L +L Q
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFL-QVRKF- 486
Query: 806 EVCKLTLIQRVNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864
L L + A +++A+ YL VH D+ NVL+ + +GDFGL++
Sbjct: 487 ---SLDLASLILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923
++ T K S + IK APE + DV+ FG+ + E+ G +P
Sbjct: 540 YMED---STYYKASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 61/252 (24%), Positives = 99/252 (39%), Gaps = 37/252 (14%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKII 768
IG G V++ L E + I A+K +NL++ S+ E L ++ + KII
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 72
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ + + +V EC N L WL + + +R + ++ A+
Sbjct: 73 RLYDYEITDQYIY--MVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHT 123
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
+H H +VH DLKP+N L+ M+ + DFG+A + + GTV
Sbjct: 124 IHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVGTV 173
Query: 889 GYVAPEYCMGSEASMTG-----------DVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937
Y+ PE +S DV+S G +L + G+ P + LH
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-- 231
Query: 938 AKIALPEKVIEI 949
I P IE
Sbjct: 232 -AIIDPNHEIEF 242
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 711 NMIGQGSFGSVYKGIL--GEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNL 764
++IG+G+FG V K + M A+K +K+ K + F E + L + H N+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS----------NDHLEVCKLTLIQ 814
I ++ C L E +G+L D+L +S + L+ Q
Sbjct: 89 INLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 815 RVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
++ A DVA ++YL +H DL N+L+ + V+ + DFGL++ +
Sbjct: 144 LLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-----GQEV 194
Query: 874 ASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
K + + ++ A E Y + + S DV+S+G+LL E+ + G P
Sbjct: 195 YVKKTMGRLPVRWM----AIESLNYSVYTTNS---DVWSYGVLLWEIVSLGGTP 241
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 53/242 (21%), Positives = 97/242 (40%), Gaps = 38/242 (15%)
Query: 696 SYAELSKATSEFASSNM--------IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGA 745
+ + T +M IG+GSFG ED +K IN+ +
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 746 FKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL 805
+ E L N++H N I+ S + G+ + +V + + G L ++ L
Sbjct: 67 REESRREVAVLANMKHPN---IVQYRESFEENGSLY--IVMDYCEGGDLFKRINAQKGVL 121
Query: 806 ----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861
++ + + A++++H ++H D+K N+ L D +GDFG
Sbjct: 122 FQEDQILD--------WFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG 170
Query: 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR 921
+A+ L+S T + GT Y++PE C + D+++ G +L EL T +
Sbjct: 171 IARVLNS----TVELARA----CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
Query: 922 RP 923
Sbjct: 223 HA 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 35/279 (12%), Positives = 73/279 (26%), Gaps = 42/279 (15%)
Query: 672 YARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEM 731
+ + ++V + + T + LS+ + + G V+ E
Sbjct: 29 ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 732 IVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLI---------------------KI 767
A+KV + + + A + +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEV-CKLTLIQRVNIAIDVASAI 826
+ D L+ LE + ++ + +
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
L +VHG P N+ + D +GD ++ T SS
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL-----WKVGTRGPASS------V 253
Query: 887 TVGYVAPEYCMGSEASMTG--DVYSFGILLLELFTGRRP 923
V Y E+ S A+ T + + G+ + ++ P
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 60/259 (23%), Positives = 102/259 (39%), Gaps = 27/259 (10%)
Query: 685 TSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG 744
P++ P + Y L+ F IG+G F VY+ D + VA+K + +
Sbjct: 16 FQPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 745 AFK---SFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS 801
K + E L+ + H N +I +S +V E G L +
Sbjct: 72 DAKARADCIKEIDLLKQLNHPN---VIKYYASFIEDNELN--IVLELADAGDLSRMIKHF 126
Query: 802 NDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861
+ + + + SA+E++H ++H D+KP+NV + V +GD G
Sbjct: 127 KKQKRLIPERTVW--KYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLG 181
Query: 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR 921
L +F SS + S + GT Y++PE + + D++S G LL E+ +
Sbjct: 182 LGRFFSS----KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
Query: 922 RPTDAAFTEGLTLHEFAKI 940
P +L KI
Sbjct: 234 SPFYGDKMNLYSL--CKKI 250
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 48/232 (20%), Positives = 99/232 (42%), Gaps = 50/232 (21%)
Query: 713 IGQGSFGSVYKGIL-------GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLI 765
+GQG+F ++KG+ E V +KV++ + +SF + + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+C D LV E +K GSL+ +L + N + + ++ ++ +A +A+A
Sbjct: 76 LNYGVCVCGDE-----NILVQEFVKFGSLDTYL-KKNKN----CINILWKLEVAKQLAAA 125
Query: 826 IEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSH--------VGDFGLAKFLSSHQLDTASK 876
+ +L + +HG++ N+LL + + D G++ +
Sbjct: 126 MHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ 175
Query: 877 TSSSSIGIKGTVGYVAPE----YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
++ + +V PE + A+ D +SFG L E+ + G +P
Sbjct: 176 ------ILQERIPWVPPECIENPKNLNLAT---DKWSFGTTLWEICSGGDKP 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-31
Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 713 IGQGSFGSVYKGIL--GEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKI 767
+G G+FGSV +G+ + ++ VA+KV LK +K + M E + + + + ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
I +C + + LV E G L +L + + + + V+ ++
Sbjct: 402 IGVCQA------EALMLVMEMAGGGPLHKFLVGKREEI-----PVSNVAELLHQVSMGMK 450
Query: 828 YL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YL + VH +L NVLL + + + DFGL+K L + + S+ +K
Sbjct: 451 YLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKW 505
Query: 887 TVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
APE + S S DV+S+G+ + E + G++P
Sbjct: 506 Y----APECINFRKFSSRS---DVWSYGVTMWEALSYGQKP 539
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 43/235 (18%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQK---GAFKSFMAECKALRNI-RHRN 763
+G+G+FG V + VAVK+ LK+ ++ M+E K L +I H N
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWL----------HQSNDHLEVCKLTLI 813
++ ++ C+ ++ E K G+L +L + + L LTL
Sbjct: 93 VVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 814 QRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLD 872
+ + VA +E+L C +H DL N+LL V + DFGLA+ + ++
Sbjct: 149 HLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDI--YKDP 202
Query: 873 TASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ + + +K APE + + S DV+SFG+LL E+F+ G P
Sbjct: 203 DYVRKGDARLPLKWM----APETIFDRVYTIQS---DVWSFGVLLWEIFSLGASP 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-31
Identities = 53/229 (23%), Positives = 102/229 (44%), Gaps = 39/229 (17%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA----FKSFMAECKALRNIRHRN 763
+G G+FG VY+G + + VAVK + + F+ E + H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS-NDHLEVCKLTLIQRVNIAIDV 822
+++ I + + ++ E M G L+ +L ++ + L ++ +++A D+
Sbjct: 136 IVRCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 823 ASAIEYL-HHHCQPPMVHGDLKPSNVLLD---HDMVSHVGDFGLAKFLSSHQLDTASKTS 878
A +YL +H +H D+ N LL V+ +GDFG+A+ + ++ K
Sbjct: 191 ACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYYRKGG 244
Query: 879 SSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+ + +K PE + + + D +SFG+LL E+F+ G P
Sbjct: 245 CAMLPVKWM----PPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMP 286
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-31
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 34/226 (15%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKII 768
IG G V++ L E + I A+K +NL++ S+ E L ++ + KII
Sbjct: 62 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 119
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ + + +V EC N L WL + + +R + ++ A+
Sbjct: 120 RLYDYEITDQYIY--MVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHT 170
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
+H H +VH DLKP+N L+ M+ + DFG+A + + G V
Sbjct: 171 IHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVGAV 220
Query: 889 GYVAPEYCMGSEASMTG-----------DVYSFGILLLELFTGRRP 923
Y+ PE +S DV+S G +L + G+ P
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 48/238 (20%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA----FKSFMAECKALRNI-RHR 762
+G G+FG V + + M VAVK++ A ++ M+E K L + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL------------HQSNDHLEVCKL 810
N++ ++ C+ ++ E G L ++L + + L
Sbjct: 88 NIVNLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 811 TLIQRVNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869
L ++ + VA + +L +C +H DL N+LL H ++ + DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI--K 196
Query: 870 QLDTASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
++ + +K APE C+ + S DV+S+GI L ELF+ G P
Sbjct: 197 NDSNYVVKGNARLPVKWM----APESIFNCVYTFES---DVWSYGIFLWELFSLGSSP 247
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 66/295 (22%), Positives = 110/295 (37%), Gaps = 42/295 (14%)
Query: 674 RRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIV 733
+ RR + + + + S E S F + +G GS+G V+K ED +
Sbjct: 27 QPRRVSFRGEASETLQSPGYDPSRPE-SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLY 85
Query: 734 AVKVINLKQKGAF--KSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVFE-CM 789
AVK +G +AE + + +H +++ + + G + L E C
Sbjct: 86 AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE---QAWEEGGILY--LQTELC- 139
Query: 790 KNGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 846
SL+ L +V D A+ +LH +VH D+KP+N
Sbjct: 140 -GPSLQQHCEAWGASLPEAQVW--------GYLRDTLLALAHLHSQ---GLVHLDVKPAN 187
Query: 847 VLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGD 906
+ L +GDFGL +L TA +G Y+APE GS D
Sbjct: 188 IFLGPRGRCKLGDFGLLV-----ELGTAGAGEV----QEGDPRYMAPELLQGS-YGTAAD 237
Query: 907 VYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLL--LIEVM 959
V+S G+ +LE+ G + + LP + + L ++ +M
Sbjct: 238 VFSLGLTILEVACNMEL----PHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMM 288
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 59/237 (24%), Positives = 107/237 (45%), Gaps = 46/237 (19%)
Query: 713 IGQGSFGSVYKGIL-------GEDEMIVAVKVINLKQK---GAFKSFMAECKALRNI-RH 761
+G+G+FG V ++ + VAVK+ LK ++E + ++ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL----------HQSNDHLEVCKLT 811
+N+I ++ C+ ++ E G+L ++L + + ++T
Sbjct: 101 KNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 812 LIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQ 870
V+ +A +EYL C +H DL NVL+ + V + DFGLA+ + +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--NN 209
Query: 871 LDTASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+D KT++ + +K APE + + S DV+SFG+L+ E+FT G P
Sbjct: 210 IDYYKKTTNGRLPVKWM----APEALFDRVYTHQS---DVWSFGVLMWEIFTLGGSP 259
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-31
Identities = 52/242 (21%), Positives = 93/242 (38%), Gaps = 31/242 (12%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFKSFMAECKALRNIRHRNLIKIITI 770
++GQG+ +V++G + + A+KV N + M E + L+ + H+N++K+ I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
+ K L+ E GSL L + L + + + DV + +L
Sbjct: 76 ---EEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 831 HHCQPPMVHGDLKPSNVLL----DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
+ +VH ++KP N++ D V + DFG A+ L D + + G
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVS------LYG 177
Query: 887 TVGYVAPEYCMGSEASMTG--------DVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938
T Y+ P+ + D++S G+ TG P
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 939 KI 940
KI
Sbjct: 238 KI 239
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA----FKSFMAECKALRNI-RHR 762
+G G+FG V + + + VAVK+ LK A ++ M+E K + ++ +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LK-STAHADEKEALMSELKIMSHLGQHE 110
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL--------HQSNDHLEVCKLTLIQ 814
N++ ++ C+ G ++ E G L ++L + +
Sbjct: 111 NIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 815 RVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
++ + VA + +L +C +H D+ NVLL + V+ +GDFGLA+ +
Sbjct: 166 LLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI--MNDSN 219
Query: 874 ASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
++ + +K APE C+ + S DV+S+GILL E+F+ G P
Sbjct: 220 YIVKGNARLPVKWM----APESIFDCVYTVQS---DVWSYGILLWEIFSLGLNP 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 53/243 (21%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA----FKSFMAECKALRNIRHRN 763
+G+G FG V K VAVK+ LK + A + ++E L+ + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LK-ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWL------------------HQSNDHL 805
+IK+ CS L+ E K GSL +L S DH
Sbjct: 88 VIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 806 EVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864
+ LT+ ++ A ++ ++YL VH DL N+L+ + DFGL++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-G 920
+ ++ D+ K S I +K A E + + S DV+SFG+LL E+ T G
Sbjct: 199 DV--YEEDSYVKRSQGRIPVKWM----AIESLFDHIYTTQS---DVWSFGVLLWEIVTLG 249
Query: 921 RRP 923
P
Sbjct: 250 GNP 252
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 34/219 (15%)
Query: 713 IGQGSFGSVYKG---ILGEDEMIVAVKVI--NLKQKGAFKS-FMAECKALRNIRHRNLIK 766
+G G +VY IL VA+K I ++K F E + H+N++
Sbjct: 19 LGGGGMSTVYLAEDTILNIK---VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 767 IITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
+I D + LV E ++ +L +++ L++ +N +
Sbjct: 76 MI------DV-DEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILD 122
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
I++ H +VH D+KP N+L+D + + DFG+AK LS S T ++ +
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-----TSLTQTNHV-- 172
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GTV Y +PE G D+YS GI+L E+ G P
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 48/238 (20%)
Query: 713 IGQGSFGSVYKGIL-------GEDEMIVAVKVINLKQKGA----FKSFMAECKALRNI-R 760
+G+G FG V ++ + VAVK+ LK A ++E + ++ I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LK-DDATEKDLSDLVSEMEMMKMIGK 145
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL----------HQSNDHLEVCKL 810
H+N+I ++ C+ ++ E G+L ++L + + ++
Sbjct: 146 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 811 TLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869
T V+ +A +EYL C +H DL NVL+ + V + DFGLA+ + +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--N 254
Query: 870 QLDTASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+D KT++ + +K APE + + S DV+SFG+L+ E+FT G P
Sbjct: 255 NIDYYKKTTNGRLPVKWM----APEALFDRVYTHQS---DVWSFGVLMWEIFTLGGSP 305
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 62/243 (25%), Positives = 101/243 (41%), Gaps = 53/243 (21%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA----FKSFMAECKALRNI-RHR 762
+G G+FG V + VAVK+ LK + A ++ M+E K + + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKM--LK-EKADSSEREALMSELKMMTQLGSHE 109
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL-----------------HQSNDHL 805
N++ ++ C+ L+FE G L ++L + +
Sbjct: 110 NIVNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 806 EVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864
++ LT + A VA +E+L C VH DL NVL+ H V + DFGLA+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-G 920
+ ++ + +K APE + + S DV+S+GILL E+F+ G
Sbjct: 221 DI--MSDSNYVVRGNARLPVKWM----APESLFEGIYTIKS---DVWSYGILLWEIFSLG 271
Query: 921 RRP 923
P
Sbjct: 272 VNP 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 712 MIGQGSFGSVYKG---ILGEDEMIVAVKVI--NLKQKGAFKS-FMAECKALRNIRHRNLI 765
++G G V+ D VAVKV+ +L + +F F E + + H ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRD---VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+ + ++ +V E + +L D +H +T + + + D A
Sbjct: 76 AVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQA 128
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+ + H + ++H D+KP+N+++ V DFG+A+ ++ S T ++++
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTAAV--I 180
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y++PE G DVYS G +L E+ TG P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-30
Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 48/238 (20%)
Query: 713 IGQGSFGSVYKGIL-------GEDEMIVAVKVINLKQKGA----FKSFMAECKALRNI-R 760
+G+G+FG V VAVK++ A ++E + ++ I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL----------HQSNDHLEVCKL 810
H+N+I ++ C+ ++ E G+L ++L + H +L
Sbjct: 134 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 811 TLIQRVNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869
+ V+ A VA +EYL C +H DL NVL+ D V + DFGLA+ + H
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDI--H 242
Query: 870 QLDTASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
+D KT++ + +K APE + + S DV+SFG+LL E+FT G P
Sbjct: 243 HIDYYKKTTNGRLPVKWM----APEALFDRIYTHQS---DVWSFGVLLWEIFTLGGSP 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 48/313 (15%), Positives = 97/313 (30%), Gaps = 43/313 (13%)
Query: 674 RRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIV 733
+ +A V TS P +EL + ++GQ + + E
Sbjct: 47 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 106
Query: 734 AVKVINLKQK---GAFKSFMAECKALRNIRH----------------RNLIKIITICSSI 774
V V ++ A K E LR +R +L+K I
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166
Query: 775 DSKGADFKA------LVFECMKNGSLEDWLHQSNDHLEVCK-LTLIQRVNIAIDVASAIE 827
+ + ++ M+ +L+ + H K L R+ + + V +
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 225
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
LHH+ +VH L+P +++LD + F + ++ +
Sbjct: 226 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGASAVSPIGR--GFAP 275
Query: 888 VGYVAPEYCMGSEASMTG-----DVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA- 941
A + T D ++ G+ + ++ P G + F
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN 335
Query: 942 LPEKVIEIVDPLL 954
+P+ V +++ L
Sbjct: 336 IPQPVRALLEGFL 348
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 22/222 (9%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKII-T 769
+G G FG V + I + VA+K + + + E + ++ + H N++
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
D L E + G L +L N C L + D++SA+ YL
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 830 HHHCQPPMVHGDLKPSNVLLD---HDMVSHVGDFGLAKFLSS-HQLDTASKTSSSSIGIK 885
H + ++H DLKP N++L ++ + D G AK L
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----------V 184
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAA 927
GT+ Y+APE + ++T D +SFG L E TG RP
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 72/410 (17%), Positives = 134/410 (32%), Gaps = 43/410 (10%)
Query: 222 NLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNN 281
++ + + N + S + L+ + + + + L +L L + N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 282 FFGSIPDS-LSNASNVEILDLGFNQFKGKVSID--FSSLKNLSWLNLEQNNLGMGTANDL 338
F + + +N+E+L L G V F L +L L L NN+ +
Sbjct: 91 -FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI-----KKI 144
Query: 339 DFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVN 398
+F N +L L N+ + N L +
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTL---------------LRLSS 189
Query: 399 LIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQ 458
+ M L + ++ L L N + S+ + K+ S
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249
Query: 459 GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNL 517
N+ SS G+ F N L + DLS + + +L + +
Sbjct: 250 YNMGSSFGHTN----FKDPDNFTFKGLEASGVK------TCDLSKSKIF-ALLKSVFSHF 298
Query: 518 KNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNN 577
+L +L ++ N+ + + L L++S N + L ++VL+ S N+
Sbjct: 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH 358
Query: 578 LSGQIPE-FLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLS---LQGN 623
+ + + L L+ L N L+ VP G+F T L L N
Sbjct: 359 IR-ALGDQSFLGLPNLKELALDTNQLK-SVP-DGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-28
Identities = 75/394 (19%), Positives = 142/394 (36%), Gaps = 30/394 (7%)
Query: 175 LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPT-TLGLLRNLVDLHVGGNQF 233
+ + + N + L L+ + + G I T L +L+ L + NQF
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 234 SGTFPQSICNISSLERIYLPFNRF-SGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSL-S 291
+ +++LE + L L + L +L+ L + NN P S
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
Query: 292 NASNVEILDLGFNQFKGKVSIDFSSL--KNLSWLNLEQNNLGMGTANDLDFVTF--LTNC 347
N +LDL FN+ K D + K+ + L L L L +
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 348 SSLKILSLAANQF----VGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALG 403
+S+ L L+ N F +IA + N + ++ N G
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 404 MQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIP 462
++++ ++ L K+ + ++ V + T L +L ++ N +
Sbjct: 272 LEAS--------------GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDD 316
Query: 463 SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLKNLV 521
++ +L+ N S N L ++ ++ LDLS N++ +L Q L NL
Sbjct: 317 NAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLK 374
Query: 522 KLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFH 555
+L + +NQ V SL+ + + +N +
Sbjct: 375 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-26
Identities = 85/437 (19%), Positives = 148/437 (33%), Gaps = 67/437 (15%)
Query: 127 LEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYL 185
+ + L NS + T+ SR +L L+V I L L L + N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 186 TGRLPDFV-GNLSALEVFSITGNSLGGKI--PTTLGLLRNLVDLHVGGNQFSGTFPQSI- 241
+L L+ LEV ++T +L G + L +L L + N P S
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 242 CNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDL 301
N+ + L FN+ ++ + ++N L +S + D+
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFT-------------LLRLSSI-TLQDM 195
Query: 302 GFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLT-------NCSSLKILS 354
+ + +++ L+L N A T + S S
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 355 LAANQFVGELPHSIANLS-SSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGT 412
F + L S + + ++IF + + + +L L + N+++
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKI 314
Query: 413 IPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGNCQNL 471
+ L +L L L +N L SI S + NL KL L +SYN ++ +
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQS------ 366
Query: 472 IGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLKNLVKLIISSNQF 530
F L L L L N L S+P I L +L K+ + +N +
Sbjct: 367 --F----LGLP-----NL-------KELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
Query: 531 SGVIPVTLSTCVSLEYL 547
+C ++YL
Sbjct: 408 D-------CSCPRIDYL 417
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 80/397 (20%), Positives = 135/397 (34%), Gaps = 63/397 (15%)
Query: 80 TRLDLSNQRIGGILSPYV-GNLSFLRYINLSDNSFHGEIPQEI-GNLLRLEKLALPNNSF 137
L + Q G ++ LS L + L N F ++ L LE L L +
Sbjct: 57 QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNL 115
Query: 138 -SGTIPTNL-SRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLT----GRLP 190
+ N ++L L + +N ++ PA ++ + L + N + L
Sbjct: 116 DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL 175
Query: 191 DFVG------NLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNI 244
+F G LS++ + + LG + ++ L + GN F + + +
Sbjct: 176 NFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235
Query: 245 SSLERI-YLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGF 303
+ +I L + N + + G AS V+ DL
Sbjct: 236 IAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGL-----------EASGVKTCDLSK 284
Query: 304 NQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGE 363
++ + FS +L L L QN + N +D F + L L+L+ N
Sbjct: 285 SKIFALLKSVFSHFTDLEQLTLAQNEI-----NKIDDNAF-WGLTHLLKLNLSQNF---- 334
Query: 364 LPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGTIPDVIGELKN 422
L S I S + NL L L + N + L N
Sbjct: 335 -------LGS---------------IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPN 372
Query: 423 LQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQ 458
L+ L L N L+ S+P G+ LT L K+ + N
Sbjct: 373 LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-17
Identities = 46/294 (15%), Positives = 91/294 (30%), Gaps = 43/294 (14%)
Query: 366 HSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIP-DVIGELKNLQ 424
H + L + + + N I + + L +L L ++ I + L +L
Sbjct: 23 HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82
Query: 425 GLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNI--PSSLGNCQNLIGFNASHNKL 481
L L N + +G L L L ++ +L G + + +L N +
Sbjct: 83 ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 482 T----GALPQQLLSITTLSVYLDLSNNNLN----------GSLPLQIGNLKNLVKLIISS 527
+ + LDL+ N + + L ++ ++
Sbjct: 142 KKIQPASFFLNMRRFHV----LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197
Query: 528 NQFSGVIPVTLSTCVSLEYLDISSNSFHGVIP---HSLGFLKSIKVLNFSSNN-----LS 579
S+ LD+S N F + I+ L S++
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257
Query: 580 GQIPEFLENLSF-------LEFLNFSHNDLEGEVPTKGVFSSKTK---LSLQGN 623
+ +N +F ++ + S + + + K VFS T L+L N
Sbjct: 258 HTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL-KSVFSHFTDLEQLTLAQN 309
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 33/141 (23%), Positives = 56/141 (39%), Gaps = 8/141 (5%)
Query: 73 GHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI-GNLLRLEKLA 131
G V DLS +I +L + + L + L+ N + +I L L KL
Sbjct: 271 GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLN 329
Query: 132 LPNNSFSGTIPTNL-SRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRL 189
L N +I + + L L +S N + + + L L+ LA+ N L +
Sbjct: 330 LSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SV 386
Query: 190 PDFV-GNLSALEVFSITGNSL 209
PD + L++L+ + N
Sbjct: 387 PDGIFDRLTSLQKIWLHTNPW 407
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 51/242 (21%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNL 764
IG+G+FG V++ E +VAVK+ LK+ F E + + N+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDNPNI 112
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCK--------------- 809
+K++ +C+ L+FE M G L ++L + H
Sbjct: 113 VKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 810 ---LTLIQRVNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865
L+ +++ IA VA+ + YL VH DL N L+ +MV + DFGL++
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GR 921
+ + D + +I I+ PE Y + S DV+++G++L E+F+ G
Sbjct: 224 I--YSADYYKADGNDAIPIRWM----PPESIFYNRYTTES---DVWAYGVVLWEIFSYGL 274
Query: 922 RP 923
+P
Sbjct: 275 QP 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 60/277 (21%), Positives = 102/277 (36%), Gaps = 63/277 (22%)
Query: 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFKSFMAECKALRNI 759
S+ ++F +G+G FG V++ D+ A+K I L + A + M E KAL +
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 760 RHRNLIKI------------------------------------------ITICSSIDSK 777
H +++ I +K
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 778 GADFKALVFECMK----------NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ +L+DW+++ + + +I I +A A+E
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL---HIFIQIAEAVE 178
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK-- 885
+LH ++H DLKPSN+ D V VGDFGL + + + T +
Sbjct: 179 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 886 --GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG 920
GT Y++PE G+ S D++S G++L EL
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 712 MIGQGSFGSVYKG---ILGEDEMIVAVKVI--NLKQKGAFKS-FMAECKALRNIRHRNLI 765
++G+G G VY+ + VA+K++ L F++ E + ++ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERI---VALKLMSETLSSDPVFRTRMQREARTAGRLQEPH-- 95
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
++ I + G + + + L L + L + V I + SA
Sbjct: 96 -VVPIHDFGEIDGQLY--VDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSA 146
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
++ H H D+KP N+L+ D +++ DFG+A + +L T +
Sbjct: 147 LDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-----TQLGNT--V 196
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT+ Y+APE S A+ D+Y+ +L E TG P
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 43/222 (19%), Positives = 88/222 (39%), Gaps = 14/222 (6%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKII-- 768
++ +G F VY+ A+K + ++ ++ + E ++ + H N+++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+S + L+ + G L ++L + L+ + I A+++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLKIFYQTCRAVQH 151
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSS----IGI 884
+H +PP++H DLK N+LL + + DFG A +S + + S + I
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 885 KGTVGYVAPEYC---MGSEASMTGDVYSFGILLLELFTGRRP 923
T Y PE D+++ G +L L + P
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 46/233 (19%), Positives = 92/233 (39%), Gaps = 42/233 (18%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA-----------------ECKA 755
+ QG F + +D A+K + F E +
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 756 LRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL--HQSNDHLEVCKLTLI 813
+ +I++ + I I + + +++E M+N S+ + D C + +
Sbjct: 97 ITDIKNEYCLTCEGI---ITNYDEVY--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 814 QRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
I V ++ Y+H+ + H D+KPSN+L+D + + DFG ++++ ++
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG---DVYSFGILLLELFTGRRP 923
+ +GT ++ PE+ E+S G D++S GI L +F P
Sbjct: 210 S----------RGTYEFMPPEFFSN-ESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 58/251 (23%), Positives = 87/251 (34%), Gaps = 25/251 (9%)
Query: 674 RRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIV 733
R + EK P E + +G+GSFG V++ +
Sbjct: 29 RLGPETEDNEGVLLTEKLKPVDY--EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86
Query: 734 AVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGS 793
AVK + L+ + E A + I +G + E ++ GS
Sbjct: 87 AVKKVRLE-----VFRVEELVACAGLSSPR----IVPLYGAVREGPWVN-IFMELLEGGS 136
Query: 794 LEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853
L + Q E +EYLH ++HGD+K NVLL D
Sbjct: 137 LGQLIKQMGCLPE----DRAL--YYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDG 187
Query: 854 VS-HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGI 912
+ DFG A L L + T I GT ++APE MG D++S
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDY---IPGTETHMAPEVVMGKPCDAKVDIWSSCC 244
Query: 913 LLLELFTGRRP 923
++L + G P
Sbjct: 245 MMLHMLNGCHP 255
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITIC 771
++G+G++G VY G +++ +A+K I + + E ++++H+N I
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN----IVQY 84
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
S+ K + E + GSL L L+ + I + ++YLH
Sbjct: 85 LGSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLKDNE-QTIG--FYTKQILEGLKYLHD 140
Query: 832 HCQPPMVHGDLKPSNVLLD-HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ +VH D+K NVL++ + V + DFG +K L+ T + GT+ Y
Sbjct: 141 NQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--------FTGTLQY 189
Query: 891 VAPEYCMGSEASMTG--DVYSFGILLLELFTGRRP 923
+APE D++S G ++E+ TG+ P
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-28
Identities = 53/323 (16%), Positives = 102/323 (31%), Gaps = 62/323 (19%)
Query: 674 RRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIV 733
+ +A V TS P +EL + ++GQ + + E
Sbjct: 42 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 734 AVKVINLKQK---GAFKSFMAECKALRNIR----------------------HRNLIKII 768
V V ++ A K E LR +R K+I
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCK-LTLIQRVNIAIDVASAIE 827
+ + ++ M+ +L+ + H K L R+ + + V +
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 220
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
LHH+ +VH L+P +++LD + F D A SS +
Sbjct: 221 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGARVVSS------VS 265
Query: 888 VGYVAPEY-----------CMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936
G+ PE + + + D ++ G+++ ++ P T+ L
Sbjct: 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP----ITKDAALGG 321
Query: 937 FAKI-----ALPEKVIEIVDPLL 954
I +P+ V +++ L
Sbjct: 322 SEWIFRSCKNIPQPVRALLEGFL 344
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 51/228 (22%), Positives = 96/228 (42%), Gaps = 34/228 (14%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNL 764
F +++G G+ G++ + ++ VAVK I + F E + LR H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPEC---FSFADREVQLLRESDEHPNV 80
Query: 765 IKIITICSSIDSKGADFKALVFE-CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
I+ C+ D F+ + E C +L++++ Q + ++ + +
Sbjct: 81 IRYF--CTEKDR---QFQYIAIELC--AATLQEYVEQKDF-----AHLGLEPITLLQQTT 128
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLL-----DHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
S + +LH +VH DLKP N+L+ + + + DFGL K L+ + +
Sbjct: 129 SGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-----HSF 180
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTG---DVYSFGILLLELFTGRRP 923
S G+ GT G++APE D++S G + + +
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/242 (23%), Positives = 98/242 (40%), Gaps = 12/242 (4%)
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQ-GSIPSGV-GNLTK 446
+P+GI + L ++SN+L V +L L L L N L S T
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 447 LAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNL 506
L L +S+N + + S+ + L + H+ L + +YLD+S+ +
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 507 NGSLPLQI-GNLKNLVKLIISSNQF-SGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGF 564
I L +L L ++ N F +P + +L +LD+S + P +
Sbjct: 139 R-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 565 LKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT---KGVFSSKTKLSLQ 621
L S++VLN S NN + L+ L+ L++S N + + SS L+L
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLT 256
Query: 622 GN 623
N
Sbjct: 257 QN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 59/281 (20%), Positives = 95/281 (33%), Gaps = 40/281 (14%)
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
+ S+P + S+ L+L N+ + F L L+ L+L N L
Sbjct: 16 SKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS 73
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNL 399
+SLK L L+ N + + S L L
Sbjct: 74 D----FGTTSLKYLDLSFNGVI--------------------------TMSSNFLGLEQL 103
Query: 400 IALGMQSNQLHGTIPD--VIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNS 456
L Q + L + + V L+NL L + + +G+ L+ L L M+ NS
Sbjct: 104 EHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNS 161
Query: 457 LQGNIPS-SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIG 515
Q N +NL + S +L L + + L++S+NN
Sbjct: 162 FQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 516 NLKNLVKLIISSNQFSGVIPVTLSTCV-SLEYLDISSNSFH 555
L +L L S N L SL +L+++ N F
Sbjct: 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 58/268 (21%), Positives = 101/268 (37%), Gaps = 39/268 (14%)
Query: 245 SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNN--FFGSIPDSLSNASNVEILDLG 302
SS R+ L N+ +LP + L L L++ N F G S ++++ LDL
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 303 FNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVG 362
FN +S +F L+ L L+ + +NL + + + +L L ++
Sbjct: 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-----MSEFSVFLSLRNLIYLDISHTH--- 137
Query: 363 ELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGTI-PDVIGEL 420
+GI L +L L M N PD+ EL
Sbjct: 138 --------TRV---------------AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 174
Query: 421 KNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHN 479
+NL L L + L+ + +L+ L L MS+N+ +L + S N
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 480 KLTGALPQQLLSITTLSVYLDLSNNNLN 507
+ + Q+L + +L+L+ N+
Sbjct: 234 HIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 53/259 (20%), Positives = 95/259 (36%), Gaps = 14/259 (5%)
Query: 106 INLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQ- 164
I + +P I +L L +N + + L +L +S+N L +
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 165 IPAEIGS-LLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPT-TLGLLRN 222
++ L+ L + N + +F+G L LE ++L LRN
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 223 LVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF 282
L+ L + F +SSLE + + N F DI L NL L +
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ- 186
Query: 283 FGSIP-DSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFV 341
+ + ++ S++++L++ N F + + L +L L+ N++
Sbjct: 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-----SKKQ 241
Query: 342 TFLTNCSSLKILSLAANQF 360
SSL L+L N F
Sbjct: 242 ELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 36/161 (22%), Positives = 59/161 (36%), Gaps = 9/161 (5%)
Query: 80 TRLDLSNQRIGGILSPYV-GNLSFLRYINLSDNSFHGEIPQEI-GNLLRLEKLALPNNSF 137
LD + + + V +L L Y+++S I L LE L + NSF
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSF 162
Query: 138 SGTIPTN-LSRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFVGN 195
+ + NL L +S +LE Q+ SL LQ L + N
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221
Query: 196 LSALEVFSITGNSLGGKIPTTL--GLLRNLVDLHVGGNQFS 234
L++L+V + N + +L L++ N F+
Sbjct: 222 LNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 52/235 (22%), Positives = 94/235 (40%), Gaps = 35/235 (14%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKII 768
+G+G F ++ + + + A K++ L + + E R++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASA 825
+ F +V E + SL + LH+ L E L Q +
Sbjct: 82 GF---FEDNDFVF--VVLELCRRRSLLE-LHKRRKALTEPEARYY-LRQ-------IVLG 127
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+YLH + ++H DLK N+ L+ D+ +GDFGLA + K
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLC------ 176
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940
GT Y+APE S DV+S G ++ L G+ P + + + + +I
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRI 227
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 58/274 (21%), Positives = 106/274 (38%), Gaps = 37/274 (13%)
Query: 673 ARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMI 732
+A + +P K+ P V S+ + +G+G F ++ + + +
Sbjct: 11 GVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR--RYVRGRFLGKGGFAKCFEISDADTKEV 68
Query: 733 VAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECM 789
A K++ L + + E R++ H++++ + F +V E
Sbjct: 69 FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF---FEDNDFVF--VVLELC 123
Query: 790 KNGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 846
+ SL + LH+ L E L Q + +YLH + ++H DLK N
Sbjct: 124 RRRSLLE-LHKRRKALTEPEARYY-LRQ-------IVLGCQYLHRNR---VIHRDLKLGN 171
Query: 847 VLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGD 906
+ L+ D+ +GDFGLA + K GT Y+APE S D
Sbjct: 172 LFLNEDLEVKIGDFGLATKV--EYDGERKKVLC------GTPNYIAPEVLSKKGHSFEVD 223
Query: 907 VYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940
V+S G ++ L G+ P + + + + +I
Sbjct: 224 VWSIGCIMYTLLVGKPPFETSCLKET----YLRI 253
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-26
Identities = 76/491 (15%), Positives = 173/491 (35%), Gaps = 35/491 (7%)
Query: 105 YINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQ 164
++ S+ + +P+++ R + L+L NS S ++S S L LR+S+N++
Sbjct: 35 MVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-S 90
Query: 165 IPAEI-GSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGL---- 219
+ + L+ L V N L + +++L ++ N L +
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDF-----DVLPVCKEF 142
Query: 220 --LRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAI 277
L L L + +F + ++ L I L + + +PN L +
Sbjct: 143 GNLTKLTFLGLSAAKFRQLDLLPVAHLH-LSCILLDLVSYHIKGGETESLQIPNTTVLHL 201
Query: 278 GGNN---FFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFS--SLKNLSWLNLEQNNLGM 332
+ F + S++ ++++ ++ N + + F + + LN+ ++
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261
Query: 333 GTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEF----RIGGNQIFGI 388
+ F ++ L++ + S + ++ +
Sbjct: 262 TWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFS 320
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLA 448
+ + + + + L +NV S+ G L +L
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380
Query: 449 KLVMSYNSLQ--GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNL 506
L++ N L+ + N +L + S N L + + + L+LS+N L
Sbjct: 381 TLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML 440
Query: 507 NGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLK 566
GS+ + + L + +N+ IP ++ +L+ L+++SN V L
Sbjct: 441 TGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLT 497
Query: 567 SIKVLNFSSNN 577
S++ + N
Sbjct: 498 SLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-26
Identities = 83/468 (17%), Positives = 165/468 (35%), Gaps = 26/468 (5%)
Query: 103 LRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNL-SRCSNLIQLRVSNNKL 161
+ ++LS NS +I L L L L +N ++ ++ +L L VS+N+L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 162 EGQIPAEIGSLLKLQTLAVGKNYLT--GRLPDFVGNLSALEVFSITGNSLGGKIPTTLGL 219
+ I + L+ L + N +F GNL+ L ++ +
Sbjct: 113 QN-ISC--CPMASLRHLDLSFNDFDVLPVCKEF-GNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 220 LR-NLVDLHVGGNQFSGTFPQSICNI-SSLERIYLPFNRFSGTLPFDIVVNLPNL--KSL 275
L + + L + G +S+ +++ + N V L +L ++
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 276 AIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLG---- 331
+ N + +L++ + + +E N+
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 332 MGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPS 391
+ +F T SL I + F+ ++ ++ + M + + I
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTPFIHMV 347
Query: 392 GIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLV 451
+ + L N ++ LK LQ L L +N L+ + ++ L
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLE 406
Query: 452 MSYNSLQ----GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLN 507
SL + ++++ N S N LTG++ + L LDL NN +
Sbjct: 407 TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVK---VLDLHNNRIM 463
Query: 508 GSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFH 555
S+P + +L+ L +L ++SNQ V SL+Y+ + N +
Sbjct: 464 -SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-26
Identities = 93/498 (18%), Positives = 162/498 (32%), Gaps = 51/498 (10%)
Query: 141 IPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFV-GNLSAL 199
+P +L L +S N + +I L +L+ L + N + L V L
Sbjct: 46 VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSIC--NISSLERIYLPFNRF 257
E ++ N L I + +L L + N F P N++ L + L +F
Sbjct: 103 EYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 258 SGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSL 317
L V +L L + N +L L F+ S+
Sbjct: 159 R-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 318 KNLSWLNLEQNNLGMGTANDLD-FVTFLTNCSSLKILSLAANQFVGELPHSIANL--SSS 374
L L L L L F++ LT +L ++L + + +
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 375 MIEFRIGGNQIFGIIPSGI-----RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLY 429
+ I I I L +L+ +++ + + + L
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 430 KNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQ 488
+ I + + L + N ++ + L N L +
Sbjct: 338 ISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKV 395
Query: 489 LLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLD 548
L +S L+ + +LN SL S T + S+ L+
Sbjct: 396 ALMTKNMS-SLETLDVSLN-SLN-------------------SHAYDRTCAWAESILVLN 434
Query: 549 ISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT 608
+SSN G + L +KVL+ +N + IP+ + +L L+ LN + N L+ VP
Sbjct: 435 LSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP- 489
Query: 609 KGVF---SSKTKLSLQGN 623
GVF +S + L N
Sbjct: 490 DGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 42/296 (14%), Positives = 93/296 (31%), Gaps = 23/296 (7%)
Query: 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLL-----RLEKLAL 132
+++ + L+++ +++ +N++ + +E L +
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283
Query: 133 PNNSFSGTIPTNLSRCSN-----LIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTG 187
N + + I S L+ V N A ++ + +
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
Query: 188 RLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSL 247
+ S+ + T N + L+ L L + N F + ++
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402
Query: 248 ERIYLPFNRFSG--TLPFDIVVNLP-NLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFN 304
+ + + +D ++ L + N GS+ L V++LDL N
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNN 460
Query: 305 QFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360
+ + D + L+ L LN+ N L D +SL+ + L N +
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFD------RLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 30/180 (16%), Positives = 64/180 (35%), Gaps = 10/180 (5%)
Query: 59 NNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIP 118
+I+ + + C T L+ + + L L+ + L N
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFF 393
Query: 119 QEIGNLLRLEKLALPNNSF----SGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLK 174
+ + L + S S + +++ L +S+N L G + + K
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--K 451
Query: 175 LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPT-TLGLLRNLVDLHVGGNQF 233
++ L + N + +P V +L AL+ ++ N L +P L +L + + N +
Sbjct: 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL-KSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKI 767
+G+G FG+VY + + I+A+KV+ L++ G E + ++RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ L+ E G++ L + + K + ++A+A+
Sbjct: 75 YGY---FHDATRVY--LILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALS 123
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
Y H ++H D+KP N+LL + DFG + S + GT
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----------GT 170
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ Y+ PE G D++S G+L E G+ P
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 68/305 (22%), Positives = 107/305 (35%), Gaps = 59/305 (19%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALR-NIRHRNLI 765
S ++G GS G+V + VAVK + + E K L + H N+I
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRP-VAVKRML---IDFCDIALMEIKLLTESDDHPNVI 72
Query: 766 KIITICSSIDSKGADFKALVFE-CMKNGSLEDWLHQSNDHLEVCK-LTLIQRVNIAIDVA 823
+ ++ F + E C N +L+D + N E K +++ +A
Sbjct: 73 RYYCSETT-----DRFLYIALELC--NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG-------------DFGLAKFLSSHQ 870
S + +LH ++H DLKP N+L+ DFGL K L S Q
Sbjct: 126 SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 871 LDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG-------DVYSFGILLLEL------ 917
+ + GT G+ APE S T D++S G + +
Sbjct: 183 SSFRTNLN----NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 918 -FTGRRPTDAAFTEG-LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQED--IRAKT 973
F + ++ G +L E + + E D LI MI D R
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD---LIS-----QMIDHDPLKRPTA 290
Query: 974 QECLN 978
+ L
Sbjct: 291 MKVLR 295
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 57/302 (18%), Positives = 102/302 (33%), Gaps = 42/302 (13%)
Query: 269 LPNLKSLAIGGNNFFGSIP----DSLSNASNVEILDLGFNQFKGKVS-IDFSSLKNLSWL 323
LP + ++ N+F+ +I D S E L VS + + S L
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64
Query: 324 NLEQNNLGMGTANDLDFVTFL--TNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIG 381
L + NL + L + +L + N + LP A+L
Sbjct: 65 QLNRLNL-----------SSLPDNLPPQITVLEITQNALI-SLPELPASLE----YLDAC 108
Query: 382 GNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV 441
N++ +P +L +L + +NQL +P++ L+ + N L +P
Sbjct: 109 DNRL-STLPELPASLKHLD---VDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELP 159
Query: 442 GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTG--ALPQQLLSITTLSVYL 499
+L L + N L +P + + L + S N L A+P + ++
Sbjct: 160 TSLEVL---SVRNNQLTF-LPELPESLEAL---DVSTNLLESLPAVPVRNHHSEETEIFF 212
Query: 500 DLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIP 559
N + +P I +L +I+ N S I +LS + F
Sbjct: 213 RCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
Query: 560 HS 561
Sbjct: 272 QQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 52/266 (19%), Positives = 97/266 (36%), Gaps = 38/266 (14%)
Query: 347 CSSLKILSLAANQFVGEL---PHSIANLSSSMIEFRIGG---NQIFGIIPSGIRNLVNLI 400
SL+ N F + + + + G N+ ++ + +
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62
Query: 401 ALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGN 460
L + L ++PD + + L + +N L S+P +L L N L
Sbjct: 63 ELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-T 114
Query: 461 IPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNL 520
+P + ++L + +N+LT LP+ + Y++ NN L LP +L+
Sbjct: 115 LPELPASLKHL---DVDNNQLT-MLPELPALLE----YINADNNQLT-MLPELPTSLE-- 163
Query: 521 VKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIK----VLNFSSN 576
L + +NQ + +P SLE LD+S+N +P + N
Sbjct: 164 -VLSVRNNQLT-FLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCREN 217
Query: 577 NLSGQIPEFLENLSFLEFLNFSHNDL 602
++ IPE + +L + N L
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPL 242
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 3e-21
Identities = 49/255 (19%), Positives = 88/255 (34%), Gaps = 33/255 (12%)
Query: 82 LDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI--GNLLRLEKLALPNNSFSG 139
+ I G + Y L + E + + + +L L + S
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGEN-RNEAVSLLKECLINQFSELQLNRLNLS- 72
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
++P NL + L ++ N L +P S L+ L N L+ LP+ +L L
Sbjct: 73 SLPDNL--PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKHL 125
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
+ N L +P LL ++ NQ + P+ + LE + + N+ +
Sbjct: 126 ---DVDNNQL-TMLPELPALLEY---INADNNQLT-MLPELPTS---LEVLSVRNNQLT- 173
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASN----VEILDLGFNQFKGKVSIDFS 315
LP +L++L + N S+P + N+ + +
Sbjct: 174 FLP----ELPESLEALDV-STNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
Query: 316 SLKNLSWLNLEQNNL 330
SL + LE N L
Sbjct: 228 SLDPTCTIILEDNPL 242
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 1e-14
Identities = 38/183 (20%), Positives = 67/183 (36%), Gaps = 22/183 (12%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
LD + R+ + + L+++++ +N +P+ L E + NN +
Sbjct: 103 EYLDACDNRLSTLPE----LPASLKHLDVDNNQLT-MLPELPALL---EYINADNNQLT- 153
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
+P + +L L V NN+L +P SL + L V N L LP
Sbjct: 154 MLPELPT---SLEVLSVRNNQLT-FLPELPESL---EALDVSTNLLE-SLPAVPVRNHHS 205
Query: 200 E----VFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFN 255
E F N + IP + L + + N S +S+ ++ + P
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264
Query: 256 RFS 258
FS
Sbjct: 265 YFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 25/132 (18%), Positives = 48/132 (36%), Gaps = 15/132 (11%)
Query: 495 LSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISS---NQFSGVIPVTLSTCVSLEYLDISS 551
S+ + N ++G+ K + N+ ++ L L ++
Sbjct: 11 FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN--QFSELQLNR 68
Query: 552 NSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGV 611
+ +P +L I VL + N L +PE +L E+L+ N L +P +
Sbjct: 69 LNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLP--EL 118
Query: 612 FSSKTKLSLQGN 623
+S L + N
Sbjct: 119 PASLKHLDVDNN 130
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 15/91 (16%), Positives = 26/91 (28%), Gaps = 6/91 (6%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLR----YINLSDNSFHGEIPQEIGNLLRLEKLALPNN 135
LD+S + L + +N IP+ I +L + L +N
Sbjct: 183 EALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN 240
Query: 136 SFSGTIPTNLSRCSNLIQLRVSNNKLEGQIP 166
S I +LS+ +
Sbjct: 241 PLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 36/229 (15%), Positives = 76/229 (33%), Gaps = 31/229 (13%)
Query: 711 NMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLI 765
+++G+G+F VY+ G +++ +KV F + L+
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM-- 128
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+ S+ + + LV E G+L + ++ + E + ++ A+ +
Sbjct: 129 -FMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKV-MPQGLVISFAMRMLYM 184
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG-----------DFGLAKFLSSHQLDTA 874
IE +H ++HGD+KP N +L + + D G + + T
Sbjct: 185 IEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 875 SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T G+ E + D + + + G
Sbjct: 242 FTAKC------ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 52/271 (19%), Positives = 99/271 (36%), Gaps = 57/271 (21%)
Query: 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--KSFMAECKALRN 758
S+ T+EF IG G FGSV+K + D I A+K G+ ++ + E A
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 759 I-RHRNLIKIITICSSIDSKGADFKA----LVFECMKNGSLEDWLHQSNDHLEVCKLTLI 813
+ +H ++++ A + + E GSL D + ++ + K +
Sbjct: 67 LGQHSHVVRY---------FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 814 QRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV---------------- 857
+ ++ + V + Y+H +VH D+KPSN+ + + +
Sbjct: 118 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 858 ---GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGIL 913
GD G +SS Q+ +G ++A E + D+++ +
Sbjct: 173 FKIGDLGHVTRISSPQV------------EEGDSRFLANEVLQENYTHLPKADIFALALT 220
Query: 914 LLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944
++ G HE + LP
Sbjct: 221 VVCAAGAEPL----PRNGDQWHEIRQGRLPR 247
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 65/313 (20%), Positives = 120/313 (38%), Gaps = 33/313 (10%)
Query: 65 CQWTGVTCGHRH---------QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHG 115
C V C LDL N +I I NL L + L +N
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 116 EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLK 174
P L++LE+L L N +P + + L +LRV N++ ++ + L +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KVRKSVFNGLNQ 146
Query: 175 LQTLAVGKNYLT-GRLPD--FVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGN 231
+ + +G N L + + F G + L I ++ IP GL +L +LH+ GN
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQG-MKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGN 202
Query: 232 QFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLS 291
+ + S+ +++L ++ L FN S + + N P+L+ L + N +P L+
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKL-VKVPGGLA 260
Query: 292 NASNVEILDLGFNQFKG------KVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLT 345
+ ++++ L N + + S ++L N + ++ TF
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV---QYWEIQPSTF-R 316
Query: 346 NCSSLKILSLAAN 358
+ L
Sbjct: 317 CVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 69/356 (19%), Positives = 117/356 (32%), Gaps = 78/356 (21%)
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
+ +P L + +LDL N+ DF +LKNL L L N + + +
Sbjct: 40 DLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-----SKIS 92
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNL 399
F L+ L L+ NQ ELP + ++ E R+ N+I + S L +
Sbjct: 93 PGAF-APLVKLERLYLSKNQLK-ELP---EKMPKTLQELRVHENEITKVRKSVFNGLNQM 147
Query: 400 IALGMQSNQLHGTI--PDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSL 457
I + + +N L + +K L + + + +IP G+
Sbjct: 148 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---------------- 190
Query: 458 QGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GN 516
P SL L L N + +
Sbjct: 191 ----PPSL-------------------------------TELHLDGNKIT-KVDAASLKG 214
Query: 517 LKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSN 576
L NL KL +S N S V +L+ L L +++N +P L K I+V+ +N
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 577 NLSG------QIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLS---LQGN 623
N+S P + + ++ N ++ F + L
Sbjct: 274 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 57/301 (18%), Positives = 108/301 (35%), Gaps = 25/301 (8%)
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
+P +L + L + NNK+ + +L L TL + N ++ P L L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRF-S 258
E ++ N L ++P + + L +L V N+ + ++ + + L N S
Sbjct: 103 ERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159
Query: 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLK 318
+ + L + I N +IP L ++ L L N+ + L
Sbjct: 160 SGIENGAFQGMKKLSYIRIADTNI-TTIPQGLP--PSLTELHLDGNKITKVDAASLKGLN 216
Query: 319 NLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEF 378
NL+ L L N++ + +D + N L+ L L N+ V ++P +A+ +
Sbjct: 217 NLAKLGLSFNSI-----SAVDNGSL-ANTPHLRELHLNNNKLV-KVPGGLADH-KYIQVV 268
Query: 379 RIGGNQIFGI------IPSGIRNLVNLIALGMQSNQLHGTI--PDVIGELKNLQGLFLYK 430
+ N I I P + + + SN + P + + L
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328
Query: 431 N 431
Sbjct: 329 Y 329
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 34/219 (15%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G+GSF VY+ + VA+K+I+ + + G + E K ++H +++++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAI 826
+ + LV E NG + +L E + Q + + +
Sbjct: 79 Y---FEDSNYVY--LVLEMCHNGEMNRYLKNRVKPFSENEARHF-MHQ-------IITGM 125
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS--SHQLDTASKTSSSSIGI 884
YLH H ++H DL SN+LL +M + DFGLA L + T +
Sbjct: 126 LYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT----------L 172
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y++PE S + DV+S G + L GR P
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G+G FG+VY +++ I+A+KV+ L+++G E + ++RH N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ + L+ E G L L + + + ++A A+ Y
Sbjct: 82 Y---FHDRKRIY--LMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYC 130
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H ++H D+KP N+L+ + + DFG + S + T GT+
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----------GTLD 177
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+ PE G D++ G+L E G P
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 58/257 (22%), Positives = 99/257 (38%), Gaps = 54/257 (21%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN----LKQKGAFKSFMA----------------- 751
IG+GS+G V D A+KV++ ++Q G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 752 -----ECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLE 806
E L+ + H N++K++ + +D D +VFE + G + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLK----- 132
Query: 807 VCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866
L+ Q D+ IEYLH+ ++H D+KPSN+L+ D + DFG++
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG---DVYSFGILLLELFTGRRP 923
D + GT ++APE + +G DV++ G+ L G+ P
Sbjct: 188 KGS--DALLSNTV------GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 924 TDAAFTEGLTLHEFAKI 940
L +KI
Sbjct: 240 FMDERIMCL----HSKI 252
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FKSFMAECKALRNIRHRNLIKIITIC 771
+G G+ G V+K +++A K+I+L+ K A + E + L ++
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG----- 95
Query: 772 SSIDSKGADFKA----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
GA + + E M GSL+ L ++ E + + ++I V +
Sbjct: 96 ----FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGK--VSIAVIKGLT 145
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
YL + ++H D+KPSN+L++ + DFG++ L D+ + + GT
Sbjct: 146 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFV------GT 193
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y++PE G+ S+ D++S G+ L+E+ GR P
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 53/263 (20%), Positives = 97/263 (36%), Gaps = 16/263 (6%)
Query: 369 ANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL 428
+S + N I + + L +L AL + +N++ L+ LQ L++
Sbjct: 50 KEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109
Query: 429 YKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLT-GALPQ 487
KN L IP + + L +L + N ++ +N+ N L
Sbjct: 110 SKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 488 QLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYL 547
L+ YL +S L G + + L +L + N+ + L L L
Sbjct: 167 GAFDGLKLN-YLRISEAKLTG---IPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRL 222
Query: 548 DISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE---- 603
+ N + SL FL +++ L+ +N LS ++P L +L L+ + N++
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGV 281
Query: 604 ---GEVPTKGVFSSKTKLSLQGN 623
V + +SL N
Sbjct: 282 NDFCPVGFGVKRAYYNGISLFNN 304
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 55/282 (19%), Positives = 99/282 (35%), Gaps = 22/282 (7%)
Query: 348 SSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSN 407
+L L N L + + N+I I L L L + N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQH-LYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 408 QLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQ-GNIPSSL 465
L IP +L L ++ N ++ +P GV L + + M N L+
Sbjct: 113 HLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 466 GNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLKNLVKLI 524
+ L S KLT +P+ L L L +N + ++ L+ L +L
Sbjct: 169 FDGLKLNYLRISEAKLT-GIPKDLPETLN---ELHLDHNKIQ-AIELEDLLRYSKLYRLG 223
Query: 525 ISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPE 584
+ NQ + +LS +L L + +N +P L LK ++V+ +NN++ ++
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGV 281
Query: 585 -------FLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLS 619
F ++ ++ +N + F T
Sbjct: 282 NDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 66/307 (21%), Positives = 101/307 (32%), Gaps = 46/307 (14%)
Query: 65 CQWTGVTCGHRH---------QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHG 115
C V C T LDL N I + L L + L +N
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 116 EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLK 174
+ L +L+KL + N IP NL +L++LR+ +N++ ++P + L
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SLVELRIHDNRIR-KVPKGVFSGLRN 148
Query: 175 LQTLAVGKNYLT-GRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQF 233
+ + +G N L + L I+ L IP L L +LH+ N+
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKI 205
Query: 234 SGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPD-SLSN 292
+ L L +G N I + SLS
Sbjct: 206 Q----------------AIELEDLLR---------YSKLYRLGLGHNQI-RMIENGSLSF 239
Query: 293 ASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKI 352
+ L L N+ +V LK L + L NN+ ND V F +
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNG 298
Query: 353 LSLAANQ 359
+SL N
Sbjct: 299 ISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 57/320 (17%), Positives = 112/320 (35%), Gaps = 39/320 (12%)
Query: 213 IPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNL 272
+P + + L + N S + L + L N+ S + L L
Sbjct: 48 VPK--EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKL 104
Query: 273 KSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGM 332
+ L I N+ IP +L S++ L + N+ + FS L+N++ + + N L
Sbjct: 105 QKLYISKNHL-VEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN 161
Query: 333 GTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSG 392
F + L L ++ + +P +L ++ E + N+I I
Sbjct: 162 SGFEPGAF-----DGLKLNYLRISEAKLT-GIP---KDLPETLNELHLDHNKIQAIELED 212
Query: 393 IRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVM 452
+ L LG+ NQ+ + L L+ L L N L +P+G+ +L L + +
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271
Query: 453 SYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPL 512
N++ + N +GF + L NN + +
Sbjct: 272 HTNNIT-KVGV---NDFCPVGFGVKRAYYN---------------GISLFNNPVP-YWEV 311
Query: 513 QIG---NLKNLVKLIISSNQ 529
Q + + + + + +
Sbjct: 312 QPATFRCVTDRLAIQFGNYK 331
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-24
Identities = 56/235 (23%), Positives = 104/235 (44%), Gaps = 8/235 (3%)
Query: 369 ANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL 428
+S++ + NQI I + ++L +L L + N + L NL L L
Sbjct: 60 DGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119
Query: 429 YKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSL-GNCQNLIGFNASH-NKLTGAL 485
+ N L +IP+G L+KL +L + N ++ +IPS +L + +L+
Sbjct: 120 FDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYIS 177
Query: 486 PQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLE 545
++ L YL+L+ NL +P + L L +L +S N S + P + + L+
Sbjct: 178 EGAFEGLSNLR-YLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ 234
Query: 546 YLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
L + + + ++ L+S+ +N + NNL+ + L LE ++ HN
Sbjct: 235 KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 8e-21
Identities = 53/278 (19%), Positives = 105/278 (37%), Gaps = 39/278 (14%)
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
+PD +S +N +L+L NQ + F L++L L L +N++ ++
Sbjct: 52 RKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-----IE 104
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVN 398
F ++L L L N+ L++ IP+G L
Sbjct: 105 IGAF-NGLANLNTLELFDNR-----------LTT---------------IPNGAFVYLSK 137
Query: 399 LIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSL 457
L L +++N + + +L+ L L + I G L+ L L ++ +L
Sbjct: 138 LKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197
Query: 458 QGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNL 517
+ IP+ L L + S N L+ A+ L + + + NL
Sbjct: 198 R-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254
Query: 518 KNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFH 555
++LV++ ++ N + + + LE + + N ++
Sbjct: 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 9e-20
Identities = 57/255 (22%), Positives = 102/255 (40%), Gaps = 29/255 (11%)
Query: 213 IPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNL 272
+P G+ N L++ NQ S ++ LE + L N T+ L NL
Sbjct: 58 VPD--GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114
Query: 273 KSLAIGGNNFFGSIP-DSLSNASNVEILDLGFNQFKGKVSID---FSSLKNLSWLNLEQN 328
+L + N +IP + S ++ L L N + SI F+ + +L L+L +
Sbjct: 115 NTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE---SIPSYAFNRIPSLRRLDLGEL 170
Query: 329 N----LGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQ 384
+ G S+L+ L+LA E+P+ + L + E + GN
Sbjct: 171 KRLSYISEGA---------FEGLSNLRYLNLAMCNLR-EIPN-LTPLIK-LDELDLSGNH 218
Query: 385 IFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GN 443
+ I P + L++L L M +Q+ + L++L + L N L +P +
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTP 277
Query: 444 LTKLAKLVMSYNSLQ 458
L L ++ + +N
Sbjct: 278 LHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 47/273 (17%), Positives = 90/273 (32%), Gaps = 41/273 (15%)
Query: 70 VTCGHRH---------QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQE 120
V C ++ L+L +I I +L L + LS N
Sbjct: 48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR------ 101
Query: 121 IGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLA 179
+ +F+G +NL L + +N+L IP L KL+ L
Sbjct: 102 ----------TIEIGAFNG--------LANLNTLELFDNRLT-TIPNGAFVYLSKLKELW 142
Query: 180 VGKNYLTGRLPDFV-GNLSALEVFSITG-NSLGGKIPTTLGLLRNLVDLHVGGNQFSGTF 237
+ N + +P + + +L + L L NL L++
Sbjct: 143 LRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL--RE 199
Query: 238 PQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVE 297
++ + L+ + L N S + L +L+ L + + ++ N ++
Sbjct: 200 IPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258
Query: 298 ILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330
++L N F+ L +L ++L N
Sbjct: 259 EINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 42/193 (21%), Positives = 75/193 (38%), Gaps = 13/193 (6%)
Query: 436 SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTL 495
+P G+ T+L L + N +Q +S + ++L S N + + L
Sbjct: 57 EVPDGISTNTRL--LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 496 SVYLDLSNNNLNGSLPLQI-GNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISS-NS 553
L+L +N L ++P L L +L + +N + + SL LD+
Sbjct: 115 -NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 554 FHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFS 613
+ + L +++ LN + NL +IP L L+ L+ S N L + G F
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIPNL-TPLIKLDELDLSGNHLS-AIR-PGSFQ 228
Query: 614 SKT---KLSLQGN 623
KL + +
Sbjct: 229 GLMHLQKLWMIQS 241
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 25/150 (16%), Positives = 50/150 (33%), Gaps = 8/150 (5%)
Query: 477 SHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPV 536
L +P + + T L+L N + +L++L L +S N +
Sbjct: 51 VRKNLR-EVPDGISTNTR---LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106
Query: 537 TLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLN 596
+ +L L++ N + + +L +K L +N + + L L+
Sbjct: 107 AFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166
Query: 597 FSHNDLEGEVPTKGVF---SSKTKLSLQGN 623
+ G F S+ L+L
Sbjct: 167 LGELKRLSYISE-GAFEGLSNLRYLNLAMC 195
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 58/268 (21%), Positives = 111/268 (41%), Gaps = 17/268 (6%)
Query: 369 ANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL 428
+ L+ ++ + N+I I S ++ VNL AL + SN ++ D L +L+ L L
Sbjct: 48 SGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107
Query: 429 YKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSL-GNCQNLIGFNASHNKLTGALP 486
N L ++ S L+ L L + N + +SL + L + +
Sbjct: 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 487 QQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEY 546
++ + T L++ ++L P + +++N+ LI+ Q ++ + + S+E
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226
Query: 547 LDISSN--------SFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFS 598
L++ +SL + + + + +L Q+ + L +S L L FS
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285
Query: 599 HNDLEGEVPTKGVFSSKTKL---SLQGN 623
N L+ VP G+F T L L N
Sbjct: 286 RNQLKS-VP-DGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 57/328 (17%), Positives = 110/328 (33%), Gaps = 37/328 (11%)
Query: 233 FSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSN 292
+ Q+ + + ++P + +KSL + N L
Sbjct: 19 KEESSNQASLSCDRNGICKGSSGSLN-SIPSGL---TEAVKSLDLSNNRITYISNSDLQR 74
Query: 293 ASNVEILDLGFNQFKGKVSID---FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSS 349
N++ L L N +I+ FSSL +L L+L N L L F SS
Sbjct: 75 CVNLQALVLTSNGIN---TIEEDSFSSLGSLEHLDLSYNYLSN-----LSSSWF-KPLSS 125
Query: 350 LKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQ 408
L L+L N + S+ + + + R+G F I L L L + ++
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185
Query: 409 LHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGN 467
L P + ++N+ L L+ + + + L + L
Sbjct: 186 LQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF------- 237
Query: 468 CQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISS 527
++L+ L+ T + +++ +L + + + L++L S
Sbjct: 238 ---------HFSELSTGETNSLIKKFTFR-NVKITDESLF-QVMKLLNQISGLLELEFSR 286
Query: 528 NQFSGVIPVTLSTCVSLEYLDISSNSFH 555
NQ V SL+ + + +N +
Sbjct: 287 NQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 61/311 (19%), Positives = 108/311 (34%), Gaps = 49/311 (15%)
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
+ SIP L+ V+ LDL N+ + D NL L L N + N ++
Sbjct: 40 SGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-----NTIE 92
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVN 398
+F ++ SL+ L L+ N LS+ + S + L +
Sbjct: 93 EDSF-SSLGSLEHLDLSYNY-----------LSN---------------LSSSWFKPLSS 125
Query: 399 LIALGMQSNQLHGTIPD--VIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYN 455
L L + N T+ + + L LQ L + I LT L +L + +
Sbjct: 126 LTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 456 SLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI- 514
LQ P SL + QN+ + L + + +T+ L+L + +L+ ++
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243
Query: 515 -------GNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKS 567
+ I+ + L+ L L+ S N V L S
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTS 302
Query: 568 IKVLNFSSNNL 578
++ + +N
Sbjct: 303 LQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-20
Identities = 52/295 (17%), Positives = 105/295 (35%), Gaps = 31/295 (10%)
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
+IP+ L+ + L +SNN++ +++ + LQ L + N + D +L +L
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSI-CNISSLERIYLPFNRFS 258
E ++ N L + L +L L++ GN + S+ +++ L+ + +
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLK 318
+ L L+ L I ++ P SL + NV L L Q + I
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 319 NLSWLNLEQNNLGMGTANDLDFVTF--LTNCSSLKILSLAANQFVGELPHSIANLSSSMI 376
++ L L +L ++L L + + + +
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-------------- 268
Query: 377 EFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKN 431
+ + + L+ L NQL + L +LQ ++L+ N
Sbjct: 269 ------------VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 59/263 (22%), Positives = 100/263 (38%), Gaps = 14/263 (5%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI-GNLLRLEKLALPNNSF 137
V LDLSN RI I + + L+ + L+ N + I ++ +L LE L L N
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 138 SGTIPTNL-SRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFV-G 194
S + ++ S+L L + N + + L KLQ L VG ++
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 195 NLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPF 254
L+ LE I + L P +L ++N+ L + Q + SS+E + L
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 255 NRFSG-------TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFK 307
T + ++ +++ I + F + L+ S + L+ NQ K
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK 290
Query: 308 GKVSIDFSSLKNLSWLNLEQNNL 330
F L +L + L N
Sbjct: 291 SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 38/217 (17%), Positives = 81/217 (37%), Gaps = 16/217 (7%)
Query: 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI--GNLLRLEKLALPNN 135
+ LDLS + + S + LS L ++NL N + + + +L +L+ L + N
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNM 159
Query: 136 SFSGTIPTN-LSRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFV 193
I + + L +L + + L+ + S+ + L + L FV
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFV 218
Query: 194 GNLSALEVFSITGNSLGG----KIPT----TLGLLRNLVDLHVGGNQFSGTFPQSICNIS 245
S++E + L ++ T +L ++ + + + IS
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
Query: 246 SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF 282
L + N+ ++P I L +L+ + + N +
Sbjct: 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 8/235 (3%)
Query: 369 ANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL 428
+ S+ + N I I R+L +L L + N + L +L L L
Sbjct: 71 QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130
Query: 429 YKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPS-SLGNCQNLIGFNASH-NKLTGAL 485
+ N L IPSG L+KL +L + N ++ +IPS + +L+ + KL +
Sbjct: 131 FDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YI 187
Query: 486 PQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLE 545
+ YL+L N+ +P + L L +L +S N F + P + SL+
Sbjct: 188 SEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLK 245
Query: 546 YLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
L + ++ + ++ L S+ LN + NNLS + L +L L+ HN
Sbjct: 246 KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 57/302 (18%), Positives = 101/302 (33%), Gaps = 65/302 (21%)
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
+P + SN L+L N + + F L +L L L +N++ ++
Sbjct: 63 RRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-----IE 115
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVN 398
F +SL L L N L+ IPSG L
Sbjct: 116 VGAF-NGLASLNTLELFDNW-----------LTV---------------IPSGAFEYLSK 148
Query: 399 LIALGMQSNQLHGTIPDVI-GELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNS 456
L L +++N + +IP + +L L L + I G L L L + +
Sbjct: 149 LRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207
Query: 457 LQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGN 516
++ ++P+ L L L++S N+ P
Sbjct: 208 IK-DMPN-LTPLVGL-------------------------EELEMSGNHFPEIRPGSFHG 240
Query: 517 LKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSN 576
L +L KL + ++Q S + SL L+++ N+ + L+ + L+ N
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
Query: 577 NL 578
Sbjct: 301 PW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 61/289 (21%), Positives = 104/289 (35%), Gaps = 37/289 (12%)
Query: 147 RCSN-LIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSIT 205
CSN ++ + L ++P I + L + +N + D +L LEV +
Sbjct: 51 SCSNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107
Query: 206 GNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDI 265
NS+ L +L L + N + + +S L ++L N ++P
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
Query: 266 VVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNL 325
+P+L L +G I + F L NL +LNL
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISEGA-----------------------FEGLFNLKYLNL 203
Query: 326 EQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQI 385
N+ + LT L+ L ++ N F P S LSS + + + +Q+
Sbjct: 204 GMCNI--------KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSS-LKKLWVMNSQV 254
Query: 386 FGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQ 434
I + L +L+ L + N L D+ L+ L L L+ N
Sbjct: 255 SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 8e-17
Identities = 60/256 (23%), Positives = 93/256 (36%), Gaps = 43/256 (16%)
Query: 65 CQWTG--VTCGHRH---------QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDN-- 111
C V C R L+L I I + +L L + L N
Sbjct: 52 CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 112 ------SFHG---------------EIPQEI-GNLLRLEKLALPNNSFSGTIPTN-LSRC 148
+F+G IP L +L +L L NN +IP+ +R
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRV 170
Query: 149 SNLIQLRVS-NNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITG 206
+L++L + KLE I L L+ L +G + +P+ L LE ++G
Sbjct: 171 PSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPNLT-PLVGLEELEMSG 227
Query: 207 NSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIV 266
N P + L +L L V +Q S + ++SL + L N S +LP D+
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLF 286
Query: 267 VNLPNLKSLAIGGNNF 282
L L L + N +
Sbjct: 287 TPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 7e-15
Identities = 44/225 (19%), Positives = 83/225 (36%), Gaps = 16/225 (7%)
Query: 405 QSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPS 463
L +P I N + L L +N +Q I + +L L L + NS++
Sbjct: 62 TRRGLS-EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVG 117
Query: 464 SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLKNLVK 522
+ +L N LT +P + L L NN + S+P + +L++
Sbjct: 118 AFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMR 175
Query: 523 LIISS-NQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQ 581
L + + + +L+YL++ + + +L L ++ L S N+
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEI 233
Query: 582 IPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKL---SLQGN 623
P LS L+ L ++ + + + F L +L N
Sbjct: 234 RPGSFHGLSSLKKLWVMNSQVS-LIE-RNAFDGLASLVELNLAHN 276
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FKSFMAECKALRNIRHRNLIKIITI 770
IG+G+F V VA+K+I+ Q + E + ++ + H N++K+ +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
I+++ + L+ E G + D+L ++ + + + SA++Y H
Sbjct: 83 ---IETEKTLY--LIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCH 131
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL-AKFLSSHQLDTASKTSSSSIGIKGTVG 889
+VH DLK N+LLD DM + DFG +F +LD G
Sbjct: 132 QKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----------GAPP 178
Query: 890 YVAPEYCMGSE-ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940
Y APE G + DV+S G++L L +G P D + L ++
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL----RERV 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-23
Identities = 60/209 (28%), Positives = 85/209 (40%), Gaps = 31/209 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G+F V+ + A+K I S E L+ I+H N++ + I
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
S LV + + G L D + LE T + V SA++YLH +
Sbjct: 77 S-----TTHYYLVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 833 CQPPMVHGDLKPSNVLL-DHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
+VH DLKP N+L + S + DFGL+K + + TA GT G
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----------GTPG 172
Query: 890 YVAPEYCMGSEASMTGDVYSFG----ILL 914
YVAPE S D +S G ILL
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 33/224 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FKSFMAECKALRNIRHRNLIKIITIC 771
IG G+ V + VA+K INL++ + E +A+ H N++
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY--YT 80
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVASAIEY 828
S + + LV + + GS+ D + E L + IA +V +EY
Sbjct: 81 SFV--VKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVLEGLEY 136
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG----- 883
LH + Q +H D+K N+LL D + DFG++ FL++ T +K + +G
Sbjct: 137 LHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 884 ----IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
++ GY +A D++SFGI +EL TG P
Sbjct: 194 APEVMEQVRGY-------DFKA----DIWSFGITAIELATGAAP 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 56/254 (22%), Positives = 88/254 (34%), Gaps = 55/254 (21%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFKSFMAECKALRNIRHRNLIKI 767
IGQGS+G V I + I A+K++N + + E + ++ + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV----------- 816
+ + LV E G L D L+ D + +
Sbjct: 94 YEVYED-----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 817 -----------------------NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853
NI + SA+ YLH+ + H D+KP N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 854 VSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEAS--MTGDVYS 909
+ DFGL+K + GT +VAPE + S D +S
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMT----TKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 910 FGILLLELFTGRRP 923
G+LL L G P
Sbjct: 262 AGVLLHLLLMGAVP 275
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-22
Identities = 59/241 (24%), Positives = 109/241 (45%), Gaps = 26/241 (10%)
Query: 690 KQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFKS 748
KQ+ +V + S++ IGQG+FG V+K + VA+K + + +K F
Sbjct: 3 KQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP- 60
Query: 749 FMA--ECKALRNIRHRNLIKIITICSSIDSKGADFKA---LVFECMKNGSLEDWLHQSND 803
A E K L+ ++H N++ +I IC + S K LVF+ ++ L L
Sbjct: 61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV 119
Query: 804 HLEV--CKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861
+ K + + + + Y+H + ++H D+K +NVL+ D V + DFG
Sbjct: 120 KFTLSEIKRVMQM-------LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169
Query: 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTG 920
LA+ S + ++ ++ + T+ Y PE +G D++ G ++ E++T
Sbjct: 170 LARAFSLAKNSQPNRYTNRVV----TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
Query: 921 R 921
Sbjct: 226 S 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA-----ECKALRNIRHRNLIKI 767
+G+GS+G V + + E AVK++ K+K E + LR +RH+N+I++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILK-KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ + + + K + +V E G E + D + + + Q + +E
Sbjct: 72 VDVLYN-EEKQKMY--MVMEYCVCGMQE--ML---DSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
YLH +VH D+KP N+LL + G+A+ L D +TS G+
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ------GS 174
Query: 888 VGYVAPEYCMGSE--ASMTGDVYSFGILLLELFTGRRPTD 925
+ PE G + + D++S G+ L + TG P +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 57/262 (21%), Positives = 104/262 (39%), Gaps = 41/262 (15%)
Query: 676 RRSARKSVDTSPREKQFPTVSYAELSKATSEFASS----------NMIGQGSFGSVYKGI 725
S+ + T Q V++ + A IG+GS G V
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 726 LGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA-- 783
VAVK+++L+++ + E +R+ +H N++++ +
Sbjct: 66 EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMY---------KSYLVGEE 116
Query: 784 --LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGD 841
++ E ++ G+L D + Q +L Q + V A+ YLH ++H D
Sbjct: 117 LWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRD 166
Query: 842 LKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA 901
+K ++LL D + DFG +S K S + GT ++APE S
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQIS----KDVPKRKS----LVGTPYWMAPEVISRSLY 218
Query: 902 SMTGDVYSFGILLLELFTGRRP 923
+ D++S GI+++E+ G P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 54/215 (25%), Positives = 83/215 (38%), Gaps = 8/215 (3%)
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKL 447
+P GI + + N++ +NL L+L+ NVL I + L L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82
Query: 448 AKLVMSYNSLQGNIPSS-LGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNL 506
+L +S N+ ++ + L + L L L YL L +N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 507 NGSLPLQI-GNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFL 565
+LP +L NL L + N+ S V SL+ L + N V PH+ L
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 566 KSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
+ L +NNLS E L L L++L + N
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 43/213 (20%), Positives = 79/213 (37%), Gaps = 6/213 (2%)
Query: 369 ANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL 428
+ ++ + GN+I + + R NL L + SN L L L+ L L
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87
Query: 429 YKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPS-SLGNCQNLIGFNASHNKLTGALP 486
N S+ L +L L + LQ + L N L
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPD 146
Query: 487 QQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLKNLVKLIISSNQFSGVIPVTLSTCVSLE 545
+ L+ +L L N ++ S+P + L +L +L++ N+ + V P L
Sbjct: 147 DTFRDLGNLT-HLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 546 YLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578
L + +N+ + +L L++++ L + N
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 48/279 (17%), Positives = 89/279 (31%), Gaps = 63/279 (22%)
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
++P + + + + L N+ + F + +NL+ L L N L A
Sbjct: 20 QQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNL 399
+ L+ L L+ N Q+ + P+ L L
Sbjct: 78 ------GLALLEQLDLSDN------------------------AQLRSVDPATFHGLGRL 107
Query: 400 IALGMQSNQLHGTIP-DVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSL 457
L + L + + L LQ L+L N LQ ++P +L L L + N +
Sbjct: 108 HTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI 165
Query: 458 QGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GN 516
+ +L L L N + + +
Sbjct: 166 SSVPERAFRGLHSL-------------------------DRLLLHQNRVA-HVHPHAFRD 199
Query: 517 LKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFH 555
L L+ L + +N S + L+ +L+YL ++ N +
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 46/207 (22%), Positives = 77/207 (37%), Gaps = 8/207 (3%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI-GNLLRLEKLALPNNSFS 138
R+ L RI + + L + L N I L LE+L L +N+
Sbjct: 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 139 GTIPTN-LSRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFV-GN 195
++ L L + L+ ++ + L LQ L + N L LPD +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
Query: 196 LSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFN 255
L L + GN + L +L L + N+ + P + ++ L +YL N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 256 RFSGTLPFDIVVNLPNLKSLAIGGNNF 282
S LP + + L L+ L + N +
Sbjct: 212 NLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 50/267 (18%), Positives = 84/267 (31%), Gaps = 65/267 (24%)
Query: 197 SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR 256
+A + + GN + + RNL L + N + +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA----------------RIDAAA 75
Query: 257 FSGTLPFDIVVNLPNLKSLAIGGNNFFGSIP-DSLSNASNVEILDLGFNQFKGKVSID-- 313
F+G L L+ L + N S+ + + L L + +
Sbjct: 76 FTG---------LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ---ELGPG 123
Query: 314 -FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLS 372
F L L +L L+ N L L TF + +L L L
Sbjct: 124 LFRGLAALQYLYLQDNAL-----QALPDDTF-RDLGNLTHLFL----------------- 160
Query: 373 SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNV 432
GN+I + R L +L L + N++ P +L L L+L+ N
Sbjct: 161 --------HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 433 LQGSIPSGV-GNLTKLAKLVMSYNSLQ 458
L ++P+ L L L ++ N
Sbjct: 213 LS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 37/192 (19%), Positives = 62/192 (32%), Gaps = 9/192 (4%)
Query: 436 SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTL 495
++P G+ ++ + N + +S C+NL N L + L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 496 SVYLDLSNNNLNGSLPLQI-GNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSF 554
LDLS+N S+ L L L + + P +L+YL + N+
Sbjct: 83 E-QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 555 HGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFS- 613
+ + L ++ L N +S L L+ L N + V F
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVH-PHAFRD 199
Query: 614 --SKTKLSLQGN 623
L L N
Sbjct: 200 LGRLMTLYLFAN 211
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 45/225 (20%), Positives = 78/225 (34%), Gaps = 22/225 (9%)
Query: 116 EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLK 174
+P I +++ L N S + C NL L + +N L +I A L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81
Query: 175 LQTLAVGKNYLTGRLPDFV-GNLSALEVFSITGNSLGGKIPT-TLGLLRNLVDLHVGGNQ 232
L+ L + N + L L + L ++ L L L++ N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNA 140
Query: 233 FS----GTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPD 288
TF ++ +L ++L NR S ++P L +L L + N P
Sbjct: 141 LQALPDDTFR----DLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 289 SLSNASNVEILDLGFNQFKGKVSID---FSSLKNLSWLNLEQNNL 330
+ + + L L N ++ + L+ L +L L N
Sbjct: 196 AFRDLGRLMTLYLFANNLS---ALPTEALAPLRALQYLRLNDNPW 237
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 59/227 (25%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---------KGAFKSFMAECKALRNI-RHR 762
+G+G V + I AVK+I++ + ++ + E LR + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 822
N+I++ + F LVF+ MK G L D+L E L+ + I +
Sbjct: 85 NIIQLKDTYET-----NTFFFLVFDLMKKGELFDYL------TEKVTLSEKETRKIMRAL 133
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
I LH +VH DLKP N+LLD DM + DFG + L +
Sbjct: 134 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR--------- 181
Query: 883 GIKGTVGYVAPEYCMGSEASMTG------DVYSFGILLLELFTGRRP 923
+ GT Y+APE S D++S G+++ L G P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-22
Identities = 63/270 (23%), Positives = 107/270 (39%), Gaps = 42/270 (15%)
Query: 673 ARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFAS----SNMIGQGSFGSVYKGILGE 728
A++ A+ + + A EF ++IG+G V + +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117
Query: 729 DEMIVAVKVINLKQ--------KGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGA 779
AVK++ + + ++ E LR + H ++I +I S +
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-----S 172
Query: 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVH 839
F LVF+ M+ G L D+L E L+ + +I + A+ +LH + +VH
Sbjct: 173 SFMFLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLLEAVSFLHANN---IVH 223
Query: 840 GDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS 899
DLKP N+LLD +M + DFG + L + + GT GY+APE S
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---------ELCGTPGYLAPEILKCS 274
Query: 900 EASMTG------DVYSFGILLLELFTGRRP 923
D+++ G++L L G P
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FKSFMAECK-ALRNIRHRNLIKIITI 770
+G+G++G V K I+AVK I K + + ++R + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70
Query: 771 CSSIDSKGADFK----ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
GA F+ + E M + SL+ + Q D + ++ + IA+ + A+
Sbjct: 71 -----FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKAL 122
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
E+LH ++H D+KPSNVL++ + DFG++ +L D +K + G
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV----DDVAKDIDA-----G 171
Query: 887 TVGYVAPE----YCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+APE S+ D++S GI ++EL R P
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IGQG+ G+VY + VA++ +NL+Q+ + + E +R ++ N++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL---- 83
Query: 773 SIDSKGADFKA----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ +V E + GSL D + + + Q + + A+E+
Sbjct: 84 -----DSYLVGDELWVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEF 131
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
LH + ++H D+K N+LL D + DFG ++ SK S+ + GT
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRST----MVGTP 180
Query: 889 GYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
++APE D++S GI+ +E+ G P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 37/222 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FKSFMAECKAL-RNIRHRNLIKIITI 770
+G G+ G V+K + ++AVK + K + + + ++ +++
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88
Query: 771 CSSIDSKGADFKA----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
G + E M E + + L + + + A+
Sbjct: 89 -----CFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG-----KMTVAIVKAL 137
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YL ++H D+KPSN+LLD + DFG++ L D +K S+ G
Sbjct: 138 YYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRSA-----G 186
Query: 887 TVGYVAPE-----YCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+APE + + DV+S GI L+EL TG+ P
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 43/238 (18%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G G+FG V G VAVK++N ++ E + L+ RH ++IK+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ I + F +V E + G L D++ + ++ ++ + + SA++Y
Sbjct: 79 V---ISTPTDFF--MVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYC 127
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL-AKFLSSHQLDTASKTSSSSIGIKGTV 888
H H +VH DLKP NVLLD M + + DFGL L T+ G+
Sbjct: 128 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----------GSP 174
Query: 889 GYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940
Y APE Y G E D++S G++L L G P D L F KI
Sbjct: 175 NYAAPEVISGRLYA-GPEV----DIWSCGVILYALLCGTLPFDDEHVPTL----FKKI 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 57/260 (21%), Positives = 99/260 (38%), Gaps = 47/260 (18%)
Query: 674 RRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIV 733
S + + P K++ +LSK ++G G G V +
Sbjct: 6 HHHSSGLEVLFQGPEPKKYAVTDDYQLSK--------QVLGLGVNGKVLECFHRRTGQKC 57
Query: 734 AVKVINLKQKGAFKSFMAECKAL-RNIRHRNLIKIITICSSIDSKGADFKALVFECMKNG 792
A+K++ A + E + +++ I+ + ++ ++ ECM+ G
Sbjct: 58 ALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGG 111
Query: 793 SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL--- 849
L + + D T + I D+ +AI++LH H + H D+KP N+L
Sbjct: 112 ELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSK 164
Query: 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPE------YCMGSEASM 903
+ D V + DFG AK + + L T T YVAPE Y
Sbjct: 165 EKDAVLKLTDFGFAKETTQNALQTPC----------YTPYYVAPEVLGPEKY--DKSC-- 210
Query: 904 TGDVYSFGILLLELFTGRRP 923
D++S G+++ L G P
Sbjct: 211 --DMWSLGVIMYILLCGFPP 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 53/243 (21%), Positives = 91/243 (37%), Gaps = 24/243 (9%)
Query: 383 NQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVG 442
I I P L N I + + + T+ +L + L + + +I GV
Sbjct: 7 TAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQ 60
Query: 443 NLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLS--VYLD 500
L L L + N + ++ + L N + S N L + +I L LD
Sbjct: 61 YLNNLIGLELKDNQIT-DL-APLKNLTKITELELSGNPLK-----NVSAIAGLQSIKTLD 113
Query: 501 LSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPH 560
L++ + PL L NL L + NQ + + P L+ +L+YL I + + P
Sbjct: 114 LTSTQITDVTPLA--GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP- 168
Query: 561 SLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSL 620
L L + L N +S L +L L ++ +N + P S+ ++L
Sbjct: 169 -LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLAN-TSNLFIVTL 224
Query: 621 QGN 623
Sbjct: 225 TNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 57/300 (19%), Positives = 112/300 (37%), Gaps = 35/300 (11%)
Query: 243 NISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLG 302
+++ +I + + T+ +L + +L+ G +I + +N+ L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGV-TTIE-GVQYLNNLIGLELK 71
Query: 303 FNQFKGKVSID-FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFV 361
NQ + +L ++ L L N L ++ + L + +K L L + Q
Sbjct: 72 DNQIT---DLAPLKNLTKITELELSGNPL-----KNVSAIAGLQS---IKTLDLTSTQI- 119
Query: 362 GELPHSIANLS--SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGE 419
+ L+ S++ + NQI I S + L NL L + + Q+ P +
Sbjct: 120 ----TDVTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LAN 171
Query: 420 LKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHN 479
L L L N + I S + +L L ++ + N + S L N NL ++
Sbjct: 172 LSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQ 227
Query: 480 KLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLS 539
+T Q + L V + + P I + ++ N S + V+ +
Sbjct: 228 TITN---QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYT 284
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 69/326 (21%), Positives = 127/326 (38%), Gaps = 43/326 (13%)
Query: 290 LSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSS 349
+N + G + V+ + L ++ L+ + ++ V +L N
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-----TTIEGVQYLNN--- 64
Query: 350 LKILSLAANQFVGELPHSIANLS--SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSN 407
L L L NQ +A L + + E + GN + + S I L ++ L + S
Sbjct: 65 LIGLELKDNQI-----TDLAPLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTST 117
Query: 408 QLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGN 467
Q+ P + L NLQ L+L N + +I S + LT L L + + ++ + L N
Sbjct: 118 QITDVTP--LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS-DL-TPLAN 171
Query: 468 CQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISS 527
L A NK++ P L S+ L + L NN ++ PL N NL + +++
Sbjct: 172 LSKLTTLKADDNKISDISP--LASLPNLI-EVHLKNNQISDVSPL--ANTSNLFIVTLTN 226
Query: 528 NQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLE 587
+ + V + S + + P ++ ++S NL+ + F+
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAP--IAPATISDN-----GTYASPNLTWNLTSFIN 279
Query: 588 NLSFLEFLNFSHNDLEGEVPTKGVFS 613
N+S+ F+ + T FS
Sbjct: 280 NVSY----TFNQSVTFKN--TTVPFS 299
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 18/219 (8%)
Query: 405 QSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSS 464
Q ++ PD L N + K+ + +L + L + I
Sbjct: 5 QPTAINVIFPD--PALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EG 58
Query: 465 LGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLI 524
+ NLIG N++T P L ++T ++ L+LS N L + L+++ L
Sbjct: 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKIT-ELELSGNPLKNVSAI--AGLQSIKTLD 113
Query: 525 ISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPE 584
++S Q + V P L+ +L+ L + N + P L L +++ L+ + +S
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD--LT 167
Query: 585 FLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGN 623
L NLS L L N + ++ + ++ L+ N
Sbjct: 168 PLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 66/396 (16%), Positives = 128/396 (32%), Gaps = 110/396 (27%)
Query: 143 TNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVF 202
+N I++ + + + L + TL+ +T
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT---------------- 54
Query: 203 SITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLP 262
+I G + L NL+ L + NQ I +++ L+
Sbjct: 55 TIEG----------VQYLNNLIGLELKDNQ--------ITDLAPLK-------------- 82
Query: 263 FDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSW 322
NL + L + GN +++ +++ LDL Q + L NL
Sbjct: 83 -----NLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQV 133
Query: 323 LNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGG 382
L L+ N + ++ L ++L+ LS+ Q +++L
Sbjct: 134 LYLDLNQITN--------ISPLAGLTNLQYLSIGNAQ--------VSDL----------- 166
Query: 383 NQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVG 442
+ + NL L L N++ I + L NL + L N + S S +
Sbjct: 167 --------TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQI--SDVSPLA 214
Query: 443 NLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLS 502
N + L + ++ ++ NL+ N ++ T+S +
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYN---NNLVVPNVVKG-----PSGAPIAPATISDNGTYA 266
Query: 503 NNNLNGSLPLQIGNL----KNLVKLIISSNQFSGVI 534
+ NL +L I N+ V ++ FSG +
Sbjct: 267 SPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSGTV 302
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 45/233 (19%), Positives = 90/233 (38%), Gaps = 21/233 (9%)
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158
L+ I ++ + Q +L + L+ + TI + +NLI L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLG 218
N++ P + +L K+ L + N L + L +++ +T + P L
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 219 LLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIG 278
L NL L++ NQ + + +++L+ + + + S P NL L +L
Sbjct: 127 GLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTPLA---NLSKLTTLKAD 181
Query: 279 GNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID-FSSLKNLSWLNLEQNNL 330
N I L++ N+ + L NQ + ++ NL + L +
Sbjct: 182 DNK-ISDIS-PLASLPNLIEVHLKNNQIS---DVSPLANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 53/244 (21%), Positives = 95/244 (38%), Gaps = 19/244 (7%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
L+L + +I + + NL+ + + LS N + I L ++ L L + +
Sbjct: 66 IGLELKDNQITDL--APLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD 121
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
T L+ SNL L + N++ I + L LQ L++G ++ + NLS L
Sbjct: 122 V--TPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD--LTPLANLSKL 175
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
N + I L L NL+++H+ NQ S + N S+L + L +
Sbjct: 176 TTLKADDNKI-SDIS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITN 231
Query: 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQ--FKGKVSIDFSSL 317
+ N + + G + P ++S+ +L +N F VS F+
Sbjct: 232 ---QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQS 288
Query: 318 KNLS 321
Sbjct: 289 VTFK 292
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 52/228 (22%), Positives = 84/228 (36%), Gaps = 48/228 (21%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA-ECKALRNIRHRNLIKIITIC 771
+G+G++G V + E VAVK++++K+ + E + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA-------- 823
+ L E G L D + + + A
Sbjct: 74 --RREGNIQY--LFLEYCSGGELFDRI--------------EPDIGMPEPDAQRFFHQLM 115
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+ + YLH + H D+KP N+LLD + DFGLA + +
Sbjct: 116 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---- 168
Query: 884 IKGTVGYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
GT+ YVAPE + DV+S GI+L + G P D
Sbjct: 169 --GTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWD 209
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFKSFMAECKALRNIRHRNLIKIITIC 771
+G G+FG V+ + +K IN + + + AE + L+++ H N+IKI +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+V E + G L + + + + L+ + + +A+ Y H
Sbjct: 90 ED-----YHNMYIVMETCEGGELLERIVSAQARGK--ALSEGYVAELMKQMMNALAYFHS 142
Query: 832 HCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
+VH DLKP N+L + DFGLA+ S + T GT
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST---------NAAGTA 190
Query: 889 GYVAPE---YCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+APE + + D++S G+++ L TG P
Sbjct: 191 LYMAPEVFKRDVTFKC----DIWSAGVVMYFLLTGCLP 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G+GSFG V AVKVI+ +KQK +S + E + L+ + H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ LV E G L D + EV +I++ V S I Y+
Sbjct: 94 FFED-----KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYM 142
Query: 830 HHHCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
H + +VH DLKP N+LL D + DFGL+ + + G
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---------DKIG 190
Query: 887 TVGYVAPE-----YCMGSEASMTGDVYSFGILLLELFTGRRP 923
T Y+APE Y + DV+S G++L L +G P
Sbjct: 191 TAYYIAPEVLHGTY--DEKC----DVWSTGVILYILLSGCPP 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 28/220 (12%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNL 764
+ + +G+G++ +VYKG + +VA+K I L+ + GA + + E L++++H N+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVC--KLTLIQRVNIAIDV 822
+ + I + S LVFE + L+ +L + + + KL L Q +
Sbjct: 63 VTLHDIIHTEKSL-----TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL------ 110
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
+ Y H ++H DLKP N+L++ + DFGLA+ S +KT + +
Sbjct: 111 -RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYDNEV 161
Query: 883 GIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
T+ Y P+ +GS T D++ G + E+ TGR
Sbjct: 162 ---VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-21
Identities = 45/222 (20%), Positives = 77/222 (34%), Gaps = 29/222 (13%)
Query: 713 IGQG--SFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKII 768
IG+G +V V V+ INL+ E + H N++
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY- 91
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQS-NDHLEVCKLTLIQRVNIAIDVASAIE 827
+ I + +V M GS +D + D + + I + V A++
Sbjct: 92 -RATFI--ADNEL-WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ-----GVLKALD 142
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQL-DTASKTSSSSIGIKG 886
Y+HH VH +K S++L+ D ++ S+ + + K
Sbjct: 143 YIHHMGY---VHRSVKASHILISVDGKVYLSGLR-----SNLSMISHGQRQRVVHDFPKY 194
Query: 887 TVG---YVAPE--YCMGSEASMTGDVYSFGILLLELFTGRRP 923
+V +++PE D+YS GI EL G P
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 61/221 (27%), Positives = 91/221 (41%), Gaps = 39/221 (17%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
+G+GSFG V K + AVKVIN + + E + L+ + H N++K+ I
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
+ +V E G L D + + E +I+ V S I Y+H
Sbjct: 90 LED-----SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITYMH 138
Query: 831 HHCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
H +VH DLKP N+LL + D + DFGL+ + GT
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---------DRIGT 186
Query: 888 VGYVAPE-----YCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+APE Y + DV+S G++L L +G P
Sbjct: 187 AYYIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP 221
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 46/226 (20%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G+FG VYK E + A KVI K + + ++ E + L H ++K++
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL---- 82
Query: 773 SIDSKGADFKA----LVFECMKNGSLEDWLHQSNDHLE------VCKLTLIQRVNIAIDV 822
GA + ++ E G+++ + + + L VC+ L
Sbjct: 83 -----GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---------- 127
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
A+ +LH ++H DLK NVL+ + + DFG++ T K S
Sbjct: 128 -EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL----KTLQKRDSFI- 178
Query: 883 GIKGTVGYVAPEYCMGSEASMTG-----DVYSFGILLLELFTGRRP 923
GT ++APE M T D++S GI L+E+ P
Sbjct: 179 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FKSFMAECK-ALRNIRHRNLIKIITI 770
IG+G++GSV K + I+AVK I K + + +R+ +++
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85
Query: 771 CSSIDSKGADFKA----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRV--NIAIDVAS 824
GA F+ + E M + S + + V + + + I +
Sbjct: 86 -----FYGALFREGDCWICMELM-STSFDKFYKYV---YSVLDDVIPEEILGKITLATVK 136
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
A+ +L + + ++H D+KPSN+LLD + DFG++ L D+ +KT +
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV----DSIAKTRDA---- 186
Query: 885 KGTVGYVAPEYCMGSEA----SMTGDVYSFGILLLELFTGRRP 923
G Y+APE S + + DV+S GI L EL TGR P
Sbjct: 187 -GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-21
Identities = 62/245 (25%), Positives = 100/245 (40%), Gaps = 47/245 (19%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN--------LKQKGAFKSFMAECKALRNIRHRNL 764
+G G+ G V + VA+++I+ ++ + E + L+ + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDV 822
IKI + D +V E M+ G L D + N L CKL Q +
Sbjct: 203 IKIKNFFDAED------YYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQ-------M 248
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
A++YLH + ++H DLKP NVLL + D + + DFG +K L L
Sbjct: 249 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR------ 299
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTG---DVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936
+ GT Y+APE + + D +S G++L +G P F+E T
Sbjct: 300 ---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEHRTQVS 352
Query: 937 -FAKI 940
+I
Sbjct: 353 LKDQI 357
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 55/231 (23%), Positives = 88/231 (38%), Gaps = 49/231 (21%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMA-----ECKALRNIRHRNL 764
+G G+FG V+ + E V VK I + + + E L + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGS-LEDWL--HQSNDHLEVCKLTLIQRVNIAID 821
IK++ I +++G LV E +G L ++ H D + Q
Sbjct: 92 IKVLDI---FENQGFFQ--LVMEKHGSGLDLFAFIDRHPRLDEPLASYI-FRQ------- 138
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSS-HQLDTASKTSSS 880
+ SA+ YL ++H D+K N+++ D + DFG A +L T
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC----- 190
Query: 881 SIGIKGTVGYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
GT+ Y APE Y G E +++S G+ L L P
Sbjct: 191 -----GTIEYCAPEVLMGNPYR-GPEL----EMWSLGVTLYTLVFEENPFC 231
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-21
Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 39/221 (17%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
+G G++G V + A+K+I + + E L+ + H N++K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
LV EC K G L D + EV +I+ V S + YLH
Sbjct: 105 FED-----KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------QVLSGVTYLH 153
Query: 831 HHCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
H +VH DLKP N+LL + D + + DFGL+ + + GT
Sbjct: 154 KHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---------ERLGT 201
Query: 888 VGYVAPE-----YCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+APE Y + DV+S G++L L G P
Sbjct: 202 AYYIAPEVLRKKY--DEKC----DVWSIGVILFILLAGYPP 236
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 47/245 (19%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN--------LKQKGAFKSFMAECKALRNIRHRNL 764
+G G+ G V + VA+K+I+ ++ + E + L+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDV 822
IKI D++ +V E M+ G L D + N L CKL Q +
Sbjct: 78 IKIKNF---FDAE---DYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQ-------M 123
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
A++YLH + ++H DLKP NVLL + D + + DFG +K L L +T
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 177
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTG---DVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936
GT Y+APE + + D +S G++L +G P F+E T
Sbjct: 178 ------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEHRTQVS 227
Query: 937 -FAKI 940
+I
Sbjct: 228 LKDQI 232
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKII 768
IG+G++G+V+K E IVA+K + L G S + E L+ ++H+N++++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVC--KLTLIQRVNIAIDVASAI 826
+ S LVFE L+ + N L+ K L Q + +
Sbjct: 68 DVLHSDKKL-----TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ-------LLKGL 114
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
+ H ++H DLKP N+L++ + + +FGLA+ + S+ +
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----VRCYSAEV---V 163
Query: 887 TVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGRRP 923
T+ Y P+ G++ T D++S G + EL RP
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 53/219 (24%), Positives = 81/219 (36%), Gaps = 37/219 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG+GS+G V + + A K I F E + ++++ H N+I++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
LV E G L + + E +++ DV SA+ Y H
Sbjct: 77 D-----NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCHKL 125
Query: 833 CQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
+ H DLKP N L D + DFGLA ++ GT
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR---------TKVGTPY 173
Query: 890 YVAPE-----YCMGSEASMTGDVYSFGILLLELFTGRRP 923
YV+P+ Y G E D +S G+++ L G P
Sbjct: 174 YVSPQVLEGLY--GPEC----DEWSAGVMMYVLLCGYPP 206
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 26/222 (11%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS-FMAECKALRNIR-HRNLIKIIT 769
++G+G+ V I AVK+I KQ G +S E + L + HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
D LVFE M+ GS+ +H+ E+ ++Q DVASA+++L
Sbjct: 79 FFEE-----EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASALDFL 127
Query: 830 HHHCQPPMVHGDLKPSNVLLDH-DMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
H+ + H DLKP N+L +H + VS V DF L + + + T G
Sbjct: 128 HNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-G 183
Query: 887 TVGYVAPEYCMGSEASMTG-----DVYSFGILLLELFTGRRP 923
+ Y+APE + D++S G++L L +G P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 52/228 (22%), Positives = 84/228 (36%), Gaps = 48/228 (21%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA-ECKALRNIRHRNLIKIITIC 771
+G+G++G V + E VAVK++++K+ + E + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA-------- 823
+ L E G L D + + + A
Sbjct: 74 --RREGNIQY--LFLEYCSGGELFDRI--------------EPDIGMPEPDAQRFFHQLM 115
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+ + YLH + H D+KP N+LLD + DFGLA + +
Sbjct: 116 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---- 168
Query: 884 IKGTVGYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
GT+ YVAPE + DV+S GI+L + G P D
Sbjct: 169 --GTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWD 209
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-21
Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 52/262 (19%)
Query: 678 SARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKV 737
+ D S T + + +IG GSFG VY+ L + +VA+K
Sbjct: 27 KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK 86
Query: 738 INLKQKGAFKSFMAECKALRNIRHRNLIKII-TICSSIDSKGADFKALVFECMKNGSLED 796
+ ++ FK+ E + +R + H N++++ SS + K + LV + + E
Sbjct: 87 VLQDKR--FKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ET 138
Query: 797 WLHQSNDH---------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNV 847
+++ H + KL + Q + ++ Y+H + H D+KP N+
Sbjct: 139 -VYRVARHYSRAKQTLPVIYVKLYMYQ-------LFRSLAYIHSFG---ICHRDIKPQNL 187
Query: 848 LLDHDMVS-HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV------APEYCMGS- 899
LLD D + DFG AK L + + + Y+ APE G+
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVS---------------YICSRYYRAPELIFGAT 232
Query: 900 EASMTGDVYSFGILLLELFTGR 921
+ + + DV+S G +L EL G+
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQ 254
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-21
Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 39/223 (17%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKII 768
M+G+GSFG V K + AVKVIN + + E + L+ + H N++K+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
I + +V E G L D + + E +I+ V S I Y
Sbjct: 88 EILED-----SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITY 136
Query: 829 LHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+H H +VH DLKP N+LL + D + DFGL+ +
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---------DRI 184
Query: 886 GTVGYVAPE-----YCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE Y + DV+S G++L L +G P
Sbjct: 185 GTAYYIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 65/253 (25%), Positives = 105/253 (41%), Gaps = 40/253 (15%)
Query: 675 RRRSARKSVDTSPREKQFPTVS-YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIV 733
VD F ++ Y L +G+GS+G V K + IV
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMEKYENLGL----------VGEGSYGMVMKCRNKDTGRIV 53
Query: 734 AVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKN 791
A+K K K M E K L+ +RH NL+ ++ +C K + LVFE + +
Sbjct: 54 AIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK---KKRWY--LVFEFVDH 108
Query: 792 GSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
++ D L + L +V + L Q + + I + H H ++H D+KP N+L+
Sbjct: 109 -TILDDLELFPNGLDYQVVQKYLFQ-------IINGIGFCHSHN---IIHRDIKPENILV 157
Query: 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVY 908
V + DFG A+ L++ + + T Y APE +G DV+
Sbjct: 158 SQSGVVKLCDFGFARTLAAP-----GEVYDDEV---ATRWYRAPELLVGDVKYGKAVDVW 209
Query: 909 SFGILLLELFTGR 921
+ G L+ E+F G
Sbjct: 210 AIGCLVTEMFMGE 222
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITIC 771
IG+GSFG V+KGI + +VA+K+I+L++ + + E L + K
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK----- 84
Query: 772 SSIDSKGADFKA----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVAS 824
G+ K ++ E + GS D L + + IA ++
Sbjct: 85 ----YYGSYLKDTKLWIIMEYLGGGSALDLL----------EPGPLDETQIATILREILK 130
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
++YLH +H D+K +NVLL + DFG+A L+ DT K ++
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNT----F 179
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT ++APE S D++S GI +EL G P
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIIT 769
+G G++ +VYKG+ + VA+K + L + G + + E ++ ++H N++++
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ + + LVFE M + L+ ++ L L + + +
Sbjct: 71 VIHTENKL-----TLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H + ++H DLKP N+L++ +GDFGLA+ T SS + T+
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-----VNTFSSEV---VTLW 173
Query: 890 YVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
Y AP+ MGS T D++S G +L E+ TG+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 61/252 (24%), Positives = 108/252 (42%), Gaps = 49/252 (19%)
Query: 688 REKQFPTVSYAELSKATSE------FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK 741
+ + P +L + + F +G+GS+GSVYK I E IVA+K + ++
Sbjct: 6 QLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE 65
Query: 742 QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA----LVFECMKNGSLEDW 797
+ + E ++ +++K G+ FK +V E GS+ D
Sbjct: 66 SD--LQEIIKEISIMQQCDSPHVVKYY---------GSYFKNTDLWIVMEYCGAGSVSDI 114
Query: 798 LHQSNDHLE------VCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 851
+ N L + + TL +EYLH +H D+K N+LL+
Sbjct: 115 IRLRNKTLTEDEIATILQSTL-----------KGLEYLHFM---RKIHRDIKAGNILLNT 160
Query: 852 DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFG 911
+ + + DFG+A L+ DT +K ++ + GT ++APE + D++S G
Sbjct: 161 EGHAKLADFGVAGQLT----DTMAKRNT----VIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 912 ILLLELFTGRRP 923
I +E+ G+ P
Sbjct: 213 ITAIEMAEGKPP 224
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 53/234 (22%), Positives = 89/234 (38%), Gaps = 51/234 (21%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA-------ECKALRNIR---- 760
++G+G FG+V+ G D + VA+KVI + + S ++ E L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 761 HRNLIKIITICSSIDSKGADFKALVFE-CMKNGSLEDWLHQSNDHL--EVCKLTLIQRVN 817
H +I+++ +++ LV E + L D++ L + Q
Sbjct: 97 HPGVIRLLDW---FETQEGFM--LVLERPLPAQDLFDYI-TEKGPLGEGPSRCFFGQ--- 147
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS-HVGDFGLAKFLSSHQLDTASK 876
V +AI++ H +VH D+K N+L+D + DFG L
Sbjct: 148 ----VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 877 TSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTD 925
GT Y PE+ A V+S GILL ++ G P +
Sbjct: 200 ---------GTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVCGDIPFE 240
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 49/244 (20%), Positives = 83/244 (34%), Gaps = 21/244 (8%)
Query: 103 LRYINLSDNSFHGEIPQEIGNLL---RLEKLALPNNSFSGTIPTNLSRCS--NLIQLRVS 157
L+ + + I +L L++L L N +GT P L + +L L +
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 158 NNKLEG--QIPAEIGSLLK--LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKI 213
N AE+ LK L+ L++ + + + V AL ++ N G+
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 214 -------PTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIV 266
P L+ L + G SG L+ + L N
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 267 VNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLE 326
L SL + +P L + + +LDL +N+ S D L + L+L+
Sbjct: 250 DWPSQLNSLNLSFTG-LKQVPKGLP--AKLSVLDLSYNRLDRNPSPDE--LPQVGNLSLK 304
Query: 327 QNNL 330
N
Sbjct: 305 GNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 5e-20
Identities = 48/300 (16%), Positives = 84/300 (28%), Gaps = 29/300 (9%)
Query: 281 NFFGSIPDSLS-----NASNVEILDLGFNQFKGKVSID-----FSSLKNLSWLNLEQNNL 330
NF PD S A++VE+ G + +D + L+L++ +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 331 GMGTANDLDFVTFL--TNCSSLKILSLAANQFVGELPHSIANLS-SSMIEFRIGGNQI-- 385
L S L+ L+L + G P + + + +
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 386 FGIIPSGIRNLV--NLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIP----S 439
+ ++ + L L + + + L L L N G
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
Query: 440 GVGNLTKLAKLVMSYN---SLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLS 496
L L + + G + L G + SHN L A +
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 497 VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHG 556
L+LS L +P + L L +S N+ + L + N F
Sbjct: 256 NSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 52/216 (24%), Positives = 77/216 (35%), Gaps = 19/216 (8%)
Query: 422 NLQGLFLYKNVLQGSIPSGVGNLT--KLAKLVMSYNSLQG--NIPSSLGNC--QNLIGFN 475
LQ L L + G+ P + T L L + S + L L +
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 476 ASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI----GNLKNLVKLIISSNQF- 530
+ +Q+ LS LDLS+N G L L L + +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALS-TLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 531 --SGVIPVTLSTCVSLEYLDISSNSFHGVIPHSL-GFLKSIKVLNFSSNNLSGQIPEFLE 587
SGV + V L+ LD+S NS + + LN S L Q+P+ L
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL- 272
Query: 588 NLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGN 623
+ L L+ S+N L+ P+ LSL+GN
Sbjct: 273 -PAKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGN 306
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 38/220 (17%), Positives = 68/220 (30%), Gaps = 17/220 (7%)
Query: 415 DVIGELKNLQGLFLYKNVLQGSIP-SGVGNLTKLAKLVMSYNSLQGNIPSS---LGNCQN 470
++ G ++L+ L + + + L +L + + I +
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 471 LIGFNASHNKLTGALPQQLLSITTLSV-YLDLSNNNLNGSLP----LQIGNLKNLVKLII 525
L + ++TG P LL T + L+L N + LQ L L I
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 526 SSNQFSGVIPVTLSTCVSLEYLDISSNSF-------HGVIPHSLGFLKSIKVLNFSSNNL 578
+ + +L LD+S N + P L+ + + N
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 579 SGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKL 618
SG L+ L+ SHN L ++L
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRD-AAGAPSCDWPSQL 255
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 42/247 (17%), Positives = 72/247 (29%), Gaps = 37/247 (14%)
Query: 75 RHQRVTRLDLSNQRIGGILSPY---VGNLSFLRYINLSDNSFHGEIPQEIGNL--LRLEK 129
+ + RL + RI + V +S L+ + L + G P + L
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 130 LALPNNSFSG--TIPTNLSRCS--NLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYL 185
L L N S++ L + L L ++ ++ L TL + N
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 186 TGRLP----DFVGNLSALEVFSITGN---SLGGKIPTTLGLLRNLVDLHVGGNQFSGTFP 238
G L+V ++ + G L L + N
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 239 QSICNI-SSLERIYLPFNRFSGTLPFDIVVNL-------------------PNLKSLAIG 278
C+ S L + L F +P + L P + +L++
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLK 304
Query: 279 GNNFFGS 285
GN F S
Sbjct: 305 GNPFLDS 311
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 45/213 (21%), Positives = 81/213 (38%), Gaps = 24/213 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G+FG V++ + + K IN + E + + H LI +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
L+ E + G L D + + K++ + +N ++++H H
Sbjct: 119 D-----KYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 168
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+VH D+KP N++ + S V DFGLA L+ ++ T +
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---------TTATAEF 216
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
APE D+++ G+L L +G P
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 54/233 (23%), Positives = 86/233 (36%), Gaps = 61/233 (26%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKV------INLKQKGAFKSFMAECKALRNIRHRNLIK 766
+G+GSF +V A+K+ I + E + + H +K
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENK---VPYVTRERDVMSRLDHPFFVK 94
Query: 767 IITICSSIDSKGADFKA-----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI--- 818
+ F+ KNG L L I+++
Sbjct: 95 L---------YFT-FQDDEKLYFGLSYAKNGEL---------------LKYIRKIGSFDE 129
Query: 819 ------AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQ 870
++ SA+EYLH ++H DLKP N+LL+ DM H+ DFG AK LS
Sbjct: 130 TCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPES 184
Query: 871 LDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ + GT YV+PE A + D+++ G ++ +L G P
Sbjct: 185 KQARANS------FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
+G+G+F V + + + A K+IN K+ F+ E + R ++H N++++
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
F LVF+ + G L + + + E IQ + +I Y H
Sbjct: 74 IQE-----ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QILESIAYCH 122
Query: 831 HHCQPPMVHGDLKPSNVLL-DHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+ +VH +LKP N+LL + V DFGLA ++ + G GT
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---------GFAGT 170
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GY++PE S D+++ G++L L G P
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 57/252 (22%), Positives = 101/252 (40%), Gaps = 29/252 (11%)
Query: 682 SVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK 741
S+ + + + + L F ++G G++G VYKG + + A+KV+++
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 742 QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKA-LVFECMKNGSLEDWLH 799
+ E L+ HRN+ + G D + LV E GS+ D +
Sbjct: 61 GD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 800 QSNDHLEVCKLTLIQRVNIAI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856
+ + L IA ++ + +LH H ++H D+K NVLL +
Sbjct: 120 NTKGN----TLKEEW---IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169
Query: 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG-----DVYSFG 911
+ DFG++ L T + ++ GT ++APE E D++S G
Sbjct: 170 LVDFGVSAQLD----RTVGRRNT----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221
Query: 912 ILLLELFTGRRP 923
I +E+ G P
Sbjct: 222 ITAIEMAEGAPP 233
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-20
Identities = 57/232 (24%), Positives = 88/232 (37%), Gaps = 50/232 (21%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ-------------KGAFKSFMAECKALRNI 759
+G G++G V A+KVI Q + + E L+++
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 760 RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
H N+IK+ + + LV E + G L + + + E NI
Sbjct: 104 DHPNIIKLFDVFED-----KKYFYLVTEFYEGGELFEQIINRHKFDEC------DAANIM 152
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASK 876
+ S I YLH H +VH D+KP N+LL + + + DFGL+ F S
Sbjct: 153 KQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR--- 206
Query: 877 TSSSSIGIKGTVGYVAPE-----YCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE Y + DV+S G+++ L G P
Sbjct: 207 ------DRLGTAYYIAPEVLKKKY--NEKC----DVWSCGVIMYILLCGYPP 246
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 49/231 (21%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA-------ECKALRNIRHR--N 763
+G G FGSVY GI D + VA+K + K + + + E L+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 764 LIKIITICSSIDSKGADFKALVFE-CMKNGSLEDWLHQSNDHL--EVCKLTLIQRVNIAI 820
+I+++ + + L+ E L D++ L E+ + Q
Sbjct: 110 VIRLLDW---FERPDSFV--LILERPEPVQDLFDFI-TERGALQEELARSFFWQ------ 157
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVSHVGDFGLAKFLSSHQLDTASKTSS 879
V A+ + H+ ++H D+K N+L+D + + DFG L
Sbjct: 158 -VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---- 209
Query: 880 SSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTD 925
GT Y PE+ G A V+S GILL ++ G P +
Sbjct: 210 ------GTRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVCGDIPFE 250
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 6e-20
Identities = 44/213 (20%), Positives = 81/213 (38%), Gaps = 24/213 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G+FG V++ A K + + ++ E + + +RH L+ +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
+ +++E M G L + + ++ ++ + V V + ++H +
Sbjct: 225 D-----DNEMVMIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHEN 274
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
VH DLKP N++ + + DFGL L Q GT +
Sbjct: 275 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---------TTGTAEF 322
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
APE G D++S G+L L +G P
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 56/257 (21%), Positives = 96/257 (37%), Gaps = 48/257 (18%)
Query: 684 DTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK 743
S + K F M GQG+FG+V G M VA+K + +
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 744 GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD--FKALVFECMKNGSLEDWLHQS 801
+ + L + H N++++ + ++ + + +V E + D LH+
Sbjct: 62 FRNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRC 115
Query: 802 NDH---------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-H 851
+ + K+ L Q + +I LH + H D+KP NVL++
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQ-------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEA 167
Query: 852 DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV------APEYCMGSEASMTG 905
D + DFG AK LS + + A Y+ APE G++ T
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPNVA---------------YICSRYYRAPELIFGNQHYTTA 212
Query: 906 -DVYSFGILLLELFTGR 921
D++S G + E+ G
Sbjct: 213 VDIWSVGCIFAEMMLGE 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKII 768
+G+G++G VYK + IVA+K I L + G + + E L+ + H N++ +I
Sbjct: 27 EKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVC--KLTLIQRVNIAIDVASAI 826
+ S LVFE M+ L+ L ++ L+ K+ L Q + +
Sbjct: 86 DVIHSERCL-----TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ-------LLRGV 132
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
+ H H ++H DLKP N+L++ D + DFGLA+ ++ + +
Sbjct: 133 AHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-----VRSYTHEV---V 181
Query: 887 TVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
T+ Y AP+ MGS+ T D++S G + E+ TG+
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 7e-20
Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 32/231 (13%)
Query: 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS---FMA--EC 753
++ + + +G+G F +VYK IVA+K I L + K A E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 754 KALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLE--VCKLT 811
K L+ + H N+I ++ + +LVF+ M+ LE + ++ L K
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNI-----SLVFDFMET-DLEVIIKDNSLVLTPSHIKAY 117
Query: 812 LIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQL 871
++ +EYLH H ++H DLKP+N+LLD + V + DFGLAK S
Sbjct: 118 MLM-------TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-- 165
Query: 872 DTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
++ + + T Y APE G+ G D+++ G +L EL
Sbjct: 166 ---NRAYTHQV---VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-20
Identities = 48/247 (19%), Positives = 94/247 (38%), Gaps = 37/247 (14%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR--------HRN 763
+G G F +V+ + VA+K++ + ++ E K L+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 764 LIKIITICSSIDSKGADFK--ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821
I+ + + KG + +VFE + +L + + L +++ I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHR--GIPLIYVKQ--ISKQ 139
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH------VGDFGLAKFLSSHQLDTAS 875
+ ++Y+H C ++H D+KP NVL++ + D G A + H ++
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRR--PTDAAFTEGLT 933
T Y +PE +G+ D++S L+ EL TG D +
Sbjct: 198 -----------TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 934 LHEFAKI 940
A+I
Sbjct: 247 DDHIAQI 253
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-20
Identities = 55/248 (22%), Positives = 99/248 (39%), Gaps = 28/248 (11%)
Query: 681 KSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL 740
S+ + + +K + + +G+G+F V + + + A K+IN
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 741 KQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWL 798
K+ F+ E + R ++H N++++ F LVF+ + G L + +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESFHYLVFDLVTGGELFEDI 119
Query: 799 HQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVS 855
+ E IQ + +I Y H + +VH +LKP N+LL
Sbjct: 120 VAREFYSEADASHCIQ------QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAV 170
Query: 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLL 915
+ DFGLA ++ + G GT GY++PE S D+++ G++L
Sbjct: 171 KLADFGLAIEVNDSEAWH---------GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 221
Query: 916 ELFTGRRP 923
L G P
Sbjct: 222 ILLVGYPP 229
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 8e-20
Identities = 57/244 (23%), Positives = 97/244 (39%), Gaps = 29/244 (11%)
Query: 686 SPREKQFPTVSYAELSKATSE-FASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LK 741
S +F + E T F ++G+G FG V + + A K + +K
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223
Query: 742 QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS 801
++ + E + L + R ++++ + ++K A LV M G L+ ++
Sbjct: 224 KRKGEAMALNEKQILEKVNSRF---VVSLAYAYETKDALC--LVLTLMNGGDLKFHIYHM 278
Query: 802 NDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GD 859
+ V A ++ +E LH +V+ DLKP N+LLD H+ D
Sbjct: 279 GQA----GFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISD 329
Query: 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
GLA + GTVGY+APE + + D ++ G LL E+
Sbjct: 330 LGLAV-----HVPEGQTIKGRV----GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 920 GRRP 923
G+ P
Sbjct: 381 GQSP 384
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 70/240 (29%), Positives = 101/240 (42%), Gaps = 47/240 (19%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G G+FG V G VAVK++N ++ E + L+ RH ++IK+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWL--HQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ I + F +V E + G L D++ + D E +L Q + S ++
Sbjct: 84 V---ISTPSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRL-FQQIL-------SGVD 130
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL-AKFLSSHQLDTASKTSSSSIGIKG 886
Y H H +VH DLKP NVLLD M + + DFGL L T+ G
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----------G 177
Query: 887 TVGYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940
+ Y APE Y G E D++S G++L L G P D L F KI
Sbjct: 178 SPNYAAPEVISGRLYA-GPEV----DIWSSGVILYALLCGTLPFDDDHVPTL----FKKI 228
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFKSFMAECKALRNIRHRNLIKI 767
IG+G F V + I E AVK++++ + + + E ++H +++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ SS +VFE M L + + D + + + A+
Sbjct: 92 LETYSS-----DGMLYMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALR 144
Query: 828 YLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
Y H + ++H D+KP VLL ++ +G FG+A L ++ + G
Sbjct: 145 YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--------GESGLVAGGR 193
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT ++APE DV+ G++L L +G P
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-19
Identities = 51/317 (16%), Positives = 108/317 (34%), Gaps = 59/317 (18%)
Query: 290 LSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSS 349
+ +L V+ + L ++ + +++ + + +L N
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDI-----KSVQGIQYLPN--- 66
Query: 350 LKILSLAANQFVGELPHSIANLSS--SMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSN 407
+ L L N+ I L++ ++ + N+I + S +++L L +L ++ N
Sbjct: 67 VTKLFLNGNKL-----TDIKPLTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHN 119
Query: 408 QLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGN 467
+ + + + L L+ L+L N + + + + LTKL L + N + +I L
Sbjct: 120 GI--SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI-VPLAG 173
Query: 468 CQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISS 527
L S N ++ DL + LKNL L + S
Sbjct: 174 LTKLQNLYLSKNHIS-----------------DLRA----------LAGLKNLDVLELFS 206
Query: 528 NQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLE 587
+ S V + + S S ++ N+ +PEF
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS-------DDGDYEKPNVKWHLPEFTN 259
Query: 588 NLSFLEFLNFSHNDLEG 604
+SF+ + + +
Sbjct: 260 EVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 46/236 (19%), Positives = 95/236 (40%), Gaps = 25/236 (10%)
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158
+ NL S + Q L ++++ N+ ++ + N+ +L ++
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVG--NLSALEVFSITGNSLGGKIPTT 216
NKL I + +L L L + +N + D +L L+ S+ N +
Sbjct: 75 NKLT-DIKP-LTNLKNLGWLFLDENKIK----DLSSLKDLKKLKSLSLEHNGI--SDING 126
Query: 217 LGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLA 276
L L L L++G N+ + + ++ L+ + L N+ S +P L L++L
Sbjct: 127 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLY 181
Query: 277 IGGNNFFGSIPD--SLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330
+ N+ I D +L+ N+++L+L + K S+L + + +L
Sbjct: 182 LSKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 5e-16
Identities = 50/293 (17%), Positives = 88/293 (30%), Gaps = 44/293 (15%)
Query: 195 NLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNIS---SLERIY 251
+ ++ S+ T L ++ + + S+ I ++ +++
Sbjct: 19 AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-----SVQGIQYLPNVTKLF 71
Query: 252 LPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPD--SLSNASNVEILDLGFNQFKGK 309
L N+ + P NL NL L + N I D SL + ++ L L N
Sbjct: 72 LNGNKLTDIKPLT---NLKNLGWLFLDENK----IKDLSSLKDLKKLKSLSLEHNGIS-- 122
Query: 310 VSID-FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSI 368
I+ L L L L N + +T L+ + L LSL NQ I
Sbjct: 123 -DINGLVHLPQLESLYLGNNKI--------TDITVLSRLTKLDTLSLEDNQI-----SDI 168
Query: 369 ANLSS--SMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGL 426
L+ + + N I + + L NL L + S + + L +
Sbjct: 169 VPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
Query: 427 FLYKNVLQG----SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFN 475
L S L N + + + F+
Sbjct: 227 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFH 279
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 2e-13
Identities = 41/196 (20%), Positives = 67/196 (34%), Gaps = 30/196 (15%)
Query: 447 LAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQ-QLLSITTLSVY------- 498
+ + + ++ I I N +T A+ Q +L SI +
Sbjct: 1 MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV 58
Query: 499 -----------LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYL 547
L L+ N L PL NLKNL L + N+ + L L+ L
Sbjct: 59 QGIQYLPNVTKLFLNGNKLTDIKPL--TNLKNLGWLFLDENKIKDLSS--LKDLKKLKSL 114
Query: 548 DISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVP 607
+ N + L L ++ L +N ++ L L+ L+ L+ N + VP
Sbjct: 115 SLEHNGISDING--LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP 170
Query: 608 TKGVFSSKTKLSLQGN 623
G + L L N
Sbjct: 171 LAG-LTKLQNLYLSKN 185
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 44/214 (20%), Positives = 82/214 (38%), Gaps = 27/214 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G+G FG V++ + + K + + E L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASAIEYLHH 831
S + ++FE + + + ++ S L E ++ + V A+++LH
Sbjct: 72 S-----MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH------QVCEALQFLHS 120
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H + H D++P N++ S + +FG A+ L +
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---------LFTAPE 168
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y APE S D++S G L+ L +G P
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 24/220 (10%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLI 765
+ + ++G G FG V+K + +A K+I + + E + + H NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
++ + +SK + LV E + G L D + + LT + + +
Sbjct: 150 QLY---DAFESK--NDIVLVMEYVDGGELFDRIIDES-----YNLTELDTILFMKQICEG 199
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIG 883
I ++H ++H DLKP N+L + + DFGLA+ +
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--------- 247
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT ++APE S D++S G++ L +G P
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-19
Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 29/217 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA---ECKALRNIRHRNLIKIIT 769
+G+G+F V + + A +IN +K + + E + R ++H N++++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIIN-TKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
S L+F+ + G L + + + + + + A+ +
Sbjct: 78 SISE-----EGHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHC 126
Query: 830 HHHCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
H +VH +LKP N+LL + DFGLA + Q G G
Sbjct: 127 HQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--------GFAG 175
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T GY++PE D+++ G++L L G P
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 711 NMIGQGSFGSVYKGI--LGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIK 766
IG+G++G VYK GE A+K I L+++ G + + E L+ ++H N++K
Sbjct: 8 EKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLE--VCKLTLIQRVNIAIDVAS 824
+ + + LVFE + L+ L LE K L+Q + +
Sbjct: 65 LYDVIHTKKRL-----VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ-------LLN 111
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
I Y H ++H DLKP N+L++ + + DFGLA+ + + I
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-----VRKYTHEI-- 161
Query: 885 KGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
T+ Y AP+ MGS+ T D++S G + E+ G
Sbjct: 162 -VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-19
Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 26/244 (10%)
Query: 686 SPREKQFPTVSYAELSKATSE-FASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LK 741
S +F + E + F ++G+G FG V+ + + A K +N LK
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 742 QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQS 801
++ ++ M E K L + R I+++ + ++K LV M G + H
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRF---IVSLAYAFETKTDLC--LVMTIMNGGDI--RYHIY 277
Query: 802 NDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GD 859
N + + + + S +E+LH +++ DLKP NVLLD D +V D
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISD 332
Query: 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919
GLA +KT + GT G++APE +G E + D ++ G+ L E+
Sbjct: 333 LGLAV----ELKAGQTKTKGYA----GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
Query: 920 GRRP 923
R P
Sbjct: 385 ARGP 388
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-19
Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 53/227 (23%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKII-TIC 771
IG GSFG V++ L E + VA+K + ++ FK+ E + +R ++H N++ +
Sbjct: 48 IGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--FKN--RELQIMRIVKHPNVVDLKAFFY 102
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDH---------LEVCKLTLIQRVNIAIDV 822
S+ D K F LV E + E +++++ H + + KL + Q +
Sbjct: 103 SNGDKKDEVFLNLVLEYVP----ET-VYRASRHYAKLKQTMPMLLIKLYMYQ-------L 150
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS-HVGDFGLAKFLSSHQLDTASKTSSSS 881
++ Y+H + H D+KP N+LLD + DFG AK L + + + +
Sbjct: 151 LRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS------- 200
Query: 882 IGIKGTVGYV------APEYCMGS-EASMTGDVYSFGILLLELFTGR 921
Y+ APE G+ + D++S G ++ EL G+
Sbjct: 201 --------YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 51/233 (21%)
Query: 699 ELSKATSEFAS----SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECK 754
+L + + +F IG GS+ + I M AVK+I+ ++ + E +
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIE 67
Query: 755 AL-RNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLI 813
L R +H N+I + + + +V E MK G L D + + +
Sbjct: 68 ILLRYGQHPNIITLKDVYDD-----GKYVYVVTELMKGGELLDKILRQK------FFSER 116
Query: 814 QRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVSHVGDFGLAKFLSSH 869
+ + + +EYLH +VH DLKPSN+L + + DFG AK L +
Sbjct: 117 EASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 870 Q--LDTASKTSSSSIGIKGTVGYVAPE------YCMGSEASMTGDVYSFGILL 914
L T T +VAPE Y + D++S G+LL
Sbjct: 174 NGLLMTPC----------YTANFVAPEVLERQGY--DAAC----DIWSLGVLL 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
IG+GS+G V+K + IVA+K + K + E + L+ ++H NL+ ++ +
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVASAIEY 828
K LVFE + ++ L + + + K Q A+ +
Sbjct: 71 ---FRRKRRLH--LVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ-------TLQAVNF 117
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
H H +H D+KP N+L+ V + DFG A+ L+ S + T
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG-----PSDYYDDEV---ATR 166
Query: 889 GYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
Y +PE +G DV++ G + EL +G
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 69/238 (28%), Positives = 103/238 (43%), Gaps = 44/238 (18%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G+GSFG V + + VA+K I+ LK+ E L+ +RH ++IK+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ I + +V E G L D++ + ++T + + AIEY
Sbjct: 77 V---ITTPTDIV--MVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYC 124
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL-AKFLSSHQLDTASKTSSSSIGIKGTV 888
H H +VH DLKP N+LLD ++ + DFGL + L T+ G+
Sbjct: 125 HRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----------GSP 171
Query: 889 GYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940
Y APE Y G E DV+S GI+L + GR P D F L F K+
Sbjct: 172 NYAAPEVINGKLYA-GPEV----DVWSCGIVLYVMLVGRLPFDDEFIPNL----FKKV 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 56/255 (21%), Positives = 101/255 (39%), Gaps = 36/255 (14%)
Query: 676 RRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAV 735
++ P + + + +G+G++G VYK I VA+
Sbjct: 8 HMGTLEAQTQGPGSMSVSAAPS---ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAI 64
Query: 736 KVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGS 793
K I L+ + G + + E L+ ++HRN+I++ ++ L+FE +N
Sbjct: 65 KRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR-----LHLIFEYAEN-D 118
Query: 794 LEDWLHQSND-HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 852
L+ ++ ++ D + V K L Q + + + + H +H DLKP N+LL
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQ-------LINGVNFCHSRR---CLHRDLKPQNLLLSVS 168
Query: 853 MVSHVG-----DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG-D 906
S DFGLA+ + + I T+ Y PE +GS T D
Sbjct: 169 DASETPVLKIGDFGLARAFGIP-----IRQFTHEI---ITLWYRPPEILLGSRHYSTSVD 220
Query: 907 VYSFGILLLELFTGR 921
++S + E+
Sbjct: 221 IWSIACIWAEMLMKT 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 31/232 (13%)
Query: 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFKSF----MAECKA 755
S ATS + IG G++G+VYK VA+K + + G + E
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 756 LRNIR---HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSND---HLEVCK 809
LR + H N+++++ +C++ + LVFE + L +L ++ E K
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 810 LTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869
+ Q +++LH +C +VH DLKP N+L+ + DFGLA+ S
Sbjct: 124 DLMRQ-------FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 870 QLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR 921
+ + T+ Y APE + S + D++S G + E+F +
Sbjct: 174 M-----ALTPVVV----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITIC 771
+G+GSF K + + AVK+I+ K + E AL+ H N++K+ +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
LV E + G L + + + E +++ + SA+ ++H
Sbjct: 76 HD-----QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR------KLVSAVSHMHD 124
Query: 832 HCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQ--LDTASKTSSSSIGIKG 886
+VH DLKP N+L + ++ + DFG A+ L T
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC----------F 171
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T+ Y APE + + D++S G++L + +G+ P
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 37/221 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG G+FG + +VAVK I + ++ E R++RH N+++ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEV-- 84
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHL---EVCKL--TLIQRVNIAIDVASAIE 827
I + A++ E G L + + + E L+ S +
Sbjct: 85 -ILTP--THLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLL----------SGVS 130
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSH--VGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
Y H + H DLK N LLD + DFG +K H K++
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTV------ 178
Query: 886 GTVGYVAPEYCMGSE-ASMTGDVYSFGILLLELFTGRRPTD 925
GT Y+APE + E DV+S G+ L + G P +
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 60/273 (21%), Positives = 95/273 (34%), Gaps = 58/273 (21%)
Query: 285 SIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFL 344
IPD+L + + LDL FN + S F S L L+L + + ++ +
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-----QTIEDGAY- 72
Query: 345 TNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALG 403
+ S L L L N + S + G L +L L
Sbjct: 73 QSLSHLSTLILTGNP-----------IQS---------------LALGAFSGLSSLQKLV 106
Query: 404 MQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIP 462
L IG LK L+ L + N++Q NLT L L +S N +Q +I
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIY 165
Query: 463 SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVK 522
L + L + L++ LDLS N +N + L +
Sbjct: 166 C-------------------TDL-RVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204
Query: 523 LIISSNQFSGVIPVTLSTCVSLEYLDISSNSFH 555
L + +NQ V SL+ + + +N +
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 19/222 (8%)
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKL 447
IP + + L + N L LQ L L + +Q +I G +L+ L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 448 AKLVMSYN---SLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNN 504
+ L+++ N SL S L + Q L A L +L + L++++N
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKL---VAVETNLA-SLENFPIGHLKTLKELNVAHN 134
Query: 505 NLNGSLPLQ--IGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEY----LDISSNSFHGVI 558
+ S L NL NL L +SSN+ + L + LD+S N + +
Sbjct: 135 LIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193
Query: 559 PHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
P + ++ +K L +N L + L+ L+ + N
Sbjct: 194 PGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 50/217 (23%), Positives = 88/217 (40%), Gaps = 15/217 (6%)
Query: 369 ANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPD-VIGELKNLQGLF 427
NL S + N + + + L L + ++ TI D L +L L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 428 LYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSL-GNCQNLIGFNASHNKLTG-A 484
L N +Q S+ G L+ L KLV +L ++ + G+ + L N +HN +
Sbjct: 83 LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 485 LPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLKNL----VKLIISSNQFSGVIPVTLS 539
LP+ ++T L +LDLS+N + S+ L + + L +S N + I
Sbjct: 141 LPEYFSNLTNLE-HLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 540 TCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSN 576
+ L+ L + +N V L S++ + +N
Sbjct: 198 KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 45/282 (15%), Positives = 82/282 (29%), Gaps = 72/282 (25%)
Query: 65 CQWTGVTC-GHRHQRV--------TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHG 115
C ++ LDLS + + S + L+ ++LS
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 116 EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLK 174
+ + ++ S+L L ++ N ++ + L
Sbjct: 66 ---------------TIEDGAYQSL--------SHLSTLILTGNPIQ-SLALGAFSGLSS 101
Query: 175 LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFS 234
LQ L + L L +F L+ L +L+V N
Sbjct: 102 LQKLVAVETNLA-SLENF--------PIGH---------------LKTLKELNVAHNLIQ 137
Query: 235 -----GTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIG---GNNFFGSI 286
F N+++LE + L N+ ++ + L + L + N I
Sbjct: 138 SFKLPEYFS----NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 287 PDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQN 328
++ L L NQ K F L +L + L N
Sbjct: 193 QPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 40/161 (24%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 460 NIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLK 518
N+P S +NL + S N L S L LDLS + ++ +L
Sbjct: 25 NLPFST---KNL---DLSFNPLRHLGSYSFFSFPEL-QVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 519 NLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578
+L LI++ N + S SL+ L + + +G LK++K LN + N +
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 579 -SGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKL 618
S ++PE+ NL+ LE L+ S N ++ + ++
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC-TDLRVLHQM 175
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 27/252 (10%), Positives = 60/252 (23%), Gaps = 64/252 (25%)
Query: 713 IGQGSFGSVYKGILGEDEMI---VAVKVI--NLKQKGAFKS-FMAECKALRNIRHRNLIK 766
G ++ D + VA+ + ++ L I
Sbjct: 39 HGGVPPLQFWQA---LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG--- 92
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + + ++ +V E ++ GSL++ S + + + +A+A
Sbjct: 93 VARVLDVVHTRAGGL--VVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAA 142
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
+ H + PS V + D G
Sbjct: 143 DAAHRA---GVALSIDHPSRVRVSID--------GDVVL--------------------A 171
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP----TDAAFTEGLTLHEFAKIAL 942
+ + D+ G L L R P + +
Sbjct: 172 YPATMPDA----NPQD---DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE 224
Query: 943 PEKVIEIVDPLL 954
P + + +
Sbjct: 225 PADIDRDIPFQI 236
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 5e-18
Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 713 IGQGSFGSVYKGI--LGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITI 770
+G+G++G VYK G+D+ A+K I + G S E LR ++H N+I + +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 771 CSSIDSKGADFKALVFECMKN--GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
S L+F+ ++ + + S + + +L ++ + I Y
Sbjct: 87 ---FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSH----VGDFGLAKFLSSHQLDTASKTSSSSIGI 884
LH + ++H DLKP+N+L+ + + D G A+ +S K + +
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP-----LKPLADLDPV 195
Query: 885 KGTVGYVAPEYCMGSEASMTG-DVYSFGILLLELFTGR 921
T Y APE +G+ D+++ G + EL T
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 40/220 (18%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G+G+ VY+ + A+KV+ K E L + H N+IK+ I
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEIF- 117
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
++ LV E + G L D + +E + + + A+ YLH +
Sbjct: 118 --ETPTEIS--LVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 833 CQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
+VH DLKP N+L D + DFGL+K + L + GT G
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---------TVCGTPG 215
Query: 890 YVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y APE Y G E D++S GI+ L G P
Sbjct: 216 YCAPEILRGCAY--GPEV----DMWSVGIITYILLCGFEP 249
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 40/222 (18%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITIC 771
+G G G V + + A+K++ A + E + + ++++I+ +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
++ + +V EC+ G L + D T + I + AI+YLH
Sbjct: 125 ENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHS 179
Query: 832 HCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQ-LDTASKTSSSSIGIKGT 887
+ H D+KP N+L + + + DFG AK +SH L T T
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT----------PCYT 226
Query: 888 VGYVAPE------YCMGSEASMTGDVYSFGILLLELFTGRRP 923
YVAPE Y D++S G+++ L G P
Sbjct: 227 PYYVAPEVLGPEKY--DKSC----DMWSLGVIMYILLCGYPP 262
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 44/245 (17%), Positives = 85/245 (34%), Gaps = 12/245 (4%)
Query: 213 IPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNL 272
IP+ L RN ++L + + LE+I + N + D+ NLP L
Sbjct: 24 IPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 273 KSLAIGGNNFFGSIP-DSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLG 331
+ I N I ++ N N++ L + K + L+++ N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI-- 139
Query: 332 MGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPS 391
+ ++ +F+ IL L N E+ +S N + N + +
Sbjct: 140 --NIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPND 196
Query: 392 GIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLV 451
+ L + ++H + LK L+ Y +P+ + L L +
Sbjct: 197 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT-LEKLVALMEAS 252
Query: 452 MSYNS 456
++Y S
Sbjct: 253 LTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 46/243 (18%), Positives = 83/243 (34%), Gaps = 10/243 (4%)
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKL 447
IPS + N I L +L +L+ + + +N + I + V NL KL
Sbjct: 24 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 448 AKLVMS-YNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNL 506
++ + N+L P + N NL S+ + LP + V LD+ +N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNIN 140
Query: 507 NGSLPLQI--GNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGF 564
++ G V L ++ N + + E +N+ +
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200
Query: 565 LKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNV 624
+L+ S + LENL L + + ++PT + + SL
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYPS 257
Query: 625 KLC 627
C
Sbjct: 258 HCC 260
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 48/232 (20%), Positives = 81/232 (34%), Gaps = 14/232 (6%)
Query: 104 RYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTN-LSRCSNLIQLRVSNNKLE 162
R ++ EIP ++ +L I S +L ++ +S N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67
Query: 163 GQIPAEI-GSLLKLQTLAVGK-NYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGL- 219
I A++ +L KL + + K N L P+ NL L+ I+ + +P +
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIH 126
Query: 220 LRNLVDLHVGGNQFSGTFPQ-SICNISS-LERIYLPFNRFSGTLPFDIVVNLPNLKSLAI 277
V L + N T + S +S ++L N + N L L +
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNS-AFNGTQLDELNL 184
Query: 278 GGNNFFGSIP-DSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQN 328
NN +P D AS ILD+ + S +LK L +
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 62/270 (22%), Positives = 105/270 (38%), Gaps = 33/270 (12%)
Query: 663 VLSSCLTIVYARRRRSARKSVDTSPREKQFPTVSYAELSKATSE--FASSNMIGQGSFGS 720
+ + + R + S + +F EL+ + F+ +IG+G FG
Sbjct: 145 LFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGE 204
Query: 721 VYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777
VY + + A+K ++ +K K + E L + + I+ + + +
Sbjct: 205 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264
Query: 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAIEYLHHHCQPP 836
+ + M G L L Q E + A ++ +E++H+
Sbjct: 265 DKLS--FILDLMNGGDLHYHLSQHGVFSE-------ADMRFYAAEIILGLEHMHNRF--- 312
Query: 837 MVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPE 894
+V+ DLKP+N+LLD HV D GLA S K +S GT GY+APE
Sbjct: 313 VVYRDLKPANILLDEH--GHVRISDLGLACDFSK------KKPHASV----GTHGYMAPE 360
Query: 895 YCMGSEA-SMTGDVYSFGILLLELFTGRRP 923
A + D +S G +L +L G P
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 51/231 (22%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA------ECKALRNIRHRNLIK 766
+G+G++G V IVA+K I F + E K L++ +H N+I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIE-----PFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 767 IITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ-------SNDHLEVCKLTLIQRVN 817
I I + +F ++ E M + LH+ S+DH + + Q
Sbjct: 74 IFNIQRPDSFE--NFNEVYIIQELM-----QTDLHRVISTQMLSDDH---IQYFIYQ--- 120
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
A++ LH ++H DLKPSN+L++ + V DFGLA+ + D + T
Sbjct: 121 ----TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 878 SSSSIGIKGTVGYV------APEYCMGSEA-SMTGDVYSFGILLLELFTGR 921
S V +V APE + S S DV+S G +L ELF R
Sbjct: 174 GQQSG----MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 61/271 (22%), Positives = 104/271 (38%), Gaps = 58/271 (21%)
Query: 675 RRRSARKSVDTSPREKQFPTVSYAELSKATSE------FASSNMIGQGSFGSVYKGILGE 728
+ ++D P + ++ ++++ + F+ IG GSFG+VY
Sbjct: 18 ENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVR 77
Query: 729 DEMIVAVKVINLKQKGA---FKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA-- 783
+ +VA+K ++ K + ++ + E + L+ +RH N I+ G +
Sbjct: 78 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR---------GCYLREHT 128
Query: 784 --LVFECMKNGSLEDWLHQSNDHLE------VCKLTLIQRVNIAIDVASAIEYLHHHCQP 835
LV E GS D L L+ V L + YLH H
Sbjct: 129 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGAL-----------QGLAYLHSH--- 173
Query: 836 PMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEY 895
M+H D+K N+LL G L F S+ + + +S GT ++APE
Sbjct: 174 NMIHRDVKAGNILLSEP-----GLVKLGDFGSASIM---APANS----FVGTPYWMAPEV 221
Query: 896 CMGSEASMTG---DVYSFGILLLELFTGRRP 923
+ + DV+S GI +EL + P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 27/229 (11%)
Query: 701 SKATSEFASSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQK--GAFKSFMAECKALR 757
+A ++ IG+G++G V+K L VA+K + ++ G S + E LR
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 758 NIR---HRNLIKIITICSSIDSKGADFKALVFECMKN--GSLEDWLHQSNDHLEVCKLTL 812
++ H N++++ +C+ + LVFE + + D + + E K +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 813 IQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLD 872
Q + +++LH H +VH DLKP N+L+ + DFGLA+ S
Sbjct: 127 FQ-------LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-- 174
Query: 873 TASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR 921
+S + T+ Y APE + S + D++S G + E+F +
Sbjct: 175 ---ALTSVVV----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 43/211 (20%), Positives = 80/211 (37%), Gaps = 18/211 (8%)
Query: 382 GNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV 441
I + P L N + + + + EL +Q + +Q S+ +G+
Sbjct: 6 PTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGM 59
Query: 442 GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDL 501
T L +L +S+N + ++ S L + L + + N+L ++ L L
Sbjct: 60 QFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLS----RLFL 113
Query: 502 SNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHS 561
NN L + L +LKNL L I +N+ ++ L LE LD+ N
Sbjct: 114 DNNELRDTDSLI--HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGG-- 167
Query: 562 LGFLKSIKVLNFSSNNLSGQIPEFLENLSFL 592
L LK + ++ + + ++ L
Sbjct: 168 LTRLKKVNWIDLTGQKCVNEPVKYQPELYIT 198
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 35/203 (17%), Positives = 75/203 (36%), Gaps = 28/203 (13%)
Query: 405 QSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSS 464
+ ++ PD L N L K + L+ + +++Q ++ +
Sbjct: 5 RPTPINQVFPD--PGLANAVKQNLGKQ--SVTDLVSQKELSGVQNFNGDNSNIQ-SL-AG 58
Query: 465 LGNCQNLIGFNASHNKLTGALPQQLLSITTLS-----VYLDLSNNNLNGSLPLQIGNLKN 519
+ NL + SHN+++ ++ L L ++ N L +
Sbjct: 59 MQFFTNLKELHLSHNQIS--------DLSPLKDLTKLEELSVNRNRLKNLNGI---PSAC 107
Query: 520 LVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLS 579
L +L + +N+ L +LE L I +N ++ LGFL ++VL+ N ++
Sbjct: 108 LSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT 163
Query: 580 GQIPEFLENLSFLEFLNFSHNDL 602
L L + +++ +
Sbjct: 164 N--TGGLTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 42/274 (15%), Positives = 90/274 (32%), Gaps = 53/274 (19%)
Query: 268 NLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID-FSSLKNLSWLNLE 326
L N +G + + S S V+ + + + S+ NL L+L
Sbjct: 17 GLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ---SLAGMQFFTNLKELHLS 71
Query: 327 QNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSS-SMIEFRIGGNQI 385
N + ++ L + + L+ LS+ N+ ++ + S + + N++
Sbjct: 72 HNQISD--------LSPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNEL 118
Query: 386 FGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLT 445
+ +L NL L +++N+L K++ L G L+
Sbjct: 119 RDT--DSLIHLKNLEILSIRNNKL-----------KSIVML---------------GFLS 150
Query: 446 KLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNN 505
KL L + N + N L + + + + K + + L + + + +
Sbjct: 151 KLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCV---NEPVKYQPELYITNTVKDPD 205
Query: 506 LNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLS 539
P I N + V + V+
Sbjct: 206 GRWISPYYISNGGSYVDGCVLWELPVYTDEVSYK 239
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 43/248 (17%), Positives = 77/248 (31%), Gaps = 33/248 (13%)
Query: 217 LGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLA 276
L N V ++G + Q +S ++ + NLK L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAGMQ---FFTNLKELH 69
Query: 277 IGGNNFFGSIPD--SLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGT 334
+ N I D L + + +E L + N+ K +++ LS L L+ N L
Sbjct: 70 LSHNQ----ISDLSPLKDLTKLEELSVNRNRLK---NLNGIPSACLSRLFLDNNEL---- 118
Query: 335 ANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLS--SSMIEFRIGGNQIFGIIPSG 392
L + +L+ILS+ N+ SI L S + + GN+I G
Sbjct: 119 ----RDTDSLIHLKNLEILSIRNNKLK-----SIVMLGFLSKLEVLDLHGNEITNT--GG 167
Query: 393 IRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVM 452
+ L + + + + EL + P + N +
Sbjct: 168 LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCV 225
Query: 453 SYNSLQGN 460
+
Sbjct: 226 LWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 51/246 (20%), Positives = 93/246 (37%), Gaps = 22/246 (8%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
+ +L Q + ++S LS ++ N +++ + + L++L L +N S
Sbjct: 21 AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQIS 76
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
+ + L + L +L V+ N+L+ L L + N L D + +L
Sbjct: 77 -DL-SPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD--TDSLIHLKN 129
Query: 199 LEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFS 258
LE+ SI N L K LG L L L + GN+ + + + + I L +
Sbjct: 130 LEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCV 185
Query: 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSI-PDSLSNASNVEILDLGFNQ--FKGKVSIDFS 315
+ V P L + I P +SN + + + + +VS FS
Sbjct: 186 ----NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFS 241
Query: 316 SLKNLS 321
N+
Sbjct: 242 EYINVG 247
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 31/141 (21%), Positives = 54/141 (38%), Gaps = 12/141 (8%)
Query: 463 SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVK 522
N + N +T + Q+ L + + + N+N+ +Q NL +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQKEL--SGVQ-NFNGDNSNIQSLAGMQ--FFTNLKE 67
Query: 523 LIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQI 582
L +S NQ S + P L LE L ++ N + + L +N L
Sbjct: 68 LHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPS---ACLSRLFLDNNELRD-- 120
Query: 583 PEFLENLSFLEFLNFSHNDLE 603
+ L +L LE L+ +N L+
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 39/218 (17%), Positives = 68/218 (31%), Gaps = 48/218 (22%)
Query: 143 TNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVF 202
+N ++ + + + L +Q + +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ---------------- 54
Query: 203 SITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLP 262
S+ G + NL +LH+ NQ S P + +++ LE + + NR
Sbjct: 55 SLAG----------MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG 102
Query: 263 FDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID-FSSLKNLS 321
L L + N DSL + N+EIL + N+ K SI L L
Sbjct: 103 I----PSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK---SIVMLGFLSKLE 153
Query: 322 WLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQ 359
L+L N + LT + + L +
Sbjct: 154 VLDLHGNE--------ITNTGGLTRLKKVNWIDLTGQK 183
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 50/225 (22%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA------ECKALRNIRHRNLIK 766
IG G+ G V E VA+K K F++ E ++ + H+N+I
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 767 IITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ--SNDHLEVCKLTLIQRVNIAIDV 822
++ + + S +F+ +V E M + +L + ++ L Q +
Sbjct: 89 LLNVFTPQKSLE-EFQDVYIVMELM-DANLCQVIQMELDHER---MSYLLYQ-------M 136
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
I++LH ++H DLKPSN+++ D + DFGLA+ + + T
Sbjct: 137 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT--------- 184
Query: 883 GIKGTVGYV------APEYCMGSEASMTGDVYSFGILLLELFTGR 921
YV APE +G D++S G ++ E+ G
Sbjct: 185 ------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 44/221 (19%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITIC 771
+G+G + V++ I + V VK++ +K K E K L N+R N+I + I
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQ-SNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
S+ ALVFE + N + ++ + + + + A++Y H
Sbjct: 101 KDPVSRT---PALVFEHVNNTDFKQLYQTLTDYD---IRFYMYE-------ILKALDYCH 147
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVS-HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
++H D+KP NV++DH+ + D+GLA+F Q
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---------------V 189
Query: 890 YV------APEYCMGSEA-SMTGDVYSFGILLLELFTGRRP 923
V PE + + + D++S G +L + + P
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 53/221 (23%), Positives = 82/221 (37%), Gaps = 33/221 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK------SFMAECKALRNIRHRNLIK 766
+G G F V K + A K I +Q A + E LR + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + + L+ E + G L D+L Q E + I+ + +
Sbjct: 80 LHDVYEN-----RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK------QILDGV 128
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSH----VGDFGLAKFLSSHQLDTASKTSSSSI 882
YLH + H DLKP N++L + + DFGLA +
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--------- 176
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
I GT +VAPE + D++S G++ L +G P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 41/224 (18%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKII 768
IG+GSFG V + + + A+K +N ++ ++ E + ++ + H L+ +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL- 80
Query: 769 TICSSIDSKGADFKA-----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDV 822
+ F+ +V + + G L HL+ + V + ++
Sbjct: 81 --------WYS-FQDEEDMFMVVDLLLGGDLRY-------HLQQNVHFKEETVKLFICEL 124
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
A++YL + ++H D+KP N+LLD H+ DF +A L ++ ++ +
Sbjct: 125 VMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA-----MLPRETQITTMA- 175
Query: 883 GIKGTVGYVAPEYCMGSEA---SMTGDVYSFGILLLELFTGRRP 923
GT Y+APE + S D +S G+ EL GRRP
Sbjct: 176 ---GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 52/221 (23%), Positives = 82/221 (37%), Gaps = 33/221 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS------FMAECKALRNIRHRNLIK 766
+G G F V K + A K I +Q A + E LR + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + + L+ E + G L D+L Q L+ + + + +
Sbjct: 80 LHDVYEN-----RTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGV 128
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSH----VGDFGLAKFLSSHQLDTASKTSSSSI 882
YLH + H DLKP N++L + + DFGLA +
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--------- 176
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
I GT +VAPE + D++S G++ L +G P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 46/239 (19%), Positives = 90/239 (37%), Gaps = 65/239 (27%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA------ECKALRNIRHRNLIK 766
+G G G V+ + + + VA+K K + E K +R + H N++K
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIK------KIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 767 IITI-------CSSIDSKGADFKA--LVFECMKNGSLEDWLHQ-------SNDHLEVCKL 810
+ I + + + +V E M E L +H +L
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEH---ARL 124
Query: 811 TLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVSHVGDFGLAKFLSSH 869
+ Q + ++Y+H ++H DLKP+N+ ++ D+V +GDFGLA+ + H
Sbjct: 125 FMYQ-------LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 870 QLDTASKTSSSSIGIKGTVGYV------APEYCMGSEA-SMTGDVYSFGILLLELFTGR 921
+ + +P + + D+++ G + E+ TG+
Sbjct: 175 YSHKGHLS-----------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 58/231 (25%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA------ECKALRNIRHRNLIK 766
IG+G++G V +++ VA+K I+ F+ E K L RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKIS-----PFEHQTYCQRTLREIKILLRFRHENIIG 89
Query: 767 IITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ-------SNDHLEVCKLTLIQRVN 817
I I + + K +V + M E L++ SNDH L Q
Sbjct: 90 INDIIRAPTIE--QMKDVYIVQDLM-----ETDLYKLLKTQHLSNDH---ICYFLYQ--- 136
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
+ ++Y+H ++H DLKPSN+LL+ + DFGLA+ T T
Sbjct: 137 ----ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 878 SSSSIGIKGTVGYV------APEYCMGSEA-SMTGDVYSFGILLLELFTGR 921
YV APE + S+ + + D++S G +L E+ + R
Sbjct: 190 -----------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 59/302 (19%), Positives = 110/302 (36%), Gaps = 62/302 (20%)
Query: 673 ARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSN------MIGQGSFGSVYKGIL 726
+ + + R++ + A + + S++ + +IG GS+G V +
Sbjct: 15 GTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYD 74
Query: 727 GEDEMIVAVKVINLKQKGAFKSFMA------ECKALRNIRHRNLIKIITICSSIDSKGAD 780
++ +VA+K I F+ + E L + H +++K++ I D +
Sbjct: 75 KLEKRVVAIKKILR----VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE--K 128
Query: 781 FKA--LVFECMKNGSLEDW-LHQ---SNDHLEV--CKLTLIQRVNIAIDVASAIEYLHHH 832
F +V E D + + +L K L + ++Y+H
Sbjct: 129 FDELYVVLEIA------DSDFKKLFRTPVYLTELHIKTLLYN-------LLVGVKYVHSA 175
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV---- 888
++H DLKP+N L++ D V DFGLA+ + + + S V
Sbjct: 176 ---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 889 ---------GYV------APEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932
G+V APE + E + DV+S G + EL + A +
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292
Query: 933 TL 934
L
Sbjct: 293 PL 294
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 50/238 (21%), Positives = 91/238 (38%), Gaps = 58/238 (24%)
Query: 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA------ECKALR 757
+ + IG G+ G V + VA+K K F++ E ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK----KLSRPFQNQTHAKRAYRELVLMK 116
Query: 758 NIRHRNLIKIITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ------SNDHLEVCK 809
+ H+N+I ++ + + + +F+ LV E M + L Q ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLE-EFQDVYLVMELM-----DANLCQVIQMELDHER---MS 167
Query: 810 LTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSH 869
L Q + I++LH ++H DLKPSN+++ D + DFGLA+ +
Sbjct: 168 YLLYQ-------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 870 QLDTASKTSSSSIGIKGTVGYV------APEYCMGSEASMTGDVYSFGILLLELFTGR 921
+ T YV APE +G D++S G ++ E+ +
Sbjct: 218 FMMT---------------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-16
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHR---NLIKII 768
+IG+GSFG V K + VA+K++ +++ + E + L ++R + N + +I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR-FHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASAIE 827
+ + + + FE + +L + + ++ L L+++ A + ++
Sbjct: 163 HMLENFTFRN--HICMTFELLSM-NLYELIKKNKFQGFS---LPLVRK--FAHSILQCLD 214
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSH--VGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
LH + ++H DLKP N+LL S V DFG + + S
Sbjct: 215 ALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----QRVYTYIQSRF--- 264
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR 921
Y APE +G+ M D++S G +L EL TG
Sbjct: 265 ----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 33/221 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS------FMAECKALRNIRHRNLIK 766
+G G F V K + A K I ++ + + E L+ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + + L+ E + G L D+L + E ++ + + +
Sbjct: 79 LHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLK------QILNGV 127
Query: 827 EYLHHHCQPPMVHGDLKPSNVLL-DHDMVSH---VGDFGLAKFLSSHQLDTASKTSSSSI 882
YLH + H DLKP N++L D ++ + DFGLA +
Sbjct: 128 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--------- 175
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
I GT +VAPE + D++S G++ L +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 52/221 (23%), Positives = 85/221 (38%), Gaps = 33/221 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA------FKSFMAECKALRNIRHRNLIK 766
+G G F V K A K I ++ + + E LR IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ I + L+ E + G L D+L + E ++ + +
Sbjct: 73 LHDIFEN-----KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK------QILDGV 121
Query: 827 EYLHHHCQPPMVHGDLKPSNVLL-DHDMVSH---VGDFGLAKFLSSHQLDTASKTSSSSI 882
YLH + H DLKP N++L D ++ + + DFG+A + +
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK--------- 169
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
I GT +VAPE + D++S G++ L +G P
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 53/234 (22%), Positives = 84/234 (35%), Gaps = 54/234 (23%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKII 768
+IG+G+F V + + + A+K++N + ++G F E L N R I
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR---WIT 124
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID------- 821
+ + + + LV E G L LTL+ + I
Sbjct: 125 QLHFAFQDENYLY--LVMEYYVGGDL---------------LTLLSKFGERIPAEMARFY 167
Query: 822 ---VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASK 876
+ AI+ +H VH D+KP N+LLD H+ DFG +L
Sbjct: 168 LAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCL-----KLRADGT 217
Query: 877 TSSSSIGIKGTVGYVAPEYCMGSEASMTGDVY-------SFGILLLELFTGRRP 923
S GT Y++PE Y + G+ E+F G+ P
Sbjct: 218 VRSLVAV--GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 55/326 (16%), Positives = 109/326 (33%), Gaps = 65/326 (19%)
Query: 290 LSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSS 349
+ +L V+ + L ++ + +++ + + +L N
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDI-----KSVQGIQYLPN--- 69
Query: 350 LKILSLAANQFVGELPHSIANLSS--SMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSN 407
+ L L N+ I L++ ++ + N++ + S +++L L +L ++ N
Sbjct: 70 VTKLFLNGNKLT-----DIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHN 122
Query: 408 QLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGN 467
+ + + + L L+ L+L N + + + + LTKL L + N + +I L
Sbjct: 123 GI--SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI-VPLAG 176
Query: 468 CQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISS 527
L S N ++ DL + LKNL L + S
Sbjct: 177 LTKLQNLYLSKNHIS-----------------DLRA----------LAGLKNLDVLELFS 209
Query: 528 NQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLE 587
+ S V + + S V P + + N + PEF
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHL-----PEFTN 262
Query: 588 NLSFLEFLNFSHNDLEGEVPTKGVFS 613
+SF F G+ K F
Sbjct: 263 EVSF----IFYQPVTIGK--AKARFH 282
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 46/236 (19%), Positives = 95/236 (40%), Gaps = 25/236 (10%)
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158
+ NL S + Q L ++++ N+ ++ + N+ +L ++
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVG--NLSALEVFSITGNSLGGKIPTT 216
NKL I + +L L L + +N + D +L L+ S+ N +
Sbjct: 78 NKLT-DIK-PLANLKNLGWLFLDENKVK----DLSSLKDLKKLKSLSLEHNGI--SDING 129
Query: 217 LGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLA 276
L L L L++G N+ + + ++ L+ + L N+ S +P L L++L
Sbjct: 130 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLY 184
Query: 277 IGGNNFFGSIPD--SLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330
+ N+ I D +L+ N+++L+L + K S+L + + +L
Sbjct: 185 LSKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 30/170 (17%), Positives = 58/170 (34%), Gaps = 23/170 (13%)
Query: 439 SGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLS-- 496
+ K + S+ + ++ A+++ + S+ +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK--------SVQGIQYL 67
Query: 497 ---VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNS 553
L L+ N L PL NLKNL L + N+ + L L+ L + N
Sbjct: 68 PNVTKLFLNGNKLTDIKPL--ANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNG 123
Query: 554 FHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE 603
+ L L ++ L +N ++ L L+ L+ L+ N +
Sbjct: 124 ISDING--LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 45/247 (18%), Positives = 79/247 (31%), Gaps = 40/247 (16%)
Query: 195 NLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISS---LERIY 251
+ ++ S+ T L ++ + + S+ I + +++
Sbjct: 22 AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-----SVQGIQYLPNVTKLF 74
Query: 252 LPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPD--SLSNASNVEILDLGFNQFKGK 309
L N+ + P NL NL L + N + D SL + ++ L L N
Sbjct: 75 LNGNKLTDIKPLA---NLKNLGWLFLDENK----VKDLSSLKDLKKLKSLSLEHNGIS-- 125
Query: 310 VSID-FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSI 368
I+ L L L L N + +T L+ + L LSL NQ I
Sbjct: 126 -DINGLVHLPQLESLYLGNNKITD--------ITVLSRLTKLDTLSLEDNQI-----SDI 171
Query: 369 ANLSS--SMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGL 426
L+ + + N I + + L NL L + S + + L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 427 FLYKNVL 433
L
Sbjct: 230 KNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 39/202 (19%), Positives = 81/202 (40%), Gaps = 15/202 (7%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
T+L L+ ++ I + NL L ++ L +N ++ + +L +L+ L+L +N S
Sbjct: 71 TKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS- 125
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
I L L L + NNK+ I + L KL TL++ N ++ + L+ L
Sbjct: 126 DI-NGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVPL-AGLTKL 180
Query: 200 EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSG 259
+ ++ N + L L+NL L + + N+ +
Sbjct: 181 QNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL-- 236
Query: 260 TLPFDIVVNLPNLKSLAIGGNN 281
+ +I+ + + + + +
Sbjct: 237 -VTPEIISDDGDYEKPNVKWHL 257
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 46/185 (24%), Positives = 70/185 (37%), Gaps = 17/185 (9%)
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
++P L + IL L N L+ LNL++ L L
Sbjct: 19 KRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-----LQ 71
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVN 398
L L L L+ NQ LP L ++ + N++ +P G R L
Sbjct: 72 VDGTLPV---LGTLDLSHNQLQ-SLPLLGQTL-PALTVLDVSFNRL-TSLPLGALRGLGE 125
Query: 399 LIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSL 457
L L ++ N+L P ++ L+ L L N L +P+G+ L L L++ NSL
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184
Query: 458 QGNIP 462
IP
Sbjct: 185 Y-TIP 188
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 48/223 (21%), Positives = 76/223 (34%), Gaps = 46/223 (20%)
Query: 213 IPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNL 272
+P L ++ LH+ N ++ + L ++ L + LP L
Sbjct: 25 LPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG---TLPVL 79
Query: 273 KSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID-FSSLKNLSWLNLEQNNLG 331
+L + N S+P + +LD+ FN+ + + L L L L+ N L
Sbjct: 80 GTLDLSHNQ-LQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137
Query: 332 MGTANDLDFVTF--LTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGII 389
L L+ LSLA N L+ +
Sbjct: 138 T-----LPPGLLTPTPK---LEKLSLANNN-----------LTE---------------L 163
Query: 390 PSGI-RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKN 431
P+G+ L NL L +Q N L+ TIP L FL+ N
Sbjct: 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 47/204 (23%), Positives = 68/204 (33%), Gaps = 17/204 (8%)
Query: 63 NLCQWTGVTC-GHRHQRV--------TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSF 113
+ V C + T L LS + + + L +NL
Sbjct: 8 KVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 114 HGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSL 172
++ G L L L L +N ++P L L VS N+L +P L
Sbjct: 68 -TKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL 123
Query: 173 LKLQTLAVGKNYLTGRLPDFV-GNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGN 231
+LQ L + N L LP + LE S+ N+L L L NL L + N
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 232 QFSGTFPQSICNISSLERIYLPFN 255
T P+ L +L N
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 42/150 (28%), Positives = 60/150 (40%), Gaps = 12/150 (8%)
Query: 477 SHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPV 536
LT ALP L TT L LS N L + L +L + + + + V
Sbjct: 18 DKRNLT-ALPPDLPKDTT---ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV 72
Query: 537 TLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLN 596
T L LD+S N +P L ++ VL+ S N L+ L L L+ L
Sbjct: 73 -DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130
Query: 597 FSHNDLEGEVPTKGVFSSKTKL---SLQGN 623
N+L+ +P G+ + KL SL N
Sbjct: 131 LKGNELK-TLPP-GLLTPTPKLEKLSLANN 158
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 38/249 (15%), Positives = 75/249 (30%), Gaps = 68/249 (27%)
Query: 285 SIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFL 344
+IPDS LG + +I + + +L+++ L N+ DL + +
Sbjct: 16 NIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-----TDLTGIEYA 65
Query: 345 TNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGM 404
N +K L++ + I L NL L +
Sbjct: 66 HN---IKDLTI-------------------------NNIHATNY--NPISGLSNLERLRI 95
Query: 405 QSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSS 464
+ + L +L L + + SI + + L K+ + +SYN +I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MP 154
Query: 465 LGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLI 524
L L L++ + ++ ++ + L +L
Sbjct: 155 LKTLPELK-------------------------SLNIQFDGVHDYRGIE--DFPKLNQLY 187
Query: 525 ISSNQFSGV 533
S G
Sbjct: 188 AFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 29/161 (18%), Positives = 53/161 (32%), Gaps = 16/161 (9%)
Query: 445 TKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLS-----VYL 499
+ + + +L ++ +T +T + L
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT--------DLTGIEYAHNIKDL 71
Query: 500 DLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIP 559
++N + P+ L NL +L I + LS SL LDIS ++ I
Sbjct: 72 TINNIHATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
Query: 560 HSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
+ L + ++ S N I L+ L L+ LN +
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 26/157 (16%), Positives = 61/157 (38%), Gaps = 7/157 (4%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
+T + L+N + + + ++ + +++ P I L LE+L + +
Sbjct: 46 LTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVT 101
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
NLS ++L L +S++ + I +I +L K+ ++ + N + + L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPE 160
Query: 199 LEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSG 235
L+ +I + + + L L+ G
Sbjct: 161 LKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 23/172 (13%), Positives = 58/172 (33%), Gaps = 19/172 (11%)
Query: 216 TLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSL 275
T + +L + + + I +++ + + + P L NL+ L
Sbjct: 39 TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNPIS---GLSNLERL 93
Query: 276 AIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTA 335
I G + +LS +++ +LD+ + + ++L ++ ++L N
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA----- 148
Query: 336 NDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLS--SSMIEFRIGGNQI 385
+ + L LK L++ + H + + + I
Sbjct: 149 --ITDIMPLKTLPELKSLNIQFDGV-----HDYRGIEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 30/212 (14%), Positives = 62/212 (29%), Gaps = 41/212 (19%)
Query: 123 NLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNK---LEGQIPAEIGSLLKLQTLA 179
L +S + ++ +L + ++N L G I ++ L
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMN---SLTYITLANINVTDLTG-----IEYAHNIKDLT 72
Query: 180 VGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQ 239
+ + T + + LS LE I G + L L +L L + + +
Sbjct: 73 INNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS--- 127
Query: 240 SICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEIL 299
++ + LP + S+ + N I L ++ L
Sbjct: 128 ---ILTKIN-------------------TLPKVNSIDLSYNGAITDI-MPLKTLPELKSL 164
Query: 300 DLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLG 331
++ F+ L+ L +G
Sbjct: 165 NIQFDGVH-DYR-GIEDFPKLNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 14/93 (15%), Positives = 36/93 (38%), Gaps = 7/93 (7%)
Query: 516 NLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSS 575
K + ++ + +T + SL Y+ +++ + + + + +IK L ++
Sbjct: 21 TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 576 NNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT 608
+ + + LS LE L D+ +
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIP 106
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 52/248 (20%), Positives = 87/248 (35%), Gaps = 55/248 (22%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA------ECKALRNIRHRNLIK 766
IG+GS+G VY E VA+K K F+ + E L ++ +I+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIK----KVNRMFEDLIDCKRILREITILNRLKSDYIIR 89
Query: 767 IITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ--------SNDHLEVCKLTLIQRV 816
+ + D F +V E + L + + +H K L
Sbjct: 90 LYDLIIPDDLL--KFDELYIVLEIA-----DSDLKKLFKTPIFLTEEH---IKTILYN-- 137
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASK 876
+ ++H + ++H DLKP+N LL+ D V DFGLA+ ++S +
Sbjct: 138 -----LLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 877 TSSSSIGIKGTV--------GYV------APEYCMGSEASMTG-DVYSFGILLLELFTGR 921
+ +V APE + E D++S G + EL
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 922 RPTDAAFT 929
+ T
Sbjct: 250 QSHINDPT 257
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 81.4 bits (200), Expect = 9e-16
Identities = 107/634 (16%), Positives = 194/634 (30%), Gaps = 192/634 (30%)
Query: 73 GHRHQRVTRL--DLSNQR-------IGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGN 123
RL L +++ + +L N FL + E Q
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRI---NYKFLM------SPIKTEQRQPSMM 108
Query: 124 LLR----LEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAE---------IG 170
++L N F+ N+SR ++LR L PA+ G
Sbjct: 109 TRMYIEQRDRLYNDNQVFA---KYNVSRLQPYLKLR---QALLELRPAKNVLIDGVLGSG 162
Query: 171 SLLKLQTLA--VGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHV 228
K +A V +Y DF ++F + + +L L L
Sbjct: 163 ---K-TWVALDVCLSYKVQCKMDF-------KIFWLNL----KNCNSPETVLEMLQKLLY 207
Query: 229 GGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPD 288
Q + I L + L ++ + P L +
Sbjct: 208 ---QIDPNWTS---RSDHSSNIKLRIHSIQAELR-RLLKSKPYENCLLV----------- 249
Query: 289 SLSNASNVEILDLGFNQFKGKV-------SI-DFSSLKNLSWLNLEQNNLGMGTANDLDF 340
L N N + + FN K+ + DF S + ++L+ +++
Sbjct: 250 -LLNVQNAKAWN-AFN-LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT--------- 297
Query: 341 VTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLI 400
LT +L + +LP + + + II IR+ +
Sbjct: 298 ---LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL----------SIIAESIRDGLATW 344
Query: 401 A--LGMQSNQLHGTIPDVIGELK--NLQGLFLY-----KNVLQGSIPSGVGNLTKL---- 447
+ ++L I + L+ + +F + IP+ + L+ +
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH---IPTIL--LSLIWFDV 399
Query: 448 ----AKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSN 503
+V+ N L SL Q + T ++P S+YL+L
Sbjct: 400 IKSDVMVVV--NKLHK---YSLVEKQP--------KESTISIP---------SIYLELK- 436
Query: 504 NNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTL-STCVSLEYLDISSNSFHGVIPH-- 560
+++ N L + I+ + ++ IP T S + YLD F+ I H
Sbjct: 437 --------VKLENEYALHRSIV--DHYN--IPKTFDSDDLIPPYLD---QYFYSHIGHHL 481
Query: 561 -----------------SLGFLKSIKVLNFSSN-NLSGQIPEFLENLSFLE-FLNFSHND 601
FL+ K+ + S+ N SG I L+ L F + ++ +
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLEQ-KIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPK 540
Query: 602 LEGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHL 635
E V F K ++ N+ TD L +
Sbjct: 541 YERLVNAILDFLPK----IEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 4e-08
Identities = 78/522 (14%), Positives = 137/522 (26%), Gaps = 189/522 (36%)
Query: 560 HSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKT--K 617
H + F + ++ + F + F++ NF D++ K + S +
Sbjct: 5 HHMDF--ETGEHQYQYKDI---LSVFEDA--FVD--NFDCKDVQDM--PKSILSKEEIDH 53
Query: 618 LSLQGNVKLCGGTDELHLPTCPSKGSRKPKI---TLLK-----VLIPVAVLCMVLSSCLT 669
+ + + GT L T SK + +L+ ++ P+ S +T
Sbjct: 54 IIMSKDAVS--GTLRL-FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ-PSMMT 109
Query: 670 IVYARRRRSARKSVD-----TSPREKQFPTVSYAELSKATSEFASSNMI---GQGSFGSV 721
+Y +R R + Y +L +A E + + G G
Sbjct: 110 RMYIEQRDRLYNDNQVFAKYNVSRLQP-----YLKLRQALLELRPAKNVLIDGVLGSG-- 162
Query: 722 YKGILGEDEMIVAVKVIN---LKQKGAFKSF---MAECKALRNIRHRNLIKII-TICSSI 774
K + A+ V ++ K FK F + C +++++ + I
Sbjct: 163 -KTWV-------ALDVCLSYKVQCKMDFKIFWLNLKNCN-----SPETVLEMLQKLLYQI 209
Query: 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQ 834
D +DH NI + + S L
Sbjct: 210 DPN--------------------WTSRSDHSS----------NIKLRIHSIQAELRRL-- 237
Query: 835 PPMVHGDLKPSNVLLDHDMV---SHVGDFGL-AKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ + N LL V F L K L L T K + + T
Sbjct: 238 --LKSKPYE--NCLLVLLNVQNAKAWNAFNLSCKIL----LTTRFKQVTDFLSAATTTHI 289
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA------LPE 944
+ M T K LP
Sbjct: 290 SLDHHSMT-----------------------------LTPDEVKSLLLKYLDCRPQDLPR 320
Query: 945 KVIEIVDPLLLIEVMANNSMIQEDIR-----------------AKTQE-CLN-------- 978
+V+ +P L S+I E IR E LN
Sbjct: 321 EVLTT-NPRRL-------SIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 979 ------AI------IRIGVLCSM--ESPFERMEMRDVVAKLC 1006
++ I +L + + ++ VV KL
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKS--DVMVVVNKLH 412
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 3e-04
Identities = 56/427 (13%), Positives = 115/427 (26%), Gaps = 148/427 (34%)
Query: 581 QIPEFLENLSFLEFLNFSHNDLEGEVPTKG-VFSSKTKLSLQ---------GNVKLCG-- 628
+ P + ++E + +ND +V K V + L L+ NV + G
Sbjct: 103 RQPS-MMTRMYIEQRDRLYND--NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159
Query: 629 --GTDELHLPTCPSKG--SRKPK----ITLLKVLIPVAVLCMVLSSCLTIVYARRRRSAR 680
G + L C S + + L P VL M+ I RS
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS-- 217
Query: 681 KSVDTSPREKQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINL 740
D S K + S Y+ L +++ N+
Sbjct: 218 ---DHSSNIKL----RIHSIQAELRRLLKSKP---------YENCL----LVLL----NV 253
Query: 741 KQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLED---- 796
+ A+ +F CK L R + + + A + + D
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFL--------SAATTTHISLDHHSMTLTPDEVKS 305
Query: 797 ----WLHQSNDHL--EVCKLTLIQRVN-IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
+L L EV N + + +
Sbjct: 306 LLLKYLDCRPQDLPREVLT------TNPRRLSIIAE-----------------------S 336
Query: 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVY- 908
D ++ ++ K ++ +L T I+ ++ + P ++
Sbjct: 337 IRDGLATWDNW---KHVNCDKLTTI---------IESSLNVLEPAE--------YRKMFD 376
Query: 909 SFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIV-------DPLLLIEVMAN 961
+ P A I P ++ ++ D ++++ +
Sbjct: 377 RLSVF---------PPS------------AHI--PTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 962 NSMIQED 968
S++++
Sbjct: 414 YSLVEKQ 420
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 53/218 (24%), Positives = 87/218 (39%), Gaps = 30/218 (13%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKALRNIRHRNLIKII 768
++G+G+FG V A+K++ + K + E + L+N RH L +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAIE 827
S + V E G L L + E R ++ SA++
Sbjct: 215 ---YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSE-------DRARFYGAEIVSALD 262
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIK 885
YLH +V+ DLK N++LD D H+ DFGL K + + +
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKD--GHIKITDFGLCK----EGIKDGATMKTFC---- 310
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE ++ D + G+++ E+ GR P
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 56/261 (21%), Positives = 97/261 (37%), Gaps = 63/261 (24%)
Query: 689 EKQFPTVSYAELSKAT-SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKG 744
E P S + + +F +IG+G+FG V L + + A+K++N + ++
Sbjct: 57 EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA 116
Query: 745 AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA-----LVFECMKNGSLEDWLH 799
F E L N + + + A F+ LV + G L
Sbjct: 117 ETACFREERDVLVNGDSKWITTL---------HYA-FQDDNNLYLVMDYYVGGDL----- 161
Query: 800 QSNDHLEVCKLTLIQRVNIAID----------VASAIEYLHHHCQPPMVHGDLKPSNVLL 849
LTL+ + + + AI+ +H VH D+KP N+L+
Sbjct: 162 ----------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILM 208
Query: 850 DHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTG-- 905
D + H+ DFG ++ + SS ++ GT Y++PE E
Sbjct: 209 DMN--GHIRLADFGSCL----KLMEDGTVQSSVAV---GTPDYISPEILQAMEGGKGRYG 259
Query: 906 ---DVYSFGILLLELFTGRRP 923
D +S G+ + E+ G P
Sbjct: 260 PECDWWSLGVCMYEMLYGETP 280
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 61/230 (26%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA------ECKALRNIRHRNLIK 766
+G G++GSV I VA+K K F+S + E L++++H N+I
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 767 IITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ------SNDHLEVCKLTLIQRVNI 818
++ + + S +F LV M + L + S + + + Q
Sbjct: 88 LLDVFTP-ASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEK---IQYLVYQ---- 134
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
+ ++Y+H +VH DLKP N+ ++ D + DFGLA+ + T
Sbjct: 135 ---MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MT- 181
Query: 879 SSSIGIKGTVGYV------APEYCMGS-EASMTGDVYSFGILLLELFTGR 921
GYV APE + + T D++S G ++ E+ TG+
Sbjct: 182 ----------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 3e-15
Identities = 57/283 (20%), Positives = 103/283 (36%), Gaps = 85/283 (30%)
Query: 711 NMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQK---GAFKSFMAECKALRNI-RH 761
+G+G+FG V + VAVK+ LK+ ++ M+E K L +I H
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHH 85
Query: 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLH-----------------QSNDH 804
N++ ++ C+ ++ E K G+L +L Q D+
Sbjct: 86 LNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 805 LEVCKLTLIQRVNIAIDVASA----------IEYLHHHCQPPMVHGD------------- 841
+ + L +R++ S+ + + P ++ D
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 842 -----------------LKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
L N+LL V + DFGLA+ + ++ + + + +
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPL 259
Query: 885 KGTVGYVAPE---YCMGSEASMTGDVYSFGILLLELFT-GRRP 923
K APE + + S DV+SFG+LL E+F+ G P
Sbjct: 260 KWM----APETIFDRVYTIQS---DVWSFGVLLWEIFSLGASP 295
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 50/225 (22%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA------ECKALRNIRHRNLIK 766
+G G++GSV + + VAVK K F+S + E + L++++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 767 IITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ-------SNDHLEVCKLTLIQRVN 817
++ + + S +F LV M L+ ++DH + + Q
Sbjct: 93 LLDVFTPARSLE-EFNDVYLVTHLM-----GADLNNIVKCQKLTDDH---VQFLIYQ--- 140
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
+ ++Y+H ++H DLKPSN+ ++ D + DFGLA+ + +
Sbjct: 141 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-- 191
Query: 878 SSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGR 921
T Y APE + + T D++S G ++ EL TGR
Sbjct: 192 ---------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 47/232 (20%), Positives = 84/232 (36%), Gaps = 38/232 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--------FKSFMAECKALRNIRHRNL 764
IG G FG +Y A V+ ++ + F +A+ ++ R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 765 IKIITI-----CSSIDSKGADFKALVFECMKNG-SLEDWLHQSNDHLEVCKLTLIQRVNI 818
+ + I + KG ++ +V E + G L+ Q+ + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG------TFKKSTVLQL 156
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASK 876
I + +EY+H + VHGD+K +N+LL + V D+GL+ + +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 877 TSSSSIGIKGTVGYVAPEYC-----MGSEASMTGDVYSFGILLLELFTGRRP 923
+ G GT+ E+ G S DV G +L G+ P
Sbjct: 214 ENPRK-GHNGTI-----EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKALRNIRHRNLIKII 768
++G+G+FG V A+K++ + K + E + L+N RH L +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAIE 827
+ + V E G L HL ++ +R ++ SA+E
Sbjct: 72 ---YAFQTHDRLC--FVMEYANGGEL---FF----HLSRERVFTEERARFYGAEIVSALE 119
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIK 885
YLH +V+ D+K N++LD D H+ DFGL K + + +
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK----EGISDGATMKT----FC 166
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE ++ D + G+++ E+ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 6e-15
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 712 MIGQGSFGSVY---KGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKALRNIRHRNLI 765
++GQGSFG V+ K + + A+KV+ LK + ++ E L + H ++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 89
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVAS 824
K+ + ++G + L+ + ++ G L L + + V ++A
Sbjct: 90 KLH---YAFQTEGKLY--LILDFLRGGDL---FT----RLSKEVMFTEEDVKFYLAELAL 137
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSI 882
A+++LH +++ DLKP N+LLD + H+ DFGL+K +D K S
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK----ESIDHEKKAYS--- 185
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GTV Y+APE + + D +SFG+L+ E+ TG P
Sbjct: 186 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 46/259 (17%), Positives = 86/259 (33%), Gaps = 84/259 (32%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G GSFG V + E A+K + + + E ++ + H N+IK++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 773 SIDSKGADFKA---------------------------------LVFECMKNGSLEDWLH 799
+ + ++ E + D LH
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-----PDTLH 125
Query: 800 QSNDH---------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850
+ + + + + Q + A+ ++H + H D+KP N+L++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQ-------LFRAVGFIHSL---GICHRDIKPQNLLVN 175
Query: 851 -HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV------APEYCMGSEASM 903
D + DFG AK L + A Y+ APE +G+
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVA---------------YICSRFYRAPELMLGATEYT 220
Query: 904 TG-DVYSFGILLLELFTGR 921
D++S G + EL G+
Sbjct: 221 PSIDLWSIGCVFGELILGK 239
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 50/234 (21%), Positives = 92/234 (39%), Gaps = 39/234 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMI-----VAVKVIN-----LKQKGAFKSFMAECKALRNIRHR 762
IGQG FG +Y + E + VKV L + F A+ + ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 763 NLIKIITICS-----SIDSKGADFKALVFECMKNG-SLEDWLHQSNDHLEVCKLTLIQRV 816
+K + + D G ++ ++ + G L+ ++++N + + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANAK----RFSRKTVL 155
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTA 874
+++ + +EY+H H VHGD+K SN+LL++ V D+GLA + A
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 875 SKTSSSSIGIKGTVGYVAPEYC-----MGSEASMTGDVYSFGILLLELFTGRRP 923
GT+ E+ G S GD+ G +++ TG P
Sbjct: 213 YAADPKR-CHDGTI-----EFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 62/231 (26%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMA------ECKALRNIRHRNLIK 766
+G G++G+V + G VA+K K F+S + E + L+++RH N+I
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIK----KLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 767 IITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ-------SNDHLEVCKLTLIQRVN 817
++ + + D DF LV M L + D + + Q
Sbjct: 89 LLDVFTP-DETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR---IQFLVYQ--- 136
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT 877
+ + Y+H ++H DLKP N+ ++ D + DFGLA+ S
Sbjct: 137 ----MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG----- 184
Query: 878 SSSSIGIKGTVGYV------APEYCMGS-EASMTGDVYSFGILLLELFTGR 921
YV APE + + T D++S G ++ E+ TG+
Sbjct: 185 ------------YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 49/238 (20%), Positives = 80/238 (33%), Gaps = 65/238 (27%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN-----LKQKGAFKSFMA------ECKALRNIRH 761
I GS+G+V G+ E VA+K + + E + L + H
Sbjct: 30 ISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 762 RNLIKIITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ---------SNDHLEVCKL 810
N++ + I + LV E M L Q S H +
Sbjct: 89 PNILGLRDIFVHFEEP--AMHKLYLVTELM-----RTDLAQVIHDQRIVISPQH---IQY 138
Query: 811 TLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQ 870
+ + + LH + +VH DL P N+LL + + DF LA+ ++
Sbjct: 139 FMYH-------ILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 871 LDTASKTSSSSIGIKGTVGYV------APEYCMGS-EASMTGDVYSFGILLLELFTGR 921
T YV APE M + D++S G ++ E+F +
Sbjct: 189 NKT---------------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 56/266 (21%), Positives = 99/266 (37%), Gaps = 57/266 (21%)
Query: 676 RRSARKSVDTSPREKQFPTVSYAELSKAT-SEFASSNMIGQGSFGSVYKGILGEDEMIVA 734
+ + K +E + A +F +G GSFG V E A
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 735 VK------VINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFEC 788
+K V+ LKQ + + E + L+ + L+K+ S D+ +V E
Sbjct: 71 MKILDKQKVVKLKQ---IEHTLNEKRILQAVNFPFLVKLE--FSFKDN---SNLYMVMEY 122
Query: 789 MKNGSLEDWLHQSNDHLEVCKLTLIQRVNI---------AIDVASAIEYLHHHCQPPMVH 839
+ G + + ++R+ A + EYLH +++
Sbjct: 123 VAGGEM---------------FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 840 GDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM 897
DLKP N+L+D ++ DFG AK + +T + + GT +APE +
Sbjct: 165 RDLKPENLLIDQQ--GYIQVTDFGFAKRVK-------GRTWT----LCGTPEALAPEIIL 211
Query: 898 GSEASMTGDVYSFGILLLELFTGRRP 923
+ D ++ G+L+ E+ G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 42/217 (19%), Positives = 77/217 (35%), Gaps = 27/217 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FKSFMAECKALRNIRHR-NLIKIIT 769
+G+G F V + I A K + +++G + E L + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ + L+ E G + ++ + + + + YL
Sbjct: 97 VYEN-----TSEIILILEYAAGGEIFSLCLPELAE----MVSENDVIRLIKQILEGVYYL 147
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSH---VGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
H + +VH DLKP N+LL + DFG+++ + I G
Sbjct: 148 HQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---------EIMG 195
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T Y+APE + D+++ GI+ L T P
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-14
Identities = 67/360 (18%), Positives = 120/360 (33%), Gaps = 50/360 (13%)
Query: 74 HRHQRVTRLDLSNQRIG----GILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLR--- 126
++ +L L N + G+LS + L L+ ++LSDN Q + L
Sbjct: 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141
Query: 127 --LEKLALPNNSFSGT----IPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLK-----L 175
LEKL L S S + + L + +L VSNN + + LK L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 176 QTLAVGKNYLTGR----LPDFVGNLSALEVFSITGNSLGGK-----IPTTLGLLRNLVDL 226
+ L + +T L V + ++L ++ N LG P L L L
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261
Query: 227 HVGGNQFSGTFPQSICNI----SSLERIYLPFNRFSGT----LPFDIVVNLPNLKSLAIG 278
+ + +C + SL+ + L N L ++ L+SL +
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321
Query: 279 GNNF----FGSIPDSLSNASNVEILDLGFNQFKGKVSIDFS-----SLKNLSWLNLEQNN 329
+F L+ + L + N+ + + L L L +
Sbjct: 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381
Query: 330 LGMGTANDLDFVTFLTNCSSLKILSLAANQF----VGELPHSIANLSSSMIEFRIGGNQI 385
+ + + L L SL+ L L+ N + +L S+ + + +
Sbjct: 382 VSDSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-12
Identities = 69/460 (15%), Positives = 138/460 (30%), Gaps = 65/460 (14%)
Query: 199 LEVFSITGNSLGGK-IPTTLGLLRNLVDLHVGGNQFSGTFPQSICNI----SSLERIYLP 253
++ I L L LL+ + + + + I + +L + L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 254 FNRFSG----TLPFDIVVNLPNLKSLAIGGNNF----FGSIPDSLSNASNVEILDLGFNQ 305
N + + ++ L++ G + +L ++ L L N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 306 FKGKVSIDFSSL-----KNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360
L L LE +L + L V L K L+++ N
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV--LRAKPDFKELTVSNNDI 182
Query: 361 ----VGELPHSIANLSSSMIEFRIGGNQI----FGIIPSGIRNLVNLIALGMQSNQLHGT 412
V L + + + ++ + + + + +L L + SN+L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 413 -----IPDVIGELKNLQGLFLYKNVLQ----GSIPSGVGNLTKLAKLVMSYNSLQG---- 459
P ++ L+ L++++ + G + + L +L ++ N L
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 460 NIPSSLGNCQ-NLIGFNASHNKLTG----ALPQQLLSITTLSVYLDLSNNNL--NGSLPL 512
+ +L L T L L L +SNN L G L
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE-LQISNNRLEDAGVREL 361
Query: 513 QIG---NLKNLVKLIISSNQFS--GVIPVT--LSTCVSLEYLDISSNSFH--GV--IPHS 561
G L L ++ S + L SL LD+S+N G+ + S
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 421
Query: 562 LGFLKS-IKVLNFSSNNLSGQ----IPEFLENLSFLEFLN 596
+ ++ L S + + ++ L ++
Sbjct: 422 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 67/378 (17%), Positives = 116/378 (30%), Gaps = 61/378 (16%)
Query: 267 VNLPNLKSLAIGGNNF-FGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSL----KNLS 321
++L +++SL I + L +++ L D SS L+
Sbjct: 1 MSL-DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59
Query: 322 WLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANL---SSSMIEF 378
LNL N LG + + T ++ LSL G +++ ++ E
Sbjct: 60 ELNLRSNELGDVGVHCV-LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 379 RIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQ---- 434
+ N + +G + L+ G+ Q L+ L L L
Sbjct: 119 HLSDNL---LGDAG----LQLLCEGLLDPQ------------CRLEKLQLEYCSLSAASC 159
Query: 435 GSIPSGVGNLTKLAKLVMSYNSLQG----NIPSSLGNCQ-NLIGFNASHNKLT----GAL 485
+ S + +L +S N + + L + L +T L
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219
Query: 486 PQQLLSITTLSVYLDLSNNNLNGS-----LPLQIGNLKNLVKLIISSNQFS--GVIPVT- 537
+ S +L L L +N L P + L L I + G +
Sbjct: 220 CGIVASKASLR-ELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278
Query: 538 -LSTCVSLEYLDISSNSFH--GVIPHSLGFLK---SIKVLNFSSNNLSGQ----IPEFLE 587
L SL+ L ++ N G L+ ++ L S + + L
Sbjct: 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLA 338
Query: 588 NLSFLEFLNFSHNDLEGE 605
FL L S+N LE
Sbjct: 339 QNRFLLELQISNNRLEDA 356
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 38/255 (14%), Positives = 77/255 (30%), Gaps = 38/255 (14%)
Query: 197 SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR 256
E F +T + +IP L + L + + N+ ++ RIY+ +
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 257 FSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSS 316
L NL + + I I
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA-----------------------LKE 103
Query: 317 LKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELP-HSIANLSSSM 375
L L +L + L +T + + IL + N ++ +P ++ L +
Sbjct: 104 LPLLKFLGIFNTGL-----KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158
Query: 376 IEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVI--GELKNLQGLFLYKNVL 433
+ ++ N + N L A+ + N+ I G L + + +
Sbjct: 159 LTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217
Query: 434 QGSIPSGV-GNLTKL 447
++PS +L +L
Sbjct: 218 T-ALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 36/205 (17%), Positives = 74/205 (36%), Gaps = 7/205 (3%)
Query: 398 NLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNS 456
+ L + L L N+ +++ +V + S NL+K+ + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 457 LQGNIPSS-LGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI- 514
I L L + L + T + L++++N S+P+
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 515 GNLKN-LVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSL--GFLKSIKVL 571
L N + L + +N F+ V + L+ + ++ N + VI G +L
Sbjct: 152 QGLCNETLTLKLYNNGFTSVQGYAFNGT-KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 572 NFSSNNLSGQIPEFLENLSFLEFLN 596
+ S +++ + LE+L L N
Sbjct: 211 DVSQTSVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 45/257 (17%), Positives = 77/257 (29%), Gaps = 60/257 (23%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
L L + I S NL + I +S + L+ L ++SF
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSID-----------VTLQ----QLESHSFY 77
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPD--FVGN 195
S + + + N + I + L L+ L + L PD V +
Sbjct: 78 NL--------SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128
Query: 196 LSALEVFSITGNSLGGKIPTTL--GLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLP 253
+ IT N IP GL + L + N F+ +
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT----------------SVQ 172
Query: 254 FNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIP-DSLSNA-SNVEILDLGFNQFKGKVS 311
F+GT L ++ + N + I D+ S +LD+ +
Sbjct: 173 GYAFNGT----------KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT---A 219
Query: 312 IDFSSLKNLSWLNLEQN 328
+ L++L L
Sbjct: 220 LPSKGLEHLKELIARNT 236
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 42/235 (17%), Positives = 84/235 (35%), Gaps = 41/235 (17%)
Query: 713 IGQGSFGSVYKGI--------LGEDEMIVAVKV--INLKQKGAFKSFMAECKA--LRNIR 760
+ + G +Y+ G + ++K+ + + F K + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 761 HRNLIKIITICSSIDS--KGADFKALVFECMKNG-SLEDWLHQSNDHLEVCKLTLIQRVN 817
++ I + + ++ LV + G SL+ L S H+ + L
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVL----Q 163
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAK-FLSSHQLDT 873
+A + A+E+LH + VHG++ N+ + D V + +G A + S +
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPSGKHVA 219
Query: 874 ASKTSSSSIGIKGTVGYVAPEYC-----MGSEASMTGDVYSFGILLLELFTGRRP 923
+ S S +G + E+ G S D+ S G +L+ G P
Sbjct: 220 YVEGSRSP--HEGDL-----EFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 51/263 (19%), Positives = 90/263 (34%), Gaps = 65/263 (24%)
Query: 712 MIGQGSFGSVYKGILGEDEMI---VAVKVINLKQKGAFKSFMAECKALRNIR-----HRN 763
+G G F +V+ L D VA+KV+ + ++ + E + L+++R N
Sbjct: 44 KLGWGHFSTVW---LSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPN 99
Query: 764 LIKIITICSS--IDSKGADFKALVFECMKNGSLEDWLHQSND---HLEVCKLTLIQRVNI 818
++ + I +VFE + + L W+ +SN L K + Q
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQ---- 154
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
V ++YLH C+ ++H D+KP N+LL + A S ++
Sbjct: 155 ---VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 879 SSSIGIKG--------------------------------------TVGYVAPEYCMGSE 900
S+ T Y + E +GS
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG 269
Query: 901 ASMTGDVYSFGILLLELFTGRRP 923
+ D++S + EL TG
Sbjct: 270 YNTPADIWSTACMAFELATGDYL 292
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF-KSFMAECKALRNIRHR---NLIK 766
++IG+GSFG V K ++ VA+K+I K K AF E + L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASA 825
I+ + + LVFE + +L D L +N + L L ++ A + +A
Sbjct: 118 IVHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTNFRGVS---LNLTRK--FAQQMCTA 169
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH--VGDFGLAKFLSSHQLDTASKTSSSSIG 883
+ +L + ++H DLKP N+LL + S + DFG + L + S
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QRIYQYIQSRF- 223
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR 921
Y +PE +G + D++S G +L+E+ TG
Sbjct: 224 ------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 4e-14
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 712 MIGQGSFGSVY---KGILGEDEMIVAVKVIN----LKQKGAFKSFMAECKALRNIRHRNL 764
++G+G +G V+ K I A+KV+ ++ AE L ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVA 823
+ +I + + G + L+ E + G L L + +E +++
Sbjct: 84 VDLI---YAFQTGGKLY--LILEYLSGGELFMQLEREGIFME-------DTACFYLAEIS 131
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSS 881
A+ +LH +++ DLKP N++L+H HV DFGL K + + T +
Sbjct: 132 MALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCKE----SIHDGTVTHT-- 180
Query: 882 IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT+ Y+APE M S + D +S G L+ ++ TG P
Sbjct: 181 --FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 48/251 (19%), Positives = 91/251 (36%), Gaps = 63/251 (25%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKII 768
+IG+G+FG V + A+K+++ + ++ F E + ++++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 134
Query: 769 TICSSIDSKGADFKA-----LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
A F+ +V E M G L + L+ ++ A
Sbjct: 135 --------FYA-FQDDRYLYMVMEYMPGGDL---------------VNLMSNYDVPEKWA 170
Query: 824 --------SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDT 873
A++ +H +H D+KP N+LLD H+ DFG ++ +
Sbjct: 171 RFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNK---EG 222
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMGSEAS----MTGDVYSFGILLLELFTGRRPTDAAFT 929
+ ++ GT Y++PE D +S G+ L E+ G P F
Sbjct: 223 MVRCDTAV----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP----FY 274
Query: 930 EGLTLHEFAKI 940
+ ++KI
Sbjct: 275 ADSLVGTYSKI 285
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKAL-RNIRHRNLIKI 767
M+G+GSFG V+ + A+K + + + M E + L H L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ +K F V E + G L + + K L + A ++ ++
Sbjct: 84 F---CTFQTKENLF--FVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQ 132
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+LH +V+ DLK N+LLD D H+ DFG+ K + +KT++
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK----ENMLGDAKTNT----FC 179
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE +G + + + D +SFG+LL E+ G+ P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 59/240 (24%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECK-ALRNIR-------HRNL 764
+G+G++G V+K I +VAVK K AF++ + + R I H N+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVK----KIFDAFQNST-DAQRTFREIMILTELSGHENI 71
Query: 765 IKIITICSSIDSKGADFKA--LVFECMKNGSLEDWLHQ-------SNDHLEVCKLTLIQR 815
+ ++ + + + + LVF+ M E LH H + + Q
Sbjct: 72 VNLLNVLRA-----DNDRDVYLVFDYM-----ETDLHAVIRANILEPVH---KQYVVYQL 118
Query: 816 VNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875
+ I+YLH ++H D+KPSN+LL+ + V DFGL++ + + T +
Sbjct: 119 IK-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 876 KTSSSSIGIKGTV-------GYV------APEYCMGSEA-SMTGDVYSFGILLLELFTGR 921
S + + YV APE +GS + D++S G +L E+ G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 8e-14
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 30/218 (13%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKAL-RNIRHRNLIKI 767
++G+GSFG V + + AVK++ + Q + M E + L + L ++
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
S + + V E + G L + Q + V A ++A +
Sbjct: 408 H---SCFQTMDRLY--FVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLF 456
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+L +++ DLK NV+LD + H+ DFG+ K + T +
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK----ENIWDGVTTKT----FC 503
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE + D ++FG+LL E+ G+ P
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKAL-RNIRHRNLIKI 767
+IG+GSFG V +E+ AVKV+ + +K K M+E L +N++H L+ +
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAI 826
S + + V + + G L L + LE R A ++ASA+
Sbjct: 105 H---FSFQTADKLY--FVLDYINGGELFYHLQRERCFLE-------PRARFYAAEIASAL 152
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGI 884
YLH +V+ DLKP N+LLD H+ DFGL K ++ S TS+
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK----ENIEHNSTTST----F 199
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE T D + G +L E+ G P
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 56/236 (23%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKV------INLKQKGAFKSFMAECKALRN 758
+F +G GSFG V+ + A+KV + LKQ + E L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ---VEHTNDERLMLSI 62
Query: 759 IRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
+ H +I++ + D+ ++ + ++ G L +L+++
Sbjct: 63 VTHPFIIRMW--GTFQDA---QQIFMIMDYIEGGEL---------------FSLLRKSQR 102
Query: 819 ---------AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLS 867
A +V A+EYLH +++ DLKP N+LLD + H+ DFG AK++
Sbjct: 103 FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAKYVP 157
Query: 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T + + GT Y+APE + + D +SFGIL+ E+ G P
Sbjct: 158 -------DVTYT----LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 47/235 (20%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHR-----NLIK 766
+G G+FG V +++ AVKV+ +K +S E L+ I++ N++K
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK-YTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 767 IIT-------ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
+C L+FE + SL + + N++ + I+
Sbjct: 101 YHGKFMYYDHMC------------LIFEPLGP-SLYEII-TRNNYNGF-HIEDIKL--YC 143
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
I++ A+ YL + H DLKP N+LLD +K++
Sbjct: 144 IEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 880 -------SSIGIKGTVG-------YVAPEYCMGSEASMTGDVYSFGILLLELFTG 920
+ G Y APE + ++ D++SFG +L EL+TG
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 54/241 (22%), Positives = 101/241 (41%), Gaps = 35/241 (14%)
Query: 712 MIGQGSFGSVY---KGILGEDEMIVAVKVIN----LKQKGAFKSFMAECKALRNIRHRNL 764
++G G++G V+ K + + A+KV+ +++ + E + L +IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVA 823
+ +T+ + ++ L+ + + G L HL + V I ++
Sbjct: 121 L--VTLHYAFQTETKLH--LILDYINGGEL---FT----HLSQRERFTEHEVQIYVGEIV 169
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSS 881
A+E+LH +++ D+K N+LLD + HV DFGL+K D +
Sbjct: 170 LALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSK---EFVADETERAYD-- 219
Query: 882 IGIKGTVGYVAPEYCMGSEA--SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939
GT+ Y+AP+ G ++ D +S G+L+ EL TG P + +
Sbjct: 220 --FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277
Query: 940 I 940
I
Sbjct: 278 I 278
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 5e-13
Identities = 47/328 (14%), Positives = 102/328 (31%), Gaps = 24/328 (7%)
Query: 42 LAIKSQLHDTSGVTSSWNNTINLCQWTGVTCGHRHQRVTRL---DLSNQRIGGILSPYVG 98
L +++ HD L + T L D + +
Sbjct: 235 LLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRN 294
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS----GTIPTNLSRCSNLIQL 154
S + +L S + ++PQ ++ + + + L +
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRC 354
Query: 155 RVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIP 214
+S K + +E+ S +LQ L + + + L L + +
Sbjct: 355 ELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLL-YEKETLQYFSTL- 411
Query: 215 TTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKS 274
+ +R + ++F + + ++L + L + L +
Sbjct: 412 KAVDPMRAAYLDDLR-SKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH--LEQLLLVTH 467
Query: 275 LAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID-FSSLKNLSWLNLEQNNLGMG 333
L + N ++P +L+ +E+L N + ++D ++L L L L N L
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALE---NVDGVANLPRLQELLLCNNRL--- 520
Query: 334 TANDLDFVTFLTNCSSLKILSLAANQFV 361
+ L +C L +L+L N
Sbjct: 521 --QQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 3e-12
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 19/210 (9%)
Query: 388 IIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKL 447
++ S + + L L ++ TI I ++ L L K LQ + +
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 448 AKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALP--QQLLSITTLSVYLDLSNNN 505
A L + ++ + +H LT L +QLL +T +LDLS+N
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVT----HLDLSHNR 474
Query: 506 LNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSN---SFHGVIPHSL 562
L +LP + L+ L L S N V ++ L+ L + +N + P L
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNRLQQSAAIQP--L 529
Query: 563 GFLKSIKVLNFSSNNLSGQIPEFLENLSFL 592
+ +LN N+L Q E L+ +
Sbjct: 530 VSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.9 bits (165), Expect = 9e-12
Identities = 37/218 (16%), Positives = 64/218 (29%), Gaps = 19/218 (8%)
Query: 390 PSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAK 449
L + + + + K LQ L +I + L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 450 LVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGS 509
+ + ++ + + L L L L++ +L
Sbjct: 401 EKETLQYF--STLKAVDPMRAAYLDDLRSKFLLE--NSVLKMEYADVRVLHLAHKDLT-V 455
Query: 510 LPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSN---SFHGVIPHSLGFLK 566
L + L + L +S N+ +P L+ LE L S N + G + L
Sbjct: 456 LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG-----VANLP 508
Query: 567 SIKVLNFSSNNLSGQIPEF--LENLSFLEFLNFSHNDL 602
++ L +N L Q L + L LN N L
Sbjct: 509 RLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 7e-11
Identities = 39/210 (18%), Positives = 66/210 (31%), Gaps = 10/210 (4%)
Query: 431 NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLL 490
+L + +S + S L +C+ L + + +
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 491 SITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDIS 550
++ L Y + + L+ + L ++F V + L ++
Sbjct: 394 ALDPLL-YEKETLQYFST---LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 551 SNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKG 610
V+ H L L + L+ S N L +P L L LE L S N LE V
Sbjct: 450 HKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVA 505
Query: 611 VFSSKTKLSLQGNVKLCGGTDELHLPTCPS 640
+L L N +L L +CP
Sbjct: 506 NLPRLQELLLCNN-RLQQSAAIQPLVSCPR 534
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 2e-08
Identities = 33/234 (14%), Positives = 70/234 (29%), Gaps = 19/234 (8%)
Query: 251 YLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKV 310
+ L + + L + ++ L+ +
Sbjct: 330 ECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI 388
Query: 311 SIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIAN 370
+ +L L + + L V + + S +
Sbjct: 389 ILLMRALDPLLYEKETLQYF-----STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV 443
Query: 371 LSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYK 430
+ + + + L+ + L + N+L +P + L+ L+ L
Sbjct: 444 R-----VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASD 495
Query: 431 NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPS--SLGNCQNLIGFNASHNKLT 482
N L+ ++ GV NL +L +L++ N LQ + L +C L+ N N L
Sbjct: 496 NALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 30/218 (13%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKAL-RNIRHRNLIKI 767
++G+GSFG V + + AVK++ + Q + M E + L + L ++
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
S + + V E + G L + Q + V A ++A +
Sbjct: 87 H---SCFQTMDRLY--FVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLF 135
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+L +++ DLK NV+LD + H+ DFG+ K + T +
Sbjct: 136 FLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK----ENIWDGVTTKT----FC 182
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE + D ++FG+LL E+ G+ P
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKALRNIRHRNLIKII 768
+IG+GS+ V L + + I A+KV+ + E + + +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL--V 73
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAIE 827
+ S ++ F V E + G L + + E + + +++ A+
Sbjct: 74 GLHSCFQTESRLF--FVIEYVNGGDLMFHMQRQRKLPE-------EHARFYSAEISLALN 124
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIK 885
YLH +++ DLK NVLLD + H+ D+G+ K L TS+
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK----EGLRPGDTTST----FC 171
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE G + + D ++ G+L+ E+ GR P
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKALRNIRHRNLIKII 768
+IG+GS+ V L + + I A++V+ + E + + +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL--V 116
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAIE 827
+ S ++ F V E + G L + + E + + +++ A+
Sbjct: 117 GLHSCFQTESRLF--FVIEYVNGGDLMFHMQRQRKLPE-------EHARFYSAEISLALN 167
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIK 885
YLH +++ DLK NVLLD + H+ D+G+ K L TS+
Sbjct: 168 YLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK----EGLRPGDTTST----FC 214
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y+APE G + + D ++ G+L+ E+ GR P
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 28/217 (12%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFKSFMAECKALRNIRHRNLIKII 768
++G+GSFG V + E + AVKV+ + Q + M E + L R+ +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL--T 87
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ + F V E + G L + +S + + A ++ SA+ +
Sbjct: 88 QLFCCFQTPDRLF--FVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMF 139
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
LH +++ DLK NVLLDH+ H DFG+ K + T++ G
Sbjct: 140 LHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK----EGICNGVTTAT----FCG 186
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T Y+APE D ++ G+LL E+ G P
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 34/156 (21%), Positives = 62/156 (39%), Gaps = 17/156 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITIC 771
+G G G V + + A+K++ A + E + + ++++I+ +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+ G +V EC+ G L + D T + I + AI+YLH
Sbjct: 81 EN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHS 135
Query: 832 HCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAK 864
+ H D+KP N+L + + + DFG AK
Sbjct: 136 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 44/224 (19%), Positives = 90/224 (40%), Gaps = 29/224 (12%)
Query: 712 MIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHR---NLIKI 767
+G+G+FG V + + + VA+K+I K ++ E L+ I+ + N
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-YREAARLEINVLKKIKEKDKENKFLC 84
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASAI 826
+ + + G + FE + + ++L ++N L ++ +A + A+
Sbjct: 85 VLMSDWFNFHG--HMCIAFELLGK-NTFEFLKENNFQPY---PLPHVRH--MAYQLCHAL 136
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKT----SSSSI 882
+LH + + H DLKP N+L + + + + +T+ + S++
Sbjct: 137 RFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE-EKSVKNTSIRVADFGSATFD 192
Query: 883 GIKGTVGYV------APEYCMGSEASMTGDVYSFGILLLELFTG 920
T V PE + + DV+S G +L E + G
Sbjct: 193 HEHHTT-IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 52/167 (31%), Positives = 66/167 (39%), Gaps = 35/167 (20%)
Query: 294 SNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKIL 353
++ E LDL F L L+WLNL+ N L +A D +T L L
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGT------L 88
Query: 354 SLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGT 412
LA NQ L+S +P G+ +L L L + NQL
Sbjct: 89 GLANNQ-----------LAS---------------LPLGVFDHLTQLDKLYLGGNQLKSL 122
Query: 413 IPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQ 458
V L L+ L L N LQ SIP+G LT L L +S N LQ
Sbjct: 123 PSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ 168
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 43/154 (27%), Positives = 61/154 (39%), Gaps = 11/154 (7%)
Query: 382 GNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV 441
+ + + R L L L + NQL V +L L L L N L S+P GV
Sbjct: 44 STGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGV 102
Query: 442 -GNLTKLAKLVMSYNSLQGNIPS----SLGNCQNLIGFNASHNKLTGALPQQLLSITTLS 496
+LT+L KL + N L+ +PS L + L + N+L ++P T
Sbjct: 103 FDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKEL---RLNTNQLQ-SIPAGAFDKLTNL 157
Query: 497 VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQF 530
L LS N L L L + + NQF
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 40/161 (24%), Positives = 63/161 (39%), Gaps = 17/161 (10%)
Query: 176 QTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSG 235
+ L + L L+ L ++ N L L L L + NQ +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 236 TFPQSI-CNISSLERIYLPFNRFSGTLP---FDIVVNLPNLKSLAIGGNNFFGSIP---- 287
+ P + +++ L+++YL N+ +LP FD L LK L + N SIP
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFD---RLTKLKELRLN-TNQLQSIPAGAF 151
Query: 288 DSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQN 328
D L+N ++ L L NQ + F L L + L N
Sbjct: 152 DKLTN---LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 42/159 (26%), Positives = 62/159 (38%), Gaps = 24/159 (15%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG G+FG + G VA+K+ K E + + L I
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFY-----KQLGSGDGIPQ 69
Query: 773 SIDS-KGADFKALVFECMKNG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
+ A+V E + G SLED L D +L + IAI + S +EY+H
Sbjct: 70 VYYFGPCGKYNAMVLELL--GPSLED-LFDLCDR----TFSLKTVLMIAIQLISRMEYVH 122
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVS-----HVGDFGLAK 864
+++ D+KP N L+ H+ DF LAK
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 2e-11
Identities = 36/197 (18%), Positives = 59/197 (29%), Gaps = 39/197 (19%)
Query: 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVI--------NLKQKGAFKSFMAE-- 752
T + IG+G FG V++ I D VA+K+I N + F+ + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 753 -CKALRNIRHRNLIKIITICSSIDS---KGADFKALVFECM----KNGSLEDWLHQSNDH 804
K L + + +G+ L+ GS D D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 805 -----LEVC------------KLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNV 847
LE +L +I + +++ + H DL NV
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193
Query: 848 LLDHDMVSHVGDFGLAK 864
LL + + K
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 52/214 (24%), Positives = 79/214 (36%), Gaps = 31/214 (14%)
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKL 447
IPS I + L +QSN+L L L+ L+L N LQ ++P+G+ L L
Sbjct: 31 IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 448 AKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLN 507
L ++ N LQ ALP + L L N L
Sbjct: 88 ETLWVTDNKLQ-------------------------ALPIGVFDQLVNLAELRLDRNQLK 122
Query: 508 GSLPLQI-GNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLK 566
SLP ++ +L L L + N+ + SL+ L + +N V + L
Sbjct: 123 -SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLT 181
Query: 567 SIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
+K L +N L ++L L+ L N
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 48/192 (25%), Positives = 76/192 (39%), Gaps = 27/192 (14%)
Query: 285 SIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGM---GTANDLDFV 341
+IP ++ ++ + LDL N+ S F L L L L N L G +L +
Sbjct: 30 AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 342 TFL---------------TNCSSLKILSLAANQFVGELPHSI-ANLSSSMIEFRIGGNQI 385
L +L L L NQ LP + +L+ + +G N++
Sbjct: 88 ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK-LTYLSLGYNEL 145
Query: 386 FGIIPSGI-RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GN 443
+P G+ L +L L + +NQL +L L+ L L N L+ +P G +
Sbjct: 146 -QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDS 203
Query: 444 LTKLAKLVMSYN 455
L KL L + N
Sbjct: 204 LEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 8/180 (4%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEI-GNLLRLEKLALPNNSFS 138
+LDL + ++ + S L+ LR + L+DN +P I L LE L + +N
Sbjct: 40 KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ 98
Query: 139 GTIPTNL-SRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFV-GN 195
+P + + NL +LR+ N+L+ +P + SL KL L++G N L LP V
Sbjct: 99 -ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 196 LSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFN 255
L++L+ + N L L L L + NQ + ++ L+ + L N
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 55/208 (26%), Positives = 83/208 (39%), Gaps = 37/208 (17%)
Query: 127 LEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYL 185
+KL L +N S R + L L +++NKL+ +PA I L L+TL V N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 186 TGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFS----GTFPQSI 241
LP VF L NL +L + NQ F
Sbjct: 98 Q-ALPI--------GVFD---------------QLVNLAELRLDRNQLKSLPPRVFD--- 130
Query: 242 CNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSL-SNASNVEILD 300
+++ L + L +N +LP + L +LK L + N +P+ + ++ L
Sbjct: 131 -SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQ-LKRVPEGAFDKLTELKTLK 187
Query: 301 LGFNQFKGKVSIDFSSLKNLSWLNLEQN 328
L NQ K F SL+ L L L++N
Sbjct: 188 LDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 37/170 (21%), Positives = 61/170 (35%), Gaps = 41/170 (24%)
Query: 285 SIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTF- 343
IP +L + + L N K FS K L ++L N + ++L F
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-----SELAPDAFQ 77
Query: 344 -LTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIA 401
L + L L L N+ ++ +P + L +L
Sbjct: 78 GLRS---LNSLVLYGNK-----------ITE---------------LPKSLFEGLFSLQL 108
Query: 402 LGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKL 450
L + +N+++ D +L NL L LY N LQ +I G L + +
Sbjct: 109 LLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 30/169 (17%), Positives = 57/169 (33%), Gaps = 31/169 (18%)
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKL 447
IP+ + + + ++ N + P K L+ + L N + + L L
Sbjct: 26 IPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 448 AKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLN 507
LV+ N + LP+ L L L+ N +N
Sbjct: 83 NSLVLYGNKIT-------------------------ELPKSLFEGLFSLQLLLLNANKIN 117
Query: 508 GSLPLQI-GNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFH 555
L + +L NL L + N+ + T S +++ + ++ N F
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 38/180 (21%), Positives = 60/180 (33%), Gaps = 37/180 (20%)
Query: 65 CQWTGVTCGHRH---------QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHG 115
C V C + + +T + L I I LR I+LS+N
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS- 69
Query: 116 EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLK 174
L ++F G +L L + NK+ ++P + L
Sbjct: 70 ---------------ELAPDAFQGL--------RSLNSLVLYGNKIT-ELPKSLFEGLFS 105
Query: 175 LQTLAVGKNYLTGRLPDFV-GNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQF 233
LQ L + N + L +L L + S+ N L T LR + +H+ N F
Sbjct: 106 LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 28/145 (19%), Positives = 59/145 (40%), Gaps = 7/145 (4%)
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEI-GSLLKLQTLAVGKNYLTGRLPDFV-GNLS 197
IPTNL + ++R+ N ++ IP KL+ + + N ++ L L
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 198 ALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRF 257
+L + GN + + L +L L + N+ + + ++ +L + L N+
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 258 SGTLPFDIVVNLPNLKSLAIGGNNF 282
T+ L ++++ + N F
Sbjct: 141 Q-TIAKGTFSPLRAIQTMHLAQNPF 164
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 33/222 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG+GSFG +++G + VA+K + E + + L I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTY-----KLLAGCTGIPN 70
Query: 773 SIDS-KGADFKALVFECMKNG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
+ LV + + G SLED L K ++ A + + ++ +H
Sbjct: 71 VYYFGQEGLHNVLVIDLL--GPSLED-LLDLCGR----KFSVKTVAMAAKQMLARVQSIH 123
Query: 831 HHCQPPMVHGDLKPSNVLL------DHDMVSHVGDFGLAKFLSSHQLDTASKT---SSSS 881
+V+ D+KP N L+ + +M+ +V DFG+ KF D +K
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVKFY----RDPVTKQHIPYREK 175
Query: 882 IGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+ GT Y++ +G E S D+ + G + + G P
Sbjct: 176 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG GSFG +Y G VA+K+ +K K E K + ++ I I C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 773 SIDSKGADFKALVFECMKNG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+ D+ +V E + G SLED L K +L + +A + S IEY+H
Sbjct: 75 AEG----DYNVMVMELL--GPSLED-LFNFCSR----KFSLKTVLLLADQMISRIEYIHS 123
Query: 832 HCQPPMVHGDLKPSNVLL---DHDMVSHVGDFGLAKFLSSHQLDTASKT---SSSSIGIK 885
+H D+KP N L+ + ++ DFGLAK D + + +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY----RDARTHQHIPYRENKNLT 176
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y + +G E S D+ S G +L+ G P
Sbjct: 177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 49/319 (15%), Positives = 96/319 (30%), Gaps = 46/319 (14%)
Query: 79 VTRLDLSNQRIGG----ILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLR----LEKL 130
+ L I + + ++ I LS N+ E + + + LE
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 131 ALPNNSFS----------GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLK----LQ 176
+ + L +C L +R+S+N + L L+
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 177 TLAVGKNYLTGRLPDFVGNLS-ALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSG 235
L + N L P ++ AL+ ++ + ++ RN + N
Sbjct: 126 HLYLHNNGLG---PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL-----ENGSMK 177
Query: 236 TFPQSICNISSLERIYLPFNRFS----GTLPFDIVVNLPNLKSLAIGGNNF----FGSIP 287
+ ++ + L + + N L + + LK L + N F ++
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237
Query: 288 DSLSNASNVEILDLGFNQFKGKVSIDFSSL------KNLSWLNLEQNNLGMGTANDLDFV 341
+L + N+ L L + + L L L+ N + + L V
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297
Query: 342 TFLTNCSSLKILSLAANQF 360
L L L N+F
Sbjct: 298 -IDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 45/258 (17%), Positives = 81/258 (31%), Gaps = 50/258 (19%)
Query: 75 RHQRVTRLDLSNQRIGGI----------LSPYVGNLSFLRYINLSDNSFHGEIPQEIGNL 124
+ + + S+ G + L + L + LSDN+F + + +
Sbjct: 58 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 117
Query: 125 LR----LEKLALPNNSFS-------------GTIPTNLSRCSNLIQLRVSNNKLEGQIPA 167
L LE L L NN + L + N+LE
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 177
Query: 168 EIGSLLK----LQTLAVGKNYLTGR-----LPDFVGNLSALEVFSITGNSLGGK----IP 214
E + L T+ + +N + L + + L+V + N+ +
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237
Query: 215 TTLGLLRNLVDLHVGGNQFSGTFPQSICNI------SSLERIYLPFNRFSG----TLPFD 264
L NL +L + S ++ + L+ + L +N TL
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297
Query: 265 IVVNLPNLKSLAIGGNNF 282
I +P+L L + GN F
Sbjct: 298 IDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 48/322 (14%), Positives = 93/322 (28%), Gaps = 51/322 (15%)
Query: 272 LKSLAIGGNNF----FGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSL----KNLSWL 323
++ ++ + S+ L +V+ + L N + + S K+L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 324 NLEQNNLG----MGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANL---SSSMI 376
G + L C L + L+ N F + + + +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 377 EFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQG- 435
+ N + G P + + + + L+ + +N L+
Sbjct: 126 HLYLHNNGL-G--PQAGAKIARALQELAVNKKAKNA--------PPLRSIICGRNRLENG 174
Query: 436 ---SIPSGVGNLTKLAKLVMSYNSL-----QGNIPSSLGNCQNLIGFNASHNKLTG---- 483
+ L + M N + + + L CQ L + N T
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 234
Query: 484 ALPQQLLSITTLSVYLDLSNNNLNG------SLPLQIGNLKNLVKLIISSNQFSGVIPVT 537
AL L S L L L++ L+ L L + N+ T
Sbjct: 235 ALAIALKSWPNLRE-LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 293
Query: 538 LSTCV-----SLEYLDISSNSF 554
L T + L +L+++ N F
Sbjct: 294 LKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 53/362 (14%), Positives = 106/362 (29%), Gaps = 77/362 (21%)
Query: 290 LSNASNVEILDLGFNQFKGK----VSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLT 345
++ S +E L + + V ++ + L N +G A L +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWL--SENIA 57
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405
+ L+I + F G + I +++ + L + +
Sbjct: 58 SKKDLEIAEFSDI-FTGRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLS 102
Query: 406 SNQLHGTIPDVIGEL----KNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNI 461
N T + + + L+ L+L+ N L P K+A+ +
Sbjct: 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAG---AKIARALQELAVN---- 152
Query: 462 PSSLGNCQNLIGFNASHNKLTG----ALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNL 517
N L N+L + S L + + N
Sbjct: 153 -KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT-VKMVQNG------------ 198
Query: 518 KNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHG----VIPHSLGFLKSIKVLNF 573
I ++ L+ C L+ LD+ N+F + +L +++ L
Sbjct: 199 -------IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 251
Query: 574 SSNNLSGQ----IPEFLENLSF--LEFLNFSHNDLEGEVPT------KGVFSSKTKLSLQ 621
+ LS + + + L L+ L +N++E + L L
Sbjct: 252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 311
Query: 622 GN 623
GN
Sbjct: 312 GN 313
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 51/233 (21%), Positives = 95/233 (40%), Gaps = 47/233 (20%)
Query: 712 MIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAF-KSFMAECKALRNIRHR---NLIK 766
+G+G+FG V + I VAVK++ K + ++ +E + L ++ + +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + + G +VFE + S D++ + N L +L I++ +A + ++
Sbjct: 79 CVQMLEWFEHHG--HICIVFELLGL-STYDFI-KENGFLPF-RLDHIRK--MAYQICKSV 131
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG-------------------DFGLAKFLS 867
+LH + + H DLKP N+L + DFG A +
Sbjct: 132 NFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG 920
H ++ S+ Y APE + S DV+S G +L+E + G
Sbjct: 189 EHH---STLVSTRH--------YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 44/196 (22%), Positives = 66/196 (33%), Gaps = 40/196 (20%)
Query: 319 NLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEF 378
+ L+L NNL L T ++L L L+ N L+
Sbjct: 40 YTALLDLSHNNLSR-----LRAEWTPTRLTNLHSLLLSHNH-----------LNF----- 78
Query: 379 RIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSI 437
I S + NL L + SN LH + +L+ L+ L LY N + +
Sbjct: 79 ----------ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VV 127
Query: 438 PSGV-GNLTKLAKLVMSYNSLQGNIP----SSLGNCQNLIGFNASHNKLTGALPQQLLSI 492
++ +L KL +S N + P L+ + S NKL L +
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKL 186
Query: 493 TTLSV-YLDLSNNNLN 507
L L NN L
Sbjct: 187 PAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 41/174 (23%), Positives = 68/174 (39%), Gaps = 20/174 (11%)
Query: 460 NIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLK 518
++PS L + SHN L+ + + T L LS+N+LN + + +
Sbjct: 36 SLPSYT---ALL---DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 519 NLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578
NL L +SSN + S +LE L + +N V ++ + ++ L S N +
Sbjct: 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI 148
Query: 579 SGQIPE----FLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTK-----LSLQGN 623
S + P L L L+ S N L+ ++P L L N
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLP-LTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 39/188 (20%), Positives = 67/188 (35%), Gaps = 23/188 (12%)
Query: 65 CQWTGVTCGHRH---------QRVTRLDLSNQRIGGILSPYV-GNLSFLRYINLSDNSFH 114
C ++C + LDLS+ + + + + L+ L + LS N +
Sbjct: 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77
Query: 115 GEIPQEI-GNLLRLEKLALPNNSFSGTIPTN-LSRCSNLIQLRVSNNKLEGQIPAEI-GS 171
I E + L L L +N T+ S L L + NN + +
Sbjct: 78 -FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED 134
Query: 172 LLKLQTLAVGKNYLTGRLPD--FVG--NLSALEVFSITGNSLGGKIPTTLGLLRNLV--D 225
+ +LQ L + +N ++ R P L L + ++ N L T L L V
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 226 LHVGGNQF 233
L++ N
Sbjct: 194 LYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 42/203 (20%), Positives = 71/203 (34%), Gaps = 49/203 (24%)
Query: 268 NLP-NLKSLAIGGNNFFGSIP--DSLSNASNVEILDLGFNQFKGKVSID---FSSLKNLS 321
+LP L + NN + + + +N+ L L N I F + NL
Sbjct: 36 SLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN---FISSEAFVPVPNLR 91
Query: 322 WLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIG 381
+L+L N+L + LD F ++ +L++L L N +
Sbjct: 92 YLDLSSNHL-----HTLDEFLF-SDLQALEVLLLYNNH-----------IVV-------- 126
Query: 382 GNQIFGIIPSGI-RNLVNLIALGMQSNQLHGTIPDVIG---ELKNLQGLFLYKNVLQGSI 437
+ ++ L L + NQ+ ++I +L L L L N L+ +
Sbjct: 127 -------VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KL 178
Query: 438 PSGVGNLTKLAKLVMSYNSLQGN 460
P L KL V + L N
Sbjct: 179 PLTD--LQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 41/186 (22%), Positives = 62/186 (33%), Gaps = 30/186 (16%)
Query: 245 SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIP-DSLSNASNVEILDLGF 303
S + L N S L NL SL + N+ I ++ N+ LDL
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSS 97
Query: 304 NQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGE 363
N FS L+ L L L N++ +D F + + L+ L L+ NQ
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHI-----VVVDRNAF-EDMAQLQKLYLSQNQ---- 147
Query: 364 LPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNL 423
I+ +I L L+ L + SN+L + +L
Sbjct: 148 ----ISRFPVELI--------------KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW 189
Query: 424 QGLFLY 429
LY
Sbjct: 190 VKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 35/175 (20%), Positives = 59/175 (33%), Gaps = 19/175 (10%)
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIPAEI--GSLLKLQTLAVGKNYLTGRLPDFV-GNL 196
+P +L S L +S+N L ++ AE L L +L + N+L + +
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 197 SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFS----GTFPQSICNISSLERIYL 252
L ++ N L L+ L L + N F +++ L+++YL
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFE----DMAQLQKLYL 143
Query: 253 PFNRFSGTLP---FDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFN 304
N+ S P LP L L + N L L +
Sbjct: 144 SQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 31/171 (18%), Positives = 61/171 (35%), Gaps = 42/171 (24%)
Query: 285 SIPDSLSNASNVEILDLGFNQFKG-KVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTF 343
IP+ + L L N+F + + F L L +N N + D++ F
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-----TDIEEGAF 77
Query: 344 --LTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLI 400
+ + + L +N+ L + + + + L +L
Sbjct: 78 EGASG---VNEILLTSNR-----------LEN---------------VQHKMFKGLESLK 108
Query: 401 ALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKL 450
L ++SN++ D L +++ L LY N + ++ G L L+ L
Sbjct: 109 TLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTL 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 28/189 (14%), Positives = 58/189 (30%), Gaps = 52/189 (27%)
Query: 369 ANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLF 427
++ E R+ N+ + +GI + L L + +N++ + +
Sbjct: 28 EHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL 87
Query: 428 LYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALP 486
L N L+ ++ + L L L++ N + + + F
Sbjct: 88 LTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDS--------FI----------- 126
Query: 487 QQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEY 546
L ++ L + NQ + V P T SL
Sbjct: 127 -----------------------------GLSSVRLLSLYDNQITTVAPGAFDTLHSLST 157
Query: 547 LDISSNSFH 555
L++ +N F+
Sbjct: 158 LNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 29/117 (24%), Positives = 46/117 (39%), Gaps = 8/117 (6%)
Query: 245 SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPD-SLSNASNVEILDLGF 303
+ L N F+ I LP L+ + NN I + + AS V + L
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINF-SNNKITDIEEGAFEGASGVNEILLTS 90
Query: 304 NQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360
N+ + F L++L L L N + + +F SS+++LSL NQ
Sbjct: 91 NRLENVQHKMFKGLESLKTLMLRSNRITC-----VGNDSF-IGLSSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 35/152 (23%), Positives = 58/152 (38%), Gaps = 12/152 (7%)
Query: 477 SHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI-GNLKNLVKLIISSNQFSGVIP 535
S+ KL +P+ + T L L+NN I L L K+ S+N+ + +
Sbjct: 19 SNQKLN-KIPEHIPQYTA---ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEE 74
Query: 536 VTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFL-ENLSFLEF 594
+ + ++SN V L+S+K L SN ++ + LS +
Sbjct: 75 GAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRL 133
Query: 595 LNFSHNDLEGEVPTKGVFSSKTKLS---LQGN 623
L+ N + V G F + LS L N
Sbjct: 134 LSLYDNQIT-TVA-PGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 29/156 (18%), Positives = 60/156 (38%), Gaps = 16/156 (10%)
Query: 65 CQWTGVTCGHR---------HQRVTRLDLSNQRIGGILSPYV-GNLSFLRYINLSDNSFH 114
C+ T V C ++ Q L L+N + + + L LR IN S+N
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 115 GEIPQEI-GNLLRLEKLALPNNSFSGTIPTNL-SRCSNLIQLRVSNNKLEGQIPAEI-GS 171
+I + + ++ L +N + + +L L + +N++ + +
Sbjct: 71 -DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIG 127
Query: 172 LLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGN 207
L ++ L++ N +T P L +L ++ N
Sbjct: 128 LSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 31/150 (20%), Positives = 59/150 (39%), Gaps = 16/150 (10%)
Query: 140 TIPTNLSRCSNLIQLRVSNNKLEGQIP-AEIGSLLKLQTLAVGKNYLTGRLPD--FVGNL 196
IP ++ +LR++NN+ L +L+ + N +T + + F G
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEG-A 80
Query: 197 SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFS----GTFPQSICNISSLERIYL 252
S + +T N L L +L L + N+ + +F +SS+ + L
Sbjct: 81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFI----GLSSVRLLSL 136
Query: 253 PFNRFSGTLPFDIVVNLPNLKSLAIGGNNF 282
N+ + T+ L +L +L + N F
Sbjct: 137 YDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 48/156 (30%), Positives = 61/156 (39%), Gaps = 36/156 (23%)
Query: 294 SNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKIL 353
+N +IL L NQ F SL NL L L N LG D LT L +L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD---SLTQ---LTVL 93
Query: 354 SLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGT 412
L NQ L+ +PS + LV+L L M N+L
Sbjct: 94 DLGTNQ-----------LTV---------------LPSAVFDRLVHLKELFMCCNKLT-E 126
Query: 413 IPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKL 447
+P I L +L L L +N L+ SIP G L+ L
Sbjct: 127 LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSL 161
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 38/137 (27%), Positives = 54/137 (39%), Gaps = 15/137 (10%)
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405
+C S + S+ A +P + L + NQI + P +L+NL L +
Sbjct: 25 DCRSKRHASVPAG-----IPTNAQIL-------YLHDNQITKLEPGVFDSLINLKELYLG 72
Query: 406 SNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSS 464
SNQL V L L L L N L +PS V L L +L M N L +P
Sbjct: 73 SNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRG 130
Query: 465 LGNCQNLIGFNASHNKL 481
+ +L N+L
Sbjct: 131 IERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 34/129 (26%), Positives = 52/129 (40%), Gaps = 16/129 (12%)
Query: 207 NSLGGKIPTTLGLLRNLVDLHVGGNQF----SGTFPQSICNISSLERIYLPFNRFSGTLP 262
N + P L NL +L++G NQ G F ++ L + L N+ + LP
Sbjct: 50 NQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS----LTQLTVLDLGTNQLT-VLP 104
Query: 263 ---FDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKN 319
FD L +LK L + N +P + +++ L L NQ K F L +
Sbjct: 105 SAVFD---RLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 320 LSWLNLEQN 328
L+ L N
Sbjct: 161 LTHAYLFGN 169
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG GSFG +Y G + VA+K+ N+K K + E K R ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 773 SIDSKGADFKALVFECMKNG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
D+ LV + + G SLED L KL+L + +A + + +E++H
Sbjct: 73 VEG----DYNVLVMDLL--GPSLED-LFNFCSR----KLSLKTVLMLADQMINRVEFVHS 121
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSH---VGDFGLAKFLSSHQLDTASKT---SSSSIGIK 885
+H D+KP N L+ ++ + DFGLAK DT++ + +
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIPYRENKNLT 174
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT Y + +G E S D+ S G +L+ G P
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 21/164 (12%)
Query: 299 LDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAAN 358
+L V+ + L ++ + +++ L N ++ L+L N
Sbjct: 24 ANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQY-----LPN---VRYLALGGN 73
Query: 359 QFVGELP--HSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGTIPD 415
+ ++ + NL+ + GNQ +P+G+ L NL L + NQL
Sbjct: 74 KLH-DISALKELTNLT----YLILTGNQ-LQSLPNGVFDKLTNLKELVLVENQLQSLPDG 127
Query: 416 VIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQ 458
V +L NL L L N LQ S+P GV LT L +L +SYN LQ
Sbjct: 128 VFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ 170
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 23/115 (20%), Positives = 48/115 (41%), Gaps = 15/115 (13%)
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGM 404
+C+ + + + +P L + N++ I G+ L +L+ L +
Sbjct: 14 DCTGRGLKEIPRD-----IPLHTTEL-------LLNDNELGRISSDGLFGRLPHLVKLEL 61
Query: 405 QSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQ 458
+ NQL G P+ ++Q L L +N ++ I + + L +L L + N +
Sbjct: 62 KRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 25/143 (17%), Positives = 45/143 (31%), Gaps = 40/143 (27%)
Query: 294 SNVEILDLGFNQF-KGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTF--LTNCSSL 350
+ L L N+ + F L +L L L++N L ++ F ++ +
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-----TGIEPNAFEGASH---I 80
Query: 351 KILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQL 409
+ L L N+ + I + + L L L + NQ+
Sbjct: 81 QELQLGENK-----------IKE---------------ISNKMFLGLHQLKTLNLYDNQI 114
Query: 410 HGTIPD-VIGELKNLQGLFLYKN 431
+ L +L L L N
Sbjct: 115 S-CVMPGSFEHLNSLTSLNLASN 136
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 24/77 (31%), Positives = 39/77 (50%), Gaps = 2/77 (2%)
Query: 383 NQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV- 441
N++ + L L L + NQ+ V +L L L+L++N LQ S+P+GV
Sbjct: 38 NKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVF 96
Query: 442 GNLTKLAKLVMSYNSLQ 458
LT+L +L + N L+
Sbjct: 97 DKLTQLKELALDTNQLK 113
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 26/71 (36%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKL 447
+P+GI + L ++SN+L V +L L L L +N +Q S+P GV LTKL
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 448 AKLVMSYNSLQ 458
L + N LQ
Sbjct: 79 TILYLHENKLQ 89
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 37/142 (26%), Positives = 57/142 (40%), Gaps = 39/142 (27%)
Query: 294 SNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTF--LTNCSSLK 351
S+ L+L N+ + F L L+ L+L QN + L F LT L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-----QSLPDGVFDKLTK---LT 79
Query: 352 ILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLH 410
IL L N+ L S +P+G+ L L L + +NQL
Sbjct: 80 ILYLHENK-----------LQS---------------LPNGVFDKLTQLKELALDTNQLK 113
Query: 411 GTIPD-VIGELKNLQGLFLYKN 431
++PD + L +LQ ++L+ N
Sbjct: 114 -SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 14/114 (12%)
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405
C S S+ +P L + N + + L +L L +
Sbjct: 13 ECYSQGRTSVPTG-----IPAQTTYL-------DLETNSLKSLPNGVFDELTSLTQLYLG 60
Query: 406 SNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQ 458
N+L V +L +L L L N LQ S+P+GV LT+L +L ++ N LQ
Sbjct: 61 GNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ 113
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 47/165 (28%), Positives = 69/165 (41%), Gaps = 37/165 (22%)
Query: 294 SNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKIL 353
+ LDL N K + F L +L+ L L N L + LT+ L L
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN---KLTS---LTYL 81
Query: 354 SLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGT 412
+L+ NQ L S +P+G+ L L L + +NQL +
Sbjct: 82 NLSTNQ-----------LQS---------------LPNGVFDKLTQLKELALNTNQLQ-S 114
Query: 413 IPD-VIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYN 455
+PD V +L L+ L LY+N L+ S+P GV LT L + + N
Sbjct: 115 LPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 24/101 (23%), Positives = 37/101 (36%), Gaps = 2/101 (1%)
Query: 503 NNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIP-VTLSTCVSLEYLDISSNSFHGVIPHS 561
+ + +NL +L I + Q + L L L I + V P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 562 LGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDL 602
F + LN S N L + ++ LS L+ L S N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 8e-07
Identities = 21/102 (20%), Positives = 31/102 (30%), Gaps = 3/102 (2%)
Query: 478 HNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQ-IGNLKNLVKLIISSNQFSGVIPV 536
L L L + N L L+ + L L L I + V P
Sbjct: 16 TRDGALDSLHHLPGAENL-TELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 537 TLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578
L L++S N+ + S++ L S N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 20/103 (19%), Positives = 36/103 (34%), Gaps = 3/103 (2%)
Query: 406 SNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSS 464
+ + +NL L++ + L +L L + + L+ P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 465 LGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLN 507
L N S N L +L + + +L L LS N L+
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 3/94 (3%)
Query: 238 PQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSI-PDSLSNASNV 296
+ +L +Y+ + L + L L++L I + + PD+ +
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-LRFVAPDAFHFTPRL 82
Query: 297 EILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330
L+L FN + L +L L L N L
Sbjct: 83 SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 23/97 (23%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 363 ELPHSIANLSSSMIEFRIGGNQIFGIIPSG-IRNLVNLIALGMQSNQLHGTIPDVIGELK 421
+ H + + + E I Q + +R L L L + + L PD
Sbjct: 22 DSLHHLPGAEN-LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80
Query: 422 NLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQ 458
L L L N L+ S+ L +LV+S N L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 4/90 (4%)
Query: 99 NLSFLRYINLSDNSFHGEIPQE-IGNLLRLEKLALPNNSFSGTIPTN-LSRCSNLIQLRV 156
L + + + + + L L L + + + + L +L +
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNL 87
Query: 157 SNNKLEGQIPAEIGSLLKLQTLAVGKNYLT 186
S N LE + + L LQ L + N L
Sbjct: 88 SFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 28/139 (20%), Positives = 51/139 (36%), Gaps = 8/139 (5%)
Query: 487 QQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEY 546
+ +++ V L + + + LK L +S+N + LS +L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRI 74
Query: 547 LDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE--G 604
L + N I + +++ L S N ++ + +E L L L S+N + G
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWG 131
Query: 605 EVPTKGVFSSKTKLSLQGN 623
E+ L L GN
Sbjct: 132 EIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 34/156 (21%), Positives = 54/156 (34%), Gaps = 35/156 (22%)
Query: 212 KIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPN 271
K+ TL L+ L + N I ISSL + N
Sbjct: 39 KMDATLSTLKACKHLALSTNN--------IEKISSLS-------------------GMEN 71
Query: 272 LKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLG 331
L+ L++G N I + + A +E L + +NQ +S L NL L + N +
Sbjct: 72 LRILSLGRNLI-KKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKI- 127
Query: 332 MGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHS 367
+ + L L+ L LA N + +
Sbjct: 128 ----TNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 30/170 (17%), Positives = 57/170 (33%), Gaps = 44/170 (25%)
Query: 119 QEIGNLLRLEKLALPNNSFSG--TIPTNLSRCSNLIQLRVSNN---KLEGQIPAEIGSLL 173
++ EK+ L + + LS L +S N K+ + +
Sbjct: 17 RKSVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS-----LSGME 70
Query: 174 KLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQF 233
L+ L++G+N + KI + L +L + NQ
Sbjct: 71 NLRILSLGRNLIK-------------------------KIENLDAVADTLEELWISYNQI 105
Query: 234 SGTFPQSICNIS---SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGN 280
+ S+ I +L +Y+ N+ + D + L L+ L + GN
Sbjct: 106 A-----SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 34/149 (22%), Positives = 55/149 (36%), Gaps = 41/149 (27%)
Query: 286 IPDSLSNASNVEILDLGFNQFKGKVSID-FSSLKNLSWLNLEQNNLGMGTANDLDFVTFL 344
+ +LS + L L N + I S ++NL L+L +N +
Sbjct: 40 MDATLSTLKACKHLALSTNNIE---KISSLSGMENLRILSLGRNLIK-------KIENLD 89
Query: 345 TNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGM 404
+L+ L ++ NQ IA+L SGI LVNL L M
Sbjct: 90 AVADTLEELWISYNQ--------IASL-------------------SGIEKLVNLRVLYM 122
Query: 405 QSNQLHGTIPDV--IGELKNLQGLFLYKN 431
+N++ ++ + L L+ L L N
Sbjct: 123 SNNKI-TNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 36/161 (22%), Positives = 58/161 (36%), Gaps = 21/161 (13%)
Query: 116 EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKL 175
++ + L + LAL N+ I ++LS NL L + N ++ +I L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 176 QTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGG-KIPTTLGLLRNLVDLHVGGNQFS 234
+ L + N + L L L V ++ N + L L L DL + GN
Sbjct: 96 EELWISYNQIA-SLSGI-EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL- 152
Query: 235 GTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSL 275
+ ++ Y +V LPNLK L
Sbjct: 153 ----YNDYKENNATSEYRIE----------VVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 30/151 (19%), Positives = 56/151 (37%), Gaps = 30/151 (19%)
Query: 446 KLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLS-----VYLD 500
+ +L ++ + ++L + S N + I++LS L
Sbjct: 26 EKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE--------KISSLSGMENLRILS 76
Query: 501 LSNNNLNGSLPLQIGNL----KNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSN---S 553
L N + +I NL L +L IS NQ + + + V+L L +S+N +
Sbjct: 77 LGRNLIK-----KIENLDAVADTLEELWISYNQIASLSG--IEKLVNLRVLYMSNNKITN 129
Query: 554 FHGVIPHSLGFLKSIKVLNFSSNNLSGQIPE 584
+ + L L ++ L + N L E
Sbjct: 130 WGEIDK--LAALDKLEDLLLAGNPLYNDYKE 158
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 25/116 (21%), Positives = 45/116 (38%), Gaps = 7/116 (6%)
Query: 243 NISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLG 302
S ++ + L +R + + L+ L+ SI + L + ++ L+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELS 72
Query: 303 FNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAAN 358
N+ G + + NL+ LNL N + DL + L +LK L L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 22/115 (19%), Positives = 44/115 (38%), Gaps = 5/115 (4%)
Query: 512 LQIGNLKNLVKLIISSNQFS-GVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKV 570
L+ ++ +L++ +++ + G + LE+L + + +L L +K
Sbjct: 11 LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKK 68
Query: 571 LNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE--GEVPTKGVFSSKTKLSLQGN 623
L S N +SG + E L LN S N ++ + + L L
Sbjct: 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 24/117 (20%), Positives = 46/117 (39%), Gaps = 15/117 (12%)
Query: 443 NLTKLAKLVMSYNSLQ-GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLS----- 496
+ + +LV+ + G + + L + + LT SI L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--------SIANLPKLNKL 66
Query: 497 VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVT-LSTCVSLEYLDISSN 552
L+LS+N ++G L + NL L +S N+ + + L +L+ LD+ +
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 20/111 (18%), Positives = 44/111 (39%), Gaps = 4/111 (3%)
Query: 99 NLSFLRYINLSDNSF-HGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVS 157
S ++ + L ++ G++ LE L+ N + +I NL + + L +L +S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 158 NNKLEGQIPAEIGSLLKLQTLAVGKNYLTG-RLPDFVGNLSALEVFSITGN 207
+N++ G + L L + N + + + L L+ +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 23/114 (20%), Positives = 41/114 (35%), Gaps = 15/114 (13%)
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405
CS+ + L +P + L + GNQ ++P + N +L + +
Sbjct: 16 RCSNKGLKVLPKG-----IPRDVTEL-------YLDGNQF-TLVPKELSNYKHLTLIDLS 62
Query: 406 SNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQ 458
+N++ + L L L N L+ IP L L L + N +
Sbjct: 63 NNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 5/75 (6%)
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKL 447
+P+GI + L + +NQ+ P V L NLQ L+ N L +IP+GV LT+L
Sbjct: 27 VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83
Query: 448 AKLVMSYNSLQGNIP 462
+L ++ N L+ +IP
Sbjct: 84 TQLDLNDNHLK-SIP 97
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 25/75 (33%), Positives = 37/75 (49%), Gaps = 5/75 (6%)
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV-GNLTKL 447
+P+GI L + NQ+ P V L L L L N L +P+GV LT+L
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80
Query: 448 AKLVMSYNSLQGNIP 462
+L ++ N L+ +IP
Sbjct: 81 TQLSLNDNQLK-SIP 94
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 24/66 (36%), Positives = 29/66 (43%), Gaps = 2/66 (3%)
Query: 383 NQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV- 441
NQI + P L L L + +NQL V +L L L L N L+ SIP G
Sbjct: 40 NQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAF 98
Query: 442 GNLTKL 447
NL L
Sbjct: 99 DNLKSL 104
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 24/116 (20%), Positives = 45/116 (38%), Gaps = 7/116 (6%)
Query: 243 NISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLG 302
+++ + L + + + NL+ L++ S+ +L ++ L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISV-SNLPKLPKLKKLELS 79
Query: 303 FNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAAN 358
N+ G + + L NL+ LNL N L D+ + L LK L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 5/115 (4%)
Query: 512 LQIGNLKNLVKLIISSNQFS-GVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKV 570
L+ + +L++ + + + G I + V+LE+L + + V +L L +K
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKK 75
Query: 571 LNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE--GEVPTKGVFSSKTKLSLQGN 623
L S N + G + E L L LN S N L+ + L L
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 22/84 (26%), Positives = 37/84 (44%), Gaps = 11/84 (13%)
Query: 498 YLDLSNNNLN--GSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSN--- 552
+L L N L +LP L L KL +S N+ G + + +L +L++S N
Sbjct: 53 FLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
Query: 553 SFHGVIPHSLGFLKSIKVLNFSSN 576
+ P L L+ +K L+ +
Sbjct: 109 DISTLEP--LKKLECLKSLDLFNC 130
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 56/358 (15%), Positives = 115/358 (32%), Gaps = 64/358 (17%)
Query: 145 LSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSI 204
S + L +S N L E+ +++ ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFA-------------------NTPASVTSLNL 58
Query: 205 TGNSLGGKIPTTLGLL-----RNLVDLHVGGNQFSGTFPQSICNI-----SSLERIYLPF 254
+GNSLG K L + N+ L++ GN S + ++ + L +
Sbjct: 59 SGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118
Query: 255 NRFS--GTLPFDIVVNLPN--LKSLAIGGNNFFGSIPDSLSNA-----SNVEILDLGFNQ 305
N FS + F + + SL + GN+ D L +NV L+L N
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178
Query: 306 FKGKVSIDFSSL-----KNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360
K + + +++ L+L N LG+ + +L ++ F + + + L+L N
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYI-FSSIPNHVVSLNLCLNCL 237
Query: 361 VGELPHSIANL---SSSMIEFRIGGNQIFGIIPSGIRNLV-------NLIALGMQSNQLH 410
G ++ L + + + + + + L +I + ++H
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
Query: 411 GTIPDVIGEL-----KNLQGLFLYKNVL-----QGSIPSGVGNLTKLAKLVMSYNSLQ 458
+ I L L L + + +L + + + L
Sbjct: 298 PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 46/332 (13%), Positives = 105/332 (31%), Gaps = 50/332 (15%)
Query: 103 LRYINLSDNSFHGEIPQEIGNLLR-----LEKLALPNNSFSGTIPTNLSR-----CSNLI 152
+ ++LS N+ + E+ + L L NS L + +N+
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83
Query: 153 QLRVSNNKLEGQIPAEIGSLLK-----LQTLAVGKNYLTGR-----LPDFVGNLSALEVF 202
L +S N L + E+ L + L +G N + + F +++
Sbjct: 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL 143
Query: 203 SITGNSLGGKIPTTLGLL-----RNLVDLHVGGNQFSGTFPQSICNI-----SSLERIYL 252
++ GN LG K L + N+ L++ GN + + +S+ + L
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDL 203
Query: 253 PFNRFSGT----LPFDIVVNLPNLKSLAIGGNNFFGS----IPDSLSNASNVEILDLGFN 304
N L + ++ SL + N G + + +++ + L ++
Sbjct: 204 SANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYD 263
Query: 305 QFKGKVSID-------FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAA 357
K F +++ + ++ + + + + + + SL
Sbjct: 264 IVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSG-KADVPSLLN 322
Query: 358 NQFVGELPHSIA----NLSSSMIEFRIGGNQI 385
+ H N+ + E +
Sbjct: 323 QCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 57/365 (15%), Positives = 105/365 (28%), Gaps = 78/365 (21%)
Query: 290 LSNASNVEILDLGFNQFKGKVSIDFSSL-----KNLSWLNLEQNNLGMGTANDLDFVTFL 344
S V LDL N +++ +++ LNL N+LG +++L +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI-LA 76
Query: 345 TNCSSLKILSLAANQF----VGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLI 400
+++ L+L+ N EL ++A + ++ +G N
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS---SKSSSEFKQAF 133
Query: 401 ALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNL--------TKLAKLVM 452
+ ++ L L N L L + L +
Sbjct: 134 S----------------NLPASITSLNLRGNDLG---IKSSDELIQILAAIPANVNSLNL 174
Query: 453 SYNSLQGN----IPSSL-GNCQNLIGFNASHNKLT----GALPQQLLSITTLSVYLDLSN 503
N+L + L ++ + S N L L SI V L+L
Sbjct: 175 RGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCL 234
Query: 504 NNLNGS----LPLQIGNLKNLVKLIISSNQFSGVIPV-------TLSTCVSLEYLDISSN 552
N L+G L L +LK+L + + + + + +D +
Sbjct: 235 NCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGK 294
Query: 553 SFH--GVIPHSLGFLKSIKVLNFSSNNLS------------GQIPEFLENLSFLEFLNFS 598
H I I+ L+ ++ S E L L +
Sbjct: 295 EIHPSHSI----PISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQT 350
Query: 599 HNDLE 603
L
Sbjct: 351 CKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 45/327 (13%), Positives = 96/327 (29%), Gaps = 62/327 (18%)
Query: 74 HRHQRVTRLDLSNQRIG-----GILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLR-- 126
+ VT L+LS +G ++ + + +NLS N + E+ L
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107
Query: 127 ---LEKLALPNNSFSGT----IPTNLSRC-SNLIQLRVSNNKLEGQIPAEIGSLLK---- 174
+ L L N FS S +++ L + N L + E+ +L
Sbjct: 108 PFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA 167
Query: 175 -LQTLAVGKNYLTGRLPDFVGNL-SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQ 232
+ +L + N L L L + + L + N
Sbjct: 168 NVNSLNLRGNNLA---SKNCAELAKFLASIPAS-----------------VTSLDLSANL 207
Query: 233 FSGTFPQSIC-----NISSLERIYLPFNRFSGTLPFDIVV---NLPNLKSLAIGGNNF-- 282
+ + + + L N G ++ + +L +L+++ + +
Sbjct: 208 LGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKN 267
Query: 283 -----FGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSL-----KNLSWLNLEQNNLGM 332
++ + N + ++D + SI S+L +L L
Sbjct: 268 MSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIF 327
Query: 333 GTANDLDFVTFLTNCSSLKILSLAANQ 359
+ + + L L+
Sbjct: 328 AQKHQTN-IEDLNIPDELRESIQTCKP 353
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 49/325 (15%), Positives = 107/325 (32%), Gaps = 30/325 (9%)
Query: 242 CNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDL 301
I R + P ++ P ++S+ L + +L
Sbjct: 38 YEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSV-------------ELKGKPHFADFNL 84
Query: 302 GFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFV 361
+ + G V ++ + S+ LE+ L D + + K+L L++ +
Sbjct: 85 VPDGWGGYVYPWIEAMSS-SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGF 143
Query: 362 GELP-HSIANLSSSMIEFRIGGNQIFGIIPSGI-------RNLVNLIALGMQSNQLHGTI 413
+IA ++ E + + + + + +LV+L + S +
Sbjct: 144 STDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSAL 203
Query: 414 PDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGN------IPSSLGN 467
++ NL+ L L + V + + + +L +L + + + +L
Sbjct: 204 ERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG 263
Query: 468 CQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNG-SLPLQIGNLKNLVKLIIS 526
C+ L + + + LP + L L+LS + L + L +L +
Sbjct: 264 CKELRCLSGFWDAVPAYLPAVYSVCSRL-TTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322
Query: 527 SNQFSGVIPVTLSTCVSLEYLDISS 551
+ V STC L L +
Sbjct: 323 DYIEDAGLEVLASTCKDLRELRVFP 347
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 21/117 (17%), Positives = 42/117 (35%), Gaps = 9/117 (7%)
Query: 463 SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVK 522
+ N + K+ + + L + +D S+N + L L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKT 68
Query: 523 LIISSNQFSGVIPVTLSTCVSLEYLDISSN---SFHGVIPHSLGFLKSIKVLNFSSN 576
L++++N+ + L L +++N + P L LKS+ L N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP--LASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 20/118 (16%), Positives = 39/118 (33%), Gaps = 13/118 (11%)
Query: 243 NISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIP--DSLSNASNVEILD 300
N + L + + ++ L ++ N I D ++ L
Sbjct: 17 NAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNE----IRKLDGFPLLRRLKTLL 70
Query: 301 LGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAAN 358
+ N+ +L +L+ L L N+L +L + L + SL L + N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 27/103 (26%), Positives = 39/103 (37%), Gaps = 9/103 (8%)
Query: 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIP--QEIGNLLRLEKLALPNN 135
R LDL +I I L I+ SDN EI L RL+ L + NN
Sbjct: 20 RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLVNNN 74
Query: 136 SFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTL 178
+L +L ++NN L ++ L L++L
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSL 115
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 29/179 (16%), Positives = 54/179 (30%), Gaps = 44/179 (24%)
Query: 379 RIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIP 438
++ I + N V L ++ ++ I ++ L + N ++ +
Sbjct: 3 KLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL- 57
Query: 439 SGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVY 498
G L +L L+++ N + +L ++N L
Sbjct: 58 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV---------------- 101
Query: 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVT---------LSTCVSLEYLD 548
L PL +LK+L L I N PVT + + LD
Sbjct: 102 ------ELGDLDPLA--SLKSLTYLCILRN------PVTNKKHYRLYVIYKVPQVRVLD 146
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 32/211 (15%), Positives = 68/211 (32%), Gaps = 31/211 (14%)
Query: 403 GMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIP 462
G + + I + + + +GLF + S + L+ ++ + L
Sbjct: 121 GEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWI-EQVDLSPVLDAMPLLNNL-- 177
Query: 463 SSLGNCQNLIGFNASHNKL----------TGALPQQLLS-----ITTLSVYLDLSNNNLN 507
+ NL L ++ + +L + L +Y+ + + +
Sbjct: 178 -KIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFD 236
Query: 508 GSLP-----LQIGNLKNLVKLIISSNQFSGVIPVTLSTCV---SLEYLDISSNSFHGV-- 557
G + NL L I + V+ LE +DIS+
Sbjct: 237 GDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296
Query: 558 --IPHSLGFLKSIKVLNFSSNNLSGQIPEFL 586
+ + +K +K +N N LS ++ + L
Sbjct: 297 RLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 44/307 (14%), Positives = 79/307 (25%), Gaps = 37/307 (12%)
Query: 80 TRLDLSNQRIGGI----LSPYVGNLSFLRYINLSDNSF--HGEIPQEIGNLLRLEKLALP 133
L+ I L N L + + D + NL +L
Sbjct: 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLN 254
Query: 134 NNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGK-NYLTGRLPDF 192
+ NL L +L +S +P +++ L + T
Sbjct: 255 EDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTL 313
Query: 193 VGNLSALEVFSITGNSLGGK-IPTTLGLLRNLVDLHVGGNQFSGTFPQSICNIS------ 245
+ LEV N +G + + + L L + +S
Sbjct: 314 IQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIA 372
Query: 246 ------SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDS---------L 290
LE + + + + I L NL + + I D L
Sbjct: 373 LAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLL 432
Query: 291 SNASNVEILDLGFNQFKGKVSIDFSSLKNLSWL--NLEQNNLGMGTANDLDFVTFLTNCS 348
+ Q + L + N+ LG +D + F C
Sbjct: 433 IGCKKLRRFAFYLRQGG----LTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCP 488
Query: 349 SLKILSL 355
+L+ L +
Sbjct: 489 NLQKLEM 495
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 55/407 (13%), Positives = 113/407 (27%), Gaps = 53/407 (13%)
Query: 242 CNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNV----- 296
I S R ++ P + PNL+SL + G N
Sbjct: 45 FKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWV 104
Query: 297 ----------EILDLGFNQF--KGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFL 344
+ + + + +L L L+ ++ +
Sbjct: 105 TEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD----KCSGFTTDGLLSIV 160
Query: 345 TNCSSLKILSLAANQFV---GELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLV---- 397
T+C +K L + + F G+ H +A ++S+ + I P + +
Sbjct: 161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCR 220
Query: 398 NLIALGMQSNQL--HGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYN 455
+L+++ + ++ L+ G L +++ + KL +L +SY
Sbjct: 221 SLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM 280
Query: 456 SLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIG 515
+P + + + L L+ L+ N + L +
Sbjct: 281 GPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQ 339
Query: 516 NLKNLVKLIISSNQFSGVIPVTLST------------CVSLEYLDISSNSF--HGV--IP 559
K L +L I + C LEY+ + + + I
Sbjct: 340 YCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIG 399
Query: 560 HSLGFLKSIKVLNFSSNN------LSGQIPEFLENLSFLEFLNFSHN 600
L L +++ L + L L F
Sbjct: 400 TYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR 446
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 12/46 (26%), Positives = 18/46 (39%), Gaps = 3/46 (6%)
Query: 821 DVASAIEYLHHH---CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863
D ++L + HGDL SN+ + VS D G +
Sbjct: 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211
|
| >4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 7/30 (23%), Positives = 11/30 (36%)
Query: 834 QPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863
+ HGD N++ D + D G
Sbjct: 192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1017 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.37 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.35 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.27 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.02 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.01 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.93 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.93 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.82 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.57 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.52 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.42 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.96 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.94 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.79 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.76 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.52 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.28 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.22 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.15 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.13 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.97 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.92 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.89 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.88 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.83 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.78 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.74 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.69 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.67 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.99 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.9 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.65 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.21 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-83 Score=799.45 Aligned_cols=603 Identities=30% Similarity=0.483 Sum_probs=449.8
Q ss_pred CcCCCCCHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCceeeEEECCCCCeEEEEEcCCCCCccc---cC----------
Q 043932 28 FSAGQTNETDRLALLAIKSQLHDTSGVTSSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGI---LS---------- 94 (1017)
Q Consensus 28 ~~~~~~~~~~~~aLl~~k~~~~~~~~~~~sw~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~---~~---------- 94 (1017)
++++.+.++|++||++||+++.||. .++||+.++|||+|.||+|+ .++|+.|||++++++|. ++
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~ 80 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred CccccCCHHHHHHHHHHHhhCCCcc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence 3445568899999999999999998 89999888899999999997 68999999999999886 43
Q ss_pred -------------cccCCCCCCCEEEccCCCCCCCCCc--ccccccccccccCCCCcccccCCCcc-cCCCcceEeeccc
Q 043932 95 -------------PYVGNLSFLRYINLSDNSFHGEIPQ--EIGNLLRLEKLALPNNSFSGTIPTNL-SRCSNLIQLRVSN 158 (1017)
Q Consensus 95 -------------~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~ 158 (1017)
+.++.+++|++|||++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|||++
T Consensus 81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 4678889999999999999988888 89999999999999999998888776 7888888888888
Q ss_pred ccccccCccc---ccccCCccEEEeccccccC----------------------CCCccccCCCcccEEEEecCCCCCCC
Q 043932 159 NKLEGQIPAE---IGSLLKLQTLAVGKNYLTG----------------------RLPDFVGNLSALEVFSITGNSLGGKI 213 (1017)
Q Consensus 159 n~l~~~~p~~---~~~l~~L~~L~L~~n~l~~----------------------~~p~~~~~l~~L~~L~L~~N~l~~~~ 213 (1017)
|++++..|.. +.++++|++|++++|.+++ .+|. ++++++|++|++++|.+++.+
T Consensus 161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~ 239 (768)
T 3rgz_A 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDF 239 (768)
T ss_dssp SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCH
T ss_pred CccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcc
Confidence 8888777665 5555555555555555544 3333 444445555555555554444
Q ss_pred CcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccC
Q 043932 214 PTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNA 293 (1017)
Q Consensus 214 ~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 293 (1017)
|..++.+++|++|++++|++++.+|.. .+++|++|+|++|+++|.+|..++..+++|++|+|++|++++.+|..++.+
T Consensus 240 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l 317 (768)
T 3rgz_A 240 SRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317 (768)
T ss_dssp HHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGC
T ss_pred cHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcC
Confidence 444445555555555555444444433 444555555555555555555544444677777777777776777777777
Q ss_pred CccceeecccCcccceeecc-ccccCccceEecccCcCCCCCCCChhhH-------------------hhhcc--cCccc
Q 043932 294 SNVEILDLGFNQFKGKVSID-FSSLKNLSWLNLEQNNLGMGTANDLDFV-------------------TFLTN--CSSLK 351 (1017)
Q Consensus 294 ~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~~-------------------~~l~~--l~~L~ 351 (1017)
++|++|++++|++.+.+|.. |..+++|++|++++|.+....+..+... ..+.. +++|+
T Consensus 318 ~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~ 397 (768)
T 3rgz_A 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 397 (768)
T ss_dssp TTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCC
T ss_pred CCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCcc
Confidence 77777777777776555544 6777777777777776653222221111 01111 44566
Q ss_pred EEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceecccc
Q 043932 352 ILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKN 431 (1017)
Q Consensus 352 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 431 (1017)
+|++++|++++.+|..+..+ ++|+.|++++|++++..|..+..+++|++|++++|++++.+|..+..+++|++|+|++|
T Consensus 398 ~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 476 (768)
T 3rgz_A 398 ELYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476 (768)
T ss_dssp EEECCSSEEEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred EEECCCCccccccCHHHhcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCC
Confidence 66666666666666666554 35777777777777777777777777777777777777777777777777777777777
Q ss_pred ccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCcc
Q 043932 432 VLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLP 511 (1017)
Q Consensus 432 ~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p 511 (1017)
++++.+|..+.++++|++|+|++|++++.+|.+++.+++|+.|++++|++++.+|..+..+..+. +|+|++|.++|.+|
T Consensus 477 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~g~ip 555 (768)
T 3rgz_A 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI-WLDLNTNLFNGTIP 555 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCC-EEECCSSEEESBCC
T ss_pred cccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCC-EEECCCCccCCcCC
Confidence 77777777777777777777777777777777777777777777777777777777777666554 57788777776666
Q ss_pred cc----------------------------------------------------------------------ccccccce
Q 043932 512 LQ----------------------------------------------------------------------IGNLKNLV 521 (1017)
Q Consensus 512 ~~----------------------------------------------------------------------~~~l~~L~ 521 (1017)
.. ++.+++|+
T Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~ 635 (768)
T 3rgz_A 556 AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMM 635 (768)
T ss_dssp GGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCC
T ss_pred hHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccccc
Confidence 54 34467899
Q ss_pred EEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCC
Q 043932 522 KLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHND 601 (1017)
Q Consensus 522 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 601 (1017)
.|||++|+++|.+|..|+++++|+.|||++|+++|.+|..|+.+++|+.||||+|+++|.+|..+.++++|++|||++|+
T Consensus 636 ~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~ 715 (768)
T 3rgz_A 636 FLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715 (768)
T ss_dssp EEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE
T ss_pred EEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCcCCCCCCCCCCCcccccCcccccCCcCCCCCCCCCCCC
Q 043932 602 LEGEVPTKGVFSSKTKLSLQGNVKLCGGTDELHLPTCPSKG 642 (1017)
Q Consensus 602 l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~c~~~~ 642 (1017)
|+|.+|..+++.++...++.|||++||.|+ ++|+...
T Consensus 716 l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l----~~C~~~~ 752 (768)
T 3rgz_A 716 LSGPIPEMGQFETFPPAKFLNNPGLCGYPL----PRCDPSN 752 (768)
T ss_dssp EEEECCSSSSGGGSCGGGGCSCTEEESTTS----CCCCSCC
T ss_pred ccccCCCchhhccCCHHHhcCCchhcCCCC----cCCCCCc
Confidence 999999999999999999999999999886 4786543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-65 Score=635.22 Aligned_cols=518 Identities=33% Similarity=0.503 Sum_probs=439.8
Q ss_pred CeEEEEEcCCCCCccccCccc-CCCCCCCEEEccCCCCCCCCCcc---c----------------------ccccccccc
Q 043932 77 QRVTRLDLSNQRIGGILSPYV-GNLSFLRYINLSDNSFHGEIPQE---I----------------------GNLLRLEKL 130 (1017)
Q Consensus 77 ~~v~~l~l~~~~l~~~~~~~l-~~l~~L~~L~L~~n~l~~~~p~~---~----------------------~~l~~L~~L 130 (1017)
.+++.|||++|.+++.++..+ .++++|++|||++|.+++..|.. + +.+++|++|
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L 205 (768)
T 3rgz_A 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFL 205 (768)
T ss_dssp TTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEE
T ss_pred CCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEE
Confidence 356777777777776665554 56666666666666666555544 3 455666666
Q ss_pred cCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCC
Q 043932 131 ALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLG 210 (1017)
Q Consensus 131 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 210 (1017)
+|++|++++.+|. ++++++|++|+|++|++++.+|..++++++|++|++++|++++.+|.. .+++|++|++++|.++
T Consensus 206 ~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~ 282 (768)
T 3rgz_A 206 DVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFT 282 (768)
T ss_dssp ECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEE
T ss_pred ECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccC
Confidence 6666666665555 677777777777777777777777777777777777777777666654 6777777777777777
Q ss_pred CCCCcccccc-cCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCc
Q 043932 211 GKIPTTLGLL-RNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDS 289 (1017)
Q Consensus 211 ~~~~~~l~~l-~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 289 (1017)
+.+|..+..+ ++|++|+|++|++++.+|..|+++++|++|+|++|.++|.+|...+..+++|++|++++|++++.+|..
T Consensus 283 ~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~ 362 (768)
T 3rgz_A 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362 (768)
T ss_dssp ESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTT
T ss_pred CccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHH
Confidence 7888887765 899999999999998999999999999999999999988899887888999999999999999889999
Q ss_pred cccCC-ccceeecccCcccceeeccccc--cCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccch
Q 043932 290 LSNAS-NVEILDLGFNQFKGKVSIDFSS--LKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPH 366 (1017)
Q Consensus 290 l~~l~-~L~~L~Ls~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 366 (1017)
+..++ +|++|++++|++++..+..+.. +++|++|++++|.+.... +..+.++++|++|++++|++++.+|.
T Consensus 363 l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~------p~~l~~l~~L~~L~Ls~N~l~~~~p~ 436 (768)
T 3rgz_A 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI------PPTLSNCSELVSLHLSFNYLSGTIPS 436 (768)
T ss_dssp HHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEEC------CGGGGGCTTCCEEECCSSEEESCCCG
T ss_pred HHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcccccc------CHHHhcCCCCCEEECcCCcccCcccH
Confidence 98887 8999999999999888888776 889999999999886432 34578899999999999999999999
Q ss_pred hHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccc
Q 043932 367 SIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTK 446 (1017)
Q Consensus 367 ~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 446 (1017)
.+..+. +|+.|++++|.+++.+|..+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..|+++++
T Consensus 437 ~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 515 (768)
T 3rgz_A 437 SLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515 (768)
T ss_dssp GGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred HHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCC
Confidence 988874 6999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcc---------------------------------
Q 043932 447 LAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSIT--------------------------------- 493 (1017)
Q Consensus 447 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~--------------------------------- 493 (1017)
|++|+|++|++++.+|..++++++|+.|++++|+++|.+|..++...
T Consensus 516 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (768)
T 3rgz_A 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595 (768)
T ss_dssp CCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEE
T ss_pred CCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999999999999998765421
Q ss_pred ------------------------------------cccceeccCCCcCCCCccccccccccceEEEccCCccccccccc
Q 043932 494 ------------------------------------TLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVT 537 (1017)
Q Consensus 494 ------------------------------------~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 537 (1017)
..+++|||++|+++|.+|..++++++|+.|+|++|+++|.+|..
T Consensus 596 ~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~ 675 (768)
T 3rgz_A 596 FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675 (768)
T ss_dssp CTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGG
T ss_pred cccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChH
Confidence 22457999999999999999999999999999999999999999
Q ss_pred ccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCC-CcCc
Q 043932 538 LSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHND-LEGE 605 (1017)
Q Consensus 538 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~ 605 (1017)
|+++++|+.|||++|+++|.+|..|+.+++|++||||+|+++|.+|.. ..+.++....+.+|+ |.|.
T Consensus 676 l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp GGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence 999999999999999999999999999999999999999999999964 344555566677886 6663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=596.24 Aligned_cols=563 Identities=20% Similarity=0.220 Sum_probs=481.3
Q ss_pred CceeeEEECCC---------CCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCC
Q 043932 65 CQWTGVTCGHR---------HQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNN 135 (1017)
Q Consensus 65 c~w~gv~c~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 135 (1017)
|.++.|.|+.. ..+++.|+|++|.+++..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 55666777532 247999999999999998889999999999999999999999999999999999999999
Q ss_pred cccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCc
Q 043932 136 SFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPT 215 (1017)
Q Consensus 136 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 215 (1017)
++++..+..|+++++|++|+|++|++++..|..|+++++|++|++++|.+++..|..++++++|++|++++|.+++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99965555799999999999999999988888999999999999999999999999999999999999999999988887
Q ss_pred ccc--cccCcceeEeecCccccccchhhccc---------------------------CcCcEEeCCCccCccccCchhh
Q 043932 216 TLG--LLRNLVDLHVGGNQFSGTFPQSICNI---------------------------SSLERIYLPFNRFSGTLPFDIV 266 (1017)
Q Consensus 216 ~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l---------------------------~~L~~L~Ls~N~l~~~l~~~~~ 266 (1017)
.++ .+++|++|++++|++++..|..+..+ ++|+.|++++|.+++..| ..+
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~-~~~ 242 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN-TTF 242 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECT-TTT
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccCh-hHh
Confidence 765 45899999999999998888877765 456777777777774444 445
Q ss_pred ccCCc--cceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCC----CCChhh
Q 043932 267 VNLPN--LKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGT----ANDLDF 340 (1017)
Q Consensus 267 ~~l~~--L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~ 340 (1017)
.+++. |++|+|++|++++..|..+..+++|++|++++|++.+..+..|..+++|++|++++|...... ...+.
T Consensus 243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~- 321 (680)
T 1ziw_A 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID- 321 (680)
T ss_dssp GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEEC-
T ss_pred hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccC-
Confidence 55544 999999999988888888888899999999999998888888889999999999876543110 00000
Q ss_pred HhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccc--cccCcccccc--ccccEEeccccCCCCCcchh
Q 043932 341 VTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIF--GIIPSGIRNL--VNLIALGMQSNQLHGTIPDV 416 (1017)
Q Consensus 341 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~--~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~ 416 (1017)
...+..+++|++|++++|++.+..+..+..+ ++|++|++++|.+. .+....|..+ ++|+.|++++|++++..|..
T Consensus 322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~ 400 (680)
T 1ziw_A 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBCCCCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTT
T ss_pred hhhcccCCCCCEEECCCCccCCCChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhh
Confidence 0136678999999999999998777666665 56999999999743 3344455544 58999999999999999999
Q ss_pred hcccccccceeccccccccccC-cccccccccceeeccCcccCCCCccccccccCCceeecCCCccc--CCccchhhhcc
Q 043932 417 IGELKNLQGLFLYKNVLQGSIP-SGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLT--GALPQQLLSIT 493 (1017)
Q Consensus 417 ~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~--~~~p~~~~~~~ 493 (1017)
|..+++|+.|+|++|.+++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..+..+.
T Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~ 480 (680)
T 1ziw_A 401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480 (680)
T ss_dssp TTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCT
T ss_pred hhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCC
Confidence 9999999999999999987666 68999999999999999999888999999999999999999987 56788888777
Q ss_pred cccceeccCCCcCCCCccccccccccceEEEccCCccccccc--------ccccccccceEEeccCCccCCCCCcccccc
Q 043932 494 TLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIP--------VTLSTCVSLEYLDISSNSFHGVIPHSLGFL 565 (1017)
Q Consensus 494 ~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 565 (1017)
++. +|+|++|++++..|..|..+++|++|+|++|++++..+ ..|.++++|+.|+|++|+++.+.+..|..+
T Consensus 481 ~L~-~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 559 (680)
T 1ziw_A 481 NLT-ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559 (680)
T ss_dssp TCC-EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCC-EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence 764 69999999998888889999999999999999986532 237899999999999999997767789999
Q ss_pred ccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCC-C-CCCCCCcccccCcccccCCcC
Q 043932 566 KSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTK-G-VFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 566 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
++|+.|+|++|++++..+..|.++++|+.|+|++|++++.+|.. + .+.+++.+++.+|||.|+|..
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 99999999999999877788899999999999999999987752 2 578899999999999999874
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-60 Score=573.20 Aligned_cols=514 Identities=20% Similarity=0.269 Sum_probs=298.5
Q ss_pred CCCCHHHHHHHHHHHHhcCCC-CC-------CCCCCCCCCCCCce---eeEEECCCCCeEEEEEcCCCCCccccCcccCC
Q 043932 31 GQTNETDRLALLAIKSQLHDT-SG-------VTSSWNNTINLCQW---TGVTCGHRHQRVTRLDLSNQRIGGILSPYVGN 99 (1017)
Q Consensus 31 ~~~~~~~~~aLl~~k~~~~~~-~~-------~~~sw~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~ 99 (1017)
+.....|++||.+||.++.++ +. ..++|+.+.+||.| .||+|+.. +||+.|+|++++++|.+|+.+++
T Consensus 25 ~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~ 103 (636)
T 4eco_A 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQ 103 (636)
T ss_dssp CCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGG
T ss_pred hhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhc
Confidence 344567999999999998644 22 23489988999999 99999765 89999999999999999999999
Q ss_pred CCCCCEEEccCCCC------CC------CCCcccccccccccccCCCCcccccCCCcccC-CCcceEeecc---------
Q 043932 100 LSFLRYINLSDNSF------HG------EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSR-CSNLIQLRVS--------- 157 (1017)
Q Consensus 100 l~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~L~--------- 157 (1017)
|++|++|||++|.+ .| .+|.+. +.+|+ +++++|.+.+.+|..+.. +..+..+++.
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~ 180 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCC
T ss_pred CccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccc
Confidence 99999999999976 33 566555 66777 888999888888877763 2233333333
Q ss_pred -----------cccccccCcccccccCCccEEEeccccccCC-----------------CCcccc--CCCcccEEEEecC
Q 043932 158 -----------NNKLEGQIPAEIGSLLKLQTLAVGKNYLTGR-----------------LPDFVG--NLSALEVFSITGN 207 (1017)
Q Consensus 158 -----------~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-----------------~p~~~~--~l~~L~~L~L~~N 207 (1017)
.|+++| +|..|+++++|++|+|++|.+++. +|..++ ++++|++|+|++|
T Consensus 181 ~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp CCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred cchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence 455555 566666666666666666666653 555555 5666666666666
Q ss_pred CCCCCCCcccccccCcceeEeecCc-ccc-ccchhhccc------CcCcEEeCCCccCccccCc-hhhccCCccceeeec
Q 043932 208 SLGGKIPTTLGLLRNLVDLHVGGNQ-FSG-TFPQSICNI------SSLERIYLPFNRFSGTLPF-DIVVNLPNLKSLAIG 278 (1017)
Q Consensus 208 ~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~p~~l~~l------~~L~~L~Ls~N~l~~~l~~-~~~~~l~~L~~L~L~ 278 (1017)
.+.+.+|..|+++++|++|++++|+ +++ .+|..++.+ ++|++|+|++|+++ .+|. ..+.++++|++|+++
T Consensus 260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~ 338 (636)
T 4eco_A 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECL 338 (636)
T ss_dssp TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECC
T ss_pred cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCc
Confidence 6555556556566666666666665 555 555555544 55555555555555 4443 133445555555555
Q ss_pred ccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCc
Q 043932 279 GNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAAN 358 (1017)
Q Consensus 279 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 358 (1017)
+|+++|.+| .+..+++|++|++++|+++ .+|..|..+++ +|++|++++|
T Consensus 339 ~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~-----------------------------~L~~L~Ls~N 387 (636)
T 4eco_A 339 YNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTE-----------------------------QVENLSFAHN 387 (636)
T ss_dssp SCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECT-----------------------------TCCEEECCSS
T ss_pred CCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcc-----------------------------cCcEEEccCC
Confidence 555554444 4455555555555555544 33333333333 0444444444
Q ss_pred ccccccchhHHhhc-ccceEEEecCCccccccCcccc-------ccccccEEeccccCCCCCcchhhcccccccceeccc
Q 043932 359 QFVGELPHSIANLS-SSMIEFRIGGNQIFGIIPSGIR-------NLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYK 430 (1017)
Q Consensus 359 ~l~~~~p~~~~~~~-~~L~~L~l~~N~i~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 430 (1017)
+++ .+|..+.... .+|+.|++++|.+++..|..|. .+++|++|+|++|++++..+..+..+++|++|+|++
T Consensus 388 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~ 466 (636)
T 4eco_A 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466 (636)
T ss_dssp CCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCS
T ss_pred cCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCC
Confidence 433 2332221110 1233333333333333333333 344444444444444433333333344444444444
Q ss_pred cccccccCccccc-ccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCC
Q 043932 431 NVLQGSIPSGVGN-LTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGS 509 (1017)
Q Consensus 431 N~l~~~~p~~~~~-l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~ 509 (1017)
|+++ .+|..+.. +. ..+.++++|+.|++++|+++ .
T Consensus 467 N~l~-~i~~~~~~~~~-----------------~~~~~l~~L~~L~Ls~N~l~--------------------------~ 502 (636)
T 4eco_A 467 NMLT-EIPKNSLKDEN-----------------ENFKNTYLLTSIDLRFNKLT--------------------------K 502 (636)
T ss_dssp SCCS-BCCSSSSEETT-----------------EECTTGGGCCEEECCSSCCC--------------------------B
T ss_pred CCCC-CcCHHHhcccc-----------------ccccccCCccEEECcCCcCC--------------------------c
Confidence 4444 22222111 10 00011113444444444333 2
Q ss_pred cccccc--ccccceEEEccCCcccccccccccccccceEEec------cCCccCCCCCccccccccCcEEeccCCcccCC
Q 043932 510 LPLQIG--NLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDI------SSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQ 581 (1017)
Q Consensus 510 ~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 581 (1017)
+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..|+.+++|++|+|++|++ +.
T Consensus 503 lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ 580 (636)
T 4eco_A 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RK 580 (636)
T ss_dssp CCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CB
T ss_pred cChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-Cc
Confidence 333443 45555555555555554 4555555555555555 67888888898899999999999999999 57
Q ss_pred ChhhhcccCCCcEEEcccCCCcCcCCCCC---CCCCCCcccccCcccccCCc
Q 043932 582 IPEFLENLSFLEFLNFSHNDLEGEVPTKG---VFSSKTKLSLQGNVKLCGGT 630 (1017)
Q Consensus 582 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~---~~~~~~~~~~~~n~~~c~~~ 630 (1017)
+|..+. ++|+.||+++|++....+... .......+.+..+...|||+
T Consensus 581 ip~~~~--~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~C~ 630 (636)
T 4eco_A 581 VNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCD 630 (636)
T ss_dssp CCSCCC--TTCCEEECCSCTTCEEECTTTHHHHHTTCCEEECCTTSEEESCG
T ss_pred cCHhHh--CcCCEEECcCCCCccccHHhcchhhhcccceeecCCccccCCCc
Confidence 787765 789999999998775433210 11223344555566666665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-58 Score=562.02 Aligned_cols=524 Identities=22% Similarity=0.249 Sum_probs=462.4
Q ss_pred CeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeec
Q 043932 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRV 156 (1017)
Q Consensus 77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (1017)
.+++.|+|++|.+++..+..++++++|++|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 46899999999999999999999999999999999999655557999999999999999999777789999999999999
Q ss_pred ccccccccCcccccccCCccEEEeccccccCCCCcccc--CCCcccEEEEecCCCCCCCCcccccc--------------
Q 043932 157 SNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVG--NLSALEVFSITGNSLGGKIPTTLGLL-------------- 220 (1017)
Q Consensus 157 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~l~~l-------------- 220 (1017)
++|.+++..|..++++++|++|++++|.+++..+..++ .+++|+.|++++|.+++..|..+..+
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~ 208 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCH
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccC
Confidence 99999999999999999999999999999988777665 56899999999999998888877654
Q ss_pred -------------cCcceeEeecCccccccchhhcccCc--CcEEeCCCccCccccCchhhccCCccceeeecccccCCC
Q 043932 221 -------------RNLVDLHVGGNQFSGTFPQSICNISS--LERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGS 285 (1017)
Q Consensus 221 -------------~~L~~L~L~~n~l~~~~p~~l~~l~~--L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~ 285 (1017)
++|+.|++++|.+++..|.+|..++. |++|+|++|.++ .++...+..+++|++|++++|++++.
T Consensus 209 ~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~ 287 (680)
T 1ziw_A 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN-VVGNDSFAWLPQLEYFFLEYNNIQHL 287 (680)
T ss_dssp HHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCC-EECTTTTTTCTTCCEEECCSCCBSEE
T ss_pred hhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcC-ccCcccccCcccccEeeCCCCccCcc
Confidence 56788889999999889999998865 999999999998 45556678899999999999999999
Q ss_pred CCCccccCCccceeecccCcccc---------eeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEecc
Q 043932 286 IPDSLSNASNVEILDLGFNQFKG---------KVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLA 356 (1017)
Q Consensus 286 ~p~~l~~l~~L~~L~Ls~N~l~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls 356 (1017)
.|..+..+++|++|++++|...+ +....|..+++|++|++++|.+...... .+.++++|++|+++
T Consensus 288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~Ls 361 (680)
T 1ziw_A 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN------MFTGLINLKYLSLS 361 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTT------TTTTCTTCCEEECT
T ss_pred ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChh------HhccccCCcEEECC
Confidence 99999999999999999886553 2233788999999999999999875543 36789999999999
Q ss_pred Ccccccc-cch-hHHhhc-ccceEEEecCCccccccCccccccccccEEeccccCCCCCcc-hhhcccccccceeccccc
Q 043932 357 ANQFVGE-LPH-SIANLS-SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIP-DVIGELKNLQGLFLYKNV 432 (1017)
Q Consensus 357 ~N~l~~~-~p~-~~~~~~-~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~ 432 (1017)
+|.+... ++. .+..+. ..++.|++++|+++++.|..|..+++|+.|+|++|++++.+| ..|.++++|++|++++|+
T Consensus 362 ~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~ 441 (680)
T 1ziw_A 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441 (680)
T ss_dssp TCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCS
T ss_pred CCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCC
Confidence 9986532 222 232222 479999999999999999999999999999999999987555 789999999999999999
Q ss_pred cccccCcccccccccceeeccCcccC--CCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCc
Q 043932 433 LQGSIPSGVGNLTKLAKLVMSYNSLQ--GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSL 510 (1017)
Q Consensus 433 l~~~~p~~~~~l~~L~~L~Ls~N~i~--~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~ 510 (1017)
+++..+..|..+++|++|++++|.++ +.+|..|.++++|+.|++++|++++..|..+..+..+ ++|+|++|++++..
T Consensus 442 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L-~~L~Ls~N~l~~~~ 520 (680)
T 1ziw_A 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL-EILDLQHNNLARLW 520 (680)
T ss_dssp EEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCGGGG
T ss_pred cceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccccc-CEEeCCCCCccccc
Confidence 99999999999999999999999997 5789999999999999999999996666666666665 57999999998642
Q ss_pred c--------ccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCC
Q 043932 511 P--------LQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQI 582 (1017)
Q Consensus 511 p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 582 (1017)
+ ..|.++++|+.|+|++|+++.+.+..|.++++|+.|||++|+|++..+..|..+++|+.|+|++|++++..
T Consensus 521 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~ 600 (680)
T 1ziw_A 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600 (680)
T ss_dssp STTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred hhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccC
Confidence 2 23789999999999999999666678999999999999999999988888999999999999999999999
Q ss_pred hhhhc-ccCCCcEEEcccCCCcCcCCC
Q 043932 583 PEFLE-NLSFLEFLNFSHNDLEGEVPT 608 (1017)
Q Consensus 583 p~~~~-~l~~L~~L~l~~N~l~~~~~~ 608 (1017)
|..+. .+++|+.|++++|++.+.++.
T Consensus 601 ~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 601 KKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp HHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred hhHhcccccccCEEEccCCCcccCCcc
Confidence 88887 899999999999999999885
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-58 Score=556.38 Aligned_cols=526 Identities=21% Similarity=0.196 Sum_probs=385.8
Q ss_pred eeeEEECCC---------CCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcc
Q 043932 67 WTGVTCGHR---------HQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSF 137 (1017)
Q Consensus 67 w~gv~c~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 137 (1017)
+..|.|... ...++.|||++|.+++..+..|+++++|++|+|++|.+++..|.+|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 456888642 24678888888888888888888888888888888888877788888888888888888888
Q ss_pred cccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCccc
Q 043932 138 SGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTL 217 (1017)
Q Consensus 138 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l 217 (1017)
++..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++..+..+.++++|++|++++|.+++..+..|
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 88888888888888888888888887767788888888888888888887554455558888888888888887778888
Q ss_pred ccccCcc--eeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccC-----CCCCCcc
Q 043932 218 GLLRNLV--DLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFF-----GSIPDSL 290 (1017)
Q Consensus 218 ~~l~~L~--~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~-----~~~p~~l 290 (1017)
+.+++|+ .|++++|++++..|..+.. .+|++|++++|... + ..+..+.+++...+.-+.+. ...+..+
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~---~-~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~ 248 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNL---L-VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCH---H-HHHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred hhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhH---H-HHhhhccccchhheechhhccccccccChhHh
Confidence 8888888 7888888888777766654 67888888887622 1 22333444333333322222 1122233
Q ss_pred ccCC--ccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhH
Q 043932 291 SNAS--NVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSI 368 (1017)
Q Consensus 291 ~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 368 (1017)
..+. +|+.|++++|.+++..+..|..+++|++|++++|+++..+. .+..+++|++|++++|++.+..|..+
T Consensus 249 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~-------~l~~l~~L~~L~l~~n~l~~~~~~~~ 321 (606)
T 3t6q_A 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS-------GLVGLSTLKKLVLSANKFENLCQISA 321 (606)
T ss_dssp GGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCS-------SCCSCTTCCEEECTTCCCSBGGGGCG
T ss_pred chhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCCh-------hhcccccCCEEECccCCcCcCchhhh
Confidence 3333 78899999999988888888999999999999998875432 36778889999999999887777677
Q ss_pred HhhcccceEEEecCCccccccC-ccccccccccEEeccccCCCCCc--chhhcccccccceeccccccccccCccccccc
Q 043932 369 ANLSSSMIEFRIGGNQIFGIIP-SGIRNLVNLIALGMQSNQLHGTI--PDVIGELKNLQGLFLYKNVLQGSIPSGVGNLT 445 (1017)
Q Consensus 369 ~~~~~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 445 (1017)
..+ ++|++|++++|.+.+.++ ..+..+++|++|++++|++++.. +..+..+++|++|++++|.+++..|..|.+++
T Consensus 322 ~~l-~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 400 (606)
T 3t6q_A 322 SNF-PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400 (606)
T ss_dssp GGC-TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCT
T ss_pred hcc-CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCc
Confidence 666 468999999998885444 45889999999999999998766 77889999999999999999988888899999
Q ss_pred ccceeeccCcccCCCCccc-cccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCC---ccccccccccce
Q 043932 446 KLAKLVMSYNSLQGNIPSS-LGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGS---LPLQIGNLKNLV 521 (1017)
Q Consensus 446 ~L~~L~Ls~N~i~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~---~p~~~~~l~~L~ 521 (1017)
+|++|++++|++++..|.. +.++++|+.|++++|++++..|..+..+..+ ++|+|++|.+++. .+..+..+++|+
T Consensus 401 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~~~~l~~L~ 479 (606)
T 3t6q_A 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLE 479 (606)
T ss_dssp TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTC-CEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCC-CEEECCCCCCCccccccchhhccCCCcc
Confidence 9999999999998776554 8889999999999998885555444444333 2355555555442 123455556666
Q ss_pred EEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCC
Q 043932 522 KLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHND 601 (1017)
Q Consensus 522 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 601 (1017)
+|+|++|++++..|..|+++++|+.|+|++|++++.+|..|..+++| +|+|++|++++.+|..+..+++|+.|++++|+
T Consensus 480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 558 (606)
T 3t6q_A 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP 558 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCC
T ss_pred EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCC
Confidence 66666666665555556666666666666666665555666666666 66666666665555555556666666666555
Q ss_pred CcCcCC
Q 043932 602 LEGEVP 607 (1017)
Q Consensus 602 l~~~~~ 607 (1017)
+++.++
T Consensus 559 ~~c~c~ 564 (606)
T 3t6q_A 559 LDCTCS 564 (606)
T ss_dssp EECSGG
T ss_pred ccccCC
Confidence 555444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-58 Score=564.64 Aligned_cols=503 Identities=18% Similarity=0.230 Sum_probs=309.8
Q ss_pred CCCCCHHHHHHHHHHHHhcCCCCCCCCCCCCCC-----CC--Cce------------eeEEECCCCCeEEEEEcCCCCCc
Q 043932 30 AGQTNETDRLALLAIKSQLHDTSGVTSSWNNTI-----NL--CQW------------TGVTCGHRHQRVTRLDLSNQRIG 90 (1017)
Q Consensus 30 ~~~~~~~~~~aLl~~k~~~~~~~~~~~sw~~~~-----~~--c~w------------~gv~c~~~~~~v~~l~l~~~~l~ 90 (1017)
++.+..+|++||++||+++.|| +|+.+. +| |.| .||+|+. .+||+.|+|++++++
T Consensus 263 ~~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~ 336 (876)
T 4ecn_A 263 ETAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAK 336 (876)
T ss_dssp CCCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCE
T ss_pred ccccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCC
Confidence 3445678999999999999887 786543 55 999 9999976 689999999999999
Q ss_pred cccCcccCCCCCCCEEEc-cCCCCCCCCCcccccc----c-----cccc------ccC-CCCccccc-----------CC
Q 043932 91 GILSPYVGNLSFLRYINL-SDNSFHGEIPQEIGNL----L-----RLEK------LAL-PNNSFSGT-----------IP 142 (1017)
Q Consensus 91 ~~~~~~l~~l~~L~~L~L-~~n~l~~~~p~~~~~l----~-----~L~~------L~L-~~n~l~~~-----------~p 142 (1017)
|.+|+.+++|++|++||| ++|.++|..|...... . .++. ++. ....+++. .+
T Consensus 337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~ 416 (876)
T 4ecn_A 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416 (876)
T ss_dssp EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence 999999999999999999 8998887755331111 0 0000 000 00000000 01
Q ss_pred CcccCCCcceEeeccc--ccccccCcccccccCCccEEEeccccccC-----------------CCCcccc--CCCcccE
Q 043932 143 TNLSRCSNLIQLRVSN--NKLEGQIPAEIGSLLKLQTLAVGKNYLTG-----------------RLPDFVG--NLSALEV 201 (1017)
Q Consensus 143 ~~l~~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~ 201 (1017)
........++.+.+.. |++++ +|..|+++++|++|+|++|++++ .+|..++ ++++|+.
T Consensus 417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~ 495 (876)
T 4ecn_A 417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495 (876)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence 1111222333333333 55555 55556666666666666666655 3777766 7777888
Q ss_pred EEEecCCCCCCCCcccccccCcceeEeecCc-ccc-ccchhhcccC-------cCcEEeCCCccCccccCc-hhhccCCc
Q 043932 202 FSITGNSLGGKIPTTLGLLRNLVDLHVGGNQ-FSG-TFPQSICNIS-------SLERIYLPFNRFSGTLPF-DIVVNLPN 271 (1017)
Q Consensus 202 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~p~~l~~l~-------~L~~L~Ls~N~l~~~l~~-~~~~~l~~ 271 (1017)
|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..++.++ +|++|+|++|+++ .+|. ..+.++++
T Consensus 496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~ 574 (876)
T 4ecn_A 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK 574 (876)
T ss_dssp EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence 8887777777777777777788888888777 777 6777666655 7888888888877 6775 35567778
Q ss_pred cceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCc-cceEecccCcCCCCCCCChhhHhhhccc--C
Q 043932 272 LKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKN-LSWLNLEQNNLGMGTANDLDFVTFLTNC--S 348 (1017)
Q Consensus 272 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~~l~~l--~ 348 (1017)
|+.|+|++|+++ .+| .++.+++|+.|+|++|+++ .+|..+..+++ |++|+|++|.+...+. .+..+ +
T Consensus 575 L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~-------~~~~~~~~ 644 (876)
T 4ecn_A 575 LGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPN-------IFNAKSVY 644 (876)
T ss_dssp CCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCS-------CCCTTCSS
T ss_pred CCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCch-------hhhccccC
Confidence 888888888877 667 7777888888888888877 66666777777 8888888887763321 12333 3
Q ss_pred cccEEeccCcccccccchhHHhhcccceEEEecCCccccccCcccc--ccccccEEeccccCCCCCcchhhcccccccce
Q 043932 349 SLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIR--NLVNLIALGMQSNQLHGTIPDVIGELKNLQGL 426 (1017)
Q Consensus 349 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 426 (1017)
+|+.|+|++|++.+.+|... ..+. .+.+|+.|+|++|+++...+..+..+++|+.|
T Consensus 645 ~L~~L~Ls~N~l~g~ip~l~----------------------~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L 702 (876)
T 4ecn_A 645 VMGSVDFSYNKIGSEGRNIS----------------------CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTI 702 (876)
T ss_dssp CEEEEECCSSCTTTTSSSCS----------------------SCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEE
T ss_pred CCCEEECcCCcCCCccccch----------------------hhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEE
Confidence 37777777777766544211 1111 22345555555555553333333455555555
Q ss_pred eccccccccccCccccc--------ccccceeeccCcccCCCCccccc--cccCCceeecCCCcccCCccchhhhccccc
Q 043932 427 FLYKNVLQGSIPSGVGN--------LTKLAKLVMSYNSLQGNIPSSLG--NCQNLIGFNASHNKLTGALPQQLLSITTLS 496 (1017)
Q Consensus 427 ~L~~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~i~~~~p~~~~--~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~ 496 (1017)
+|++|+++ .+|..+.. +++|++|+|++|+|+ .+|..+. .+++|+.|+|++|++++
T Consensus 703 ~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~------------- 767 (876)
T 4ecn_A 703 ILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS------------- 767 (876)
T ss_dssp ECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-------------
T ss_pred ECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-------------
Confidence 55555555 33333222 225666666666665 4555554 55556555555555552
Q ss_pred ceeccCCCcCCCCccccccccccceEEEcc------CCcccccccccccccccceEEeccCCccCCCCCccccccccCcE
Q 043932 497 VYLDLSNNNLNGSLPLQIGNLKNLVKLIIS------SNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKV 570 (1017)
Q Consensus 497 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls------~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 570 (1017)
+|..+..+++|+.|+|+ +|++.+.+|..|..+++|+.|+|++|+| +.+|..+. ++|+.
T Consensus 768 -------------lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~ 831 (876)
T 4ecn_A 768 -------------FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYI 831 (876)
T ss_dssp -------------CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCE
T ss_pred -------------cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCE
Confidence 22233333344444443 3555555566666666666666666666 34555443 46666
Q ss_pred EeccCCcccCCChhhhcccCCCcEEEcccCCCc
Q 043932 571 LNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE 603 (1017)
Q Consensus 571 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 603 (1017)
|||++|++....+..+.....+..+.|++|++.
T Consensus 832 LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 832 LDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp EECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred EECCCCCCCccChHHccccccchheeecCCCcc
Confidence 666666665555455544444555555555544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-58 Score=554.84 Aligned_cols=512 Identities=21% Similarity=0.191 Sum_probs=310.8
Q ss_pred CeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeec
Q 043932 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRV 156 (1017)
Q Consensus 77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (1017)
.+++.|+|++|.+++..+..++++++|++|+|++|.+++..|.+|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 34666666666666666666666666666666666666555666666666666666666666655666666666666666
Q ss_pred ccccccccCcccccccCCccEEEeccccccC-CCCccccCCCcccEEEEecCCCCCCCCcccccccCcc----eeEeecC
Q 043932 157 SNNKLEGQIPAEIGSLLKLQTLAVGKNYLTG-RLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLV----DLHVGGN 231 (1017)
Q Consensus 157 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~----~L~L~~n 231 (1017)
++|++++..|..++++++|++|++++|.+++ .+|..|+++++|++|++++|.+++..+..|+.+++|+ +|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 6666665555666666666666666666664 4466666666666666666666666666666655554 5666666
Q ss_pred ccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCC---------CCCccccCCccceeec-
Q 043932 232 QFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGS---------IPDSLSNASNVEILDL- 301 (1017)
Q Consensus 232 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~---------~p~~l~~l~~L~~L~L- 301 (1017)
++++..+..+... +|++|++++|.+.+......+.+++.|+.+++..+.+.+. .+..+..+ .++.+++
T Consensus 192 ~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l-~l~~l~l~ 269 (606)
T 3vq2_A 192 PIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV-TIDEFRLT 269 (606)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGS-EEEEEEEC
T ss_pred CcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhc-cHhheecc
Confidence 6665444444433 6666666666665444445556666666666654443321 11111222 3455555
Q ss_pred ccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEec
Q 043932 302 GFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIG 381 (1017)
Q Consensus 302 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~ 381 (1017)
..|.+.+..+. +..+++|+.|++++|.+...+ .+..+++|+.|++++|++ +.+|. + ..++|++|+++
T Consensus 270 ~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l-~~lp~-~--~l~~L~~L~l~ 336 (606)
T 3vq2_A 270 YTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQL-KQFPT-L--DLPFLKSLTLT 336 (606)
T ss_dssp CCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCC-SSCCC-C--CCSSCCEEEEE
T ss_pred ccccccccccc-cccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccC-ccccc-C--CCCccceeecc
Confidence 55666666655 667777777777777665433 245566677777777766 45552 2 33456666666
Q ss_pred CCccccccCccccccccccEEeccccCCCCCc--chhhcccccccceeccccccccccCcccccccccceeeccCcccCC
Q 043932 382 GNQIFGIIPSGIRNLVNLIALGMQSNQLHGTI--PDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQG 459 (1017)
Q Consensus 382 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~ 459 (1017)
+|...+.. .+..+++|++|++++|++++.. |..+..+++|++|++++|.+++ +|..|.++++|++|++++|++++
T Consensus 337 ~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~ 413 (606)
T 3vq2_A 337 MNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR 413 (606)
T ss_dssp SCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEES
T ss_pred CCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCC
Confidence 66443322 4556666666666666665442 5566666666666666666663 44556666666666666666665
Q ss_pred CCc-cccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccc-ccccc
Q 043932 460 NIP-SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSG-VIPVT 537 (1017)
Q Consensus 460 ~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~ 537 (1017)
..| ..+.++++|+.|++++|+++ +..|..+..+++|++|+|++|++++ .+|..
T Consensus 414 ~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 468 (606)
T 3vq2_A 414 VTEFSAFLSLEKLLYLDISYTNTK-------------------------IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468 (606)
T ss_dssp TTTTTTTTTCTTCCEEECTTSCCE-------------------------ECCTTTTTTCTTCCEEECTTCEEGGGEECSC
T ss_pred ccChhhhhccccCCEEECcCCCCC-------------------------ccchhhhcCCCCCCEEECCCCcCCCcchHHh
Confidence 555 45566666666666666665 4445555566666666666666665 35556
Q ss_pred ccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCCCCCC-CCC
Q 043932 538 LSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFS-SKT 616 (1017)
Q Consensus 538 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-~~~ 616 (1017)
|+.+++|+.|+|++|++++.+|..|..+++|++|+|++|++++.+|..+.++++|++|++++|+++..++....+. +++
T Consensus 469 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~ 548 (606)
T 3vq2_A 469 FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548 (606)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCC
T ss_pred hccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCc
Confidence 6666666666666666666666666666666666666666666666666666666666666666664333333343 356
Q ss_pred cccccCcccccCCcC
Q 043932 617 KLSLQGNVKLCGGTD 631 (1017)
Q Consensus 617 ~~~~~~n~~~c~~~~ 631 (1017)
.+++.+||+.|+|+.
T Consensus 549 ~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 549 FFNLTNNSVACICEH 563 (606)
T ss_dssp EEECCSCCCCCSSTT
T ss_pred EEEccCCCcccCCcc
Confidence 666666666666553
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=553.21 Aligned_cols=533 Identities=19% Similarity=0.199 Sum_probs=464.5
Q ss_pred EEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeeccccc
Q 043932 81 RLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNK 160 (1017)
Q Consensus 81 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 160 (1017)
.++.++.+++.. |..+. +++++|||++|.+++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 16 ~~~c~~~~l~~i-P~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLNEI-PGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCSSC-CTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcccC-cCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 578888888754 45554 379999999999998889999999999999999999999899999999999999999999
Q ss_pred ccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchh
Q 043932 161 LEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQS 240 (1017)
Q Consensus 161 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~ 240 (1017)
+++..|..|+++++|++|++++|++++..|..++++++|++|++++|.+++..+..+..+++|++|++++|++++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 99999999999999999999999999887889999999999999999999865555666999999999999999888999
Q ss_pred hcccCcCc--EEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcc-----cceeecc
Q 043932 241 ICNISSLE--RIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQF-----KGKVSID 313 (1017)
Q Consensus 241 l~~l~~L~--~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l-----~~~~~~~ 313 (1017)
++.+++|+ .|++++|.+++..| ..+ ...+|+.|++++|. .++..+..+.++....+..+.+ ..+.+..
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~-~~~-~~~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~ 247 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEP-GAF-DSAVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECT-TTT-TTCEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGG
T ss_pred hhhhcccceeEEecCCCccCccCh-hHh-hhccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhH
Confidence 99999999 89999999985444 444 34689999999997 3444555555544444333222 2333445
Q ss_pred ccccC--ccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCc
Q 043932 314 FSSLK--NLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPS 391 (1017)
Q Consensus 314 ~~~l~--~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~ 391 (1017)
|..+. +|+.|++++|.+...... .+..+++|++|++++|+++ .+|..+..+ ++|++|++++|.+++..|.
T Consensus 248 ~~~l~~~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~-~lp~~l~~l-~~L~~L~l~~n~l~~~~~~ 319 (606)
T 3t6q_A 248 FEGLCEMSVESINLQKHYFFNISSN------TFHCFSGLQELDLTATHLS-ELPSGLVGL-STLKKLVLSANKFENLCQI 319 (606)
T ss_dssp GGGGGGSEEEEEECTTCCCSSCCTT------TTTTCTTCSEEECTTSCCS-CCCSSCCSC-TTCCEEECTTCCCSBGGGG
T ss_pred hchhhcCceeEEEeecCccCccCHH------HhccccCCCEEeccCCccC-CCChhhccc-ccCCEEECccCCcCcCchh
Confidence 55554 799999999999876654 3678999999999999998 788877665 5799999999999999999
Q ss_pred cccccccccEEeccccCCCCCcc-hhhcccccccceecccccccccc--CcccccccccceeeccCcccCCCCccccccc
Q 043932 392 GIRNLVNLIALGMQSNQLHGTIP-DVIGELKNLQGLFLYKNVLQGSI--PSGVGNLTKLAKLVMSYNSLQGNIPSSLGNC 468 (1017)
Q Consensus 392 ~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l 468 (1017)
.+.++++|++|++++|.+.+.+| ..+..+++|++|++++|.+++.. |..+.++++|++|++++|++++..|..|..+
T Consensus 320 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 399 (606)
T 3t6q_A 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC 399 (606)
T ss_dssp CGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTC
T ss_pred hhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCC
Confidence 99999999999999999986655 45999999999999999999776 7889999999999999999998889999999
Q ss_pred cCCceeecCCCcccCCccch-hhhcccccceeccCCCcCCCCccccccccccceEEEccCCccccc---ccccccccccc
Q 043932 469 QNLIGFNASHNKLTGALPQQ-LLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGV---IPVTLSTCVSL 544 (1017)
Q Consensus 469 ~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L 544 (1017)
++|+.|++++|++++..|.. +..+.. +++|++++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|
T Consensus 400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L 478 (606)
T 3t6q_A 400 PQLELLDLAFTRLKVKDAQSPFQNLHL-LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478 (606)
T ss_dssp TTCSEEECTTCCEECCTTCCTTTTCTT-CCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred ccCCeEECCCCcCCCcccchhhhCccc-CCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCc
Confidence 99999999999999877765 444444 45799999999999999999999999999999999873 33679999999
Q ss_pred eEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCC-CCCCCCCCcccccCc
Q 043932 545 EYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT-KGVFSSKTKLSLQGN 623 (1017)
Q Consensus 545 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~~~~n 623 (1017)
+.|+|++|++++.+|..|+.+++|+.|+|++|++++.+|..+.++++| .|++++|++++.+|. ...+.+++.+++.+|
T Consensus 479 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 557 (606)
T 3t6q_A 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN 557 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTC
T ss_pred cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCC
Confidence 999999999999999999999999999999999999999999999999 999999999998876 356788899999999
Q ss_pred ccccCCcC
Q 043932 624 VKLCGGTD 631 (1017)
Q Consensus 624 ~~~c~~~~ 631 (1017)
|+.|+|+.
T Consensus 558 ~~~c~c~~ 565 (606)
T 3t6q_A 558 PLDCTCSN 565 (606)
T ss_dssp CEECSGGG
T ss_pred CccccCCc
Confidence 99999875
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=563.24 Aligned_cols=520 Identities=20% Similarity=0.196 Sum_probs=315.8
Q ss_pred CceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCC-CcccccccccccccCCCCcccccCCC
Q 043932 65 CQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEI-PQEIGNLLRLEKLALPNNSFSGTIPT 143 (1017)
Q Consensus 65 c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~ 143 (1017)
|.|.+|-+ ...+++.|||++|.|++..+..++++++|++|||++|.+.+.+ |.+|+++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 45666655 3456788888888888877778888888888888888666666 67788888888888888888877788
Q ss_pred cccCCCcceEeecccccccccCccc--ccccCCccEEEeccccccCCCC-ccccCCCcccEEEEecCCCCCCCCcccccc
Q 043932 144 NLSRCSNLIQLRVSNNKLEGQIPAE--IGSLLKLQTLAVGKNYLTGRLP-DFVGNLSALEVFSITGNSLGGKIPTTLGLL 220 (1017)
Q Consensus 144 ~l~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l 220 (1017)
.|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|++++..+ ..|+++++|++|+|++|.+++..+..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 8888888888888888887766654 7788888888888888876654 467888888888888888887777777777
Q ss_pred --cCcceeEeecCccccccchhhcccCc------CcEEeCCCccCccccCchhhccC--Cccceeeeccc---------c
Q 043932 221 --RNLVDLHVGGNQFSGTFPQSICNISS------LERIYLPFNRFSGTLPFDIVVNL--PNLKSLAIGGN---------N 281 (1017)
Q Consensus 221 --~~L~~L~L~~n~l~~~~p~~l~~l~~------L~~L~Ls~N~l~~~l~~~~~~~l--~~L~~L~L~~n---------~ 281 (1017)
++|+.|++++|.+++..|..+..+++ |++|+|++|.+++.++..+...+ .+++.|.++.+ .
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 77888888888887777776666555 78888888877766665554332 45666666533 2
Q ss_pred cCCCCCCccccC--CccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcc
Q 043932 282 FFGSIPDSLSNA--SNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQ 359 (1017)
Q Consensus 282 l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 359 (1017)
+.+..+..+..+ ++|+.|++++|.+.+..+..|..+++|+.|+|++|++...... .+..+++|++|+|++|+
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~------~~~~l~~L~~L~Ls~N~ 325 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE------AFYGLDNLQVLNLSYNL 325 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTT------TTTTCSSCCEEEEESCC
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChH------HhcCCCCCCEEECCCCC
Confidence 332333334433 5677777777777766666667777777777777766544332 24455666666666666
Q ss_pred cccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCc
Q 043932 360 FVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPS 439 (1017)
Q Consensus 360 l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 439 (1017)
+++..|..+..+ ++|+.|++++|++..+.+..|.++++|++|+|++|.+++.. .+++|+.|++++|+++ .+|.
T Consensus 326 l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~-~l~~ 398 (844)
T 3j0a_A 326 LGELYSSNFYGL-PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLV-TLPK 398 (844)
T ss_dssp CSCCCSCSCSSC-TTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCC-CCCC
T ss_pred CCccCHHHhcCC-CCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc-----CCCCcchhccCCCCcc-cccc
Confidence 654444444443 23555555555555555555555555555555555555321 2455555555555555 3333
Q ss_pred ccccccccceeeccCcccCCCC-ccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccc
Q 043932 440 GVGNLTKLAKLVMSYNSLQGNI-PSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLK 518 (1017)
Q Consensus 440 ~~~~l~~L~~L~Ls~N~i~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~ 518 (1017)
. ..+++.|++++|++++.. +..+.++++|+.|++++|++++..+... +..++
T Consensus 399 ~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~------------------------~~~~~ 451 (844)
T 3j0a_A 399 I---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT------------------------PSENP 451 (844)
T ss_dssp C---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSS------------------------SCSCT
T ss_pred c---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccc------------------------cccCC
Confidence 2 234555555555555321 1123355555555555555553322222 23344
Q ss_pred cceEEEccCCccc-----ccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCc
Q 043932 519 NLVKLIISSNQFS-----GVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLE 593 (1017)
Q Consensus 519 ~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 593 (1017)
+|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++..|..+. ++|+
T Consensus 452 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~ 529 (844)
T 3j0a_A 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLE 529 (844)
T ss_dssp TCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCC
T ss_pred ccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cccc
Confidence 4555555555544 22233444555555555555555555555555555555555555555544443333 4455
Q ss_pred EEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCc
Q 043932 594 FLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGT 630 (1017)
Q Consensus 594 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 630 (1017)
.|||++|+|++.+|.. +.++..+++.||||.|+|+
T Consensus 530 ~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 530 ILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE 564 (844)
T ss_dssp EEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred EEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence 5555555555544432 3344445555555555443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=552.73 Aligned_cols=508 Identities=21% Similarity=0.161 Sum_probs=414.2
Q ss_pred EEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccC-CCcccCCCcceEeecccc
Q 043932 81 RLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTI-PTNLSRCSNLIQLRVSNN 159 (1017)
Q Consensus 81 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n 159 (1017)
..|.++++++.++. ..++|++|||++|.+++..|.+|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|
T Consensus 8 ~~dcs~~~L~~vP~----lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLTQVPQ----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSSCCCS----SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCCCCCC----CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 34566788887643 4578999999999999888999999999999999999776666 788999999999999999
Q ss_pred cccccCcccccccCCccEEEeccccccCCCCcc--ccCCCcccEEEEecCCCCCCCC-cccccccCcceeEeecCccccc
Q 043932 160 KLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDF--VGNLSALEVFSITGNSLGGKIP-TTLGLLRNLVDLHVGGNQFSGT 236 (1017)
Q Consensus 160 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~ 236 (1017)
.+++..|..|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999999999999999877665 9999999999999999988765 6799999999999999999998
Q ss_pred cchhhccc--CcCcEEeCCCccCccccCchhhccCC------ccceeeecccccCCCCCCccccC---CccceeecccCc
Q 043932 237 FPQSICNI--SSLERIYLPFNRFSGTLPFDIVVNLP------NLKSLAIGGNNFFGSIPDSLSNA---SNVEILDLGFNQ 305 (1017)
Q Consensus 237 ~p~~l~~l--~~L~~L~Ls~N~l~~~l~~~~~~~l~------~L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~Ls~N~ 305 (1017)
.+..+..+ ++|+.|+|+.|.+.+..|..+ ..++ .|+.|++++|.+++..+..+... .+++.|+++.+.
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~-~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~ 242 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDW-GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCC-CSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred CHHHcccccCCccceEECCCCccccccccch-hhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence 99999887 899999999999987766543 2233 38888888888887777766543 456667666443
Q ss_pred ccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcc--cCcccEEeccCcccccccchhHHhhcccceEEEecCC
Q 043932 306 FKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTN--CSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGN 383 (1017)
Q Consensus 306 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~--l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N 383 (1017)
+... +..+.+....... +.. .++|+.|++++|.+.+..|..+..+ ++|+.|++++|
T Consensus 243 ~~~~---------------~~~~~l~~~~~~~------f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L~~n 300 (844)
T 3j0a_A 243 MGAG---------------FGFHNIKDPDQNT------FAGLARSSVRHLDLSHGFVFSLNSRVFETL-KDLKVLNLAYN 300 (844)
T ss_dssp CBCS---------------SSCSSSTTGGGTT------TTTTTTSCCCEEECTTCCCCEECSCCSSSC-CCCCEEEEESC
T ss_pred cccc---------------ccccccCCCChhh------hhccccCCccEEECCCCcccccChhhhhcC-CCCCEEECCCC
Confidence 3210 1122222111111 122 3678888888888876666555544 46888888888
Q ss_pred ccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCcc
Q 043932 384 QIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPS 463 (1017)
Q Consensus 384 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~ 463 (1017)
+++++.+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|.++++|++|+|++|.+++ ++
T Consensus 301 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~- 378 (844)
T 3j0a_A 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH- 378 (844)
T ss_dssp CCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS-
T ss_pred cCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc-
Confidence 8888888899999999999999999998889999999999999999999998778889999999999999999984 33
Q ss_pred ccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCc-cccccccccceEEEccCCcccccccc-ccccc
Q 043932 464 SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSL-PLQIGNLKNLVKLIISSNQFSGVIPV-TLSTC 541 (1017)
Q Consensus 464 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l 541 (1017)
.+++|+.|++++|+++ .+|.... ...+|++++|++++.. +..+..+++|+.|+|++|++++..+. .+..+
T Consensus 379 ---~~~~L~~L~l~~N~l~-~l~~~~~----~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 450 (844)
T 3j0a_A 379 ---FIPSIPDIFLSGNKLV-TLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSEN 450 (844)
T ss_dssp ---SCCSCSEEEEESCCCC-CCCCCCT----TCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSC
T ss_pred ---CCCCcchhccCCCCcc-ccccccc----ccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccC
Confidence 3788999999999998 6665432 2356999999998642 23456899999999999999976544 46778
Q ss_pred ccceEEeccCCccC-----CCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCCCCCCCCC
Q 043932 542 VSLEYLDISSNSFH-----GVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKT 616 (1017)
Q Consensus 542 ~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~ 616 (1017)
++|+.|+|++|.++ +..|..|..+++|+.|+|++|++++.+|..|.++++|+.|+|++|+|++.+|.... .+++
T Consensus 451 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~ 529 (844)
T 3j0a_A 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLE 529 (844)
T ss_dssp TTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCC
T ss_pred CccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-cccc
Confidence 99999999999997 45567899999999999999999999999999999999999999999987776433 7889
Q ss_pred cccccCcccc
Q 043932 617 KLSLQGNVKL 626 (1017)
Q Consensus 617 ~~~~~~n~~~ 626 (1017)
.+++++|...
T Consensus 530 ~L~Ls~N~l~ 539 (844)
T 3j0a_A 530 ILDISRNQLL 539 (844)
T ss_dssp EEEEEEECCC
T ss_pred EEECCCCcCC
Confidence 9999998643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=509.17 Aligned_cols=495 Identities=17% Similarity=0.174 Sum_probs=378.2
Q ss_pred CCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCC
Q 043932 64 LCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPT 143 (1017)
Q Consensus 64 ~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 143 (1017)
.|.|.|| | |.++++++.+ |+.+. ++|++|+|++|++++..|.+|+++++|++|+|++|++++..|.
T Consensus 3 ~C~~~~~-c----------~~~~~~l~~i-p~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~ 68 (549)
T 2z81_A 3 SCDASGV-C----------DGRSRSFTSI-PSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68 (549)
T ss_dssp EECTTSE-E----------ECTTSCCSSC-CSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred cCCCCce-E----------ECCCCccccc-cccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence 5999998 8 4566777754 44443 7899999999999988889999999999999999999988889
Q ss_pred cccCCCcceEeecccccccccCcccccccCCccEEEeccccccC-CCCccccCCCcccEEEEecCCCCCCCC-ccccccc
Q 043932 144 NLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTG-RLPDFVGNLSALEVFSITGNSLGGKIP-TTLGLLR 221 (1017)
Q Consensus 144 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~ 221 (1017)
.|+++++|++|+|++|++++..|..|+++++|++|++++|++++ ..|..++++++|++|++++|.+.+.+| ..|+.++
T Consensus 69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~ 148 (549)
T 2z81_A 69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148 (549)
T ss_dssp TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence 99999999999999999998888889999999999999999987 357889999999999999999555554 6899999
Q ss_pred CcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCC--C-CccccCCccce
Q 043932 222 NLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSI--P-DSLSNASNVEI 298 (1017)
Q Consensus 222 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~--p-~~l~~l~~L~~ 298 (1017)
+|++|++++|++++..|..+..+++|++|+++.|.+. .+|..++..+++|++|++++|++++.. | .....+++|+.
T Consensus 149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~ 227 (549)
T 2z81_A 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227 (549)
T ss_dssp EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred ccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence 9999999999999999999999999999999999986 777777778999999999999998742 2 23345789999
Q ss_pred eecccCcccceeecc----ccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccc----hhHHh
Q 043932 299 LDLGFNQFKGKVSID----FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELP----HSIAN 370 (1017)
Q Consensus 299 L~Ls~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 370 (1017)
|++++|++++..+.. +..+++|+.+++++|.+.....-.......+..+.+|+.|+++++.+..... ..+..
T Consensus 228 L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~ 307 (549)
T 2z81_A 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307 (549)
T ss_dssp EEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHH
T ss_pred eeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhh
Confidence 999999998755443 4667899999999998765332111112234567788888888887653210 11223
Q ss_pred hcccceEEEecCCccccccCccccccccccEEeccccCCCCCcch---hhcccccccceeccccccccccC--ccccccc
Q 043932 371 LSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPD---VIGELKNLQGLFLYKNVLQGSIP--SGVGNLT 445 (1017)
Q Consensus 371 ~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~ 445 (1017)
...++++|++++|.+..++...+.++++|++|+|++|++++..|. .++.+++|++|+|++|++++..+ ..+..++
T Consensus 308 ~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~ 387 (549)
T 2z81_A 308 LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387 (549)
T ss_dssp HSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCT
T ss_pred hcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCC
Confidence 345677777777776643333335677777777777777665532 35666777777777777764322 3466667
Q ss_pred ccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEc
Q 043932 446 KLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLII 525 (1017)
Q Consensus 446 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 525 (1017)
+|++|++++|+++ .+|..+..+++|+.|++++|+++ .+|..+ .++|++|+|
T Consensus 388 ~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~--------------------------~l~~~~--~~~L~~L~L 438 (549)
T 2z81_A 388 NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR--------------------------VVKTCI--PQTLEVLDV 438 (549)
T ss_dssp TCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS--------------------------CCCTTS--CTTCSEEEC
T ss_pred CCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc--------------------------cccchh--cCCceEEEC
Confidence 7777777777776 46666666667777777766665 122222 146788888
Q ss_pred cCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCc
Q 043932 526 SSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGE 605 (1017)
Q Consensus 526 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 605 (1017)
++|++++.+ ..+++|++|+|++|+|+ .+|. ...+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.
T Consensus 439 s~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 439 SNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp CSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred CCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 888887643 46788888888888888 4555 46788888888888888888888888888888888888888887
Q ss_pred CCC
Q 043932 606 VPT 608 (1017)
Q Consensus 606 ~~~ 608 (1017)
+|.
T Consensus 513 ~~~ 515 (549)
T 2z81_A 513 CPR 515 (549)
T ss_dssp HHH
T ss_pred Ccc
Confidence 774
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=510.27 Aligned_cols=492 Identities=19% Similarity=0.167 Sum_probs=432.2
Q ss_pred CCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEee
Q 043932 76 HQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLR 155 (1017)
Q Consensus 76 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 155 (1017)
-.+++.|+|++|.+++..+..|+++++|++|+|++|.+++..|.+|+++++|++|+|++|.+++..|..++++++|++|+
T Consensus 55 l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 134 (606)
T 3vq2_A 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134 (606)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred CccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence 35799999999999999899999999999999999999988899999999999999999999987778999999999999
Q ss_pred cccccccc-cCcccccccCCccEEEeccccccCCCCccccCCCccc----EEEEecCCCCCCCCcccccccCcceeEeec
Q 043932 156 VSNNKLEG-QIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALE----VFSITGNSLGGKIPTTLGLLRNLVDLHVGG 230 (1017)
Q Consensus 156 L~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 230 (1017)
|++|.+++ .+|..|+++++|++|++++|++++..|..|+.+++|+ +|++++|.+++..+..+... +|++|++++
T Consensus 135 L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~ 213 (606)
T 3vq2_A 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRG 213 (606)
T ss_dssp CCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEES
T ss_pred CCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccC
Confidence 99999986 6799999999999999999999999899999888776 89999999997666666655 999999999
Q ss_pred Cccc-cccchhhcccCcCcEEeCCCccCcc-----ccCchhhccCC--ccceeee-cccccCCCCCCccccCCccceeec
Q 043932 231 NQFS-GTFPQSICNISSLERIYLPFNRFSG-----TLPFDIVVNLP--NLKSLAI-GGNNFFGSIPDSLSNASNVEILDL 301 (1017)
Q Consensus 231 n~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~-----~l~~~~~~~l~--~L~~L~L-~~n~l~~~~p~~l~~l~~L~~L~L 301 (1017)
|.++ +..|..+.++++|+.+++..+.+.+ .++...+..+. .++.+++ ..|.+.+.+|. +..+++|+.|++
T Consensus 214 n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l 292 (606)
T 3vq2_A 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSL 292 (606)
T ss_dssp CCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEE
T ss_pred CccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEe
Confidence 9997 4678899999999999987665532 12233333332 4566677 77888888887 999999999999
Q ss_pred ccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEec
Q 043932 302 GFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIG 381 (1017)
Q Consensus 302 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~ 381 (1017)
++|.+.... .+..+++|++|++++|.++..+ .+ .+++|+.|++++|+..+.+ .+. ..++|++|+++
T Consensus 293 ~~~~~~~l~--~l~~~~~L~~L~l~~n~l~~lp--------~~-~l~~L~~L~l~~n~~~~~~--~~~-~l~~L~~L~ls 358 (606)
T 3vq2_A 293 AGVSIKYLE--DVPKHFKWQSLSIIRCQLKQFP--------TL-DLPFLKSLTLTMNKGSISF--KKV-ALPSLSYLDLS 358 (606)
T ss_dssp ESCCCCCCC--CCCTTCCCSEEEEESCCCSSCC--------CC-CCSSCCEEEEESCSSCEEC--CCC-CCTTCCEEECC
T ss_pred cCccchhhh--hccccccCCEEEcccccCcccc--------cC-CCCccceeeccCCcCccch--hhc-cCCCCCEEECc
Confidence 999997654 8899999999999999995443 13 7899999999999665544 233 33579999999
Q ss_pred CCcccccc--CccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccC-cccccccccceeeccCcccC
Q 043932 382 GNQIFGII--PSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIP-SGVGNLTKLAKLVMSYNSLQ 458 (1017)
Q Consensus 382 ~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~i~ 458 (1017)
+|.+++.. +..+..+++|++|++++|.+++ .|..|..+++|+.|++++|++++..| ..+.++++|++|++++|+++
T Consensus 359 ~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~ 437 (606)
T 3vq2_A 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437 (606)
T ss_dssp SSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCE
T ss_pred CCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCC
Confidence 99999874 8889999999999999999985 66889999999999999999998877 68999999999999999999
Q ss_pred CCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccc
Q 043932 459 GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTL 538 (1017)
Q Consensus 459 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 538 (1017)
+..|..+.++++|+.|++++|++++. .+|..+..+++|+.|+|++|++++.+|..|
T Consensus 438 ~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 493 (606)
T 3vq2_A 438 IDFDGIFLGLTSLNTLKMAGNSFKDN------------------------TLSNVFANTTNLTFLDLSKCQLEQISWGVF 493 (606)
T ss_dssp ECCTTTTTTCTTCCEEECTTCEEGGG------------------------EECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred ccchhhhcCCCCCCEEECCCCcCCCc------------------------chHHhhccCCCCCEEECCCCcCCccChhhh
Confidence 99999999999999999999998721 356778899999999999999999999999
Q ss_pred cccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccC-CCcEEEcccCCCcCcCCCC
Q 043932 539 STCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLS-FLEFLNFSHNDLEGEVPTK 609 (1017)
Q Consensus 539 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~ 609 (1017)
+++++|+.|+|++|++++.+|..|+.+++|++|+|++|+++ .+|..+..++ +|+.|++++|++.+.++..
T Consensus 494 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp TTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred cccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 99999999999999999999999999999999999999999 6787799997 5999999999999988863
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=500.56 Aligned_cols=492 Identities=22% Similarity=0.252 Sum_probs=296.4
Q ss_pred eEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecc
Q 043932 78 RVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVS 157 (1017)
Q Consensus 78 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 157 (1017)
+++.|||++|.+++..+..+.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 45666666666666655566666666666666666665555556666666666666666665555666666666666666
Q ss_pred cccccccCcccccccCCccEEEeccccccC-CCCccccCCCcccEEEEecCCCCCCCCcccccccCc----ceeEeecCc
Q 043932 158 NNKLEGQIPAEIGSLLKLQTLAVGKNYLTG-RLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNL----VDLHVGGNQ 232 (1017)
Q Consensus 158 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L----~~L~L~~n~ 232 (1017)
+|++++..+..++++++|++|++++|.+++ .+|..|+++++|++|++++|.+++..+..++.+++| +.|++++|.
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 666664444456666666666666666654 346666666666666666666665555566666665 566666666
Q ss_pred cccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCC------CCCCccccCC--ccceeecccC
Q 043932 233 FSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFG------SIPDSLSNAS--NVEILDLGFN 304 (1017)
Q Consensus 233 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~------~~p~~l~~l~--~L~~L~Ls~N 304 (1017)
+++..|..+..+ +|++|++++|..........+..+++++.+.+..+.+.. .....+..+. .++.+++++|
T Consensus 189 l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 267 (570)
T 2z63_A 189 MNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267 (570)
T ss_dssp CCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEET
T ss_pred ceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcc
Confidence 665555555544 566666666543322222333444444444443322211 1111122221 2344444444
Q ss_pred -cccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCC
Q 043932 305 -QFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGN 383 (1017)
Q Consensus 305 -~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N 383 (1017)
.+.+..+..|..+++|++|++++|.+..... .+..+ +|+.|++++|.+. .+|.
T Consensus 268 ~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~-------~~~~~-~L~~L~l~~n~~~-~l~~----------------- 321 (570)
T 2z63_A 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD-------FSYNF-GWQHLELVNCKFG-QFPT----------------- 321 (570)
T ss_dssp TEEESCSTTTTGGGTTCSEEEEESCEECSCCB-------CCSCC-CCSEEEEESCBCS-SCCB-----------------
T ss_pred hhhhhhchhhhcCcCcccEEEecCccchhhhh-------hhccC-CccEEeeccCccc-ccCc-----------------
Confidence 4444445555555555555555555442221 12333 4555555555444 3332
Q ss_pred ccccccCccccccccccEEeccccCCCCCcchhhcccccccceecccccccccc--CcccccccccceeeccCcccCCCC
Q 043932 384 QIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSI--PSGVGNLTKLAKLVMSYNSLQGNI 461 (1017)
Q Consensus 384 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~i~~~~ 461 (1017)
..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|++|++++|++++.
T Consensus 322 ----------~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~- 388 (570)
T 2z63_A 322 ----------LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM- 388 (570)
T ss_dssp ----------CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-
T ss_pred ----------ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-
Confidence 2344455555555554433332 44455555555555554332 34444555555555555555432
Q ss_pred ccccccccCCceeecCCCcccCCccc-hhhhcccccceeccCCCcCCCCccccccccccceEEEccCCccc-cccccccc
Q 043932 462 PSSLGNCQNLIGFNASHNKLTGALPQ-QLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFS-GVIPVTLS 539 (1017)
Q Consensus 462 p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~ 539 (1017)
|..+..+++|+.|++++|++++..|. .+..+.. +++|++++|.+.+..|..+..+++|++|+|++|+++ +.+|..|.
T Consensus 389 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~ 467 (570)
T 2z63_A 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN-LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467 (570)
T ss_dssp EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTT-CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT
T ss_pred cccccccCCCCEEEccCCccccccchhhhhcCCC-CCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhh
Confidence 22245555555555555555543332 2222222 234555555555677788899999999999999998 57899999
Q ss_pred ccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCCC
Q 043932 540 TCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKG 610 (1017)
Q Consensus 540 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 610 (1017)
.+++|+.|+|++|++++..|..|..+++|++|+|++|++++.+|..+.++++|+.|++++|+++|.+|...
T Consensus 468 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred cccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 99999999999999999989999999999999999999999888889999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=445.98 Aligned_cols=264 Identities=30% Similarity=0.458 Sum_probs=207.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..+++++.++||+|+||+||+|++.. .||||+++... ....+.|.+|++++++++|||||+++++|.. +
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------C
Confidence 44678889999999999999999853 48999987443 3345789999999999999999999998743 3
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.+++..... .+++.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+||
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCC
T ss_pred eEEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeec
Confidence 47999999999999999976543 799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC---CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG---SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|+|+....... ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||........ ....
T Consensus 177 Gla~~~~~~~~------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~ 249 (307)
T 3omv_A 177 GLATVKSRWSG------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFM 249 (307)
T ss_dssp SSCBC------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHH
T ss_pred cCceecccCCc------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHH
Confidence 99986543221 112234679999999999864 3589999999999999999999999975422211 1111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
...... .| .......++++++.+++.+||+.||++|||+.||+++|+.++..+
T Consensus 250 ~~~~~~-------~p---------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 250 VGRGYA-------SP---------------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HHTTCC-------CC---------------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HhcCCC-------CC---------------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 111000 00 001122345678999999999999999999999999999887665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=485.79 Aligned_cols=513 Identities=19% Similarity=0.204 Sum_probs=414.6
Q ss_pred EEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccc
Q 043932 82 LDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKL 161 (1017)
Q Consensus 82 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 161 (1017)
++-++.+++.+ |..+. +++++|||++|.+++..+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 12 ~~c~~~~l~~i-p~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFYKI-PDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCSSC-CSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcccc-CCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 34445556543 33332 5799999999999987788899999999999999999987788899999999999999999
Q ss_pred cccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCC-CCCcccccccCcceeEeecCccccccchh
Q 043932 162 EGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGG-KIPTTLGLLRNLVDLHVGGNQFSGTFPQS 240 (1017)
Q Consensus 162 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~p~~ 240 (1017)
++..|..|+++++|++|++++|++++..+..++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~ 168 (570)
T 2z63_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (570)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG
T ss_pred CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHH
Confidence 98888899999999999999999997766679999999999999999987 46888999999999999999998888888
Q ss_pred hcccCcC----cEEeCCCccCccccCchhhccCCccceeeecccccCC-CCCCccccCCccceeecccCcccceeecccc
Q 043932 241 ICNISSL----ERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFG-SIPDSLSNASNVEILDLGFNQFKGKVSIDFS 315 (1017)
Q Consensus 241 l~~l~~L----~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 315 (1017)
++.+++| +.|++++|.++ .++...+... +|+.|++++|.... .++..+..+++++.+++..+.+.
T Consensus 169 ~~~l~~L~~~~~~L~l~~n~l~-~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~-------- 238 (570)
T 2z63_A 169 LRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR-------- 238 (570)
T ss_dssp GHHHHTCTTCCCEEECTTCCCC-EECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECC--------
T ss_pred ccchhccchhhhhcccCCCCce-ecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeecccccc--------
Confidence 8888888 78888888887 4444555444 78888888775432 23445556666666555433221
Q ss_pred ccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCc-ccccccchhHHhhcccceEEEecCCccccccCcccc
Q 043932 316 SLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAAN-QFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIR 394 (1017)
Q Consensus 316 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~ 394 (1017)
...+++.+ ....+ ..+.++ .++.++++++ .+.+.+|..+..+ ++++.|++++|.+++ +|..+.
T Consensus 239 ~~~~l~~~----------~~~~~---~~l~~l-~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~l~~-l~~~~~ 302 (570)
T 2z63_A 239 NEGNLEKF----------DKSAL---EGLCNL-TIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIER-VKDFSY 302 (570)
T ss_dssp CCSSCEEC----------CTTTT---GGGGGS-EEEEEEEEETTEEESCSTTTTGGG-TTCSEEEEESCEECS-CCBCCS
T ss_pred Cchhhhhc----------chhhh---cccccc-chhhhhhhcchhhhhhchhhhcCc-CcccEEEecCccchh-hhhhhc
Confidence 11111111 11111 111222 3667777777 6777777776665 568999999999884 677888
Q ss_pred ccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCC--ccccccccCCc
Q 043932 395 NLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNI--PSSLGNCQNLI 472 (1017)
Q Consensus 395 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~--p~~~~~l~~L~ 472 (1017)
.+ +|+.|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|+
T Consensus 303 ~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~ 376 (570)
T 2z63_A 303 NF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376 (570)
T ss_dssp CC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCC
T ss_pred cC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccC
Confidence 88 9999999999998 4554 5789999999999999877665 78999999999999998654 77889999999
Q ss_pred eeecCCCcccCCccchhhhcccccceeccCCCcCCCCcc-ccccccccceEEEccCCcccccccccccccccceEEeccC
Q 043932 473 GFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLP-LQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISS 551 (1017)
Q Consensus 473 ~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 551 (1017)
.|++++|++++ +|..+..+..+ ++|++++|.+.+..| ..+.++++|++|++++|++++..|..|.++++|+.|+|++
T Consensus 377 ~L~l~~n~l~~-~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 454 (570)
T 2z63_A 377 YLDLSFNGVIT-MSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454 (570)
T ss_dssp EEECCSCSEEE-EEEEEETCTTC-CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTT
T ss_pred EEECCCCcccc-ccccccccCCC-CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcC
Confidence 99999999985 44446666555 579999999998766 5789999999999999999999999999999999999999
Q ss_pred CccC-CCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCC-CCCCCCCCcccccCcccccCC
Q 043932 552 NSFH-GVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT-KGVFSSKTKLSLQGNVKLCGG 629 (1017)
Q Consensus 552 N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~ 629 (1017)
|+++ +.+|..|..+++|++|+|++|++++..|..+.++++|+.|++++|++++.+|. ...+.+++.+++.+|++.|+|
T Consensus 455 n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 9998 67899999999999999999999999999999999999999999999998875 467889999999999999988
Q ss_pred cC
Q 043932 630 TD 631 (1017)
Q Consensus 630 ~~ 631 (1017)
+.
T Consensus 535 ~~ 536 (570)
T 2z63_A 535 PR 536 (570)
T ss_dssp TT
T ss_pred cc
Confidence 75
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=446.03 Aligned_cols=264 Identities=25% Similarity=0.420 Sum_probs=212.5
Q ss_pred ccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
++|.+.+.||+|+||+||+|++. .+++.||||+++.......++|.+|++++++++|||||+++++|.+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----- 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----- 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence 57888999999999999999975 35789999999866666678899999999999999999999999765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCC-------CccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC
Q 043932 780 DFKALVFECMKNGSLEDWLHQSND-------HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 852 (1017)
+..++||||+++|+|.++++..+. ......+++.+++.|+.|||+||+|||++ +||||||||+|||++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 568999999999999999986531 11234799999999999999999999999 99999999999999999
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccC
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEG 931 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 931 (1017)
+.+||+|||+|+......... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||......+
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~------~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~ 238 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEE------ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred CcEEECCcccceecCCCCcee------ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999998664332111 1122468999999999999999999999999999999999 899997642211
Q ss_pred ccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 932 LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
.......... ...+..+++++.+++.+||+.||++|||++||.+.|+.+.+
T Consensus 239 -~~~~i~~~~~---------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 239 -VIECITQGRV---------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -HHHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHcCCC---------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0111111000 01122356788999999999999999999999999988764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=445.98 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=210.6
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
+.|++.++||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++|||||++++++.+. +..|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence 4689999999999999999999999999999999876666667789999999999999999999999765 67999
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||++||+|.+++... .+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 149 vmEy~~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EECCCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 99999999999999753 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
.+.... ......+||+.|||||++.+..|+.++||||+||++|||++|++||....... .+... ....+.
T Consensus 219 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i-~~~~~~ 288 (346)
T 4fih_A 219 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMI-RDNLPP 288 (346)
T ss_dssp ECCSSS--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHH-HHSSCC
T ss_pred ecCCCC--------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHH-HcCCCC
Confidence 764322 12234689999999999999999999999999999999999999997642211 11111 111110
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. .....+++++.+++.+||+.||++|||+.|+++|
T Consensus 289 ~~------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 289 RL------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CC------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 0111235678999999999999999999999886
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=448.16 Aligned_cols=265 Identities=25% Similarity=0.416 Sum_probs=208.3
Q ss_pred ccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
++|.+.++||+|+||+||+|++. .+++.||||+++.......++|.+|++++++++|||||+++++|.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----- 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG----- 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence 46788899999999999999875 36889999999876666678899999999999999999999999765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCC---------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDH---------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
+..|+||||+++|+|.++++..... ....++++.+++.|+.|||+||+|||++ +||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 5689999999999999999865421 1224699999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccc
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFT 929 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 929 (1017)
+++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~------~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp TTTEEEECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred CCCcEEEcccccceeccCCCcc------eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999866433211 11223579999999999999999999999999999999999 8999976422
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
.. .......... ...+..+++++.+++.+||+.||++|||+.||+++|+.+.
T Consensus 267 ~~-~~~~i~~g~~---------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 267 TE-AIDCITQGRE---------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HH-HHHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HH-HHHHHHcCCC---------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 11 0111100000 0111235678899999999999999999999999999887
Q ss_pred cc
Q 043932 1010 ET 1011 (1017)
Q Consensus 1010 ~~ 1011 (1017)
+.
T Consensus 319 ~~ 320 (329)
T 4aoj_A 319 QA 320 (329)
T ss_dssp HS
T ss_pred hC
Confidence 53
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=445.10 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=204.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+++.+|++++++++|||||++++++.+. +.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CE
Confidence 368999999999999999999999999999999997543 23457889999999999999999999998765 77
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+|||||+||+|.+++...+. ..+++.+++.|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG 170 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG 170 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccc
Confidence 9999999999999999976532 3678999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+...... ......+||+.|||||++.+..|+.++||||+||++|||++|++||....... .........
T Consensus 171 la~~~~~~~--------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~ 241 (350)
T 4b9d_A 171 IARVLNSTV--------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGS 241 (350)
T ss_dssp EESCCCHHH--------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTC
T ss_pred cceeecCCc--------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCC
Confidence 998764321 11223579999999999999999999999999999999999999997642211 111111111
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+. ....+++++.+++.+||+.||++|||+.|+++|
T Consensus 242 ~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 FPP---------------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCC---------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 110 111235678999999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=441.37 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=210.4
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.++++++|||||++++++.+. +..
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~-----~~~ 125 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREG-----PWV 125 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEET-----TEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence 34578889999999999999999999999999999975432 24799999999999999999998765 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-CeEEeecc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VSHVGDFG 861 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG 861 (1017)
|+||||++||+|.++++..+ .+++.++..++.||+.||+|||++ +||||||||+|||++.+| ++||+|||
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFG 196 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFG 196 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred EEEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCC
Confidence 99999999999999998654 689999999999999999999999 999999999999999987 69999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+.+........ ......++||+.|||||++.+..|+.++||||+||++|||++|++||........ ........
T Consensus 197 la~~~~~~~~~~~---~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~ 272 (336)
T 4g3f_A 197 HALCLQPDGLGKS---LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP 272 (336)
T ss_dssp TCEEC---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC
T ss_pred CCeEccCCCcccc---eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC
Confidence 9987754322111 1112235799999999999999999999999999999999999999986543322 22221111
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
. .. ...+..+++.+.+++.+||+.||++|||+.|++++|..+.+.
T Consensus 273 ~--~~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 273 P--PI-----------------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp C--GG-----------------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C--Cc-----------------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 0 00 011223466789999999999999999999999998876544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=478.09 Aligned_cols=489 Identities=18% Similarity=0.147 Sum_probs=408.1
Q ss_pred CCCCCCCCCceeeEEECC--CCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCC
Q 043932 57 SWNNTINLCQWTGVTCGH--RHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPN 134 (1017)
Q Consensus 57 sw~~~~~~c~w~gv~c~~--~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 134 (1017)
.|.+. ..|++.+++.-+ ....++.|+|++|++++..+..++++++|++|+|++|.+++..|.+|+++++|++|+|++
T Consensus 5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 83 (549)
T 2z81_A 5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83 (549)
T ss_dssp CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence 45433 225566665432 235799999999999999999999999999999999999988889999999999999999
Q ss_pred CcccccCCCcccCCCcceEeecccccccc-cCcccccccCCccEEEeccccccCCCC-ccccCCCcccEEEEecCCCCCC
Q 043932 135 NSFSGTIPTNLSRCSNLIQLRVSNNKLEG-QIPAEIGSLLKLQTLAVGKNYLTGRLP-DFVGNLSALEVFSITGNSLGGK 212 (1017)
Q Consensus 135 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~ 212 (1017)
|++++..|..|+++++|++|+|++|++++ ..|..++++++|++|++++|.+.+.+| ..|+++++|++|++++|.+++.
T Consensus 84 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 163 (549)
T 2z81_A 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163 (549)
T ss_dssp SCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccccc
Confidence 99998777779999999999999999987 467889999999999999999554554 6899999999999999999999
Q ss_pred CCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCcccc--CchhhccCCccceeeecccccCCCCC---
Q 043932 213 IPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTL--PFDIVVNLPNLKSLAIGGNNFFGSIP--- 287 (1017)
Q Consensus 213 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l--~~~~~~~l~~L~~L~L~~n~l~~~~p--- 287 (1017)
.|..++.+++|++|++++|.+....+..+..+++|++|++++|++++.. |......+++|+.|++++|.+++..+
T Consensus 164 ~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l 243 (549)
T 2z81_A 164 QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243 (549)
T ss_dssp CTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHH
T ss_pred ChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHH
Confidence 9999999999999999999987443334467999999999999998532 33445567899999999999986543
Q ss_pred -CccccCCccceeecccCcccceee------ccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCccc
Q 043932 288 -DSLSNASNVEILDLGFNQFKGKVS------IDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360 (1017)
Q Consensus 288 -~~l~~l~~L~~L~Ls~N~l~~~~~------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 360 (1017)
..+..+++|+.+++++|.+.+... ..+..+++|+.|++.++.+...... .+....+....+|+.|++++|++
T Consensus 244 ~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~-~~l~~~~~~~~~L~~L~l~~n~l 322 (549)
T 2z81_A 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKV 322 (549)
T ss_dssp HGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGS-CCCCHHHHHSTTCCEEEEESSCC
T ss_pred HHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhc-ccchhhhhhcccceEEEeccCcc
Confidence 445677899999999999887532 2357788999999999987543210 01112234567899999999998
Q ss_pred ccccchhHHhhcccceEEEecCCccccccC---ccccccccccEEeccccCCCCCcc--hhhcccccccceecccccccc
Q 043932 361 VGELPHSIANLSSSMIEFRIGGNQIFGIIP---SGIRNLVNLIALGMQSNQLHGTIP--DVIGELKNLQGLFLYKNVLQG 435 (1017)
Q Consensus 361 ~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~ 435 (1017)
. .+|..++...++|++|++++|++++..| ..++.+++|++|+|++|++++..+ ..+..+++|++|+|++|+++
T Consensus 323 ~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~- 400 (549)
T 2z81_A 323 F-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH- 400 (549)
T ss_dssp C-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-
T ss_pred c-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-
Confidence 7 7888887666789999999999998764 458899999999999999997653 67999999999999999999
Q ss_pred ccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCcccccc
Q 043932 436 SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIG 515 (1017)
Q Consensus 436 ~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~ 515 (1017)
.+|..+..+++|++|++++|+|+ .+|..+ .++|+.|++++|+++ +. +.
T Consensus 401 ~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~-------------------------~~----~~ 448 (549)
T 2z81_A 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-------------------------SF----SL 448 (549)
T ss_dssp CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCS-------------------------CC----CC
T ss_pred cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChh-------------------------hh----cc
Confidence 68989999999999999999998 445433 256777777777766 22 14
Q ss_pred ccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCCh
Q 043932 516 NLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIP 583 (1017)
Q Consensus 516 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 583 (1017)
.+++|++|+|++|+|+ .+|. ...+++|+.|||++|+|++.+|+.|..+++|+.|+|++|++++..|
T Consensus 449 ~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 449 FLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 6789999999999999 5665 5789999999999999999999999999999999999999999887
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=431.93 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=201.2
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
|++.++||+|+||+||+|++..+++.||+|++.... ....+++.+|++++++++|||||+++++|.... .+.+..|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 366778999999999999999999999999997543 334577999999999999999999999986531 22367899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeecCCCCceEeCC-CCCeEEeecc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDH-DMVSHVGDFG 861 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~-~~~~kl~DfG 861 (1017)
||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ + ||||||||+|||++. ++.+||+|||
T Consensus 107 vmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred EEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCc
Confidence 999999999999998654 789999999999999999999998 6 999999999999974 7999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||++||.................
T Consensus 178 la~~~~~~----------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~ 246 (290)
T 3fpq_A 178 LATLKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 246 (290)
T ss_dssp GGGGCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred CCEeCCCC----------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC
Confidence 99754321 2234689999999999876 699999999999999999999999965322111111110000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+.. ....+++++.+++.+||+.||++|||+.|+++|
T Consensus 247 ~~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 247 KPAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCC--------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 011124568899999999999999999999876
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=439.90 Aligned_cols=263 Identities=23% Similarity=0.354 Sum_probs=210.1
Q ss_pred ccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
+++++.++||+|+||+||+|++. .+++.||||+++... ....++|.+|+.++++++|||||+++|+|...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---- 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD---- 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC----
Confidence 45677889999999999999974 357889999997443 33457899999999999999999999999764
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceE
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 848 (1017)
+..++||||+++|+|.+++...... .....+++.+++.|+.|||+||+|||++ +||||||||+|||
T Consensus 102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 5679999999999999999764321 1234689999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcc
Q 043932 849 LDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAA 927 (1017)
Q Consensus 849 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 927 (1017)
+++++.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYY------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCB------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred ECCCCCEEECCcccceeccCCCce------eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999866433211 11223579999999999999999999999999999999999 89999764
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
... .+........ ..+.+.++++++.+++.+||+.||++||||+||+++|+.
T Consensus 252 ~~~--~~~~~i~~~~--------------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 252 SNQ--DVVEMIRNRQ--------------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp CHH--HHHHHHHTTC--------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CHH--HHHHHHHcCC--------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 221 1111110000 001123457789999999999999999999999999987
Q ss_pred cc
Q 043932 1008 TR 1009 (1017)
Q Consensus 1008 ~~ 1009 (1017)
..
T Consensus 304 ~~ 305 (308)
T 4gt4_A 304 WG 305 (308)
T ss_dssp SC
T ss_pred cc
Confidence 53
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=480.95 Aligned_cols=516 Identities=18% Similarity=0.177 Sum_probs=349.9
Q ss_pred CCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEec
Q 043932 102 FLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVG 181 (1017)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 181 (1017)
++++|||++|+|++..|.+|.++++|++|+|++|+|++..|.+|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 56677777777765555566777777777777777765555666777777777777777765555666777777777777
Q ss_pred cccccCCCCccccCCCcccEEEEecCCCCC-CCCcccccccCcceeEeecCccccccchhhcccCcCc----EEeCCCcc
Q 043932 182 KNYLTGRLPDFVGNLSALEVFSITGNSLGG-KIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLE----RIYLPFNR 256 (1017)
Q Consensus 182 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~Ls~N~ 256 (1017)
+|++++..+..|+++++|++|+|++|.+++ ..|..++.+++|++|++++|+|++..+..+..+.+++ .++++.|.
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~ 212 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 212 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence 777766666666777777777777776654 3456666677777777777777666666665554433 56666666
Q ss_pred CccccCchhhccCCccceeeecccccCCC-CCCccccCCccceeecccCc------ccceeeccccccCccceEecccCc
Q 043932 257 FSGTLPFDIVVNLPNLKSLAIGGNNFFGS-IPDSLSNASNVEILDLGFNQ------FKGKVSIDFSSLKNLSWLNLEQNN 329 (1017)
Q Consensus 257 l~~~l~~~~~~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~L~~N~ 329 (1017)
+. .++...+. ...++.+++.+|..... .+..+..+..++...+..+. +.......+..+..+....+..+.
T Consensus 213 l~-~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 213 MN-FIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CC-EECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred cc-ccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 65 34444332 23455666666654322 22334445555554443222 222233344455555555554443
Q ss_pred CCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCC
Q 043932 330 LGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQL 409 (1017)
Q Consensus 330 l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 409 (1017)
....... ....+..+.+++.+++.+|.+....+. .....++.|++.+|.+....+. .+..|+.+++.+|.+
T Consensus 291 ~~~~~~~---~~~~~~~~~~l~~l~~~~~~~~~~~~~---~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~ 361 (635)
T 4g8a_A 291 LDYYLDG---IIDLFNCLTNVSSFSLVSVTIERVKDF---SYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKG 361 (635)
T ss_dssp CCSCEEE---CTTTTGGGTTCSEEEEESCEEEECGGG---GSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCS
T ss_pred hcccccc---hhhhhhhhccccccccccccccccccc---ccchhhhhhhcccccccCcCcc---cchhhhhcccccccC
Confidence 3221111 112244556677777777766543221 1223577777777777665443 345677778887776
Q ss_pred CCCcchhhcccccccceecccccccc--ccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccc
Q 043932 410 HGTIPDVIGELKNLQGLFLYKNVLQG--SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQ 487 (1017)
Q Consensus 410 ~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 487 (1017)
... ..+..+++|+.|++++|.+.. ..+..+..+.+|++|+++.|.+. ..+..+..+++|+.+++++|......+.
T Consensus 362 ~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~ 438 (635)
T 4g8a_A 362 GNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 438 (635)
T ss_dssp CCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSS
T ss_pred CCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccc
Confidence 633 234567888888888887753 34555667778888888888877 4556677788888888888877766655
Q ss_pred hhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcc-cccccccccccccceEEeccCCccCCCCCccccccc
Q 043932 488 QLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQF-SGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLK 566 (1017)
Q Consensus 488 ~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 566 (1017)
..+.......++++++|.+.+..|..+..+++|+.|+|++|++ .+.+|..|..+++|++|||++|+|++++|.+|..++
T Consensus 439 ~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~ 518 (635)
T 4g8a_A 439 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 518 (635)
T ss_dssp CTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCC
Confidence 5444444455688888888888888888999999999999975 446788899999999999999999999999999999
Q ss_pred cCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCC-CCC-CCCCcccccCcccccCCcC
Q 043932 567 SIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTK-GVF-SSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 567 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-~~~~~~~~~~n~~~c~~~~ 631 (1017)
+|++|+|++|+|++..|..|.++++|++|||++|+|++.+|.. ..+ .+++.+++.+|||.|+|..
T Consensus 519 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 519 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp TCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 9999999999999888888999999999999999999988863 334 6788899999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=437.12 Aligned_cols=252 Identities=21% Similarity=0.336 Sum_probs=209.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.++||+|+||+||+|++..+++.||||++... .....+.+.+|++++++++|||||++++++.+. +
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----E 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 35799999999999999999999999999999999743 234457899999999999999999999998765 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||++||+|.+++++.+ .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DF 176 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDF 176 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEc
Confidence 7999999999999999998654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+|+.+..... ......++||+.|||||++.+..|+.++||||+||++|||++|++||...... .........
T Consensus 177 Gla~~~~~~~~------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~ 249 (311)
T 4aw0_A 177 GTAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-LIFAKIIKL 249 (311)
T ss_dssp TTCEECCTTTT------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHT
T ss_pred CCceecCCCCC------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcC
Confidence 99987653321 12233468999999999999999999999999999999999999999764221 111111111
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .+...++++.+++.+||+.||++|||++|++.+
T Consensus 250 ~~~----------------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 250 EYD----------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp CCC----------------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred CCC----------------------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 000 001224568899999999999999999987544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=470.78 Aligned_cols=465 Identities=20% Similarity=0.166 Sum_probs=301.9
Q ss_pred EEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccc
Q 043932 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNN 159 (1017)
Q Consensus 80 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 159 (1017)
+.||+++|+++. +|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|||++|
T Consensus 3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 368999999985 555555 88999999999999877888999999999999999999888889999999999999999
Q ss_pred cccccCcccccccCCccEEEeccccccC-CCCccccCCCcccEEEEecCCCCCCCCcccccccCc--ceeEeecCcc--c
Q 043932 160 KLEGQIPAEIGSLLKLQTLAVGKNYLTG-RLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNL--VDLHVGGNQF--S 234 (1017)
Q Consensus 160 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L--~~L~L~~n~l--~ 234 (1017)
+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++ ..+..+++| ++|++++|++ +
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 998 56666 78899999999999987 468889999999999999998875 456777777 8899999888 7
Q ss_pred cccchhhcccC-cCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeecc
Q 043932 235 GTFPQSICNIS-SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID 313 (1017)
Q Consensus 235 ~~~p~~l~~l~-~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 313 (1017)
+..|..+..+. ....+++++|.+.+.++...+..+++|+.|++++|.-.... ..+.+.++ .
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~-----------------~~~~~~~~-~ 215 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC-----------------SYFLSILA-K 215 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTT-----------------HHHHHHHH-G
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccccccccccc-----------------ceeecchh-h
Confidence 77777777665 33456667777666555555555555555555555410000 00333222 3
Q ss_pred ccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHh--hcccceEEEecCCccccccCc
Q 043932 314 FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIAN--LSSSMIEFRIGGNQIFGIIPS 391 (1017)
Q Consensus 314 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~~~L~~L~l~~N~i~~~~~~ 391 (1017)
|..+++|+.|++++|.+. +..+..+.. ...+|++|++++|++++.+|.
T Consensus 216 l~~l~~L~~L~l~~~~l~------------------------------~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~ 265 (520)
T 2z7x_B 216 LQTNPKLSNLTLNNIETT------------------------------WNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265 (520)
T ss_dssp GGGCTTCCEEEEEEEEEE------------------------------HHHHHHHHHHHHTSSCSEEEEEEEEEESCCCC
T ss_pred hccccchhhccccccccC------------------------------HHHHHHHHHHhhhCcccEEEeecccccCcccc
Confidence 334444444444433332 111111110 012344555555555545555
Q ss_pred cc-----cccccccEEeccccCCCCCcchhhccc---ccccceeccccccccccCcccccccccceeeccCcccCCCCcc
Q 043932 392 GI-----RNLVNLIALGMQSNQLHGTIPDVIGEL---KNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPS 463 (1017)
Q Consensus 392 ~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~ 463 (1017)
.+ .++++|+.+++++|.+ ......+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++.+|.
T Consensus 266 ~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~ 342 (520)
T 2z7x_B 266 RDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFE 342 (520)
T ss_dssp CCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTT
T ss_pred chhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhh
Confidence 55 7788888888888888 2333566655 67888888888886432 125778888888888888887888
Q ss_pred ccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccc-cccccc
Q 043932 464 SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPV-TLSTCV 542 (1017)
Q Consensus 464 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~ 542 (1017)
.+.++++|+.|++++|++++ ++ .+|..+..+++|++|+|++|++++.+|. .+..++
T Consensus 343 ~~~~l~~L~~L~L~~N~l~~-l~----------------------~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~ 399 (520)
T 2z7x_B 343 NCGHLTELETLILQMNQLKE-LS----------------------KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399 (520)
T ss_dssp TCCCCSSCCEEECCSSCCCB-HH----------------------HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCT
T ss_pred hhccCCCCCEEEccCCccCc-cc----------------------cchHHHhhCCCCCEEECCCCcCCcccccchhccCc
Confidence 88888888888888888873 11 1233444555555555555555542332 245555
Q ss_pred cceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCC-CCCCCCCCccccc
Q 043932 543 SLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT-KGVFSSKTKLSLQ 621 (1017)
Q Consensus 543 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~~~ 621 (1017)
+|+.|+|++|++++.+|..+. ++|++|+|++|+++ .+|..+..+++|++|++++|++++.++. ...+.+++.+++.
T Consensus 400 ~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~ 476 (520)
T 2z7x_B 400 SLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLH 476 (520)
T ss_dssp TCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred cCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECc
Confidence 555555555555554444432 45555555555555 4454444555555555555555533332 3344455555555
Q ss_pred CcccccCCc
Q 043932 622 GNVKLCGGT 630 (1017)
Q Consensus 622 ~n~~~c~~~ 630 (1017)
+|++.|+|+
T Consensus 477 ~N~~~c~c~ 485 (520)
T 2z7x_B 477 TNPWDCSCP 485 (520)
T ss_dssp SSCBCCCHH
T ss_pred CCCCcccCC
Confidence 555555544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=485.88 Aligned_cols=495 Identities=20% Similarity=0.239 Sum_probs=378.1
Q ss_pred CCCHHHHHHHHHHHHhcCCCCCCCCCCCCCCC----CCceee-EEECCC--CCeEEEEEcCCCCCccccCcccCCCCCCC
Q 043932 32 QTNETDRLALLAIKSQLHDTSGVTSSWNNTIN----LCQWTG-VTCGHR--HQRVTRLDLSNQRIGGILSPYVGNLSFLR 104 (1017)
Q Consensus 32 ~~~~~~~~aLl~~k~~~~~~~~~~~sw~~~~~----~c~w~g-v~c~~~--~~~v~~l~l~~~~l~~~~~~~l~~l~~L~ 104 (1017)
...+++.+.-.++++-...-.+ .+|....+ .|.|.. ..|..- ...|+- . .-.+++
T Consensus 23 ~~~~~~~~d~~aL~~~~~~~~~--~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C-------------~---~~~~V~ 84 (636)
T 4eco_A 23 SRTAEYIKDYLALKEIWDALNG--KNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL-------------N---SNGRVT 84 (636)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTG--GGCCCCC------CCCCCSSCGGGTTCCTTEEE-------------C---TTCCEE
T ss_pred hhhhhHHHHHHHHHHHHHHcCC--CCcccCCcCCccCCCCCCCCCcccccCCCCeEE-------------c---CCCCEE
Confidence 3445666667777766555544 47874332 247952 112111 011221 0 114789
Q ss_pred EEEccCCCCCCCCCcccccccccccccCCCCcc------cc------cCCCcccCCCcceEeecccccccccCccccccc
Q 043932 105 YINLSDNSFHGEIPQEIGNLLRLEKLALPNNSF------SG------TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSL 172 (1017)
Q Consensus 105 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l------~~------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 172 (1017)
.|+|++|+++|.+|.+|++|++|++|+|++|.+ .| .+|... +..|+ +++++|.+.+.+|..+..+
T Consensus 85 ~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~ 161 (636)
T 4eco_A 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDL 161 (636)
T ss_dssp EEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHH
T ss_pred EEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHH
Confidence 999999999999999999999999999999987 33 344433 66788 9999999999888877632
Q ss_pred -C------------------CccEEEec--cccccCCCCccccCCCcccEEEEecCCCCCC-----------------CC
Q 043932 173 -L------------------KLQTLAVG--KNYLTGRLPDFVGNLSALEVFSITGNSLGGK-----------------IP 214 (1017)
Q Consensus 173 -~------------------~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~~ 214 (1017)
. .++.+.+. .|+++| +|..++++++|++|+|++|.+++. +|
T Consensus 162 ~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip 240 (636)
T 4eco_A 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240 (636)
T ss_dssp HHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCc
Confidence 1 22222222 688988 899999999999999999999986 88
Q ss_pred cccc--cccCcceeEeecCccccccchhhcccCcCcEEeCCCcc-Ccc-ccCchhhc-----cCCccceeeecccccCCC
Q 043932 215 TTLG--LLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR-FSG-TLPFDIVV-----NLPNLKSLAIGGNNFFGS 285 (1017)
Q Consensus 215 ~~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~l~~~~~~-----~l~~L~~L~L~~n~l~~~ 285 (1017)
..++ ++++|++|+|++|++.+.+|..++++++|++|+|++|+ ++| .+|..+.. .+++|++|+|++|+++ .
T Consensus 241 ~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ 319 (636)
T 4eco_A 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-T 319 (636)
T ss_dssp SCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-S
T ss_pred hhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-c
Confidence 9988 99999999999999999999999999999999999998 887 78866532 2388888888888888 7
Q ss_pred CCC--ccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccc
Q 043932 286 IPD--SLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGE 363 (1017)
Q Consensus 286 ~p~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 363 (1017)
+|. .++.+++|++|++++|+++|.+| .|..+++|++|+|+ +|+++
T Consensus 320 ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~------------------------------~N~l~-- 366 (636)
T 4eco_A 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA------------------------------YNQIT-- 366 (636)
T ss_dssp CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECC------------------------------SSEEE--
T ss_pred cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECC------------------------------CCccc--
Confidence 787 88888888888888888886666 55554444444444 44333
Q ss_pred cchhHHhhcccceEEEecCCccccccCcccccccc-ccEEeccccCCCCCcchhhcccc--cccceeccccccccccCcc
Q 043932 364 LPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVN-LIALGMQSNQLHGTIPDVIGELK--NLQGLFLYKNVLQGSIPSG 440 (1017)
Q Consensus 364 ~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~ 440 (1017)
.+|..+.++++ |++|++++|+++ .+|..+..++ +|++|++++|.+++.+|..
T Consensus 367 ------------------------~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 421 (636)
T 4eco_A 367 ------------------------EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421 (636)
T ss_dssp ------------------------ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCS
T ss_pred ------------------------cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhh
Confidence 23455667777 888888888887 6677776654 7888888888888888877
Q ss_pred cc-------cccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCcccc
Q 043932 441 VG-------NLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQ 513 (1017)
Q Consensus 441 ~~-------~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~ 513 (1017)
|. .+++|++|+|++|+|+...+..+..+++|+.|++++|+++ .+|..++.. .+..
T Consensus 422 l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~-----------------~~~~ 483 (636)
T 4eco_A 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKD-----------------ENEN 483 (636)
T ss_dssp SCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEE-----------------TTEE
T ss_pred hcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhcc-----------------cccc
Confidence 77 7778888888888888444444556888888888888887 555443221 1122
Q ss_pred ccccccceEEEccCCccccccccccc--ccccceEEeccCCccCCCCCccccccccCcEEec------cCCcccCCChhh
Q 043932 514 IGNLKNLVKLIISSNQFSGVIPVTLS--TCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNF------SSNNLSGQIPEF 585 (1017)
Q Consensus 514 ~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~ 585 (1017)
+.++++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+| ++|++.+.+|..
T Consensus 484 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~ 561 (636)
T 4eco_A 484 FKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561 (636)
T ss_dssp CTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTT
T ss_pred ccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHH
Confidence 445679999999999999 6788886 99999999999999998 8999999999999999 568899999999
Q ss_pred hcccCCCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCC
Q 043932 586 LENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGG 629 (1017)
Q Consensus 586 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 629 (1017)
+.++++|++|+|++|++ +.+|.. ...+++.+++.+|+..|-.
T Consensus 562 l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 562 ITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISID 603 (636)
T ss_dssp GGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEE
T ss_pred HhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCcccc
Confidence 99999999999999999 677764 3488999999999988753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=447.61 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=210.9
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
+.|++.++||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|++++|||||++++++.+. +..|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence 5699999999999999999999999999999999877666667889999999999999999999999765 67999
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
|||||+||+|.++++.. .+++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 226 VmEy~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEECCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence 99999999999999754 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
.+.... ......+||+.|||||++.+..|+.++||||+||++|||++|++||....... .+.. .....+.
T Consensus 296 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~-i~~~~~~ 365 (423)
T 4fie_A 296 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKM-IRDNLPP 365 (423)
T ss_dssp ECCSSC--------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH-HHHSCCC
T ss_pred ECCCCC--------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHH-HHcCCCC
Confidence 764322 12234689999999999999999999999999999999999999997642211 1111 1111110
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. .....+++++.+++.+||+.||++|||+.|+++|
T Consensus 366 ~~------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 366 RL------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CC------------------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 0011235678999999999999999999999886
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=421.59 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=192.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+++.+|++++++++|||||++++++.+. +
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----D 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----C
Confidence 368999999999999999999999999999999997432 33456789999999999999999999998765 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+ +|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred EEEEEEeCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence 789999999 679999998764 789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+|+...... .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||...... ........
T Consensus 157 Gla~~~~~~~---------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~~~~~i~~ 226 (275)
T 3hyh_A 157 GLSNIMTDGN---------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-VLFKNISN 226 (275)
T ss_dssp SCC------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred CCCeecCCCC---------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHc
Confidence 9998654322 1223679999999999998876 58999999999999999999999753211 00111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+ .+..+++++.+++.+||+.||++|||+.|+++|
T Consensus 227 ~~~~----------------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 227 GVYT----------------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp TCCC----------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCC----------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 001235668899999999999999999999986
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=478.14 Aligned_cols=461 Identities=19% Similarity=0.232 Sum_probs=363.7
Q ss_pred CCCCEEEccCCCCCCCCCcccccccccccccC-CCCcccccCCCcccCC----CcceEeec------------ccccccc
Q 043932 101 SFLRYINLSDNSFHGEIPQEIGNLLRLEKLAL-PNNSFSGTIPTNLSRC----SNLIQLRV------------SNNKLEG 163 (1017)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-~~n~l~~~~p~~l~~l----~~L~~L~L------------~~n~l~~ 163 (1017)
.+++.|+|++|+++|.+|++|++|++|++|+| ++|.++|..|-..... +.++...+ ....+++
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 9999998855332211 10000000 0011111
Q ss_pred cC-----------cccccccCCccEEEecc--ccccCCCCccccCCCcccEEEEecCCCCC-----------------CC
Q 043932 164 QI-----------PAEIGSLLKLQTLAVGK--NYLTGRLPDFVGNLSALEVFSITGNSLGG-----------------KI 213 (1017)
Q Consensus 164 ~~-----------p~~~~~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~ 213 (1017)
.+ +........++.+.++. |++++ +|..|+++++|+.|+|++|.+++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 11 11112333455555554 89998 89999999999999999999998 38
Q ss_pred Ccccc--cccCcceeEeecCccccccchhhcccCcCcEEeCCCcc-Ccc-ccCchhh------ccCCccceeeecccccC
Q 043932 214 PTTLG--LLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR-FSG-TLPFDIV------VNLPNLKSLAIGGNNFF 283 (1017)
Q Consensus 214 ~~~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~l~~~~~------~~l~~L~~L~L~~n~l~ 283 (1017)
|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..+. ..+++|++|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 99987 99999999999999999999999999999999999998 988 7886542 24459999999999999
Q ss_pred CCCCC--ccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCc-ccEEeccCccc
Q 043932 284 GSIPD--SLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSS-LKILSLAANQF 360 (1017)
Q Consensus 284 ~~~p~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~-L~~L~Ls~N~l 360 (1017)
.+|. .++.+++|+.|+|++|+++ .+| .|..+++|+.|+|++|++...+ ..+.++++ |+.|+|++|++
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp-------~~l~~l~~~L~~L~Ls~N~L 631 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIP-------EDFCAFTDQVEGLGFSHNKL 631 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCC-------TTSCEECTTCCEEECCSSCC
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccch-------HHHhhccccCCEEECcCCCC
Confidence 8898 9999999999999999999 666 8999999999999999997433 33778888 99999999998
Q ss_pred ccccchhHHhhcccceEEEecCCccccccCcccccc--ccccEEeccccCCCCCcchhh---c--ccccccceecccccc
Q 043932 361 VGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNL--VNLIALGMQSNQLHGTIPDVI---G--ELKNLQGLFLYKNVL 433 (1017)
Q Consensus 361 ~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l 433 (1017)
+ .+|. .+..+ ++|+.|+|++|++.+.+|... . .+++|+.|+|++|++
T Consensus 632 ~-~lp~-------------------------~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L 685 (876)
T 4ecn_A 632 K-YIPN-------------------------IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI 685 (876)
T ss_dssp C-SCCS-------------------------CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCC
T ss_pred C-cCch-------------------------hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcC
Confidence 7 4443 33333 348888888888887665332 2 345899999999999
Q ss_pred ccccCccc-ccccccceeeccCcccCCCCcccccc--------ccCCceeecCCCcccCCccchhhhcccccceeccCCC
Q 043932 434 QGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGN--------CQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNN 504 (1017)
Q Consensus 434 ~~~~p~~~-~~l~~L~~L~Ls~N~i~~~~p~~~~~--------l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N 504 (1017)
+ .+|..+ ..+++|++|+|++|+|+ .+|..+.. +++|+.|+|++|+++
T Consensus 686 ~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~---------------------- 741 (876)
T 4ecn_A 686 Q-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT---------------------- 741 (876)
T ss_dssp C-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC----------------------
T ss_pred C-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc----------------------
Confidence 9 566654 58999999999999999 56665443 237888888888776
Q ss_pred cCCCCcccccc--ccccceEEEccCCcccccccccccccccceEEeccC------CccCCCCCccccccccCcEEeccCC
Q 043932 505 NLNGSLPLQIG--NLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISS------NSFHGVIPHSLGFLKSIKVLNFSSN 576 (1017)
Q Consensus 505 ~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N 576 (1017)
.+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..|..+++|+.|+|++|
T Consensus 742 ----~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N 816 (876)
T 4ecn_A 742 ----SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816 (876)
T ss_dssp ----CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSS
T ss_pred ----cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCC
Confidence 4556665 88999999999999997 798999999999999976 8899999999999999999999999
Q ss_pred cccCCChhhhcccCCCcEEEcccCCCcCcCCCC-CCCCCCCcccccCcccc--cCCc
Q 043932 577 NLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTK-GVFSSKTKLSLQGNVKL--CGGT 630 (1017)
Q Consensus 577 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~--c~~~ 630 (1017)
++ +.+|..+. ++|+.|||++|++....+.. ..........+.+|+.. |||+
T Consensus 817 ~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~ 870 (876)
T 4ecn_A 817 DI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCD 870 (876)
T ss_dssp CC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCG
T ss_pred CC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCC
Confidence 99 68898876 69999999999998654431 11122344556666554 4766
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=437.19 Aligned_cols=275 Identities=23% Similarity=0.314 Sum_probs=217.6
Q ss_pred HHHHHHhhccccccCcccccCCceEEEEEeCCC-----cEEEEEEEeeecCc-chHHHHHHHHHHHHhcCC-CCceeeee
Q 043932 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGED-----EMIVAVKVINLKQK-GAFKSFMAECKALRNIRH-RNLIKIIT 769 (1017)
Q Consensus 697 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~~ 769 (1017)
..+++...++|++.++||+|+||+||+|++... ++.||||++..... ...+.+.+|++++++++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 345566678999999999999999999997543 47899999975433 345679999999999965 89999999
Q ss_pred eeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCcee
Q 043932 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVH 839 (1017)
Q Consensus 770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 839 (1017)
+|... .+..++|||||++|+|.++++..... .....+++.++..++.|||+||+|||++ +|||
T Consensus 136 ~~~~~----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiH 208 (353)
T 4ase_A 136 ACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 208 (353)
T ss_dssp EECCT----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred EEEec----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ceec
Confidence 98643 14579999999999999999865321 1124589999999999999999999999 9999
Q ss_pred ecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh
Q 043932 840 GDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919 (1017)
Q Consensus 840 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 919 (1017)
|||||+|||+++++.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||++|||+|
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~------~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCc------eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHh
Confidence 999999999999999999999999866432211 11223578999999999999999999999999999999998
Q ss_pred -CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 043932 920 -GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM 998 (1017)
Q Consensus 920 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 998 (1017)
|+.||........ +.......... ..+..+++++.+++.+||+.||++|||+
T Consensus 283 ~G~~Pf~~~~~~~~-~~~~i~~g~~~--------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~ 335 (353)
T 4ase_A 283 LGASPYPGVKIDEE-FCRRLKEGTRM--------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTF 335 (353)
T ss_dssp TSCCSSTTCCCSHH-HHHHHHHTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCCCCHHHH-HHHHHHcCCCC--------------------------CCCccCCHHHHHHHHHHcCcChhHCcCH
Confidence 9999976432211 11111110000 0112346678999999999999999999
Q ss_pred HHHHHHHhhcccc
Q 043932 999 RDVVAKLCHTRET 1011 (1017)
Q Consensus 999 ~evl~~L~~~~~~ 1011 (1017)
.||+++|+.+.+.
T Consensus 336 ~eil~~L~~llq~ 348 (353)
T 4ase_A 336 SELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999988764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=425.11 Aligned_cols=275 Identities=24% Similarity=0.301 Sum_probs=204.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
++|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++++|...+. .....|+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEE
Confidence 5688899999999999999998 4889999998644322 1223456666678899999999999976422 2246799
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhC-----CCCCceeecCCCCceEeCCCCCeEEee
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH-----CQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
||||+++|+|.++++.. .+++.++.+++.|++.||+|||++ ..++||||||||+|||++.++.+||+|
T Consensus 79 V~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 99999999999999764 589999999999999999999976 245899999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCC------CcCccccchhHHHHHHHHHhCCCCCCcccccC--
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS------EASMTGDVYSFGILLLELFTGRRPTDAAFTEG-- 931 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~-- 931 (1017)
||+|+......... ........||+.|||||++.+. .++.++|||||||++|||+||++||.......
T Consensus 152 FGla~~~~~~~~~~----~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 152 LGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp CTTCEEEETTTTEE----SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred CCCCccccCCCCce----eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 99998764332111 1112235799999999998764 46789999999999999999998875432211
Q ss_pred --------ccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 932 --------LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 932 --------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
.............. .+|.. .......++++.+.+++.+||+.||++||||.||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~----~rp~~-------------p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQK----LRPNI-------------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSC----CCCCC-------------CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chhcccccchHHHHHHHHhccc----CCCCC-------------CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11111111111100 00000 001112356778999999999999999999999999
Q ss_pred HHhhcccc
Q 043932 1004 KLCHTRET 1011 (1017)
Q Consensus 1004 ~L~~~~~~ 1011 (1017)
.|+.+.+.
T Consensus 291 ~L~~l~~~ 298 (303)
T 3hmm_A 291 TLSQLSQQ 298 (303)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHHH
Confidence 99998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=421.76 Aligned_cols=265 Identities=24% Similarity=0.397 Sum_probs=195.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCC------
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDS------ 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 776 (1017)
.++|++.+.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|++++++++|||||++++++.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4579999999999999999999999999999999976543 345678999999999999999999999865432
Q ss_pred -CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCe
Q 043932 777 -KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 777 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
....+.|+||||+++|+|.+++..... ....++..++.++.||++||+|||++ +||||||||+|||++.++.+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCT---IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCS---GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCC---CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence 123457999999999999999986542 12456677889999999999999999 99999999999999999999
Q ss_pred EEeecccccccccccccccc----cCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC
Q 043932 856 HVGDFGLAKFLSSHQLDTAS----KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG 931 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 931 (1017)
||+|||+|+........... .........+||+.|||||++.+..|+.++||||+||++|||++ ||.......
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~ 234 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence 99999999877543321111 11122334679999999999999999999999999999999996 775432110
Q ss_pred ccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 932 LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........... +....+..+...+++.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~---------------------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 235 RTLTDVRNLKF---------------------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHTTCC---------------------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhcCCC---------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00000000000 11122334556789999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=423.19 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=197.0
Q ss_pred ccccccCcccccCCceEEEEEeC---CCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
++|++.+.||+|+||+||+|++. .+++.||||+++... .....++.+|++++++++|||||++++++.+.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~----- 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE----- 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-----
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----
Confidence 57999999999999999999874 467899999997432 22335688999999999999999999999765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..|+||||++||+|.+++.+.+ .+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence 77999999999999999998654 789999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+|+...... ......+||+.|||||++.+..|+.++||||+||++|||+||++||.+..... .......
T Consensus 170 FGla~~~~~~~--------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~ 240 (304)
T 3ubd_A 170 FGLSKESIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILK 240 (304)
T ss_dssp SEEEEC-------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred cccceeccCCC--------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHc
Confidence 99998653321 11234679999999999999999999999999999999999999997642211 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM-----RDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 1004 (1017)
...+ .+..+++++.+++.+||+.||++|||+ +|+++|
T Consensus 241 ~~~~----------------------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 241 AKLG----------------------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCCC----------------------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0000 011235678899999999999999985 677765
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=446.32 Aligned_cols=465 Identities=18% Similarity=0.125 Sum_probs=308.3
Q ss_pred EEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccc
Q 043932 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNN 159 (1017)
Q Consensus 80 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 159 (1017)
..+|++++++++ +|..+. ++|++|+|++|.+++..|.+|+++++|++|+|++|++++..|..|+++++|++|||++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 789999999997 455454 89999999999999888889999999999999999999888999999999999999999
Q ss_pred cccccCcccccccCCccEEEeccccccCC-CCccccCCCcccEEEEecCCCCCCCCcccccccCc--ceeEeecCcc--c
Q 043932 160 KLEGQIPAEIGSLLKLQTLAVGKNYLTGR-LPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNL--VDLHVGGNQF--S 234 (1017)
Q Consensus 160 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L--~~L~L~~n~l--~ 234 (1017)
+++ .+|.. .+++|++|+|++|++++. +|..|+++++|++|++++|++++. .+..+++| ++|++++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 999 66766 899999999999999873 468999999999999999999763 45555555 9999999998 7
Q ss_pred cccchhhcccC-cCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeecc
Q 043932 235 GTFPQSICNIS-SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSID 313 (1017)
Q Consensus 235 ~~~p~~l~~l~-~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 313 (1017)
+..|..+..+. ..-.++++.|.+.+.++...+..+++|+.|++++|+.... .+.+. ...
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~-------------------~l~~~-~~~ 244 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ-------------------RLMTF-LSE 244 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH-------------------HHHHH-HHH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc-------------------hHHHH-HHH
Confidence 77887777654 1224566777766555555555555555555555531100 01111 112
Q ss_pred ccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccc
Q 043932 314 FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI 393 (1017)
Q Consensus 314 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~ 393 (1017)
|..+++|+.|+++++.+. +|.+.+ ++..+. ..++++|++++|.+++.+|..+
T Consensus 245 l~~l~~L~~L~L~~~~l~-------------------------~~~~~~-~~~~~~--~~~L~~L~l~~n~l~~~ip~~~ 296 (562)
T 3a79_B 245 LTRGPTLLNVTLQHIETT-------------------------WKCSVK-LFQFFW--PRPVEYLNIYNLTITERIDREE 296 (562)
T ss_dssp HHSCSSCEEEEEEEEEEC-------------------------HHHHHH-HHHHHT--TSSEEEEEEEEEEECSCCCCCC
T ss_pred HhccCcceEEEecCCcCc-------------------------HHHHHH-HHHhhh--cccccEEEEeccEeeccccchh
Confidence 333444444444433321 111110 111111 1245556666666655555555
Q ss_pred -----cccccccEEeccccCCCCCcchhhccc---ccccceeccccccccccCcccccccccceeeccCcccCCCCcccc
Q 043932 394 -----RNLVNLIALGMQSNQLHGTIPDVIGEL---KNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSL 465 (1017)
Q Consensus 394 -----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~ 465 (1017)
.+++.|+.++++.|.+ ......+..+ .+|++|++++|.+.... ....+++|++|++++|++++.+|..+
T Consensus 297 ~~~~~~~L~~L~~~~~~~~~~-~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~ 373 (562)
T 3a79_B 297 FTYSETALKSLMIEHVKNQVF-LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGC 373 (562)
T ss_dssp CCCCSCSCCEEEEEEEEECCC-SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTC
T ss_pred hhcccccchheehhhccccee-ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhh
Confidence 6777788888888877 2332444433 56888888888876322 12677888888888888888888888
Q ss_pred ccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCccccccc-ccccccccc
Q 043932 466 GNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIP-VTLSTCVSL 544 (1017)
Q Consensus 466 ~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L 544 (1017)
.++++|+.|++++|++++ ++ .+|..+..+++|++|+|++|++++.+| ..+..+++|
T Consensus 374 ~~l~~L~~L~L~~N~l~~-~~----------------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 374 STLKRLQTLILQRNGLKN-FF----------------------KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp CSCSSCCEEECCSSCCCB-TT----------------------HHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred cccCCCCEEECCCCCcCC-cc----------------------cchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 888888888888888873 11 123345555666666666666665233 335556666
Q ss_pred eEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCC-CCCCCCCCcccccCc
Q 043932 545 EYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT-KGVFSSKTKLSLQGN 623 (1017)
Q Consensus 545 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~~~~n 623 (1017)
+.|+|++|++++.+|..+. ++|++|+|++|+++ .+|..+..+++|++|+|++|++++.++. ...+.+++.+++.+|
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N 507 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSC
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCC
Confidence 6666666666555444433 45666666666665 4555455666666666666666643333 344555556666666
Q ss_pred ccccCCc
Q 043932 624 VKLCGGT 630 (1017)
Q Consensus 624 ~~~c~~~ 630 (1017)
||.|+|+
T Consensus 508 ~~~c~c~ 514 (562)
T 3a79_B 508 PWDCTCP 514 (562)
T ss_dssp CBCCCHH
T ss_pred CcCCCcc
Confidence 6666554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=448.14 Aligned_cols=437 Identities=21% Similarity=0.253 Sum_probs=302.1
Q ss_pred CeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeec
Q 043932 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRV 156 (1017)
Q Consensus 77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (1017)
.+++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 57999999999999988889999999999999999999888999999999999999999999 67776 8999999999
Q ss_pred ccccccc-cCcccccccCCccEEEeccccccCCCCccccCCCcc--cEEEEecCCC--CCCCCccccccc-CcceeEeec
Q 043932 157 SNNKLEG-QIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL--EVFSITGNSL--GGKIPTTLGLLR-NLVDLHVGG 230 (1017)
Q Consensus 157 ~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~~~~l~~l~-~L~~L~L~~ 230 (1017)
++|++++ .+|..|+++++|++|++++|++++ ..++.+++| +.|++++|.+ ++..|..+..+. +...+++++
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 9999997 578999999999999999999986 567888888 9999999999 888898888876 455678899
Q ss_pred Cccccccc-hhhcccCcCcEEeCCCcc-------CccccCchhhccCCccceeeecccccCCCCCCccc---cCCcccee
Q 043932 231 NQFSGTFP-QSICNISSLERIYLPFNR-------FSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLS---NASNVEIL 299 (1017)
Q Consensus 231 n~l~~~~p-~~l~~l~~L~~L~Ls~N~-------l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~---~l~~L~~L 299 (1017)
|++.+.++ ..+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.+++..+..+. ..++|++|
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~--~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L 252 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA--KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH--GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred Ccchhhhhhhhhhcccceeeccccccccccccceeecchh--hhccccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence 99887655 467889999999999997 665555 456788999999998888754322221 23578888
Q ss_pred ecccCcccceeeccc-----cccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccc-hhHHhhc-
Q 043932 300 DLGFNQFKGKVSIDF-----SSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELP-HSIANLS- 372 (1017)
Q Consensus 300 ~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~- 372 (1017)
++++|++++.+|..+ ..+++|+.+++++|.+ .+| ..+..+.
T Consensus 253 ~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--------------------------------~~p~~~~~~~~~ 300 (520)
T 2z7x_B 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--------------------------------GFPQSYIYEIFS 300 (520)
T ss_dssp EEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--------------------------------CSCTHHHHHHHH
T ss_pred EeecccccCccccchhhcccccCceeEeccccccce--------------------------------ecchhhhhcccc
Confidence 888888887777666 5555555555555544 222 2222221
Q ss_pred -ccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceee
Q 043932 373 -SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLV 451 (1017)
Q Consensus 373 -~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 451 (1017)
.+++.|++++|.+.... .+..+++|++|++++|++++ .+|..++++++|++|+
T Consensus 301 ~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~------------------------~~~~~~~~l~~L~~L~ 354 (520)
T 2z7x_B 301 NMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTD------------------------TVFENCGHLTELETLI 354 (520)
T ss_dssp TCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCT------------------------TTTTTCCCCSSCCEEE
T ss_pred cCceeEEEcCCCcccccc--chhhCCcccEEEeECCccCh------------------------hhhhhhccCCCCCEEE
Confidence 12333333333332211 11344444445555444444 4444445555555555
Q ss_pred ccCcccCC--CCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCc
Q 043932 452 MSYNSLQG--NIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQ 529 (1017)
Q Consensus 452 Ls~N~i~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 529 (1017)
+++|+|++ .+|..+..+++|+.|++++|++++.+|. ..+..+++|++|+|++|+
T Consensus 355 L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~------------------------~~~~~l~~L~~L~Ls~N~ 410 (520)
T 2z7x_B 355 LQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK------------------------GDCSWTKSLLSLNMSSNI 410 (520)
T ss_dssp CCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG------------------------CSCCCCTTCCEEECCSSC
T ss_pred ccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc------------------------chhccCccCCEEECcCCC
Confidence 55555543 2344455555555555555555521221 123445556666666666
Q ss_pred ccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChh-hhcccCCCcEEEcccCCCcCcCC
Q 043932 530 FSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPE-FLENLSFLEFLNFSHNDLEGEVP 607 (1017)
Q Consensus 530 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~ 607 (1017)
+++..|..+. ++|+.|+|++|+++ .+|..+..+++|++|+|++|++++ +|. .+..+++|++|++++|++++.++
T Consensus 411 l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 411 LTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCC
Confidence 6555554443 56666666666666 455555566666666666666663 343 36666677777777777766555
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=424.31 Aligned_cols=286 Identities=21% Similarity=0.233 Sum_probs=210.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCC-CCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSID-SKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 780 (1017)
.++|++.++||+|+||+||+|++..+|+.||||+++.... ...+++.+|+++|++++|||||++++++.... ....+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3579999999999999999999999999999999964432 33467889999999999999999999886542 12346
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||++ |+|.+++...+ .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence 7899999996 58999997654 799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+|+.+...... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+ .+..+..
T Consensus 203 Gla~~~~~~~~~----~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~ 277 (398)
T 4b99_A 203 GMARGLCTSPAE----HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMM 277 (398)
T ss_dssp TTCBCC-----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHH
T ss_pred ceeeecccCccc----cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHH
Confidence 999876432211 11223347899999999998875 46999999999999999999999998643221 2222222
Q ss_pred hhcCc--hhhhhccchhhHHHHhhc-chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPE--KVIEIVDPLLLIEVMANN-SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~--~~~~~~d~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..... .............+.... ..............++++.+++.+||+.||++|||+.|+++|
T Consensus 278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 22111 111111110000100000 000000111122335678899999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=412.56 Aligned_cols=286 Identities=20% Similarity=0.257 Sum_probs=206.1
Q ss_pred HHHhhccccccCcccccCCceEEEEEeC---CCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCC
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSID 775 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 775 (1017)
+....++|++.++||+|+||+||+|+++ .+++.||+|++.... ...++.+|+++++.+ +||||+++++++.+.
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~- 92 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN- 92 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET-
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC-
Confidence 3445678999999999999999999874 467899999986443 335678999999998 699999999998765
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-CC
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MV 854 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 854 (1017)
++.|+||||+++|+|.++++ .+++.++..++.||+.||+|||++ ||+||||||+|||++.+ +.
T Consensus 93 ----~~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~ 156 (361)
T 4f9c_A 93 ----DHVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKK 156 (361)
T ss_dssp ----TEEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred ----CEEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCe
Confidence 78999999999999999984 478999999999999999999999 99999999999999877 89
Q ss_pred eEEeecccccccccccccccc--------------------cCCCcccccccCccccCcccccCC-CcCccccchhHHHH
Q 043932 855 SHVGDFGLAKFLSSHQLDTAS--------------------KTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGIL 913 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~--------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~i 913 (1017)
+||+|||+|+........... .........+||+.|+|||++.+. .|+.++||||+||+
T Consensus 157 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~i 236 (361)
T 4f9c_A 157 YALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI 236 (361)
T ss_dssp EEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred EEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHH
Confidence 999999999866433211100 011122345799999999999875 58999999999999
Q ss_pred HHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhc---c----------chhhHHHHhhcch-------hHHH-----
Q 043932 914 LLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIV---D----------PLLLIEVMANNSM-------IQED----- 968 (1017)
Q Consensus 914 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---d----------~~l~~~~~~~~~~-------~~~~----- 968 (1017)
+|||++|+.||.....+...+................ . ............. ....
T Consensus 237 l~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 316 (361)
T 4f9c_A 237 FLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHA 316 (361)
T ss_dssp HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----------------
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccc
Confidence 9999999999976544333333332221111100000 0 0000000000000 0000
Q ss_pred -hHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 969 -IRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 969 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........+++..+++.+||+.||++|||++|+++|
T Consensus 317 ~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 317 TNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp -----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 001112345678899999999999999999999876
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=401.82 Aligned_cols=293 Identities=30% Similarity=0.488 Sum_probs=274.5
Q ss_pred CCCHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCc--eeeEEECCCC--CeEEEEEcCCCCCcc--ccCcccCCCCCCCE
Q 043932 32 QTNETDRLALLAIKSQLHDTSGVTSSWNNTINLCQ--WTGVTCGHRH--QRVTRLDLSNQRIGG--ILSPYVGNLSFLRY 105 (1017)
Q Consensus 32 ~~~~~~~~aLl~~k~~~~~~~~~~~sw~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L~~ 105 (1017)
.|.++|++||++||+++.||. .+++|+.+.+||. |.||+|+..+ ++|+.|+|+++++++ .+++.++++++|++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~ 80 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence 489999999999999999887 7899988889998 9999998655 899999999999999 89999999999999
Q ss_pred EEccC-CCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEecccc
Q 043932 106 INLSD-NSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNY 184 (1017)
Q Consensus 106 L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 184 (1017)
|+|++ |.+++.+|.+|+++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|++|++++|+
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 99995 99999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCC-cccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCc
Q 043932 185 LTGRLPDFVGNLS-ALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPF 263 (1017)
Q Consensus 185 l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~ 263 (1017)
+++.+|..+++++ +|+.|++++|++++.+|..+..++ |++|++++|++++..|..+..+++|++|+|++|.+++.+|.
T Consensus 161 l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 239 (313)
T 1ogq_A 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc
Confidence 9999999999998 999999999999999999999997 99999999999999999999999999999999999876665
Q ss_pred hhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCc
Q 043932 264 DIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNN 329 (1017)
Q Consensus 264 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 329 (1017)
+..+++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|.. ..+++|+.|++++|.
T Consensus 240 --~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 240 --VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp --CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred --ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 567899999999999999999999999999999999999999888875 777788888777776
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=419.61 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=201.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHH---HHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSF---MAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++|++.++||+|+||+||+|+++.+|+.||||++.... ....... ..++.+++.++|||||++++++.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--- 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--- 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS---
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC---
Confidence 357999999999999999999999999999999997432 1222233 3446667778999999999999765
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
+..|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++ +||||||||+|||++.+|++||
T Consensus 265 --~~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 265 --DKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp --SEEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred --CEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence 78999999999999999998654 789999999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
+|||+|+.+.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|++||........ .+
T Consensus 334 ~DFGlA~~~~~~~----------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~ 401 (689)
T 3v5w_A 334 SDLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE 401 (689)
T ss_dssp CCCTTCEECSSCC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HH
T ss_pred cccceeeecCCCC----------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HH
Confidence 9999998764322 223689999999999964 5799999999999999999999999976433221 11
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1004 (1017)
......... ...+...++++.+++.+||+.||.+|++ +.||++|
T Consensus 402 i~~~i~~~~------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 402 IDRMTLTMA------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHCC------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHhhcCCC------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111100000 0001123566889999999999999998 6888765
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=428.47 Aligned_cols=528 Identities=21% Similarity=0.203 Sum_probs=440.1
Q ss_pred CCcee----eEEECCCC---------CeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccc
Q 043932 64 LCQWT----GVTCGHRH---------QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKL 130 (1017)
Q Consensus 64 ~c~w~----gv~c~~~~---------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 130 (1017)
+|.|. .|.|.+.. ..++.|||++|.|++..+.+|.++++|++|||++|+|++..|.+|+++++|++|
T Consensus 26 ~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L 105 (635)
T 4g8a_A 26 PCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL 105 (635)
T ss_dssp CSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred CccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEE
Confidence 46543 47896432 368999999999999988999999999999999999997778889999999999
Q ss_pred cCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccC-CCCccccCCCcccEEEEecCCC
Q 043932 131 ALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTG-RLPDFVGNLSALEVFSITGNSL 209 (1017)
Q Consensus 131 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l 209 (1017)
+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..++++++|++|++++|++
T Consensus 106 ~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 185 (635)
T 4g8a_A 106 ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 185 (635)
T ss_dssp ECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred EccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc
Confidence 999999997767789999999999999999998877889999999999999999986 4688899999999999999999
Q ss_pred CCCCCcccccccCcc----eeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeeccccc---
Q 043932 210 GGKIPTTLGLLRNLV----DLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF--- 282 (1017)
Q Consensus 210 ~~~~~~~l~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l--- 282 (1017)
++..+..|..+.+++ .++++.|.++...+..+ ....++.++++.|.....++...+..+..++...+..+..
T Consensus 186 ~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~ 264 (635)
T 4g8a_A 186 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 264 (635)
T ss_dssp CEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTS
T ss_pred cccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccc
Confidence 998899988877654 68899999986555544 4456788999999877666667777888888777755433
Q ss_pred ---CCCCCCccccCCccceeecccCcccc---eeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEecc
Q 043932 283 ---FGSIPDSLSNASNVEILDLGFNQFKG---KVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLA 356 (1017)
Q Consensus 283 ---~~~~p~~l~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls 356 (1017)
.......+.....+...++..+.... .....+..+.+++.+.+.+|.+.... .+.....|+.|+++
T Consensus 265 ~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--------~~~~~~~L~~L~l~ 336 (635)
T 4g8a_A 265 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--------DFSYNFGWQHLELV 336 (635)
T ss_dssp CCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--------GGGSCCCCSEEEEE
T ss_pred cccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--------ccccchhhhhhhcc
Confidence 23344456666677777766655432 23345677888999999988875432 24566789999999
Q ss_pred CcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCC--Ccchhhcccccccceeccccccc
Q 043932 357 ANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHG--TIPDVIGELKNLQGLFLYKNVLQ 434 (1017)
Q Consensus 357 ~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~ 434 (1017)
+|.+.+..+.. ...++.+.+.+|.+... .....+++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+.
T Consensus 337 ~~~~~~~~~~~----l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~ 410 (635)
T 4g8a_A 337 NCKFGQFPTLK----LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI 410 (635)
T ss_dssp SCEESSCCCCB----CTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE
T ss_pred cccccCcCccc----chhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc
Confidence 99987544432 24688899999988754 345679999999999999864 45677788999999999999998
Q ss_pred cccCcccccccccceeeccCcccCCCCc-cccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCC-CCccc
Q 043932 435 GSIPSGVGNLTKLAKLVMSYNSLQGNIP-SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLN-GSLPL 512 (1017)
Q Consensus 435 ~~~p~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~-~~~p~ 512 (1017)
..+..+..+++|+.++++.|++....+ ..|..+++++.+++++|++.+..|..+.....+ +.|+|++|.+. +..|.
T Consensus 411 -~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L-~~L~Ls~N~~~~~~~~~ 488 (635)
T 4g8a_A 411 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQENFLPD 488 (635)
T ss_dssp -EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECS
T ss_pred -cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhh-hhhhhhhcccccccCch
Confidence 456678899999999999988776554 567899999999999999997766666655555 56999999754 45788
Q ss_pred cccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhccc-CC
Q 043932 513 QIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENL-SF 591 (1017)
Q Consensus 513 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~ 591 (1017)
.|..+++|++|+|++|+|++.+|..|.++++|++|+|++|+|++.+|..|..+++|++|||++|+|++.+|..+..+ ++
T Consensus 489 ~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~ 568 (635)
T 4g8a_A 489 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 568 (635)
T ss_dssp CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTT
T ss_pred hhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999998 68
Q ss_pred CcEEEcccCCCcCcCCC
Q 043932 592 LEFLNFSHNDLEGEVPT 608 (1017)
Q Consensus 592 L~~L~l~~N~l~~~~~~ 608 (1017)
|++|+|++|+|.+.+..
T Consensus 569 L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 569 LAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CCEEECTTCCBCCSGGG
T ss_pred CCEEEeeCCCCcccCCc
Confidence 99999999999998764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=423.35 Aligned_cols=439 Identities=20% Similarity=0.227 Sum_probs=290.7
Q ss_pred CeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeec
Q 043932 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRV 156 (1017)
Q Consensus 77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (1017)
..++.|+|++|.+++..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 57999999999999998899999999999999999999888999999999999999999999 78877 8999999999
Q ss_pred ccccccc-cCcccccccCCccEEEeccccccCCCCccccCCCcc--cEEEEecCCC--CCCCCccccccc-CcceeEeec
Q 043932 157 SNNKLEG-QIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL--EVFSITGNSL--GGKIPTTLGLLR-NLVDLHVGG 230 (1017)
Q Consensus 157 ~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~~~~l~~l~-~L~~L~L~~ 230 (1017)
++|++++ .+|..|+++++|++|++++|++++. .+.++++| +.|++++|.+ ++..|..+..+. ..-.+++++
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 205 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECS
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecC
Confidence 9999997 4578999999999999999999863 45566666 9999999999 889999988765 223668899
Q ss_pred Cccccccch-hhcccCcCcEEeCCCccC-----ccccCchhhccCCccceeeecccccCCCC----CCccccCCccceee
Q 043932 231 NQFSGTFPQ-SICNISSLERIYLPFNRF-----SGTLPFDIVVNLPNLKSLAIGGNNFFGSI----PDSLSNASNVEILD 300 (1017)
Q Consensus 231 n~l~~~~p~-~l~~l~~L~~L~Ls~N~l-----~~~l~~~~~~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~ 300 (1017)
|.+.+.++. .+..+++|+.|++++|+. .+.+ ..+..+++|+.|+++++.+.+.. +..+ ..++|++|+
T Consensus 206 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~--~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~ 282 (562)
T 3a79_B 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL--SELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLN 282 (562)
T ss_dssp SSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH--HHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEE
T ss_pred ccchhhhhhhcccccceEEEecccccccccchHHHHH--HHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEE
Confidence 998876554 567889999999999862 2222 23567788888888888776421 1111 234788888
Q ss_pred cccCcccceeeccc-----cccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccc-hhHHhhccc
Q 043932 301 LGFNQFKGKVSIDF-----SSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELP-HSIANLSSS 374 (1017)
Q Consensus 301 Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~~ 374 (1017)
+++|++++.+|..+ ..++.|+.+++.. |.+ .+| ..+......
T Consensus 283 l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~------------------------------~~~--~~p~~~~~~~~~~ 330 (562)
T 3a79_B 283 IYNLTITERIDREEFTYSETALKSLMIEHVKN------------------------------QVF--LFSKEALYSVFAE 330 (562)
T ss_dssp EEEEEECSCCCCCCCCCCSCSCCEEEEEEEEE------------------------------CCC--SSCHHHHHHHHHT
T ss_pred EeccEeeccccchhhhcccccchheehhhccc------------------------------cee--ecChhhhhhhhcc
Confidence 88888887666655 3344444444333 333 222 222221110
Q ss_pred ceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccC
Q 043932 375 MIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSY 454 (1017)
Q Consensus 375 L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (1017)
.+|+.|++++|.+.... ....+++|++|++++|++++.+|..+.++++|++|+|++
T Consensus 331 ----------------------~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 386 (562)
T 3a79_B 331 ----------------------MNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386 (562)
T ss_dssp ----------------------CCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCS
T ss_pred ----------------------CcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCC
Confidence 12333444444332111 013444455555555555544455555555555555555
Q ss_pred cccCCC--CccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccc
Q 043932 455 NSLQGN--IPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSG 532 (1017)
Q Consensus 455 N~i~~~--~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 532 (1017)
|++++. +|..+.++++|+.|++++|++++.+|. ..+..+++|++|+|++|++++
T Consensus 387 N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~------------------------~~~~~l~~L~~L~l~~n~l~~ 442 (562)
T 3a79_B 387 NGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD------------------------RTCAWAESILVLNLSSNMLTG 442 (562)
T ss_dssp SCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSS------------------------CCCCCCTTCCEEECCSSCCCG
T ss_pred CCcCCcccchhhhcCCCCCCEEECCCCcCCCccCh------------------------hhhcCcccCCEEECCCCCCCc
Confidence 555532 234455556666655555555522221 123445556666666666655
Q ss_pred cccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhh-hcccCCCcEEEcccCCCcCcCCC
Q 043932 533 VIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEF-LENLSFLEFLNFSHNDLEGEVPT 608 (1017)
Q Consensus 533 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~ 608 (1017)
.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++ +|.. +..+++|+.|++++|+++|.+|.
T Consensus 443 ~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 443 SVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp GGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred chhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 5444433 45666666666666 344444466666666666666663 3333 66666666666666666665553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=424.24 Aligned_cols=254 Identities=20% Similarity=0.288 Sum_probs=210.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||+||+|+++.+|+.||+|++........+.+.+|+++|+.++|||||++++++.+. +..|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-----SEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEE
Confidence 46899999999999999999999999999999999866655667889999999999999999999998765 7899
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC--CCeEEeecc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD--MVSHVGDFG 861 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG 861 (1017)
+||||++||+|.+++..... .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 231 iv~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence 99999999999999975432 689999999999999999999999 99999999999999854 899999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+.+.... .....+||+.|||||++.+..|+.++||||+||++|||++|++||.+..... .+.......
T Consensus 303 ~a~~~~~~~---------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~i~~~~ 372 (573)
T 3uto_A 303 LTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCD 372 (573)
T ss_dssp SCEECCTTS---------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTC
T ss_pred ceeEccCCC---------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHhCC
Confidence 998765322 1223579999999999999999999999999999999999999997643221 111111110
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... . ......+++++.+++.+||+.||.+|||+.|+++|
T Consensus 373 ~~~------~------------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 373 WNM------D------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCC------C------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC------C------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 00111235667899999999999999999999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=404.55 Aligned_cols=397 Identities=18% Similarity=0.173 Sum_probs=244.4
Q ss_pred CEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccC-cccccccCCccEEEecc
Q 043932 104 RYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQI-PAEIGSLLKLQTLAVGK 182 (1017)
Q Consensus 104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~ 182 (1017)
+.++.++++++ .+|. +. ++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 35666666666 4554 22 55666666666666555666666666666666666665433 33455555555555555
Q ss_pred ccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccC
Q 043932 183 NYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLP 262 (1017)
Q Consensus 183 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~ 262 (1017)
|++++..|..|+++++|++|+|++|.+++..+.. ..+..+++|++|+|++|++++..|
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----------------------~~~~~l~~L~~L~L~~n~l~~~~~ 146 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG----------------------NFFKPLTSLEMLVLRDNNIKKIQP 146 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHS----------------------STTTTCTTCCEEECCSSBCCSCCC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCc----------------------ccccCcccCCEEECCCCccCccCc
Confidence 5555544555555555555555554444322222 114455555555555555554434
Q ss_pred chhhccCCccceeeecccccCCCCCCccccC--CccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhh
Q 043932 263 FDIVVNLPNLKSLAIGGNNFFGSIPDSLSNA--SNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDF 340 (1017)
Q Consensus 263 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 340 (1017)
..++.++++|++|++++|++++..|..+..+ .+|+.|++++|.+.+..+..+.. ..
T Consensus 147 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------------~~ 204 (455)
T 3v47_A 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------------EK 204 (455)
T ss_dssp CGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------------HH
T ss_pred ccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccc----------------------cc
Confidence 4444555555555555555555555555544 45666666666655433322110 01
Q ss_pred HhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhccc
Q 043932 341 VTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGEL 420 (1017)
Q Consensus 341 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 420 (1017)
...+..+++|++|++++|++.+..|..+.... ...+|+.|++++|.+.+..
T Consensus 205 ~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~----------------------~~~~L~~L~l~~~~~~~~~------- 255 (455)
T 3v47_A 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAI----------------------AGTKIQSLILSNSYNMGSS------- 255 (455)
T ss_dssp HCCTTTTCEEEEEECTTSCCCHHHHHHHHHHT----------------------TTCCEEEEECTTCTTTSCC-------
T ss_pred cccccccceeeeEecCCCcccccchhhhhccc----------------------cccceeeEeeccccccccc-------
Confidence 11123456677777777777766666655442 1134555555555443221
Q ss_pred ccccceeccccccccccCcccccc--cccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccce
Q 043932 421 KNLQGLFLYKNVLQGSIPSGVGNL--TKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVY 498 (1017)
Q Consensus 421 ~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~ 498 (1017)
+..+.+.+..+..+..+ ++|++|++++|++++..|..|..+++|+.|++++|+++
T Consensus 256 -------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~---------------- 312 (455)
T 3v47_A 256 -------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN---------------- 312 (455)
T ss_dssp -------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC----------------
T ss_pred -------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccc----------------
Confidence 11122222222223322 56777777777777777777777777777777777766
Q ss_pred eccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcc
Q 043932 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578 (1017)
Q Consensus 499 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 578 (1017)
+..|..|.++++|++|+|++|++++..|..|+++++|+.|+|++|++++..|..|..+++|++|+|++|++
T Consensus 313 ---------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 383 (455)
T 3v47_A 313 ---------KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQL 383 (455)
T ss_dssp ---------EECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred ---------ccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcc
Confidence 34455677788888888888888877788888888888999998888888888888889999999999998
Q ss_pred cCCChhhhcccCCCcEEEcccCCCcCcCCCC
Q 043932 579 SGQIPEFLENLSFLEFLNFSHNDLEGEVPTK 609 (1017)
Q Consensus 579 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 609 (1017)
++..+..+..+++|+.|++++|++++.+|..
T Consensus 384 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 384 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred ccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 8777777788889999999999999888854
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=404.12 Aligned_cols=422 Identities=23% Similarity=0.291 Sum_probs=218.3
Q ss_pred cccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCC
Q 043932 95 PYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLK 174 (1017)
Q Consensus 95 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 174 (1017)
+.-...++|++|++++|.+ |.+|++|+++++|++|++++|.++|.+|..++++++|++++++.|.. .+
T Consensus 5 p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~ 72 (454)
T 1jl5_A 5 PRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQ 72 (454)
T ss_dssp ------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HT
T ss_pred ccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cC
Confidence 3444568899999999999 79999999999999999999999999999999999987777766643 35
Q ss_pred ccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCC
Q 043932 175 LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPF 254 (1017)
Q Consensus 175 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 254 (1017)
|++|++++|.+++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++
T Consensus 73 l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~ 140 (454)
T 1jl5_A 73 AHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSN 140 (454)
T ss_dssp CSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCS
T ss_pred CCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcC
Confidence 6777777777774 3332 2567777777777765 4432 3566777777776663 2221 14666666666
Q ss_pred ccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCC
Q 043932 255 NRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGT 334 (1017)
Q Consensus 255 N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 334 (1017)
|++++ +| + +.++++|++|++++|++++ +|..+ .+|++|++++|++++. | .|..+++|++|++++|+++..+
T Consensus 141 n~l~~-lp-~-~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~l~ 211 (454)
T 1jl5_A 141 NQLEK-LP-E-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKKLP 211 (454)
T ss_dssp SCCSS-CC-C-CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSSCC
T ss_pred CCCCC-Cc-c-cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCcCC
Confidence 66663 55 2 5566666666666666663 44332 3666666666666653 2 3555555555555555554321
Q ss_pred CCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcc
Q 043932 335 ANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIP 414 (1017)
Q Consensus 335 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 414 (1017)
.. ..+|++|++++|.++. +| .+..+++|++|++++|++++ +|
T Consensus 212 -------------------------------~~----~~~L~~L~l~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-l~ 253 (454)
T 1jl5_A 212 -------------------------------DL----PLSLESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLKT-LP 253 (454)
T ss_dssp -------------------------------CC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CC
T ss_pred -------------------------------CC----cCcccEEECcCCcCCc-cc-ccCCCCCCCEEECCCCcCCc-cc
Confidence 10 1234555555555542 33 36667777777777777764 33
Q ss_pred hhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhccc
Q 043932 415 DVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITT 494 (1017)
Q Consensus 415 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~ 494 (1017)
+. +++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|+.|++++|++++ ++. ...
T Consensus 254 ~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~----~~~ 317 (454)
T 1jl5_A 254 DL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCD----LPP 317 (454)
T ss_dssp SC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECC----CCT
T ss_pred cc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccC----CcC
Confidence 32 3667777777777774 4443 3667777777777764 2211 1567777777777763 221 122
Q ss_pred ccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCC--CCCccccccccCcEEe
Q 043932 495 LSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHG--VIPHSLGFLKSIKVLN 572 (1017)
Q Consensus 495 ~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ 572 (1017)
.+++|++++|++++ +|.. +++|+.|++++|++++ +|. .+++|+.|+|++|++++ .+|.+++.
T Consensus 318 ~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~-------- 381 (454)
T 1jl5_A 318 SLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED-------- 381 (454)
T ss_dssp TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------
T ss_pred cCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------
Confidence 33457777777765 5543 4677888888888874 554 46778888888888887 56665543
Q ss_pred ccCCcccCCChhhhcccCCCcEEEcccCCCcC--cCCCCCCCCCCCcccccCccccc
Q 043932 573 FSSNNLSGQIPEFLENLSFLEFLNFSHNDLEG--EVPTKGVFSSKTKLSLQGNVKLC 627 (1017)
Q Consensus 573 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~~~~~~~~~~~n~~~c 627 (1017)
|+.|++.|.+|.. +++|+.|++++|++++ .+|. ++..+.+.+|...|
T Consensus 382 L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~-----sl~~L~~~~~~~~~ 430 (454)
T 1jl5_A 382 LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE-----SVEDLRMNSERVVD 430 (454)
T ss_dssp EECCC----------------------------------------------------
T ss_pred hhhcccccccccc---cCcCCEEECCCCcCCccccchh-----hHhheeCcCcccCC
Confidence 2346666667663 4678888999999887 5553 45566666665444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=397.90 Aligned_cols=396 Identities=18% Similarity=0.190 Sum_probs=291.1
Q ss_pred CCCceee--EEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCccccc
Q 043932 63 NLCQWTG--VTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGT 140 (1017)
Q Consensus 63 ~~c~w~g--v~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 140 (1017)
..|.|.+ |.|++ ++++.. |. + .++|++|||++|.+++..|..|+++++|++|+|++|.+.+.
T Consensus 6 ~~c~~~~~~~~c~~------------~~l~~l-p~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~ 69 (455)
T 3v47_A 6 SECSVIGYNAICIN------------RGLHQV-PE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69 (455)
T ss_dssp -CCEEETTEEECCS------------SCCSSC-CC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCE
T ss_pred ceeEEEccccCcCC------------CCcccC-CC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccce
Confidence 4577766 77743 445443 32 2 27899999999999988899999999999999999999866
Q ss_pred C-CCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCcc--ccCCCcccEEEEecCCCCCCCCcc-
Q 043932 141 I-PTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDF--VGNLSALEVFSITGNSLGGKIPTT- 216 (1017)
Q Consensus 141 ~-p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~~~~- 216 (1017)
+ |..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|.. |+++++|++|+|++|.+++..|..
T Consensus 70 i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 149 (455)
T 3v47_A 70 IRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149 (455)
T ss_dssp ECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGG
T ss_pred ECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccc
Confidence 6 567999999999999999999899999999999999999999999865544 999999999999999999887876
Q ss_pred cccccCcceeEeecCccccccchhhccc--CcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCC
Q 043932 217 LGLLRNLVDLHVGGNQFSGTFPQSICNI--SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNAS 294 (1017)
Q Consensus 217 l~~l~~L~~L~L~~n~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 294 (1017)
+..+++|++|++++|++++..|..+..+ .+|+.|++++|.+.+ ++...+. ......+..++
T Consensus 150 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~-~~~~~~~----------------~~~~~~~~~~~ 212 (455)
T 3v47_A 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQD-MNEYWLG----------------WEKCGNPFKNT 212 (455)
T ss_dssp GGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTT-CSTTCTT----------------HHHHCCTTTTC
T ss_pred cCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccc-cchhhcc----------------ccccccccccc
Confidence 8899999999999999998888888776 677788888887763 2221110 01112234556
Q ss_pred ccceeecccCcccceeecccccc---CccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhh
Q 043932 295 NVEILDLGFNQFKGKVSIDFSSL---KNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANL 371 (1017)
Q Consensus 295 ~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 371 (1017)
+|+.|++++|++++..+..+..+ ++|+.|++++|. +.+..
T Consensus 213 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~------------------------------~~~~~------- 255 (455)
T 3v47_A 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY------------------------------NMGSS------- 255 (455)
T ss_dssp EEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCT------------------------------TTSCC-------
T ss_pred eeeeEecCCCcccccchhhhhccccccceeeEeecccc------------------------------ccccc-------
Confidence 77777777777776666554332 344444444443 22110
Q ss_pred cccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceee
Q 043932 372 SSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLV 451 (1017)
Q Consensus 372 ~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 451 (1017)
+..+.+....+..+..+ ..++|+.|++++|.+++.+|..|.++++|++|+
T Consensus 256 --------~~~~~~~~~~~~~~~~~----------------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 305 (455)
T 3v47_A 256 --------FGHTNFKDPDNFTFKGL----------------------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLT 305 (455)
T ss_dssp --------TTCCSSCCCCTTTTGGG----------------------TTSCCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred --------cchhhhccCcccccccc----------------------cccCceEEEecCccccccchhhcccCCCCCEEE
Confidence 00111111111111111 124566666666666666666666777777777
Q ss_pred ccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCccc
Q 043932 452 MSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFS 531 (1017)
Q Consensus 452 Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 531 (1017)
|++|++++..|..|.++++|+.|++++|+++ +..|..|..+++|++|+|++|+++
T Consensus 306 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~Ls~N~l~ 360 (455)
T 3v47_A 306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-------------------------SIDSRMFENLDKLEVLDLSYNHIR 360 (455)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCC-------------------------EECGGGGTTCTTCCEEECCSSCCC
T ss_pred CCCCcccccChhHhcCcccCCEEECCCCccC-------------------------CcChhHhcCcccCCEEECCCCccc
Confidence 7777777666667777777777777777765 234556677888888999999988
Q ss_pred ccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCCh
Q 043932 532 GVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIP 583 (1017)
Q Consensus 532 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 583 (1017)
+..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..|
T Consensus 361 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 361 ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 8888889999999999999999998777888999999999999999998887
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=397.47 Aligned_cols=399 Identities=21% Similarity=0.262 Sum_probs=253.1
Q ss_pred cccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEE
Q 043932 123 NLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVF 202 (1017)
Q Consensus 123 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 202 (1017)
+.++|++|++++|.+ |.+|..++++++|++|++++|.++|.+|..++++++|+.+++..|.. .++++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 468899999999999 68999999999999999999999999999999988888888877753 467888
Q ss_pred EEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeeccccc
Q 043932 203 SITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF 282 (1017)
Q Consensus 203 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l 282 (1017)
++++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|+++ .+|. ..++|++|++++|++
T Consensus 77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~----~~~~L~~L~L~~n~l 143 (454)
T 1jl5_A 77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSD----LPPLLEYLGVSNNQL 143 (454)
T ss_dssp ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCS----CCTTCCEEECCSSCC
T ss_pred EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccC----CCCCCCEEECcCCCC
Confidence 888888875 3331 3678888888888875 5543 367788888888776 3332 125677777777777
Q ss_pred CCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCccccc
Q 043932 283 FGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVG 362 (1017)
Q Consensus 283 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 362 (1017)
++ +| .++.+++|++|++++|++++. |.. ..+|++|++++|++...+ .+.++++
T Consensus 144 ~~-lp-~~~~l~~L~~L~l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~l~--------~~~~l~~------------- 196 (454)
T 1jl5_A 144 EK-LP-ELQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEELP--------ELQNLPF------------- 196 (454)
T ss_dssp SS-CC-CCTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSCC--------CCTTCTT-------------
T ss_pred CC-Cc-ccCCCCCCCEEECCCCcCccc-CCC---cccccEEECcCCcCCcCc--------cccCCCC-------------
Confidence 74 55 477777777777777777652 221 235555555555554321 1233344
Q ss_pred ccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccc
Q 043932 363 ELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVG 442 (1017)
Q Consensus 363 ~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 442 (1017)
|++|++++|++++ +|... .+|++|++++|+++ .+| .++.+++|++|++++|++++ +|..
T Consensus 197 ------------L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~-- 255 (454)
T 1jl5_A 197 ------------LTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL-- 255 (454)
T ss_dssp ------------CCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC--
T ss_pred ------------CCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc--
Confidence 5555555555554 23322 58999999999998 566 48999999999999999985 5543
Q ss_pred cccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCcccccccc-ccce
Q 043932 443 NLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNL-KNLV 521 (1017)
Q Consensus 443 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l-~~L~ 521 (1017)
+++|++|++++|++++ +|.. +++|+.|++++|++++ +|. .....++|++++|.+++ ++ .+ ++|+
T Consensus 256 -~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~----~~~~L~~L~l~~N~l~~-i~----~~~~~L~ 320 (454)
T 1jl5_A 256 -PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSE----LPPNLYYLNASSNEIRS-LC----DLPPSLE 320 (454)
T ss_dssp -CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESC----CCTTCCEEECCSSCCSE-EC----CCCTTCC
T ss_pred -ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccC----cCCcCCEEECcCCcCCc-cc----CCcCcCC
Confidence 4789999999999995 5654 4789999999999985 221 11334579999999985 33 23 5899
Q ss_pred EEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccC--CChhhhcccCCCcEEEccc
Q 043932 522 KLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSG--QIPEFLENLSFLEFLNFSH 599 (1017)
Q Consensus 522 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~ 599 (1017)
+|++++|++++ +|.. +++|+.|++++|++++ +|. .+++|++|+|++|++++ .+|..+.+ ++.
T Consensus 321 ~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~ 384 (454)
T 1jl5_A 321 ELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRM 384 (454)
T ss_dssp EEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EEC
T ss_pred EEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhh
Confidence 99999999996 5544 5889999999999995 565 47899999999999998 67776543 456
Q ss_pred CCCcCcCCCCCCCCCCCcccccCccccc
Q 043932 600 NDLEGEVPTKGVFSSKTKLSLQGNVKLC 627 (1017)
Q Consensus 600 N~l~~~~~~~~~~~~~~~~~~~~n~~~c 627 (1017)
|.+.|.+|.. +.+++.+++.+|+...
T Consensus 385 n~~~~~i~~~--~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 385 NSHLAEVPEL--PQNLKQLHVETNPLRE 410 (454)
T ss_dssp CC--------------------------
T ss_pred cccccccccc--cCcCCEEECCCCcCCc
Confidence 8888888873 5789999999997654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=374.13 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=209.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|+.++++++||||+++++++... +..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence 46899999999999999999999999999999999876666667889999999999999999999998765 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++|+|.+++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 94 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999999764 578999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .........+
T Consensus 164 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~ 234 (297)
T 3fxz_A 164 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP 234 (297)
T ss_dssp EECCSTTC--------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSC
T ss_pred eecCCccc--------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC
Confidence 86543221 12235799999999999999999999999999999999999999975422111 1111100000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
. . .....+++.+.+++.+||+.||++|||+.|++++-
T Consensus 235 ~----~---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 235 E----L---------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp C----C---------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred C----C---------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 0 0 00112356688999999999999999999998763
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=379.17 Aligned_cols=285 Identities=32% Similarity=0.506 Sum_probs=225.7
Q ss_pred cCHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecC
Q 043932 695 VSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSI 774 (1017)
Q Consensus 695 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 774 (1017)
+++.++...+++|++.+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 344456667889999999999999999999975 6889999998876666678899999999999999999999998654
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 854 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 854 (1017)
+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 108 -----~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~ 177 (321)
T 2qkw_B 108 -----NEMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV 177 (321)
T ss_dssp -----TCCEEEEECCTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCC
T ss_pred -----CeEEEEEEcCCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCC
Confidence 568999999999999999876432 223689999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC-cc
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG-LT 933 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~-~~ 933 (1017)
+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 178 ~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~ 251 (321)
T 2qkw_B 178 PKITDFGISKKGTELDQ------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251 (321)
T ss_dssp EEECCCTTCEECSSSSC------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred EEEeecccccccccccc------cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence 99999999986532221 111223468999999999988899999999999999999999999997654332 22
Q ss_pred HHHHHHhh-cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 934 LHEFAKIA-LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 934 ~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
...+.... ........+++... .....+++..+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 252 LAEWAVESHNNGQLEQIVDPNLA--------------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHHTHHHHTTTCCCSSSSSSCT--------------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhhccccccHHHhcChhhc--------------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 22221111 11111122222110 11234567889999999999999999999999999998865
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=375.64 Aligned_cols=268 Identities=24% Similarity=0.380 Sum_probs=218.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.++||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++... +..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence 46899999999999999999999999999999998766666678899999999999999999999998765 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++|+|.+++..... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence 99999999999999987543 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccc------cCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc----
Q 043932 864 KFLSSHQLDTAS------KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT---- 933 (1017)
Q Consensus 864 ~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~---- 933 (1017)
+........... ..........||+.|+|||++.+..++.++||||||+++|||++|..||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 876543321110 0011112457999999999999999999999999999999999999998754322111
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccc
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1013 (1017)
....... .....+++.+.+++.+||+.||++|||+.|+++.|+.+++...
T Consensus 236 ~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 236 VRGFLDR------------------------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HHHHHHH------------------------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhccccc------------------------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1110000 0112345678899999999999999999999999999987654
Q ss_pred c
Q 043932 1014 G 1014 (1017)
Q Consensus 1014 ~ 1014 (1017)
+
T Consensus 286 ~ 286 (310)
T 3s95_A 286 G 286 (310)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=377.80 Aligned_cols=290 Identities=35% Similarity=0.601 Sum_probs=229.6
Q ss_pred CCCCCcCHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeee
Q 043932 690 KQFPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKII 768 (1017)
Q Consensus 690 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~ 768 (1017)
.....+++.++....++|++.+.||+|+||+||+|++. +++.||||++..... .....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 34556888999999999999999999999999999865 688999999875432 2234788999999999999999999
Q ss_pred eeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceE
Q 043932 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848 (1017)
Q Consensus 769 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 848 (1017)
+++... +..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+++.++|+||||||+||+
T Consensus 94 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil 166 (326)
T 3uim_A 94 GFCMTP-----TERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166 (326)
T ss_dssp EEECCS-----SCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred EEEecC-----CceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence 998654 567899999999999999987543 2345899999999999999999999987778999999999999
Q ss_pred eCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 849 LDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 849 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (326)
T 3uim_A 167 LDEEFEAVVGDFGLAKLMDYKDT-------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239 (326)
T ss_dssp ECTTCCEEECCCSSCEECCSSSS-------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHH
T ss_pred ECCCCCEEeccCccccccCcccc-------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccc
Confidence 99999999999999986643221 11223469999999999988889999999999999999999999997432
Q ss_pred ---ccCccHHHHHHhhcCch-hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 929 ---TEGLTLHEFAKIALPEK-VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 929 ---~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........+........ .....+.... .....++++.+.+++.+||+.||.+|||+.||+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 305 (326)
T 3uim_A 240 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQ--------------GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305 (326)
T ss_dssp HTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT--------------TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred cccccchhHHHHHHHHhhchhhhhhcChhhc--------------cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHH
Confidence 22233333433322221 2222222111 11234567889999999999999999999999999
Q ss_pred Hhhc
Q 043932 1005 LCHT 1008 (1017)
Q Consensus 1005 L~~~ 1008 (1017)
|+..
T Consensus 306 L~~~ 309 (326)
T 3uim_A 306 LEGD 309 (326)
T ss_dssp HHTS
T ss_pred hcCc
Confidence 9764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=376.39 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=207.4
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
....++|++.+.||+|+||.||+|++..+|+.||||++.... ....+++.+|+++++.++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~---- 86 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE---- 86 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC----
Confidence 344678999999999999999999999999999999997543 33456788999999999999999999998654
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..|+||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 -~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~ 156 (328)
T 3fe3_A 87 -KTLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIA 156 (328)
T ss_dssp -SEEEEEECCCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred -CEEEEEEECCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEe
Confidence 67899999999999999997653 689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcC-ccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEAS-MTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|||++....... ......||+.|+|||++.+..+. .++||||+||++|||++|+.||...... ..
T Consensus 157 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~ 222 (328)
T 3fe3_A 157 DFGFSNEFTVGG---------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-----EL 222 (328)
T ss_dssp STTCCGGGSSSC---------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH
T ss_pred eccCceecCCCC---------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-----HH
Confidence 999997654321 12335799999999999887764 8999999999999999999999764221 11
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........ .. .+..+++.+.+++.+||+.||.+|||+.|+++|
T Consensus 223 ~~~i~~~~-----------------~~-------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 223 RERVLRGK-----------------YR-------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHCC-----------------CC-------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHhCC-----------------CC-------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11000000 00 001124567899999999999999999999886
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=373.19 Aligned_cols=283 Identities=25% Similarity=0.393 Sum_probs=213.6
Q ss_pred hccccccCcccccCCceEEEEE----eCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGI----LGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.+.||+|+||+||+|+ +..+++.||||++........+.+.+|++++++++||||+++++++...+ .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence 4689999999999999999999 56689999999998666666678999999999999999999999985432 2
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence 457999999999999999987642 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++......... ........+|..|+|||++.+..++.++||||+|+++|||++|..||...... +..
T Consensus 158 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~ 226 (295)
T 3ugc_A 158 FGLTKVLPQDKEF-----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMR 226 (295)
T ss_dssp CCSCC------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HHH
T ss_pred CcccccccCCcce-----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HHh
Confidence 9999876433211 11112245788899999999889999999999999999999999998653211 111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1014 (1017)
....................... .......+++++.+++.+||+.||++|||+.|+++.|+.+++++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~g 295 (295)
T 3ugc_A 227 MIGNDKQGQMIVFHLIELLKNNG------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295 (295)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTC------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hhcCccccchhHHHHHHHHhccC------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhccC
Confidence 00000000000000000000000 0111234567899999999999999999999999999999887643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=374.11 Aligned_cols=288 Identities=23% Similarity=0.285 Sum_probs=212.8
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.-..++|++.++||+|+||+||+|++. ++.||||++..... ......+|+.++++++||||+++++++..... ...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~ 95 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDV 95 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSE
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCc
Confidence 344679999999999999999999985 78999999975433 23455678999999999999999999876422 134
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhC-------CCCCceeecCCCCceEeCCCC
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH-------CQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
..++||||+++|+|.++++.. .+++.+++.++.|++.||+|||+. +.++|+||||||+||+++.++
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred eEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 579999999999999999764 589999999999999999999976 133899999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccC-----CCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----SEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 169 ~~kL~DFg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 169 TACIADFGLALKFEAGKS------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CEEECCCTTCEEECTTSC------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred eEEEccCCcccccccccC------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999987653321 111223579999999999976 356778999999999999999999997654
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
..............+. ..++.+ ...................+++++.+++.+||+.||++|||+.||++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPS-LEDMQE-----VVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCCCCTTHHHHCSSCC-HHHHHH-----HHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhccchhhhhccCCc-hhhhhh-----hhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3321111000000000 000000 0000000000000011224567799999999999999999999999999998
Q ss_pred ccc
Q 043932 1009 RET 1011 (1017)
Q Consensus 1009 ~~~ 1011 (1017)
.+.
T Consensus 317 ~~~ 319 (322)
T 3soc_A 317 QRL 319 (322)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=374.59 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=208.1
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc------hHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG------AFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
..++|++.+.||+|+||+||+|++..+|+.||+|++...... ..+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-- 87 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-- 87 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC--
Confidence 356899999999999999999999999999999999754322 346789999999999999999999998654
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC---
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM--- 853 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 853 (1017)
+..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 88 ---~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 88 ---TDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp ---SEEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSS
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCc
Confidence 67899999999999999997653 689999999999999999999999 999999999999998877
Q ss_pred -CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCc
Q 043932 854 -VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932 (1017)
Q Consensus 854 -~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 932 (1017)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.......
T Consensus 156 ~~vkl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~- 225 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE- 225 (361)
T ss_dssp CCEEECCCSSCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-
T ss_pred cCEEEEecCCceEcCCCC---------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 79999999998664321 1123579999999999999899999999999999999999999997642211
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
........... .+ ......+++.+.+++.+||..||.+|||+.|+++|-
T Consensus 226 ~~~~i~~~~~~------~~------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 226 TLANITAVSYD------FD------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp HHHHHHTTCCC------CC------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHHhcCCC------CC------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 11111110000 00 011123356789999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=370.71 Aligned_cols=255 Identities=19% Similarity=0.265 Sum_probs=208.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+++++.++||||+++++++... +..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-----EELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEE
Confidence 468999999999999999999999999999999987443 3346788999999999999999999998765 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC--CCCeEEeecc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH--DMVSHVGDFG 861 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG 861 (1017)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 78 lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEEeCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 9999999999999997653 2689999999999999999999999 9999999999999987 7899999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||....... .........
T Consensus 150 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~ 219 (321)
T 1tki_A 150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAE 219 (321)
T ss_dssp TCEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTC
T ss_pred CCeECCCCC---------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCC
Confidence 998764322 1123568999999999999889999999999999999999999997642211 111111110
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
... + ......+++++.+++.+||..||.+|||+.|+++|-.
T Consensus 220 ~~~------~------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 220 YTF------D------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CCC------C------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCC------C------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 000 0 0112234667899999999999999999999998643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=362.78 Aligned_cols=285 Identities=29% Similarity=0.462 Sum_probs=223.7
Q ss_pred CCCCcCHHHHHHhhcccccc------CcccccCCceEEEEEeCCCcEEEEEEEeeecC----cchHHHHHHHHHHHHhcC
Q 043932 691 QFPTVSYAELSKATSEFASS------NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ----KGAFKSFMAECKALRNIR 760 (1017)
Q Consensus 691 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~ 760 (1017)
....+++.++..++++|... +.||+|+||.||+|++ +++.||+|++.... ....+.+.+|++++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 45678899999999988877 8999999999999997 57789999986432 234577899999999999
Q ss_pred CCCceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceee
Q 043932 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHG 840 (1017)
Q Consensus 761 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 840 (1017)
||||+++++++... +..++||||+++++|.+++.... ....+++..++.++.|++.||+|||++ +|+||
T Consensus 89 h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~ 157 (307)
T 2nru_A 89 HENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHR 157 (307)
T ss_dssp CTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecC
Confidence 99999999998654 56899999999999999997543 123689999999999999999999999 99999
Q ss_pred cCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhC
Q 043932 841 DLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG 920 (1017)
Q Consensus 841 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 920 (1017)
||||+||+++.++.+||+|||++......... .......||+.|+|||++.+ .++.++||||||+++|+|++|
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQT------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSSC------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC
T ss_pred CCCHHHEEEcCCCcEEEeeccccccccccccc------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC
Confidence 99999999999999999999999865432211 11123568999999998876 588999999999999999999
Q ss_pred CCCCCcccccCccHHHHHHh--hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 043932 921 RRPTDAAFTEGLTLHEFAKI--ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM 998 (1017)
Q Consensus 921 ~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 998 (1017)
+.||......... ..+... .....+.+.+++.. ......+++.+.+++.+||+.||.+|||+
T Consensus 231 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 294 (307)
T 2nru_A 231 LPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKM---------------NDADSTSVEAMYSVASQCLHEKKNKRPDI 294 (307)
T ss_dssp CCSBCTTBSSSBT-THHHHHHHTTSCCHHHHSCSSC---------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCCcccCcchHHH-HHHHHHhhhhhhhhhhhccccc---------------cccchHHHHHHHHHHHHHcCCCcccCcCH
Confidence 9999865433221 111111 11111222222111 11234557789999999999999999999
Q ss_pred HHHHHHHhhcccc
Q 043932 999 RDVVAKLCHTRET 1011 (1017)
Q Consensus 999 ~evl~~L~~~~~~ 1011 (1017)
.|++++|+++.++
T Consensus 295 ~~l~~~L~~l~~s 307 (307)
T 2nru_A 295 KKVQQLLQEMTAS 307 (307)
T ss_dssp HHHHHHHHHHC--
T ss_pred HHHHHHHHHHhcC
Confidence 9999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=367.41 Aligned_cols=266 Identities=22% Similarity=0.315 Sum_probs=215.1
Q ss_pred CCcCHHHHHHhhcc----------ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCC
Q 043932 693 PTVSYAELSKATSE----------FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHR 762 (1017)
Q Consensus 693 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 762 (1017)
+.++++++..+++. |...++||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45677777766653 77778999999999999999989999999999876666678899999999999999
Q ss_pred CceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecC
Q 043932 763 NLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDL 842 (1017)
Q Consensus 763 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 842 (1017)
||+++++++... +..++||||+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||
T Consensus 103 niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl 167 (321)
T 2c30_A 103 NVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI 167 (321)
T ss_dssp TBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred CcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence 999999998765 6789999999999999998643 589999999999999999999999 9999999
Q ss_pred CCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCC
Q 043932 843 KPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRR 922 (1017)
Q Consensus 843 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 922 (1017)
||+||+++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 239 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKDV--------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSSS--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccCc--------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999998654321 11123579999999999999899999999999999999999999
Q ss_pred CCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 923 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
||....... ....... ..+ +.. .....+++.+.+++.+||+.||++|||+.|++
T Consensus 240 pf~~~~~~~-~~~~~~~-~~~--------~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 293 (321)
T 2c30_A 240 PYFSDSPVQ-AMKRLRD-SPP--------PKL----------------KNSHKVSPVLRDFLERMLVRDPQERATAQELL 293 (321)
T ss_dssp TTTTSCHHH-HHHHHHH-SSC--------CCC----------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCCHHH-HHHHHhc-CCC--------CCc----------------CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 997532210 0111100 000 000 00112355688999999999999999999999
Q ss_pred HHHhh
Q 043932 1003 AKLCH 1007 (1017)
Q Consensus 1003 ~~L~~ 1007 (1017)
++-.-
T Consensus 294 ~hp~~ 298 (321)
T 2c30_A 294 DHPFL 298 (321)
T ss_dssp TSGGG
T ss_pred cChhh
Confidence 87543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=370.67 Aligned_cols=269 Identities=26% Similarity=0.363 Sum_probs=204.5
Q ss_pred HHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecC
Q 043932 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSI 774 (1017)
Q Consensus 697 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 774 (1017)
..++....++|++.+.||+|+||+||+|++ +++.||||++.... ....+++.+|++++++++||||+++++++...
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 334445567899999999999999999988 47889999987543 23346788999999999999999999998654
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeecCCCCceEeCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~ 852 (1017)
+..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ + |+||||||+||+++.+
T Consensus 107 -----~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~ 175 (309)
T 3p86_A 107 -----PNLSIVTEYLSRGSLYRLLHKSG---AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKK 175 (309)
T ss_dssp -----TCCEEEEECCTTCBHHHHHHSTT---HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTT
T ss_pred -----CceEEEEecCCCCcHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCC
Confidence 56899999999999999998653 123489999999999999999999999 8 9999999999999999
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCc
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 932 (1017)
+.+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus 176 ~~~kL~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~- 246 (309)
T 3p86_A 176 YTVKVCDFGLSRLKASTF--------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ- 246 (309)
T ss_dssp CCEEECCCC-------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-
T ss_pred CcEEECCCCCCccccccc--------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999999999997543221 11123568999999999999999999999999999999999999997542211
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
........... ......+++++.+++.+||+.||++|||+.|+++.|+.+.++.
T Consensus 247 -~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 247 -VVAAVGFKCKR-------------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -HHHHHHHSCCC-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -HHHHHHhcCCC-------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 00000000000 0011123567899999999999999999999999999987764
Q ss_pred c
Q 043932 1013 F 1013 (1017)
Q Consensus 1013 ~ 1013 (1017)
.
T Consensus 301 ~ 301 (309)
T 3p86_A 301 V 301 (309)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=373.21 Aligned_cols=267 Identities=25% Similarity=0.386 Sum_probs=210.7
Q ss_pred hccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.++||+|+||+||+|++..+ +..||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG----- 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-----
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence 46899999999999999999999754 4569999997542 33456789999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++|+|.++++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 194 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD 194 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence 668999999999999999976542 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||+++.......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... .....
T Consensus 195 fg~a~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~ 267 (325)
T 3kul_A 195 FGLSRVLEDDPDAAY-----TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSV 267 (325)
T ss_dssp CSSCEECC----CCE-----ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHH
T ss_pred CCcccccccCcccee-----eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH
Confidence 999987654321111 1112346889999999998899999999999999999999 999996542211 00000
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccccccC
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGRR 1016 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 1016 (1017)
..... ......+++.+.+++.+||+.||++|||+.||++.|+.+.+...+-|
T Consensus 268 ~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~ 319 (325)
T 3kul_A 268 EEGYR--------------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLR 319 (325)
T ss_dssp HTTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC---
T ss_pred HcCCC--------------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccc
Confidence 00000 00111345678999999999999999999999999999987655443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=364.10 Aligned_cols=269 Identities=22% Similarity=0.349 Sum_probs=208.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHh--cCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRN--IRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..++|++.+.||+|+||+||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++... .....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCc
Confidence 356899999999999999999998 5889999998643 23455667777766 7999999999987553 22236
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHh--------hCCCCCceeecCCCCceEeCCC
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH--------HHCQPPMVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~ 852 (1017)
..++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+||+++.+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTT
T ss_pred eeEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCC
Confidence 689999999999999999643 6899999999999999999999 77 99999999999999999
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCC------CcCccccchhHHHHHHHHHhC------
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS------EASMTGDVYSFGILLLELFTG------ 920 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg------ 920 (1017)
+.+||+|||+|+.......... .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLD----VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEE----CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CCEEEeeCCCeeeccccccccc----ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 9999999999976543321111 111234799999999999876 456799999999999999999
Q ss_pred ----CCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC
Q 043932 921 ----RRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM 996 (1017)
Q Consensus 921 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 996 (1017)
+.||............................ ......+++.+.+++.+||+.||++||
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~Rp 288 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN-----------------RWFSDPTLTSLAKLMKECWYQNPSARL 288 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG-----------------GGGGSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred cccccccccccCCCCcchhhhhHHHhccCCCCCCCh-----------------hhccCccHHHHHHHHHHHhhcChhhCC
Confidence 88887654444444333332211110000000 111234577899999999999999999
Q ss_pred CHHHHHHHHhhc
Q 043932 997 EMRDVVAKLCHT 1008 (1017)
Q Consensus 997 s~~evl~~L~~~ 1008 (1017)
|+.||++.|+++
T Consensus 289 s~~~i~~~L~~i 300 (301)
T 3q4u_A 289 TALRIKKTLTKI 300 (301)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHhcc
Confidence 999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.40 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=206.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. .....+.+.+|+.+++.++||||+++++++... +
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----C
Confidence 46899999999999999999999999999999999754 234457788999999999999999999998765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence 7899999999999999997653 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....
T Consensus 150 G~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~ 216 (337)
T 1o6l_A 150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFEL 216 (337)
T ss_dssp TTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred cchhhcccCC--------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-----HHHHH
Confidence 9997532211 1123367999999999999999999999999999999999999999753221 11100
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAKL 1005 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 1005 (1017)
..... .. ....+++++.+++.+||+.||++|| ++.|+++|-
T Consensus 217 i~~~~-----------------~~-------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 217 ILMEE-----------------IR-------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp HHHCC-----------------CC-------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHcCC-----------------CC-------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 00000 00 0012356788999999999999999 899998863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=375.97 Aligned_cols=266 Identities=24% Similarity=0.397 Sum_probs=212.7
Q ss_pred hccccccCcccccCCceEEEEEeC-------CCcEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeeeeeeecC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILG-------EDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKIITICSSI 774 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 774 (1017)
.++|++.+.||+|+||+||+|++. .++..||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999863 3567899999975432 3456789999999999 899999999998654
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKP 844 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 844 (1017)
+..|+||||+++|+|.+++...... .....+++.+++.++.||+.||+|||++ +|+||||||
T Consensus 160 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 160 -----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp -----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred -----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 5689999999999999999875421 1223589999999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCC
Q 043932 845 SNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923 (1017)
Q Consensus 845 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 923 (1017)
+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p 305 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTT------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred hhEEECCCCCEEEccccCCcccCcccce------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999866432211 11122457889999999999999999999999999999999 9999
Q ss_pred CCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 924 TDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 924 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
|....... .......... ......+++++.+++.+||+.||++||++.|+++
T Consensus 306 ~~~~~~~~--~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 306 YPGIPVEE--LFKLLKEGHR--------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp STTCCGGG--HHHHHHTTCC--------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHH--HHHHHhcCCC--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 97642221 1111110000 0011234567899999999999999999999999
Q ss_pred HHhhcccc
Q 043932 1004 KLCHTRET 1011 (1017)
Q Consensus 1004 ~L~~~~~~ 1011 (1017)
+|+.+.+.
T Consensus 358 ~L~~il~~ 365 (370)
T 2psq_A 358 DLDRILTL 365 (370)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=365.97 Aligned_cols=263 Identities=22% Similarity=0.400 Sum_probs=209.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++... +
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-----D 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-----S
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-----C
Confidence 468999999999999999999999999999999986433 23356788999999999999999999998654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence 7899999999999999998653 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||........... ....
T Consensus 156 g~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~ 227 (294)
T 4eqm_A 156 GIAKALSETSL-------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK-HIQD 227 (294)
T ss_dssp SSSTTC--------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH-HHSS
T ss_pred CCccccccccc-------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-Hhhc
Confidence 99986643221 111235699999999999998999999999999999999999999976422111000 0000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhcccc
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-EMRDVVAKLCHTRET 1011 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~ 1011 (1017)
..+. . .......+++.+.+++.+|++.||++|| ++.++.+.|+.+...
T Consensus 228 ~~~~---------~--------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 228 SVPN---------V--------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp CCCC---------H--------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cCCC---------c--------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0000 0 0011123467789999999999999999 899999999887654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=368.52 Aligned_cols=282 Identities=20% Similarity=0.251 Sum_probs=215.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.++||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.... ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceE
Confidence 468999999999999999999999999999999997443 234577889999999999999999999886542 2467
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe----CCCCCeEEe
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVSHVG 858 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~ 858 (1017)
++||||+++++|.+++..... ...+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred EEEEeCCCCCCHHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEc
Confidence 999999999999999986532 12489999999999999999999999 99999999999999 788889999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCccccc--------CCCcCccccchhHHHHHHHHHhCCCCCCccccc
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM--------GSEASMTGDVYSFGILLLELFTGRRPTDAAFTE 930 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 930 (1017)
|||+++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 159 Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 159 DFGAARELEDDE---------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp CCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred cCCCceecCCCC---------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 999998664322 112356899999999986 567899999999999999999999999754332
Q ss_pred CccHHHHHHhh--cCch-hhhhccchhhHHHHhhcchhHH---HhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 931 GLTLHEFAKIA--LPEK-VIEIVDPLLLIEVMANNSMIQE---DIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 931 ~~~~~~~~~~~--~~~~-~~~~~d~~l~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........... .+.. ...+.... .....+.. .........+..+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h 303 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAE------NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECST------TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred chhHHHHHHHhcCCCcccchhhhccc------CCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence 22222221111 1111 00000000 00000000 0012234567789999999999999999999999999
Q ss_pred Hhhcc
Q 043932 1005 LCHTR 1009 (1017)
Q Consensus 1005 L~~~~ 1009 (1017)
..+..
T Consensus 304 ~~d~~ 308 (319)
T 4euu_A 304 TSDIL 308 (319)
T ss_dssp HHHHT
T ss_pred cHHHh
Confidence 98754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=369.08 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=206.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++... +..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeE
Confidence 4689999999999999999999999999999999974432 2346688999999999999999999998754 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence 99999999999999987553 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++.+...... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+....
T Consensus 152 a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 225 (323)
T 3tki_A 152 ATVFRYNNRE------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225 (323)
T ss_dssp CEECEETTEE------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC
T ss_pred cceeccCCcc------cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc
Confidence 9865432211 11223579999999999987765 7899999999999999999999976543322222221111
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
... .....+++.+.+++.+||+.||++|||+.|++++-.
T Consensus 226 ~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 226 TYL--------------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp TTS--------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ccC--------------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 000 001123566789999999999999999999988643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=366.94 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=207.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc------hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG------AFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--- 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---
Confidence 46799999999999999999999999999999999754321 357789999999999999999999998654
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC----
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---- 853 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 853 (1017)
...++||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 87 --~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 87 --TDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp --SEEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred --CEEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence 67899999999999999997643 689999999999999999999999 999999999999999887
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .
T Consensus 156 ~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~ 225 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-T 225 (326)
T ss_dssp CEEECCCTTCEECCTTS---------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-H
T ss_pred CEEEEECCCCeECCCCC---------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-H
Confidence 89999999998664221 1123569999999999998899999999999999999999999997542211 1
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.......... .. ......+++.+.+++.+||+.||++|||+.|+++|-
T Consensus 226 ~~~~~~~~~~----------~~--------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 226 LANVSAVNYE----------FE--------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHHHHTCCC----------CC--------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHHHHhcCCC----------cC--------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 1111110000 00 011123356788999999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=379.75 Aligned_cols=256 Identities=20% Similarity=0.261 Sum_probs=206.9
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
...++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE----- 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-----
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-----
Confidence 456789999999999999999999999999999999975432 3346788999999999999999999998755
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC---CCCCeE
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVSH 856 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~k 856 (1017)
+..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++ .++.+|
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk 153 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK 153 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred CEEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence 67899999999999999998754 689999999999999999999999 999999999999998 568899
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|+|||++....... .......||+.|+|||++.+..++.++||||+||++|+|++|.+||...... .....
T Consensus 154 L~DFG~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~ 224 (444)
T 3soa_A 154 LADFGLAIEVEGEQ--------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQ 224 (444)
T ss_dssp ECCCSSCBCCCTTC--------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHH
T ss_pred EccCceeEEecCCC--------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHH
Confidence 99999997654322 1122357999999999999989999999999999999999999999764221 11111
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........ .. .....+++++.+++.+||+.||++|||+.|+++|
T Consensus 225 i~~~~~~~-----~~-------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 225 IKAGAYDF-----PS-------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHTCCCC-----CT-------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCCCCC-----Cc-------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111000 00 0111235678899999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.30 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=210.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||+||+|++. ++..||+|++..... ..+++.+|++++++++||||+++++++... +..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CceE
Confidence 468999999999999999999997 577899999975433 347789999999999999999999998654 5689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred EEEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence 99999999999999976543 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+........ ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....... ..... ....
T Consensus 154 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-~~~~~-~~~~ 224 (269)
T 4hcu_A 154 RFVLDDQYT-------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDI-STGF 224 (269)
T ss_dssp GGBCCHHHH-------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHH-HTTC
T ss_pred ccccccccc-------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHH-hcCc
Confidence 866433211 1122457889999999998899999999999999999999 999997532211 00000 0000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
.. . ....+++.+.+++.+||+.||++|||+.|++++|+++.++
T Consensus 225 ~~-----~---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 RL-----Y---------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CC-----C---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cC-----C---------------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00 0 0011245688999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=355.98 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=210.0
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||.||+|++. ++..||+|++..... ..+++.+|++++++++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE-----YPI 78 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----Cce
Confidence 3568999999999999999999987 677899999975443 347789999999999999999999998654 568
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGM 150 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCcc
Confidence 99999999999999998653 2689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+.......... .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||........ .......
T Consensus 151 ~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~- 221 (268)
T 3sxs_A 151 TRYVLDDQYVS-------SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-VLKVSQG- 221 (268)
T ss_dssp EEECCTTCEEE-------CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTT-
T ss_pred ceecchhhhhc-------ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-HHHHHcC-
Confidence 98665432111 122456788999999998889999999999999999999 9999975422110 0000000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
... .. ...+++.+.+++.+||+.||++|||+.|++++|+.++++
T Consensus 222 ~~~-----~~---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 222 HRL-----YR---------------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCC-----CC---------------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCC-----CC---------------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000 00 011245688999999999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=371.91 Aligned_cols=255 Identities=21% Similarity=0.311 Sum_probs=207.0
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----- 100 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE----- 100 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----
Confidence 345789999999999999999999999999999999975432 3456788999999999999999999998755
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC---CCeE
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVSH 856 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~k 856 (1017)
+..|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.+ +.+|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEE
T ss_pred CEEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence 67899999999999999997653 689999999999999999999999 99999999999999865 4599
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|+|||++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .....
T Consensus 172 l~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~ 241 (362)
T 2bdw_A 172 LADFGLAIEVNDSE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQ 241 (362)
T ss_dssp ECCCTTCBCCTTCC---------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred EeecCcceEecCCc---------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence 99999998654321 112357999999999999989999999999999999999999999764221 01111
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........ . ......+++++.+++.+||+.||++|||+.|++++
T Consensus 242 i~~~~~~~-----~-------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 242 IKAGAYDY-----P-------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHTCCCC-----C-------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHhCCCCC-----C-------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11110000 0 00112235678999999999999999999999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=374.78 Aligned_cols=277 Identities=22% Similarity=0.323 Sum_probs=218.3
Q ss_pred cCHHHHHHhhccccccCcccccCCceEEEEE-----eCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceee
Q 043932 695 VSYAELSKATSEFASSNMIGQGSFGSVYKGI-----LGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKI 767 (1017)
Q Consensus 695 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~ 767 (1017)
+...++....++|++.+.||+|+||.||+|+ ...+++.||||++..... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4456667778899999999999999999999 556779999999975432 3446789999999999 79999999
Q ss_pred eeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCc------------------------------------------
Q 043932 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL------------------------------------------ 805 (1017)
Q Consensus 768 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------ 805 (1017)
++++... ....++||||+++|+|.+++.......
T Consensus 92 ~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9998653 244799999999999999998754210
Q ss_pred ------------------cccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccc
Q 043932 806 ------------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867 (1017)
Q Consensus 806 ------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 867 (1017)
....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 012289999999999999999999999 99999999999999999999999999998654
Q ss_pred cccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCchh
Q 043932 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKV 946 (1017)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 946 (1017)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||............ ........
T Consensus 245 ~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~- 316 (359)
T 3vhe_A 245 KDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMR- 316 (359)
T ss_dssp SCTTC------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH-HHHTCCCC-
T ss_pred ccccc------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH-HHcCCCCC-
Confidence 32211 11223568999999999998899999999999999999998 99999764332111111 11100000
Q ss_pred hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 947 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
....+++++.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 317 -------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 317 -------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 0112355788999999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=362.09 Aligned_cols=279 Identities=24% Similarity=0.294 Sum_probs=206.3
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
...++|++.++||+|+||+||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE----- 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-----
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-----
Confidence 44679999999999999999999996 58899999987443 23346788999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++ +|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 162 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLAD 162 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred CEEEEEEcCCCC-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEcc
Confidence 678999999975 88888876542 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||+++...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. .....
T Consensus 163 fg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~ 233 (311)
T 3niz_A 163 FGLARAFGIPV--------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIF 233 (311)
T ss_dssp CTTCEETTSCC--------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHH
T ss_pred CcCceecCCCc--------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Confidence 99998654221 11122468999999999876 5689999999999999999999999987544322 22222
Q ss_pred HhhcCchhhhhccchhhHHHHhhcch--hHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSM--IQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..........+........+...... ...........+++++.+++.+||+.||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 234 SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 22111111110000000000000000 0000011122345678999999999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=378.03 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=212.4
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
...++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++... +
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 185 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----Q 185 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----C
Confidence 345689999999999999999999998999999999874432 3345688999999999999999999998654 5
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.++++... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcC
Confidence 6799999999999999998643 3689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... .......
T Consensus 258 G~s~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~ 329 (377)
T 3cbl_A 258 GMSREEADGVYAA------SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVE 329 (377)
T ss_dssp GGCEECTTSEEEC------CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHH
T ss_pred CCceecCCCceee------cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 9998643322111 0111235778999999988889999999999999999998 99999764221 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
.... ......+++++.+++.+||+.||++|||+.|+++.|+.+++++
T Consensus 330 ~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 330 KGGR--------------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp TTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCC--------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 0000 0011224567899999999999999999999999999988654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=376.25 Aligned_cols=358 Identities=20% Similarity=0.208 Sum_probs=195.6
Q ss_pred CcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccC
Q 043932 94 SPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLL 173 (1017)
Q Consensus 94 ~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 173 (1017)
+..++++++|++|+|++|.+++ +| +++.+++|++|+|++|++++ +| ++.+++|++|+|++|++++. | +++++
T Consensus 35 ~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~ 106 (457)
T 3bz5_A 35 TISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLT 106 (457)
T ss_dssp EEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCT
T ss_pred ccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCC
Confidence 3455566666677777666664 34 56666666666666666664 33 66666666666666666643 2 56666
Q ss_pred CccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCC
Q 043932 174 KLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLP 253 (1017)
Q Consensus 174 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 253 (1017)
+|++|++++|++++. | ++++++|++|++++|++++. .++.+++|++|++++|+..+.+ .+..+++|++|+++
T Consensus 107 ~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls 178 (457)
T 3bz5_A 107 KLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCS 178 (457)
T ss_dssp TCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECC
T ss_pred cCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECC
Confidence 666666666666642 2 55666666666666666542 2555555555555555433333 24445555555555
Q ss_pred CccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCC
Q 043932 254 FNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMG 333 (1017)
Q Consensus 254 ~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 333 (1017)
+|++++ +| +..+++|+.|++++|++++. .++.+++|+.|++++|+++++ | +
T Consensus 179 ~n~l~~-l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~------------------- 229 (457)
T 3bz5_A 179 FNKITE-LD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--V------------------- 229 (457)
T ss_dssp SSCCCC-CC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--C-------------------
T ss_pred CCccce-ec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--c-------------------
Confidence 555542 33 33444455555555554432 244444444444444444432 1 3
Q ss_pred CCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCc
Q 043932 334 TANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTI 413 (1017)
Q Consensus 334 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 413 (1017)
..+++|++|++++|++++. . +..+++|+.|++++|
T Consensus 230 -----------~~l~~L~~L~l~~N~l~~~-------------------------~---~~~l~~L~~L~l~~n------ 264 (457)
T 3bz5_A 230 -----------TPLTQLTYFDCSVNPLTEL-------------------------D---VSTLSKLTTLHCIQT------ 264 (457)
T ss_dssp -----------TTCTTCSEEECCSSCCSCC-------------------------C---CTTCTTCCEEECTTC------
T ss_pred -----------cccCCCCEEEeeCCcCCCc-------------------------C---HHHCCCCCEEeccCC------
Confidence 3344555555555554421 1 223445566665554
Q ss_pred chhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcc
Q 043932 414 PDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSIT 493 (1017)
Q Consensus 414 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~ 493 (1017)
+|+.|++++|.+.+.+| ++++++|+.|++++|.+.+.+|. ...+|+.|++++|
T Consensus 265 --------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------- 317 (457)
T 3bz5_A 265 --------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------- 317 (457)
T ss_dssp --------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC--------------
T ss_pred --------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc--------------
Confidence 34556666666665555 34566666666666665555543 2233333333322
Q ss_pred cccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEec
Q 043932 494 TLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNF 573 (1017)
Q Consensus 494 ~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 573 (1017)
++|+.|+|++|+|++. + ++.+++|+.||+++|+|++. +.|..|++
T Consensus 318 ------------------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~l--------~~L~~L~l 362 (457)
T 3bz5_A 318 ------------------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQDF--------SSVGKIPA 362 (457)
T ss_dssp ------------------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCBC--------TTGGGSSG
T ss_pred ------------------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCCc--------cccccccc
Confidence 3455666666666653 2 56666666666666666641 34455566
Q ss_pred cCCcccCCChhhhcccCCCcEEEcccCCCcCcCCC
Q 043932 574 SSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT 608 (1017)
Q Consensus 574 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 608 (1017)
++|+++|. .++..|..+++++|+|+|.+|.
T Consensus 363 ~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 363 LNNNFEAE-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp GGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred cCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence 66666654 2344556666777777766664
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.69 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=201.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 778 (1017)
..++|++.++||+|+||+||+|++..+++.||||++... .....+.+.+|..+++.+ +||||+++++++...
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~---- 96 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP---- 96 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC----
Confidence 356899999999999999999999999999999999743 233456788999999988 799999999998765
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 97 -~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 97 -DRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred -CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence 67899999999999999998654 689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||+|+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......
T Consensus 167 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~ 237 (353)
T 3txo_A 167 DFGMCKEGICNG--------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAIL 237 (353)
T ss_dssp CCTTCBCSCC-----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH
T ss_pred cccceeecccCC--------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 999997533211 12233579999999999998889999999999999999999999997642211 111111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM------RDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 1004 (1017)
.... . .....++.+.+++.+||+.||++||++ .|+++|
T Consensus 238 ~~~~---------------------~-------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 238 NDEV---------------------V-------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HCCC---------------------C-------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred cCCC---------------------C-------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1000 0 001124567899999999999999998 777765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=364.49 Aligned_cols=269 Identities=20% Similarity=0.282 Sum_probs=211.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||+||+|++..+++.||||++..... .+.+.+|+++++++ +||||+++++++... +..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----Ccc
Confidence 4689999999999999999999999999999999875432 24678999999999 999999999998764 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC-----eEE
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV-----SHV 857 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl 857 (1017)
++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++. +||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl 151 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI 151 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred EEEEEeC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence 9999999 899999998753 2789999999999999999999999 9999999999999998887 999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||+++........... .........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+
T Consensus 152 ~DFg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~ 229 (330)
T 2izr_A 152 IDFALAKEYIDPETKKHI-PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-KERY 229 (330)
T ss_dssp CCCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHH
T ss_pred EEcccceeeecCCCCccc-cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-HHHH
Confidence 999999876543221111 11122346799999999999999999999999999999999999999986432211 1111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
.... .... ..........++ ++.+++..|++.||.+||++.+|.+.|+++.++
T Consensus 230 ~~i~-~~~~-------------------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 230 QKIG-DTKR-------------------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHHH-HHHH-------------------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHH-hhhc-------------------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 1000 0000 000000011124 899999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=373.16 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=202.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.++||+|+||+||+|++..+++.||+|+++... ....+.+.+|..+++++ +||||+++++++...
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~----- 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE----- 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-----
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-----
Confidence 468999999999999999999999999999999997542 23345678899999887 899999999998765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence 67899999999999999998653 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCc----cHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL----TLH 935 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~----~~~ 935 (1017)
||+|+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 197 FGla~~~~~~~--------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~ 268 (396)
T 4dc2_A 197 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268 (396)
T ss_dssp CTTCBCCCCTT--------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH
T ss_pred cceeeecccCC--------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH
Confidence 99997532111 122346799999999999999999999999999999999999999965322110 000
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM------RDVVAK 1004 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 1004 (1017)
....... .... ..+..++.++.+++.+||+.||.+||++ .|+++|
T Consensus 269 ~~~~~i~-----------------~~~~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 269 YLFQVIL-----------------EKQI-------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHH-----------------HCCC-------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHHHh-----------------cccc-------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 0000000 0000 0111235678899999999999999996 566665
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=373.04 Aligned_cols=281 Identities=18% Similarity=0.273 Sum_probs=211.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCC-----cEEEEEEEeeecCcch-----------HHHHHHHHHHHHhcCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGED-----EMIVAVKVINLKQKGA-----------FKSFMAECKALRNIRHRNLIK 766 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 766 (1017)
..++|++.++||+|+||+||+|.+..+ ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999999764 4789999987543211 123345666677788999999
Q ss_pred eeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCc
Q 043932 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 846 (1017)
Q Consensus 767 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 846 (1017)
+++++... ..+..+.++||||+ +++|.+++..... .+++.+++.++.||+.||+|||++ +|+||||||+|
T Consensus 113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 99998664 22346689999999 9999999987542 789999999999999999999999 99999999999
Q ss_pred eEeC--CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCC
Q 043932 847 VLLD--HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPT 924 (1017)
Q Consensus 847 Ill~--~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 924 (1017)
|+++ .++.+||+|||+++.+......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY-AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCS-SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred EEEecCCCCeEEEEECCcceecccCCccccc-ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999 8899999999999876543322111 111223456999999999999989999999999999999999999999
Q ss_pred CcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 925 DAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....... .............+.++.++.+ ....+++++.+++..||+.||.+||++.++++.
T Consensus 262 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 262 EDNLKDP-KYVRDSKIRYRENIASLMDKCF-----------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp GGGTTCH-HHHHHHHHHHHHCHHHHHHHHS-----------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cccccCH-HHHHHHHHHhhhhHHHHHHHhc-----------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 8643221 1111111111111111111100 002336789999999999999999999999999
Q ss_pred Hhhccccc
Q 043932 1005 LCHTRETF 1012 (1017)
Q Consensus 1005 L~~~~~~~ 1012 (1017)
|+.+.+..
T Consensus 324 l~~~~~~~ 331 (364)
T 3op5_A 324 LLQGLKAI 331 (364)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHc
Confidence 99887643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=370.44 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=205.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-----cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD---- 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC----
Confidence 468999999999999999999999999999999996432 12357789999999999999999999998765
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC---e
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV---S 855 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~ 855 (1017)
+..|+||||+++|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +
T Consensus 99 -~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 99 -GMLYMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp -TEEEEEEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred -CEEEEEEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence 678999999999999988865321 112589999999999999999999999 9999999999999987654 9
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHH
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 935 (1017)
||+|||++........ ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ...
T Consensus 173 kl~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~ 242 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGL--------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--LFE 242 (351)
T ss_dssp EECCCTTCEECCTTSC--------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--HHH
T ss_pred EEecCcceeEecCCCe--------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--HHH
Confidence 9999999987643221 112357999999999999989999999999999999999999999763210 111
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......... . ......+++++.+++.+||+.||++|||+.|+++|
T Consensus 243 ~i~~~~~~~------~------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 243 GIIKGKYKM------N------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHTCCCC------C------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCCC------C------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111100000 0 01112345678999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=367.63 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=204.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.++||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++... +
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----E 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence 468999999999999999999999999999999997432 34457788999999999999999999998765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence 7899999999999999998653 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC---CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG---SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....
T Consensus 160 G~a~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~ 228 (384)
T 4fr4_A 160 NIAAMLPRET---------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEI 228 (384)
T ss_dssp TTCEECCTTC---------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHH
T ss_pred ceeeeccCCC---------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHH
Confidence 9998654221 1233679999999999864 458999999999999999999999997543221 1111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-MRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 1004 (1017)
....... .......+++.+.+++.+||+.||.+||+ +.++++|
T Consensus 229 ~~~~~~~------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 229 VHTFETT------------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHC------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHhhc------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 1100000 00001123567899999999999999998 7777653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=368.01 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=203.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++... +
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 468999999999999999999999999999999997432 22346788999999999999999999998765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+ +|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred EEEEEEECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence 789999999 679999887653 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|++....... ......||+.|+|||++.+..+ ++++||||+||++|+|++|+.||.........
T Consensus 153 G~s~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------ 217 (336)
T 3h4j_B 153 GLSNIMTDGN---------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------ 217 (336)
T ss_dssp SCTBTTTTSB---------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------
T ss_pred ccceeccCCc---------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------
Confidence 9998654322 1123569999999999988776 78999999999999999999999764322110
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..+ .... .......++.+.+++.+||+.||.+|||+.|++++-
T Consensus 218 ----~~i---~~~~----------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 218 ----KKV---NSCV----------------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp ----CCC---CSSC----------------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred ----HHH---HcCC----------------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 000 0000 000011245688999999999999999999998763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=357.17 Aligned_cols=271 Identities=17% Similarity=0.234 Sum_probs=214.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .+.+.+|+.+++++ +|+|++++++++... ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCC-----cee
Confidence 4689999999999999999999998999999999864432 35678899999999 799999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC-----eEE
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV-----SHV 857 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl 857 (1017)
++||||+ +++|.+++..... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++. +||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEec-CCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 9999999 8999999987542 689999999999999999999999 9999999999999987776 999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||+++........... .........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+
T Consensus 153 ~Dfg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~ 230 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKY 230 (298)
T ss_dssp CCCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHH
T ss_pred EECccccccccccccccc-cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-HHHH
Confidence 999999876543321111 11123346799999999999998999999999999999999999999976432211 1110
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
.... .. ............+++++.+++.+||+.||++||++.+|++.|+++.++.
T Consensus 231 ~~~~---------~~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 231 ERIG---------EK-----------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHH---------HH-----------HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHH---------hh-----------ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 0000 00 0000001112234678999999999999999999999999999987654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=363.08 Aligned_cols=283 Identities=22% Similarity=0.285 Sum_probs=208.1
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-----chHHHHHHHHHHHHhcC---CCCceeeeeeeecC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-----GAFKSFMAECKALRNIR---HRNLIKIITICSSI 774 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 774 (1017)
..++|++.++||+|+||+||+|++..+++.||+|++..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 35799999999999999999999999999999999974331 22346677887777764 99999999999776
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 854 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 854 (1017)
........++||||++ |+|.+++..... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 5444457899999997 599999987642 2489999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|++||........ .
T Consensus 159 ~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~ 228 (308)
T 3g33_A 159 VKLADFGLARIYSYQM---------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-L 228 (308)
T ss_dssp EEECSCSCTTTSTTCC---------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-H
T ss_pred EEEeeCccccccCCCc---------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 9999999998654221 12235789999999999998999999999999999999999999976433221 1
Q ss_pred HHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..............+........ ................++++.+.+++.+||+.||++|||+.|+++|
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPR-GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCG-GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhCCCChhhccchhhccc-cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 12211111100000000000000 0000000001111222346778999999999999999999999876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=365.14 Aligned_cols=283 Identities=22% Similarity=0.325 Sum_probs=194.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++++... +..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE-----NKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-----TEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-----CeE
Confidence 4689999999999999999999999999999999975432 3446788999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||++ |+|.+++...........+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999998 59999987643222234689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .........
T Consensus 155 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~ 225 (317)
T 2pmi_A 155 ARAFGIPV--------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIM 225 (317)
T ss_dssp CEETTSCC--------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ceecCCCc--------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence 98654221 111234689999999998764 68999999999999999999999997643321 111221111
Q ss_pred c-C-chhhhhccc--hhhHHHHh-hcchhHHHh-HHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 L-P-EKVIEIVDP--LLLIEVMA-NNSMIQEDI-RAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~-~-~~~~~~~d~--~l~~~~~~-~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. + +........ ........ ......... .......+.++.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 1 0 000000000 00000000 000000000 00111245678999999999999999999999876
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=379.47 Aligned_cols=280 Identities=18% Similarity=0.207 Sum_probs=205.1
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 779 (1017)
..++|++.++||+|+||+||+|++..+++.||||++... .....+++.+|+.+++.++||||+++++++..... ...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999754 33445778899999999999999999999865432 233
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...|+||||+++ ++.+.+.. .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred CeEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence 578999999976 57766642 478999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+.....
T Consensus 208 FG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~ 277 (464)
T 3ttj_A 208 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIE 277 (464)
T ss_dssp CCCC-----CC---------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred EEeeeecCCCc---------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 99998654321 1233579999999999999999999999999999999999999997643221 1222221
Q ss_pred hhcCc--hhhhhccchhhHHHHhhc-----chhHH--------HhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPE--KVIEIVDPLLLIEVMANN-----SMIQE--------DIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~--~~~~~~d~~l~~~~~~~~-----~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..... .....+.+... .+.... ..+.. ..........+++.+++.+||+.||++|||+.|+++|
T Consensus 278 ~lg~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 278 QLGTPCPEFMKKLQPTVR-NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHCSCCHHHHTTSCHHHH-HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCCCCHHHHHHcchhhh-hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111 01111111100 000000 00000 0011223346778999999999999999999999987
Q ss_pred H
Q 043932 1005 L 1005 (1017)
Q Consensus 1005 L 1005 (1017)
-
T Consensus 357 p 357 (464)
T 3ttj_A 357 P 357 (464)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=356.55 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=204.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc-------hHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-------AFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|++...... ..+.+.+|++++++++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 46899999999999999999999999999999998644322 126788999999999999999999998543
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeecCCCCceEeCCCCC
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDHDMV 854 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~ 854 (1017)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ + |+||||||+||+++.++.
T Consensus 96 -----~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 96 -----PRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp -----TEEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT
T ss_pred -----CeEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC
Confidence 2699999999999999876542 789999999999999999999999 8 999999999999988776
Q ss_pred -----eEEeecccccccccccccccccCCCcccccccCccccCccccc--CCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 855 -----SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM--GSEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 855 -----~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
+||+|||+++.... ......||+.|+|||++. +..++.++||||+||++|||++|+.||...
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVH-----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp TCSCCEEECCCTTCBCCSS-----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCceeEEeCCCCccccccc-----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999874332 122356899999999984 456789999999999999999999999764
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
................ .+ .....+++.+.+++.+||+.||++|||+.|+++.|++
T Consensus 232 ~~~~~~~~~~~~~~~~-------~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 232 SYGKIKFINMIREEGL-------RP------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCHHHHHHHHHHSCC-------CC------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cccHHHHHHHHhccCC-------CC------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 3322111111111000 00 0112335678999999999999999999999999986
Q ss_pred c
Q 043932 1008 T 1008 (1017)
Q Consensus 1008 ~ 1008 (1017)
+
T Consensus 287 l 287 (287)
T 4f0f_A 287 L 287 (287)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=371.82 Aligned_cols=254 Identities=19% Similarity=0.267 Sum_probs=207.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||+||+|.+..+++.||+|++..........+.+|++++++++||||+++++++... ...+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-----CEEE
Confidence 46899999999999999999999999999999999866555556789999999999999999999998654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC--CCCeEEeecc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH--DMVSHVGDFG 861 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG 861 (1017)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 125 lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence 9999999999999997653 2689999999999999999999999 9999999999999974 5789999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..........
T Consensus 197 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~ 266 (387)
T 1kob_A 197 LATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCD 266 (387)
T ss_dssp TCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCC
T ss_pred cceecCCCc---------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC
Confidence 998764322 112246899999999999989999999999999999999999999764221 1111111100
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. .++ .....+++++.+++.+||+.||++|||+.|++++
T Consensus 267 ~~------~~~------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 267 WE------FDE------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CC------CCS------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CC------CCc------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 000 0111235678999999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.13 Aligned_cols=247 Identities=24% Similarity=0.305 Sum_probs=205.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. .
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----Q 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----S
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----C
Confidence 468999999999999999999999999999999997432 23456788999999999999999999998654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence 7899999999999999998754 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........
T Consensus 151 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~ 218 (318)
T 1fot_A 151 GFAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNA 218 (318)
T ss_dssp SSCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHC
T ss_pred CcceecCCc-----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC
Confidence 999865321 123579999999999999999999999999999999999999997532210 01111100
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
.. . .....++++.+++.+|++.||++|| ++.|+++|
T Consensus 219 ~~---------------------~-------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 219 EL---------------------R-------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CC---------------------C-------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC---------------------C-------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 00 0 0011245688999999999999999 89999876
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=374.02 Aligned_cols=266 Identities=23% Similarity=0.388 Sum_probs=208.9
Q ss_pred hccccccCcccccCCceEEEEEe-----CCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++|++.++||+|+||+||+|++ ..+++.||||++.... .....++.+|+.++++++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 46899999999999999999994 4567899999986432 33446788999999999999999999998654
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCC-ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC---
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM--- 853 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 853 (1017)
...++||||+++|+|.+++...... .....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 147 --LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred --CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence 5579999999999999999875421 1224689999999999999999999999 999999999999999555
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGL 932 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 932 (1017)
.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 222 ~~kL~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~- 294 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGY------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE- 294 (367)
T ss_dssp CEEECCCHHHHHHHHHSS------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred eEEECCCccccccccccc------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 599999999986533221 111223468999999999988899999999999999999998 999997642211
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
.......... ......++..+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 295 -~~~~i~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 295 -VLEFVTSGGR--------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -HHHHHHTTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHHHHHcCCC--------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111100000 000112356789999999999999999999999999988764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=373.08 Aligned_cols=263 Identities=25% Similarity=0.428 Sum_probs=199.5
Q ss_pred hccccccCcccccCCceEEEEEeC---CCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.+.||+|+||.||+|++. .++..||||+++... ....+.+.+|+.++++++||||+++++++...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS----- 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----
Confidence 458999999999999999999986 467789999997543 33456789999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECc
Confidence 56899999999999999998654 2689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||+++.......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... .....
T Consensus 191 fg~a~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i 263 (373)
T 2qol_A 191 FGLGRVLEDDPEAAY-----TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAV 263 (373)
T ss_dssp C---------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHH
T ss_pred CccccccccCCccce-----eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 999987653221110 1112345788999999998899999999999999999998 999996542210 00000
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
..... ......++..+.+++.+||+.||++||++.||++.|+.+.+..
T Consensus 264 ~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 264 DEGYR--------------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HTTEE--------------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HcCCC--------------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 00000 0001134567899999999999999999999999999886543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=372.02 Aligned_cols=288 Identities=17% Similarity=0.146 Sum_probs=209.4
Q ss_pred hhccccccCccccc--CCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 703 ATSEFASSNMIGQG--SFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
..++|++.++||+| +||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 98 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD---- 98 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC----
Confidence 35789999999999 99999999999999999999997543 23456788899999999999999999998765
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 99 -~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 99 -NELWVVTSFMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp -TEEEEEEECCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred -CEEEEEEEccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence 678999999999999999987532 3689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC--CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|||.+............ .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 171 dfg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~- 248 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRV-VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE- 248 (389)
T ss_dssp CGGGCEECEETTEECSC-BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-
T ss_pred ccccceeeccccccccc-cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-
Confidence 99998755332211111 1112223478999999999987 5789999999999999999999999976433221111
Q ss_pred HHHhhcCchhhhhc---------------cchhhHHHH---hhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 043932 937 FAKIALPEKVIEIV---------------DPLLLIEVM---ANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM 998 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~---------------d~~l~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 998 (1017)
......+....... ......... ................+++.+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 11110000000000 000000000 000000000111233456779999999999999999999
Q ss_pred HHHHHH
Q 043932 999 RDVVAK 1004 (1017)
Q Consensus 999 ~evl~~ 1004 (1017)
.|+++|
T Consensus 329 ~ell~h 334 (389)
T 3gni_B 329 STLLNH 334 (389)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.48 Aligned_cols=267 Identities=24% Similarity=0.374 Sum_probs=205.4
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCC----
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDS---- 776 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 776 (1017)
+..++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++.+...
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 345789999999999999999999999999999999975443 345788999999999999999999998865422
Q ss_pred ------------------------------------------------CCCceeEEEEEeccCCCHHHHHhhCCCCcccc
Q 043932 777 ------------------------------------------------KGADFKALVFECMKNGSLEDWLHQSNDHLEVC 808 (1017)
Q Consensus 777 ------------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 808 (1017)
....+.++||||+++|+|.+++..... ..
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~ 159 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS---LE 159 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---GG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---cc
Confidence 112358999999999999999987643 23
Q ss_pred ccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccccccccccccc----cCCCccccc
Q 043932 809 KLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS----KTSSSSIGI 884 (1017)
Q Consensus 809 ~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~----~~~~~~~~~ 884 (1017)
..++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........... .........
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 457778899999999999999999 9999999999999999999999999999876543211110 001122335
Q ss_pred ccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcch
Q 043932 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSM 964 (1017)
Q Consensus 885 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 964 (1017)
.||+.|+|||++.+..++.++||||+||++|||++|..|+..... ....... .
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~---~~~~~~~---------~--------------- 289 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---IITDVRN---------L--------------- 289 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH---HHHHHHT---------T---------------
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH---HHHHhhc---------c---------------
Confidence 799999999999999999999999999999999998776432100 0000000 0
Q ss_pred hHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 965 IQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 965 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.........++.+.+++.+||+.||++|||+.|++++
T Consensus 290 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 290 ---KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp ---CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ---CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 0011223345667899999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=366.38 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=204.2
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 777 (1017)
...++|++.++||+|+||+||+|+++.+++.||+|+++... ....+.+..|..+++.+ +||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--- 90 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--- 90 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS---
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC---
Confidence 34578999999999999999999999999999999997542 33456778899999887 899999999998765
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
+..|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 91 --~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL 159 (345)
T 1xjd_A 91 --ENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI 159 (345)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred --CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEE
Confidence 67899999999999999998643 689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....
T Consensus 160 ~DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i 230 (345)
T 1xjd_A 160 ADFGMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-LFHSI 230 (345)
T ss_dssp CCCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH
T ss_pred eEChhhhhcccCC--------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH
Confidence 9999997543211 11234679999999999999899999999999999999999999997642211 01110
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR-DVVAK 1004 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 1004 (1017)
... .+ . ....+++++.+++.+||+.||++||++. |+++|
T Consensus 231 ~~~-~~-~--------------------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 231 RMD-NP-F--------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHC-CC-C--------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HhC-CC-C--------------------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 000 00 0 0011245688999999999999999997 66544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=360.25 Aligned_cols=278 Identities=19% Similarity=0.264 Sum_probs=205.1
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.++||+|+||+||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++... +..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence 579999999999999999999999999999999975432 3347788999999999999999999998765 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++ ++.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCC-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999976 6666665543 2689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCC-cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE-ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++...... .......||+.|+|||++.+.. ++.++||||+||++|||++|..||.................
T Consensus 148 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~ 219 (292)
T 3o0g_A 148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp CEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred ceecCCcc--------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 98654221 1122346899999999997765 79999999999999999999888644333222222222221
Q ss_pred cCchhhhhccchhhHHHHhh-cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMAN-NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.......+........+... ...............++.+.+++.+||+.||++|||++|+++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 11110000000000000000 0000000011112345678899999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=381.66 Aligned_cols=291 Identities=21% Similarity=0.266 Sum_probs=195.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.++||+|+||+||+|++..+++.||||++.... ....+++.+|++++++++||||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999999999999999986432 234577899999999999999999999987655455577
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecc-ccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence 89999998 469999997653 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccc-------------------cCCCcccccccCccccCcccc-cCCCcCccccchhHHHHHHHHHh--
Q 043932 862 LAKFLSSHQLDTAS-------------------KTSSSSIGIKGTVGYVAPEYC-MGSEASMTGDVYSFGILLLELFT-- 919 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt-- 919 (1017)
+|+........... .........+||+.|+|||++ .+..++.++||||+||++|||++
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 99876432211000 001123446789999999976 45679999999999999999999
Q ss_pred ---------CCCCCCcccccCc-------------------cHHHHHHhhc--CchhhhhccchhhHHHHhh-cchhHHH
Q 043932 920 ---------GRRPTDAAFTEGL-------------------TLHEFAKIAL--PEKVIEIVDPLLLIEVMAN-NSMIQED 968 (1017)
Q Consensus 920 ---------g~~pf~~~~~~~~-------------------~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~-~~~~~~~ 968 (1017)
|+++|.+...... .+..+..... +......+.......+... .......
T Consensus 282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (458)
T 3rp9_A 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD 361 (458)
T ss_dssp TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC
T ss_pred cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC
Confidence 5666654321000 0000000000 0000000110000000000 0000001
Q ss_pred hHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 969 IRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 969 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.......+++++.+++.+||+.||++|||++|+++|
T Consensus 362 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111223346778999999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=368.00 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=192.3
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++... +..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeE
Confidence 4568999999999999999999999999999999997543 236678999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC---CCCeEEee
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVSHVGD 859 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D 859 (1017)
++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence 99999999999999997653 689999999999999999999999 9999999999999975 88999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 195 fg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~ 265 (349)
T 2w4o_A 195 FGLSKIVEHQV---------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265 (349)
T ss_dssp CC-------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred CccccccCccc---------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh
Confidence 99998654221 112356899999999999989999999999999999999999999754322111111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... .. .....+++..+.+++.+||+.||++|||+.|++++
T Consensus 266 ~~~~-----~~-------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 266 CEYY-----FI-------------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TCCC-----CC-------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCc-----cC-------------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1000 00 00111235678899999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=369.81 Aligned_cols=296 Identities=23% Similarity=0.350 Sum_probs=207.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHH--HHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKA--LRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.+.||+|+||+||+|++ +++.||||++..... ..+..|.++ +..++||||+++++++......+...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 56899999999999999999987 588999999974432 334444444 45579999999998776554555567
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC------CCCceeecCCCCceEeCCCCCe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC------QPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
.++||||+++|+|.+++... ..++..++.++.||+.||+|||+.. .++|+||||||+||+++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 89999999999999999765 4588899999999999999999873 2389999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccC-------CCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-------SEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
||+|||+++.....................||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987654332221112222334579999999999977 456789999999999999999977764432
Q ss_pred ccCccHHHHHH-hhcCchhhhhccchhhHHHHhhcc-hhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 929 TEGLTLHEFAK-IALPEKVIEIVDPLLLIEVMANNS-MIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 929 ~~~~~~~~~~~-~~~~~~~~~~~d~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
........+.. ........+. . ........ ...+........+++++.+++.+||+.||++|||+.|+++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDM-Q----VLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHH-H----HHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHH-H----hhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 21110000000 0000000000 0 00000000 0000000112235678999999999999999999999999999
Q ss_pred hccccccccC
Q 043932 1007 HTRETFFGRR 1016 (1017)
Q Consensus 1007 ~~~~~~~~~~ 1016 (1017)
++.+.|..++
T Consensus 315 ~ll~~~~~~~ 324 (336)
T 3g2f_A 315 ELMMIWERNK 324 (336)
T ss_dssp HHHHCCCC--
T ss_pred HHHHHHHhcc
Confidence 9998886553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.14 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=197.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--------------------------chHHHHHHHHHHHH
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------------------------GAFKSFMAECKALR 757 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 757 (1017)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999999999999999874421 12356889999999
Q ss_pred hcCCCCceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 043932 758 NIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPM 837 (1017)
Q Consensus 758 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 837 (1017)
+++||||+++++++.... .+..++||||+++++|.++... ..+++.+++.++.||+.||+|||++ +|
T Consensus 92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i 158 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHYQ---KI 158 (298)
T ss_dssp TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 999999999999986532 3678999999999999876432 2689999999999999999999999 99
Q ss_pred eeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCC---cCccccchhHHHHH
Q 043932 838 VHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE---ASMTGDVYSFGILL 914 (1017)
Q Consensus 838 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il 914 (1017)
+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||+||++
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l 230 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred eccCCCHHHEEECCCCCEEEecCCCccccccccc--------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence 9999999999999999999999999986643221 112356999999999997754 47889999999999
Q ss_pred HHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC
Q 043932 915 LELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE 994 (1017)
Q Consensus 915 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 994 (1017)
|||++|+.||...... ........... ... ....+++.+.+++.+||+.||++
T Consensus 231 ~~l~~g~~pf~~~~~~--~~~~~~~~~~~----~~~---------------------~~~~~~~~l~~li~~~l~~dp~~ 283 (298)
T 2zv2_A 231 YCFVFGQCPFMDERIM--CLHSKIKSQAL----EFP---------------------DQPDIAEDLKDLITRMLDKNPES 283 (298)
T ss_dssp HHHHHSSCSSCCSSHH--HHHHHHHHCCC----CCC---------------------SSSCCCHHHHHHHHHHTCSCTTT
T ss_pred HHHHHCCCCCCCccHH--HHHHHHhcccC----CCC---------------------CccccCHHHHHHHHHHhhcChhh
Confidence 9999999999753211 00000000000 000 00123567899999999999999
Q ss_pred CCCHHHHHHH
Q 043932 995 RMEMRDVVAK 1004 (1017)
Q Consensus 995 RPs~~evl~~ 1004 (1017)
|||+.|+++|
T Consensus 284 R~s~~e~l~h 293 (298)
T 2zv2_A 284 RIVVPEIKLH 293 (298)
T ss_dssp SCCHHHHTTC
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=365.89 Aligned_cols=265 Identities=20% Similarity=0.348 Sum_probs=200.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++..... ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CC
Confidence 3568999999999999999999999999999999997543 2334678899999999999999999999865422 22
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...|+||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 159 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMD 159 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECC
T ss_pred cccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEee
Confidence 45699999999999999997653 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+++........ ........||+.|+|||++.+..++.++||||+||++|||++|+.||...............
T Consensus 160 fg~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 234 (311)
T 3ork_A 160 FGIARAIADSGNS-----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234 (311)
T ss_dssp CSCC-----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred ccCcccccccccc-----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence 9999866432211 11122356899999999999999999999999999999999999999764322111000000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH-HHhh
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA-KLCH 1007 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~-~L~~ 1007 (1017)
...+ .......+++++.+++.+||+.||++||++.++++ .+..
T Consensus 235 ~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 235 DPIP-------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CCCC-------------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCC-------------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 0000 00111224667899999999999999997666554 4433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=366.08 Aligned_cols=256 Identities=21% Similarity=0.274 Sum_probs=196.4
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.++++++||||+++++++... +..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEE
Confidence 35689999999999999999999999999999999975433 236788999999999999999999998765 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC--eEEeec
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV--SHVGDF 860 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Df 860 (1017)
++||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++. +||+||
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Df 162 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDF 162 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred EEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeec
Confidence 99999999999999997643 689999999999999999999999 9999999999999987765 999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCcc-ccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMT-GDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+++...... ......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...............
T Consensus 163 g~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 233 (361)
T 3uc3_A 163 GYSKSSVLHS---------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR 233 (361)
T ss_dssp CCC------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH
T ss_pred CccccccccC---------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 9987432211 1123569999999999988777655 89999999999999999999765332221111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
. ..... ... ....+++.+.+++.+||+.||++|||+.|+++|-
T Consensus 234 ~-~~~~~-----------------~~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 234 I-LSVKY-----------------SIP-----DDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp H-HTTCC-----------------CCC-----TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred H-hcCCC-----------------CCC-----CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 1 00000 000 0001245688999999999999999999999873
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=368.01 Aligned_cols=276 Identities=23% Similarity=0.380 Sum_probs=199.6
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcE---EEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecC
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEM---IVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSI 774 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 774 (1017)
+....++|++.+.||+|+||+||+|++..++. .||||++... .....+.+.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 33446789999999999999999999887665 7999999754 344567899999999999999999999998665
Q ss_pred CCCC-CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 775 DSKG-ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 775 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
...+ ....++||||+++|+|.+++...........+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 3221 123489999999999999997643322333689999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGL 932 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 932 (1017)
.+||+|||+++........ .......+|+.|+|||++.+..++.++||||+||++|||++ |+.||.......
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~- 247 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYY------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE- 247 (323)
T ss_dssp CEEECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-
T ss_pred CEEEeeccccccccccccc------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-
Confidence 9999999999866433211 11122457889999999999899999999999999999999 999997643221
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
........... .....+++.+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 248 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 248 IYNYLIGGNRL---------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhcCCCC---------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111100000 001123567899999999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=370.50 Aligned_cols=275 Identities=24% Similarity=0.381 Sum_probs=214.4
Q ss_pred HHHHhhccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeee
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICS 772 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 772 (1017)
++....++|++.+.||+|+||.||+|++. .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34445679999999999999999999986 3568999999975433 34567899999999999999999999986
Q ss_pred cCCCCCCceeEEEEEeccCCCHHHHHhhCCCCc------------------cccccCHHHHHHHHHHHHHHHHHHhhCCC
Q 043932 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHL------------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQ 834 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 834 (1017)
.. +..++||||+++|+|.+++....... ....+++.+++.++.||++||+|||++
T Consensus 121 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-- 193 (343)
T 1luf_A 121 VG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 193 (343)
T ss_dssp SS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cC-----CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 54 56899999999999999998753210 114789999999999999999999999
Q ss_pred CCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHH
Q 043932 835 PPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILL 914 (1017)
Q Consensus 835 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 914 (1017)
+|+||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++
T Consensus 194 -~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 266 (343)
T 1luf_A 194 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266 (343)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred -CeecCCCCcceEEECCCCeEEEeecCCCcccccCccc------cccCCCcccceecChhhhccCCcCcccccHHHHHHH
Confidence 9999999999999999999999999999866432211 111234688999999999888899999999999999
Q ss_pred HHHHh-CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCC
Q 043932 915 LELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPF 993 (1017)
Q Consensus 915 ~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 993 (1017)
|||++ |..||...... +.......... ......+++.+.+++.+||+.||+
T Consensus 267 ~el~t~g~~p~~~~~~~-----~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~ 318 (343)
T 1luf_A 267 WEIFSYGLQPYYGMAHE-----EVIYYVRDGNI-----------------------LACPENCPLELYNLMRLCWSKLPA 318 (343)
T ss_dssp HHHHTTTCCTTTTSCHH-----HHHHHHHTTCC-----------------------CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHhcCCCcCCCCChH-----HHHHHHhCCCc-----------------------CCCCCCCCHHHHHHHHHHcccCcc
Confidence 99999 99999754221 11110000000 001112356789999999999999
Q ss_pred CCCCHHHHHHHHhhcccccccc
Q 043932 994 ERMEMRDVVAKLCHTRETFFGR 1015 (1017)
Q Consensus 994 ~RPs~~evl~~L~~~~~~~~~~ 1015 (1017)
+||++.|++++|+++.+++.++
T Consensus 319 ~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 319 DRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp GSCCHHHHHHHHHHTTC-----
T ss_pred cCCCHHHHHHHHHHHHhhhhhh
Confidence 9999999999999999887653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=380.44 Aligned_cols=265 Identities=19% Similarity=0.210 Sum_probs=209.4
Q ss_pred HHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeec
Q 043932 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 697 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
+.++....++|++.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|..+++.++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445556789999999999999999999999999999999997432 2223458899999999999999999999876
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
. +..|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +||||||||+|||++.++
T Consensus 146 ~-----~~~~lV~Ey~~gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 146 D-----NNLYLVMDYYVGGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNG 212 (437)
T ss_dssp S-----SEEEEEECCCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred C-----CEEEEEEecCCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCC
Confidence 5 67899999999999999998743 2689999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
.+||+|||+|+........ ......||+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus 213 ~vkL~DFGla~~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDGTV-------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp CEEECCCTTCEECCTTSCE-------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CEEEcchhhhhhcccCCCc-------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999765432211 112357999999999986 4578999999999999999999999997642
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE--RMEMRDVVAKL 1005 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 1005 (1017)
..+ ......... ....- +.....+++++.+++.+|++.+|++ ||+++|+++|-
T Consensus 286 ~~~-~~~~i~~~~-----~~~~~------------------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 286 LVE-TYGKIMNHK-----ERFQF------------------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHH-HHHHHHTHH-----HHCCC------------------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred hhH-HHHhhhhcc-----ccccC------------------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 211 111110000 00000 0000123567889999999999988 99999998863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=364.20 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=203.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|..+++++ +||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~----- 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE----- 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-----
Confidence 357999999999999999999999999999999997543 23446688999999988 899999999998664
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEe
Confidence 67899999999999999997653 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCc----cHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL----TLH 935 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~----~~~ 935 (1017)
||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 154 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 225 (345)
T 3a8x_A 154 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 225 (345)
T ss_dssp GGGCBCSCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHH
T ss_pred ccccccccCCC--------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHH
Confidence 99997532211 112335799999999999999999999999999999999999999965321110 000
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM------RDVVAK 1004 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 1004 (1017)
...... ..... ......+.++.+++.+||+.||.+||++ .|+++|
T Consensus 226 ~~~~~i-----------------~~~~~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 226 YLFQVI-----------------LEKQI-------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHH-----------------HHCCC-------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHHH-----------------HcCCC-------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 000000 00000 0011235678899999999999999996 677655
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=356.90 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=208.6
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
+....++|++.+.||+|+||+||+|++. ++..||+|++..... ..+++.+|++++++++||||+++++++...
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 91 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ----- 91 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecC-----
Confidence 3345678999999999999999999987 677899999975433 347789999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~D 163 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 163 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECS
T ss_pred CCeEEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcc
Confidence 66899999999999999997643 2689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||+++........ ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....... ......
T Consensus 164 fg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~ 235 (283)
T 3gen_A 164 FGLSRYVLDDEYT-------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHIA 235 (283)
T ss_dssp TTGGGGBCCHHHH-------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHH
T ss_pred ccccccccccccc-------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-HHHHHh
Confidence 9999866433211 1122457889999999998889999999999999999998 999997642211 011100
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
. .... . ....+++.+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus 236 ~-~~~~-----~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 236 Q-GLRL-----Y---------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp T-TCCC-----C---------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c-ccCC-----C---------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0 0000 0 0011245688999999999999999999999999988653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=373.22 Aligned_cols=262 Identities=18% Similarity=0.255 Sum_probs=209.0
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecC
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSI 774 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 774 (1017)
.++....++|++.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 345556789999999999999999999999999999999997422 22335678999999999999999999998764
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 854 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 854 (1017)
+..|+||||+++|+|.++++.. .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 142 -----~~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 142 -----RYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp -----SEEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred -----CEEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence 6789999999999999999754 578999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccCCC----cCccccchhHHHHHHHHHhCCCCCCccccc
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE----ASMTGDVYSFGILLLELFTGRRPTDAAFTE 930 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~ 930 (1017)
+||+|||+|+........ ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||......
T Consensus 207 ikL~DFG~a~~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 279 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279 (410)
T ss_dssp EEECCCTTCEECCTTSEE-------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred EEEeccceeEeeccCCcc-------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh
Confidence 999999999866432211 112357999999999997655 789999999999999999999999764221
Q ss_pred CccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHh
Q 043932 931 GLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE--RMEMRDVVAKLC 1006 (1017)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~ 1006 (1017)
. .......... ...- +....+++++.+++.+||+.+|.+ ||++.||++|-.
T Consensus 280 ~-~~~~i~~~~~-----~~~~-------------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 280 G-TYSKIMNHKN-----SLTF-------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp H-HHHHHHTHHH-----HCCC-------------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred h-HHHHHHhccc-----cccC-------------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 1 1111110000 0000 000123567889999999999998 999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=352.26 Aligned_cols=253 Identities=22% Similarity=0.254 Sum_probs=207.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||.||+|++..++..||+|++........+.+.+|++++++++||||+++++++... +..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----TDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CeE
Confidence 356899999999999999999999999999999999876666678899999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe---CCCCCeEEee
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGD 859 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~D 859 (1017)
++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D 152 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID 152 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence 99999999999999987653 689999999999999999999999 99999999999999 7889999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++....... ......||+.|+|||++.+ .++.++||||+|+++|||++|+.||....... .......
T Consensus 153 fg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~ 221 (277)
T 3f3z_A 153 FGLAARFKPGK---------MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIRE 221 (277)
T ss_dssp CTTCEECCTTS---------CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred cccceeccCcc---------chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh
Confidence 99998654322 1123468999999999876 48999999999999999999999997642211 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...... ......+++.+.+++.+|++.||++|||+.|++++
T Consensus 222 ~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 222 GTFTFP------------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCCCCC------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCCC------------------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00111345678999999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=368.82 Aligned_cols=250 Identities=21% Similarity=0.270 Sum_probs=199.3
Q ss_pred cccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEEE
Q 043932 708 ASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 708 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
...++||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++... +..++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEe
Confidence 3367899999999999999999999999999876655667899999999999999999999998764 67899999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe--CCCCCeEEeecccccc
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL--DHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfG~a~~ 865 (1017)
|+++|+|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 167 ~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 167 YVDGGELFDRIIDES-----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp CCTTCEEHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred CCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 999999999987643 3689999999999999999999999 99999999999999 6678999999999987
Q ss_pred cccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCch
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 239 ~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~ 308 (373)
T 2x4f_A 239 YKPRE---------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDLE 308 (373)
T ss_dssp CCTTC---------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCSC
T ss_pred cCCcc---------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCC
Confidence 64322 112246999999999999889999999999999999999999999764221 11111111111000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......+++++.+++.+||+.||.+|||+.|++++
T Consensus 309 ------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 309 ------------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp ------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00112235678999999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=363.79 Aligned_cols=259 Identities=24% Similarity=0.409 Sum_probs=202.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEE----EEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMI----VAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.++|++.++||+|+||+||+|++..+++. ||+|.+.... ....+++.+|+.++++++||||++++++|...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence 46899999999999999999999877765 4777765332 34457899999999999999999999998653
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
..++|+||+++|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 90 --~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~ 159 (327)
T 3poz_A 90 --TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp --SEEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred --CeEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEc
Confidence 36899999999999999987543 689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....
T Consensus 160 Dfg~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~ 231 (327)
T 3poz_A 160 DFGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI 231 (327)
T ss_dssp CTTHHHHHTTTCC-------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH
T ss_pred cCcceeEccCCccc------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHH
Confidence 99999876533211 11122457889999999999999999999999999999999 999997643221 1111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
....... .....++..+.+++.+||+.||++||++.|++++|+.+.+
T Consensus 232 ~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 232 LEKGERL--------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCC--------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCC--------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111000 0011235568899999999999999999999999988764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=359.55 Aligned_cols=257 Identities=21% Similarity=0.343 Sum_probs=205.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCc-------EEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDE-------MIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
.++|++.+.||+|+||+||+|++..++ ..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-- 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence 468999999999999999999987665 57999999766666678899999999999999999999998654
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC--
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV-- 854 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-- 854 (1017)
+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 85 ---~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 85 ---DENILVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp ---TCCEEEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred ---CCCEEEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence 56789999999999999998754 2589999999999999999999999 9999999999999998887
Q ss_pred ------eEEeecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 855 ------SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 855 ------~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
+||+|||.+...... ....||+.|+|||++.+ ..++.++||||+||++|||++|..|+...
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLPK------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSCH------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccceeeeccCcccccccCc------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 999999998754321 12357899999999987 67899999999999999999965554332
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
....... ..... ... .....++++.+++.+||+.||++|||+.|++++|+.
T Consensus 222 ~~~~~~~-~~~~~--~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 222 LDSQRKL-QFYED--RHQ--------------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp SCHHHHH-HHHHT--TCC--------------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred cchHHHH-HHhhc--cCC--------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2111100 00000 000 000113457899999999999999999999999999
Q ss_pred ccccccc
Q 043932 1008 TRETFFG 1014 (1017)
Q Consensus 1008 ~~~~~~~ 1014 (1017)
+.....+
T Consensus 273 l~~p~~~ 279 (289)
T 4fvq_A 273 LFTPDLV 279 (289)
T ss_dssp CC-----
T ss_pred hcCCCCC
Confidence 8765443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=362.09 Aligned_cols=278 Identities=24% Similarity=0.415 Sum_probs=207.9
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCC---CcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeee
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICS 772 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 772 (1017)
.++....++|.+.+.||+|+||.||+|++.. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444556789999999999999999998754 56789999987543 334567899999999999999999999987
Q ss_pred cCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC
Q 043932 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 852 (1017)
.....+....++||||+++|+|.+++...........+++.+++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 765444456799999999999999996543322335799999999999999999999999 99999999999999999
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccC
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEG 931 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 931 (1017)
+.+||+|||++......... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYY------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp SCEEECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CcEEEeecCcceeccccccc------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 99999999999866432211 11122457889999999999899999999999999999999 889987643221
Q ss_pred ccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 932 LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
........... .....+++.+.+++.+||+.||++|||+.|++++|+.+.++
T Consensus 258 --~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 258 --MYDYLLHGHRL--------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp --HHHHHHTTCCC--------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCC--------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111100000 00112356789999999999999999999999999998876
Q ss_pred c
Q 043932 1012 F 1012 (1017)
Q Consensus 1012 ~ 1012 (1017)
.
T Consensus 310 l 310 (313)
T 3brb_A 310 L 310 (313)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=370.61 Aligned_cols=358 Identities=19% Similarity=0.231 Sum_probs=227.1
Q ss_pred CCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCC
Q 043932 111 NSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP 190 (1017)
Q Consensus 111 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 190 (1017)
....+..+..++++++|++|+|++|.+++ +| .++.+++|++|+|++|++++. | ++.+++|++|++++|++++. |
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~ 101 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D 101 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C
T ss_pred cCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e
Confidence 34444555667777777777777777774 34 567777777777777777653 3 66666777777777776653 2
Q ss_pred ccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCC
Q 043932 191 DFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLP 270 (1017)
Q Consensus 191 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~ 270 (1017)
++++++|++|++++|++++. + ++.+++|++|++++|++++. + ++.+++|++|++++|+..
T Consensus 102 --~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~------------ 161 (457)
T 3bz5_A 102 --VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKI------------ 161 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCC------------
T ss_pred --cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcc------------
Confidence 56666666666666666542 2 55555566666666555542 1 444555555555555333
Q ss_pred ccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcc
Q 043932 271 NLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSL 350 (1017)
Q Consensus 271 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L 350 (1017)
+.+ .+..+++|+.|++++|++++.. +..+++|+.|++++|+++... +..+++|
T Consensus 162 -------------~~~--~~~~l~~L~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~~~~---------l~~l~~L 214 (457)
T 3bz5_A 162 -------------TKL--DVTPQTQLTTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKLD---------LNQNIQL 214 (457)
T ss_dssp -------------CCC--CCTTCTTCCEEECCSSCCCCCC---CTTCTTCCEEECCSSCCSCCC---------CTTCTTC
T ss_pred -------------ccc--ccccCCcCCEEECCCCccceec---cccCCCCCEEECcCCcCCeec---------cccCCCC
Confidence 233 2445555666666666555431 445555555555555554321 2334455
Q ss_pred cEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccc
Q 043932 351 KILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYK 430 (1017)
Q Consensus 351 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 430 (1017)
++|++++|+++ + +| +..+++|+.|++++|++++.. ++.+++|+.|+++.
T Consensus 215 ~~L~Ls~N~l~-------------------------~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~ 263 (457)
T 3bz5_A 215 TFLDCSSNKLT-------------------------E-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQ 263 (457)
T ss_dssp SEEECCSSCCS-------------------------C-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTT
T ss_pred CEEECcCCccc-------------------------c-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccC
Confidence 55555555444 2 12 456677788888888777653 34566677777665
Q ss_pred cccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCc
Q 043932 431 NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSL 510 (1017)
Q Consensus 431 N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~ 510 (1017)
| +|+.|++++|++.+.+| ++.+++|+.|++++|+.. +.+
T Consensus 264 n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l-------------------------~~l 302 (457)
T 3bz5_A 264 T--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQL-------------------------YLL 302 (457)
T ss_dssp C--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTC-------------------------CEE
T ss_pred C--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCccc-------------------------cee
Confidence 4 35566777777766665 456677777777776655 344
Q ss_pred cccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccC
Q 043932 511 PLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLS 590 (1017)
Q Consensus 511 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 590 (1017)
|. ...+|+.|++++| ++|+.|+|++|+|++. + ++.+++|+.|++++|++++ ++
T Consensus 303 ~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~ 355 (457)
T 3bz5_A 303 DC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FS 355 (457)
T ss_dssp EC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CT
T ss_pred cc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------cc
Confidence 42 2345666666665 6899999999999985 3 9999999999999999996 24
Q ss_pred CCcEEEcccCCCcCcCCCCCCCCCCCcccccCcc
Q 043932 591 FLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNV 624 (1017)
Q Consensus 591 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~ 624 (1017)
.|..|++++|.++|. +.+..++.+.+..|.
T Consensus 356 ~L~~L~l~~n~l~g~----~~~~~l~~l~l~~N~ 385 (457)
T 3bz5_A 356 SVGKIPALNNNFEAE----GQTITMPKETLTNNS 385 (457)
T ss_dssp TGGGSSGGGTSEEEE----EEEEECCCBCCBTTB
T ss_pred ccccccccCCcEEec----ceeeecCccccccCc
Confidence 677788999999997 245567778888774
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=374.92 Aligned_cols=291 Identities=21% Similarity=0.229 Sum_probs=206.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.++||+|+||.||+|++..+++.||||++.... ....+++.+|++++++++||||+++++++..........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 568999999999999999999999999999999997432 234578899999999999999999999987654444467
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||++ |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence 899999986 59999997653 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccc--------------cCCCcccccccCccccCcccc-cCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 043932 862 LAKFLSSHQLDTAS--------------KTSSSSIGIKGTVGYVAPEYC-MGSEASMTGDVYSFGILLLELFTGRRPTDA 926 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~~ 926 (1017)
+|+........... .........+||+.|+|||++ .+..++.++||||+||++|||++|..||..
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 99876533211000 000123456899999999986 556799999999999999999986555543
Q ss_pred ccccC---------------------------ccHHHHHHhhcCc--h-hhhhccchhhHHHHhhcchhHHHhHHhHHHH
Q 043932 927 AFTEG---------------------------LTLHEFAKIALPE--K-VIEIVDPLLLIEVMANNSMIQEDIRAKTQEC 976 (1017)
Q Consensus 927 ~~~~~---------------------------~~~~~~~~~~~~~--~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~ 976 (1017)
..... ..+.........+ . +..+..+.......................+
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 21110 0001111111100 0 1111111111000000000001111122345
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 977 LNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 977 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
++++.+++.+||+.||++|||+.|+++|
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 6788999999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=372.11 Aligned_cols=288 Identities=21% Similarity=0.326 Sum_probs=200.6
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 778 (1017)
...++|++.+.||+|+||.||+|.+..+++.||||++... .....+++.+|+.+++++. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--- 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN--- 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---
Confidence 3457899999999999999999999999999999998533 2344567889999999997 999999999986532
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
....|+||||++ ++|.++++.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred CCEEEEEecccC-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence 256899999997 5999999763 688999999999999999999999 99999999999999999999999
Q ss_pred eccccccccccccccc-------------ccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCC
Q 043932 859 DFGLAKFLSSHQLDTA-------------SKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPT 924 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~-------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf 924 (1017)
|||+|+.+........ ...........||+.|+|||++.+ ..++.++||||+||++|||++|++||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 9999986643111000 001122334689999999999977 57899999999999999999999999
Q ss_pred CcccccCccHHHHHHhh-cCch-hhhhccchhhHHHHhh----c-------chhHHHhHH------hHHHHHHHHHHHHh
Q 043932 925 DAAFTEGLTLHEFAKIA-LPEK-VIEIVDPLLLIEVMAN----N-------SMIQEDIRA------KTQECLNAIIRIGV 985 (1017)
Q Consensus 925 ~~~~~~~~~~~~~~~~~-~~~~-~~~~~d~~l~~~~~~~----~-------~~~~~~~~~------~~~~~~~~l~~li~ 985 (1017)
.+..... .+....... .|.. ....+.......+... . ....+.... ....+++++.+++.
T Consensus 232 ~~~~~~~-~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 232 PGSSTMN-QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp CCSSHHH-HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred CCCCHHH-HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 8653221 122221111 1111 0000000000000000 0 000000000 00134667899999
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 043932 986 LCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 986 ~cl~~dP~~RPs~~evl~~ 1004 (1017)
+||+.||++|||+.|+++|
T Consensus 311 ~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HhhccCcccCCCHHHHhCC
Confidence 9999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=358.24 Aligned_cols=276 Identities=22% Similarity=0.299 Sum_probs=201.1
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.+.||+|+||+||+|++ .+++.||+|++..... ...+.+.+|++++++++||||+++++++... +..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence 5799999999999999999999 5788999999864432 2346788999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++ +|.+++..... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEEecCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 999999976 99999876542 688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .........
T Consensus 147 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~ 217 (288)
T 1ob3_A 147 ARAFGIPV--------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRIL 217 (288)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ccccCccc--------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHH
Confidence 98654221 111224689999999998764 58999999999999999999999997643221 111111111
Q ss_pred cCchhhhhccchhhHHHHhhcch-hHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSM-IQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.......+........+...... ............++++.+++.+||+.||++|||+.|+++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11000000000000000000000 0000001112345678899999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=356.66 Aligned_cols=263 Identities=29% Similarity=0.446 Sum_probs=198.7
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
...++|++.++||+|+||+||+|++.. .||+|++..... ...+.+.+|++++++++||||+++++++..
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------ 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------
Confidence 345789999999999999999999753 499999875433 345778999999999999999999997532
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D 163 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGD 163 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred CccEEEEEecCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcc
Confidence 45789999999999999997654 3689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
||++........ ........||+.|+|||++. +..++.++||||+|+++|||++|+.||............
T Consensus 164 fg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 237 (289)
T 3og7_A 164 FGLATEKSRWSG------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237 (289)
T ss_dssp CC------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH
T ss_pred ceeccccccccc------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 999976542211 11122356899999999986 567888999999999999999999999764322111111
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
.......... ......+++.+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 238 ~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 238 VGRGSLSPDL-----------------------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHTSCCCCT-----------------------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hcccccCcch-----------------------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111111110 01112346778999999999999999999999999998865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=362.67 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=204.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.++||+|+||+||+|++..+++.||+|++... .....+.+.+|..+++.+ +||+|+++++++...
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~----- 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----- 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-----
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-----
Confidence 46899999999999999999999999999999999754 234456788999999988 799999999998664
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEe
Confidence 67899999999999999998653 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......
T Consensus 165 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~ 235 (353)
T 2i0e_A 165 FGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIME 235 (353)
T ss_dssp CTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred CCcccccccCC--------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HHHHHHh
Confidence 99997532211 11233679999999999999999999999999999999999999997642210 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1004 (1017)
... . .....++++.+++.+||+.||.+||+ +.|+++|
T Consensus 236 ~~~---------------------~-------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 236 HNV---------------------A-------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCC---------------------C-------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCC---------------------C-------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 000 0 00123567889999999999999995 5777765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=361.95 Aligned_cols=248 Identities=20% Similarity=0.253 Sum_probs=206.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++... +
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----S 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----C
Confidence 468999999999999999999999999999999997432 23456788999999999999999999998754 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence 7899999999999999998653 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .........
T Consensus 186 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~ 253 (350)
T 1rdq_E 186 GFAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSG 253 (350)
T ss_dssp TTCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC
T ss_pred ccceeccCC-----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHcC
Confidence 999865321 12357999999999999989999999999999999999999999754221 001111110
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAKL 1005 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 1005 (1017)
... ....+++.+.+++.+||+.||.+||+ +.|+++|-
T Consensus 254 ~~~----------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 254 KVR----------------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp CCC----------------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCC----------------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 000 00123567889999999999999998 88888764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=364.62 Aligned_cols=289 Identities=20% Similarity=0.235 Sum_probs=214.6
Q ss_pred HHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
+.....++|++.++||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 21 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred EeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 333445789999999999999999999999999999999975433 3347788999999999999999999998766545
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
.....++||||+++ +|.+++... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 101 ~~~~~~iv~e~~~~-~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 101 QMKDVYIVQDLMET-DLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp TCCCEEEEEECCSE-EHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred ccceEEEEEcccCc-CHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEE
Confidence 55678999999975 999998754 589999999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
+|||++......... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ....
T Consensus 170 ~Dfg~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~ 243 (364)
T 3qyz_A 170 CDFGLARVADPDHDH-----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNH 243 (364)
T ss_dssp CCCTTCEECCGGGCB-----CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHH
T ss_pred EeCcceEecCCCCCc-----cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHH
Confidence 999999876533211 111233579999999998755 458999999999999999999999997653332 2222
Q ss_pred HHHhhcCch---hhhhccchhhHHHHhh-cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 937 FAKIALPEK---VIEIVDPLLLIEVMAN-NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 937 ~~~~~~~~~---~~~~~d~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
......... +....+.. ...+... ..............+++++.+++.+||+.||++|||+.|+++|-
T Consensus 244 i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 244 ILGILGSPSQEDLNCIINLK-ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHHHHCSCCHHHHHTCCCHH-HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHHhCCCCHHHHHHhhhhh-HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 222111111 11111100 0000000 00000000111223456789999999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=358.87 Aligned_cols=268 Identities=24% Similarity=0.370 Sum_probs=213.4
Q ss_pred HhhccccccCcccccCCceEEEEEe-----CCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSID 775 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 775 (1017)
...++|.+.+.||+|+||.||+|++ ..+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 98 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD- 98 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC-
Confidence 3467899999999999999999998 3456899999997543 33457789999999999999999999998654
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCC------------------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDH------------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPM 837 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 837 (1017)
+..++||||+++|+|.+++...... .....+++.+++.++.||+.||+|||++ +|
T Consensus 99 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i 171 (314)
T 2ivs_A 99 ----GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KL 171 (314)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred ----CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CC
Confidence 5689999999999999999875421 0123589999999999999999999999 99
Q ss_pred eeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHH
Q 043932 838 VHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLEL 917 (1017)
Q Consensus 838 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 917 (1017)
+||||||+||+++.++.+||+|||++.......... ......+|+.|+|||++.+..++.++||||+||++|||
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 245 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE------CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccce------eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHH
Confidence 999999999999999999999999998664332111 11224578899999999988899999999999999999
Q ss_pred Hh-CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC
Q 043932 918 FT-GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM 996 (1017)
Q Consensus 918 lt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 996 (1017)
++ |+.||....... ........... .....+++.+.+++.+||+.||++||
T Consensus 246 ~t~g~~p~~~~~~~~--~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp 297 (314)
T 2ivs_A 246 VTLGGNPYPGIPPER--LFNLLKTGHRM--------------------------ERPDNCSEEMYRLMLQCWKQEPDKRP 297 (314)
T ss_dssp HTTSCCSSTTCCGGG--HHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhCCCCCCCCCCHHH--HHHHhhcCCcC--------------------------CCCccCCHHHHHHHHHHccCChhhCc
Confidence 99 999997643221 11111110000 00112356789999999999999999
Q ss_pred CHHHHHHHHhhcccc
Q 043932 997 EMRDVVAKLCHTRET 1011 (1017)
Q Consensus 997 s~~evl~~L~~~~~~ 1011 (1017)
++.|++++|+++.++
T Consensus 298 s~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 298 VFADISKDLEKMMVK 312 (314)
T ss_dssp CHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHhh
Confidence 999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=373.56 Aligned_cols=285 Identities=20% Similarity=0.248 Sum_probs=216.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.++||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.... ....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence 468999999999999999999999999999999997443 234577889999999999999999999986542 2467
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe----CCCCCeEEe
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVSHVG 858 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~ 858 (1017)
++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EEEEecCCCCCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEe
Confidence 999999999999999976531 12489999999999999999999999 99999999999999 778889999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC--------CCcCccccchhHHHHHHHHHhCCCCCCccccc
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--------SEASMTGDVYSFGILLLELFTGRRPTDAAFTE 930 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 930 (1017)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 159 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 159 DFGAARELEDDE---------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp CGGGCEECCCGG---------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred cCCCceEccCCC---------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 999998664322 1122569999999999865 46788999999999999999999999754333
Q ss_pred CccHHHHHHhh--cCchhhhhccchhhHHHHhhcchhH---HHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 931 GLTLHEFAKIA--LPEKVIEIVDPLLLIEVMANNSMIQ---EDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 931 ~~~~~~~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
......+.... .+......+.... .....+. +.........+..+.+++.+||+.||++||++.|+++.+
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAE-----NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECST-----TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cchHHHHHHHhcCCCcccchhheecc-----CCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 22222222211 1111000000000 0000000 000112345677899999999999999999999999999
Q ss_pred hhcccc
Q 043932 1006 CHTRET 1011 (1017)
Q Consensus 1006 ~~~~~~ 1011 (1017)
+++.++
T Consensus 305 ~~il~~ 310 (396)
T 4eut_A 305 SDILHR 310 (396)
T ss_dssp HHHHTC
T ss_pred HHHhhc
Confidence 887654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=357.78 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=207.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc------hHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG------AFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 87 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-- 87 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 356899999999999999999999999999999999754321 357789999999999999999999998654
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC---
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM--- 853 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 853 (1017)
+..++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 88 ---~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~ 155 (321)
T 2a2a_A 88 ---TDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPI 155 (321)
T ss_dssp ---SEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSS
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCc
Confidence 67899999999999999997653 689999999999999999999999 999999999999999888
Q ss_pred -CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCc
Q 043932 854 -VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932 (1017)
Q Consensus 854 -~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 932 (1017)
.+||+|||++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.......
T Consensus 156 ~~~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 225 (321)
T 2a2a_A 156 PHIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE- 225 (321)
T ss_dssp CCEEECCCTTCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-
T ss_pred CCEEEccCccceecCccc---------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-
Confidence 79999999998654321 1123468999999999999899999999999999999999999997642211
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
........... .+ .......++.+.+++.+||+.||++|||+.|++++-
T Consensus 226 ~~~~i~~~~~~------~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 226 TLANITSVSYD------FD------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp HHHHHHTTCCC------CC------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHhcccc------cC------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 01110000000 00 011123356789999999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=361.79 Aligned_cols=280 Identities=23% Similarity=0.313 Sum_probs=213.9
Q ss_pred hccccccCcccccCCceEEEEE----eCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGI----LGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.+.||+|+||.||+|+ ...+++.||||++........+.+.+|++++++++||||+++++++... +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CC
Confidence 3689999999999999999999 4668999999999876666667899999999999999999999988643 23
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcc
Confidence 67899999999999999998643 2689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++........... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ...
T Consensus 171 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~ 240 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYV-----VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-----LRM 240 (327)
T ss_dssp GGGCEECCTTCSEEE-----CSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHH
T ss_pred cccceecccCCccce-----eeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-----hhh
Confidence 999987643321111 1122468889999999998889999999999999999999999986532210 000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
.......... ... ........ .......+++.+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 241 ~~~~~~~~~~--~~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 241 MGCERDVPAL--SRL-LELLEEGQ-----RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp CC----CCHH--HHH-HHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred cccccccccH--HHH-HHHhhccc-----CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0000000000 000 00000000 00112244678999999999999999999999999999987644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=356.89 Aligned_cols=262 Identities=21% Similarity=0.364 Sum_probs=200.6
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
....++|++.+.||+|+||.||+|++..+ +..||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---
Confidence 33457899999999999999999998643 5679999986433 3345678999999999999999999998732
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
+..++||||+++++|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 88 ---~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 156 (281)
T 1mp8_A 88 ---NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK 156 (281)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred ---CccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEE
Confidence 457899999999999999986542 689999999999999999999999 999999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~ 935 (1017)
|+|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|||++ |..||......+ ...
T Consensus 157 l~Dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-~~~ 228 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYY-------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIG 228 (281)
T ss_dssp ECC--------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHH
T ss_pred ECccccccccCccccc-------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-HHH
Confidence 9999999876432211 1112356889999999988889999999999999999997 999997643221 111
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
........ .....+++.+.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 229 ~i~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 229 RIENGERL---------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCC---------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11100000 01112356789999999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=363.60 Aligned_cols=274 Identities=23% Similarity=0.343 Sum_probs=211.0
Q ss_pred HHHhhccccccCcccccCCceEEEEEe-----CCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeeeee
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITICS 772 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 772 (1017)
+....++|++.+.||+|+||.||+|++ ..+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 344567899999999999999999997 3467889999997442 33457889999999999 8999999999986
Q ss_pred cCCCCCCceeEEEEEeccCCCHHHHHhhCCCCc-----------------cccccCHHHHHHHHHHHHHHHHHHhhCCCC
Q 043932 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHL-----------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQP 835 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~ 835 (1017)
.. +..++||||+++|+|.+++....... ....+++.+++.++.||+.||+|||++
T Consensus 120 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 191 (344)
T 1rjb_A 120 LS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--- 191 (344)
T ss_dssp SS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred eC-----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 54 56899999999999999998754211 113479999999999999999999999
Q ss_pred CceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHH
Q 043932 836 PMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLL 915 (1017)
Q Consensus 836 ~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ 915 (1017)
+|+||||||+||+++.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 265 (344)
T 1rjb_A 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265 (344)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccc------eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHH
Confidence 9999999999999999999999999999866432211 1112345788999999998888999999999999999
Q ss_pred HHHh-CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC
Q 043932 916 ELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE 994 (1017)
Q Consensus 916 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 994 (1017)
||++ |..||....... ............. ....+++++.+++.+||+.||.+
T Consensus 266 el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~ 318 (344)
T 1rjb_A 266 EIFSLGVNPYPGIPVDA-NFYKLIQNGFKMD--------------------------QPFYATEEIYIIMQSCWAFDSRK 318 (344)
T ss_dssp HHTTTSCCSSTTCCCSH-HHHHHHHTTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHcCCCCCcccCCcHH-HHHHHHhcCCCCC--------------------------CCCCCCHHHHHHHHHHcCCCchh
Confidence 9998 999997643221 1111111110000 01123567899999999999999
Q ss_pred CCCHHHHHHHHhhccccccc
Q 043932 995 RMEMRDVVAKLCHTRETFFG 1014 (1017)
Q Consensus 995 RPs~~evl~~L~~~~~~~~~ 1014 (1017)
|||+.|++++|+.+.+...+
T Consensus 319 Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 319 RPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp SCCHHHHHHHHHHHC-----
T ss_pred CcCHHHHHHHHHHHHHHHHH
Confidence 99999999999998876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=355.83 Aligned_cols=277 Identities=22% Similarity=0.282 Sum_probs=203.1
Q ss_pred hcccccc-CcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++. ++||+|+||+||+|++..+++.||||++........+.+.+|+++++++ +||||+++++++... +.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CE
Confidence 4578885 7899999999999999989999999999866666668899999999985 799999999998765 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC---eEEe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV---SHVG 858 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 858 (1017)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++. +||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred EEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEE
Confidence 899999999999999998653 689999999999999999999999 9999999999999998776 9999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC-----CCcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
|||++............ .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+..
T Consensus 157 Dfg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPI-STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CTTCCC--------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EccCccccccCCccccc-cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 99999765422211100 1111223469999999999875 45889999999999999999999999765432211
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..... ..+... ..+............ ......+++++.+++.+||+.||++|||+.|+++|-
T Consensus 236 ~~~~~--~~~~~~-----~~~~~~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 236 WDRGE--ACPACQ-----NMLFESIQEGKYEFP---DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp C------CCHHHH-----HHHHHHHHHCCCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred ccccc--cchhHH-----HHHHHHHhccCcccC---chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 00000 000000 000000000000000 011123466789999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=350.38 Aligned_cols=271 Identities=22% Similarity=0.290 Sum_probs=213.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++..... .+.+.+|+.+++.++|++++..+.++... .+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC----CCce
Confidence 35789999999999999999999998999999999875433 25688999999999998888777766443 2568
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe---CCCCCeEEee
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGD 859 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~D 859 (1017)
++||||+ +++|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 151 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred EEEEEec-CCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEee
Confidence 9999999 8899999985442 689999999999999999999999 99999999999999 4889999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC--ccHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG--LTLHEF 937 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--~~~~~~ 937 (1017)
||++............ .........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 152 fg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 3uzp_A 152 FGLAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CTTCEECBCTTTCCBC-CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred CCCccccccccccccc-ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence 9999876543321111 1112234679999999999999899999999999999999999999998643221 111111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
....... ........+++++.+++.+||+.||++|||+.|+++.|+.+.++.
T Consensus 231 ~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 231 SEKKMST-----------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHHS-----------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cccccCC-----------------------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 1100000 001111234677999999999999999999999999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=371.05 Aligned_cols=264 Identities=21% Similarity=0.246 Sum_probs=208.0
Q ss_pred HHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeec
Q 043932 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 697 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
+.+.....++|++.++||+|+||+||+|+++.+++.||+|++.... ....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3445556789999999999999999999999999999999997432 2234567899999999999999999999876
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
. +..|+||||+++|+|.+++...+ ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 133 ~-----~~~~lVmE~~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g 199 (412)
T 2vd5_A 133 E-----NYLYLVMEYYVGGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCG 199 (412)
T ss_dssp S-----SEEEEEECCCCSCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred C-----CEEEEEEcCCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCC
Confidence 5 67899999999999999998643 2689999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCccccc-------CCCcCccccchhHHHHHHHHHhCCCCCCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-------GSEASMTGDVYSFGILLLELFTGRRPTDA 926 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~pf~~ 926 (1017)
++||+|||+++....... .......||+.|+|||++. +..++.++||||+||++|||++|+.||..
T Consensus 200 ~vkL~DFGla~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 200 HIRLADFGSCLKLRADGT-------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp CEEECCCTTCEECCTTSC-------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CEEEeechhheeccCCCc-------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 999999999986643221 1112357999999999987 35689999999999999999999999976
Q ss_pred ccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 043932 927 AFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFER---MEMRDVVA 1003 (1017)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 1003 (1017)
..... ......... ..... +.....+++++.+++.+||+ +|.+| |+++|+++
T Consensus 273 ~~~~~-~~~~i~~~~-----~~~~~------------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 273 DSTAE-TYGKIVHYK-----EHLSL------------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp SSHHH-HHHHHHTHH-----HHCCC------------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCHHH-HHHHHHhcc-----cCcCC------------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 42211 011110000 00000 00112246678999999999 99998 58999987
Q ss_pred HH
Q 043932 1004 KL 1005 (1017)
Q Consensus 1004 ~L 1005 (1017)
|=
T Consensus 328 Hp 329 (412)
T 2vd5_A 328 HP 329 (412)
T ss_dssp SG
T ss_pred CC
Confidence 63
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.59 Aligned_cols=265 Identities=23% Similarity=0.440 Sum_probs=216.3
Q ss_pred HHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
++....++|++.+.||+|+||+||+|.+..++..||+|++... ....+.+.+|++++++++||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 81 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE---- 81 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC----
Confidence 4445677899999999999999999999989999999999743 34457889999999999999999999998654
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 82 -~~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 82 -PPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred -CCEEEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEc
Confidence 568999999999999999987532 3689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||.+........ .......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||...... .....
T Consensus 154 Dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~ 224 (288)
T 3kfa_A 154 DFGLSRLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYEL 224 (288)
T ss_dssp CCCGGGTSCSSSS-------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH
T ss_pred cCccceeccCCcc-------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence 9999986653321 11122457889999999988899999999999999999999 99999764322 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
....... .....+++.+.+++.+|++.||.+|||+.|+++.|+.+.+.
T Consensus 225 ~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 225 LEKDYRM--------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhccCCC--------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1110000 00112356789999999999999999999999999987653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=350.55 Aligned_cols=271 Identities=22% Similarity=0.288 Sum_probs=209.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||+||+|++..+++.||||++...... +.+.+|+++++.++|++++..++++... .+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCC----CCce
Confidence 457899999999999999999999999999999987644322 4578899999999998888887776443 2678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe---CCCCCeEEee
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGD 859 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~D 859 (1017)
++||||+ +++|.+++..... .+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred EEEEEcc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence 9999999 8899999986542 689999999999999999999999 99999999999999 7889999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCc--cHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL--TLHEF 937 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~--~~~~~ 937 (1017)
||+++........... .........||+.|+|||++.+..++.++||||+||++|||++|+.||........ .....
T Consensus 152 fg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CTTCEECBCTTTCCBC-CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred CccceeccCcccCccC-CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence 9999876543321111 11122346799999999999999999999999999999999999999976433211 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
.....+ .........+++++.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus 231 ~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 231 SEKKMS-----------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHH-----------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hccccc-----------------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 110000 0001111233678999999999999999999999999999987653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=352.97 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=201.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||+||+|++. ++.||+|++.. ....+.+.+|++++++++||||+++++++.. ..+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcE
Confidence 457899999999999999999985 67899999863 3345788999999999999999999998752 368
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC-eEEeeccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV-SHVGDFGL 862 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~ 862 (1017)
+||||+++|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred EEEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 99999999999999986542 235788999999999999999999932229999999999999998886 79999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||..................
T Consensus 153 ~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 221 (307)
T 2eva_A 153 ACDIQTHM-----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221 (307)
T ss_dssp -----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC
T ss_pred cccccccc-----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC
Confidence 97543211 1235899999999999989999999999999999999999999753222111110000000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1013 (1017)
.. .....+++.+.+++.+||+.||++|||+.|++++|+.+.+.+.
T Consensus 222 ~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 222 RP--------------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CC--------------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CC--------------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 0011235678899999999999999999999999999887654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=359.52 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=204.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEE----EEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMI----VAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.++|++.++||+|+||+||+|++..+++. ||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG----- 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-----
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence 35799999999999999999999877765 7777765332 2334567789999999999999999998842
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 -~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~ 157 (325)
T 3kex_A 87 -SSLQLVTQYLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVA 157 (325)
T ss_dssp -SSEEEEEECCTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEEC
T ss_pred -CccEEEEEeCCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEEC
Confidence 45789999999999999998653 2688899999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++........ .......||..|+|||++.+..++.++||||+||++|||++ |+.||...... .....
T Consensus 158 Dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~ 229 (325)
T 3kex_A 158 DFGVADLLPPDDKQ------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDL 229 (325)
T ss_dssp SCSGGGGSCCCTTC------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHH
T ss_pred CCCcccccCccccc------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHH
Confidence 99999876543211 11223567889999999998899999999999999999999 99999764322 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
........ ....++..+.+++.+||+.||.+||++.|++++|+.+..
T Consensus 230 ~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 230 LEKGERLA--------------------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HHTTCBCC--------------------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHcCCCCC--------------------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11100000 001124457889999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=364.25 Aligned_cols=278 Identities=21% Similarity=0.284 Sum_probs=203.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 780 (1017)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+++.+|+++++.++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999999999999999986432 2335678899999999999999999999865422 1224
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+ +++|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence 569999999 77999999763 588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..... .+.....
T Consensus 173 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~ 240 (367)
T 1cm8_A 173 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMK 240 (367)
T ss_dssp TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred ecccccccc-----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 999865321 123578999999999877 679999999999999999999999997643221 1222221
Q ss_pred hhc--CchhhhhccchhhHHHHhhcc-hhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IAL--PEKVIEIVDPLLLIEVMANNS-MIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~--~~~~~~~~d~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... +......+.......+..... ............+++.+.+++.+||+.||++|||+.|+++|
T Consensus 241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 111 111111111111111111000 00001111223346778999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=354.56 Aligned_cols=281 Identities=24% Similarity=0.328 Sum_probs=208.6
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc--CCCCceeeeeeeecCC
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI--RHRNLIKIITICSSID 775 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~ 775 (1017)
.......++|++.+.||+|+||.||+|++. ++.||||++.... ...+.+|.+++... +||||+++++++....
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 334455679999999999999999999985 8899999986432 23445566666554 8999999999986542
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC-----CCCceeecCCCCceEeC
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC-----QPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~ 850 (1017)
. .....++||||+++|+|.++++.. .+++.+++.++.|++.||+|||++. .++|+||||||+||+++
T Consensus 105 ~-~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 105 G-SWTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp G-GGCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred C-CCCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 2 225689999999999999999754 5899999999999999999999762 34899999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCcc------ccchhHHHHHHHHHhC----
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMT------GDVYSFGILLLELFTG---- 920 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg---- 920 (1017)
.++.+||+|||+++.......... .......||+.|+|||++.+..++.+ +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVD----IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp TTSCEEECCCTTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred CCCCEEEEeCCCceeecccccccc----CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 999999999999976643321111 11123579999999999987766554 9999999999999999
Q ss_pred ------CCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCC
Q 043932 921 ------RRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE 994 (1017)
Q Consensus 921 ------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 994 (1017)
+.||........................... ......++++++.+++.+||+.||++
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~ 315 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP-----------------NRWSSDECLRQMGKLMTECWAHNPAS 315 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-----------------GGGGGSHHHHHHHHHHHHHSCSSGGG
T ss_pred cccccccccHhhhcCCCCchhhhHHHHhhhccCcccc-----------------ccchhhHHHHHHHHHHHHhhhhChhh
Confidence 5565543333333322222211111000000 01112356888999999999999999
Q ss_pred CCCHHHHHHHHhhccccc
Q 043932 995 RMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 995 RPs~~evl~~L~~~~~~~ 1012 (1017)
|||+.||+++|+.+.++.
T Consensus 316 Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 316 RLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SCCHHHHHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHHHHhhc
Confidence 999999999999988753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.86 Aligned_cols=272 Identities=22% Similarity=0.363 Sum_probs=215.3
Q ss_pred HHHhhccccccCcccccCCceEEEEEe-----CCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeeeeeee
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKIITICS 772 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 772 (1017)
+....++|++.+.||+|+||+||+|++ ..+++.||+|++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 344467899999999999999999985 45788999999975433 3457789999999999 9999999999986
Q ss_pred cCCCCCCceeEEEEEeccCCCHHHHHhhCCCC------------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceee
Q 043932 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDH------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHG 840 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 840 (1017)
.. +..++||||+++|+|.+++...... .....+++.+++.++.||+.||+|||++ +|+||
T Consensus 98 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~ 169 (313)
T 1t46_A 98 IG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHR 169 (313)
T ss_dssp SS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred cC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecC
Confidence 54 5679999999999999999876421 1123589999999999999999999999 99999
Q ss_pred cCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-
Q 043932 841 DLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT- 919 (1017)
Q Consensus 841 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt- 919 (1017)
||||+||+++.++.+||+|||++.......... ......||+.|+|||++.+..++.++||||+|+++|||++
T Consensus 170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 243 (313)
T 1t46_A 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243 (313)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSE------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCccceEEEcCCCCEEEccccccccccccccce------eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999998665332111 1122457889999999988899999999999999999999
Q ss_pred CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 920 GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 920 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
|+.||........ ........... .....+++.+.+++.+||+.||.+|||+.
T Consensus 244 g~~p~~~~~~~~~-~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 296 (313)
T 1t46_A 244 GSSPYPGMPVDSK-FYKMIKEGFRM--------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFK 296 (313)
T ss_dssp TCCSSTTCCSSHH-HHHHHHHTCCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCcccchhH-HHHHhccCCCC--------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHH
Confidence 9999976432211 11111111000 00112356789999999999999999999
Q ss_pred HHHHHHhhccccc
Q 043932 1000 DVVAKLCHTRETF 1012 (1017)
Q Consensus 1000 evl~~L~~~~~~~ 1012 (1017)
|++++|+++.++.
T Consensus 297 ell~~L~~~~~~~ 309 (313)
T 1t46_A 297 QIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHh
Confidence 9999999887653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=364.15 Aligned_cols=269 Identities=22% Similarity=0.253 Sum_probs=205.9
Q ss_pred HHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec-----CcchHHHHHHHHHHHHhcCCCCceeeeeeeec
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-----QKGAFKSFMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
++....++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+.+|++++++++||||+++++++..
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4456678999999999999999999999999999999998743 23456789999999999999999999999865
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCC----------------------------------ccccccCHHHHHHHH
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDH----------------------------------LEVCKLTLIQRVNIA 819 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------~~~~~l~~~~~~~i~ 819 (1017)
. +..++||||+++|+|.+++...... .....+++..++.++
T Consensus 100 ~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 100 E-----QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp S-----SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred C-----CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 4 6789999999999999998631110 001234677889999
Q ss_pred HHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC--CeEEeecccccccccccccccccCCCcccccccCccccCccccc
Q 043932 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM--VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM 897 (1017)
Q Consensus 820 ~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 897 (1017)
.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+++.+....... ........||+.|+|||++.
T Consensus 175 ~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~ 247 (345)
T 3hko_A 175 RQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE----YYGMTTKAGTPYFVAPEVLN 247 (345)
T ss_dssp HHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccc----cccccccCCCccccCchhhc
Confidence 9999999999999 999999999999998776 89999999998654322111 11122356999999999986
Q ss_pred C--CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHH
Q 043932 898 G--SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQE 975 (1017)
Q Consensus 898 ~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~ 975 (1017)
+ ..++.++|||||||++|||++|+.||....... ............ . ......
T Consensus 248 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~-----~-------------------~~~~~~ 302 (345)
T 3hko_A 248 TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLCF-----E-------------------NPNYNV 302 (345)
T ss_dssp CSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCT-----T-------------------SGGGGG
T ss_pred cCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhccccc-----C-------------------Cccccc
Confidence 5 578999999999999999999999997643221 111111100000 0 001112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 976 CLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 976 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+++.+.+++.+||+.||.+||++.|++++
T Consensus 303 ~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 303 LSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 35678999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=361.43 Aligned_cols=276 Identities=17% Similarity=0.231 Sum_probs=206.6
Q ss_pred hccccccCcccccCCceEEEEEeCC---CcEEEEEEEeeecCcc-----------hHHHHHHHHHHHHhcCCCCceeeee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQKG-----------AFKSFMAECKALRNIRHRNLIKIIT 769 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 769 (1017)
.++|++.+.||+|+||+||+|++.. ++..||+|++...... ..+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 7889999998754321 1234667888999999999999999
Q ss_pred eeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
++.... .+....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||++
T Consensus 116 ~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 184 (345)
T 2v62_A 116 SGLTEF-KGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL 184 (345)
T ss_dssp EEEEES-SSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred cccccc-CCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence 987632 2347889999999 899999997653 789999999999999999999999 99999999999999
Q ss_pred CCCC--CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 850 DHDM--VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 850 ~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
+.++ .+||+|||+++.+........ ..........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQ-YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCC-CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred ccCCCCcEEEEeCCCceeccccccccc-chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 8887 999999999987654321111 1112223467999999999999989999999999999999999999999653
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHh--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAK--TQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
............. .... +. ...... ...+++++.+++.+||+.||++||++.||++.|
T Consensus 264 ~~~~~~~~~~~~~-~~~~----~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 323 (345)
T 2v62_A 264 LKDPVAVQTAKTN-LLDE----LP---------------QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323 (345)
T ss_dssp TTCHHHHHHHHHH-HHHT----TT---------------HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred ccccHHHHHHHHh-hccc----cc---------------HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 2221111111110 0000 00 000000 013466899999999999999999999999999
Q ss_pred hhcccc
Q 043932 1006 CHTRET 1011 (1017)
Q Consensus 1006 ~~~~~~ 1011 (1017)
+.+...
T Consensus 324 ~~~~~~ 329 (345)
T 2v62_A 324 NPHGIP 329 (345)
T ss_dssp CTTCCC
T ss_pred hccCCc
Confidence 987643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=363.91 Aligned_cols=287 Identities=23% Similarity=0.258 Sum_probs=213.0
Q ss_pred CCCcCHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-----CCCcee
Q 043932 692 FPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-----HRNLIK 766 (1017)
Q Consensus 692 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 766 (1017)
...+++.+.....++|++.++||+|+||+||+|++..+++.||||++... ....+.+..|+++++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34556666667788999999999999999999999999999999998632 233466778999999986 999999
Q ss_pred eeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCc
Q 043932 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 846 (1017)
Q Consensus 767 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 846 (1017)
+++++... +..++||||+ +++|.+++..... ..+++.+++.++.||+.||+|||++ +|+||||||+|
T Consensus 101 ~~~~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 167 (360)
T 3llt_A 101 YHGKFMYY-----DHMCLIFEPL-GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPEN 167 (360)
T ss_dssp EEEEEEET-----TEEEEEECCC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccceeeEC-----CeeEEEEcCC-CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCccc
Confidence 99998765 6789999999 8899999987542 2589999999999999999999999 99999999999
Q ss_pred eEeCC-------------------------CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCc
Q 043932 847 VLLDH-------------------------DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA 901 (1017)
Q Consensus 847 Ill~~-------------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 901 (1017)
|+++. ++.+||+|||+|+..... .....||+.|+|||++.+..+
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~ 236 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----------HGSIINTRQYRAPEVILNLGW 236 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----------CCSCCSCGGGCCHHHHTTCCC
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----------CcCccCcccccCcHHHcCCCC
Confidence 99975 789999999999754321 123568999999999999999
Q ss_pred CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh--cCchhhhhccchhhHHHH----------hhcch-----
Q 043932 902 SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA--LPEKVIEIVDPLLLIEVM----------ANNSM----- 964 (1017)
Q Consensus 902 ~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~l~~~~~----------~~~~~----- 964 (1017)
+.++||||+||++|||++|+.||....... ......... .+..............+. .....
T Consensus 237 ~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 315 (360)
T 3llt_A 237 DVSSDMWSFGCVLAELYTGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315 (360)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHH
T ss_pred CCccchHHHHHHHHHHHHCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhh
Confidence 999999999999999999999997643221 111111111 111110000000000000 00000
Q ss_pred -hHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 965 -IQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 965 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.............+.+.+++.+||+.||++|||+.|+++|
T Consensus 316 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000111123678899999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.70 Aligned_cols=280 Identities=20% Similarity=0.233 Sum_probs=215.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.... ......
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCcee
Confidence 4578999999999999999999999899999999998766666788999999999999999999999986431 223578
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EEEEEeCCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 999999999999999986321 123689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccc-cCCCcccccccCccccCcccccCCC---cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 863 AKFLSSHQLDTAS-KTSSSSIGIKGTVGYVAPEYCMGSE---ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 863 a~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
+............ ..........||+.|+|||++.+.. ++.++||||||+++|||++|+.||..............
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 260 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence 8765321110000 0000112245799999999987653 68999999999999999999999965332222221111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1014 (1017)
...... .....+++.+.+++.+||+.||.+|||+.|++++|+.+....-+
T Consensus 261 ~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 261 QNQLSI--------------------------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HCC--C--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred hccCCC--------------------------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 110000 00112356789999999999999999999999999998765443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=357.87 Aligned_cols=278 Identities=21% Similarity=0.279 Sum_probs=202.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.++||+|+||+||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++++... +.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----Ce
Confidence 3589999999999999999999999999999999865433 2346678999999999999999999998765 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence 899999999999999887553 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
.+........ ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+. .......
T Consensus 148 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~ 218 (311)
T 4agu_A 148 FARLLTGPSD--------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKT 218 (311)
T ss_dssp TCEECC--------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred CchhccCccc--------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH
Confidence 9986542211 1123468999999999876 5689999999999999999999999976433211 1111111
Q ss_pred h--cCchhhhhc-cchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 A--LPEKVIEIV-DPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~--~~~~~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. ..+...... .........................+++.+.+++.+||+.||++|||++|+++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 219 LGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred hcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000000000 000000000000000000011122456678999999999999999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=348.82 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=205.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.+.||+|+||+||+|++. ++.||+|++.... ....+.+.+|+.++++++||||+++++++.... .+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 468999999999999999999995 7889999997553 234567899999999999999999999986542 256
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeecCCCCceEeCCCCCeEEee
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ + |+||||||+||+++.++.++++|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred eEeeecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence 7999999999999999986542 3589999999999999999999998 7 99999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCc---cccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASM---TGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
||++..... ....||+.|+|||++.+..++. ++||||+||++|||++|+.||......... ..
T Consensus 157 ~~~~~~~~~-------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~ 222 (271)
T 3kmu_A 157 ADVKFSFQS-------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-MK 222 (271)
T ss_dssp GGSCCTTSC-------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-HH
T ss_pred ccceeeecc-------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-HH
Confidence 998754221 1246899999999998765544 799999999999999999999754221110 00
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
........ .....+++.+.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus 223 ~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~~ 271 (271)
T 3kmu_A 223 VALEGLRP--------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271 (271)
T ss_dssp HHHSCCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC-
T ss_pred HHhcCCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 00000000 00112356789999999999999999999999999998763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=364.11 Aligned_cols=269 Identities=25% Similarity=0.373 Sum_probs=213.6
Q ss_pred hhccccccCcccccCCceEEEEEeC-------CCcEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeeeeeeec
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILG-------EDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKIITICSS 773 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 773 (1017)
..++|.+.++||+|+||+||+|++. ..+..||||++..... ...+++.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4578999999999999999999974 3447899999975432 3457788999999999 89999999999865
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLK 843 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 843 (1017)
. +..++||||+++|+|.+++...... .....+++.+++.++.||+.||+|||++ +|+|||||
T Consensus 147 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk 218 (382)
T 3tt0_A 147 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 218 (382)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred C-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCC
Confidence 4 5689999999999999999875421 1123689999999999999999999999 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCC
Q 043932 844 PSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRR 922 (1017)
Q Consensus 844 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~ 922 (1017)
|+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~ 292 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 292 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTT------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cceEEEcCCCcEEEcccCccccccccccc------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999866432211 11222457889999999999999999999999999999999 999
Q ss_pred CCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 923 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
||...... ............ .....+++++.+++.+||+.||++|||+.||+
T Consensus 293 p~~~~~~~--~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 344 (382)
T 3tt0_A 293 PYPGVPVE--ELFKLLKEGHRM--------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344 (382)
T ss_dssp SSTTCCHH--HHHHHHHTTCCC--------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHH--HHHHHHHcCCCC--------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99754221 011111100000 00112356789999999999999999999999
Q ss_pred HHHhhcccccc
Q 043932 1003 AKLCHTRETFF 1013 (1017)
Q Consensus 1003 ~~L~~~~~~~~ 1013 (1017)
++|+.+.+...
T Consensus 345 ~~L~~~~~~~~ 355 (382)
T 3tt0_A 345 EDLDRIVALTS 355 (382)
T ss_dssp HHHHHHHHHSC
T ss_pred HHHHHHHHHHh
Confidence 99999876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=372.86 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=205.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++... +
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 468999999999999999999999999999999997442 23456789999999999999999999998765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence 7899999999999999997653 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|++....... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... .......
T Consensus 161 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~ 230 (476)
T 2y94_A 161 GLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICD 230 (476)
T ss_dssp SSCEECCTTC---------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-HHHHHHT
T ss_pred cchhhccccc---------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhc
Confidence 9998664322 1123569999999999988765 789999999999999999999997642210 0111100
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... ....+++.+.+++.+||+.||++|||+.|+++|
T Consensus 231 ~~~~----------------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 231 GIFY----------------------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TCCC----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCcC----------------------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0000 001124568899999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=359.56 Aligned_cols=255 Identities=20% Similarity=0.260 Sum_probs=184.2
Q ss_pred ccccc---cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCc
Q 043932 705 SEFAS---SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~---~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 780 (1017)
.+|++ .++||+|+||+||+|++..+++.||||++... ....+.+|+.+++.+. ||||+++++++... .
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-----~ 79 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-----L 79 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-----C
Confidence 34554 47899999999999999999999999998643 3466788999999996 99999999998654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC---CeEE
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---VSHV 857 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 857 (1017)
..|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++ .+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl 150 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKI 150 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEE
T ss_pred EEEEEEEccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEE
Confidence 7899999999999999998754 689999999999999999999999 999999999999998766 8999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC--ccHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG--LTLH 935 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--~~~~ 935 (1017)
+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....
T Consensus 151 ~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 222 (325)
T 3kn6_A 151 IDFGFARLKPPDN--------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222 (325)
T ss_dssp CCCTTCEECCC------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH
T ss_pred eccccceecCCCC--------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH
Confidence 9999998654322 11123468999999999999899999999999999999999999997643211 1111
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+......... ... .......+++++.+++.+||+.||.+|||+.|++++
T Consensus 223 ~~~~~i~~~~-----------------~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 223 EIMKKIKKGD-----------------FSF---EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHTTTC-----------------CCC---CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHcCC-----------------CCC---CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1111100000 000 011123346778999999999999999999999865
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=365.67 Aligned_cols=344 Identities=25% Similarity=0.383 Sum_probs=159.0
Q ss_pred CCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEe
Q 043932 101 SFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAV 180 (1017)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 180 (1017)
++|+.|+++++.++ .+| .+..+++|++|+|++|.+++.. . +.++++|++|+|++|++++..| ++++++|++|++
T Consensus 46 ~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~-~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 46 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDIT-P-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp HTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCch-h-hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 34444444444444 233 2444445555555555444322 2 4455555555555555543322 445555555555
Q ss_pred ccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccc
Q 043932 181 GKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGT 260 (1017)
Q Consensus 181 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 260 (1017)
++|.+++..+ ++++++|++|++++|.+++. + .++.+++|++|+++ |.+.+.. .+.++++|++|++++|.+++
T Consensus 120 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~- 191 (466)
T 1o6v_A 120 FNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD- 191 (466)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC-
T ss_pred CCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC-
Confidence 5555543322 44555555555555554432 1 24455555555554 2333221 14555555555555555542
Q ss_pred cCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhh
Q 043932 261 LPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDF 340 (1017)
Q Consensus 261 l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 340 (1017)
++ .+..+++|++|++++|.+++..| ++.+++|+.|++++|++++. ..
T Consensus 192 ~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~--------------------------- 238 (466)
T 1o6v_A 192 IS--VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GT--------------------------- 238 (466)
T ss_dssp CG--GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GG---------------------------
T ss_pred Ch--hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hh---------------------------
Confidence 21 13344444444444444443322 33344444444444444321 11
Q ss_pred HhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhccc
Q 043932 341 VTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGEL 420 (1017)
Q Consensus 341 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 420 (1017)
+..+++|+.|++++|++.+. .+ +..+++|+.|++++|++++..+ +..+
T Consensus 239 ---l~~l~~L~~L~l~~n~l~~~-------------------------~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l 286 (466)
T 1o6v_A 239 ---LASLTNLTDLDLANNQISNL-------------------------AP--LSGLTKLTELKLGANQISNISP--LAGL 286 (466)
T ss_dssp ---GGGCTTCSEEECCSSCCCCC-------------------------GG--GTTCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred ---hhcCCCCCEEECCCCccccc-------------------------hh--hhcCCCCCEEECCCCccCcccc--ccCC
Confidence 22333444444444433321 11 3344455555555555554333 4455
Q ss_pred ccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceec
Q 043932 421 KNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLD 500 (1017)
Q Consensus 421 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~ 500 (1017)
++|+.|++++|++++..| +..+++|++|++++|++++..| +..+++|+.|++++|++++
T Consensus 287 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~----------------- 345 (466)
T 1o6v_A 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD----------------- 345 (466)
T ss_dssp TTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-----------------
T ss_pred CccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC-----------------
Confidence 555555555555553322 4455555555555555554433 4455555555555555441
Q ss_pred cCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCC
Q 043932 501 LSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHG 556 (1017)
Q Consensus 501 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 556 (1017)
. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 346 --------~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 346 --------V--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp --------C--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred --------c--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 1 123445555555555555555444 5555555555555555554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=359.06 Aligned_cols=256 Identities=24% Similarity=0.309 Sum_probs=201.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCce
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
..++|++.+.||+|+||+||+|++..+++.||+|++...... ..+|++++.++ +||||+++++++.+. +.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDG-----KY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECS-----SE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcC-----CE
Confidence 457899999999999999999999999999999999754332 34688888888 799999999998654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC----CCeEE
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD----MVSHV 857 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl 857 (1017)
.|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||++..+ +.+||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence 899999999999999997653 689999999999999999999999 99999999999998543 35999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.
T Consensus 162 ~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~ 231 (342)
T 2qr7_A 162 CDFGFAKQLRAEN--------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEI 231 (342)
T ss_dssp CCCTTCEECBCTT--------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHH
T ss_pred EECCCcccCcCCC--------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHH
Confidence 9999998654321 1122357899999999998888999999999999999999999999753221 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
......... ... ......+++++.+++.+||+.||++||++.|+++|-.
T Consensus 232 ~~~i~~~~~-~~~-------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 232 LARIGSGKF-SLS-------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp HHHHHHCCC-CCC-------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHccCCc-ccC-------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 111000000 000 0001123567899999999999999999999988644
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=366.59 Aligned_cols=347 Identities=28% Similarity=0.372 Sum_probs=186.7
Q ss_pred ccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccE
Q 043932 122 GNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEV 201 (1017)
Q Consensus 122 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 201 (1017)
..+++|+.|++++|.++ .+|. +..+++|++|+|++|.+++..| +.++++|++|++++|++++..+ ++++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 34667777777777776 4553 6677777777777777775433 6777777777777777765443 666777777
Q ss_pred EEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccc
Q 043932 202 FSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNN 281 (1017)
Q Consensus 202 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~ 281 (1017)
|++++|.+++..+ +..+++|++|++++|.+++ ++ .+..+++|++|+++ |.
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~------------------------- 166 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQ------------------------- 166 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ES-------------------------
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-Cc-------------------------
Confidence 7777776664432 6666666666666666653 22 25555555555553 22
Q ss_pred cCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccc
Q 043932 282 FFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFV 361 (1017)
Q Consensus 282 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 361 (1017)
+.+.. .+..+++|+.|++++|++++.. .+..+++|++|++++|.+..... +..+++|+.|++++|+++
T Consensus 167 ~~~~~--~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--------~~~l~~L~~L~l~~n~l~ 234 (466)
T 1o6v_A 167 VTDLK--PLANLTTLERLDISSNKVSDIS--VLAKLTNLESLIATNNQISDITP--------LGILTNLDELSLNGNQLK 234 (466)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCSEEECCSSCCCCCGG--------GGGCTTCCEEECCSSCCC
T ss_pred ccCch--hhccCCCCCEEECcCCcCCCCh--hhccCCCCCEEEecCCccccccc--------ccccCCCCEEECCCCCcc
Confidence 22221 2555556666666666655432 24444455555555444432110 222333334444333332
Q ss_pred cccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCccc
Q 043932 362 GELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGV 441 (1017)
Q Consensus 362 ~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 441 (1017)
++ ..+..+++|+.|++++|++++..+ +
T Consensus 235 -------------------------~~--~~l~~l~~L~~L~l~~n~l~~~~~--------------------------~ 261 (466)
T 1o6v_A 235 -------------------------DI--GTLASLTNLTDLDLANNQISNLAP--------------------------L 261 (466)
T ss_dssp -------------------------CC--GGGGGCTTCSEEECCSSCCCCCGG--------------------------G
T ss_pred -------------------------cc--hhhhcCCCCCEEECCCCccccchh--------------------------h
Confidence 11 123444555555555555544332 4
Q ss_pred ccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccce
Q 043932 442 GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLV 521 (1017)
Q Consensus 442 ~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~ 521 (1017)
..+++|++|++++|++++..+ +..+++|+.|++++|++++ ..| +..+++|+
T Consensus 262 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~-------------------------~~~--~~~l~~L~ 312 (466)
T 1o6v_A 262 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-------------------------ISP--ISNLKNLT 312 (466)
T ss_dssp TTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC-------------------------CGG--GGGCTTCS
T ss_pred hcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccC-------------------------chh--hcCCCCCC
Confidence 444555555555555553322 4455555555555555541 111 34445555
Q ss_pred EEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCC
Q 043932 522 KLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHND 601 (1017)
Q Consensus 522 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 601 (1017)
.|+|++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++.+| +..+++|+.|++++|+
T Consensus 313 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~ 386 (466)
T 1o6v_A 313 YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 386 (466)
T ss_dssp EEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEE
T ss_pred EEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCc
Confidence 55555555554443 45555555555555555543 245555666666666666655544 5555666666666666
Q ss_pred CcC
Q 043932 602 LEG 604 (1017)
Q Consensus 602 l~~ 604 (1017)
+++
T Consensus 387 ~~~ 389 (466)
T 1o6v_A 387 WTN 389 (466)
T ss_dssp EEC
T ss_pred ccC
Confidence 655
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=355.32 Aligned_cols=247 Identities=23% Similarity=0.257 Sum_probs=195.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.++||+|+||+||+|++..+++.||||++..... ....+...|+..+.++ +||||++++++|... +
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----G 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----C
Confidence 3689999999999999999999999999999999864332 2334455666666655 899999999999765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF 201 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF 201 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred EEEEEEecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence 789999999 669999987654 2689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... .......
T Consensus 202 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~~ 267 (311)
T 3p1a_A 202 GLLVELGTAG---------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQG 267 (311)
T ss_dssp TTCEECC---------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTTT
T ss_pred eeeeecccCC---------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhcc
Confidence 9987654322 1122468999999999887 789999999999999999999777644211 1111000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..+ ......+++++.+++.+||+.||++|||+.|++++
T Consensus 268 ~~~--------------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 268 YLP--------------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CCC--------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCC--------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 000 01112346778999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=354.64 Aligned_cols=277 Identities=24% Similarity=0.364 Sum_probs=209.3
Q ss_pred hccccccCcccccCCceEEEEE----eCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGI----LGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
..+|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--- 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence 3568999999999999999999 56689999999997443 344578899999999999999999999986542
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
....++||||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEEC
Confidence 2567999999999999999965442 689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||++.......... .......||..|+|||++.+..++.++||||+|+++|||++|..|+..... ...
T Consensus 169 Dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~ 237 (302)
T 4e5w_A 169 DFGLTKAIETDKEYY-----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LFL 237 (302)
T ss_dssp CCTTCEECCTTCCEE-----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHH
T ss_pred cccccccccCCCcce-----eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HHh
Confidence 999998765432111 112234688899999999988999999999999999999999998654211 111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
....+... ............... .......+++.+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 238 KMIGPTHG-QMTVTRLVNTLKEGK------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHCSCCG-GGHHHHHHHHHHTTC------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCccc-ccCHHHHHHHHhccC------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111000 000000000000000 00112234678999999999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=359.77 Aligned_cols=283 Identities=25% Similarity=0.397 Sum_probs=216.1
Q ss_pred hccccccCcccccCCceEEEEE----eCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGI----LGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.+.||+|+||.||+|+ ...+++.||+|++........+.+.+|++++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---C
Confidence 4579999999999999999999 45689999999998766666788999999999999999999999886532 2
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred CceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence 467999999999999999987642 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++........... ......++..|+|||++.+..++.++||||||+++|||++|..||...... +..
T Consensus 189 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~------~~~ 257 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYK-----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMR 257 (326)
T ss_dssp CTTCEECCSSCSEEE-----CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH------HHH
T ss_pred Ccchhhccccccccc-----cccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH------HHH
Confidence 999987653321111 111235788899999998888999999999999999999999997643111 111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1014 (1017)
..............+......... ......+++++.+++.+||+.||++|||+.|+++.|+.+++++.|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~g 326 (326)
T 2w1i_A 258 MIGNDKQGQMIVFHLIELLKNNGR------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326 (326)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred hhccccchhhhHHHHHHHhhcCCC------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcC
Confidence 000000000000000000000000 011223567899999999999999999999999999999887643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=352.54 Aligned_cols=267 Identities=21% Similarity=0.253 Sum_probs=202.7
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~----- 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID----- 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----
Confidence 35789999999999999999999999999999999874422 2346788999999999999999999998764
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred CeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEec
Confidence 67899999999999999998653 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......
T Consensus 178 fg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~ 248 (309)
T 2h34_A 178 FGIASATTDEKLT-------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHIN 248 (309)
T ss_dssp CCC-----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHH
T ss_pred CccCccccccccc-------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhc
Confidence 9999765432211 112346899999999999989999999999999999999999999764221 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhccccccccC
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-EMRDVVAKLCHTRETFFGRR 1016 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~~~~ 1016 (1017)
...+. .......+++++.+++.+||+.||++|| +++++++.|+.+.+.....+
T Consensus 249 ~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 249 QAIPR------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp SCCCC------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred cCCCC------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 00000 0011123356788999999999999999 99999999998877655433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=366.84 Aligned_cols=267 Identities=25% Similarity=0.446 Sum_probs=201.2
Q ss_pred ccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..|++.++||+|+||+||+|++..+ +..||+|.+.... ....+++.+|+.++++++||||+++++++... .+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CC
Confidence 3577788999999999999997432 3568999986433 34567899999999999999999999987543 24
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.++++.... .+++.+++.++.||++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DF 236 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF 236 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CeEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeec
Confidence 57899999999999999986542 678999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+++......... ........+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+ ......
T Consensus 237 G~a~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~ 310 (373)
T 3c1x_A 237 GLARDMYDKEFDS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLL 310 (373)
T ss_dssp -------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHH
T ss_pred ccccccccccccc----ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHH
Confidence 9998664332111 111223457889999999998899999999999999999999 677776543221 111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGR 1015 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1015 (1017)
..... . ....+++.+.+++.+||+.||++|||+.|++++|+.+...+.+.
T Consensus 311 ~~~~~-----~---------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 311 QGRRL-----L---------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp TTCCC-----C---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred cCCCC-----C---------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 00000 0 01123567899999999999999999999999999998877654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=347.23 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=208.2
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++... +.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 79 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NI 79 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CE
Confidence 4578999999999999999999999899999999997543 33457789999999999999999999998764 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 150 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG 150 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEEecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence 899999999999999987543 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
.+......... .......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||............+...
T Consensus 151 ~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 224 (276)
T 2yex_A 151 LATVFRYNNRE------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224 (276)
T ss_dssp TCEECEETTEE------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT
T ss_pred CccccCCCcch------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc
Confidence 99865432211 11223568999999999987665 789999999999999999999997654332222222111
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.... ......++.+.+++.+||+.||++|||+.|++++-
T Consensus 225 ~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 225 KTYL--------------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp CTTS--------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred cccc--------------------------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 0000 00112356688999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=350.76 Aligned_cols=255 Identities=21% Similarity=0.307 Sum_probs=206.3
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++... +
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----S 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----C
Confidence 3578999999999999999999999999999999997543 23456788999999999999999999998654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC---eEE
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV---SHV 857 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl 857 (1017)
..++||||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl 149 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 149 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEE
Confidence 7899999999999999887653 689999999999999999999999 9999999999999986655 999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... .....
T Consensus 150 ~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~ 219 (284)
T 3kk8_A 150 ADFGLAIEVNDSE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQI 219 (284)
T ss_dssp CCCTTCEECCSSC---------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH
T ss_pred eeceeeEEcccCc---------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHH
Confidence 9999997654322 1123568999999999999899999999999999999999999997542211 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
....... .. .....+++++.+++.+||+.||++|||+.|++++-
T Consensus 220 ~~~~~~~-----~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 220 KAGAYDY-----PS-------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp HHTCCCC-----CT-------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred HhccccC-----Cc-------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 1110000 00 00112356788999999999999999999998863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=349.44 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=193.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc----chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK----GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.++||+|+||.||+|++. ++.||||++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE----- 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence 468999999999999999999985 78899999874432 2346788999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC---ceeecCCCCceEeCC-----
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP---MVHGDLKPSNVLLDH----- 851 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~---ivH~Dlkp~NIll~~----- 851 (1017)
+..++||||+++++|.+++... .+++..++.++.|++.||+|||++ + |+||||||+||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~ 148 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENG 148 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSS
T ss_pred CceEEEEEcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccc
Confidence 5689999999999999998643 689999999999999999999999 7 999999999999986
Q ss_pred ---CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 852 ---DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 852 ---~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
++.+||+|||.+....... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||....
T Consensus 149 ~~~~~~~kl~Dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 149 DLSNKILKITDFGLAREWHRTT----------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp CCSSCCEEECCCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccCcceEEccCCccccccccc----------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7789999999997654321 112468999999999998889999999999999999999999997642
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
..... .......... .....+++.+.+++.+||+.||++|||+.|++++|+.+
T Consensus 219 ~~~~~-~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 219 GLAVA-YGVAMNKLAL--------------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHH-HHHHTSCCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHH-HhhhcCCCCC--------------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 21100 0000000000 00112356789999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=349.02 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=203.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
...|++.+.||+|+||+||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++.... .+...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCce
Confidence 346888899999999999999999999999999997543 334577899999999999999999999886542 23467
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeecCCCCceEeC-CCCCeEEe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLD-HDMVSHVG 858 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~ 858 (1017)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+||+
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EEEEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEe
Confidence 899999999999999998643 689999999999999999999999 7 99999999999997 78999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||++...... ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||..............
T Consensus 175 Dfg~~~~~~~~----------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 243 (290)
T 1t4h_A 175 DLGLATLKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp CTTGGGGCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred eCCCccccccc----------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh
Confidence 99999754321 1123568999999998875 589999999999999999999999975322211111110
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....+.. .....++++.+++.+||+.||.+|||+.|+++|
T Consensus 244 ~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 244 SGVKPAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTCCCGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCccc--------------------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0000000 011124568999999999999999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=369.84 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=197.6
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--------cchHHHHHHHHHHHHhcCCCCceeeeeeeec
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--------KGAFKSFMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
...++|.+.+.||+|+||+||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999999999999999997432 1122357899999999999999999999743
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
+..++||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 212 ------~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 212 ------EDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp ------SEEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred ------CceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence 34689999999999999887553 689999999999999999999999 999999999999997544
Q ss_pred ---CeEEeecccccccccccccccccCCCcccccccCccccCcccccC---CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 854 ---VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG---SEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 854 ---~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
.+||+|||+|+...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 277 ~~~~~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGETS---------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CcceEEEeecccceecCCCc---------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 59999999998664321 1123579999999999853 56788999999999999999999999764
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
................. .......+++.+.+++.+||+.||++|||+.|+++|-
T Consensus 348 ~~~~~~~~~i~~~~~~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 348 RTQVSLKDQITSGKYNF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp SSSCCHHHHHHTTCCCC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred cchHHHHHHHhcCCCCC------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 33222111111111000 0111223466789999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=376.33 Aligned_cols=261 Identities=23% Similarity=0.443 Sum_probs=213.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
...+|++.++||+|+||.||+|++..++..||||+++... ...+.+.+|++++++++||||++++++|... +..
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 291 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPF 291 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcE
Confidence 3567999999999999999999999889999999997543 3457899999999999999999999998654 567
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++|+|.++++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccc
Confidence 999999999999999986532 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++........ ......+|..|+|||++.+..++.++|||||||++|||++ |..||...... .........
T Consensus 365 a~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~ 435 (495)
T 1opk_A 365 SRLMTGDTYT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKD 435 (495)
T ss_dssp EECCTTCCEE-------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTT
T ss_pred ceeccCCcee-------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC
Confidence 9876432211 1112356789999999998899999999999999999999 99999764322 111111100
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
.. ......+++.+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 436 ~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 436 YR--------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CC--------------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 00 001123467789999999999999999999999999987643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=361.38 Aligned_cols=280 Identities=20% Similarity=0.321 Sum_probs=199.0
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.....++|++.++||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 105 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--- 105 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET---
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC---
Confidence 34456799999999999999999999999999999999974432 2345678999999999999999999998765
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe-----CCC
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DHD 852 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-----~~~ 852 (1017)
+..++||||+++ +|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||++ +.+
T Consensus 106 --~~~~lv~e~~~~-~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 173 (329)
T 3gbz_A 106 --HRLHLIFEYAEN-DLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASET 173 (329)
T ss_dssp --TEEEEEEECCSE-EHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----C
T ss_pred --CEEEEEEecCCC-CHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCcc
Confidence 678999999975 9999998764 689999999999999999999999 99999999999999 455
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccC
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEG 931 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 931 (1017)
+.+||+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.......
T Consensus 174 ~~~kl~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 245 (329)
T 3gbz_A 174 PVLKIGDFGLARAFGIPI--------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245 (329)
T ss_dssp CEEEECCTTHHHHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ceEEECcCCCccccCCcc--------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence 569999999998664221 111224689999999999874 48999999999999999999999997643322
Q ss_pred ccHHHHHHhhcCch--hhhhcc-chhhHHHHh-hcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 932 LTLHEFAKIALPEK--VIEIVD-PLLLIEVMA-NNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 932 ~~~~~~~~~~~~~~--~~~~~d-~~l~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
...........+.. ...... +.....+.. ...... ......+++++.+++.+||+.||++|||+.|+++|-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 246 QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLK---RVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHH---HHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHh---hhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 11111111111111 000000 000000000 000000 011112456789999999999999999999999763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=362.28 Aligned_cols=276 Identities=21% Similarity=0.295 Sum_probs=200.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc-hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++|++.+.||+|+||+||+|++..+++.||+|++...... ....+.+|++++++++||||+++++++... +..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEE
Confidence 5799999999999999999999999999999998644322 122455799999999999999999998654 6689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++ +|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 77 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 77 LVFEYLDK-DLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp EEEECCSE-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred EEeccccc-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence 99999975 99999887643 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ..........
T Consensus 148 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~ 218 (324)
T 3mtl_A 148 RAKSIPT--------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILG 218 (324)
T ss_dssp ECC--------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred ccccCCc--------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 7543221 11122468999999999876 568999999999999999999999997643321 1222222111
Q ss_pred ---CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 ---PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+..+...........+. ...............+++.+.+++.+||+.||++|||+.|+++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 219 TPTEETWPGILSNEEFKTYN-YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCTTTSTTGGGCHHHHHTC-CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCChHhchhhhcchhhcccc-cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 11111111111000000 00000001111222346678999999999999999999999885
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=350.57 Aligned_cols=268 Identities=25% Similarity=0.421 Sum_probs=209.0
Q ss_pred hccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..+|++.++||+|+||+||+|++..+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence 45789999999999999999997543 3468999887433 34457789999999999999999999987543 2
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred CceEEEEeCCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECc
Confidence 46789999999999999997644 2678999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||+++......... ........||+.|+|||.+.+..++.++||||+|+++|||++ |.+||....... ......
T Consensus 172 fg~a~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~~ 246 (298)
T 3f66_A 172 FGLARDMYDKEYYS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLL 246 (298)
T ss_dssp CGGGCCCSCGGGCB----C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-HHHHHH
T ss_pred ccccccccccchhc----cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHh
Confidence 99998765433211 112233568899999999998899999999999999999999 555665432221 111111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGR 1015 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1015 (1017)
..... .....+++.+.+++.+||+.||++|||+.|+++.|+.+.+.+.+.
T Consensus 247 ~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 247 QGRRL---------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp TTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred cCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 10000 001112456899999999999999999999999999999887764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=375.81 Aligned_cols=264 Identities=23% Similarity=0.415 Sum_probs=212.6
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++....++|++.+.||+|+||+||+|++. ++..||||+++... ...+.+.+|+.++++++||||+++++++..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---- 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---- 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC----
Confidence 344556678999999999999999999996 57789999997543 346789999999999999999999999752
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
+..++||||+++|+|.++++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 255 --~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl 325 (454)
T 1qcf_A 255 --EPIYIITEFMAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKI 325 (454)
T ss_dssp --SSCEEEECCCTTCBHHHHHHSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEE
T ss_pred --CccEEEEeecCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEE
Confidence 45799999999999999997542 13678899999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~ 936 (1017)
+|||+++......... .....+|..|+|||++.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 326 ~DFG~a~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~ 396 (454)
T 1qcf_A 326 ADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIR 396 (454)
T ss_dssp CSTTGGGGBCCHHHHT-------TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH
T ss_pred eeCCCceEcCCCceec-------cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence 9999998764322111 112346889999999988889999999999999999999 999997532211 000
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
....... ......+++++.+++.+||+.||++|||+.+|++.|+++...
T Consensus 397 ~i~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 397 ALERGYR--------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHTCC--------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHcCCC--------------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0000000 001123467789999999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=346.95 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=209.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||.||+|++. ++..||+|++..... ..+.+.+|++++++++||||+++++++... +..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeE
Confidence 468999999999999999999997 677899999975443 347789999999999999999999998654 5689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++++|.+++..... .+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+
T Consensus 80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence 99999999999999987542 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
......... ......||+.|+|||++.+..++.++||||+|+++|||++ |+.||....... ..... ....
T Consensus 152 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~i-~~~~ 222 (267)
T 3t9t_A 152 RFVLDDQYT-------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDI-STGF 222 (267)
T ss_dssp GGBCCHHHH-------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHH-HTTC
T ss_pred ccccccccc-------ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-HHHHH-hcCC
Confidence 866432211 1112457889999999988889999999999999999999 899987532210 00000 0000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
.. . ....+++.+.+++.+||+.||++||++.|++++|+++.++
T Consensus 223 ~~-----~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 223 RL-----Y---------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CC-----C---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cC-----C---------------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00 0 0011255688999999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=353.55 Aligned_cols=268 Identities=21% Similarity=0.298 Sum_probs=202.7
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----- 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----
Confidence 3468999999999999999999999899999999997432 33456788999999999999999999998765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred CcEEEEEecCCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEe
Confidence 678999999999999999875321 123689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...............
T Consensus 180 fg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 251 (310)
T 2wqm_A 180 LGLGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 251 (310)
T ss_dssp C--------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH
T ss_pred ccceeeecCCCc--------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh
Confidence 999876543211 112346899999999999989999999999999999999999999754222111111100
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1013 (1017)
. ...... ....+++++.+++.+||+.||++|||+.||++.|+++++...
T Consensus 252 ~---~~~~~~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 252 Q---CDYPPL----------------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp T---TCSCCC----------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred c---ccCCCC----------------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0 000000 001235678999999999999999999999999999887543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=361.02 Aligned_cols=245 Identities=23% Similarity=0.339 Sum_probs=203.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--------chHHHHHHHHHHHHhcCCCCceeeeeeeecC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFKSFMAECKALRNIRHRNLIKIITICSSI 774 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 774 (1017)
..++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45789999999999999999999999999999999975431 1234577899999999999999999998654
Q ss_pred CCCCCceeEEEEEeccCC-CHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 775 DSKGADFKALVFECMKNG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
+..++||||+.+| +|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 102 -----~~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 102 -----GFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp -----SEEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred -----CEEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCC
Confidence 6789999999777 9999998654 689999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~ 932 (1017)
.+||+|||+++...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......
T Consensus 168 ~~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~- 237 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGK---------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV- 237 (335)
T ss_dssp CEEECCCTTCEECCTTC---------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-
T ss_pred cEEEeecccceECCCCC---------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-
Confidence 99999999998664322 1123568999999999988776 889999999999999999999996532110
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.....+ ...+++++.+++.+||+.||++|||+.|++++-
T Consensus 238 --------------~~~~~~--------------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 238 --------------EAAIHP--------------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp --------------TTCCCC--------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred --------------hhccCC--------------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000000 001245688999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=348.62 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=203.7
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA----- 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----
Confidence 3568999999999999999999999999999999986432 22346788999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECS
T ss_pred CEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEe
Confidence 67899999999999999997653 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++....... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... .......
T Consensus 153 fg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~ 221 (279)
T 3fdn_A 153 FGWSVHAPSSR----------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISR 221 (279)
T ss_dssp CCEESCC------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHH
T ss_pred ccccccCCccc----------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HHHHHHh
Confidence 99986543211 123468999999999999899999999999999999999999997532110 0000000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
... .....+++.+.+++.+||+.||++|||+.|+++|-.
T Consensus 222 ~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 222 VEF----------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp TCC----------------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred CCC----------------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 000 000113456889999999999999999999998743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=376.35 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=207.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.++||+|+||.||+|++..+|+.||+|++.... ......+.+|++++++++||||+++++++.+. +
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----D 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-----C
Confidence 467999999999999999999999999999999997432 23446788999999999999999999998664 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence 78999999999999999976532 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......
T Consensus 331 Gla~~~~~~~---------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~ 400 (576)
T 2acx_A 331 GLAVHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERL 400 (576)
T ss_dssp TTCEECCTTC---------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHH
T ss_pred ccceecccCc---------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHH
Confidence 9998664322 11235799999999999998999999999999999999999999976432211 1111110
Q ss_pred h--cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 941 A--LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 941 ~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
. .+.. ....+++++.+++.+||+.||.+|| ++.||++|
T Consensus 401 i~~~~~~--------------------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 401 VKEVPEE--------------------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHCCCC--------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred hhccccc--------------------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 0000 0112356789999999999999999 78999876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=355.90 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=195.2
Q ss_pred hccccccCcccccCCceEEEEEeC---CCcEEEEEEEeeecC----cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
.++|++.++||+|+||.||+|++. .+++.||+|++.... ......+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-- 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence 468999999999999999999985 578999999997442 23345678899999999999999999998664
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
+..|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 94 ---~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k 161 (327)
T 3a62_A 94 ---GKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK 161 (327)
T ss_dssp ---SCEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred ---CEEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence 67899999999999999997653 688999999999999999999999 999999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....
T Consensus 162 l~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~ 232 (327)
T 3a62_A 162 LTDFGLCKESIHDG--------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDK 232 (327)
T ss_dssp ECCCSCC------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred EEeCCcccccccCC--------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHH
Confidence 99999987543211 11223579999999999999899999999999999999999999997642211 1111
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAKL 1005 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 1005 (1017)
...... . .....++.+.+++.+||+.||++|| ++.|+++|-
T Consensus 233 i~~~~~---------------------~-------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 233 ILKCKL---------------------N-------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHHTCC---------------------C-------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred HHhCCC---------------------C-------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 111000 0 0012256688999999999999999 788888764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.62 Aligned_cols=277 Identities=22% Similarity=0.378 Sum_probs=216.9
Q ss_pred cCHHHHHHhhccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeee
Q 043932 695 VSYAELSKATSEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKII 768 (1017)
Q Consensus 695 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~ 768 (1017)
+..+++....++|++.+.||+|+||.||+|++. .+++.||+|++..... .....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344556667789999999999999999999876 3578899999974432 3345788999999999999999999
Q ss_pred eeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCC----ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCC
Q 043932 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH----LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKP 844 (1017)
Q Consensus 769 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 844 (1017)
+++... +..++||||+++|+|.+++...... .....+++.+++.++.||+.||+|||++ +|+||||||
T Consensus 95 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp 166 (322)
T 1p4o_A 95 GVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 166 (322)
T ss_dssp EEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSG
T ss_pred EEEccC-----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCcc
Confidence 998654 5679999999999999999764210 0113568999999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCC
Q 043932 845 SNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923 (1017)
Q Consensus 845 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 923 (1017)
+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++||||+|+++|||++ |+.|
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 240 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEE------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred ceEEEcCCCeEEECcCccccccccccccc------cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCc
Confidence 99999999999999999998654332111 1122457889999999988889999999999999999999 8999
Q ss_pred CCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 924 TDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 924 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
|...... ........... ......+++.+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~-----~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~ 292 (322)
T 1p4o_A 241 YQGLSNE-----QVLRFVMEGGL-----------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292 (322)
T ss_dssp TTTSCHH-----HHHHHHHTTCC-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCHH-----HHHHHHHcCCc-----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8653221 11110000000 0011123567899999999999999999999999
Q ss_pred HHhhcccccc
Q 043932 1004 KLCHTRETFF 1013 (1017)
Q Consensus 1004 ~L~~~~~~~~ 1013 (1017)
+|+++.+..+
T Consensus 293 ~L~~~~~~~~ 302 (322)
T 1p4o_A 293 SIKEEMEPGF 302 (322)
T ss_dssp HHGGGSCTTH
T ss_pred HHHHhhccCC
Confidence 9999876544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=354.13 Aligned_cols=280 Identities=23% Similarity=0.320 Sum_probs=215.2
Q ss_pred CHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHh--cCCCCceeeeeeeec
Q 043932 696 SYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRN--IRHRNLIKIITICSS 773 (1017)
Q Consensus 696 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~ 773 (1017)
...--....++|++.+.||+|+||+||+|++ +++.||||++... ..+.+.+|+++++. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3333445667999999999999999999998 4889999998633 33567788888887 689999999999866
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHh--------hCCCCCceeecCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH--------HHCQPPMVHGDLKPS 845 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~ 845 (1017)
... .....++||||+++|+|.+++... .+++.+++.++.|++.||+||| +. +|+||||||+
T Consensus 108 ~~~-~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~ 176 (342)
T 1b6c_B 108 DNG-TWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSK 176 (342)
T ss_dssp CCS-SCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGG
T ss_pred cCC-ccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHH
Confidence 522 123689999999999999999754 5899999999999999999999 77 9999999999
Q ss_pred ceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCC------CcCccccchhHHHHHHHHHh
Q 043932 846 NVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS------EASMTGDVYSFGILLLELFT 919 (1017)
Q Consensus 846 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ellt 919 (1017)
||+++.++.+||+|||++........... .......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTID----IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEE----ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HEEECCCCCEEEEECCCceeccccccccc----cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence 99999999999999999986643321110 011235699999999998775 34478999999999999999
Q ss_pred C----------CCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccC
Q 043932 920 G----------RRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSM 989 (1017)
Q Consensus 920 g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 989 (1017)
| ..||............+............+.. .....++++.+.+++.+||+
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~cl~ 315 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN-----------------RWQSCEALRVMAKIMRECWY 315 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG-----------------GGGTSHHHHHHHHHHHHHCC
T ss_pred ccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcc-----------------cccchhHHHHHHHHHHHHhc
Confidence 9 67876654433333333332211111000000 01123567789999999999
Q ss_pred CCCCCCCCHHHHHHHHhhccccc
Q 043932 990 ESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 990 ~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
.||++|||+.||+++|+.+.++.
T Consensus 316 ~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 316 ANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999988754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=363.74 Aligned_cols=257 Identities=20% Similarity=0.289 Sum_probs=196.9
Q ss_pred hcccccc-CcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHh-cCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRN-IRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|.+. ++||+|+||+||+|++..+++.||||++... ..+.+|++++.+ .+||||+++++++... ..+..+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 4567766 6899999999999999999999999998632 456788888754 4899999999988642 122367
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC---CCCeEEe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVSHVG 858 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 858 (1017)
.|+||||+++|+|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence 8999999999999999986532 3689999999999999999999999 9999999999999987 7899999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc--H-H
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT--L-H 935 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~--~-~ 935 (1017)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... . .
T Consensus 207 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 277 (400)
T 1nxk_A 207 DFGFAKETTSHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277 (400)
T ss_dssp CCTTCEECC--------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH
T ss_pred ecccccccCCCC---------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH
Confidence 999998654221 112357899999999999989999999999999999999999999765332211 1 1
Q ss_pred HHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
......... . ......+++++.+++.+||+.||++|||+.|+++|-.
T Consensus 278 ~i~~~~~~~-----~-------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 278 RIRMGQYEF-----P-------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp HHHHTCCCC-----C-------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHcCcccC-----C-------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 111100000 0 0011223567899999999999999999999998743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=356.24 Aligned_cols=277 Identities=22% Similarity=0.321 Sum_probs=217.1
Q ss_pred CHHHHHHhhccccccCcccccCCceEEEEEe-----CCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeee
Q 043932 696 SYAELSKATSEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKII 768 (1017)
Q Consensus 696 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~ 768 (1017)
...++....++|++.+.||+|+||+||+|++ ..+++.||||++..... ...+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 4455666678999999999999999999985 45778999999975433 3446788999999999 799999999
Q ss_pred eeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCcc----------ccccCHHHHHHHHHHHHHHHHHHhhCCCCCce
Q 043932 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLE----------VCKLTLIQRVNIAIDVASAIEYLHHHCQPPMV 838 (1017)
Q Consensus 769 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 838 (1017)
+++... ....++||||+++|+|.+++........ ...+++.+++.++.|++.||+|||++ +|+
T Consensus 98 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~ 170 (316)
T 2xir_A 98 GACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 170 (316)
T ss_dssp EEECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred EEEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 998643 2457999999999999999987643110 12388999999999999999999999 999
Q ss_pred eecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHH
Q 043932 839 HGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELF 918 (1017)
Q Consensus 839 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 918 (1017)
||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||+||++|||+
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 244 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccc------eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHH
Confidence 9999999999999999999999999865432211 1112346789999999998889999999999999999999
Q ss_pred h-CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC
Q 043932 919 T-GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME 997 (1017)
Q Consensus 919 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 997 (1017)
+ |..||................ .... ....+++.+.+++.+||+.||.+|||
T Consensus 245 t~g~~p~~~~~~~~~~~~~~~~~-~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps 297 (316)
T 2xir_A 245 SLGASPYPGVKIDEEFCRRLKEG-TRMR--------------------------APDYTTPEMYQTMLDCWHGEPSQRPT 297 (316)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHHT-CCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hCCCCCCcccchhHHHHHHhccC-ccCC--------------------------CCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 8 999997643221111111110 0000 00112556889999999999999999
Q ss_pred HHHHHHHHhhccccc
Q 043932 998 MRDVVAKLCHTRETF 1012 (1017)
Q Consensus 998 ~~evl~~L~~~~~~~ 1012 (1017)
+.|++++|+.+.+..
T Consensus 298 ~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 298 FSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhh
Confidence 999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.71 Aligned_cols=268 Identities=24% Similarity=0.373 Sum_probs=209.8
Q ss_pred ccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
-.|...++||+|+||+||+|++..+ +..||+|++..... ...+.+.+|+.++++++||||+++++++...+ .
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----G 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----S
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----C
Confidence 3566779999999999999996443 44799999874333 34577899999999999999999999986541 3
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+.+|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Df 168 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADF 168 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCT
T ss_pred CcEEEEecccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcC
Confidence 4589999999999999998644 2688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++......... ........+|+.|+|||.+.+..++.++||||+|+++|+|++|..|+........ .......
T Consensus 169 g~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~ 243 (298)
T 3pls_A 169 GLARDILDREYYS----VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQ 243 (298)
T ss_dssp TSSCTTTTGGGGC----SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHT
T ss_pred CCcccccCCcccc----cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhc
Confidence 9998664332111 1122235688999999999999999999999999999999996666543222211 1111111
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccccc
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGR 1015 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1015 (1017)
..... ....+++.+.+++.+||+.||.+|||+.|+++.|+++.+.+.+.
T Consensus 244 ~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 244 GRRLP--------------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp TCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred CCCCC--------------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 11000 01123557899999999999999999999999999998877654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=348.57 Aligned_cols=260 Identities=21% Similarity=0.380 Sum_probs=206.1
Q ss_pred hhccccccCcccccCCceEEEEEeCC---CcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
..++|++.+.||+|+||+||+|++.. ++..||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 35689999999999999999998643 45679999987543 2345778999999999999999999998753
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEEC
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeC
Confidence 23589999999999999997654 2689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||.+......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 156 Dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~ 226 (281)
T 3cc6_A 156 DFGLSRYIEDEDYY-------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGV 226 (281)
T ss_dssp CCCGGGCC----------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHH
T ss_pred ccCCCccccccccc-------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHH
Confidence 99999866432211 1122457889999999988889999999999999999998 999997532221 1111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
....... .....+++.+.+++.+||+.||++||++.|++++|+.+.+.
T Consensus 227 ~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 227 LEKGDRL--------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCC--------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1100000 00112356789999999999999999999999999988653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=357.34 Aligned_cols=260 Identities=24% Similarity=0.401 Sum_probs=202.6
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEE----EEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIV----AVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.++|++.++||+|+||+||+|++..+++.| |+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence 468999999999999999999998777654 66666433 334567899999999999999999999998653
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
..++|+||+++|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 90 --~~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~ 159 (327)
T 3lzb_A 90 --TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp --SEEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred --CceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEc
Confidence 36899999999999999987643 689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++........ .......||+.|+|||++.+..++.++||||+||++|||++ |+.||....... ....
T Consensus 160 DfG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~ 231 (327)
T 3lzb_A 160 DFGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI 231 (327)
T ss_dssp CTTC----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH
T ss_pred cCcceeEccCcccc------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHH
Confidence 99999876433211 11122457889999999999899999999999999999999 999997643221 1111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
....... .....++..+.+++.+||+.||.+||++.|+++.|+.+.+.
T Consensus 232 ~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 232 LEKGERL--------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHTTCCC--------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHcCCCC--------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111000 00112355688999999999999999999999999988743
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=348.75 Aligned_cols=255 Identities=23% Similarity=0.335 Sum_probs=199.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|.+.++||+|+||+||+|++..++..||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-----HNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC-----CeE
Confidence 468999999999999999999999999999999997554 33457889999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe---CCCCCeEEee
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGD 859 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~D 859 (1017)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 999999999999999865321 123689999999999999999999999 99999999999999 4568899999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++....... ......||+.|+|||++.+ .++.++||||+|+++|||++|+.||........ .....
T Consensus 171 fg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~ 238 (285)
T 3is5_A 171 FGLAELFKSDE---------HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKAT 238 (285)
T ss_dssp CCCCCC-------------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred eecceecCCcc---------cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--Hhhhc
Confidence 99997654322 1123468999999998864 689999999999999999999999976422110 00000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+. . .......++.+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~---------~---------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 239 YKEPN---------Y---------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HCCCC---------C---------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCCcc---------c---------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0 00001124568899999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=374.56 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=196.6
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.++||+|+||.||+|++..+++.||||++... .......+.+|+.+++.++||||+++++++... +
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----D 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----T
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----C
Confidence 46899999999999999999999999999999999743 233446778899999999999999999998765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred EEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence 7899999999999999997653 68999999999999999999998 8 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+|+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......
T Consensus 293 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~ 363 (446)
T 4ejn_A 293 FGLCKEGIKDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFELILM 363 (446)
T ss_dssp CCCCCTTCC-------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred CCCceeccCCC--------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHHHh
Confidence 99997543211 11223679999999999999999999999999999999999999997542210 0000000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAKL 1005 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 1005 (1017)
... . .....++++.+++.+||+.||.+|| ++.|+++|-
T Consensus 364 ~~~---------------------~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 364 EEI---------------------R-------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp CCC---------------------C-------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCC---------------------C-------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 000 0 0112356788999999999999999 999998763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=370.60 Aligned_cols=256 Identities=30% Similarity=0.388 Sum_probs=208.2
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||.||+|++. ++.||||+++... ..+.+.+|++++++++||||+++++++... ....
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~ 262 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 262 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCce
Confidence 3568999999999999999999985 7799999997543 457899999999999999999999998653 1358
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++|+|.++++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 999999999999999986532 2478999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
++...... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ........
T Consensus 336 a~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~ 402 (450)
T 1k9a_A 336 TKEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG 402 (450)
T ss_dssp CEECC-----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTT
T ss_pred cccccccc-----------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC
Confidence 97543211 11246889999999999999999999999999999998 999997643221 11111100
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
.. ......+++++.+++.+||+.||++|||+.|+++.|+.+...-
T Consensus 403 ~~--------------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 403 YK--------------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CC--------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 00 0011234678899999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=362.68 Aligned_cols=283 Identities=23% Similarity=0.291 Sum_probs=201.5
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-----chHHHHHHHHHHHHhcCCCCceeeeeeeecCC
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-----GAFKSFMAECKALRNIRHRNLIKIITICSSID 775 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 775 (1017)
....++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 84 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK- 84 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-
Confidence 3446789999999999999999999998999999999874322 1235678999999999999999999998654
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCe
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
+..++||||+++ +|.+++..... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 85 ----~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 85 ----SNISLVFDFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp ----TCCEEEEECCSE-EHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred ----CceEEEEEcCCC-CHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence 568999999986 89999876542 678889999999999999999999 99999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
||+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|.+||....... ..
T Consensus 152 kl~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~ 222 (346)
T 1ua2_A 152 KLADFGLAKSFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QL 222 (346)
T ss_dssp EECCCGGGSTTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred EEEecccceeccCCc--------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HH
Confidence 999999998654321 111235689999999998764 58999999999999999999999987643221 11
Q ss_pred HHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
..............+.+.....++.................+++++.+++.+||+.||++|||+.|++++-.
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 111111111000000000000000000000000001112334577999999999999999999999998743
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=361.35 Aligned_cols=246 Identities=28% Similarity=0.329 Sum_probs=192.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHH-HHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKA-LRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.++||+|+||+||+|++..+++.||+|++..... ...+.+.+|..+ ++.++||||+++++++...
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~----- 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA----- 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-----
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-----
Confidence 4689999999999999999999999999999999975432 233456667776 5678999999999998765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+|
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence 67899999999999999998653 688999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......
T Consensus 183 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~ 253 (373)
T 2r5t_A 183 FGLCKENIEHN--------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILN 253 (373)
T ss_dssp CCBCGGGBCCC--------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHH
T ss_pred CccccccccCC--------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHh
Confidence 99997533211 12234679999999999999999999999999999999999999997642211 0111110
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRD 1000 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1000 (1017)
... . ....++..+.+++.+||+.||.+||++.+
T Consensus 254 ~~~---------------------~-------~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 254 KPL---------------------Q-------LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp SCC---------------------C-------CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ccc---------------------C-------CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 000 0 00122456889999999999999999853
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=358.28 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=202.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.+.|+..+.||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++... +
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----C
Confidence 3568999999999999999999999999999999975432 2346788999999999999999999998765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||++ |++.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 198 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF 198 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred eEEEEEecCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeec
Confidence 7899999997 58888886543 2789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|++...... ....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .....
T Consensus 199 G~a~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~ 265 (348)
T 1u5q_A 199 GSASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHI 265 (348)
T ss_dssp TTCBSSSSB------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHH
T ss_pred cCceecCCC------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 999765321 1246899999999984 4578999999999999999999999996532211 01111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1007 (1017)
.....+. . ....+++.+.+++.+||+.||++|||+.|++++..-
T Consensus 266 ~~~~~~~---------~-----------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 266 AQNESPA---------L-----------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp HHSCCCC---------C-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HhcCCCC---------C-----------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 1100000 0 001224568899999999999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.83 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=203.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc------chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--- 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC---
Confidence 4579999999999999999999999999999999975432 1357889999999999999999999998654
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC----
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---- 853 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 853 (1017)
+..++||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 81 --TDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp --SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSC
T ss_pred --CeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCC
Confidence 67899999999999999997643 689999999999999999999999 999999999999998877
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
.+||+|||.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... .
T Consensus 150 ~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~ 219 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-T 219 (283)
T ss_dssp CEEECCCTTCEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H
T ss_pred ceEEEecccceeccCCC---------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-H
Confidence 89999999998654321 1122468999999999998899999999999999999999999997642210 0
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......... ... ......+++.+.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~~~~----------~~~--------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 220 LTNISAVNY----------DFD--------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHHTTCC----------CCC--------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHhHhccc----------CCc--------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 100000000 000 01112335678999999999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=358.31 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=195.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCC--CCceeeeeeeecCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRH--RNLIKIITICSSIDSKG 778 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~ 778 (1017)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++| |||+++++++...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~---- 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD---- 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC----
Confidence 3467999999999999999999985 688999999975433 334678899999999976 9999999998755
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
...++|||+ .+++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++ ++.+||+
T Consensus 82 -~~~~lv~e~-~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~ 149 (343)
T 3dbq_A 82 -QYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLI 149 (343)
T ss_dssp -SEEEEEECC-CSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEEC
T ss_pred -CEEEEEEeC-CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEe
Confidence 678999995 5779999998754 689999999999999999999999 999999999999997 6789999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC-----------CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----------SEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 150 DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 150 DFGIANQMQPDTT------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp CCSSSCCC------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ecccccccCcccc------cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 9999986643221 111223579999999999864 57889999999999999999999999753
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.................. .....+..+.+++.+||+.||.+|||+.|+++|-.
T Consensus 224 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 224 INQISKLHAIIDPNHEIE--------------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp CSHHHHHHHHHCTTSCCC--------------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred hhHHHHHHHHhcCCcccC--------------------------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 221111111110000000 00011346789999999999999999999998743
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=347.46 Aligned_cols=253 Identities=24% Similarity=0.396 Sum_probs=186.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS----- 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----
Confidence 3468999999999999999999998899999999997432 23347789999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECC
T ss_pred CeEEEEEecCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEe
Confidence 67899999999999999998654 2689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||.+........ ......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ . ..
T Consensus 156 fg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~---~~ 223 (278)
T 3cok_A 156 FGLATQLKMPHE--------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-L---NK 223 (278)
T ss_dssp CTTCEECC------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------
T ss_pred ecceeeccCCCC--------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-H---HH
Confidence 999986542211 11224689999999999988899999999999999999999999976432211 0 00
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
. .... .. ....++.++.+++.+||+.||++|||+.|++++-
T Consensus 224 ~-~~~~---~~---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 224 V-VLAD---YE---------------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp C-CSSC---CC---------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred H-hhcc---cC---------------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 0 0000 00 0011245688999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=358.46 Aligned_cols=279 Identities=23% Similarity=0.314 Sum_probs=204.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.++||+|+||.||+|++..+++.||+|++...... ..+.+.+|++++++++||||+++++++... +.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----KR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-----CE
Confidence 46899999999999999999999999999999998654432 345678999999999999999999998765 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++++|.++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence 899999999999988876543 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
++........ ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||......... ......
T Consensus 170 ~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~ 240 (331)
T 4aaa_A 170 FARTLAAPGE--------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL-YHIMMC 240 (331)
T ss_dssp TC--------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHH
T ss_pred CceeecCCcc--------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHH
Confidence 9976543211 11224689999999999775 6899999999999999999999999765332111 111111
Q ss_pred h--cCchhhhhccch-hhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 941 A--LPEKVIEIVDPL-LLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 941 ~--~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
. ..+......... ......................+++.+.+++.+||+.||++|||+.|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp HCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred hCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0 000000000000 0000000000000001112224567899999999999999999999998763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=362.07 Aligned_cols=279 Identities=20% Similarity=0.261 Sum_probs=192.7
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 779 (1017)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+++.+|+++++.++||||+++++++..... ...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3578999999999999999999999999999999986432 2345678899999999999999999999865321 122
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~D 175 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 175 (367)
T ss_dssp CCCEEEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CeEEEEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEee
Confidence 5579999999 67999988652 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+....
T Consensus 176 FG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~ 243 (367)
T 2fst_X 176 FGLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLIL 243 (367)
T ss_dssp --------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH
T ss_pred cccccccccc-----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 9999764321 123578999999999877 67899999999999999999999999764322 1122222
Q ss_pred HhhcCc--hhhhhccchhhHHHHhhcc-hhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPE--KVIEIVDPLLLIEVMANNS-MIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~--~~~~~~d~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...... .....+.......+..... ............+++.+.+++.+||+.||++|||+.|+++|
T Consensus 244 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 244 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 211111 1111111111111111000 00001111222346778999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=353.08 Aligned_cols=274 Identities=20% Similarity=0.272 Sum_probs=206.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|++... ..+.+.+|++++++++ ||||+++++++.... ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCce
Confidence 46899999999999999999999999999999998633 3467889999999997 999999999986532 2568
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-CeEEeecc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VSHVGDFG 861 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG 861 (1017)
++||||+++++|.+++. .+++.++..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 109 ~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg 176 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG 176 (330)
T ss_dssp EEEEECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence 99999999999999885 478889999999999999999999 999999999999999776 89999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||................
T Consensus 177 ~a~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~ 247 (330)
T 3nsz_A 177 LAEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247 (330)
T ss_dssp TCEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred CceEcCCCC---------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence 998654322 1122468999999999877 678999999999999999999999996543332222222222
Q ss_pred hcCchhhhhccchh---h---HHHHhhc--chhHHHh-HHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLL---L---IEVMANN--SMIQEDI-RAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l---~---~~~~~~~--~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+...+.++... . .+..... ..+.... ......+++++.+++.+||+.||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22222111111000 0 0000000 0000000 00111246788999999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=362.46 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=195.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcC--CCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIR--HRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~ 779 (1017)
..+|++.+.||+|+||+||+|.+.. ++.||||++.... ....+.+.+|++++++++ ||||+++++++...
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~----- 128 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 128 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----
Confidence 3569999999999999999999874 8899999997543 234577899999999996 59999999998765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..|+||| +.+++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++ ++.+||+|
T Consensus 129 ~~~~lv~E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~D 197 (390)
T 2zmd_A 129 QYIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 197 (390)
T ss_dssp SEEEEEEE-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECC
T ss_pred CEEEEEEe-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEe
Confidence 66899999 56789999998754 678899999999999999999999 999999999999995 58999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccC-----------CCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----------SEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 198 FG~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 198 FGIANQMQPDTTS------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CSSSCCC---------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCccccccCCCcc------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 9999866432211 11223579999999999865 368899999999999999999999997532
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.. ...... ++++..... .....+..+.+++.+||+.||.+|||+.|++++-
T Consensus 272 ~~---~~~~~~---------~~~~~~~~~--------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 272 NQ---ISKLHA---------IIDPNHEIE--------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CH---HHHHHH---------HHCTTSCCC--------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HH---HHHHHH---------HhCccccCC--------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 21 111111 111000000 0001134678999999999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=357.11 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=206.9
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--------chHHHHHHHHHHHHhc-CCCCceeee
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFKSFMAECKALRNI-RHRNLIKII 768 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~ 768 (1017)
.......++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 3445566789999999999999999999998999999999975432 1245678999999999 799999999
Q ss_pred eeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceE
Q 043932 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848 (1017)
Q Consensus 769 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 848 (1017)
+++... ...++||||+++++|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+||+
T Consensus 167 ~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl 232 (365)
T 2y7j_A 167 DSYESS-----SFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENIL 232 (365)
T ss_dssp EEEEBS-----SEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred EEEeeC-----CEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 998654 67899999999999999997543 689999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccC------CCcCccccchhHHHHHHHHHhCCC
Q 043932 849 LDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG------SEASMTGDVYSFGILLLELFTGRR 922 (1017)
Q Consensus 849 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~ 922 (1017)
++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPGE---------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred ECCCCCEEEEecCcccccCCCc---------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 9999999999999998664322 1123579999999999863 358899999999999999999999
Q ss_pred CCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 923 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
||...... .............. ......++..+.+++.+||+.||++|||+.|++
T Consensus 304 pf~~~~~~-~~~~~i~~~~~~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 358 (365)
T 2y7j_A 304 PFWHRRQI-LMLRMIMEGQYQFS------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQAL 358 (365)
T ss_dssp SSCCSSHH-HHHHHHHHTCCCCC------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCCHH-HHHHHHHhCCCCCC------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 99753211 00000000000000 001122356789999999999999999999999
Q ss_pred HH
Q 043932 1003 AK 1004 (1017)
Q Consensus 1003 ~~ 1004 (1017)
++
T Consensus 359 ~h 360 (365)
T 2y7j_A 359 QH 360 (365)
T ss_dssp HS
T ss_pred cC
Confidence 75
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=371.88 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=207.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|.+.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++... +
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-----T 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-----C
Confidence 367999999999999999999999999999999997432 23456788999999999999999999998664 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||++||+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEeccCCCHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence 78999999999999999976532 123689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........
T Consensus 334 Gla~~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~ 404 (543)
T 3c4z_A 334 GLAVELKAGQT--------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQR 404 (543)
T ss_dssp TTCEECCTTCC--------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHH
T ss_pred ceeeeccCCCc--------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHH
Confidence 99986543221 1223579999999999999999999999999999999999999997643221 11111111
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM-----RDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 1004 (1017)
..... . .....+++.+.+++.+||+.||++||++ .|+++|
T Consensus 405 i~~~~-----------------~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 405 VLEQA-----------------V-------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHCC-----------------C-------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred Hhhcc-----------------c-------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 00000 0 0011235678899999999999999964 677654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=351.45 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=203.7
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|.+.+.||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++... +..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 81 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-----THY 81 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC-----CEE
Confidence 356899999999999999999999999999999999865544456788999999999999999999998654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe---CCCCCeEEee
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGD 859 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~D 859 (1017)
++||||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~D 152 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITD 152 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred EEEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEcc
Confidence 99999999999999987643 689999999999999999999999 99999999999999 7889999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... .......
T Consensus 153 fg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~ 221 (304)
T 2jam_A 153 FGLSKMEQNG----------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKE 221 (304)
T ss_dssp CSTTCCCCCB----------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred CCcceecCCC----------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHc
Confidence 9998754321 1122468999999999999899999999999999999999999997542210 0111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.... . . ......+++.+.+++.+||+.||++|||+.|++++-
T Consensus 222 ~~~~-----~-~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 222 GYYE-----F-E------------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp CCCC-----C-C------------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCCC-----C-C------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 0000 0 0 001112356789999999999999999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=356.22 Aligned_cols=268 Identities=24% Similarity=0.392 Sum_probs=210.2
Q ss_pred hhccccccCcccccCCceEEEEEeC-------CCcEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeeeeeeec
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILG-------EDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKIITICSS 773 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 773 (1017)
..++|++.+.||+|+||+||+|++. .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999975 3567899999975432 3456788999999999 89999999999865
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLK 843 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 843 (1017)
. +..++||||+++|+|.+++...... .....+++.+++.++.||+.||+|||++ +|+|||||
T Consensus 113 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk 184 (334)
T 2pvf_A 113 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA 184 (334)
T ss_dssp S-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred C-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCc
Confidence 4 5689999999999999999875421 1123589999999999999999999999 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCC
Q 043932 844 PSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRR 922 (1017)
Q Consensus 844 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~ 922 (1017)
|+||+++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++||||+||++|||++ |+.
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEE------CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cceEEEcCCCCEEEcccccccccccccccc------ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999998665332111 1122457889999999988889999999999999999999 999
Q ss_pred CCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 923 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
||....... ........... .....++..+.+++.+||+.||.+|||+.|++
T Consensus 259 p~~~~~~~~--~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 310 (334)
T 2pvf_A 259 PYPGIPVEE--LFKLLKEGHRM--------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310 (334)
T ss_dssp SSTTCCHHH--HHHHHHHTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcCcCCHHH--HHHHHhcCCCC--------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 997542210 00000000000 01112356789999999999999999999999
Q ss_pred HHHhhccccc
Q 043932 1003 AKLCHTRETF 1012 (1017)
Q Consensus 1003 ~~L~~~~~~~ 1012 (1017)
++|+.+.+..
T Consensus 311 ~~L~~l~~~~ 320 (334)
T 2pvf_A 311 EDLDRILTLT 320 (334)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHhcc
Confidence 9999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=355.88 Aligned_cols=288 Identities=23% Similarity=0.307 Sum_probs=207.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCC---CC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDS---KG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 778 (1017)
.++|++.++||+|+||+||+|++..+++.||+|++..... .....+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4689999999999999999999999999999999864432 234678899999999999999999999876432 11
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
.+..++||||+++ +|.+.+..... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence 3568999999976 88888766542 689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++.+....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .....
T Consensus 167 Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i 241 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQ----PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALI 241 (351)
T ss_dssp CCTTCEECCCCSSSS----CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred cchhccccccccccc----ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 999998765322111 112233578999999999876 458999999999999999999999998643221 11111
Q ss_pred HHhh--cCchhhhhccchhhHHHHhhc--chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 938 AKIA--LPEKVIEIVDPLLLIEVMANN--SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 938 ~~~~--~~~~~~~~~d~~l~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.... .+.......+........... ...............+.+.+++.+||+.||++|||+.|+++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 1111 111111111100000000000 0000000001111246689999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.89 Aligned_cols=263 Identities=27% Similarity=0.442 Sum_probs=202.4
Q ss_pred hccccccCcccccCCceEEEEEeCCC----cEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED----EMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.++|++.+.||+|+||+||+|++..+ +..||+|++..... .....+.+|++++++++||||+++++++...
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 118 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY---- 118 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS----
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC----
Confidence 35788889999999999999998644 35699999975432 3346788999999999999999999998654
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..++||||+++|+|.+++..... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 119 -~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~ 189 (333)
T 1mqb_A 119 -KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVS 189 (333)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred -CCcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEEC
Confidence 668999999999999999986542 689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++......... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....
T Consensus 190 Dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~ 262 (333)
T 1mqb_A 190 DFGLSRVLEDDPEAT-----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKA 262 (333)
T ss_dssp CCCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH
T ss_pred CCCcchhhccccccc-----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHH
Confidence 999998764322111 11112346889999999998899999999999999999999 999996532210 0000
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
...... ......+++.+.+++.+||+.||++||++.|++++|+.+.+..
T Consensus 263 ~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 263 INDGFR--------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHTTCC--------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHCCCc--------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 000000 0001123567899999999999999999999999999876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=358.97 Aligned_cols=276 Identities=21% Similarity=0.314 Sum_probs=215.5
Q ss_pred HHHHhhccccccCcccccCCceEEEEEeCCCcE-----EEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeeeeee
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDEM-----IVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKIITIC 771 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 771 (1017)
++....++|++.+.||+|+||.||+|.+..++. .||+|++..... ...+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344556789999999999999999999876553 799999975432 3456789999999999 899999999998
Q ss_pred ecCCCCCCceeEEEEEeccCCCHHHHHhhCCCC--------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCC
Q 043932 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDH--------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLK 843 (1017)
Q Consensus 772 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 843 (1017)
... +..++||||+++|+|.+++...... .....+++..++.++.||+.||+|||++ +|+|||||
T Consensus 120 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 191 (333)
T 2i1m_A 120 THG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVA 191 (333)
T ss_dssp CSS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred ecC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcc
Confidence 654 5689999999999999999754210 0123579999999999999999999999 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCC
Q 043932 844 PSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRR 922 (1017)
Q Consensus 844 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~ 922 (1017)
|+||+++.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 265 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNY------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTS------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred cceEEECCCCeEEECccccccccccccce------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999865432211 11122457889999999988889999999999999999999 999
Q ss_pred CCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 923 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
||........ ............ ....+++.+.+++.+||+.||.+|||+.|++
T Consensus 266 p~~~~~~~~~-~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 318 (333)
T 2i1m_A 266 PYPGILVNSK-FYKLVKDGYQMA--------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318 (333)
T ss_dssp SSTTCCSSHH-HHHHHHHTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCcccchhHH-HHHHHhcCCCCC--------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 9976432211 111111111000 0011245788999999999999999999999
Q ss_pred HHHhhcccccccc
Q 043932 1003 AKLCHTRETFFGR 1015 (1017)
Q Consensus 1003 ~~L~~~~~~~~~~ 1015 (1017)
++|+++.+.....
T Consensus 319 ~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 319 SFLQEQAQEDRRE 331 (333)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHhhhcc
Confidence 9999987765443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=372.07 Aligned_cols=253 Identities=25% Similarity=0.317 Sum_probs=204.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..++|++.++||+|+||+||+|++..+++.||||++.... ......+.+|++++++++||||+++++++... .
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----S 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-----C
Confidence 3568999999999999999999999999999999996432 33457889999999999999999999998754 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC---CCCCeEE
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVSHV 857 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl 857 (1017)
..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++ .++.+||
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence 7899999999999999987653 689999999999999999999999 999999999999995 4568999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||....... .....
T Consensus 166 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i 234 (486)
T 3mwu_A 166 IDFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRV 234 (486)
T ss_dssp CSCSCTTTBCCC-------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH
T ss_pred EECCcCeECCCCC---------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 9999998654321 1223569999999999876 58999999999999999999999997642211 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.....+.. ......+++.+.+++.+||+.||.+|||+.|+++|
T Consensus 235 ~~~~~~~~------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 235 ETGKYAFD------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHTCCCSC------------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HhCCCCCC------------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111000 00112235678899999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=364.17 Aligned_cols=283 Identities=18% Similarity=0.220 Sum_probs=201.6
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC----
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS---- 776 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 776 (1017)
....++|++.++||+|+||+||+|++..+++.||||++...... ..+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999999999999999998644322 2479999999999999999999865432
Q ss_pred -----------------------------CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHH
Q 043932 777 -----------------------------KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827 (1017)
Q Consensus 777 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~ 827 (1017)
.+..+.++||||+++ +|.+.+..... ....+++..+..++.||+.||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR--SGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHH
Confidence 234568899999985 88877764211 1237899999999999999999
Q ss_pred HHhhCCCCCceeecCCCCceEeC-CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccc
Q 043932 828 YLHHHCQPPMVHGDLKPSNVLLD-HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTG 905 (1017)
Q Consensus 828 ~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 905 (1017)
|||++ +|+||||||+||+++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---------PSVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---------CCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---------CCcCcccCCCccCHHHhcCCCCCCcch
Confidence 99999 999999999999997 68999999999998664322 11235689999999998775 489999
Q ss_pred cchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhh--ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHH
Q 043932 906 DVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI--VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRI 983 (1017)
Q Consensus 906 DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 983 (1017)
||||+||++|||++|+.||......+ ................+ .++..... .................+++.+.++
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEV-RFPTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--C-CCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccc-cCCccCcccHHhhCCCCCCHHHHHH
Confidence 99999999999999999998643322 12222221111110000 00000000 0000000000011122346678999
Q ss_pred HhhccCCCCCCCCCHHHHHHH
Q 043932 984 GVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 984 i~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+.+||+.||++|||+.|+++|
T Consensus 302 i~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=355.35 Aligned_cols=280 Identities=25% Similarity=0.363 Sum_probs=212.3
Q ss_pred hccc-cccCcccccCCceEEEEEe----CCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEF-ASSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++| ++.+.||+|+||+||+|.+ ..+++.||||++..... ...+.+.+|++++++++||||+++++++....
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG-- 106 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC--
Confidence 3455 9999999999999988764 34789999999975432 34567899999999999999999999987542
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
....++||||+++|+|.+++... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 107 -~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl 175 (318)
T 3lxp_A 107 -AASLQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKI 175 (318)
T ss_dssp -TTEEEEEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred -CceEEEEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEE
Confidence 36789999999999999999764 489999999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||++.......... .......||..|+|||++.+..++.++||||+|+++|||++|+.||....... .
T Consensus 176 ~Dfg~a~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~ 245 (318)
T 3lxp_A 176 GDFGLAKAVPEGHEYY-----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----L 245 (318)
T ss_dssp CCGGGCEECCTTCSEE-----EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----H
T ss_pred CCcccccccccccccc-----ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----h
Confidence 9999998765432111 11122458889999999998889999999999999999999999986532110 0
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1014 (1017)
............. .......... .......+++++.+++.+||+.||++|||+.|+++.|+.+.+++.+
T Consensus 246 ~~~~~~~~~~~~~---~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 246 ELIGIAQGQMTVL---RLTELLERGE-----RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHCSCCHHHHHH---HHHHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred hhhcccccchhHH---HHHHHHhccc-----CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 0000000000000 0000000000 0011223567899999999999999999999999999999887754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=357.94 Aligned_cols=280 Identities=18% Similarity=0.192 Sum_probs=200.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 780 (1017)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999999999999999997532 2345678899999999999999999999865432 2234
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++ +|.+++.. .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence 78999999975 88888852 578899999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........
T Consensus 172 g~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~ 241 (371)
T 2xrw_A 172 GLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQ 241 (371)
T ss_dssp CC-------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-
T ss_pred eccccccccc---------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 9998654221 1123578999999999999899999999999999999999999997643211 11111111
Q ss_pred hcC--chhhhhccchhhHHHHhhcc----hhH--------HHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 941 ALP--EKVIEIVDPLLLIEVMANNS----MIQ--------EDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 941 ~~~--~~~~~~~d~~l~~~~~~~~~----~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
... ......+.+........... .+. +.........++.+.+++.+||+.||++|||+.|+++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000 00111111111000000000 000 000112234567899999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.92 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=208.3
Q ss_pred HHhhccccccC-cccccCCceEEEEE--eCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCC
Q 043932 701 SKATSEFASSN-MIGQGSFGSVYKGI--LGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSID 775 (1017)
Q Consensus 701 ~~~~~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 775 (1017)
....++|++.+ .||+|+||+||+|. ...+++.||||++.... ....+++.+|++++++++||||+++++++..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-- 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC--
Confidence 33456888888 99999999999995 45678899999997543 2335788999999999999999999999832
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCe
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
+..++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 90 ----~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~ 156 (291)
T 1xbb_A 90 ----ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYA 156 (291)
T ss_dssp ----SSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ----CCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcE
Confidence 45789999999999999998753 689999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccH
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTL 934 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 934 (1017)
||+|||++........... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 157 kl~Dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~ 229 (291)
T 1xbb_A 157 KISDFGLSKALRADENYYK-----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV 229 (291)
T ss_dssp EECCCTTCEECCTTCSEEE-----C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH
T ss_pred EEccCCcceeeccCCCccc-----ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HH
Confidence 9999999987643321111 1112346789999999988889999999999999999999 99999764221 11
Q ss_pred HHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
.......... .....+++.+.+++.+||+.||++||++.|+++.|+.+..+.
T Consensus 230 ~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 230 TAMLEKGERM--------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1111100000 001133567899999999999999999999999999887654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=344.27 Aligned_cols=263 Identities=22% Similarity=0.354 Sum_probs=209.6
Q ss_pred hccccccC-cccccCCceEEEEEeC--CCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSN-MIGQGSFGSVYKGILG--EDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++.... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------
Confidence 45677766 9999999999999864 467889999997543 3345778999999999999999999999832
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~D 153 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD 153 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECc
Confidence 44799999999999999997543 2689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||++.......... .......||+.|+|||++.+..++.++||||+|+++|||++ |+.||...... ......
T Consensus 154 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i 226 (287)
T 1u59_A 154 FGLSKALGADDSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFI 226 (287)
T ss_dssp CTTCEECTTCSCEE-----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHH
T ss_pred ccceeeeccCccee-----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH
Confidence 99998764332111 11122357899999999988889999999999999999998 99999764221 111111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1013 (1017)
...... .....+++.+.+++.+||+.||++||++.|++++|+.+..+..
T Consensus 227 ~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 227 EQGKRM--------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp HTTCCC--------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcCCcC--------------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 100000 0111346678999999999999999999999999999876554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=345.53 Aligned_cols=258 Identities=22% Similarity=0.343 Sum_probs=207.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC------
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS------ 776 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 776 (1017)
...+|++.+.||+|+||.||+|++..+++.||+|++.... +.+.+|++++++++||||+++++++...+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4568999999999999999999999899999999997543 346789999999999999999998754211
Q ss_pred -----CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC
Q 043932 777 -----KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 851 (1017)
Q Consensus 777 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 851 (1017)
......++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 12356899999999999999997643 13689999999999999999999999 9999999999999999
Q ss_pred CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccC
Q 043932 852 DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEG 931 (1017)
Q Consensus 852 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 931 (1017)
++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|..|+....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 225 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG---------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--- 225 (284)
T ss_dssp TTEEEECCCTTCEESSCCS---------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---
T ss_pred CCCEEECcchhheeccccc---------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---
Confidence 9999999999998664322 1122468999999999999899999999999999999999998864311
Q ss_pred ccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 932 LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
..... ..+.. ....++..+.+++.+||+.||.+|||+.|++++|+.++++
T Consensus 226 ----~~~~~--------~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 226 ----KFFTD--------LRDGI------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ----HHHHH--------HHTTC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ----HHHHH--------hhccc------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 00000 00000 0011245678999999999999999999999999998876
Q ss_pred cc
Q 043932 1012 FF 1013 (1017)
Q Consensus 1012 ~~ 1013 (1017)
..
T Consensus 276 ~~ 277 (284)
T 2a19_B 276 PE 277 (284)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=352.25 Aligned_cols=283 Identities=20% Similarity=0.294 Sum_probs=202.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-------
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS------- 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 776 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++........+++.+|++++++++||||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999999999999999987766667889999999999999999999998754311
Q ss_pred --CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC-CCC
Q 043932 777 --KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDM 853 (1017)
Q Consensus 777 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~ 853 (1017)
......++||||++ |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++ .++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 22367899999997 5999998653 588999999999999999999999 999999999999997 567
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 932 (1017)
.+||+|||+++........ ........||..|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 232 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSH-----KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE- 232 (320)
T ss_dssp EEEECCCTTCBCC-------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred eEEEccCccccccCCCccc-----ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence 9999999999866432111 111223467999999998865 678999999999999999999999997643221
Q ss_pred cHHHHHHhhc-Cc--hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 933 TLHEFAKIAL-PE--KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 933 ~~~~~~~~~~-~~--~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.......... .. ...+.... ......................+++++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhcCCCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1111111100 00 00000000 000000000000000111222456789999999999999999999999876
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=367.80 Aligned_cols=330 Identities=22% Similarity=0.221 Sum_probs=222.1
Q ss_pred ccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcc
Q 043932 271 NLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSL 350 (1017)
Q Consensus 271 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L 350 (1017)
+++.|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|+++..... .+.++++|
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L 106 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLG------VFTGLSNL 106 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTT------SSTTCTTC
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcc------cccCCCCC
Confidence 445555555555544445555555555555555555555555555555555555555555433322 13345555
Q ss_pred cEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccc
Q 043932 351 KILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYK 430 (1017)
Q Consensus 351 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 430 (1017)
++|+|++|++.+..|..+..+ .+|++|++++|.++++.+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++
T Consensus 107 ~~L~Ls~n~i~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~ 185 (477)
T 2id5_A 107 TKLDISENKIVILLDYMFQDL-YNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185 (477)
T ss_dssp CEEECTTSCCCEECTTTTTTC-TTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEES
T ss_pred CEEECCCCccccCChhHcccc-ccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCC
Confidence 555555555554333333332 2355555555555555566666666677777777766666666666666666666666
Q ss_pred cccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCc
Q 043932 431 NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSL 510 (1017)
Q Consensus 431 N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~ 510 (1017)
|.+++..+..|.++++|++|++++|.+.+.+|.......+|+.|++++|+++ +..
T Consensus 186 n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-------------------------~~~ 240 (477)
T 2id5_A 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-------------------------AVP 240 (477)
T ss_dssp CCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-------------------------SCC
T ss_pred CcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-------------------------ccC
Confidence 6666655566666666666666666655555555444445555555555554 333
Q ss_pred cccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccC
Q 043932 511 PLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLS 590 (1017)
Q Consensus 511 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 590 (1017)
+..+..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..++
T Consensus 241 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 320 (477)
T 2id5_A 241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVG 320 (477)
T ss_dssp HHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGG
T ss_pred HHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCc
Confidence 35678889999999999999988888899999999999999999999999999999999999999999988888889999
Q ss_pred CCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCcCC
Q 043932 591 FLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDE 632 (1017)
Q Consensus 591 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~ 632 (1017)
+|+.|+|++|++.+.++..+.+.......+.++...|+.|..
T Consensus 321 ~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~ 362 (477)
T 2id5_A 321 NLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEF 362 (477)
T ss_dssp GCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred ccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCchH
Confidence 999999999999988775444444555678888889987764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=344.85 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=200.5
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
++|....+||+|+||.||+|++..+++.||+|++........+.+.+|+.+++.++||||+++++++... +..++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEE
Confidence 3455566999999999999999999999999999876666668899999999999999999999998765 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-CCCeEEeecccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVSHVGDFGLA 863 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a 863 (1017)
||||+++++|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||.+
T Consensus 97 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEECCSEEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEeCCCCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccc
Confidence 9999999999999987532 23567889999999999999999999 9999999999999987 899999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCC--cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE--ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.................
T Consensus 171 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 242 (295)
T 2clq_A 171 KRLAGIN--------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242 (295)
T ss_dssp EESCC-------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC
T ss_pred cccCCCC--------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc
Confidence 8654321 1112356899999999987643 78999999999999999999999965322111000000000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. + .....+++++.+++.+||+.||++||++.|++++
T Consensus 243 ~~--------~------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 243 VH--------P------------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CC--------C------------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cc--------c------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0 0111235678899999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=358.85 Aligned_cols=277 Identities=21% Similarity=0.316 Sum_probs=205.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++... +..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEE
Confidence 458999999999999999999999999999999997553 33456789999999999999999999998765 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 178 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EEEEECCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCC
Confidence 99999999999999998653 6899999999999999999999831 799999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||........ ........
T Consensus 179 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~ 246 (360)
T 3eqc_A 179 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQV 246 (360)
T ss_dssp CHHHHHHC--------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH--HHHHC---
T ss_pred Cccccccc----------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccc
Confidence 97553211 1224689999999999999999999999999999999999999976432211 00000000
Q ss_pred Cchhhhhc-cchh----hHHHH--h-hcchhHHHhH---------HhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 943 PEKVIEIV-DPLL----LIEVM--A-NNSMIQEDIR---------AKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 943 ~~~~~~~~-d~~l----~~~~~--~-~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
........ .... ...+. . .......... .....++.++.+++.+||+.||++|||+.|+++|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ---------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred cccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 00000000 0000 00000 0 0000000000 00112356789999999999999999999998864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=357.65 Aligned_cols=274 Identities=18% Similarity=0.209 Sum_probs=196.8
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCC--
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDS-- 776 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-- 776 (1017)
+.....+|++.++||+|+||.||+|++..+++.||+|++........+.+.+|+.+++++. ||||+++++++.....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3344568999999999999999999999999999999997666666678899999999996 9999999999853322
Q ss_pred -CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeecCCCCceEeCCCC
Q 043932 777 -KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 777 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~ 853 (1017)
......++||||++ |+|.+++.... ....+++.+++.++.||+.||+|||++ + |+||||||+||+++.++
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHH---TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTS
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCC
Confidence 33466899999996 69999987522 113689999999999999999999999 8 99999999999999999
Q ss_pred CeEEeeccccccccccccccccc----CCCcccccccCccccCcccc---cCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASK----TSSSSIGIKGTVGYVAPEYC---MGSEASMTGDVYSFGILLLELFTGRRPTDA 926 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~ 926 (1017)
.+||+|||+++............ .........||+.|+|||++ .+..++.++|||||||++|||++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998765432111000 00111234689999999998 566789999999999999999999999965
Q ss_pred ccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 927 AFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
..... .......... ...++..+.+++.+||+.||++|||+.|++++|+
T Consensus 256 ~~~~~-----~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 256 GAKLR-----IVNGKYSIPP--------------------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ---------------CCCCT--------------------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHH-----hhcCcccCCc--------------------------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 32210 0000000000 0011334778999999999999999999999999
Q ss_pred hcccc
Q 043932 1007 HTRET 1011 (1017)
Q Consensus 1007 ~~~~~ 1011 (1017)
.+.+.
T Consensus 305 ~~~~~ 309 (337)
T 3ll6_A 305 EIAAA 309 (337)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 88754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=372.28 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=200.4
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..++|++.++||+|+||+||+|++..++..||+|++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 109 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----R 109 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 3568999999999999999999999999999999997543 33457789999999999999999999998754 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC---CCeEE
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVSHV 857 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl 857 (1017)
..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.. +.+||
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 180 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKI 180 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEE
Confidence 7899999999999999887653 689999999999999999999999 99999999999999764 55999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||....... .....
T Consensus 181 ~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i 249 (494)
T 3lij_A 181 VDFGLSAVFENQK---------KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKV 249 (494)
T ss_dssp CCCTTCEECBTTB---------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH
T ss_pred EECCCCeECCCCc---------cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 9999998664322 1223569999999998864 69999999999999999999999997643211 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........ ......+++.+.+++.+||+.||.+|||+.|+++|
T Consensus 250 ~~~~~~~~------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 250 EKGKYTFD------------------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHTCCCCC------------------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HhCCCCCC------------------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11111000 00112235678899999999999999999999876
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.96 Aligned_cols=248 Identities=22% Similarity=0.349 Sum_probs=204.6
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++... +
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----K 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----C
Confidence 468999999999999999999999999999999996432 23346788999999999999999999998654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence 7899999999999999998653 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|++....... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ........
T Consensus 159 g~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~ 227 (284)
T 2vgo_A 159 GWSVHAPSLR----------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVNV 227 (284)
T ss_dssp TTCEECSSSC----------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTT
T ss_pred cccccCcccc----------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HHHHHhcc
Confidence 9987543211 123568999999999999899999999999999999999999997542211 00000000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+. . .....+..+.+++.+|++.||.+||++.|++++
T Consensus 228 ----------~~-----------~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 ----------DL-----------K-------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----------CC-----------C-------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----------cc-----------C-------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 00 0 001224568899999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.52 Aligned_cols=267 Identities=16% Similarity=0.212 Sum_probs=209.8
Q ss_pred CCcCHHHHHHhhcccccc-CcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhc-CCCCceeee
Q 043932 693 PTVSYAELSKATSEFASS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNI-RHRNLIKII 768 (1017)
Q Consensus 693 ~~~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~ 768 (1017)
+.+.+.......++|.+. +.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++++ .||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 344555556677788887 89999999999999999999999999997433 33457889999999999 579999999
Q ss_pred eeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceE
Q 043932 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848 (1017)
Q Consensus 769 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 848 (1017)
+++... +..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||++ +|+||||||+||+
T Consensus 96 ~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl 163 (327)
T 3lm5_A 96 EVYENT-----SEIILILEYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNIL 163 (327)
T ss_dssp EEEECS-----SEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred EEEEeC-----CeEEEEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEE
Confidence 998654 67899999999999999986542 13689999999999999999999999 9999999999999
Q ss_pred eCC---CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCC
Q 043932 849 LDH---DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTD 925 (1017)
Q Consensus 849 l~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 925 (1017)
++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHAC---------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EecCCCCCcEEEeeCccccccCCcc---------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 988 7899999999998664321 1122569999999999999899999999999999999999999997
Q ss_pred cccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 926 AAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
....... ............ ......+++.+.+++.+||+.||++|||+.|++++-
T Consensus 235 ~~~~~~~-~~~i~~~~~~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 235 GEDNQET-YLNISQVNVDYS------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp CSSHHHH-HHHHHHTCCCCC------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred CCCchHH-HHHHHhcccccC------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 6422111 111111000000 001122356788999999999999999999998763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=356.30 Aligned_cols=290 Identities=22% Similarity=0.257 Sum_probs=209.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
..++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|++++++++||||+++++++..........
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 35689999999999999999999999999999999964433 33467889999999999999999999986654444567
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||++ ++|.+++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEeccC-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence 899999997 5999998763 689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccc--CCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 862 LAKFLSSHQLDTASK--TSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
++............. .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ .....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~ 236 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIF 236 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHH
Confidence 998765332111110 1111223578999999998765 6789999999999999999999999976432211 11111
Q ss_pred Hhhc-Cc--hhhhhccchhhHHHHhhc-chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIAL-PE--KVIEIVDPLLLIEVMANN-SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~-~~--~~~~~~d~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... +. ............++.... .............+++++.+++.+||+.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111 10 000001100000100000 000000111223456788999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.54 Aligned_cols=254 Identities=23% Similarity=0.291 Sum_probs=200.2
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--------cchHHHHHHHHHHHHhcCCCCceeeeeeeecC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--------KGAFKSFMAECKALRNIRHRNLIKIITICSSI 774 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 774 (1017)
..++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3568999999999999999999999999999999986432 12234578999999999999999999998542
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 854 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 854 (1017)
..++||||+++++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 88 ------~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 88 ------DYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp ------SEEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSS
T ss_pred ------ceEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCC
Confidence 3799999999999999987653 689999999999999999999999 9999999999999987664
Q ss_pred ---eEEeecccccccccccccccccCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 855 ---SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 855 ---~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
+||+|||+++...... ......||+.|+|||++. +..++.++||||+||++|+|++|+.||....
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETS---------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp SCCEEECCCTTCEECCCCH---------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred CCeEEEccCccceeccccc---------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999998654321 112246899999999873 4578999999999999999999999997643
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
................ .......+++.+.+++.+||+.||++||++.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 224 TQVSLKDQITSGKYNF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CSSCHHHHHHHTCCCC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHHHHhCcccc------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 3222111111111000 001112345678999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=362.10 Aligned_cols=270 Identities=23% Similarity=0.305 Sum_probs=208.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.++||+|+||.||+|++..+++.||||++...... +++.+|+++++.++|++.+..+.++... .+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~----~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE----GDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE----TTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee----CCEEE
Confidence 46899999999999999999999989999999998754332 4578899999999875544444443322 26789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe---CCCCCeEEeec
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSHVGDF 860 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df 860 (1017)
+||||+ +++|.+++..... .+++.+++.|+.||+.||+|||++ +||||||||+|||+ +.++.+||+||
T Consensus 80 lvme~~-g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEECC-CCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence 999999 8899999986442 789999999999999999999999 99999999999999 68899999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++.+......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...
T Consensus 151 Gla~~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i 228 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHI-PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKI 228 (483)
T ss_dssp TTCEECBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-HHHHHHH
T ss_pred CcceeccCCcccccc-ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-HHHHHHH
Confidence 999876543321111 11122346799999999999999999999999999999999999999976432211 1111000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
.... ...........+++++.+++..||+.||++||++.+|++.|+++..
T Consensus 229 -~~~~-------------------~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 229 -SEKK-------------------VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -HHHH-------------------HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -hhcc-------------------ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0000 0000111123446789999999999999999999999999998865
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.98 Aligned_cols=265 Identities=24% Similarity=0.425 Sum_probs=210.7
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
+....++|++.+.||+|+||.||+|++. ++..||+|++.... ...+.+.+|++++++++||||+++++++..
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------ 79 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------ 79 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------
Confidence 3444578999999999999999999986 67789999987543 335788999999999999999999998753
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred CCcEEEEecCCCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECC
Confidence 34789999999999999997532 13689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||.+.......... .....++..|+|||++.+..++.++||||+|+++|||++ |+.||....... .....
T Consensus 153 fg~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~ 223 (279)
T 1qpc_A 153 FGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNL 223 (279)
T ss_dssp CTTCEECSSSCEEC-------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH
T ss_pred CcccccccCccccc-------ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHH
Confidence 99998765332111 112457889999999988889999999999999999999 999987532210 00000
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1014 (1017)
...... .....+++.+.+++.+|++.||++|||+.++++.|+++.....+
T Consensus 224 ~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 224 ERGYRM--------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp HTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred hcccCC--------------------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 000000 00112356789999999999999999999999999998766543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.27 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=201.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++... +..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeE
Confidence 356899999999999999999999999999999999876666678899999999999999999999998754 568
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGV 163 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred EEEEEeCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCC
Confidence 99999999999999987643 2689999999999999999999999 999999999999999999999999998
Q ss_pred ccccccccccccccCCCcccccccCccccCcccc-----cCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYC-----MGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+....... .......||+.|+|||++ .+..++.++||||+|+++|+|++|+.||....... .....
T Consensus 164 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~ 234 (302)
T 2j7t_A 164 SAKNLKTL--------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKI 234 (302)
T ss_dssp HHHHHHHH--------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHH
T ss_pred Cccccccc--------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHH
Confidence 76432111 011224689999999998 35678999999999999999999999997642211 01111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.....+. . .....++..+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~----~---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 235 AKSDPPT----L---------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHSCCCC----C---------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred hccCCcc----c---------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1100000 0 0011235578899999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=356.71 Aligned_cols=287 Identities=20% Similarity=0.263 Sum_probs=208.1
Q ss_pred HHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc-----------hHHHHHHHHHHHHhcCCCCce
Q 043932 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----------AFKSFMAECKALRNIRHRNLI 765 (1017)
Q Consensus 697 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv 765 (1017)
..++....++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|++++++++||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4577788899999999999999999999987 4889999998643221 237789999999999999999
Q ss_pred eeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCC
Q 043932 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPS 845 (1017)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 845 (1017)
++++++...+.......++||||++ |+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 163 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG 163 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence 9999987765555678899999997 58988887554 2689999999999999999999999 9999999999
Q ss_pred ceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCC
Q 043932 846 NVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPT 924 (1017)
Q Consensus 846 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf 924 (1017)
||+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADA---------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp GEEECTTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred HEEEcCCCCEEEEecCccccccccc---------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 9999999999999999997543221 1123568999999999877 67899999999999999999999999
Q ss_pred CcccccCccHHHHHHhhcCchhhhh---ccchhhHHHHhhc-c-hhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 925 DAAFTEGLTLHEFAKIALPEKVIEI---VDPLLLIEVMANN-S-MIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~---~d~~l~~~~~~~~-~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
....... ................. ..+.. .++.... . ............+++.+.+++.+||+.||++|||+.
T Consensus 235 ~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 312 (362)
T 3pg1_A 235 RGSTFYN-QLNKIVEVVGTPKIEDVVMFSSPSA-RDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312 (362)
T ss_dssp CCSSHHH-HHHHHHHHHCCCCHHHHHHTSCHHH-HHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCHHH-HHHHHHHHcCCCChHHhhhccchhh-hHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 7643221 11111111111111110 00000 0000000 0 000001111223456789999999999999999999
Q ss_pred HHHHH
Q 043932 1000 DVVAK 1004 (1017)
Q Consensus 1000 evl~~ 1004 (1017)
|+++|
T Consensus 313 ell~h 317 (362)
T 3pg1_A 313 QALRH 317 (362)
T ss_dssp HHHTS
T ss_pred HHHcC
Confidence 99986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=352.46 Aligned_cols=269 Identities=22% Similarity=0.335 Sum_probs=204.3
Q ss_pred CCcCHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeee
Q 043932 693 PTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITIC 771 (1017)
Q Consensus 693 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 771 (1017)
..+++.++....++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 344555566678899999999999999999999998999999999975433 347788999999999 799999999998
Q ss_pred ecCCCCC-CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 772 SSIDSKG-ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 772 ~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
......+ .+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~ 163 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT 163 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEc
Confidence 7643211 367899999999999999998653 23689999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCC
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTD 925 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~ 925 (1017)
.++.+||+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||.
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 164 ENAEVKLVDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp TTCCEEECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCEEEeeCcCceecCcCc--------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 99999999999987654221 1112346899999999986 4568999999999999999999999996
Q ss_pred cccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 926 AAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...... ..........+ .. ....+++.+.+++.+||+.||.+||++.|++++
T Consensus 236 ~~~~~~-~~~~~~~~~~~---------~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 236 DMHPMR-ALFLIPRNPAP---------RL-----------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp TSCHHH-HHHHHHHSCCC---------CC-----------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCcHHH-HHHHhhcCccc---------cC-----------------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 532210 00000000000 00 001224678899999999999999999999885
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.11 Aligned_cols=252 Identities=20% Similarity=0.314 Sum_probs=206.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 87 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN----- 87 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-----
Confidence 3568999999999999999999999999999999987542 23456788999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 158 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGD 158 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred CEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEe
Confidence 67899999999999999987643 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||.+....... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... .+..
T Consensus 159 fg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~ 226 (294)
T 2rku_A 159 FGLATKVEYDG--------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLR 226 (294)
T ss_dssp CTTCEECCSTT--------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHH
T ss_pred ccCceecccCc--------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH
Confidence 99998654221 11123568999999999998889999999999999999999999997642211 1110
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..... .. ....+++.+.+++.+||+.||++|||+.|++++-
T Consensus 227 ~~~~~------------------~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 227 IKKNE------------------YS-------IPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp HHTTC------------------CC-------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred Hhhcc------------------CC-------CccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 00000 00 0012245688999999999999999999998864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=349.80 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=207.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.... ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---Cce
Confidence 568999999999999999999999999999999997543 234567889999999999999999999875431 257
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC-----ceeecCCCCceEeCCCCCeE
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP-----MVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~k 856 (1017)
.++||||+++++|.+++..... ....+++.+++.++.|++.||+|||+. + |+||||||+||+++.++.+|
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred EEEEEeCCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence 8999999999999999976421 123589999999999999999999999 7 99999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|+|||.++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....
T Consensus 157 l~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~ 227 (279)
T 2w5a_A 157 LGDFGLARILNHDTS--------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGK 227 (279)
T ss_dssp ECCCCHHHHC---CH--------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH
T ss_pred EecCchheeeccccc--------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-HHHH
Confidence 999999986543211 1122468999999999998889999999999999999999999997642210 0001
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
......+ .....+++++.+++.+||+.||++||++.|+++++.....
T Consensus 228 i~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 228 IREGKFR---------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred Hhhcccc---------------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 1000000 0011235678999999999999999999999998765543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=371.65 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=206.1
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
+....++|++.++||+|+||+||+|.+.. +..||||+++.... ..+.+.+|++++++++||||+++++++..
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------ 250 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------ 250 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------
Confidence 34456789999999999999999999974 56799999975433 34789999999999999999999999853
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred CceEEEehhhcCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECC
Confidence 34789999999999999997532 13589999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||+++........ ......+|..|+|||++.+..++.++|||||||++|||++ |+.||......+ .....
T Consensus 324 fG~a~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i 394 (452)
T 1fmk_A 324 FGLARLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQV 394 (452)
T ss_dssp CCTTC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH
T ss_pred CccceecCCCcee-------cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 9999866432211 1122357889999999988899999999999999999999 999997542210 00000
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
..... ......+++.+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 395 ~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 395 ERGYR--------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HTTCC--------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HcCCC--------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 00000 0011234677899999999999999999999999999987543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=359.49 Aligned_cols=273 Identities=14% Similarity=0.171 Sum_probs=208.0
Q ss_pred hccccccCcccccCCceEEEEEeCC--------CcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCcee---------
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE--------DEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIK--------- 766 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 766 (1017)
.++|++.+.||+|+||.||+|++.. +++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999987 4789999998743 45789999999999999998
Q ss_pred ------eeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceee
Q 043932 767 ------IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHG 840 (1017)
Q Consensus 767 ------~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 840 (1017)
+++++... ....++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||++ +|+||
T Consensus 116 ~~~i~~~~~~~~~~----~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~ 183 (352)
T 2jii_A 116 LLAIPTCMGFGVHQ----DKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHEN---EYVHG 183 (352)
T ss_dssp TCSCCCCCEEEEET----TTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCS
T ss_pred ccCccchhhccccC----CcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCC
Confidence 44454331 36789999999 999999998752 23789999999999999999999999 99999
Q ss_pred cCCCCceEeCCCC--CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHH
Q 043932 841 DLKPSNVLLDHDM--VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELF 918 (1017)
Q Consensus 841 Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 918 (1017)
||||+||+++.++ .+||+|||+++........... .........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 184 Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY-VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp CCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCC-CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCceEEEecCcceeeccCCCccccc-cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999998 9999999999876543221111 111223357999999999999989999999999999999999
Q ss_pred hCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 043932 919 TGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM 998 (1017)
Q Consensus 919 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 998 (1017)
+|+.||................. ........+.. .....+++++.+++.+||+.||++||++
T Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~ 324 (352)
T 2jii_A 263 YGFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPC-----------------GHWIRPSETLQKYLKVVMALTYEEKPPY 324 (352)
T ss_dssp HSCCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTT-----------------SCEECCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred hCCCCcccCCcCHHHHHHHHHhc-cCChhhhhhhc-----------------cccCCCcHHHHHHHHHHHhCChhhCCCH
Confidence 99999976532211111111100 00000000000 0001125678999999999999999999
Q ss_pred HHHHHHHhhccccc
Q 043932 999 RDVVAKLCHTRETF 1012 (1017)
Q Consensus 999 ~evl~~L~~~~~~~ 1012 (1017)
.|+++.|+.+.++.
T Consensus 325 ~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 325 AMLRNNLEALLQDL 338 (352)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhc
Confidence 99999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=370.85 Aligned_cols=254 Identities=23% Similarity=0.307 Sum_probs=203.3
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-------------chHHHHHHHHHHHHhcCCCCceeeee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-------------GAFKSFMAECKALRNIRHRNLIKIIT 769 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~ 769 (1017)
..++|++.++||+|+||+||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999999999999999974321 23467889999999999999999999
Q ss_pred eeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
++... ...++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||++
T Consensus 114 ~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 114 VFEDK-----KYFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL 179 (504)
T ss_dssp EEECS-----SEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred EEEcC-----CEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence 98754 67899999999999999987653 689999999999999999999999 99999999999999
Q ss_pred CCCC---CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 043932 850 DHDM---VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926 (1017)
Q Consensus 850 ~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 926 (1017)
+.++ .+||+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||..
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSKDY---------KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCTTS---------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCCCccEEEEECCCCEEcCCCC---------ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 8776 69999999998664321 1223569999999999875 689999999999999999999999976
Q ss_pred ccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 927 AFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
..... ............. ......+++++.+++.+||+.||.+|||+.|+++|-
T Consensus 250 ~~~~~-~~~~i~~~~~~~~------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 250 QNDQD-IIKKVEKGKYYFD------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp SSHHH-HHHHHHHCCCCCC------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCHHH-HHHHHHcCCCCCC------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 42211 1111111000000 011123456789999999999999999999998763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=352.73 Aligned_cols=251 Identities=20% Similarity=0.310 Sum_probs=206.3
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 113 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN----- 113 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----
Confidence 3568999999999999999999999999999999987542 23456788999999999999999999998754
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D 184 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGD 184 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred CeEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEee
Confidence 67899999999999999987643 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......
T Consensus 185 fg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~ 255 (335)
T 2owb_A 185 FGLATKVEYDG--------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKK 255 (335)
T ss_dssp CTTCEECCSTT--------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHH
T ss_pred ccCceecccCc--------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhc
Confidence 99998654221 11123568999999999999889999999999999999999999997532111 0000000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... . ....+++.+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~---------------------~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 256 NEY---------------------S-------IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp TCC---------------------C-------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCC---------------------C-------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 001224567899999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=373.91 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=206.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|++.++||+|+||+||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK----- 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence 3468999999999999999999999999999999997442 34457889999999999999999999998764
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe---CCCCCeE
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVSH 856 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~k 856 (1017)
+..++||||+.+|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 169 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIR 169 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEE
Confidence 67899999999999999997654 689999999999999999999999 99999999999999 5678999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||....... ....
T Consensus 170 l~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~ 238 (484)
T 3nyv_A 170 IIDFGLSTHFEASK---------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKK 238 (484)
T ss_dssp ECCTTHHHHBCCCC---------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH
T ss_pred EEeeeeeEEccccc---------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHH
Confidence 99999998664322 1223469999999999877 68999999999999999999999997642211 1111
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
......... ......+++.+.+++.+||+.||.+|||+.|+++|-
T Consensus 239 i~~~~~~~~------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 239 VEKGKYTFE------------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HHHCCCCCC------------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred HHcCCCCCC------------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 111111000 001122356789999999999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=344.04 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=207.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.+.|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeE
Confidence 457999999999999999999999899999999997554 34467889999999999999999999998764 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 96 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeeccc
Confidence 9999999999999998653 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .........
T Consensus 166 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~ 235 (303)
T 3a7i_A 166 AGQLTDTQI--------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNN 235 (303)
T ss_dssp CEECBTTBC--------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSC
T ss_pred ceecCcccc--------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCC
Confidence 986643221 1123568999999999999899999999999999999999999997532210 000000000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
+. .....++..+.+++.+||+.||++|||+.|++++..
T Consensus 236 ~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 236 PP--------------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CC--------------------------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CC--------------------------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 00 001123556899999999999999999999988654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=357.93 Aligned_cols=264 Identities=14% Similarity=0.133 Sum_probs=205.2
Q ss_pred HHHHhhccccccCcccccCCceEEEEE-----eCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC---CCCceeeeee
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGI-----LGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR---HRNLIKIITI 770 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~ 770 (1017)
++....++|.+.++||+|+||+||+|. +..+++.||+|++.... ..++.+|++++++++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344456789999999999999999994 56678899999986443 356777888887776 9999999999
Q ss_pred eecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 771 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
+... +..++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||++ +||||||||+|||++
T Consensus 136 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 136 HLFQ-----NGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILG 206 (365)
T ss_dssp EECS-----SCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEEC
T ss_pred eecC-----CCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEec
Confidence 8765 6689999999999999999753211 123699999999999999999999999 999999999999999
Q ss_pred C-----------CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh
Q 043932 851 H-----------DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT 919 (1017)
Q Consensus 851 ~-----------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 919 (1017)
. ++.+||+|||+|+.+.... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 280 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFP------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSC------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccC------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 8 8999999999997653221 1112233579999999999999999999999999999999999
Q ss_pred CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCC-CCH
Q 043932 920 GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFER-MEM 998 (1017)
Q Consensus 920 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~ 998 (1017)
|+.||......... ........ ...+.+.+++..|++.+|.+| |++
T Consensus 281 g~~pf~~~~~~~~~------------~~~~~~~~---------------------~~~~~~~~~~~~~l~~~p~~r~~~~ 327 (365)
T 3e7e_A 281 GTYMKVKNEGGECK------------PEGLFRRL---------------------PHLDMWNEFFHVMLNIPDCHHLPSL 327 (365)
T ss_dssp SSCCCEEEETTEEE------------ECSCCTTC---------------------SSHHHHHHHHHHHHCCCCTTCCCCH
T ss_pred CCCccccCCCCcee------------echhcccc---------------------CcHHHHHHHHHHHcCCCCCCcchHH
Confidence 99999654322110 00000000 013456788899999999998 578
Q ss_pred HHHHHHHhhcccccc
Q 043932 999 RDVVAKLCHTRETFF 1013 (1017)
Q Consensus 999 ~evl~~L~~~~~~~~ 1013 (1017)
.++.+.|++..+...
T Consensus 328 ~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 328 DLLRQKLKKVFQQHY 342 (365)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhh
Confidence 888888888765543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=368.69 Aligned_cols=253 Identities=15% Similarity=0.171 Sum_probs=191.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHH---HHHhcCCCCceeee-------e
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECK---ALRNIRHRNLIKII-------T 769 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~ 769 (1017)
..++|++.+.||+|+||+||+|++..+++.||||++... .....+.+.+|+. .+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999999889999999999743 3345578889994 55555899999998 4
Q ss_pred eeecCCC---------CCC---ceeEEEEEeccCCCHHHHHhhCCCCc-cccccCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 043932 770 ICSSIDS---------KGA---DFKALVFECMKNGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASAIEYLHHHCQPP 836 (1017)
Q Consensus 770 ~~~~~~~---------~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 836 (1017)
++..... .+. ...|+||||+ +|+|.+++....... ....+++..++.|+.||+.||+|||++ +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4433211 000 0378999999 579999998643111 123455688899999999999999999 9
Q ss_pred ceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCC-----------CcCccc
Q 043932 837 MVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-----------EASMTG 905 (1017)
Q Consensus 837 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~ 905 (1017)
|+||||||+||+++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 294 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF 294 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----------cccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence 99999999999999999999999999985322 1123467 999999999887 799999
Q ss_pred cchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHh
Q 043932 906 DVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGV 985 (1017)
Q Consensus 906 DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 985 (1017)
|||||||++|||++|+.||......... .. +.. ....+++++.+++.
T Consensus 295 DvwSlG~il~elltg~~Pf~~~~~~~~~----------~~---~~~--------------------~~~~~~~~~~~li~ 341 (377)
T 3byv_A 295 DAWALGLVIYWIWCADLPITKDAALGGS----------EW---IFR--------------------SCKNIPQPVRALLE 341 (377)
T ss_dssp HHHHHHHHHHHHHHSSCCC------CCS----------GG---GGS--------------------SCCCCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHHCCCCCcccccccch----------hh---hhh--------------------hccCCCHHHHHHHH
Confidence 9999999999999999999754322110 00 000 00122567889999
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 043932 986 LCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 986 ~cl~~dP~~RPs~~evl~~ 1004 (1017)
+||+.||++|||+.|++++
T Consensus 342 ~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 342 GFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHTCSSGGGCCCHHHHHTS
T ss_pred HHcCCCchhCCCHHHHhhC
Confidence 9999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=346.12 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=200.2
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.++++++||||+++++++... +..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEE
Confidence 4568999999999999999999999999999999997543 346789999999999999999999998764 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEeecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 99999999999999997433 2689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+....... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ . .......
T Consensus 172 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~-~~~~~~~ 241 (314)
T 3com_A 172 AGQLTDTM--------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-I-FMIPTNP 241 (314)
T ss_dssp CEECBTTB--------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H-HHHHHSC
T ss_pred chhhhhhc--------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-H-HHHhcCC
Confidence 97654321 111235689999999999998999999999999999999999999975322100 0 0000000
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
+.. . .....++..+.+++.+||+.||.+|||+.|++++
T Consensus 242 ~~~--------~----------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 242 PPT--------F----------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCC--------C----------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred Ccc--------c----------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 0 0011225678899999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=362.47 Aligned_cols=201 Identities=24% Similarity=0.339 Sum_probs=173.4
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc------CCCCceeeeeeeecCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI------RHRNLIKIITICSSIDS 776 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~ 776 (1017)
...+|++.++||+|+||+||+|++..+++.||||++... ....+.+.+|+++++.+ .|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-- 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-- 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--
Confidence 346799999999999999999999999999999999743 23345677888888877 577999999998765
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC--
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV-- 854 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-- 854 (1017)
+..++||||++ ++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 172 ---~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~ 240 (429)
T 3kvw_A 172 ---NHICMTFELLS-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSG 240 (429)
T ss_dssp ---TEEEEEECCCC-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCC
T ss_pred ---CeEEEEEeccC-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcc
Confidence 67899999996 599999987542 3589999999999999999999999 9999999999999999987
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 241 vkL~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQR-----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EEECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEEeecccceecCCc-----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999754321 123578999999999999999999999999999999999999997653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=350.52 Aligned_cols=267 Identities=22% Similarity=0.384 Sum_probs=204.5
Q ss_pred hhccccccCcccccCCceEEEEE-----eCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGI-----LGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS 776 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 776 (1017)
..++|++.+.||+|+||.||+|+ ...+++.||||++.... .....++.+|+.++++++||||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC--
Confidence 35689999999999999999999 44567889999996432 33456788999999999999999999998654
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCC-ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC---C
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---D 852 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~ 852 (1017)
...++||||+++++|.+++...... .....+++.+++.++.|++.||+|||++ +|+||||||+||+++. +
T Consensus 106 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 106 ---LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTT
T ss_pred ---CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCc
Confidence 5679999999999999999876421 1224589999999999999999999999 9999999999999984 4
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccC
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEG 931 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 931 (1017)
..+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 252 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYY------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ- 252 (327)
T ss_dssp CCEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred ceEEECcccccccccccccc------ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-
Confidence 56999999999765432211 11123467899999999988889999999999999999998 99998753221
Q ss_pred ccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 932 LTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
............ .....+++.+.+++.+||+.||.+||++.|++++|+.+.+.
T Consensus 253 -~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 253 -EVLEFVTSGGRM--------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -HHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHHHHHhcCCCC--------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 011111000000 00112356789999999999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=350.53 Aligned_cols=262 Identities=25% Similarity=0.405 Sum_probs=205.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEE--EEEEeeec-CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIV--AVKVINLK-QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 780 (1017)
++|++.+.||+|+||.||+|++..++..+ |+|.+... .....+.+.+|+++++++ +||||+++++++... +
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----C
Confidence 57999999999999999999998888755 99988743 233456789999999999 899999999998765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
..++||||+++|+|.+++...... .....+++.+++.++.||+.||+|||++ +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 789999999999999999865310 1123689999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccc
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFT 929 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 929 (1017)
.++.+||+|||+++...... ......+++.|+|||++.+..++.++||||+||++|||++ |+.||.....
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp GGGCEEECCTTCEESSCEEC---------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCeEEEcccCcCccccccc---------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 99999999999987432111 1112357889999999988889999999999999999998 9999975422
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
. +...... .. ... .....+++.+.+++.+||+.||.+|||+.|++++|+.+.
T Consensus 248 ~-----~~~~~~~-~~----~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 248 A-----ELYEKLP-QG----YRL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp H-----HHHHHGG-GT----CCC------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-----HHHHHhh-cC----CCC------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 1111000 00 000 001123567899999999999999999999999999876
Q ss_pred cc
Q 043932 1010 ET 1011 (1017)
Q Consensus 1010 ~~ 1011 (1017)
+.
T Consensus 300 ~~ 301 (327)
T 1fvr_A 300 EE 301 (327)
T ss_dssp HS
T ss_pred Hh
Confidence 54
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=340.33 Aligned_cols=249 Identities=25% Similarity=0.395 Sum_probs=197.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++... +
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----T 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence 468999999999999999999999899999999997432 23456788999999999999999999998654 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence 7899999999999999997653 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|.+........ .....||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||....... ......
T Consensus 156 g~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~ 224 (276)
T 2h6d_A 156 GLSNMMSDGEF---------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIR 224 (276)
T ss_dssp CGGGCCCC----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred ccccccCCCcc---------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHhh
Confidence 99986543221 122468999999999988765 689999999999999999999997532110 000000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... .....++..+.+++.+|++.||++|||+.|++++
T Consensus 225 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 225 GGVF---------------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCcc---------------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000 0001124568899999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=355.44 Aligned_cols=278 Identities=19% Similarity=0.253 Sum_probs=204.7
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC-CC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSK-GA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~ 779 (1017)
..++|.+.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++...... ..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34689999999999999999999999999999999975432 3357788999999999999999999998665321 12
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
...++||||++ ++|.+++.. .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred eeEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence 23489999997 589888742 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
||+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+. .....
T Consensus 188 fg~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~ 255 (371)
T 4exu_A 188 FGLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQIL 255 (371)
T ss_dssp TTCC-------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH
T ss_pred cCcccccccC-----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Confidence 9999754321 123568999999999877 6789999999999999999999999976432211 11111
Q ss_pred Hhh-cC-chhhhhccchhhHHHHhhc-chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIA-LP-EKVIEIVDPLLLIEVMANN-SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~-~~-~~~~~~~d~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .+ ......+.......+.... .............+++.+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 256 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 111 11 1111111111111111000 000011111223346789999999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=355.84 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=203.4
Q ss_pred hccccccCcccccCCceEEEEEeC---CCcEEEEEEEeeecC----cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFKSFMAECKALRNI-RHRNLIKIITICSSID 775 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 775 (1017)
.++|++.++||+|+||+||+|++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 468999999999999999999984 478999999986432 23345677899999999 699999999998665
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCe
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
+..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 132 ----~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 198 (355)
T 1vzo_A 132 ----TKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV 198 (355)
T ss_dssp ----TEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred ----ceEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence 67899999999999999998653 689999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccC--CCcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 199 kl~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~- 270 (355)
T 1vzo_A 199 VLTDFGLSKEFVADET-------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS- 270 (355)
T ss_dssp EESCSSEEEECCGGGG-------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-
T ss_pred EEeeCCCCeecccCCC-------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-
Confidence 9999999986543221 11223579999999999986 3478999999999999999999999975432221
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhh
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAKLCH 1007 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~ 1007 (1017)
...+....... . .....+++..+.+++.+||+.||.+|| ++.|++++..-
T Consensus 271 ~~~~~~~~~~~------~------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 271 QAEISRRILKS------E------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp HHHHHHHHHHC------C------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred HHHHHHHHhcc------C------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 11111110000 0 001112355688999999999999999 99999987644
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=353.60 Aligned_cols=290 Identities=21% Similarity=0.293 Sum_probs=198.4
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS- 776 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 776 (1017)
.+.....++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455677889999999999999999999999999999999986443 333567788888999999999999999866433
Q ss_pred -CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHh--hCCCCCceeecCCCCceEeCC-C
Q 043932 777 -KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVLLDH-D 852 (1017)
Q Consensus 777 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~ 852 (1017)
....+.++||||+++ +|.+.+..... ....+++..+..++.|++.||+||| +. +|+||||||+||+++. +
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 223457899999976 65554442110 1236889999999999999999999 87 9999999999999997 8
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCC-cCccccchhHHHHHHHHHhCCCCCCcccccC
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE-ASMTGDVYSFGILLLELFTGRRPTDAAFTEG 931 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~ 931 (1017)
+.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus 169 ~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 239 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSE---------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239 (360)
T ss_dssp TEEEECCCTTCBCCCTTS---------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CcEEEeeCCCceecCCCC---------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH
Confidence 999999999998664322 112356899999999986654 8999999999999999999999997643221
Q ss_pred ccHHHHHHhh-cCc-hhhhhccchhh-HHHH-hhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 932 LTLHEFAKIA-LPE-KVIEIVDPLLL-IEVM-ANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 932 ~~~~~~~~~~-~~~-~~~~~~d~~l~-~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......... .+. ......++... .... .....+..........+++++.+++.+||+.||.+|||+.|+++|
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 240 -QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp -HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 122222111 111 11111111000 0000 000001111111122246789999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=344.06 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=200.7
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 779 (1017)
..++|++.+.||+|+||+||+|++..+++.||+|++.... .....++.+|+..+.++ +||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~----- 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED----- 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----
Confidence 4578999999999999999999999999999999997542 33456788999999999 999999999998765
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-------
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD------- 852 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------- 852 (1017)
+..++||||+++++|.+++..... ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence 678999999999999999976421 113689999999999999999999999 99999999999999844
Q ss_pred ------------CCeEEeecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHh
Q 043932 853 ------------MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFT 919 (1017)
Q Consensus 853 ------------~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt 919 (1017)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||+||++|||++
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCSC------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCCceEEEEcccccccccCCcc------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence 479999999998654321 13589999999999775 56789999999999999999
Q ss_pred CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 920 GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 920 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
|.+|+.... ..........+. ....+++.+.+++.+||+.||++|||+.
T Consensus 227 ~~~~~~~~~----~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ 275 (289)
T 1x8b_A 227 AEPLPRNGD----QWHEIRQGRLPR---------------------------IPQVLSQEFTELLKVMIHPDPERRPSAM 275 (289)
T ss_dssp CCCCCSSSH----HHHHHHTTCCCC---------------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCcchh----HHHHHHcCCCCC---------------------------CCcccCHHHHHHHHHHhCCCcccCCCHH
Confidence 998764321 111111111100 0112356789999999999999999999
Q ss_pred HHHHHH
Q 043932 1000 DVVAKL 1005 (1017)
Q Consensus 1000 evl~~L 1005 (1017)
|++++-
T Consensus 276 ~ll~h~ 281 (289)
T 1x8b_A 276 ALVKHS 281 (289)
T ss_dssp HHHTCT
T ss_pred HHhhCh
Confidence 998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=343.07 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=204.3
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---------chHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---------GAFKSFMAECKALRNIR-HRNLIKIITICS 772 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 772 (1017)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45789999999999999999999999999999999975431 22456789999999995 999999999986
Q ss_pred cCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC
Q 043932 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 852 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 852 (1017)
.. ...++||||+++++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 95 ~~-----~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 95 TN-----TFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD 160 (298)
T ss_dssp CS-----SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred cC-----CeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence 54 67899999999999999998643 689999999999999999999999 99999999999999999
Q ss_pred CCeEEeecccccccccccccccccCCCcccccccCccccCccccc------CCCcCccccchhHHHHHHHHHhCCCCCCc
Q 043932 853 MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM------GSEASMTGDVYSFGILLLELFTGRRPTDA 926 (1017)
Q Consensus 853 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~ 926 (1017)
+.+||+|||.+....... ......||+.|+|||++. ...++.++||||+|+++|||++|+.||..
T Consensus 161 ~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp CCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcEEEecccchhhcCCCc---------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 999999999998654322 112346899999999885 44688999999999999999999999965
Q ss_pred ccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 927 AFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..... ............ . ......+++.+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~-~~~~~~~~~~~~-----~-------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 232 RKQML-MLRMIMSGNYQF-----G-------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp SSHHH-HHHHHHHTCCCC-----C-------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccHHH-HHHHHhcCCccc-----C-------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 32210 011111100000 0 00112335678999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=340.66 Aligned_cols=256 Identities=30% Similarity=0.382 Sum_probs=201.2
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||+||+|++. ++.||+|++.... ..+.+.+|++++++++||||+++++++... .+..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 90 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 90 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCce
Confidence 3578999999999999999999984 7899999986432 457789999999999999999999987543 2467
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEecCCCCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccc
Confidence 99999999999999997642 12478999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+....... ....+++.|+|||++.+..++.++||||+|+++|||++ |+.||....... ........
T Consensus 164 ~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~ 230 (278)
T 1byg_A 164 TKEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG 230 (278)
T ss_dssp -----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTT
T ss_pred cccccccc-----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcC
Confidence 87543211 11357889999999988889999999999999999998 999997642211 11100000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
.. ......+++.+.+++.+||+.||++|||+.|+++.|+.++...
T Consensus 231 ~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 231 YK--------------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CC--------------------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 00 0001123567899999999999999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=359.60 Aligned_cols=281 Identities=22% Similarity=0.283 Sum_probs=200.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 782 (1017)
..+|++.++||+|+||+||+|++..+++.||||++..... ...+|++++++++||||+++++++..... .+..+.
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 4579999999999999999999998999999999864332 23479999999999999999998855322 233457
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC-CCeEEeecc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVSHVGDFG 861 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 861 (1017)
++||||+++ ++.+.+..... ....+++..++.++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred Eeehhcccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 799999976 67766653210 123789999999999999999999999 99999999999999965 578999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
+++...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+.+..+.
T Consensus 203 ~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~ 272 (420)
T 1j1b_A 203 SAKQLVRGE---------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKV 272 (420)
T ss_dssp TCEECCTTC---------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred hhhhcccCC---------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 998654322 11235789999999998764 78999999999999999999999998643221 22222221
Q ss_pred hcCchhhhh--ccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 941 ALPEKVIEI--VDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 941 ~~~~~~~~~--~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
........+ ..+........ ...............++++.+++.+||+.||++|||+.|+++|-
T Consensus 273 lg~p~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 273 LGTPTREQIREMNPNYTEFKFP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HCSCCHHHHHHHCSCCCCCCCC-CCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hCCCCHHHHHhhChhhhhhccC-ccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 111100000 00000000000 00000000001122356789999999999999999999998763
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=347.14 Aligned_cols=281 Identities=20% Similarity=0.290 Sum_probs=207.6
Q ss_pred hccccccCcccccCCceEEEEEe-CCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCC------ceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRN------LIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 776 (1017)
.++|++.+.||+|+||+||+|.+ ..+++.||||++... ....+.+.+|+++++.++|++ ++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-- 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-- 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--
Confidence 46899999999999999999998 568899999998643 234467889999999887654 99999998765
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-----
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH----- 851 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----- 851 (1017)
+..++||||+ +++|.+++..... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 90 ---~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 90 ---GHICIVFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp ---TEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred ---CcEEEEEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence 6789999999 8899999987542 3688999999999999999999999 9999999999999987
Q ss_pred --------------CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHH
Q 043932 852 --------------DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLEL 917 (1017)
Q Consensus 852 --------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 917 (1017)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence 678999999999754321 1224689999999999998999999999999999999
Q ss_pred HhCCCCCCcccccCccHHHHHHh--hcCchhhhhccch--------------hhHHHHhhcchhHHHhHHhHHHHHHHHH
Q 043932 918 FTGRRPTDAAFTEGLTLHEFAKI--ALPEKVIEIVDPL--------------LLIEVMANNSMIQEDIRAKTQECLNAII 981 (1017)
Q Consensus 918 ltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~--------------l~~~~~~~~~~~~~~~~~~~~~~~~~l~ 981 (1017)
++|+.||....... ........ ..+..+....... ......................+++++.
T Consensus 228 ~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 306 (339)
T 1z57_A 228 YLGFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306 (339)
T ss_dssp HHSSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHH
Confidence 99999997643221 11111111 1111111100000 0000000000000000011234577899
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH--Hhhccc
Q 043932 982 RIGVLCSMESPFERMEMRDVVAK--LCHTRE 1010 (1017)
Q Consensus 982 ~li~~cl~~dP~~RPs~~evl~~--L~~~~~ 1010 (1017)
+++.+||+.||.+|||+.|++++ ++.+++
T Consensus 307 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 307 DLIQKMLEYDPAKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence 99999999999999999999976 444443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=376.65 Aligned_cols=261 Identities=21% Similarity=0.356 Sum_probs=204.1
Q ss_pred ccccccC-cccccCCceEEEEEeC--CCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSN-MIGQGSFGSVYKGILG--EDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
+++.+.+ .||+|+||.||+|.+. .++..||||+++... ....+.+.+|++++++++||||++++++|.. +
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~ 408 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 408 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------S
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------C
Confidence 3444444 7999999999999875 456789999997543 3456789999999999999999999999854 3
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DF 480 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDF 480 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred CeEEEEEeCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeec
Confidence 4799999999999999997654 2689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+++......... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ......
T Consensus 481 Gla~~~~~~~~~~-----~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~ 553 (613)
T 2ozo_A 481 GLSKALGADDSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE 553 (613)
T ss_dssp STTTTCC-------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHH
T ss_pred cCcccccCCCcee-----eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH
Confidence 9998764322111 11112346789999999998899999999999999999998 999997643211 111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
.... ......+++++.+++.+||+.||++||++.+|++.|+.+..+.
T Consensus 554 ~~~~--------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 554 QGKR--------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TTCC--------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCC--------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 0000 0011234678999999999999999999999999999876554
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.08 Aligned_cols=257 Identities=21% Similarity=0.335 Sum_probs=201.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC----cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ----KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---E 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---C
Confidence 3578999999999999999999999999999999997432 23457889999999999999999999998533 2
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
....++||||++++ +.+++..... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred CCeEEEEehhccCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEee
Confidence 25689999999876 8787776432 3689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCC--cCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE--ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|||.+......... .......||+.|+|||++.+.. ++.++||||+|+++|||++|+.||...... .
T Consensus 152 dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~ 220 (305)
T 2wtk_C 152 ALGVAEALHPFAAD------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-----K 220 (305)
T ss_dssp CCTTCEECCTTCSS------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----H
T ss_pred ccccccccCccccc------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-----H
Confidence 99999865432211 1112346899999999987643 478999999999999999999999753211 1
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
........ .. .....+++.+.+++.+||+.||.+|||+.|++++-
T Consensus 221 ~~~~i~~~-----------------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 221 LFENIGKG-----------------SY-------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp HHHHHHHC-----------------CC-------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred HHHHHhcC-----------------CC-------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 11000000 00 00112356788999999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=377.61 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=205.1
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 778 (1017)
..++|++.++||+|+||+||+|++..+++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~---- 414 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM---- 414 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS----
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC----
Confidence 356899999999999999999999999999999999743 234456788899999988 799999999988654
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 415 -~~~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 415 -DRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred -CEEEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence 67899999999999999998654 689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..
T Consensus 485 DFGla~~~~~~~--------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-----~~~ 551 (674)
T 3pfq_A 485 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELF 551 (674)
T ss_dssp CCTTCEECCCTT--------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH
T ss_pred ecceeeccccCC--------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-----HHH
Confidence 999998543211 1123467999999999999999999999999999999999999999764221 111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM-----RDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 1004 (1017)
....... .. .....++++.+++.+||+.||++||++ +||++|
T Consensus 552 ~~i~~~~-----------------~~-------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 552 QSIMEHN-----------------VA-------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHSSC-----------------CC-------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHhCC-----------------CC-------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1100000 00 001235678999999999999999997 777654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.43 Aligned_cols=273 Identities=23% Similarity=0.310 Sum_probs=187.2
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
...++|++.+.||+|+||.||+|++..+++.||||++.... ....+++.+|+.++++++||||+++++++... +
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----D 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----S
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----C
Confidence 34578999999999999999999998889999999986443 23456788999999999999999999998765 5
Q ss_pred eeEEEEEeccCCCHHHHHhhCCC--CccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 781 FKALVFECMKNGSLEDWLHQSND--HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
..++||||+++++|.+++..... ......+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence 68999999999999999874210 01123689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|||.+.......... .........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.......... ..
T Consensus 164 dfg~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~ 239 (303)
T 2vwi_A 164 DFGVSAFLATGGDIT---RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LT 239 (303)
T ss_dssp CCHHHHHCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HH
T ss_pred eccchheeccCCCcc---chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-HH
Confidence 999997664322110 1111223568999999999866 468999999999999999999999997643221111 00
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. ..+........ .......+++.+.+++.+||+.||.+|||+.|++++
T Consensus 240 ~~-~~~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQ-NDPPSLETGVQ-----------------DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HT-SSCCCTTC----------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hc-cCCCccccccc-----------------cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 00000000000 000111235678899999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=358.68 Aligned_cols=279 Identities=21% Similarity=0.267 Sum_probs=197.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 782 (1017)
..+|++.++||+|+||+||+|++..+++ ||+|++...... ..+|+++++.++||||+++++++..... .+..+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4579999999999999999999986666 888877543221 2369999999999999999999866533 334567
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC-CCCCeEEeecc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVSHVGDFG 861 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG 861 (1017)
++||||++++ +.+.+..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++ .++.+||+|||
T Consensus 114 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 114 NLVLEYVPET-VYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEECCSEE-HHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEeeccCcc-HHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 8999999874 4443332110 113789999999999999999999999 999999999999999 79999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
+|+...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .+....+.
T Consensus 188 ~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~ 257 (394)
T 4e7w_A 188 SAKILIAGE---------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKV 257 (394)
T ss_dssp TCEECCTTC---------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred CcccccCCC---------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 998664322 11235689999999998765 58999999999999999999999998753221 12222221
Q ss_pred hcCchh--hhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPEKV--IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~--~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...... .....+......... ....+........+++++.+++.+||+.||.+|||+.|+++|
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCC-CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hCCCCHHHHHhhChhhhhhcccc-ccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 111110 000000000000000 000000001112245688999999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=342.10 Aligned_cols=257 Identities=22% Similarity=0.252 Sum_probs=188.5
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+.++...++.++||||+++++++... +
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----G 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----C
Confidence 35789999999999999999999999999999999975432 2223344555567888999999999998754 5
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++ +|.+++..... ....+++..++.++.|++.||+|||++. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Df 154 (290)
T 3fme_A 80 DVWICMELMDT-SLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDF 154 (290)
T ss_dssp SEEEEEECCSE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred CEEEEEehhcc-chHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeec
Confidence 68999999975 88888764211 1237899999999999999999999842 8999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccc----cCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYC----MGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|+++....... .....||+.|+|||++ .+..++.++||||+||++|||++|+.||............
T Consensus 155 g~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 225 (290)
T 3fme_A 155 GISGYLVDDVA---------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ 225 (290)
T ss_dssp ------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH
T ss_pred CCccccccccc---------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH
Confidence 99986543221 1123689999999996 4567899999999999999999999999753222111111
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......+.. ....+++++.+++.+||+.||++|||+.|+++|
T Consensus 226 ~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 226 VVEEPSPQL--------------------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHSCCCCC--------------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhccCCCCc--------------------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 111111100 001235678999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=341.24 Aligned_cols=264 Identities=27% Similarity=0.381 Sum_probs=198.3
Q ss_pred hccccccCcccccCCceEEEEEeCC-C--cEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE-D--EMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~-~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++|++.+.||+|+||+||+|++.. + +..||+|+++.. .....+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 4689999999999999999998632 2 346999998744 234567889999999999999999999998643
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 94 ---~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl 162 (291)
T 1u46_A 94 ---PMKMVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI 162 (291)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred ---CceeeEecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEE
Confidence 2689999999999999998643 2689999999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~ 936 (1017)
+|||++........... ......+|..|+|||++.+..++.++||||+|+++|||++ |+.||....... ....
T Consensus 163 ~Dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~ 236 (291)
T 1u46_A 163 GDFGLMRALPQNDDHYV-----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHK 236 (291)
T ss_dssp CCCTTCEECCC-CCEEE-----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHH
T ss_pred ccccccccccccccchh-----hhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-HHHH
Confidence 99999987643321111 1122457889999999988889999999999999999999 999997642210 0000
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccc
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFF 1013 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1013 (1017)
........ .....+++.+.+++.+||+.||++|||+.|++++|+++...-.
T Consensus 237 ~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 237 IDKEGERL--------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp HHTSCCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHccCCCC--------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 00000000 0011235678999999999999999999999999999876543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=377.53 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=200.9
Q ss_pred CcccccCCceEEEEEe--CCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGIL--GEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||+||+|.+ ..+++.||||+++... ....+++.+|++++++++||||+++++++.. +..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 4799999999999955 4567899999997543 2345789999999999999999999999853 3478999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 449 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred EccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 9999999999997653 689999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCch
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... ..........
T Consensus 520 ~~~~~~~-----~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~-- 590 (635)
T 4fl3_A 520 RADENYY-----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGER-- 590 (635)
T ss_dssp TC------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC--
T ss_pred ccCcccc-----ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--
Confidence 5332111 11122357889999999998899999999999999999998 999997642211 1111110000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
......+++++.+++.+||+.||++||++.+|++.|+++..+.
T Consensus 591 ------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 591 ------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0011234677899999999999999999999999999876654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.81 Aligned_cols=267 Identities=23% Similarity=0.332 Sum_probs=198.2
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC------
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS------ 776 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 776 (1017)
..++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|++++++++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 457899999999999999999999989999999999643 3345778899999999999999999998865321
Q ss_pred --CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC
Q 043932 777 --KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 854 (1017)
Q Consensus 777 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 854 (1017)
......++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 23467899999999999999998654 3678899999999999999999999 9999999999999999999
Q ss_pred eEEeeccccccccccccccc------ccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 855 SHVGDFGLAKFLSSHQLDTA------SKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
+||+|||.+........... ...........||+.|+|||++.+. .++.++||||+||++|||++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 99999999986543210000 0001122335689999999999764 68999999999999999998 55432
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
............... .. . ......+++.+.+++.+||+.||.+|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~--~~----~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 232 MERVNILKKLRSVSI--EF----P------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp HHHHHHHHHHHSTTC--CC----C------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred hhHHHHHHhcccccc--cc----C------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 111111111000000 00 0 001112355688999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.99 Aligned_cols=283 Identities=21% Similarity=0.325 Sum_probs=207.2
Q ss_pred HhhccccccCcccccCCceEEEEEeC-CCcEEEEEEEeeecCc--chHHHHHHHHHHHHhc---CCCCceeeeeeeecCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILG-EDEMIVAVKVINLKQK--GAFKSFMAECKALRNI---RHRNLIKIITICSSID 775 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~ 775 (1017)
...++|++.+.||+|+||.||+|++. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45678999999999999999999995 6789999999875432 2234566777777766 8999999999986433
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCe
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVS 855 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 855 (1017)
.......++||||++ |+|.+++..... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCE
Confidence 334477899999997 599999987542 2589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHH
Q 043932 856 HVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935 (1017)
Q Consensus 856 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 935 (1017)
||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...
T Consensus 160 kl~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~ 229 (326)
T 1blx_A 160 KLADFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLG 229 (326)
T ss_dssp EECSCCSCCCCCGGG---------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH
T ss_pred EEecCcccccccCCC---------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHH
Confidence 999999997654221 1123568999999999998899999999999999999999999997643221 111
Q ss_pred HHHHhhcCchhhhhccch-hhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 936 EFAKIALPEKVIEIVDPL-LLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 936 ~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.............+.... ...... ..............+++.+.+++.+||+.||++|||+.|+++|
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 230 KILDVIGLPGEEDWPRDVALPRQAF--HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGGS--CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCCCcccCccccccchhhh--cccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111111100000000000 000000 0000000111122346678999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=373.97 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=211.1
Q ss_pred HHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
++....++|++.++||+|+||+||+|++.. +..||||+++.... ..+.+.+|++++++++||||+++++++..
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 333 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE----- 333 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-----
Confidence 344456789999999999999999999974 56799999975443 34789999999999999999999999853
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..++||||+++|+|.++++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred -ccceEeeehhcCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEc
Confidence 34789999999999999997532 13589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ....
T Consensus 406 DFG~a~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~ 476 (535)
T 2h8h_A 406 DFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ 476 (535)
T ss_dssp CTTSTTTCCCHHHHT-------TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHH
T ss_pred ccccceecCCCceec-------ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH
Confidence 999998664322111 112356889999999988899999999999999999999 999997542210 0000
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
...... ......+++.+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 477 i~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 477 VERGYR--------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHTTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHcCCC--------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 000000 0011234667899999999999999999999999999987643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=358.40 Aligned_cols=289 Identities=19% Similarity=0.224 Sum_probs=189.8
Q ss_pred hccccc-cCcccccCCceEEEEEeC--CCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFAS-SNMIGQGSFGSVYKGILG--EDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.+.|.+ +++||+|+||+||+|++. .+++.||||++..... .+.+.+|++++++++||||+++++++.... ..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~ 93 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHA---DR 93 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CC
Confidence 345666 568999999999999976 4678899999864432 357889999999999999999999985432 26
Q ss_pred eeEEEEEeccCCCHHHHHhhCCC---CccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe----CCCC
Q 043932 781 FKALVFECMKNGSLEDWLHQSND---HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDM 853 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~ 853 (1017)
..++||||+++ +|.+++..... ......+++..++.++.||+.||+|||++ +|+||||||+||++ +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 78999999965 88888764321 11123589999999999999999999999 99999999999999 6778
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccC-
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEG- 931 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~- 931 (1017)
.+||+|||+|+....... .........||+.|+|||++.+. .++.++||||+||++|||++|++||.......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 244 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244 (405)
T ss_dssp CEEECCTTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred cEEEEECCCceecCCCCc-----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccc
Confidence 999999999987643211 11122335799999999999874 58999999999999999999999997643221
Q ss_pred -------ccHHHHHHhhc-Cc--hhhhhccchhhHHHHhhcch-------hHHHhHHhHHHHHHHHHHHHhhccCCCCCC
Q 043932 932 -------LTLHEFAKIAL-PE--KVIEIVDPLLLIEVMANNSM-------IQEDIRAKTQECLNAIIRIGVLCSMESPFE 994 (1017)
Q Consensus 932 -------~~~~~~~~~~~-~~--~~~~~~d~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 994 (1017)
..+........ +. .+..+..-............ .............+.+.+++.+||+.||.+
T Consensus 245 ~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~ 324 (405)
T 3rgf_A 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324 (405)
T ss_dssp --CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGG
T ss_pred ccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCccc
Confidence 11111111111 10 01000000000000000000 000000000112456889999999999999
Q ss_pred CCCHHHHHHHHh
Q 043932 995 RMEMRDVVAKLC 1006 (1017)
Q Consensus 995 RPs~~evl~~L~ 1006 (1017)
|||+.|+++|-.
T Consensus 325 R~ta~e~L~hp~ 336 (405)
T 3rgf_A 325 RITSEQAMQDPY 336 (405)
T ss_dssp SCCHHHHHTSGG
T ss_pred CCCHHHHhcChh
Confidence 999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=357.49 Aligned_cols=261 Identities=10% Similarity=0.025 Sum_probs=184.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhc--CCCCceeee-------eee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNI--RHRNLIKII-------TIC 771 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~ 771 (1017)
..+|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4569999999999999999999999999999999986543 3345677785555444 699988855 333
Q ss_pred ecCCCC------------CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHH------HHHHHHHHHHHHHHhhCC
Q 043932 772 SSIDSK------------GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQR------VNIAIDVASAIEYLHHHC 833 (1017)
Q Consensus 772 ~~~~~~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~ 833 (1017)
...... .....|+||||++ |+|.+++..... .+++..+ ..++.||+.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSK- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence 221110 0145799999998 799999986432 3344445 67889999999999999
Q ss_pred CCCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccC--CCcCccccchhHH
Q 043932 834 QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--SEASMTGDVYSFG 911 (1017)
Q Consensus 834 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG 911 (1017)
+|+||||||+|||++.++.+||+|||+|+...... ....||+.|+|||++.+ ..++.++||||||
T Consensus 214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG 280 (371)
T 3q60_A 214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----------PASSVPVTYAPREFLNASTATFTHALNAWQLG 280 (371)
T ss_dssp --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred --CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----------cCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence 99999999999999999999999999998653211 12457799999999987 6799999999999
Q ss_pred HHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCC
Q 043932 912 ILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMES 991 (1017)
Q Consensus 912 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 991 (1017)
|++|||++|+.||.......... +.... ......... . ......+++.+.+++.+||+.|
T Consensus 281 ~il~elltg~~Pf~~~~~~~~~~--~~~~~----~~~~~~~~~---------~-----~~~~~~~~~~~~~li~~~L~~d 340 (371)
T 3q60_A 281 LSIYRVWCLFLPFGLVTPGIKGS--WKRPS----LRVPGTDSL---------A-----FGSCTPLPDFVKTLIGRFLNFD 340 (371)
T ss_dssp HHHHHHHHSSCSTTBCCTTCTTC--CCBCC----TTSCCCCSC---------C-----CTTSSCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHhCCCCCCCcCcccccc--hhhhh----hhhcccccc---------c-----hhhccCCCHHHHHHHHHHcCCC
Confidence 99999999999998753321100 00000 000000000 0 0001123567899999999999
Q ss_pred CCCCCCHHHHHHH
Q 043932 992 PFERMEMRDVVAK 1004 (1017)
Q Consensus 992 P~~RPs~~evl~~ 1004 (1017)
|++|||+.|+++|
T Consensus 341 P~~Rpt~~e~l~h 353 (371)
T 3q60_A 341 RRRRLLPLEAMET 353 (371)
T ss_dssp TTTCCCHHHHTTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=354.51 Aligned_cols=279 Identities=21% Similarity=0.277 Sum_probs=205.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC--------CCCceeeeeeeecCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR--------HRNLIKIITICSSID 775 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~ 775 (1017)
.++|++.++||+|+||+||+|++..+++.||||++... ....+.+.+|++++++++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999999999999999999743 334567889999999985 788999999886431
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC--
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-- 853 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 853 (1017)
......++||||+ ++++.+++..... ..+++.+++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred -CCCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 1236789999999 5577776655421 36899999999999999999999853 799999999999999775
Q ss_pred -----------------------------------------------CeEEeecccccccccccccccccCCCccccccc
Q 043932 854 -----------------------------------------------VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886 (1017)
Q Consensus 854 -----------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~g 886 (1017)
.+||+|||.++..... .....|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----------~~~~~g 255 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----------FTEDIQ 255 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----------SCSCCS
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----------CccCCC
Confidence 8999999999865421 122468
Q ss_pred CccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc-----HHHHHHhhc--CchhhhhccchhhHHHH
Q 043932 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT-----LHEFAKIAL--PEKVIEIVDPLLLIEVM 959 (1017)
Q Consensus 887 t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-----~~~~~~~~~--~~~~~~~~d~~l~~~~~ 959 (1017)
|+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... +.... ........+.
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~~~~~~ 333 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYSKEFF 333 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH--HHCTTGGGTB
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh--hccccccccc
Confidence 99999999999989999999999999999999999999765433221 111111110 11000 0000000000
Q ss_pred hh-----------cchhH---HHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 960 AN-----------NSMIQ---EDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 960 ~~-----------~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. ..... ........+++..+.+++.+||+.||++|||+.|+++|
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 00000 00011234567889999999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=348.84 Aligned_cols=277 Identities=20% Similarity=0.258 Sum_probs=202.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC-CCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK-GAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 780 (1017)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+++.+|+.++++++||||+++++++...... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999996533 23346788999999999999999999998654221 113
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||++ ++|.+++.. .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred eEEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence 4589999997 588877642 588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .......
T Consensus 171 g~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~ 238 (353)
T 3coi_A 171 GLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 238 (353)
T ss_dssp TCTTC-------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHH
T ss_pred ccccCCCCC-----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 999754321 123468999999999877 678999999999999999999999997643221 1111111
Q ss_pred hh-cC-chhhhhccchhhHHHHhhc-chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IA-LP-EKVIEIVDPLLLIEVMANN-SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~-~~-~~~~~~~d~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. .+ ......+.......+.... .............+++.+.+++.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11 11 1111111111111111000 000001111122446789999999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=336.60 Aligned_cols=254 Identities=25% Similarity=0.309 Sum_probs=203.7
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 93 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS----- 93 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----
Confidence 44578999999999999999999999899999999997443 23457889999999999999999999998654
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC---CCeE
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVSH 856 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~k 856 (1017)
+..++||||+++++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.+ +.+|
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k 164 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK 164 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CeEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence 67899999999999999987643 689999999999999999999999 99999999999999764 4799
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHE 936 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 936 (1017)
|+|||++....... ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||....... ....
T Consensus 165 L~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~ 233 (287)
T 2wei_A 165 IIDFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKR 233 (287)
T ss_dssp ECSTTGGGTBCCCS---------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH
T ss_pred EeccCcceeecCCC---------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 99999998654321 1112458999999999876 48999999999999999999999997642211 0111
Q ss_pred HHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 937 FAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 937 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
......+.. ......+++++.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 234 VETGKYAFD------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHCCCCCC------------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHcCCCCCC------------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 111000000 00112235678999999999999999999999985
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=366.76 Aligned_cols=174 Identities=13% Similarity=0.114 Sum_probs=97.6
Q ss_pred CCCCCCCCCCCCCc----eeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccc
Q 043932 53 GVTSSWNNTINLCQ----WTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLE 128 (1017)
Q Consensus 53 ~~~~sw~~~~~~c~----w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 128 (1017)
..+++|.++.+||. |.++.|+. .++-....... ...-..+++++.|++++|.+++..+..|+++++|+
T Consensus 7 ~~l~~~~~~~~C~~~~~~~~c~~~~~------~i~~~~~~~~~--~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~ 78 (597)
T 3oja_B 7 YNVKPRQPEYKCIDSNLQYDCVFYDV------HIDMQTQDVYF--GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78 (597)
T ss_dssp ----CCCSEECCCCC--CCSEEECSC------EECSSCCCCEE--SCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCS
T ss_pred ccccCCCCCCcCcccCcCceeEecCc------eeccccccccc--CcccccCCCceEEEeeCCCCCCcCHHHHccCCCCc
Confidence 34689998878884 77776642 11111111111 11112356677777777777644344456667777
Q ss_pred cccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCC
Q 043932 129 KLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNS 208 (1017)
Q Consensus 129 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 208 (1017)
+|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++
T Consensus 79 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l------------ 146 (597)
T 3oja_B 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT------------ 146 (597)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC------------
T ss_pred EEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccC------------
Confidence 77777777766656666666666666666666666555556666666666666666554434444444
Q ss_pred CCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCc
Q 043932 209 LGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFS 258 (1017)
Q Consensus 209 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 258 (1017)
++|++|+|++|.+++..|..|..+++|++|+|++|.++
T Consensus 147 ------------~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 147 ------------PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp ------------TTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ------------CCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 45555555555555555555555555555555555554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.36 Aligned_cols=269 Identities=23% Similarity=0.334 Sum_probs=202.0
Q ss_pred HHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecC
Q 043932 697 YAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSI 774 (1017)
Q Consensus 697 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 774 (1017)
..++....++|++.+.||+|+||.||+|++.. .||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 34455556899999999999999999999864 38999987442 23345677899999999999999999998754
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 854 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 854 (1017)
+..++||||+++++|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++ ++.
T Consensus 102 -----~~~~iv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~ 167 (319)
T 2y4i_B 102 -----PHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGK 167 (319)
T ss_dssp -----SCEEEECBCCCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---C
T ss_pred -----CceEEEeecccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCC
Confidence 56899999999999999997654 2688999999999999999999999 999999999999998 689
Q ss_pred eEEeecccccccccccccccccCCCcccccccCccccCcccccC---------CCcCccccchhHHHHHHHHHhCCCCCC
Q 043932 855 SHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG---------SEASMTGDVYSFGILLLELFTGRRPTD 925 (1017)
Q Consensus 855 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~pf~ 925 (1017)
+||+|||+++......... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 244 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGR---REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244 (319)
T ss_dssp CEECCCSCCC-------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS
T ss_pred EEEeecCCccccccccccc---cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999987653221111 1112223468999999999864 357889999999999999999999997
Q ss_pred cccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 926 AAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
....... ....... . .+.. ....++.++.+++.+||+.||++|||+.|+++.|
T Consensus 245 ~~~~~~~-~~~~~~~-~--------~~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 297 (319)
T 2y4i_B 245 TQPAEAI-IWQMGTG-M--------KPNL-----------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297 (319)
T ss_dssp SCCHHHH-HHHHHTT-C--------CCCC-----------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred CCCHHHH-HHHhccC-C--------CCCC-----------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 5422110 0000000 0 0000 0001245688999999999999999999999999
Q ss_pred hhccccc
Q 043932 1006 CHTRETF 1012 (1017)
Q Consensus 1006 ~~~~~~~ 1012 (1017)
+.+.++.
T Consensus 298 ~~l~~~~ 304 (319)
T 2y4i_B 298 EKLPKRN 304 (319)
T ss_dssp TTC----
T ss_pred HHHHHhh
Confidence 9998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=348.56 Aligned_cols=206 Identities=26% Similarity=0.346 Sum_probs=173.1
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CC-----Cceeeeeeeec
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HR-----NLIKIITICSS 773 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~ 773 (1017)
.....++|++.++||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.++ |+ +|+++++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 344568999999999999999999999999999999999733 233466778888888884 44 48999998876
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC--C
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--H 851 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~ 851 (1017)
. +..++||||++ |+|.+++..... ..+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .
T Consensus 128 ~-----~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 128 R-----NHLCLVFEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp T-----TEEEEEEECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTT
T ss_pred C-----CceEEEEecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCC
Confidence 5 67899999996 599999987532 3589999999999999999999953 22899999999999995 4
Q ss_pred CCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 043932 852 DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAF 928 (1017)
Q Consensus 852 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 928 (1017)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 197 ~~~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp SCCEEECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcEEEEeccCceecccc-----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 788999999999865321 123568999999999999899999999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.59 Aligned_cols=263 Identities=23% Similarity=0.367 Sum_probs=198.7
Q ss_pred CcCHHHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcC--CCCceeeee
Q 043932 694 TVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIR--HRNLIKIIT 769 (1017)
Q Consensus 694 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~ 769 (1017)
.+.+..+....++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++ ||||+++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 4445555566788999999999999999999996 58889999997543 234577899999999997 599999999
Q ss_pred eeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
++... +..++||| +.+++|.+++.... .+++.+++.++.|+++||+|||++ +|+||||||+||++
T Consensus 96 ~~~~~-----~~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~ 160 (313)
T 3cek_A 96 YEITD-----QYIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLI 160 (313)
T ss_dssp EEECS-----SEEEEEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred EeecC-----CEEEEEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEE
Confidence 98664 67899999 55789999998754 688999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccC-----------CCcCccccchhHHHHHHHHH
Q 043932 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-----------SEASMTGDVYSFGILLLELF 918 (1017)
Q Consensus 850 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell 918 (1017)
+ ++.+||+|||+++........ .......||+.|+|||++.+ ..++.++||||||+++|||+
T Consensus 161 ~-~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 233 (313)
T 3cek_A 161 V-DGMLKLIDFGIANQMQPDTTS------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233 (313)
T ss_dssp E-TTEEEECCCSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHH
T ss_pred E-CCeEEEeeccccccccCcccc------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHH
Confidence 6 489999999999866432211 11123468999999999875 46888999999999999999
Q ss_pred hCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 043932 919 TGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM 998 (1017)
Q Consensus 919 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 998 (1017)
+|+.||........ ..... .++.... .....+++.+.+++.+||+.||++||++
T Consensus 234 ~g~~pf~~~~~~~~---~~~~~---------~~~~~~~--------------~~~~~~~~~l~~li~~~l~~dp~~Rps~ 287 (313)
T 3cek_A 234 YGKTPFQQIINQIS---KLHAI---------IDPNHEI--------------EFPDIPEKDLQDVLKCCLKRDPKQRISI 287 (313)
T ss_dssp HSSCTTTTCCSHHH---HHHHH---------HCTTSCC--------------CCCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred hCCCchhhHHHHHH---HHHHH---------Hhccccc--------------CCcccchHHHHHHHHHHccCCcccCcCH
Confidence 99999975422111 11110 0100000 0000114568899999999999999999
Q ss_pred HHHHHHH
Q 043932 999 RDVVAKL 1005 (1017)
Q Consensus 999 ~evl~~L 1005 (1017)
.|++++-
T Consensus 288 ~ell~h~ 294 (313)
T 3cek_A 288 PELLAHP 294 (313)
T ss_dssp HHHHTSH
T ss_pred HHHhcCc
Confidence 9999864
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=352.71 Aligned_cols=180 Identities=19% Similarity=0.181 Sum_probs=116.9
Q ss_pred CCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEe
Q 043932 101 SFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAV 180 (1017)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 180 (1017)
++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 46788888888888766777777777888888777777777777777777777777777777555556677777777777
Q ss_pred ccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccc
Q 043932 181 GKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGT 260 (1017)
Q Consensus 181 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 260 (1017)
++|++++..|..|.++++|+.|++++|.+++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|.+. .
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~-~ 190 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-A 190 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCC-E
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCc-E
Confidence 777777666666777777777777766666655666666666666666666665444444555555555555555544 2
Q ss_pred cCchhhccCCccceeeecccc
Q 043932 261 LPFDIVVNLPNLKSLAIGGNN 281 (1017)
Q Consensus 261 l~~~~~~~l~~L~~L~L~~n~ 281 (1017)
++...+..+++|++|++++|.
T Consensus 191 ~~~~~~~~l~~L~~L~l~~~~ 211 (477)
T 2id5_A 191 IRDYSFKRLYRLKVLEISHWP 211 (477)
T ss_dssp ECTTCSCSCTTCCEEEEECCT
T ss_pred eChhhcccCcccceeeCCCCc
Confidence 222233333344444443333
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=343.09 Aligned_cols=175 Identities=13% Similarity=0.110 Sum_probs=107.2
Q ss_pred CCCCCCCCCCCc-eeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCC
Q 043932 55 TSSWNNTINLCQ-WTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALP 133 (1017)
Q Consensus 55 ~~sw~~~~~~c~-w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 133 (1017)
+++|....+||. |.+..|.....++ ............-..++++++|++++|.++...+..+..+++|++|+|+
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred cCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence 578988878875 4444442111111 2211111112222346788888888888874333346778888888888
Q ss_pred CCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCC
Q 043932 134 NNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKI 213 (1017)
Q Consensus 134 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 213 (1017)
+|.+++..|..|+.+++|++|+|++|++++..|..|+++++|++|++++|+++...+..|+++++|++|++++|.+++..
T Consensus 78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~ 157 (390)
T 3o6n_A 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 157 (390)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence 88888766677888888888888888887777777777777777777777777544444566666666666666666555
Q ss_pred CcccccccCcceeEeecCccc
Q 043932 214 PTTLGLLRNLVDLHVGGNQFS 234 (1017)
Q Consensus 214 ~~~l~~l~~L~~L~L~~n~l~ 234 (1017)
+..|+.+++|++|++++|+++
T Consensus 158 ~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 158 DDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp TTTTSSCTTCCEEECCSSCCS
T ss_pred hhhccCCCCCCEEECCCCcCC
Confidence 555555555555555555554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=346.22 Aligned_cols=266 Identities=20% Similarity=0.333 Sum_probs=203.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcch-----------------HHHHHHHHHHHHhcCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-----------------FKSFMAECKALRNIRHRNLIK 766 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~ 766 (1017)
.++|++.+.||+|+||.||+|++ +++.||+|++....... .+.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 56899999999999999999999 89999999997432211 178899999999999999999
Q ss_pred eeeeeecCCCCCCceeEEEEEeccCCCHHHH------HhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCcee
Q 043932 767 IITICSSIDSKGADFKALVFECMKNGSLEDW------LHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVH 839 (1017)
Q Consensus 767 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH 839 (1017)
+++++... +..++||||+++|+|.++ +.... ...+++..++.++.|++.||+|||+ . +|+|
T Consensus 108 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H 175 (348)
T 2pml_X 108 CEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH 175 (348)
T ss_dssp CSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred EEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence 99998764 678999999999999998 44321 2478999999999999999999999 8 9999
Q ss_pred ecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCC-CcCc-cccchhHHHHHHHH
Q 043932 840 GDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASM-TGDVYSFGILLLEL 917 (1017)
Q Consensus 840 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~el 917 (1017)
|||||+||+++.++.+||+|||.+...... ......||+.|+|||++.+. .++. ++||||+||++|||
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 245 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence 999999999999999999999999865432 11234689999999999887 5665 99999999999999
Q ss_pred HhCCCCCCcccccCccHHHHHHhhc--CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCC
Q 043932 918 FTGRRPTDAAFTEGLTLHEFAKIAL--PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFER 995 (1017)
Q Consensus 918 ltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 995 (1017)
++|+.||.................. +........+.. ..........+++.+.+++.+||+.||.+|
T Consensus 246 ~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 314 (348)
T 2pml_X 246 FYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLT-----------NKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314 (348)
T ss_dssp HHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTC-----------C--------CCCHHHHHHHHHHCCSSGGGS
T ss_pred HhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhcccc-----------ccccccchhhcCHHHHHHHHHHccCChhhC
Confidence 9999999764332111111111100 000000000000 000011113346778999999999999999
Q ss_pred CCHHHHHHH
Q 043932 996 MEMRDVVAK 1004 (1017)
Q Consensus 996 Ps~~evl~~ 1004 (1017)
||+.|++++
T Consensus 315 ps~~e~l~h 323 (348)
T 2pml_X 315 ITSEDALKH 323 (348)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999885
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=341.63 Aligned_cols=261 Identities=22% Similarity=0.306 Sum_probs=178.4
Q ss_pred hhccccccC-cccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 703 ATSEFASSN-MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 703 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
..++|.+.+ +||+|+||+||+|++..+++.||||++.... +...+....++.+.||||+++++++.... .+...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMH-HGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCce
Confidence 356898855 6999999999999999999999999986431 22222333456679999999999986532 22366
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC---CCCeEEe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVSHVG 858 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 858 (1017)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence 8999999999999999986532 3689999999999999999999999 9999999999999976 4569999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||+++...... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||..............
T Consensus 174 Dfg~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (336)
T 3fhr_A 174 DFGFAKETTQNA----------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243 (336)
T ss_dssp CCTTCEEC--------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred ccccceeccccc----------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence 999997654221 1124689999999999888899999999999999999999999976433211100000
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
.... ...... ......+++.+.+++.+||+.||.+|||+.|++++-.
T Consensus 244 ~~~~--~~~~~~-------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 244 RIRL--GQYGFP-------------------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp ---------CCC-------------------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hhhc--cccccC-------------------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0000 000000 0011234567899999999999999999999998643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=370.40 Aligned_cols=265 Identities=22% Similarity=0.364 Sum_probs=208.8
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCC---CcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeec
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
.+.....++|++.+.||+|+||+||+|++.. .+..||+|++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 462 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3444556789999999999999999999864 356799999875433 344778999999999999999999999742
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 463 ------~~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~ 528 (656)
T 2j0j_A 463 ------NPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND 528 (656)
T ss_dssp ------SSCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred ------CceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCC
Confidence 347899999999999999986542 689999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGL 932 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 932 (1017)
.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 529 ~vkL~DFG~a~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 600 (656)
T 2j0j_A 529 CVKLGDFGLSRYMEDSTYY-------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND- 600 (656)
T ss_dssp EEEECCCCCCCSCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-
T ss_pred CEEEEecCCCeecCCCcce-------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-
Confidence 9999999999876432211 1112357889999999988899999999999999999997 999997642211
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
......... . ......+++.+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 601 ~~~~i~~~~-~--------------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 601 VIGRIENGE-R--------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHHTC-C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCC-C--------------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 000100000 0 001123456789999999999999999999999999988653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.49 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=200.2
Q ss_pred HHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc------hHHHHHHHHHHHHhcC--CCCceeeeeeee
Q 043932 701 SKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG------AFKSFMAECKALRNIR--HRNLIKIITICS 772 (1017)
Q Consensus 701 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 772 (1017)
....++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999999999999999999754321 2245678999999996 599999999987
Q ss_pred cCCCCCCceeEEEEEeccC-CCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC-
Q 043932 773 SIDSKGADFKALVFECMKN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD- 850 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~- 850 (1017)
.. +..++|||++.+ ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 119 ~~-----~~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 119 RP-----DSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDL 184 (320)
T ss_dssp CS-----SEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET
T ss_pred cC-----CcEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeC
Confidence 54 678999999976 89999998643 689999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccc
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFT 929 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~ 929 (1017)
.++.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 254 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254 (320)
T ss_dssp TTTEEEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred CCCCEEEeeCcccccccccc----------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh
Confidence 78999999999998664321 122468999999999877665 7889999999999999999999965311
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....... . ...+++++.+++.+||+.||++|||+.|++++
T Consensus 255 -------~~~~~~~------~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 -------IIRGQVF------F----------------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -------HHHCCCC------C----------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------hhccccc------c----------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100000 0 01124568899999999999999999999885
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=340.31 Aligned_cols=274 Identities=20% Similarity=0.271 Sum_probs=201.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCc-EEEEEEEeeecCcchHHHHHHHHHHHHhcCCCC------ceeeeeeeecCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDE-MIVAVKVINLKQKGAFKSFMAECKALRNIRHRN------LIKIITICSSIDS 776 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 776 (1017)
.++|++.+.||+|+||+||+|++..++ +.||+|++... ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-- 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-- 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET--
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC--
Confidence 568999999999999999999998766 79999999643 234467888999999997766 88888887655
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe-------
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL------- 849 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll------- 849 (1017)
+..++||||+ ++++.+++..... ..+++.+++.++.||+.||+|||++ +|+||||||+||++
T Consensus 95 ---~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 95 ---GHMCIAFELL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp ---TEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred ---CeEEEEEecc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence 6789999999 6677777765432 3689999999999999999999999 99999999999999
Q ss_pred ------------CCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHH
Q 043932 850 ------------DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLEL 917 (1017)
Q Consensus 850 ------------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 917 (1017)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccccccCCCcEEEeecCcccccccc-----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence 56789999999999754321 1235689999999999998999999999999999999
Q ss_pred HhCCCCCCcccccCccHHHHHHh--hcCchhhhhccch-------------h-hHHHH-hhcchhHHHhHHhHHHHHHHH
Q 043932 918 FTGRRPTDAAFTEGLTLHEFAKI--ALPEKVIEIVDPL-------------L-LIEVM-ANNSMIQEDIRAKTQECLNAI 980 (1017)
Q Consensus 918 ltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~-------------l-~~~~~-~~~~~~~~~~~~~~~~~~~~l 980 (1017)
++|+.||....... ........ ..+..+....... . ..... ...... .........++.++
T Consensus 233 ~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 310 (355)
T 2eu9_A 233 YRGFTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQL 310 (355)
T ss_dssp HHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHH
T ss_pred HhCCCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc-cccccccchhHHHH
Confidence 99999997643221 11111111 1111111100000 0 00000 000000 00001112346689
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHH
Q 043932 981 IRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 981 ~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+++.+||+.||++|||+.|+++|
T Consensus 311 ~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 311 FDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHhcCChhhCcCHHHHhcC
Confidence 999999999999999999999865
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=340.73 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=193.5
Q ss_pred HHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc------hHHHHHHHHHHHHhc----CCCCceeee
Q 043932 699 ELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG------AFKSFMAECKALRNI----RHRNLIKII 768 (1017)
Q Consensus 699 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~ 768 (1017)
+.....++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4455677899999999999999999999989999999999754321 223456799999988 899999999
Q ss_pred eeeecCCCCCCceeEEEEEe-ccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCce
Q 043932 769 TICSSIDSKGADFKALVFEC-MKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNV 847 (1017)
Q Consensus 769 ~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 847 (1017)
+++... +..++|||| +.+++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||
T Consensus 105 ~~~~~~-----~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 170 (312)
T 2iwi_A 105 DWFETQ-----EGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI 170 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred EEEecC-----CeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence 998654 567899999 78999999998643 689999999999999999999999 999999999999
Q ss_pred EeC-CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCC
Q 043932 848 LLD-HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTD 925 (1017)
Q Consensus 848 ll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~ 925 (1017)
+++ .++.+||+|||++....... .....||..|+|||++.+..+ +.++||||+|+++|||++|+.||.
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDEP----------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSSC----------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEeCCCCeEEEEEcchhhhcccCc----------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 999 88999999999998664322 123468999999999877665 458999999999999999999996
Q ss_pred cccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 926 AAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
... ........ ....++..+.+++.+||+.||++|||+.|++++-
T Consensus 241 ~~~-------~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 241 RDQ-------EILEAELH----------------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp SHH-------HHHHTCCC----------------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ChH-------HHhhhccC----------------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 531 11100000 0012245688999999999999999999999853
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.56 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=233.4
Q ss_pred cceEEEecCCcccc--ccCccccccccccEEeccc-cCCCCCcchhhcccccccceeccccccccccCccccccccccee
Q 043932 374 SMIEFRIGGNQIFG--IIPSGIRNLVNLIALGMQS-NQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKL 450 (1017)
Q Consensus 374 ~L~~L~l~~N~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 450 (1017)
+++.|++++|.+++ .+|..|.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 46777777777777 7788888889999999995 88888889889999999999999999988889889999999999
Q ss_pred eccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcc
Q 043932 451 VMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQF 530 (1017)
Q Consensus 451 ~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 530 (1017)
+|++|+|++.+|..+..+++|++|++++|++++.+|..+..+...+++|+|++|.+++.+|..+..++ |+.|+|++|++
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 99999999888989999999999999999998888988888875566799999999989999999987 99999999999
Q ss_pred cccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCCC
Q 043932 531 SGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKG 610 (1017)
Q Consensus 531 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 610 (1017)
++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+.++++|+.|+|++|+++|.+|..+
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 999999999999999999999999987776 8899999999999999999999999999999999999999999999988
Q ss_pred CCCCCCcccccCcccccCCcC
Q 043932 611 VFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 611 ~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
.+.+++.+++.+|+++||.|+
T Consensus 289 ~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 289 NLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS
T ss_pred cccccChHHhcCCCCccCCCC
Confidence 899999999999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=342.64 Aligned_cols=280 Identities=18% Similarity=0.271 Sum_probs=203.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-----------CCCceeeeeeee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-----------HRNLIKIITICS 772 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 772 (1017)
.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999999999999999998733 233467788999998886 899999999986
Q ss_pred cCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC--
Q 043932 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-- 850 (1017)
Q Consensus 773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-- 850 (1017)
... .+....++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ +|+||||||+||+++
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 542 2234789999999 8899999987532 35899999999999999999999843 899999999999994
Q ss_pred ----CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 043932 851 ----HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDA 926 (1017)
Q Consensus 851 ----~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 926 (1017)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCcCcceEEEcccccccccCCC-----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 4458999999999865421 1124689999999999998999999999999999999999999976
Q ss_pred ccccC-----ccHHHHHHhh--cCchhhhhccchhhHHHHhh-----------cchhH---HHhHHhHHHHHHHHHHHHh
Q 043932 927 AFTEG-----LTLHEFAKIA--LPEKVIEIVDPLLLIEVMAN-----------NSMIQ---EDIRAKTQECLNAIIRIGV 985 (1017)
Q Consensus 927 ~~~~~-----~~~~~~~~~~--~~~~~~~~~d~~l~~~~~~~-----------~~~~~---~~~~~~~~~~~~~l~~li~ 985 (1017)
..... .......... .+..... +......+... ..... .........+++++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHH--HCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHh--ccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 43221 1111111111 1110000 00000000000 00000 0001123466888999999
Q ss_pred hccCCCCCCCCCHHHHHHHH
Q 043932 986 LCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 986 ~cl~~dP~~RPs~~evl~~L 1005 (1017)
+||+.||++|||+.|+++|-
T Consensus 316 ~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTCG
T ss_pred HHhccCccccCCHHHHhhCh
Confidence 99999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=334.16 Aligned_cols=255 Identities=20% Similarity=0.265 Sum_probs=182.5
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc--hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
...++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.++..+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~----- 96 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN----- 96 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----
Confidence 3457899999999999999999999989999999999754332 223344555667888999999999998764
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..++||||+ ++.+..+..... ..+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+||+
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~ 167 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLC 167 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEEC
T ss_pred CcEEEEEecc-CCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEE
Confidence 6789999999 556666655432 268999999999999999999998 6 89999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
|||++....... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.........
T Consensus 168 dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 238 (318)
T 2dyl_A 168 DFGISGRLVDDK---------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238 (318)
T ss_dssp CCTTC-----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred ECCCchhccCCc---------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH
Confidence 999997654322 112246899999999984 456889999999999999999999999753221111
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.........+. . .....+++++.+++.+||+.||.+||++.|++++
T Consensus 239 ~~~~~~~~~~~-~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 239 LTKVLQEEPPL-L------------------------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHHSCCCC-C------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHhccCCCC-C------------------------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111110000 0 0001135678899999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.69 Aligned_cols=260 Identities=22% Similarity=0.267 Sum_probs=179.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHH-HHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECK-ALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ....++..|+. +++.++||||+++++++... +.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----Cc
Confidence 4689999999999999999999999999999999975432 23345556666 66777999999999998764 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+++ +|.+++...... ....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence 8999999976 888887641100 1136899999999999999999999842 79999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccc----cCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYC----MGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+++...... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||..........
T Consensus 172 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--- 239 (327)
T 3aln_A 172 ISGQLVDSI---------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL--- 239 (327)
T ss_dssp SSCC---------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------
T ss_pred Cceeccccc---------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH---
Confidence 997654321 11123689999999998 45668999999999999999999999997532111000
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
............. .....+++.+.+++.+||+.||++|||+.|++++
T Consensus 240 -~~~~~~~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 240 -TQVVKGDPPQLSN-------------------SEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -CCCCCSCCCCCCC-------------------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -HHHhcCCCCCCCC-------------------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000000000000 0001235678999999999999999999999875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=333.76 Aligned_cols=269 Identities=20% Similarity=0.286 Sum_probs=170.7
Q ss_pred CCCCHHHHHHHHHHHHhc-CCCCCCCCCC----CCCCCCCceeeEEECC--------CCCeEEEEEcCCCCCccccCccc
Q 043932 31 GQTNETDRLALLAIKSQL-HDTSGVTSSW----NNTINLCQWTGVTCGH--------RHQRVTRLDLSNQRIGGILSPYV 97 (1017)
Q Consensus 31 ~~~~~~~~~aLl~~k~~~-~~~~~~~~sw----~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~~~~~~~l 97 (1017)
..+.++|++||++||+++ .|+.+.+++| ....++|.|.||+|.. ...+|+.|+|++|+++ .+|+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 345678999999999999 5888888999 5567899999999942 3456777888887777 456667
Q ss_pred CCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccc------
Q 043932 98 GNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGS------ 171 (1017)
Q Consensus 98 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~------ 171 (1017)
+++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..++.
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 77777888888777777 77777777777777777777777 67777777777777777777777777766554
Q ss_pred ---cCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCc
Q 043932 172 ---LLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLE 248 (1017)
Q Consensus 172 ---l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 248 (1017)
+++|++|+|++|+++ .+|..++++++|++|+|++|.+++ +|..++.+++|++|+|++|++.+.+|..+..+++|+
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 256 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence 555555555555555 445555555555555555555542 333455555555555555555555555555555555
Q ss_pred EEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCc
Q 043932 249 RIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQ 305 (1017)
Q Consensus 249 ~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 305 (1017)
+|+|++|.+.+.+|.. +.++++|++|+|++|++.+.+|..++.+++|+.+++..|.
T Consensus 257 ~L~L~~n~~~~~~p~~-~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLD-IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp EEECTTCTTCCBCCTT-GGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred EEECCCCCchhhcchh-hhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence 5555554444444433 2344444444444444444444444444444444444433
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=346.93 Aligned_cols=259 Identities=21% Similarity=0.266 Sum_probs=185.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
+.|...++||+|+||+||.+.. .+|+.||||++... ..+.+.+|+++++++ +||||+++++++... +..+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~~~~ 85 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD-----RFLY 85 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEE
T ss_pred heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC-----CeEE
Confidence 3456678899999999987654 47889999998643 235678899999887 899999999988654 6789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccc-cccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC----------
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEV-CKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---------- 852 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---------- 852 (1017)
+||||++ |+|.+++......... ...++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccC
Confidence 9999996 5999999875432111 1123445678999999999999999 99999999999999754
Q ss_pred ---CCeEEeecccccccccccccccccCCCcccccccCccccCcccccC-------CCcCccccchhHHHHHHHHHh-CC
Q 043932 853 ---MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-------SEASMTGDVYSFGILLLELFT-GR 921 (1017)
Q Consensus 853 ---~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~ 921 (1017)
+.+||+|||+++......... ........||+.|+|||++.+ ..++.++||||+||++|||++ |+
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSF----RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CCSCEEEECCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred CCceEEEEcccccceecCCCCccc----eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 489999999998765432111 111223579999999999865 568999999999999999999 99
Q ss_pred CCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 043932 922 RPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDV 1001 (1017)
Q Consensus 922 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1001 (1017)
.||....... .............. ......+++++.+++.+||+.||.+|||+.|+
T Consensus 238 ~Pf~~~~~~~---~~i~~~~~~~~~~~---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 293 (434)
T 2rio_A 238 HPFGDKYSRE---SNIIRGIFSLDEMK---------------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293 (434)
T ss_dssp CTTCSTTTHH---HHHHHTCCCCCCCT---------------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCchhhH---HHHhcCCCCccccc---------------------ccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence 9996542211 11111111000000 00112346778999999999999999999999
Q ss_pred HHH
Q 043932 1002 VAK 1004 (1017)
Q Consensus 1002 l~~ 1004 (1017)
++|
T Consensus 294 l~h 296 (434)
T 2rio_A 294 LRH 296 (434)
T ss_dssp HTS
T ss_pred HhC
Confidence 875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=335.75 Aligned_cols=114 Identities=18% Similarity=0.252 Sum_probs=62.2
Q ss_pred ccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCC
Q 043932 512 LQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSF 591 (1017)
Q Consensus 512 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 591 (1017)
..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|++++. | +..+++
T Consensus 266 ~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~ 340 (390)
T 3o6n_A 266 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHT 340 (390)
T ss_dssp GGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCC
T ss_pred hHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCcccee-C--chhhcc
Confidence 334444555555555555542 33344455555555555555553 344455556666666666666533 2 445566
Q ss_pred CcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCcC
Q 043932 592 LEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 592 L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
|+.|++++|++++.... ..+..+....+.+++..|.++.
T Consensus 341 L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 341 LKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp CSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTC
T ss_pred CCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecccc
Confidence 66666666666654322 2334455556677877887654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=353.89 Aligned_cols=277 Identities=23% Similarity=0.287 Sum_probs=199.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 781 (1017)
.++|++.++||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++..... ...+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999999989999999998754 23345678999999999999999999998755221 22467
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCC---eEEe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV---SHVG 858 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 858 (1017)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred EEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 7999999999999999986542 23588889999999999999999999 9999999999999997765 9999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||.+....... ......||+.|+|||++.+..++.++||||+||++|||++|..||...... ..+.
T Consensus 167 DFG~a~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~ 233 (676)
T 3qa8_A 167 DLGYAKELDQGE---------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWH 233 (676)
T ss_dssp SCCCCCBTTSCC---------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSS
T ss_pred cccccccccccc---------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhh
Confidence 999998664322 112357899999999999999999999999999999999999999753211 0000
Q ss_pred HhhcCchhhh-hccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 043932 939 KIALPEKVIE-IVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDV 1001 (1017)
Q Consensus 939 ~~~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1001 (1017)
.......... ........... .....+.........++.+.+++.+||++||++|||+.|+
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~~--~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAVK--FSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp TTCC------CCSCCCCSSSCC--CCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhcccchhhhhhhhhccccc--cccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000000 00000000000 0000000001122346789999999999999999999884
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.54 Aligned_cols=235 Identities=12% Similarity=0.075 Sum_probs=186.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+..+++++||||+++++++... +
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----A 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----C
Confidence 4689999999999999999999998999999999975432 3347789999999999999999999998765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+++++|.++++.. ....++.+++.|++.||+|||++ +|+||||||+||+++.++.+||+++
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC
T ss_pred cEEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec
Confidence 789999999999999999642 24557889999999999999999 9999999999999999999999744
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
| |++ .++.++|||||||++|||++|+.||.............
T Consensus 174 ~----------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--- 215 (286)
T 3uqc_A 174 A----------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--- 215 (286)
T ss_dssp C----------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---
T ss_pred c----------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---
Confidence 3 333 36889999999999999999999998753321100000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
........ ........+++++.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 216 ---~~~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 216 ---RDTAGQPI----------------EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp ---BCTTSCBC----------------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ---HHhccCCC----------------ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00000000 0001112346678999999999999999 9999999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=337.94 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=184.3
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCce
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
...+|.+.++||+|+||+||.... .+++.||||++..... ..+.+|+++++++ +||||+++++++... ..
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~ 92 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDR-----QF 92 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEET-----TE
T ss_pred ccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecC-----CE
Confidence 345799999999999999664433 4688999999864332 2356899999999 799999999988654 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-----CCCeE
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-----DMVSH 856 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~k 856 (1017)
.|+||||++ |+|.+++..... .....+++.++.||+.||+|||++ +|+||||||+||+++. ...+|
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~k 163 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAM 163 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred EEEEEECCC-CCHHHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEE
Confidence 899999996 599999986643 344445678999999999999999 9999999999999953 23688
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCccccc---CCCcCccccchhHHHHHHHHHh-CCCCCCcccccCc
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM---GSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGL 932 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 932 (1017)
|+|||+|+........ ........||+.|+|||++. +..++.++||||+||++|||++ |..||......
T Consensus 164 L~DFG~a~~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-- 236 (432)
T 3p23_A 164 ISDFGLCKKLAVGRHS-----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-- 236 (432)
T ss_dssp ECCTTEEECC-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--
T ss_pred EecccceeeccCCCcc-----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--
Confidence 9999999876432211 11123357999999999997 3567889999999999999999 99998543211
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..... .......... ........+.+++.+||+.||++|||+.||++|
T Consensus 237 -~~~~~---~~~~~~~~~~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 237 -QANIL---LGACSLDCLH--------------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -HHHHH---TTCCCCTTSC--------------------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHH---hccCCccccC--------------------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00000 0000000000 001224557899999999999999999999965
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=338.88 Aligned_cols=253 Identities=15% Similarity=0.147 Sum_probs=185.4
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCC-CCceeee---------e
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRH-RNLIKII---------T 769 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~~---------~ 769 (1017)
....|...++||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+++.++| +|..... +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 44568888999999999999999999999999999874332 235788999999999976 3221111 1
Q ss_pred e------------eecCCCCCCceeEEEEEeccCCCHHHHHhhCCC-CccccccCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 043932 770 I------------CSSIDSKGADFKALVFECMKNGSLEDWLHQSND-HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP 836 (1017)
Q Consensus 770 ~------------~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 836 (1017)
. +...........+++|+++ +++|.++++.... ......+++..++.++.||++||+|||++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 1 1110000123456777766 6799999852210 00124688889999999999999999999 9
Q ss_pred ceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccc----------cCCCcCcccc
Q 043932 837 MVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYC----------MGSEASMTGD 906 (1017)
Q Consensus 837 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~D 906 (1017)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 999999999999999999999999998764322 123467 999999999 5556889999
Q ss_pred chhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhh
Q 043932 907 VYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVL 986 (1017)
Q Consensus 907 vwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 986 (1017)
||||||++|||++|+.||......... ..+.. ....+++.+.+++.+
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~~~-------------~~~~~--------------------~~~~~~~~~~~li~~ 346 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALGGS-------------EWIFR--------------------SCKNIPQPVRALLEG 346 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGSCS-------------GGGGS--------------------SCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhhhH-------------HHHHh--------------------hcccCCHHHHHHHHH
Confidence 999999999999999999764322110 00000 000224678999999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 043932 987 CSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 987 cl~~dP~~RPs~~evl~~ 1004 (1017)
||+.||++||++.|++++
T Consensus 347 ~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 347 FLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HTCSSGGGSCCHHHHTTS
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999998887654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=355.34 Aligned_cols=246 Identities=23% Similarity=0.345 Sum_probs=197.0
Q ss_pred hccccccCcccccCCceEEEEEeCC-CcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGE-DEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.++||+|+||+||+|++.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..+...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999975 78999999986443 234567889999999999999999999998764444444
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++++|.+++.. .+++.+++.++.||+.||+|||++ +|+||||||+||+++.+ .+||+|||
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eEEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 7999999999999987643 589999999999999999999999 99999999999999875 99999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||........
T Consensus 227 ~a~~~~~~------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------- 284 (681)
T 2pzi_A 227 AVSRINSF------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------- 284 (681)
T ss_dssp TCEETTCC------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------
T ss_pred cchhcccC------------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------
Confidence 99865421 225699999999998764 48899999999999999999998865332211
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHhhcc
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-MRDVVAKLCHTR 1009 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~~~ 1009 (1017)
+.. ......++.+.+++.+||+.||++||+ ++++.+.+..+.
T Consensus 285 -~~~-------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 -PED-------------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -CTT-------------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -ccc-------------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 001123456889999999999999995 666666666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=314.27 Aligned_cols=239 Identities=19% Similarity=0.304 Sum_probs=183.7
Q ss_pred hcccccc-CcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHH-HhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKAL-RNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|.+. ++||+|+||.||+|.+..+++.||+|++... ..+.+|++++ +..+||||+++++++.... .+...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCce
Confidence 4567776 7899999999999999999999999998632 4567888888 5558999999999986521 22367
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC---CCCeEEe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVSHVG 858 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 858 (1017)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 8999999999999999987532 3689999999999999999999999 9999999999999998 7899999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||++.... +..++.++||||+||++|||++|+.||.........
T Consensus 163 Dfg~a~~~~------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----- 207 (299)
T 3m2w_A 163 DFGFAKETT------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----- 207 (299)
T ss_dssp CCTTCEECT------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------
T ss_pred ccccccccc------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----
Confidence 999986432 135678999999999999999999999754221100
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1006 (1017)
....... .... .. ........+++++.+++.+||+.||++|||+.|+++|-.
T Consensus 208 -~~~~~~~---~~~~---------~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 208 -PGMKTRI---RMGQ---------YE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp -CCSCCSS---CTTC---------CS---SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -HHHHHHH---hhcc---------cc---CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 0000000 0000 00 000111234677899999999999999999999998643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=314.66 Aligned_cols=214 Identities=22% Similarity=0.366 Sum_probs=114.2
Q ss_pred CCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEE
Q 043932 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTL 178 (1017)
Q Consensus 99 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 178 (1017)
.+++|++|++++|.++ .+| .+..+++|++|+|++|++++ +|. +..+++|++|+|++|.+++ +| .+.++++|++|
T Consensus 42 ~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L 115 (347)
T 4fmz_A 42 ELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLREL 115 (347)
T ss_dssp HHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred hcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEE
Confidence 4555666666666555 233 25556666666666666553 332 5566666666666666553 22 45556666666
Q ss_pred EeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCc
Q 043932 179 AVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFS 258 (1017)
Q Consensus 179 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 258 (1017)
++++|.+++..+ +.++++|+.|++++|.....++ .+..+++|++|++++|.+++..+ +..+++|++|++++|.+.
T Consensus 116 ~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~ 190 (347)
T 4fmz_A 116 YLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190 (347)
T ss_dssp ECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCC
T ss_pred ECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccc
Confidence 666666553322 5555566666666554433322 25555666666666666553322 555566666666666555
Q ss_pred cccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcC
Q 043932 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330 (1017)
Q Consensus 259 ~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 330 (1017)
.++. +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|.+
T Consensus 191 -~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l 255 (347)
T 4fmz_A 191 -DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255 (347)
T ss_dssp -CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred -cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCcc
Confidence 2222 3455555566666555553322 5555556666666665554433 44444555555544444
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=341.06 Aligned_cols=336 Identities=20% Similarity=0.236 Sum_probs=220.6
Q ss_pred CcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEe
Q 043932 245 SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLN 324 (1017)
Q Consensus 245 ~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 324 (1017)
++++.|++++|.+. .+|..++.++++|++|+|++|.+++..|..|..+++|++|+|++|.+++..+..|+.+++|++|+
T Consensus 51 ~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp CCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 34444444444443 34444444445555555555555544444555555555555555555555555555555555555
Q ss_pred cccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEec
Q 043932 325 LEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGM 404 (1017)
Q Consensus 325 L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L 404 (1017)
|++|.++..... .+.++++|++|+|++|. ++++.|..|.++++|++|+|
T Consensus 130 L~~n~l~~l~~~------~~~~l~~L~~L~Ls~N~-------------------------l~~~~~~~~~~l~~L~~L~L 178 (597)
T 3oja_B 130 LERNDLSSLPRG------IFHNTPKLTTLSMSNNN-------------------------LERIEDDTFQATTSLQNLQL 178 (597)
T ss_dssp CCSSCCCCCCTT------TTTTCTTCCEEECCSSC-------------------------CCBCCTTTTTTCTTCCEEEC
T ss_pred eeCCCCCCCCHH------HhccCCCCCEEEeeCCc-------------------------CCCCChhhhhcCCcCcEEEC
Confidence 555544322221 12333444444444443 34456677888899999999
Q ss_pred cccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCC
Q 043932 405 QSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGA 484 (1017)
Q Consensus 405 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~ 484 (1017)
++|.+++.. ++.+++|+.|++++|.+++ +...++|++|++++|.++. +|..+ .++|+.|++++|.+++
T Consensus 179 ~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~-~~~~~--~~~L~~L~L~~n~l~~- 246 (597)
T 3oja_B 179 SSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD- 246 (597)
T ss_dssp TTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCE-EECSC--CSCCCEEECCSSCCCC-
T ss_pred cCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccc-ccccc--CCCCCEEECCCCCCCC-
Confidence 999998653 5667889999999998874 3345679999999999884 34333 3688899999998885
Q ss_pred ccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccc
Q 043932 485 LPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGF 564 (1017)
Q Consensus 485 ~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 564 (1017)
+..+..+..+ ++|+|++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..
T Consensus 247 -~~~l~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~ 322 (597)
T 3oja_B 247 -TAWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 322 (597)
T ss_dssp -CGGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred -ChhhccCCCC-CEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCccccc
Confidence 3445555544 468888888888778888888888888888888885 5666777888888888888888 46667788
Q ss_pred cccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCcCC
Q 043932 565 LKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDE 632 (1017)
Q Consensus 565 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~ 632 (1017)
+++|++|+|++|++++. | +..+++|+.|++++|++++.... ..+..+....+.+++..|+.+..
T Consensus 323 l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~~ 386 (597)
T 3oja_B 323 FDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQ 386 (597)
T ss_dssp HTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTCE
T ss_pred CCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcchh
Confidence 88888888888888754 2 56677888888888888876432 23455556667777778876543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=312.26 Aligned_cols=308 Identities=25% Similarity=0.364 Sum_probs=197.4
Q ss_pred ccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCc
Q 043932 216 TLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASN 295 (1017)
Q Consensus 216 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 295 (1017)
.+..+++|++|++++|.++. ++ .+..+++|++|++++|.++ .++. +..+++|++|++++|.+++ + +.+..+++
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~-~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~ 111 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQIT-DISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTN 111 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTT
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccc-cchh--hhcCCcCCEEEccCCcccC-c-hHHcCCCc
Confidence 34566777777777777763 33 3666777777777777776 3443 5566677777777776663 2 24666666
Q ss_pred cceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccc
Q 043932 296 VEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSM 375 (1017)
Q Consensus 296 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L 375 (1017)
|++|++++|++.+..+ +..+++|++|++++|...... ..+..+++|++|++++|.+.
T Consensus 112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-------~~~~~l~~L~~L~l~~~~~~-------------- 168 (347)
T 4fmz_A 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-------SPLSNMTGLNYLTVTESKVK-------------- 168 (347)
T ss_dssp CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-------GGGTTCTTCCEEECCSSCCC--------------
T ss_pred CCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-------cchhhCCCCcEEEecCCCcC--------------
Confidence 6666666666665433 555555666655555322110 11334444444444444433
Q ss_pred eEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCc
Q 043932 376 IEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYN 455 (1017)
Q Consensus 376 ~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 455 (1017)
+..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|
T Consensus 169 -----------~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n 231 (347)
T 4fmz_A 169 -----------DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231 (347)
T ss_dssp -----------CCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred -----------Cchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCC
Confidence 2222 5556666666776666664433 6666666666776666664333 566666777777777
Q ss_pred ccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCccccccc
Q 043932 456 SLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIP 535 (1017)
Q Consensus 456 ~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 535 (1017)
++++..+ +..+++|+.|++++|+++ + + ..+..+++|+.|++++|++++.
T Consensus 232 ~l~~~~~--~~~l~~L~~L~l~~n~l~-------------------------~-~-~~~~~l~~L~~L~l~~n~l~~~-- 280 (347)
T 4fmz_A 232 KITDLSP--LANLSQLTWLEIGTNQIS-------------------------D-I-NAVKDLTKLKMLNVGSNQISDI-- 280 (347)
T ss_dssp CCCCCGG--GTTCTTCCEEECCSSCCC-------------------------C-C-GGGTTCTTCCEEECCSSCCCCC--
T ss_pred ccCCCcc--hhcCCCCCEEECCCCccC-------------------------C-C-hhHhcCCCcCEEEccCCccCCC--
Confidence 6664333 666666666666666665 2 1 2466778888888888888864
Q ss_pred ccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCc
Q 043932 536 VTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE 603 (1017)
Q Consensus 536 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 603 (1017)
..+..+++|+.|+|++|++++..|..|+.+++|++|+|++|++++..| +..+++|+.|++++|+++
T Consensus 281 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 357888888888888888888888888888888888888888887666 778888888888888875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=325.92 Aligned_cols=249 Identities=16% Similarity=0.157 Sum_probs=185.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--------cchHHHHHHHHHHHHhcC---------CCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--------KGAFKSFMAECKALRNIR---------HRNLIK 766 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~ 766 (1017)
.++|++.+.||+|+||+||+|++ +++.||||++.... ....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 67999999998553 223477889999998886 666666
Q ss_pred eeeee-----------------ecCC--------CCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHH
Q 043932 767 IITIC-----------------SSID--------SKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 821 (1017)
Q Consensus 767 ~~~~~-----------------~~~~--------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~q 821 (1017)
+.+++ .... ..+.+..|+||||+++|++.+.+.+ ..+++.+++.++.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQ 169 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHH
Confidence 65543 2200 0124678999999999976666643 25799999999999
Q ss_pred HHHHHHHHh-hCCCCCceeecCCCCceEeCCCC--------------------CeEEeecccccccccccccccccCCCc
Q 043932 822 VASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDM--------------------VSHVGDFGLAKFLSSHQLDTASKTSSS 880 (1017)
Q Consensus 822 i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~~~ 880 (1017)
|+.||+||| ++ +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------- 235 (336)
T 2vuw_A 170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------- 235 (336)
T ss_dssp HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----------
T ss_pred HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----------
Confidence 999999999 89 999999999999999887 8999999999865421
Q ss_pred ccccccCccccCcccccCCCcCccccchhHHHH-HHHHHhCCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHH
Q 043932 881 SIGIKGTVGYVAPEYCMGSEASMTGDVYSFGIL-LLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVM 959 (1017)
Q Consensus 881 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 959 (1017)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||..................
T Consensus 236 --~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 295 (336)
T 2vuw_A 236 --IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT----------------- 295 (336)
T ss_dssp --EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC-----------------
T ss_pred --cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc-----------------
Confidence 246999999999998766 899999998777 78899999998431000000000000000
Q ss_pred hhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HH
Q 043932 960 ANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV-AK 1004 (1017)
Q Consensus 960 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~ 1004 (1017)
............+++++.+++.+||+.| |+.|++ +|
T Consensus 296 ----~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 296 ----FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp ----CSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred ----cCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 0000001223456788999999999977 999998 65
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=346.90 Aligned_cols=362 Identities=15% Similarity=0.139 Sum_probs=203.8
Q ss_pred CcccEEEEecCCCCCCCCcc-cccccCcceeEeecCcccc----ccchhhcccCcCcEEeCCCccCccccCchhhccCC-
Q 043932 197 SALEVFSITGNSLGGKIPTT-LGLLRNLVDLHVGGNQFSG----TFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLP- 270 (1017)
Q Consensus 197 ~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~- 270 (1017)
++|++|+|++|+++...... +..+++|++|+|++|+++. .++..+..+++|++|+|++|.+.+..+..++..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45666666666665433333 6667777777777777764 34566777788888888888876544444555555
Q ss_pred ---ccceeeecccccCC----CCCCccccCCccceeecccCcccceeecccc-----ccCccceEecccCcCCCCCCCCh
Q 043932 271 ---NLKSLAIGGNNFFG----SIPDSLSNASNVEILDLGFNQFKGKVSIDFS-----SLKNLSWLNLEQNNLGMGTANDL 338 (1017)
Q Consensus 271 ---~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~ 338 (1017)
+|++|+|++|+++. .++..+..+++|++|++++|++++..+..+. ..++|++|+|++|+++.....
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-- 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-- 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--
Confidence 68888888888874 4577788888888888888888765554433 345788888888877653322
Q ss_pred hhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCC----cc
Q 043932 339 DFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGT----IP 414 (1017)
Q Consensus 339 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~ 414 (1017)
.+...+..+++|++|++++|.+.+..+..+..... ..+++|++|+|++|.+++. ++
T Consensus 161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~--------------------~~~~~L~~L~L~~n~l~~~~~~~l~ 220 (461)
T 1z7x_W 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK--------------------DSPCQLEALKLESCGVTSDNCRDLC 220 (461)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHH--------------------HSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHh--------------------cCCCCceEEEccCCCCcHHHHHHHH
Confidence 33455667788888888888877554444433211 1123455555555555432 34
Q ss_pred hhhcccccccceecccccccccc-----CcccccccccceeeccCcccCCC----CccccccccCCceeecCCCcccCCc
Q 043932 415 DVIGELKNLQGLFLYKNVLQGSI-----PSGVGNLTKLAKLVMSYNSLQGN----IPSSLGNCQNLIGFNASHNKLTGAL 485 (1017)
Q Consensus 415 ~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~ls~N~l~~~~ 485 (1017)
..+..+++|++|+|++|.+++.. +..+..+++|++|++++|+++.. ++..+..+++|+.|++++|++++..
T Consensus 221 ~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 300 (461)
T 1z7x_W 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred HHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHH
Confidence 44455555555555555554321 11222355566666666665532 3445555666666666666654322
Q ss_pred cchhhhc----ccccceeccCCCcCCCC----ccccccccccceEEEccCCcccccccccccc-----cccceEEeccCC
Q 043932 486 PQQLLSI----TTLSVYLDLSNNNLNGS----LPLQIGNLKNLVKLIISSNQFSGVIPVTLST-----CVSLEYLDISSN 552 (1017)
Q Consensus 486 p~~~~~~----~~~~~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N 552 (1017)
+..+... ...+++|+|++|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|+.|+|++|
T Consensus 301 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 380 (461)
T 1z7x_W 301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence 2222111 01112233333333222 2334444555555555555555443333332 345555555555
Q ss_pred ccCC----CCCccccccccCcEEeccCCcccC
Q 043932 553 SFHG----VIPHSLGFLKSIKVLNFSSNNLSG 580 (1017)
Q Consensus 553 ~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~ 580 (1017)
++++ .+|..+..+++|++|+|++|++++
T Consensus 381 ~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 381 DVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred CCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 5553 445555555555555555555553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-32 Score=302.69 Aligned_cols=288 Identities=20% Similarity=0.232 Sum_probs=212.6
Q ss_pred cCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEec
Q 043932 246 SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNL 325 (1017)
Q Consensus 246 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 325 (1017)
+++.+++++|.++ .+|..+. ++|++|++++|++++..|..+..+++|++|++++|++++..+..|..+++|++|+|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 5677777777776 6665442 56777778877777666677788888888888888888777777777777777777
Q ss_pred ccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEecc
Q 043932 326 EQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405 (1017)
Q Consensus 326 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~ 405 (1017)
++|.+...+. .+. ++|++|++++|+++++.+..|.++++|+.|+++
T Consensus 110 ~~n~l~~l~~-------------------------------~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 155 (332)
T 2ft3_A 110 SKNHLVEIPP-------------------------------NLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155 (332)
T ss_dssp CSSCCCSCCS-------------------------------SCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECC
T ss_pred CCCcCCccCc-------------------------------ccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECC
Confidence 7776653322 111 245555566666666666677888888888888
Q ss_pred ccCCC--CCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccC
Q 043932 406 SNQLH--GTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTG 483 (1017)
Q Consensus 406 ~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~ 483 (1017)
+|.++ +..+..+..+ +|++|++++|++++ +|..+. ++|++|++++|++++..+..|.++++|+.|++++|+++
T Consensus 156 ~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~- 230 (332)
T 2ft3_A 156 GNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR- 230 (332)
T ss_dssp SCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCC-
T ss_pred CCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC-
Confidence 88885 3667777777 88888888888874 555544 67888888888888777777888888877777777776
Q ss_pred CccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCcccc
Q 043932 484 ALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLG 563 (1017)
Q Consensus 484 ~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 563 (1017)
+..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++..+..|.
T Consensus 231 ------------------------~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 231 ------------------------MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285 (332)
T ss_dssp ------------------------CCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSS
T ss_pred ------------------------cCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcc
Confidence 344456777888889999999888 6777788888999999999999887777776
Q ss_pred cc------ccCcEEeccCCccc--CCChhhhcccCCCcEEEcccCC
Q 043932 564 FL------KSIKVLNFSSNNLS--GQIPEFLENLSFLEFLNFSHND 601 (1017)
Q Consensus 564 ~l------~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~l~~N~ 601 (1017)
.+ ..|+.|++++|++. +..|..|..+++|+.+++++|+
T Consensus 286 ~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 53 67889999999887 6778888889999999998885
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-32 Score=303.17 Aligned_cols=218 Identities=27% Similarity=0.330 Sum_probs=137.8
Q ss_pred CCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEec
Q 043932 102 FLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVG 181 (1017)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 181 (1017)
+|+.++++++.++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4556666666665 5555543 466666666666665555666667777777777777766666667777777777777
Q ss_pred cccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccc--cccchhhcccCcCcEEeCCCccCcc
Q 043932 182 KNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFS--GTFPQSICNISSLERIYLPFNRFSG 259 (1017)
Q Consensus 182 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~ 259 (1017)
+|+++ .+|..+. ++|++|++++|++++..+..|..+++|++|++++|.++ +..|..+..+ +|++|++++|+++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~- 185 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT- 185 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-
Confidence 77766 3444443 56777777777776655566677777777777777764 2555666666 7777777777776
Q ss_pred ccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcC
Q 043932 260 TLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330 (1017)
Q Consensus 260 ~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 330 (1017)
.+|..++ ++|++|++++|++++..+..+..+++|+.|++++|++++..+..|..+++|++|+|++|++
T Consensus 186 ~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 253 (332)
T 2ft3_A 186 GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253 (332)
T ss_dssp SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCC
T ss_pred ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcC
Confidence 4554432 5666677777766666556666666666666666666655555555555555555444444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=348.98 Aligned_cols=336 Identities=18% Similarity=0.147 Sum_probs=186.6
Q ss_pred ccccccccccCCCCcccc----cCCCcccCCCcceEeecccccccccCccccc-ccC----CccEEEeccccccC----C
Q 043932 122 GNLLRLEKLALPNNSFSG----TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIG-SLL----KLQTLAVGKNYLTG----R 188 (1017)
Q Consensus 122 ~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~----~L~~L~L~~n~l~~----~ 188 (1017)
..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+++..+..+. .++ +|++|+|++|+++. .
T Consensus 25 ~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~ 104 (461)
T 1z7x_W 25 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 104 (461)
T ss_dssp HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHH
Confidence 334444444444444432 1233344444444444444444432222221 122 35555555554442 2
Q ss_pred CCccccCCCcccEEEEecCCCCCCCCccccc-----ccCcceeEeecCccccc----cchhhcccCcCcEEeCCCccCcc
Q 043932 189 LPDFVGNLSALEVFSITGNSLGGKIPTTLGL-----LRNLVDLHVGGNQFSGT----FPQSICNISSLERIYLPFNRFSG 259 (1017)
Q Consensus 189 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-----l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 259 (1017)
++..+.++++|++|++++|.+++..+..+.. .++|++|++++|++++. ++..+..+++|++|+|++|.+.+
T Consensus 105 l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 184 (461)
T 1z7x_W 105 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184 (461)
T ss_dssp HHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcch
Confidence 3444555555555555555554333332222 34566666666666543 24455556667777777766653
Q ss_pred ccCchhhc----cCCccceeeecccccCCC----CCCccccCCccceeecccCccccee-----eccccccCccceEecc
Q 043932 260 TLPFDIVV----NLPNLKSLAIGGNNFFGS----IPDSLSNASNVEILDLGFNQFKGKV-----SIDFSSLKNLSWLNLE 326 (1017)
Q Consensus 260 ~l~~~~~~----~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~-----~~~~~~l~~L~~L~L~ 326 (1017)
..+..+.. ..++|++|++++|.+++. ++..+..+++|+.|++++|++++.. +..+..+++|++|+++
T Consensus 185 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~ 264 (461)
T 1z7x_W 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIW 264 (461)
T ss_dssp HHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECc
Confidence 22222211 244777777777777653 4566667777888888888776543 2223357788888888
Q ss_pred cCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhc----ccceEEEecCCccccc----cCcccccccc
Q 043932 327 QNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLS----SSMIEFRIGGNQIFGI----IPSGIRNLVN 398 (1017)
Q Consensus 327 ~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~----~~L~~L~l~~N~i~~~----~~~~~~~l~~ 398 (1017)
+|.++..+.. .++..+..+++|++|++++|.+.+..+..+.... ++|++|++++|.+++. ++..+..+++
T Consensus 265 ~n~l~~~~~~--~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~ 342 (461)
T 1z7x_W 265 ECGITAKGCG--DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342 (461)
T ss_dssp TSCCCHHHHH--HHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSS
T ss_pred CCCCCHHHHH--HHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCC
Confidence 8877542221 2445566788888888888888765555554432 3566666666666654 3444555666
Q ss_pred ccEEeccccCCCCCcchhhcc-----cccccceecccccccc----ccCcccccccccceeeccCcccCC
Q 043932 399 LIALGMQSNQLHGTIPDVIGE-----LKNLQGLFLYKNVLQG----SIPSGVGNLTKLAKLVMSYNSLQG 459 (1017)
Q Consensus 399 L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~i~~ 459 (1017)
|++|+|++|++++..+..+.. .++|++|+|++|.+++ .+|..+..+++|++|++++|+|++
T Consensus 343 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 777777777666544444432 4566666666666664 555666666666666666666653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-32 Score=300.76 Aligned_cols=199 Identities=22% Similarity=0.308 Sum_probs=107.2
Q ss_pred CCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEe
Q 043932 101 SFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAV 180 (1017)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 180 (1017)
+.|++|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|..+.
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~---------- 120 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP---------- 120 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC----------
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc----------
Confidence 45666666666666544445555555555555555555544555555555555555555555 3333322
Q ss_pred ccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCcccc--ccchhhcccCcCcEEeCCCccCc
Q 043932 181 GKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSG--TFPQSICNISSLERIYLPFNRFS 258 (1017)
Q Consensus 181 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~N~l~ 258 (1017)
++|++|++++|.+++..+..|..+++|++|++++|+++. ..+..+..+++|++|++++|.++
T Consensus 121 ----------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 121 ----------------KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp ----------------TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred ----------------ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 344444444444444444444555555555555555532 44555666666666666666665
Q ss_pred cccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcC
Q 043932 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330 (1017)
Q Consensus 259 ~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 330 (1017)
.+|..++ ++|++|++++|++++..|..+..+++|+.|++++|++++..+..|..+++|++|+|++|++
T Consensus 185 -~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 252 (330)
T 1xku_A 185 -TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252 (330)
T ss_dssp -SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred -cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcC
Confidence 4444332 4566666666666655555666666666666666666555544444444444444444444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=298.99 Aligned_cols=289 Identities=18% Similarity=0.207 Sum_probs=187.6
Q ss_pred cCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEec
Q 043932 246 SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNL 325 (1017)
Q Consensus 246 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 325 (1017)
+++.++++++.++ .+|..+. ++|++|+|++|++++..+..+..+++|++|++++|++++..|..|..+++|++|++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 4555666666555 4554332 45666666666666555556667777777777777777666666666666666666
Q ss_pred ccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEecc
Q 043932 326 EQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405 (1017)
Q Consensus 326 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~ 405 (1017)
++|.++..+.. +. ++|++|++++|.++++.+..|.++++|+.|+++
T Consensus 108 s~n~l~~l~~~-------------------------------~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 153 (330)
T 1xku_A 108 SKNQLKELPEK-------------------------------MP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153 (330)
T ss_dssp CSSCCSBCCSS-------------------------------CC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECC
T ss_pred CCCcCCccChh-------------------------------hc---ccccEEECCCCcccccCHhHhcCCccccEEECC
Confidence 66665432221 11 234444444444444555556667777777777
Q ss_pred ccCCCC--CcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccC
Q 043932 406 SNQLHG--TIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTG 483 (1017)
Q Consensus 406 ~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~ 483 (1017)
+|.+.. ..+..|.++++|++|++++|.++ .+|..+. ++|++|++++|++++..|..|.++++|+.|++++|+++
T Consensus 154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~- 229 (330)
T 1xku_A 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS- 229 (330)
T ss_dssp SSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC-
T ss_pred CCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc-
Confidence 777753 55666777777777777777776 3454443 66777777777777666667777777777777766665
Q ss_pred CccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCcccc
Q 043932 484 ALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLG 563 (1017)
Q Consensus 484 ~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 563 (1017)
+..+..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|.
T Consensus 230 ------------------------~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~ 284 (330)
T 1xku_A 230 ------------------------AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284 (330)
T ss_dssp ------------------------EECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred ------------------------eeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcC
Confidence 233445667777888888888887 6677777888888888888888877666665
Q ss_pred cc------ccCcEEeccCCcccC--CChhhhcccCCCcEEEcccCC
Q 043932 564 FL------KSIKVLNFSSNNLSG--QIPEFLENLSFLEFLNFSHND 601 (1017)
Q Consensus 564 ~l------~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~ 601 (1017)
.. +.|+.|++++|++.. ..|..|..+.+++.++|++|+
T Consensus 285 ~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 33 677888888888753 566777888888888888874
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=294.00 Aligned_cols=288 Identities=17% Similarity=0.188 Sum_probs=231.7
Q ss_pred CCCCCCCCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCc
Q 043932 57 SWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136 (1017)
Q Consensus 57 sw~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 136 (1017)
.|.....+|.|.|+ | |.++++++.. |..+. ++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 22 ~~~~~~~~C~~~~~-c----------~~~~~~l~~i-P~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 87 (353)
T 2z80_A 22 SSNQASLSCDRNGI-C----------KGSSGSLNSI-PSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87 (353)
T ss_dssp -----CCEECTTSE-E----------ECCSTTCSSC-CTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCccCCCCCCCeE-e----------eCCCCCcccc-ccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence 34444578999988 7 4567778765 44443 589999999999997666689999999999999999
Q ss_pred ccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCC-ccccCCCcccEEEEecC-CCCCCCC
Q 043932 137 FSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP-DFVGNLSALEVFSITGN-SLGGKIP 214 (1017)
Q Consensus 137 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~~ 214 (1017)
+++..|..|+++++|++|+|++|++++..+..|+++++|++|++++|++++..+ ..++++++|++|++++| .+++..+
T Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 167 (353)
T 2z80_A 88 INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167 (353)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred cCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCH
Confidence 998888899999999999999999997666669999999999999999996544 58999999999999999 5776677
Q ss_pred cccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccc---
Q 043932 215 TTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLS--- 291 (1017)
Q Consensus 215 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~--- 291 (1017)
..|+.+++|++|++++|++++..|..+..+++|++|++++|.+. .+|..++..+++|+.|++++|++++..+..+.
T Consensus 168 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~ 246 (353)
T 2z80_A 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE 246 (353)
T ss_dssp TTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------
T ss_pred HHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCcccccccccccccc
Confidence 89999999999999999999988999999999999999999996 78877777899999999999999976555443
Q ss_pred cCCccceeecccCcccc----eeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccc
Q 043932 292 NASNVEILDLGFNQFKG----KVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELP 365 (1017)
Q Consensus 292 ~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 365 (1017)
....++.+++++|.+.+ .+|..+..+++|++|+|++|+++..+.. .+..+++|++|+|++|++.+..|
T Consensus 247 ~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~------~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 247 TNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDG------IFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTT------TTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHH------HHhcCCCCCEEEeeCCCccCcCC
Confidence 34567777777777765 2455667777888888888877654432 23567777777777777776544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=332.47 Aligned_cols=406 Identities=16% Similarity=0.154 Sum_probs=205.5
Q ss_pred CHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCC
Q 043932 34 NETDRLALLAIKSQLHDTSGVTSSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSF 113 (1017)
Q Consensus 34 ~~~~~~aLl~~k~~~~~~~~~~~sw~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l 113 (1017)
-|+| .|..+-+.+.++.. ...+ ..-|++|.++.+... + .+.+.+ .....++..+..+++|++|+|+++..
T Consensus 16 LPde--il~~I~~~L~~~~d-~~~~--s~vck~W~~~~~~~~--~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~ 85 (592)
T 3ogk_B 16 TVDD--VIEQVMTYITDPKD-RDSA--SLVCRRWFKIDSETR--E--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPR 85 (592)
T ss_dssp CGGG--THHHHHTTCCCHHH-HHHH--TTSCHHHHHHHHHHC--C--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCG
T ss_pred CCHH--HHHHHHHhcCCHHH-HHHH--HHHhHHHHHhhhccc--c--EEEEee-ccccChHHHHHhCCCCeEEEecCCcc
Confidence 4555 45666655532211 1111 122457998854321 1 222332 23334455667888999999988532
Q ss_pred ---CCCCCcccc------------cccccccccCCCCcccccCCCcccCC--CcceEeeccccc-ccc-cCcccccccCC
Q 043932 114 ---HGEIPQEIG------------NLLRLEKLALPNNSFSGTIPTNLSRC--SNLIQLRVSNNK-LEG-QIPAEIGSLLK 174 (1017)
Q Consensus 114 ---~~~~p~~~~------------~l~~L~~L~L~~n~l~~~~p~~l~~l--~~L~~L~L~~n~-l~~-~~p~~~~~l~~ 174 (1017)
.+.+|..++ .+++|++|+|++|.+++..+..++.. .+|++|+|++|. ++. .++....++++
T Consensus 86 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~ 165 (592)
T 3ogk_B 86 AAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRK 165 (592)
T ss_dssp GGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTT
T ss_pred hhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCC
Confidence 134554443 56677777777777766655555553 337777777665 211 12222345667
Q ss_pred ccEEEeccccccCC----CCccccCCCcccEEEEecCCCCC----CCCcccccccCcceeEeecCccccccchhhcccCc
Q 043932 175 LQTLAVGKNYLTGR----LPDFVGNLSALEVFSITGNSLGG----KIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISS 246 (1017)
Q Consensus 175 L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 246 (1017)
|++|+|++|.+++. ++..+.++++|+.|++++|.+++ .++..+.++++|++|++++|.+.+ +|..+..+++
T Consensus 166 L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~ 244 (592)
T 3ogk_B 166 IKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAAN 244 (592)
T ss_dssp CSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTT
T ss_pred CCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhH
Confidence 77777777776654 22334556666666666666652 223334455666666666666653 4556666666
Q ss_pred CcEEeCCCccCc---cccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceee-ccccccCccce
Q 043932 247 LERIYLPFNRFS---GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVS-IDFSSLKNLSW 322 (1017)
Q Consensus 247 L~~L~Ls~N~l~---~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~ 322 (1017)
|++|+++.+... +..+ ..+..+++|+.|+++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|++
T Consensus 245 L~~L~l~~~~~~~~~~~~~-~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~ 322 (592)
T 3ogk_B 245 LEEFCGGSLNEDIGMPEKY-MNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEV 322 (592)
T ss_dssp CCEEEECBCCCCTTCTTSS-SCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCE
T ss_pred HHhhcccccccccchHHHH-HHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCE
Confidence 666666542221 0111 1223445555555555432 2444455555555555555555443322 22344555555
Q ss_pred EecccCcCCCCCCCChhhHhhhcccCcccEEecc-----------CcccccccchhHHhhcccceEEEecCCccccccCc
Q 043932 323 LNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLA-----------ANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPS 391 (1017)
Q Consensus 323 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls-----------~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~ 391 (1017)
|+++ +.+.. .........+++|++|+++ .|.+++.....+
T Consensus 323 L~L~-~~~~~-----~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l----------------------- 373 (592)
T 3ogk_B 323 LETR-NVIGD-----RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL----------------------- 373 (592)
T ss_dssp EEEE-GGGHH-----HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHH-----------------------
T ss_pred Eecc-CccCH-----HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHH-----------------------
Confidence 5555 22211 1112222344445555555 233332222222
Q ss_pred cccccccccEEeccccCCCCCcchhhcc-cccccceecc----ccccccc-----cCcccccccccceeeccCc--ccCC
Q 043932 392 GIRNLVNLIALGMQSNQLHGTIPDVIGE-LKNLQGLFLY----KNVLQGS-----IPSGVGNLTKLAKLVMSYN--SLQG 459 (1017)
Q Consensus 392 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~i~~ 459 (1017)
+..+++|++|+++.|++++..+..+.. +++|+.|+++ .|.+++. ++..+.++++|++|++++| .+++
T Consensus 374 -~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~ 452 (592)
T 3ogk_B 374 -AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD 452 (592)
T ss_dssp -HHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCH
T ss_pred -HhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccH
Confidence 234556666666666665555545444 5566666664 4455532 2223445666666666532 2443
Q ss_pred CCccccc-cccCCceeecCCCccc
Q 043932 460 NIPSSLG-NCQNLIGFNASHNKLT 482 (1017)
Q Consensus 460 ~~p~~~~-~l~~L~~L~ls~N~l~ 482 (1017)
..+..+. .+++|+.|++++|+++
T Consensus 453 ~~~~~~~~~~~~L~~L~L~~n~l~ 476 (592)
T 3ogk_B 453 LGLSYIGQYSPNVRWMLLGYVGES 476 (592)
T ss_dssp HHHHHHHHSCTTCCEEEECSCCSS
T ss_pred HHHHHHHHhCccceEeeccCCCCC
Confidence 3333333 2556666666666654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-31 Score=290.92 Aligned_cols=277 Identities=17% Similarity=0.226 Sum_probs=234.4
Q ss_pred HHhcCCCCCCCCCCCC--CCCCCceeeEEECCCCCeEEEEEcCCCCCcccc----Ccc--cCCCCCCCEEEccCCCCCCC
Q 043932 45 KSQLHDTSGVTSSWNN--TINLCQWTGVTCGHRHQRVTRLDLSNQRIGGIL----SPY--VGNLSFLRYINLSDNSFHGE 116 (1017)
Q Consensus 45 k~~~~~~~~~~~sw~~--~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~----~~~--l~~l~~L~~L~L~~n~l~~~ 116 (1017)
|.++.|+..++.+|.. ..++|.|.++.|...... -.-+...|.. +.. -...+++++|+|++|+++ .
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~-----~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~ 95 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNN-----PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-Q 95 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTC-----TTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-S
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhccccccc-----ccccccCCcchhhhHHHHhcccccceeEEEccCCCch-h
Confidence 4455566667788865 357999999988322110 0112222221 111 124588999999999999 8
Q ss_pred CCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccC-
Q 043932 117 IPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGN- 195 (1017)
Q Consensus 117 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~- 195 (1017)
+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++|++++|++.+.+|..++.
T Consensus 96 lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~ 173 (328)
T 4fcg_A 96 FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173 (328)
T ss_dssp CCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE
T ss_pred cChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc
Confidence 9999999999999999999999 89999999999999999999999 88999999999999999999999999988765
Q ss_pred --------CCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhc
Q 043932 196 --------LSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVV 267 (1017)
Q Consensus 196 --------l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~ 267 (1017)
+++|++|+|++|+++ .+|..++.+++|++|+|++|++++ +|..+..+++|++|+|++|.+.+.+|. .+.
T Consensus 174 ~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~-~~~ 250 (328)
T 4fcg_A 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP-IFG 250 (328)
T ss_dssp C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCC-CTT
T ss_pred cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHH-Hhc
Confidence 999999999999998 888899999999999999999994 677899999999999999999888875 456
Q ss_pred cCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCC
Q 043932 268 NLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGM 332 (1017)
Q Consensus 268 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 332 (1017)
.+++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..+..+++|+.+++..+.+..
T Consensus 251 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence 88999999999999999999999999999999999999999999999999999999998876643
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-31 Score=320.69 Aligned_cols=428 Identities=15% Similarity=0.116 Sum_probs=268.6
Q ss_pred CCCcccccccccccccCCCCcc---cccCCCccc------------CCCcceEeecccccccccCccccccc--CCccEE
Q 043932 116 EIPQEIGNLLRLEKLALPNNSF---SGTIPTNLS------------RCSNLIQLRVSNNKLEGQIPAEIGSL--LKLQTL 178 (1017)
Q Consensus 116 ~~p~~~~~l~~L~~L~L~~n~l---~~~~p~~l~------------~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L 178 (1017)
..+..+..+++|++|+|+++.. .+.+|..++ ++++|++|+|++|.+++..+..++.. .+|++|
T Consensus 64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L 143 (592)
T 3ogk_B 64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143 (592)
T ss_dssp CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence 3344556778888888877532 234454444 57778888888887776666666653 348888
Q ss_pred Eecccc-ccC-CCCccccCCCcccEEEEecCCCCCC----CCcccccccCcceeEeecCccc----cccchhhcccCcCc
Q 043932 179 AVGKNY-LTG-RLPDFVGNLSALEVFSITGNSLGGK----IPTTLGLLRNLVDLHVGGNQFS----GTFPQSICNISSLE 248 (1017)
Q Consensus 179 ~L~~n~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~ 248 (1017)
+|++|. ++. .++....++++|++|+|++|.+++. ++..+..+++|++|++++|.++ +.++..+.++++|+
T Consensus 144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~ 223 (592)
T 3ogk_B 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223 (592)
T ss_dssp EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence 887765 221 1122234667777777777777655 3334556677777777777776 34455556677777
Q ss_pred EEeCCCccCccccCchhhccCCccceeeecccccC---CCCCCccccCCccceeecccCcccceeeccccccCccceEec
Q 043932 249 RIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFF---GSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNL 325 (1017)
Q Consensus 249 ~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 325 (1017)
+|+|++|.+.+ +| ..+..+++|++|+++++... +..+..+..+++|+.|+++++.. ...+..+..+++|++|+|
T Consensus 224 ~L~L~~~~~~~-l~-~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~L 300 (592)
T 3ogk_B 224 SVKVGDFEILE-LV-GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDL 300 (592)
T ss_dssp EEECSSCBGGG-GH-HHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEE
T ss_pred EEeccCccHHH-HH-HHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEec
Confidence 77777777763 44 44566777777777653322 23344556666677776666432 234445556666666666
Q ss_pred ccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEecc
Q 043932 326 EQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405 (1017)
Q Consensus 326 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~ 405 (1017)
++|.++. ......+..+++|++|+++ +.+.+. .++..+..+++|++|+++
T Consensus 301 s~~~l~~-----~~~~~~~~~~~~L~~L~L~-~~~~~~------------------------~l~~~~~~~~~L~~L~L~ 350 (592)
T 3ogk_B 301 LYALLET-----EDHCTLIQKCPNLEVLETR-NVIGDR------------------------GLEVLAQYCKQLKRLRIE 350 (592)
T ss_dssp TTCCCCH-----HHHHHHHTTCTTCCEEEEE-GGGHHH------------------------HHHHHHHHCTTCCEEEEE
T ss_pred CCCcCCH-----HHHHHHHHhCcCCCEEecc-CccCHH------------------------HHHHHHHhCCCCCEEEee
Confidence 6665421 1122334555666666665 333221 222333556778888888
Q ss_pred -----------ccCCCCC-cchhhcccccccceeccccccccccCccccc-ccccceeecc----CcccCCC-----Ccc
Q 043932 406 -----------SNQLHGT-IPDVIGELKNLQGLFLYKNVLQGSIPSGVGN-LTKLAKLVMS----YNSLQGN-----IPS 463 (1017)
Q Consensus 406 -----------~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~i~~~-----~p~ 463 (1017)
.|.+++. .+..+..+++|++|+++.|.+++..+..+.. +++|++|+++ .|.+++. ++.
T Consensus 351 ~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~ 430 (592)
T 3ogk_B 351 RGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRS 430 (592)
T ss_dssp CCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHH
T ss_pred cCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHH
Confidence 3566643 2333566899999999999999877777765 8999999996 7888864 445
Q ss_pred ccccccCCceeecCCCc--ccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccc-cccccccc
Q 043932 464 SLGNCQNLIGFNASHNK--LTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSG-VIPVTLST 540 (1017)
Q Consensus 464 ~~~~l~~L~~L~ls~N~--l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~ 540 (1017)
.+.++++|+.|++++|. +++..+..+ ...+++|++|+|++|++++ .++..+.+
T Consensus 431 ~~~~~~~L~~L~L~~~~~~l~~~~~~~~------------------------~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 486 (592)
T 3ogk_B 431 LLIGCKKLRRFAFYLRQGGLTDLGLSYI------------------------GQYSPNVRWMLLGYVGESDEGLMEFSRG 486 (592)
T ss_dssp HHHHCTTCCEEEEECCGGGCCHHHHHHH------------------------HHSCTTCCEEEECSCCSSHHHHHHHHTC
T ss_pred HHHhCCCCCEEEEecCCCCccHHHHHHH------------------------HHhCccceEeeccCCCCCHHHHHHHHhc
Confidence 57789999999998543 542222111 1235677788888887765 33445567
Q ss_pred cccceEEeccCCccCCC-CCccccccccCcEEeccCCcccCCChhhh-cccCCCcEEEcccC
Q 043932 541 CVSLEYLDISSNSFHGV-IPHSLGFLKSIKVLNFSSNNLSGQIPEFL-ENLSFLEFLNFSHN 600 (1017)
Q Consensus 541 l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N 600 (1017)
+++|+.|+|++|++++. ++..+..+++|++|+|++|++++.-...+ ..++.+....+..+
T Consensus 487 ~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 487 CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp CTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred CcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 77888888888877644 23344567788888888888775533333 34566665555544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=281.38 Aligned_cols=253 Identities=20% Similarity=0.247 Sum_probs=196.9
Q ss_pred CCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccc--c
Q 043932 63 NLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG--T 140 (1017)
Q Consensus 63 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~--~ 140 (1017)
..|.|.+|.|+. ++++.. |..+ .++|++|+|++|.++...+..|+++++|++|+|++|.++. .
T Consensus 5 C~C~~~~l~c~~------------~~l~~i-p~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~ 69 (306)
T 2z66_A 5 CSCSGTEIRCNS------------KGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC 69 (306)
T ss_dssp CEEETTEEECCS------------SCCSSC-CSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE
T ss_pred CeeCCCEEEcCC------------CCcccC-CCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC
Confidence 448999999954 334433 2222 2578888888888884333457888888888888888873 3
Q ss_pred CCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCC-ccccCCCcccEEEEecCCCCCCCCccccc
Q 043932 141 IPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLP-DFVGNLSALEVFSITGNSLGGKIPTTLGL 219 (1017)
Q Consensus 141 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 219 (1017)
.|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+.++++|++|++++|.+++..+..+..
T Consensus 70 ~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 148 (306)
T 2z66_A 70 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148 (306)
T ss_dssp EEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTT
T ss_pred cccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhccc
Confidence 3666777888888888888888 567778888888888888888886655 57888888888888888888888888888
Q ss_pred ccCcceeEeecCcccc-ccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccce
Q 043932 220 LRNLVDLHVGGNQFSG-TFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEI 298 (1017)
Q Consensus 220 l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 298 (1017)
+++|++|++++|.+++ ..|..+..+++|++|+|++|+++ .++...+..+++|++|+|++|++++..+..+..+++|+.
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 227 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcC-CcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence 8888888888888876 57788888888888888888887 444455677888888888888888766667888888888
Q ss_pred eecccCcccceeeccccccC-ccceEecccCcCCC
Q 043932 299 LDLGFNQFKGKVSIDFSSLK-NLSWLNLEQNNLGM 332 (1017)
Q Consensus 299 L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~ 332 (1017)
|++++|++++..+..+..++ +|++|+|++|.+..
T Consensus 228 L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp EECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred eECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 88888888888887777774 78888888887753
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-30 Score=279.95 Aligned_cols=276 Identities=22% Similarity=0.273 Sum_probs=214.8
Q ss_pred cEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCC--cchhhcccccccceec
Q 043932 351 KILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGT--IPDVIGELKNLQGLFL 428 (1017)
Q Consensus 351 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L 428 (1017)
+.++++++.++ .+|..+ .+++++|++++|+++.+.+..|.++++|++|+|++|+++.. .+..+..+++|++|+|
T Consensus 10 ~~l~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcc-cCCCCC---CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 34556666555 445432 24677778888887776666788888888888888888743 3667777888888888
Q ss_pred cccccccccCcccccccccceeeccCcccCCCCc-cccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCC
Q 043932 429 YKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIP-SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLN 507 (1017)
Q Consensus 429 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~ 507 (1017)
++|.++ .+|..+.++++|++|++++|++++..+ ..+..+++|+.|++++|++++..|..+..+..+ ++|+|++|.++
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~ 163 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQ 163 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTC-CEEECTTCEEG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCC-CEEECCCCccc
Confidence 888888 567778888888888888888886554 578888888888888888886666666665554 45888888887
Q ss_pred C-CccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhh
Q 043932 508 G-SLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFL 586 (1017)
Q Consensus 508 ~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 586 (1017)
+ .+|..+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..+
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHH
Confidence 6 578888999999999999999998888899999999999999999998888889999999999999999999999888
Q ss_pred cccC-CCcEEEcccCCCcCcCCCC---CCCCCCCcccccCcccccCCcCC
Q 043932 587 ENLS-FLEFLNFSHNDLEGEVPTK---GVFSSKTKLSLQGNVKLCGGTDE 632 (1017)
Q Consensus 587 ~~l~-~L~~L~l~~N~l~~~~~~~---~~~~~~~~~~~~~n~~~c~~~~~ 632 (1017)
..++ +|++|+|++|++++.++.. ..+...+.+....+...|..|..
T Consensus 244 ~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~ 293 (306)
T 2z66_A 244 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 293 (306)
T ss_dssp CCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred HhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence 8884 8999999999999876532 11223344555667777776654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-31 Score=291.79 Aligned_cols=250 Identities=19% Similarity=0.243 Sum_probs=202.0
Q ss_pred cCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcc-cccCCCccc-------CCCcceEeecccccccccCccc
Q 043932 97 VGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSF-SGTIPTNLS-------RCSNLIQLRVSNNKLEGQIPAE 168 (1017)
Q Consensus 97 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l-~~~~p~~l~-------~l~~L~~L~L~~n~l~~~~p~~ 168 (1017)
++..++|++|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34456788888888888 788877765 88899999988 456777665 7889999999999998888887
Q ss_pred c--cccCCccEEEeccccccCCCCccccCC-----CcccEEEEecCCCCCCCCcccccccCcceeEeecCccccc--cch
Q 043932 169 I--GSLLKLQTLAVGKNYLTGRLPDFVGNL-----SALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGT--FPQ 239 (1017)
Q Consensus 169 ~--~~l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~--~p~ 239 (1017)
+ +.+++|++|+|++|++++. |..++++ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. .|.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 6 8889999999999999877 8888877 8899999999999888888899999999999999988765 344
Q ss_pred hh--cccCcCcEEeCCCccCcc--ccCchhhccCCccceeeecccccCCCCC-CccccCCccceeecccCcccceeeccc
Q 043932 240 SI--CNISSLERIYLPFNRFSG--TLPFDIVVNLPNLKSLAIGGNNFFGSIP-DSLSNASNVEILDLGFNQFKGKVSIDF 314 (1017)
Q Consensus 240 ~l--~~l~~L~~L~Ls~N~l~~--~l~~~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 314 (1017)
.+ ..+++|++|+|++|++++ .++..++.++++|++|+|++|++++..| ..+..+++|++|+|++|+++ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 44 788899999999998873 4455666778899999999999987765 45667889999999999998 445555
Q ss_pred cccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCccccc
Q 043932 315 SSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVG 362 (1017)
Q Consensus 315 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 362 (1017)
. ++|++|+|++|+++..+. +..+++|++|+|++|++++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~p~--------~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRNPS--------PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSCCC--------TTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCChh--------HhhCCCCCEEeccCCCCCC
Confidence 4 889999999999876521 5678889999999998875
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=272.06 Aligned_cols=253 Identities=23% Similarity=0.221 Sum_probs=194.4
Q ss_pred cEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccc
Q 043932 351 KILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYK 430 (1017)
Q Consensus 351 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 430 (1017)
+.++++++.++ .+|..+ ++++++|++++|.++++.+..|..+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 45666666665 445432 34677777777777777777788888888888888888877788888888888888888
Q ss_pred cc-cccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCC
Q 043932 431 NV-LQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGS 509 (1017)
Q Consensus 431 N~-l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~ 509 (1017)
|. ++...|..|.++++|++|++++|++++..|..|.++++|+.|++++|+++ +.
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~ 144 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-------------------------AL 144 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-------------------------cc
Confidence 86 77666777888888888888888888777777888888888888777776 23
Q ss_pred ccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhccc
Q 043932 510 LPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENL 589 (1017)
Q Consensus 510 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 589 (1017)
.+..|..+++|++|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+
T Consensus 145 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 224 (285)
T 1ozn_A 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC
T ss_pred CHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccC
Confidence 34457778888888888888887777778888889999999998888888888888889999999998888777778888
Q ss_pred CCCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCcCC
Q 043932 590 SFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDE 632 (1017)
Q Consensus 590 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~ 632 (1017)
++|+.|++++|++.+..+....+..+.......|...|..|..
T Consensus 225 ~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 225 RALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp TTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGG
T ss_pred cccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchH
Confidence 8888999999988887765433334455556667677766543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=296.60 Aligned_cols=215 Identities=21% Similarity=0.205 Sum_probs=110.1
Q ss_pred cceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeecc
Q 043932 374 SMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMS 453 (1017)
Q Consensus 374 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 453 (1017)
+|+.|++++|.++++.|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.+++..+ .++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 45566666666665555666666666666666666655444 5666666666666666653221 2556666666
Q ss_pred CcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCcccccc-ccccceEEEccCCcccc
Q 043932 454 YNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIG-NLKNLVKLIISSNQFSG 532 (1017)
Q Consensus 454 ~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~ 532 (1017)
+|.|++..+. .+++|+.|++++|++++..|..+..+..+ ++|+|++|.+++..|..+. .+++|+.|+|++|.|++
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSE-EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCC-CEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 6666644333 23455555666555554444444333333 2344444444444444443 44555555555555543
Q ss_pred cccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCc
Q 043932 533 VIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE 603 (1017)
Q Consensus 533 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 603 (1017)
..+ +..+++|+.|+|++|+|++.+| .|..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++.
T Consensus 184 ~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 184 VKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp EEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred ccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 321 2234455555555555554322 24445555555555555553 3444444455555555555544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=281.32 Aligned_cols=268 Identities=18% Similarity=0.187 Sum_probs=190.2
Q ss_pred CCCCCCCCCCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCC-CCCCCcccc-------cccc
Q 043932 55 TSSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSF-HGEIPQEIG-------NLLR 126 (1017)
Q Consensus 55 ~~sw~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~~ 126 (1017)
..+|.....|+.|..+.......+++.|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++
T Consensus 21 ~~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~ 96 (312)
T 1wwl_A 21 KPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISG 96 (312)
T ss_dssp SCCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSC
T ss_pred ccchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCC
Confidence 44676555666665554332344567777777777 455555443 77778888777 345666665 6778
Q ss_pred cccccCCCCcccccCCCcc--cCCCcceEeecccccccccCccccccc-----CCccEEEeccccccCCCCccccCCCcc
Q 043932 127 LEKLALPNNSFSGTIPTNL--SRCSNLIQLRVSNNKLEGQIPAEIGSL-----LKLQTLAVGKNYLTGRLPDFVGNLSAL 199 (1017)
Q Consensus 127 L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~p~~~~~l~~L 199 (1017)
|++|+|++|++++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+++++|
T Consensus 97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L 175 (312)
T 1wwl_A 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175 (312)
T ss_dssp CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence 8888888888887777765 7788888888888888766 7777766 778888888888877777778888888
Q ss_pred cEEEEecCCCCCC--CCccc--ccccCcceeEeecCcccc---ccchhhcccCcCcEEeCCCccCccccCchhhccCCcc
Q 043932 200 EVFSITGNSLGGK--IPTTL--GLLRNLVDLHVGGNQFSG---TFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNL 272 (1017)
Q Consensus 200 ~~L~L~~N~l~~~--~~~~l--~~l~~L~~L~L~~n~l~~---~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 272 (1017)
++|+|++|++.+. .+..+ ..+++|++|+|++|++++ .....+..+++|++|+|++|++++..|...+..+++|
T Consensus 176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L 255 (312)
T 1wwl_A 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255 (312)
T ss_dssp CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTC
T ss_pred CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCC
Confidence 8888888877654 23344 677788888888888773 2223445677888888888888766655556667788
Q ss_pred ceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCC
Q 043932 273 KSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGM 332 (1017)
Q Consensus 273 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 332 (1017)
++|+|++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|++|+|++|.++.
T Consensus 256 ~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 88888888887 6666665 7788888888888776 33 7777888888888887753
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=276.35 Aligned_cols=204 Identities=21% Similarity=0.224 Sum_probs=106.6
Q ss_pred ccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEE
Q 043932 124 LLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFS 203 (1017)
Q Consensus 124 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 203 (1017)
++.....++++|.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|++++|++++..|..|+++++|++|+
T Consensus 30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 344444566666666 4555443 3566666666666544444555555555555555555554445555555555555
Q ss_pred EecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCc-hhhccCCccceeeeccc-c
Q 043932 204 ITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPF-DIVVNLPNLKSLAIGGN-N 281 (1017)
Q Consensus 204 L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~-~~~~~l~~L~~L~L~~n-~ 281 (1017)
+++|++++.. +..+.++++|++|+|++|+++ .+|. ..+..+++|++|++++| .
T Consensus 107 Ls~n~l~~~~------------------------~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~ 161 (353)
T 2z80_A 107 LSYNYLSNLS------------------------SSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDT 161 (353)
T ss_dssp CCSSCCSSCC------------------------HHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSS
T ss_pred CCCCcCCcCC------------------------HhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCcc
Confidence 5555554333 333444555555555555554 3443 34445555555555555 2
Q ss_pred cCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccc
Q 043932 282 FFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFV 361 (1017)
Q Consensus 282 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 361 (1017)
+.+..+..+..+++|+.|++++|++++..+..|..+++|++|++++|.++... ...+..+++|+.|++++|+++
T Consensus 162 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~------~~~~~~~~~L~~L~L~~n~l~ 235 (353)
T 2z80_A 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLL------EIFVDVTSSVECLELRDTDLD 235 (353)
T ss_dssp CCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHH------HHHHHHTTTEEEEEEESCBCT
T ss_pred ccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccch------hhhhhhcccccEEECCCCccc
Confidence 44344455666666666666666666655555666666666666555553211 112233445555555555544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=284.25 Aligned_cols=252 Identities=22% Similarity=0.226 Sum_probs=164.4
Q ss_pred ccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceecc
Q 043932 350 LKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLY 429 (1017)
Q Consensus 350 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 429 (1017)
...++.+++.++ .+|..+ +++++.|++++|+|+++.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus 56 ~~~v~c~~~~l~-~iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SCEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CcEEEECCCCcC-ccCCCC---CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 345666666665 455433 3567788888888888888888888888888888888888878888888888888888
Q ss_pred ccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCC
Q 043932 430 KNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGS 509 (1017)
Q Consensus 430 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~ 509 (1017)
+|++++..+..|.++++|++|+|++|+|+...+..|.++++|+.|++++|...+.+|.
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~---------------------- 189 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE---------------------- 189 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT----------------------
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccCh----------------------
Confidence 8888876667788888888888888888866666788888888888887443323332
Q ss_pred ccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhccc
Q 043932 510 LPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENL 589 (1017)
Q Consensus 510 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 589 (1017)
..|..+++|++|+|++|++++. | .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++
T Consensus 190 --~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 265 (452)
T 3zyi_A 190 --GAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL 265 (452)
T ss_dssp --TTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred --hhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCC
Confidence 2344455555555555555532 2 35555555555555555555555555555555555555555555555555555
Q ss_pred CCCcEEEcccCCCcCcCCC-CCCCCCCCcccccCcccccCCcC
Q 043932 590 SFLEFLNFSHNDLEGEVPT-KGVFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 590 ~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
++|+.|+|++|+|++.++. ...+.+++.+++.+|||.|+|..
T Consensus 266 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 5555555555555544443 23344555555555555555543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=282.79 Aligned_cols=252 Identities=21% Similarity=0.218 Sum_probs=185.1
Q ss_pred ccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceecc
Q 043932 350 LKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLY 429 (1017)
Q Consensus 350 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 429 (1017)
...++.+++.++ .+|..+ ..+++.|++++|+|+.+.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus 45 ~~~v~c~~~~l~-~iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp SCEEECCSCCCS-SCCSCC---CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCEEEeCCCCcC-cCCCCC---CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 445666666665 555543 2467788888888888888888888888888888888888888888888888888888
Q ss_pred ccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCC
Q 043932 430 KNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGS 509 (1017)
Q Consensus 430 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~ 509 (1017)
+|++++..+..|.++++|++|+|++|+|+...+..|.++++|+.|++++|+..+.++
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~----------------------- 177 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS----------------------- 177 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC-----------------------
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeC-----------------------
Confidence 888886666678888888888888888887666788888888888888754332222
Q ss_pred ccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhccc
Q 043932 510 LPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENL 589 (1017)
Q Consensus 510 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 589 (1017)
+..|.++++|++|+|++|+++. +| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++
T Consensus 178 -~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 178 -EGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp -TTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred -cchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 2345666777777777777763 34 36677777777777777777667777777777777777777777777777777
Q ss_pred CCCcEEEcccCCCcCcCCC-CCCCCCCCcccccCcccccCCcC
Q 043932 590 SFLEFLNFSHNDLEGEVPT-KGVFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 590 ~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
++|+.|+|++|+|++.++. ...+.+++.+++.+|||.|+|..
T Consensus 255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred CCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 7777777777777765554 24556677777777777777765
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-29 Score=294.27 Aligned_cols=294 Identities=22% Similarity=0.278 Sum_probs=169.3
Q ss_pred CCCCCCCCCCCCCCceeeEEEC------CCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCccccccc
Q 043932 52 SGVTSSWNNTINLCQWTGVTCG------HRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLL 125 (1017)
Q Consensus 52 ~~~~~sw~~~~~~c~w~gv~c~------~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 125 (1017)
....++|....+||.|+|..|. -....++.|++++|+++ .+|..+. ++|++|+|++|.|+ .+|. .++
T Consensus 9 ~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 9 DAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp -CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred HHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence 3445678777789999775431 01224677788888777 3454444 67777777777777 4555 456
Q ss_pred ccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEe
Q 043932 126 RLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSIT 205 (1017)
Q Consensus 126 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 205 (1017)
+|++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+++|+.|++++|++++ +|.. +++|++|+|+
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls 149 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVS 149 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECc
Confidence 7777777777776 4555 56677777777777764 333 45566677777776664 3332 3556666666
Q ss_pred cCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCC
Q 043932 206 GNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGS 285 (1017)
Q Consensus 206 ~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~ 285 (1017)
+|++++ +|. .+++|+.|++++|++++ +| ..+++|+.|+|++|.++ .+|
T Consensus 150 ~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~-~l~----------------------- 197 (622)
T 3g06_A 150 DNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLA-SLP----------------------- 197 (622)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCC-----------------------
T ss_pred CCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCC-CCC-----------------------
Confidence 666553 222 12445555555555552 33 22344555555555444 233
Q ss_pred CCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccc
Q 043932 286 IPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELP 365 (1017)
Q Consensus 286 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 365 (1017)
.. +++|+.|++++|.++.+.. .+++|++|+|++|+++..+ ..+++|+.|+|++|+|+
T Consensus 198 --~~---~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~lp----------~~l~~L~~L~Ls~N~L~---- 254 (622)
T 3g06_A 198 --TL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTSLP----------VLPSELKELMVSGNRLT---- 254 (622)
T ss_dssp --CC---CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSCCC----------CCCTTCCEEECCSSCCS----
T ss_pred --Cc---cchhhEEECcCCcccccCC----CCCCCCEEEccCCccCcCC----------CCCCcCcEEECCCCCCC----
Confidence 21 2345555555555543221 1244555555555443321 12244455555555444
Q ss_pred hhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCccccccc
Q 043932 366 HSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLT 445 (1017)
Q Consensus 366 ~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 445 (1017)
.+ |. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|.+++.+|..+..++
T Consensus 255 ---------------------~l-p~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 255 ---------------------SL-PM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp ---------------------CC-CC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred ---------------------cC-Cc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 22 22 3456777788888777 5577778888888888888888877777666555
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-28 Score=280.01 Aligned_cols=221 Identities=18% Similarity=0.183 Sum_probs=186.6
Q ss_pred ceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccC
Q 043932 375 MIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSY 454 (1017)
Q Consensus 375 L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (1017)
...++..++.++.+ |..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~i-P~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSEV-PQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSSC-CSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCcc-CCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 45677778887754 44443 5788899999999888888888899999999999988888788888888999999999
Q ss_pred cccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccC-Cccccc
Q 043932 455 NSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISS-NQFSGV 533 (1017)
Q Consensus 455 N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~ 533 (1017)
|+|++..+..|.++++|+.|++++|+++ +..+..|.++++|+.|+|++ |.+...
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L~l~~~~~l~~i 187 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIE-------------------------SIPSYAFNRVPSLMRLDLGELKKLEYI 187 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCC-------------------------EECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcc-------------------------eeCHhHHhcCCcccEEeCCCCCCcccc
Confidence 9888777777888888888888888876 23345678899999999999 566655
Q ss_pred ccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCC-CCCC
Q 043932 534 IPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT-KGVF 612 (1017)
Q Consensus 534 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~ 612 (1017)
.+..|.++++|+.|+|++|++++. | .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|. ...+
T Consensus 188 ~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 265 (452)
T 3zyi_A 188 SEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL 265 (452)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred ChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCC
Confidence 566799999999999999999965 4 488999999999999999999999999999999999999999998775 4667
Q ss_pred CCCCcccccCccc
Q 043932 613 SSKTKLSLQGNVK 625 (1017)
Q Consensus 613 ~~~~~~~~~~n~~ 625 (1017)
.+++.+++.+|..
T Consensus 266 ~~L~~L~L~~N~l 278 (452)
T 3zyi_A 266 ASLVELNLAHNNL 278 (452)
T ss_dssp TTCCEEECCSSCC
T ss_pred CCCCEEECCCCcC
Confidence 8899999999953
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=278.75 Aligned_cols=222 Identities=18% Similarity=0.201 Sum_probs=185.7
Q ss_pred ceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccC
Q 043932 375 MIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSY 454 (1017)
Q Consensus 375 L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (1017)
...++..++.++.+ |..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~~i-P~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLREV-PDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCSSC-CSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcCcC-CCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 45677788888754 44443 5788888888888888888888888888888888888877778888888888888888
Q ss_pred cccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccC-Cccccc
Q 043932 455 NSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISS-NQFSGV 533 (1017)
Q Consensus 455 N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~ 533 (1017)
|+|++..+..|.++++|+.|++++|+++ +..+..|..+++|++|+|++ |.+...
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~-------------------------~~~~~~~~~l~~L~~L~l~~~~~l~~i 176 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIE-------------------------SIPSYAFNRIPSLRRLDLGELKRLSYI 176 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCC-------------------------EECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred CcCCeeCHhHhhccccCceeeCCCCccc-------------------------ccCHHHhhhCcccCEeCCCCCCCccee
Confidence 8888766677888888888888888876 23345678899999999999 556655
Q ss_pred ccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCC-CCCC
Q 043932 534 IPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPT-KGVF 612 (1017)
Q Consensus 534 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~ 612 (1017)
.+..|.++++|+.|+|++|+++. +| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|. ...+
T Consensus 177 ~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 177 SEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp CTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred CcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 56689999999999999999995 45 489999999999999999999999999999999999999999998775 4567
Q ss_pred CCCCcccccCcccc
Q 043932 613 SSKTKLSLQGNVKL 626 (1017)
Q Consensus 613 ~~~~~~~~~~n~~~ 626 (1017)
.+++.+++.+|...
T Consensus 255 ~~L~~L~L~~N~l~ 268 (440)
T 3zyj_A 255 QSLVEINLAHNNLT 268 (440)
T ss_dssp TTCCEEECTTSCCC
T ss_pred CCCCEEECCCCCCC
Confidence 88999999999543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=263.75 Aligned_cols=223 Identities=22% Similarity=0.206 Sum_probs=130.5
Q ss_pred EEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccc
Q 043932 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNN 159 (1017)
Q Consensus 80 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 159 (1017)
+.++.++++++... .. -.++|++|+|++|.+++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~~ip-~~--~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQAVP-VG--IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSSCC-TT--CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcccCC-cC--CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 44556666666542 22 2356777777777777555566677777777777777777666666777777777777777
Q ss_pred c-ccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccc
Q 043932 160 K-LEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFP 238 (1017)
Q Consensus 160 ~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p 238 (1017)
+ ++...|..|..+++|++|++++|.+++..|..|.++++|++|++++|++++..+..|+.+++|++|++++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 5 555556666666666666666666666556666666666666666666655444445555555555555555554333
Q ss_pred hhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccC
Q 043932 239 QSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLK 318 (1017)
Q Consensus 239 ~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 318 (1017)
..+..+++ |++|+|++|++++..|..+..+++|+.|++++|++++..+..|..++
T Consensus 171 ~~~~~l~~-------------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 225 (285)
T 1ozn_A 171 RAFRGLHS-------------------------LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (285)
T ss_dssp TTTTTCTT-------------------------CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred HHhcCccc-------------------------cCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence 34444444 44444444444444455555555555555555555554444455555
Q ss_pred ccceEecccCcC
Q 043932 319 NLSWLNLEQNNL 330 (1017)
Q Consensus 319 ~L~~L~L~~N~l 330 (1017)
+|++|++++|.+
T Consensus 226 ~L~~L~l~~N~~ 237 (285)
T 1ozn_A 226 ALQYLRLNDNPW 237 (285)
T ss_dssp TCCEEECCSSCE
T ss_pred ccCEEeccCCCc
Confidence 555555554444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=270.89 Aligned_cols=249 Identities=20% Similarity=0.198 Sum_probs=145.6
Q ss_pred hccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhc
Q 043932 266 VVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLT 345 (1017)
Q Consensus 266 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~ 345 (1017)
+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+ |..+++|++|++++|+++. +.
T Consensus 30 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-----------l~ 96 (317)
T 3o53_A 30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----------LL 96 (317)
T ss_dssp HTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-----------EE
T ss_pred hccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-----------cc
Confidence 3334444444444444444444445555555555555555544433 4444455555555444432 11
Q ss_pred ccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccc
Q 043932 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQG 425 (1017)
Q Consensus 346 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 425 (1017)
..++|++|++++|++++ ..+.. +++|++|++++|++++..+..+..+++|++
T Consensus 97 ~~~~L~~L~l~~n~l~~-------------------------~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 148 (317)
T 3o53_A 97 VGPSIETLHAANNNISR-------------------------VSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQY 148 (317)
T ss_dssp ECTTCCEEECCSSCCSE-------------------------EEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEE
T ss_pred CCCCcCEEECCCCccCC-------------------------cCccc---cCCCCEEECCCCCCCCccchhhhccCCCCE
Confidence 22445555555554442 22221 345666666666666666666666777777
Q ss_pred eeccccccccccCcccc-cccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCC
Q 043932 426 LFLYKNVLQGSIPSGVG-NLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNN 504 (1017)
Q Consensus 426 L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N 504 (1017)
|+|++|.+++..|..+. .+++|++|+|++|+|++. |. ...+++|+.|++++|+++
T Consensus 149 L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~---------------------- 204 (317)
T 3o53_A 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLA---------------------- 204 (317)
T ss_dssp EECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCC----------------------
T ss_pred EECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCC----------------------
Confidence 77777777665555553 567777777777777643 32 224667777777777665
Q ss_pred cCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccC-CCCCccccccccCcEEecc-CCcccCCC
Q 043932 505 NLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFH-GVIPHSLGFLKSIKVLNFS-SNNLSGQI 582 (1017)
Q Consensus 505 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~ 582 (1017)
.+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+++ .+.++|..
T Consensus 205 ----~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~ 279 (317)
T 3o53_A 205 ----FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279 (317)
T ss_dssp ----EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSS
T ss_pred ----cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCc
Confidence 23334566677777777777777 45666777777777777777777 6667777777777777777 34566555
Q ss_pred hh
Q 043932 583 PE 584 (1017)
Q Consensus 583 p~ 584 (1017)
|.
T Consensus 280 ~~ 281 (317)
T 3o53_A 280 EE 281 (317)
T ss_dssp SC
T ss_pred hh
Confidence 54
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=276.71 Aligned_cols=168 Identities=29% Similarity=0.361 Sum_probs=86.6
Q ss_pred ccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeec
Q 043932 397 VNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNA 476 (1017)
Q Consensus 397 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l 476 (1017)
++|++|+|++|++++. |. .+++|+.|++++|.+++ +| ..+++|+.|++++|+|++ +|.. +++|+.|++
T Consensus 141 ~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L 208 (622)
T 3g06_A 141 PGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWA 208 (622)
T ss_dssp TTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred CCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEEC
Confidence 4455555555555532 22 23455555555555553 33 234556666666666653 3332 245555556
Q ss_pred CCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCC
Q 043932 477 SHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHG 556 (1017)
Q Consensus 477 s~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 556 (1017)
++|+++ .+|..+ ..+++|+|++|+|++ +| ..+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+
T Consensus 209 ~~N~l~-~l~~~~----~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~- 274 (622)
T 3g06_A 209 YNNRLT-SLPALP----SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT- 274 (622)
T ss_dssp CSSCCS-SCCCCC----TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-
T ss_pred cCCccc-ccCCCC----CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-
Confidence 655555 222111 111233334443332 33 234556666666666663 333 4456666666666666
Q ss_pred CCCccccccccCcEEeccCCcccCCChhhhcccC
Q 043932 557 VIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLS 590 (1017)
Q Consensus 557 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 590 (1017)
.+|..|..+++|+.|+|++|++++.+|..+..++
T Consensus 275 ~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 275 RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 4455666666666666666666666666555443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-28 Score=271.25 Aligned_cols=171 Identities=16% Similarity=0.159 Sum_probs=100.8
Q ss_pred CeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeec
Q 043932 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRV 156 (1017)
Q Consensus 77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (1017)
.+....+++.+.+...+...+..+++|++|+|++|.+++..|..|+++++|++|+|++|++++..| +..+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 345666777777766655566667777788888877777666777777777777777777775544 777777777777
Q ss_pred ccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccc
Q 043932 157 SNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGT 236 (1017)
Q Consensus 157 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 236 (1017)
++|++++.. ..++|++|++++|++++..+.. +++|++|++++|++++..+..++.+++|++|++++|++++.
T Consensus 88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (317)
T 3o53_A 88 NNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159 (317)
T ss_dssp CSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE
T ss_pred cCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc
Confidence 777776322 2356666666666666443322 34455555555555444444444444444444444444443
Q ss_pred cchhhc-ccCcCcEEeCCCccC
Q 043932 237 FPQSIC-NISSLERIYLPFNRF 257 (1017)
Q Consensus 237 ~p~~l~-~l~~L~~L~Ls~N~l 257 (1017)
.+..+. .+++|++|+|++|.+
T Consensus 160 ~~~~~~~~l~~L~~L~L~~N~l 181 (317)
T 3o53_A 160 NFAELAASSDTLEHLNLQYNFI 181 (317)
T ss_dssp EGGGGGGGTTTCCEEECTTSCC
T ss_pred cHHHHhhccCcCCEEECCCCcC
Confidence 333331 333444444444433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-30 Score=310.13 Aligned_cols=458 Identities=13% Similarity=0.096 Sum_probs=275.1
Q ss_pred CCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCC---CCCCcc------------cccccccc
Q 043932 64 LCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFH---GEIPQE------------IGNLLRLE 128 (1017)
Q Consensus 64 ~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~---~~~p~~------------~~~l~~L~ 128 (1017)
|++|.++.. .....+++.+.... .....+..+++|++|+|+++... +..|.. ...+++|+
T Consensus 34 ck~W~~~~~----~~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~ 108 (594)
T 2p1m_B 34 CKSWYEIER----WCRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108 (594)
T ss_dssp CHHHHHHHH----HHCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred HHHHHHhhh----hhceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence 557888722 12335556554322 12344678899999999997532 122222 24577899
Q ss_pred cccCCCCcccccCCCccc-CCCcceEeecccc-ccccc-CcccccccCCccEEEeccccccCCCCcccc----CCCcccE
Q 043932 129 KLALPNNSFSGTIPTNLS-RCSNLIQLRVSNN-KLEGQ-IPAEIGSLLKLQTLAVGKNYLTGRLPDFVG----NLSALEV 201 (1017)
Q Consensus 129 ~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~L~~ 201 (1017)
+|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+.++. .+++|+.
T Consensus 109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~ 188 (594)
T 2p1m_B 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188 (594)
T ss_dssp EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence 999999988877776675 6889999999988 55533 444555788999999999988766555444 5668888
Q ss_pred EEEecCCCCCCCCccc----ccccCcceeEeecC-ccccccchhhcccCcCcEEeCCCcc-------CccccCchhhccC
Q 043932 202 FSITGNSLGGKIPTTL----GLLRNLVDLHVGGN-QFSGTFPQSICNISSLERIYLPFNR-------FSGTLPFDIVVNL 269 (1017)
Q Consensus 202 L~L~~N~l~~~~~~~l----~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~Ls~N~-------l~~~l~~~~~~~l 269 (1017)
|++++|. .......+ ..+++|++|++++| .++ .+|..+..+++|++|+++.+. +. .++. .+.++
T Consensus 189 L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~-~l~~-~l~~~ 264 (594)
T 2p1m_B 189 LNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYS-GLSV-ALSGC 264 (594)
T ss_dssp EECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHH-HHHH-HHHTC
T ss_pred EEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHH-HHHH-HHhcC
Confidence 8888886 21112222 34588888888888 444 377778888888888865443 22 2222 34566
Q ss_pred Ccccee-eecccccCCCCCCccccCCccceeecccCcccceeec-cccccCccceEecccCcCCCCCCCChhhHhhhccc
Q 043932 270 PNLKSL-AIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSI-DFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNC 347 (1017)
Q Consensus 270 ~~L~~L-~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l 347 (1017)
++|+.| .+.+... +.++..+..+++|+.|++++|.+++.... .+..+++|++|++++| +.. ..+......+
T Consensus 265 ~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~-----~~l~~l~~~~ 337 (594)
T 2p1m_B 265 KELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IED-----AGLEVLASTC 337 (594)
T ss_dssp TTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHH-----HHHHHHHHHC
T ss_pred CCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCH-----HHHHHHHHhC
Confidence 666666 3333222 23344444556666666666665533222 2345566666666655 211 1122222345
Q ss_pred CcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccc-cccccccEEeccccCCCCCcchhhc-ccccccc
Q 043932 348 SSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGI-RNLVNLIALGMQSNQLHGTIPDVIG-ELKNLQG 425 (1017)
Q Consensus 348 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~ 425 (1017)
++|+.|+++++.-.| ....+.+++.....+ ..+++|+.|.++.|.+++.....+. .+++|+.
T Consensus 338 ~~L~~L~L~~~~~~g----------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~ 401 (594)
T 2p1m_B 338 KDLRELRVFPSEPFV----------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTR 401 (594)
T ss_dssp TTCCEEEEECSCTTC----------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEEecCcccc----------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcce
Confidence 555555552210000 001223332222222 2366777777777777765555554 4777888
Q ss_pred eecc--c----cccccc-----cCcccccccccceeeccCcccCCCCcccccc-ccCCceeecCCCcccCCccchhhhcc
Q 043932 426 LFLY--K----NVLQGS-----IPSGVGNLTKLAKLVMSYNSLQGNIPSSLGN-CQNLIGFNASHNKLTGALPQQLLSIT 493 (1017)
Q Consensus 426 L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~-l~~L~~L~ls~N~l~~~~p~~~~~~~ 493 (1017)
|+|+ + |.+++. ++..+.++++|++|+|++ .+++..+..+.. +++|+.|++++|.+++.
T Consensus 402 L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~--------- 471 (594)
T 2p1m_B 402 FRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDL--------- 471 (594)
T ss_dssp EEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHH---------
T ss_pred eEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHH---------
Confidence 8777 3 455421 122256678888888876 666554555554 78888888888887621
Q ss_pred cccceeccCCCcCCCCccccc-cccccceEEEccCCcccccccc-cccccccceEEeccCCccCCCCCccc-cccccCcE
Q 043932 494 TLSVYLDLSNNNLNGSLPLQI-GNLKNLVKLIISSNQFSGVIPV-TLSTCVSLEYLDISSNSFHGVIPHSL-GFLKSIKV 570 (1017)
Q Consensus 494 ~~~~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 570 (1017)
.+..+ ..+++|++|+|++|++++.... ....+++|+.|++++|+++......+ ..+++|+.
T Consensus 472 ----------------~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i 535 (594)
T 2p1m_B 472 ----------------GMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNV 535 (594)
T ss_dssp ----------------HHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEE
T ss_pred ----------------HHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEE
Confidence 11122 4577888888888888654443 34558889999999888854333334 45678877
Q ss_pred EeccCCccc
Q 043932 571 LNFSSNNLS 579 (1017)
Q Consensus 571 L~Ls~N~l~ 579 (1017)
..+..+.-.
T Consensus 536 ~~~~~~~~~ 544 (594)
T 2p1m_B 536 EVIDERGAP 544 (594)
T ss_dssp EEECSSSCG
T ss_pred EEecCCCcc
Confidence 777766443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-29 Score=307.12 Aligned_cols=86 Identities=20% Similarity=0.147 Sum_probs=54.7
Q ss_pred cccceEEEccCCcccccccccc-cccccceEEeccCCccCCCCCc-cccccccCcEEeccCCcccCCChhhh-cccCCCc
Q 043932 517 LKNLVKLIISSNQFSGVIPVTL-STCVSLEYLDISSNSFHGVIPH-SLGFLKSIKVLNFSSNNLSGQIPEFL-ENLSFLE 593 (1017)
Q Consensus 517 l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~ 593 (1017)
+++|+.|+|++|.+++..+..+ .++++|+.|+|++|.+++.... ....+++|+.|+|++|+++......+ ..++.|+
T Consensus 455 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~ 534 (594)
T 2p1m_B 455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLN 534 (594)
T ss_dssp CTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEE
T ss_pred chhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCE
Confidence 6677788888877765544444 5677788888888877544333 33457778888888877754433334 4566666
Q ss_pred EEEcccCCC
Q 043932 594 FLNFSHNDL 602 (1017)
Q Consensus 594 ~L~l~~N~l 602 (1017)
...+..+.-
T Consensus 535 i~~~~~~~~ 543 (594)
T 2p1m_B 535 VEVIDERGA 543 (594)
T ss_dssp EEEECSSSC
T ss_pred EEEecCCCc
Confidence 666655543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-28 Score=289.48 Aligned_cols=187 Identities=15% Similarity=0.022 Sum_probs=130.7
Q ss_pred cccccCCceEEEEEeCCCcEEEEEEEeeecC----------cchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCc
Q 043932 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ----------KGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 712 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..+.|+.|.+..++..-.|+.||+|++.... ....+++.+|+++|+++ .|+||+++++++.+. .
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-----~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-----Q 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-----S
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-----C
Confidence 3566777777766665567789999997432 12346789999999999 799999999998765 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..||||||++|++|.+++.... +++.. +|+.||+.||+|+|++ |||||||||+|||++.+|.+||+||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF 383 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF 383 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence 7999999999999999998764 45554 4889999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCC
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPT 924 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 924 (1017)
|+|+...... ......+||+.|+|||++.+ .+..++|+||+|++++++.++..|+
T Consensus 384 GlAr~~~~~~--------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 384 GSIVTTPQDC--------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp TTEESCC-----------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ccCeeCCCCC--------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 9998654322 12234679999999999977 4677899999999988876665443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=248.34 Aligned_cols=217 Identities=21% Similarity=0.275 Sum_probs=154.0
Q ss_pred CCCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccC
Q 043932 62 INLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTI 141 (1017)
Q Consensus 62 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 141 (1017)
.++|.|.|+.|.-. ..++.+++++++++.. |..+. ++|++|+|++|++++..+..|+++++|++|+|++|++++..
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~~i-p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLTAI-PSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCSSC-CSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCCcc-CCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 37999999998532 2456788888888764 44343 57888888888888666667888888888888888887544
Q ss_pred CCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCccccccc
Q 043932 142 PTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLR 221 (1017)
Q Consensus 142 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 221 (1017)
+..|.++++|++|+|++|++++..+..|.++++|++|++++|++++..+..|+++++|++|+|++|.+++..+..|..++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 55567788888888888888766666677777888888888877777677777777777777777777766556667777
Q ss_pred CcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccC
Q 043932 222 NLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFF 283 (1017)
Q Consensus 222 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~ 283 (1017)
+|++|+|++|++++..+..|..+++|++|+|++|+++ .+|...+..+++|+.|+|++|.+.
T Consensus 158 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC-cCCHHHhccccCCCEEEecCCCee
Confidence 7777777777776555556666666666666666665 455555555555666666655554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=274.83 Aligned_cols=235 Identities=14% Similarity=0.183 Sum_probs=175.6
Q ss_pred cccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceec
Q 043932 349 SLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL 428 (1017)
Q Consensus 349 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 428 (1017)
+|+.|+|++|.+++..|..+..+ ++|+.|++++|.+++..| |..+++|++|+|++|.|++..+ .++|++|++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPF-TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTC-TTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CccEEEeeCCcCCCCCHHHHhCC-CCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 56666666666665555555444 356666666666665554 7777777777777777764432 267777777
Q ss_pred cccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCC
Q 043932 429 YKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNG 508 (1017)
Q Consensus 429 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~ 508 (1017)
++|.+++..+. .+++|++|+|++|+|++..|..|+++++|+.|++++|++++..|..+......+++|+|++|.+++
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 77777765544 346677777777777777777777777777788888877776666665333334567888888775
Q ss_pred CccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCccc-CCChhhhc
Q 043932 509 SLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLS-GQIPEFLE 587 (1017)
Q Consensus 509 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~ 587 (1017)
. | .+..+++|+.|+|++|+|++.+| .|..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|++. +.+|..+.
T Consensus 184 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 184 V-K-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp E-E-CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred c-c-ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 5 3 23468999999999999997544 59999999999999999996 6778999999999999999998 77888899
Q ss_pred ccCCCcEEEcc
Q 043932 588 NLSFLEFLNFS 598 (1017)
Q Consensus 588 ~l~~L~~L~l~ 598 (1017)
.++.|+.++++
T Consensus 260 ~l~~L~~l~~~ 270 (487)
T 3oja_A 260 KNQRVQTVAKQ 270 (487)
T ss_dssp TCHHHHHHHHH
T ss_pred hCCCCcEEecc
Confidence 89888888886
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=245.91 Aligned_cols=228 Identities=21% Similarity=0.249 Sum_probs=178.7
Q ss_pred EeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccc
Q 043932 353 LSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNV 432 (1017)
Q Consensus 353 L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 432 (1017)
++..+..+. .+|..+ +.++++|++++|+++++.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.
T Consensus 12 ~~c~~~~l~-~ip~~l---~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 12 YQCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EECTTSCCS-SCCSSS---CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEecCCCcc-ccCCCC---CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 344444444 444432 3457778888888887777788888888888888888887777788888888888888888
Q ss_pred cccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccc
Q 043932 433 LQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPL 512 (1017)
Q Consensus 433 l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~ 512 (1017)
+++..+..|.++++|++|++++|++++..+..+.++++|+.|++++|++++. .+|.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------~l~~ 143 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF------------------------KLPE 143 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC------------------------CCCG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee------------------------cCch
Confidence 8877777888888888888888888876666788888888888888877620 2467
Q ss_pred cccccccceEEEccCCcccccccccccccccce----EEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcc
Q 043932 513 QIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLE----YLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLEN 588 (1017)
Q Consensus 513 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 588 (1017)
.+..+++|++|+|++|++++..+..|..+++|+ .|++++|++++..+..+.. .+|+.|+|++|++++..+..+.+
T Consensus 144 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~ 222 (276)
T 2z62_A 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDR 222 (276)
T ss_dssp GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTT
T ss_pred hhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcc
Confidence 788888899999999999887778888877777 8899999998776666654 47999999999998777777788
Q ss_pred cCCCcEEEcccCCCcCcCCCC
Q 043932 589 LSFLEFLNFSHNDLEGEVPTK 609 (1017)
Q Consensus 589 l~~L~~L~l~~N~l~~~~~~~ 609 (1017)
+++|+.|++++|++++.+|..
T Consensus 223 l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 223 LTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CCSCCEEECCSSCBCCCTTTT
T ss_pred cccccEEEccCCcccccCCch
Confidence 999999999999998887753
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=243.21 Aligned_cols=209 Identities=22% Similarity=0.200 Sum_probs=164.1
Q ss_pred cccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCC
Q 043932 392 GIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNL 471 (1017)
Q Consensus 392 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 471 (1017)
.+.++++++.+++++|.++. +|..+. ++++.|+|++|.+++..|..|.++++|++|+|++|+|++. +.. ..+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTC
T ss_pred cccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcC
Confidence 35667778888888888874 444333 5778888888888877777788888888888888888743 332 667777
Q ss_pred ceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccC
Q 043932 472 IGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISS 551 (1017)
Q Consensus 472 ~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 551 (1017)
+.|++++|+++ .+|..+..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 80 ~~L~Ls~N~l~--------------------------~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~ 133 (290)
T 1p9a_G 80 GTLDLSHNQLQ--------------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (290)
T ss_dssp CEEECCSSCCS--------------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred CEEECCCCcCC--------------------------cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCC
Confidence 77777777775 4556667788888889999988877778888888999999999
Q ss_pred CccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCcC
Q 043932 552 NSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 552 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+..++......+++.+.+.+|||.|+|..
T Consensus 134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~~ 213 (290)
T 1p9a_G 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (290)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred CCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCcc
Confidence 99888888888888899999999999887666677888889999999999886655555666788888999999998753
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=236.54 Aligned_cols=205 Identities=17% Similarity=0.170 Sum_probs=150.7
Q ss_pred CCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEe
Q 043932 101 SFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAV 180 (1017)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 180 (1017)
++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46889999999998766678888899999999999888777778888889999999999888777788888888888888
Q ss_pred ccccccCCCCccccCCCcccEEEEecCCCCCC-CCcccccccCcceeEeecCccccccchhhcccCcCc----EEeCCCc
Q 043932 181 GKNYLTGRLPDFVGNLSALEVFSITGNSLGGK-IPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLE----RIYLPFN 255 (1017)
Q Consensus 181 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~Ls~N 255 (1017)
++|.+++..+..++++++|++|++++|.+++. +|..++.+++|++|++++|++++..+..+..+++|+ +|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 88888877777788888888888888888763 577888888888888888888776666676666665 6666666
Q ss_pred cCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCccc
Q 043932 256 RFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFK 307 (1017)
Q Consensus 256 ~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 307 (1017)
.++ .++...+. ..+|++|+|++|++++..+..+..+++|+.|++++|++.
T Consensus 188 ~l~-~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 188 PMN-FIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp CCC-EECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred ccc-ccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 665 34433332 224555555555555444444445555555555555544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-24 Score=232.06 Aligned_cols=183 Identities=22% Similarity=0.253 Sum_probs=91.6
Q ss_pred cccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecC
Q 043932 398 NLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNAS 477 (1017)
Q Consensus 398 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls 477 (1017)
+|+.|+|++|++++..+..|.++++|++|+|++|.++...+..|.++++|++|++++|++++..+..|.++++|+.|+++
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 34455555555544444444445555555555555443333334445555555555555544444444444444444444
Q ss_pred CCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCC
Q 043932 478 HNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGV 557 (1017)
Q Consensus 478 ~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 557 (1017)
+|+++ +..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus 118 ~n~l~-------------------------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 118 RNQLK-------------------------SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp SSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCccC-------------------------eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 44443 12233344555555555555555544444455555555555555555555
Q ss_pred CCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCc
Q 043932 558 IPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGE 605 (1017)
Q Consensus 558 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 605 (1017)
.+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++.+.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 455555555555555555555544444455555555555555544443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5e-24 Score=231.18 Aligned_cols=203 Identities=24% Similarity=0.296 Sum_probs=149.8
Q ss_pred cCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCcc
Q 043932 97 VGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQ 176 (1017)
Q Consensus 97 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 176 (1017)
++++++|+++++++|+++ .+|..+. +++++|+|++|.+++..|..|.++++|++|+|++|.+++..+ . +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCC
Confidence 567777888888888887 5666554 577888888888877777778888888888888888775433 2 6777788
Q ss_pred EEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCcc
Q 043932 177 TLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR 256 (1017)
Q Consensus 177 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 256 (1017)
+|++++|+++ .+|..+.++++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 8888888877 566777777777777777777776666777777777777777777776666667777777777777777
Q ss_pred CccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCccc
Q 043932 257 FSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFK 307 (1017)
Q Consensus 257 l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 307 (1017)
++ .+|...+..+++|++|+|++|+++ .+|..+....+|+.|+|++|++.
T Consensus 160 l~-~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 160 LT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CS-CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CC-ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 76 666666667777777777777776 56666666667777777777654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=232.17 Aligned_cols=210 Identities=20% Similarity=0.248 Sum_probs=117.5
Q ss_pred cCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCcc
Q 043932 97 VGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQ 176 (1017)
Q Consensus 97 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 176 (1017)
+..+++|+.|++++|.++. + ..++.+++|++|+|++|.+++ + ..+.++++|++|+|++|.+++..+..|+++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 3445555555555555552 2 235555556666666555553 2 2455555666666666665555555555556666
Q ss_pred EEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCcc
Q 043932 177 TLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR 256 (1017)
Q Consensus 177 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 256 (1017)
+|++++|++++..+..|+++++|++|++++|.+++..+..++.+++|++|++++|++++..+..+..+++|++|+|++|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 66666666655555555556666666666666655555555555666666666666655555555556666666666666
Q ss_pred CccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccC
Q 043932 257 FSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLK 318 (1017)
Q Consensus 257 l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 318 (1017)
++ .++...+..+++|++|+|++|.+.+. +++|+.|+++.|+++|.+|..++.+.
T Consensus 193 l~-~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 193 LK-SVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp CS-CCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred CC-ccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccC
Confidence 65 33434455556666666666655432 33455666666666666665554443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.7e-24 Score=229.69 Aligned_cols=208 Identities=22% Similarity=0.265 Sum_probs=190.7
Q ss_pred CeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeec
Q 043932 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRV 156 (1017)
Q Consensus 77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 156 (1017)
..++.|+++++.++.. +.++.+++|++|+|++|.+++ + ..++.+++|++|+|++|.+++..|..++++++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 4688999999998864 468999999999999999996 3 48999999999999999999888888999999999999
Q ss_pred ccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccc
Q 043932 157 SNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGT 236 (1017)
Q Consensus 157 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 236 (1017)
++|++++..|..|+++++|++|++++|++++..+..++++++|+.|++++|++++..+..++.+++|++|++++|++++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSV 196 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCcc
Confidence 99999988888899999999999999999988888899999999999999999988888899999999999999999988
Q ss_pred cchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCcc
Q 043932 237 FPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNV 296 (1017)
Q Consensus 237 ~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 296 (1017)
.+..+..+++|++|+|++|.+.+. +++|+.|+++.|.++|.+|..++.+...
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~~~--------~~~l~~l~~~~n~~~g~ip~~~~~~~~~ 248 (272)
T 3rfs_A 197 PDGVFDRLTSLQYIWLHDNPWDCT--------CPGIRYLSEWINKHSGVVRNSAGSVAPD 248 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCC--------TTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred CHHHHhCCcCCCEEEccCCCcccc--------CcHHHHHHHHHHhCCCcccCcccccCCC
Confidence 888899999999999999998754 4579999999999999999999877653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-24 Score=226.63 Aligned_cols=192 Identities=19% Similarity=0.216 Sum_probs=155.1
Q ss_pred CCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCC
Q 043932 63 NLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIP 142 (1017)
Q Consensus 63 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 142 (1017)
+||.|.|.+|... .+.+++++++++.. |..+. ++|+.|+|++|++++..|..|+++++|++|+|++|++++..|
T Consensus 3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~~~-p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNEG---KKEVDCQGKSLDSV-PSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEGG---GTEEECTTCCCSSC-CSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC---CeEEecCCCCcccc-CCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 6899999999532 34688999988864 34443 578999999999988888888888999999999999888777
Q ss_pred CcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccC
Q 043932 143 TNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRN 222 (1017)
Q Consensus 143 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 222 (1017)
..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|+.+++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 156 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence 78888888999999988888777777888888888888888888777777788888888888888888777767888888
Q ss_pred cceeEeecCccccccchhhcccCcCcEEeCCCccCccc
Q 043932 223 LVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGT 260 (1017)
Q Consensus 223 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 260 (1017)
|++|+|++|++++..+..+..+++|++|+|++|.+.+.
T Consensus 157 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 88888888888876666777777788888887777643
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-25 Score=249.05 Aligned_cols=266 Identities=18% Similarity=0.192 Sum_probs=137.4
Q ss_pred EEEccCCCCCCCCCcccccccccccccCCCCcccccCC----CcccCCC-cceEeecccccccccCccccccc-----CC
Q 043932 105 YINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIP----TNLSRCS-NLIQLRVSNNKLEGQIPAEIGSL-----LK 174 (1017)
Q Consensus 105 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p----~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~ 174 (1017)
+++|++|+++|.+|..+...++|++|+|++|.+++..+ ..+.+++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 45677777777777666666667777777777775554 5566666 67777777777776666666554 66
Q ss_pred ccEEEeccccccCCCCccccCC-----CcccEEEEecCCCCCCCCccccc-----ccCcceeEeecCcccccc----chh
Q 043932 175 LQTLAVGKNYLTGRLPDFVGNL-----SALEVFSITGNSLGGKIPTTLGL-----LRNLVDLHVGGNQFSGTF----PQS 240 (1017)
Q Consensus 175 L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~l~~-----l~~L~~L~L~~n~l~~~~----p~~ 240 (1017)
|++|+|++|++++..+..+... ++|++|+|++|.+++..+..+.. .++|++|+|++|++++.. +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 6666666666665544433322 45555555555554444333322 134444444444444322 122
Q ss_pred hcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccc----cC-CccceeecccCccccee----e
Q 043932 241 ICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLS----NA-SNVEILDLGFNQFKGKV----S 311 (1017)
Q Consensus 241 l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~----~l-~~L~~L~Ls~N~l~~~~----~ 311 (1017)
+..++ ++|++|+|++|++++..+..+. .. ++|+.|||++|++++.. +
T Consensus 162 l~~~~------------------------~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~ 217 (362)
T 3goz_A 162 LAAIP------------------------ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELA 217 (362)
T ss_dssp HHTSC------------------------TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred HhcCC------------------------ccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHH
Confidence 22222 1444444444444433332222 22 35555555555555422 2
Q ss_pred ccccc-cCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccC
Q 043932 312 IDFSS-LKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIP 390 (1017)
Q Consensus 312 ~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~ 390 (1017)
..+.. .++|++|+|++|.++..+.. .+...+..+++|++|+|++|.+.+..+..+.. .+
T Consensus 218 ~~l~~~~~~L~~L~Ls~N~l~~~~~~--~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~------------------l~ 277 (362)
T 3goz_A 218 YIFSSIPNHVVSLNLCLNCLHGPSLE--NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKA------------------LG 277 (362)
T ss_dssp HHHHHSCTTCCEEECCSSCCCCCCHH--HHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHH------------------HH
T ss_pred HHHhcCCCCceEEECcCCCCCcHHHH--HHHHHHhcCCCccEEEeccCCccccCHHHHHH------------------HH
Confidence 22222 23555555555555443322 12233445566666666666655433333322 22
Q ss_pred ccccccccccEEeccccCCCCCcc
Q 043932 391 SGIRNLVNLIALGMQSNQLHGTIP 414 (1017)
Q Consensus 391 ~~~~~l~~L~~L~L~~N~l~~~~~ 414 (1017)
..+..+++|+.|++++|++.+..+
T Consensus 278 ~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 278 AAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp TTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHhccCCceEEEecCCCcCCCcch
Confidence 344556666666666666654433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-24 Score=256.35 Aligned_cols=193 Identities=16% Similarity=0.144 Sum_probs=142.9
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--------chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.+...++||+|+||+||+|.. .++.+|+|+...... ...+++.+|++++++++||||+++..++...
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--- 411 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--- 411 (540)
T ss_dssp -----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET---
T ss_pred cCCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC---
Confidence 334567999999999999965 467789998653221 1135588999999999999999555444432
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
+..|+||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+||+++. .+||
T Consensus 412 --~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL 470 (540)
T 3en9_A 412 --DNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYI 470 (540)
T ss_dssp --TTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEE
T ss_pred --CccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEE
Confidence 446999999999999999874 457999999999999999 9999999999999998 9999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccC--CCcCccccchhHHHHHHHHHhCCCCCC
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG--SEASMTGDVYSFGILLLELFTGRRPTD 925 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~ 925 (1017)
+|||+|+........... .........||+.|+|||++.+ ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 471 ~DFGla~~~~~~~~~~~~-~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 471 IDFGLGKISNLDEDKAVD-LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCTTCEECCCHHHHHHH-HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EECccCEECCCccccccc-hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999999877543211100 0001124679999999999977 568888999999999998888877763
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-25 Score=249.24 Aligned_cols=267 Identities=17% Similarity=0.180 Sum_probs=195.1
Q ss_pred EEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCC----ccccccc-ccccccCCCCcccccCCCcccCC-----Cc
Q 043932 81 RLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIP----QEIGNLL-RLEKLALPNNSFSGTIPTNLSRC-----SN 150 (1017)
Q Consensus 81 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l-----~~ 150 (1017)
..+|+.|+++|.++..+...++|++|||++|.+++..+ ..+.+++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999998888888889999999999997776 7788888 99999999999998878777775 99
Q ss_pred ceEeecccccccccCccccccc-----CCccEEEeccccccCCCCcccc----C-CCcccEEEEecCCCCCCCCcc----
Q 043932 151 LIQLRVSNNKLEGQIPAEIGSL-----LKLQTLAVGKNYLTGRLPDFVG----N-LSALEVFSITGNSLGGKIPTT---- 216 (1017)
Q Consensus 151 L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~p~~~~----~-l~~L~~L~L~~N~l~~~~~~~---- 216 (1017)
|++|+|++|++++..+..+... ++|++|+|++|++++..+..+. . .++|++|+|++|.+++..+..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999998887765554 8999999999999977765544 3 369999999999998655444
Q ss_pred ccccc-CcceeEeecCccccccchhhcc----c-CcCcEEeCCCccCccc----cCchhhccCCccceeeecccccCCCC
Q 043932 217 LGLLR-NLVDLHVGGNQFSGTFPQSICN----I-SSLERIYLPFNRFSGT----LPFDIVVNLPNLKSLAIGGNNFFGSI 286 (1017)
Q Consensus 217 l~~l~-~L~~L~L~~n~l~~~~p~~l~~----l-~~L~~L~Ls~N~l~~~----l~~~~~~~l~~L~~L~L~~n~l~~~~ 286 (1017)
+..++ +|++|+|++|++++..+..+.. + ++|++|+|++|.+++. ++..+....++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 9999999999999877765544 4 6899999999998742 33332222346777777777776543
Q ss_pred C----CccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCccccc
Q 043932 287 P----DSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVG 362 (1017)
Q Consensus 287 p----~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 362 (1017)
+ ..+..+++|+.|+|++|.+.+..+..+ ......+..+++|+.|++++|++.+
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~-----------------------~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQC-----------------------KALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHH-----------------------HHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHH-----------------------HHHHHHhccCCceEEEecCCCcCCC
Confidence 3 223444555555555555443322211 1122334566667777777777765
Q ss_pred ccchhHHh
Q 043932 363 ELPHSIAN 370 (1017)
Q Consensus 363 ~~p~~~~~ 370 (1017)
..+..+.+
T Consensus 299 ~~~~~~~~ 306 (362)
T 3goz_A 299 SHSIPISN 306 (362)
T ss_dssp GGCHHHHH
T ss_pred cchHHHHH
Confidence 54444433
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-25 Score=255.04 Aligned_cols=258 Identities=16% Similarity=0.212 Sum_probs=179.6
Q ss_pred CCCCccccCCccceeecccCcccceeecc----ccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCccc
Q 043932 285 SIPDSLSNASNVEILDLGFNQFKGKVSID----FSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360 (1017)
Q Consensus 285 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 360 (1017)
.++..+..+++|+.|+|++|++.+..+.. |..+++|++|+|++|.+ |++
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~---------------------------~~l 75 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT---------------------------GRV 75 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCT---------------------------TSC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCccccc---------------------------Ccc
Confidence 45556666777777777777776554332 34444455444444433 234
Q ss_pred ccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCC----Ccchhhcccccccceeccccccccc
Q 043932 361 VGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHG----TIPDVIGELKNLQGLFLYKNVLQGS 436 (1017)
Q Consensus 361 ~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~ 436 (1017)
.+.+|..+..+. ..+..+++|++|+|++|++++ .+|..+..+++|++|+|++|.+++.
T Consensus 76 ~~~~~~~~~~l~------------------~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~ 137 (386)
T 2ca6_A 76 KDEIPEALRLLL------------------QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 137 (386)
T ss_dssp GGGSHHHHHHHH------------------HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHH
T ss_pred ccchhHHHHHHH------------------HHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHH
Confidence 445555544332 345566777777777777776 3666777777777788877777644
Q ss_pred cCcccc----cc---------cccceeeccCcccC-CCCc---cccccccCCceeecCCCcccCCccchhhhccccccee
Q 043932 437 IPSGVG----NL---------TKLAKLVMSYNSLQ-GNIP---SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYL 499 (1017)
Q Consensus 437 ~p~~~~----~l---------~~L~~L~Ls~N~i~-~~~p---~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L 499 (1017)
.+..+. .+ ++|++|+|++|+|+ +.+| ..+..+++|+.|++++|+++.. .+.
T Consensus 138 ~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~---g~~--------- 205 (386)
T 2ca6_A 138 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE---GIE--------- 205 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH---HHH---------
T ss_pred HHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHh---HHH---------
Confidence 333333 33 78888888888887 3344 4566778888888888877610 000
Q ss_pred ccCCCcCCCCccccccccccceEEEccCCccc----ccccccccccccceEEeccCCccCCC----CCcccc--ccccCc
Q 043932 500 DLSNNNLNGSLPLQIGNLKNLVKLIISSNQFS----GVIPVTLSTCVSLEYLDISSNSFHGV----IPHSLG--FLKSIK 569 (1017)
Q Consensus 500 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~--~l~~L~ 569 (1017)
...|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++. +|..+. .+++|+
T Consensus 206 --------~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~ 277 (386)
T 2ca6_A 206 --------HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ 277 (386)
T ss_dssp --------HHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCC
T ss_pred --------HHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeE
Confidence 023446778889999999999996 57788899999999999999999876 566663 489999
Q ss_pred EEeccCCcccC----CChhhh-cccCCCcEEEcccCCCcCcCC
Q 043932 570 VLNFSSNNLSG----QIPEFL-ENLSFLEFLNFSHNDLEGEVP 607 (1017)
Q Consensus 570 ~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~l~~N~l~~~~~ 607 (1017)
.|+|++|++++ .+|..+ .++++|+.|++++|++++..+
T Consensus 278 ~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 278 TLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp EEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred EEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 99999999997 488877 668999999999999987554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.3e-24 Score=233.57 Aligned_cols=203 Identities=16% Similarity=0.156 Sum_probs=140.8
Q ss_pred cceEEEecCCccccccCccc--cccccccEEeccccCCCCCcc----hhhcccccccceeccccccccccCccccccccc
Q 043932 374 SMIEFRIGGNQIFGIIPSGI--RNLVNLIALGMQSNQLHGTIP----DVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKL 447 (1017)
Q Consensus 374 ~L~~L~l~~N~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 447 (1017)
++++|++++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..|..|.++++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 46677777777776676666 777777777777777776443 344567777777777777776666777777777
Q ss_pred ceeeccCcccCCC--C--ccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccc-cccccccceE
Q 043932 448 AKLVMSYNSLQGN--I--PSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPL-QIGNLKNLVK 522 (1017)
Q Consensus 448 ~~L~Ls~N~i~~~--~--p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~-~~~~l~~L~~ 522 (1017)
++|+|++|++.+. + +..+..+++|++|++++|+++ .+|. .+. .+.++++|++
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~----------------------~~~~l~~~l~~L~~ 228 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTG----------------------VCAALAAAGVQPHS 228 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHH----------------------HHHHHHHHTCCCSS
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHH----------------------HHHHHHhcCCCCCE
Confidence 7777777776532 1 122356667777777777665 1111 111 2456778888
Q ss_pred EEccCCccccccccccccc---ccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEccc
Q 043932 523 LIISSNQFSGVIPVTLSTC---VSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSH 599 (1017)
Q Consensus 523 L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 599 (1017)
|+|++|++++..|..+..+ ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++
T Consensus 229 L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~ 303 (310)
T 4glp_A 229 LDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDG 303 (310)
T ss_dssp EECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSS
T ss_pred EECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcC
Confidence 8888888887777777666 58888888888888 4566553 7888888888888864 33 56778888888888
Q ss_pred CCCcC
Q 043932 600 NDLEG 604 (1017)
Q Consensus 600 N~l~~ 604 (1017)
|+++.
T Consensus 304 N~l~~ 308 (310)
T 4glp_A 304 NPFLV 308 (310)
T ss_dssp TTTSC
T ss_pred CCCCC
Confidence 88864
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=222.39 Aligned_cols=197 Identities=16% Similarity=0.158 Sum_probs=123.8
Q ss_pred ccceEEEecCCccccccCccccccccccEEeccccC-CCCCcchhhcccccccceeccc-cccccccCccccccccccee
Q 043932 373 SSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQ-LHGTIPDVIGELKNLQGLFLYK-NVLQGSIPSGVGNLTKLAKL 450 (1017)
Q Consensus 373 ~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 450 (1017)
..+++|++++|+++++.+..|.++++|++|++++|+ ++++.+..|.++++|++|++++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 356667777777766666667777777777777775 6655555666667777777766 66665555566666666666
Q ss_pred eccCcccCCCCccccccccCCc---eeecCCC-cccCCccchhhhcccccceeccCCCcCCCCccccccccccce-EEEc
Q 043932 451 VMSYNSLQGNIPSSLGNCQNLI---GFNASHN-KLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLV-KLII 525 (1017)
Q Consensus 451 ~Ls~N~i~~~~p~~~~~l~~L~---~L~ls~N-~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~L 525 (1017)
++++|++++ +|. |..+++|+ .|++++| +++ +..+..|.++++|+ .|+|
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~-------------------------~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT-------------------------SIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC-------------------------EECTTTTTTTBSSEEEEEC
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchh-------------------------hcCcccccchhcceeEEEc
Confidence 666666664 444 55555555 5555554 443 23334466667777 7777
Q ss_pred cCCcccccccccccccccceEEeccCCc-cCCCCCcccccc-ccCcEEeccCCcccCCChhhhcccCCCcEEEcccC
Q 043932 526 SSNQFSGVIPVTLSTCVSLEYLDISSNS-FHGVIPHSLGFL-KSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600 (1017)
Q Consensus 526 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 600 (1017)
++|+++.+.+..|.. ++|+.|+|++|+ +++..+..|..+ ++|+.|+|++|++++ +|.. .+++|+.|+++++
T Consensus 164 ~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 164 YNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred CCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 777776433334444 677777777774 776666667777 777777777777764 3332 4556666666655
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=221.57 Aligned_cols=198 Identities=14% Similarity=0.152 Sum_probs=106.0
Q ss_pred CCCEEEccCCCCCCCCCcccccccccccccCCCCc-ccccCCCcccCCCcceEeeccc-ccccccCcccccccCCccEEE
Q 043932 102 FLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS-FSGTIPTNLSRCSNLIQLRVSN-NKLEGQIPAEIGSLLKLQTLA 179 (1017)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~ 179 (1017)
+|++|+|++|++++..+..|+++++|++|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67777777777775555566666666666666665 6544444566666666666665 666655445556666666666
Q ss_pred eccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecC-ccccccchhhcccCcCc-EEeCCCccC
Q 043932 180 VGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGN-QFSGTFPQSICNISSLE-RIYLPFNRF 257 (1017)
Q Consensus 180 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~-~L~Ls~N~l 257 (1017)
+++|++++ +|+ |+.+++|+ .|++|++++| ++++..+..|..+++|+ +|++++|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~---------------------~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTD---------------------IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCC---------------------SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred CCCCCCcc-ccc-cccccccc---------------------cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence 66666554 333 44444444 0014444444 44444444455555555 555555555
Q ss_pred ccccCchhhccCCccceeeecccc-cCCCCCCccccC-CccceeecccCcccceeeccccccCccceEeccc
Q 043932 258 SGTLPFDIVVNLPNLKSLAIGGNN-FFGSIPDSLSNA-SNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQ 327 (1017)
Q Consensus 258 ~~~l~~~~~~~l~~L~~L~L~~n~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 327 (1017)
+ .+|...+.. ++|+.|+|++|+ +++..+..|..+ ++|+.|++++|++++..+. .+++|+.|++++
T Consensus 169 ~-~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~ 235 (239)
T 2xwt_C 169 T-SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARN 235 (239)
T ss_dssp C-EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTT
T ss_pred c-ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccC
Confidence 4 444444433 455555555552 543334445555 5555555555555543332 333444444443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=8e-25 Score=244.19 Aligned_cols=235 Identities=14% Similarity=0.184 Sum_probs=124.0
Q ss_pred CCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCC--CCCCEEEccCCCCCCCCCcccccccccccccCCCCccccc
Q 043932 63 NLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNL--SFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGT 140 (1017)
Q Consensus 63 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 140 (1017)
-|..|.++.|+.. .++.+|++++.+. +..+..+ ++++.|++++|.+++..|.
T Consensus 35 vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~--------------------- 88 (336)
T 2ast_B 35 VCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE--------------------- 88 (336)
T ss_dssp SCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS---------------------
T ss_pred HHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh---------------------
Confidence 3567999988532 3445566555544 2233333 4455555555555443332
Q ss_pred CCCcccCCCcceEeeccccccccc-CcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecC-CCCC-CCCccc
Q 043932 141 IPTNLSRCSNLIQLRVSNNKLEGQ-IPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGN-SLGG-KIPTTL 217 (1017)
Q Consensus 141 ~p~~l~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~-~~~~~l 217 (1017)
+.++++|++|+|++|.+++. +|..+..+++|++|++++|.+++..+..++.+++|++|++++| .+++ .++..+
T Consensus 89 ----~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~ 164 (336)
T 2ast_B 89 ----HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 164 (336)
T ss_dssp ----CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH
T ss_pred ----hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHH
Confidence 33444555555555544433 4444445555555555555544444444455555555555555 3443 134445
Q ss_pred ccccCcceeEeecC-ccccc-cchhhcccC-cCcEEeCCCc--cCc-cccCchhhccCCccceeeecccc-cCCCCCCcc
Q 043932 218 GLLRNLVDLHVGGN-QFSGT-FPQSICNIS-SLERIYLPFN--RFS-GTLPFDIVVNLPNLKSLAIGGNN-FFGSIPDSL 290 (1017)
Q Consensus 218 ~~l~~L~~L~L~~n-~l~~~-~p~~l~~l~-~L~~L~Ls~N--~l~-~~l~~~~~~~l~~L~~L~L~~n~-l~~~~p~~l 290 (1017)
..+++|++|++++| .+++. ++..+..++ +|++|+|++| .++ +.++ ..+..+++|++|++++|. +++..+..+
T Consensus 165 ~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~-~~~~~~~~L~~L~l~~~~~l~~~~~~~l 243 (336)
T 2ast_B 165 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS-TLVRRCPNLVHLDLSDSVMLKNDCFQEF 243 (336)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHH-HHHHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred hcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHH-HHHhhCCCCCEEeCCCCCcCCHHHHHHH
Confidence 55666666666666 55543 455566666 6666666666 333 1222 234456666666666666 555555566
Q ss_pred ccCCccceeecccCc-ccceeeccccccCccceEecccC
Q 043932 291 SNASNVEILDLGFNQ-FKGKVSIDFSSLKNLSWLNLEQN 328 (1017)
Q Consensus 291 ~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N 328 (1017)
..+++|+.|++++|. +.......+..+++|+.|++++|
T Consensus 244 ~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 244 FQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp GGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred hCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 666667777776664 22222224555566666666655
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-25 Score=249.37 Aligned_cols=246 Identities=20% Similarity=0.263 Sum_probs=112.9
Q ss_pred CCcccccccccccccCCCCccccc----CCCcccCCCcceEeecccc---cccccCcccc-------cccCCccEEEecc
Q 043932 117 IPQEIGNLLRLEKLALPNNSFSGT----IPTNLSRCSNLIQLRVSNN---KLEGQIPAEI-------GSLLKLQTLAVGK 182 (1017)
Q Consensus 117 ~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n---~l~~~~p~~~-------~~l~~L~~L~L~~ 182 (1017)
++..+..+++|++|+|++|.+++. ++..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 445555555566666666655544 2233455666666666653 3334444433 4455555555555
Q ss_pred ccccC----CCCccccCCCcccEEEEecCCCCCCCCcccc----cc---------cCcceeEeecCccc-cccc---hhh
Q 043932 183 NYLTG----RLPDFVGNLSALEVFSITGNSLGGKIPTTLG----LL---------RNLVDLHVGGNQFS-GTFP---QSI 241 (1017)
Q Consensus 183 n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~----~l---------~~L~~L~L~~n~l~-~~~p---~~l 241 (1017)
|.+++ .+|..+.++++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++ +.++ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 55554 2344445555555555555555432222222 22 45555555555554 2223 244
Q ss_pred cccCcCcEEeCCCccCccc----cCchhhccCCccceeeecccccC----CCCCCccccCCccceeecccCcccce----
Q 043932 242 CNISSLERIYLPFNRFSGT----LPFDIVVNLPNLKSLAIGGNNFF----GSIPDSLSNASNVEILDLGFNQFKGK---- 309 (1017)
Q Consensus 242 ~~l~~L~~L~Ls~N~l~~~----l~~~~~~~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~---- 309 (1017)
..+++|++|+|++|+++.. +....+..+++|++|+|++|.++ +.+|..+..+++|+.|+|++|++++.
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 4555555555555555411 11112334445555555555543 23444455555555555555555443
Q ss_pred eeccc--cccCccceEecccCcCCCCCCCChhhHhhh-cccCcccEEeccCccccccc
Q 043932 310 VSIDF--SSLKNLSWLNLEQNNLGMGTANDLDFVTFL-TNCSSLKILSLAANQFVGEL 364 (1017)
Q Consensus 310 ~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~ 364 (1017)
++..+ ..+++|++|+|++|.++..+. ..++..+ .++++|++|++++|++++..
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~--~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAV--RTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHH--HHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHH--HHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 22222 124445555555544432110 0122222 33455555555555554433
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=215.80 Aligned_cols=179 Identities=20% Similarity=0.240 Sum_probs=99.8
Q ss_pred ccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCC
Q 043932 399 LIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASH 478 (1017)
Q Consensus 399 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~ 478 (1017)
.+.++++++.++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|+|++..|..|.++++|+.|++++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 444555555554 2333222 3455555555555555555555555555555555555555555555555555555555
Q ss_pred CcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCC
Q 043932 479 NKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVI 558 (1017)
Q Consensus 479 N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 558 (1017)
|+++ +..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..
T Consensus 93 n~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 147 (251)
T 3m19_A 93 NQLA-------------------------SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIP 147 (251)
T ss_dssp SCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred Cccc-------------------------ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccC
Confidence 5554 122333445555666666666666555555566666666666666666555
Q ss_pred CccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCc
Q 043932 559 PHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGE 605 (1017)
Q Consensus 559 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 605 (1017)
+..|+.+++|++|+|++|++++..|..+..+++|+.|+|++|++++.
T Consensus 148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 55566666666666666666655555566666666666666666554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=230.47 Aligned_cols=223 Identities=16% Similarity=0.159 Sum_probs=120.0
Q ss_pred CCCEEEccCCCCCCCCCc---ccccccccccccCCCCcccccCCCcc--cCCCcceEeecccccccccCc----cccccc
Q 043932 102 FLRYINLSDNSFHGEIPQ---EIGNLLRLEKLALPNNSFSGTIPTNL--SRCSNLIQLRVSNNKLEGQIP----AEIGSL 172 (1017)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~---~~~~l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~n~l~~~~p----~~~~~l 172 (1017)
.++.|.+.++.++...-. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..| ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 356667766665421100 12234557777777777776666666 666777777777777665444 233456
Q ss_pred CCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCC--C--CcccccccCcceeEeecCccccccch----hhccc
Q 043932 173 LKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGK--I--PTTLGLLRNLVDLHVGGNQFSGTFPQ----SICNI 244 (1017)
Q Consensus 173 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--~~~l~~l~~L~~L~L~~n~l~~~~p~----~l~~l 244 (1017)
++|++|+|++|++++..|..|+++++|++|+|++|++.+. + +..++.+++|++|+|++|+++. ++. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 6666666666666666666666666666666666665431 1 1122455566666666666642 121 23455
Q ss_pred CcCcEEeCCCccCccccCchhhc--cCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccce
Q 043932 245 SSLERIYLPFNRFSGTLPFDIVV--NLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSW 322 (1017)
Q Consensus 245 ~~L~~L~Ls~N~l~~~l~~~~~~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 322 (1017)
++|++|+|++|++++..|..+.. .+++|++|+|++|+++ .+|..+. ++|+.|+|++|++++... +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~--~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQ--PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCC--TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCch--hhhCCCccE
Confidence 56666666666655444433221 1245555555555555 3444443 455555555555554311 344444444
Q ss_pred EecccCcC
Q 043932 323 LNLEQNNL 330 (1017)
Q Consensus 323 L~L~~N~l 330 (1017)
|+|++|.+
T Consensus 299 L~L~~N~l 306 (310)
T 4glp_A 299 LTLDGNPF 306 (310)
T ss_dssp EECSSTTT
T ss_pred EECcCCCC
Confidence 44444444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=227.26 Aligned_cols=246 Identities=16% Similarity=0.148 Sum_probs=163.9
Q ss_pred cEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcc-hhhcccccccc-eec
Q 043932 351 KILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIP-DVIGELKNLQG-LFL 428 (1017)
Q Consensus 351 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~-L~L 428 (1017)
++++.++++++ .+|..+ +.++++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.++++|++ +.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 46677777777 667644 4568888888888888777888899999999999998866544 56788888765 566
Q ss_pred cccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCC-CcccCCccchhhhcccccceeccCCCcCC
Q 043932 429 YKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASH-NKLTGALPQQLLSITTLSVYLDLSNNNLN 507 (1017)
Q Consensus 429 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~ 507 (1017)
+.|+++...|..|.++++|++|++++|+|+...+..+....++..|++.+ |+++ .+|
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~--------------------- 145 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIE--------------------- 145 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EEC---------------------
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-ccc---------------------
Confidence 77888877788888888888888888888876666666777777777754 4554 222
Q ss_pred CCcccccccc-ccceEEEccCCcccccccccccccccceEEeccC-CccCCCCCccccccccCcEEeccCCcccCCChhh
Q 043932 508 GSLPLQIGNL-KNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISS-NSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEF 585 (1017)
Q Consensus 508 ~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 585 (1017)
+..|..+ ..++.|+|++|+|+.+.+..| ...+|+.|++++ |+++.+.+++|..+++|++|||++|+|+...+..
T Consensus 146 ---~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~ 221 (350)
T 4ay9_X 146 ---RNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 221 (350)
T ss_dssp ---TTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS
T ss_pred ---ccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh
Confidence 2233333 346677777777774433333 445677777764 5666555566777777777777777777443333
Q ss_pred hcccCCCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCc
Q 043932 586 LENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGT 630 (1017)
Q Consensus 586 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 630 (1017)
+ .+|+.|.+.++.--..+|....+.+++.+.+. |++.|.+.
T Consensus 222 ~---~~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~-~~~~c~~~ 262 (350)
T 4ay9_X 222 L---ENLKKLRARSTYNLKKLPTLEKLVALMEASLT-YPSHCCAF 262 (350)
T ss_dssp C---TTCCEEECTTCTTCCCCCCTTTCCSCCEEECS-CHHHHHHH
T ss_pred h---ccchHhhhccCCCcCcCCCchhCcChhhCcCC-CCccccch
Confidence 3 34444544444323345555556666666654 66676543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=244.71 Aligned_cols=208 Identities=24% Similarity=0.325 Sum_probs=147.5
Q ss_pred CCCCCCCCCCC-----ceeeE-EECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccc
Q 043932 55 TSSWNNTINLC-----QWTGV-TCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLE 128 (1017)
Q Consensus 55 ~~sw~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 128 (1017)
+.+|..+.++| .|.|+ .|.. .+++.|+|++|++++ +|..+. ++|++|+|++|.|+ .+| ..+++|+
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCC
Confidence 34675566778 79999 7853 468899999999988 555553 78999999999998 677 4578888
Q ss_pred cccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCC
Q 043932 129 KLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNS 208 (1017)
Q Consensus 129 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 208 (1017)
+|+|++|+|++ +|. +.+ +|++|+|++|++++ +|. .+++|++|+|++|.|++ +|. .+++|+.|+|++|+
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQ 171 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCC
Confidence 99999998886 777 665 88888888888886 565 57888888888888886 554 56778888888888
Q ss_pred CCCCCCcccccccCcceeEeecCccccccchhhcccCcC-------cEEeCCCccCccccCchhhccCCccceeeecccc
Q 043932 209 LGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSL-------ERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNN 281 (1017)
Q Consensus 209 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L-------~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~ 281 (1017)
+++ +|. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..++. +++|+.|+|++|.
T Consensus 172 L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~-l~~L~~L~L~~N~ 241 (571)
T 3cvr_A 172 LTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILS-LDPTCTIILEDNP 241 (571)
T ss_dssp CSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGG-SCTTEEEECCSSS
T ss_pred CCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhc-CCCCCEEEeeCCc
Confidence 876 555 55 77777777777777 4555 443 45 66666666665 45554443 5566666666666
Q ss_pred cCCCCCCccccC
Q 043932 282 FFGSIPDSLSNA 293 (1017)
Q Consensus 282 l~~~~p~~l~~l 293 (1017)
+++.+|..+..+
T Consensus 242 l~~~~p~~l~~l 253 (571)
T 3cvr_A 242 LSSRIRESLSQQ 253 (571)
T ss_dssp CCHHHHHHHHHH
T ss_pred CCCcCHHHHHHh
Confidence 655555554443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=4.9e-22 Score=217.77 Aligned_cols=191 Identities=24% Similarity=0.354 Sum_probs=136.7
Q ss_pred ceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccC
Q 043932 375 MIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSY 454 (1017)
Q Consensus 375 L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (1017)
+++|++++|.++.+ + .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++ ++ .+..+++|++|++++
T Consensus 43 L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 43 ITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTS 116 (308)
T ss_dssp CCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTT
T ss_pred cCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCC
Confidence 44444444444432 2 46667777777777777775444 7777777777777777764 33 567777777777777
Q ss_pred cccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccc
Q 043932 455 NSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVI 534 (1017)
Q Consensus 455 N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 534 (1017)
|++++. +. +..+++|+.|++++|+++ +. +. +..+++|+.|+|++|++++..
T Consensus 117 n~l~~~-~~-l~~l~~L~~L~l~~n~l~-------------------------~~-~~-l~~l~~L~~L~l~~n~l~~~~ 167 (308)
T 1h6u_A 117 TQITDV-TP-LAGLSNLQVLYLDLNQIT-------------------------NI-SP-LAGLTNLQYLSIGNAQVSDLT 167 (308)
T ss_dssp SCCCCC-GG-GTTCTTCCEEECCSSCCC-------------------------CC-GG-GGGCTTCCEEECCSSCCCCCG
T ss_pred CCCCCc-hh-hcCCCCCCEEECCCCccC-------------------------cC-cc-ccCCCCccEEEccCCcCCCCh
Confidence 777743 32 667777777777777665 22 22 667788888888888888654
Q ss_pred cccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcC
Q 043932 535 PVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEV 606 (1017)
Q Consensus 535 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 606 (1017)
+ +..+++|+.|+|++|++++..+ +..+++|++|+|++|++++..| +..+++|+.|++++|++++.+
T Consensus 168 ~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 168 P--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp G--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred h--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence 4 8888888888888888886544 7888888888888888886553 788888888888888887643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=3.9e-22 Score=218.57 Aligned_cols=196 Identities=24% Similarity=0.319 Sum_probs=128.5
Q ss_pred cCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCcc
Q 043932 97 VGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQ 176 (1017)
Q Consensus 97 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 176 (1017)
+.++++|++|++++|.++ .+| .+..+++|++|+|++|.+++. +. +..+++|++|+|++|++++. | .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKNV-S-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence 345666777777777776 344 566777777777777777643 33 67777777777777777643 2 566777777
Q ss_pred EEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCcc
Q 043932 177 TLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNR 256 (1017)
Q Consensus 177 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 256 (1017)
+|++++|++++. + .+.++++|++|++++|.+++..+ ++.+++|++|++++|++++..+ +..+++|++|+|++|+
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence 777777777653 2 26677777777777777765433 6667777777777777764333 6667777777777777
Q ss_pred CccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccce
Q 043932 257 FSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGK 309 (1017)
Q Consensus 257 l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 309 (1017)
+++ ++. +..+++|++|+|++|++++.. .+..+++|+.|++++|++++.
T Consensus 185 l~~-~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 185 ISD-ISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp CCC-CGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECC
T ss_pred cCc-Chh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecC
Confidence 763 332 456667777777777776443 266667777777777776643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.4e-22 Score=221.97 Aligned_cols=214 Identities=16% Similarity=0.088 Sum_probs=125.9
Q ss_pred CceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCC-
Q 043932 65 CQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPT- 143 (1017)
Q Consensus 65 c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~- 143 (1017)
|+|+.|.|++ ++++.+ |..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|.
T Consensus 9 C~~~~v~C~~------------~~Lt~i-P~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~ 73 (350)
T 4ay9_X 9 CSNRVFLCQE------------SKVTEI-PSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73 (350)
T ss_dssp EETTEEEEES------------TTCCSC-CTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred eeCCEEEecC------------CCCCcc-CcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence 7788888843 445433 3333 25677888888888743334577777777777777777655553
Q ss_pred cccCCCcceE-eecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEec-CCCCCCCCccccccc
Q 043932 144 NLSRCSNLIQ-LRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITG-NSLGGKIPTTLGLLR 221 (1017)
Q Consensus 144 ~l~~l~~L~~-L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~l~~l~ 221 (1017)
.|.++++|++ ++++.|+++...|..|.++++|++|++++|++++..+..+....++..|++.+ |.+....+..|..+.
T Consensus 74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~ 153 (350)
T 4ay9_X 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153 (350)
T ss_dssp SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence 4566766554 55566777766666677777777777777777765555566666666666654 345444444455443
Q ss_pred -CcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCC
Q 043932 222 -NLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNAS 294 (1017)
Q Consensus 222 -~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 294 (1017)
.++.|+|++|+|+. +|.......+|++|++++|...+.+|.+.|.++++|++|+|++|+|+...+..+.++.
T Consensus 154 ~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~ 226 (350)
T 4ay9_X 154 FESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLK 226 (350)
T ss_dssp SSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCC
T ss_pred hhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccch
Confidence 45666666666663 3333333445666666543222255555555556666666666665533333333333
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-22 Score=216.31 Aligned_cols=162 Identities=19% Similarity=0.168 Sum_probs=126.1
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc------------------chHHHHHHHHHHHHhcCC
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------------------GAFKSFMAECKALRNIRH 761 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 761 (1017)
+......|.+.+.||+|+||.||+|++ .+|+.||+|+++.... .....+.+|++++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 334445677779999999999999999 7899999999864321 12456889999999999
Q ss_pred CCceeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeec
Q 043932 762 RNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGD 841 (1017)
Q Consensus 762 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 841 (1017)
| +++.+++.. +..++||||+++|+|.+ +.. .+...++.|++.||+|||+. +|+|||
T Consensus 163 -~-~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~---giiHrD 218 (282)
T 1zar_A 163 -G-LAVPKVYAW------EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHR---GIVHGD 218 (282)
T ss_dssp -T-SSSCCEEEE------ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred -C-CCcCeEEec------cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHC---CCEeCC
Confidence 4 566655432 34699999999999988 421 12346999999999999999 999999
Q ss_pred CCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccC----------CCcCccccchh
Q 043932 842 LKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG----------SEASMTGDVYS 909 (1017)
Q Consensus 842 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvws 909 (1017)
|||+||+++ ++.+||+|||+|+. +..|+|||++.+ ..+...+|+|.
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~~---------------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSVE---------------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCEE---------------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCeE---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999 99999999999862 445789998754 23455566654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-23 Score=231.40 Aligned_cols=222 Identities=21% Similarity=0.283 Sum_probs=152.6
Q ss_pred cccccCCCCcccccCCCcccCC--CcceEeecccccccccCcccccccCCccEEEeccccccCC-CCccccCCCcccEEE
Q 043932 127 LEKLALPNNSFSGTIPTNLSRC--SNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGR-LPDFVGNLSALEVFS 203 (1017)
Q Consensus 127 L~~L~L~~n~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~ 203 (1017)
++.|++++|.+. |..+..+ +++++|++++|.+++..+. +..+++|++|++++|.+++. +|..+.++++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 455555555554 2334444 6677777777777765554 55678888888888887755 677777888888888
Q ss_pred EecCCCCCCCCcccccccCcceeEeecC-ccccc-cchhhcccCcCcEEeCCCc-cCccccCchhhccCC-ccceeeecc
Q 043932 204 ITGNSLGGKIPTTLGLLRNLVDLHVGGN-QFSGT-FPQSICNISSLERIYLPFN-RFSGTLPFDIVVNLP-NLKSLAIGG 279 (1017)
Q Consensus 204 L~~N~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~l~~~~~~~l~-~L~~L~L~~ 279 (1017)
|++|.+++..+..++.+++|++|++++| .+++. ++..+..+++|++|++++| .+++.-....+..++ +|++|+|++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 8888877777777778888888888888 57653 5666777888888888888 776432234456677 888888888
Q ss_pred c--ccC-CCCCCccccCCccceeecccCc-ccceeeccccccCccceEecccCc-CCCCCCCChhhHhhhcccCcccEEe
Q 043932 280 N--NFF-GSIPDSLSNASNVEILDLGFNQ-FKGKVSIDFSSLKNLSWLNLEQNN-LGMGTANDLDFVTFLTNCSSLKILS 354 (1017)
Q Consensus 280 n--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~l~~l~~L~~L~ 354 (1017)
| .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|++|++++|. +.. .....+.++++|+.|+
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~------~~~~~l~~~~~L~~L~ 278 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP------ETLLELGEIPTLKTLQ 278 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG------GGGGGGGGCTTCCEEE
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCH------HHHHHHhcCCCCCEEe
Confidence 7 444 3456666777788888888887 666666677777777777777774 211 1112355667777777
Q ss_pred ccCc
Q 043932 355 LAAN 358 (1017)
Q Consensus 355 Ls~N 358 (1017)
+++|
T Consensus 279 l~~~ 282 (336)
T 2ast_B 279 VFGI 282 (336)
T ss_dssp CTTS
T ss_pred ccCc
Confidence 7766
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.5e-22 Score=202.55 Aligned_cols=181 Identities=19% Similarity=0.217 Sum_probs=140.4
Q ss_pred CCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCC
Q 043932 63 NLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIP 142 (1017)
Q Consensus 63 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 142 (1017)
..|.|.+|.|+. ++++.. |..+ .++|++|+|++|++++..+..|+++++|++|+|++|++++..+
T Consensus 5 C~C~~~~v~c~~------------~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (208)
T 2o6s_A 5 CSCSGTTVECYS------------QGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPN 69 (208)
T ss_dssp CEEETTEEECCS------------SCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CEECCCEEEecC------------CCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccCh
Confidence 458999999964 233332 2222 3578888888888886666667888888888888888886656
Q ss_pred CcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccC
Q 043932 143 TNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRN 222 (1017)
Q Consensus 143 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 222 (1017)
..|.++++|++|+|++|++++..+..|.++++|++|++++|++++..+..|.++++|+.|++++|.+++..+..+..+++
T Consensus 70 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 149 (208)
T 2o6s_A 70 GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149 (208)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred hhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCC
Confidence 66788888888888888888666667788888888888888888777777888888888888888888777777888888
Q ss_pred cceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchh
Q 043932 223 LVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDI 265 (1017)
Q Consensus 223 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~ 265 (1017)
|++|++++|.+.+ .+++|++|+++.|+++|.+|..+
T Consensus 150 L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~ 185 (208)
T 2o6s_A 150 LQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSA 185 (208)
T ss_dssp CCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTT
T ss_pred ccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccC
Confidence 8888888887764 35678888888888888888654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-21 Score=197.13 Aligned_cols=181 Identities=20% Similarity=0.220 Sum_probs=153.9
Q ss_pred CEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccc
Q 043932 104 RYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKN 183 (1017)
Q Consensus 104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 183 (1017)
+.+++++++++ .+|..+ .++|++|+|++|++++..+..++++++|++|+|++|++++..+..|.++++|++|++++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 57888888888 667655 458999999999999766677889999999999999999776777889999999999999
Q ss_pred cccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCc
Q 043932 184 YLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPF 263 (1017)
Q Consensus 184 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~ 263 (1017)
++++..+..|+++++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|+|++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 9997777778999999999999999988777778899999999999999987777778889999999999998764
Q ss_pred hhhccCCccceeeecccccCCCCCCccccCCc
Q 043932 264 DIVVNLPNLKSLAIGGNNFFGSIPDSLSNASN 295 (1017)
Q Consensus 264 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 295 (1017)
.+++|+.|+++.|+++|.+|..++.++.
T Consensus 163 ----~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ----TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 3457888888889998888888876654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.4e-22 Score=242.99 Aligned_cols=219 Identities=23% Similarity=0.237 Sum_probs=96.5
Q ss_pred CCCHHHHHHHHHHHHhcC-CCCCCCCCCC-CCCCCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEcc
Q 043932 32 QTNETDRLALLAIKSQLH-DTSGVTSSWN-NTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLS 109 (1017)
Q Consensus 32 ~~~~~~~~aLl~~k~~~~-~~~~~~~sw~-~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~ 109 (1017)
+....++++|+++..+.. +....-.+|. .++.++.|.+++++. .+++.|+|.++.+.... .. .|+.++|+
T Consensus 128 s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~-~~-----~l~~l~Ls 199 (727)
T 4b8c_D 128 SLVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEAN-QA-----LLQHKKLS 199 (727)
T ss_dssp ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred hccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcch-hh-----HhhcCccC
Confidence 456788999999998874 3333345674 345567899999854 67999999999988742 22 24445555
Q ss_pred CCCCCC---------CCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEe
Q 043932 110 DNSFHG---------EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAV 180 (1017)
Q Consensus 110 ~n~l~~---------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 180 (1017)
.|.|.+ ..|..+..+..|++|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|+++++|++|+|
T Consensus 200 ~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 277 (727)
T 4b8c_D 200 QYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDL 277 (727)
T ss_dssp ----------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEEC
T ss_pred cccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeC
Confidence 554442 34555666666666666666666 56666666666666666666666 56666666666666666
Q ss_pred ccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCc-CcEEeCCCccCcc
Q 043932 181 GKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISS-LERIYLPFNRFSG 259 (1017)
Q Consensus 181 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~ 259 (1017)
++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..|+|++|.++|
T Consensus 278 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~ 355 (727)
T 4b8c_D 278 SHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI 355 (727)
T ss_dssp TTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred cCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence 666666 55666666666666666666664 45555666666666666666666655555544321 1224455555554
Q ss_pred ccC
Q 043932 260 TLP 262 (1017)
Q Consensus 260 ~l~ 262 (1017)
.+|
T Consensus 356 ~~p 358 (727)
T 4b8c_D 356 PLP 358 (727)
T ss_dssp CCC
T ss_pred cCc
Confidence 444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=9.3e-21 Score=222.46 Aligned_cols=187 Identities=22% Similarity=0.321 Sum_probs=140.2
Q ss_pred CCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEec
Q 043932 102 FLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVG 181 (1017)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 181 (1017)
+|++|+|++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|++++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78888888888885 777663 77888888888888 677 457888888888888886 666 665 88888888
Q ss_pred cccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCcccc
Q 043932 182 KNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTL 261 (1017)
Q Consensus 182 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l 261 (1017)
+|++++ +|. .+++|+.|+|++|.+++ +|. .+++|++|+|++|+|++ +|. |. ++|++|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 888886 555 57888888888888876 554 56788888888888875 565 55 78888888888887 66
Q ss_pred CchhhccCCcc-------ceeeecccccCCCCCCccccCCccceeecccCcccceeecccccc
Q 043932 262 PFDIVVNLPNL-------KSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSL 317 (1017)
Q Consensus 262 ~~~~~~~l~~L-------~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 317 (1017)
|. +. . +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..|..+
T Consensus 196 p~-~~-~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 196 PA-VP-V--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp CC-CC-----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred hh-HH-H--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 65 32 2 55 77788888777 567777777777777777777777666655543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.3e-21 Score=197.24 Aligned_cols=137 Identities=21% Similarity=0.197 Sum_probs=87.6
Q ss_pred cceeeccCcccCCCCc-cccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEc
Q 043932 447 LAKLVMSYNSLQGNIP-SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLII 525 (1017)
Q Consensus 447 L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 525 (1017)
+++|+|++|+|++..| ..|.++++|+.|++++|+++ +..+..|..+++|++|+|
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-------------------------~i~~~~~~~l~~L~~L~L 88 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-------------------------DIEEGAFEGASGVNEILL 88 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC-------------------------EECTTTTTTCTTCCEEEC
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC-------------------------EECHHHhCCCCCCCEEEC
Confidence 3455555555554322 23455555555555555554 223345566666777777
Q ss_pred cCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCc
Q 043932 526 SSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGE 605 (1017)
Q Consensus 526 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 605 (1017)
++|++++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++.
T Consensus 89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 77777766666677777777777777777766677777777777777777777766677777777777777777777766
Q ss_pred CCC
Q 043932 606 VPT 608 (1017)
Q Consensus 606 ~~~ 608 (1017)
++.
T Consensus 169 c~l 171 (220)
T 2v70_A 169 CYL 171 (220)
T ss_dssp GGG
T ss_pred Cch
Confidence 553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.9e-20 Score=193.17 Aligned_cols=163 Identities=21% Similarity=0.243 Sum_probs=113.6
Q ss_pred CCCCCCCCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCc
Q 043932 57 SWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136 (1017)
Q Consensus 57 sw~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 136 (1017)
-|....+.|+|.+|.|+. ++++.. |..+. ++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 11 ~~~~~~~~Cs~~~v~c~~------------~~l~~i-p~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~ 75 (229)
T 3e6j_A 11 AACPSQCSCSGTTVDCRS------------KRHASV-PAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ 75 (229)
T ss_dssp CCCCTTCEEETTEEECTT------------SCCSSC-CSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccCCCCCEEeCCEeEccC------------CCcCcc-CCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCC
Confidence 344556899999999953 334332 33332 778888888888887778888888888888888888
Q ss_pred ccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcc
Q 043932 137 FSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTT 216 (1017)
Q Consensus 137 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 216 (1017)
|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+.++++|+.|+|++|++++..+..
T Consensus 76 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~ 154 (229)
T 3e6j_A 76 LGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA 154 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTT
T ss_pred CCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHH
Confidence 87555556677888888888888877666666777777777777777777 55666666666666666666666555555
Q ss_pred cccccCcceeEeecCcccc
Q 043932 217 LGLLRNLVDLHVGGNQFSG 235 (1017)
Q Consensus 217 l~~l~~L~~L~L~~n~l~~ 235 (1017)
|..+++|+.|+|++|.+..
T Consensus 155 ~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 155 FDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp TTTCTTCCEEECTTSCBCT
T ss_pred HhCCCCCCEEEeeCCCccC
Confidence 5566666666666665553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-20 Score=195.08 Aligned_cols=96 Identities=16% Similarity=0.250 Sum_probs=52.1
Q ss_pred cccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccC
Q 043932 511 PLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLS 590 (1017)
Q Consensus 511 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 590 (1017)
|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..++
T Consensus 73 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 152 (220)
T 2v9t_B 73 PDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152 (220)
T ss_dssp TTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred HHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCC
Confidence 34444555555555555555544444455555555555555555555555555555555555555555555555555555
Q ss_pred CCcEEEcccCCCcCcC
Q 043932 591 FLEFLNFSHNDLEGEV 606 (1017)
Q Consensus 591 ~L~~L~l~~N~l~~~~ 606 (1017)
+|+.|+|++|++.+..
T Consensus 153 ~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 153 AIQTMHLAQNPFICDC 168 (220)
T ss_dssp TCCEEECCSSCEECSG
T ss_pred CCCEEEeCCCCcCCCC
Confidence 5555555555555443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3e-22 Score=236.79 Aligned_cols=222 Identities=18% Similarity=0.159 Sum_probs=143.3
Q ss_pred ceeeEEECCCCCeEEEEEcCCCCCcc-------------------------ccCc---ccCCCCCCCEEEccCCCCCCCC
Q 043932 66 QWTGVTCGHRHQRVTRLDLSNQRIGG-------------------------ILSP---YVGNLSFLRYINLSDNSFHGEI 117 (1017)
Q Consensus 66 ~w~gv~c~~~~~~v~~l~l~~~~l~~-------------------------~~~~---~l~~l~~L~~L~L~~n~l~~~~ 117 (1017)
.|+++.|.....+|-.+++..-.+.- .... .+..+++|+.|+|++|.++ .+
T Consensus 286 ~W~~~~~~~~~~~vw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~L~~L~Ls~n~L~-~L 364 (567)
T 1dce_A 286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364 (567)
T ss_dssp CCBCTTSSCCSEEEEEEECCGGGTSTTSSEEEEEEEETTTTEEEEEEEETTCSEEEEECCSTTTTSSSCCCCHHHHH-HH
T ss_pred eeccCCcccccceeEEeecCccccccccccceEEEeeccCCCCccccccCCCchhhhcccccCccceeccCChhhHH-hh
Confidence 57777776666677777776543321 0001 1356777777777777776 67
Q ss_pred CcccccccccccccCCCCc-------------ccccCCCcccCCCcceEee-cccccccccCcccccccCCccEEEeccc
Q 043932 118 PQEIGNLLRLEKLALPNNS-------------FSGTIPTNLSRCSNLIQLR-VSNNKLEGQIPAEIGSLLKLQTLAVGKN 183 (1017)
Q Consensus 118 p~~~~~l~~L~~L~L~~n~-------------l~~~~p~~l~~l~~L~~L~-L~~n~l~~~~p~~~~~l~~L~~L~L~~n 183 (1017)
|.+++++++|++|++++|. +.+.+|..++++++|+.|+ ++.|.+. +|+.+.+++|
T Consensus 365 p~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-----------~L~~l~l~~n 433 (567)
T 1dce_A 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-----------DLRSKFLLEN 433 (567)
T ss_dssp HHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-----------HHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-----------hhhhhhhhcc
Confidence 7777777777777776664 3444555555555555555 4444332 2333444455
Q ss_pred cccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCc
Q 043932 184 YLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPF 263 (1017)
Q Consensus 184 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~ 263 (1017)
.++...+ ..|+.|+|++|.+++ +|. |+.+++|+.|+|++|+|+ .+|..++.+++|++|+|++|++++ +|
T Consensus 434 ~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp- 502 (567)
T 1dce_A 434 SVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD- 502 (567)
T ss_dssp HHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-
T ss_pred cccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-
Confidence 5543211 246777777777765 454 777777777777777777 667777777777777777777773 55
Q ss_pred hhhccCCccceeeecccccCCCC-CCccccCCccceeecccCcccceee
Q 043932 264 DIVVNLPNLKSLAIGGNNFFGSI-PDSLSNASNVEILDLGFNQFKGKVS 311 (1017)
Q Consensus 264 ~~~~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~~ 311 (1017)
.+..+++|+.|+|++|++++.. |..++.+++|+.|+|++|++++.++
T Consensus 503 -~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp -GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred -ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 4566777777777777777665 7777777777777777777776544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=196.52 Aligned_cols=173 Identities=23% Similarity=0.359 Sum_probs=124.1
Q ss_pred ccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCc
Q 043932 393 IRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLI 472 (1017)
Q Consensus 393 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~ 472 (1017)
+..+++|+.|++++|.+... + .+..+++|++|+|++|++++..+ +.++++|++|++++|++++ +| .+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 34566677777777777644 2 36667777777777777775433 6777777777777777764 33 366777777
Q ss_pred eeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCC
Q 043932 473 GFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSN 552 (1017)
Q Consensus 473 ~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 552 (1017)
.|++++|++++ + ..+..+++|+.|+|++|++++. ..++.+++|+.|+|++|
T Consensus 116 ~L~L~~n~i~~--------------------------~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N 166 (291)
T 1h6t_A 116 SLSLEHNGISD--------------------------I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN 166 (291)
T ss_dssp EEECTTSCCCC--------------------------C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred EEECCCCcCCC--------------------------C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCC
Confidence 77777776651 1 2456677888888888888765 56788888888888888
Q ss_pred ccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcC
Q 043932 553 SFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEG 604 (1017)
Q Consensus 553 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 604 (1017)
++++..| +..+++|+.|+|++|++++ +|. +..+++|+.|++++|+++.
T Consensus 167 ~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 167 QISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEEEEC
T ss_pred ccccchh--hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCcccC
Confidence 8887655 7888888888888888885 443 7788888888888888876
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-21 Score=230.90 Aligned_cols=192 Identities=19% Similarity=0.147 Sum_probs=154.9
Q ss_pred cccccccEEeccccCCCCCcchhhcccccccceeccccc-------------cccccCcccccccccceee-ccCcccCC
Q 043932 394 RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNV-------------LQGSIPSGVGNLTKLAKLV-MSYNSLQG 459 (1017)
Q Consensus 394 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~i~~ 459 (1017)
..+++|+.|+|++|+|+ .+|+.++.+++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 55778888888888887 678888888888888887765 4556666777777777777 6666542
Q ss_pred CCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCccccccccccc
Q 043932 460 NIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLS 539 (1017)
Q Consensus 460 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 539 (1017)
+|..+.+++|.++. +|.. .++.|+|++|.|++ +|. ++.+++|+.|+|++|+|+ .+|..|+
T Consensus 424 ----------~L~~l~l~~n~i~~-l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLK-MEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp ----------HHHHHHHHHHHHHH-HHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred ----------hhhhhhhhcccccc-cCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 45556666676662 2211 13569999999986 676 999999999999999999 7788999
Q ss_pred ccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCC-hhhhcccCCCcEEEcccCCCcCcCCCC
Q 043932 540 TCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQI-PEFLENLSFLEFLNFSHNDLEGEVPTK 609 (1017)
Q Consensus 540 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~ 609 (1017)
++++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.+ |..+..+++|+.|+|++|++++.+|..
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 99999999999999997 56 8999999999999999999887 999999999999999999999988764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.9e-20 Score=205.68 Aligned_cols=177 Identities=23% Similarity=0.177 Sum_probs=97.3
Q ss_pred cEEeccccCCCCCcchhhcccccccceeccccccccccCcccc-cccccceeeccCcccCCCCccccccccCCceeecCC
Q 043932 400 IALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVG-NLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASH 478 (1017)
Q Consensus 400 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~ 478 (1017)
+.+++++|+++. +|..+. +.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 355556665553 333322 2355566666666655555554 566666666666666655555555666666655555
Q ss_pred CcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCC
Q 043932 479 NKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVI 558 (1017)
Q Consensus 479 N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 558 (1017)
|+|+ +..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..
T Consensus 98 N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 152 (361)
T 2xot_A 98 NHLH-------------------------TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152 (361)
T ss_dssp SCCC-------------------------EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred CcCC-------------------------cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence 5554 122334555566666666666666555666666666666666666666544
Q ss_pred Cccc---cccccCcEEeccCCcccCCChhhhcccCCC--cEEEcccCCCcC
Q 043932 559 PHSL---GFLKSIKVLNFSSNNLSGQIPEFLENLSFL--EFLNFSHNDLEG 604 (1017)
Q Consensus 559 p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~l~~N~l~~ 604 (1017)
+..| ..+++|+.|||++|+|++..+..+..++.+ +.|+|++|++.+
T Consensus 153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 4444 446666666666666665555555555442 444444444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=196.68 Aligned_cols=149 Identities=26% Similarity=0.365 Sum_probs=76.3
Q ss_pred CCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccE
Q 043932 98 GNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQT 177 (1017)
Q Consensus 98 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 177 (1017)
..+++|++|++++|.+++ +| .+..+++|++|+|++|++++..| +.++++|++|+|++|++++ +| .+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 345556666666665552 22 35555566666666665553322 5555566666666665553 22 2555555555
Q ss_pred EEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccC
Q 043932 178 LAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRF 257 (1017)
Q Consensus 178 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 257 (1017)
|++++|++++. +.+..+++|+.|++++|++++. ..++.+++|++|++++|++++..+ +..+++|++|+|++|.+
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 55555555532 3345555555555555555432 344445555555555555543322 44444444444444444
Q ss_pred c
Q 043932 258 S 258 (1017)
Q Consensus 258 ~ 258 (1017)
+
T Consensus 191 ~ 191 (291)
T 1h6t_A 191 S 191 (291)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.7e-19 Score=212.68 Aligned_cols=198 Identities=21% Similarity=0.302 Sum_probs=136.6
Q ss_pred CCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEecc
Q 043932 103 LRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGK 182 (1017)
Q Consensus 103 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 182 (1017)
+..++|+.+.+++.++ +..|.+|+.|+|++|.++ .+| .+..+++|++|+|++|++++..| +..+++|++|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 4445566666664333 466777777777777776 344 47777777777777777775544 77777777777777
Q ss_pred ccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccC
Q 043932 183 NYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLP 262 (1017)
Q Consensus 183 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~ 262 (1017)
|.+++ + ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++..|
T Consensus 97 N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 97 NKIKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SCCCC-C-TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCC-C-hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 77774 2 3577777777777777777652 4577777777777777777754 567777777777777777775444
Q ss_pred chhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeecccccc
Q 043932 263 FDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSL 317 (1017)
Q Consensus 263 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 317 (1017)
+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++.+.....+..+
T Consensus 171 ---l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l 220 (605)
T 1m9s_A 171 ---LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNL 220 (605)
T ss_dssp ---GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred ---hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccE
Confidence 56677777777777777753 357777778888888877776544444333
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=186.00 Aligned_cols=151 Identities=23% Similarity=0.287 Sum_probs=92.4
Q ss_pred EEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCC-cccccccccccccCCCCcccccCCCcccCCCcceEeecccc
Q 043932 81 RLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIP-QEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNN 159 (1017)
Q Consensus 81 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 159 (1017)
.+++++|.++.+ |..+. +.+++|+|++|.|++..| ..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~i-P~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNKI-PEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSSC-CSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcccC-ccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 345556666653 33332 345777777777775544 34666777777777777777655556667777777777777
Q ss_pred cccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccc
Q 043932 160 KLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFS 234 (1017)
Q Consensus 160 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 234 (1017)
++++..|..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|++|+|++|.++
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 766666666666666666666666666655666666666665555555555555555555555555555555544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=213.24 Aligned_cols=166 Identities=21% Similarity=0.311 Sum_probs=80.2
Q ss_pred EEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeeccc
Q 043932 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158 (1017)
Q Consensus 79 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 158 (1017)
++.|++++|.+... +.+..+++|++|+|++|.+++..| +..+++|++|+|++|.+++ +| .+..+++|++|+|++
T Consensus 45 L~~L~l~~n~i~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~ 118 (605)
T 1m9s_A 45 IDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEH 118 (605)
T ss_dssp CCCCBCTTCCCCCC--TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTT
T ss_pred CCEEECcCCCCCCC--hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecC
Confidence 44455555555443 234555555555555555553322 4555555555555555542 22 345555555555555
Q ss_pred ccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccc
Q 043932 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFP 238 (1017)
Q Consensus 159 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p 238 (1017)
|++++. ..+..+++|+.|+|++|.+++. ..++.+++|+.|+|++|.+++..| +..+++|+.|+|++|+|++.
T Consensus 119 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-- 190 (605)
T 1m9s_A 119 NGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-- 190 (605)
T ss_dssp SCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--
T ss_pred CCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--
Confidence 555432 2344555555555555555433 344455555555555555544333 44455555555555555432
Q ss_pred hhhcccCcCcEEeCCCccCc
Q 043932 239 QSICNISSLERIYLPFNRFS 258 (1017)
Q Consensus 239 ~~l~~l~~L~~L~Ls~N~l~ 258 (1017)
..+..+++|+.|+|++|++.
T Consensus 191 ~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 191 RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp GGGTTCTTCSEEECCSEEEE
T ss_pred hHHccCCCCCEEEccCCcCc
Confidence 23444455555555555444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.4e-19 Score=183.90 Aligned_cols=137 Identities=20% Similarity=0.191 Sum_probs=81.7
Q ss_pred cccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEE
Q 043932 445 TKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLI 524 (1017)
Q Consensus 445 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 524 (1017)
++|++|+|++|+|++..|..|.++++|+.|+|++|+++ +..+..|..+++|+.|+
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~i~~~~~~~l~~L~~L~ 94 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-------------------------ALPVGVFDSLTQLTVLD 94 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CCCTTTTTTCTTCCEEE
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-------------------------CcChhhcccCCCcCEEE
Confidence 45555555555555555555555555555555555554 11223345556666666
Q ss_pred ccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcC
Q 043932 525 ISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEG 604 (1017)
Q Consensus 525 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 604 (1017)
|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|+.|++++|++.+
T Consensus 95 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 6666666555555666666666666666666 455566666666666666666665555556666666666666666665
Q ss_pred cCC
Q 043932 605 EVP 607 (1017)
Q Consensus 605 ~~~ 607 (1017)
.++
T Consensus 174 ~c~ 176 (229)
T 3e6j_A 174 ECR 176 (229)
T ss_dssp TBG
T ss_pred Ccc
Confidence 554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.3e-19 Score=183.91 Aligned_cols=155 Identities=23% Similarity=0.297 Sum_probs=89.7
Q ss_pred CceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCc
Q 043932 65 CQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTN 144 (1017)
Q Consensus 65 c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 144 (1017)
|.|..|.|. +++++.+ |..+. ++|++|+|++|.|++..+..|..+++|++|+|++|++++..|..
T Consensus 11 C~~~~v~c~------------~~~l~~i-P~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~ 75 (220)
T 2v9t_B 11 CSNNIVDCR------------GKGLTEI-PTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA 75 (220)
T ss_dssp EETTEEECT------------TSCCSSC-CSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTT
T ss_pred ECCCEEEcC------------CCCcCcC-CCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHH
Confidence 667666663 3445443 33332 56777777777776555556666666666666666666555666
Q ss_pred ccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcc
Q 043932 145 LSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLV 224 (1017)
Q Consensus 145 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 224 (1017)
|.++++|++|+|++|+++...+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+
T Consensus 76 ~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 155 (220)
T 2v9t_B 76 FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155 (220)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred hhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCC
Confidence 66666666666666666644444455566666666666666655555555555555555555555544444444444455
Q ss_pred eeEeecCccc
Q 043932 225 DLHVGGNQFS 234 (1017)
Q Consensus 225 ~L~L~~n~l~ 234 (1017)
+|+|++|.+.
T Consensus 156 ~L~L~~N~~~ 165 (220)
T 2v9t_B 156 TMHLAQNPFI 165 (220)
T ss_dssp EEECCSSCEE
T ss_pred EEEeCCCCcC
Confidence 5544444443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.5e-19 Score=201.12 Aligned_cols=150 Identities=19% Similarity=0.194 Sum_probs=85.5
Q ss_pred EEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccc-cccccccccCCCCcccccCCCcccCCCcceEeeccccc
Q 043932 82 LDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIG-NLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNK 160 (1017)
Q Consensus 82 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 160 (1017)
+++++++++.. |..+. +.+++|+|++|+|++..+..+. ++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 23 l~c~~~~l~~i-P~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 99 (361)
T 2xot_A 23 LSCSKQQLPNV-PQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99 (361)
T ss_dssp EECCSSCCSSC-CSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEeCCCCcCcc-CccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCc
Confidence 44555666553 33332 3466777777777655555555 66666666666666665555566666666666666666
Q ss_pred ccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCccc---ccccCcceeEeecCccc
Q 043932 161 LEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTL---GLLRNLVDLHVGGNQFS 234 (1017)
Q Consensus 161 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l---~~l~~L~~L~L~~n~l~ 234 (1017)
+++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..| ..+++|++|+|++|+|+
T Consensus 100 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 665555556666666666666666665555555555555555555555554333333 23444444444444444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-19 Score=191.94 Aligned_cols=172 Identities=23% Similarity=0.350 Sum_probs=132.7
Q ss_pred ccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCcee
Q 043932 395 NLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGF 474 (1017)
Q Consensus 395 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 474 (1017)
.+.++..+++++|.+++.. .+..+++|+.|++++|.++ .+| .+..+++|++|+|++|+|++..+ +.++++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 5667788888888887544 5778888888888888888 455 68888889999999999886544 8888888888
Q ss_pred ecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCcc
Q 043932 475 NASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSF 554 (1017)
Q Consensus 475 ~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 554 (1017)
++++|++++ + |. +.. ++|+.|+|++|++++. + .+..+++|+.|+|++|++
T Consensus 91 ~L~~N~l~~-l-------------------------~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i 140 (263)
T 1xeu_A 91 SVNRNRLKN-L-------------------------NG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKL 140 (263)
T ss_dssp ECCSSCCSC-C-------------------------TT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCC
T ss_pred ECCCCccCC-c-------------------------Cc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcC
Confidence 888888872 2 11 112 6788888888888754 3 578888888888888888
Q ss_pred CCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcC
Q 043932 555 HGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEV 606 (1017)
Q Consensus 555 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 606 (1017)
++. | .++.+++|+.|+|++|++++. ..+..+++|+.|++++|++++.+
T Consensus 141 ~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 141 KSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp CBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred CCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence 865 3 578888888888888888865 56778888888888888887653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-19 Score=219.67 Aligned_cols=189 Identities=24% Similarity=0.279 Sum_probs=103.5
Q ss_pred ecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCC
Q 043932 380 IGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQG 459 (1017)
Q Consensus 380 l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~ 459 (1017)
+..|.+. ..+..|..+.+|+.|+|++|++. .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3344444 45666777777777777777777 45555557777777777777777 67777777777777777777777
Q ss_pred CCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCccccccccccc
Q 043932 460 NIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLS 539 (1017)
Q Consensus 460 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 539 (1017)
.+|..|+++++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+.
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~--------------------------~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT--------------------------TLPWEFGNLCNLQFLGVEGNPLEKQFLKILT 337 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC--------------------------CCCSSTTSCTTCCCEECTTSCCCSHHHHHHH
T ss_pred ccChhhcCCCCCCEEECCCCCCC--------------------------ccChhhhcCCCccEEeCCCCccCCCChHHHh
Confidence 56777777777777777777665 4566677888888888888888888887776
Q ss_pred cccc-ceEEeccCCccCCCCCccccccccCcEEeccCC--------cccCCChhhhcccCCCcEEEcccCCCcC
Q 043932 540 TCVS-LEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSN--------NLSGQIPEFLENLSFLEFLNFSHNDLEG 604 (1017)
Q Consensus 540 ~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 604 (1017)
.+.. +..|+|++|.+++.+|.. |+.|++++| .|.+..+..+.++..+....+++|-+.+
T Consensus 338 ~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 338 EKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp HHHHHHHHHHHHHCCCCCCCCCC-----------------------------------------------CCCG
T ss_pred hcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 5432 234788888888877754 445666666 3343444444455555555666665543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=5.4e-19 Score=178.92 Aligned_cols=135 Identities=26% Similarity=0.338 Sum_probs=102.2
Q ss_pred eeccCCCcCCCCccc-cccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCC
Q 043932 498 YLDLSNNNLNGSLPL-QIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSN 576 (1017)
Q Consensus 498 ~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 576 (1017)
+|+|++|++++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 33 ~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 112 (192)
T 1w8a_A 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112 (192)
T ss_dssp EEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS
T ss_pred EEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence 344444444444443 3778888999999999998888888889999999999999999888888888999999999999
Q ss_pred cccCCChhhhcccCCCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCcCC
Q 043932 577 NLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTDE 632 (1017)
Q Consensus 577 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~ 632 (1017)
+|++.+|..+..+++|++|+|++|++++.++.......+....+.++...|+.|..
T Consensus 113 ~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~ 168 (192)
T 1w8a_A 113 QISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred cCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChH
Confidence 99988888888889999999999999887775322222333345566666766543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.6e-18 Score=174.95 Aligned_cols=154 Identities=18% Similarity=0.201 Sum_probs=99.0
Q ss_pred cccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccc
Q 043932 418 GELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSV 497 (1017)
Q Consensus 418 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~ 497 (1017)
..+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|+.|++++|+++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~--------------- 101 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVT--------------- 101 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCB---------------
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccC---------------
Confidence 44556666666666665 344 46666666666666665542 235666666666666666665
Q ss_pred eeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCc-cCCCCCccccccccCcEEeccCC
Q 043932 498 YLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNS-FHGVIPHSLGFLKSIKVLNFSSN 576 (1017)
Q Consensus 498 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N 576 (1017)
+..|..+..+++|++|+|++|++++..|..++.+++|++|+|++|+ ++ .+| .+..+++|+.|+|++|
T Consensus 102 ----------~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 102 ----------SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFD 169 (197)
T ss_dssp ----------GGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTB
T ss_pred ----------cccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCC
Confidence 2334556667777777777777776667777777777777777776 55 344 5777777777777777
Q ss_pred cccCCChhhhcccCCCcEEEcccCCCcC
Q 043932 577 NLSGQIPEFLENLSFLEFLNFSHNDLEG 604 (1017)
Q Consensus 577 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 604 (1017)
++++ ++ .+..+++|+.|++++|++.+
T Consensus 170 ~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 170 GVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 7775 33 56777777777777777653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.5e-18 Score=184.46 Aligned_cols=138 Identities=21% Similarity=0.183 Sum_probs=107.4
Q ss_pred cccccCcccccCCceEEEEEeCCCcEE--EEEEEeeecCcc------------------------hHHHHHHHHHHHHhc
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMI--VAVKVINLKQKG------------------------AFKSFMAECKALRNI 759 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 759 (1017)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+..++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367788999999999999999667888 999997533111 113578899999999
Q ss_pred CCCCc--eeeeeeeecCCCCCCceeEEEEEeccC-C----CHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHh-h
Q 043932 760 RHRNL--IKIITICSSIDSKGADFKALVFECMKN-G----SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH-H 831 (1017)
Q Consensus 760 ~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~ 831 (1017)
.|+++ ..++++ +..++||||+.+ | +|.++... .++.++..++.|++.||.||| +
T Consensus 128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~ 189 (258)
T 1zth_A 128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQE 189 (258)
T ss_dssp HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHH
Confidence 88754 334432 235899999943 3 77776532 123456789999999999999 8
Q ss_pred CCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 832 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
. +|+||||||+|||++. .++|+|||+|...
T Consensus 190 ~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 190 A---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp S---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred C---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 8 9999999999999988 9999999999754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.1e-18 Score=183.93 Aligned_cols=172 Identities=19% Similarity=0.285 Sum_probs=95.1
Q ss_pred cccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEE
Q 043932 123 NLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVF 202 (1017)
Q Consensus 123 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 202 (1017)
.+.++..+++++|.+++ ++ .+..+++|++|++++|+++ .+| .+..+++|++|+|++|++++..+ ++++++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 34455555555555552 22 3455555555555555555 233 45555555555555555554333 5555555555
Q ss_pred EEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeeccccc
Q 043932 203 SITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF 282 (1017)
Q Consensus 203 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l 282 (1017)
+|++|++++. |. +.. ++|++|+|++|++++. ..+..+++|++|+|++|++++ ++ .+..+++|++|+|++|++
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~--~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV--MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG--GGGGCTTCCEEECTTSCC
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch--HHccCCCCCEEECCCCcC
Confidence 5555555542 21 112 5666666666666542 246666666666666666653 33 345566666666666666
Q ss_pred CCCCCCccccCCccceeecccCccccee
Q 043932 283 FGSIPDSLSNASNVEILDLGFNQFKGKV 310 (1017)
Q Consensus 283 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 310 (1017)
++. ..+..+++|+.|++++|++.+..
T Consensus 163 ~~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 163 TNT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp CBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred cch--HHhccCCCCCEEeCCCCcccCCc
Confidence 644 45666666777777777666543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.2e-18 Score=174.28 Aligned_cols=151 Identities=15% Similarity=0.219 Sum_probs=66.8
Q ss_pred ccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEE
Q 043932 124 LLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFS 203 (1017)
Q Consensus 124 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 203 (1017)
+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..++++++|++|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 334444444444443 233 2444444444444444332 112344444444444444444443444444444444444
Q ss_pred EecCCCCCCCCcccccccCcceeEeecCc-cccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeeccccc
Q 043932 204 ITGNSLGGKIPTTLGLLRNLVDLHVGGNQ-FSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF 282 (1017)
Q Consensus 204 L~~N~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l 282 (1017)
+++|.+++..+..++.+++|++|++++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|++|++++|++
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~--~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR--GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT--TGGGCSSCCEEEECBC--
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH--HhccCCCCCEEEeeCccc
Confidence 44444444444444444555555555554 33 223 34555555555555555542 22 234455555555555555
Q ss_pred C
Q 043932 283 F 283 (1017)
Q Consensus 283 ~ 283 (1017)
.
T Consensus 194 ~ 194 (197)
T 4ezg_A 194 G 194 (197)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=9e-18 Score=169.93 Aligned_cols=176 Identities=18% Similarity=0.231 Sum_probs=112.8
Q ss_pred cceeccccccccccCcccccccccceeeccCcccCCCCcc-ccccccCCceeecCCCcccCCccchhhhcccccceeccC
Q 043932 424 QGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPS-SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLS 502 (1017)
Q Consensus 424 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls 502 (1017)
+.+++++|.++ .+|..+.. +|++|++++|+|++..+. .|..+++|+.|++++|+++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~-------------------- 67 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-------------------- 67 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC--------------------
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCC--------------------
Confidence 34555555554 44444332 566666666666644443 3566666666666666655
Q ss_pred CCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCC
Q 043932 503 NNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQI 582 (1017)
Q Consensus 503 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 582 (1017)
+..|..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..|..+++|++|+|++|++++..
T Consensus 68 -----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 68 -----GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp -----CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred -----CcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 345666777788888888888888777777888888888888888888888888888888888888888888776
Q ss_pred hhh-hcccCCCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCcC
Q 043932 583 PEF-LENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 583 p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
+.. +.. .++...+..+...+..|. .+....-..+..+...|..+.
T Consensus 143 ~l~~~~~--~l~~~~~~~~~~~C~~P~--~l~~~~l~~l~~~~~~C~~~~ 188 (192)
T 1w8a_A 143 HLAWFAE--WLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp GGHHHHH--HHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCCC-
T ss_pred cchHHHH--HHHHcCCCCCCCCCCCCh--HHcCCChhhCcHhhcCcCCCC
Confidence 531 211 122223444555544443 233444445666666676554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.6e-17 Score=184.02 Aligned_cols=288 Identities=12% Similarity=0.056 Sum_probs=181.6
Q ss_pred cCCccEEEeccccccCCCCccccC-CCcccEEEEecCCCC--CCCCcccccccCcceeEeecCccccccchhhcc-----
Q 043932 172 LLKLQTLAVGKNYLTGRLPDFVGN-LSALEVFSITGNSLG--GKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICN----- 243 (1017)
Q Consensus 172 l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~----- 243 (1017)
+.+|++|.++++- ....-..+.. +++|+.|+|++|++. ...... ++.+..+.+..|.| .+.+|.+
T Consensus 24 ~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I---~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFV---PAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEE---CTTTTEEEETTE
T ss_pred hCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCcccc---cccccccccccccc---CHHHhccccccc
Confidence 6678888887642 2111122333 677888888888876 111111 22244455555532 2345566
Q ss_pred ---cCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcc----cceeeccccc
Q 043932 244 ---ISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQF----KGKVSIDFSS 316 (1017)
Q Consensus 244 ---l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l----~~~~~~~~~~ 316 (1017)
+++|+.|+|+. .++ .++...|.++++|+.|++++|.+....+.+|....++..+.+..+.. ......+|.+
T Consensus 97 ~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~ 174 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE 174 (329)
T ss_dssp EEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE
T ss_pred ccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccc
Confidence 78888888877 666 67777777778888888887777766667777777777766655322 2233444555
Q ss_pred cCccc-eEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccc
Q 043932 317 LKNLS-WLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRN 395 (1017)
Q Consensus 317 l~~L~-~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~ 395 (1017)
+..|+ .+.+....- .. -.....-....+++.+.+.++- .......+....++|+.+++++|+++.+....|.+
T Consensus 175 ~~~L~~~i~~~~~~~--l~---~~~~~~~~~~~~~~~l~~~~~l-~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~ 248 (329)
T 3sb4_A 175 GEPLETTIQVGAMGK--LE---DEIMKAGLQPRDINFLTIEGKL-DNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQ 248 (329)
T ss_dssp SCCCEEEEEECTTCC--HH---HHHHHTTCCGGGCSEEEEEECC-CHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTT
T ss_pred ccccceeEEecCCCc--HH---HHHhhcccCccccceEEEeeee-cHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhC
Confidence 55555 333332110 00 0000011124455566665542 21222233333567888888888888888888888
Q ss_pred cccccEEeccccCCCCCcchhhccccccc-ceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCcee
Q 043932 396 LVNLIALGMQSNQLHGTIPDVIGELKNLQ-GLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGF 474 (1017)
Q Consensus 396 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 474 (1017)
+.+|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.++++.|+++.+.+.+|.++++|+.+
T Consensus 249 ~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 249 KKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred CCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 888888888887 7767778888888888 888887 6765667788888888888888888887777788888888877
Q ss_pred ec
Q 043932 475 NA 476 (1017)
Q Consensus 475 ~l 476 (1017)
+.
T Consensus 327 y~ 328 (329)
T 3sb4_A 327 YK 328 (329)
T ss_dssp EC
T ss_pred cc
Confidence 53
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-17 Score=168.11 Aligned_cols=108 Identities=26% Similarity=0.335 Sum_probs=82.3
Q ss_pred eccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcc
Q 043932 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578 (1017)
Q Consensus 499 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 578 (1017)
|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|+++.|..|..+++|++|+|++|+|
T Consensus 36 L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l 114 (193)
T 2wfh_A 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI 114 (193)
T ss_dssp EECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCC
Confidence 444444443 4566677778888888888888877777788888888888888888887777888888888888888888
Q ss_pred cCCChhhhcccCCCcEEEcccCCCcCcCC
Q 043932 579 SGQIPEFLENLSFLEFLNFSHNDLEGEVP 607 (1017)
Q Consensus 579 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 607 (1017)
++..+..|..+++|+.|+|++|++.+...
T Consensus 115 ~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 115 SVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 86666677788888888888888877654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-17 Score=182.50 Aligned_cols=222 Identities=10% Similarity=0.058 Sum_probs=142.6
Q ss_pred ccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccc----cCCCCCCccccCCc
Q 043932 220 LRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNN----FFGSIPDSLSNASN 295 (1017)
Q Consensus 220 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~----l~~~~p~~l~~l~~ 295 (1017)
+++|+.|+|.+ .++.+.+.+|.++++|+.|+++.|.+. .++...|.+..++..+.+..+. .......+|.++..
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 55555555555 555444555555555666666555555 4555555555555544444321 12222334555555
Q ss_pred cc-eeecccCc-ccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcc
Q 043932 296 VE-ILDLGFNQ-FKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSS 373 (1017)
Q Consensus 296 L~-~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 373 (1017)
|+ .+++.... +.......-....+++.+.+.++-. ..++......+++|+.++|++|+++ .+|...+....
T Consensus 178 L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~------~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~ 250 (329)
T 3sb4_A 178 LETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLD------NADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKK 250 (329)
T ss_dssp CEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCC------HHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCT
T ss_pred cceeEEecCCCcHHHHHhhcccCccccceEEEeeeec------HHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCC
Confidence 55 34433221 1111111112345566666665421 1122223334788899999988887 56666555556
Q ss_pred cceEEEecCCccccccCcccccccccc-EEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeec
Q 043932 374 SMIEFRIGGNQIFGIIPSGIRNLVNLI-ALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVM 452 (1017)
Q Consensus 374 ~L~~L~l~~N~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 452 (1017)
+|+++++.+| ++.+.+.+|.++.+|+ .+++.+ +++.+.+.+|.++++|+.|++++|.++...+..|.++++|+.++.
T Consensus 251 ~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 251 YLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 7999999888 8888899999999999 999998 788788899999999999999999999777889999999999874
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=161.50 Aligned_cols=130 Identities=25% Similarity=0.354 Sum_probs=115.1
Q ss_pred eeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCc
Q 043932 498 YLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNN 577 (1017)
Q Consensus 498 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 577 (1017)
++++++|.++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+.+|..+++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 3566666665 4565543 58999999999999 678899999999999999999999999999999999999999999
Q ss_pred ccCCChhhhcccCCCcEEEcccCCCcCcCCC-CCCCCCCCcccccCcccccCCcC
Q 043932 578 LSGQIPEFLENLSFLEFLNFSHNDLEGEVPT-KGVFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 578 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
|++..|..|.++++|+.|+|++|++++.++. ...+.+++.+++.+|||.|+|..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 9999999999999999999999999987764 56788999999999999999875
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-16 Score=156.60 Aligned_cols=134 Identities=19% Similarity=0.215 Sum_probs=87.9
Q ss_pred cccceeeccCcccC-CCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEE
Q 043932 445 TKLAKLVMSYNSLQ-GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKL 523 (1017)
Q Consensus 445 ~~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L 523 (1017)
++|++|++++|+++ +.+|..+..+++|+.|++++|+++ +. ..+..+++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-------------------------~~--~~~~~l~~L~~L 76 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-------------------------SV--SNLPKLPKLKKL 76 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-------------------------CC--SSCCCCSSCCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-------------------------Ch--hhhccCCCCCEE
Confidence 45666666666665 455555566666666666666655 11 345566677777
Q ss_pred EccCCcccccccccccccccceEEeccCCccCCCCC-ccccccccCcEEeccCCcccCCCh---hhhcccCCCcEEEccc
Q 043932 524 IISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIP-HSLGFLKSIKVLNFSSNNLSGQIP---EFLENLSFLEFLNFSH 599 (1017)
Q Consensus 524 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~ 599 (1017)
+|++|++++.+|..+..+++|+.|+|++|++++..+ ..+..+++|++|+|++|++++..+ ..+..+++|+.|++++
T Consensus 77 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp EEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred ECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence 777777776666666667777777777777775422 567777777777777777775544 4677777777777777
Q ss_pred CCCcCc
Q 043932 600 NDLEGE 605 (1017)
Q Consensus 600 N~l~~~ 605 (1017)
|.++..
T Consensus 157 n~~~~~ 162 (168)
T 2ell_A 157 REDQEA 162 (168)
T ss_dssp TTSCBC
T ss_pred CChhhc
Confidence 776643
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=158.39 Aligned_cols=133 Identities=20% Similarity=0.161 Sum_probs=72.0
Q ss_pred CCCCEEEccCCCCC-CCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEE
Q 043932 101 SFLRYINLSDNSFH-GEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLA 179 (1017)
Q Consensus 101 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 179 (1017)
++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 45555555556666666666555533 4455555555555555555544555454555555555
Q ss_pred eccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccc---hhhcccCcCcEEeCCCcc
Q 043932 180 VGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFP---QSICNISSLERIYLPFNR 256 (1017)
Q Consensus 180 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p---~~l~~l~~L~~L~Ls~N~ 256 (1017)
+++|.+++.. .+..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.
T Consensus 102 Ls~N~l~~~~-----------------------~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~ 158 (168)
T 2ell_A 102 LSGNKLKDIS-----------------------TLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE 158 (168)
T ss_dssp CBSSSCCSSG-----------------------GGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred ccCCccCcch-----------------------hHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCC
Confidence 5555554321 11444555555555555555553333 355556666666666665
Q ss_pred Cc
Q 043932 257 FS 258 (1017)
Q Consensus 257 l~ 258 (1017)
+.
T Consensus 159 ~~ 160 (168)
T 2ell_A 159 DQ 160 (168)
T ss_dssp SC
T ss_pred hh
Confidence 54
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.6e-16 Score=152.19 Aligned_cols=128 Identities=21% Similarity=0.294 Sum_probs=87.2
Q ss_pred cccceeeccCcccC-CCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEE
Q 043932 445 TKLAKLVMSYNSLQ-GNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKL 523 (1017)
Q Consensus 445 ~~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L 523 (1017)
++|+.|++++|+++ +.+|..+..+++|+.|++++|++++ . ..+..+++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------------~--~~~~~l~~L~~L 69 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-------------------------I--ANLPKLNKLKKL 69 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCC-------------------------C--TTCCCCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCC-------------------------c--hhhhcCCCCCEE
Confidence 55666666666666 5566666666666666666666651 1 345566777777
Q ss_pred EccCCcccccccccccccccceEEeccCCccCCC-CCccccccccCcEEeccCCcccCCCh---hhhcccCCCcEEEccc
Q 043932 524 IISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGV-IPHSLGFLKSIKVLNFSSNNLSGQIP---EFLENLSFLEFLNFSH 599 (1017)
Q Consensus 524 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~ 599 (1017)
+|++|++++.+|..+..+++|+.|++++|++++. .+..++.+++|++|++++|++++..+ ..+..+++|+.||+++
T Consensus 70 ~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 7777777766676667777777777777777763 33667777777777777777776555 4677777777777763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=6.4e-16 Score=154.24 Aligned_cols=111 Identities=21% Similarity=0.258 Sum_probs=88.6
Q ss_pred eeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCc
Q 043932 498 YLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNN 577 (1017)
Q Consensus 498 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 577 (1017)
+|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 32 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 111 (177)
T 2o6r_A 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQ 111 (177)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCc
Confidence 34444444444455567788888999999999887777778888899999999999988877788888899999999999
Q ss_pred ccCCChhhhcccCCCcEEEcccCCCcCcCCC
Q 043932 578 LSGQIPEFLENLSFLEFLNFSHNDLEGEVPT 608 (1017)
Q Consensus 578 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 608 (1017)
+++..+..+..+++|+.|++++|++++.+|.
T Consensus 112 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 112 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 9876666678888899999999988887763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=6.2e-16 Score=154.35 Aligned_cols=135 Identities=19% Similarity=0.247 Sum_probs=92.0
Q ss_pred CCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCC
Q 043932 63 NLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIP 142 (1017)
Q Consensus 63 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 142 (1017)
..|+|++|.|+. ++++.. |..+ .++|++|+|++|++++..+..|+++++|++|+|++|++++..+
T Consensus 5 C~C~~~~l~~~~------------~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (177)
T 2o6r_A 5 CSCSGTEIRCNS------------KGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD 69 (177)
T ss_dssp CEEETTEEECCS------------SCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CEeCCCEEEecC------------CCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence 347898888853 344433 2222 3678888888888886656667777888888888887775555
Q ss_pred CcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCC
Q 043932 143 TNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGK 212 (1017)
Q Consensus 143 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 212 (1017)
..+.++++|++|+|++|++++..+..+..+++|++|++++|++++..+..+.++++|+.|++++|.+.+.
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 5667777777777777777766666667777777777777777755555556666666666666666543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.3e-16 Score=151.43 Aligned_cols=125 Identities=20% Similarity=0.209 Sum_probs=52.3
Q ss_pred ccccccCCCCccc-ccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEE
Q 043932 126 RLEKLALPNNSFS-GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSI 204 (1017)
Q Consensus 126 ~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 204 (1017)
+|++|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++++++|++|++++|.+++.+|..++++++|++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 3444444444443 33444444444444444444444432 33344444444444444444333333333444444444
Q ss_pred ecCCCCCC-CCcccccccCcceeEeecCccccccc---hhhcccCcCcEEeC
Q 043932 205 TGNSLGGK-IPTTLGLLRNLVDLHVGGNQFSGTFP---QSICNISSLERIYL 252 (1017)
Q Consensus 205 ~~N~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~p---~~l~~l~~L~~L~L 252 (1017)
++|.+++. .+..++.+++|++|++++|++++..+ ..+..+++|++|++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 147 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG 147 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence 44444331 12344444444444554454443332 24444444444444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.1e-17 Score=168.34 Aligned_cols=156 Identities=24% Similarity=0.243 Sum_probs=102.4
Q ss_pred hcccccccceeccccccccccCc------ccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhh
Q 043932 417 IGELKNLQGLFLYKNVLQGSIPS------GVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLL 490 (1017)
Q Consensus 417 ~~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 490 (1017)
+....+++.++++.|.+++.+|. .|..+++|++|++++|+|++ +| .+.++++|+.|++++|+++
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-------- 83 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-------- 83 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC--------
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc--------
Confidence 33445555555555555555554 66666777777777777764 45 6666777777777776665
Q ss_pred hcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCC-ccccccccCc
Q 043932 491 SITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIP-HSLGFLKSIK 569 (1017)
Q Consensus 491 ~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~ 569 (1017)
.+|..+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+
T Consensus 84 ------------------~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~ 143 (198)
T 1ds9_A 84 ------------------KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143 (198)
T ss_dssp ------------------SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCS
T ss_pred ------------------cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCC
Confidence 234444555677777777777775 34 57777777777777777775432 4677777888
Q ss_pred EEeccCCcccCCChhh----------hcccCCCcEEEcccCCCcC
Q 043932 570 VLNFSSNNLSGQIPEF----------LENLSFLEFLNFSHNDLEG 604 (1017)
Q Consensus 570 ~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~l~~N~l~~ 604 (1017)
+|++++|++++.+|.. +..+++|+.|| +|.++.
T Consensus 144 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 144 DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp EEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred EEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 8888888877665542 67788888776 566553
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=4.2e-16 Score=170.99 Aligned_cols=136 Identities=14% Similarity=0.164 Sum_probs=98.4
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--------------chHHH--------HHHHHHHHHhcCCCC
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------------GAFKS--------FMAECKALRNIRHRN 763 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~n 763 (1017)
-|++.+.||+|+||.||+|.+. +|+.||||+++.... ..... ..+|...+.++.+..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4899999999999999999986 688999999752210 00011 234566666664433
Q ss_pred c--eeeeeeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeec
Q 043932 764 L--IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGD 841 (1017)
Q Consensus 764 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 841 (1017)
+ ...+++ ...++||||++|++|.++... .....++.|++.+|.|||+. ||||||
T Consensus 175 v~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~---gIVHrD 230 (397)
T 4gyi_A 175 FPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKH---GLIHGD 230 (397)
T ss_dssp CSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCCCeeeec---------cCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence 3 222222 223799999999888654321 12356889999999999999 999999
Q ss_pred CCCCceEeCCCC----------CeEEeeccccccc
Q 043932 842 LKPSNVLLDHDM----------VSHVGDFGLAKFL 866 (1017)
Q Consensus 842 lkp~NIll~~~~----------~~kl~DfG~a~~~ 866 (1017)
|||.|||+++++ .+.|+||+.+...
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999998876 3899999987643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-16 Score=162.38 Aligned_cols=136 Identities=20% Similarity=0.287 Sum_probs=88.6
Q ss_pred cccccccccccCCCCcccccCCC------cccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCcccc
Q 043932 121 IGNLLRLEKLALPNNSFSGTIPT------NLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVG 194 (1017)
Q Consensus 121 ~~~l~~L~~L~L~~n~l~~~~p~------~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 194 (1017)
+.....++.++++.+.++|.+|. .+..+++|++|+|++|++++ +| .+.++++|++|++++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44455666666776666666665 66667777777777777764 45 6666777777777777776 4566666
Q ss_pred CCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccc-hhhcccCcCcEEeCCCccCcccc
Q 043932 195 NLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFP-QSICNISSLERIYLPFNRFSGTL 261 (1017)
Q Consensus 195 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~l 261 (1017)
.+++|+.|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+.+
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 66677777777777764 33 56666777777777777664322 35666666667776666665443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-14 Score=162.18 Aligned_cols=271 Identities=11% Similarity=0.095 Sum_probs=141.6
Q ss_pred cCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceE
Q 043932 244 ISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWL 323 (1017)
Q Consensus 244 l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 323 (1017)
+..++.+.+.. .++ .++...|.+. +|+.+.+..+ ++.....+|.+ .+|+.+.+.. .++.+...+|.++++|+.+
T Consensus 112 ~~~l~~i~ip~-~i~-~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 112 LKGYNEIILPN-SVK-SIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKA 185 (401)
T ss_dssp CSSCSEEECCT-TCC-EECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred cCCccEEEECC-ccC-EehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCee
Confidence 35566666654 333 5555555553 5666666554 44344445555 3466666654 4555555555555555555
Q ss_pred ecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEe
Q 043932 324 NLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALG 403 (1017)
Q Consensus 324 ~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~ 403 (1017)
++.+|++..++... +.. ..|+.+.+.++ ++.+...+|.++.+|+.++
T Consensus 186 ~l~~n~l~~I~~~a-------------------------------F~~-~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~ 232 (401)
T 4fdw_A 186 DLSKTKITKLPAST-------------------------------FVY-AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIE 232 (401)
T ss_dssp ECTTSCCSEECTTT-------------------------------TTT-CCCSEEECCTT-CCEECTTTTTTCTTCCCEE
T ss_pred ecCCCcceEechhh-------------------------------Eee-cccCEEEeCCc-hheehhhHhhCCCCCCEEe
Confidence 55555443332221 111 12333333211 3333444445555555555
Q ss_pred ccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccC
Q 043932 404 MQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTG 483 (1017)
Q Consensus 404 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~ 483 (1017)
+..| ++.+. ..+|.+ .+|+.+.+ .|.++.+.+.+|.+|++|+.+++.+|.+..
T Consensus 233 l~~~-l~~I~------------------------~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~ 285 (401)
T 4fdw_A 233 IPEN-VSTIG------------------------QEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFND 285 (401)
T ss_dssp CCTT-CCEEC------------------------TTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCC
T ss_pred cCCC-ccCcc------------------------cccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccC
Confidence 4432 33233 334444 45555555 233443444556666666666665554430
Q ss_pred CccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCcccc
Q 043932 484 ALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLG 563 (1017)
Q Consensus 484 ~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 563 (1017)
+.+....+..|.++++|+.++|. |.++.+...+|.+|.+|+.++|..| ++.+.+.+|.
T Consensus 286 --------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~ 343 (401)
T 4fdw_A 286 --------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFN 343 (401)
T ss_dssp --------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSS
T ss_pred --------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCC
Confidence 00111223456666777777776 3355555666777777777777444 5555566777
Q ss_pred ccccCcEEeccCCcccCCChhhhcccC-CCcEEEcccCCCc
Q 043932 564 FLKSIKVLNFSSNNLSGQIPEFLENLS-FLEFLNFSHNDLE 603 (1017)
Q Consensus 564 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~ 603 (1017)
++ +|+.+++++|.+....+..|.+++ .++.|++..|.+.
T Consensus 344 ~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 344 NT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 77 777777777766655555666663 5667776665543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.56 E-value=3.4e-14 Score=160.35 Aligned_cols=270 Identities=9% Similarity=0.066 Sum_probs=147.6
Q ss_pred CCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeC
Q 043932 173 LKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYL 252 (1017)
Q Consensus 173 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 252 (1017)
..++.+.+.+ .++.+...+|.++ +|+.+.+.+| ++.....+|.+. +|+.+.+.. .++.+.+.+|.++++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 3444444433 2333334445543 4555555444 433334444442 455555553 444444455555555555555
Q ss_pred CCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCC
Q 043932 253 PFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGM 332 (1017)
Q Consensus 253 s~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 332 (1017)
+.|+++ .++...|. ..+|+.+.|..+ ++.....+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+. +.+..
T Consensus 188 ~~n~l~-~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~ 261 (401)
T 4fdw_A 188 SKTKIT-KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN 261 (401)
T ss_dssp TTSCCS-EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE
T ss_pred CCCcce-EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE
Confidence 555555 45555544 355555555432 44344445555555555555543 44444555555 455555552 22332
Q ss_pred CCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCC
Q 043932 333 GTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGT 412 (1017)
Q Consensus 333 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 412 (1017)
++.. .|.++++|+.+++.+|.+. .+.+..+.+.+|.++++|+.++|. +.++.+
T Consensus 262 I~~~------aF~~c~~L~~l~l~~~~~~--------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I 314 (401)
T 4fdw_A 262 IASR------AFYYCPELAEVTTYGSTFN--------------------DDPEAMIHPYCLEGCPKLARFEIP-ESIRIL 314 (401)
T ss_dssp ECTT------TTTTCTTCCEEEEESSCCC--------------------CCTTCEECTTTTTTCTTCCEECCC-TTCCEE
T ss_pred EChh------HhhCCCCCCEEEeCCcccc--------------------CCcccEECHHHhhCCccCCeEEeC-CceEEE
Confidence 2222 1344455555555444332 111223556677777788888877 446666
Q ss_pred cchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCcccccccc-CCceeecCCCccc
Q 043932 413 IPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQ-NLIGFNASHNKLT 482 (1017)
Q Consensus 413 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~ls~N~l~ 482 (1017)
...+|.++++|+.++|.+| ++...+.+|.++ +|+.+++++|.+....+..|.+++ ++..|.+..+.+.
T Consensus 315 ~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 315 GQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred hhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 6777777788888887554 554556677777 788888888777766666677663 5667766666544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=4.3e-15 Score=147.92 Aligned_cols=133 Identities=19% Similarity=0.216 Sum_probs=96.7
Q ss_pred cccccccceeeccCcccCCCCcccccccc-CCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCcccccccccc
Q 043932 441 VGNLTKLAKLVMSYNSLQGNIPSSLGNCQ-NLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKN 519 (1017)
Q Consensus 441 ~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~ 519 (1017)
+.++++|+.|++++|+++. +|. +..+. +|+.|++++|+++ + + ..+..+++
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~-------------------------~-~-~~l~~l~~ 65 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIR-------------------------K-L-DGFPLLRR 65 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCC-------------------------E-E-CCCCCCSS
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCC-------------------------c-c-cccccCCC
Confidence 4556677777777777763 343 33333 6666666666665 2 2 35667788
Q ss_pred ceEEEccCCcccccccccccccccceEEeccCCccCCCCCc--cccccccCcEEeccCCcccCCChhh----hcccCCCc
Q 043932 520 LVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPH--SLGFLKSIKVLNFSSNNLSGQIPEF----LENLSFLE 593 (1017)
Q Consensus 520 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~ 593 (1017)
|++|+|++|+|++..|..|..+++|+.|+|++|+++. +|. .+..+++|+.|+|++|+++ .+|.. +..+++|+
T Consensus 66 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~ 143 (176)
T 1a9n_A 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVR 143 (176)
T ss_dssp CCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCS
T ss_pred CCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccc
Confidence 8888888888886655556888888888888888864 454 7888888888888888888 45554 78888899
Q ss_pred EEEcccCCCcC
Q 043932 594 FLNFSHNDLEG 604 (1017)
Q Consensus 594 ~L~l~~N~l~~ 604 (1017)
.||+++|....
T Consensus 144 ~Ld~~~n~~~~ 154 (176)
T 1a9n_A 144 VLDFQKVKLKE 154 (176)
T ss_dssp EETTEECCHHH
T ss_pred eeCCCcCCHHH
Confidence 99988888764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.54 E-value=7.5e-14 Score=158.49 Aligned_cols=79 Identities=11% Similarity=0.158 Sum_probs=45.2
Q ss_pred ccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCC
Q 043932 512 LQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSF 591 (1017)
Q Consensus 512 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 591 (1017)
.+|.++.+|+.++|.++ ++.+-..+|.+|.+|+.+++..| ++.+...+|.++++|+.+++..| ++ .+...|.++++
T Consensus 314 ~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~ 389 (394)
T 4fs7_A 314 EAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTK 389 (394)
T ss_dssp TTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCE
T ss_pred hhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCC
Confidence 34555666666666533 44444556666666666666655 55455566666666666666544 22 23445555555
Q ss_pred CcE
Q 043932 592 LEF 594 (1017)
Q Consensus 592 L~~ 594 (1017)
|+.
T Consensus 390 L~~ 392 (394)
T 4fs7_A 390 FKW 392 (394)
T ss_dssp EEE
T ss_pred CcE
Confidence 554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.54 E-value=6e-14 Score=159.30 Aligned_cols=333 Identities=12% Similarity=0.083 Sum_probs=161.9
Q ss_pred cccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCccccc
Q 043932 91 GILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIG 170 (1017)
Q Consensus 91 ~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~ 170 (1017)
.+...+|.++++|+.+.|.. .++..-..+|.++++|+.++|.++ ++..-..+|.++++|+.+.+..+ +......+|.
T Consensus 61 sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~ 137 (394)
T 4fs7_A 61 SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFK 137 (394)
T ss_dssp EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeee
Confidence 33445667777777777764 355333455666777777777544 44333455666666666655543 2223334444
Q ss_pred ccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEE
Q 043932 171 SLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERI 250 (1017)
Q Consensus 171 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 250 (1017)
+...+........ ......+|.++++|+.+.+.++. .......|.++.+|+.+.+..+ ++
T Consensus 138 ~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~---------------- 197 (394)
T 4fs7_A 138 GCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LK---------------- 197 (394)
T ss_dssp TCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CC----------------
T ss_pred cccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ce----------------
Confidence 4433222222111 11223345555555555554332 1122334444444444444433 22
Q ss_pred eCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcC
Q 043932 251 YLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330 (1017)
Q Consensus 251 ~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 330 (1017)
.++...|.+...|+.+.+..+... +.+......+|+.+.+..+ ++.+....|..+..|+.+.+..+..
T Consensus 198 ---------~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~ 265 (394)
T 4fs7_A 198 ---------IIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL 265 (394)
T ss_dssp ---------EECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC
T ss_pred ---------EeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc
Confidence 333334444444444444333221 1222223334444444322 2333444455555555555544432
Q ss_pred CCCCCCChhhHhhhcccCcccEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCC
Q 043932 331 GMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLH 410 (1017)
Q Consensus 331 ~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 410 (1017)
... . ..+..+..++.+....+. ++...+....+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++
T Consensus 266 ~i~-~------~~F~~~~~l~~~~~~~~~----i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~ 332 (394)
T 4fs7_A 266 RIG-G------SLFYNCSGLKKVIYGSVI----VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE 332 (394)
T ss_dssp EEC-S------CTTTTCTTCCEEEECSSE----ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred eee-c------cccccccccceeccCcee----eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc
Confidence 211 1 113344555555444332 22222222334555555433 44455666777777777777543 55
Q ss_pred CCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCcee
Q 043932 411 GTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGF 474 (1017)
Q Consensus 411 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 474 (1017)
.+...+|.++.+|+.+++..| ++.....+|.++++|+.+++..+ ++ .+...|.++++|+.+
T Consensus 333 ~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 333 EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 555666777777777777655 55455566777777777777544 22 234556666666543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=143.43 Aligned_cols=107 Identities=21% Similarity=0.260 Sum_probs=86.1
Q ss_pred eccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcc
Q 043932 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578 (1017)
Q Consensus 499 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 578 (1017)
+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|+|
T Consensus 14 l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 14 VDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 555555554 3555442 6788888999988888888888888899999999998888788888888999999999998
Q ss_pred cCCChhhhcccCCCcEEEcccCCCcCcCCC
Q 043932 579 SGQIPEFLENLSFLEFLNFSHNDLEGEVPT 608 (1017)
Q Consensus 579 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 608 (1017)
++..+..|.++++|+.|+|++|++++.++.
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 877777788888899999888888887663
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.5e-14 Score=141.66 Aligned_cols=108 Identities=21% Similarity=0.294 Sum_probs=86.3
Q ss_pred eeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCc
Q 043932 498 YLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNN 577 (1017)
Q Consensus 498 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 577 (1017)
.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+++.+..|..+++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 3555666554 5566553 788888899998888888888888889999999999888777778888889999999998
Q ss_pred ccCCChhhhcccCCCcEEEcccCCCcCcCCC
Q 043932 578 LSGQIPEFLENLSFLEFLNFSHNDLEGEVPT 608 (1017)
Q Consensus 578 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 608 (1017)
|++..+..|..+++|+.|+|++|++.+.++.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~ 123 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCECRD 123 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred cceeCHHHhccccCCCEEEeCCCCccccccc
Confidence 8876666688888888888888888876653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=9.2e-15 Score=145.55 Aligned_cols=135 Identities=19% Similarity=0.194 Sum_probs=73.9
Q ss_pred ccCCCCCCCEEEccCCCCCCCCCccccccc-ccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCC
Q 043932 96 YVGNLSFLRYINLSDNSFHGEIPQEIGNLL-RLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLK 174 (1017)
Q Consensus 96 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 174 (1017)
.+.++++|++|+|++|+++ .+|. +..+. +|++|+|++|.+++. ..++.+++|++|+|++|++++..|..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 3556666777777777776 3443 44443 666666666666643 45566666666666666666433333455555
Q ss_pred ccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccch----hhcccCcCcEE
Q 043932 175 LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQ----SICNISSLERI 250 (1017)
Q Consensus 175 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~----~l~~l~~L~~L 250 (1017)
|++|++++|+++ .+|. ...+..+++|++|++++|.++ .+|. .+..+++|++|
T Consensus 90 L~~L~L~~N~i~-~~~~----------------------~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~L 145 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGD----------------------LDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL 145 (176)
T ss_dssp CCEEECCSCCCC-CGGG----------------------GGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred CCEEECCCCcCC-cchh----------------------hHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcccee
Confidence 555555555554 2232 014444555555555555554 2333 25556666666
Q ss_pred eCCCccCc
Q 043932 251 YLPFNRFS 258 (1017)
Q Consensus 251 ~Ls~N~l~ 258 (1017)
+++.|.+.
T Consensus 146 d~~~n~~~ 153 (176)
T 1a9n_A 146 DFQKVKLK 153 (176)
T ss_dssp TTEECCHH
T ss_pred CCCcCCHH
Confidence 66665553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=136.68 Aligned_cols=109 Identities=17% Similarity=0.217 Sum_probs=99.0
Q ss_pred cceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcc
Q 043932 519 NLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFS 598 (1017)
Q Consensus 519 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 598 (1017)
..+.|++++|+++. +|..+. ++|+.|+|++|+|+++.|..|..+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 35789999999994 666553 899999999999999999999999999999999999998888888999999999999
Q ss_pred cCCCcCcCCC-CCCCCCCCcccccCcccccCCc
Q 043932 599 HNDLEGEVPT-KGVFSSKTKLSLQGNVKLCGGT 630 (1017)
Q Consensus 599 ~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~ 630 (1017)
+|+|++.++. ...+.+++.+++.+|++.|+|+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999998875 6678899999999999999976
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=135.14 Aligned_cols=108 Identities=19% Similarity=0.230 Sum_probs=98.0
Q ss_pred ceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEccc
Q 043932 520 LVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSH 599 (1017)
Q Consensus 520 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 599 (1017)
-+.+++++|+++ .+|..+. ++|+.|+|++|+|++.+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999997 6676664 8999999999999999999999999999999999999987777789999999999999
Q ss_pred CCCcCcCCC-CCCCCCCCcccccCcccccCCc
Q 043932 600 NDLEGEVPT-KGVFSSKTKLSLQGNVKLCGGT 630 (1017)
Q Consensus 600 N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~ 630 (1017)
|+|++.++. ...+.+++.+++.+|++.|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 999987775 6678899999999999999875
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.37 E-value=4.7e-13 Score=149.30 Aligned_cols=130 Identities=22% Similarity=0.241 Sum_probs=102.4
Q ss_pred eccCCC-cCCCCccccccccccceEEEccC-CcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCC
Q 043932 499 LDLSNN-NLNGSLPLQIGNLKNLVKLIISS-NQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSN 576 (1017)
Q Consensus 499 L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 576 (1017)
++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|+++++|+.|+|++|+|++++|..|..+++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 566666 666 4777 88999999999996 9999888889999999999999999999999999999999999999999
Q ss_pred cccCCChhhhcccCCCcEEEcccCCCcCcCCCCC--CCCCCCcccccCcccccCCcC
Q 043932 577 NLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKG--VFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 577 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
+|++..+..+..++ |+.|+|++|+|.+.+.... .+.......+..+...|..+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 99977776676666 9999999999998765321 111122334455667776554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.6e-14 Score=158.59 Aligned_cols=169 Identities=17% Similarity=0.153 Sum_probs=82.8
Q ss_pred cccEEeccccCCCCCcchhhccc-----ccccceeccccccccccCccc-ccccccceeeccCcccCCCCcccc-----c
Q 043932 398 NLIALGMQSNQLHGTIPDVIGEL-----KNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSL-----G 466 (1017)
Q Consensus 398 ~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~i~~~~p~~~-----~ 466 (1017)
.|+.|+|++|.++......+... ++|++|+|++|.++......+ ..+++|++|+|++|+|+......+ .
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 45555555555543333333222 455555555555543222222 234455666666665553222222 1
Q ss_pred cccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCccccc----ccccccccc
Q 043932 467 NCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGV----IPVTLSTCV 542 (1017)
Q Consensus 467 ~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~ 542 (1017)
..++|+.|+|++|.|+..-. ..++..+..+++|++|+|++|+|++. ++..+...+
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~---------------------~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~ 211 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGV---------------------AVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR 211 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHH---------------------HHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred cCCccceeeCCCCCCChHHH---------------------HHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence 23455666666665541000 01223344556666777777766532 234455556
Q ss_pred cceEEeccCCccCCC----CCccccccccCcEEeccCCcccCCChhhhc
Q 043932 543 SLEYLDISSNSFHGV----IPHSLGFLKSIKVLNFSSNNLSGQIPEFLE 587 (1017)
Q Consensus 543 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 587 (1017)
+|+.|||++|.|++. ++..+...++|++|||++|.|+..-...+.
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 666666666666542 223334456666666666666654444443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.9e-11 Score=137.11 Aligned_cols=113 Identities=10% Similarity=0.082 Sum_probs=60.2
Q ss_pred cccCcccccccC-CccEEEeccccccCCCCccccCCCcccEEEEecCC---CCCCCCcccccccCcceeEeecCcccccc
Q 043932 162 EGQIPAEIGSLL-KLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNS---LGGKIPTTLGLLRNLVDLHVGGNQFSGTF 237 (1017)
Q Consensus 162 ~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 237 (1017)
+.+...+|.+.. .|+.+.+..+ ++.+...+|.++++|+.+.+.+|. ++.....+|..+.+|+.+.+..+ ++...
T Consensus 52 t~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~ 129 (394)
T 4gt6_A 52 SKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEID 129 (394)
T ss_dssp EEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEEC
T ss_pred eEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceeh
Confidence 333345566653 4777777643 554556667777777777776653 33333445555556665555433 33344
Q ss_pred chhhcccCcCcEEeCCCccCccccCchhhccCCccceeeec
Q 043932 238 PQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIG 278 (1017)
Q Consensus 238 p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~ 278 (1017)
..+|..+.+|+.+.+..+- . .++...|....+|+.+.+.
T Consensus 130 ~~aF~~c~~L~~i~lp~~~-~-~I~~~~F~~c~~L~~i~~~ 168 (394)
T 4gt6_A 130 SEAFHHCEELDTVTIPEGV-T-SVADGMFSYCYSLHTVTLP 168 (394)
T ss_dssp TTTTTTCTTCCEEECCTTC-C-EECTTTTTTCTTCCEEECC
T ss_pred hhhhhhhccccccccccee-e-eecccceeccccccccccc
Confidence 4455555555555554332 1 3444444445555555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=3.9e-12 Score=141.82 Aligned_cols=109 Identities=21% Similarity=0.148 Sum_probs=97.9
Q ss_pred eEEEccCC-cccccccccccccccceEEeccC-CccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcc
Q 043932 521 VKLIISSN-QFSGVIPVTLSTCVSLEYLDISS-NSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFS 598 (1017)
Q Consensus 521 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 598 (1017)
..+++++| +|++ +|. +..+++|+.|+|++ |+|+++.|..|+.+++|+.|+|++|+|++.+|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35799998 9994 777 99999999999996 99999988999999999999999999999999999999999999999
Q ss_pred cCCCcCcCCCCCCCCCCCcccccCcccccCCcC
Q 043932 599 HNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 599 ~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
+|+|++.++......+++.+++.+|++.|+|.+
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~l 121 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCcc
Confidence 999998877644334499999999999998764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-10 Score=132.51 Aligned_cols=152 Identities=9% Similarity=0.034 Sum_probs=78.4
Q ss_pred cccCCC-cceEeecccccccccCcccccccCCccEEEecccc---ccCCCCccccCCCcccEEEEecCCCCCCCCccccc
Q 043932 144 NLSRCS-NLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNY---LTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGL 219 (1017)
Q Consensus 144 ~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 219 (1017)
+|.++. .|+.+.+..+ ++.+...+|.++.+|+.+.+..|. ++.+...+|.++.+|+.+.+.++ ++.....+|..
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~ 135 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHH 135 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhh
Confidence 344442 3555555432 333444455555555555555442 33333455555666655544433 33334455666
Q ss_pred ccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCcccee
Q 043932 220 LRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEIL 299 (1017)
Q Consensus 220 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 299 (1017)
+.+|+.+.+..+ ++.+...+|..+.+|+.+.+..+ ++ .++...|.+ .+|+.+.+..+-.. ....++....+++..
T Consensus 136 c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~-~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 136 CEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VT-AIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTI 210 (394)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEE
T ss_pred hcccccccccce-eeeecccceecccccccccccce-ee-Eeccccccc-cceeEEEECCcccc-cccchhhhcccccee
Confidence 777777777544 33355567777778887777654 33 455555533 45666665443222 333444444444444
Q ss_pred ecc
Q 043932 300 DLG 302 (1017)
Q Consensus 300 ~Ls 302 (1017)
...
T Consensus 211 ~~~ 213 (394)
T 4gt6_A 211 TSD 213 (394)
T ss_dssp EEC
T ss_pred ccc
Confidence 433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.8e-13 Score=151.43 Aligned_cols=62 Identities=13% Similarity=0.172 Sum_probs=28.1
Q ss_pred CcccEEEEecCCCCCCCCcccccc-----cCcceeEeecCccccccchhh-cccCcCcEEeCCCccCc
Q 043932 197 SALEVFSITGNSLGGKIPTTLGLL-----RNLVDLHVGGNQFSGTFPQSI-CNISSLERIYLPFNRFS 258 (1017)
Q Consensus 197 ~~L~~L~L~~N~l~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~N~l~ 258 (1017)
+.|+.|+|++|.++......+... ++|++|+|++|.++......+ ..+++|++|+|++|.++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~ 139 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG 139 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC
Confidence 345556666665554333333322 355555555555543222222 12344455555555443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=6.7e-11 Score=126.04 Aligned_cols=147 Identities=18% Similarity=0.139 Sum_probs=112.9
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCC
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 778 (1017)
+......|++....+.|+.+.||++... +..+++|+...........+.+|+++++.+. +..+.++++++...
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~---- 82 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD---- 82 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET----
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC----
Confidence 3445567888889999999999999864 5679999987532223346889999999884 67788888887543
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC-------------------------
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC------------------------- 833 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------- 833 (1017)
+..|+||||++|.++.+.+... .+...++.+++++++.||+..
T Consensus 83 -~~~~lv~e~i~G~~l~~~~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 83 -GWSNLLMSEADGVLCSEEYEDE-----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp -TEEEEEEECCSSEEHHHHCCTT-----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred -CceEEEEEecCCeehhhccCCc-----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 5679999999999998763211 123467889999999999810
Q ss_pred -------------------------------CCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 834 -------------------------------QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 834 -------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
++.++|+|++|.||++++++.+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876667799999775
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.02 E-value=1e-10 Score=129.37 Aligned_cols=207 Identities=12% Similarity=0.088 Sum_probs=103.1
Q ss_pred CCeEEEEEcCCCCCcc-c-------cCcccCCCCCCCEEEccCCCCC---------CCCCcccccccccccccCCCCccc
Q 043932 76 HQRVTRLDLSNQRIGG-I-------LSPYVGNLSFLRYINLSDNSFH---------GEIPQEIGNLLRLEKLALPNNSFS 138 (1017)
Q Consensus 76 ~~~v~~l~l~~~~l~~-~-------~~~~l~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~L~~n~l~ 138 (1017)
..+|+.|.+...+..| . +..++..+++|+.|.+.++... +.++..+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3467777777665542 1 1334567788888888765432 123333445566666666655211
Q ss_pred ccCCCcccCCCcceEeecccccccccCccccc--ccCCccEEEecc--ccccCCCCccccCCCcccEEEEecCCCCCCCC
Q 043932 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIG--SLLKLQTLAVGK--NYLTGRLPDFVGNLSALEVFSITGNSLGGKIP 214 (1017)
Q Consensus 139 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 214 (1017)
.++. + .+++|++|+|..|.+.......+. .+++|++|+|+. |...+.. .+. .+.
T Consensus 186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~~~-----------------~l~ 243 (362)
T 2ra8_A 186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--DMN-----------------VFR 243 (362)
T ss_dssp -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--CGG-----------------GTG
T ss_pred -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--hHH-----------------HHH
Confidence 2222 2 255666666666555433333332 455566655532 1111100 000 000
Q ss_pred ccc--ccccCcceeEeecCccccccchhhc---ccCcCcEEeCCCccCccccCchhh---ccCCccceeeecccccCCCC
Q 043932 215 TTL--GLLRNLVDLHVGGNQFSGTFPQSIC---NISSLERIYLPFNRFSGTLPFDIV---VNLPNLKSLAIGGNNFFGSI 286 (1017)
Q Consensus 215 ~~l--~~l~~L~~L~L~~n~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~~l~~~~~---~~l~~L~~L~L~~n~l~~~~ 286 (1017)
..+ ..+++|++|+|++|.+++..+..+. .+++|++|+|+.|.+.+.-+..+. ..+++|+.|+|++|.++...
T Consensus 244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~ 323 (362)
T 2ra8_A 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323 (362)
T ss_dssp GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH
T ss_pred HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH
Confidence 111 1346666666666666544333333 356677777777766542211111 34567777777777665433
Q ss_pred CCccccCCccceeecccCc
Q 043932 287 PDSLSNASNVEILDLGFNQ 305 (1017)
Q Consensus 287 p~~l~~l~~L~~L~Ls~N~ 305 (1017)
-..+...- ...++++.++
T Consensus 324 ~~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 324 KKELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHC-CSEEECCSBC
T ss_pred HHHHHHHc-CCEEEecCCc
Confidence 33333211 2457777776
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.01 E-value=9.5e-09 Score=115.73 Aligned_cols=148 Identities=14% Similarity=0.165 Sum_probs=83.8
Q ss_pred CcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhh
Q 043932 412 TIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLS 491 (1017)
Q Consensus 412 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 491 (1017)
.....+....+|+.+.+..+ ++......|.+...|+.+.+..+ ++.+-..+|.++.+|+.+.+..+ ++
T Consensus 208 i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~--------- 275 (379)
T 4h09_A 208 VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK--------- 275 (379)
T ss_dssp ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS---------
T ss_pred Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce---------
Confidence 33444555566666665443 22244445556666666666554 44344455666666666555432 21
Q ss_pred cccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEE
Q 043932 492 ITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVL 571 (1017)
Q Consensus 492 ~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 571 (1017)
......|.++++|+.+.+.++.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+
T Consensus 276 ----------------~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i 338 (379)
T 4h09_A 276 ----------------TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTI 338 (379)
T ss_dssp ----------------EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred ----------------eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence 112235666777777777777776555666777777777777644 554555677777777777
Q ss_pred eccCCcccCCChhhhccc
Q 043932 572 NFSSNNLSGQIPEFLENL 589 (1017)
Q Consensus 572 ~Ls~N~l~~~~p~~~~~l 589 (1017)
.+..+ ++.+-..+|.+.
T Consensus 339 ~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 339 SYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCCTT-CCEECTTTTTTS
T ss_pred EECCc-cCEEchhHhhCC
Confidence 76544 443334445443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.99 E-value=7.1e-10 Score=117.98 Aligned_cols=140 Identities=15% Similarity=0.104 Sum_probs=99.4
Q ss_pred HhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCC--ceeeeeeeecCCCCCC
Q 043932 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRN--LIKIITICSSIDSKGA 779 (1017)
Q Consensus 702 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~ 779 (1017)
.....|.+..+.+.|..+.||++... +|..+++|+.... ....+.+|+++++.+.+.+ +.+++++....
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~----- 87 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA----- 87 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----
T ss_pred HhcCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----
Confidence 33445655444456667999999764 6677999997543 2245778999999885434 45577765432
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC--------------------------
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC-------------------------- 833 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------- 833 (1017)
+..++||||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLV 153 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCC
T ss_pred CCCEEEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCc
Confidence 4579999999998884 211 11 1256778888888888752
Q ss_pred -----------------------------CCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 834 -----------------------------QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 834 -----------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
+..++|+|++|.||++++++.+.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 154 DQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.6e-10 Score=124.89 Aligned_cols=161 Identities=11% Similarity=0.147 Sum_probs=106.3
Q ss_pred CcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccc--cccCcceeEeec--Cccccc----
Q 043932 165 IPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLG--LLRNLVDLHVGG--NQFSGT---- 236 (1017)
Q Consensus 165 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~--~l~~L~~L~L~~--n~l~~~---- 236 (1017)
++..+..+++|+.|.|++|.-. .++. + .+++|+.|+|..|.++......++ .+++|++|+|+. |...+.
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~ 240 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN 240 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGG
T ss_pred HHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHH
Confidence 3344556677777777666311 1222 3 267788888877776544444444 678888888753 221111
Q ss_pred -cchhh--cccCcCcEEeCCCccCccccCchhh--ccCCccceeeecccccCCC----CCCccccCCccceeecccCccc
Q 043932 237 -FPQSI--CNISSLERIYLPFNRFSGTLPFDIV--VNLPNLKSLAIGGNNFFGS----IPDSLSNASNVEILDLGFNQFK 307 (1017)
Q Consensus 237 -~p~~l--~~l~~L~~L~Ls~N~l~~~l~~~~~--~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 307 (1017)
+...+ ..+++|++|+|++|.+.+..+..++ ..+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.|+
T Consensus 241 ~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 241 VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 11222 2478999999999999754443333 2578999999999999864 4455567899999999999998
Q ss_pred ceeeccccccCccceEecccCc
Q 043932 308 GKVSIDFSSLKNLSWLNLEQNN 329 (1017)
Q Consensus 308 ~~~~~~~~~l~~L~~L~L~~N~ 329 (1017)
......+...- ...+++++++
T Consensus 321 d~~~~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 321 DEMKKELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHHHC-CSEEECCSBC
T ss_pred HHHHHHHHHHc-CCEEEecCCc
Confidence 76655555411 4568999887
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.8e-08 Score=110.78 Aligned_cols=149 Identities=13% Similarity=0.085 Sum_probs=94.6
Q ss_pred cCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccc
Q 043932 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNC 468 (1017)
Q Consensus 389 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l 468 (1017)
....+....+|+.+.+..+ +..+....|.++.+|+.+.+..+ ++......|.+..+|+.+.+..+ ++......|.++
T Consensus 209 ~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c 285 (379)
T 4h09_A 209 TAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGC 285 (379)
T ss_dssp CTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTC
T ss_pred eecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccc
Confidence 3445556666666666544 33355566667777777777655 44455566777777777777544 443445567777
Q ss_pred cCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEe
Q 043932 469 QNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLD 548 (1017)
Q Consensus 469 ~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 548 (1017)
++|+.+.+.++.++ ..-..+|.++.+|+.++|..+ ++.+-..+|.+|.+|+.+.
T Consensus 286 ~~L~~i~l~~~~i~-------------------------~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 339 (379)
T 4h09_A 286 SNLTKVVMDNSAIE-------------------------TLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTIS 339 (379)
T ss_dssp TTCCEEEECCTTCC-------------------------EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCC
T ss_pred cccccccccccccc-------------------------eehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEE
Confidence 77877777766655 122345677777888887654 5545566788888888888
Q ss_pred ccCCccCCCCCcccccccc
Q 043932 549 ISSNSFHGVIPHSLGFLKS 567 (1017)
Q Consensus 549 Ls~N~l~~~~p~~~~~l~~ 567 (1017)
+..+ ++.+-..+|.++..
T Consensus 340 ip~~-v~~I~~~aF~~c~~ 357 (379)
T 4h09_A 340 YPKS-ITLIESGAFEGSSI 357 (379)
T ss_dssp CCTT-CCEECTTTTTTSSC
T ss_pred ECCc-cCEEchhHhhCCCC
Confidence 7654 55555667766543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.1e-11 Score=129.61 Aligned_cols=23 Identities=13% Similarity=0.016 Sum_probs=16.8
Q ss_pred CCceeeEEECCCCCeEEEEEcCC
Q 043932 64 LCQWTGVTCGHRHQRVTRLDLSN 86 (1017)
Q Consensus 64 ~c~w~gv~c~~~~~~v~~l~l~~ 86 (1017)
.|.|.|+.|+....+|+.+-..+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~ 99 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSS 99 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEEC
T ss_pred HHhcCcEEECCCCCEEEEEEecC
Confidence 37899999987766776655544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.6e-09 Score=118.04 Aligned_cols=196 Identities=18% Similarity=0.151 Sum_probs=123.5
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCC--ceeeeeeeecCCCCCCceeEEEE
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRN--LIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
.+.++.|....||++. ..+++|+.... .....+.+|+++++.+. +.. +.+++.+... .......|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence 4568999999999864 24888986422 33467889999998883 332 3444444322 11123457999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC---------------------------------
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC--------------------------------- 833 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------- 833 (1017)
|+++|.++.+... ..++..++..++.|+++.++.||+..
T Consensus 96 ~~i~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp ECCCCEECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred cccCCeECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 9999988865432 14677788888999999999998621
Q ss_pred ----------------------CCCceeecCCCCceEeCC--CCCeEEeecccccccccccccccccCCC---c----cc
Q 043932 834 ----------------------QPPMVHGDLKPSNVLLDH--DMVSHVGDFGLAKFLSSHQLDTASKTSS---S----SI 882 (1017)
Q Consensus 834 ----------------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~~---~----~~ 882 (1017)
++.++|+|++|.||++++ ++.+.++||+.+..-... .+-...... . ..
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHH
Confidence 245899999999999998 556889999998754221 111100000 0 00
Q ss_pred ccccCccccC-cccccCCCcCccccchhHHHHHHHHHhCCCCCC
Q 043932 883 GIKGTVGYVA-PEYCMGSEASMTGDVYSFGILLLELFTGRRPTD 925 (1017)
Q Consensus 883 ~~~gt~~y~a-PE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 925 (1017)
.+....++.. |+.... .....+.|++|.++|.+.+|..+|-
T Consensus 247 ~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0000011112 222211 1223589999999999999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.82 E-value=6.9e-09 Score=115.89 Aligned_cols=144 Identities=14% Similarity=0.182 Sum_probs=105.0
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEee--ecCc-chHHHHHHHHHHHHhcC--CCCceeeeeeeecCCCCCCceeEE
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQK-GAFKSFMAECKALRNIR--HRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
.+.++.|.++.||++... +..+++|+.. .... .....+.+|+.+++.+. +..+.+++.++..... .+..++
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeEE
Confidence 467899999999999875 3468888775 3221 22356788999999996 4567888888754322 245689
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC-------------------------------
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC------------------------------- 833 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------- 833 (1017)
||||++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 119 vme~v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp EEECCCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred EEEecCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 99999997774311 124677888899999999999999831
Q ss_pred ------------------------CCCceeecCCCCceEeCCCCC--eEEeecccccc
Q 043932 834 ------------------------QPPMVHGDLKPSNVLLDHDMV--SHVGDFGLAKF 865 (1017)
Q Consensus 834 ------------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~ 865 (1017)
++.++|||++|.||+++.++. +.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998874
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.57 E-value=1.1e-08 Score=106.92 Aligned_cols=80 Identities=21% Similarity=0.305 Sum_probs=53.9
Q ss_pred cccccceEEEccCCcccc--cccccccccccceEEeccCCccCCCCCccccccc--cCcEEeccCCcccCCCh-------
Q 043932 515 GNLKNLVKLIISSNQFSG--VIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLK--SIKVLNFSSNNLSGQIP------- 583 (1017)
Q Consensus 515 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p------- 583 (1017)
.++++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 456677778888887776 3345666777777777777777764 3344444 77777777777776554
Q ss_pred hhhcccCCCcEEE
Q 043932 584 EFLENLSFLEFLN 596 (1017)
Q Consensus 584 ~~~~~l~~L~~L~ 596 (1017)
..+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 2356677777665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.52 E-value=3.7e-09 Score=105.45 Aligned_cols=123 Identities=17% Similarity=0.145 Sum_probs=66.1
Q ss_pred ccCcccCCCCCCCEEEccCC-CCCCC----CCcccccccccccccCCCCccccc----CCCcccCCCcceEeeccccccc
Q 043932 92 ILSPYVGNLSFLRYINLSDN-SFHGE----IPQEIGNLLRLEKLALPNNSFSGT----IPTNLSRCSNLIQLRVSNNKLE 162 (1017)
Q Consensus 92 ~~~~~l~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~ 162 (1017)
.+...+...+.|++|+|++| .+... +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.++
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34455667777888888887 77642 233344445566666666655432 2222333445555555555554
Q ss_pred ccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEE--ecCCCCCC----CCcccccccCcceeEeecCccc
Q 043932 163 GQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSI--TGNSLGGK----IPTTLGLLRNLVDLHVGGNQFS 234 (1017)
Q Consensus 163 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L--~~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~ 234 (1017)
..... .+...+...++|++|+| ++|.++.. +...+...++|++|+|++|.+.
T Consensus 107 ~~g~~--------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGIL--------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHH--------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHH--------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 32100 12233444455556666 55555532 2334455577888888888775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.36 E-value=6.1e-08 Score=96.51 Aligned_cols=113 Identities=10% Similarity=0.180 Sum_probs=52.5
Q ss_pred ccCCCcceEeecccc-ccccc----CcccccccCCccEEEeccccccCC----CCccccCCCcccEEEEecCCCCCC---
Q 043932 145 LSRCSNLIQLRVSNN-KLEGQ----IPAEIGSLLKLQTLAVGKNYLTGR----LPDFVGNLSALEVFSITGNSLGGK--- 212 (1017)
Q Consensus 145 l~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~--- 212 (1017)
+...++|++|+|++| .+... +...+...++|++|+|++|.+... +...+...+.|++|+|++|.|+..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 344455555555555 44321 222333344455555555554321 112233334455555555555432
Q ss_pred -CCcccccccCcceeEe--ecCccccc----cchhhcccCcCcEEeCCCccC
Q 043932 213 -IPTTLGLLRNLVDLHV--GGNQFSGT----FPQSICNISSLERIYLPFNRF 257 (1017)
Q Consensus 213 -~~~~l~~l~~L~~L~L--~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l 257 (1017)
+...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 2334444556666666 55666543 223334445555555555555
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.6e-06 Score=92.25 Aligned_cols=135 Identities=17% Similarity=0.099 Sum_probs=99.5
Q ss_pred cccccCCc-eEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCceeEEEEEec
Q 043932 712 MIGQGSFG-SVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADFKALVFECM 789 (1017)
Q Consensus 712 ~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 789 (1017)
.+..|..+ .||+.....++..+++|+-... ....+.+|+..++.+. +--+.++++++... +..++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEee
Confidence 45556665 6999988777788999986532 3456788999998884 44467778777554 5679999999
Q ss_pred cCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC------------------------------------
Q 043932 790 KNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC------------------------------------ 833 (1017)
Q Consensus 790 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------ 833 (1017)
+|.++.+...... .....++.+++..++.||+..
T Consensus 103 ~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 103 PGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp CSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred CCccccccccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 9988887654321 223456777888888888641
Q ss_pred -------------------CCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 834 -------------------QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 834 -------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
++.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0237999999999999988777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=4.5e-06 Score=90.43 Aligned_cols=136 Identities=16% Similarity=0.152 Sum_probs=92.7
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCC---CceeeeeeeecCCCCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHR---NLIKIITICSSIDSKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~e 787 (1017)
+.++.|....||+. +..+++|+.. .......+.+|+++++.+.+. .+.+++.++... .+..++|||
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----DGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT----TSCEEEEEE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC----CCceEEEEe
Confidence 45788888899998 3458888842 223346788999999999642 355666655321 245689999
Q ss_pred eccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhC-----------------------------------
Q 043932 788 CMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH----------------------------------- 832 (1017)
Q Consensus 788 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------------------- 832 (1017)
|++|.++.+..-. .++..+...++.++++.|+.||+.
T Consensus 94 ~i~G~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 94 KVQGQILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp CCCSEECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred ccCCeECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 9999888763211 234445555556666666655543
Q ss_pred ----------------------CCCCceeecCCCCceEeCC---CCC-eEEeecccccc
Q 043932 833 ----------------------CQPPMVHGDLKPSNVLLDH---DMV-SHVGDFGLAKF 865 (1017)
Q Consensus 833 ----------------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfG~a~~ 865 (1017)
.++.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235699999999999987 455 48999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=1.3e-05 Score=89.03 Aligned_cols=84 Identities=6% Similarity=-0.045 Sum_probs=55.2
Q ss_pred cCcc-cccCCceEEEEEeC--C----CcEEEEEEEeeecC---cchHHHHHHHHHHHHhcC-C--CCceeeeeeeecCCC
Q 043932 710 SNMI-GQGSFGSVYKGILG--E----DEMIVAVKVINLKQ---KGAFKSFMAECKALRNIR-H--RNLIKIITICSSIDS 776 (1017)
Q Consensus 710 ~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~ 776 (1017)
.+.| +.|....+|++... . ++..+++|+..... ......+.+|+.+++.+. + ..+.+++.++.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998763 1 15678999865432 101245678899888884 3 356777777643311
Q ss_pred CCCceeEEEEEeccCCCHH
Q 043932 777 KGADFKALVFECMKNGSLE 795 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~ 795 (1017)
.+..++||||++|.++.
T Consensus 105 --~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 --LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp --TSSCEEEEECCCCBCCC
T ss_pred --cCCceEEEEecCCCChh
Confidence 13457999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=4.5e-05 Score=85.97 Aligned_cols=76 Identities=16% Similarity=0.105 Sum_probs=48.6
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-------chHHHHHHHHHHHHhcCC--C-CceeeeeeeecCCCCCC
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-------GAFKSFMAECKALRNIRH--R-NLIKIITICSSIDSKGA 779 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~ 779 (1017)
.+.+|.|.++.||++....+++.|++|....... ....++..|.++++.+.. + .+.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~----- 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T----- 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C-----
Confidence 4578999999999998765667899998653211 123566789999888732 3 344555432 1
Q ss_pred ceeEEEEEeccCC
Q 043932 780 DFKALVFECMKNG 792 (1017)
Q Consensus 780 ~~~~lv~e~~~~g 792 (1017)
+..++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 2347999999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.79 E-value=8.9e-06 Score=78.50 Aligned_cols=34 Identities=6% Similarity=0.065 Sum_probs=18.0
Q ss_pred cceEeecccccccccCcccccccCCccEEEeccc
Q 043932 150 NLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKN 183 (1017)
Q Consensus 150 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 183 (1017)
+|++|||+++.++...-..+.++++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 5666666666555443344445555555555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.76 E-value=1.2e-05 Score=77.61 Aligned_cols=84 Identities=11% Similarity=0.139 Sum_probs=46.0
Q ss_pred CCccEEEeccccccCCCCccccCCCcccEEEEecCC-CCCCCCcccccc----cCcceeEeecCc-cccccchhhcccCc
Q 043932 173 LKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNS-LGGKIPTTLGLL----RNLVDLHVGGNQ-FSGTFPQSICNISS 246 (1017)
Q Consensus 173 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l----~~L~~L~L~~n~-l~~~~p~~l~~l~~ 246 (1017)
.+|++||++++.++..--..+.++++|+.|+|++|. ++..--..++.+ ++|++|+|++|. +|...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356677777766665444455666666666666663 443333334432 246666666653 55444444555555
Q ss_pred CcEEeCCCcc
Q 043932 247 LERIYLPFNR 256 (1017)
Q Consensus 247 L~~L~Ls~N~ 256 (1017)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 5555555553
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00031 Score=77.30 Aligned_cols=148 Identities=18% Similarity=0.111 Sum_probs=79.3
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCC--CCceeeeeeeecCC-CCCCceeEEEEE
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRH--RNLIKIITICSSID-SKGADFKALVFE 787 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~-~~~~~~~~lv~e 787 (1017)
+.|+.|..+.||++... ++ .+++|+.... ..++..|+.+++.+.. -.+.+++....... ....+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD-SG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET-TE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC-CC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34666778999999874 34 4899988642 1334456666665531 13344443110000 001245789999
Q ss_pred eccCCCHH-----------HH---HhhC-CCC--c-c----ccccCHHH-------------------------------
Q 043932 788 CMKNGSLE-----------DW---LHQS-NDH--L-E----VCKLTLIQ------------------------------- 814 (1017)
Q Consensus 788 ~~~~gsL~-----------~~---l~~~-~~~--~-~----~~~l~~~~------------------------------- 814 (1017)
|++|.++. .. ++.. ... . . ...-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11 1111 000 0 0 00011211
Q ss_pred HHHHHHHHHHHHHHHhh----------CCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 815 RVNIAIDVASAIEYLHH----------HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 815 ~~~i~~qi~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
...+..++..++++|++ ..+..++|+|+++.||+++.++.+.++||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234456667763 124589999999999999888899999999775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00025 Score=75.92 Aligned_cols=78 Identities=18% Similarity=0.114 Sum_probs=56.1
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-C--CCceeeeeeeecCCCCCCcee
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-H--RNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~~~~ 782 (1017)
+....+.+|.|..+.||+++.. +|+.|++|+...........+..|++.|+.+. . -.+.+++++. ..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DR 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TT
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cc
Confidence 3444667899999999999986 78889999876444444456788999998884 2 2345555542 23
Q ss_pred EEEEEeccCCC
Q 043932 783 ALVFECMKNGS 793 (1017)
Q Consensus 783 ~lv~e~~~~gs 793 (1017)
++||||++++.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 69999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00096 Score=71.65 Aligned_cols=141 Identities=18% Similarity=0.166 Sum_probs=88.9
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC---CCCceeeeeeeecCCCCCCceeEEEE
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR---HRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
.+.|+.|....+|+... ++..+++|+.... ....+..|++.++.+. ...+.+++.++... +..++||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvm 110 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLL 110 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEE
Confidence 45689999999999986 3567889987633 2466888999998883 35677888776443 5679999
Q ss_pred EeccCCCHH--------HH---HhhCCC--Ccc--------------ccccCHHHHH---HHH----------------H
Q 043932 787 ECMKNGSLE--------DW---LHQSND--HLE--------------VCKLTLIQRV---NIA----------------I 820 (1017)
Q Consensus 787 e~~~~gsL~--------~~---l~~~~~--~~~--------------~~~l~~~~~~---~i~----------------~ 820 (1017)
||+++..+. +. ++.... ... ...-+|.+.. ++. .
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 999987542 11 222111 000 0012343221 011 1
Q ss_pred HHHHH-HHHHhh-CCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 821 DVASA-IEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 821 qi~~~-L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
+++.. ...|.. ..++.++|+|+.+.|++++.++ +.|+|++
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 223422 2256899999999999999887 8899984
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.22 E-value=9.2e-05 Score=72.85 Aligned_cols=72 Identities=8% Similarity=0.171 Sum_probs=38.6
Q ss_pred ccccCCccceeecccCcccceeecc----ccccCccceEecccCcC-CCCCCCChhhHhhhcccCcccEEeccCccc
Q 043932 289 SLSNASNVEILDLGFNQFKGKVSID----FSSLKNLSWLNLEQNNL-GMGTANDLDFVTFLTNCSSLKILSLAANQF 360 (1017)
Q Consensus 289 ~l~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~L~~N~l-~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 360 (1017)
.+..-+.|+.|+|++|+|.+..... +..-+.|++|+|++|.. ........++...+...+.|+.|+++.|.+
T Consensus 93 aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 93 LIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 3444556666666666666443332 33344566777765433 111112223445566667777777776654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0012 Score=74.86 Aligned_cols=80 Identities=16% Similarity=0.199 Sum_probs=48.3
Q ss_pred CCCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCC---CcCccccchhH
Q 043932 834 QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS---EASMTGDVYSF 910 (1017)
Q Consensus 834 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dvwsl 910 (1017)
++.++|+|++|.||+++.++ ++++||+.+..-... .+-..... .-...|.+|+..... ......++.+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLG------NLILAFFAQDGHATQENDRKEYKQWILRT 302 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHH------HHHHHHHHGGGGCCSSCCSHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHH------HHHHHHHhcccccccccchHHHHHHHHHH
Confidence 34899999999999998876 999999988753211 11000000 001345666544321 12234556678
Q ss_pred HHHHHHHHhCC
Q 043932 911 GILLLELFTGR 921 (1017)
Q Consensus 911 G~il~elltg~ 921 (1017)
...+|+.+++.
T Consensus 303 ~~~~~~~y~~~ 313 (420)
T 2pyw_A 303 IEQTWNLFNKR 313 (420)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 88888877653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00011 Score=72.27 Aligned_cols=17 Identities=29% Similarity=0.341 Sum_probs=8.3
Q ss_pred hhcccCcCcEEeCCCcc
Q 043932 240 SICNISSLERIYLPFNR 256 (1017)
Q Consensus 240 ~l~~l~~L~~L~Ls~N~ 256 (1017)
++..-++|+.|+++.|.
T Consensus 152 aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 152 AIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHCSSCCEEECCCCC
T ss_pred HHHhCCCcCeEeccCCC
Confidence 34444555555555444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0015 Score=70.15 Aligned_cols=71 Identities=8% Similarity=0.046 Sum_probs=43.4
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCc-eeeeeeeecCCCCCCceeEEEEEe
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL-IKIITICSSIDSKGADFKALVFEC 788 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 788 (1017)
.+.|+.|....+|++ ..+++|+........ ....+|+.+++.+....+ .++++++. +.-++|+||
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~-------~~~~~v~e~ 88 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP-------ATGVMVTRY 88 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT-------TTCCEEEEC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC-------CCCEEEEee
Confidence 567899999999999 248889876432211 223468888877742222 45555431 123689999
Q ss_pred c-cCCCH
Q 043932 789 M-KNGSL 794 (1017)
Q Consensus 789 ~-~~gsL 794 (1017)
+ +|.++
T Consensus 89 i~~g~~l 95 (301)
T 3dxq_A 89 IAGAQTM 95 (301)
T ss_dssp CTTCEEC
T ss_pred cCCCccC
Confidence 9 65444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0063 Score=66.18 Aligned_cols=167 Identities=16% Similarity=0.137 Sum_probs=90.6
Q ss_pred CCCcCHHHHHHhhccccc-----cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCC--Cc
Q 043932 692 FPTVSYAELSKATSEFAS-----SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHR--NL 764 (1017)
Q Consensus 692 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni 764 (1017)
+...+.+++......|.+ ...++ |....||++... +|+.+++|+...... ....+..|..+++.+... .+
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCee
Confidence 455666666666555543 22456 888899998764 455789999863321 235667788888877422 24
Q ss_pred eeeeeeeecCCC--CCCceeEEEEEeccCCCHH-----HH---------Hhh---CCCCccccccCHHHH----------
Q 043932 765 IKIITICSSIDS--KGADFKALVFECMKNGSLE-----DW---------LHQ---SNDHLEVCKLTLIQR---------- 815 (1017)
Q Consensus 765 v~~~~~~~~~~~--~~~~~~~lv~e~~~~gsL~-----~~---------l~~---~~~~~~~~~l~~~~~---------- 815 (1017)
.+++.. .... ...+..++||||++|.++. .+ ++. ..........++...
T Consensus 85 p~~~~~--~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 162 (328)
T 1zyl_A 85 AAPVAF--NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFED 162 (328)
T ss_dssp CCCCCB--TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHT
T ss_pred cceeec--CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhh
Confidence 444443 1100 0124568899999875331 11 111 000000111221110
Q ss_pred ------------HHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 816 ------------VNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 816 ------------~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
...+.+++..++.... ..+..++|+|+++.||+++ + .+.++||+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 163 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1112222222222211 1234689999999999998 4 899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0051 Score=66.69 Aligned_cols=168 Identities=14% Similarity=0.117 Sum_probs=88.8
Q ss_pred CCcCHHHHHHhhcccccc-----CcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCC--ce
Q 043932 693 PTVSYAELSKATSEFASS-----NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRN--LI 765 (1017)
Q Consensus 693 ~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv 765 (1017)
..++.+++.....+|... +.|+.|....+|++... ++ .+++|+..... ....+..|+.+++.+.... +.
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCC
Confidence 345666666666666552 34667888999999875 33 58899886421 1244567888887774222 33
Q ss_pred eeeeeeecCC-CCCCceeEEEEEeccCCCHH-----H------H---HhhCCCCcccc------ccCHHHHHH-------
Q 043932 766 KIITICSSID-SKGADFKALVFECMKNGSLE-----D------W---LHQSNDHLEVC------KLTLIQRVN------- 817 (1017)
Q Consensus 766 ~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~-----~------~---l~~~~~~~~~~------~l~~~~~~~------- 817 (1017)
+++....... ....+..++||+|++|..+. . . ++......... ...|.....
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 3332110000 00014468999999886431 0 0 11110000000 011211100
Q ss_pred -----HHHHHHHHHHHHhhC----CCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 818 -----IAIDVASAIEYLHHH----CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 818 -----i~~qi~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
+...+...++++++. .+.+++|+|+.+.||++++++.+.++||+.+.
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234445555532 23479999999999999887666899999775
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0014 Score=60.13 Aligned_cols=54 Identities=20% Similarity=0.335 Sum_probs=25.3
Q ss_pred EEeccCCccC-CCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCC
Q 043932 546 YLDISSNSFH-GVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHND 601 (1017)
Q Consensus 546 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 601 (1017)
.++.+++.|+ ..+|..+ .++|+.|+|++|+|+...+..|..+++|+.|+|++|+
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP 66 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSC
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCC
Confidence 4455555554 1223221 1345555555555554444445555555554444333
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0034 Score=71.29 Aligned_cols=75 Identities=16% Similarity=0.075 Sum_probs=47.9
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCc-eeeeeeeecCCCCCCceeEEEEEe
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL-IKIITICSSIDSKGADFKALVFEC 788 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 788 (1017)
.+.|+.|-...+|++.....+..+++|+........ -...+|..+++.+...++ .++++++. + ..||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~-------~--G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT-------N--GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET-------T--EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC-------C--eEEEEe
Confidence 356888989999999986545789999875332211 112578999988854444 55666542 1 259999
Q ss_pred ccCCCH
Q 043932 789 MKNGSL 794 (1017)
Q Consensus 789 ~~~gsL 794 (1017)
++|.++
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0077 Score=59.33 Aligned_cols=102 Identities=18% Similarity=0.146 Sum_probs=67.6
Q ss_pred CHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccccccccc
Q 043932 793 SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLD 872 (1017)
Q Consensus 793 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 872 (1017)
+|.+.++.... +++++++|.++.|.+.+|.-.-.... . ..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~~-----PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ-----PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cHHHHHHHcCC-----CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence 89999988764 89999999999999999887622111 1 1223446889999999987753 1110
Q ss_pred ccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCC
Q 043932 873 TASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923 (1017)
Q Consensus 873 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 923 (1017)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123467888763 3557788999999999999875444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0025 Score=72.04 Aligned_cols=73 Identities=19% Similarity=0.153 Sum_probs=48.8
Q ss_pred cCcccccCCceEEEEEeCC-------CcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCc-eeeeeeeecCCCCCCce
Q 043932 710 SNMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL-IKIITICSSIDSKGADF 781 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~ 781 (1017)
.+.|+.|....+|++.... ++..+++|+.... .....+.+|..+++.+...++ .++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~-------~- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS-------G- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-------T-
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC-------C-
Confidence 3567888899999998753 2467899988432 112455689999988843333 56666542 1
Q ss_pred eEEEEEeccCCC
Q 043932 782 KALVFECMKNGS 793 (1017)
Q Consensus 782 ~~lv~e~~~~gs 793 (1017)
.+|+||++|.+
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 38999998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0031 Score=69.65 Aligned_cols=145 Identities=10% Similarity=0.104 Sum_probs=82.3
Q ss_pred CcccccCCceEEEEEeCC-------CcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCcee
Q 043932 711 NMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
+.+..|....+|++.... +++.|++|+.... ........+|.++++.+. +.-..++++++..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--------- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--------- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---------
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---------
Confidence 467778889999998752 3467899986332 223456678999998884 3333566665421
Q ss_pred EEEEEeccCCCHHH--------------HH---hhCCCCcccccc-CHHHHHHHHHHHHH-------------------H
Q 043932 783 ALVFECMKNGSLED--------------WL---HQSNDHLEVCKL-TLIQRVNIAIDVAS-------------------A 825 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~--------------~l---~~~~~~~~~~~l-~~~~~~~i~~qi~~-------------------~ 825 (1017)
.+||||++|.++.. .+ +........... -+.++.++..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 28999998865431 11 111100011111 23445545444322 1
Q ss_pred HHHHh----hC-CCCCceeecCCCCceEeCCC----CCeEEeecccccc
Q 043932 826 IEYLH----HH-CQPPMVHGDLKPSNVLLDHD----MVSHVGDFGLAKF 865 (1017)
Q Consensus 826 L~~LH----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~ 865 (1017)
+..|. .. .+..++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22322 11 23468999999999999876 7899999998763
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.002 Score=59.16 Aligned_cols=57 Identities=14% Similarity=0.246 Sum_probs=39.2
Q ss_pred EEEccCCccc-ccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccC
Q 043932 522 KLIISSNQFS-GVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSG 580 (1017)
Q Consensus 522 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 580 (1017)
.++-+++.|+ ..+|..+. ++|+.|+|++|+|+.+.++.|..+++|+.|+|++|.+.-
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 5666666665 23343221 357788888888887777778888888888888887763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0089 Score=65.14 Aligned_cols=32 Identities=31% Similarity=0.305 Sum_probs=27.6
Q ss_pred CCCceeecCCCCceEeCCC----CCeEEeecccccc
Q 043932 834 QPPMVHGDLKPSNVLLDHD----MVSHVGDFGLAKF 865 (1017)
Q Consensus 834 ~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~ 865 (1017)
++.++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4489999999999999875 6889999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.99 E-value=0.006 Score=67.61 Aligned_cols=73 Identities=10% Similarity=0.122 Sum_probs=43.2
Q ss_pred CcccccCCceEEEEEeCCC--------cEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCC-ceeeeeeeecCCCCCCce
Q 043932 711 NMIGQGSFGSVYKGILGED--------EMIVAVKVINLKQKGAFKSFMAECKALRNIRHRN-LIKIITICSSIDSKGADF 781 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~ 781 (1017)
+.++.|....+|++..... +..+++|+...... .......|.++++.+.... +.++++.. .
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~------- 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N------- 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T-------
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C-------
Confidence 4678888899999987531 25788998753222 1122357888888874333 34566543 1
Q ss_pred eEEEEEeccCCC
Q 043932 782 KALVFECMKNGS 793 (1017)
Q Consensus 782 ~~lv~e~~~~gs 793 (1017)
-++||||++|.+
T Consensus 109 ~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 GGRIEEWLYGDP 120 (369)
T ss_dssp TEEEEECCCSEE
T ss_pred CcEEEEEecCCc
Confidence 158999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.90 E-value=0.01 Score=64.70 Aligned_cols=31 Identities=19% Similarity=0.305 Sum_probs=27.8
Q ss_pred CCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 835 PPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 835 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.65 E-value=0.039 Score=61.70 Aligned_cols=75 Identities=12% Similarity=0.086 Sum_probs=47.7
Q ss_pred cCcccccCCceEEEEEeCCC-------cEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCce
Q 043932 710 SNMIGQGSFGSVYKGILGED-------EMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.+.+..|-...+|++..... +..|++|+....... .-...+|..+++.+. +.-..++++.+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--------- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP--------- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET---------
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC---------
Confidence 34677788899999997631 467899986533222 122357888888874 333445554331
Q ss_pred eEEEEEeccCCCH
Q 043932 782 KALVFECMKNGSL 794 (1017)
Q Consensus 782 ~~lv~e~~~~gsL 794 (1017)
-+.||||++|.++
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2689999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.21 E-value=0.24 Score=55.15 Aligned_cols=30 Identities=23% Similarity=0.396 Sum_probs=25.3
Q ss_pred CceeecCCCCceEe------CCCCCeEEeecccccc
Q 043932 836 PMVHGDLKPSNVLL------DHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 836 ~ivH~Dlkp~NIll------~~~~~~kl~DfG~a~~ 865 (1017)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567899999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1017 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-29 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-29 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.001 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 7e-60
Identities = 79/300 (26%), Positives = 129/300 (43%), Gaps = 51/300 (17%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKII 768
IG GSFG+VYKG D VAVK++N+ ++F E LR RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
++ A+V + + SL LH K +I+ ++IA A ++Y
Sbjct: 71 GYSTA------PQLAIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDY 119
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
LH ++H DLK +N+ L D+ +GDFGLA S + + G++
Sbjct: 120 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ------LSGSI 170
Query: 889 GYVAPEYCMGSEA---SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945
++APE + S DVY+FGI+L EL TG+ P ++ I ++
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINNRDQ 217
Query: 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+I +V + D+ C A+ R+ C + ER ++A +
Sbjct: 218 IIFMV----------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (483), Expect = 1e-54
Identities = 76/323 (23%), Positives = 144/323 (44%), Gaps = 56/323 (17%)
Query: 696 SYAELSKATSEFASS---------NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ- 742
++ + ++A EFA +IG G FG V G L G+ E+ VA+K +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 743 KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSN 802
+ + F++E + H N+I + + + + ++ E M+NGSL+ +L Q++
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122
Query: 803 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862
+ T+IQ V + +A+ ++YL VH DL N+L++ ++V V DFGL
Sbjct: 123 -----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRR 922
++FL DT+ T +S++G K + + APE + + DV+S+GI++ E+ +
Sbjct: 175 SRFLED---DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIR 982
T + VI ++ Q+ +C +A+ +
Sbjct: 232 RPYWDMT-------------NQDVINAIE--------------QDYRLPPPMDCPSALHQ 264
Query: 983 IGVLCSMESPFERMEMRDVVAKL 1005
+ + C + R + +V L
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-53
Identities = 62/309 (20%), Positives = 119/309 (38%), Gaps = 27/309 (8%)
Query: 700 LSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKS-FMAECKALRN 758
+ +F + +G G+ G V+K +++A K+I+L+ K A ++ + E + L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 759 IRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
++ S ++ E M GSL+ L ++ ++ +
Sbjct: 61 CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKV 109
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
+I V + YL ++H D+KPSN+L++ + DFG++ L ++
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 162
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938
GT Y++PE G+ S+ D++S G+ L+E+ GR P + L L
Sbjct: 163 -----FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEM 998
++ E ++ + E L+ I+ F E
Sbjct: 218 QVE--GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL-EF 274
Query: 999 RDVVAKLCH 1007
+D V K
Sbjct: 275 QDFVNKCLI 283
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-52
Identities = 68/301 (22%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G FG V+ G VAVK + + + +F+AE ++ ++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
+ ++ E M+NGSL D+L + KLT+ + +++A +A + ++
Sbjct: 79 Q------EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEER 128
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
+H DL+ +N+L+ + + DFGLA+ + ++ G K + + A
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-------GAKFPIKWTA 178
Query: 893 PEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDP 952
PE ++ DV+SFGILL E+ T R T + E+ +V P
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP 232
Query: 953 LLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012
C + ++ LC E P +R + + L E F
Sbjct: 233 ---------------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVL----EDF 267
Query: 1013 F 1013
F
Sbjct: 268 F 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-51
Identities = 62/304 (20%), Positives = 119/304 (39%), Gaps = 33/304 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG+G FG V++G VAVK+ + +++ ++ AE +RH N++ I +
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
+ LV + ++GSL D+L++ +T+ + +A+ AS + +LH
Sbjct: 68 KDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHME 119
Query: 833 C-----QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+P + H DLK N+L+ + + D GLA S + GT
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT----DTIDIAPNHRVGT 175
Query: 888 VGYVAPEYCMGSEASMTG------DVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941
Y+APE S D+Y+ G++ E+ + +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ---LPYYDLV 232
Query: 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDV 1001
+ +E + ++ + + N R ++ E L + +I C + R+ +
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 1002 VAKL 1005
L
Sbjct: 289 KKTL 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 63/271 (23%), Positives = 115/271 (42%), Gaps = 27/271 (9%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
IG+GSF +VYKG+ E + VA + ++ K + F E + L+ ++H N+++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
S KG LV E M +G+L+ +L + + + + + +++LH
Sbjct: 77 WES-TVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLH 129
Query: 831 HHCQPPMVHGDLKPSNVLL-DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
PP++H DLK N+ + +GD GLA + + GT
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----------VIGTPE 178
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949
++APE + + DVY+FG+ +LE+ T P P ++
Sbjct: 179 FMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 950 VDPLLLIEVMANNSMIQEDI--RAKTQECLN 978
P + E++ I+++ R ++ LN
Sbjct: 238 AIP-EVKEII--EGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 6e-50
Identities = 68/309 (22%), Positives = 127/309 (41%), Gaps = 47/309 (15%)
Query: 710 SNMIGQGSFGSVYKGILGED---EMIVAVKVIN-LKQKGAFKSFMAECKALRNIRHRNLI 765
+ +IG+G FG VY G L ++ ++ AVK +N + G F+ E +++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
++ IC + S+G+ +V MK+G L +++ + V + + VA
Sbjct: 92 SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKG 142
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+ VH DL N +LD V DFGLA+ + + D+ + G K
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS----VHNKTGAK 195
Query: 886 GTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945
V ++A E + + DV+SFG+LL EL T P + +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFD--------- 242
Query: 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+ + ++ ++Q + C + + + + C R ++V+++
Sbjct: 243 --------ITVYLLQGRRLLQPE------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288
Query: 1006 CHTRETFFG 1014
TF G
Sbjct: 289 SAIFSTFIG 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-49
Identities = 66/306 (21%), Positives = 130/306 (42%), Gaps = 50/306 (16%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNI 759
S +IG G FG VYKG+L G+ E+ VA+K + + F+ E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 760 RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
H N+I++ + S ++ E M+NG+L+ +L + + +++Q V +
Sbjct: 67 SHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKDGEF-----SVLQLVGML 116
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+A+ + + VH DL N+L++ ++V V DFGL++ L + +
Sbjct: 117 RGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATY 168
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939
++ G K + + APE + + DV+SFGI++ E+ T +
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------- 218
Query: 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999
+V++ ++ + +C +AI ++ + C + R +
Sbjct: 219 ---NHEVMKAINDGFRLP--------------TPMDCPSAIYQLMMQCWQQERARRPKFA 261
Query: 1000 DVVAKL 1005
D+V+ L
Sbjct: 262 DIVSIL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-49
Identities = 59/299 (19%), Positives = 114/299 (38%), Gaps = 51/299 (17%)
Query: 713 IGQGSFGSVYKGIL--GEDEMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G G+FGSV +G+ + ++ VA+KV+ +K + M E + + + + ++++I
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+C + LV E G L +L + + + + V+ ++YL
Sbjct: 77 VCQAEA------LMLVMEMAGGGPLHKFLVGKREEI-----PVSNVAELLHQVSMGMKYL 125
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
VH DL NVLL + + + DFGL+K L + ++ K +
Sbjct: 126 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLK 177
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEKVIE 948
+ APE + S DV+S+G+ + E + G++P + E K +E
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-----KMKGPEVMAFIEQGKRME 232
Query: 949 IVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCH 1007
EC + + C + +R + V ++
Sbjct: 233 CPP-----------------------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-49
Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 49/295 (16%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITI 770
+GQG FG V+ G VA+K + + ++F+ E + ++ +RH L+++ +
Sbjct: 23 VKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
S + +V E M GSL D+L Q V++A +AS + Y+
Sbjct: 81 VSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVE 130
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
VH DL+ +N+L+ ++V V DFGLA+ + ++ ++ G K + +
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPIKW 180
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIV 950
APE + ++ DV+SFGILL EL T R +V++ V
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------------NREVLDQV 227
Query: 951 DPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+ + EC ++ + C + P ER + A L
Sbjct: 228 ERGYRMPC--------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 4e-49
Identities = 63/310 (20%), Positives = 133/310 (42%), Gaps = 47/310 (15%)
Query: 696 SYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKA 755
+Y + ++ + +G G +G VY+G+ + + VAVK + + + F+ E
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66
Query: 756 LRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQR 815
++ I+H NL++++ +C+ ++ E M G+L D+L + N +++ +
Sbjct: 67 MKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVL 117
Query: 816 VNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTAS 875
+ +A ++SA+EYL +H DL N L+ + + V DFGL++ ++
Sbjct: 118 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 168
Query: 876 KTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH 935
T ++ G K + + APE ++ S+ DV++FG+LL E+ T G+ L
Sbjct: 169 -TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLS 223
Query: 936 EFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFER 995
+ ++ + +E + C + + C +P +R
Sbjct: 224 QVYELLEKDYRMERPE-----------------------GCPEKVYELMRACWQWNPSDR 260
Query: 996 MEMRDVVAKL 1005
++
Sbjct: 261 PSFAEIHQAF 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITI 770
IG GS+G K D I+ K ++ + + ++E LR ++H N+++
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
+ +V E + G L + + E L + + + A++ H
Sbjct: 72 IID---RTNTTLYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECH 126
Query: 831 HH--CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
++H DLKP+NV LD +GDFGLA+ L+ +S + GT
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--------DTSFAKAFVGTP 178
Query: 889 GYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y++PE + D++S G LL EL P
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 6e-48
Identities = 61/301 (20%), Positives = 111/301 (36%), Gaps = 51/301 (16%)
Query: 711 NMIGQGSFGSVYKGIL--GEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIK 766
+G G+FG+V KG + VAVK++ + +AE ++ + + +++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+I IC + + LV E + G L +L Q+ + + + V+ +
Sbjct: 73 MIGICEA------ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGM 120
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
+YL VH DL NVLL + + DFGL+K L + + + K
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKW 172
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946
V + APE + S DV+SFG+L+ E F+ + +V
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------------GSEV 219
Query: 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLC 1006
+++ + + C + + LC R V +L
Sbjct: 220 TAMLE--------------KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
Query: 1007 H 1007
+
Sbjct: 266 N 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 79/297 (26%), Positives = 118/297 (39%), Gaps = 53/297 (17%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG+G FG V G VAVK I K ++F+AE + +RH NL++++ +
Sbjct: 15 IGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 69
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
++ KG + +V E M GSL D+L + L + ++DV A+EYL +
Sbjct: 70 -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 122
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
VH DL NVL+ D V+ V DFGL K SS Q K V + A
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----------KLPVKWTA 168
Query: 893 PEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDP 952
PE + S DV+SFGILL E+++ R + L + ++ D
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDAPD- 223
Query: 953 LLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009
C A+ + C R + +L H +
Sbjct: 224 ----------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 57/246 (23%), Positives = 103/246 (41%), Gaps = 28/246 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G+G FG+VY + + I+A+KV+ L++ G E + ++RH N++++
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
A L+ E G++ L + + K + ++A+A+ Y
Sbjct: 74 YFHD-----ATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYC 122
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H ++H D+KP N+LL + DFG + S + T + GT+
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----------LCGTLD 169
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAA-FTEGLTLHEFAKIALPEKVIE 948
Y+ PE G D++S G+L E G+ P +A + E + P+ V E
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229
Query: 949 IVDPLL 954
L+
Sbjct: 230 GARDLI 235
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 65/301 (21%), Positives = 117/301 (38%), Gaps = 49/301 (16%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNL 764
SE IG G FG V+ G ++ VA+K I + + + F+ E + + + H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
+++ +C LVFE M++G L D+L + + + +DV
Sbjct: 63 VQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCE 112
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
+ + + ++H DL N L+ + V V DFG+ +F+ Q +SS G
Sbjct: 113 G---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-------YTSSTGT 162
Query: 885 KGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944
K V + +PE S S DV+SFG+L+ E+F+ + + + +
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------S 216
Query: 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004
+ P + + +I C E P +R ++ +
Sbjct: 217 TGFRLYKP---------------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
Query: 1005 L 1005
L
Sbjct: 256 L 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-46
Identities = 65/293 (22%), Positives = 119/293 (40%), Gaps = 49/293 (16%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G FG V G + VA+K+I + + F+ E K + N+ H L+++ +C+
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
++ E M NG L ++L + + Q + + DV A+EYL
Sbjct: 70 K-----QRPIFIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
+H DL N L++ V V DFGL++++ + +SS+G K V +
Sbjct: 120 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-------YTSSVGSKFPVRWSP 169
Query: 893 PEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDP 952
PE M S+ S D+++FG+L+ E+++ + FT + E +
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------------NSETAEHIAQ 216
Query: 953 LLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
L + + + I C E ER + +++ +
Sbjct: 217 GLRLY--------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 26/216 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G+FG VYK E ++ A KVI+ K + + +M E L + H N++K++
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
+ ++ E G+++ + + LT Q + A+ YLH +
Sbjct: 80 Y-----ENNLWILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN 129
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA 892
++H DLK N+L D + DFG++ ++T GT ++A
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN--------TRTIQRRDSFIGTPYWMA 178
Query: 893 PEYCMGSEASMTG-----DVYSFGILLLELFTGRRP 923
PE M + DV+S GI L+E+ P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-46
Identities = 56/272 (20%), Positives = 102/272 (37%), Gaps = 31/272 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITIC 771
+G+G++G V + E VAVK++++K+ ++ E + + H N++K
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+ + + L E G L D + + + + + YLH
Sbjct: 73 -----REGNIQYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG 121
Query: 832 HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYV 891
+ H D+KP N+LLD + DFGLA + + + GT+ YV
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 172
Query: 892 APEYCMGSE-ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIV 950
APE E + DV+S GI+L + G P D ++ + + +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 951 DPLL--LIEVMANNSMIQEDI--RAKTQECLN 978
D L+ ++ E+ R +
Sbjct: 233 DSAPLALLH-----KILVENPSARITIPDIKK 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (417), Expect = 7e-46
Identities = 66/334 (19%), Positives = 119/334 (35%), Gaps = 65/334 (19%)
Query: 696 SYAELSKATSEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLK-QKGAFKSF 749
L + IG+G+FG V++ E +VAVK++ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 750 MAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVC- 808
E + + N++K++ +C+ L+FE M G L ++L + H
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 809 -----------------KLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 851
L+ +++ IA VA+ + YL VH DL N L+
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175
Query: 852 DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFG 911
+MV + DFGL++ + S A + ++ PE + + DV+++G
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGN------DAIPIRWMPPESIFYNRYTTESDVWAYG 229
Query: 912 ILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRA 971
++L E+F+ E+VI V +I A
Sbjct: 230 VVLWEIFSYGLQPYYGMA-------------HEEVIYYV--------------RDGNILA 262
Query: 972 KTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+ C + + LC + P +R + L
Sbjct: 263 CPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 9e-46
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITI 770
IGQG+ G+VY + VA++ +NL+Q+ + + E +R ++ N++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
D +V E + GSL D + ++ Q + + A+E+LH
Sbjct: 86 YLV-----GDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLH 133
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ ++H D+K N+LL D + DFG ++ Q ++ + GT +
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--------MVGTPYW 182
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
+APE D++S GI+ +E+ G P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 7e-45
Identities = 52/223 (23%), Positives = 87/223 (39%), Gaps = 32/223 (14%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRN 763
F+ IG GSFG+VY + +VA+K ++ K ++ + E + L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
I+ LV E + + L ++ +
Sbjct: 77 TIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGAL 125
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
+ YLH H M+H D+K N+LL + +GDFG A + + +
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------APANS 170
Query: 884 IKGTVGYVAPEYCMGS---EASMTGDVYSFGILLLELFTGRRP 923
GT ++APE + + DV+S GI +EL + P
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 8e-45
Identities = 65/328 (19%), Positives = 126/328 (38%), Gaps = 65/328 (19%)
Query: 692 FPTVSYAELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKS 748
+P + + ++ ++IG+G+FG V K + +D + + + +K+ K +
Sbjct: 4 YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 749 FMAECKALRNI-RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSN----- 802
F E + L + H N+I ++ C + + L E +G+L D+L +S
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 803 -----DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857
+ L+ Q ++ A DVA + + Q +H DL N+L+ + V+ +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKI 168
Query: 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLEL 917
DFGL++ + T + V ++A E S + DV+S+G+LL E+
Sbjct: 169 ADFGLSRGQEVYVKKTMG---------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 918 FTGRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECL 977
+ G+T E + +E C
Sbjct: 220 VSLGGT----PYCGMTCAELYEKLPQGYRLEKPL-----------------------NCD 252
Query: 978 NAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+ + + C E P+ER ++ L
Sbjct: 253 DEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-44
Identities = 63/318 (19%), Positives = 114/318 (35%), Gaps = 64/318 (20%)
Query: 712 MIGQGSFGSVYKGIL-----GEDEMIVAVKVINLK-QKGAFKSFMAECKALRNI-RHRNL 764
++G G+FG V + VAVK++ K ++ M+E K + + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL-----------------EV 807
+ ++ C+ + L+FE G L ++L + ++
Sbjct: 104 VNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 808 CKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867
LT + A VA +E+L VH DL NVL+ H V + DFGLA+ +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 868 SHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAA 927
S + V ++APE ++ DV+S+GILL E+F+
Sbjct: 216 SDS------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--- 266
Query: 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLC 987
+ I + +++ ++ + I I C
Sbjct: 267 ---------YPGIPVDANFYKLIQNGFKMD--------------QPFYATEEIYIIMQSC 303
Query: 988 SMESPFERMEMRDVVAKL 1005
+R ++ + L
Sbjct: 304 WAFDSRKRPSFPNLTSFL 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 7e-44
Identities = 63/306 (20%), Positives = 122/306 (39%), Gaps = 52/306 (16%)
Query: 705 SEFASSNMIGQGSFGSVYKGILGED----EMIVAVKVINL-KQKGAFKSFMAECKALRNI 759
+EF ++G G+FG+VYKG+ + ++ VA+K + A K + E + ++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 760 RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
+ ++ +++ IC + L+ + M G L D++ + D++ +N
Sbjct: 69 DNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNI-----GSQYLLNWC 117
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
+ +A + YL +VH DL NVL+ + DFGLAK L + +
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE------KEY 168
Query: 880 SSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939
+ G K + ++A E + + DV+S+G+ + EL T +G+ E +
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASEISS 224
Query: 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999
I + + C + I V C M R + R
Sbjct: 225 ILEKGERLPQPP-----------------------ICTIDVYMIMVKCWMIDADSRPKFR 261
Query: 1000 DVVAKL 1005
+++ +
Sbjct: 262 ELIIEF 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-43
Identities = 71/299 (23%), Positives = 106/299 (35%), Gaps = 51/299 (17%)
Query: 713 IGQGSFGSVYKGIL---GEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIK 766
+G GSFG V +G + VAVK + L Q A F+ E A+ ++ HRNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + + +V E GSL D L + H L A+ VA +
Sbjct: 76 LYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGHF-----LLGTLSRYAVQVAEGM 124
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
YL +H DL N+LL + +GDFGL + L + + K
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH-----RKV 176
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKV 946
+ APE S D + FG+ L E+FT + LH KI +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---KIDKEGER 233
Query: 947 IEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+ + +C I + V C P +R + L
Sbjct: 234 LPRPE-----------------------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 59/319 (18%), Positives = 122/319 (38%), Gaps = 51/319 (15%)
Query: 705 SEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFKSFMAECKALRN 758
+ S +GQGSFG VY+G+ E E VA+K +N F+ E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 759 IRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLE----VCKLTLIQ 814
++++++ + S ++ E M G L+ +L + + +L +
Sbjct: 80 FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 815 RVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTA 874
+ +A ++A + YL+ + VH DL N ++ D +GDFG+ + +
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 875 SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934
V +++PE + DV+SFG++L E+ T +GL+
Sbjct: 192 GGK------GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSN 241
Query: 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE 994
+ + + +++ D C + + + +C +P
Sbjct: 242 EQVLRFVMEGGLLDKPD-----------------------NCPDMLFELMRMCWQYNPKM 278
Query: 995 RMEMRDVVAKLCHTRETFF 1013
R ++++ + E F
Sbjct: 279 RPSFLEIISSIKEEMEPGF 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 59/312 (18%), Positives = 107/312 (34%), Gaps = 59/312 (18%)
Query: 713 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLI 765
+G G+FG V + + M VAVK++ ++ M+E K L + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHL------------EVCKLTLI 813
++ C+ ++ E G L ++L + D + L L
Sbjct: 91 NLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 814 QRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
++ + VA + +L +H DL N+LL H ++ + DFGLA+ + +
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 199
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933
+ V ++APE + DV+S+GI L ELF+
Sbjct: 200 ---NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPF 993
++ K E + I C P
Sbjct: 257 FYKMIKEGFRMLSPE--------------------------HAPAEMYDIMKTCWDADPL 290
Query: 994 ERMEMRDVVAKL 1005
+R + +V +
Sbjct: 291 KRPTFKQIVQLI 302
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 159 bits (403), Expect = 2e-43
Identities = 46/213 (21%), Positives = 83/213 (38%), Gaps = 24/213 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G+FG V++ A K + + ++ E + + +RH L+ +
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
+ +++E M G L + + ++ K++ + V V + ++H +
Sbjct: 94 D-----DNEMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
VH DLKP N++ + + DFGL L Q S GT +
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---------SVKVTTGTAEF 191
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
APE G D++S G+L L +G P
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-43
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 23/225 (10%)
Query: 702 KATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRN 758
K +F ++G+GSF +V A+K++ + ++ E +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 759 IRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNI 818
+ H +K+ + KNG L ++ +
Sbjct: 65 LDHPFFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRKIG------SFDETCTRFY 113
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTS 878
++ SA+EYLH ++H DLKP N+LL+ DM + DFG AK LS + +
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS- 169
Query: 879 SSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
GT YV+PE A + D+++ G ++ +L G P
Sbjct: 170 -----FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 156 bits (395), Expect = 3e-42
Identities = 54/273 (19%), Positives = 98/273 (35%), Gaps = 34/273 (12%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G G+FG V++ + + K IN + E + + H LI +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
L+ E + G L D + + K++ + +N ++++H H
Sbjct: 97 D-----KYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 146
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+VH D+KP N++ + S V DFGLA L+ ++ T +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---------VKVTTATAEF 194
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRP-TDAAFTEGLTLHEFAKIALPEKVIEI 949
APE D+++ G+L L +G P E L + E
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 950 VDPLL--LIEVMANNSMIQEDI--RAKTQECLN 978
V P I+ +++Q++ R + L
Sbjct: 255 VSPEAKDFIK-----NLLQKEPRKRLTVHDALE 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (387), Expect = 4e-42
Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 18/215 (8%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKII 768
++G G V+ VAVKV+ + + F E + + H ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ G +V E + +L D +H +T + + + D A+ +
Sbjct: 74 DTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNF 126
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
H + ++H D+KP+N+++ V DFG+A+ ++ + + GT
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-----VIGTA 178
Query: 889 GYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y++PE G DVYS G +L E+ TG P
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-40
Identities = 56/298 (18%), Positives = 106/298 (35%), Gaps = 52/298 (17%)
Query: 712 MIGQGSFGSVYKGIL---GEDEMIVAVKVI-NLKQKGAFKSFMAECKALRNIRHRNLIKI 767
IG+G FG V++GI + VA+K N + F+ E +R H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
I + + + ++ E G L +L L L + A +++A
Sbjct: 74 IGVITE------NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTA-- 120
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
L + VH D+ NVL+ + +GDFGL++++ ASK K
Sbjct: 121 -LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-------GKLP 172
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVI 947
+ ++APE + DV+ FG+ + E+
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----------------N 216
Query: 948 EIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005
+++ + E + + + +C P R ++ A+L
Sbjct: 217 DVIGRIENGERLPMPPNCPPTLYSLMTKCWA-----------YDPSRRPRFTELKAQL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 9e-40
Identities = 62/312 (19%), Positives = 113/312 (36%), Gaps = 60/312 (19%)
Query: 713 IGQGSFGSVYKGIL-------GEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRN 763
+G+G+FG V VAVK++ + ++E + ++ I +H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQ----------SNDHLEVCKLTLI 813
+I ++ C+ ++ E G+L ++L + H +L+
Sbjct: 81 IINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135
Query: 814 QRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
V+ A VA + + +H DL NVL+ D V + DFGLA+ +
Sbjct: 136 DLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH----- 187
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933
+ + V ++APE + DV+SFG+LL E+FT G+
Sbjct: 188 -IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVP 242
Query: 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPF 993
+ E K+ ++ C N + + C P
Sbjct: 243 VEELFKLLKEGHRMDKPS-----------------------NCTNELYMMMRDCWHAVPS 279
Query: 994 ERMEMRDVVAKL 1005
+R + +V L
Sbjct: 280 QRPTFKQLVEDL 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 8e-39
Identities = 60/311 (19%), Positives = 106/311 (34%), Gaps = 54/311 (17%)
Query: 711 NMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNL 764
+G+G+FG V + VAVK++ ++ M+E K L +I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 765 IKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCK----------LTLIQ 814
+ + + ++ E K G+L +L + K LTL
Sbjct: 79 VVNLLGACTKPG---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 815 RVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTA 874
+ + VA +E+L +H DL N+LL V + DFGLA+ +
Sbjct: 136 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---- 188
Query: 875 SKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934
+ + ++APE ++ DV+SFG+LL E+F+ +
Sbjct: 189 --DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKID 243
Query: 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFE 994
EF + + D + + + C P +
Sbjct: 244 EEFCRRLKEGTRMRAPD-----------------------YTTPEMYQTMLDCWHGEPSQ 280
Query: 995 RMEMRDVVAKL 1005
R ++V L
Sbjct: 281 RPTFSELVEHL 291
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 2e-38
Identities = 51/214 (23%), Positives = 78/214 (36%), Gaps = 21/214 (9%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIIT 769
+++G G+F V + +VA+K I K +G S E L I+H N++ +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
I S L+ + + G L D + + T + V A++YL
Sbjct: 75 IYES-----GGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYL 123
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H LD D + DFGL+K + + GT G
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---------TACGTPG 174
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
YVAPE S D +S G++ L G P
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (359), Expect = 2e-38
Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 39/229 (17%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF---------KSFMAECKALRNIR- 760
++G+G V + I AVK+I++ G+F ++ + E LR +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 820
H N+I++ + F LVF+ MK G L D+L + L+ + I
Sbjct: 69 HPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMR 117
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSS 880
+ I LH +VH DLKP N+LLD DM + DFG + L +
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR------- 167
Query: 881 SIGIKGTVGYVAPEYCMGSEASMTG------DVYSFGILLLELFTGRRP 923
+ GT Y+APE S D++S G+++ L G P
Sbjct: 168 --EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 26/217 (11%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKAL-RNIRHRNLIK 766
M+G+GSFG V+ + A+K + + + M E + L H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + + V E + G L + + K L + A ++ +
Sbjct: 68 MFCTFQT-----KENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGL 116
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKG 886
++LH +V+ DLK N+LLD D + DFG+ K + + G
Sbjct: 117 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--------AKTNTFCG 165
Query: 887 TVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T Y+APE +G + + + D +SFG+LL E+ G+ P
Sbjct: 166 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (363), Expect = 5e-38
Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 33/263 (12%)
Query: 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK------QKGAFKSFMAECKALRNI 759
+F+ +IG+G FG VY + + A+K ++ K + + +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 760 RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIA 819
++ + + D + + + M G L L Q E A
Sbjct: 65 DCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQHGVFSE------ADMRFYA 113
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSS 879
++ +E++H+ +V+ DLKP+N+LLD + D GLA S +
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA------ 164
Query: 880 SSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938
GT GY+APE A + D +S G +L +L G P T+ +
Sbjct: 165 ----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
Query: 939 KIALPEKVIEIVDPLL--LIEVM 959
+ + ++ + P L L+E +
Sbjct: 221 TLTMAVELPDSFSPELRSLLEGL 243
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (357), Expect = 7e-38
Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 19/217 (8%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITIC 771
IG GSFG +Y G VA+K+ +K K E K + ++ I I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
+ D+ +V E + + + S K +L + +A + S IEY+H
Sbjct: 72 GAEG----DYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHS 121
Query: 832 HCQPPMVHGDLKPSNVL---LDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
+H D+KP N L + ++ DFGLAK + + + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK-NLTGTA 177
Query: 889 GYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
Y + +G E S D+ S G +L+ G P
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-38
Identities = 45/213 (21%), Positives = 83/213 (38%), Gaps = 25/213 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
+G+G FG V++ + + K + +K E L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
S + ++FE + + + ++ S +L + V+ V A+++LH H
Sbjct: 72 S-----MEELVMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH 121
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHV--GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
+ H D++P N++ S + +FG A+ L + Y
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---------LFTAPEY 169
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
APE S D++S G L+ L +G P
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-37
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 18/215 (8%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+ IG+G++G V +++ VA+K I+ + + + + E K L RH N+I I
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
I + + LV M L L L+ + ++Y+
Sbjct: 74 IIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYI 125
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H ++H DLKPSN+LL+ + DFGLA+ T T T
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE-----YVATRW 177
Query: 890 YVAPEYCMGSEASMT-GDVYSFGILLLELFTGRRP 923
Y APE + S+ D++S G +L E+ + R
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-37
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 22/220 (10%)
Query: 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIK 766
+ + +IG GSFG VY+ L + +VA+K + + + E + +R + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 767 IITIC-SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+ SS + K + LV + + H S L +I + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHD-MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGI 884
+ Y+H + H D+KP N+LLD D V + DFG AK L + + +
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---------VSY 182
Query: 885 KGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRP 923
+ Y APE G+ + + DV+S G +L EL G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-37
Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 26/237 (10%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKAL-RNIRHRNLIKIITI 770
++G G G V + + A+K++ K E + R + ++++I+ +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
++ + +V EC+ G L + D T + I + AI+YLH
Sbjct: 74 YENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLH 128
Query: 831 HHCQPPMVHGDLKPSNVLLDH---DMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+ H D+KP N+L + + + DFG AK +SH S T
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYT 176
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944
YVAPE + + D++S G+++ L G P + ++ +I + +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (353), Expect = 4e-37
Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 28/214 (13%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIIT 769
+G GSFG V+ + A+KV+ + + + E L + H +I++
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 770 ICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
A ++ + ++ G L L +S V L
Sbjct: 72 TFQD-----AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV---------CLAL 117
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
+ +++ DLKP N+LLD + + DFG AK++ + GT
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----------LCGTPD 166
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y+APE + + D +SFGIL+ E+ G P
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 7e-37
Identities = 65/316 (20%), Positives = 125/316 (39%), Gaps = 32/316 (10%)
Query: 700 LSKATSEFASSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLK--QKGAFKSFMAECKAL 756
L +A ++ IG+G++G V+K L VA+K + ++ ++G S + E L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 757 RNI---RHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLI 813
R++ H N++++ +C+ + LVFE + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTE 116
Query: 814 QRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDT 873
++ + +++LH H +VH DLKP N+L+ + DFGLA+ S T
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 173
Query: 874 ASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933
+ T+ Y APE + S + D++S G + E+F + +
Sbjct: 174 ---------SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224
Query: 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSM--IQEDIRAKTQECLNAIIRIGVLCSMES 991
I LP + D L + + S I++ + + + +++ C +
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK----CLTFN 280
Query: 992 PFERMEMRDVVAKLCH 1007
P +R+ L H
Sbjct: 281 PAKRISAYSA---LSH 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-36
Identities = 63/299 (21%), Positives = 132/299 (44%), Gaps = 24/299 (8%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITI 770
IGQG+FG V+K + VA+K + ++ ++G + + E K L+ ++H N++ +I I
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 771 CSSIDSKGADFKA---LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
C + S K LVF+ ++ + K TL + + + +
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNG-- 129
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
L++ + ++H D+K +NVL+ D V + DFGLA+ S + ++ ++ T
Sbjct: 130 -LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN----RVVT 184
Query: 888 VGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI--ALPE 944
+ Y PE +G D++ G ++ E++T TE L +++ ++
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSITP 243
Query: 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSM--ESPFERMEMRDV 1001
+V VD L E + + ++ + + + + ++ + P +R++ D
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 28/219 (12%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK-----QKGAFKSFMAECKALRNIRHRNLI 765
+ +G+G F +VYK IVA+K I L + G ++ + E K L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
++ +LVF+ M+ S +
Sbjct: 64 GLLDAFGH-----KSNISLVFDFMETDLEVIIKDNSLVLTPS------HIKAYMLMTLQG 112
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+EYLH H ++H DLKP+N+LLD + V + DFGLAK S +
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--------RAYTHQV 161
Query: 886 GTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRP 923
T Y APE G+ + D+++ G +L EL
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 8e-35
Identities = 47/221 (21%), Positives = 84/221 (38%), Gaps = 33/221 (14%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLK------QKGAFKSFMAECKALRNIRHRNLIK 766
+G G F V K + A K I + + + + E L+ I+H N+I
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 767 IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 826
+ + + L+ E + G L D+L + E ++++ +
Sbjct: 78 LHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---------L 123
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDHDMVS----HVGDFGLAKFLSSHQLDTASKTSSSSI 882
+++ + H DLKP N++L V + DFGLA + +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---------GNEFK 174
Query: 883 GIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
I GT +VAPE + D++S G++ L +G P
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (333), Expect = 8e-35
Identities = 38/218 (17%), Positives = 73/218 (33%), Gaps = 21/218 (9%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICS 772
IG+GSFG +++G + VA+K + E + + + I +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 773 SIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 832
LV + + + K ++ A + + ++ +H
Sbjct: 71 QEG----LHNVLVIDLLGPSLEDLLDLCGR------KFSVKTVAMAAKQMLARVQSIHEK 120
Query: 833 CQPPMVHGDLKPSNVLLDHDMVSHVG-----DFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
+V+ D+KP N L+ + DFG+ KF + GT
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK-NLSGT 176
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTD 925
Y++ +G E S D+ + G + + G P
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-34
Identities = 52/240 (21%), Positives = 89/240 (37%), Gaps = 26/240 (10%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKI 767
++G+G+FG V A+K++ + K + E + L+N RH L +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 768 ITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 827
+ D V E G L L + T + ++ SA
Sbjct: 71 KYAFQT-----HDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSA-- 117
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGT 887
L + +V+ D+K N++LD D + DFGL K S ++ GT
Sbjct: 118 -LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMKTFCGT 168
Query: 888 VGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP-TDAAFTEGLTLHEFAKIALPEKV 946
Y+APE ++ D + G+++ E+ GR P + L +I P +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 228
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 8e-34
Identities = 46/230 (20%), Positives = 89/230 (38%), Gaps = 23/230 (10%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITI 770
IG+G++G+V+K E IVA+K + L +G S + E L+ ++H+N++++ +
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 830
S LVFE + + + D + + ++ ++ L
Sbjct: 70 LHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL---------LKGLG 115
Query: 831 HHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
++H DLKP N+L++ + + +FGLA+ S +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-------VRCYSAEVVTLWYR 168
Query: 891 VAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940
S + D++S G + EL RP L ++
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (324), Expect = 3e-33
Identities = 57/270 (21%), Positives = 107/270 (39%), Gaps = 30/270 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITIC 771
+G+G + V++ I + V VK++ +K K E K L N+R N+I + I
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 99
Query: 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 831
S+ ALVFE + N + LT ++ A++Y H
Sbjct: 100 KDPVSR---TPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS 147
Query: 832 HCQPPMVHGDLKPSNVLLDHD-MVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGY 890
++H D+KP NV++DH+ + D+GLA+F Q + +
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---------VRVASRYF 195
Query: 891 VAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEKVIEI 949
PE + + + D++S G +L + + P L AK+ E + +
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 950 VDPLLLIEVMANNSMIQEDIRAKTQECLNA 979
+D + N ++ R + + +++
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHS 285
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 4e-33
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 30/233 (12%)
Query: 699 ELSKATSEFASS----NMIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAFKSFMAE 752
E++K E + +G G++G+V + G VA+K + + + K E
Sbjct: 8 EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67
Query: 753 CKALRNIRHRNLIKIITICSSIDSKGADFK-ALVFECMKNGSLEDWLHQSNDHLEVCKLT 811
+ L+++RH N+I ++ + + ++ LV M G+ L + KL
Sbjct: 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE------KLG 119
Query: 812 LIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQL 871
+ + + + Y+H ++H DLKP N+ ++ D + DFGLA+ S
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-- 174
Query: 872 DTASKTSSSSIGIKGTVGYVAPEYCMGSE-ASMTGDVYSFGILLLELFTGRRP 923
G T Y APE + + T D++S G ++ E+ TG+
Sbjct: 175 ---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-32
Identities = 49/253 (19%), Positives = 86/253 (33%), Gaps = 34/253 (13%)
Query: 712 MIGQGSFGSVYKGILGEDEMIVAVKVINLK------QKGAFKSFMAECKALRNIR--HRN 763
++G G FGSVY GI D + VA+K + + E L+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 764 LIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 823
+I+++ D L+ E + L + V
Sbjct: 71 VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVL 120
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVSHVGDFGLAKFLSSHQLDTASKTSSSSI 882
A+ + H+ ++H D+K N+L+D + + DFG L
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD--------- 168
Query: 883 GIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941
GT Y PE+ + V+S GILL ++ G P + E + F +
Sbjct: 169 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-EEIIRGQVFFRQR 226
Query: 942 LPEKVIEIVDPLL 954
+ + ++ L
Sbjct: 227 VSSECQHLIRWCL 239
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 1e-32
Identities = 53/264 (20%), Positives = 98/264 (37%), Gaps = 44/264 (16%)
Query: 673 ARRRRSARKSVDTSPREKQFPTVSYAELSKATSEFASSNM----------IGQGSFGSVY 722
A ++ S ++SV K+F + + K + + +G GSFG V
Sbjct: 5 AAKKGSEQESV------KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 723 KGILGEDEMIVAVKVIN---LKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779
E A+K+++ + + + + E + L+ + L+K+
Sbjct: 59 LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS---- 114
Query: 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVH 839
+V E + G + L + + + A + EYLH +++
Sbjct: 115 -NLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 840 GDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS 899
DLKP N+L+D V DFG AK + + GT +APE +
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----------LCGTPEALAPEIILSK 213
Query: 900 EASMTGDVYSFGILLLELFTGRRP 923
+ D ++ G+L+ E+ G P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKII 768
IG+G++G VYK +VA+K I L +G + + E L+ + H N++K++
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ + + LVFE + L + D + + L + + + +
Sbjct: 68 DVIHT-----ENKLYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
H H ++H DLKP N+L++ + + DFGLA+ + T+
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--------PVRTYTHEVVTL 166
Query: 889 GYVAPEYCMGSEASMTG-DVYSFGILLLELFTGRRP 923
Y APE +G + T D++S G + E+ T R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-31
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 28/238 (11%)
Query: 693 PTVSYAELSKATSEFASS----NMIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAF 746
PT EL+K E + +G G++GSV + + VAVK ++ +
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 747 KSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLE 806
K E + L++++H N+I ++ + + S + + L + +
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----- 116
Query: 807 VCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866
KLT + + ++Y+H ++H DLKPSN+ ++ D + DFGLA+
Sbjct: 117 --KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171
Query: 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE-ASMTGDVYSFGILLLELFTGRRP 923
G T Y APE + + T D++S G ++ EL TGR
Sbjct: 172 DDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 122 bits (307), Expect = 2e-31
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 26/216 (12%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKII 768
IG+G++G VYK E A+K I L++ +G + + E L+ ++H N++K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 828
+ + LVFE + + L + + + + + I Y
Sbjct: 67 DVIHT-----KKRLVLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAY 115
Query: 829 LHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTV 888
H ++H DLKP N+L++ + + DFGLA+ T+
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI--------PVRKYTHEIVTL 164
Query: 889 GYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRP 923
Y AP+ MGS+ S T D++S G + E+ G
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 3e-30
Identities = 44/214 (20%), Positives = 85/214 (39%), Gaps = 24/214 (11%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAFKSFMAECKALRNIRHRNLIKIITI 770
IG G+ G V + VA+K ++ + + K E ++ + H+N+I ++ +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 771 CSSIDSKGADFK-ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 829
+ + LV E M + + + + + + I++L
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQMLCGIKHL 135
Query: 830 HHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVG 889
H ++H DLKPSN+++ D + DFGLA+ + + T T
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVTRY 183
Query: 890 YVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
Y APE +G D++S G ++ E+ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (299), Expect = 1e-29
Identities = 47/220 (21%), Positives = 88/220 (40%), Gaps = 21/220 (9%)
Query: 713 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIK------ 766
+G G F +V+ + VA+K++ K ++ E K L+ + + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 767 --IITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 824
I+ + + KG + +V G L + +H + LI I+ +
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH---RGIPLIYVKQISKQLLL 136
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIG 883
++Y+H C ++H D+KP NVL++ D ++ +A ++ D
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE------HYTN 188
Query: 884 IKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRP 923
T Y +PE +G+ D++S L+ EL TG
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 117 bits (294), Expect = 2e-29
Identities = 83/305 (27%), Positives = 127/305 (41%), Gaps = 13/305 (4%)
Query: 34 NETDRLALLAIKSQLHDTSGVTSSWNNTINLCQ--WTGVTC--GHRHQRVTRLDLSNQRI 89
N D+ ALL IK L + + SSW T + C W GV C + RV LDLS +
Sbjct: 4 NPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 90 GGI--LSPYVGNLSFLRYINLSDN-SFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLS 146
+ + NL +L ++ + + G IP I L +L L + + + SG IP LS
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 147 RCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEV-FSIT 205
+ L+ L S N L G +P I SL L + N ++G +PD G+ S L +I+
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 206 GNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDI 265
N L GKIP T L ++ S+ S + + S
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDL---SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 266 VVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNL 325
V NL L + N +G++P L+ + L++ FN G++ +L+
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAY 298
Query: 326 EQNNL 330
N
Sbjct: 299 ANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 92.9 bits (229), Expect = 5e-21
Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 9/266 (3%)
Query: 376 IEFRIGGNQIFGI--IPSGIRNLVNLIALGMQSN-QLHGTIPDVIGELKNLQGLFLYKNV 432
+ G + IPS + NL L L + L G IP I +L L L++
Sbjct: 53 NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
Query: 433 LQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSI 492
+ G+IP + + L L SYN+L G +P S+ + NL+G N+++GA+P S
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172
Query: 493 TTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSN 552
+ L + +S N L G +P NL + S L +
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 553 SFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVF 612
+ +G K++ L+ +N + G +P+ L L FL LN S N+L GE+P G
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290
Query: 613 SSKTKLSLQGNVKLCGGTDELHLPTC 638
+ N LCG LP C
Sbjct: 291 QRFDVSAYANNKCLCGS----PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.9 bits (159), Expect = 4e-12
Identities = 63/284 (22%), Positives = 105/284 (36%), Gaps = 13/284 (4%)
Query: 134 NNSFSGTIPTNLSRCSNLIQLRVSNNKLEG--QIPAEIGSLLKLQTLAVGKNY-LTGRLP 190
N ++ G + ++ + L +S L IP+ + +L L L +G L G +P
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 191 DFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERI 250
+ L+ L IT ++ G IP L ++ LV L N SGT P SI ++ +L I
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 251 YLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKV 310
NR SG +P S+ I N G IP + +N + +
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDAS 214
Query: 311 SIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIAN 370
+ + + + + + + +L L L N+ G LP +
Sbjct: 215 VLF--------GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266
Query: 371 LSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIP 414
L + + N + G IP G NL +N+ P
Sbjct: 267 L-KFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 20/109 (18%), Positives = 35/109 (32%), Gaps = 1/109 (0%)
Query: 58 WNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEI 117
+ + + + T+ + VG L ++L +N +G +
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260
Query: 118 PQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIP 166
PQ + L L L + N+ G IP +NNK P
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.8 bits (130), Expect = 2e-08
Identities = 22/69 (31%), Positives = 32/69 (46%), Gaps = 3/69 (4%)
Query: 148 CSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGN 207
NL L + NN++ G +P + L L +L V N L G +P GNL +V + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301
Query: 208 SL--GGKIP 214
G +P
Sbjct: 302 KCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.9 bits (120), Expect = 4e-07
Identities = 16/60 (26%), Positives = 25/60 (41%), Gaps = 1/60 (1%)
Query: 183 NYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSIC 242
N + G LP + L L +++ N+L G+IP G L+ N+ P C
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 39.7 bits (91), Expect = 0.001
Identities = 35/141 (24%), Positives = 57/141 (40%), Gaps = 2/141 (1%)
Query: 439 SGVGNLTKLAKLVMSYNSLQGN--IPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLS 496
++ L +S +L IPSSL N L ++ T
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 497 VYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHG 556
YL +++ N++G++P + +K LV L S N SG +P ++S+ +L + N G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 557 VIPHSLGFLKSIKVLNFSSNN 577
IP S G + S N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRN 184
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-28
Identities = 47/220 (21%), Positives = 89/220 (40%), Gaps = 29/220 (13%)
Query: 713 IGQGSFGSVYKGILGEDE---MIVAVKVIN----LKQKGAFKSFMAECKALRNIRHRNLI 765
+G G++G V+ + A+KV+ +++ + E + L +IR +
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 766 KIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 825
+ + L+ + + G L L Q E + I V
Sbjct: 92 VTLHYAFQTE----TKLHLILDYINGGELFTHLSQRERFTEHE---------VQIYVGEI 138
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIK 885
+ L H + +++ D+K N+LLD + + DFGL+K + + + +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-------TERAYDFC 191
Query: 886 GTVGYVAPEYCMGSEASMTG--DVYSFGILLLELFTGRRP 923
GT+ Y+AP+ G ++ D +S G+L+ EL TG P
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 108 bits (271), Expect = 6e-26
Identities = 74/387 (19%), Positives = 132/387 (34%), Gaps = 30/387 (7%)
Query: 220 LRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGG 279
L + +G + T Q+ ++ + + D V L NL +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS---IDGVEYLNNLTQINFSN 75
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
N P L N + + + + NQ + + L Q N +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIAN------LSSSMIEFRIGGNQIFGIIPSGI 393
+ +++ +S + + L++ R+ + S +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 394 RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMS 453
L NL +L +NQ+ P I NL L L N L+ + +LT L L ++
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 454 YNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQ 513
N + P L L N+++ P L+ T + +++
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS-----P 302
Query: 514 IGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNF 573
I NLKNL L + N S + P +S+ L+ L ++N SL L +I L+
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 574 SSNNLSGQIPEFLENLSFLEFLNFSHN 600
N +S P L NL+ + L +
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.9 bits (245), Expect = 1e-22
Identities = 82/406 (20%), Positives = 143/406 (35%), Gaps = 42/406 (10%)
Query: 171 SLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGG 230
+L + +GK +T + +L + + K + L NL ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 75
Query: 231 NQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSL 290
NQ + P + N++ L I + N+ + P + N +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTN-------------------LTG 114
Query: 291 SNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSL 350
N +I D+ + ++ S +S ++ + + + VT L ++L
Sbjct: 115 LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANL 174
Query: 351 KILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLH 410
L S+ +++ NQI I P GI NL L + NQL
Sbjct: 175 TTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLK 232
Query: 411 GTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQN 470
+ L NL L L N + P + LTKL +L + N + P L
Sbjct: 233 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTA 286
Query: 471 LIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQF 530
L + N+L P L T YL L NN++ P + +L L +L ++N+
Sbjct: 287 LTNLELNENQLEDISPISNLKNLT---YLTLYFNNISDISP--VSSLTKLQRLFFANNKV 341
Query: 531 SGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSN 576
S +L+ ++ +L N + P L L I L +
Sbjct: 342 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.9 bits (232), Expect = 5e-21
Identities = 75/393 (19%), Positives = 128/393 (32%), Gaps = 41/393 (10%)
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158
L+ L + + Q +L ++ L + +NL Q+ SN
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPT--- 215
N+L P + +L KL + + N + P + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 216 ---------TLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIV 266
T+ + L L G + +++L + + ++
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 267 VNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLE 326
L NL+SL N P +N++ L L NQ K + +SL NL+ L+L
Sbjct: 194 AKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLA 249
Query: 327 QNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIF 386
N + + L+ + L L L ANQ P + +++ I
Sbjct: 250 NNQISN--------LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS 301
Query: 387 GIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTK 446
I NL NL L + N + P + L LQ LF N + S + NLT
Sbjct: 302 -----PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 447 LAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHN 479
+ L +N + P L N + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 80.4 bits (197), Expect = 2e-16
Identities = 74/368 (20%), Positives = 123/368 (33%), Gaps = 41/368 (11%)
Query: 77 QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNS 136
+VT L I I V L+ L IN S+N P + NL +L + + NN
Sbjct: 44 DQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
Query: 137 FSGTIPTNLSRCSNLIQLRVSNNKLEGQIPA------------EIGSLLKLQTLAVGKNY 184
+ P + L + + I + L L +
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 159
Query: 185 LTGRLPDFVGNLSAL-EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICN 243
G + L+ L + + +S + L L NL L NQ S P
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL--GI 217
Query: 244 ISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGF 303
+++L+ + L N+ + +L NL L + N P LS + + L LG
Sbjct: 218 LTNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272
Query: 304 NQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGE 363
NQ L N L+ ++ ++N +L L+L N
Sbjct: 273 NQISN----------ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI 322
Query: 364 LPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNL 423
P +++L + + N++ S + NL N+ L NQ+ P + L +
Sbjct: 323 SP--VSSL-TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRI 375
Query: 424 QGLFLYKN 431
L L
Sbjct: 376 TQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.4 bits (184), Expect = 6e-15
Identities = 72/381 (18%), Positives = 132/381 (34%), Gaps = 39/381 (10%)
Query: 243 NISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLG 302
++ + L + T+ +L + +L SI D + +N+ ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGI-KSI-DGVEYLNNLTQINFS 74
Query: 303 FNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVG 362
NQ +L L + + N + T
Sbjct: 75 NNQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTL-----------FNNQ 121
Query: 363 ELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKN 422
+++ + N I I + S T + L
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ-----QLSFGNQVTDLKPLANLTT 176
Query: 423 LQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLT 482
L+ L + N + S S + LT L L+ + N + P NL + + N+L
Sbjct: 177 LERLDISSN--KVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLK 232
Query: 483 GALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCV 542
L S+T L LDL+NN ++ PL L L +L + +NQ S + P+ T +
Sbjct: 233 D--IGTLASLTNL-TDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTAL 287
Query: 543 SLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDL 602
+ L+ + I + LK++ L NN+S P + +L+ L+ L F++N +
Sbjct: 288 TNLELNENQLEDISPISN----LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV 341
Query: 603 EGEVPTKGVFSSKTKLSLQGN 623
V + ++ LS N
Sbjct: 342 SD-VSSLANLTNINWLSAGHN 361
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 71.2 bits (173), Expect = 2e-13
Identities = 39/188 (20%), Positives = 77/188 (40%), Gaps = 14/188 (7%)
Query: 65 CQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNL 124
Q + +T + L L+ ++ I + +L+ L ++L++N P + L
Sbjct: 207 NQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL 262
Query: 125 LRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNY 184
+L +L L N S P + N+ + + + I +L L L + N
Sbjct: 263 TKLTELKLGANQISNISPL----AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318
Query: 185 LTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNI 244
++ P V +L+ L+ N + ++L L N+ L G NQ S P + N+
Sbjct: 319 ISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANL 372
Query: 245 SSLERIYL 252
+ + ++ L
Sbjct: 373 TRITQLGL 380
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.1 bits (139), Expect = 2e-09
Identities = 27/152 (17%), Positives = 58/152 (38%), Gaps = 26/152 (17%)
Query: 52 SGVTSSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILS----------------- 94
+ +T+ + + Q + + ++T L L +I I
Sbjct: 238 ASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297
Query: 95 ---PYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNL 151
+ NL L Y+ L N+ P + +L +L++L NN S ++L+ +N+
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353
Query: 152 IQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKN 183
L +N++ P + +L ++ L +
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.3 bits (238), Expect = 3e-22
Identities = 57/281 (20%), Positives = 101/281 (35%), Gaps = 21/281 (7%)
Query: 65 CQWTGVTCGHRH---------QRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHG 115
C V C LDL N +I I NL L + L +N
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 116 EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKL 175
P L++LE+L L N L K+ + + ++ +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 176 QTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSG 235
+ L +G + L I ++ IP GL +L +LH+ GN+ +
Sbjct: 130 E-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITK 185
Query: 236 TFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASN 295
S+ +++L ++ L FN S + N P+L+ L + N +P L++
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAV-DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243
Query: 296 VEILDLGFNQFKGKVSIDF------SSLKNLSWLNLEQNNL 330
++++ L N S DF + + S ++L N +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.9 bits (224), Expect = 2e-20
Identities = 50/262 (19%), Positives = 102/262 (38%), Gaps = 13/262 (4%)
Query: 369 ANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL 428
+L + N+I I +NL NL L + +N++ P L L+ L+L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 429 YKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQ 488
KN L+ L +L ++ ++ + L + + K +G
Sbjct: 87 SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGA 145
Query: 489 LLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLD 548
+ LS +++ N+ + G +L +L + N+ + V +L +L L
Sbjct: 146 FQGMKKLSYI-RIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 549 ISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEG---- 604
+S NS V SL ++ L+ ++N L ++P L + +++ + +N++
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 260
Query: 605 ---EVPTKGVFSSKTKLSLQGN 623
+S + +SL N
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.9 bits (193), Expect = 2e-16
Identities = 48/273 (17%), Positives = 92/273 (33%), Gaps = 14/273 (5%)
Query: 245 SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFN 304
+ L N+ + + NL NL +L + N P + + +E L L N
Sbjct: 31 PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 305 QFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGEL 364
Q K +L+ L E + N L+ + + ++ + G
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-------LKSSGIE 142
Query: 365 PHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQ 424
+ + + RI I IP G+ +L L + N++ + L NL
Sbjct: 143 NGAFQGM-KKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 425 GLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGA 484
L L N + + N L +L ++ N L +P L + + + +N ++
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257
Query: 485 LPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNL 517
+ S +L + P+Q +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSN-PVQYWEI 289
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 1e-09
Identities = 37/145 (25%), Positives = 56/145 (38%), Gaps = 7/145 (4%)
Query: 477 SHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPV 536
S L +P+ L T LDL NN + NLKNL LI+ +N+ S + P
Sbjct: 18 SDLGLE-KVPKDLPPDTA---LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73
Query: 537 TLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLN 596
+ V LE L +S N + K+++ L N ++ L+ + +
Sbjct: 74 AFAPLVKLERLYLSKNQLKELPEK---MPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130
Query: 597 FSHNDLEGEVPTKGVFSSKTKLSLQ 621
N L+ G F KLS
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYI 155
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (229), Expect = 3e-21
Identities = 45/257 (17%), Positives = 87/257 (33%), Gaps = 5/257 (1%)
Query: 348 SSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSN 407
++ + + L N+ S + I + + + +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 408 QLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGN 467
QL P L L L L + LQ P L L L + N+LQ + +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 468 CQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISS 527
NL N+++ + + +L L N + P +L L+ L + +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 528 NQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLE 587
N S + L+ +L+YL ++ N + + ++ SS+ + +P+ L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 588 NLSFLEFLNFSHNDLEG 604
+ NDL+G
Sbjct: 270 GRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (184), Expect = 2e-15
Identities = 41/255 (16%), Positives = 73/255 (28%), Gaps = 30/255 (11%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEI--------------------- 117
R+ L RI + + L + L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 118 ----PQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLL 173
P L RL L L P + L L + +N L+ L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 174 KLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQF 233
L L + N ++ L +L+ + N + P L L+ L++ N
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 234 SGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNA 293
S +++ + +L+ + L N + L+ + S+P L+
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDC--RARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 294 SNVEILDLGFNQFKG 308
+ L N +G
Sbjct: 272 D---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (164), Expect = 8e-13
Identities = 48/271 (17%), Positives = 88/271 (32%), Gaps = 13/271 (4%)
Query: 213 IPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNL 272
+P G+ + + GN+ S S +L ++L N +
Sbjct: 26 VPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 273 KSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGM 332
+ P + + L L + F L L +L L+ N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 333 GTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSG 392
+ + +L L L N+ + L S+ + N++ + P
Sbjct: 144 LPDD------TFRDLGNLTHLFLHGNRISSVPERAFRGL-HSLDRLLLHQNRVAHVHPHA 196
Query: 393 IRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVM 452
R+L L+ L + +N L + + L+ LQ L L N + L K
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRG 255
Query: 453 SYNSLQGNIPSSLGNCQNLIGFNASHNKLTG 483
S + + ++P L ++L + N L G
Sbjct: 256 SSSEVPCSLPQRLAG-RDLK--RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 3e-12
Identities = 47/261 (18%), Positives = 83/261 (31%), Gaps = 11/261 (4%)
Query: 199 LEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFS 258
+ + GN + + RNL L + N + + ++ LE++ L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLK 318
++ L L +L + P + ++ L L N + F L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 319 NLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEF 378
NL+ L L N + SL L L N+ PH+ +L ++
Sbjct: 154 NLTHLFLHGNRISSVPER------AFRGLHSLDRLLLHQNRVAHVHPHAFRDL-GRLMTL 206
Query: 379 RIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIP 438
+ N + + + L L L + N LQ + + S+P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP 265
Query: 439 SGVGNLTKLAKLVMSYNSLQG 459
L ++ N LQG
Sbjct: 266 Q---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (153), Expect = 2e-11
Identities = 39/217 (17%), Positives = 62/217 (28%), Gaps = 3/217 (1%)
Query: 412 TIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNL 471
+P I Q +FL+ N + + L L + N L ++ L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 472 IGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFS 531
+ S N ++ L L L P L L L + N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 532 GVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSF 591
+ T +L +L + N V + L S+ L N ++ P +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 592 LEFLNFSHN-DLEGEVPTKGVFSSKTKLSLQGNVKLC 627
L L N + L L N +C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.8 bits (201), Expect = 3e-18
Identities = 25/167 (14%), Positives = 51/167 (30%), Gaps = 29/167 (17%)
Query: 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFK----------SFMAECKALRNIR 760
++G+G +V+ + VK + K F
Sbjct: 6 KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 761 HRNLIKIITICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 820
R L K+ + + A++ E + L ++ D +
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMELIDAKELYRVRVENPDE-------------VLD 110
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLS 867
+ + +H +VHGDL NVL+ + + + DF + +
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 39/219 (17%), Positives = 72/219 (32%), Gaps = 15/219 (6%)
Query: 240 SICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEIL 299
+ ++S + + LP D+ + L + N + +L + + L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 300 DLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQ 359
+L ++ + +L L L+L N L S L+
Sbjct: 61 NL--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT----- 113
Query: 360 FVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGE 419
LP + E + GN++ + P + L L + +N L ++
Sbjct: 114 ---SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170
Query: 420 LKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQ 458
L+NL L L +N L +IP G L + N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 3e-07
Identities = 43/192 (22%), Positives = 67/192 (34%), Gaps = 6/192 (3%)
Query: 436 SIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTL 495
++P + T L +S N L ++L L N +LT L
Sbjct: 24 ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP---- 77
Query: 496 SVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFH 555
+ ++N SLPL L L L +S N+ + + L L+ L + N
Sbjct: 78 VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137
Query: 556 GVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSK 615
+ P L ++ L+ ++NNL+ L L L+ L N L
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLL 197
Query: 616 TKLSLQGNVKLC 627
L GN LC
Sbjct: 198 PFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 2e-06
Identities = 38/179 (21%), Positives = 59/179 (32%), Gaps = 4/179 (2%)
Query: 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFS 138
T L LS + + + L +NL L + +++
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGT---LPVLGTLDLSHNQL 89
Query: 139 GTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
++P L L VS N+L + L +LQ L + N L P +
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 199 LEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRF 257
LE S+ N+L L L NL L + N T P+ L +L N +
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 12/57 (21%), Positives = 20/57 (35%), Gaps = 3/57 (5%)
Query: 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFH 555
++ NL +LP + K+ L +S N TL L L++
Sbjct: 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 9e-04
Identities = 13/64 (20%), Positives = 21/64 (32%), Gaps = 3/64 (4%)
Query: 537 TLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLN 596
+S S ++ + +P L K +L+ S N L L + L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 597 FSHN 600
Sbjct: 62 LDRA 65
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 3e-09
Identities = 37/218 (16%), Positives = 69/218 (31%), Gaps = 21/218 (9%)
Query: 395 NLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSY 454
L N I + + + T+ +L + L + + GV L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 455 NSLQGNIPSS------LGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNG 508
N + P N S ++ L+ T ++ L+ +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 509 SLPLQIGNLKNLVKL-------IISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHS 561
L L + + N+ L +S L+ L L N + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 562 LGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSH 599
L L ++ ++ +N +S P L N S L + ++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 34/221 (15%), Positives = 69/221 (31%), Gaps = 24/221 (10%)
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158
L+ I ++ + Q +L + L+ + + +NLI L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITG------------ 206
N++ P + + + L+ + + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 207 --NSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFD 264
+I L ++ + + N+S L + N+ S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192
Query: 265 IVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQ 305
+LPNL + + N P L+N SN+ I+ L NQ
Sbjct: 193 ---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 48/244 (19%), Positives = 82/244 (33%), Gaps = 29/244 (11%)
Query: 286 IPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLT 345
PD +N + G + V+ + L ++ L+ + ++ V +L
Sbjct: 13 FPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-----TTIEGVQYLN 63
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405
N L L L NQ P + + + I +
Sbjct: 64 N---LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIK-------TLD 113
Query: 406 SNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSL 465
T + L NLQ L+L N + P + +S + Q + + L
Sbjct: 114 LTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQY----LSIGNAQVSDLTPL 169
Query: 466 GNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLII 525
N L A NK++ P L S+ L + + L NN ++ PL N NL + +
Sbjct: 170 ANLSKLTTLKADDNKISDISP--LASLPNL-IEVHLKNNQISDVSPL--ANTSNLFIVTL 224
Query: 526 SSNQ 529
+NQ
Sbjct: 225 -TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 39/234 (16%), Positives = 75/234 (32%), Gaps = 26/234 (11%)
Query: 220 LRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGG 279
L N + + G + + T Q+ ++ + + + + V L NL L +
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT---IEGVQYLNNLIGLELKD 72
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
N P + + L+ T+ +
Sbjct: 73 NQITDLAPLK------------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT 120
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNL 399
VT L S+L++L L NQ +I+ L+ + + + NL L
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKL 175
Query: 400 IALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMS 453
L N++ P + L NL + L N + P + N + L + ++
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 39/229 (17%), Positives = 77/229 (33%), Gaps = 20/229 (8%)
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405
++ ++ + + + A+L + G + I G++ L NLI L ++
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDG-ITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 406 SNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSL 465
NQ+ + L + L L N L+ K L + + +
Sbjct: 72 DNQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 466 GNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLII 525
+ N N + L+ LS N S + NL L L
Sbjct: 130 NLQVLYLDLNQITNISP---------LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180
Query: 526 SSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFS 574
N+ S + P L++ +L + + +N V P L ++ ++ +
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 43/237 (18%), Positives = 82/237 (34%), Gaps = 26/237 (10%)
Query: 123 NLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGK 182
L K+A ++ + T+ + + L + I + L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 183 NYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSIC 242
N +T + NL+ + ++GN L +++ L + Q + P +
Sbjct: 73 NQITD--LAPLKNLTKITELELSGNPLKNVSAIAGL--QSIKTLDLTSTQITDVTPLAGL 128
Query: 243 NISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLG 302
+ + + L L + + N S L+N S + L
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLS-------IGNAQVSDLTPLANLSKLTTLKAD 181
Query: 303 FNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQ 359
N+ +SL NL ++L+ N + V+ L N S+L I++L NQ
Sbjct: 182 DNKISD--ISPLASLPNLIEVHLKNNQISD--------VSPLANTSNLFIVTL-TNQ 227
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.6 bits (128), Expect = 4e-09
Identities = 26/109 (23%), Positives = 44/109 (40%), Gaps = 6/109 (5%)
Query: 498 YLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGV 557
L L++ +L ++ + L + L +S N+ + P L+ LE L S N+ V
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 558 IPHSLGFLKSIKVLNFSSNNL-SGQIPEFLENLSFLEFLNFSHNDLEGE 605
+ L ++ L +N L + L + L LN N L E
Sbjct: 59 DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 1e-06
Identities = 27/126 (21%), Positives = 43/126 (34%), Gaps = 10/126 (7%)
Query: 426 LFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGAL 485
L L L ++ + L + L +S+N L+ P+ L + L AS N L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 486 PQQLLSITTLSVYLDLSNNNLNG-SLPLQIGNLKNLVKLIISSNQFS---GVIPVTLSTC 541
L L L NN L + + + LV L + N G+
Sbjct: 60 GVANLPRLQ---ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 542 VSLEYL 547
S+ +
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 23/119 (19%), Positives = 46/119 (38%), Gaps = 7/119 (5%)
Query: 82 LDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTI 141
L L+++ + + ++ L + +++LS N P + L LE L +N+
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 142 PTNLSRCSNLIQLRVSNNKLEG-QIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSAL 199
L +L + NN+L+ + S +L L + N L L+ +
Sbjct: 60 GVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 5e-04
Identities = 25/126 (19%), Positives = 46/126 (36%), Gaps = 8/126 (6%)
Query: 402 LGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNI 461
L + L T+ + +L + L L N L+ P+ + L L V+ +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLE--VLQASDNALEN 57
Query: 462 PSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQ---IGNLK 518
+ N L +N+L + Q L V L+L N+L +Q L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 519 NLVKLI 524
++ ++
Sbjct: 118 SVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 22/107 (20%), Positives = 37/107 (34%), Gaps = 6/107 (5%)
Query: 130 LALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRL 189
L L + T+ +L + + L +S+N+L P + +L L+ L N L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 190 PDFVGNLSALEVFSITGNSL-GGKIPTTLGLLRNLVDLHVGGNQFSG 235
+ + N L L LV L++ GN
Sbjct: 60 GVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 23/107 (21%), Positives = 40/107 (37%), Gaps = 5/107 (4%)
Query: 176 QTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSG 235
+ L + LT + L + ++ N L P L LR L L + +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQA--SDNAL 55
Query: 236 TFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF 282
+ N+ L+ + L NR + +V+ P L L + GN+
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.004
Identities = 22/125 (17%), Positives = 44/125 (35%), Gaps = 7/125 (5%)
Query: 201 VFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGT 260
V + L + L L + L + N+ P +++L + + +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55
Query: 261 LPFDIVVNLPNLKSLAIGGNNFFG-SIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKN 319
D V NLP L+ L + N + L + + +L+L N + I +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 320 LSWLN 324
L ++
Sbjct: 116 LPSVS 120
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 9e-08
Identities = 19/103 (18%), Positives = 40/103 (38%), Gaps = 3/103 (2%)
Query: 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGV- 557
LDL+ NL+ + ++ + ++ + + S ++++D+S++
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVST 62
Query: 558 IPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
+ L ++ L+ LS I L S L LN S
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 1e-07
Identities = 41/299 (13%), Positives = 77/299 (25%), Gaps = 29/299 (9%)
Query: 80 TRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG 139
LDL+ + + ++ + + + + + E + R++ + L N+
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60
Query: 140 -TIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSA 198
T+ LS+CS L L + +L I + L L NLS
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL----------------NLSG 104
Query: 199 LEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFS 258
FS + L L I+ L N
Sbjct: 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 164
Query: 259 GTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDL-GFNQFKGKVSIDFSSL 317
L + + + ++ L L + ++ +
Sbjct: 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224
Query: 318 KNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMI 376
L L + G D L+I + F +I N + I
Sbjct: 225 PTLKTLQV------FGIVPDGTLQLLKEALPHLQINC---SHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 6e-07
Identities = 43/271 (15%), Positives = 85/271 (31%), Gaps = 10/271 (3%)
Query: 129 KLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGR 188
L L + + L +I R + ++ + E S ++Q + + + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 189 -LPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDL--HVGGNQFSGTFPQSICNIS 245
L + S L+ S+ G L I TL NLV L + + S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 246 SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQ 305
L+ + L + + V + + + + ++ S + +L
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 306 FKGKVSIDFSSLKNLSWLN-LEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGEL 364
V + + LN L+ +L + + L +LK L + G L
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 365 PHSIANLSSSMIEFRIGGNQIFGIIPSGIRN 395
L ++ +I + I I N
Sbjct: 242 QL----LKEALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 35/270 (12%), Positives = 77/270 (28%), Gaps = 40/270 (14%)
Query: 353 LSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHG- 411
L L ++ + LS +I FR + + + + + + ++ +
Sbjct: 5 LDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVS 61
Query: 412 TIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKL--VMSYNSLQGNIPSSLGNCQ 469
T+ ++ + LQ L L L I + + + L +L + + + L +C
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 470 NLIGFNAS------------------------------HNKLTGALPQQLLSITTLSVYL 499
L N S N L + L
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 500 DLSNNNLNGSLPLQIGNLKNLVKLIISS-NQFSGVIPVTLSTCVSLEYLDISSNSFHGVI 558
+ L + L L L +S + L +L+ L + G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 559 PHSLGFLKSIKVLNFSSNNLSGQIPEFLEN 588
+++ L + ++ + + N
Sbjct: 242 QL---LKEALPHLQINCSHFTTIARPTIGN 268
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 22/128 (17%), Positives = 34/128 (26%), Gaps = 9/128 (7%)
Query: 49 HDTSGVTSSWNNTINLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINL 108
D + + L +N+
Sbjct: 232 RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNV 291
Query: 109 SDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAE 168
S+N E+P L E+L N + +P NL QL V N L + P
Sbjct: 292 SNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDI 342
Query: 169 IGSLLKLQ 176
S+ L+
Sbjct: 343 PESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 9/96 (9%)
Query: 501 LSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPH 560
N + + +L +L +S+N+ +P LE L S N +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHL-AEVPE 321
Query: 561 SLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLN 596
++K L+ N L + P+ E++ L +
Sbjct: 322 LPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 20/94 (21%), Positives = 35/94 (37%), Gaps = 9/94 (9%)
Query: 404 MQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPS 463
N I + +L+ L + N L +P+ L +L+ S+N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPE 321
Query: 464 SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSV 497
N + L + +N L P S+ L +
Sbjct: 322 LPQNLKQL---HVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 51/335 (15%), Positives = 99/335 (29%), Gaps = 29/335 (8%)
Query: 242 CNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDL 301
C + L S +LP P+L+SL N+ +P+ +++ L +
Sbjct: 35 CLDRQAHELELNNLGLS-SLP----ELPPHLESLVASCNS-LTELPELP---QSLKSLLV 85
Query: 302 GFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFV 361
N K +S L+ L N + L + + + N S K+ L +
Sbjct: 86 DNNNLKA-LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEF 144
Query: 362 GELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELK 421
++ + + L + + + L
Sbjct: 145 IAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLP 204
Query: 422 NLQGLFLYKNVLQGSIPSGVGNLTKLAKL--------VMSYNSLQGNIPSSLGNCQNLIG 473
L ++ N+L+ + + + + L
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264
Query: 474 FNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGV 533
N + + +L L++SNN L LP L+ +LI S N +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSL-EELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE- 318
Query: 534 IPVTLSTCVSLEYLDISSNSFHGV--IPHSLGFLK 566
+P +L+ L + N IP S+ L+
Sbjct: 319 VPELPQ---NLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 3e-05
Identities = 26/100 (26%), Positives = 37/100 (37%), Gaps = 13/100 (13%)
Query: 452 MSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLP 511
N+ I S +L N S+NKL LP + L S N+L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE----RLIASFNHLA-EVP 320
Query: 512 LQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISS 551
NLK +L + N P S+E L ++S
Sbjct: 321 ELPQNLK---QLHVEYNPLRE-FPDIPE---SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 22/88 (25%), Positives = 37/88 (42%), Gaps = 11/88 (12%)
Query: 207 NSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIV 266
N+ +I + L +L +L+V N+ P LER+ FN + ++
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-----EVP 320
Query: 267 VNLPNLKSLAIGGNNF--FGSIPDSLSN 292
NLK L + N F IP+S+ +
Sbjct: 321 ELPQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 24/91 (26%), Positives = 33/91 (36%), Gaps = 9/91 (9%)
Query: 157 SNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTT 216
N +I + L+ L V N L LP L L + N L ++P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP-- 320
Query: 217 LGLLRNLVDLHVGGNQFSGTFPQSICNISSL 247
L +NL LHV N FP ++ L
Sbjct: 321 -ELPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 20/72 (27%), Positives = 31/72 (43%), Gaps = 7/72 (9%)
Query: 552 NSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGV 611
N+ I S++ LN S+N L ++P LE L S N L EVP +
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP--EL 322
Query: 612 FSSKTKLSLQGN 623
+ +L ++ N
Sbjct: 323 PQNLKQLHVEYN 334
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 9e-07
Identities = 16/85 (18%), Positives = 28/85 (32%), Gaps = 8/85 (9%)
Query: 542 VSLEYLDISSNSF-HGVIPHSLGFLKSIKVLNFSSNNLSGQ----IPEFLENLSFLEFLN 596
+ ++ LDI L L+ +V+ L+ I L L LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 597 FSHNDLEGEVP---TKGVFSSKTKL 618
N+L +G+ + K+
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 13/89 (14%), Positives = 26/89 (29%), Gaps = 5/89 (5%)
Query: 498 YLDLSNNNLNGS-LPLQIGNLKNLVKLIISSNQFSGV----IPVTLSTCVSLEYLDISSN 552
LD+ L+ + + L+ + + + I L +L L++ SN
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 553 SFHGVIPHSLGFLKSIKVLNFSSNNLSGQ 581
V H + +L
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 13/79 (16%), Positives = 23/79 (29%), Gaps = 9/79 (11%)
Query: 538 LSTCVSLEYLDISSNSFHGV----IPHSLGFLKSIKVLNFSSNNLSGQIPEFL-----EN 588
L L ++ + +L S++ L+ S+N L L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 589 LSFLEFLNFSHNDLEGEVP 607
LE L E+
Sbjct: 425 GCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 13/90 (14%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 103 LRYINLSDNSFHGEIPQEIGNLLR-LEKLALPNNSFSG----TIPTNLSRCSNLIQLRVS 157
++ +++ E+ LL+ + + L + + I + L L +L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 158 NNKLEGQIPAEIGSLLKLQTLAVGKNYLTG 187
+N+L + L+ + + K L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 12/78 (15%), Positives = 28/78 (35%), Gaps = 3/78 (3%)
Query: 295 NVEILDLGFNQFKGK-VSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKIL 353
+++ LD+ + + L+ + L+ L D+ + L +L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAEL 60
Query: 354 SLAANQFVGELPHSIANL 371
+L +N+ H +
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 12/95 (12%), Positives = 32/95 (33%), Gaps = 9/95 (9%)
Query: 470 NLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNG----SLPLQIGNLKNLVKLII 525
++ + +L+ A +LL + + L + L + + L +L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 526 SSNQFSGVIPVTL-----STCVSLEYLDISSNSFH 555
SN+ V + + ++ L + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 16/83 (19%), Positives = 27/83 (32%), Gaps = 9/83 (10%)
Query: 516 NLKNLVKLIISSNQFSGV----IPVTLSTCVSLEYLDISSNSFHGVIPHSLG-----FLK 566
L L ++ S + TL SL LD+S+N L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 567 SIKVLNFSSNNLSGQIPEFLENL 589
++ L S ++ + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 18/106 (16%), Positives = 35/106 (33%), Gaps = 15/106 (14%)
Query: 65 CQWTGVTCGHRHQRVTRLDLSNQRIGGI----LSPYVGNLSFLRYINLSDNSFHGEIPQE 120
+ G + L L++ + L+ + LR ++LS+N +
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 121 IGNLLR-----LEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKL 161
+ +R LE+L L + +S + L L L
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQ------ALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 16/95 (16%), Positives = 28/95 (29%), Gaps = 5/95 (5%)
Query: 290 LSNASNVEILDLGFNQFKGKVSIDFSS----LKNLSWLNLEQNNLGMGTANDLDFVTFLT 345
S + +L L ++ +L L+L N LG L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQ 423
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRI 380
L+ L L + E+ + L R+
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 8/91 (8%), Positives = 26/91 (28%), Gaps = 4/91 (4%)
Query: 246 SLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNF----FGSIPDSLSNASNVEILDL 301
++ + + S +++ L + + + I +L + L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 302 GFNQFKGKVSIDFSSLKNLSWLNLEQNNLGM 332
N+ +++ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 15/94 (15%), Positives = 35/94 (37%), Gaps = 9/94 (9%)
Query: 443 NLTKLAKLVMSYNSLQGN----IPSSLGNCQNLIGFNASHNKLTG----ALPQQLLSITT 494
+ L L ++ + + + ++L +L + S+N L L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 495 LSVYLDLSNNNLNGSLPLQIGNL-KNLVKLIISS 527
L L L + + + ++ L K+ L + S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 12/92 (13%), Positives = 26/92 (28%), Gaps = 10/92 (10%)
Query: 519 NLVKLIISSNQFSGV-IPVTLSTCVSLEYLDISSNSFHGV----IPHSLGFLKSIKVLNF 573
++ L I + S L + + + I +L ++ LN
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 574 SSNNLSGQIPEFL-----ENLSFLEFLNFSHN 600
SN L + ++ L+ +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 17/87 (19%), Positives = 35/87 (40%), Gaps = 13/87 (14%)
Query: 498 YLDLSNNNLNG----SLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCV-----SLEYLD 548
L L++ +++ SL + +L +L +S+N + L V LE L
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 549 ISSNSFHGVIPHSLGFLK----SIKVL 571
+ + + L L+ S++V+
Sbjct: 433 LYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 15/96 (15%), Positives = 28/96 (29%), Gaps = 11/96 (11%)
Query: 268 NLPNLKSLAIGGNNF----FGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSS-----LK 318
L+ L + + S+ +L ++ LDL N +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 319 NLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILS 354
L L L + L + SL+++S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQ--ALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 17/96 (17%), Positives = 32/96 (33%), Gaps = 9/96 (9%)
Query: 110 DNSFHGEIPQEIGNLLRLEKLALPNNSFSGT----IPTNLSRCSNLIQLRVSNNKLEGQI 165
D L L L + S + + L +L +L +SNN L
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 166 PAEIGSLLK-----LQTLAVGKNYLTGRLPDFVGNL 196
++ ++ L+ L + Y + + D + L
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 19/95 (20%), Positives = 31/95 (32%), Gaps = 6/95 (6%)
Query: 271 NLKSLAIGGNNF-FGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSS----LKNLSWLNL 325
+++SL I + L +++ L D SS L+ LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 326 EQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360
N LG + + T ++ LSL
Sbjct: 63 RSNELGDVGVHCV-LQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 14/90 (15%), Positives = 33/90 (36%), Gaps = 10/90 (11%)
Query: 173 LKLQTLAVGKNYLT-GRLPDFVGNLSALEVFSITGNSLGGK----IPTTLGLLRNLVDLH 227
L +Q+L + L+ R + + L +V + L I + L + L +L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 228 VGGNQFSGTFPQSIC-----NISSLERIYL 252
+ N+ + ++++ L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 14/93 (15%), Positives = 30/93 (32%), Gaps = 12/93 (12%)
Query: 195 NLSALEVFSITGNSLGGK----IPTTLGLLRNLVDLHVGGNQFSGTFPQSIC-----NIS 245
S L V + + + TL +L +L + N +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 246 SLERIYLPFNRFSGTLPF---DIVVNLPNLKSL 275
LE++ L +S + + + P+L+ +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 14/94 (14%), Positives = 24/94 (25%), Gaps = 11/94 (11%)
Query: 447 LAKLVMSYNSLQGN-IPSSLGNCQNLIGFNASHNKLTG----ALPQQLLSITTLSVYLDL 501
+ L + L L Q LT + L L+ L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA-ELNL 62
Query: 502 SNNNLNGSLPLQIG-----NLKNLVKLIISSNQF 530
+N L + + KL + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 32/196 (16%), Positives = 64/196 (32%), Gaps = 23/196 (11%)
Query: 395 NLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSY 454
I ++ + + EL ++ + + ++ G+ L + KL ++
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 455 NSLQGNIPSSLGNCQNLIGFNASHNKLT---------------GALPQQLLSITTLSVYL 499
N L P + + + + K + + L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 500 DLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIP 559
L N + + L L L + NQ S ++P L+ L+ L +S N +
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-- 193
Query: 560 HSLGFLKSIKVLNFSS 575
+L LK++ VL S
Sbjct: 194 RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 34/207 (16%), Positives = 69/207 (33%), Gaps = 18/207 (8%)
Query: 99 NLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158
+ NL S + Q L ++++ N+ + N+ +L ++
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLG 218
NKL P L L + + + I G
Sbjct: 78 NKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 219 LLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIG 278
L+ + T + ++ L+ + L N+ S +P L L++L +
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLYLS 186
Query: 279 GNNFFGSIPDSLSNASNVEILDLGFNQ 305
N+ S +L+ N+++L+L F+Q
Sbjct: 187 KNHI--SDLRALAGLKNLDVLEL-FSQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 31/195 (15%), Positives = 60/195 (30%), Gaps = 17/195 (8%)
Query: 268 NLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQ 327
+ + ++ + + ++++ + + K I + L N++ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNG 77
Query: 328 N---------NLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEF 378
N NL LD S + L + I L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 379 RIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIP 438
+ + + L L L ++ NQ+ +P + L LQ L+L KN +
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--L 193
Query: 439 SGVGNLTKLAKLVMS 453
+ L L L +
Sbjct: 194 RALAGLKNLDVLELF 208
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 32/186 (17%), Positives = 56/186 (30%), Gaps = 14/186 (7%)
Query: 65 CQWTGVTCGHRH---------QRVTRLDLS-NQRIGGILSPYVGNLSFLRYINLSDNSFH 114
C+ T V C R T L L+ N+ G L L + L N
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 115 GEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLK 174
G P +++L L N L L + +N++ +P L
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 175 LQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFS 234
L + + L S+ G + P+ +R++ + ++F
Sbjct: 128 LTS-LNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183
Query: 235 GTFPQS 240
+ S
Sbjct: 184 CSSENS 189
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 35/201 (17%), Positives = 63/201 (31%), Gaps = 17/201 (8%)
Query: 395 NLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSY 454
L + + + T+ +L + L + ++ SI GV L L ++ S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 71
Query: 455 NSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQI 514
N L P I N + L N + +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN----NQITDIDPLKNL 127
Query: 515 GNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFS 574
NL L + + S + +T ++ ++ L L +++ L+ S
Sbjct: 128 TNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-------LKPLANLTTLERLDIS 180
Query: 575 SNNLSGQIPEFLENLSFLEFL 595
SN +S L L+ LE L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 32/232 (13%), Positives = 63/232 (27%), Gaps = 9/232 (3%)
Query: 280 NNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLD 339
+ IP L N L + + FS +L + + QN++ D+
Sbjct: 17 ESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 340 FVTFLTNCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNL 399
+ ++ + + + I I S + L+++
Sbjct: 75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134
Query: 400 IALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQG 459
N +G L+L KN +Q + N+L+
Sbjct: 135 Q---DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191
Query: 460 NIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLP 511
+ + S ++ L ++ L S NL LP
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA---RSTYNL-KKLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 30/237 (12%), Positives = 67/237 (28%), Gaps = 17/237 (7%)
Query: 346 NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQ 405
C K+ + ++ L + IE R ++ I +L + +
Sbjct: 14 LCQESKVTEIPSD------------LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEIS 61
Query: 406 SNQLHGTIPDVIGELKNLQGLFLY---KNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIP 462
N + I + N+L + + L+ +
Sbjct: 62 QNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 121
Query: 463 SSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVK 522
+ + Q ++ + + + ++ SV L L+ N + +
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181
Query: 523 LIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLS 579
+ +N + LDIS H + + L LK ++ + NL
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 29/215 (13%), Positives = 65/215 (30%), Gaps = 5/215 (2%)
Query: 389 IPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLA 448
IPS + N I L +L +L+ + + +N + I + V +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 449 ---KLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNN 505
++ + N L N + ++ ++ S+ + + + + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 506 LNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFL 565
+G V L ++ N + + E +N+ +
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 566 KSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600
+L+ S + LENL L + +
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 30/244 (12%), Positives = 64/244 (26%), Gaps = 10/244 (4%)
Query: 238 PQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVE 297
IC+ S+ ++ + +P D+ N L + S ++E
Sbjct: 2 HHRICHCSNRV-FLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLE 56
Query: 298 ILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAA 357
+++ N + D S + + N F L +
Sbjct: 57 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116
Query: 358 NQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVI 417
+ HS+ + + + V L ++H +
Sbjct: 117 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT 176
Query: 418 GELKNLQGLFLYKNVLQGSIPSGV-GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNA 476
+ L N +P+ V + L +S + L N + L +
Sbjct: 177 QLDEL----NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 477 SHNK 480
+ K
Sbjct: 233 YNLK 236
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 45/350 (12%), Positives = 99/350 (28%), Gaps = 38/350 (10%)
Query: 271 NLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGK----VSIDFSSLKNLSWLNLE 326
+LK AI + S+ L +V+ + L N + +S + +S K+L
Sbjct: 9 SLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 327 QNNLGMGTANDLDFVTFLT----NCSSLKILSLAANQFVGELPHSIANLSSSMIEFRIGG 382
G + + L C L + L+ N F + + S
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 383 NQIFGIIPSGIRNLVNLIALGMQSNQLHG-TIPDVIGELKNLQGLFLYKNVLQGSIPSGV 441
G+ P + + + + I +N K + +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 442 GNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLS---ITTLSVY 498
+ K+ + + ++ + L CQ L + N T L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 499 LDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVI 558
L L++ L+ + + + + L+ L + N
Sbjct: 248 LGLNDCLLSARGAAAVVD------------------AFSKLENIGLQTLRLQYNEIELDA 289
Query: 559 PHSL-----GFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLE 603
+L + + L + N + + ++ + + F +L+
Sbjct: 290 VRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV-FSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 39/326 (11%), Positives = 91/326 (27%), Gaps = 26/326 (7%)
Query: 103 LRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSG----TIPTNLSRCSNLIQLRVSN 158
L+ ++ + + ++++ L N+ + N++ +L S+
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 159 N---KLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPT 215
+++ +IP + LL+ + + F + ++ ++ +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 216 TLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSL 275
L + + N L I NR + + + L
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 276 AIGGNNFFGSIPDSLSNASNVEILDLGF------------NQFKGKVSIDFSSLKNLSWL 323
G P+ + + + + ++I S NL L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248
Query: 324 NLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGE----LPHSIANLSSSMIEFR 379
L L A + L+ L L N+ + L I ++
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 380 IGGNQI--FGIIPSGIRNLVNLIALG 403
+ GN+ + IR + + G
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.004
Identities = 14/93 (15%), Positives = 30/93 (32%), Gaps = 4/93 (4%)
Query: 490 LSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSG----VIPVTLSTCVSLE 545
SI S+ LD S+ + ++ ++++S N + +++ LE
Sbjct: 3 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62
Query: 546 YLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNL 578
+ S V L+ + L
Sbjct: 63 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.004
Identities = 22/145 (15%), Positives = 47/145 (32%), Gaps = 7/145 (4%)
Query: 212 KIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPN 271
++ + + + + + + + I N+P
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMA--ATLRIIEENIPE 66
Query: 272 LKSLAIGGNNF--FGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNN 329
L SL + N + + A N++IL+L N+ K + +D L L L+ N+
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 330 LGMGTANDLDFVTF-LTNCSSLKIL 353
L + +++ L L
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRL 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1017 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.57 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.5 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.58 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.55 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.64 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.56 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.49 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.47 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.89 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.1 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=429.96 Aligned_cols=263 Identities=29% Similarity=0.452 Sum_probs=206.9
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
..++|++.++||+|+||+||+|++.. .||||+++.. .....+.|.+|++++++++||||+++++++.. +
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~ 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------c
Confidence 45689999999999999999998753 4999998744 34456789999999999999999999998743 3
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.+++..... .+++.++..|+.||++||+|||++ +||||||||+|||++.++.+||+||
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCC
T ss_pred EEEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccc
Confidence 47899999999999999976543 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCC---CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS---EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|+|+....... ........||+.|||||++.+. .++.++|||||||++|||+||+.||.............
T Consensus 149 Gla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~ 222 (276)
T d1uwha_ 149 GLATVKSRWSG------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222 (276)
T ss_dssp CCSCC------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cceeeccccCC------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 99987643221 1122345799999999998653 47899999999999999999999997643221111111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
.....++. ......++++++.+++.+||+.||++|||++||+++|+.++++
T Consensus 223 ~~~~~~p~-----------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 223 GRGYLSPD-----------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHTSCCCC-----------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCCCCc-----------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11111111 0111224567899999999999999999999999999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=426.20 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=206.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+++.+|++++++++||||+++++++.+. +..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----cee
Confidence 4689999999999999999999999999999999975432 3346788999999999999999999999765 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence 99999999999999997543 789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
|+........ ......+||+.|||||++.+..+ +.++||||+||++|||++|++||.................
T Consensus 150 a~~~~~~~~~------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~ 223 (271)
T d1nvra_ 150 ATVFRYNNRE------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 223 (271)
T ss_dssp CEECEETTEE------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC
T ss_pred heeeccCCcc------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence 9876533211 12234679999999999988776 6789999999999999999999976543322222211110
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... .....+++++.+++.+||+.||++|||++|+++|
T Consensus 224 ~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 224 TYL--------------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTS--------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCC--------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 0011234567899999999999999999999775
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=425.53 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=209.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
++|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|++++++++||||+++++++.+. +..|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEE
Confidence 4799999999999999999999999999999999876666668899999999999999999999999765 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++|+|.+++... .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 95 vmEy~~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 99999999999988653 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCc
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPE 944 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 944 (1017)
.+.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .........+.
T Consensus 165 ~~~~~~--------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~ 235 (293)
T d1yhwa1 165 QITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE 235 (293)
T ss_dssp ECCSTT--------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC
T ss_pred eecccc--------ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCCCC
Confidence 764322 112235799999999999999999999999999999999999999975422111 11111110000
Q ss_pred hhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 945 KVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 945 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. .....+++.+.+++.+||+.||++|||+.|+++|
T Consensus 236 ----~---------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 ----L---------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ----C---------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ----C---------------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0011235678899999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=417.84 Aligned_cols=247 Identities=22% Similarity=0.376 Sum_probs=206.9
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||+||+|+++.+++.||+|++... +....+.+.+|++++++++||||+++++++.+. +.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CE
Confidence 5799999999999999999999999999999998743 234457789999999999999999999998765 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|+|.+++.... .+++.+++.++.||++||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEeecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence 899999999999999998654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........
T Consensus 152 ~a~~~~~~~----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~ 220 (263)
T d2j4za1 152 WSVHAPSSR----------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVE 220 (263)
T ss_dssp SCSCCCCCC----------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTC
T ss_pred eeeecCCCc----------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCC
Confidence 997654321 223579999999999999999999999999999999999999997542211 111111100
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. . .+..+++++.+++.+||+.||++|||++|+++|
T Consensus 221 ~--~--------------------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 F--T--------------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp C--C--------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C--C--------------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0 0 001235678899999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-49 Score=424.92 Aligned_cols=266 Identities=22% Similarity=0.418 Sum_probs=215.7
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
++++...++|++.+.||+|+||+||+|++..+++.||||+++.. ....+++.+|++++++++|||||+++++|.+.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--- 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--- 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeC---
Confidence 34445567899999999999999999999989999999998744 33457899999999999999999999998654
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
+..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 86 --~~~~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl 156 (287)
T d1opja_ 86 --PPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKV 156 (287)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred --CeeEEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEE
Confidence 568999999999999999976532 4789999999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ..+.
T Consensus 157 ~DFG~a~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~ 228 (287)
T d1opja_ 157 ADFGLSRLMTGDTYT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYEL 228 (287)
T ss_dssp CCCCCTTTCCSSSSE-------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHH
T ss_pred ccccceeecCCCCce-------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHH
Confidence 999999876543211 11234589999999999999999999999999999999997777644322111 1111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
....... .....+++++.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 229 i~~~~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 229 LEKDYRM--------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HhcCCCC--------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111000 0112346678999999999999999999999999988754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=418.11 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=199.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++||||++++|+|... +..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEE
Confidence 57889999999999999999997 57789999997543 3347899999999999999999999998654 56899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++|+|.+++..... .+++..+..++.|||.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence 9999999999999876543 789999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhC-CCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG-RRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......||+.|+|||++.+..++.++|||||||++|||+|+ ++||... ........... ...
T Consensus 150 ~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~-~~~ 220 (263)
T d1sm2a_ 150 FVLDDQYT-------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDIST-GFR 220 (263)
T ss_dssp ----------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHHHHHH-TCC
T ss_pred eccCCCce-------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHHHHHh-cCC
Confidence 76533211 11235689999999999999999999999999999999995 5444432 11111111111 000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
. ..+..+++++.+++.+||+.||++|||++||+++|++++++
T Consensus 221 ~--------------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 L--------------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp C--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C--------------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0 00112356789999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=420.72 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=208.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
+.|++.+.||+|+||+||+|++..+++.||||++........+.+.+|++++++++|||||++++++.+. +..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEE
Confidence 4689999999999999999999999999999999877667778899999999999999999999998765 67899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++|+|.+++..... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 vmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence 9999999999999875432 689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccCCCcccccccCccccCccccc-----CCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCM-----GSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
....... ......||+.|+|||++. +..|+.++||||+||++|||++|+.||....... .......
T Consensus 159 ~~~~~~~--------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~ 229 (288)
T d2jfla1 159 KNTRTIQ--------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAK 229 (288)
T ss_dssp ECHHHHH--------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHH
T ss_pred ccCCCcc--------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHc
Confidence 6532211 112357999999999984 4568899999999999999999999997643221 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+. ......+++++.+++.+||+.||++|||+.|+++|
T Consensus 230 ~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 230 SEPPT-------------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SCCCC-------------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCC-------------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11000 00111235678999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=413.67 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=201.2
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
|++.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.... .+....|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 366778999999999999999999999999987543 334567899999999999999999999986532 23467899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeecCCCCceEeC-CCCCeEEeecc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLD-HDMVSHVGDFG 861 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG 861 (1017)
||||+++|+|.+++.... .+++.+++.++.||++||+|||++ + |+||||||+|||++ +++.+||+|||
T Consensus 90 vmE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp EEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEeCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence 999999999999998653 689999999999999999999998 6 99999999999996 57899999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+..... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.................
T Consensus 161 la~~~~~~----------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~ 229 (270)
T d1t4ha_ 161 LATLKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 229 (270)
T ss_dssp GGGGCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred cceeccCC----------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC
Confidence 99754321 1224679999999999876 599999999999999999999999975322211111111100
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+.. ....+++++.+++.+||+.||++|||+.|+++|
T Consensus 230 ~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 KPAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcc--------------------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0100 011224568899999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=421.93 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=197.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... +...+.+.+|++++++++||||+++++++.+.. .+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence 368999999999999999999999999999999997553 234567889999999999999999999886432 256
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC--CCCceeecCCCCceEeCCCCCeEEee
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC--QPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
.|+||||+++|+|.+++..... ....+++.+++.++.||+.||+|||++. ..+||||||||+|||++.++.+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 7999999999999999875321 2237899999999999999999999871 11399999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+|+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .......
T Consensus 158 FG~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-~~~~i~~ 228 (269)
T d2java1 158 FGLARILNHDT--------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGKIRE 228 (269)
T ss_dssp HHHHHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred ccceeecccCC--------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-HHHHHHc
Confidence 99998764322 11223679999999999999999999999999999999999999997642211 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+ .....+++++.+++.+||+.||.+|||+.|+++|
T Consensus 229 ~~~~---------------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 229 GKFR---------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp TCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCC---------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0000 0011235678999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-48 Score=421.99 Aligned_cols=263 Identities=26% Similarity=0.429 Sum_probs=199.2
Q ss_pred ccccccCcccccCCceEEEEEeCCCcE---EEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEM---IVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
++|++.++||+|+||+||+|+++.+++ .||||.+.... ....++|.+|++++++++|||||+++++|... +
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence 467778899999999999999976654 68999886443 34457899999999999999999999998654 5
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..++||||+++|+|.+++..... .+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 172 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF 172 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence 68999999999999999886543 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+|+......... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .......
T Consensus 173 Gla~~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~ 247 (299)
T d1jpaa_ 173 GLSRFLEDDTSDP---TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIE 247 (299)
T ss_dssp --------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH
T ss_pred ccceEccCCCCcc---eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 9998765432111 1112223468999999999999999999999999999999998 89999764221 1111110
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
.... .....++++++.+++.+||+.||++|||+.||++.|+.+.++
T Consensus 248 ~~~~--------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 QDYR--------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCC--------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 0000 001123467789999999999999999999999999988764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=427.16 Aligned_cols=278 Identities=22% Similarity=0.321 Sum_probs=207.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
..++|++.++||+|+||+||+|++..+|+.||+|+++... ....+++.+|+.++++++|||||+++++|.+. +.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 3568999999999999999999999999999999997553 33456789999999999999999999999765 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
.|+||||+++|+|.+++.+.+ .+++..++.++.|++.||+|||+ + +|+||||||+|||++.++.+||+||
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeC
Confidence 899999999999999998654 68999999999999999999996 6 8999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+|+...... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||................
T Consensus 150 Gla~~~~~~~----------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 219 (322)
T d1s9ja_ 150 GVSGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219 (322)
T ss_dssp CCCHHHHHHT----------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----
T ss_pred CCccccCCCc----------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 9998664321 123579999999999999999999999999999999999999997643221111000000
Q ss_pred hc-----CchhhhhccchhhHHHHhh-cchhHHHhHHh---------HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 AL-----PEKVIEIVDPLLLIEVMAN-NSMIQEDIRAK---------TQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~-----~~~~~~~~d~~l~~~~~~~-~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. +.................. ........... ....+.++.+++.+||+.||++||||+|+++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 0000000000000000000 00000000000 01124678999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=417.10 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=205.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||+||+|++..+++.||||++... .....+.+.+|++++++++||||+++++++.+. +.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----SE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----CE
Confidence 5799999999999999999999999999999999743 234457789999999999999999999998765 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|+|.+++...+ .+++.+++.++.|++.||+|||++ +||||||||+||++++++.+||+|||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence 899999999999999988654 789999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+.+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........
T Consensus 154 ~a~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~ 226 (288)
T d1uu3a_ 154 TAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLE 226 (288)
T ss_dssp TCEECC----------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTC
T ss_pred cceecccCCc------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcCC
Confidence 9987653221 111223579999999999999999999999999999999999999997642211 011111000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
. . .+..+++++.+++.+||+.||++|||++|++++-
T Consensus 227 ~--~--------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 227 Y--D--------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp C--C--------------------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred C--C--------------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 0 0 0012355688999999999999999999976543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=414.19 Aligned_cols=258 Identities=24% Similarity=0.435 Sum_probs=206.6
Q ss_pred hhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
..++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.+.+|++++++++|||||++++++.. +..
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~ 82 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPI 82 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCe
Confidence 4568999999999999999999986 67889999997543 345789999999999999999999998743 346
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+++|+|.+++.... ...+++.+++.|+.||++||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccc
Confidence 89999999999999876542 24689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
|+........ ......||+.|+|||++.+..++.++|||||||++|||+||..|+................ .
T Consensus 156 a~~~~~~~~~-------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~ 227 (272)
T d1qpca_ 156 ARLIEDNEYT-------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-Y 227 (272)
T ss_dssp CEECSSSCEE-------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C
T ss_pred eEEccCCccc-------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-C
Confidence 9876543211 1123568999999999998899999999999999999999666554322211111111000 0
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
. ...+..+++++.+++.+||+.||++|||++||++.|+++-
T Consensus 228 ~--------------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 228 R--------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C--------------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 0 0011134567899999999999999999999999998753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-48 Score=421.07 Aligned_cols=253 Identities=24% Similarity=0.298 Sum_probs=192.5
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.+.|++.+.||+|+||+||+|+++.+++.||||++..... ...+.+.+|++++++++||||+++++++.+. +..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG-----GHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence 4579999999999999999999999999999999975432 2345678999999999999999999998765 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC---CCCCeEEee
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVSHVGD 859 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~D 859 (1017)
|+||||++||+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||++. +++.+||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence 99999999999999997653 789999999999999999999999 999999999999994 578999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|++||....... .......
T Consensus 154 FG~a~~~~~~~---------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~ 223 (307)
T d1a06a_ 154 FGLSKMEDPGS---------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILK 223 (307)
T ss_dssp C---------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHT
T ss_pred cceeEEccCCC---------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhc
Confidence 99998654322 1223579999999999999999999999999999999999999997642211 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...+.. ......+++++.+++.+||+.||++|||+.|+++|
T Consensus 224 ~~~~~~------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 224 AEYEFD------------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TCCCCC------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCCCCC------------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 100000 00112235678999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=402.54 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=209.6
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
++|++.++||+|+||+||+|+++ +++.||||+++.... ..+.+.+|+.++++++||||++++++|.+. +..++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEE
Confidence 58999999999999999999996 788999999985543 347899999999999999999999998654 56899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||+++|+|.+++.... ..+++..+++++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 77 v~Ey~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp EEECCTTEEHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred EEEccCCCcHHHhhhccc-----cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence 999999999999977654 3788999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ ....... ...
T Consensus 149 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-~~~~i~~-~~~ 219 (258)
T d1k2pa_ 149 YVLDDEYT-------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHIAQ-GLR 219 (258)
T ss_dssp BCSSSSCC-------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHHHHHT-TCC
T ss_pred eccCCCce-------eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-HHHHHHh-CCC
Confidence 76543221 1223568999999999999999999999999999999998 899997643221 1111110 000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
. . .+..+++++.+++.+||+.||++|||++|++++|.++
T Consensus 220 ~-----~---------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 L-----Y---------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp C-----C---------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred C-----C---------------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 0 0 0112356789999999999999999999999999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-47 Score=422.02 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=210.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|+.++++++|||||++++++.+. +..|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence 46899999999999999999999999999999999866666667889999999999999999999998765 7799
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC--CCCeEEeecc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH--DMVSHVGDFG 861 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG 861 (1017)
+||||+++|+|.+++..... .+++.+++.++.||+.||+|||++ +||||||||+|||++. ++.+||+|||
T Consensus 100 ivmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence 99999999999999965432 699999999999999999999999 9999999999999964 6889999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+...... ......||+.|||||++.+..++.++||||+||++|||++|+.||.+.... ..........
T Consensus 172 ~a~~~~~~~---------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~ 241 (350)
T d1koaa2 172 LTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCD 241 (350)
T ss_dssp TCEECCTTS---------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTC
T ss_pred hheeccccc---------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC
Confidence 998765322 122357999999999999999999999999999999999999999754221 1111111111
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
... + ......+++++.+++.+||+.||++|||+.|+++|
T Consensus 242 ~~~------~------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 WNM------D------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCS------C------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCC------C------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 100 0 00111235678899999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=407.78 Aligned_cols=263 Identities=22% Similarity=0.364 Sum_probs=210.1
Q ss_pred ccccccCc-ccccCCceEEEEEeCC--CcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNM-IGQGSFGSVYKGILGE--DEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
++|.+.+. ||+|+||+||+|.++. ++..||||+++... ....+++.+|++++++++|||||++++++.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 46777774 9999999999998753 45689999997543 3446789999999999999999999999853 3
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+++|+|.+++...+. .+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred eEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence 47899999999999999876543 789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 939 (1017)
|+|+......... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .......
T Consensus 154 Gla~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~ 226 (285)
T d1u59a_ 154 GLSKALGADDSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIE 226 (285)
T ss_dssp TTCEECTTCSCEE-----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHH
T ss_pred hhhhccccccccc-----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 9998775433211 11223468999999999998899999999999999999998 99999764221 1111111
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccccc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFG 1014 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1014 (1017)
.... ...+..+++++.+++.+||+.||++|||+.+|++.|+.+..++..
T Consensus 227 ~~~~--------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 227 QGKR--------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp TTCC--------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred cCCC--------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 0000 001123467789999999999999999999999999887655443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=413.96 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=202.6
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
+.|+..+.||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++|||||++++++.+. +.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence 469999999999999999999999999999999975542 3346788999999999999999999998765 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||+++|++..++.... .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEEecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence 899999999999987776543 789999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccC---CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG---SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
+|+..... ....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||....... ......
T Consensus 161 ~a~~~~~~------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~ 227 (309)
T d1u5ra_ 161 SASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIA 227 (309)
T ss_dssp TCBSSSSB------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHH
T ss_pred cccccCCC------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHH
Confidence 99854321 23579999999999864 358999999999999999999999997532211 111111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
....+. . ....+++++.+++.+||+.||++|||+.|+++|
T Consensus 228 ~~~~~~----~----------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 228 QNESPA----L----------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HSCCCC----C----------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred hCCCCC----C----------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 110000 0 011235678999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=408.99 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=202.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCc----EEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDE----MIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
.++|+..++||+|+||+||+|.++.++ ..||||++..... ...+++.+|++++++++|||||+++|++...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~---- 81 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY---- 81 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS----
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC----
Confidence 356888999999999999999986544 5799999864432 3346789999999999999999999998654
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..++||||+.+|++.+++..... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 82 -~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~ 152 (283)
T d1mqba_ 82 -KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVS 152 (283)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred -CceEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEc
Confidence 568999999999999998876643 789999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||+|+........ ........||+.|+|||++.+..++.++|||||||++|||++|..|+.............
T Consensus 153 DFGla~~~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i- 226 (283)
T d1mqba_ 153 DFGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI- 226 (283)
T ss_dssp CCCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-
T ss_pred ccchhhcccCCCcc-----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-
Confidence 99999876533211 111223468999999999999999999999999999999999766654332211111111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
..... .....+++.++.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 227 ~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 227 NDGFR--------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HTTCC--------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hccCC--------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 10000 011123466789999999999999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-47 Score=419.98 Aligned_cols=254 Identities=19% Similarity=0.267 Sum_probs=209.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++.+. +..|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence 35799999999999999999999999999999999866555567788999999999999999999998765 7789
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC--CCCCeEEeecc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--HDMVSHVGDFG 861 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG 861 (1017)
+||||+++|+|.+++.... .++++.+++.|+.||+.||+|||++ |||||||||+|||++ .++.+||+|||
T Consensus 103 ivmE~~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence 9999999999999887654 2699999999999999999999999 999999999999997 67899999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... .........
T Consensus 175 la~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~ 244 (352)
T d1koba_ 175 LATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCD 244 (352)
T ss_dssp TCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCC
T ss_pred cceecCCCC---------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence 998765332 1223568999999999999999999999999999999999999997642211 111111111
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+. . ......+++++.+++.+||+.||.+|||+.|+++|
T Consensus 245 ~~~------~------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 WEF------D------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCC------C------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCC------C------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 100 0 00111235678999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=408.18 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=207.6
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC------cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ------KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 777 (1017)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--- 85 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--- 85 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---
Confidence 357999999999999999999999999999999997432 12357889999999999999999999998765
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC----
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---- 853 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 853 (1017)
+..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 86 --~~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 86 --TDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp --SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSC
T ss_pred --CEEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCccc
Confidence 77899999999999999998653 689999999999999999999999 999999999999998876
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCcc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLT 933 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 933 (1017)
.+|++|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... .
T Consensus 155 ~vkl~DfG~a~~~~~~~---------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~ 224 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-T 224 (293)
T ss_dssp CEEECCCTTCEECTTSC---------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred ceEecchhhhhhcCCCc---------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-H
Confidence 59999999998764322 1223578999999999999899999999999999999999999997642211 1
Q ss_pred HHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 934 LHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 934 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.......... .. ......+++.+.+++.+||+.||++|||++|+++|
T Consensus 225 ~~~i~~~~~~---------------------~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 225 LANVSAVNYE---------------------FE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHTTCCC---------------------CC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcCCC---------------------CC---chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111110000 00 01112345678899999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=416.11 Aligned_cols=264 Identities=24% Similarity=0.369 Sum_probs=206.8
Q ss_pred hhccccccCcccccCCceEEEEEeCCCc-----EEEEEEEeeec-CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGILGEDE-----MIVAVKVINLK-QKGAFKSFMAECKALRNI-RHRNLIKIITICSSID 775 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 775 (1017)
..++|++.++||+|+||+||+|++..++ ..||+|++... .......+.+|+.+++++ +|||||++++++.+.
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~- 113 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 113 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-
Confidence 3468999999999999999999986443 47999998643 234456789999999998 899999999999765
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCCc-----------------cccccCHHHHHHHHHHHHHHHHHHhhCCCCCce
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDHL-----------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMV 838 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 838 (1017)
+..++||||+++|+|.++++...... ....+++.+++.++.||++||+|||++ +||
T Consensus 114 ----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~Ii 186 (325)
T d1rjba_ 114 ----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 186 (325)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ----CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 66899999999999999998654211 123589999999999999999999999 999
Q ss_pred eecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHH
Q 043932 839 HGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELF 918 (1017)
Q Consensus 839 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 918 (1017)
||||||+||+++.++.+||+|||+|+....... ........||+.|||||++.+..++.++|||||||++|||+
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCc------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence 999999999999999999999999986543221 11122356899999999999999999999999999999999
Q ss_pred h-CCCCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC
Q 043932 919 T-GRRPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME 997 (1017)
Q Consensus 919 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 997 (1017)
| |++||.+..... .+........+. ..+..+++++.+++.+||+.||++|||
T Consensus 261 t~g~~Pf~~~~~~~-~~~~~~~~~~~~--------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt 313 (325)
T d1rjba_ 261 SLGVNPYPGIPVDA-NFYKLIQNGFKM--------------------------DQPFYATEEIYIIMQSCWAFDSRKRPS 313 (325)
T ss_dssp TTSCCSSTTCCCSH-HHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hCCCCCCCCCCHHH-HHHHHHhcCCCC--------------------------CCCCcCCHHHHHHHHHHcCCChhHCcC
Confidence 8 899997643321 112221111110 011224567899999999999999999
Q ss_pred HHHHHHHHhh
Q 043932 998 MRDVVAKLCH 1007 (1017)
Q Consensus 998 ~~evl~~L~~ 1007 (1017)
++||+++|..
T Consensus 314 ~~ei~~~L~~ 323 (325)
T d1rjba_ 314 FPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhC
Confidence 9999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=400.58 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=199.6
Q ss_pred CcccccCCceEEEEEeC--CCcEEEEEEEeeec--CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEEE
Q 043932 711 NMIGQGSFGSVYKGILG--EDEMIVAVKVINLK--QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALVF 786 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 786 (1017)
++||+|+||+||+|.++ .+++.||||+++.. +....+++.+|++++++++|||||+++++|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 46999999999999864 35688999999643 23345789999999999999999999999853 2368999
Q ss_pred EeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccccc
Q 043932 787 ECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFL 866 (1017)
Q Consensus 787 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 866 (1017)
||+++|+|.+++.... .+++.++..++.||+.||+|||++ +||||||||+||+++.++.+||+|||+|+..
T Consensus 87 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence 9999999999998754 689999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhcCch
Q 043932 867 SSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ..........+
T Consensus 158 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~~-- 228 (277)
T d1xbba_ 158 RADENYY-----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER-- 228 (277)
T ss_dssp CTTCSEE-----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC--
T ss_pred ccccccc-----ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCCC--
Confidence 5332111 11223568999999999999899999999999999999998 89999763221 11111110000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
...+..+++++.+++.+||+.||++|||++||++.|+...
T Consensus 229 ------------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 ------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 0011234677899999999999999999999999887754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-46 Score=403.69 Aligned_cols=266 Identities=19% Similarity=0.326 Sum_probs=206.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+++.+|++++++++||||+++++++...+. ...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~-~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS-SSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC-CCc
Confidence 467999999999999999999999999999999997443 2345678999999999999999999999876432 235
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||++||+|.+++...+ .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++..+++||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred eEEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 6899999999999999987654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|.+........ .........||+.|+|||++.+..+++++||||+||++|||+||++||.......... .....
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-~~~~~ 229 (277)
T d1o6ya_ 156 GIARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-QHVRE 229 (277)
T ss_dssp TTCEECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHC
T ss_pred hhhhhhccccc-----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH-HHHhc
Confidence 99876543221 1122234679999999999999999999999999999999999999997642221111 00000
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhcc
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-EMRDVVAKLCHTR 1009 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 1009 (1017)
... .. ......+++++.+++.+||+.||++|| |++|+++.|.+++
T Consensus 230 ~~~--~~----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 230 DPI--PP----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCC--CG----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCC--CC----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000 00 001122356789999999999999999 8999999988765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=407.05 Aligned_cols=250 Identities=23% Similarity=0.287 Sum_probs=208.2
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
.++|++.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. +
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----c
Confidence 35799999999999999999999999999999999743 234567889999999999999999999999765 7
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ccccceeccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence 8999999999999999998754 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+|+...... ......+||+.|+|||++.+..|+.++||||+||++|||++|++||.+..... ........
T Consensus 150 G~a~~~~~~~--------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i~~~ 220 (337)
T d1o6la_ 150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILME 220 (337)
T ss_dssp TTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC
T ss_pred ccccccccCC--------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHHhcC
Confidence 9998654221 12234679999999999999999999999999999999999999997643211 01111100
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1004 (1017)
.. ..+..+++++.+++.+||+.||++||+ +.|+++|
T Consensus 221 ~~----------------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 EI----------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CC----------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC----------------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 00 001123566889999999999999995 8888876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=401.35 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=203.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||+||+|+++.+ +.||||+++... ...+.|.+|+.++++++|||||+++++|.+ +..+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence 46899999999999999999999754 579999997443 334789999999999999999999999843 3468
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++|+|.+++.... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 88 lv~Ey~~~g~l~~~~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp EEECCCTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEEEecCCCchhhhhhhcc----cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence 9999999999999987542 13689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|..||............... ...
T Consensus 161 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~ 232 (285)
T d1fmka3 161 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYR 232 (285)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCC
T ss_pred hhccCCCce-------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCC
Confidence 866433211 112346899999999999999999999999999999999977666443222111111111 000
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccccc
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETF 1012 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1012 (1017)
......+++++.+++.+||+.||++||++++|++.|+....+.
T Consensus 233 --------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 233 --------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 0011234667899999999999999999999999998866543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-45 Score=401.74 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=206.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+. +.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----Ce
Confidence 5799999999999999999999999999999999743 234457889999999999999999999998765 78
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.|+||||++||+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eeeEeeecCCccccccccccc------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence 999999999999999998765 678889999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........
T Consensus 150 ~a~~~~~~-----------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~ 217 (316)
T d1fota_ 150 FAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAE 217 (316)
T ss_dssp SCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCC
T ss_pred cceEeccc-----------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHHHHHcCC
Confidence 99875422 123579999999999999999999999999999999999999997642211 111111100
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
. . .+...++++.+++.+||..||.+|| |++|+++|
T Consensus 218 ~--~--------------------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 L--R--------------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C--C--------------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--C--------------------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0 0 0012245688999999999999996 89999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-46 Score=404.59 Aligned_cols=271 Identities=23% Similarity=0.366 Sum_probs=213.0
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeC-----CCcEEEEEEEeeecCc-chHHHHHHHHHHHHhcCCCCceeeeeee
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQK-GAFKSFMAECKALRNIRHRNLIKIITIC 771 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 771 (1017)
.+++...++|++.+.||+|+||+||+|+++ .+++.||||+++.... ...+++.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344445678999999999999999999975 3568999999875433 3356799999999999999999999998
Q ss_pred ecCCCCCCceeEEEEEeccCCCHHHHHhhCCCC------------------ccccccCHHHHHHHHHHHHHHHHHHhhCC
Q 043932 772 SSIDSKGADFKALVFECMKNGSLEDWLHQSNDH------------------LEVCKLTLIQRVNIAIDVASAIEYLHHHC 833 (1017)
Q Consensus 772 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 833 (1017)
... +..++||||+++|+|.+++...... .....+++.++..|+.|++.||+|||++
T Consensus 86 ~~~-----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~- 159 (301)
T d1lufa_ 86 AVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER- 159 (301)
T ss_dssp CSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ccC-----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-
Confidence 764 5689999999999999999754321 1223589999999999999999999999
Q ss_pred CCCceeecCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHH
Q 043932 834 QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGIL 913 (1017)
Q Consensus 834 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 913 (1017)
+||||||||+||+++.++.+||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||+
T Consensus 160 --~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvv 231 (301)
T d1lufa_ 160 --KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 231 (301)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred --CeEeeEEcccceEECCCCcEEEccchhheeccCCccc------cccCCCCcCcCcCCHHHHccCCCChhhhhccchhh
Confidence 9999999999999999999999999999866443211 11223568999999999999999999999999999
Q ss_pred HHHHHhCC-CCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCC
Q 043932 914 LLELFTGR-RPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESP 992 (1017)
Q Consensus 914 l~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 992 (1017)
+|||++|. +||......+ .......... ...+..+++++.+++.+||+.||
T Consensus 232 l~ell~~~~~p~~~~~~~e-~~~~v~~~~~---------------------------~~~p~~~~~~~~~li~~cl~~~P 283 (301)
T d1lufa_ 232 LWEIFSYGLQPYYGMAHEE-VIYYVRDGNI---------------------------LACPENCPLELYNLMRLCWSKLP 283 (301)
T ss_dssp HHHHHTTTCCTTTTSCHHH-HHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHccCCCCCCCCCHHH-HHHHHHcCCC---------------------------CCCCccchHHHHHHHHHHcCCCh
Confidence 99999986 5665532211 1111110000 01112345678999999999999
Q ss_pred CCCCCHHHHHHHHhhccc
Q 043932 993 FERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 993 ~~RPs~~evl~~L~~~~~ 1010 (1017)
++||||.||++.|+++.+
T Consensus 284 ~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 284 ADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp GGSCCHHHHHHHHHHTTC
T ss_pred hHCcCHHHHHHHHHHhcC
Confidence 999999999999998864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=401.03 Aligned_cols=259 Identities=22% Similarity=0.371 Sum_probs=200.2
Q ss_pred hccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
.++|++.+.||+|+||+||+|++..+ +..||||+++... ....+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 46899999999999999999998644 4678999886433 3345679999999999999999999999843
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
+..++||||+++|++.+++..... .+++.+++.++.||++||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence 457999999999999998876543 789999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++ |.+||....... ......
T Consensus 152 fG~a~~~~~~~~~-------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-~~~~i~ 223 (273)
T d1mp8a_ 152 FGLSRYMEDSTYY-------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIE 223 (273)
T ss_dssp --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHH
T ss_pred chhheeccCCcce-------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-HHHHHH
Confidence 9999876432211 1223468999999999999999999999999999999998 899987643321 111111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
....+ ..+..+++++.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 224 ~~~~~---------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 224 NGERL---------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 10000 01123467789999999999999999999999999988654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=406.13 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=204.0
Q ss_pred ccccccCcccccCCceEEEEEeCCCcE----EEEEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGA 779 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 779 (1017)
++|++.++||+|+||+||+|++..+|+ +||+|.++.. .....+++.+|++++++++|||||+++++|.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 469999999999999999999987775 5888887643 334567899999999999999999999998653
Q ss_pred ceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEee
Q 043932 780 DFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGD 859 (1017)
Q Consensus 780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 859 (1017)
..++++||+.+|+|.+++..... .+++..++.++.||+.||+|||++ +||||||||+||+++.++.+||+|
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred -CeeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence 35789999999999999887653 789999999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHH
Q 043932 860 FGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 860 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 938 (1017)
||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |++||+...... +....
T Consensus 155 FGla~~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i 226 (317)
T d1xkka_ 155 FGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL 226 (317)
T ss_dssp CSHHHHTTTTCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHH
T ss_pred cccceeccccccc------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHH
Confidence 9999876543211 11223468999999999999999999999999999999999 788887643221 11111
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
...... ..+..+++++.+++.+||+.||++|||+.||+++|+.+.+
T Consensus 227 ~~~~~~--------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 227 EKGERL--------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHTCCC--------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCC--------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111000 0112345678999999999999999999999999988753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=403.38 Aligned_cols=253 Identities=19% Similarity=0.268 Sum_probs=207.1
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ....+.+|++++++++||||+++++++.+. +..|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM-----EELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEE
Confidence 4689999999999999999999999999999999975543 335688999999999999999999998765 6799
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCC--CCeEEeecc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD--MVSHVGDFG 861 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG 861 (1017)
+||||++||+|.+++..... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||
T Consensus 78 lvmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence 99999999999999976542 689999999999999999999999 99999999999999854 489999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+++...... ......||+.|+|||.+.+..++.++||||+||++|+|++|+.||....... .........
T Consensus 150 ~~~~~~~~~---------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~~ 219 (321)
T d1tkia_ 150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAE 219 (321)
T ss_dssp TCEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTC
T ss_pred hhhccccCC---------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence 998654322 1223568999999999999999999999999999999999999997643211 111111110
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. +. ......+++++.+++.+||..||++|||+.|+++|
T Consensus 220 ~~---------------------~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 YT---------------------FD---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CC---------------------CC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC---------------------CC---hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00 01112335678999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-45 Score=394.38 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=205.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc---------chHHHHHHHHHHHHhcC-CCCceeeeeeeec
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---------GAFKSFMAECKALRNIR-HRNLIKIITICSS 773 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 773 (1017)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 3689999999999999999999999999999999975432 12346889999999996 9999999999976
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 853 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 853 (1017)
. +..|+||||+++|+|.++++... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 82 ~-----~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 82 N-----TFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM 147 (277)
T ss_dssp S-----SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred C-----cceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCC
Confidence 5 78999999999999999998654 789999999999999999999999 999999999999999999
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccC------CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG------SEASMTGDVYSFGILLLELFTGRRPTDAA 927 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~ 927 (1017)
.+||+|||+|+...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 148 ~~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp CEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CeEEccchheeEccCCC---------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 99999999998765322 1123579999999999853 34688999999999999999999999764
Q ss_pred cccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 928 FTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... ............ . ......+++++.+++.+||+.||++|||+.||++|
T Consensus 219 ~~~~-~~~~i~~~~~~~-----~-------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 219 KQML-MLRMIMSGNYQF-----G-------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp SHHH-HHHHHHHTCCCC-----C-------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHH-HHHHHHhCCCCC-----C-------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 3221 111111110000 0 00112345678999999999999999999999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=400.30 Aligned_cols=273 Identities=22% Similarity=0.317 Sum_probs=203.1
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecC-cchHHHHHHHHHHHHhc-CCCCceeeeee
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQ-KGAFKSFMAECKALRNI-RHRNLIKIITI 770 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 770 (1017)
.+++...++|++.++||+|+||+||+|++.. +++.||||+++... ....+.+.+|...+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3343445789999999999999999999743 45789999987443 33456778888888877 68999999998
Q ss_pred eecCCCCCCceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceee
Q 043932 771 CSSIDSKGADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHG 840 (1017)
Q Consensus 771 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 840 (1017)
+... ....++||||+++|+|.++++..... .....+++.++..++.||++||+|||++ +||||
T Consensus 86 ~~~~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr 158 (299)
T d1ywna1 86 CTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 158 (299)
T ss_dssp ECST----TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred eccC----CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCC
Confidence 7543 24579999999999999999865321 0123589999999999999999999999 99999
Q ss_pred cCCCCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhC
Q 043932 841 DLKPSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG 920 (1017)
Q Consensus 841 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 920 (1017)
||||+|||++.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~ 232 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 232 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTT------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cCCccceeECCCCcEEEccCcchhhcccccc------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhC
Confidence 9999999999999999999999986543221 1122235799999999999999999999999999999999997
Q ss_pred C-CCCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 043932 921 R-RPTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR 999 (1017)
Q Consensus 921 ~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 999 (1017)
. +||...... ..+........... ....+++++.+++.+||+.||++|||+.
T Consensus 233 ~~~p~~~~~~~-~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 285 (299)
T d1ywna1 233 GASPYPGVKID-EEFCRRLKEGTRMR--------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFS 285 (299)
T ss_dssp SCCSSTTCCCS-HHHHHHHHHTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCCCHH-HHHHHHHhcCCCCC--------------------------CCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 5 567553222 11111111111100 0112356789999999999999999999
Q ss_pred HHHHHHhhccc
Q 043932 1000 DVVAKLCHTRE 1010 (1017)
Q Consensus 1000 evl~~L~~~~~ 1010 (1017)
||+++|+.+.+
T Consensus 286 eil~~L~~ilq 296 (299)
T d1ywna1 286 ELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999998865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-45 Score=406.35 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=200.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC---cchHHHH---HHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFKSF---MAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
++|++.++||+|+||+||+|++..+|+.||||++.... ......+ .+|+.+++.++||||+++++++...
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~---- 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---- 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC----
Confidence 57999999999999999999999999999999986332 1122233 3456777778899999999998765
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +||||||||+|||++.+|.+||+
T Consensus 80 -~~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 80 -DKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred -CEEEEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEe
Confidence 67899999999999999998654 688999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|||+|+.+.... .....||+.|+|||++.+ ..++.++||||+||++|||+||+.||....... ....
T Consensus 150 DFGla~~~~~~~----------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~ 217 (364)
T d1omwa3 150 DLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEI 217 (364)
T ss_dssp CCTTCEECSSSC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHH
T ss_pred eeceeeecCCCc----------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 999998664322 123579999999999864 568999999999999999999999997643321 1112
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERME-----MRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1004 (1017)
......... .....+++++.+++.+||+.||++||| |+|+++|
T Consensus 218 ~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 218 DRMTLTMAV------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHSSSCCC------------------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHhcccCCC------------------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111111100 001123567899999999999999999 7888875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=395.45 Aligned_cols=263 Identities=25% Similarity=0.433 Sum_probs=209.1
Q ss_pred cCcccccCCceEEEEEeCCC---cEEEEEEEeeec-CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEEE
Q 043932 710 SNMIGQGSFGSVYKGILGED---EMIVAVKVINLK-QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKALV 785 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 785 (1017)
.++||+|+||+||+|++..+ ...||||+++.. +....+++.+|++++++++||||++++|++... ....++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEEE
Confidence 56899999999999998654 346999998743 344567899999999999999999999998654 1468999
Q ss_pred EEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccccc
Q 043932 786 FECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAKF 865 (1017)
Q Consensus 786 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 865 (1017)
|||+++|+|.+++..... ..++.+++.++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 108 ~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence 999999999999886543 677889999999999999999999 999999999999999999999999999987
Q ss_pred cccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcCch
Q 043932 866 LSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALPEK 945 (1017)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 945 (1017)
........ ........||+.|+|||.+.+..++.++||||||+++|||+||+.||..................+.
T Consensus 180 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~- 254 (311)
T d1r0pa_ 180 MYDKEFDS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL- 254 (311)
T ss_dssp TTTTTCCC----TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-
T ss_pred cccccccc----ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 65433221 1222335789999999999999999999999999999999998888765433221111111111000
Q ss_pred hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccccccc
Q 043932 946 VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRETFFGR 1015 (1017)
Q Consensus 946 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1015 (1017)
.+..+++++.+++.+||+.||++||++.||+++|+.+.+++.+.
T Consensus 255 --------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 255 --------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred --------------------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 01123567899999999999999999999999999999887654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=401.45 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=202.5
Q ss_pred hccccccC-cccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSN-MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|.+.+ +||+|+||+||+|++..+++.||||+++.. +.+.+|++++.++ +||||+++++++.+.. ....+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCE
Confidence 46888865 699999999999999999999999998632 5577899987655 8999999999986531 22367
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC---CCCeEEe
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVSHVG 858 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 858 (1017)
.|+|||||+||+|.+++..... ..+++.+++.|+.||+.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 8999999999999999986432 3699999999999999999999999 9999999999999985 5679999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFA 938 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 938 (1017)
|||+|+...... ......||+.|+|||++.+..|+.++||||+||++|+|+||++||.+....... ....
T Consensus 157 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-~~~~ 226 (335)
T d2ozaa1 157 DFGFAKETTSHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMK 226 (335)
T ss_dssp CCTTCEECCCCC---------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred ccceeeeccCCC---------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-HHHH
Confidence 999998664322 122357999999999999999999999999999999999999999764322111 0000
Q ss_pred HhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 939 KIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 939 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
. .......... ......+++++.+++.+||+.||++|||+.|+++|
T Consensus 227 ~-~i~~~~~~~~-------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 227 T-RIRMGQYEFP-------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CCCSCSSSCC-------------------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H-HHhcCCCCCC-------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 0000000000 01123456778999999999999999999999886
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=388.98 Aligned_cols=253 Identities=30% Similarity=0.393 Sum_probs=199.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeE
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
-++|++.++||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++||||++++|+|.+. .+..+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEE
Confidence 357889999999999999999985 778999999643 3447899999999999999999999988543 14579
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLA 863 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 863 (1017)
+||||+++|+|.+++.... ...+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++|||++
T Consensus 78 lv~ey~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp EEECCCTTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEeccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccc
Confidence 9999999999999997542 13589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+...... ....+|..|+|||++.+..++.++|||||||++|||+| |++||...... ..........
T Consensus 151 ~~~~~~~-----------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~ 217 (262)
T d1byga_ 151 KEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY 217 (262)
T ss_dssp ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTC
T ss_pred eecCCCC-----------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC
Confidence 8653211 12357899999999998899999999999999999998 68777654222 1111111110
Q ss_pred CchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhccc
Q 043932 943 PEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRE 1010 (1017)
Q Consensus 943 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 1010 (1017)
.. .....+++++.+++.+||+.||++||||.|++++|+.++.
T Consensus 218 ~~--------------------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 218 KM--------------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC--------------------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 00 0111235678999999999999999999999999998864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-45 Score=403.37 Aligned_cols=246 Identities=20% Similarity=0.260 Sum_probs=205.9
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
++|++.+.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cc
Confidence 5899999999999999999999999999999998743 234457789999999999999999999998765 67
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||||+.+|+|.+++...+ .+++.+++.++.||+.||.|||++ +||||||||+|||++.+|.+||+|||
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccccccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 899999999999999997654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
+|+..... .....||+.|||||++.+..++.++||||+||++|||+||+.||.+..... .........
T Consensus 187 ~a~~~~~~-----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~ 254 (350)
T d1rdqe_ 187 FAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGK 254 (350)
T ss_dssp TCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC
T ss_pred eeeecccc-----------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-HHHHHhcCC
Confidence 99876421 123579999999999999999999999999999999999999997642110 011111000
Q ss_pred cCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
. .....+++++.+++.+||+.||.+|+ |++|+++|
T Consensus 255 ~----------------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 V----------------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C----------------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----------------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 0 00112356788999999999999994 89999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=399.12 Aligned_cols=281 Identities=22% Similarity=0.322 Sum_probs=205.7
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.+.||+|+||+||+|++..+++.||||+++.... ...+++.+|++++++++||||+++++++.+. +..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence 589999999999999999999999999999999964432 3357889999999999999999999999765 778
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
|+||||+.+ ++.+++..... ..+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||.
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred eEEEeecCC-chhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 999999976 45555443321 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCC-cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE-ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
|+...... .......||+.|+|||++.... ++.++||||+||++|+|++|+.||......+..........
T Consensus 149 a~~~~~~~--------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~ 220 (298)
T d1gz8a_ 149 ARAFGVPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220 (298)
T ss_dssp HHHHCCCS--------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ceeccCCc--------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 98664322 1222357999999999887765 57899999999999999999999976432221111111111
Q ss_pred cCch-hhhhcc--chhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhcc
Q 043932 942 LPEK-VIEIVD--PLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK--LCHTR 1009 (1017)
Q Consensus 942 ~~~~-~~~~~d--~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 1009 (1017)
.+.. ...... +...... ...............++++.+++.+||+.||++|||+.|+++| ++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 221 TPDEVVWPGVTSMPDYKPSF---PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CCCTTTSTTGGGSTTCCTTS---CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCchhhcccccccccccccc---ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 1111 000000 0000000 0000011111222345678999999999999999999999987 55443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=400.85 Aligned_cols=272 Identities=24% Similarity=0.267 Sum_probs=197.6
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEEeeecCcc-----hHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 710 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 710 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
.++||+|+||+||+|++..+|+.||||+++..... ..+.+.+|++++++++||||+++++++... +..|+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Cceee
Confidence 57899999999999999999999999998644321 235688999999999999999999998665 66899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
||||++++++..+..... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 78 vmE~~~~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp EEECCSEEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred hhhhhcchHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccc
Confidence 999999887776655432 688889999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhcC
Q 043932 865 FLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIALP 943 (1017)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 943 (1017)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|++||......+ .+....+....
T Consensus 149 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~ 219 (299)
T d1ua2a_ 149 SFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGT 219 (299)
T ss_dssp TTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCC
T ss_pred ccCCCc--------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCC
Confidence 654322 112235799999999988654 57999999999999999999999997643321 12222221111
Q ss_pred chhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 944 EKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 944 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.....+.+.........................++++.+++.+||+.||++||||+|+++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 1100000000000000000000000111112335678999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=391.85 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=197.5
Q ss_pred ccccccCcccccCCceEEEEEeCCC---cEEEEEEEeeec---CcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGED---EMIVAVKVINLK---QKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKG 778 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 778 (1017)
++|++.+.||+|+||+||+|++..+ ...||||++... .....++|.+|++++++++||||++++++|.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 5799999999999999999986432 357999998643 23445789999999999999999999999854
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
+..++||||+++|++.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred -cchheeeeeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence 24589999999999999887654 3799999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++.......... ......||..|+|||++.+..++.++|||||||++|||+| |+.||......+ .....
T Consensus 154 DfGl~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-~~~~i 227 (273)
T d1u46a_ 154 DFGLMRALPQNDDHYV-----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKI 227 (273)
T ss_dssp CCTTCEECCC-CCEEE-----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHH
T ss_pred cchhhhhcccCCCcce-----ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-HHHHH
Confidence 9999987654332111 1123467889999999999999999999999999999998 899997542221 11111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
...... ......+++++.+++.+||+.||++||||.||.+.|+++
T Consensus 228 ~~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 228 DKEGER--------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HTSCCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCC--------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 110000 001123356789999999999999999999999988865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=398.04 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=202.9
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeec---CcchHHHHHHHHHHHH-hcCCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFKSFMAECKALR-NIRHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 780 (1017)
++|++.++||+|+||+||+|++..+++.||||+++.. .....+.+..|..++. .++||||+++++++.+. +
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence 5799999999999999999999999999999999743 2334456677777665 68999999999998765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEEeecCCCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence 7999999999999999998654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+|+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ..... ..
T Consensus 148 G~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i-~~ 217 (320)
T d1xjda_ 148 GMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-LFHSI-RM 217 (320)
T ss_dssp TTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH-HH
T ss_pred chhhhccccc--------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHH-Hc
Confidence 9998654322 11223579999999999999999999999999999999999999997642211 01000 00
Q ss_pred hcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 043932 941 ALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMR-DVVAK 1004 (1017)
Q Consensus 941 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 1004 (1017)
..+ ..+..+++++.+++.+||+.||++||++. |+++|
T Consensus 218 ~~~---------------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 218 DNP---------------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CCC---------------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCC---------------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 000 00112356789999999999999999995 77653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=389.70 Aligned_cols=274 Identities=24% Similarity=0.341 Sum_probs=204.3
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHH--HHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFM--AECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|...+.||+|+||+||+|++ +|+.||||+++.... +.+. .|+..+.+++||||++++++|...+ .....
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceE
Confidence 35788889999999999999997 588999999864332 3333 4555556789999999999997653 23356
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC-----CCCceeecCCCCceEeCCCCCeE
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC-----QPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
.|+||||+++|+|.+++++. .+++.++++++.|+|.||+|+|+.. .++||||||||+|||++.++.+|
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred EEEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence 89999999999999999864 5899999999999999999999731 23999999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCC------CcCccccchhHHHHHHHHHhCCCCCCccccc
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS------EASMTGDVYSFGILLLELFTGRRPTDAAFTE 930 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~ 930 (1017)
|+|||+++......... ........||+.|+|||++.+. .++.++|||||||++|||+||..||......
T Consensus 149 l~DFGl~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp ECCCTTCEEEETTTTEE----CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred EEecCccccccCCCcce----eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence 99999998765432111 1122346799999999998764 2677899999999999999999887653322
Q ss_pred Cc----------cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 043932 931 GL----------TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRD 1000 (1017)
Q Consensus 931 ~~----------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1000 (1017)
.. ...........+.. +|.. .......++...+.+++.+||+.||++|||+.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~-------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 287 (303)
T d1vjya_ 225 QLPYYDLVPSDPSVEEMRKVVCEQKL----RPNI-------------PNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCC----CCCC-------------CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred ccchhhcccccchHHHHHHHHhcccc----CCCC-------------CcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 11 11111111110000 0000 001122345677999999999999999999999
Q ss_pred HHHHHhhcccc
Q 043932 1001 VVAKLCHTRET 1011 (1017)
Q Consensus 1001 vl~~L~~~~~~ 1011 (1017)
|+++|+++.+.
T Consensus 288 i~~~L~~i~~~ 298 (303)
T d1vjya_ 288 IKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999988753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=394.77 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=204.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEE--EEEEEeeec-CcchHHHHHHHHHHHHhc-CCCCceeeeeeeecCCCCCCc
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMI--VAVKVINLK-QKGAFKSFMAECKALRNI-RHRNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 780 (1017)
++|++.++||+|+||+||+|+++.++.. ||||.+... .....+.+.+|+++++++ +||||++++++|... +
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence 5788999999999999999999877764 677777533 334557899999999999 799999999999765 6
Q ss_pred eeEEEEEeccCCCHHHHHhhCCC----------CccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeC
Q 043932 781 FKALVFECMKNGSLEDWLHQSND----------HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 850 (1017)
..++||||+++|+|.++++.... ......+++.++.+++.||+.||.|+|++ +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 78999999999999999976421 11234789999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCC-CCCcccc
Q 043932 851 HDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRR-PTDAAFT 929 (1017)
Q Consensus 851 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-pf~~~~~ 929 (1017)
.++.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.....
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp GGGCEEECCTTCEESSCEEC---------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCceEEccccccccccccc---------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999997554221 1122468999999999999999999999999999999999765 5644211
Q ss_pred cCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 930 EGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
.+........ .. ......+++++.+++.+||+.||++||||+||+++|+++.
T Consensus 233 -----~~~~~~i~~~-----~~------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 233 -----AELYEKLPQG-----YR------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp -----HHHHHHGGGT-----CC------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHHhc-----CC------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111111000 00 0011224567899999999999999999999999999877
Q ss_pred c
Q 043932 1010 E 1010 (1017)
Q Consensus 1010 ~ 1010 (1017)
+
T Consensus 285 ~ 285 (309)
T d1fvra_ 285 E 285 (309)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=395.34 Aligned_cols=282 Identities=20% Similarity=0.288 Sum_probs=205.6
Q ss_pred hccccccCcccccCCceEEEEEeCCC-cEEEEEEEeeecC--cchHHHHHHHHHHHHhc---CCCCceeeeeeeecCCCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED-EMIVAVKVINLKQ--KGAFKSFMAECKALRNI---RHRNLIKIITICSSIDSK 777 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~ 777 (1017)
.++|++.++||+|+||+||+|++..+ ++.||||+++... ......+.+|+.+++.+ +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57899999999999999999999654 7889999987543 22234566777777666 799999999998765444
Q ss_pred CCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEE
Q 043932 778 GADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHV 857 (1017)
Q Consensus 778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 857 (1017)
.....+++|||++++++........ ..+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCceEEEEEEeccCCchhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 5578899999998877665544433 3789999999999999999999999 9999999999999999999999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||.++...... ......||+.|+|||++.+..++.++||||+||++|||++|++||...... ..+...
T Consensus 158 ~dfg~~~~~~~~~---------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i 227 (305)
T d1blxa_ 158 ADFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKI 227 (305)
T ss_dssp CSCCSCCCCCGGG---------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred cchhhhhhhcccc---------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHH
Confidence 9999987653222 222357999999999999999999999999999999999999999764322 122222
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
...........+........ ..................++.+.+++.+||++||++||||.|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPR-QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCG-GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhCCCchhcccccccchh-hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 22111111101000000000 0000000000111122335678899999999999999999999886
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=390.57 Aligned_cols=267 Identities=22% Similarity=0.361 Sum_probs=211.1
Q ss_pred hhccccccCcccccCCceEEEEEe-----CCCcEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeeeeeeecCC
Q 043932 703 ATSEFASSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKIITICSSID 775 (1017)
Q Consensus 703 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 775 (1017)
..++|++.++||+|+||.||+|++ ..+++.||||+++.... ....++.+|+.+++++ +|||||+++++|...
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~- 99 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence 457899999999999999999986 34678999999975443 3456788999999999 699999999999765
Q ss_pred CCCCceeEEEEEeccCCCHHHHHhhCCCC------------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCC
Q 043932 776 SKGADFKALVFECMKNGSLEDWLHQSNDH------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLK 843 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 843 (1017)
+..++||||+++|+|.++++..... .....+++.++..++.||++||+|||++ ++||||||
T Consensus 100 ----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLK 172 (311)
T d1t46a_ 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (311)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred ----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccc
Confidence 5689999999999999999865421 1223689999999999999999999999 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhC-CC
Q 043932 844 PSNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTG-RR 922 (1017)
Q Consensus 844 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~ 922 (1017)
|+||+++.++.+|++|||.++........ .......||+.|+|||++.+..++.++|||||||++|||+|+ .+
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccccccccCcccccccchheeccCCCcc------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCC
Confidence 99999999999999999999876533211 112235789999999999998999999999999999999995 55
Q ss_pred CCCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 043932 923 PTDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVV 1002 (1017)
Q Consensus 923 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1002 (1017)
||... .....+........+.. ....+++.+.+++.+||+.||++||||.||+
T Consensus 247 ~~~~~-~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il 299 (311)
T d1t46a_ 247 PYPGM-PVDSKFYKMIKEGFRML--------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (311)
T ss_dssp SSTTC-CSSHHHHHHHHHTCCCC--------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCC-CHHHHHHHHHhcCCCCC--------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 55443 22222222222111110 0112356789999999999999999999999
Q ss_pred HHHhhccc
Q 043932 1003 AKLCHTRE 1010 (1017)
Q Consensus 1003 ~~L~~~~~ 1010 (1017)
+.|+++.+
T Consensus 300 ~~L~~~i~ 307 (311)
T d1t46a_ 300 QLIEKQIS 307 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhhc
Confidence 99987543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=387.92 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=206.5
Q ss_pred hccccccCcccccCCceEEEEEeCCC-------cEEEEEEEeeecCc-chHHHHHHHHHHHHhc-CCCCceeeeeeeecC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGED-------EMIVAVKVINLKQK-GAFKSFMAECKALRNI-RHRNLIKIITICSSI 774 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 774 (1017)
.++|++.+.||+|+||.||+|+...+ +..||||+++.... ....++.+|+..+.++ +||||++++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 46899999999999999999997544 35799999975443 3457788899999888 899999999999754
Q ss_pred CCCCCceeEEEEEeccCCCHHHHHhhCCCC----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCC
Q 043932 775 DSKGADFKALVFECMKNGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKP 844 (1017)
Q Consensus 775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 844 (1017)
+..++||||+++|+|.+++...... .....+++.+++.++.||+.||+|||++ +||||||||
T Consensus 92 -----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 92 -----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp -----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred -----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 5689999999999999999765421 1234689999999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHh-CCCC
Q 043932 845 SNVLLDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFT-GRRP 923 (1017)
Q Consensus 845 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 923 (1017)
+|||++.++.+||+|||+++....... ........||+.|+|||.+.+..|+.++|||||||++|||++ |.+|
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCT------TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cceeecCCCCeEeccchhhcccccccc------ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence 999999999999999999987654321 122234578999999999999999999999999999999998 6888
Q ss_pred CCcccccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 043932 924 TDAAFTEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVA 1003 (1017)
Q Consensus 924 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1003 (1017)
|...... ............ .....+++++.+++.+||+.||++||||.||++
T Consensus 238 ~~~~~~~--~~~~~i~~~~~~--------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 238 YPGVPVE--ELFKLLKEGHRM--------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp STTCCHH--HHHHHHHTTCCC--------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHH--HHHHHHHcCCCC--------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8653221 111111110000 001123567899999999999999999999999
Q ss_pred HHhhccc
Q 043932 1004 KLCHTRE 1010 (1017)
Q Consensus 1004 ~L~~~~~ 1010 (1017)
.|+.+.+
T Consensus 290 ~L~~i~a 296 (299)
T d1fgka_ 290 DLDRIVA 296 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 9998865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=389.20 Aligned_cols=242 Identities=22% Similarity=0.318 Sum_probs=197.9
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc------chHHHHHHHHHHHHhcC--CCCceeeeeeeecCC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFKSFMAECKALRNIR--HRNLIKIITICSSID 775 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 775 (1017)
.++|++.++||+|+||+||+|++..+++.||||++..... ....++.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~- 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence 4689999999999999999999999999999999874321 11244678999999996 89999999998765
Q ss_pred CCCCceeEEEEEeccC-CCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-CC
Q 043932 776 SKGADFKALVFECMKN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DM 853 (1017)
Q Consensus 776 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~ 853 (1017)
+..++||||+.+ +++.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++. ++
T Consensus 82 ----~~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 82 ----DSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp ----SEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred ----CeEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCC
Confidence 678999999976 68888887653 789999999999999999999999 9999999999999985 47
Q ss_pred CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCc-CccccchhHHHHHHHHHhCCCCCCcccccCc
Q 043932 854 VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEA-SMTGDVYSFGILLLELFTGRRPTDAAFTEGL 932 (1017)
Q Consensus 854 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~ 932 (1017)
.+||+|||+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 149 ~vkl~DFG~a~~~~~~~----------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---- 214 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 214 (273)
T ss_dssp EEEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred eEEECccccceeccccc----------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----
Confidence 99999999998653221 223579999999999987665 677999999999999999999997531
Q ss_pred cHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 933 TLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
........ .. ..+++++.+++.+||+.||++|||++|+++|
T Consensus 215 ---~i~~~~~~------~~----------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 ---EIIRGQVF------FR----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---HHHHCCCC------CS----------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHhhcccC------CC----------------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11111000 00 1124568899999999999999999999886
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=392.77 Aligned_cols=272 Identities=21% Similarity=0.369 Sum_probs=213.4
Q ss_pred HHHhhccccccCcccccCCceEEEEEeCC-----CcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeec
Q 043932 700 LSKATSEFASSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSS 773 (1017)
Q Consensus 700 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 773 (1017)
++...++|++.+.||+|+||+||+|++.. +++.||||+++... ......+.+|++++++++||||++++++|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 34445789999999999999999999852 45789999997443 2344578999999999999999999999865
Q ss_pred CCCCCCceeEEEEEeccCCCHHHHHhhCCCC----ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEe
Q 043932 774 IDSKGADFKALVFECMKNGSLEDWLHQSNDH----LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 849 (1017)
. +..++||||+++|+|.+++...... .....+++..+.+++.|+++||+|||++ +|+||||||+|||+
T Consensus 95 ~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 95 G-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166 (308)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred C-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceee
Confidence 4 5689999999999999998753210 1123578999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCC-CCCCccc
Q 043932 850 DHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGR-RPTDAAF 928 (1017)
Q Consensus 850 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~~~~ 928 (1017)
+.++++||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||++|||+||. +||....
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCE------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cCCceEEEeecccceeccCCcce------eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999876543311 1122346899999999999999999999999999999999985 6665431
Q ss_pred ccCccHHHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 043932 929 TEGLTLHEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHT 1008 (1017)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 1008 (1017)
. .+.......... ......+++.+.+++.+||+.||++|||+.||+++|++.
T Consensus 241 ~-----~~~~~~i~~~~~-----------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 241 N-----EQVLRFVMEGGL-----------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp H-----HHHHHHHHTTCC-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred H-----HHHHHHHHhCCC-----------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 111111000000 001123456799999999999999999999999999998
Q ss_pred ccccc
Q 043932 1009 RETFF 1013 (1017)
Q Consensus 1009 ~~~~~ 1013 (1017)
.+..+
T Consensus 293 ~~~~~ 297 (308)
T d1p4oa_ 293 MEPGF 297 (308)
T ss_dssp SCTTH
T ss_pred cCCCC
Confidence 77654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.2e-43 Score=387.39 Aligned_cols=292 Identities=30% Similarity=0.482 Sum_probs=266.9
Q ss_pred CCHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCC--ceeeEEECCCC--CeEEEEEcCCCCCcc--ccCcccCCCCCCCEE
Q 043932 33 TNETDRLALLAIKSQLHDTSGVTSSWNNTINLC--QWTGVTCGHRH--QRVTRLDLSNQRIGG--ILSPYVGNLSFLRYI 106 (1017)
Q Consensus 33 ~~~~~~~aLl~~k~~~~~~~~~~~sw~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L~~L 106 (1017)
|+|+|++||++||+++.||. .++||..++||| .|+||+|+..+ .||+.|||++++++| .+|+.+++|++|++|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 89999999999999999885 689999888999 49999998644 489999999999998 478999999999999
Q ss_pred EccC-CCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccc
Q 043932 107 NLSD-NSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYL 185 (1017)
Q Consensus 107 ~L~~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 185 (1017)
||++ |+++|.+|.+|+++++|++|+|++|++.+..|..+..+.+|+++++++|.+.+.+|..++++++|+++++++|.+
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 9997 899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCccccCCCcc-cEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCch
Q 043932 186 TGRLPDFVGNLSAL-EVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFD 264 (1017)
Q Consensus 186 ~~~~p~~~~~l~~L-~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~ 264 (1017)
++.+|+.++.+..+ +.+++++|++++..|..+..+..+ .++++++.+.+.+|..+..+++|+.+++++|.+.+.+|.
T Consensus 162 ~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~- 239 (313)
T d1ogqa_ 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK- 239 (313)
T ss_dssp EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-
T ss_pred ccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc-
Confidence 99999999999887 889999999999999999887655 799999999999999999999999999999999876653
Q ss_pred hhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCc
Q 043932 265 IVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNN 329 (1017)
Q Consensus 265 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 329 (1017)
+..+++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+| .+..+++|+.+++++|+
T Consensus 240 -~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302 (313)
T ss_dssp -CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSSS
T ss_pred -cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-CcccCCCCCHHHhCCCc
Confidence 5678999999999999999999999999999999999999998877 45667777777777665
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-44 Score=385.72 Aligned_cols=276 Identities=21% Similarity=0.265 Sum_probs=201.9
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.++||+|+||+||+|+++ +++.||||++.... ....+++.+|+.++++++||||+++++++... +..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence 58999999999999999999996 78899999997543 23357899999999999999999999998765 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++||||+.++.+..+..... .+++.++..++.||+.||+|||+. +||||||||+|||++.++.+|++|||.
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred eEEEEeehhhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence 99999998876666655443 799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
|........ ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+ .........
T Consensus 147 a~~~~~~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~ 217 (286)
T d1ob3a_ 147 ARAFGIPVR--------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRIL 217 (286)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ceecccCcc--------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhh
Confidence 987643221 12234689999999998764 56899999999999999999999997643221 112222111
Q ss_pred cCchhhhhccchhhHHHHhh-cchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMAN-NSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.......+.+.......... ...............++.+.+++.+||+.||++|||++|+++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110000000000000000 0000000011122335678899999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=389.27 Aligned_cols=285 Identities=20% Similarity=0.235 Sum_probs=205.0
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC-cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.++||+|+||+||+|++..+|+.||||++.... ....+++.+|++++++++||||+++++++...........
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 468999999999999999999999999999999997543 3345678999999999999999999999876544433444
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++| +|+.+|+|.+++... .+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 87 ~l~-~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 87 YLV-THLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp EEE-EECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEE-EeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence 555 556688999999754 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
|+......... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+..........
T Consensus 156 a~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 156 ARVADPDHDHT-----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CEECCGGGCBC-----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eeeccCCCccc-----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence 98765433211 12234679999999999855 4578999999999999999999999976432211111111111
Q ss_pred cCchhh--hhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVI--EIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~--~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+.... ..............................+++.+++.+||+.||++||||.|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111100 000000000000000000000111122334578999999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=380.91 Aligned_cols=288 Identities=22% Similarity=0.298 Sum_probs=203.6
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC---CC
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS---KG 778 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 778 (1017)
.++|++.++||+|+||+||+|++..+|+.||||++.... ....+++.+|++++++++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 479999999999999999999999999999999986442 3345778999999999999999999999865422 12
Q ss_pred CceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEe
Q 043932 779 ADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVG 858 (1017)
Q Consensus 779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 858 (1017)
.+..|+||||++++.+..+.... ..+++.+++.++.||+.||.|||++ +|+||||||+||+++.++.+|++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCCCccchhhhcc------cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence 35689999999887666554433 2688999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 859 DFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 859 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
|||+++......... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .....
T Consensus 160 dfg~~~~~~~~~~~~----~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i 234 (318)
T d3blha1 160 DFGLARAFSLAKNSQ----PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALI 234 (318)
T ss_dssp CCTTCEECCC---------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred ecceeeecccccccc----cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHH
Confidence 999998765433221 1122335799999999998765 68999999999999999999999997643221 11111
Q ss_pred HHhh--cCchhhhhccchhhHHHHhhcchhHHHhHH--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 043932 938 AKIA--LPEKVIEIVDPLLLIEVMANNSMIQEDIRA--KTQECLNAIIRIGVLCSMESPFERMEMRDVVAKL 1005 (1017)
Q Consensus 938 ~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1005 (1017)
.... .+.......+.................... ......+.+.+++.+||++||++||||+|+++|=
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 1111 111111111111111101000000000111 1122345678999999999999999999999873
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=385.76 Aligned_cols=283 Identities=20% Similarity=0.272 Sum_probs=205.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 780 (1017)
.++|++.++||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++|||||+++++|...+. ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999999999999999997432 2345678899999999999999999999866532 2335
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
+.|+||||+ +.+|..+.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecc-cccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence 679999999 56888887643 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHH
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAK 939 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 939 (1017)
|.|+..... .....||+.|+|||++.+. .++.++||||+||++|||++|++||...... ........
T Consensus 166 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~ 233 (346)
T d1cm8a_ 166 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMK 233 (346)
T ss_dssp TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred cceeccCCc-----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHh
Confidence 999865421 1235799999999998764 5689999999999999999999999764322 11111111
Q ss_pred hh--cCchhhhhccchhhHHHHhhcc-hhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhcc
Q 043932 940 IA--LPEKVIEIVDPLLLIEVMANNS-MIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK--LCHTR 1009 (1017)
Q Consensus 940 ~~--~~~~~~~~~d~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 1009 (1017)
.. .+.................... ..............+.+.+++.+||+.||++||||.|+++| ++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 11 1112222222111111111000 00001111122345678899999999999999999999987 55443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-42 Score=375.33 Aligned_cols=266 Identities=22% Similarity=0.293 Sum_probs=204.1
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCceeEE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFKAL 784 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 784 (1017)
++|++.+.||+|+||+||+|++..+++.||||++..... .+++..|+++++.++|++++..++.+... .+..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEE
Confidence 579999999999999999999999999999999875433 24578899999999888776666555433 267899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC---CCCeEEeecc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVSHVGDFG 861 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 861 (1017)
||||+ ++++.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+|++|||
T Consensus 81 vme~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEc-CCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence 99999 5577777765442 789999999999999999999999 9999999999999864 4579999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHH--HHHH
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLH--EFAK 939 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~--~~~~ 939 (1017)
+|+.+......... .........||+.|+|||++.+..+++++|||||||++|||++|+.||........... ....
T Consensus 152 ~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 152 LAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SCEECBCTTTCCBC-CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred cceeccccccccce-eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 99987644322211 11223346799999999999999999999999999999999999999976433211110 0000
Q ss_pred hhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcc
Q 043932 940 IALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTR 1009 (1017)
Q Consensus 940 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 1009 (1017)
... ..........+++++.+++..|++.||++||++.++.+.|+.+.
T Consensus 231 ~~~-----------------------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 231 KKM-----------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHH-----------------------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ccC-----------------------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 000 00011122345678999999999999999999999988888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=389.15 Aligned_cols=283 Identities=23% Similarity=0.284 Sum_probs=200.5
Q ss_pred cccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCceeEE
Q 043932 706 EFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGADFKAL 784 (1017)
Q Consensus 706 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l 784 (1017)
+|+..++||+|+||+||+|++..+|+.||||++...... ..+|++++++++||||+++++++..... .+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 788999999999999999999999999999999754322 3479999999999999999999865432 33457899
Q ss_pred EEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-CeEEeecccc
Q 043932 785 VFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VSHVGDFGLA 863 (1017)
Q Consensus 785 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a 863 (1017)
||||++++.+..+..... ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 97 v~Ey~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEECCSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEeccCCccHHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 999998754333322111 123789999999999999999999999 999999999999999775 8999999999
Q ss_pred cccccccccccccCCCcccccccCccccCcccccC-CCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhhc
Q 043932 864 KFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMG-SEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIAL 942 (1017)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 942 (1017)
+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|++||......+ .+....+...
T Consensus 171 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g 240 (350)
T d1q5ka_ 171 KQLVRGE---------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLG 240 (350)
T ss_dssp EECCTTS---------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHC
T ss_pred hhccCCc---------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 8664322 1223579999999998765 568999999999999999999999997643221 1212211111
Q ss_pred Cch--hhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhhcc
Q 043932 943 PEK--VIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK--LCHTR 1009 (1017)
Q Consensus 943 ~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 1009 (1017)
... ......+........ .....+.........++++.+++.+||+.||++||||.|+++| +++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCHHHHHHHCC---CCCCC-CCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CChHHhhhhhccchhhcccc-ccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 110 000000000000000 0000000001112235678999999999999999999999976 44443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-42 Score=369.80 Aligned_cols=270 Identities=17% Similarity=0.240 Sum_probs=210.7
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCC-CCceeeeeeeecCCCCCCcee
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRH-RNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 782 (1017)
.++|++.++||+|+||+||+|++..+++.||||++..... .+.+.+|++.++.++| +|++.+++++... ...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecC-----Ccc
Confidence 3689999999999999999999999999999999864432 2456788999999965 8999999988654 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCC-----CCCeEE
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-----DMVSHV 857 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl 857 (1017)
++||||+ +++|.+++..... .++..++..++.|++.||+|||++ +|+||||||+||+++. ++.+||
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl 147 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 147 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEec-CCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEE
Confidence 9999999 6799999887653 689999999999999999999999 9999999999999974 578999
Q ss_pred eecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHH
Q 043932 858 GDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEF 937 (1017)
Q Consensus 858 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 937 (1017)
+|||+|+.+......... .........||+.|||||++.+..+++++||||+||++|||++|+.||......... ...
T Consensus 148 ~DFG~a~~~~~~~~~~~~-~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-~~~ 225 (293)
T d1csna_ 148 VDFGMVKFYRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKY 225 (293)
T ss_dssp CCCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHH
T ss_pred cccceeEEcccCccccce-eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-HHH
Confidence 999999887543322111 122233468999999999999999999999999999999999999999764332111 111
Q ss_pred HHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcccc
Q 043932 938 AKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAKLCHTRET 1011 (1017)
Q Consensus 938 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 1011 (1017)
..... .. ...........+++++.+++..|++.+|++||+++.+.+.++++.++
T Consensus 226 ~~i~~-~~-------------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 226 ERIGE-KK-------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHHH-HH-------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHh-cc-------------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 00000 00 00000111223567899999999999999999999999888877643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-42 Score=381.14 Aligned_cols=273 Identities=21% Similarity=0.249 Sum_probs=201.8
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCceeE
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADFKA 783 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 783 (1017)
++|++.++||+|+||+||+|++..+++.||||+++.. ..+++.+|+++++++. ||||+++++++.... ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~---~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC---CCcee
Confidence 5899999999999999999999999999999998643 3467889999999995 999999999986532 25689
Q ss_pred EEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCC-CeEEeeccc
Q 043932 784 LVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VSHVGDFGL 862 (1017)
Q Consensus 784 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~ 862 (1017)
+||||+++++|.++.+ .+++.+++.++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+
T Consensus 109 ~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp EEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred EEEeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence 9999999999876532 689999999999999999999999 999999999999998655 689999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
|+...... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.................
T Consensus 177 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 177 AEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp CEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred ceeccCCC---------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 98765322 12235689999999998765 479999999999999999999999976433222222221111
Q ss_pred cCchhhhhcc---chhhHHHHhh-----cchhHHH-hHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVD---PLLLIEVMAN-----NSMIQED-IRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d---~~l~~~~~~~-----~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
..+...+... ......+... ....... .......+++++.+++.+||+.||++|||++|+++|
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111100000 0000000000 0000000 001112345678999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=376.83 Aligned_cols=278 Identities=18% Similarity=0.196 Sum_probs=198.8
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCC-CCCc
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDS-KGAD 780 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 780 (1017)
.++|++.++||+|+||+||+|++..+|+.||||++.... ....+++.+|+.++++++||||+++++++..... +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999999999999999997543 3344678899999999999999999999865432 2447
Q ss_pred eeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeec
Q 043932 781 FKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDF 860 (1017)
Q Consensus 781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 860 (1017)
+.|+||||+.++.+ +.+.. .+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+|++||
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eeEEEEeccchHHH-Hhhhc--------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeech
Confidence 88999999977544 44432 578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 861 GLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 861 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|++||.+.... .........
T Consensus 164 ~~~~~~~~~~---------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~ 233 (355)
T d2b1pa1 164 GLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQ 233 (355)
T ss_dssp CC------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred hhhhcccccc---------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHh
Confidence 9987654322 223357899999999999999999999999999999999999999764322 111111111
Q ss_pred hcCc--hhhhhccchhhHHHHhhc-------------chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 ALPE--KVIEIVDPLLLIEVMANN-------------SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~~~--~~~~~~d~~l~~~~~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.... ........... ...... ..............++.+.+++.+||+.||++||||+|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 234 LGTPCPEFMKKLQPTVR-NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HCCCCHHHHTTSCHHHH-HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCCHHHHHHhhhhHH-HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1110 01100111000 000000 000011112234557788999999999999999999999977
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=372.85 Aligned_cols=278 Identities=19% Similarity=0.239 Sum_probs=208.1
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecC--cchHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCcee
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
++|++.++||+|+||+||+|++..+++.||||+++... ....+++.+|+.+++.++||||+++++++... +..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence 47999999999999999999999999999999997543 34467889999999999999999999999765 678
Q ss_pred EEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeeccc
Q 043932 783 ALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFGL 862 (1017)
Q Consensus 783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 862 (1017)
++|+|++.++++..++...+ .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEeeecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 99999999999988877654 688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccCCCcccccccCccccCcccccCCC-cCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHhh
Q 043932 863 AKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSE-ASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKIA 941 (1017)
Q Consensus 863 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 941 (1017)
|+...... .......+++.|+|||++.+.. ++.++||||+||++|||++|+.||.................
T Consensus 148 a~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 219 (292)
T d1unla_ 148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp CEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred hhcccCCC--------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc
Confidence 98764322 1112245788999999987655 68999999999999999999999754333222222222222
Q ss_pred cCchhhhhccchhhHHHHh-hcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 942 LPEKVIEIVDPLLLIEVMA-NNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 942 ~~~~~~~~~d~~l~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+.....+.......+... .................+.+.+++.+||+.||.+||||+|+++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111000000000000000 00000001111122335668899999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=381.29 Aligned_cols=279 Identities=19% Similarity=0.252 Sum_probs=204.4
Q ss_pred hccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc--chHHHHHHHHHHHHhcCCCCceeeeeeeecCCCCCCce
Q 043932 704 TSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFKSFMAECKALRNIRHRNLIKIITICSSIDSKGADF 781 (1017)
Q Consensus 704 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 781 (1017)
.++|++.++||+|+||+||+|++..+|+.||||+++.... ...+++.+|++++++++||||+++++++..........
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5689999999999999999999999999999999975432 34467889999999999999999999986554333344
Q ss_pred eEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeEEeecc
Q 043932 782 KALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSHVGDFG 861 (1017)
Q Consensus 782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 861 (1017)
.++||+|+.+|+|.+++... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence 56677788899999998643 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccCCCcccccccCccccCcccccCC-CcCccccchhHHHHHHHHHhCCCCCCcccccCccHHHHHHh
Q 043932 862 LAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS-EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTLHEFAKI 940 (1017)
Q Consensus 862 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 940 (1017)
.|...... .....||+.|+|||+..+. .++.++||||+||++|+|++|++||.+...... .......
T Consensus 167 ~a~~~~~~-----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~ 234 (348)
T d2gfsa1 167 LARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRL 234 (348)
T ss_dssp ---CCTGG-----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred hhcccCcc-----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHh
Confidence 98754321 1235689999999987665 468999999999999999999999976432211 1111111
Q ss_pred hc--CchhhhhccchhhHHHHhhc-chhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 043932 941 AL--PEKVIEIVDPLLLIEVMANN-SMIQEDIRAKTQECLNAIIRIGVLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 941 ~~--~~~~~~~~d~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.. +................... ..............++.+.+++.+||+.||++||||.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 11 11111111111111111100 000001111122345678999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=374.01 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=202.6
Q ss_pred ccccccCcccccCCceEEEEEe---CCCcEEEEEEEeeec----CcchHHHHHHHHHHHHhcCC-CCceeeeeeeecCCC
Q 043932 705 SEFASSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINLK----QKGAFKSFMAECKALRNIRH-RNLIKIITICSSIDS 776 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 776 (1017)
++|++.++||+|+||+||+|++ +.+|+.||||+++.. +....+.+.+|++++++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 6799999999999999999987 446899999998633 22334678899999999976 8999999998765
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceEeCCCCCeE
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVSH 856 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 856 (1017)
...++||||+.+|+|.+++.... .+++..+..++.||+.||+|+|++ +||||||||+||+++.++.+|
T Consensus 102 ---~~~~~v~e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 102 ---TKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp ---TEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred ---CceeeeeecccccHHHHHHHhcc------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence 67899999999999999998764 578889999999999999999999 999999999999999999999
Q ss_pred EeecccccccccccccccccCCCcccccccCccccCcccccCC--CcCccccchhHHHHHHHHHhCCCCCCcccccCccH
Q 043932 857 VGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGS--EASMTGDVYSFGILLLELFTGRRPTDAAFTEGLTL 934 (1017)
Q Consensus 857 l~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 934 (1017)
|+|||+|+.+...... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.........
T Consensus 170 L~DFG~a~~~~~~~~~-------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~- 241 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETE-------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ- 241 (322)
T ss_dssp ESCSSEEEECCGGGGG-------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-
T ss_pred Eeeccchhhhcccccc-------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence 9999999876543221 12235799999999998764 4688999999999999999999999875443222
Q ss_pred HHHHHhhcCchhhhhccchhhHHHHhhcchhHHHhHHhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 043932 935 HEFAKIALPEKVIEIVDPLLLIEVMANNSMIQEDIRAKTQECLNAIIRIGVLCSMESPFERM-----EMRDVVAK 1004 (1017)
Q Consensus 935 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1004 (1017)
........... ......+++++.+++.+||++||++|| |++|+++|
T Consensus 242 ~~i~~~~~~~~------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 242 AEISRRILKSE------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHHHHHHCC------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHhcccCC------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 12111110000 001123467789999999999999999 58899875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-36 Score=341.10 Aligned_cols=276 Identities=17% Similarity=0.217 Sum_probs=192.4
Q ss_pred ccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-----------CCCceeeeeeeec
Q 043932 705 SEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-----------HRNLIKIITICSS 773 (1017)
Q Consensus 705 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 773 (1017)
++|+++++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999999999999999997432 23466788999888875 5789999988754
Q ss_pred CCCCCCceeEEEEEeccCCCH-HHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCC
Q 043932 774 IDSKGADFKALVFECMKNGSL-EDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDH 851 (1017)
Q Consensus 774 ~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~ 851 (1017)
.. ....++|++++..+.. ....... ....+++..+..++.||+.||+|||+ . +|+||||||+|||++.
T Consensus 92 ~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 92 KG---PNGVHVVMVFEVLGENLLALIKKY----EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI 161 (362)
T ss_dssp EE---TTEEEEEEEECCCCEEHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred cc---ccceeeeeeecccccccccccccc----cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence 32 2455667776655443 2322222 22478899999999999999999998 6 9999999999999986
Q ss_pred CC------CeEEeecccccccccccccccccCCCcccccccCccccCcccccCCCcCccccchhHHHHHHHHHhCCCCCC
Q 043932 852 DM------VSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVAPEYCMGSEASMTGDVYSFGILLLELFTGRRPTD 925 (1017)
Q Consensus 852 ~~------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 925 (1017)
++ .++++|||.|...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||.
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEH-----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC-----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cCcccccceeeEeecccccccccc-----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence 65 3899999998754321 123569999999999999999999999999999999999999997
Q ss_pred cccccCc-----cHHHHHHhhc--CchhhhhccchhhHHHHhh-----------cchhH---HHhHHhHHHHHHHHHHHH
Q 043932 926 AAFTEGL-----TLHEFAKIAL--PEKVIEIVDPLLLIEVMAN-----------NSMIQ---EDIRAKTQECLNAIIRIG 984 (1017)
Q Consensus 926 ~~~~~~~-----~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~-----------~~~~~---~~~~~~~~~~~~~l~~li 984 (1017)
....... .......... +..... .......+... ..... ..........++++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 308 (362)
T d1q8ya_ 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308 (362)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHH--HCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred CCccccccchhHHHHHHHHHhCCCCHHHhh--cccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHH
Confidence 6432110 1111111111 111000 00000000000 00000 001112345678899999
Q ss_pred hhccCCCCCCCCCHHHHHHH
Q 043932 985 VLCSMESPFERMEMRDVVAK 1004 (1017)
Q Consensus 985 ~~cl~~dP~~RPs~~evl~~ 1004 (1017)
.+|+++||.+||||+|+++|
T Consensus 309 ~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 309 SPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp GGGGCSSTTTCBCHHHHHTC
T ss_pred HHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-33 Score=309.28 Aligned_cols=259 Identities=29% Similarity=0.482 Sum_probs=239.9
Q ss_pred cceEEEecCCcccc--ccCccccccccccEEeccc-cCCCCCcchhhcccccccceeccccccccccCccccccccccee
Q 043932 374 SMIEFRIGGNQIFG--IIPSGIRNLVNLIALGMQS-NQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKL 450 (1017)
Q Consensus 374 ~L~~L~l~~N~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 450 (1017)
.+++|+|++|.+++ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..|..+..+.+|+++
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 35666666666665 3678999999999999997 89999999999999999999999999999999999999999999
Q ss_pred eccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcc
Q 043932 451 VMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQF 530 (1017)
Q Consensus 451 ~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 530 (1017)
++++|++.+.+|..+.+++.|+.+++++|++++.+|..+..+..+..++++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 9999999999999999999999999999999999999999998888899999999999999988887655 699999999
Q ss_pred cccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCCC
Q 043932 531 SGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKG 610 (1017)
Q Consensus 531 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 610 (1017)
.+.+|..+..+++|+.|++++|.+++.+| .++.+++|+.|+|++|+++|.+|..|.++++|++|||++|+|+|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999998765 68899999999999999999999999999999999999999999999988
Q ss_pred CCCCCCcccccCcccccCCcCCCCCCCC
Q 043932 611 VFSSKTKLSLQGNVKLCGGTDELHLPTC 638 (1017)
Q Consensus 611 ~~~~~~~~~~~~n~~~c~~~~~~~~~~c 638 (1017)
.+.+++.+++.||+.+||.|+ |+|
T Consensus 289 ~L~~L~~l~l~~N~~l~g~pl----p~c 312 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPL----PAC 312 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS----SCC
T ss_pred cCCCCCHHHhCCCccccCCCC----CCC
Confidence 899999999999999999886 677
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=8.4e-29 Score=279.39 Aligned_cols=164 Identities=30% Similarity=0.396 Sum_probs=94.3
Q ss_pred cccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecC
Q 043932 398 NLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNAS 477 (1017)
Q Consensus 398 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls 477 (1017)
+|+.|++++|++++. +.+..+++|+.|++++|.+++..+ +..+++|++|++++|++++.. .+..++.++.++++
T Consensus 220 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~ 293 (384)
T d2omza2 220 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELN 293 (384)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccc
Confidence 444444444444421 234445555555555555553322 455566666666666665332 24455556666665
Q ss_pred CCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCC
Q 043932 478 HNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGV 557 (1017)
Q Consensus 478 ~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 557 (1017)
+|++++ ...+..+++++.|++++|++++..| +..+++|++|+|++|+|++
T Consensus 294 ~n~l~~---------------------------~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~- 343 (384)
T d2omza2 294 ENQLED---------------------------ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD- 343 (384)
T ss_dssp SSCCSC---------------------------CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-
T ss_pred cccccc---------------------------ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-
Confidence 555541 1124455666677777777765432 6666777777777777764
Q ss_pred CCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccC
Q 043932 558 IPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHN 600 (1017)
Q Consensus 558 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 600 (1017)
++ .|+.+++|++|+|++|++++.+| +.++++|+.|+|++|
T Consensus 344 l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 344 VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 23 46677777777777777775544 667777777777766
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.3e-28 Score=277.83 Aligned_cols=358 Identities=22% Similarity=0.308 Sum_probs=190.6
Q ss_pred cccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCC
Q 043932 129 KLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNS 208 (1017)
Q Consensus 129 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 208 (1017)
...++.+.+++.++ ...+.+|++|++++|.++. + +.+..+++|++|+|++|+|++.. .++++++|++|++++|+
T Consensus 26 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~ 99 (384)
T d2omza2 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQ 99 (384)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccc
Confidence 34566666665543 2456677777777777763 2 35666777777777777776432 26666666666666666
Q ss_pred CCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCC
Q 043932 209 LGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPD 288 (1017)
Q Consensus 209 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~ 288 (1017)
+.+.. .++.+++|+.|++++|.+++..+ ......+..+....|. +....+.
T Consensus 100 i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-------------------------l~~~~~~ 150 (384)
T d2omza2 100 IADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNT-------------------------ISDISAL 150 (384)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEE-------------------------ECCCGGG
T ss_pred ccccc--ccccccccccccccccccccccc--cccccccccccccccc-------------------------ccccccc
Confidence 65432 25555555555555555543221 2222333334433333 3322111
Q ss_pred ccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhH
Q 043932 289 SLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSI 368 (1017)
Q Consensus 289 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 368 (1017)
.................+ ..+.............|.... ......+++++.+++++|.+++..|.
T Consensus 151 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~~~~l~l~~n~i~~~~~~-- 215 (384)
T d2omza2 151 SGLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKVSD--------ISVLAKLTNLESLIATNNQISDITPL-- 215 (384)
T ss_dssp TTCTTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCCCC--------CGGGGGCTTCSEEECCSSCCCCCGGG--
T ss_pred cccccccccccccccchh-----hhhcccccccccccccccccc--------ccccccccccceeeccCCccCCCCcc--
Confidence 111111111111111111 112222222222222222211 11123444555555555555433321
Q ss_pred HhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccc
Q 043932 369 ANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLA 448 (1017)
Q Consensus 369 ~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 448 (1017)
....++++|++++|+++.. ..+..+++|+.|++++|++++..+ +..+++|++|++++|++++.. .+.+++.++
T Consensus 216 -~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~ 288 (384)
T d2omza2 216 -GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALT 288 (384)
T ss_dssp -GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCS
T ss_pred -cccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccc
Confidence 1223455556666655542 345666777777777777765443 666677777777777776432 256667777
Q ss_pred eeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCC
Q 043932 449 KLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSN 528 (1017)
Q Consensus 449 ~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 528 (1017)
.++++.|++++. ..+..+++++.|++++|++++ . + .+..+++|++|+|++|
T Consensus 289 ~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~-------------------------l-~-~l~~l~~L~~L~L~~n 339 (384)
T d2omza2 289 NLELNENQLEDI--SPISNLKNLTYLTLYFNNISD-------------------------I-S-PVSSLTKLQRLFFANN 339 (384)
T ss_dssp EEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSC-------------------------C-G-GGGGCTTCCEEECCSS
T ss_pred cccccccccccc--cccchhcccCeEECCCCCCCC-------------------------C-c-ccccCCCCCEEECCCC
Confidence 777777777642 235566666666666666651 1 1 2455667777777777
Q ss_pred cccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCC
Q 043932 529 QFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSN 576 (1017)
Q Consensus 529 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 576 (1017)
+|++ ++ .|+++++|++|+|++|+|++.+| +.++++|+.|+|++|
T Consensus 340 ~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 340 KVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 7764 33 46777777777777777776544 667777777777776
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.1e-25 Score=244.52 Aligned_cols=276 Identities=22% Similarity=0.254 Sum_probs=196.1
Q ss_pred CCCceeeEEECCCCCeEEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCC
Q 043932 63 NLCQWTGVTCGHRHQRVTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIP 142 (1017)
Q Consensus 63 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 142 (1017)
.-|.|++|.|++ ++++.. |..+. +++++|+|++|+|+...+.+|.++++|++|++++|.++...|
T Consensus 8 c~c~~~~~~C~~------------~~L~~l-P~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~ 72 (305)
T d1xkua_ 8 CQCHLRVVQCSD------------LGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 72 (305)
T ss_dssp CEEETTEEECTT------------SCCCSC-CCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT
T ss_pred CEecCCEEEecC------------CCCCcc-CCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccch
Confidence 347899999964 344433 34442 568888888888874334468888888888888888886667
Q ss_pred CcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCC--CCCCcccccc
Q 043932 143 TNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLG--GKIPTTLGLL 220 (1017)
Q Consensus 143 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~l~~l 220 (1017)
..|.++++|++|++++|+++ .+|..+. ..|+.|++.+|.+.+..+..+.....++.++...|... ...+..+..+
T Consensus 73 ~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l 149 (305)
T d1xkua_ 73 GAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149 (305)
T ss_dssp TTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGC
T ss_pred hhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccc
Confidence 77888888888888888887 4554432 46778888888887666666777777777777776543 2345567777
Q ss_pred cCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceee
Q 043932 221 RNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILD 300 (1017)
Q Consensus 221 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 300 (1017)
++|+.+++++|.++ .+|..+ +++|++|++++|...+..+ ..+.+++.+++|++++|++++..+..+..+++|++|+
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~-~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~ 225 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDA-ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECT-GGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCCh-hHhhccccccccccccccccccccccccccccceeee
Confidence 77888888888776 344433 4677788888887774433 4566777788888888888777777777788888888
Q ss_pred cccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCcccc
Q 043932 301 LGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFV 361 (1017)
Q Consensus 301 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 361 (1017)
|++|+|+.+ |..|..+++|++|+|++|+|+.++...+.....+..+.+|+.|+|++|++.
T Consensus 226 L~~N~L~~l-p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 226 LNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCSSCCSSC-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccccccccc-ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 888887754 557777888888888888887776665554455566677777777777764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=5.3e-25 Score=239.18 Aligned_cols=151 Identities=17% Similarity=0.187 Sum_probs=90.5
Q ss_pred chhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcc
Q 043932 414 PDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSIT 493 (1017)
Q Consensus 414 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~ 493 (1017)
+..+..+++|+.+++++|.++ .+|..+ .++|++|++++|.+++..+..|.+++.++.|++++|+++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~----------- 208 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS----------- 208 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC-----------
T ss_pred ccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccc-----------
Confidence 344555566666666666655 334332 356666677777666666666666666666666666665
Q ss_pred cccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCcc------cccccc
Q 043932 494 TLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHS------LGFLKS 567 (1017)
Q Consensus 494 ~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------~~~l~~ 567 (1017)
+..+..+.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+.+...+ +..+.+
T Consensus 209 --------------~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~ 273 (305)
T d1xkua_ 209 --------------AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 273 (305)
T ss_dssp --------------EECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCC
T ss_pred --------------ccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCC
Confidence 122344555666667777777666 44556666777777777777766543333 345677
Q ss_pred CcEEeccCCccc--CCChhhhcccCCCc
Q 043932 568 IKVLNFSSNNLS--GQIPEFLENLSFLE 593 (1017)
Q Consensus 568 L~~L~Ls~N~l~--~~~p~~~~~l~~L~ 593 (1017)
|+.|+|++|++. ...|..|.-+....
T Consensus 274 L~~L~L~~N~~~~~~~~~~~f~~~~~~~ 301 (305)
T d1xkua_ 274 YSGVSLFSNPVQYWEIQPSTFRCVYVRA 301 (305)
T ss_dssp CSEEECCSSSSCGGGSCGGGGTTCCCGG
T ss_pred CCEEECCCCcCccCcCCHhHhcccccCc
Confidence 788888888764 34444454443333
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.8e-26 Score=244.50 Aligned_cols=251 Identities=22% Similarity=0.216 Sum_probs=183.8
Q ss_pred EEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceec-cc
Q 043932 352 ILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFL-YK 430 (1017)
Q Consensus 352 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L-~~ 430 (1017)
.++.++++++ .+|..+ ++.+++|+|++|+|+.+.+..|.++++|++|++++|++.++.+..+..+..++.+.. ..
T Consensus 15 ~v~c~~~~L~-~iP~~i---p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCCC-ccCCCC---CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 3455555555 555432 345677777777777777777777777777777777777777777777777777654 35
Q ss_pred cccccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCc
Q 043932 431 NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSL 510 (1017)
Q Consensus 431 N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~ 510 (1017)
|.++...|..|.++++|++|++++|.+....+..+..+.+|+.+++++|+++ +..
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-------------------------~i~ 145 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-------------------------ALP 145 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CCC
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc-------------------------ccC
Confidence 5666555667777777777777777777666666666777777777766665 344
Q ss_pred cccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhhcccC
Q 043932 511 PLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLS 590 (1017)
Q Consensus 511 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 590 (1017)
+..|..+++|+.|+|++|++++..+.+|.++++|+++++++|++++..|..|..+++|++||+++|++++..|..|.+++
T Consensus 146 ~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~ 225 (284)
T d1ozna_ 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred hhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccc
Confidence 55677788888999999999888888888899999999999999888888899999999999999999988888888889
Q ss_pred CCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCcC
Q 043932 591 FLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 591 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
+|++|++++|++.+..+.......+++.....+...|..|.
T Consensus 226 ~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~ 266 (284)
T d1ozna_ 226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266 (284)
T ss_dssp TCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred ccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCch
Confidence 99999999999888776533223334444444555565444
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.2e-24 Score=230.73 Aligned_cols=203 Identities=23% Similarity=0.203 Sum_probs=113.1
Q ss_pred cccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeecC
Q 043932 398 NLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNAS 477 (1017)
Q Consensus 398 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls 477 (1017)
++.+.+.+++.|+. +|+.+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|+.|+++
T Consensus 11 ~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccc
Confidence 34444555555552 333332 34555555555555444445555555555555555555 222 23445555555555
Q ss_pred CCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCC
Q 043932 478 HNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGV 557 (1017)
Q Consensus 478 ~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 557 (1017)
+|+++ ..+..+..+++|+.|++++|++.+..+..+..+.+++.|++++|.+++.
T Consensus 86 ~N~l~--------------------------~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l 139 (266)
T d1p9ag_ 86 HNQLQ--------------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139 (266)
T ss_dssp SSCCS--------------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred ccccc--------------------------ccccccccccccccccccccccceeecccccccccccccccccccccee
Confidence 55554 1233444555566666666666655555556666666666666666655
Q ss_pred CCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCcC
Q 043932 558 IPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGTD 631 (1017)
Q Consensus 558 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 631 (1017)
.+..+..+++|+.|++++|+|++..+..|..+++|++|||++|+|+..++....+.+++.+++.||||.|+|..
T Consensus 140 ~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred ccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 55556666666666666666665555556666666666666666663333333455566667777888888754
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.3e-24 Score=233.25 Aligned_cols=205 Identities=20% Similarity=0.184 Sum_probs=105.3
Q ss_pred CCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEec
Q 043932 102 FLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVG 181 (1017)
Q Consensus 102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 181 (1017)
.+++|+|++|+|+...+.+|.++++|++|++++|++.+..+..+.+++.++.++.. .
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~-----------------------~ 89 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS-----------------------D 89 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC-----------------------S
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc-----------------------c
Confidence 45555555555553333345555555555555555554444444444444444432 2
Q ss_pred cccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCcccc
Q 043932 182 KNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTL 261 (1017)
Q Consensus 182 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l 261 (1017)
.|.++...|..|.++++|++|++++|.+....+..+...++|+.+++++|+|++..+.+|..+++|++|++++|+++ .+
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~-~l 168 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SV 168 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-EE
T ss_pred ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccc-cc
Confidence 33333333444444444444444444444444444444455555555555555444444555555555555555554 34
Q ss_pred CchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcC
Q 043932 262 PFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNL 330 (1017)
Q Consensus 262 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 330 (1017)
+...|.++++|+.+++++|++++..|..|..+++|++||+++|++.+..+..|..+++|++|+|++|.+
T Consensus 169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l 237 (284)
T d1ozna_ 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCE
T ss_pred chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCC
Confidence 444455555555555555555555556666666666666666666655555555555555555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.5e-23 Score=222.10 Aligned_cols=181 Identities=23% Similarity=0.215 Sum_probs=137.9
Q ss_pred ccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCceeec
Q 043932 397 VNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNA 476 (1017)
Q Consensus 397 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l 476 (1017)
++|++|+|++|+|+++.+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++|+++ ..+..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 367777777777776666777777778888888887773 44 3567788888888888887 45667778888888888
Q ss_pred CCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCC
Q 043932 477 SHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHG 556 (1017)
Q Consensus 477 s~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 556 (1017)
++|++.+ ..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|++
T Consensus 108 ~~~~~~~-------------------------~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~ 162 (266)
T d1p9ag_ 108 SFNRLTS-------------------------LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (266)
T ss_dssp CSSCCCC-------------------------CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred cccccce-------------------------eeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence 7777762 233445667778888888888887777777888888888888888888
Q ss_pred CCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcC
Q 043932 557 VIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEV 606 (1017)
Q Consensus 557 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 606 (1017)
..++.|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++.+..
T Consensus 163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 77778888888888888888888 67777778888888888888887654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=4.3e-22 Score=199.11 Aligned_cols=164 Identities=18% Similarity=0.168 Sum_probs=120.0
Q ss_pred ccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCc------------------chHHHHHHHHHHHHhcCCCCceeee
Q 043932 707 FASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------------------GAFKSFMAECKALRNIRHRNLIKII 768 (1017)
Q Consensus 707 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~ 768 (1017)
+.++++||+|+||+||+|++. +|+.||||+++.... .......+|+..+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 356789999999999999986 788999998753210 0113345688899999999999888
Q ss_pred eeeecCCCCCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeecCCCCceE
Q 043932 769 TICSSIDSKGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848 (1017)
Q Consensus 769 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 848 (1017)
++. ..++||||++++.+.+ ++......++.|++.|++|||++ +|+||||||+|||
T Consensus 81 ~~~---------~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NIL 135 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 135 (191)
T ss_dssp EEE---------TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred Eec---------CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhee
Confidence 753 1379999998754432 33344567999999999999999 9999999999999
Q ss_pred eCCCCCeEEeecccccccccccccccccCCCcccccccCccccC------cccccCCCcCccccchhHHHHH
Q 043932 849 LDHDMVSHVGDFGLAKFLSSHQLDTASKTSSSSIGIKGTVGYVA------PEYCMGSEASMTGDVYSFGILL 914 (1017)
Q Consensus 849 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwslG~il 914 (1017)
++++ .++|+|||.|.....+... .|.. .|. ..+.|+.++|+||+.--+
T Consensus 136 v~~~-~~~liDFG~a~~~~~~~~~----------------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEVGEEGWR----------------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EETT-EEEECCCTTCEETTSTTHH----------------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred eeCC-CEEEEECCCcccCCCCCcH----------------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9865 4899999999765422110 1111 111 135688999999986543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=1.3e-19 Score=200.49 Aligned_cols=136 Identities=27% Similarity=0.330 Sum_probs=69.9
Q ss_pred EEEEEcCCCCCccccCcccCCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeeccc
Q 043932 79 VTRLDLSNQRIGGILSPYVGNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSN 158 (1017)
Q Consensus 79 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 158 (1017)
+++|||++++++. +|+. .++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .++|++|+|++
T Consensus 40 l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 40 AHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp CSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred CCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 5567777777764 3332 356677777777776 556543 35566666666665 33321 12466666666
Q ss_pred ccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccc
Q 043932 159 NKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFS 234 (1017)
Q Consensus 159 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 234 (1017)
|.++ .+|. ++.+++|++|++++|.++.. +.. ...+..+.+.++.. .....+..++.++.|++++|.+.
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~--~~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCC--SSCCCCTTCTTCCEEECCSSCCS
T ss_pred cccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhccccc--cccccccccccceeccccccccc
Confidence 6665 3342 45566666666666665522 211 23334444443333 22233444444445555444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=6.1e-19 Score=195.09 Aligned_cols=95 Identities=28% Similarity=0.369 Sum_probs=50.8
Q ss_pred ccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccCCCcccEEEEe
Q 043932 126 RLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSIT 205 (1017)
Q Consensus 126 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 205 (1017)
++++|+|++|.++ .+|+. +++|++|+|++|+|+ .+|..+ .+|++|++++|+++. +++.. +.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~lp---~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDLP---PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSCC---TTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhhc---ccccccccc
Confidence 5677777777776 56653 356677777777776 555543 356666666666652 22110 234555555
Q ss_pred cCCCCCCCCcccccccCcceeEeecCccc
Q 043932 206 GNSLGGKIPTTLGLLRNLVDLHVGGNQFS 234 (1017)
Q Consensus 206 ~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 234 (1017)
+|.+.. +|. ++.+++|++|++++|.++
T Consensus 107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp SSCCSS-CCC-CTTCTTCCEEECCSSCCS
T ss_pred cccccc-ccc-hhhhccceeecccccccc
Confidence 555442 221 334444444444444443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.3e-21 Score=225.31 Aligned_cols=384 Identities=15% Similarity=0.125 Sum_probs=185.8
Q ss_pred cccEEEEecCCCCCCC-CcccccccCcceeEeecCcccc----ccchhhcccCcCcEEeCCCccCccc----cCchhhcc
Q 043932 198 ALEVFSITGNSLGGKI-PTTLGLLRNLVDLHVGGNQFSG----TFPQSICNISSLERIYLPFNRFSGT----LPFDIVVN 268 (1017)
Q Consensus 198 ~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----l~~~~~~~ 268 (1017)
+|+.|++++|++++.. ...+..+++++.|+|++|.++. .+..++..+++|++|+|++|.|+.. +...+...
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 3445555555554321 2234445555666666665542 2334455666666666666666421 11111112
Q ss_pred CCccceeeecccccCCC----CCCccccCCccceeecccCcccceeecccc-----ccCccceEecccCcCCCCCCCChh
Q 043932 269 LPNLKSLAIGGNNFFGS----IPDSLSNASNVEILDLGFNQFKGKVSIDFS-----SLKNLSWLNLEQNNLGMGTANDLD 339 (1017)
Q Consensus 269 l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~ 339 (1017)
..+|++|+|++|++++. ++..+..+++|++|++++|++.......+. ..............+.... ...
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~--~~~ 160 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS--CEP 160 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG--HHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhh--hcc
Confidence 23577777777766543 344566677777777777777643322221 1112223333333322111 112
Q ss_pred hHhhhcccCcccEEeccCcccccccc----hhHHhhcccceEEEecCCcccccc----CccccccccccEEeccccCCCC
Q 043932 340 FVTFLTNCSSLKILSLAANQFVGELP----HSIANLSSSMIEFRIGGNQIFGII----PSGIRNLVNLIALGMQSNQLHG 411 (1017)
Q Consensus 340 ~~~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~~~~~L~~L~l~~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~~ 411 (1017)
....+.....++.++++.+......- ..+.........+.+..+.+.... ...+.....++.+++++|++..
T Consensus 161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~ 240 (460)
T d1z7xw1 161 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 240 (460)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccc
Confidence 23344556677777777776542211 112222223445555555443211 1123344555666666655432
Q ss_pred -----Ccchhhcccccccceecccccccccc----CcccccccccceeeccCcccCCCCcccc-----ccccCCceeecC
Q 043932 412 -----TIPDVIGELKNLQGLFLYKNVLQGSI----PSGVGNLTKLAKLVMSYNSLQGNIPSSL-----GNCQNLIGFNAS 477 (1017)
Q Consensus 412 -----~~~~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~i~~~~p~~~-----~~l~~L~~L~ls 477 (1017)
.....+.....++.|++++|.+.... ...+...+.++.+++++|.++......+ .....|+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~ 320 (460)
T d1z7xw1 241 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 320 (460)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred cccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccc
Confidence 11222333445555555555554221 1122334455555555555542111111 112344444444
Q ss_pred CCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCccccc----cccccc-ccccceEEeccCC
Q 043932 478 HNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGV----IPVTLS-TCVSLEYLDISSN 552 (1017)
Q Consensus 478 ~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N 552 (1017)
+|.++...... +...+...++|++|+|++|++++. ++..+. ..+.|++|+|++|
T Consensus 321 ~~~l~~~~~~~---------------------l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n 379 (460)
T d1z7xw1 321 SCSFTAACCSH---------------------FSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379 (460)
T ss_dssp TSCCBGGGHHH---------------------HHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred ccchhhhhhhh---------------------cccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCC
Confidence 44443111000 112233455677888888877642 223332 3556778888888
Q ss_pred ccCCC----CCccccccccCcEEeccCCcccCCChhhhc-----ccCCCcEEEcccCCCcC
Q 043932 553 SFHGV----IPHSLGFLKSIKVLNFSSNNLSGQIPEFLE-----NLSFLEFLNFSHNDLEG 604 (1017)
Q Consensus 553 ~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~ 604 (1017)
+|+.. +++.+..+++|++|||++|+|+......+. +...|+.|++++|.+..
T Consensus 380 ~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred CCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 77642 334455667788888888877754333331 23467778888777764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=5.5e-22 Score=228.55 Aligned_cols=403 Identities=17% Similarity=0.125 Sum_probs=211.0
Q ss_pred cceEeecccccccccC-cccccccCCccEEEeccccccC----CCCccccCCCcccEEEEecCCCCCCC----Ccccc-c
Q 043932 150 NLIQLRVSNNKLEGQI-PAEIGSLLKLQTLAVGKNYLTG----RLPDFVGNLSALEVFSITGNSLGGKI----PTTLG-L 219 (1017)
Q Consensus 150 ~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~l~-~ 219 (1017)
+|+.||+++|++++.. ...+..+++|++|+|++|.++. .++..+..+++|++|+|++|.|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4555555555555321 2233445555555555555542 22333455556666666666554211 11111 1
Q ss_pred ccCcceeEeecCccccc----cchhhcccCcCcEEeCCCccCccccCchhhc----cCCccceeeecccccCCC----CC
Q 043932 220 LRNLVDLHVGGNQFSGT----FPQSICNISSLERIYLPFNRFSGTLPFDIVV----NLPNLKSLAIGGNNFFGS----IP 287 (1017)
Q Consensus 220 l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~----~l~~L~~L~L~~n~l~~~----~p 287 (1017)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.+...-...+.. ..............+... ..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 23577777777776543 3445566677777777777765211111111 111122222222222110 01
Q ss_pred CccccCCccceeecccCcccceeecc----c-cccCccceEecccCcCCCCCCCChhhHhhhcccCcccEEeccCccccc
Q 043932 288 DSLSNASNVEILDLGFNQFKGKVSID----F-SSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVG 362 (1017)
Q Consensus 288 ~~l~~l~~L~~L~Ls~N~l~~~~~~~----~-~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 362 (1017)
..+.....++.++++++.+....... + ..-.....+++..+.+..... ......+...+.++.+++++|++..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~--~~~~~~l~~~~~~~~l~~~~n~~~~ 240 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC--RDLCGIVASKASLRELALGSNKLGD 240 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH--HHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhh--hcccccccccccccccchhhccccc
Confidence 12233456667777766654321111 1 112244556666655533221 1233445556667777777766542
Q ss_pred ccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCc----chhhcccccccceeccccccccccC
Q 043932 363 ELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTI----PDVIGELKNLQGLFLYKNVLQGSIP 438 (1017)
Q Consensus 363 ~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p 438 (1017)
..... ...........++.|++++|.+.... ...+...+.++.+++++|.++....
T Consensus 241 ~~~~~--------------------~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~ 300 (460)
T d1z7xw1 241 VGMAE--------------------LCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 300 (460)
T ss_dssp HHHHH--------------------HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred cccch--------------------hhccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 21110 11222334456677777777665322 2334556777777777777753222
Q ss_pred ccc-----ccccccceeeccCcccCCCCcc----ccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCC
Q 043932 439 SGV-----GNLTKLAKLVMSYNSLQGNIPS----SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGS 509 (1017)
Q Consensus 439 ~~~-----~~l~~L~~L~Ls~N~i~~~~p~----~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~ 509 (1017)
..+ .....|+.+++++|.++..... .+...++|++|+|++|++++.-.. .
T Consensus 301 ~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~---------------------~ 359 (460)
T d1z7xw1 301 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR---------------------E 359 (460)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH---------------------H
T ss_pred chhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccc---------------------h
Confidence 211 1235788888888888754333 234456788888888887621100 1
Q ss_pred cccccc-ccccceEEEccCCccccc----ccccccccccceEEeccCCccCCCCCccc----c-ccccCcEEeccCCccc
Q 043932 510 LPLQIG-NLKNLVKLIISSNQFSGV----IPVTLSTCVSLEYLDISSNSFHGVIPHSL----G-FLKSIKVLNFSSNNLS 579 (1017)
Q Consensus 510 ~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~ 579 (1017)
++..+. ..+.|++|+|++|.|+.. ++..+..+++|++|||++|+|+......| . +...|+.|++++|.+.
T Consensus 360 l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred hhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 122222 345688889998888742 44556677889999999998875433333 1 3347999999999988
Q ss_pred CCChhhh----cccCCCcEE
Q 043932 580 GQIPEFL----ENLSFLEFL 595 (1017)
Q Consensus 580 ~~~p~~~----~~l~~L~~L 595 (1017)
...+..+ .+.++|++|
T Consensus 440 ~~~~~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 440 EEMEDRLQALEKDKPSLRVI 459 (460)
T ss_dssp HHHHHHHHHHHHHCTTSEEE
T ss_pred HHHHHHHHHHHHhCCCCEEe
Confidence 6655544 344566554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=8.3e-19 Score=180.54 Aligned_cols=189 Identities=23% Similarity=0.309 Sum_probs=120.8
Q ss_pred cccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCce
Q 043932 394 RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIG 473 (1017)
Q Consensus 394 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 473 (1017)
..+.+|+.|++.+|.|+.. +.+..+++|++|++++|++++..| +..+++|+++++++|.++. ++ .+.++++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-cccccccccc
Confidence 4445555555555555532 235555555555555555553322 5555556666666655552 22 3455566666
Q ss_pred eecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCc
Q 043932 474 FNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNS 553 (1017)
Q Consensus 474 L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 553 (1017)
+++++|...+..+ +.. ......+.++++.+... ..+...++|+.|++++|++++.. .++++++|+.|||++|+
T Consensus 112 l~l~~~~~~~~~~--~~~-~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~ 184 (227)
T d1h6ua2 112 LDLTSTQITDVTP--LAG-LSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNK 184 (227)
T ss_dssp EECTTSCCCCCGG--GTT-CTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred cccccccccccch--hcc-ccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCc
Confidence 6666555543222 111 11223455666665533 23667888999999999987543 38889999999999999
Q ss_pred cCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEccc
Q 043932 554 FHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSH 599 (1017)
Q Consensus 554 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 599 (1017)
+++. + .|+.+++|++|+|++|++++. |. +.++++|+.|++++
T Consensus 185 l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 185 ISDI-S-PLASLPNLIEVHLKNNQISDV-SP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCCC-G-GGGGCTTCCEEECTTSCCCBC-GG-GTTCTTCCEEEEEE
T ss_pred cCCC-h-hhcCCCCCCEEECcCCcCCCC-cc-cccCCCCCEEEeeC
Confidence 9864 3 388999999999999999954 42 78999999999974
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=5.4e-19 Score=184.17 Aligned_cols=219 Identities=16% Similarity=0.132 Sum_probs=136.6
Q ss_pred cEEeccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCc-chhhcccccccceecc
Q 043932 351 KILSLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTI-PDVIGELKNLQGLFLY 429 (1017)
Q Consensus 351 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~ 429 (1017)
+.++.+++.++ .+|..+ +.++++|++++|+|+.+.+..|.++++|++|++++|.+...+ +..|.+++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l---~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCS---CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCC---CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 57778877777 666543 346777777777777766667777777777777777776533 4456777777777665
Q ss_pred c-cccccccCcccccccccceeeccCcccCCCCcc-ccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCC
Q 043932 430 K-NVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPS-SLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLN 507 (1017)
Q Consensus 430 ~-N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~ 507 (1017)
. |.+....+..|.++++|++|++++|+++...+. .+..++.+..+..+++++.
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~------------------------- 141 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH------------------------- 141 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC-------------------------
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccc-------------------------
Confidence 3 566656666677777777777777777633221 2223444444444555544
Q ss_pred CCcccccccc-ccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChhhh
Q 043932 508 GSLPLQIGNL-KNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFL 586 (1017)
Q Consensus 508 ~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 586 (1017)
...+..|..+ ..++.|++++|+++.+.+..|....-++.+++++|+++.+.++.|.++++|++|+|++|+|+...+..|
T Consensus 142 ~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~ 221 (242)
T d1xwdc1 142 TIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL 221 (242)
T ss_dssp EECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSC
T ss_pred cccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHH
Confidence 2222333333 356677777777775544444443334444567777776555667777777777777777775545556
Q ss_pred cccCCCcEEEcc
Q 043932 587 ENLSFLEFLNFS 598 (1017)
Q Consensus 587 ~~l~~L~~L~l~ 598 (1017)
.++++|+.+++.
T Consensus 222 ~~l~~L~~l~~~ 233 (242)
T d1xwdc1 222 ENLKKLRARSTY 233 (242)
T ss_dssp TTCCEEESSSEE
T ss_pred cCCcccccCcCC
Confidence 666666665553
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.1e-18 Score=181.89 Aligned_cols=201 Identities=16% Similarity=0.075 Sum_probs=95.5
Q ss_pred CCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCC-CcccCCCcceEeeccc-ccccccCcccccccCCccEE
Q 043932 101 SFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIP-TNLSRCSNLIQLRVSN-NKLEGQIPAEIGSLLKLQTL 178 (1017)
Q Consensus 101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L 178 (1017)
+++++|||++|.|+...+..|.++++|++|+|++|.+...+| ..|.+++++++|++.. |.+....+..|.++++|++|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 356666666666663333345556666666666655544332 2445555555555442 44444444455555555555
Q ss_pred EeccccccCCCCccccCCCcccEEEEecCCCCCCCCcccccccCcceeEeecCccccccchhhcccC-cCcEEeCCCccC
Q 043932 179 AVGKNYLTGRLPDFVGNLSALEVFSITGNSLGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNIS-SLERIYLPFNRF 257 (1017)
Q Consensus 179 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l 257 (1017)
++++|+++...+. ..+..++.+..+..+++++....+..|..++ .++.|++++|++
T Consensus 109 ~l~~~~l~~~~~~-----------------------~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l 165 (242)
T d1xwdc1 109 LISNTGIKHLPDV-----------------------HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165 (242)
T ss_dssp EEESCCCCSCCCC-----------------------TTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred ccchhhhcccccc-----------------------cccccccccccccccccccccccccccccccccceeeecccccc
Confidence 5555555422111 1122233333334444444433333343332 444555555555
Q ss_pred ccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEec
Q 043932 258 SGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNL 325 (1017)
Q Consensus 258 ~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 325 (1017)
+ .++...+.....++.+++++|+++...+..|.++++|++|+|++|+|+.+.+..|.++++|+.+++
T Consensus 166 ~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 166 Q-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp C-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred c-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 4 344333322222222234445555333334555555666666666555555555555555555544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.7e-18 Score=173.85 Aligned_cols=166 Identities=23% Similarity=0.356 Sum_probs=116.9
Q ss_pred ccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCcee
Q 043932 395 NLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGF 474 (1017)
Q Consensus 395 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 474 (1017)
.+.+|+.|++++|.++... .+..+++|++|+|++|++++. + .++++++|++|++++|+|++ +| .+.++++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccccccc
Confidence 4566777777777776432 366677777777777777743 2 35677777777777777773 44 46677777777
Q ss_pred ecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCcc
Q 043932 475 NASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSF 554 (1017)
Q Consensus 475 ~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 554 (1017)
++++|.+. .+ ..+..+++|+.+++++|.+++. ..+..+++|+.+++++|++
T Consensus 118 ~l~~~~~~--------------------------~~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l 168 (210)
T d1h6ta2 118 SLEHNGIS--------------------------DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 168 (210)
T ss_dssp ECTTSCCC--------------------------CC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred cccccccc--------------------------cc-cccccccccccccccccccccc--ccccccccccccccccccc
Confidence 77777665 11 2356677788888888888743 3467788888888888888
Q ss_pred CCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEccc
Q 043932 555 HGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSH 599 (1017)
Q Consensus 555 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 599 (1017)
++..+ +.++++|+.|+|++|+++. +| .+.++++|++|+|++
T Consensus 169 ~~i~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 169 SDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ccccc--ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 86432 7788888888888888874 55 478888888888864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.1e-18 Score=174.03 Aligned_cols=175 Identities=18% Similarity=0.221 Sum_probs=106.5
Q ss_pred ceeccccccccccCcccccccccceeeccCcccCC-CCccccccccCCceeecCCCcccCCccchhhhcccccceeccCC
Q 043932 425 GLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQG-NIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSN 503 (1017)
Q Consensus 425 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~ 503 (1017)
+++.++|+++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|++++|+++
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~--------------------- 67 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT--------------------- 67 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC---------------------
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc---------------------
Confidence 4455555555 4444432 456666666666654 23445566666666666666655
Q ss_pred CcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCCh
Q 043932 504 NNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIP 583 (1017)
Q Consensus 504 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 583 (1017)
+..+..|..+++|++|+|++|+|+.+.|.+|.++++|++|+|++|+|+++.|++|..+++|++|+|++|.+.+..+
T Consensus 68 ----~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 68 ----GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp ----CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ----cccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 3344556666777777777777776666677777777777777777777777777777777777777777765433
Q ss_pred hhhcccCCCcEEEcccCCCcCcCCCCCCCCCCCcccccCcccccCCc
Q 043932 584 EFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKTKLSLQGNVKLCGGT 630 (1017)
Q Consensus 584 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 630 (1017)
... -...++.+.+..|.+++..|. .+....-+++..|...|.++
T Consensus 144 ~~~-~~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 144 LAW-FAEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp GHH-HHHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCCC
T ss_pred hHH-HhhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCcCCCC
Confidence 211 112245556666777665554 24445555666676666544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=4.4e-18 Score=174.98 Aligned_cols=76 Identities=30% Similarity=0.348 Sum_probs=33.2
Q ss_pred CCccceeeecccccCCCCCCccccCCccceeecccCcccceeeccccccCccceEecccCcCCCCCCCChhhHhhhcccC
Q 043932 269 LPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCS 348 (1017)
Q Consensus 269 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~ 348 (1017)
.++|+.|++++|.+++. ..+.++++|+.|+|++|+++++. .|+.+++|++|+|++|+++... .+.+++
T Consensus 150 ~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~--------~l~~l~ 217 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS--------PLANTS 217 (227)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--------GGTTCT
T ss_pred ccccccccccccccccc--hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc--------ccccCC
Confidence 34444444444444321 12444444444444444444322 1444445555555555443221 134455
Q ss_pred cccEEecc
Q 043932 349 SLKILSLA 356 (1017)
Q Consensus 349 ~L~~L~Ls 356 (1017)
+|++|+++
T Consensus 218 ~L~~L~ls 225 (227)
T d1h6ua2 218 NLFIVTLT 225 (227)
T ss_dssp TCCEEEEE
T ss_pred CCCEEEee
Confidence 55555554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=2e-18 Score=172.21 Aligned_cols=170 Identities=22% Similarity=0.298 Sum_probs=93.6
Q ss_pred ccCCCCcccccCCCcccCCCcceEeecccccccccC-cccccccCCccEEEeccccccCCCCccccCCCcccEEEEecCC
Q 043932 130 LALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQI-PAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITGNS 208 (1017)
Q Consensus 130 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 208 (1017)
+++++++++ .+|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|.+.+..+..|..+++|++|+|++|+
T Consensus 13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 344444444 3444332 34555555555554322 3345555555566665555555555556666666666666666
Q ss_pred CCCCCCcccccccCcceeEeecCccccccchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCC
Q 043932 209 LGGKIPTTLGLLRNLVDLHVGGNQFSGTFPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPD 288 (1017)
Q Consensus 209 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~ 288 (1017)
+++..+.+|.++++|++|+|++|+|++..+.+|..+++|++|+|++|.+....+..++. ..++.+.+..+.++...|.
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~--~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCSST
T ss_pred ccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHh--hhhhhhcccCCCeEeCCCh
Confidence 65555556666666666666666666555666666666666666666665433333321 2345555566666555554
Q ss_pred ccccCCccceeecccCccc
Q 043932 289 SLSNASNVEILDLGFNQFK 307 (1017)
Q Consensus 289 ~l~~l~~L~~L~Ls~N~l~ 307 (1017)
.+ ..++.++|+.|.+.
T Consensus 168 ~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 168 KV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp TT---TTSBGGGSCTTTCC
T ss_pred hh---cCCEeeecCHhhCc
Confidence 33 34455566666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.4e-17 Score=167.18 Aligned_cols=163 Identities=34% Similarity=0.439 Sum_probs=109.5
Q ss_pred cccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCce
Q 043932 394 RNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIG 473 (1017)
Q Consensus 394 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 473 (1017)
..+.++++|++++|.++.. +.+..+++|++|++++|++++..| ++++++|++|++++|.+.. ++ .+.++++|+.
T Consensus 37 ~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~ 110 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTG 110 (199)
T ss_dssp HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccc
Confidence 3456677777777776643 236667777777777777764332 6677777777777777663 33 3666777777
Q ss_pred eecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCc
Q 043932 474 FNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNS 553 (1017)
Q Consensus 474 L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 553 (1017)
|++++|.+.. + ..+..+++|+.|++++|++.. ++ .+..+++|+.|++++|+
T Consensus 111 L~l~~~~~~~--------------------------~-~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 111 LTLFNNQITD--------------------------I-DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp EECCSSCCCC--------------------------C-GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSC
T ss_pred cccccccccc--------------------------c-cccchhhhhHHhhhhhhhhcc-cc-ccccccccccccccccc
Confidence 7776666551 1 235567778888888888764 33 47778888888888888
Q ss_pred cCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEE
Q 043932 554 FHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFL 595 (1017)
Q Consensus 554 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 595 (1017)
+++.. .|+++++|++|++++|++++ +| .+.++++|++|
T Consensus 162 l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 162 VTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 87643 37778888888888888874 44 46777777765
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=6.5e-18 Score=169.55 Aligned_cols=182 Identities=26% Similarity=0.375 Sum_probs=143.2
Q ss_pred ccccccEEeccccCCCCCcchhhcccccccceeccccccccccCcccccccccceeeccCcccCCCCccccccccCCcee
Q 043932 395 NLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVLQGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGF 474 (1017)
Q Consensus 395 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 474 (1017)
++.++..+.++.+.+++..+ ...+.++++|++++|.++. + +++..+++|++|++++|+|++..| ++++++|+.|
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L 89 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 89 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence 34455566777788776543 3467889999999999884 3 357888999999999999986433 7888889888
Q ss_pred ecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccceEEEccCCcccccccccccccccceEEeccCCcc
Q 043932 475 NASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSF 554 (1017)
Q Consensus 475 ~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 554 (1017)
++++|.+. .++ .+.++++|+.|++++|.+.... .+..+++|+.|++++|++
T Consensus 90 ~l~~n~~~--------------------------~~~-~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l 140 (199)
T d2omxa2 90 LMNNNQIA--------------------------DIT-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTI 140 (199)
T ss_dssp ECCSSCCC--------------------------CCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCC
T ss_pred cccccccc--------------------------ccc-cccccccccccccccccccccc--ccchhhhhHHhhhhhhhh
Confidence 88888776 223 3678899999999999998543 488999999999999999
Q ss_pred CCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEcccCCCcCcCCCCCCCCCCC
Q 043932 555 HGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSHNDLEGEVPTKGVFSSKT 616 (1017)
Q Consensus 555 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~ 616 (1017)
.. + +.+..+++|+.|++++|++++. + .+.++++|+.|++++|+++. ++..+.+.+++
T Consensus 141 ~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~~l~~L~~L~ 197 (199)
T d2omxa2 141 SD-I-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-ISVLAKLTNLE 197 (199)
T ss_dssp CC-C-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCS
T ss_pred cc-c-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-CccccCCCCCC
Confidence 85 3 3588999999999999999964 3 38899999999999999986 44434444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.4e-17 Score=166.78 Aligned_cols=180 Identities=27% Similarity=0.394 Sum_probs=142.5
Q ss_pred eccCcccccccchhHHhhcccceEEEecCCccccccCccccccccccEEeccccCCCCCcchhhcccccccceecccccc
Q 043932 354 SLAANQFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVNLIALGMQSNQLHGTIPDVIGELKNLQGLFLYKNVL 433 (1017)
Q Consensus 354 ~Ls~N~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 433 (1017)
.++.+.+++.++.. .+ .++++|++++|.++++. .+..+++|++|+|++|+|++..+ ++.+++|+.|++++|++
T Consensus 30 ~l~~~~~~~~~~~~--~L-~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 30 NLKKKSVTDAVTQN--EL-NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV 102 (210)
T ss_dssp HTTCSCTTSEECHH--HH-HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HhCcCccCCccCHH--Hh-cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCccc--cccCccccccccccccc
Confidence 44555555444431 11 35778888888887643 48889999999999999997543 68899999999999999
Q ss_pred ccccCcccccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCcccc
Q 043932 434 QGSIPSGVGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQ 513 (1017)
Q Consensus 434 ~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~ 513 (1017)
++ +| .+.++++|+.|++++|.+.. + ..+.++++|+.+++++|.+++ +..
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~---------------------------~~~ 151 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD---------------------------ITV 151 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC---------------------------CGG
T ss_pred cc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc---------------------------ccc
Confidence 84 55 58899999999999999873 3 357888999999999988862 123
Q ss_pred ccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccC
Q 043932 514 IGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSS 575 (1017)
Q Consensus 514 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 575 (1017)
+..+++|+.+++++|++++..+ ++++++|+.|+|++|+++. +| .|..+++|++|+|++
T Consensus 152 ~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 152 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccccccccccccccccccccc--ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 5667889999999999986533 8899999999999999985 44 589999999999974
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=4.6e-16 Score=165.15 Aligned_cols=200 Identities=14% Similarity=0.145 Sum_probs=107.9
Q ss_pred ccccCCCCcccccCCCcccCCCcceEeeccccccccc-CcccccccCCccEEEeccccccCCCCccccCCCcccEEEEec
Q 043932 128 EKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQ-IPAEIGSLLKLQTLAVGKNYLTGRLPDFVGNLSALEVFSITG 206 (1017)
Q Consensus 128 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 206 (1017)
..+.++...+...+ .......+|++|||++|.++.. ++..+.++++|++|+|++|.+++..+..++.+++|+.|++++
T Consensus 26 ~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 26 IAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp SEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred eEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 34444444444222 2233445666677766666533 233455666666666666666655555666666666666666
Q ss_pred C-CCCCCC-CcccccccCcceeEeecC-ccccc-cchhhcc-cCcCcEEeCCCc--cCccccCchhhccCCccceeeecc
Q 043932 207 N-SLGGKI-PTTLGLLRNLVDLHVGGN-QFSGT-FPQSICN-ISSLERIYLPFN--RFSGTLPFDIVVNLPNLKSLAIGG 279 (1017)
Q Consensus 207 N-~l~~~~-~~~l~~l~~L~~L~L~~n-~l~~~-~p~~l~~-l~~L~~L~Ls~N--~l~~~l~~~~~~~l~~L~~L~L~~ 279 (1017)
+ .++... ..-...+++|++|+++++ .++.. +...+.. .++|+.|+++++ .+++.--..+..++++|++|++++
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~ 184 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccc
Confidence 3 343211 112345667777777765 34321 2223333 356777777754 233222223344566777777766
Q ss_pred c-ccCCCCCCccccCCccceeecccC-cccceeeccccccCccceEecccC
Q 043932 280 N-NFFGSIPDSLSNASNVEILDLGFN-QFKGKVSIDFSSLKNLSWLNLEQN 328 (1017)
Q Consensus 280 n-~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N 328 (1017)
| .+++.....+..+++|++|++++| .+++.....++.+++|++|+++++
T Consensus 185 ~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 4 355555566666667777777663 455444444555555555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3.3e-15 Score=143.23 Aligned_cols=129 Identities=17% Similarity=0.158 Sum_probs=95.2
Q ss_pred cccccccceeeccCcccCCCCccccccccCCceeecCCCcccCCccchhhhcccccceeccCCCcCCCCccccccccccc
Q 043932 441 VGNLTKLAKLVMSYNSLQGNIPSSLGNCQNLIGFNASHNKLTGALPQQLLSITTLSVYLDLSNNNLNGSLPLQIGNLKNL 520 (1017)
Q Consensus 441 ~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~L~Ls~N~l~~~~p~~~~~l~~L 520 (1017)
|.+..+|++|+|++|+|+ .++..+..+++|+.||+++|+|+ .++ .|..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~--------------------------~l~-~~~~l~~L 65 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--------------------------KLD-GFPLLRRL 65 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC--------------------------EEC-CCCCCSSC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC--------------------------ccC-CcccCcch
Confidence 556777888888888887 44666677778888888877776 222 35677888
Q ss_pred eEEEccCCcccccccccccccccceEEeccCCccCCCCC-ccccccccCcEEeccCCcccCCC---hhhhcccCCCcEEE
Q 043932 521 VKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIP-HSLGFLKSIKVLNFSSNNLSGQI---PEFLENLSFLEFLN 596 (1017)
Q Consensus 521 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 596 (1017)
++|++++|+++...+..+..+++|+.|+|++|+++.... ..+..+++|++|++++|+++... +..+..+++|++||
T Consensus 66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 888888888886666667778888888888888875432 46788888888888888887432 23577888888877
Q ss_pred c
Q 043932 597 F 597 (1017)
Q Consensus 597 l 597 (1017)
-
T Consensus 146 ~ 146 (162)
T d1a9na_ 146 F 146 (162)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=1.6e-14 Score=131.28 Aligned_cols=87 Identities=25% Similarity=0.316 Sum_probs=39.1
Q ss_pred ccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCCh-hhhcccCCC
Q 043932 514 IGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIP-EFLENLSFL 592 (1017)
Q Consensus 514 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L 592 (1017)
+..+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|++. | .++.+++|+.|++++|+++...+ ..+..+++|
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L 92 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence 444444444444444444 2333444444444444444444432 2 24444444444444444443221 234444444
Q ss_pred cEEEcccCCCc
Q 043932 593 EFLNFSHNDLE 603 (1017)
Q Consensus 593 ~~L~l~~N~l~ 603 (1017)
+.|++++|+++
T Consensus 93 ~~L~l~~N~i~ 103 (124)
T d1dcea3 93 VLLNLQGNSLC 103 (124)
T ss_dssp CEEECTTSGGG
T ss_pred CEEECCCCcCC
Confidence 44444444444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=1.2e-14 Score=132.12 Aligned_cols=101 Identities=26% Similarity=0.382 Sum_probs=51.4
Q ss_pred CEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccc
Q 043932 104 RYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKN 183 (1017)
Q Consensus 104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 183 (1017)
|+|||++|+++ .+| .++++++|++|+|++|+|+ .+|..++.+++|++|++++|++++ +| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 45666666665 333 2555555555666555555 455555555555555555555553 22 3555555555555555
Q ss_pred cccCCC-CccccCCCcccEEEEecCCC
Q 043932 184 YLTGRL-PDFVGNLSALEVFSITGNSL 209 (1017)
Q Consensus 184 ~l~~~~-p~~~~~l~~L~~L~L~~N~l 209 (1017)
+++... ...++.+++|+.|++++|.+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcC
Confidence 554322 12344444444444444443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=7.2e-16 Score=169.21 Aligned_cols=88 Identities=17% Similarity=0.187 Sum_probs=36.6
Q ss_pred cCcceeEeecCccccc----cchhhcccCcCcEEeCCCccCccc----cCchhhccCCccceeeecccccCCC----CCC
Q 043932 221 RNLVDLHVGGNQFSGT----FPQSICNISSLERIYLPFNRFSGT----LPFDIVVNLPNLKSLAIGGNNFFGS----IPD 288 (1017)
Q Consensus 221 ~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----l~~~~~~~l~~L~~L~L~~n~l~~~----~p~ 288 (1017)
+.|+.+++++|+++.. +...+...++|++|+|++|++... +....+...++|+.|+|++|.++.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 3455555555554321 222334445555555555554321 0011123334444444444444321 222
Q ss_pred ccccCCccceeecccCcccc
Q 043932 289 SLSNASNVEILDLGFNQFKG 308 (1017)
Q Consensus 289 ~l~~l~~L~~L~Ls~N~l~~ 308 (1017)
.+...++|++|+|++|.|++
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCH
T ss_pred cccccccchhhhhhcCccCc
Confidence 33344444455555544443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=6.1e-15 Score=156.38 Aligned_cols=182 Identities=18% Similarity=0.138 Sum_probs=84.6
Q ss_pred CcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccC-cccceee-ccccccCccce
Q 043932 245 SSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFN-QFKGKVS-IDFSSLKNLSW 322 (1017)
Q Consensus 245 ~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~-~~~~~l~~L~~ 322 (1017)
.+|++|+|++|.+++.....++.++++|++|+|++|.+++..+..++.+++|++|+++++ .+++..- ..+.++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 355555555555543333334445555555555555555444455555555666665553 3332211 11233455555
Q ss_pred EecccCc-CCCCCCCChhhHhhhc-ccCcccEEeccCc--ccccccchhHHhhcccceEEEecCCccccccCcccccccc
Q 043932 323 LNLEQNN-LGMGTANDLDFVTFLT-NCSSLKILSLAAN--QFVGELPHSIANLSSSMIEFRIGGNQIFGIIPSGIRNLVN 398 (1017)
Q Consensus 323 L~L~~N~-l~~~~~~~~~~~~~l~-~l~~L~~L~Ls~N--~l~~~~p~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~ 398 (1017)
|+++++. ++.. .....+. ..+.|+.|+++++ .+++... ...+.++++
T Consensus 126 L~ls~c~~~~~~-----~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l------------------------~~l~~~~~~ 176 (284)
T d2astb2 126 LNLSWCFDFTEK-----HVQVAVAHVSETITQLNLSGYRKNLQKSDL------------------------STLVRRCPN 176 (284)
T ss_dssp EECCCCTTCCHH-----HHHHHHHHSCTTCCEEECCSCGGGSCHHHH------------------------HHHHHHCTT
T ss_pred cccccccccccc-----cchhhhcccccccchhhhcccccccccccc------------------------ccccccccc
Confidence 5555432 2110 0111111 1234555555432 1221111 112234555
Q ss_pred ccEEecccc-CCCCCcchhhcccccccceecccc-ccccccCcccccccccceeeccCc
Q 043932 399 LIALGMQSN-QLHGTIPDVIGELKNLQGLFLYKN-VLQGSIPSGVGNLTKLAKLVMSYN 455 (1017)
Q Consensus 399 L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N 455 (1017)
|++|++++| .+++.....+.++++|++|+|++| .+++.....++++++|++|+++++
T Consensus 177 L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 666666554 344445555556666666666663 455444445556666666666655
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=8.8e-15 Score=140.19 Aligned_cols=62 Identities=18% Similarity=0.195 Sum_probs=25.6
Q ss_pred CCCCCCCEEEccCCCCCCCCCcccccccccccccCCCCcccccCCCcccCCCcceEeeccccccc
Q 043932 98 GNLSFLRYINLSDNSFHGEIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLE 162 (1017)
Q Consensus 98 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 162 (1017)
.+...|++|||++|+|+ .+|..+..+++|++|+|++|+|+ .++ .+..+++|++|+|++|+++
T Consensus 15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~ 76 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC 76 (162)
T ss_dssp ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC
T ss_pred cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc
Confidence 34444444444444444 23333333444444444444444 222 2334444444444444443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.50 E-value=2.4e-15 Score=165.02 Aligned_cols=212 Identities=14% Similarity=0.131 Sum_probs=96.2
Q ss_pred CCcccccccccccccCCCCccccc----CCCcccCCCcceEeeccccccccc---CcccccccCCccEEEeccccccCCC
Q 043932 117 IPQEIGNLLRLEKLALPNNSFSGT----IPTNLSRCSNLIQLRVSNNKLEGQ---IPAEIGSLLKLQTLAVGKNYLTGRL 189 (1017)
Q Consensus 117 ~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~---~p~~~~~l~~L~~L~L~~n~l~~~~ 189 (1017)
+...+.+...|++|+|++|.++.. +...+...++|+.|+++++..... .|..+. .+
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~-----------------~l 85 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR-----------------LL 85 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH-----------------HH
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHH-----------------HH
Confidence 344455566666666666666432 223344556666666655543211 111110 01
Q ss_pred CccccCCCcccEEEEecCCCCCC----CCcccccccCcceeEeecCccccccchhh-------------cccCcCcEEeC
Q 043932 190 PDFVGNLSALEVFSITGNSLGGK----IPTTLGLLRNLVDLHVGGNQFSGTFPQSI-------------CNISSLERIYL 252 (1017)
Q Consensus 190 p~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~p~~l-------------~~l~~L~~L~L 252 (1017)
...+..+++|+.|+|++|.++.. +...+...++|++|++++|.++......+ ...+.|+.+++
T Consensus 86 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l 165 (344)
T d2ca6a1 86 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 165 (344)
T ss_dssp HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEEC
T ss_pred HHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeec
Confidence 12233444555555555555433 22233345566666666666542211111 23345556666
Q ss_pred CCccCccccCchhhccCCccceeeecccccCCCCCCccccCCccceeecccCcccce-----eeccccccCccceEeccc
Q 043932 253 PFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNASNVEILDLGFNQFKGK-----VSIDFSSLKNLSWLNLEQ 327 (1017)
Q Consensus 253 s~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~L~~ 327 (1017)
++|.+...--. .+...+...+.|+.|+|++|++... ....+...++|+.|+|++
T Consensus 166 ~~n~i~~~~~~---------------------~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~ 224 (344)
T d2ca6a1 166 GRNRLENGSMK---------------------EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 224 (344)
T ss_dssp CSSCCTGGGHH---------------------HHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCS
T ss_pred ccccccccccc---------------------cccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccc
Confidence 65555311110 0111223334455555555544321 122344455555555555
Q ss_pred CcCCCCCCCChhhHhhhcccCcccEEeccCcccccccchhH
Q 043932 328 NNLGMGTANDLDFVTFLTNCSSLKILSLAANQFVGELPHSI 368 (1017)
Q Consensus 328 N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 368 (1017)
|.++..+.. .....+..+++|++|+|++|.+.+.....+
T Consensus 225 N~i~~~g~~--~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l 263 (344)
T d2ca6a1 225 NTFTHLGSS--ALAIALKSWPNLRELGLNDCLLSARGAAAV 263 (344)
T ss_dssp SCCHHHHHH--HHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred ccccccccc--cccccccccccchhhhhhcCccCchhhHHH
Confidence 554322211 223445566666666666666654433333
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.41 E-value=4.4e-15 Score=147.64 Aligned_cols=77 Identities=26% Similarity=0.298 Sum_probs=37.6
Q ss_pred ccceEEEccCCcccccccccccccccceEEeccCCccCCCCC-ccccccccCcEEeccCCcccCCChh----------hh
Q 043932 518 KNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIP-HSLGFLKSIKVLNFSSNNLSGQIPE----------FL 586 (1017)
Q Consensus 518 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----------~~ 586 (1017)
++|+.|++++|+++.. + .+..+++|+.|+|++|+++.... ..|..+++|+.|+|++|++....+. .+
T Consensus 93 ~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi 170 (198)
T d1m9la_ 93 DTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV 170 (198)
T ss_dssp HHCCEEECSEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHH
T ss_pred cccccccccccccccc-c-cccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHH
Confidence 3445555555555432 1 24445555555555555543211 2345555555555555555432221 14
Q ss_pred cccCCCcEEE
Q 043932 587 ENLSFLEFLN 596 (1017)
Q Consensus 587 ~~l~~L~~L~ 596 (1017)
..+++|+.||
T Consensus 171 ~~lp~L~~LD 180 (198)
T d1m9la_ 171 KRLPNLKKLD 180 (198)
T ss_dssp HHCSSCCEES
T ss_pred HHCCCcCEeC
Confidence 5566676665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.39 E-value=1e-14 Score=144.92 Aligned_cols=114 Identities=24% Similarity=0.278 Sum_probs=62.1
Q ss_pred CCCcccccccccccccCCCCcccccCCCcccCCCcceEeecccccccccCcccccccCCccEEEeccccccCCCCccccC
Q 043932 116 EIPQEIGNLLRLEKLALPNNSFSGTIPTNLSRCSNLIQLRVSNNKLEGQIPAEIGSLLKLQTLAVGKNYLTGRLPDFVGN 195 (1017)
Q Consensus 116 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 195 (1017)
.+|.++..+++|++|+|++|+|+ .++ .+..+++|++|+|++|+++ .+|..+..+++|++|++++|+++.. +.+.+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence 34555666666666666666665 343 3556666666666666665 3444444445566666666665532 23455
Q ss_pred CCcccEEEEecCCCCCCCC-cccccccCcceeEeecCccc
Q 043932 196 LSALEVFSITGNSLGGKIP-TTLGLLRNLVDLHVGGNQFS 234 (1017)
Q Consensus 196 l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~ 234 (1017)
+++|+.|++++|+++.... ..+..+++|++|+|++|.++
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 5555555555555543211 34555555555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=5.9e-13 Score=126.32 Aligned_cols=107 Identities=21% Similarity=0.156 Sum_probs=74.3
Q ss_pred eeccCCCcCCCCccccccccccceEEEccCC-cccccccccccccccceEEeccCCccCCCCCccccccccCcEEeccCC
Q 043932 498 YLDLSNNNLNGSLPLQIGNLKNLVKLIISSN-QFSGVIPVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSN 576 (1017)
Q Consensus 498 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 576 (1017)
.++.+++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+++.|++|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 4667777776 45666777777777777655 477666667777777777777777777777777777777777777777
Q ss_pred cccCCChhhhcccCCCcEEEcccCCCcCcC
Q 043932 577 NLSGQIPEFLENLSFLEFLNFSHNDLEGEV 606 (1017)
Q Consensus 577 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 606 (1017)
+|+...+..+. ..+|+.|+|++|++....
T Consensus 91 ~l~~l~~~~~~-~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 91 ALESLSWKTVQ-GLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CCSCCCSTTTC-SCCCCEEECCSSCCCCCG
T ss_pred CCcccChhhhc-cccccccccCCCcccCCc
Confidence 77743333343 335777777777775433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=8.6e-13 Score=125.16 Aligned_cols=108 Identities=21% Similarity=0.107 Sum_probs=50.4
Q ss_pred eEEEccCCcccccccccccccccceEEeccCC-ccCCCCCccccccccCcEEeccCCcccCCChhhhcccCCCcEEEccc
Q 043932 521 VKLIISSNQFSGVIPVTLSTCVSLEYLDISSN-SFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPEFLENLSFLEFLNFSH 599 (1017)
Q Consensus 521 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 599 (1017)
..++.+++.+. ..|..+.++++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.|..|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34444444444 23444444455555555433 24444444455555555555555555544444455555555555555
Q ss_pred CCCcCcCCCCCCCCCCCcccccCcccccCC
Q 043932 600 NDLEGEVPTKGVFSSKTKLSLQGNVKLCGG 629 (1017)
Q Consensus 600 N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 629 (1017)
|+|+...+......++..+++.||||.|+|
T Consensus 90 N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 90 NALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCCcccChhhhccccccccccCCCcccCCc
Confidence 555533333222223444555555555443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=2.5e-09 Score=101.58 Aligned_cols=82 Identities=20% Similarity=0.196 Sum_probs=47.4
Q ss_pred cccccceEEEccCCcccccc--cccccccccceEEeccCCccCCCCCccccccccCcEEeccCCcccCCChh-------h
Q 043932 515 GNLKNLVKLIISSNQFSGVI--PVTLSTCVSLEYLDISSNSFHGVIPHSLGFLKSIKVLNFSSNNLSGQIPE-------F 585 (1017)
Q Consensus 515 ~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~ 585 (1017)
..+++|++|+||+|+|+.+. +..+..+++|+.|||++|+++...+-.+....+|+.|+|++|++++.... .
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 44566666666666666432 23455666666777777766654333333444566777777776654332 2
Q ss_pred hcccCCCcEEE
Q 043932 586 LENLSFLEFLN 596 (1017)
Q Consensus 586 ~~~l~~L~~L~ 596 (1017)
+..+|+|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 45567777665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=3.5e-09 Score=100.50 Aligned_cols=59 Identities=19% Similarity=0.155 Sum_probs=32.9
Q ss_pred ccccccceEEEccCCcccccccccccccccceEEeccCCccCCCCCc-------cccccccCcEEe
Q 043932 514 IGNLKNLVKLIISSNQFSGVIPVTLSTCVSLEYLDISSNSFHGVIPH-------SLGFLKSIKVLN 572 (1017)
Q Consensus 514 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~ 572 (1017)
+..+++|+.|+|++|+|+...+-.+.+...|+.|+|++|.++..... .+..+|+|+.||
T Consensus 87 ~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred HhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 44555666666666666643332333344566666666666654432 245667777765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.38 E-value=8.9e-07 Score=91.25 Aligned_cols=149 Identities=18% Similarity=0.160 Sum_probs=103.7
Q ss_pred HHHHHhhccccccCcccccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCC
Q 043932 698 AELSKATSEFASSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDS 776 (1017)
Q Consensus 698 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 776 (1017)
.++.+....|+..+..+.++.+.||++.. ++..+++|+...........+.+|...++.+. +--+.+++.+....
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-- 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-- 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--
Confidence 35666677888777655555678999875 45557888876554444456778888888774 44456677665433
Q ss_pred CCCceeEEEEEeccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC-----------------------
Q 043932 777 KGADFKALVFECMKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC----------------------- 833 (1017)
Q Consensus 777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------- 833 (1017)
+..++||++++|.++.+...... ....++.++++.++.||+..
T Consensus 83 ---~~~~lv~~~l~G~~~~~~~~~~~-----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 83 ---GWSNLLMSEADGVLCSEEYEDEQ-----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp ---TEEEEEEECCSSEEHHHHTTTCS-----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred ---CceEEEEEecccccccccccccc-----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 56789999999988876543211 12335667777777777532
Q ss_pred ---------------------------------CCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 834 ---------------------------------QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 834 ---------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
++.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0237899999999999987777799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.64 E-value=6.7e-05 Score=76.17 Aligned_cols=130 Identities=15% Similarity=0.104 Sum_probs=82.7
Q ss_pred cccccCC-ceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcC--CCCceeeeeeeecCCCCCCceeEEEEEe
Q 043932 712 MIGQGSF-GSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIR--HRNLIKIITICSSIDSKGADFKALVFEC 788 (1017)
Q Consensus 712 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~ 788 (1017)
.+..|.. +.||+.... ++..+++|....... ..+..|+..++.+. .-.+.+++++.... +..++||++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-----~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccc-----cceEEEEEe
Confidence 3455554 678999875 566688898654332 34667888887773 33356667665433 567899999
Q ss_pred ccCCCHHHHHhhCCCCccccccCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 043932 789 MKNGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC----------------------------------- 833 (1017)
Q Consensus 789 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------------- 833 (1017)
++|.++.+. .... ...+.++++.++-||+..
T Consensus 88 i~G~~~~~~-----------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 88 VPGQDLLSS-----------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp CSSEETTTS-----------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred eeccccccc-----------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence 988654321 0111 112334444444444321
Q ss_pred --------------------CCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 834 --------------------QPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 834 --------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
++.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1247999999999999987777899999765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.56 E-value=1.1e-05 Score=76.06 Aligned_cols=15 Identities=33% Similarity=0.366 Sum_probs=6.7
Q ss_pred hcccCcCcEEeCCCc
Q 043932 241 ICNISSLERIYLPFN 255 (1017)
Q Consensus 241 l~~l~~L~~L~Ls~N 255 (1017)
+...++|+.|+++.+
T Consensus 127 L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 127 IEENESLLRVGISFA 141 (167)
T ss_dssp HHHCSSCCEEECCCC
T ss_pred HHhCCCccEeeCcCC
Confidence 333444455544443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.49 E-value=3.2e-05 Score=72.79 Aligned_cols=18 Identities=22% Similarity=0.495 Sum_probs=9.3
Q ss_pred hcccCcccEEeccCcccc
Q 043932 344 LTNCSSLKILSLAANQFV 361 (1017)
Q Consensus 344 l~~l~~L~~L~Ls~N~l~ 361 (1017)
+...+.|+.|+|++|.+.
T Consensus 68 L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 68 IETSPSLRVLNVESNFLT 85 (167)
T ss_dssp HHHCSSCCEEECCSSBCC
T ss_pred hhhcccccceeeehhhcc
Confidence 344455555555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.47 E-value=0.00013 Score=79.14 Aligned_cols=76 Identities=16% Similarity=0.135 Sum_probs=48.6
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEEeeecC-------cchHHHHHHHHHHHHhc-CC--CCceeeeeeeecCCCCCCc
Q 043932 711 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-------KGAFKSFMAECKALRNI-RH--RNLIKIITICSSIDSKGAD 780 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l-~h--~niv~~~~~~~~~~~~~~~ 780 (1017)
+.||.|....||++....+++.|+||...... +....+...|++.++.+ .+ ..+.+++.+.. +
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-------~ 104 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------E 104 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------T
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------C
Confidence 46899999999999988778889999754211 12234566788888776 22 34556665432 2
Q ss_pred eeEEEEEeccCCC
Q 043932 781 FKALVFECMKNGS 793 (1017)
Q Consensus 781 ~~~lv~e~~~~gs 793 (1017)
..++|||++++..
T Consensus 105 ~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 MAVTVMEDLSHLK 117 (392)
T ss_dssp TTEEEECCCTTSE
T ss_pred CCEEEEeccCCcc
Confidence 3479999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.00036 Score=73.36 Aligned_cols=142 Identities=14% Similarity=0.123 Sum_probs=76.3
Q ss_pred ceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCC--ceeeeeeeecCCCCCCceeEEEEEeccCCCH--
Q 043932 719 GSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRN--LIKIITICSSIDSKGADFKALVFECMKNGSL-- 794 (1017)
Q Consensus 719 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL-- 794 (1017)
-.||+++.. +|+.|++|+.+.... ..+++..|.+.+..+.... ++..+...........+..+.|+++++|..+
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 589999985 788899999864432 3466788998888874222 2222221111111123567889999876422
Q ss_pred ---HHHH---------hh---CCCCccccccCHH----------------------HHHHHHHHHHHHHHHHh-hCCCCC
Q 043932 795 ---EDWL---------HQ---SNDHLEVCKLTLI----------------------QRVNIAIDVASAIEYLH-HHCQPP 836 (1017)
Q Consensus 795 ---~~~l---------~~---~~~~~~~~~l~~~----------------------~~~~i~~qi~~~L~~LH-~~~~~~ 836 (1017)
..+. +. ..........+.. .....+.++...+.-.- +..+.+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1111 00 0000011111111 11222233333332221 222457
Q ss_pred ceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 837 MVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 837 ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
+||+|+.+.||+++++ ..++||+-+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999743 4589999876
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.89 E-value=0.00011 Score=69.00 Aligned_cols=119 Identities=13% Similarity=0.170 Sum_probs=56.7
Q ss_pred cccCcceeEeec-Cccccc----cchhhcccCcCcEEeCCCccCccccCchhhccCCccceeeecccccCCCCCCccccC
Q 043932 219 LLRNLVDLHVGG-NQFSGT----FPQSICNISSLERIYLPFNRFSGTLPFDIVVNLPNLKSLAIGGNNFFGSIPDSLSNA 293 (1017)
Q Consensus 219 ~l~~L~~L~L~~-n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 293 (1017)
+.++|++|+|++ +.++.. +-.++...++|++|+|++|.+....... +...+...
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~---------------------L~~~l~~~ 73 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA---------------------LAEMLKVN 73 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH---------------------HHHHHHHC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHH---------------------HHHHHhhc
Confidence 345666666665 334322 2233344555666666666554211111 11223334
Q ss_pred CccceeecccCcccceee----ccccccCccceEec--ccCcCCCCCCCChhhHhhhcccCcccEEeccCccc
Q 043932 294 SNVEILDLGFNQFKGKVS----IDFSSLKNLSWLNL--EQNNLGMGTANDLDFVTFLTNCSSLKILSLAANQF 360 (1017)
Q Consensus 294 ~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L--~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 360 (1017)
+.++.+++++|.+..... ..+...++|+.++| ++|.++..+. ......+...+.|+.|+++.+..
T Consensus 74 ~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~--~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 74 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE--MEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH--HHHHHHHHHCSSCCEEECCCSSH
T ss_pred ccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH--HHHHHHHHhCCCcCEEeCcCCCC
Confidence 455555555555543322 23444555655444 3444432222 23445566677777777766653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.89 E-value=7.6e-05 Score=70.08 Aligned_cols=20 Identities=15% Similarity=0.127 Sum_probs=10.2
Q ss_pred hhhcccCcccEEeccCcccc
Q 043932 342 TFLTNCSSLKILSLAANQFV 361 (1017)
Q Consensus 342 ~~l~~l~~L~~L~Ls~N~l~ 361 (1017)
..+..+++|+.|++++|.+.
T Consensus 40 ~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 40 EALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HHHTTCCSCCEEECTTSCCC
T ss_pred HHHhcCCccCeeeccCCccc
Confidence 33444555555555555544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.21 E-value=0.0062 Score=65.46 Aligned_cols=73 Identities=18% Similarity=0.126 Sum_probs=49.0
Q ss_pred CcccccCCceEEEEEeCC-------CcEEEEEEEeeecCcchHHHHHHHHHHHHhcC-CCCceeeeeeeecCCCCCCcee
Q 043932 711 NMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQKGAFKSFMAECKALRNIR-HRNLIKIITICSSIDSKGADFK 782 (1017)
Q Consensus 711 ~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 782 (1017)
+.|+.|-.-.+|++.... ..+.|.+++.. .... .....+|..+++.+. +.-..++++++..
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~--------- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG--------- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT---------
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC---------
Confidence 568888888999998753 23557777765 2222 334568999988884 4334567776532
Q ss_pred EEEEEeccCCCH
Q 043932 783 ALVFECMKNGSL 794 (1017)
Q Consensus 783 ~lv~e~~~~gsL 794 (1017)
.+|+||++|.++
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 589999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.10 E-value=0.0066 Score=63.01 Aligned_cols=167 Identities=10% Similarity=0.007 Sum_probs=84.0
Q ss_pred CcCHHHHHHhhccccccCcc-----cccCCceEEEEEeCCCcEEEEEEEeeecCcchHHHHHHHHHHHHhcCCCC--cee
Q 043932 694 TVSYAELSKATSEFASSNMI-----GQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFKSFMAECKALRNIRHRN--LIK 766 (1017)
Q Consensus 694 ~~~~~~~~~~~~~y~~~~~l-----g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 766 (1017)
.++.+|+.....+|.+++.. ..|.--+.|+++.. +| .+++|++.... ..+.+..|++++..+.... +..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccc
Confidence 35677888888889876544 45666789999875 34 48999986432 2244556777777764222 222
Q ss_pred eeeeeecCC-CCCCceeEEEEEeccCCCHH-----H------H---Hhh---CCCCccccc------------------c
Q 043932 767 IITICSSID-SKGADFKALVFECMKNGSLE-----D------W---LHQ---SNDHLEVCK------------------L 810 (1017)
Q Consensus 767 ~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~-----~------~---l~~---~~~~~~~~~------------------l 810 (1017)
.+....... ..-....+.++.+..+.... . . ++. ......... .
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 211100000 00013345666666553221 0 0 000 000000000 0
Q ss_pred CHHHHHHHHHHHHHHHHHHhh-CCCCCceeecCCCCceEeCCCCCeEEeeccccc
Q 043932 811 TLIQRVNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVSHVGDFGLAK 864 (1017)
Q Consensus 811 ~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 864 (1017)
........+..+...+...+. ..+.|+||+|+.++||+++.+...-++||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111122222222222222 124589999999999999988877899999875
|